drugbank_target|P08709	-	466	sp|O97302|RH5IP_PL	-	1086	8.4e-32	108.3	14.7	1	1	1.3e-34	1.2e-31	107.8	14.7	627	746	96	214	72	223	0.93	Coagulation factor VII (DB00036; DB00100; DB04590; DB04593; DB04606; DB04758; DB04767; DB06552; DB07207; DB07247; DB07376; DB08232; DB09332; DB13151; DB13152; DB13933)
drugbank_target|P00740	-	461	sp|O97302|RH5IP_PL	-	1086	4.5e-31	105.9	15.5	1	1	8.3e-34	7.3e-31	105.2	15.5	629	738	85	190	76	197	0.95	Coagulation factor IX (DB00025; DB00170; DB05131; DB09109; DB09332; DB13150; DB13192; DB13923; DB13998; DB13999; DB14738)
drugbank_target|P00742	-	488	sp|O97302|RH5IP_PL	-	1086	9.5e-14	48.5	14.6	1	1	1.7e-16	1.5e-13	47.9	14.6	628	736	77	182	70	193	0.87	Coagulation factor X (DB00025; DB00036; DB00100; DB00569; DB01109; DB01225; DB03847; DB04673; DB05362; DB05713; DB06228; DB06245; DB06406; DB06552; DB06605; DB06635; DB06920; DB07211; DB07261; DB07277; DB07278; DB07605; DB07629; DB07630; DB07800; DB07804; DB07843; DB07844; DB07847; DB07848; DB07872; DB07875; DB07973; DB07974; DB08143; DB08173; DB08174; DB08426; DB08487; DB08488; DB08495; DB08745; DB08746; DB09075; DB09109; DB09141; DB09258; DB09332; DB11166; DB12364; DB12598; DB13149; DB13150; DB13151; DB13152; DB13192; DB13884; DB13923; DB13933; DB13998; DB13999; DB14738)
drugbank_target|O14594	-	1321	sp|O97302|RH5IP_PL	-	1086	1.7e-07	27.8	7.0	1	2	0.0019	1.7	4.6	9.0	638	679	1009	1048	1005	1050	0.88	Neurocan core protein (DB02379; DB04396; DB08818)
drugbank_target|O14594	-	1321	sp|O97302|RH5IP_PL	-	1086	1.7e-07	27.8	7.0	2	2	1.9e-10	1.7e-07	27.8	7.0	637	691	1048	1099	1046	1113	0.84	Neurocan core protein (DB02379; DB04396; DB08818)
drugbank_target|P13611	-	3396	sp|O97302|RH5IP_PL	-	1086	3.1e-05	20.3	18.9	1	2	2.9e-05	0.025	10.7	6.1	639	679	3091	3129	3079	3133	0.86	Versican core protein (DB08818)
drugbank_target|P13611	-	3396	sp|O97302|RH5IP_PL	-	1086	3.1e-05	20.3	18.9	2	2	2e-06	0.0017	14.5	7.1	640	695	3130	3184	3127	3201	0.81	Versican core protein (DB08818)
drugbank_target|Q9ULB1	-	1477	sp|O97302|RH5IP_PL	-	1086	1.9	4.4	22.3	1	3	0.88	7.7e+02	-4.2	2.5	670	708	213	251	210	264	0.73	Neurexin-1 (DB11093; DB11348; DB14481)
drugbank_target|Q9ULB1	-	1477	sp|O97302|RH5IP_PL	-	1086	1.9	4.4	22.3	2	3	9e-06	0.0079	12.3	4.1	638	680	679	718	669	729	0.86	Neurexin-1 (DB11093; DB11348; DB14481)
drugbank_target|Q9ULB1	-	1477	sp|O97302|RH5IP_PL	-	1086	1.9	4.4	22.3	3	3	0.00084	0.74	5.8	1.0	639	684	1085	1129	1079	1164	0.80	Neurexin-1 (DB11093; DB11348; DB14481)
drugbank_target|P21890	-	440	sp|C6KT68|FENR_PLA	-	371	8.2e-115	382.0	0.3	1	2	5.4e-45	1.5e-42	144.2	1.7	43	123	128	211	125	213	0.98	Ferredoxin--NADP reductase (DB03147; DB03461)
drugbank_target|P21890	-	440	sp|C6KT68|FENR_PLA	-	371	8.2e-115	382.0	0.3	2	2	2.5e-73	6.8e-71	237.4	0.0	151	371	209	440	209	440	0.97	Ferredoxin--NADP reductase (DB03147; DB03461)
drugbank_target|P58558	-	440	sp|C6KT68|FENR_PLA	-	371	8.7e-115	381.9	0.3	1	2	5.4e-45	1.5e-42	144.2	1.7	43	123	128	211	125	213	0.98	Ferredoxin--NADP reductase (DB03147; DB03461)
drugbank_target|P58558	-	440	sp|C6KT68|FENR_PLA	-	371	8.7e-115	381.9	0.3	2	2	2.6e-73	7.3e-71	237.3	0.0	151	371	209	440	209	440	0.97	Ferredoxin--NADP reductase (DB03147; DB03461)
drugbank_target|P14779	-	1049	sp|C6KT68|FENR_PLA	-	371	7.6e-73	243.9	0.0	1	2	7.5e-25	2.1e-22	77.9	0.0	45	117	637	709	624	716	0.84	Bifunctional cytochrome P450/NADPH--P450 reductase (DB03440; DB04257; DB08086)
drugbank_target|P14779	-	1049	sp|C6KT68|FENR_PLA	-	371	7.6e-73	243.9	0.0	2	2	7e-51	1.9e-48	163.6	0.0	154	355	826	1017	818	1032	0.89	Bifunctional cytochrome P450/NADPH--P450 reductase (DB03440; DB04257; DB08086)
drugbank_target|P35228	-	1153	sp|C6KT68|FENR_PLA	-	371	6e-58	194.9	0.0	1	2	0.002	0.55	7.4	0.0	68	115	730	779	723	782	0.88	Nitric oxide synthase, inducible (DB00125; DB00155; DB01017; DB01110; DB01234; DB01686; DB01835; DB01997; DB02044; DB02207; DB02234; DB02462; DB02644; DB03100; DB03144; DB03366; DB03449; DB03953; DB04400; DB04534; DB05214; DB05252; DB05383; DB06879; DB06916; DB07002; DB07003; DB07007; DB07008; DB07011; DB07029; DB07306; DB07318; DB07388; DB07389; DB07405; DB08214; DB08750; DB08814; DB09237; DB11327; DB14649)
drugbank_target|P35228	-	1153	sp|C6KT68|FENR_PLA	-	371	6e-58	194.9	0.0	2	2	1.8e-57	4.9e-55	185.3	0.0	154	370	904	1127	893	1128	0.88	Nitric oxide synthase, inducible (DB00125; DB00155; DB01017; DB01110; DB01234; DB01686; DB01835; DB01997; DB02044; DB02207; DB02234; DB02462; DB02644; DB03100; DB03144; DB03366; DB03449; DB03953; DB04400; DB04534; DB05214; DB05252; DB05383; DB06879; DB06916; DB07002; DB07003; DB07007; DB07008; DB07011; DB07029; DB07306; DB07318; DB07388; DB07389; DB07405; DB08214; DB08750; DB08814; DB09237; DB11327; DB14649)
drugbank_target|P29475	-	1434	sp|C6KT68|FENR_PLA	-	371	5.3e-56	188.4	0.0	1	2	7.8e-06	0.0022	15.3	0.0	44	117	969	1046	944	1064	0.73	Nitric oxide synthase, brain (DB00155; DB00843; DB01221; DB01821; DB01942; DB01997; DB02027; DB02044; DB02077; DB02143; DB02644; DB02727; DB02991; DB03144; DB03147; DB03247; DB03449; DB03461; DB03707; DB03710; DB03892; DB04223; DB06096; DB08018; DB08019; DB09241)
drugbank_target|P29475	-	1434	sp|C6KT68|FENR_PLA	-	371	5.3e-56	188.4	0.0	2	2	7.4e-53	2.1e-50	170.1	0.0	153	354	1175	1369	1166	1382	0.89	Nitric oxide synthase, brain (DB00155; DB00843; DB01221; DB01821; DB01942; DB01997; DB02027; DB02044; DB02077; DB02143; DB02644; DB02727; DB02991; DB03144; DB03147; DB03247; DB03449; DB03461; DB03707; DB03710; DB03892; DB04223; DB06096; DB08018; DB08019; DB09241)
drugbank_target|P29474	-	1203	sp|C6KT68|FENR_PLA	-	371	4e-52	175.7	0.0	1	2	0.00087	0.24	8.6	0.0	71	115	759	805	751	807	0.87	Nitric oxide synthase, endothelial (DB00125; DB00155; DB00360; DB01110; DB01686; DB01821; DB01833; DB01997; DB02027; DB02044; DB02048; DB02077; DB02141; DB02207; DB02234; DB02335; DB02589; DB02911; DB02979; DB02994; DB03065; DB03100; DB03144; DB03305; DB03332; DB03707; DB03910; DB03918; DB03963; DB03974; DB04018; DB04223; DB04534; DB04559; DB07001; DB07244; DB07388; DB08018; DB08019; DB09237)
drugbank_target|P29474	-	1203	sp|C6KT68|FENR_PLA	-	371	4e-52	175.7	0.0	2	2	3.9e-51	1.1e-48	164.4	0.0	154	353	936	1128	928	1144	0.91	Nitric oxide synthase, endothelial (DB00125; DB00155; DB00360; DB01110; DB01686; DB01821; DB01833; DB01997; DB02027; DB02044; DB02048; DB02077; DB02141; DB02207; DB02234; DB02335; DB02589; DB02911; DB02979; DB02994; DB03065; DB03100; DB03144; DB03305; DB03332; DB03707; DB03910; DB03918; DB03963; DB03974; DB04018; DB04223; DB04534; DB04559; DB07001; DB07244; DB07388; DB08018; DB08019; DB09237)
drugbank_target|P16435	-	677	sp|C6KT68|FENR_PLA	-	371	2.4e-51	173.1	0.0	1	2	4.4e-05	0.012	12.9	0.0	66	116	277	327	246	355	0.86	NADPH--cytochrome P450 reductase (DB03147; DB03247; DB03461)
drugbank_target|P16435	-	677	sp|C6KT68|FENR_PLA	-	371	2.4e-51	173.1	0.0	2	2	3.4e-49	9.4e-47	158.0	0.0	152	352	450	643	442	666	0.88	NADPH--cytochrome P450 reductase (DB03147; DB03247; DB03461)
drugbank_target|P38038	-	599	sp|C6KT68|FENR_PLA	-	371	3.3e-51	172.6	0.0	1	2	8.3e-06	0.0023	15.2	0.0	65	111	231	278	222	284	0.91	Sulfite reductase [NADPH] flavoprotein alpha-component (DB03147; DB03461)
drugbank_target|P38038	-	599	sp|C6KT68|FENR_PLA	-	371	3.3e-51	172.6	0.0	2	2	2.3e-48	6.5e-46	155.2	0.0	145	353	375	567	366	590	0.93	Sulfite reductase [NADPH] flavoprotein alpha-component (DB03147; DB03461)
drugbank_target|Q9UBK8	-	725	sp|C6KT68|FENR_PLA	-	371	2.3e-48	163.3	0.0	1	2	0.044	12	3.0	0.0	78	119	308	350	287	363	0.85	Methionine synthase reductase (DB00115; DB00134)
drugbank_target|Q9UBK8	-	725	sp|C6KT68|FENR_PLA	-	371	2.3e-48	163.3	0.0	2	2	3.5e-49	9.7e-47	158.0	0.0	145	353	468	692	465	709	0.88	Methionine synthase reductase (DB00115; DB00134)
drugbank_target|P28861	-	248	sp|C6KT68|FENR_PLA	-	371	2.2e-37	127.2	0.0	1	1	1e-39	2.8e-37	126.8	0.0	188	365	70	238	48	244	0.93	Ferredoxin--NADP reductase (DB03147)
drugbank_target|P00387	-	301	sp|C6KT68|FENR_PLA	-	371	6.3e-32	109.2	0.0	1	1	2.8e-34	7.8e-32	108.9	0.0	149	321	85	260	76	284	0.87	NADH-cytochrome b5 reductase 3 (DB00157; DB03147; DB09130)
drugbank_target|P07771	-	348	sp|C6KT68|FENR_PLA	-	371	5.4e-31	106.1	0.0	1	1	2.9e-33	7.9e-31	105.6	0.0	188	354	186	332	177	339	0.93	Benzoate 1,2-dioxygenase electron transfer component (DB03147)
drugbank_target|Q9UHQ9	-	305	sp|C6KT68|FENR_PLA	-	371	1.8e-28	97.8	0.0	1	1	8.5e-31	2.3e-28	97.5	0.0	149	320	89	263	70	291	0.82	NADH-cytochrome b5 reductase 1 (DB03147)
drugbank_target|Q9L6V3	-	272	sp|C6KT68|FENR_PLA	-	371	1.8e-28	97.8	0.0	1	1	9.2e-31	2.6e-28	97.4	0.0	187	354	83	247	60	261	0.94	NADPH:ferredoxin reductase (DB04450)
drugbank_target|P39662	-	403	sp|C6KT68|FENR_PLA	-	371	2.9e-28	97.2	0.0	1	1	1.5e-30	4.1e-28	96.7	0.0	179	355	222	384	201	396	0.88	Flavohemoprotein (DB03147; DB03979)
drugbank_target|P24232	-	396	sp|C6KT68|FENR_PLA	-	371	4.7e-27	93.2	0.0	1	1	2.6e-29	7.1e-27	92.6	0.0	186	352	222	375	215	387	0.91	Flavohemoprotein (DB03147)
drugbank_target|Q44532	-	258	sp|C6KT68|FENR_PLA	-	371	1.4e-26	91.6	0.0	1	1	8.4e-29	2.3e-26	90.9	0.0	185	353	68	233	45	240	0.86	Ferredoxin--NADP reductase (DB03147)
drugbank_target|P04839	-	570	sp|C6KT68|FENR_PLA	-	371	9.6e-13	46.1	0.0	1	1	6.8e-15	1.9e-12	45.1	0.0	215	316	391	495	375	510	0.79	Cytochrome b-245 heavy chain (DB00514)
drugbank_target|Q9Y5S8	-	564	sp|C6KT68|FENR_PLA	-	371	2.2e-12	44.9	0.0	1	2	1.7e-14	4.8e-12	43.8	0.0	214	293	384	461	363	470	0.87	NADPH oxidase 1 (DB09140)
drugbank_target|Q9Y5S8	-	564	sp|C6KT68|FENR_PLA	-	371	2.2e-12	44.9	0.0	2	2	4.6	1.3e+03	-3.7	0.0	336	359	528	551	524	556	0.76	NADPH oxidase 1 (DB09140)
drugbank_target|P00780	-	379	sp|Q8I0V0|SUB1_PLA	-	688	7.1e-76	254.4	18.0	1	2	0.0013	0.61	6.8	0.0	365	383	130	148	119	150	0.90	Subtilisin Carlsberg (DB01942; DB02560; DB02677; DB03290; DB03316; DB03607)
drugbank_target|P00780	-	379	sp|Q8I0V0|SUB1_PLA	-	688	7.1e-76	254.4	18.0	2	2	1e-76	4.9e-74	248.3	15.7	410	644	150	363	147	369	0.95	Subtilisin Carlsberg (DB01942; DB02560; DB02677; DB03290; DB03316; DB03607)
drugbank_target|P00781	-	274	sp|Q8I0V0|SUB1_PLA	-	688	7.7e-75	251.0	18.0	1	2	0.0059	2.8	4.5	0.0	364	383	24	43	11	45	0.89	Subtilisin DY (DB06886)
drugbank_target|P00781	-	274	sp|Q8I0V0|SUB1_PLA	-	688	7.7e-75	251.0	18.0	2	2	1.8e-76	8.4e-74	247.5	15.1	411	643	46	257	43	262	0.95	Subtilisin DY (DB06886)
drugbank_target|P00782	-	382	sp|Q8I0V0|SUB1_PLA	-	688	1.4e-73	246.8	15.4	1	2	2.6e-05	0.013	12.3	0.1	365	383	132	150	126	153	0.91	Subtilisin BPN' (DB01805; DB01915; DB02442; DB03297; DB04491)
drugbank_target|P00782	-	382	sp|Q8I0V0|SUB1_PLA	-	688	1.4e-73	246.8	15.4	2	2	5.7e-73	2.7e-70	235.9	11.5	412	643	154	365	151	370	0.94	Subtilisin BPN' (DB01805; DB01915; DB02442; DB03297; DB04491)
drugbank_target|P27693	-	380	sp|Q8I0V0|SUB1_PLA	-	688	5.1e-72	241.7	15.0	1	2	0.15	72	-0.1	0.0	365	383	136	153	128	155	0.88	Alkaline protease (DB01973)
drugbank_target|P27693	-	380	sp|Q8I0V0|SUB1_PLA	-	688	5.1e-72	241.7	15.0	2	2	1.9e-74	9.1e-72	240.8	13.8	410	645	155	365	147	372	0.94	Alkaline protease (DB01973)
drugbank_target|P29600	-	269	sp|Q8I0V0|SUB1_PLA	-	688	9.5e-72	240.8	15.4	1	2	0.11	52	0.4	0.0	365	383	25	42	22	44	0.87	Subtilisin Savinase (DB01973)
drugbank_target|P29600	-	269	sp|Q8I0V0|SUB1_PLA	-	688	9.5e-72	240.8	15.4	2	2	4.1e-74	2e-71	239.7	14.1	410	645	44	254	37	262	0.94	Subtilisin Savinase (DB01973)
drugbank_target|P29120	-	753	sp|Q8I0V0|SUB1_PLA	-	688	4.7e-57	192.2	0.3	1	2	3.3e-59	1.6e-56	190.5	0.1	323	633	109	409	99	427	0.79	Neuroendocrine convertase 1 (DB00071)
drugbank_target|P29120	-	753	sp|Q8I0V0|SUB1_PLA	-	688	4.7e-57	192.2	0.3	2	2	0.35	1.7e+02	-1.3	0.0	98	144	628	674	618	682	0.62	Neuroendocrine convertase 1 (DB00071)
drugbank_target|Q8GB52	-	530	sp|Q8I0V0|SUB1_PLA	-	688	1.7e-52	177.2	5.5	1	1	5e-55	2.4e-52	176.7	5.5	408	636	189	389	108	396	0.83	Extracellular subtilisin-like serine proteinase (DB03297)
drugbank_target|Q93UV9	-	640	sp|Q8I0V0|SUB1_PLA	-	688	2.1e-48	163.6	4.7	1	1	6.6e-51	3.1e-48	163.0	4.7	418	617	264	472	245	486	0.94	Protease (DB02235)
drugbank_target|Q8NBP7	-	692	sp|Q8I0V0|SUB1_PLA	-	688	6.7e-32	109.1	0.0	1	1	2.2e-34	1e-31	108.4	0.0	382	635	185	415	177	423	0.86	Proprotein convertase subtilisin/kexin type 9 (DB09302)
drugbank_target|P09958	-	794	sp|Q8I0V0|SUB1_PLA	-	688	3.4e-31	106.7	0.3	1	1	1.2e-33	5.5e-31	106.0	0.3	337	635	115	397	100	416	0.64	Furin (DB03600; DB04951)
drugbank_target|P16519	-	638	sp|Q8I0V0|SUB1_PLA	-	688	1.8e-30	104.3	0.4	1	1	1.5e-32	7.4e-30	102.3	0.4	335	631	121	409	115	422	0.66	Neuroendocrine convertase 2 (DB00071)
drugbank_target|Q53ET4	-	504	sp|Q8I566|GLYA_PLA	-	442	1.6e-239	793.2	0.0	1	1	5.3e-242	2e-239	792.9	0.0	4	441	46	498	44	499	0.98	Serine hydroxymethyltransferase (DB00114; DB00116; DB00145)
drugbank_target|P34897	-	504	sp|Q8I566|GLYA_PLA	-	442	1.8e-239	793.0	0.0	1	1	5.9e-242	2.2e-239	792.7	0.0	4	441	46	498	44	499	0.98	Serine hydroxymethyltransferase, mitochondrial (DB00114; DB00116; DB00145; DB11638)
drugbank_target|P34896	-	483	sp|Q8I566|GLYA_PLA	-	442	5.5e-232	768.3	0.0	1	1	1.7e-234	6.3e-232	768.1	0.0	4	441	23	477	20	478	0.98	Serine hydroxymethyltransferase, cytosolic (DB00114; DB00116; DB00145; DB01055; DB02067; DB02800; DB02824)
drugbank_target|P0A827	-	417	sp|Q8I566|GLYA_PLA	-	442	4.4e-198	656.6	0.1	1	1	1.5e-200	5.6e-198	656.2	0.1	5	399	6	391	2	409	0.98	Serine hydroxymethyltransferase (DB02824; DB11596)
drugbank_target|Q5KUI2	-	412	sp|Q8I566|GLYA_PLA	-	442	6.6e-196	649.4	0.2	1	1	2.1e-198	7.8e-196	649.2	0.2	5	404	2	387	1	407	0.97	Serine hydroxymethyltransferase (DB03256)
drugbank_target|P0AB77	-	398	sp|Q8I566|GLYA_PLA	-	442	1.1e-52	177.4	0.0	1	1	4.9e-55	1.8e-52	176.7	0.0	152	341	150	341	133	363	0.91	2-amino-3-ketobutyrate coenzyme A ligase (DB03915)
drugbank_target|O75600	-	419	sp|Q8I566|GLYA_PLA	-	442	4.3e-21	73.3	0.0	1	1	2e-23	7.4e-21	72.5	0.0	159	348	177	369	132	390	0.87	2-amino-3-ketobutyrate coenzyme A ligase, mitochondrial (DB00114; DB00145)
drugbank_target|P13196	-	640	sp|Q8I566|GLYA_PLA	-	442	1.7e-13	48.3	0.0	1	1	6.9e-16	2.6e-13	47.7	0.0	164	363	362	568	352	577	0.83	5-aminolevulinate synthase, nonspecific, mitochondrial (DB00114; DB00145)
drugbank_target|Q5JAM2	-	640	sp|Q8I566|GLYA_PLA	-	442	1.7e-13	48.3	0.0	1	1	6.9e-16	2.6e-13	47.7	0.0	164	363	362	568	352	577	0.83	5-aminolevulinate synthase (DB00114)
drugbank_target|Q9NUV7	-	552	sp|Q8I566|GLYA_PLA	-	442	5.2e-12	43.4	0.0	1	1	2.2e-14	8.1e-12	42.7	0.0	171	327	296	459	284	488	0.81	Serine palmitoyltransferase 3 (DB00114)
drugbank_target|P22557	-	587	sp|Q8I566|GLYA_PLA	-	442	1e-11	42.4	0.0	1	1	4.2e-14	1.6e-11	41.8	0.0	164	362	308	513	301	521	0.83	5-aminolevulinate synthase, erythroid-specific, mitochondrial (DB00114; DB00145)
drugbank_target|O15270	-	562	sp|Q8I566|GLYA_PLA	-	442	1.5e-11	41.8	0.0	1	1	5.7e-14	2.1e-11	41.3	0.0	171	336	302	477	269	534	0.84	Serine palmitoyltransferase 2 (DB00114; DB00133)
drugbank_target|P12998	-	384	sp|Q8I566|GLYA_PLA	-	442	0.00012	19.1	0.0	1	1	4.8e-06	0.0018	15.2	0.0	164	268	153	266	86	313	0.73	8-amino-7-oxononanoate synthase (DB03160)
drugbank_target|Q9KM65	-	389	sp|Q8I566|GLYA_PLA	-	442	0.00015	18.8	0.0	1	1	5.5e-07	0.00021	18.3	0.0	159	269	151	267	132	319	0.75	CAI-1 autoinducer synthase (DB08364)
drugbank_target|T1RTG8	-	340	sp|Q9TY96|SERA6_PL	-	1031	5.5e-150	499.7	35.2	1	2	5.4e-90	2.2e-87	292.4	22.6	370	546	4	174	1	175	0.98	Serine repeat antigen 5 (DB11638)
drugbank_target|T1RTG8	-	340	sp|Q9TY96|SERA6_PL	-	1031	5.5e-150	499.7	35.2	2	2	1.4e-66	5.8e-64	214.9	5.5	611	777	173	339	172	340	0.99	Serine repeat antigen 5 (DB11638)
drugbank_target|O60911	-	334	sp|Q9TY96|SERA6_PL	-	1031	2.8e-68	229.2	5.2	1	2	8e-42	3.2e-39	133.0	0.1	596	738	93	230	61	235	0.92	Cathepsin L2 (DB02869; DB04451)
drugbank_target|O60911	-	334	sp|Q9TY96|SERA6_PL	-	1031	2.8e-68	229.2	5.2	2	2	3e-31	1.2e-28	98.0	1.7	769	860	235	326	232	330	0.95	Cathepsin L2 (DB02869; DB04451)
drugbank_target|P07711	-	333	sp|Q9TY96|SERA6_PL	-	1031	1.1e-67	227.2	3.4	1	2	1.4e-41	5.6e-39	132.2	0.1	595	736	92	228	60	234	0.91	Cathepsin L1 (DB03661; DB07477; DB12010)
drugbank_target|P07711	-	333	sp|Q9TY96|SERA6_PL	-	1031	1.1e-67	227.2	3.4	2	2	1.2e-30	4.7e-28	96.0	0.6	769	859	234	324	231	329	0.94	Cathepsin L1 (DB03661; DB07477; DB12010)
drugbank_target|P25774	-	331	sp|Q9TY96|SERA6_PL	-	1031	1.1e-58	197.4	8.4	1	2	2.9e-34	1.2e-31	107.9	1.7	612	726	110	219	78	235	0.87	Cathepsin S (DB03767; DB03837; DB03984; DB07520; DB07587; DB07589; DB07839; DB07878; DB08195; DB08611; DB08752; DB08755; DB12010)
drugbank_target|P25774	-	331	sp|Q9TY96|SERA6_PL	-	1031	1.1e-58	197.4	8.4	2	2	7.3e-30	3e-27	93.4	0.6	768	859	236	322	234	326	0.94	Cathepsin S (DB03767; DB03837; DB03984; DB07520; DB07587; DB07589; DB07839; DB07878; DB08195; DB08611; DB08752; DB08755; DB12010)
drugbank_target|P07858	-	339	sp|Q9TY96|SERA6_PL	-	1031	2.1e-58	196.5	1.0	1	1	6.8e-61	2.8e-58	196.1	1.0	616	859	79	321	70	327	0.94	Cathepsin B (DB02108; DB02148; DB02685; DB02855; DB03329; DB03588; DB04126; DB04579; DB07160; DB07219; DB07223; DB07224; DB07225; DB07231)
drugbank_target|P09668	-	335	sp|Q9TY96|SERA6_PL	-	1031	1.4e-55	187.2	1.3	1	1	1.8e-56	7.2e-54	181.5	1.3	600	859	101	324	83	329	0.92	Pro-cathepsin H (DB02140; DB03120; DB04126; DB08526)
drugbank_target|P43235	-	329	sp|Q9TY96|SERA6_PL	-	1031	2.3e-55	186.4	8.2	1	2	2.4e-31	9.9e-29	98.3	0.4	616	726	114	216	98	232	0.90	Cathepsin K (DB01858; DB02679; DB02869; DB03405; DB03456; DB03642; DB03891; DB04234; DB04244; DB04523; DB05736; DB06367; DB06670; DB07563; DB07592; DB07593; DB07965; DB07967; DB08270; DB08287; DB08594; DB15599)
drugbank_target|P43235	-	329	sp|Q9TY96|SERA6_PL	-	1031	2.3e-55	186.4	8.2	2	2	2.1e-29	8.6e-27	91.8	2.4	769	860	234	321	224	326	0.94	Cathepsin K (DB01858; DB02679; DB02869; DB03405; DB03456; DB03642; DB03891; DB04234; DB04244; DB04523; DB05736; DB06367; DB06670; DB07563; DB07592; DB07593; DB07965; DB07967; DB08270; DB08287; DB08594; DB15599)
drugbank_target|Q24940	-	326	sp|Q9TY96|SERA6_PL	-	1031	4.6e-52	175.5	7.4	1	2	7.4e-32	3e-29	100.0	1.3	607	725	100	209	74	221	0.88	Cathepsin L-like proteinase (DB12245)
drugbank_target|Q24940	-	326	sp|Q9TY96|SERA6_PL	-	1031	4.6e-52	175.5	7.4	2	2	1.5e-25	6e-23	79.1	0.5	770	861	229	315	212	322	0.90	Cathepsin L-like proteinase (DB12245)
drugbank_target|P25779	-	467	sp|Q9TY96|SERA6_PL	-	1031	2e-49	166.8	2.8	1	2	1.4e-27	5.6e-25	85.8	0.0	616	713	122	215	107	237	0.90	Cruzipain (DB01810; DB01871; DB02051; DB02128; DB02200; DB03536; DB03573; DB03691; DB04427; DB04502)
drugbank_target|P25779	-	467	sp|Q9TY96|SERA6_PL	-	1031	2e-49	166.8	2.8	2	2	5.5e-26	2.2e-23	80.6	1.2	775	860	252	328	244	336	0.93	Cruzipain (DB01810; DB01871; DB02051; DB02128; DB02200; DB03536; DB03573; DB03691; DB04427; DB04502)
drugbank_target|Q9UBX1	-	484	sp|Q9TY96|SERA6_PL	-	1031	5.4e-49	165.3	2.2	1	2	4.3e-28	1.7e-25	87.5	0.5	617	733	271	379	246	393	0.85	Cathepsin F (DB01810; DB01871; DB02243; DB03536; DB03573; DB03691; DB07913; DB08775)
drugbank_target|Q9UBX1	-	484	sp|Q9TY96|SERA6_PL	-	1031	5.4e-49	165.3	2.2	2	2	2.3e-25	9.3e-23	78.5	0.2	751	863	376	478	372	483	0.84	Cathepsin F (DB01810; DB01871; DB02243; DB03536; DB03573; DB03691; DB07913; DB08775)
dgbank_trgt|A0A144A2G5	-	700	sp|Q9TY96|SERA6_PL	-	1031	5.8e-45	152.0	15.3	1	2	2.6e-31	1.1e-28	98.2	5.5	587	748	342	507	292	535	0.86	Dipeptidyl aminopeptidase 1 (DB11638)
dgbank_trgt|A0A144A2G5	-	700	sp|Q9TY96|SERA6_PL	-	1031	5.8e-45	152.0	15.3	2	2	1.7e-19	6.7e-17	59.1	2.2	795	856	609	668	601	680	0.92	Dipeptidyl aminopeptidase 1 (DB11638)
drugbank_target|Q96A05	-	226	sp|Q9TY96|SERA6_PL	-	1031	1.5e-28	97.6	7.6	1	1	4.7e-31	1.9e-28	97.3	7.6	341	421	6	85	2	115	0.95	V-type proton ATPase subunit E 2 (DB01133)
drugbank_target|P36543	-	226	sp|Q9TY96|SERA6_PL	-	1031	6.4e-27	92.3	11.2	1	1	2.1e-29	8.6e-27	91.8	11.2	342	421	7	85	3	93	0.96	V-type proton ATPase subunit E 1 (DB01133)
drugbank_target|C6KT50	-	301	sp|C6KT50|PDX1_PLA	-	301	1.6e-209	692.4	8.0	1	1	2.8e-212	1.8e-209	692.3	8.0	1	301	1	301	1	301	1.00	Pyridoxal 5'-phosphate synthase subunit Pdx1 (DB11638)
drugbank_target|P25053	-	205	sp|C6KT50|PDX1_PLA	-	301	2e-15	55.1	0.0	1	1	4.4e-18	2.9e-15	54.6	0.0	196	253	136	192	122	205	0.90	Thiazole tautomerase (DB03570)
drugbank_target|P20839	-	514	sp|C6KT50|PDX1_PLA	-	301	2.5e-14	51.5	2.1	1	2	2e-15	1.3e-12	45.8	0.3	191	240	278	327	260	339	0.92	Inosine-5'-monophosphate dehydrogenase 1 (DB00157; DB00688; DB00811; DB01024; DB03948; DB06103; DB06408)
drugbank_target|P20839	-	514	sp|C6KT50|PDX1_PLA	-	301	2.5e-14	51.5	2.1	2	2	0.0057	3.8	5.0	0.1	201	242	351	392	342	400	0.86	Inosine-5'-monophosphate dehydrogenase 1 (DB00157; DB00688; DB00811; DB01024; DB03948; DB06103; DB06408)
drugbank_target|P20839	-	514	sp|C6KT50|PDX1_PLA	-	301	2.5e-14	51.5	2.1	1	2	2e-15	1.3e-12	45.8	0.3	191	240	278	327	260	339	0.92	Inosine-5'-monophosphate dehydrogenase 1 (DB01033)
drugbank_target|P20839	-	514	sp|C6KT50|PDX1_PLA	-	301	2.5e-14	51.5	2.1	2	2	0.0057	3.8	5.0	0.1	201	242	351	392	342	400	0.86	Inosine-5'-monophosphate dehydrogenase 1 (DB01033)
drugbank_target|P39594	-	222	sp|C6KT50|PDX1_PLA	-	301	4e-13	47.6	1.0	1	2	0.34	2.3e+02	-0.9	0.1	220	259	79	118	64	132	0.74	Thiamine-phosphate synthase (DB01788; DB02254; DB02885; DB03145; DB03416; DB07782)
drugbank_target|P39594	-	222	sp|C6KT50|PDX1_PLA	-	301	4e-13	47.6	1.0	2	2	1.5e-15	1e-12	46.2	0.1	192	253	150	211	139	221	0.85	Thiamine-phosphate synthase (DB01788; DB02254; DB02885; DB03145; DB03416; DB07782)
drugbank_target|P12268	-	514	sp|C6KT50|PDX1_PLA	-	301	3.6e-10	37.9	2.8	1	2	8e-12	5.3e-09	34.0	0.4	191	239	278	326	262	347	0.92	Inosine-5'-monophosphate dehydrogenase 2 (DB00157; DB00688; DB00811; DB01024; DB03070; DB03948; DB04566; DB06103)
drugbank_target|P12268	-	514	sp|C6KT50|PDX1_PLA	-	301	3.6e-10	37.9	2.8	2	2	0.014	9.1	3.7	0.1	200	242	350	392	342	400	0.86	Inosine-5'-monophosphate dehydrogenase 2 (DB00157; DB00688; DB00811; DB01024; DB03070; DB03948; DB04566; DB06103)
drugbank_target|P12268	-	514	sp|C6KT50|PDX1_PLA	-	301	3.6e-10	37.9	2.8	1	2	8e-12	5.3e-09	34.0	0.4	191	239	278	326	262	347	0.92	Inosine-5'-monophosphate dehydrogenase 2 (DB01033)
drugbank_target|P12268	-	514	sp|C6KT50|PDX1_PLA	-	301	3.6e-10	37.9	2.8	2	2	0.014	9.1	3.7	0.1	200	242	350	392	342	400	0.86	Inosine-5'-monophosphate dehydrogenase 2 (DB01033)
drugbank_target|P0C0H6	-	493	sp|C6KT50|PDX1_PLA	-	301	0.0053	14.3	0.2	1	2	2.7	1.8e+03	-3.8	0.1	207	248	46	89	37	95	0.55	Inosine-5'-monophosphate dehydrogenase (DB04566; DB04862)
drugbank_target|P0C0H6	-	493	sp|C6KT50|PDX1_PLA	-	301	0.0053	14.3	0.2	2	2	8.1e-06	0.0053	14.3	0.2	200	240	266	306	245	332	0.85	Inosine-5'-monophosphate dehydrogenase (DB04566; DB04862)
drugbank_target|Q92800	-	747	sp|Q8IE95|SETVS_PL	-	2548	4e-72	241.0	10.6	1	1	4.4e-75	5.8e-72	240.5	10.6	2064	2242	553	730	541	734	0.97	Histone-lysine N-methyltransferase EZH1 (DB12887)
drugbank_target|Q15910	-	746	sp|Q8IE95|SETVS_PL	-	2548	8.9e-72	239.8	10.8	1	2	2.4	3.1e+03	-7.5	7.5	987	1013	182	208	164	214	0.53	Histone-lysine N-methyltransferase EZH2 (DB12887; DB14581)
drugbank_target|Q15910	-	746	sp|Q8IE95|SETVS_PL	-	2548	8.9e-72	239.8	10.8	2	2	6.8e-75	8.9e-72	239.8	10.8	2063	2242	551	729	539	733	0.97	Histone-lysine N-methyltransferase EZH2 (DB12887; DB14581)
drugbank_target|Q8WTS6	-	366	sp|Q8IE95|SETVS_PL	-	2548	2.4e-35	119.0	0.0	1	1	2.5e-38	3.2e-35	118.6	0.0	2127	2242	224	338	214	340	0.97	Histone-lysine N-methyltransferase SETD7 (DB01752)
drugbank_target|P06748	-	294	sp|Q8IE95|SETVS_PL	-	2548	1.9	3.2	9.7	1	1	0.0019	2.4	2.9	9.7	993	1045	161	214	141	234	0.55	Nucleophosmin (DB11638)
drugbank_target|Q9NXA8	-	310	sp|Q8IE47|SIR5_PLA	-	273	5.6e-95	315.7	0.0	1	1	1.3e-97	7.6e-95	315.3	0.0	8	247	30	288	26	296	0.95	NAD-dependent protein deacylase sirtuin-5, mitochondrial (DB02059; DB02701; DB03478; DB04786; DB15493)
drugbank_target|Q96EB6	-	747	sp|Q8IE47|SIR5_PLA	-	273	1.4e-89	298.0	0.0	1	1	3.8e-92	2.2e-89	297.4	0.0	10	235	235	467	229	472	0.97	NAD-dependent protein deacetylase sirtuin-1 (DB02709; DB13978; DB15493)
drugbank_target|Q8IXJ6	-	389	sp|Q8IE47|SIR5_PLA	-	273	1.9e-85	284.5	0.0	1	1	4.5e-88	2.6e-85	284.0	0.0	14	236	60	289	49	295	0.94	NAD-dependent protein deacetylase sirtuin-2 (DB15493)
drugbank_target|Q9NTG7	-	399	sp|Q8IE47|SIR5_PLA	-	273	1.7e-82	274.8	0.0	1	1	3.9e-85	2.3e-82	274.4	0.0	11	228	118	339	110	348	0.94	NAD-dependent protein deacetylase sirtuin-3, mitochondrial (DB02059)
drugbank_target|Q59EB3	-	712	sp|Q8IE47|SIR5_PLA	-	273	1.7e-18	64.9	0.1	1	1	5.7e-21	3.4e-18	64.0	0.1	81	161	60	143	11	146	0.82	Met proto-oncogene variant (DB08111)
drugbank_target|P08581	-	1390	sp|Q8IE47|SIR5_PLA	-	273	4.4e-18	63.6	0.1	1	1	1.4e-20	8.3e-18	62.7	0.1	81	161	738	821	689	824	0.82	Hepatocyte growth factor receptor (DB02152; DB06314; DB06896; DB06995; DB06997; DB07369; DB07969; DB08079; DB08791; DB08865; DB08875; DB11791; DB12010; DB12200; DB12267; DB12742)
drugbank_target|Q13423	-	1086	sp|Q8IE47|SIR5_PLA	-	273	7.5e-17	59.5	0.0	1	2	1.8	1e+03	-3.2	0.0	15	41	911	937	908	940	0.87	NAD(P) transhydrogenase, mitochondrial (DB00157; DB01763; DB03461; DB09092)
drugbank_target|Q13423	-	1086	sp|Q8IE47|SIR5_PLA	-	273	7.5e-17	59.5	0.0	2	2	4.4e-19	2.6e-16	57.8	0.0	190	244	990	1044	976	1054	0.93	NAD(P) transhydrogenase, mitochondrial (DB00157; DB01763; DB03461; DB09092)
drugbank_target|P0C188	-	464	sp|Q8IE47|SIR5_PLA	-	273	6.6e-07	26.9	0.0	1	2	0.034	20	2.4	0.0	17	42	296	321	289	335	0.85	NAD(P) transhydrogenase subunit beta (DB03461)
drugbank_target|P0C188	-	464	sp|Q8IE47|SIR5_PLA	-	273	6.6e-07	26.9	0.0	2	2	3e-08	1.7e-05	22.2	0.0	190	243	373	426	358	450	0.90	NAD(P) transhydrogenase subunit beta (DB03461)
drugbank_target|Q9L915	-	128	sp|Q8IE47|SIR5_PLA	-	273	0.33	8.2	5.4	1	2	0.0015	0.85	6.9	0.4	120	154	31	65	27	80	0.83	Cytochrome c3 (DB03317)
drugbank_target|Q9L915	-	128	sp|Q8IE47|SIR5_PLA	-	273	0.33	8.2	5.4	2	2	0.009	5.3	4.3	0.7	127	156	87	116	73	128	0.77	Cytochrome c3 (DB03317)
drugbank_target|T1RTG8	-	340	sp|Q9TY95|SERA5_PL	-	997	3.2e-234	778.4	34.2	1	1	8.7e-237	3.5e-234	778.2	34.2	391	729	1	339	1	340	1.00	Serine repeat antigen 5 (DB11638)
drugbank_target|P07858	-	339	sp|Q9TY95|SERA5_PL	-	997	9.2e-63	210.8	1.7	1	1	3e-65	1.2e-62	210.4	1.7	580	814	92	324	86	334	0.94	Cathepsin B (DB02108; DB02148; DB02685; DB02855; DB03329; DB03588; DB04126; DB04579; DB07160; DB07219; DB07223; DB07224; DB07225; DB07231)
drugbank_target|P07711	-	333	sp|Q9TY95|SERA5_PL	-	997	7.1e-59	197.9	4.8	1	2	6.4e-28	2.6e-25	86.8	0.4	585	669	127	210	119	225	0.92	Cathepsin L1 (DB03661; DB07477; DB12010)
drugbank_target|P07711	-	333	sp|Q9TY95|SERA5_PL	-	997	7.1e-59	197.9	4.8	2	2	8.1e-36	3.3e-33	112.9	1.1	715	816	228	329	207	332	0.91	Cathepsin L1 (DB03661; DB07477; DB12010)
drugbank_target|O60911	-	334	sp|Q9TY95|SERA5_PL	-	997	2.8e-58	195.9	6.7	1	2	1.3e-27	5.3e-25	85.8	0.4	585	673	127	212	121	228	0.89	Cathepsin L2 (DB02869; DB04451)
drugbank_target|O60911	-	334	sp|Q9TY95|SERA5_PL	-	997	2.8e-58	195.9	6.7	2	2	5.7e-36	2.3e-33	113.4	1.4	716	816	230	330	215	333	0.94	Cathepsin L2 (DB02869; DB04451)
drugbank_target|P25774	-	331	sp|Q9TY95|SERA5_PL	-	997	2.8e-54	182.7	6.4	1	2	4.4e-27	1.8e-24	84.0	1.7	578	671	123	214	118	218	0.92	Cathepsin S (DB03767; DB03837; DB03984; DB07520; DB07587; DB07589; DB07839; DB07878; DB08195; DB08611; DB08752; DB08755; DB12010)
drugbank_target|P25774	-	331	sp|Q9TY95|SERA5_PL	-	997	2.8e-54	182.7	6.4	2	2	3.5e-32	1.4e-29	100.9	0.5	702	815	218	326	213	329	0.90	Cathepsin S (DB03767; DB03837; DB03984; DB07520; DB07587; DB07589; DB07839; DB07878; DB08195; DB08611; DB08752; DB08755; DB12010)
drugbank_target|Q24940	-	326	sp|Q9TY95|SERA5_PL	-	997	2e-51	173.2	6.2	1	2	1.6e-24	6.5e-22	75.5	1.6	585	669	121	203	111	214	0.92	Cathepsin L-like proteinase (DB12245)
drugbank_target|Q24940	-	326	sp|Q9TY95|SERA5_PL	-	997	2e-51	173.2	6.2	2	2	6.6e-32	2.7e-29	100.0	0.2	715	817	222	319	210	324	0.93	Cathepsin L-like proteinase (DB12245)
drugbank_target|P43235	-	329	sp|Q9TY95|SERA5_PL	-	997	4.5e-51	172.1	12.5	1	3	0.044	18	1.3	0.2	270	313	19	61	11	87	0.79	Cathepsin K (DB01858; DB02679; DB02869; DB03405; DB03456; DB03642; DB03891; DB04234; DB04244; DB04523; DB05736; DB06367; DB06670; DB07563; DB07592; DB07593; DB07965; DB07967; DB08270; DB08287; DB08594; DB15599)
drugbank_target|P43235	-	329	sp|Q9TY95|SERA5_PL	-	997	4.5e-51	172.1	12.5	2	3	2.4e-24	9.8e-22	75.0	0.6	585	672	128	210	119	216	0.92	Cathepsin K (DB01858; DB02679; DB02869; DB03405; DB03456; DB03642; DB03891; DB04234; DB04244; DB04523; DB05736; DB06367; DB06670; DB07563; DB07592; DB07593; DB07965; DB07967; DB08270; DB08287; DB08594; DB15599)
drugbank_target|P43235	-	329	sp|Q9TY95|SERA5_PL	-	997	4.5e-51	172.1	12.5	3	3	2e-32	8e-30	101.7	2.6	708	816	221	325	206	328	0.90	Cathepsin K (DB01858; DB02679; DB02869; DB03405; DB03456; DB03642; DB03891; DB04234; DB04244; DB04523; DB05736; DB06367; DB06670; DB07563; DB07592; DB07593; DB07965; DB07967; DB08270; DB08287; DB08594; DB15599)
dgbank_trgt|A0A144A2G5	-	700	sp|Q9TY95|SERA5_PL	-	997	3.5e-49	165.8	6.3	1	1	1.8e-51	7.3e-49	164.7	6.3	583	813	385	673	378	679	0.91	Dipeptidyl aminopeptidase 1 (DB11638)
drugbank_target|P09668	-	335	sp|Q9TY95|SERA5_PL	-	997	1.6e-48	163.7	3.8	1	2	1.3e-23	5.2e-21	72.5	0.2	585	664	130	208	123	218	0.94	Pro-cathepsin H (DB02140; DB03120; DB04126; DB08526)
drugbank_target|P09668	-	335	sp|Q9TY95|SERA5_PL	-	997	1.6e-48	163.7	3.8	2	2	1.4e-29	5.5e-27	92.3	0.5	718	817	235	330	211	335	0.92	Pro-cathepsin H (DB02140; DB03120; DB04126; DB08526)
drugbank_target|P25779	-	467	sp|Q9TY95|SERA5_PL	-	997	3.6e-48	162.5	4.5	1	2	7.9e-24	3.2e-21	73.3	0.5	585	665	136	215	130	228	0.92	Cruzipain (DB01810; DB01871; DB02051; DB02128; DB02200; DB03536; DB03573; DB03691; DB04427; DB04502)
drugbank_target|P25779	-	467	sp|Q9TY95|SERA5_PL	-	997	3.6e-48	162.5	4.5	2	2	3.6e-29	1.5e-26	90.9	0.3	715	823	240	339	223	353	0.88	Cruzipain (DB01810; DB01871; DB02051; DB02128; DB02200; DB03536; DB03573; DB03691; DB04427; DB04502)
drugbank_target|Q9UBX1	-	484	sp|Q9TY95|SERA5_PL	-	997	1.1e-47	160.8	1.2	1	2	7.4e-22	3e-19	66.7	0.6	584	666	283	362	276	379	0.89	Cathepsin F (DB01810; DB01871; DB02243; DB03536; DB03573; DB03691; DB07913; DB08775)
drugbank_target|Q9UBX1	-	484	sp|Q9TY95|SERA5_PL	-	997	1.1e-47	160.8	1.2	2	2	7e-30	2.8e-27	93.3	0.0	714	820	382	483	361	484	0.87	Cathepsin F (DB01810; DB01871; DB02243; DB03536; DB03573; DB03691; DB07913; DB08775)
drugbank_target|Q08460	-	1209	sp|Q9TY95|SERA5_PL	-	997	1.7	4.6	33.9	1	2	0.0019	0.78	5.8	17.6	206	233	33	60	2	80	0.45	Calcium-activated potassium channel subunit alpha-1 (DB08837)
drugbank_target|Q08460	-	1209	sp|Q9TY95|SERA5_PL	-	997	1.7	4.6	33.9	2	2	0.0043	1.7	4.6	8.3	210	257	1156	1205	1149	1208	0.69	Calcium-activated potassium channel subunit alpha-1 (DB08837)
drugbank_target|P06434	-	280	sp|Q9TY95|SERA5_PL	-	997	9	2.2	9.9	1	1	0.031	13	1.8	9.9	205	236	87	109	12	164	0.69	30 kDa immediate-early protein 2 (DB06759)
drugbank_target|Q08210	-	569	sp|Q08210|PYRD_PLA	-	569	0	1189.8	34.7	1	1	0	0	1189.6	34.7	1	569	1	569	1	569	1.00	Dihydroorotate dehydrogenase (quinone), mitochondrial (DB01117)
drugbank_target|Q02127	-	395	sp|Q08210|PYRD_PLA	-	569	4.2e-149	495.8	0.0	1	2	5e-97	1.5e-94	315.6	0.0	154	376	24	245	5	247	0.96	Dihydroorotate dehydrogenase (quinone), mitochondrial (DB01097; DB01117; DB02262; DB02613; DB03247; DB03480; DB03523; DB04147; DB04281; DB04583; DB05125; DB06481; DB07443; DB07559; DB07561; DB07646; DB07975; DB07976; DB07977; DB07978; DB08006; DB08008; DB08169; DB08172; DB08249; DB08880)
drugbank_target|Q02127	-	395	sp|Q08210|PYRD_PLA	-	569	4.2e-149	495.8	0.0	2	2	1.1e-55	3.4e-53	179.2	0.0	421	567	246	394	244	395	0.98	Dihydroorotate dehydrogenase (quinone), mitochondrial (DB01097; DB01117; DB02262; DB02613; DB03247; DB03480; DB03523; DB04147; DB04281; DB04583; DB05125; DB06481; DB07443; DB07559; DB07561; DB07646; DB07975; DB07976; DB07977; DB07978; DB08006; DB08008; DB08169; DB08172; DB08249; DB08880)
drugbank_target|P0A7E1	-	336	sp|Q08210|PYRD_PLA	-	569	7e-126	419.1	0.1	1	2	2.1e-87	6.5e-85	283.8	0.0	167	375	1	205	1	210	0.98	Dihydroorotate dehydrogenase (quinone) (DB01942; DB02262; DB03247)
drugbank_target|P0A7E1	-	336	sp|Q08210|PYRD_PLA	-	569	7e-126	419.1	0.1	2	2	5.7e-42	1.8e-39	133.8	0.1	421	544	210	334	206	336	0.96	Dihydroorotate dehydrogenase (quinone) (DB01942; DB02262; DB03247)
drugbank_target|Q53ZE5	-	311	sp|Q08210|PYRD_PLA	-	569	2.5e-74	248.9	0.2	1	2	3e-47	9.1e-45	151.3	0.0	207	361	1	146	1	155	0.93	Dihydroorotate dehydrogenase A (fumarate) (DB02262; DB03247)
drugbank_target|Q53ZE5	-	311	sp|Q08210|PYRD_PLA	-	569	2.5e-74	248.9	0.2	2	2	1.7e-30	5.3e-28	96.0	0.1	470	567	213	310	186	311	0.94	Dihydroorotate dehydrogenase A (fumarate) (DB02262; DB03247)
drugbank_target|Q12882	-	1025	sp|Q08210|PYRD_PLA	-	569	2.3e-60	202.8	0.0	1	2	5.7e-20	1.8e-17	61.2	0.0	203	272	528	599	518	683	0.72	Dihydropyrimidine dehydrogenase [NADP(+)] (DB02303; DB02338; DB03048; DB03147; DB03247; DB03419; DB03516; DB03554; DB09257; DB09327)
drugbank_target|Q12882	-	1025	sp|Q08210|PYRD_PLA	-	569	2.3e-60	202.8	0.0	2	2	1.6e-43	4.9e-41	139.0	0.0	415	565	696	853	689	857	0.97	Dihydropyrimidine dehydrogenase [NADP(+)] (DB02303; DB02338; DB03048; DB03147; DB03247; DB03419; DB03516; DB03554; DB09257; DB09327)
drugbank_target|Q9NYQ3	-	351	sp|Q08210|PYRD_PLA	-	569	1.2e-11	42.0	0.4	1	1	2.1e-13	6.5e-11	39.5	0.4	477	561	247	341	204	346	0.85	Hydroxyacid oxidase 2 (DB03247)
drugbank_target|Q9UJM8	-	370	sp|Q08210|PYRD_PLA	-	569	1.5e-11	41.6	0.1	1	2	0.48	1.5e+02	-1.3	0.0	495	525	228	255	209	267	0.72	Hydroxyacid oxidase 1 (DB02164; DB02279; DB03064; DB03247; DB03884; DB04374; DB06979; DB07060; DB07907)
drugbank_target|Q9UJM8	-	370	sp|Q08210|PYRD_PLA	-	569	1.5e-11	41.6	0.1	2	2	1.6e-13	5e-11	39.9	0.0	484	560	270	354	261	362	0.89	Hydroxyacid oxidase 1 (DB02164; DB02279; DB03064; DB03247; DB03884; DB04374; DB06979; DB07060; DB07907)
drugbank_target|Q746I8	-	332	sp|Q08210|PYRD_PLA	-	569	1.8e-11	41.4	0.0	1	1	8.2e-14	2.5e-11	40.9	0.0	487	564	245	328	227	331	0.89	Isopentenyl-diphosphate delta-isomerase (DB03247)
drugbank_target|Q9FBC5	-	324	sp|Q08210|PYRD_PLA	-	569	3.3e-08	30.6	0.6	1	2	2.7	8.5e+02	-3.8	0.1	90	117	52	77	48	86	0.73	Putative enoyl-(Acyl-carrier-protein) reductase II (DB08657)
drugbank_target|Q9FBC5	-	324	sp|Q08210|PYRD_PLA	-	569	3.3e-08	30.6	0.6	2	2	1.1e-10	3.3e-08	30.6	0.6	481	545	146	208	122	227	0.83	Putative enoyl-(Acyl-carrier-protein) reductase II (DB08657)
drugbank_target|P50740	-	349	sp|Q08210|PYRD_PLA	-	569	3.7e-08	30.4	0.8	1	2	0.92	2.8e+02	-2.2	0.0	91	114	168	191	161	198	0.81	Isopentenyl-diphosphate delta-isomerase (DB03247)
drugbank_target|P50740	-	349	sp|Q08210|PYRD_PLA	-	569	3.7e-08	30.4	0.8	2	2	2.9e-10	9.1e-08	29.2	0.1	497	561	249	321	234	325	0.83	Isopentenyl-diphosphate delta-isomerase (DB03247)
drugbank_target|P20839	-	514	sp|Q08210|PYRD_PLA	-	569	5.1e-07	26.7	0.0	1	1	2.7e-09	8.2e-07	26.0	0.0	489	534	350	393	339	422	0.83	Inosine-5'-monophosphate dehydrogenase 1 (DB01033)
drugbank_target|P20839	-	514	sp|Q08210|PYRD_PLA	-	569	5.1e-07	26.7	0.0	1	1	2.7e-09	8.2e-07	26.0	0.0	489	534	350	393	339	422	0.83	Inosine-5'-monophosphate dehydrogenase 1 (DB00157; DB00688; DB00811; DB01024; DB03948; DB06103; DB06408)
drugbank_target|Q5SJ28	-	220	sp|Q08210|PYRD_PLA	-	569	2e-06	24.7	0.1	1	1	9e-09	2.8e-06	24.2	0.1	482	530	159	207	151	214	0.90	Deoxyribose-phosphate aldolase (DB04087)
drugbank_target|P39594	-	222	sp|Q08210|PYRD_PLA	-	569	2.9e-06	24.2	0.2	1	1	1.1e-08	3.3e-06	24.0	0.2	490	545	158	213	96	220	0.83	Thiamine-phosphate synthase (DB01788; DB02254; DB02885; DB03145; DB03416; DB07782)
drugbank_target|P12268	-	514	sp|Q08210|PYRD_PLA	-	569	4.3e-06	23.6	0.0	1	1	2.6e-08	8.2e-06	22.7	0.0	489	534	350	393	339	421	0.83	Inosine-5'-monophosphate dehydrogenase 2 (DB01033)
drugbank_target|P12268	-	514	sp|Q08210|PYRD_PLA	-	569	4.3e-06	23.6	0.0	1	1	2.6e-08	8.2e-06	22.7	0.0	489	534	350	393	339	421	0.83	Inosine-5'-monophosphate dehydrogenase 2 (DB00157; DB00688; DB00811; DB01024; DB03070; DB03948; DB04566; DB06103)
drugbank_target|P0C0H6	-	493	sp|Q08210|PYRD_PLA	-	569	0.0053	13.4	0.2	1	1	3.3e-05	0.01	12.5	0.2	497	536	335	374	312	400	0.81	Inosine-5'-monophosphate dehydrogenase (DB04566; DB04862)
drugbank_target|P62344	-	524	sp|P62344|CDPK1_PL	-	524	1.3e-211	702.0	18.9	1	1	1.1e-212	1.4e-211	701.8	18.9	1	524	1	524	1	524	1.00	Calcium-dependent protein kinase 1 (DB12010)
drugbank_target|Q15418	-	735	sp|P62344|CDPK1_PL	-	524	2.1e-178	592.4	0.0	1	2	5.5e-89	7e-88	293.7	0.0	37	330	42	326	21	336	0.90	Ribosomal protein S6 kinase alpha-1 (DB04751; DB12010)
drugbank_target|Q15418	-	735	sp|P62344|CDPK1_PL	-	524	2.1e-178	592.4	0.0	2	2	6.8e-90	8.7e-89	296.7	0.0	44	347	406	697	388	730	0.88	Ribosomal protein S6 kinase alpha-1 (DB04751; DB12010)
drugbank_target|P51812	-	740	sp|P62344|CDPK1_PL	-	524	8.7e-177	587.0	0.0	1	2	6.2e-91	7.8e-90	300.1	0.1	31	331	39	333	13	342	0.87	Ribosomal protein S6 kinase alpha-3 (DB00945; DB12010)
drugbank_target|P51812	-	740	sp|P62344|CDPK1_PL	-	524	8.7e-177	587.0	0.0	2	2	2.6e-86	3.3e-85	284.9	0.0	43	341	409	695	388	730	0.88	Ribosomal protein S6 kinase alpha-3 (DB00945; DB12010)
drugbank_target|Q9UK32	-	745	sp|P62344|CDPK1_PL	-	524	1.7e-175	582.8	0.1	1	2	3.6e-88	4.6e-87	291.0	0.1	42	331	58	336	32	347	0.91	Ribosomal protein S6 kinase alpha-6 (DB12010)
drugbank_target|Q9UK32	-	745	sp|P62344|CDPK1_PL	-	524	1.7e-175	582.8	0.1	2	2	8.6e-88	1.1e-86	289.7	0.0	44	342	414	700	393	734	0.90	Ribosomal protein S6 kinase alpha-6 (DB12010)
drugbank_target|Q8IBS5	-	528	sp|P62344|CDPK1_PL	-	524	1.1e-162	540.6	15.2	1	1	1e-163	1.3e-162	540.3	15.2	7	520	18	527	12	528	0.95	Calcium-dependent protein kinase 4 (DB11638)
drugbank_target|O75676	-	772	sp|P62344|CDPK1_PL	-	524	9.9e-160	530.8	0.0	1	2	6.4e-81	8.2e-80	267.1	0.0	40	328	17	304	2	314	0.87	Ribosomal protein S6 kinase alpha-4 (DB03247)
drugbank_target|O75676	-	772	sp|P62344|CDPK1_PL	-	524	9.9e-160	530.8	0.0	2	2	2.8e-79	3.6e-78	261.7	0.0	60	331	414	680	392	691	0.90	Ribosomal protein S6 kinase alpha-4 (DB03247)
drugbank_target|O60674	-	1132	sp|P62344|CDPK1_PL	-	524	6.3e-117	389.5	0.1	1	2	4.1e-47	5.3e-46	155.5	0.0	51	321	540	803	517	812	0.86	Tyrosine-protein kinase JAK2 (DB04716; DB05243; DB07161; DB07162; DB08067; DB08877; DB08895; DB11817; DB11986; DB12010; DB12500; DB15035)
drugbank_target|O60674	-	1132	sp|P62344|CDPK1_PL	-	524	6.3e-117	389.5	0.1	2	2	3.5e-70	4.5e-69	231.6	0.1	50	319	842	1119	833	1124	0.83	Tyrosine-protein kinase JAK2 (DB04716; DB05243; DB07161; DB07162; DB08067; DB08877; DB08895; DB11817; DB11986; DB12010; DB12500; DB15035)
drugbank_target|P23458	-	1154	sp|P62344|CDPK1_PL	-	524	1.5e-113	378.4	5.9	1	2	1.3e-46	1.7e-45	153.8	0.0	51	322	578	844	555	864	0.87	Tyrosine-protein kinase JAK1 (DB02375; DB04716; DB08877; DB08895; DB11817; DB12010; DB12500; DB15091)
drugbank_target|P23458	-	1154	sp|P62344|CDPK1_PL	-	524	1.5e-113	378.4	5.9	2	2	4.3e-69	5.4e-68	228.1	0.1	38	320	856	1146	844	1148	0.83	Tyrosine-protein kinase JAK1 (DB02375; DB04716; DB08877; DB08895; DB11817; DB12010; DB12500; DB15091)
drugbank_target|P29597	-	1187	sp|P62344|CDPK1_PL	-	524	1.7e-108	361.7	0.0	1	2	1.4e-40	1.8e-39	133.9	0.0	73	322	630	865	575	884	0.86	Non-receptor tyrosine-protein kinase TYK2 (DB04716; DB08895; DB12010)
drugbank_target|P29597	-	1187	sp|P62344|CDPK1_PL	-	524	1.7e-108	361.7	0.0	2	2	4.9e-68	6.2e-67	224.6	0.0	52	319	892	1165	870	1177	0.84	Non-receptor tyrosine-protein kinase TYK2 (DB04716; DB08895; DB12010)
drugbank_target|Q13557	-	499	sp|P62344|CDPK1_PL	-	524	2.3e-107	358.0	0.0	1	1	2.2e-108	2.8e-107	357.7	0.0	50	405	8	358	1	411	0.87	Calcium/calmodulin-dependent protein kinase type II subunit delta (DB07853; DB08039; DB12010)
drugbank_target|Q8IU85	-	385	sp|P62344|CDPK1_PL	-	524	8.1e-107	356.2	0.1	1	1	7.6e-108	9.7e-107	355.9	0.1	40	365	7	319	1	332	0.96	Calcium/calmodulin-dependent protein kinase type 1D (DB08454; DB12010)
drugbank_target|Q13555	-	558	sp|P62344|CDPK1_PL	-	524	1.6e-106	355.2	0.0	1	1	1.7e-107	2.1e-106	354.8	0.0	49	395	7	332	1	362	0.91	Calcium/calmodulin-dependent protein kinase type II subunit gamma (DB06616; DB08699; DB12010)
drugbank_target|Q9UQM7	-	478	sp|P62344|CDPK1_PL	-	524	2.4e-105	351.3	0.0	1	1	2.8e-106	3.5e-105	350.8	0.0	50	366	7	309	3	397	0.88	Calcium/calmodulin-dependent protein kinase type II subunit alpha (DB04119; DB04447; DB07766; DB12010)
drugbank_target|P52333	-	1124	sp|P62344|CDPK1_PL	-	524	1e-104	349.3	0.0	1	2	3.8e-40	4.9e-39	132.5	0.0	49	320	514	774	481	779	0.85	Tyrosine-protein kinase JAK3 (DB04716; DB06321; DB08895; DB11817; DB12010; DB15035)
drugbank_target|P52333	-	1124	sp|P62344|CDPK1_PL	-	524	1e-104	349.3	0.0	2	2	5.3e-65	6.8e-64	214.5	0.0	54	318	820	1090	804	1094	0.85	Tyrosine-protein kinase JAK3 (DB04716; DB06321; DB08895; DB11817; DB12010; DB15035)
drugbank_target|Q14012	-	370	sp|P62344|CDPK1_PL	-	524	2.4e-104	348.0	0.0	1	1	2.4e-105	3.1e-104	347.7	0.0	47	369	11	320	6	331	0.95	Calcium/calmodulin-dependent protein kinase type 1 (DB12010)
drugbank_target|Q13554	-	666	sp|P62344|CDPK1_PL	-	524	5.1e-104	346.9	0.0	1	1	5.4e-105	6.9e-104	346.5	0.0	50	364	8	308	1	319	0.96	Calcium/calmodulin-dependent protein kinase type II subunit beta (DB07168; DB12010)
drugbank_target|Q96NX5	-	476	sp|P62344|CDPK1_PL	-	524	2.2e-103	344.9	0.2	1	1	2.2e-104	2.8e-103	344.5	0.2	37	365	4	317	1	324	0.95	Calcium/calmodulin-dependent protein kinase type 1G (DB08009; DB12010)
drugbank_target|P53355	-	1430	sp|P62344|CDPK1_PL	-	524	1.8e-99	331.9	0.1	1	1	2.1e-100	2.6e-99	331.4	0.1	49	361	6	310	2	367	0.92	Death-associated protein kinase 1 (DB04069; DB04395; DB07444; DB12010)
drugbank_target|P27448	-	753	sp|P62344|CDPK1_PL	-	524	1.5e-98	328.9	0.0	1	1	1.8e-99	2.3e-98	328.3	0.0	13	354	13	336	5	386	0.88	MAP/microtubule affinity-regulating kinase 3 (DB12010)
drugbank_target|Q16566	-	473	sp|P62344|CDPK1_PL	-	524	1.5e-98	328.9	0.0	1	1	1.5e-99	2e-98	328.5	0.0	49	385	38	360	13	381	0.91	Calcium/calmodulin-dependent protein kinase type IV (DB07664; DB07676)
drugbank_target|O43293	-	454	sp|P62344|CDPK1_PL	-	524	6e-98	326.9	0.1	1	1	1.1e-98	1.5e-97	325.6	0.0	49	341	6	291	2	324	0.91	Death-associated protein kinase 3 (DB04716; DB07125; DB07242; DB12010)
drugbank_target|Q9UIK4	-	370	sp|P62344|CDPK1_PL	-	524	6.4e-98	326.8	0.2	1	1	6.4e-99	8.1e-98	326.5	0.2	48	359	15	318	3	337	0.93	Death-associated protein kinase 2 (DB12010)
drugbank_target|O15075	-	740	sp|P62344|CDPK1_PL	-	524	1.9e-97	325.3	0.0	1	1	2.2e-98	2.8e-97	324.7	0.0	13	360	343	679	334	704	0.87	Serine/threonine-protein kinase DCLK1 (DB12010)
drugbank_target|Q7KZI7	-	788	sp|P62344|CDPK1_PL	-	524	2.9e-97	324.7	0.0	1	1	4.4e-98	5.5e-97	323.7	0.0	29	333	25	312	5	332	0.91	Serine/threonine-protein kinase MARK2 (DB12010)
drugbank_target|Q96L34	-	752	sp|P62344|CDPK1_PL	-	524	1.2e-96	322.7	0.0	1	1	1.2e-97	1.6e-96	322.2	0.0	48	351	51	336	12	374	0.89	MAP/microtubule affinity-regulating kinase 4 (DB12010)
drugbank_target|Q9P0L2	-	795	sp|P62344|CDPK1_PL	-	524	1.3e-96	322.5	0.0	1	1	1.5e-97	1.9e-96	321.9	0.0	37	345	41	331	8	356	0.87	Serine/threonine-protein kinase MARK1 (DB12010)
drugbank_target|Q9C098	-	648	sp|P62344|CDPK1_PL	-	524	2.2e-96	321.7	0.0	1	1	2.6e-97	3.3e-96	321.2	0.0	39	353	339	641	299	648	0.87	Serine/threonine-protein kinase DCLK3 (DB12010)
drugbank_target|Q9BYT3	-	514	sp|P62344|CDPK1_PL	-	524	7.7e-96	319.9	5.7	1	1	8e-97	1e-95	319.6	5.7	13	378	70	429	56	467	0.85	Serine/threonine-protein kinase 33 (DB12010)
drugbank_target|Q9P2K8	-	1649	sp|P62344|CDPK1_PL	-	524	1.1e-95	319.5	13.7	1	3	6.4e-39	8.2e-38	128.5	0.1	99	349	329	563	318	587	0.87	eIF-2-alpha kinase GCN2 (DB12010)
drugbank_target|Q9P2K8	-	1649	sp|P62344|CDPK1_PL	-	524	1.1e-95	319.5	13.7	2	3	2.2e-13	2.8e-12	44.2	0.0	55	138	589	658	576	662	0.88	eIF-2-alpha kinase GCN2 (DB12010)
drugbank_target|Q9P2K8	-	1649	sp|P62344|CDPK1_PL	-	524	1.1e-95	319.5	13.7	3	3	5.1e-46	6.5e-45	151.9	0.0	139	349	796	1024	787	1050	0.82	eIF-2-alpha kinase GCN2 (DB12010)
drugbank_target|P31751	-	481	sp|P62344|CDPK1_PL	-	524	6.2e-94	313.7	0.0	1	1	6.4e-95	8.1e-94	313.3	0.0	34	333	129	417	103	433	0.91	RAC-beta serine/threonine-protein kinase (DB07812; DB07859; DB07947; DB08073)
drugbank_target|O60285	-	661	sp|P62344|CDPK1_PL	-	524	9.7e-94	313.0	0.2	1	1	1e-94	1.3e-93	312.6	0.2	42	328	41	309	27	383	0.91	NUAK family SNF1-like kinase 1 (DB12010)
drugbank_target|O96017	-	543	sp|P62344|CDPK1_PL	-	524	2e-93	312.0	0.0	1	1	2.3e-94	3e-93	311.4	0.0	50	349	214	510	204	535	0.90	Serine/threonine-protein kinase Chk2 (DB05149; DB06486; DB12010)
drugbank_target|O14965	-	403	sp|P62344|CDPK1_PL	-	524	2.2e-93	311.8	0.0	1	1	2.1e-94	2.7e-93	311.6	0.0	23	342	100	400	75	403	0.92	Aurora kinase A (DB02482; DB05169; DB05198; DB05220; DB06134; DB06347; DB06486; DB07186; DB07266; DB07360; DB07362; DB07545; DB07801; DB08065; DB08066; DB12010; DB13061)
drugbank_target|Q9Y2K2	-	1321	sp|P62344|CDPK1_PL	-	524	2.6e-93	311.6	0.2	1	2	2e-94	2.6e-93	311.6	0.2	56	368	66	357	61	377	0.92	Serine/threonine-protein kinase SIK3 (DB12010)
drugbank_target|Q9Y2K2	-	1321	sp|P62344|CDPK1_PL	-	524	2.6e-93	311.6	0.2	2	2	0.45	5.8	3.6	0.7	359	393	998	1031	987	1044	0.77	Serine/threonine-protein kinase SIK3 (DB12010)
drugbank_target|P31749	-	480	sp|P62344|CDPK1_PL	-	524	3.8e-93	311.0	0.1	1	1	3.8e-94	4.8e-93	310.7	0.1	27	332	121	415	96	472	0.87	RAC-alpha serine/threonine-protein kinase (DB00171; DB01169; DB01645; DB01863; DB02709; DB05971; DB06486; DB06641; DB07584; DB07585)
drugbank_target|O14936	-	926	sp|P62344|CDPK1_PL	-	524	5.8e-93	310.4	0.0	1	1	8e-94	1e-92	309.6	0.0	52	367	8	315	2	319	0.94	Peripheral plasma membrane protein CASK (DB01942; DB12010)
drugbank_target|Q8N568	-	766	sp|P62344|CDPK1_PL	-	524	1.2e-92	309.4	0.0	1	1	1.3e-93	1.7e-92	308.9	0.0	46	358	384	684	352	704	0.89	Serine/threonine-protein kinase DCLK2 (DB12010)
drugbank_target|Q16816	-	387	sp|P62344|CDPK1_PL	-	524	2.2e-92	308.6	0.0	1	1	2.2e-93	2.8e-92	308.2	0.0	46	332	10	295	2	309	0.93	Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform (DB12010)
drugbank_target|Q02156	-	737	sp|P62344|CDPK1_PL	-	524	2.3e-92	308.5	0.0	1	1	2.5e-93	3.2e-92	308.0	0.0	6	332	353	675	349	729	0.85	Protein kinase C epsilon type (DB06064; DB11752; DB12010)
drugbank_target|Q02156	-	737	sp|P62344|CDPK1_PL	-	524	2.3e-92	308.5	0.0	1	1	2.5e-93	3.2e-92	308.0	0.0	6	332	353	675	349	729	0.85	Protein kinase C epsilon type (DB00675)
drugbank_target|Q13131	-	559	sp|P62344|CDPK1_PL	-	524	3.5e-92	307.9	0.1	1	1	3.6e-93	4.5e-92	307.5	0.1	44	332	14	286	2	342	0.90	5'-AMP-activated protein kinase catalytic subunit alpha-1 (DB00131; DB00945; DB12010)
drugbank_target|Q13131	-	559	sp|P62344|CDPK1_PL	-	524	3.5e-92	307.9	0.1	1	1	3.6e-93	4.5e-92	307.5	0.1	44	332	14	286	2	342	0.90	5'-AMP-activated protein kinase catalytic subunit alpha-1 (DB00131; DB00171; DB00914; DB12010)
drugbank_target|Q9H093	-	628	sp|P62344|CDPK1_PL	-	524	4.3e-92	307.6	0.1	1	1	4.9e-93	6.2e-92	307.1	0.1	39	326	36	304	26	319	0.94	NUAK family SNF1-like kinase 2 (DB12010)
drugbank_target|Q15746	-	1914	sp|P62344|CDPK1_PL	-	524	7.8e-92	306.7	0.4	1	1	1.1e-92	1.4e-91	305.9	0.4	29	359	1437	1748	1411	1767	0.88	Myosin light chain kinase, smooth muscle (DB12010)
drugbank_target|Q9NRH2	-	765	sp|P62344|CDPK1_PL	-	524	1.1e-91	306.2	0.1	1	1	1.5e-92	1.9e-91	305.5	0.1	50	337	10	281	4	323	0.91	SNF-related serine/threonine-protein kinase (DB12010)
drugbank_target|Q13188	-	491	sp|P62344|CDPK1_PL	-	524	2.5e-91	305.0	0.0	1	1	3.4e-92	4.4e-91	304.3	0.0	49	372	20	325	4	333	0.92	Serine/threonine-protein kinase 3 (DB12010)
drugbank_target|Q9Y6E0	-	443	sp|P62344|CDPK1_PL	-	524	3.1e-91	304.7	0.0	1	1	3.2e-92	4e-91	304.4	0.0	50	399	30	361	18	383	0.85	Serine/threonine-protein kinase 24 (DB12010)
drugbank_target|Q32MK0	-	819	sp|P62344|CDPK1_PL	-	524	3.4e-91	304.6	0.2	1	1	3.9e-92	4.9e-91	304.1	0.2	43	359	500	802	494	813	0.92	Myosin light chain kinase 3 (DB12010)
drugbank_target|P57059	-	783	sp|P62344|CDPK1_PL	-	524	1.2e-90	302.8	0.0	1	1	1.3e-91	1.7e-90	302.3	0.0	54	327	25	280	4	286	0.94	Serine/threonine-protein kinase SIK1 (DB08912; DB12010)
drugbank_target|Q13177	-	524	sp|P62344|CDPK1_PL	-	524	1.4e-90	302.6	0.0	1	1	1.6e-91	2e-90	302.0	0.0	22	330	215	505	207	523	0.93	Serine/threonine-protein kinase PAK 2 (DB12010)
drugbank_target|Q13153	-	545	sp|P62344|CDPK1_PL	-	524	2e-90	302.1	0.0	1	1	2.5e-91	3.2e-90	301.4	0.0	22	330	236	526	222	544	0.93	Serine/threonine-protein kinase PAK 1 (DB12010)
drugbank_target|P54646	-	552	sp|P62344|CDPK1_PL	-	524	2.5e-90	301.8	0.0	1	1	2.5e-91	3.2e-90	301.4	0.0	47	384	6	327	1	341	0.86	5'-AMP-activated protein kinase catalytic subunit alpha-2 (DB00131; DB00945; DB12010)
drugbank_target|O75914	-	559	sp|P62344|CDPK1_PL	-	524	2.8e-90	301.6	0.0	1	1	3.5e-91	4.5e-90	300.9	0.0	17	330	244	539	231	558	0.92	Serine/threonine-protein kinase PAK 3 (DB12010)
drugbank_target|P17612	-	351	sp|P62344|CDPK1_PL	-	524	3.1e-90	301.4	0.0	1	1	3.2e-91	4.1e-90	301.0	0.0	32	329	22	302	3	317	0.89	cAMP-dependent protein kinase catalytic subunit alpha (DB01919; DB01940; DB02155; DB02482; DB02611; DB03374; DB04098; DB04522; DB04530; DB04707; DB06959; DB06977; DB07107; DB07124; DB07204; DB07235; DB07458; DB07583; DB07854; DB07855; DB07856; DB07857; DB07858; DB07859; DB07860; DB07876; DB07947; DB07995; DB07996; DB07997; DB08070; DB08073; DB08113; DB08114; DB08148; DB08149; DB08150; DB08162; DB08231; DB08568; DB08569; DB08756; DB08846; DB12010)
drugbank_target|Q86YV6	-	388	sp|P62344|CDPK1_PL	-	524	5.3e-90	300.7	0.1	1	1	5.2e-91	6.6e-90	300.4	0.1	45	340	93	376	49	386	0.93	Myosin light chain kinase family member 4 (DB12010)
drugbank_target|Q9P289	-	416	sp|P62344|CDPK1_PL	-	524	1e-89	299.8	0.1	1	1	9.6e-91	1.2e-89	299.5	0.1	50	375	18	319	9	409	0.89	Serine/threonine-protein kinase 26 (DB07853; DB12010)
drugbank_target|P22694	-	351	sp|P62344|CDPK1_PL	-	524	1.6e-89	299.1	0.0	1	1	1.4e-90	1.8e-89	298.9	0.0	46	331	34	304	3	350	0.89	cAMP-dependent protein kinase catalytic subunit beta (DB02482; DB12010)
drugbank_target|P17252	-	672	sp|P62344|CDPK1_PL	-	524	4e-89	297.8	0.0	1	1	4.7e-90	6e-89	297.2	0.0	48	333	330	605	295	625	0.88	Protein kinase C alpha type (DB00144; DB00163; DB05013; DB06451; DB06595; DB06641; DB08846; DB11752; DB14001; DB14002)
drugbank_target|P17252	-	672	sp|P62344|CDPK1_PL	-	524	4e-89	297.8	0.0	1	1	4.7e-90	6e-89	297.2	0.0	48	333	330	605	295	625	0.88	Protein kinase C alpha type (DB00675)
drugbank_target|Q14680	-	651	sp|P62344|CDPK1_PL	-	524	5.7e-89	297.3	0.8	1	1	5.9e-90	7.5e-89	296.9	0.8	50	338	5	276	1	307	0.92	Maternal embryonic leucine zipper kinase (DB12010)
drugbank_target|Q04759	-	706	sp|P62344|CDPK1_PL	-	524	6.2e-89	297.2	0.2	1	1	7.7e-90	9.8e-89	296.5	0.2	54	334	378	643	352	688	0.92	Protein kinase C theta type (DB02010; DB02482; DB04522; DB12010)
drugbank_target|Q04759	-	706	sp|P62344|CDPK1_PL	-	524	6.2e-89	297.2	0.2	1	1	7.7e-90	9.8e-89	296.5	0.2	54	334	378	643	352	688	0.92	Protein kinase C theta type (DB00675)
drugbank_target|Q9H0K1	-	926	sp|P62344|CDPK1_PL	-	524	6.9e-89	297.0	0.1	1	1	5.4e-90	6.9e-89	297.0	0.1	56	328	20	274	9	328	0.92	Serine/threonine-protein kinase SIK2 (DB12010)
drugbank_target|O00444	-	970	sp|P62344|CDPK1_PL	-	524	1e-88	296.4	0.0	1	1	8.2e-90	1e-88	296.4	0.0	54	335	10	275	5	308	0.93	Serine/threonine-protein kinase PLK4 (DB12010)
drugbank_target|Q16513	-	984	sp|P62344|CDPK1_PL	-	524	1.2e-88	296.2	0.0	1	1	1.9e-89	2.4e-88	295.2	0.0	5	334	602	925	598	979	0.86	Serine/threonine-protein kinase N2 (DB12010)
drugbank_target|O00141	-	431	sp|P62344|CDPK1_PL	-	524	5.1e-88	294.1	0.0	1	1	5.1e-89	6.5e-88	293.8	0.0	53	326	95	356	59	369	0.91	Serine/threonine-protein kinase Sgk1 (DB03247; DB07837; DB08191)
drugbank_target|Q9H1R3	-	596	sp|P62344|CDPK1_PL	-	524	8.2e-88	293.5	0.4	1	1	8.6e-89	1.1e-87	293.0	0.4	55	362	284	575	267	588	0.91	Myosin light chain kinase 2, skeletal/cardiac muscle (DB04825; DB12010)
drugbank_target|Q9NRP7	-	1315	sp|P62344|CDPK1_PL	-	524	2.7e-87	291.7	0.0	1	1	3.7e-88	4.7e-87	290.9	0.0	54	328	2	257	1	271	0.96	Serine/threonine-protein kinase 36 (DB12010)
drugbank_target|Q9UQB9	-	309	sp|P62344|CDPK1_PL	-	524	3.7e-87	291.3	0.0	1	1	3.7e-88	4.7e-87	291.0	0.0	51	330	38	298	9	304	0.93	Aurora kinase C (DB06134; DB12010)
drugbank_target|P05771	-	671	sp|P62344|CDPK1_PL	-	524	4.6e-87	291.0	0.0	1	1	5.2e-88	6.6e-87	290.5	0.0	16	336	302	611	292	646	0.84	Protein kinase C beta type (DB00675)
drugbank_target|P05771	-	671	sp|P62344|CDPK1_PL	-	524	4.6e-87	291.0	0.0	1	1	5.2e-88	6.6e-87	290.5	0.0	16	336	302	611	292	646	0.84	Protein kinase C beta type (DB00163; DB01738; DB06486; DB08846; DB08862; DB14001; DB14002)
drugbank_target|Q9UEE5	-	414	sp|P62344|CDPK1_PL	-	524	5e-87	290.9	0.2	1	1	5e-88	6.4e-87	290.5	0.2	53	358	56	354	45	401	0.90	Serine/threonine-protein kinase 17A (DB12010)
drugbank_target|Q96BR1	-	496	sp|P62344|CDPK1_PL	-	524	5.1e-87	290.8	0.0	1	1	5.9e-88	7.6e-87	290.3	0.0	20	331	125	425	111	433	0.85	Serine/threonine-protein kinase Sgk3 (DB12010)
drugbank_target|Q9H2G2	-	1235	sp|P62344|CDPK1_PL	-	524	1.9e-86	289.0	0.1	1	1	1.5e-87	1.9e-86	289.0	0.1	38	354	16	325	7	356	0.85	STE20-like serine/threonine-protein kinase (DB07664; DB07853; DB12010)
drugbank_target|Q9H4B4	-	646	sp|P62344|CDPK1_PL	-	524	3e-86	288.3	0.0	1	1	3.3e-87	4.2e-86	287.8	0.0	53	330	59	319	52	342	0.95	Serine/threonine-protein kinase PLK3 (DB12010)
drugbank_target|Q9NYY3	-	685	sp|P62344|CDPK1_PL	-	524	6.1e-86	287.3	0.1	1	1	6.4e-87	8.1e-86	286.9	0.1	40	334	66	343	25	416	0.88	Serine/threonine-protein kinase PLK2 (DB12010)
drugbank_target|O75385	-	1050	sp|P62344|CDPK1_PL	-	524	6.7e-86	287.1	0.0	1	1	7.4e-87	9.4e-86	286.7	0.0	55	330	15	283	4	293	0.92	Serine/threonine-protein kinase ULK1 (DB12010)
drugbank_target|Q00532	-	358	sp|P62344|CDPK1_PL	-	524	7.7e-86	287.0	0.3	1	2	2.4e-75	3.1e-74	248.7	0.0	53	291	2	227	1	237	0.92	Cyclin-dependent kinase-like 1 (DB12010)
drugbank_target|Q00532	-	358	sp|P62344|CDPK1_PL	-	524	7.7e-86	287.0	0.3	2	2	3.9e-11	5e-10	36.8	0.0	289	356	252	318	239	336	0.75	Cyclin-dependent kinase-like 1 (DB12010)
drugbank_target|P51956	-	506	sp|P62344|CDPK1_PL	-	524	8.4e-86	286.8	0.2	1	1	8.2e-87	1e-85	286.5	0.2	54	376	2	314	1	345	0.90	Serine/threonine-protein kinase Nek3 (DB12010)
drugbank_target|Q8IYT8	-	1036	sp|P62344|CDPK1_PL	-	524	8.6e-86	286.8	0.0	1	1	1.1e-86	1.3e-85	286.2	0.0	55	330	8	276	2	284	0.93	Serine/threonine-protein kinase ULK2 (DB12010)
drugbank_target|Q8IVH8	-	894	sp|P62344|CDPK1_PL	-	524	9.8e-86	286.6	0.0	1	1	1.1e-86	1.4e-85	286.1	0.0	49	333	9	281	5	324	0.93	Mitogen-activated protein kinase kinase kinase kinase 3 (DB12010)
drugbank_target|Q9UKE5	-	1360	sp|P62344|CDPK1_PL	-	524	9.9e-86	286.6	0.0	1	1	7.8e-87	9.9e-86	286.6	0.0	56	369	25	331	14	340	0.87	TRAF2 and NCK-interacting protein kinase (DB12010)
drugbank_target|P54756	-	1037	sp|P62344|CDPK1_PL	-	524	1.3e-85	286.2	0.0	1	1	1.4e-86	1.8e-85	285.7	0.0	3	321	621	930	619	954	0.93	Ephrin type-A receptor 5 (DB01254; DB12010)
drugbank_target|P53350	-	603	sp|P62344|CDPK1_PL	-	524	1.5e-85	286.0	0.0	1	1	1.6e-86	2.1e-85	285.5	0.0	52	327	49	307	42	313	0.96	Serine/threonine-protein kinase PLK1 (DB06897; DB06963; DB07186; DB07789; DB08059; DB12010)
drugbank_target|P54762	-	984	sp|P62344|CDPK1_PL	-	524	1.5e-85	286.0	0.0	1	1	1.7e-86	2.2e-85	285.4	0.0	37	321	599	876	562	894	0.90	Ephrin type-B receptor 1 (DB12010)
drugbank_target|Q05655	-	676	sp|P62344|CDPK1_PL	-	524	2.1e-85	285.5	0.0	1	1	2.2e-86	2.8e-85	285.1	0.0	33	329	326	607	291	656	0.87	Protein kinase C delta type (DB04376; DB05013; DB12010)
drugbank_target|Q05655	-	676	sp|P62344|CDPK1_PL	-	524	2.1e-85	285.5	0.0	1	1	2.2e-86	2.8e-85	285.1	0.0	33	329	326	607	291	656	0.87	Protein kinase C delta type (DB00675)
drugbank_target|P41743	-	596	sp|P62344|CDPK1_PL	-	524	3.1e-85	284.9	0.0	1	2	7.2	92	-0.4	0.0	368	391	78	100	41	102	0.57	Protein kinase C iota type (DB00675)
drugbank_target|P41743	-	596	sp|P62344|CDPK1_PL	-	524	3.1e-85	284.9	0.0	2	2	1.2e-85	1.6e-84	282.6	0.0	22	335	220	532	201	541	0.87	Protein kinase C iota type (DB00675)
drugbank_target|P41743	-	596	sp|P62344|CDPK1_PL	-	524	3.1e-85	284.9	0.0	1	2	7.2	92	-0.4	0.0	368	391	78	100	41	102	0.57	Protein kinase C iota type (DB03777; DB12010)
drugbank_target|P41743	-	596	sp|P62344|CDPK1_PL	-	524	3.1e-85	284.9	0.0	2	2	1.2e-85	1.6e-84	282.6	0.0	22	335	220	532	201	541	0.87	Protein kinase C iota type (DB03777; DB12010)
drugbank_target|Q9Y2H1	-	464	sp|P62344|CDPK1_PL	-	524	3.8e-85	284.7	3.0	1	1	3.5e-85	4.4e-84	281.1	3.0	7	366	40	424	34	441	0.86	Serine/threonine-protein kinase 38-like (DB12010)
drugbank_target|Q9HBH9	-	465	sp|P62344|CDPK1_PL	-	524	3.9e-85	284.6	0.0	1	1	4.1e-86	5.2e-85	284.2	0.0	33	367	60	412	50	422	0.87	MAP kinase-interacting serine/threonine-protein kinase 2 (DB12010)
drugbank_target|P54764	-	986	sp|P62344|CDPK1_PL	-	524	8.5e-85	283.5	0.0	1	1	1.1e-85	1.4e-84	282.8	0.0	10	321	574	876	565	899	0.88	Ephrin type-A receptor 4 (DB12010)
drugbank_target|Q6PHR2	-	472	sp|P62344|CDPK1_PL	-	524	1.3e-84	282.9	0.0	1	1	1.5e-85	2e-84	282.3	0.0	56	351	14	296	10	308	0.92	Serine/threonine-protein kinase ULK3 (DB12010)
drugbank_target|P24941	-	298	sp|P62344|CDPK1_PL	-	524	1.4e-84	282.8	0.0	1	2	3.9e-77	4.9e-76	254.6	0.0	54	295	2	231	1	235	0.94	Cyclin-dependent kinase 2 (DB01888; DB02010; DB02052; DB02091; DB02116; DB02197; DB02297; DB02407; DB02538; DB02603; DB02647; DB02733; DB02833; DB02898; DB02915; DB02950; DB02963; DB02973; DB03019; DB03307; DB03365; DB03428; DB03490; DB03496; DB03583; DB03663; DB03737; DB03801; DB04006; DB04101; DB04186; DB04288; DB04407; DB04518; DB04607; DB04662; DB04669; DB06195; DB06616; DB06844; DB06888; DB06944; DB06948; DB06976; DB06983; DB07024; DB07054; DB07065; DB07126; DB07137; DB07163; DB07164; DB07179; DB07203; DB07210; DB07220; DB07431; DB07471; DB07493; DB07501; DB07504; DB07529; DB07531; DB07533; DB07534; DB07538; DB07539; DB07540; DB07562; DB07595; DB07606; DB07612; DB07618; DB07622; DB07685; DB07686; DB07687; DB07688; DB07731; DB07750; DB07751; DB07755; DB07761; DB07790; DB07791; DB07852; DB07889; DB07936; DB07982; DB08066; DB08094; DB08122; DB08123; DB08124; DB08125; DB08126; DB08132; DB08133; DB08134; DB08135; DB08136; DB08137; DB08138; DB08139; DB08140; DB08141; DB08142; DB08178; DB08182; DB08218; DB08219; DB08233; DB08241; DB08247; DB08248; DB08285; DB08309; DB08312; DB08355; DB08441; DB08463; DB08527; DB08531; DB08532; DB08533; DB08534; DB08535; DB08536; DB08537; DB08538; DB08539; DB08572; DB08673; DB08677; DB08694; DB08768)
drugbank_target|P24941	-	298	sp|P62344|CDPK1_PL	-	524	1.4e-84	282.8	0.0	2	2	5.5e-08	7e-07	26.4	0.0	292	330	253	291	240	296	0.87	Cyclin-dependent kinase 2 (DB01888; DB02010; DB02052; DB02091; DB02116; DB02197; DB02297; DB02407; DB02538; DB02603; DB02647; DB02733; DB02833; DB02898; DB02915; DB02950; DB02963; DB02973; DB03019; DB03307; DB03365; DB03428; DB03490; DB03496; DB03583; DB03663; DB03737; DB03801; DB04006; DB04101; DB04186; DB04288; DB04407; DB04518; DB04607; DB04662; DB04669; DB06195; DB06616; DB06844; DB06888; DB06944; DB06948; DB06976; DB06983; DB07024; DB07054; DB07065; DB07126; DB07137; DB07163; DB07164; DB07179; DB07203; DB07210; DB07220; DB07431; DB07471; DB07493; DB07501; DB07504; DB07529; DB07531; DB07533; DB07534; DB07538; DB07539; DB07540; DB07562; DB07595; DB07606; DB07612; DB07618; DB07622; DB07685; DB07686; DB07687; DB07688; DB07731; DB07750; DB07751; DB07755; DB07761; DB07790; DB07791; DB07852; DB07889; DB07936; DB07982; DB08066; DB08094; DB08122; DB08123; DB08124; DB08125; DB08126; DB08132; DB08133; DB08134; DB08135; DB08136; DB08137; DB08138; DB08139; DB08140; DB08141; DB08142; DB08178; DB08182; DB08218; DB08219; DB08233; DB08241; DB08247; DB08248; DB08285; DB08309; DB08312; DB08355; DB08441; DB08463; DB08527; DB08531; DB08532; DB08533; DB08534; DB08535; DB08536; DB08537; DB08538; DB08539; DB08572; DB08673; DB08677; DB08694; DB08768)
drugbank_target|Q96GD4	-	344	sp|P62344|CDPK1_PL	-	524	2.2e-84	282.1	0.0	1	1	2.2e-85	2.8e-84	281.8	0.0	53	330	74	332	41	340	0.94	Aurora kinase B (DB04703; DB05169; DB06486; DB07340; DB12010)
drugbank_target|P51957	-	841	sp|P62344|CDPK1_PL	-	524	2.4e-84	282.0	0.6	1	1	4.2e-85	5.3e-84	280.9	0.0	56	346	6	283	2	305	0.90	Serine/threonine-protein kinase Nek4 (DB12010)
drugbank_target|P29323	-	1055	sp|P62344|CDPK1_PL	-	524	2.8e-84	281.8	0.0	1	1	3.5e-85	4.4e-84	281.1	0.0	37	321	601	878	569	894	0.91	Ephrin type-B receptor 2 (DB04395; DB12010)
drugbank_target|P53778	-	367	sp|P62344|CDPK1_PL	-	524	3.1e-84	281.6	0.0	1	2	8.1e-76	1e-74	250.2	0.0	42	309	13	269	7	277	0.93	Mitogen-activated protein kinase 12 (DB02482; DB04395; DB05157; DB05403)
drugbank_target|P53778	-	367	sp|P62344|CDPK1_PL	-	524	3.1e-84	281.6	0.0	2	2	5e-09	6.3e-08	29.8	0.0	292	351	278	337	267	356	0.84	Mitogen-activated protein kinase 12 (DB02482; DB04395; DB05157; DB05403)
drugbank_target|P53778	-	367	sp|P62344|CDPK1_PL	-	524	3.1e-84	281.6	0.0	1	2	8.1e-76	1e-74	250.2	0.0	42	309	13	269	7	277	0.93	Mitogen-activated protein kinase 12 (DB01017)
drugbank_target|P53778	-	367	sp|P62344|CDPK1_PL	-	524	3.1e-84	281.6	0.0	2	2	5e-09	6.3e-08	29.8	0.0	292	351	278	337	267	356	0.84	Mitogen-activated protein kinase 12 (DB01017)
drugbank_target|P29320	-	983	sp|P62344|CDPK1_PL	-	524	3.8e-84	281.4	0.0	1	1	4.4e-85	5.6e-84	280.8	0.0	28	320	592	875	568	879	0.89	Ephrin type-A receptor 3 (DB12010)
drugbank_target|Q15375	-	998	sp|P62344|CDPK1_PL	-	524	5.9e-84	280.7	0.0	1	1	7e-85	8.9e-84	280.1	0.0	32	320	608	887	590	897	0.92	Ephrin type-A receptor 7 (DB07970; DB12010)
drugbank_target|Q6P3R8	-	708	sp|P62344|CDPK1_PL	-	524	6.2e-84	280.7	0.1	1	1	4.9e-85	6.2e-84	280.7	0.1	54	331	2	265	1	301	0.92	Serine/threonine-protein kinase Nek5 (DB12010)
drugbank_target|Q92772	-	493	sp|P62344|CDPK1_PL	-	524	8.9e-84	280.1	5.2	1	1	3.9e-84	5e-83	277.7	5.2	54	362	2	329	1	343	0.88	Cyclin-dependent kinase-like 2 (DB12010)
drugbank_target|P49137	-	400	sp|P62344|CDPK1_PL	-	524	1e-83	280.0	0.2	1	1	9.9e-85	1.3e-83	279.6	0.2	46	345	53	346	44	380	0.86	MAP kinase-activated protein kinase 2 (DB02010; DB07234; DB07406; DB07430; DB07431; DB07728; DB08358)
drugbank_target|Q15208	-	465	sp|P62344|CDPK1_PL	-	524	1.1e-83	279.8	4.8	1	1	7.5e-84	9.5e-83	276.7	4.8	4	370	36	427	33	436	0.87	Serine/threonine-protein kinase 38 (DB12010)
drugbank_target|O94804	-	968	sp|P62344|CDPK1_PL	-	524	1.2e-83	279.7	0.0	1	1	9.6e-85	1.2e-83	279.7	0.0	39	352	20	320	8	348	0.84	Serine/threonine-protein kinase 10 (DB12010)
drugbank_target|Q13237	-	762	sp|P62344|CDPK1_PL	-	524	1.3e-83	279.6	0.0	1	2	0.014	0.17	8.6	0.0	88	209	258	380	231	383	0.65	cGMP-dependent protein kinase 2 (DB12010)
drugbank_target|Q13237	-	762	sp|P62344|CDPK1_PL	-	524	1.3e-83	279.6	0.0	2	2	2.2e-81	2.8e-80	268.6	0.0	16	328	413	714	402	728	0.90	cGMP-dependent protein kinase 2 (DB12010)
drugbank_target|O95819	-	1239	sp|P62344|CDPK1_PL	-	524	1.4e-83	279.5	0.0	1	1	1.1e-84	1.4e-83	279.5	0.0	55	366	24	328	15	339	0.87	Mitogen-activated protein kinase kinase kinase kinase 4 (DB12010)
drugbank_target|Q8IY84	-	436	sp|P62344|CDPK1_PL	-	524	2.6e-83	278.6	0.0	1	1	2.6e-84	3.3e-83	278.3	0.0	34	349	52	349	20	376	0.84	Serine/threonine-protein kinase NIM1 (DB12010)
drugbank_target|Q15139	-	912	sp|P62344|CDPK1_PL	-	524	4.3e-83	277.9	0.0	1	1	4.9e-84	6.2e-83	277.4	0.0	42	330	567	844	544	865	0.91	Serine/threonine-protein kinase D1 (DB11752; DB12010)
drugbank_target|Q16644	-	382	sp|P62344|CDPK1_PL	-	524	4.4e-83	277.9	0.1	1	1	4.4e-84	5.6e-83	277.5	0.1	48	340	35	320	27	369	0.87	MAP kinase-activated protein kinase 3 (DB07728; DB08358)
drugbank_target|O94768	-	372	sp|P62344|CDPK1_PL	-	524	5.6e-83	277.5	0.0	1	1	5.5e-84	7e-83	277.2	0.0	48	359	24	328	13	359	0.86	Serine/threonine-protein kinase 17B (DB04216; DB12010)
drugbank_target|P00521	-	746	sp|P62344|CDPK1_PL	-	524	7.2e-83	277.1	0.1	1	1	8.1e-84	1e-82	276.6	0.1	49	322	120	378	104	401	0.89	Tyrosine-protein kinase transforming protein Abl (DB02567; DB03814; DB03878; DB05489)
drugbank_target|Q7L7X3	-	1001	sp|P62344|CDPK1_PL	-	524	9.9e-83	276.7	0.0	1	1	7.8e-84	9.9e-83	276.7	0.0	49	372	21	334	4	341	0.85	Serine/threonine-protein kinase TAO1 (DB12010)
drugbank_target|Q13464	-	1354	sp|P62344|CDPK1_PL	-	524	1e-82	276.7	0.0	1	1	8e-84	1e-82	276.7	0.0	31	331	49	344	44	355	0.89	Rho-associated protein kinase 1 (DB04707; DB07876; DB08162; DB08756; DB13165; DB13931)
drugbank_target|P05129	-	697	sp|P62344|CDPK1_PL	-	524	1.3e-82	276.3	0.0	1	1	1.5e-83	1.9e-82	275.8	0.0	54	315	349	599	339	615	0.91	Protein kinase C gamma type (DB00675)
drugbank_target|P05129	-	697	sp|P62344|CDPK1_PL	-	524	1.3e-82	276.3	0.0	1	1	1.5e-83	1.9e-82	275.8	0.0	54	315	349	599	339	615	0.91	Protein kinase C gamma type (DB12010)
drugbank_target|Q99759	-	626	sp|P62344|CDPK1_PL	-	524	1.4e-82	276.2	0.0	1	1	1.7e-83	2.2e-82	275.5	0.0	31	326	337	623	324	625	0.92	Mitogen-activated protein kinase kinase kinase 3 (DB12010)
drugbank_target|O95747	-	527	sp|P62344|CDPK1_PL	-	524	1.7e-82	275.9	0.0	1	1	1.8e-83	2.3e-82	275.5	0.0	53	355	14	320	3	334	0.88	Serine/threonine-protein kinase OSR1 (DB12010)
drugbank_target|P00519	-	1130	sp|P62344|CDPK1_PL	-	524	2e-82	275.7	0.0	1	1	2.3e-83	3e-82	275.1	0.0	49	322	234	492	217	539	0.89	Tyrosine-protein kinase ABL1 (DB00171; DB00619; DB01254; DB03878; DB04868; DB05184; DB06616; DB07831; DB08043; DB08231; DB08339; DB08350; DB08583; DB08896; DB08901; DB12010; DB12267; DB12323)
drugbank_target|Q9UPZ9	-	632	sp|P62344|CDPK1_PL	-	524	3.4e-82	274.9	0.1	1	1	2.3e-81	2.9e-80	268.6	0.1	54	335	2	294	1	308	0.88	Serine/threonine-protein kinase ICK (DB12010)
drugbank_target|Q56UN5	-	1328	sp|P62344|CDPK1_PL	-	524	3.9e-82	274.7	2.2	1	1	1.2e-82	1.5e-81	272.8	0.0	27	328	1030	1327	1007	1328	0.86	Mitogen-activated protein kinase kinase kinase 19 (DB12010)
drugbank_target|O75116	-	1388	sp|P62344|CDPK1_PL	-	524	4e-82	274.7	0.0	1	1	3.1e-83	4e-82	274.7	0.0	30	334	64	363	60	377	0.89	Rho-associated protein kinase 2 (DB08162; DB08756; DB12010; DB13165; DB13931)
drugbank_target|Q9UF33	-	1036	sp|P62344|CDPK1_PL	-	524	7.4e-82	273.8	0.0	1	1	1.5e-82	1.9e-81	272.5	0.0	7	320	581	927	575	938	0.93	Ephrin type-A receptor 6 (DB12010)
drugbank_target|Q9NQU5	-	681	sp|P62344|CDPK1_PL	-	524	7.8e-82	273.7	0.0	1	1	8.6e-83	1.1e-81	273.2	0.0	59	328	410	661	385	673	0.94	Serine/threonine-protein kinase PAK 6 (DB12010)
drugbank_target|Q8N4C8	-	1332	sp|P62344|CDPK1_PL	-	524	9e-82	273.5	0.0	1	1	7.1e-83	9e-82	273.5	0.0	56	371	25	333	17	343	0.89	Misshapen-like kinase 1 (DB12010)
drugbank_target|Q9H2K8	-	898	sp|P62344|CDPK1_PL	-	524	9.8e-82	273.4	0.0	1	1	7.7e-83	9.8e-82	273.4	0.0	52	374	20	327	12	350	0.88	Serine/threonine-protein kinase TAO3 (DB12010)
drugbank_target|Q9P286	-	719	sp|P62344|CDPK1_PL	-	524	1.1e-81	273.2	0.0	1	1	1.3e-82	1.7e-81	272.6	0.0	39	326	432	701	412	707	0.92	Serine/threonine-protein kinase PAK 5 (DB12010)
drugbank_target|Q16512	-	942	sp|P62344|CDPK1_PL	-	524	1.2e-81	273.2	0.0	1	1	1.5e-82	1.9e-81	272.5	0.0	52	327	611	876	560	885	0.91	Serine/threonine-protein kinase N1 (DB12010)
drugbank_target|Q96PY6	-	1258	sp|P62344|CDPK1_PL	-	524	1.2e-81	273.1	0.0	1	1	9.7e-83	1.2e-81	273.1	0.0	54	334	2	267	1	309	0.91	Serine/threonine-protein kinase Nek1 (DB12010)
drugbank_target|P54760	-	987	sp|P62344|CDPK1_PL	-	524	1.3e-81	273.0	0.0	1	1	1.4e-82	1.8e-81	272.6	0.0	37	320	595	871	564	883	0.91	Ephrin type-B receptor 4 (DB01254; DB07249; DB07250; DB07251; DB07252; DB07253; DB07254; DB07255; DB07256; DB11973; DB12010)
drugbank_target|P42685	-	505	sp|P62344|CDPK1_PL	-	524	1.3e-81	273.0	0.0	1	1	1.4e-82	1.8e-81	272.5	0.0	48	319	225	483	218	499	0.92	Tyrosine-protein kinase FRK (DB01254; DB08896; DB12010; DB15035)
drugbank_target|P42684	-	1182	sp|P62344|CDPK1_PL	-	524	1.5e-81	272.8	0.0	1	1	1.8e-82	2.3e-81	272.2	0.0	48	321	279	537	265	591	0.90	Abelson tyrosine-protein kinase 2 (DB00171; DB01254; DB05184; DB07664; DB12010)
drugbank_target|Q05397	-	1052	sp|P62344|CDPK1_PL	-	524	4.2e-81	271.3	0.0	1	1	5.3e-82	6.8e-81	270.6	0.0	23	339	389	692	372	706	0.84	Focal adhesion kinase 1 (DB06423; DB07248; DB07460; DB12010)
drugbank_target|P06493	-	297	sp|P62344|CDPK1_PL	-	524	6.6e-81	270.7	0.0	1	1	3.8e-80	4.9e-79	264.5	0.0	54	334	2	296	1	297	0.91	Cyclin-dependent kinase 1 (DB02052; DB02116; DB02950; DB03428; DB03496; DB04014; DB06195; DB08142; DB12010)
drugbank_target|P28482	-	360	sp|P62344|CDPK1_PL	-	524	6.7e-81	270.7	0.0	1	1	1.2e-81	1.6e-80	269.4	0.0	44	334	13	322	5	338	0.93	Mitogen-activated protein kinase 1 (DB00945)
drugbank_target|P28482	-	360	sp|P62344|CDPK1_PL	-	524	6.7e-81	270.7	0.0	1	1	1.2e-81	1.6e-80	269.4	0.0	44	334	13	322	5	338	0.93	Mitogen-activated protein kinase 1 (DB01064; DB01169; DB02116; DB02482; DB02733; DB04338; DB06195; DB06641; DB06877; DB07010; DB07264; DB07788; DB07794; DB07905; DB08513; DB08521; DB11120; DB13930)
drugbank_target|P28482	-	360	sp|P62344|CDPK1_PL	-	524	6.7e-81	270.7	0.0	1	1	1.2e-81	1.6e-80	269.4	0.0	44	334	13	322	5	338	0.93	Mitogen-activated protein kinase 1 (DB01017)
drugbank_target|Q16539	-	360	sp|P62344|CDPK1_PL	-	524	7.9e-81	270.4	0.0	1	1	2.5e-80	3.2e-79	265.1	0.0	42	340	10	323	2	335	0.89	Mitogen-activated protein kinase 14 (DB01254; DB01761; DB01807; DB01948; DB01953; DB01988; DB02195; DB02277; DB02352; DB02873; DB02984; DB03044; DB03110; DB03980; DB04338; DB04632; DB04797; DB05157; DB05412; DB05470; DB06518; DB06882; DB06940; DB06991; DB07138; DB07307; DB07459; DB07607; DB07811; DB07829; DB07832; DB07833; DB07834; DB07835; DB07941; DB07942; DB07943; DB08064; DB08068; DB08091; DB08092; DB08093; DB08095; DB08096; DB08097; DB08242; DB08349; DB08351; DB08352; DB08395; DB08423; DB08424; DB08521; DB08522; DB08730; DB12010)
drugbank_target|Q16539	-	360	sp|P62344|CDPK1_PL	-	524	7.9e-81	270.4	0.0	1	1	2.5e-80	3.2e-79	265.1	0.0	42	340	10	323	2	335	0.89	Mitogen-activated protein kinase 14 (DB01017)
drugbank_target|O15264	-	365	sp|P62344|CDPK1_PL	-	524	8.7e-81	270.3	1.9	1	1	2e-80	2.6e-79	265.4	1.9	42	351	11	334	4	357	0.88	Mitogen-activated protein kinase 13 (DB05157; DB12010)
drugbank_target|O15264	-	365	sp|P62344|CDPK1_PL	-	524	8.7e-81	270.3	1.9	1	1	2e-80	2.6e-79	265.4	1.9	42	351	11	334	4	357	0.88	Mitogen-activated protein kinase 13 (DB01017)
drugbank_target|P16591	-	822	sp|P62344|CDPK1_PL	-	524	9.1e-81	270.2	0.0	1	1	7.1e-82	9.1e-81	270.2	0.0	53	325	560	816	538	821	0.91	Tyrosine-protein kinase Fer (DB12010)
drugbank_target|O96013	-	591	sp|P62344|CDPK1_PL	-	524	9.3e-81	270.2	0.0	1	1	9.8e-82	1.2e-80	269.8	0.0	47	329	312	576	290	589	0.92	Serine/threonine-protein kinase PAK 4 (DB12010)
drugbank_target|Q05513	-	592	sp|P62344|CDPK1_PL	-	524	1e-80	270.0	0.0	1	1	1.4e-81	1.8e-80	269.3	0.0	25	329	219	522	199	534	0.85	Protein kinase C zeta type (DB00675)
drugbank_target|Q8NEV4	-	1616	sp|P62344|CDPK1_PL	-	524	1.1e-80	270.0	2.0	1	1	1.2e-81	1.5e-80	269.5	0.0	52	346	17	307	8	335	0.87	Myosin-IIIa (DB12010)
drugbank_target|O15530	-	556	sp|P62344|CDPK1_PL	-	524	1.2e-80	269.8	0.0	1	1	1.4e-81	1.7e-80	269.3	0.0	49	333	75	350	63	369	0.92	3-phosphoinositide-dependent protein kinase 1 (DB00482; DB01863; DB01933; DB01946; DB02010; DB03777; DB04522; DB06932; DB07033; DB07132; DB07300; DB07456; DB07457; DB12010)
drugbank_target|Q9UEW8	-	545	sp|P62344|CDPK1_PL	-	524	1.6e-80	269.4	0.0	1	1	1.6e-81	2e-80	269.1	0.0	53	351	60	362	50	409	0.87	STE20/SPS1-related proline-alanine-rich protein kinase (DB12010)
drugbank_target|P12931	-	536	sp|P62344|CDPK1_PL	-	524	2e-80	269.1	0.0	1	1	2.1e-81	2.7e-80	268.7	0.0	42	320	255	516	234	531	0.89	Proto-oncogene tyrosine-protein kinase Src (DB01254; DB01678; DB01866; DB01893; DB01908; DB01947; DB01962; DB02175; DB02336; DB02432; DB02762; DB02908; DB03023; DB03078; DB03104; DB03114; DB03217; DB03268; DB03298; DB03306; DB03525; DB03591; DB03628; DB03712; DB03828; DB03902; DB04080; DB04272; DB04495; DB04739; DB04751; DB05184; DB06137; DB06616; DB06882; DB06883; DB07335; DB07662; DB07966; DB08052; DB08053; DB08054; DB08192; DB08462; DB08564; DB08901; DB09079; DB12010)
drugbank_target|P06241	-	537	sp|P62344|CDPK1_PL	-	524	2.6e-80	268.7	0.0	1	1	2.9e-81	3.6e-80	268.2	0.0	50	320	264	517	252	531	0.90	Tyrosine-protein kinase Fyn (DB01254; DB02078; DB12010)
drugbank_target|Q13882	-	451	sp|P62344|CDPK1_PL	-	524	2.8e-80	268.6	0.0	1	1	3e-81	3.9e-80	268.1	0.0	50	321	185	439	169	449	0.93	Protein-tyrosine kinase 6 (DB05294; DB12010; DB15035)
drugbank_target|P07948	-	512	sp|P62344|CDPK1_PL	-	524	3e-80	268.5	0.0	1	1	3.3e-81	4.2e-80	268.0	0.0	40	320	230	494	207	505	0.90	Tyrosine-protein kinase Lyn (DB01254; DB03023; DB06616; DB08901; DB09079; DB12010)
drugbank_target|P00524	-	526	sp|P62344|CDPK1_PL	-	524	3.1e-80	268.5	0.0	1	1	3.3e-81	4.2e-80	268.0	0.0	41	321	251	514	227	517	0.90	Tyrosine-protein kinase transforming protein Src (DB08434)
drugbank_target|Q96RR4	-	588	sp|P62344|CDPK1_PL	-	524	3.5e-80	268.3	0.0	1	1	5.1e-81	6.4e-80	267.4	0.0	54	345	163	465	135	509	0.85	Calcium/calmodulin-dependent protein kinase kinase 2 (DB12010)
drugbank_target|P63185	-	526	sp|P62344|CDPK1_PL	-	524	3.7e-80	268.2	0.0	1	1	3.9e-81	5e-80	267.8	0.0	41	321	251	514	227	517	0.90	Tyrosine-protein kinase transforming protein Src (DB01773)
drugbank_target|O95835	-	1130	sp|P62344|CDPK1_PL	-	524	3.7e-80	268.2	2.2	1	2	2.5e-53	3.2e-52	176.0	1.3	11	225	659	861	645	869	0.83	Serine/threonine-protein kinase LATS1 (DB12010)
drugbank_target|O95835	-	1130	sp|P62344|CDPK1_PL	-	524	3.7e-80	268.2	2.2	2	2	2.3e-27	2.9e-26	90.4	0.0	224	337	906	1022	895	1055	0.88	Serine/threonine-protein kinase LATS1 (DB12010)
drugbank_target|Q07785	-	288	sp|P62344|CDPK1_PL	-	524	4e-80	268.1	0.1	1	2	4.1e-73	5.2e-72	241.3	0.0	54	296	2	230	1	234	0.94	Cell division control protein 2 homolog (DB02519; DB02733)
drugbank_target|Q07785	-	288	sp|P62344|CDPK1_PL	-	524	4e-80	268.1	0.1	2	2	1.4e-07	1.8e-06	25.1	0.0	292	328	251	287	241	288	0.89	Cell division control protein 2 homolog (DB02519; DB02733)
drugbank_target|Q9UL54	-	1235	sp|P62344|CDPK1_PL	-	524	4.1e-80	268.1	0.0	1	1	3.2e-81	4.1e-80	268.1	0.0	51	357	23	314	11	338	0.87	Serine/threonine-protein kinase TAO2 (DB04522; DB12010)
drugbank_target|Q9Y4K4	-	846	sp|P62344|CDPK1_PL	-	524	4.2e-80	268.0	0.0	1	1	4.8e-81	6.2e-80	267.5	0.0	50	332	14	284	8	324	0.92	Mitogen-activated protein kinase kinase kinase kinase 5 (DB12010)
drugbank_target|Q12851	-	820	sp|P62344|CDPK1_PL	-	524	4.4e-80	267.9	0.0	1	1	5.1e-81	6.5e-80	267.4	0.0	50	329	10	277	5	290	0.94	Mitogen-activated protein kinase kinase kinase kinase 2 (DB12010)
drugbank_target|Q9BUB5	-	465	sp|P62344|CDPK1_PL	-	524	5.2e-80	267.7	0.1	1	2	5.4e-30	6.9e-29	99.0	0.2	34	186	26	165	4	171	0.91	MAP kinase-interacting serine/threonine-protein kinase 1 (DB12010)
drugbank_target|Q9BUB5	-	465	sp|P62344|CDPK1_PL	-	524	5.2e-80	267.7	0.1	2	2	1.8e-50	2.3e-49	166.6	0.0	185	347	205	396	197	429	0.84	MAP kinase-interacting serine/threonine-protein kinase 1 (DB12010)
drugbank_target|P53779	-	464	sp|P62344|CDPK1_PL	-	524	5.5e-80	267.6	2.2	1	2	4.4e-73	5.6e-72	241.2	0.5	29	303	37	299	21	304	0.91	Mitogen-activated protein kinase 10 (DB01782; DB02388; DB03084; DB03623; DB04395; DB06933; DB07010; DB07217; DB08005; DB08010; DB08011; DB08015; DB08021; DB08023; DB08025; DB08026; DB08555; DB12010)
drugbank_target|P53779	-	464	sp|P62344|CDPK1_PL	-	524	5.5e-80	267.6	2.2	2	2	6.5e-08	8.2e-07	26.2	0.1	287	334	321	368	312	408	0.75	Mitogen-activated protein kinase 10 (DB01782; DB02388; DB03084; DB03623; DB04395; DB06933; DB07010; DB07217; DB08005; DB08010; DB08011; DB08015; DB08021; DB08023; DB08025; DB08026; DB08555; DB12010)
drugbank_target|P53779	-	464	sp|P62344|CDPK1_PL	-	524	5.5e-80	267.6	2.2	1	2	4.4e-73	5.6e-72	241.2	0.5	29	303	37	299	21	304	0.91	Mitogen-activated protein kinase 10 (DB01017)
drugbank_target|P53779	-	464	sp|P62344|CDPK1_PL	-	524	5.5e-80	267.6	2.2	2	2	6.5e-08	8.2e-07	26.2	0.1	287	334	321	368	312	408	0.75	Mitogen-activated protein kinase 10 (DB01017)
drugbank_target|P53779	-	464	sp|P62344|CDPK1_PL	-	524	5.5e-80	267.6	2.2	1	2	4.4e-73	5.6e-72	241.2	0.5	29	303	37	299	21	304	0.91	Mitogen-activated protein kinase 10 (DB15624)
drugbank_target|P53779	-	464	sp|P62344|CDPK1_PL	-	524	5.5e-80	267.6	2.2	2	2	6.5e-08	8.2e-07	26.2	0.1	287	334	321	368	312	408	0.75	Mitogen-activated protein kinase 10 (DB15624)
drugbank_target|P29317	-	976	sp|P62344|CDPK1_PL	-	524	6.3e-80	267.4	0.0	1	1	7.1e-81	9e-80	266.9	0.0	19	320	575	868	556	872	0.86	Ephrin type-A receptor 2 (DB01254; DB04395; DB08896; DB12010)
drugbank_target|Q8N5S9	-	505	sp|P62344|CDPK1_PL	-	524	8.2e-80	267.1	0.0	1	1	9.2e-81	1.2e-79	266.5	0.0	45	345	116	428	98	471	0.87	Calcium/calmodulin-dependent protein kinase kinase 1 (DB12010)
drugbank_target|Q8NG66	-	645	sp|P62344|CDPK1_PL	-	524	9.2e-80	266.9	3.1	1	1	2.6e-80	3.3e-79	265.1	3.1	51	352	24	316	6	406	0.85	Serine/threonine-protein kinase Nek11 (DB08912; DB12010)
drugbank_target|Q9Y2H9	-	1570	sp|P62344|CDPK1_PL	-	524	1.1e-79	266.7	0.0	1	1	1.4e-80	1.8e-79	265.9	0.0	30	378	348	702	338	715	0.87	Microtubule-associated serine/threonine-protein kinase 1 (DB12010)
drugbank_target|Q8TD08	-	544	sp|P62344|CDPK1_PL	-	524	1.7e-79	266.0	0.0	1	1	8e-80	1e-78	263.5	0.0	51	334	8	313	3	325	0.90	Mitogen-activated protein kinase 15 (DB12010)
drugbank_target|Q8TD08	-	544	sp|P62344|CDPK1_PL	-	524	1.7e-79	266.0	0.0	1	1	8e-80	1e-78	263.5	0.0	51	334	8	313	3	325	0.90	Mitogen-activated protein kinase 15 (DB00945)
drugbank_target|Q8TD08	-	544	sp|P62344|CDPK1_PL	-	524	1.7e-79	266.0	0.0	1	1	8e-80	1e-78	263.5	0.0	51	334	8	313	3	325	0.90	Mitogen-activated protein kinase 15 (DB01017)
drugbank_target|P06239	-	509	sp|P62344|CDPK1_PL	-	524	2.3e-79	265.6	0.0	1	1	2.5e-80	3.2e-79	265.1	0.0	37	319	225	490	208	503	0.89	Tyrosine-protein kinase Lck (DB01254; DB01830; DB02010; DB03023; DB04003; DB04395; DB06925; DB07146; DB07297; DB08055; DB08056; DB08057; DB08901; DB09079; DB12010; DB15035)
drugbank_target|O43283	-	966	sp|P62344|CDPK1_PL	-	524	2.6e-79	265.4	0.3	1	1	3.1e-80	3.9e-79	264.8	0.3	44	380	155	465	145	508	0.89	Mitogen-activated protein kinase kinase kinase 13 (DB12010)
drugbank_target|P08631	-	526	sp|P62344|CDPK1_PL	-	524	3e-79	265.2	0.0	1	1	2.9e-80	3.7e-79	264.9	0.0	37	320	242	508	220	525	0.90	Tyrosine-protein kinase HCK (DB01809; DB01962; DB04216; DB06616; DB12010)
drugbank_target|Q86UE8	-	772	sp|P62344|CDPK1_PL	-	524	3.5e-79	265.0	0.1	1	1	2.8e-80	3.5e-79	265.0	0.1	12	334	416	750	409	768	0.85	Serine/threonine-protein kinase tousled-like 2 (DB12010)
drugbank_target|P42680	-	631	sp|P62344|CDPK1_PL	-	524	4.4e-79	264.7	0.0	1	1	5.4e-80	6.8e-79	264.0	0.0	48	321	361	617	345	619	0.92	Tyrosine-protein kinase Tec (DB12010; DB15035)
drugbank_target|Q9Y2U5	-	619	sp|P62344|CDPK1_PL	-	524	4.4e-79	264.7	0.0	1	1	4.8e-80	6.1e-79	264.2	0.0	51	326	351	617	328	619	0.92	Mitogen-activated protein kinase kinase kinase 2 (DB06616; DB12010)
drugbank_target|P51955	-	445	sp|P62344|CDPK1_PL	-	524	4.6e-79	264.6	0.2	1	1	3.6e-80	4.6e-79	264.6	0.2	53	352	5	298	2	360	0.87	Serine/threonine-protein kinase Nek2 (DB07180; DB12010)
drugbank_target|P07332	-	822	sp|P62344|CDPK1_PL	-	524	7.2e-79	263.9	0.7	1	1	3e-79	3.8e-78	261.6	0.0	45	321	549	812	533	821	0.91	Tyrosine-protein kinase Fes/Fps (DB12010)
drugbank_target|P27361	-	379	sp|P62344|CDPK1_PL	-	524	1.1e-78	263.3	0.1	1	1	3.8e-79	4.8e-78	261.2	0.1	43	335	29	340	25	362	0.89	Mitogen-activated protein kinase 3 (DB00945)
drugbank_target|P27361	-	379	sp|P62344|CDPK1_PL	-	524	1.1e-78	263.3	0.1	1	1	3.8e-79	4.8e-78	261.2	0.1	43	335	29	340	25	362	0.89	Mitogen-activated protein kinase 3 (DB00605; DB01169; DB02733; DB04604; DB06195; DB08862; DB13930)
drugbank_target|P27361	-	379	sp|P62344|CDPK1_PL	-	524	1.1e-78	263.3	0.1	1	1	3.8e-79	4.8e-78	261.2	0.1	43	335	29	340	25	362	0.89	Mitogen-activated protein kinase 3 (DB01017)
drugbank_target|P45983	-	427	sp|P62344|CDPK1_PL	-	524	1.1e-78	263.3	1.6	1	2	3.8e-72	4.8e-71	238.1	0.2	41	301	11	259	1	266	0.92	Mitogen-activated protein kinase 8 (DB00675; DB01782; DB07218; DB07268; DB07272; DB07276; DB07845)
drugbank_target|P45983	-	427	sp|P62344|CDPK1_PL	-	524	1.1e-78	263.3	1.6	2	2	1.8e-07	2.3e-06	24.7	0.1	287	332	283	328	272	365	0.82	Mitogen-activated protein kinase 8 (DB00675; DB01782; DB07218; DB07268; DB07272; DB07276; DB07845)
drugbank_target|P45983	-	427	sp|P62344|CDPK1_PL	-	524	1.1e-78	263.3	1.6	1	2	3.8e-72	4.8e-71	238.1	0.2	41	301	11	259	1	266	0.92	Mitogen-activated protein kinase 8 (DB01017)
drugbank_target|P45983	-	427	sp|P62344|CDPK1_PL	-	524	1.1e-78	263.3	1.6	2	2	1.8e-07	2.3e-06	24.7	0.1	287	332	283	328	272	365	0.82	Mitogen-activated protein kinase 8 (DB01017)
drugbank_target|P45983	-	427	sp|P62344|CDPK1_PL	-	524	1.1e-78	263.3	1.6	1	2	3.8e-72	4.8e-71	238.1	0.2	41	301	11	259	1	266	0.92	Mitogen-activated protein kinase 8 (DB15624)
drugbank_target|P45983	-	427	sp|P62344|CDPK1_PL	-	524	1.1e-78	263.3	1.6	2	2	1.8e-07	2.3e-06	24.7	0.1	287	332	283	328	272	365	0.82	Mitogen-activated protein kinase 8 (DB15624)
drugbank_target|P07947	-	543	sp|P62344|CDPK1_PL	-	524	1.2e-78	263.3	0.0	1	1	1.2e-79	1.6e-78	262.8	0.0	42	320	262	523	229	537	0.89	Tyrosine-protein kinase Yes (DB01254; DB12010)
drugbank_target|P45984	-	424	sp|P62344|CDPK1_PL	-	524	1.7e-78	262.7	2.0	1	2	3.7e-71	4.7e-70	234.8	0.6	41	302	11	260	2	264	0.93	Mitogen-activated protein kinase 9 (DB07020; DB12010)
drugbank_target|P45984	-	424	sp|P62344|CDPK1_PL	-	524	1.7e-78	262.7	2.0	2	2	3.1e-08	3.9e-07	27.2	0.0	288	333	284	329	263	366	0.81	Mitogen-activated protein kinase 9 (DB07020; DB12010)
drugbank_target|P45984	-	424	sp|P62344|CDPK1_PL	-	524	1.7e-78	262.7	2.0	1	2	3.7e-71	4.7e-70	234.8	0.6	41	302	11	260	2	264	0.93	Mitogen-activated protein kinase 9 (DB01017)
drugbank_target|P45984	-	424	sp|P62344|CDPK1_PL	-	524	1.7e-78	262.7	2.0	2	2	3.1e-08	3.9e-07	27.2	0.0	288	333	284	329	263	366	0.81	Mitogen-activated protein kinase 9 (DB01017)
drugbank_target|P45984	-	424	sp|P62344|CDPK1_PL	-	524	1.7e-78	262.7	2.0	1	2	3.7e-71	4.7e-70	234.8	0.6	41	302	11	260	2	264	0.93	Mitogen-activated protein kinase 9 (DB15624)
drugbank_target|P45984	-	424	sp|P62344|CDPK1_PL	-	524	1.7e-78	262.7	2.0	2	2	3.1e-08	3.9e-07	27.2	0.0	288	333	284	329	263	366	0.81	Mitogen-activated protein kinase 9 (DB15624)
drugbank_target|Q9Y6R4	-	1608	sp|P62344|CDPK1_PL	-	524	2e-78	262.5	0.2	1	1	3.2e-79	4.1e-78	261.4	0.2	23	329	1307	1605	1287	1608	0.87	Mitogen-activated protein kinase kinase kinase 4 (DB12010)
drugbank_target|Q8IW41	-	473	sp|P62344|CDPK1_PL	-	524	3.3e-78	261.8	0.2	1	1	4.2e-79	5.3e-78	261.1	0.2	41	346	5	325	1	351	0.87	MAP kinase-activated protein kinase 5 (DB12010)
drugbank_target|Q15759	-	364	sp|P62344|CDPK1_PL	-	524	3.6e-78	261.7	0.0	1	1	4.6e-77	5.8e-76	254.4	0.0	43	350	11	333	6	350	0.89	Mitogen-activated protein kinase 11 (DB05157; DB08896)
drugbank_target|Q15759	-	364	sp|P62344|CDPK1_PL	-	524	3.6e-78	261.7	0.0	1	1	4.6e-77	5.8e-76	254.4	0.0	43	350	11	333	6	350	0.89	Mitogen-activated protein kinase 11 (DB01017)
drugbank_target|Q9UKI8	-	766	sp|P62344|CDPK1_PL	-	524	5.4e-78	261.1	0.2	1	1	4.2e-79	5.4e-78	261.1	0.2	12	335	410	744	403	754	0.86	Serine/threonine-protein kinase tousled-like 1 (DB12010)
drugbank_target|P29322	-	1005	sp|P62344|CDPK1_PL	-	524	6.5e-78	260.8	0.0	1	1	7.5e-79	9.5e-78	260.2	0.0	36	320	614	889	606	895	0.91	Ephrin type-A receptor 8 (DB12010)
drugbank_target|P42681	-	527	sp|P62344|CDPK1_PL	-	524	7.4e-78	260.6	0.1	1	1	8.7e-79	1.1e-77	260.0	0.1	54	321	269	518	256	521	0.92	Tyrosine-protein kinase TXK (DB12010; DB15035)
drugbank_target|Q8WU08	-	396	sp|P62344|CDPK1_PL	-	524	8.1e-78	260.5	0.4	1	1	6.3e-79	8.1e-78	260.5	0.4	47	329	13	285	3	295	0.91	Serine/threonine-protein kinase 32A (DB12010)
drugbank_target|Q9BXA7	-	367	sp|P62344|CDPK1_PL	-	524	2.4e-77	258.9	0.0	1	1	2.3e-78	3e-77	258.6	0.0	56	335	12	282	3	320	0.90	Testis-specific serine/threonine-protein kinase 1 (DB12010)
drugbank_target|Q16620	-	822	sp|P62344|CDPK1_PL	-	524	3.5e-77	258.4	0.1	1	1	3.9e-78	5e-77	257.9	0.1	54	318	536	802	519	810	0.90	BDNF/NT-3 growth factors receptor (DB00321; DB11823; DB11986; DB12010; DB14723)
drugbank_target|Q00535	-	292	sp|P62344|CDPK1_PL	-	524	3.9e-77	258.2	0.0	1	2	1.3e-71	1.7e-70	236.3	0.0	54	295	2	231	1	234	0.94	Cyclin-dependent-like kinase 5 (DB02052; DB02116; DB02950; DB03428; DB03496; DB04014; DB07364)
drugbank_target|Q00535	-	292	sp|P62344|CDPK1_PL	-	524	3.9e-77	258.2	0.0	2	2	4.7e-06	6e-05	20.0	0.0	291	326	252	287	244	290	0.90	Cyclin-dependent-like kinase 5 (DB02052; DB02116; DB02950; DB03428; DB03496; DB04014; DB07364)
drugbank_target|Q00534	-	326	sp|P62344|CDPK1_PL	-	524	4.2e-77	258.1	0.0	1	1	2.8e-77	3.5e-76	255.1	0.0	52	336	9	311	2	325	0.89	Cyclin-dependent kinase 6 (DB03496; DB07379; DB07795; DB09073; DB11730; DB12001)
drugbank_target|P49759	-	484	sp|P62344|CDPK1_PL	-	524	4.2e-77	258.1	3.4	1	2	1.4e-73	1.8e-72	242.9	0.8	4	326	108	437	105	449	0.86	Dual specificity protein kinase CLK1 (DB04367; DB06376; DB08691; DB12010)
drugbank_target|P49759	-	484	sp|P62344|CDPK1_PL	-	524	4.2e-77	258.1	3.4	2	2	3.3e-07	4.2e-06	23.8	0.1	296	327	448	479	441	484	0.88	Dual specificity protein kinase CLK1 (DB04367; DB06376; DB08691; DB12010)
drugbank_target|P11362	-	822	sp|P62344|CDPK1_PL	-	524	5.1e-77	257.9	0.0	1	1	6.7e-78	8.6e-77	257.1	0.0	52	321	474	752	460	766	0.89	Fibroblast growth factor receptor 1 (DB00039; DB00398; DB01109; DB02058; DB05014; DB07525; DB07840; DB08577; DB08896; DB08901; DB09078; DB09079; DB12010; DB12147; DB15102; DB15685)
drugbank_target|P80192	-	1104	sp|P62344|CDPK1_PL	-	524	6.2e-77	257.6	0.0	1	1	7.4e-78	9.4e-77	257.0	0.0	56	413	144	500	136	508	0.86	Mitogen-activated protein kinase kinase kinase 9 (DB08703; DB12010)
drugbank_target|P51813	-	675	sp|P62344|CDPK1_PL	-	524	6.6e-77	257.5	0.2	1	1	5.2e-78	6.6e-77	257.5	0.2	53	321	414	664	376	674	0.91	Cytoplasmic tyrosine-protein kinase BMX (DB12010; DB15035)
drugbank_target|Q00537	-	523	sp|P62344|CDPK1_PL	-	524	7.5e-77	257.3	0.0	1	1	7.3e-77	9.3e-76	253.7	0.0	52	335	188	483	168	507	0.89	Cyclin-dependent kinase 17 (DB12010)
drugbank_target|Q92918	-	833	sp|P62344|CDPK1_PL	-	524	8.6e-77	257.1	0.0	1	1	9.4e-78	1.2e-76	256.6	0.0	49	327	10	276	5	284	0.94	Mitogen-activated protein kinase kinase kinase kinase 1 (DB12010)
drugbank_target|P21709	-	976	sp|P62344|CDPK1_PL	-	524	1e-76	256.8	0.0	1	1	1.1e-77	1.4e-76	256.4	0.0	31	322	598	879	567	890	0.84	Ephrin type-A receptor 1 (DB12010)
drugbank_target|Q13164	-	816	sp|P62344|CDPK1_PL	-	524	1.3e-76	256.5	3.7	1	1	2.1e-77	2.7e-76	255.4	0.0	49	365	48	386	27	401	0.84	Mitogen-activated protein kinase 7 (DB12010)
drugbank_target|Q13164	-	816	sp|P62344|CDPK1_PL	-	524	1.3e-76	256.5	3.7	1	1	2.1e-77	2.7e-76	255.4	0.0	49	365	48	386	27	401	0.84	Mitogen-activated protein kinase 7 (DB00945)
drugbank_target|Q13164	-	816	sp|P62344|CDPK1_PL	-	524	1.3e-76	256.5	3.7	1	1	2.1e-77	2.7e-76	255.4	0.0	49	365	48	386	27	401	0.84	Mitogen-activated protein kinase 7 (DB01017)
drugbank_target|Q9HAZ1	-	481	sp|P62344|CDPK1_PL	-	524	2.2e-76	255.8	13.3	1	2	1.3e-72	1.7e-71	239.6	3.5	6	314	107	423	99	445	0.87	Dual specificity protein kinase CLK4 (DB12010)
drugbank_target|Q9HAZ1	-	481	sp|P62344|CDPK1_PL	-	524	2.2e-76	255.8	13.3	2	2	3.7e-07	4.7e-06	23.7	0.1	295	327	445	477	435	481	0.88	Dual specificity protein kinase CLK4 (DB12010)
drugbank_target|Q8TD19	-	979	sp|P62344|CDPK1_PL	-	524	2.3e-76	255.7	0.0	1	1	2.9e-77	3.7e-76	255.0	0.0	53	335	49	318	34	348	0.91	Serine/threonine-protein kinase Nek9 (DB12010)
drugbank_target|Q08881	-	620	sp|P62344|CDPK1_PL	-	524	4.9e-76	254.6	0.0	1	1	6.2e-77	7.9e-76	253.9	0.0	55	322	362	611	351	614	0.92	Tyrosine-protein kinase ITK/TSK (DB02010; DB06589; DB12010; DB15035)
drugbank_target|Q6ZN16	-	1313	sp|P62344|CDPK1_PL	-	524	5.9e-76	254.3	0.0	1	1	7.4e-77	9.5e-76	253.7	0.0	61	333	657	916	617	925	0.92	Mitogen-activated protein kinase kinase kinase 15 (DB12010)
drugbank_target|P21802	-	821	sp|P62344|CDPK1_PL	-	524	6.4e-76	254.2	0.0	1	1	7.2e-77	9.2e-76	253.7	0.0	52	321	477	755	446	778	0.86	Fibroblast growth factor receptor 2 (DB00039; DB01041; DB01109; DB01901; DB02058; DB02491; DB08896; DB08901; DB09078; DB09079; DB10770; DB10772; DB12010; DB12147; DB15102; DB15685)
drugbank_target|O14578	-	2027	sp|P62344|CDPK1_PL	-	524	7e-76	254.1	0.0	1	1	5.5e-77	7e-76	254.1	0.0	52	332	93	367	67	397	0.91	Citron Rho-interacting kinase (DB12010)
drugbank_target|Q12852	-	859	sp|P62344|CDPK1_PL	-	524	8.1e-76	253.9	0.1	1	1	8.9e-77	1.1e-75	253.4	0.1	40	348	108	391	101	456	0.85	Mitogen-activated protein kinase kinase kinase 12 (DB12010)
drugbank_target|Q06187	-	659	sp|P62344|CDPK1_PL	-	524	9e-76	253.7	0.2	1	1	1.1e-76	1.4e-75	253.1	0.2	50	321	395	649	362	655	0.90	Tyrosine-protein kinase BTK (DB01254; DB01863; DB05204; DB09053; DB11703; DB12010; DB15035)
drugbank_target|P09769	-	529	sp|P62344|CDPK1_PL	-	524	9.6e-76	253.6	0.0	1	1	1.1e-76	1.3e-75	253.2	0.0	46	320	252	509	243	524	0.91	Tyrosine-protein kinase Fgr (DB01254; DB12010; DB15035)
drugbank_target|Q00536	-	496	sp|P62344|CDPK1_PL	-	524	1.1e-75	253.4	0.0	1	1	2.6e-75	3.2e-74	248.6	0.0	54	349	163	470	149	485	0.89	Cyclin-dependent kinase 16 (DB07766; DB12010)
drugbank_target|P51451	-	505	sp|P62344|CDPK1_PL	-	524	2.1e-75	252.5	0.0	1	1	2.3e-76	2.9e-75	252.1	0.0	42	319	226	486	219	502	0.90	Tyrosine-protein kinase Blk (DB12010; DB15035)
drugbank_target|P50613	-	346	sp|P62344|CDPK1_PL	-	524	2.4e-75	252.3	0.0	1	2	1.3e-73	1.7e-72	242.9	0.0	53	294	9	240	3	244	0.94	Cyclin-dependent kinase 7 (DB02482; DB03496; DB05969; DB06195)
drugbank_target|P50613	-	346	sp|P62344|CDPK1_PL	-	524	2.4e-75	252.3	0.0	2	2	0.032	0.41	7.4	0.0	295	328	265	298	255	333	0.88	Cyclin-dependent kinase 7 (DB02482; DB03496; DB05969; DB06195)
drugbank_target|Q16584	-	847	sp|P62344|CDPK1_PL	-	524	2.5e-75	252.3	0.0	1	1	2.6e-76	3.3e-75	251.9	0.0	55	329	116	382	110	470	0.82	Mitogen-activated protein kinase kinase kinase 11 (DB12010)
drugbank_target|Q02779	-	954	sp|P62344|CDPK1_PL	-	524	2.7e-75	252.2	0.0	1	1	3e-76	3.8e-75	251.7	0.0	55	412	97	453	90	461	0.80	Mitogen-activated protein kinase kinase kinase 10 (DB12010)
drugbank_target|Q6DT37	-	1551	sp|P62344|CDPK1_PL	-	524	3.6e-75	251.7	0.0	1	1	2.8e-76	3.6e-75	251.7	0.0	52	332	67	344	43	357	0.90	Serine/threonine-protein kinase MRCK gamma (DB12010)
drugbank_target|P22607	-	806	sp|P62344|CDPK1_PL	-	524	4.3e-75	251.5	0.0	1	1	4.8e-76	6.1e-75	251.0	0.0	53	321	469	746	452	756	0.87	Fibroblast growth factor receptor 3 (DB00039; DB05014; DB06589; DB08901; DB09078; DB09079; DB12010; DB12147; DB15102; DB15685)
drugbank_target|O14757	-	476	sp|P62344|CDPK1_PL	-	524	9.9e-75	250.3	0.0	1	1	1.7e-75	2.2e-74	249.2	0.0	53	335	6	275	2	312	0.91	Serine/threonine-protein kinase Chk1 (DB05149; DB06486; DB06852; DB06876; DB07025; DB07034; DB07037; DB07038; DB07075; DB07078; DB07158; DB07213; DB07228; DB07243; DB07311; DB07314; DB07320; DB07336; DB07647; DB07648; DB07653; DB07654; DB07655; DB07959; DB08392; DB08393; DB08683; DB08774; DB08776; DB08777; DB08778; DB08779; DB08780; DB08781; DB12010)
drugbank_target|Q9H2X6	-	1198	sp|P62344|CDPK1_PL	-	524	1e-74	250.2	0.1	1	2	4.1e-63	5.3e-62	208.3	0.0	26	286	168	420	146	432	0.82	Homeodomain-interacting protein kinase 2 (DB12010)
drugbank_target|Q9H2X6	-	1198	sp|P62344|CDPK1_PL	-	524	1e-74	250.2	0.1	2	2	6.2e-12	7.9e-11	39.4	0.2	292	371	494	576	465	601	0.81	Homeodomain-interacting protein kinase 2 (DB12010)
drugbank_target|Q14289	-	1009	sp|P62344|CDPK1_PL	-	524	1.1e-74	250.1	0.0	1	1	8.9e-76	1.1e-74	250.1	0.0	52	322	421	678	386	706	0.89	Protein-tyrosine kinase 2-beta (DB01097; DB01645; DB08341; DB11817; DB12010)
drugbank_target|Q16288	-	839	sp|P62344|CDPK1_PL	-	524	1.5e-74	249.7	0.0	1	1	1.7e-75	2.1e-74	249.2	0.0	53	321	535	822	513	826	0.85	NT-3 growth factor receptor (DB11986; DB12010; DB14723)
drugbank_target|Q13627	-	763	sp|P62344|CDPK1_PL	-	524	2.5e-74	248.9	0.5	1	2	5.5e-67	7e-66	221.1	0.7	11	303	113	396	104	405	0.85	Dual specificity tyrosine-phosphorylation-regulated kinase 1A (DB07608; DB12010)
drugbank_target|Q13627	-	763	sp|P62344|CDPK1_PL	-	524	2.5e-74	248.9	0.5	2	2	1.3e-07	1.7e-06	25.2	0.0	297	352	451	507	448	529	0.75	Dual specificity tyrosine-phosphorylation-regulated kinase 1A (DB07608; DB12010)
drugbank_target|P41240	-	450	sp|P62344|CDPK1_PL	-	524	3.2e-74	248.6	0.0	1	1	3.4e-75	4.3e-74	248.2	0.0	50	321	188	438	166	447	0.91	Tyrosine-protein kinase CSK (DB01254; DB02010; DB05075; DB12010)
drugbank_target|Q13233	-	1512	sp|P62344|CDPK1_PL	-	524	3.7e-74	248.4	0.2	1	1	5.9e-75	7.5e-74	247.4	0.0	42	326	1229	1509	1215	1511	0.88	Mitogen-activated protein kinase kinase kinase 1 (DB06061; DB11967; DB12010)
drugbank_target|P06213	-	1382	sp|P62344|CDPK1_PL	-	524	4.5e-74	248.1	0.0	1	1	5.4e-75	6.9e-74	247.5	0.0	50	321	1017	1288	1001	1330	0.87	Insulin receptor (DB00030; DB00046; DB00047; DB00071; DB01277; DB01306; DB01307; DB01309; DB03909; DB05115; DB05120; DB08513; DB09129; DB09564; DB12010; DB12267; DB14751)
drugbank_target|Q02763	-	1124	sp|P62344|CDPK1_PL	-	524	1.1e-73	246.9	0.0	1	1	1.2e-74	1.6e-73	246.3	0.0	55	321	823	1090	774	1110	0.89	Angiopoietin-1 receptor (DB00415; DB05294; DB08221; DB08896; DB08901; DB12010; DB14840)
drugbank_target|P35626	-	688	sp|P62344|CDPK1_PL	-	524	1.3e-73	246.6	1.4	1	1	1.6e-74	2e-73	246.0	0.1	53	331	188	459	167	466	0.88	Beta-adrenergic receptor kinase 2 (DB00171)
drugbank_target|P49760	-	499	sp|P62344|CDPK1_PL	-	524	1.4e-73	246.5	1.8	1	2	1.6e-70	2e-69	232.8	0.7	5	337	112	450	107	453	0.84	Dual specificity protein kinase CLK2 (DB12010)
drugbank_target|P49760	-	499	sp|P62344|CDPK1_PL	-	524	1.4e-73	246.5	1.8	2	2	2.6e-06	3.4e-05	20.9	0.0	297	332	451	486	447	496	0.87	Dual specificity protein kinase CLK2 (DB12010)
drugbank_target|P22455	-	802	sp|P62344|CDPK1_PL	-	524	1.5e-73	246.4	0.0	1	1	1.7e-74	2.1e-73	245.9	0.0	53	321	464	741	460	744	0.89	Fibroblast growth factor receptor 4 (DB00039; DB01109; DB08901; DB09078; DB12147; DB15102)
drugbank_target|P43403	-	619	sp|P62344|CDPK1_PL	-	524	1.9e-73	246.1	0.0	1	1	2e-74	2.6e-73	245.6	0.0	45	321	326	591	305	606	0.86	Tyrosine-protein kinase ZAP-70 (DB02010; DB12010)
drugbank_target|Q9H3Y6	-	488	sp|P62344|CDPK1_PL	-	524	2.1e-73	245.9	0.0	1	1	2.2e-74	2.8e-73	245.5	0.0	50	321	224	478	207	482	0.91	Tyrosine-protein kinase Srms (DB12010)
drugbank_target|P04629	-	796	sp|P62344|CDPK1_PL	-	524	2.1e-73	245.9	0.0	1	1	2.3e-74	2.9e-73	245.4	0.0	50	320	503	778	484	786	0.88	High affinity nerve growth factor receptor (DB00321; DB00619; DB08896; DB11986; DB12010; DB13926; DB14723)
drugbank_target|P50750	-	372	sp|P62344|CDPK1_PL	-	524	2.4e-73	245.7	0.0	1	1	6.6e-73	8.4e-72	240.6	0.0	55	381	18	372	13	372	0.83	Cyclin-dependent kinase 9 (DB03496; DB06195)
drugbank_target|P15056	-	766	sp|P62344|CDPK1_PL	-	524	3.8e-73	245.0	0.0	1	1	4.4e-74	5.6e-73	244.5	0.0	23	322	423	713	409	735	0.85	Serine/threonine-protein kinase B-raf (DB00398; DB05190; DB05984; DB06999; DB07000; DB08553; DB08881; DB08896; DB08912; DB11718; DB12010; DB14840)
drugbank_target|P07949	-	1114	sp|P62344|CDPK1_PL	-	524	5.2e-73	244.6	0.0	1	1	6e-74	7.7e-73	244.1	0.0	48	321	715	1003	675	1017	0.84	Proto-oncogene tyrosine-protein kinase receptor Ret (DB00398; DB01809; DB05294; DB08875; DB08896; DB08901; DB09078; DB12010; DB12742; DB15685)
drugbank_target|O95382	-	1288	sp|P62344|CDPK1_PL	-	524	6.3e-73	244.3	0.0	1	1	7.2e-74	9.2e-73	243.8	0.0	60	333	650	914	621	944	0.90	Mitogen-activated protein kinase kinase kinase 6 (DB12010)
drugbank_target|P49761	-	638	sp|P62344|CDPK1_PL	-	524	8.7e-73	243.9	3.5	1	2	3.4e-67	4.3e-66	221.8	2.5	8	335	254	589	249	594	0.86	Dual specificity protein kinase CLK3 (DB07664; DB08691; DB12010)
drugbank_target|P49761	-	638	sp|P62344|CDPK1_PL	-	524	8.7e-73	243.9	3.5	2	2	1.6e-06	2.1e-05	21.5	0.0	298	337	593	632	586	637	0.88	Dual specificity protein kinase CLK3 (DB07664; DB08691; DB12010)
drugbank_target|Q9NYL2	-	800	sp|P62344|CDPK1_PL	-	524	1.1e-72	243.6	0.2	1	1	1.3e-73	1.7e-72	242.9	0.2	54	330	14	265	7	329	0.84	Mitogen-activated protein kinase kinase kinase MLT (DB01254; DB12010)
drugbank_target|P43405	-	635	sp|P62344|CDPK1_PL	-	524	1.3e-72	243.3	0.2	1	1	1.6e-73	2e-72	242.7	0.2	59	318	374	621	342	625	0.88	Tyrosine-protein kinase SYK (DB02010; DB06834; DB07159; DB07194; DB08361; DB08846; DB12010)
drugbank_target|P25098	-	689	sp|P62344|CDPK1_PL	-	524	1.3e-72	243.3	0.1	1	1	2.5e-73	3.2e-72	242.0	0.1	53	331	188	459	167	466	0.89	Beta-adrenergic receptor kinase 1 (DB00171)
drugbank_target|Q16832	-	855	sp|P62344|CDPK1_PL	-	524	5.1e-72	241.3	0.0	1	1	5.8e-73	7.3e-72	240.8	0.0	54	319	561	845	549	849	0.88	Discoidin domain-containing receptor 2 (DB08896; DB12010)
drugbank_target|Q09013	-	629	sp|P62344|CDPK1_PL	-	524	1e-71	240.3	0.1	1	1	1.9e-72	2.4e-71	239.1	0.0	46	325	60	339	41	345	0.89	Myotonin-protein kinase (DB01946)
drugbank_target|P30530	-	894	sp|P62344|CDPK1_PL	-	524	1.1e-71	240.3	0.0	1	1	1.2e-72	1.5e-71	239.8	0.0	23	321	502	801	490	811	0.87	Tyrosine-protein kinase receptor UFO (DB12010; DB12141)
drugbank_target|Q15303	-	1308	sp|P62344|CDPK1_PL	-	524	1.9e-71	239.5	0.0	1	1	2.3e-72	2.9e-71	238.8	0.0	54	321	716	972	676	988	0.89	Receptor tyrosine-protein kinase erbB-4 (DB08916; DB12010; DB12267; DB15035)
drugbank_target|Q02750	-	393	sp|P62344|CDPK1_PL	-	524	2.8e-71	238.9	0.0	1	1	3e-72	3.8e-71	238.5	0.0	26	332	34	368	17	377	0.88	Dual specificity mitogen-activated protein kinase kinase 1 (DB02152; DB03115; DB05239; DB06616; DB06892; DB07046; DB07101; DB08130; DB08208; DB08911; DB11689)
drugbank_target|Q16659	-	721	sp|P62344|CDPK1_PL	-	524	3e-71	238.8	0.0	1	1	7.7e-72	9.8e-71	237.1	0.0	44	329	8	320	1	340	0.90	Mitogen-activated protein kinase 6 (DB00945)
drugbank_target|Q16659	-	721	sp|P62344|CDPK1_PL	-	524	3e-71	238.8	0.0	1	1	7.7e-72	9.8e-71	237.1	0.0	44	329	8	320	1	340	0.90	Mitogen-activated protein kinase 6 (DB01017)
drugbank_target|O15146	-	869	sp|P62344|CDPK1_PL	-	524	3.4e-71	238.6	0.0	1	1	4e-72	5.1e-71	238.0	0.0	53	319	572	852	567	859	0.90	Muscle, skeletal receptor tyrosine-protein kinase (DB12010)
drugbank_target|P11802	-	303	sp|P62344|CDPK1_PL	-	524	4.2e-71	238.3	0.0	1	2	8.3e-66	1.1e-64	217.2	0.0	53	292	3	239	1	244	0.91	Cyclin-dependent kinase 4 (DB02733; DB03496; DB09073; DB11730; DB12001; DB12010)
drugbank_target|P11802	-	303	sp|P62344|CDPK1_PL	-	524	4.2e-71	238.3	0.0	2	2	7.7e-06	9.8e-05	19.3	0.0	289	329	259	299	251	303	0.85	Cyclin-dependent kinase 4 (DB02733; DB03496; DB09073; DB11730; DB12001; DB12010)
drugbank_target|P08069	-	1367	sp|P62344|CDPK1_PL	-	524	4.4e-71	238.3	0.0	1	1	6.9e-72	8.7e-71	237.3	0.0	46	321	989	1264	968	1273	0.87	Insulin-like growth factor 1 receptor (DB00030; DB00046; DB00047; DB00071; DB01277; DB01306; DB01307; DB01309; DB04395; DB05023; DB05184; DB05897; DB06075; DB06343; DB07156; DB07474; DB09098; DB09564; DB12250; DB12267; DB14751)
drugbank_target|Q9Y463	-	629	sp|P62344|CDPK1_PL	-	524	5e-71	238.1	0.0	1	2	1.5e-67	1.9e-66	222.9	0.2	11	298	65	344	56	350	0.87	Dual specificity tyrosine-phosphorylation-regulated kinase 1B (DB12010)
drugbank_target|Q9Y463	-	629	sp|P62344|CDPK1_PL	-	524	5e-71	238.1	0.0	2	2	0.00069	0.0088	12.9	0.0	298	334	404	440	395	460	0.91	Dual specificity tyrosine-phosphorylation-regulated kinase 1B (DB12010)
drugbank_target|Q13163	-	448	sp|P62344|CDPK1_PL	-	524	6.1e-71	237.8	0.0	1	1	6.2e-72	7.9e-71	237.4	0.0	35	349	145	443	114	447	0.87	Dual specificity mitogen-activated protein kinase kinase 5 (DB12010)
drugbank_target|P08922	-	2347	sp|P62344|CDPK1_PL	-	524	8.9e-71	237.2	0.0	1	1	1.1e-71	1.4e-70	236.6	0.0	53	321	1942	2213	1927	2234	0.88	Proto-oncogene tyrosine-protein kinase ROS (DB11986; DB12010)
drugbank_target|P04049	-	648	sp|P62344|CDPK1_PL	-	524	1.1e-70	236.9	0.0	1	1	1.2e-71	1.5e-70	236.5	0.0	41	329	333	612	307	640	0.83	RAF proto-oncogene serine/threonine-protein kinase (DB00398; DB04973; DB05190; DB05268; DB08862; DB08896; DB08912; DB12010)
drugbank_target|Q96Q40	-	435	sp|P62344|CDPK1_PL	-	524	1.5e-70	236.5	0.0	1	2	8.8e-68	1.1e-66	223.7	0.0	16	296	62	330	47	332	0.90	Cyclin-dependent kinase 15 (DB00171; DB06486; DB12010)
drugbank_target|Q96Q40	-	435	sp|P62344|CDPK1_PL	-	524	1.5e-70	236.5	0.0	2	2	0.0031	0.039	10.7	0.0	296	332	358	394	351	414	0.86	Cyclin-dependent kinase 15 (DB00171; DB06486; DB12010)
drugbank_target|P31152	-	587	sp|P62344|CDPK1_PL	-	524	1.6e-70	236.4	0.0	1	1	1.4e-69	1.8e-68	229.6	0.0	52	342	16	329	8	356	0.88	Mitogen-activated protein kinase 4 (DB12010)
drugbank_target|P31152	-	587	sp|P62344|CDPK1_PL	-	524	1.6e-70	236.4	0.0	1	1	1.4e-69	1.8e-68	229.6	0.0	52	342	16	329	8	356	0.88	Mitogen-activated protein kinase 4 (DB00945)
drugbank_target|P31152	-	587	sp|P62344|CDPK1_PL	-	524	1.6e-70	236.4	0.0	1	1	1.4e-69	1.8e-68	229.6	0.0	52	342	16	329	8	356	0.88	Mitogen-activated protein kinase 4 (DB01017)
drugbank_target|P35590	-	1138	sp|P62344|CDPK1_PL	-	524	4.9e-70	234.8	0.0	1	1	5.5e-71	7e-70	234.3	0.0	54	320	837	1104	831	1115	0.90	Tyrosine-protein kinase receptor Tie-1 (DB12010)
drugbank_target|P10398	-	606	sp|P62344|CDPK1_PL	-	524	5.1e-70	234.7	0.0	1	1	5.5e-71	7e-70	234.3	0.0	20	325	270	569	258	592	0.85	Serine/threonine-protein kinase A-Raf (DB00171)
drugbank_target|P16234	-	1089	sp|P62344|CDPK1_PL	-	524	5.7e-70	234.6	0.0	1	2	3.2e-21	4.1e-20	70.1	0.0	53	162	590	691	565	700	0.83	Platelet-derived growth factor receptor alpha (DB00102; DB00619; DB01268; DB05146; DB06043; DB06589; DB06595; DB08896; DB08901; DB09078; DB09079; DB10772; DB12010; DB12147; DB12742; DB14840)
drugbank_target|P16234	-	1089	sp|P62344|CDPK1_PL	-	524	5.7e-70	234.6	0.0	2	2	3.9e-49	5e-48	162.2	0.0	154	319	779	946	772	967	0.86	Platelet-derived growth factor receptor alpha (DB00102; DB00619; DB01268; DB05146; DB06043; DB06589; DB06595; DB08896; DB08901; DB09078; DB09079; DB10772; DB12010; DB12147; DB12742; DB14840)
drugbank_target|Q07912	-	1038	sp|P62344|CDPK1_PL	-	524	6.1e-70	234.5	0.0	1	1	7.2e-71	9.2e-70	233.9	0.0	53	320	123	382	116	407	0.90	Activated CDC42 kinase 1 (DB00171; DB04367; DB11986; DB12010)
drugbank_target|P42679	-	507	sp|P62344|CDPK1_PL	-	524	6.7e-70	234.4	0.0	1	1	7.3e-71	9.3e-70	233.9	0.0	38	321	216	476	191	486	0.89	Megakaryocyte-associated tyrosine-protein kinase (DB12010)
drugbank_target|P36507	-	400	sp|P62344|CDPK1_PL	-	524	1e-69	233.7	0.0	1	1	1.1e-70	1.4e-69	233.3	0.0	35	332	48	376	25	389	0.88	Dual specificity mitogen-activated protein kinase kinase 2 (DB06616; DB08911; DB11689; DB11967; DB12010)
drugbank_target|P07333	-	972	sp|P62344|CDPK1_PL	-	524	1e-69	233.7	0.0	1	2	3.1e-23	4e-22	76.7	0.0	41	160	566	678	542	686	0.82	Macrophage colony-stimulating factor 1 receptor (DB00619; DB01268; DB06080; DB07167; DB07202; DB12010; DB12147; DB12978)
drugbank_target|P07333	-	972	sp|P62344|CDPK1_PL	-	524	1e-69	233.7	0.0	2	2	6.7e-47	8.5e-46	154.8	0.0	159	335	746	920	734	950	0.87	Macrophage colony-stimulating factor 1 receptor (DB00619; DB01268; DB06080; DB07167; DB07202; DB12010; DB12147; DB12978)
drugbank_target|P10721	-	976	sp|P62344|CDPK1_PL	-	524	1.1e-69	233.6	0.0	1	2	3.9e-19	5e-18	63.2	0.0	40	162	572	687	554	703	0.82	Mast/stem cell growth factor receptor Kit (DB00398; DB00619; DB01254; DB01268; DB01962; DB04868; DB05146; DB05913; DB06080; DB06589; DB06595; DB08896; DB08901; DB09078; DB09103; DB12010; DB12147; DB12742; DB12978; DB14840; DB15233)
drugbank_target|P10721	-	976	sp|P62344|CDPK1_PL	-	524	1.1e-69	233.6	0.0	2	2	5.9e-51	7.5e-50	168.2	0.0	162	321	763	922	746	968	0.87	Mast/stem cell growth factor receptor Kit (DB00398; DB00619; DB01254; DB01268; DB01962; DB04868; DB05146; DB05913; DB06080; DB06589; DB06595; DB08896; DB08901; DB09078; DB09103; DB12010; DB12147; DB12742; DB12978; DB14840; DB15233)
drugbank_target|P36888	-	993	sp|P62344|CDPK1_PL	-	524	2e-69	232.8	0.4	1	2	2.4e-24	3.1e-23	80.4	0.2	43	164	596	711	562	726	0.76	Receptor-type tyrosine-protein kinase FLT3 (DB00398; DB01268; DB05014; DB05465; DB06080; DB06469; DB06595; DB08901; DB09079; DB12010; DB12141; DB12267; DB12500; DB12742; DB12874; DB12978)
drugbank_target|P36888	-	993	sp|P62344|CDPK1_PL	-	524	2e-69	232.8	0.4	2	2	1.5e-45	1.9e-44	150.3	0.0	160	329	780	949	765	979	0.83	Receptor-type tyrosine-protein kinase FLT3 (DB00398; DB01268; DB05014; DB05465; DB06080; DB06469; DB06595; DB08901; DB09079; DB12010; DB12141; DB12267; DB12500; DB12742; DB12874; DB12978)
drugbank_target|Q08345	-	913	sp|P62344|CDPK1_PL	-	524	2.3e-69	232.6	0.0	1	1	2.6e-70	3.3e-69	232.1	0.0	54	320	608	902	602	911	0.87	Epithelial discoidin domain-containing receptor 1 (DB00619; DB12010)
drugbank_target|P14616	-	1297	sp|P62344|CDPK1_PL	-	524	2.9e-69	232.3	0.0	1	1	3.2e-70	4.1e-69	231.8	0.0	40	321	963	1244	945	1249	0.87	Insulin receptor-related protein (DB12010)
drugbank_target|P09619	-	1106	sp|P62344|CDPK1_PL	-	524	3.1e-69	232.1	0.0	1	2	2.2e-23	2.8e-22	77.2	0.0	48	162	591	698	565	707	0.80	Platelet-derived growth factor receptor beta (DB00102; DB00398; DB00619; DB01254; DB01268; DB05014; DB05146; DB06589; DB06595; DB08896; DB09079; DB09221; DB09283; DB10770; DB12010; DB12147; DB12978; DB14840)
drugbank_target|P09619	-	1106	sp|P62344|CDPK1_PL	-	524	3.1e-69	232.1	0.0	2	2	2.8e-46	3.6e-45	152.8	0.0	157	320	792	955	784	976	0.90	Platelet-derived growth factor receptor beta (DB00102; DB00398; DB00619; DB01254; DB01268; DB05014; DB05146; DB06589; DB06595; DB08896; DB09079; DB09221; DB09283; DB10770; DB12010; DB12147; DB12978; DB14840)
drugbank_target|Q13546	-	671	sp|P62344|CDPK1_PL	-	524	3.8e-69	231.9	0.4	1	1	5e-70	6.4e-69	231.1	0.4	55	364	16	328	5	342	0.86	Receptor-interacting serine/threonine-protein kinase 1 (DB12010)
drugbank_target|Q06418	-	890	sp|P62344|CDPK1_PL	-	524	4.2e-69	231.7	0.0	1	1	4.5e-70	5.7e-69	231.3	0.0	52	319	514	782	475	786	0.86	Tyrosine-protein kinase receptor TYRO3 (DB12010)
drugbank_target|Q59EB3	-	712	sp|P62344|CDPK1_PL	-	524	7.6e-69	230.9	0.0	1	1	8.5e-70	1.1e-68	230.4	0.0	58	321	402	657	389	662	0.89	Met proto-oncogene variant (DB08111)
drugbank_target|Q9H422	-	1215	sp|P62344|CDPK1_PL	-	524	9.1e-69	230.6	0.0	1	1	4.9e-67	6.2e-66	221.3	0.0	46	384	187	585	164	597	0.84	Homeodomain-interacting protein kinase 3 (DB12010)
drugbank_target|Q9UM73	-	1620	sp|P62344|CDPK1_PL	-	524	1.3e-68	230.1	0.0	1	1	1.5e-69	1.9e-68	229.6	0.0	44	322	1104	1382	1063	1419	0.88	ALK tyrosine kinase receptor (DB00171; DB08865; DB09063; DB11363; DB12010; DB12130; DB12141; DB12267)
drugbank_target|P17948	-	1338	sp|P62344|CDPK1_PL	-	524	1.9e-68	229.5	0.1	1	2	1.4e-19	1.7e-18	64.7	0.0	47	162	817	926	783	938	0.84	Vascular endothelial growth factor receptor 1 (DB00398; DB01268; DB04879; DB05075; DB05913; DB05932; DB06080; DB06101; DB06589; DB06626; DB07288; DB08896; DB09078; DB09079; DB09221; DB10770; DB12010; DB15685)
drugbank_target|P17948	-	1338	sp|P62344|CDPK1_PL	-	524	1.9e-68	229.5	0.1	2	2	2.9e-49	3.7e-48	162.6	0.0	160	321	991	1152	974	1164	0.89	Vascular endothelial growth factor receptor 1 (DB00398; DB01268; DB04879; DB05075; DB05913; DB05932; DB06080; DB06101; DB06589; DB06626; DB07288; DB08896; DB09078; DB09079; DB09221; DB10770; DB12010; DB15685)
drugbank_target|P08581	-	1390	sp|P62344|CDPK1_PL	-	524	2.4e-68	229.2	0.0	1	1	2.9e-69	3.7e-68	228.6	0.0	58	321	1080	1335	1068	1340	0.89	Hepatocyte growth factor receptor (DB02152; DB06314; DB06896; DB06995; DB06997; DB07369; DB07969; DB08079; DB08791; DB08865; DB08875; DB11791; DB12010; DB12200; DB12267; DB12742)
drugbank_target|P00533	-	1210	sp|P62344|CDPK1_PL	-	524	2.9e-68	229.0	0.0	1	1	3.4e-69	4.3e-68	228.4	0.0	54	320	710	965	676	978	0.91	Epidermal growth factor receptor (DB00002; DB00281; DB00317; DB00530; DB01259; DB01269; DB03496; DB04988; DB05101; DB05294; DB05374; DB05424; DB05524; DB05944; DB06021; DB07602; DB07662; DB08916; DB09330; DB09559; DB10772; DB11731; DB11737; DB11828; DB11963; DB12010; DB12202; DB12267; DB13164; DB15035)
drugbank_target|P04626	-	1255	sp|P62344|CDPK1_PL	-	524	4.7e-68	228.3	0.0	1	1	5.1e-69	6.5e-68	227.8	0.0	46	321	708	974	674	991	0.85	Receptor tyrosine-protein kinase erbB-2 (DB00072; DB01259; DB04988; DB05773; DB05944; DB06021; DB06366; DB08916; DB11652; DB11973; DB12010; DB12267; DB15035)
drugbank_target|P52564	-	334	sp|P62344|CDPK1_PL	-	524	8.6e-68	227.4	0.0	1	1	7.7e-69	9.8e-68	227.2	0.0	21	332	17	321	1	329	0.87	Dual specificity mitogen-activated protein kinase kinase 6 (DB12010)
drugbank_target|P46734	-	347	sp|P62344|CDPK1_PL	-	524	3.4e-67	225.4	0.0	1	1	3.3e-68	4.2e-67	225.1	0.0	44	334	51	334	7	342	0.86	Dual specificity mitogen-activated protein kinase kinase 3 (DB12010)
drugbank_target|Q12866	-	999	sp|P62344|CDPK1_PL	-	524	4.1e-67	225.1	0.1	1	1	4.8e-68	6.1e-67	224.6	0.1	52	319	582	850	553	876	0.85	Tyrosine-protein kinase Mer (DB08325; DB12010)
drugbank_target|P35968	-	1356	sp|P62344|CDPK1_PL	-	524	9.2e-67	224.0	0.0	1	2	6.9e-18	8.8e-17	59.1	0.0	49	162	826	933	813	946	0.84	Vascular endothelial growth factor receptor 2 (DB00398; DB01268; DB04727; DB04849; DB04879; DB05014; DB05075; DB05146; DB05198; DB05578; DB05931; DB05984; DB06080; DB06101; DB06436; DB06589; DB06595; DB06626; DB06938; DB07183; DB07274; DB07326; DB07333; DB07334; DB07514; DB07528; DB07537; DB08042; DB08519; DB08875; DB08896; DB08901; DB09078; DB09079; DB12010; DB12147; DB12307; DB14840)
drugbank_target|P35968	-	1356	sp|P62344|CDPK1_PL	-	524	9.2e-67	224.0	0.0	2	2	2.9e-49	3.6e-48	162.6	0.0	150	323	980	1160	975	1179	0.83	Vascular endothelial growth factor receptor 2 (DB00398; DB01268; DB04727; DB04849; DB04879; DB05014; DB05075; DB05146; DB05198; DB05578; DB05931; DB05984; DB06080; DB06101; DB06436; DB06589; DB06595; DB06626; DB06938; DB07183; DB07274; DB07326; DB07333; DB07334; DB07514; DB07528; DB07537; DB08042; DB08519; DB08875; DB08896; DB08901; DB09078; DB09079; DB12010; DB12147; DB12307; DB14840)
drugbank_target|Q04912	-	1400	sp|P62344|CDPK1_PL	-	524	1.8e-66	223.0	0.0	1	1	2.1e-67	2.6e-66	222.5	0.0	59	319	1085	1337	1072	1340	0.89	Macrophage-stimulating protein receptor (DB12010)
drugbank_target|P11309	-	404	sp|P62344|CDPK1_PL	-	524	1.8e-66	223.0	0.0	1	1	2e-67	2.6e-66	222.5	0.0	46	329	119	385	101	398	0.91	Serine/threonine-protein kinase pim-1 (DB01754; DB02010; DB02656; DB03366; DB03650; DB03777; DB04216; DB04395; DB04522; DB04530; DB04715; DB07151; DB07242; DB07524; DB08022; DB08166; DB08230; DB08705; DB08707; DB08708; DB08709; DB12010)
drugbank_target|P33981	-	857	sp|P62344|CDPK1_PL	-	524	2.7e-66	222.4	1.5	1	1	2.1e-67	2.7e-66	222.4	1.5	54	343	523	808	492	837	0.89	Dual specificity protein kinase TTK (DB01782; DB12010; DB15498)
drugbank_target|Q8IIR9	-	335	sp|P62344|CDPK1_PL	-	524	3.3e-66	222.1	2.2	1	1	2.8e-66	3.6e-65	218.7	2.2	50	330	37	333	19	335	0.90	Casein kinase 2, alpha subunit (DB11638)
drugbank_target|P68400	-	391	sp|P62344|CDPK1_PL	-	524	4.8e-66	221.6	3.4	1	1	2.9e-66	3.7e-65	218.7	3.5	48	334	31	333	8	341	0.88	Casein kinase II subunit alpha (DB00171; DB01765; DB02170; DB02709; DB03035; DB03127; DB03924; DB04216; DB04395; DB04462; DB04719; DB04720; DB04721; DB07715; DB07802; DB08338; DB08340; DB08345; DB08353; DB08354; DB08360; DB08362; DB08473; DB08660; DB08846; DB12010)
drugbank_target|P49841	-	420	sp|P62344|CDPK1_PL	-	524	7e-66	221.1	0.0	1	1	1.1e-65	1.4e-64	216.8	0.0	54	335	54	350	18	378	0.87	Glycogen synthase kinase-3 beta (DB01356; DB01772; DB01793; DB01950; DB02010; DB02052; DB03444; DB04014; DB04395; DB07014; DB07058; DB07149; DB07584; DB07585; DB07676; DB07812; DB07859; DB07947; DB08073; DB12010; DB12129; DB14507; DB14508; DB14509)
drugbank_target|P49840	-	483	sp|P62344|CDPK1_PL	-	524	8.5e-66	220.8	0.0	1	1	1.3e-65	1.6e-64	216.6	0.0	54	328	117	406	105	417	0.88	Glycogen synthase kinase-3 alpha (DB12010)
drugbank_target|P19525	-	551	sp|P62344|CDPK1_PL	-	524	1.8e-65	219.7	0.5	1	1	2e-66	2.5e-65	219.3	0.5	27	336	238	549	210	551	0.87	Interferon-induced, double-stranded RNA-activated protein kinase (DB12010)
drugbank_target|P19784	-	350	sp|P62344|CDPK1_PL	-	524	3.4e-65	218.8	4.1	1	1	1.5e-65	1.9e-64	216.4	4.1	50	334	34	334	9	344	0.88	Casein kinase II subunit alpha' (DB07546; DB12010)
drugbank_target|P29376	-	864	sp|P62344|CDPK1_PL	-	524	7.1e-65	217.8	0.0	1	1	7.8e-66	9.9e-65	217.3	0.0	55	322	509	776	502	789	0.90	Leukocyte tyrosine kinase receptor (DB12010)
drugbank_target|P9WI81	-	626	sp|P62344|CDPK1_PL	-	524	7.6e-65	217.7	0.0	1	1	7.9e-66	1e-64	217.3	0.0	51	325	6	274	2	297	0.90	Serine/threonine-protein kinase PknB (DB02930; DB03909; DB12010)
drugbank_target|P53667	-	647	sp|P62344|CDPK1_PL	-	524	7.9e-65	217.6	0.0	1	1	8.8e-66	1.1e-64	217.1	0.0	54	319	337	600	307	609	0.86	LIM domain kinase 1 (DB08912; DB12010)
drugbank_target|P35916	-	1363	sp|P62344|CDPK1_PL	-	524	1.7e-64	216.5	0.0	1	1	1.5e-64	1.9e-63	213.0	0.0	47	321	835	1167	822	1196	0.89	Vascular endothelial growth factor receptor 3 (DB00398; DB01268; DB04879; DB05075; DB05932; DB06080; DB06101; DB06589; DB06626; DB08896; DB09078; DB09079; DB12010; DB15685)
drugbank_target|Q52WX2	-	424	sp|P62344|CDPK1_PL	-	524	2.8e-64	215.8	0.0	1	1	2.8e-65	3.6e-64	215.5	0.0	49	324	46	317	33	332	0.88	Serine/threonine-protein kinase SBK1 (DB12010)
drugbank_target|Q9NWZ3	-	460	sp|P62344|CDPK1_PL	-	524	4.7e-64	215.1	0.1	1	1	4.9e-65	6.2e-64	214.7	0.1	46	321	174	452	128	457	0.80	Interleukin-1 receptor-associated kinase 4 (DB08590; DB12010)
drugbank_target|Q59H18	-	835	sp|P62344|CDPK1_PL	-	524	1.2e-63	213.7	0.0	1	1	1.5e-64	1.8e-63	213.1	0.0	55	320	462	716	453	720	0.93	Serine/threonine-protein kinase TNNI3K (DB12010)
drugbank_target|Q86V86	-	326	sp|P62344|CDPK1_PL	-	524	1.2e-63	213.7	0.0	1	1	1.3e-64	1.6e-63	213.3	0.0	46	326	30	294	24	303	0.92	Serine/threonine-protein kinase pim-3 (DB12010)
drugbank_target|P53671	-	638	sp|P62344|CDPK1_PL	-	524	1.3e-62	210.3	0.0	1	1	1.4e-63	1.8e-62	209.9	0.0	55	319	330	597	279	601	0.87	LIM domain kinase 2 (DB12010)
drugbank_target|O15111	-	745	sp|P62344|CDPK1_PL	-	524	3.3e-62	209.0	0.0	1	1	4.6e-63	5.9e-62	208.1	0.0	57	287	16	242	11	297	0.83	Inhibitor of nuclear factor kappa-B kinase subunit alpha (DB00233; DB00244; DB00795; DB06151)
drugbank_target|O14920	-	756	sp|P62344|CDPK1_PL	-	524	4e-61	205.4	0.5	1	1	7.7e-62	9.8e-61	204.1	0.0	56	274	15	229	8	290	0.84	Inhibitor of nuclear factor kappa-B kinase subunit beta (DB00244; DB00795; DB00945; DB00995; DB01169; DB05183; DB06151; DB06521; DB12010)
drugbank_target|P49336	-	464	sp|P62344|CDPK1_PL	-	524	7.8e-61	204.4	0.1	1	1	1.1e-61	1.4e-60	203.6	0.1	45	328	9	338	2	383	0.87	Cyclin-dependent kinase 8 (DB03496)
drugbank_target|P21860	-	1342	sp|P62344|CDPK1_PL	-	524	1.4e-60	203.6	0.0	1	1	1.5e-61	1.9e-60	203.1	0.0	53	322	706	964	667	979	0.86	Receptor tyrosine-protein kinase erbB-3 (DB11652)
drugbank_target|Q8TDR2	-	534	sp|P62344|CDPK1_PL	-	524	1.6e-60	203.4	0.0	1	1	2.8e-61	3.5e-60	202.3	0.0	51	320	197	524	185	527	0.91	Serine/threonine-protein kinase 35 (DB12010)
drugbank_target|Q13523	-	1007	sp|P62344|CDPK1_PL	-	524	2.6e-60	202.7	1.1	1	2	2.2e-57	2.8e-56	189.4	0.1	30	291	660	913	642	918	0.88	Serine/threonine-protein kinase PRP4 homolog (DB12010)
drugbank_target|Q13523	-	1007	sp|P62344|CDPK1_PL	-	524	2.6e-60	202.7	1.1	2	2	1.9e-06	2.4e-05	21.4	0.1	282	327	962	1005	947	1007	0.82	Serine/threonine-protein kinase PRP4 homolog (DB12010)
drugbank_target|Q15569	-	626	sp|P62344|CDPK1_PL	-	524	3.6e-60	202.2	0.0	1	1	4e-61	5.2e-60	201.7	0.0	54	333	55	322	40	339	0.86	Dual specificity testis-specific protein kinase 1 (DB12010)
drugbank_target|Q8NFD2	-	765	sp|P62344|CDPK1_PL	-	524	3.8e-60	202.2	0.0	1	1	4e-61	5e-60	201.8	0.0	59	319	25	281	15	345	0.88	Ankyrin repeat and protein kinase domain-containing protein 1 (DB12010)
drugbank_target|Q9BQI3	-	630	sp|P62344|CDPK1_PL	-	524	2.1e-59	199.7	1.4	1	2	2e-18	2.6e-17	60.8	0.2	22	140	128	238	107	241	0.73	Eukaryotic translation initiation factor 2-alpha kinase 1 (DB12010)
drugbank_target|Q9BQI3	-	630	sp|P62344|CDPK1_PL	-	524	2.1e-59	199.7	1.4	2	2	8.9e-42	1.1e-40	137.9	0.1	139	349	378	609	342	620	0.81	Eukaryotic translation initiation factor 2-alpha kinase 1 (DB12010)
drugbank_target|Q99640	-	499	sp|P62344|CDPK1_PL	-	524	2.6e-59	199.4	0.0	1	1	2.7e-60	3.4e-59	199.0	0.0	35	327	89	361	76	365	0.91	Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase (DB12010)
drugbank_target|P30291	-	646	sp|P62344|CDPK1_PL	-	524	3.7e-59	198.9	0.2	1	1	3.9e-60	5e-59	198.5	0.2	14	364	252	609	244	641	0.82	Wee1-like protein kinase (DB04608; DB07006; DB07226; DB07257; DB07265; DB08365; DB11740; DB12010)
drugbank_target|O14976	-	1311	sp|P62344|CDPK1_PL	-	524	6.5e-59	198.1	0.0	1	1	8.1e-60	1e-58	197.4	0.0	51	322	34	312	20	333	0.84	Cyclin-G-associated kinase (DB12010)
drugbank_target|P57078	-	832	sp|P62344|CDPK1_PL	-	524	8.4e-59	197.7	0.0	1	1	8.9e-60	1.1e-58	197.3	0.0	55	317	21	277	15	288	0.88	Receptor-interacting serine/threonine-protein kinase 4 (DB12010)
drugbank_target|O15197	-	1021	sp|P62344|CDPK1_PL	-	524	1.3e-58	197.1	0.0	1	1	1.5e-59	1.9e-58	196.6	0.0	31	321	644	913	618	924	0.89	Ephrin type-B receptor 6 (DB12010)
drugbank_target|Q13470	-	666	sp|P62344|CDPK1_PL	-	524	1.9e-56	189.9	0.0	1	1	2.2e-57	2.8e-56	189.4	0.0	58	319	118	373	112	376	0.88	Non-receptor tyrosine-protein kinase TNK1 (DB12010)
drugbank_target|O43353	-	540	sp|P62344|CDPK1_PL	-	524	1.1e-55	187.4	0.0	1	1	1.3e-56	1.7e-55	186.8	0.0	57	320	19	287	11	338	0.86	Receptor-interacting serine/threonine-protein kinase 2 (DB12010)
drugbank_target|O75716	-	305	sp|P62344|CDPK1_PL	-	524	1.5e-55	187.0	0.0	1	1	1.5e-56	1.9e-55	186.7	0.0	53	321	17	288	9	300	0.87	Serine/threonine-protein kinase 16 (DB12010)
drugbank_target|Q14164	-	716	sp|P62344|CDPK1_PL	-	524	1.1e-54	184.1	0.0	1	1	1.7e-55	2.2e-54	183.2	0.0	58	283	11	241	2	245	0.88	Inhibitor of nuclear factor kappa-B kinase subunit epsilon (DB12010)
drugbank_target|Q9UHD2	-	729	sp|P62344|CDPK1_PL	-	524	5.7e-54	181.8	0.6	1	1	7.6e-55	9.7e-54	181.0	0.0	59	284	12	242	2	251	0.88	Serine/threonine-protein kinase TBK1 (DB12010)
drugbank_target|Q2M2I8	-	961	sp|P62344|CDPK1_PL	-	524	2.5e-53	179.6	0.0	1	1	2e-54	2.5e-53	179.6	0.0	54	321	44	309	38	364	0.84	AP2-associated protein kinase 1 (DB12010)
drugbank_target|O00238	-	502	sp|P62344|CDPK1_PL	-	524	3.8e-53	179.1	0.0	1	1	4.1e-54	5.2e-53	178.6	0.0	50	321	198	489	181	500	0.85	Bone morphogenetic protein receptor type-1B (DB12010)
drugbank_target|P0DP23	-	149	sp|P62344|CDPK1_PL	-	524	7.2e-53	178.2	8.4	1	1	6.1e-54	7.7e-53	178.0	8.4	368	516	4	147	1	149	0.95	Calmodulin (DB00477; DB00527; DB00622; DB00623; DB00753; DB00831; DB00836; DB00850; DB00925; DB01023; DB01065; DB01069; DB01100; DB01115; DB01244; DB01373; DB01429; DB02868; DB03900; DB03977; DB04513; DB04825; DB04841; DB08039; DB08231; DB11093; DB11348; DB13800; DB14481)
drugbank_target|P0DP24	-	149	sp|P62344|CDPK1_PL	-	524	7.2e-53	178.2	8.4	1	1	6.1e-54	7.7e-53	178.0	8.4	368	516	4	147	1	149	0.95	Calmodulin-2 (DB11093; DB11348; DB14481)
drugbank_target|P0DP25	-	149	sp|P62344|CDPK1_PL	-	524	7.2e-53	178.2	8.4	1	1	6.1e-54	7.7e-53	178.0	8.4	368	516	4	147	1	149	0.95	Calmodulin-3 (DB11093; DB11348; DB14481)
drugbank_target|P36894	-	532	sp|P62344|CDPK1_PL	-	524	1e-52	177.6	0.0	1	1	1.1e-53	1.4e-52	177.2	0.0	49	321	227	519	184	529	0.85	Bone morphogenetic protein receptor type-1A (DB11639)
drugbank_target|Q9NSY1	-	1161	sp|P62344|CDPK1_PL	-	524	2.6e-52	176.3	0.0	1	1	2e-53	2.6e-52	176.3	0.0	55	320	50	312	38	369	0.84	BMP-2-inducible protein kinase (DB12010)
drugbank_target|O75460	-	977	sp|P62344|CDPK1_PL	-	524	3.6e-52	175.8	0.0	1	1	5e-53	6.4e-52	175.0	0.0	23	335	541	842	518	857	0.77	Serine/threonine-protein kinase/endoribonuclease IRE1 (DB07382; DB12010)
drugbank_target|Q04771	-	509	sp|P62344|CDPK1_PL	-	524	8e-52	174.7	0.0	1	1	8.6e-53	1.1e-51	174.2	0.0	50	321	202	493	198	504	0.85	Activin receptor type-1 (DB00171; DB08597; DB12010)
drugbank_target|Q5S007	-	2527	sp|P62344|CDPK1_PL	-	524	3.9e-50	169.1	0.0	1	1	5.2e-51	6.7e-50	168.4	0.0	61	319	1884	2128	1869	2133	0.87	Leucine-rich repeat serine/threonine-protein kinase 2 (DB12010)
drugbank_target|P36897	-	503	sp|P62344|CDPK1_PL	-	524	4.2e-50	169.0	0.0	1	1	4.7e-51	6e-50	168.5	0.0	51	321	200	490	196	500	0.84	TGF-beta receptor type-1 (DB03921; DB04434; DB04480; DB07152; DB07267; DB08450; DB12010)
drugbank_target|Q13873	-	1038	sp|P62344|CDPK1_PL	-	524	1.1e-48	164.4	0.0	1	1	1.3e-49	1.6e-48	163.8	0.0	45	376	191	558	176	576	0.80	Bone morphogenetic protein receptor type-2 (DB11639; DB12010)
drugbank_target|P37023	-	503	sp|P62344|CDPK1_PL	-	524	3.7e-48	162.6	0.0	1	1	3.9e-49	5e-48	162.2	0.0	50	321	196	487	192	501	0.85	Serine/threonine-protein kinase receptor R3 (DB00171)
drugbank_target|P36896	-	505	sp|P62344|CDPK1_PL	-	524	2.9e-47	159.7	0.0	1	1	3.2e-48	4.1e-47	159.2	0.0	51	321	202	492	197	501	0.83	Activin receptor type-1B (DB00171; DB12010)
drugbank_target|P78362	-	688	sp|P62344|CDPK1_PL	-	524	3.1e-47	159.5	0.1	1	2	6.6e-31	8.4e-30	102.0	0.0	29	202	54	225	45	230	0.81	SRSF protein kinase 2 (DB00173; DB02733; DB04395)
drugbank_target|P78362	-	688	sp|P62344|CDPK1_PL	-	524	3.1e-47	159.5	0.1	2	2	2.1e-19	2.7e-18	64.1	0.0	204	326	522	687	511	688	0.92	SRSF protein kinase 2 (DB00173; DB02733; DB04395)
drugbank_target|P51617	-	712	sp|P62344|CDPK1_PL	-	524	1.2e-46	157.6	0.0	1	1	1.4e-47	1.8e-46	157.1	0.0	56	320	212	515	205	519	0.85	Interleukin-1 receptor-associated kinase 1 (DB12010)
drugbank_target|P20594	-	1047	sp|P62344|CDPK1_PL	-	524	1.9e-46	157.0	0.0	1	1	2.1e-47	2.7e-46	156.5	0.0	78	320	544	783	535	833	0.86	Atrial natriuretic peptide receptor 2 (DB01613; DB04899)
drugbank_target|P37173	-	567	sp|P62344|CDPK1_PL	-	524	5.5e-46	155.4	0.1	1	1	6.2e-47	7.9e-46	154.9	0.1	56	320	244	535	192	546	0.79	TGF-beta receptor type-2 (DB10770; DB10772; DB12010)
drugbank_target|P02585	-	160	sp|P62344|CDPK1_PL	-	524	1.7e-45	153.8	8.4	1	1	1.6e-46	2e-45	153.6	8.4	365	516	9	157	2	160	0.93	Troponin C, skeletal muscle (DB01023; DB01373; DB04682)
drugbank_target|Q9Y616	-	596	sp|P62344|CDPK1_PL	-	524	1.4e-44	150.8	0.1	1	1	1.7e-45	2.1e-44	150.2	0.1	54	322	163	442	145	455	0.84	Interleukin-1 receptor-associated kinase 3 (DB12010)
drugbank_target|P27037	-	513	sp|P62344|CDPK1_PL	-	524	1.3e-43	147.6	0.1	1	1	1.4e-44	1.8e-43	147.1	0.1	57	317	193	473	189	504	0.79	Activin receptor type-2A (DB12118)
drugbank_target|P16066	-	1061	sp|P62344|CDPK1_PL	-	524	1.3e-43	147.6	0.0	1	1	1.6e-44	2e-43	147.0	0.0	69	322	551	800	547	861	0.79	Atrial natriuretic peptide receptor 1 (DB00325; DB00727; DB00883; DB01612; DB01613; DB04899; DB05034)
drugbank_target|Q9HCP0	-	422	sp|P62344|CDPK1_PL	-	524	7.9e-43	145.0	0.0	1	1	8.3e-44	1.1e-42	144.6	0.0	21	301	9	289	2	307	0.84	Casein kinase I isoform gamma-1 (DB08325)
drugbank_target|P19105	-	171	sp|P62344|CDPK1_PL	-	524	1.8e-42	143.8	6.2	1	1	1.5e-43	2e-42	143.7	6.2	347	523	4	170	1	171	0.94	Myosin regulatory light chain 12A (DB08378)
drugbank_target|Q9Y6M4	-	447	sp|P62344|CDPK1_PL	-	524	1.9e-42	143.8	0.9	1	1	1.7e-43	2.1e-42	143.6	0.0	23	289	9	274	1	290	0.81	Casein kinase I isoform gamma-3 (DB04751; DB07488; DB07489; DB07664)
drugbank_target|P20807	-	821	sp|P62344|CDPK1_PL	-	524	2.7e-42	143.3	8.9	1	2	6.5e-43	8.2e-42	141.7	4.9	334	517	611	788	592	792	0.89	Calpain-3 (DB06124)
drugbank_target|P20807	-	821	sp|P62344|CDPK1_PL	-	524	2.7e-42	143.3	8.9	2	2	0.49	6.2	3.5	0.1	459	476	794	811	788	819	0.81	Calpain-3 (DB06124)
drugbank_target|P48729	-	337	sp|P62344|CDPK1_PL	-	524	4.6e-42	142.5	0.1	1	1	4e-43	5.1e-42	142.3	0.1	46	306	7	264	2	337	0.82	Casein kinase I isoform alpha (DB12010)
drugbank_target|P63316	-	161	sp|P62344|CDPK1_PL	-	524	1.3e-41	141.0	10.9	1	1	1.3e-42	1.7e-41	140.6	10.9	365	516	8	158	2	160	0.93	Troponin C, slow skeletal and cardiac muscles (DB00831; DB00922; DB01023; DB01244; DB01373; DB01375; DB03944; DB04513)
drugbank_target|P49674	-	416	sp|P62344|CDPK1_PL	-	524	4.3e-41	139.3	0.1	1	1	4.1e-42	5.2e-41	139.0	0.1	51	300	4	250	1	271	0.86	Casein kinase I isoform epsilon (DB06195)
drugbank_target|P78368	-	415	sp|P62344|CDPK1_PL	-	524	1.1e-40	137.9	0.0	1	1	1.1e-41	1.4e-40	137.6	0.0	51	300	41	289	6	308	0.86	Casein kinase I isoform gamma-2 (DB03083; DB03693; DB04604)
drugbank_target|P63098	-	170	sp|P62344|CDPK1_PL	-	524	1.2e-40	137.9	3.9	1	1	1.1e-41	1.4e-40	137.6	3.9	364	515	11	157	3	164	0.89	Calcineurin subunit B type 1 (DB08231; DB11693)
drugbank_target|P0C264	-	359	sp|P62344|CDPK1_PL	-	524	3.2e-40	136.4	0.0	1	1	3e-41	3.8e-40	136.2	0.0	49	314	36	295	2	303	0.87	Uncharacterized serine/threonine-protein kinase SBK3 (DB12010)
drugbank_target|Q96LZ3	-	170	sp|P62344|CDPK1_PL	-	524	8e-39	131.8	3.6	1	1	7.5e-40	9.5e-39	131.6	3.6	364	517	11	159	3	165	0.89	Calcineurin subunit B type 2 (DB00091; DB11693)
drugbank_target|P25092	-	1073	sp|P62344|CDPK1_PL	-	524	4e-38	129.5	1.7	1	1	4.6e-39	5.9e-38	128.9	1.7	82	322	498	744	487	791	0.83	Heat-stable enterotoxin receptor (DB08890)
drugbank_target|P04632	-	268	sp|P62344|CDPK1_PL	-	524	1.7e-37	127.5	0.5	1	2	2.7e-37	3.4e-36	123.1	0.1	367	517	91	235	69	239	0.91	Calpain small subunit 1 (DB02570)
drugbank_target|P04632	-	268	sp|P62344|CDPK1_PL	-	524	1.7e-37	127.5	0.5	2	2	0.69	8.8	3.0	0.0	424	474	242	256	236	267	0.51	Calpain small subunit 1 (DB02570)
drugbank_target|O75340	-	191	sp|P62344|CDPK1_PL	-	524	2.2e-37	127.1	2.9	1	2	4.8e-35	6.1e-34	115.7	0.5	374	514	25	154	19	158	0.93	Programmed cell death protein 6 (DB01373; DB01593; DB11093; DB11348; DB14481; DB14487)
drugbank_target|O75340	-	191	sp|P62344|CDPK1_PL	-	524	2.2e-37	127.1	2.9	2	2	0.0012	0.016	12.0	0.1	455	475	159	179	155	188	0.89	Programmed cell death protein 6 (DB01373; DB01593; DB11093; DB11348; DB14481; DB14487)
drugbank_target|P22676	-	271	sp|P62344|CDPK1_PL	-	524	5.1e-37	125.9	12.0	1	2	1.3e-25	1.6e-24	84.6	3.7	372	481	16	136	5	149	0.91	Calretinin (DB11093; DB11348; DB13800; DB14481)
drugbank_target|P22676	-	271	sp|P62344|CDPK1_PL	-	524	5.1e-37	125.9	12.0	2	2	4.9e-14	6.2e-13	46.4	1.5	374	455	152	234	138	243	0.79	Calretinin (DB11093; DB11348; DB13800; DB14481)
drugbank_target|P9WI73	-	750	sp|P62344|CDPK1_PL	-	524	1.9e-36	124.0	0.0	1	1	2.4e-37	3.1e-36	123.3	0.0	53	265	148	343	140	393	0.85	Serine/threonine-protein kinase PknG (DB07398)
drugbank_target|P62166	-	190	sp|P62344|CDPK1_PL	-	524	1.9e-34	117.4	3.9	1	2	4e-31	5.1e-30	102.8	1.1	369	507	19	150	3	150	0.90	Neuronal calcium sensor 1 (DB11093; DB11348; DB14481)
drugbank_target|P62166	-	190	sp|P62344|CDPK1_PL	-	524	1.9e-34	117.4	3.9	2	2	1.5e-05	0.00019	18.4	0.1	417	444	145	172	137	187	0.75	Neuronal calcium sensor 1 (DB11093; DB11348; DB14481)
drugbank_target|P43080	-	201	sp|P62344|CDPK1_PL	-	524	3.9e-33	113.0	1.4	1	2	2.1e-26	2.7e-25	87.2	0.1	369	483	10	118	3	123	0.89	Guanylyl cyclase-activating protein 1 (DB08231)
drugbank_target|P43080	-	201	sp|P62344|CDPK1_PL	-	524	3.9e-33	113.0	1.4	2	2	2.7e-08	3.5e-07	27.4	0.1	360	411	118	170	116	193	0.80	Guanylyl cyclase-activating protein 1 (DB08231)
drugbank_target|Q16671	-	573	sp|P62344|CDPK1_PL	-	524	4.3e-33	112.9	0.0	1	1	4.8e-34	6.1e-33	112.4	0.0	58	322	205	504	186	519	0.75	Anti-Muellerian hormone type-2 receptor (DB00171)
drugbank_target|P07384	-	714	sp|P62344|CDPK1_PL	-	524	1.9e-32	110.8	2.8	1	2	1.7e-33	2.1e-32	110.6	0.6	365	517	535	681	515	687	0.92	Calpain-1 catalytic subunit (DB04276; DB04653; DB07627)
drugbank_target|P07384	-	714	sp|P62344|CDPK1_PL	-	524	1.9e-32	110.8	2.8	2	2	5	63	0.2	0.1	421	441	685	705	681	709	0.65	Calpain-1 catalytic subunit (DB04276; DB04653; DB07627)
drugbank_target|Q99653	-	195	sp|P62344|CDPK1_PL	-	524	4.7e-31	106.2	1.7	1	1	4.5e-32	5.7e-31	105.9	1.7	368	518	22	183	5	189	0.89	Calcineurin B homologous protein 1 (DB11093; DB11348; DB14481)
drugbank_target|P30626	-	198	sp|P62344|CDPK1_PL	-	524	4.7e-31	106.2	0.0	1	1	5.2e-32	6.7e-31	105.7	0.0	379	518	37	166	29	172	0.89	Sorcin (DB11093; DB11348; DB14481)
drugbank_target|Q9UJS0	-	675	sp|P62344|CDPK1_PL	-	524	8.5e-31	105.3	0.7	1	2	4.9e-30	6.3e-29	99.2	1.0	371	518	11	158	2	163	0.92	Calcium-binding mitochondrial carrier protein Aralar2 (DB00128)
drugbank_target|Q9UJS0	-	675	sp|P62344|CDPK1_PL	-	524	8.5e-31	105.3	0.7	2	2	0.25	3.2	4.4	0.0	375	510	161	289	156	294	0.78	Calcium-binding mitochondrial carrier protein Aralar2 (DB00128)
drugbank_target|O75746	-	678	sp|P62344|CDPK1_PL	-	524	2.7e-30	103.7	0.2	1	2	4.7e-28	6e-27	92.6	0.1	371	518	10	157	1	162	0.89	Calcium-binding mitochondrial carrier protein Aralar1 (DB00128)
drugbank_target|O75746	-	678	sp|P62344|CDPK1_PL	-	524	2.7e-30	103.7	0.2	2	2	0.0054	0.069	9.9	0.0	374	510	159	288	155	293	0.69	Calcium-binding mitochondrial carrier protein Aralar1 (DB00128)
drugbank_target|P28676	-	217	sp|P62344|CDPK1_PL	-	524	8.4e-30	102.0	0.0	1	1	8.4e-31	1.1e-29	101.7	0.0	378	518	55	185	42	189	0.88	Grancalcin (DB11093; DB11348; DB14481)
drugbank_target|Q13938	-	189	sp|P62344|CDPK1_PL	-	524	1.7e-27	94.4	0.0	1	1	1.7e-28	2.1e-27	94.1	0.0	371	514	20	165	4	174	0.86	Calcyphosin (DB11093; DB11348; DB14481)
drugbank_target|P14649	-	208	sp|P62344|CDPK1_PL	-	524	1.8e-27	94.3	0.0	1	1	1.7e-28	2.1e-27	94.1	0.0	370	513	62	203	33	207	0.89	Myosin light chain 6B (DB08378)
drugbank_target|P35243	-	200	sp|P62344|CDPK1_PL	-	524	2.6e-27	93.8	3.8	1	2	5.1e-28	6.5e-27	92.5	2.1	367	512	18	173	5	175	0.93	Recoverin (DB08231)
drugbank_target|P35243	-	200	sp|P62344|CDPK1_PL	-	524	2.6e-27	93.8	3.8	2	2	0.02	0.25	8.1	0.4	370	411	145	185	141	200	0.71	Recoverin (DB08231)
drugbank_target|P12814	-	892	sp|P62344|CDPK1_PL	-	524	5.1e-27	92.8	0.1	1	1	4e-28	5.1e-27	92.8	0.1	353	479	727	850	686	866	0.89	Alpha-actinin-1 (DB06773; DB09130)
drugbank_target|Q9UBV8	-	284	sp|P62344|CDPK1_PL	-	524	2.4e-26	90.6	0.1	1	1	4.8e-27	6.1e-26	89.3	0.0	412	522	110	217	101	219	0.96	Peflin (DB11093; DB11348; DB14481)
drugbank_target|O75838	-	187	sp|P62344|CDPK1_PL	-	524	2.3e-24	84.1	0.5	1	1	2.2e-25	2.7e-24	83.8	0.5	411	520	62	178	51	182	0.89	Calcium and integrin-binding family member 2 (DB11093; DB11348; DB14481)
drugbank_target|Q96KG9	-	808	sp|P62344|CDPK1_PL	-	524	2.1e-20	71.1	0.0	1	1	2.8e-21	3.5e-20	70.3	0.0	72	266	33	221	30	232	0.87	N-terminal kinase-like protein (DB05036)
drugbank_target|P31949	-	105	sp|P62344|CDPK1_PL	-	524	1.1e-17	62.0	0.1	1	1	9.6e-19	1.2e-17	61.9	0.1	362	445	2	84	1	96	0.92	Protein S100-A11 (DB02482)
drugbank_target|P49619	-	791	sp|P62344|CDPK1_PL	-	524	2.9e-17	60.7	0.0	1	1	4.9e-18	6.3e-17	59.6	0.0	364	446	167	250	151	259	0.93	Diacylglycerol kinase gamma (DB00144)
drugbank_target|P49619	-	791	sp|P62344|CDPK1_PL	-	524	2.9e-17	60.7	0.0	1	1	4.9e-18	6.3e-17	59.6	0.0	364	446	167	250	151	259	0.93	Diacylglycerol kinase gamma (DB14001)
drugbank_target|Q9Y6T7	-	804	sp|P62344|CDPK1_PL	-	524	3.9e-17	60.2	0.0	1	1	6.7e-18	8.5e-17	59.1	0.0	365	447	142	225	130	241	0.91	Diacylglycerol kinase beta (DB14001)
drugbank_target|P23297	-	94	sp|P62344|CDPK1_PL	-	524	2.7e-16	57.5	0.7	1	1	2.3e-17	2.9e-16	57.4	0.7	367	447	4	81	1	90	0.85	Protein S100-A1 (DB00768)
drugbank_target|Q99828	-	191	sp|P62344|CDPK1_PL	-	524	4e-16	56.9	0.5	1	1	7.3e-17	9.3e-16	55.7	0.4	418	520	67	182	50	186	0.63	Calcium and integrin-binding protein 1 (DB11093; DB11348; DB14481)
drugbank_target|P29377	-	79	sp|P62344|CDPK1_PL	-	524	2.4e-15	54.4	0.7	1	1	1.9e-16	2.5e-15	54.3	0.7	368	448	1	76	1	79	0.85	Protein S100-G (DB04464)
drugbank_target|Q8TF76	-	798	sp|P62344|CDPK1_PL	-	524	2.8e-13	47.5	0.5	1	1	1.5e-13	1.9e-12	44.8	0.1	51	203	479	661	447	697	0.79	Serine/threonine-protein kinase haspin (DB04604; DB07698; DB07995; DB08004)
drugbank_target|P60903	-	97	sp|P62344|CDPK1_PL	-	524	3e-13	47.4	0.3	1	1	2.4e-14	3.1e-13	47.4	0.3	371	446	6	77	1	90	0.88	Protein S100-A10 (DB12695)
drugbank_target|P23743	-	735	sp|P62344|CDPK1_PL	-	524	3.1e-13	47.4	0.0	1	1	4.3e-14	5.4e-13	46.6	0.0	451	513	109	182	98	186	0.91	Diacylglycerol kinase alpha (DB00163)
drugbank_target|P23743	-	735	sp|P62344|CDPK1_PL	-	524	3.1e-13	47.4	0.0	1	1	4.3e-14	5.4e-13	46.6	0.0	451	513	109	182	98	186	0.91	Diacylglycerol kinase alpha (DB14001)
drugbank_target|P06702	-	114	sp|P62344|CDPK1_PL	-	524	5.5e-13	46.6	2.9	1	1	4.6e-14	5.9e-13	46.5	2.9	367	459	5	96	1	97	0.86	Protein S100-A9 (DB01373; DB01593; DB14487; DB14533; DB14548)
drugbank_target|P20472	-	110	sp|P62344|CDPK1_PL	-	524	5.8e-13	46.5	2.1	1	1	4.6e-14	5.8e-13	46.5	2.1	367	447	34	109	3	110	0.82	Parvalbumin alpha (DB01942)
drugbank_target|P04271	-	92	sp|P62344|CDPK1_PL	-	524	6.3e-13	46.4	2.7	1	1	5.3e-14	6.7e-13	46.3	2.7	372	447	6	80	1	90	0.82	Protein S100-B (DB00768; DB01373; DB04464; DB05343; DB06941; DB07004; DB11093; DB11348; DB14481)
drugbank_target|P26447	-	101	sp|P62344|CDPK1_PL	-	524	8.6e-12	42.6	0.8	1	1	7.4e-13	9.4e-12	42.5	0.8	380	446	15	80	7	96	0.88	Protein S100-A4 (DB00831; DB09130)
drugbank_target|P06703	-	90	sp|P62344|CDPK1_PL	-	524	1.1e-11	42.3	0.1	1	1	9.4e-13	1.2e-11	42.1	0.1	378	447	13	79	6	88	0.80	Protein S100-A6 (DB11093; DB11348; DB14481)
drugbank_target|P25815	-	95	sp|P62344|CDPK1_PL	-	524	1.1e-11	42.2	0.1	1	1	9e-13	1.1e-11	42.2	0.1	379	447	13	80	2	92	0.84	Protein S100-P (DB01003)
drugbank_target|P80511	-	92	sp|P62344|CDPK1_PL	-	524	2.8e-11	40.9	0.4	1	1	2.3e-12	2.9e-11	40.9	0.4	372	446	6	79	1	91	0.83	Protein S100-A12 (DB00768; DB01025)
drugbank_target|P29034	-	98	sp|P62344|CDPK1_PL	-	524	2.9e-11	40.9	0.3	1	1	2.5e-12	3.1e-11	40.8	0.3	379	446	15	81	2	89	0.85	Protein S100-A2 (DB00768; DB01373; DB01593; DB09130; DB14487; DB14533; DB14548)
drugbank_target|Q9NXG6	-	502	sp|P62344|CDPK1_PL	-	524	3.8e-11	40.5	0.0	1	1	4.1e-12	5.2e-11	40.0	0.0	346	447	161	255	151	286	0.82	Transmembrane prolyl 4-hydroxylase (DB00126)
drugbank_target|Q8NI22	-	146	sp|P62344|CDPK1_PL	-	524	8.1e-11	39.4	0.1	1	1	6.6e-12	8.5e-11	39.3	0.1	360	443	55	143	24	146	0.86	Multiple coagulation factor deficiency protein 2 (DB00025; DB13998; DB13999)
drugbank_target|Q68101	-	707	sp|P62344|CDPK1_PL	-	524	3.1e-10	37.5	0.0	1	1	3.9e-11	4.9e-10	36.8	0.0	61	222	336	491	328	508	0.82	Serine/threonine protein kinase UL97 (DB06234)
drugbank_target|P16788	-	707	sp|P62344|CDPK1_PL	-	524	3.1e-10	37.5	0.0	1	1	3.9e-11	4.9e-10	36.8	0.0	61	222	336	491	328	508	0.82	Serine/threonine protein kinase UL97 (DB06234)
drugbank_target|Q86YZ3	-	2850	sp|P62344|CDPK1_PL	-	524	4.2e-10	37.1	0.2	1	1	6.6e-11	8.5e-10	36.0	0.2	380	450	14	83	9	91	0.84	Hornerin (DB01593; DB14487)
drugbank_target|Q96FQ6	-	103	sp|P62344|CDPK1_PL	-	524	5.9e-10	36.5	0.0	1	1	5e-11	6.4e-10	36.4	0.0	389	445	30	83	14	99	0.87	Protein S100-A16 (DB11093; DB11348; DB14481)
drugbank_target|P31151	-	101	sp|P62344|CDPK1_PL	-	524	2.9e-07	27.7	1.0	1	1	2.4e-08	3e-07	27.6	1.0	368	447	4	81	1	93	0.78	Protein S100-A7 (DB01050; DB01593; DB04474; DB09213; DB14487; DB14533; DB14548)
drugbank_target|P51178	-	756	sp|P62344|CDPK1_PL	-	524	1.1e-05	22.4	1.2	1	1	1.3e-06	1.6e-05	21.9	1.2	408	518	132	240	118	246	0.78	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase delta-1 (DB03401; DB03956)
drugbank_target|Q99584	-	98	sp|P62344|CDPK1_PL	-	524	1.6e-05	22.0	0.8	1	1	1.3e-06	1.6e-05	21.9	0.8	369	450	8	85	1	97	0.70	Protein S100-A13 (DB00768; DB01025; DB01164; DB01373; DB11093; DB11348; DB14481)
drugbank_target|P05109	-	93	sp|P62344|CDPK1_PL	-	524	1.9e-05	21.6	0.0	1	1	1.5e-06	1.9e-05	21.6	0.0	412	448	43	81	2	92	0.60	Protein S100-A8 (DB01373; DB01593; DB09130; DB14487; DB14533; DB14548)
drugbank_target|P11413	-	515	sp|Q8IKU0|GLUPH_PL	-	910	5.8e-235	780.6	0.0	1	2	2.5e-41	1.6e-38	130.5	0.0	330	444	23	128	17	132	0.97	Glucose-6-phosphate 1-dehydrogenase (DB03085; DB03461; DB05107; DB11638)
drugbank_target|P11413	-	515	sp|Q8IKU0|GLUPH_PL	-	910	5.8e-235	780.6	0.0	2	2	8.2e-198	5.4e-195	648.3	0.0	509	890	132	508	129	513	0.99	Glucose-6-phosphate 1-dehydrogenase (DB03085; DB03461; DB05107; DB11638)
drugbank_target|P11411	-	486	sp|Q8IKU0|GLUPH_PL	-	910	7e-199	661.2	1.9	1	2	2.6e-33	1.7e-30	104.0	0.6	336	441	3	100	1	104	0.95	Glucose-6-phosphate 1-dehydrogenase (DB02338; DB03461; DB04122)
drugbank_target|P11411	-	486	sp|Q8IKU0|GLUPH_PL	-	910	7e-199	661.2	1.9	2	2	2.8e-170	1.8e-167	557.2	0.0	503	879	103	475	99	479	0.99	Glucose-6-phosphate 1-dehydrogenase (DB02338; DB03461; DB04122)
drugbank_target|O95479	-	791	sp|Q8IKU0|GLUPH_PL	-	910	3.3e-196	652.4	0.0	1	4	8.2e-36	5.4e-33	112.2	0.0	336	443	23	126	10	134	0.94	GDH/6PGL endoplasmic bifunctional protein (DB00157)
drugbank_target|O95479	-	791	sp|Q8IKU0|GLUPH_PL	-	910	3.3e-196	652.4	0.0	2	4	1e-114	6.6e-112	373.4	0.0	510	768	135	383	129	395	0.97	GDH/6PGL endoplasmic bifunctional protein (DB00157)
drugbank_target|O95479	-	791	sp|Q8IKU0|GLUPH_PL	-	910	3.3e-196	652.4	0.0	3	4	1.8e-16	1.2e-13	48.2	0.0	813	862	451	498	445	509	0.91	GDH/6PGL endoplasmic bifunctional protein (DB00157)
drugbank_target|O95479	-	791	sp|Q8IKU0|GLUPH_PL	-	910	3.3e-196	652.4	0.0	4	4	4.4e-36	2.9e-33	113.1	0.0	46	170	577	705	559	709	0.94	GDH/6PGL endoplasmic bifunctional protein (DB00157)
drugbank_target|Q9KL51	-	238	sp|Q8IKU0|GLUPH_PL	-	910	2.4e-38	130.0	0.0	1	1	4.8e-41	3.2e-38	129.6	0.0	33	170	8	151	2	159	0.94	DevB protein (DB03556)
drugbank_target|P46926	-	289	sp|Q8IKU0|GLUPH_PL	-	910	3e-37	126.3	0.0	1	1	6.4e-40	4.2e-37	125.8	0.0	33	165	15	145	6	152	0.94	Glucosamine-6-phosphate isomerase 1 (DB02379; DB02445; DB03951)
drugbank_target|Q9X0N8	-	220	sp|Q8IKU0|GLUPH_PL	-	910	7.9e-37	124.9	0.0	1	1	1.6e-39	1.1e-36	124.5	0.0	37	168	16	143	9	150	0.92	6-phosphogluconolactonase (DB01942; DB04272)
drugbank_target|P0A759	-	266	sp|Q8IKU0|GLUPH_PL	-	910	1.1e-36	124.4	0.0	1	1	2.9e-39	1.9e-36	123.7	0.0	33	166	15	146	7	154	0.92	Glucosamine-6-phosphate deaminase (DB02445; DB03951)
drugbank_target|O35000	-	242	sp|Q8IKU0|GLUPH_PL	-	910	4.7e-31	105.8	0.0	1	1	9.2e-34	6e-31	105.5	0.0	45	165	21	140	5	155	0.93	Glucosamine-6-phosphate deaminase 1 (DB02726; DB04277)
drugbank_target|Q8IBS5	-	528	sp|Q8IBS5|CDPK4_PL	-	528	2.7e-215	714.3	16.2	1	1	2.4e-216	3.1e-215	714.2	16.2	1	528	1	528	1	528	1.00	Calcium-dependent protein kinase 4 (DB11638)
drugbank_target|Q15418	-	735	sp|Q8IBS5|CDPK4_PL	-	528	6.6e-182	604.2	0.0	1	2	3.8e-90	4.9e-89	297.7	0.0	59	341	51	334	21	344	0.90	Ribosomal protein S6 kinase alpha-1 (DB04751; DB12010)
drugbank_target|Q15418	-	735	sp|Q8IBS5|CDPK4_PL	-	528	6.6e-182	604.2	0.0	2	2	3.7e-92	4.7e-91	304.4	0.0	59	346	407	693	391	729	0.91	Ribosomal protein S6 kinase alpha-1 (DB04751; DB12010)
drugbank_target|P51812	-	740	sp|Q8IBS5|CDPK4_PL	-	528	9e-182	603.7	0.0	1	2	1.6e-92	2e-91	305.6	0.0	24	339	21	338	9	346	0.87	Ribosomal protein S6 kinase alpha-3 (DB00945; DB12010)
drugbank_target|P51812	-	740	sp|Q8IBS5|CDPK4_PL	-	528	9e-182	603.7	0.0	2	2	1.2e-89	1.5e-88	296.1	0.0	57	350	409	701	388	737	0.89	Ribosomal protein S6 kinase alpha-3 (DB00945; DB12010)
drugbank_target|Q9UK32	-	745	sp|Q8IBS5|CDPK4_PL	-	528	3.3e-179	595.3	0.0	1	2	1.8e-89	2.3e-88	295.5	0.1	64	340	67	342	31	350	0.91	Ribosomal protein S6 kinase alpha-6 (DB12010)
drugbank_target|Q9UK32	-	745	sp|Q8IBS5|CDPK4_PL	-	528	3.3e-179	595.3	0.0	2	2	4e-90	5.1e-89	297.7	0.0	52	348	408	703	389	741	0.90	Ribosomal protein S6 kinase alpha-6 (DB12010)
drugbank_target|P62344	-	524	sp|Q8IBS5|CDPK4_PL	-	528	8.6e-173	574.1	18.2	1	1	8.3e-174	1.1e-172	573.8	18.2	22	527	8	520	2	521	0.96	Calcium-dependent protein kinase 1 (DB12010)
drugbank_target|O75676	-	772	sp|Q8IBS5|CDPK4_PL	-	528	1.5e-161	537.0	0.0	1	2	5.7e-82	7.3e-81	270.7	0.0	51	332	14	305	3	320	0.91	Ribosomal protein S6 kinase alpha-4 (DB03247)
drugbank_target|O75676	-	772	sp|Q8IBS5|CDPK4_PL	-	528	1.5e-161	537.0	0.0	2	2	5.7e-80	7.3e-79	264.1	0.0	74	336	415	682	388	694	0.90	Ribosomal protein S6 kinase alpha-4 (DB03247)
drugbank_target|O60674	-	1132	sp|Q8IBS5|CDPK4_PL	-	528	5.3e-122	406.5	0.1	1	2	2.8e-50	3.6e-49	166.2	0.0	61	324	536	803	514	818	0.90	Tyrosine-protein kinase JAK2 (DB04716; DB05243; DB07161; DB07162; DB08067; DB08877; DB08895; DB11817; DB11986; DB12010; DB12500; DB15035)
drugbank_target|O60674	-	1132	sp|Q8IBS5|CDPK4_PL	-	528	5.3e-122	406.5	0.1	2	2	4.8e-72	6.1e-71	238.0	0.1	66	322	845	1119	833	1123	0.85	Tyrosine-protein kinase JAK2 (DB04716; DB05243; DB07161; DB07162; DB08067; DB08877; DB08895; DB11817; DB11986; DB12010; DB12500; DB15035)
drugbank_target|P23458	-	1154	sp|Q8IBS5|CDPK4_PL	-	528	1.8e-115	385.0	4.4	1	2	4.9e-47	6.3e-46	155.5	0.0	45	325	558	844	534	864	0.85	Tyrosine-protein kinase JAK1 (DB02375; DB04716; DB08877; DB08895; DB11817; DB12010; DB12500; DB15091)
drugbank_target|P23458	-	1154	sp|Q8IBS5|CDPK4_PL	-	528	1.8e-115	385.0	4.4	2	2	6.5e-70	8.3e-69	231.0	0.1	55	323	859	1146	844	1148	0.81	Tyrosine-protein kinase JAK1 (DB02375; DB04716; DB08877; DB08895; DB11817; DB12010; DB12500; DB15091)
drugbank_target|P29597	-	1187	sp|Q8IBS5|CDPK4_PL	-	528	1.7e-112	375.1	0.0	1	2	1.1e-42	1.4e-41	141.2	0.0	63	325	582	865	567	879	0.90	Non-receptor tyrosine-protein kinase TYK2 (DB04716; DB08895; DB12010)
drugbank_target|P29597	-	1187	sp|Q8IBS5|CDPK4_PL	-	528	1.7e-112	375.1	0.0	2	2	3.9e-70	5e-69	231.7	0.0	58	322	885	1165	868	1178	0.87	Non-receptor tyrosine-protein kinase TYK2 (DB04716; DB08895; DB12010)
drugbank_target|P52333	-	1124	sp|Q8IBS5|CDPK4_PL	-	528	3.3e-110	367.6	0.0	1	2	3.7e-43	4.6e-42	142.7	0.0	48	323	499	774	478	782	0.88	Tyrosine-protein kinase JAK3 (DB04716; DB06321; DB08895; DB11817; DB12010; DB15035)
drugbank_target|P52333	-	1124	sp|Q8IBS5|CDPK4_PL	-	528	3.3e-110	367.6	0.0	2	2	2.1e-67	2.7e-66	222.7	0.0	67	321	819	1090	805	1094	0.90	Tyrosine-protein kinase JAK3 (DB04716; DB06321; DB08895; DB11817; DB12010; DB15035)
drugbank_target|Q8IU85	-	385	sp|Q8IBS5|CDPK4_PL	-	528	2.2e-106	355.0	0.1	1	1	2e-107	2.5e-106	354.8	0.1	51	374	4	330	1	346	0.91	Calcium/calmodulin-dependent protein kinase type 1D (DB08454; DB12010)
drugbank_target|Q13557	-	499	sp|Q8IBS5|CDPK4_PL	-	528	5e-106	353.8	0.0	1	1	4.6e-107	5.9e-106	353.6	0.0	64	462	8	408	1	414	0.87	Calcium/calmodulin-dependent protein kinase type II subunit delta (DB07853; DB08039; DB12010)
drugbank_target|Q9C098	-	648	sp|Q8IBS5|CDPK4_PL	-	528	3.5e-105	351.0	0.0	1	1	4.3e-106	5.4e-105	350.4	0.0	11	357	293	642	285	648	0.92	Serine/threonine-protein kinase DCLK3 (DB12010)
drugbank_target|O60285	-	661	sp|Q8IBS5|CDPK4_PL	-	528	1.4e-104	349.0	0.1	1	1	1.6e-105	2e-104	348.5	0.1	55	400	40	383	28	395	0.91	NUAK family SNF1-like kinase 1 (DB12010)
drugbank_target|Q14012	-	370	sp|Q8IBS5|CDPK4_PL	-	528	1.6e-104	348.8	0.0	1	1	1.7e-105	2.1e-104	348.4	0.0	61	378	11	331	5	341	0.90	Calcium/calmodulin-dependent protein kinase type 1 (DB12010)
drugbank_target|Q9UQM7	-	478	sp|Q8IBS5|CDPK4_PL	-	528	3.4e-104	347.7	0.0	1	1	3.5e-105	4.5e-104	347.3	0.0	65	442	8	387	3	411	0.86	Calcium/calmodulin-dependent protein kinase type II subunit alpha (DB04119; DB04447; DB07766; DB12010)
drugbank_target|Q96NX5	-	476	sp|Q8IBS5|CDPK4_PL	-	528	1.6e-102	342.2	0.3	1	1	1.6e-103	2e-102	341.9	0.3	53	359	6	307	1	324	0.90	Calcium/calmodulin-dependent protein kinase type 1G (DB08009; DB12010)
drugbank_target|P27448	-	753	sp|Q8IBS5|CDPK4_PL	-	528	3e-102	341.3	0.0	1	1	3.9e-103	5e-102	340.6	0.0	27	349	11	327	2	416	0.85	MAP/microtubule affinity-regulating kinase 3 (DB12010)
drugbank_target|Q16566	-	473	sp|Q8IBS5|CDPK4_PL	-	528	4e-102	340.9	0.0	1	1	4.3e-103	5.5e-102	340.4	0.0	49	393	24	368	7	375	0.92	Calcium/calmodulin-dependent protein kinase type IV (DB07664; DB07676)
drugbank_target|Q13555	-	558	sp|Q8IBS5|CDPK4_PL	-	528	7.4e-102	340.0	0.0	1	1	8.1e-103	1e-101	339.5	0.0	64	369	8	309	1	325	0.94	Calcium/calmodulin-dependent protein kinase type II subunit gamma (DB06616; DB08699; DB12010)
drugbank_target|Q9P0L2	-	795	sp|Q8IBS5|CDPK4_PL	-	528	1.4e-100	335.8	0.0	1	1	2e-101	2.5e-100	335.0	0.0	42	341	32	324	7	337	0.90	Serine/threonine-protein kinase MARK1 (DB12010)
drugbank_target|Q13554	-	666	sp|Q8IBS5|CDPK4_PL	-	528	2.1e-100	335.2	0.0	1	1	2.3e-101	2.9e-100	334.8	0.0	65	371	9	311	2	361	0.94	Calcium/calmodulin-dependent protein kinase type II subunit beta (DB07168; DB12010)
drugbank_target|Q7KZI7	-	788	sp|Q8IBS5|CDPK4_PL	-	528	2.6e-100	334.9	0.0	1	1	4.9e-101	6.3e-100	333.7	0.0	46	341	30	317	6	332	0.90	Serine/threonine-protein kinase MARK2 (DB12010)
drugbank_target|Q9P2K8	-	1649	sp|Q8IBS5|CDPK4_PL	-	528	1.8e-99	332.1	14.2	1	3	1.8e-38	2.2e-37	127.2	0.2	107	341	335	552	328	564	0.90	eIF-2-alpha kinase GCN2 (DB12010)
drugbank_target|Q9P2K8	-	1649	sp|Q8IBS5|CDPK4_PL	-	528	1.8e-99	332.1	14.2	2	3	2.6e-15	3.3e-14	50.8	0.0	69	140	589	658	556	661	0.86	eIF-2-alpha kinase GCN2 (DB12010)
drugbank_target|Q9P2K8	-	1649	sp|Q8IBS5|CDPK4_PL	-	528	1.8e-99	332.1	14.2	3	3	5.9e-48	7.6e-47	158.5	0.0	141	362	796	1033	785	1049	0.85	eIF-2-alpha kinase GCN2 (DB12010)
drugbank_target|O43293	-	454	sp|Q8IBS5|CDPK4_PL	-	528	2.2e-99	331.9	0.1	1	1	2.8e-100	3.5e-99	331.2	0.1	62	362	5	311	1	363	0.88	Death-associated protein kinase 3 (DB04716; DB07125; DB07242; DB12010)
drugbank_target|Q96L34	-	752	sp|Q8IBS5|CDPK4_PL	-	528	4.2e-99	330.9	0.0	1	1	4.5e-100	5.7e-99	330.5	0.0	54	342	43	324	12	359	0.92	MAP/microtubule affinity-regulating kinase 4 (DB12010)
drugbank_target|P53355	-	1430	sp|Q8IBS5|CDPK4_PL	-	528	7.7e-99	330.1	0.1	1	1	9.2e-100	1.2e-98	329.5	0.1	63	382	6	327	2	366	0.91	Death-associated protein kinase 1 (DB04069; DB04395; DB07444; DB12010)
drugbank_target|Q9H093	-	628	sp|Q8IBS5|CDPK4_PL	-	528	1.6e-98	329.1	0.0	1	1	1.8e-99	2.3e-98	328.5	0.0	52	341	35	316	21	341	0.93	NUAK family SNF1-like kinase 2 (DB12010)
drugbank_target|Q9UKE5	-	1360	sp|Q8IBS5|CDPK4_PL	-	528	4.4e-98	327.6	0.3	1	1	3.5e-99	4.4e-98	327.6	0.3	69	407	24	361	10	381	0.88	TRAF2 and NCK-interacting protein kinase (DB12010)
drugbank_target|O95819	-	1239	sp|Q8IBS5|CDPK4_PL	-	528	2.2e-96	322.0	0.0	1	1	1.7e-97	2.2e-96	322.0	0.0	68	415	23	365	14	383	0.89	Mitogen-activated protein kinase kinase kinase kinase 4 (DB12010)
drugbank_target|O15075	-	740	sp|Q8IBS5|CDPK4_PL	-	528	2.7e-96	321.7	0.0	1	1	3e-97	3.8e-96	321.2	0.0	23	349	345	666	334	709	0.85	Serine/threonine-protein kinase DCLK1 (DB12010)
drugbank_target|Q15746	-	1914	sp|Q8IBS5|CDPK4_PL	-	528	7.4e-96	320.2	0.4	1	1	1.1e-96	1.5e-95	319.3	0.4	22	362	1416	1753	1404	1772	0.94	Myosin light chain kinase, smooth muscle (DB12010)
drugbank_target|O14965	-	403	sp|Q8IBS5|CDPK4_PL	-	528	1.5e-95	319.2	0.0	1	1	1.4e-96	1.8e-95	319.0	0.0	8	345	71	400	62	403	0.92	Aurora kinase A (DB02482; DB05169; DB05198; DB05220; DB06134; DB06347; DB06486; DB07186; DB07266; DB07360; DB07362; DB07545; DB07801; DB08065; DB08066; DB12010; DB13061)
drugbank_target|Q9BYT3	-	514	sp|Q8IBS5|CDPK4_PL	-	528	1.5e-95	319.2	5.5	1	1	1.6e-96	2e-95	318.8	5.5	14	367	61	420	46	473	0.81	Serine/threonine-protein kinase 33 (DB12010)
drugbank_target|Q8N4C8	-	1332	sp|Q8IBS5|CDPK4_PL	-	528	2e-95	318.8	0.1	1	1	1.6e-96	2e-95	318.8	0.1	69	426	24	373	15	382	0.88	Misshapen-like kinase 1 (DB12010)
drugbank_target|Q13188	-	491	sp|Q8IBS5|CDPK4_PL	-	528	2.3e-95	318.6	0.1	1	1	4e-96	5.1e-95	317.4	0.0	56	370	13	316	2	337	0.88	Serine/threonine-protein kinase 3 (DB12010)
drugbank_target|Q9UIK4	-	370	sp|Q8IBS5|CDPK4_PL	-	528	2.4e-95	318.6	0.2	1	1	2.3e-96	2.9e-95	318.3	0.2	59	358	12	313	2	339	0.91	Death-associated protein kinase 2 (DB12010)
drugbank_target|Q13131	-	559	sp|Q8IBS5|CDPK4_PL	-	528	3.8e-95	317.9	0.0	1	1	4.4e-96	5.6e-95	317.3	0.0	55	347	12	298	3	335	0.91	5'-AMP-activated protein kinase catalytic subunit alpha-1 (DB00131; DB00171; DB00914; DB12010)
drugbank_target|Q13131	-	559	sp|Q8IBS5|CDPK4_PL	-	528	3.8e-95	317.9	0.0	1	1	4.4e-96	5.6e-95	317.3	0.0	55	347	12	298	3	335	0.91	5'-AMP-activated protein kinase catalytic subunit alpha-1 (DB00131; DB00945; DB12010)
drugbank_target|O96017	-	543	sp|Q8IBS5|CDPK4_PL	-	528	7.5e-95	316.9	0.0	1	1	1e-95	1.3e-94	316.1	0.0	64	351	214	509	200	537	0.88	Serine/threonine-protein kinase Chk2 (DB05149; DB06486; DB12010)
drugbank_target|P31751	-	481	sp|Q8IBS5|CDPK4_PL	-	528	8.9e-95	316.7	0.0	1	1	8.8e-96	1.1e-94	316.3	0.0	51	341	133	422	91	447	0.91	RAC-beta serine/threonine-protein kinase (DB07812; DB07859; DB07947; DB08073)
drugbank_target|P31749	-	480	sp|Q8IBS5|CDPK4_PL	-	528	3.2e-94	314.8	0.1	1	1	3.2e-95	4.1e-94	314.5	0.1	35	341	115	421	85	473	0.85	RAC-alpha serine/threonine-protein kinase (DB00171; DB01169; DB01645; DB01863; DB02709; DB05971; DB06486; DB06641; DB07584; DB07585)
drugbank_target|Q9Y2K2	-	1321	sp|Q8IBS5|CDPK4_PL	-	528	3.7e-94	314.6	0.1	1	2	2.9e-95	3.7e-94	314.6	0.1	69	360	65	348	60	369	0.92	Serine/threonine-protein kinase SIK3 (DB12010)
drugbank_target|Q9Y2K2	-	1321	sp|Q8IBS5|CDPK4_PL	-	528	3.7e-94	314.6	0.1	2	2	0.59	7.5	3.4	0.7	363	397	998	1031	982	1048	0.81	Serine/threonine-protein kinase SIK3 (DB12010)
drugbank_target|Q8N568	-	766	sp|Q8IBS5|CDPK4_PL	-	528	6.2e-94	313.9	0.0	1	1	6.6e-95	8.4e-94	313.4	0.0	60	355	384	680	333	702	0.89	Serine/threonine-protein kinase DCLK2 (DB12010)
drugbank_target|Q9Y6E0	-	443	sp|Q8IBS5|CDPK4_PL	-	528	6.9e-94	313.7	0.0	1	1	6.8e-95	8.7e-94	313.4	0.0	61	367	27	325	13	369	0.89	Serine/threonine-protein kinase 24 (DB12010)
drugbank_target|Q9NRH2	-	765	sp|Q8IBS5|CDPK4_PL	-	528	2.3e-93	312.0	0.2	1	1	1.8e-94	2.3e-93	312.0	0.2	68	345	14	286	5	348	0.92	SNF-related serine/threonine-protein kinase (DB12010)
drugbank_target|Q9P289	-	416	sp|Q8IBS5|CDPK4_PL	-	528	4.8e-93	310.9	0.1	1	1	4.8e-94	6.1e-93	310.6	0.1	60	409	14	353	7	408	0.85	Serine/threonine-protein kinase 26 (DB07853; DB12010)
drugbank_target|P54646	-	552	sp|Q8IBS5|CDPK4_PL	-	528	7.4e-93	310.3	0.0	1	1	7.1e-94	9e-93	310.0	0.0	59	354	5	294	1	341	0.89	5'-AMP-activated protein kinase catalytic subunit alpha-2 (DB00131; DB00945; DB12010)
drugbank_target|Q16816	-	387	sp|Q8IBS5|CDPK4_PL	-	528	7.6e-93	310.3	0.0	1	1	7.6e-94	9.7e-93	309.9	0.0	60	334	10	294	2	308	0.92	Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform (DB12010)
drugbank_target|P57059	-	783	sp|Q8IBS5|CDPK4_PL	-	528	8.9e-93	310.1	0.0	1	1	1e-93	1.3e-92	309.5	0.0	68	330	25	280	8	286	0.95	Serine/threonine-protein kinase SIK1 (DB08912; DB12010)
drugbank_target|O75914	-	559	sp|Q8IBS5|CDPK4_PL	-	528	4e-92	307.9	0.0	1	1	4.3e-93	5.5e-92	307.5	0.0	20	351	233	557	218	559	0.92	Serine/threonine-protein kinase PAK 3 (DB12010)
drugbank_target|Q13153	-	545	sp|Q8IBS5|CDPK4_PL	-	528	4.7e-92	307.7	0.0	1	1	6e-93	7.6e-92	307.0	0.0	29	350	229	543	215	545	0.92	Serine/threonine-protein kinase PAK 1 (DB12010)
drugbank_target|P17612	-	351	sp|Q8IBS5|CDPK4_PL	-	528	6.9e-92	307.1	0.0	1	1	6.5e-93	8.3e-92	306.9	0.0	28	334	4	304	1	316	0.93	cAMP-dependent protein kinase catalytic subunit alpha (DB01919; DB01940; DB02155; DB02482; DB02611; DB03374; DB04098; DB04522; DB04530; DB04707; DB06959; DB06977; DB07107; DB07124; DB07204; DB07235; DB07458; DB07583; DB07854; DB07855; DB07856; DB07857; DB07858; DB07859; DB07860; DB07876; DB07947; DB07995; DB07996; DB07997; DB08070; DB08073; DB08113; DB08114; DB08148; DB08149; DB08150; DB08162; DB08231; DB08568; DB08569; DB08756; DB08846; DB12010)
drugbank_target|P22694	-	351	sp|Q8IBS5|CDPK4_PL	-	528	7.2e-92	307.1	0.0	1	1	6.4e-93	8.2e-92	306.9	0.0	27	335	3	305	1	337	0.94	cAMP-dependent protein kinase catalytic subunit beta (DB02482; DB12010)
drugbank_target|Q13177	-	524	sp|Q8IBS5|CDPK4_PL	-	528	9.9e-92	306.6	0.0	1	1	1.1e-92	1.3e-91	306.2	0.0	36	350	215	522	204	524	0.93	Serine/threonine-protein kinase PAK 2 (DB12010)
drugbank_target|O00444	-	970	sp|Q8IBS5|CDPK4_PL	-	528	1.1e-91	306.5	0.0	1	1	8.6e-93	1.1e-91	306.5	0.0	67	365	9	300	4	311	0.92	Serine/threonine-protein kinase PLK4 (DB12010)
drugbank_target|Q86YV6	-	388	sp|Q8IBS5|CDPK4_PL	-	528	1.1e-91	306.4	0.2	1	1	1.1e-92	1.4e-91	306.1	0.2	59	345	93	378	33	386	0.91	Myosin light chain kinase family member 4 (DB12010)
drugbank_target|O14936	-	926	sp|Q8IBS5|CDPK4_PL	-	528	1.1e-91	306.4	0.0	1	1	1.5e-92	1.9e-91	305.6	0.0	62	373	4	317	1	326	0.93	Peripheral plasma membrane protein CASK (DB01942; DB12010)
drugbank_target|Q9H0K1	-	926	sp|Q8IBS5|CDPK4_PL	-	528	2.5e-91	305.3	0.1	1	1	2e-92	2.5e-91	305.3	0.1	69	333	19	276	9	329	0.91	Serine/threonine-protein kinase SIK2 (DB12010)
drugbank_target|Q9H2G2	-	1235	sp|Q8IBS5|CDPK4_PL	-	528	5e-91	304.3	0.4	1	1	3.9e-92	5e-91	304.3	0.4	51	373	15	339	7	403	0.83	STE20-like serine/threonine-protein kinase (DB07664; DB07853; DB12010)
drugbank_target|Q32MK0	-	819	sp|Q8IBS5|CDPK4_PL	-	528	5.1e-91	304.3	0.4	1	1	5.8e-92	7.4e-91	303.7	0.4	68	351	513	793	495	811	0.91	Myosin light chain kinase 3 (DB12010)
drugbank_target|Q14680	-	651	sp|Q8IBS5|CDPK4_PL	-	528	5.9e-91	304.1	1.0	1	1	6.1e-92	7.8e-91	303.7	1.0	65	334	6	269	1	304	0.93	Maternal embryonic leucine zipper kinase (DB12010)
drugbank_target|P17252	-	672	sp|Q8IBS5|CDPK4_PL	-	528	8e-91	303.6	0.0	1	1	9.4e-92	1.2e-90	303.0	0.0	49	341	318	610	289	622	0.91	Protein kinase C alpha type (DB00675)
drugbank_target|P17252	-	672	sp|Q8IBS5|CDPK4_PL	-	528	8e-91	303.6	0.0	1	1	9.4e-92	1.2e-90	303.0	0.0	49	341	318	610	289	622	0.91	Protein kinase C alpha type (DB00144; DB00163; DB05013; DB06451; DB06595; DB06641; DB08846; DB11752; DB14001; DB14002)
drugbank_target|Q9UQB9	-	309	sp|Q8IBS5|CDPK4_PL	-	528	2.2e-90	302.2	0.0	1	1	2.1e-91	2.7e-90	301.9	0.0	54	333	27	298	8	306	0.93	Aurora kinase C (DB06134; DB12010)
drugbank_target|O00141	-	431	sp|Q8IBS5|CDPK4_PL	-	528	4.4e-90	301.2	0.0	1	1	4.3e-91	5.5e-90	300.8	0.0	63	339	91	366	39	376	0.91	Serine/threonine-protein kinase Sgk1 (DB03247; DB07837; DB08191)
drugbank_target|Q04759	-	706	sp|Q8IBS5|CDPK4_PL	-	528	4.7e-90	301.1	0.1	1	1	5.7e-91	7.2e-90	300.5	0.1	65	340	375	646	347	694	0.92	Protein kinase C theta type (DB00675)
drugbank_target|Q04759	-	706	sp|Q8IBS5|CDPK4_PL	-	528	4.7e-90	301.1	0.1	1	1	5.7e-91	7.2e-90	300.5	0.1	65	340	375	646	347	694	0.92	Protein kinase C theta type (DB02010; DB02482; DB04522; DB12010)
drugbank_target|P05771	-	671	sp|Q8IBS5|CDPK4_PL	-	528	9.4e-90	300.1	0.0	1	1	1.1e-90	1.4e-89	299.6	0.0	25	352	298	625	291	654	0.89	Protein kinase C beta type (DB00163; DB01738; DB06486; DB08846; DB08862; DB14001; DB14002)
drugbank_target|P05771	-	671	sp|Q8IBS5|CDPK4_PL	-	528	9.4e-90	300.1	0.0	1	1	1.1e-90	1.4e-89	299.6	0.0	25	352	298	625	291	654	0.89	Protein kinase C beta type (DB00675)
drugbank_target|Q00532	-	358	sp|Q8IBS5|CDPK4_PL	-	528	1.6e-89	299.4	0.1	1	1	2e-89	2.5e-88	295.4	0.1	67	377	2	341	1	348	0.90	Cyclin-dependent kinase-like 1 (DB12010)
drugbank_target|Q8IVH8	-	894	sp|Q8IBS5|CDPK4_PL	-	528	1.7e-89	299.2	0.0	1	1	1.9e-90	2.5e-89	298.7	0.0	62	335	8	280	4	340	0.88	Mitogen-activated protein kinase kinase kinase kinase 3 (DB12010)
drugbank_target|Q02156	-	737	sp|Q8IBS5|CDPK4_PL	-	528	2e-89	299.0	0.0	1	1	2.2e-90	2.8e-89	298.5	0.0	58	342	396	682	345	731	0.85	Protein kinase C epsilon type (DB00675)
drugbank_target|Q02156	-	737	sp|Q8IBS5|CDPK4_PL	-	528	2e-89	299.0	0.0	1	1	2.2e-90	2.8e-89	298.5	0.0	58	342	396	682	345	731	0.85	Protein kinase C epsilon type (DB06064; DB11752; DB12010)
drugbank_target|Q8IY84	-	436	sp|Q8IBS5|CDPK4_PL	-	528	7.1e-89	297.2	0.0	1	1	7.3e-90	9.2e-89	296.8	0.0	18	369	20	365	11	383	0.88	Serine/threonine-protein kinase NIM1 (DB12010)
drugbank_target|Q05655	-	676	sp|Q8IBS5|CDPK4_PL	-	528	1.9e-88	295.7	0.0	1	1	2.1e-89	2.7e-88	295.3	0.0	19	333	296	608	279	661	0.87	Protein kinase C delta type (DB00675)
drugbank_target|Q05655	-	676	sp|Q8IBS5|CDPK4_PL	-	528	1.9e-88	295.7	0.0	1	1	2.1e-89	2.7e-88	295.3	0.0	19	333	296	608	279	661	0.87	Protein kinase C delta type (DB04376; DB05013; DB12010)
drugbank_target|Q9H4B4	-	646	sp|Q8IBS5|CDPK4_PL	-	528	2.6e-88	295.3	0.0	1	1	2.7e-89	3.5e-88	294.9	0.0	68	339	60	325	49	364	0.95	Serine/threonine-protein kinase PLK3 (DB12010)
drugbank_target|Q9NYY3	-	685	sp|Q8IBS5|CDPK4_PL	-	528	3.3e-88	295.0	0.0	1	1	3.7e-89	4.7e-88	294.5	0.0	40	345	52	351	22	448	0.84	Serine/threonine-protein kinase PLK2 (DB12010)
drugbank_target|O94804	-	968	sp|Q8IBS5|CDPK4_PL	-	528	5.1e-88	294.4	0.0	1	1	4e-89	5.1e-88	294.4	0.0	52	370	19	339	7	353	0.86	Serine/threonine-protein kinase 10 (DB12010)
drugbank_target|Q96BR1	-	496	sp|Q8IBS5|CDPK4_PL	-	528	9.3e-88	293.5	0.0	1	1	9.5e-89	1.2e-87	293.1	0.0	23	341	117	432	102	467	0.89	Serine/threonine-protein kinase Sgk3 (DB12010)
drugbank_target|Q9H1R3	-	596	sp|Q8IBS5|CDPK4_PL	-	528	2.2e-87	292.3	0.4	1	1	2.3e-88	2.9e-87	291.9	0.4	70	343	285	556	269	589	0.90	Myosin light chain kinase 2, skeletal/cardiac muscle (DB04825; DB12010)
drugbank_target|P51956	-	506	sp|Q8IBS5|CDPK4_PL	-	528	3.4e-87	291.6	0.3	1	1	3.4e-88	4.4e-87	291.3	0.3	68	380	2	314	1	352	0.87	Serine/threonine-protein kinase Nek3 (DB12010)
drugbank_target|Q9NRP7	-	1315	sp|Q8IBS5|CDPK4_PL	-	528	3.8e-87	291.5	0.0	1	1	4.5e-88	5.7e-87	290.9	0.0	68	331	2	257	1	266	0.96	Serine/threonine-protein kinase 36 (DB12010)
drugbank_target|O75385	-	1050	sp|Q8IBS5|CDPK4_PL	-	528	4e-87	291.4	0.0	1	1	4.4e-88	5.6e-87	290.9	0.0	69	336	15	286	6	362	0.87	Serine/threonine-protein kinase ULK1 (DB12010)
drugbank_target|O95747	-	527	sp|Q8IBS5|CDPK4_PL	-	528	4.3e-87	291.3	0.0	1	1	4.5e-88	5.8e-87	290.9	0.0	64	354	11	317	2	332	0.90	Serine/threonine-protein kinase OSR1 (DB12010)
drugbank_target|O94768	-	372	sp|Q8IBS5|CDPK4_PL	-	528	4.8e-87	291.2	0.0	1	1	4.7e-88	6e-87	290.8	0.0	64	401	26	366	15	371	0.90	Serine/threonine-protein kinase 17B (DB04216; DB12010)
drugbank_target|Q6PHR2	-	472	sp|Q8IBS5|CDPK4_PL	-	528	5.1e-87	291.1	0.0	1	1	5.7e-88	7.2e-87	290.6	0.0	70	335	14	277	9	309	0.93	Serine/threonine-protein kinase ULK3 (DB12010)
drugbank_target|Q96GD4	-	344	sp|Q8IBS5|CDPK4_PL	-	528	5.7e-87	290.9	0.0	1	1	5.5e-88	7e-87	290.6	0.0	64	333	71	332	38	342	0.92	Aurora kinase B (DB04703; DB05169; DB06486; DB07340; DB12010)
drugbank_target|Q7L7X3	-	1001	sp|Q8IBS5|CDPK4_PL	-	528	8.4e-87	290.4	0.0	1	1	6.6e-88	8.4e-87	290.4	0.0	63	370	21	323	4	342	0.89	Serine/threonine-protein kinase TAO1 (DB12010)
drugbank_target|P41743	-	596	sp|Q8IBS5|CDPK4_PL	-	528	9.8e-87	290.1	0.0	1	1	1.4e-87	1.8e-86	289.2	0.0	33	340	220	534	197	548	0.88	Protein kinase C iota type (DB00675)
drugbank_target|P41743	-	596	sp|Q8IBS5|CDPK4_PL	-	528	9.8e-87	290.1	0.0	1	1	1.4e-87	1.8e-86	289.2	0.0	33	340	220	534	197	548	0.88	Protein kinase C iota type (DB03777; DB12010)
drugbank_target|P53350	-	603	sp|Q8IBS5|CDPK4_PL	-	528	1.2e-86	289.9	0.0	1	1	1.3e-87	1.7e-86	289.4	0.0	66	334	49	311	40	329	0.95	Serine/threonine-protein kinase PLK1 (DB06897; DB06963; DB07186; DB07789; DB08059; DB12010)
drugbank_target|Q9HBH9	-	465	sp|Q8IBS5|CDPK4_PL	-	528	1.7e-86	289.4	0.0	1	1	1.7e-87	2.2e-86	289.0	0.0	42	371	55	412	39	425	0.87	MAP kinase-interacting serine/threonine-protein kinase 2 (DB12010)
drugbank_target|Q9UEE5	-	414	sp|Q8IBS5|CDPK4_PL	-	528	1.9e-86	289.2	0.2	1	1	1.9e-87	2.4e-86	288.8	0.2	72	355	63	344	44	399	0.87	Serine/threonine-protein kinase 17A (DB12010)
drugbank_target|Q8IYT8	-	1036	sp|Q8IBS5|CDPK4_PL	-	528	2.1e-86	289.1	0.0	1	1	2.5e-87	3.2e-86	288.4	0.0	69	337	8	280	2	295	0.92	Serine/threonine-protein kinase ULK2 (DB12010)
drugbank_target|Q9Y2H1	-	464	sp|Q8IBS5|CDPK4_PL	-	528	2.1e-86	289.0	0.1	1	1	2.4e-87	3.1e-86	288.5	0.1	19	364	41	418	26	440	0.84	Serine/threonine-protein kinase 38-like (DB12010)
drugbank_target|Q9H2K8	-	898	sp|Q8IBS5|CDPK4_PL	-	528	2.3e-86	288.9	0.1	1	1	1.8e-87	2.3e-86	288.9	0.1	65	384	19	333	10	384	0.90	Serine/threonine-protein kinase TAO3 (DB12010)
drugbank_target|P51957	-	841	sp|Q8IBS5|CDPK4_PL	-	528	2.8e-86	288.6	0.1	1	1	2.2e-87	2.8e-86	288.6	0.1	69	355	5	288	1	305	0.92	Serine/threonine-protein kinase Nek4 (DB12010)
drugbank_target|Q92772	-	493	sp|Q8IBS5|CDPK4_PL	-	528	6.6e-86	287.4	3.3	1	1	1.6e-86	2.1e-85	285.7	3.3	68	365	2	328	1	356	0.90	Cyclin-dependent kinase-like 2 (DB12010)
drugbank_target|P53779	-	464	sp|Q8IBS5|CDPK4_PL	-	528	1.2e-85	286.5	2.4	1	2	4.3e-75	5.5e-74	248.1	0.5	41	306	35	299	22	304	0.91	Mitogen-activated protein kinase 10 (DB01782; DB02388; DB03084; DB03623; DB04395; DB06933; DB07010; DB07217; DB08005; DB08010; DB08011; DB08015; DB08021; DB08023; DB08025; DB08026; DB08555; DB12010)
drugbank_target|P53779	-	464	sp|Q8IBS5|CDPK4_PL	-	528	1.2e-85	286.5	2.4	2	2	1.5e-11	1.9e-10	38.4	0.1	290	370	321	401	311	415	0.78	Mitogen-activated protein kinase 10 (DB01782; DB02388; DB03084; DB03623; DB04395; DB06933; DB07010; DB07217; DB08005; DB08010; DB08011; DB08015; DB08021; DB08023; DB08025; DB08026; DB08555; DB12010)
drugbank_target|P53779	-	464	sp|Q8IBS5|CDPK4_PL	-	528	1.2e-85	286.5	2.4	1	2	4.3e-75	5.5e-74	248.1	0.5	41	306	35	299	22	304	0.91	Mitogen-activated protein kinase 10 (DB01017)
drugbank_target|P53779	-	464	sp|Q8IBS5|CDPK4_PL	-	528	1.2e-85	286.5	2.4	2	2	1.5e-11	1.9e-10	38.4	0.1	290	370	321	401	311	415	0.78	Mitogen-activated protein kinase 10 (DB01017)
drugbank_target|P53779	-	464	sp|Q8IBS5|CDPK4_PL	-	528	1.2e-85	286.5	2.4	1	2	4.3e-75	5.5e-74	248.1	0.5	41	306	35	299	22	304	0.91	Mitogen-activated protein kinase 10 (DB15624)
drugbank_target|P53779	-	464	sp|Q8IBS5|CDPK4_PL	-	528	1.2e-85	286.5	2.4	2	2	1.5e-11	1.9e-10	38.4	0.1	290	370	321	401	311	415	0.78	Mitogen-activated protein kinase 10 (DB15624)
drugbank_target|Q16513	-	984	sp|Q8IBS5|CDPK4_PL	-	528	1.4e-85	286.3	0.1	1	1	2.7e-86	3.4e-85	285.0	0.0	53	339	641	927	606	953	0.89	Serine/threonine-protein kinase N2 (DB12010)
drugbank_target|P24941	-	298	sp|Q8IBS5|CDPK4_PL	-	528	1.5e-85	286.2	0.0	1	1	1.7e-85	2.1e-84	282.4	0.0	68	333	2	291	1	294	0.90	Cyclin-dependent kinase 2 (DB01888; DB02010; DB02052; DB02091; DB02116; DB02197; DB02297; DB02407; DB02538; DB02603; DB02647; DB02733; DB02833; DB02898; DB02915; DB02950; DB02963; DB02973; DB03019; DB03307; DB03365; DB03428; DB03490; DB03496; DB03583; DB03663; DB03737; DB03801; DB04006; DB04101; DB04186; DB04288; DB04407; DB04518; DB04607; DB04662; DB04669; DB06195; DB06616; DB06844; DB06888; DB06944; DB06948; DB06976; DB06983; DB07024; DB07054; DB07065; DB07126; DB07137; DB07163; DB07164; DB07179; DB07203; DB07210; DB07220; DB07431; DB07471; DB07493; DB07501; DB07504; DB07529; DB07531; DB07533; DB07534; DB07538; DB07539; DB07540; DB07562; DB07595; DB07606; DB07612; DB07618; DB07622; DB07685; DB07686; DB07687; DB07688; DB07731; DB07750; DB07751; DB07755; DB07761; DB07790; DB07791; DB07852; DB07889; DB07936; DB07982; DB08066; DB08094; DB08122; DB08123; DB08124; DB08125; DB08126; DB08132; DB08133; DB08134; DB08135; DB08136; DB08137; DB08138; DB08139; DB08140; DB08141; DB08142; DB08178; DB08182; DB08218; DB08219; DB08233; DB08241; DB08247; DB08248; DB08285; DB08309; DB08312; DB08355; DB08441; DB08463; DB08527; DB08531; DB08532; DB08533; DB08534; DB08535; DB08536; DB08537; DB08538; DB08539; DB08572; DB08673; DB08677; DB08694; DB08768)
drugbank_target|Q9Y4K4	-	846	sp|Q8IBS5|CDPK4_PL	-	528	7e-85	284.0	0.0	1	1	8.2e-86	1e-84	283.4	0.0	64	357	14	306	6	343	0.90	Mitogen-activated protein kinase kinase kinase kinase 5 (DB12010)
drugbank_target|Q6P3R8	-	708	sp|Q8IBS5|CDPK4_PL	-	528	7.6e-85	283.9	0.1	1	1	6e-86	7.6e-85	283.9	0.1	68	335	2	266	1	299	0.92	Serine/threonine-protein kinase Nek5 (DB12010)
drugbank_target|Q05513	-	592	sp|Q8IBS5|CDPK4_PL	-	528	8.9e-85	283.7	0.0	1	1	1.2e-85	1.5e-84	282.9	0.0	20	332	201	522	185	550	0.92	Protein kinase C zeta type (DB00675)
drugbank_target|Q9UL54	-	1235	sp|Q8IBS5|CDPK4_PL	-	528	1.1e-84	283.3	0.1	1	1	4.2e-85	5.4e-84	281.1	0.0	64	364	22	317	11	342	0.90	Serine/threonine-protein kinase TAO2 (DB04522; DB12010)
drugbank_target|Q15208	-	465	sp|Q8IBS5|CDPK4_PL	-	528	1.6e-84	282.8	0.8	1	1	1.9e-85	2.4e-84	282.3	0.8	16	368	36	421	20	437	0.85	Serine/threonine-protein kinase 38 (DB12010)
drugbank_target|Q8NEV4	-	1616	sp|Q8IBS5|CDPK4_PL	-	528	3e-84	281.9	2.1	1	1	2.7e-85	3.5e-84	281.7	0.0	65	344	16	303	7	332	0.88	Myosin-IIIa (DB12010)
drugbank_target|Q96PY6	-	1258	sp|Q8IBS5|CDPK4_PL	-	528	3.1e-84	281.9	0.0	1	1	2.5e-85	3.1e-84	281.9	0.0	68	355	2	284	1	309	0.91	Serine/threonine-protein kinase Nek1 (DB12010)
drugbank_target|P53778	-	367	sp|Q8IBS5|CDPK4_PL	-	528	3.4e-84	281.7	0.0	1	2	3e-76	3.8e-75	251.9	0.0	58	311	15	268	7	275	0.93	Mitogen-activated protein kinase 12 (DB02482; DB04395; DB05157; DB05403)
drugbank_target|P53778	-	367	sp|Q8IBS5|CDPK4_PL	-	528	3.4e-84	281.7	0.0	2	2	1.8e-08	2.3e-07	28.2	0.0	295	354	278	336	267	353	0.82	Mitogen-activated protein kinase 12 (DB02482; DB04395; DB05157; DB05403)
drugbank_target|P53778	-	367	sp|Q8IBS5|CDPK4_PL	-	528	3.4e-84	281.7	0.0	1	2	3e-76	3.8e-75	251.9	0.0	58	311	15	268	7	275	0.93	Mitogen-activated protein kinase 12 (DB01017)
drugbank_target|P53778	-	367	sp|Q8IBS5|CDPK4_PL	-	528	3.4e-84	281.7	0.0	2	2	1.8e-08	2.3e-07	28.2	0.0	295	354	278	336	267	353	0.82	Mitogen-activated protein kinase 12 (DB01017)
drugbank_target|Q9P286	-	719	sp|Q8IBS5|CDPK4_PL	-	528	5.1e-84	281.2	0.0	1	1	5.8e-85	7.4e-84	280.6	0.0	48	330	427	702	406	714	0.93	Serine/threonine-protein kinase PAK 5 (DB12010)
drugbank_target|P49137	-	400	sp|Q8IBS5|CDPK4_PL	-	528	5.2e-84	281.1	0.3	1	1	5.3e-85	6.8e-84	280.8	0.3	62	372	55	369	41	390	0.85	MAP kinase-activated protein kinase 2 (DB02010; DB07234; DB07406; DB07430; DB07431; DB07728; DB08358)
drugbank_target|Q16644	-	382	sp|Q8IBS5|CDPK4_PL	-	528	6.6e-84	280.8	0.0	1	1	6.5e-85	8.3e-84	280.5	0.0	62	367	35	343	27	375	0.84	MAP kinase-activated protein kinase 3 (DB07728; DB08358)
drugbank_target|Q15139	-	912	sp|Q8IBS5|CDPK4_PL	-	528	7.3e-84	280.6	0.0	1	1	8.7e-85	1.1e-83	280.0	0.0	39	335	552	846	543	892	0.89	Serine/threonine-protein kinase D1 (DB11752; DB12010)
drugbank_target|O95835	-	1130	sp|Q8IBS5|CDPK4_PL	-	528	8.3e-84	280.5	0.1	1	1	1.9e-84	2.5e-83	278.9	0.1	20	347	654	1029	637	1062	0.90	Serine/threonine-protein kinase LATS1 (DB12010)
drugbank_target|P00521	-	746	sp|Q8IBS5|CDPK4_PL	-	528	9.3e-84	280.3	0.0	1	1	1e-84	1.3e-83	279.8	0.0	60	337	118	392	95	424	0.89	Tyrosine-protein kinase transforming protein Abl (DB02567; DB03814; DB03878; DB05489)
drugbank_target|Q9NQU5	-	681	sp|Q8IBS5|CDPK4_PL	-	528	9.9e-84	280.2	0.0	1	1	1e-84	1.3e-83	279.8	0.0	75	334	412	664	387	680	0.94	Serine/threonine-protein kinase PAK 6 (DB12010)
drugbank_target|P45983	-	427	sp|Q8IBS5|CDPK4_PL	-	528	1.3e-83	279.8	1.9	1	2	2e-74	2.5e-73	245.9	0.2	53	306	9	261	1	266	0.93	Mitogen-activated protein kinase 8 (DB00675; DB01782; DB07218; DB07268; DB07272; DB07276; DB07845)
drugbank_target|P45983	-	427	sp|Q8IBS5|CDPK4_PL	-	528	1.3e-83	279.8	1.9	2	2	3.9e-10	5e-09	33.7	0.1	290	355	283	348	271	370	0.81	Mitogen-activated protein kinase 8 (DB00675; DB01782; DB07218; DB07268; DB07272; DB07276; DB07845)
drugbank_target|P45983	-	427	sp|Q8IBS5|CDPK4_PL	-	528	1.3e-83	279.8	1.9	1	2	2e-74	2.5e-73	245.9	0.2	53	306	9	261	1	266	0.93	Mitogen-activated protein kinase 8 (DB01017)
drugbank_target|P45983	-	427	sp|Q8IBS5|CDPK4_PL	-	528	1.3e-83	279.8	1.9	2	2	3.9e-10	5e-09	33.7	0.1	290	355	283	348	271	370	0.81	Mitogen-activated protein kinase 8 (DB01017)
drugbank_target|P45983	-	427	sp|Q8IBS5|CDPK4_PL	-	528	1.3e-83	279.8	1.9	1	2	2e-74	2.5e-73	245.9	0.2	53	306	9	261	1	266	0.93	Mitogen-activated protein kinase 8 (DB15624)
drugbank_target|P45983	-	427	sp|Q8IBS5|CDPK4_PL	-	528	1.3e-83	279.8	1.9	2	2	3.9e-10	5e-09	33.7	0.1	290	355	283	348	271	370	0.81	Mitogen-activated protein kinase 8 (DB15624)
drugbank_target|Q12851	-	820	sp|Q8IBS5|CDPK4_PL	-	528	1.3e-83	279.8	0.0	1	1	1.5e-84	1.9e-83	279.3	0.0	64	337	10	282	4	293	0.93	Mitogen-activated protein kinase kinase kinase kinase 2 (DB12010)
drugbank_target|Q13237	-	762	sp|Q8IBS5|CDPK4_PL	-	528	1.4e-83	279.8	0.1	1	2	0.49	6.2	3.7	0.0	96	211	261	379	244	383	0.66	cGMP-dependent protein kinase 2 (DB12010)
drugbank_target|Q13237	-	762	sp|Q8IBS5|CDPK4_PL	-	528	1.4e-83	279.8	0.1	2	2	7.5e-83	9.5e-82	273.7	0.0	27	332	413	715	388	732	0.89	cGMP-dependent protein kinase 2 (DB12010)
drugbank_target|Q9UEW8	-	545	sp|Q8IBS5|CDPK4_PL	-	528	1.7e-83	279.4	0.0	1	1	1.8e-84	2.3e-83	279.0	0.0	66	354	59	363	49	418	0.87	STE20/SPS1-related proline-alanine-rich protein kinase (DB12010)
drugbank_target|Q9UPZ9	-	632	sp|Q8IBS5|CDPK4_PL	-	528	2.2e-83	279.1	0.1	1	1	9.9e-83	1.3e-81	273.3	0.1	68	348	2	304	1	313	0.89	Serine/threonine-protein kinase ICK (DB12010)
drugbank_target|P00519	-	1130	sp|Q8IBS5|CDPK4_PL	-	528	2.2e-83	279.0	0.0	1	1	2.6e-84	3.3e-83	278.5	0.0	60	339	232	508	209	549	0.87	Tyrosine-protein kinase ABL1 (DB00171; DB00619; DB01254; DB03878; DB04868; DB05184; DB06616; DB07831; DB08043; DB08231; DB08339; DB08350; DB08583; DB08896; DB08901; DB12010; DB12267; DB12323)
drugbank_target|P45984	-	424	sp|Q8IBS5|CDPK4_PL	-	528	2.6e-83	278.9	2.3	1	2	4.5e-74	5.8e-73	244.7	0.4	56	306	12	261	2	266	0.94	Mitogen-activated protein kinase 9 (DB07020; DB12010)
drugbank_target|P45984	-	424	sp|Q8IBS5|CDPK4_PL	-	528	2.6e-83	278.9	2.3	2	2	2.8e-10	3.5e-09	34.2	0.1	295	353	288	346	272	392	0.83	Mitogen-activated protein kinase 9 (DB07020; DB12010)
drugbank_target|P45984	-	424	sp|Q8IBS5|CDPK4_PL	-	528	2.6e-83	278.9	2.3	1	2	4.5e-74	5.8e-73	244.7	0.4	56	306	12	261	2	266	0.94	Mitogen-activated protein kinase 9 (DB01017)
drugbank_target|P45984	-	424	sp|Q8IBS5|CDPK4_PL	-	528	2.6e-83	278.9	2.3	2	2	2.8e-10	3.5e-09	34.2	0.1	295	353	288	346	272	392	0.83	Mitogen-activated protein kinase 9 (DB01017)
drugbank_target|P45984	-	424	sp|Q8IBS5|CDPK4_PL	-	528	2.6e-83	278.9	2.3	1	2	4.5e-74	5.8e-73	244.7	0.4	56	306	12	261	2	266	0.94	Mitogen-activated protein kinase 9 (DB15624)
drugbank_target|P45984	-	424	sp|Q8IBS5|CDPK4_PL	-	528	2.6e-83	278.9	2.3	2	2	2.8e-10	3.5e-09	34.2	0.1	295	353	288	346	272	392	0.83	Mitogen-activated protein kinase 9 (DB15624)
drugbank_target|P06241	-	537	sp|Q8IBS5|CDPK4_PL	-	528	3.2e-83	278.5	0.0	1	1	3.5e-84	4.4e-83	278.1	0.0	58	323	259	517	250	533	0.92	Tyrosine-protein kinase Fyn (DB01254; DB02078; DB12010)
drugbank_target|Q13464	-	1354	sp|Q8IBS5|CDPK4_PL	-	528	4.4e-83	278.1	0.0	1	1	3.4e-84	4.4e-83	278.1	0.0	50	334	54	344	45	367	0.90	Rho-associated protein kinase 1 (DB04707; DB07876; DB08162; DB08756; DB13165; DB13931)
drugbank_target|O96013	-	591	sp|Q8IBS5|CDPK4_PL	-	528	4.5e-83	278.0	0.0	1	1	4.7e-84	5.9e-83	277.6	0.0	66	336	317	580	291	590	0.93	Serine/threonine-protein kinase PAK 4 (DB12010)
drugbank_target|O15530	-	556	sp|Q8IBS5|CDPK4_PL	-	528	6.2e-83	277.6	0.0	1	1	6.6e-84	8.3e-83	277.2	0.0	63	343	75	357	58	390	0.91	3-phosphoinositide-dependent protein kinase 1 (DB00482; DB01863; DB01933; DB01946; DB02010; DB03777; DB04522; DB06932; DB07033; DB07132; DB07300; DB07456; DB07457; DB12010)
drugbank_target|P12931	-	536	sp|Q8IBS5|CDPK4_PL	-	528	8.8e-83	277.1	0.0	1	1	9.5e-84	1.2e-82	276.6	0.0	55	324	255	517	233	534	0.90	Proto-oncogene tyrosine-protein kinase Src (DB01254; DB01678; DB01866; DB01893; DB01908; DB01947; DB01962; DB02175; DB02336; DB02432; DB02762; DB02908; DB03023; DB03078; DB03104; DB03114; DB03217; DB03268; DB03298; DB03306; DB03525; DB03591; DB03628; DB03712; DB03828; DB03902; DB04080; DB04272; DB04495; DB04739; DB04751; DB05184; DB06137; DB06616; DB06882; DB06883; DB07335; DB07662; DB07966; DB08052; DB08053; DB08054; DB08192; DB08462; DB08564; DB08901; DB09079; DB12010)
drugbank_target|P42684	-	1182	sp|Q8IBS5|CDPK4_PL	-	528	1.2e-82	276.7	0.0	1	1	1.4e-83	1.8e-82	276.1	0.0	57	325	275	538	248	593	0.90	Abelson tyrosine-protein kinase 2 (DB00171; DB01254; DB05184; DB07664; DB12010)
drugbank_target|Q99759	-	626	sp|Q8IBS5|CDPK4_PL	-	528	1.3e-82	276.5	0.0	1	1	1.5e-83	1.9e-82	276.0	0.0	48	329	341	623	319	626	0.89	Mitogen-activated protein kinase kinase kinase 3 (DB12010)
drugbank_target|O75116	-	1388	sp|Q8IBS5|CDPK4_PL	-	528	1.7e-82	276.2	0.1	1	1	1.3e-83	1.7e-82	276.2	0.1	51	334	71	360	61	379	0.90	Rho-associated protein kinase 2 (DB08162; DB08756; DB12010; DB13165; DB13931)
drugbank_target|Q8NG66	-	645	sp|Q8IBS5|CDPK4_PL	-	528	1.8e-82	276.1	0.8	1	1	1.4e-83	1.8e-82	276.1	0.8	63	368	22	327	5	362	0.85	Serine/threonine-protein kinase Nek11 (DB08912; DB12010)
drugbank_target|P42685	-	505	sp|Q8IBS5|CDPK4_PL	-	528	3.1e-82	275.3	0.0	1	1	3.3e-83	4.2e-82	274.8	0.0	61	322	225	483	217	502	0.91	Tyrosine-protein kinase FRK (DB01254; DB08896; DB12010; DB15035)
drugbank_target|Q16539	-	360	sp|Q8IBS5|CDPK4_PL	-	528	3.5e-82	275.1	0.1	1	1	2.4e-81	3e-80	268.7	0.1	59	337	13	317	2	333	0.88	Mitogen-activated protein kinase 14 (DB01254; DB01761; DB01807; DB01948; DB01953; DB01988; DB02195; DB02277; DB02352; DB02873; DB02984; DB03044; DB03110; DB03980; DB04338; DB04632; DB04797; DB05157; DB05412; DB05470; DB06518; DB06882; DB06940; DB06991; DB07138; DB07307; DB07459; DB07607; DB07811; DB07829; DB07832; DB07833; DB07834; DB07835; DB07941; DB07942; DB07943; DB08064; DB08068; DB08091; DB08092; DB08093; DB08095; DB08096; DB08097; DB08242; DB08349; DB08351; DB08352; DB08395; DB08423; DB08424; DB08521; DB08522; DB08730; DB12010)
drugbank_target|Q16539	-	360	sp|Q8IBS5|CDPK4_PL	-	528	3.5e-82	275.1	0.1	1	1	2.4e-81	3e-80	268.7	0.1	59	337	13	317	2	333	0.88	Mitogen-activated protein kinase 14 (DB01017)
drugbank_target|Q56UN5	-	1328	sp|Q8IBS5|CDPK4_PL	-	528	3.6e-82	275.1	0.0	1	1	2.8e-83	3.6e-82	275.1	0.0	25	331	1014	1327	1001	1328	0.89	Mitogen-activated protein kinase kinase kinase 19 (DB12010)
drugbank_target|P05129	-	697	sp|Q8IBS5|CDPK4_PL	-	528	3.6e-82	275.1	0.0	1	1	4e-83	5.1e-82	274.6	0.0	67	329	348	615	334	628	0.91	Protein kinase C gamma type (DB00675)
drugbank_target|P05129	-	697	sp|Q8IBS5|CDPK4_PL	-	528	3.6e-82	275.1	0.0	1	1	4e-83	5.1e-82	274.6	0.0	67	329	348	615	334	628	0.91	Protein kinase C gamma type (DB12010)
drugbank_target|P00524	-	526	sp|Q8IBS5|CDPK4_PL	-	528	4.1e-82	274.9	0.0	1	1	4.3e-83	5.4e-82	274.5	0.0	54	323	251	513	222	517	0.92	Tyrosine-protein kinase transforming protein Src (DB08434)
drugbank_target|P63185	-	526	sp|Q8IBS5|CDPK4_PL	-	528	4.4e-82	274.8	0.0	1	1	4.6e-83	5.9e-82	274.4	0.0	54	323	251	513	222	517	0.92	Tyrosine-protein kinase transforming protein Src (DB01773)
drugbank_target|P06493	-	297	sp|Q8IBS5|CDPK4_PL	-	528	6.1e-82	274.3	0.0	1	1	2.1e-81	2.6e-80	268.9	0.0	68	334	2	293	1	297	0.91	Cyclin-dependent kinase 1 (DB02052; DB02116; DB02950; DB03428; DB03496; DB04014; DB06195; DB08142; DB12010)
drugbank_target|O15264	-	365	sp|Q8IBS5|CDPK4_PL	-	528	6.7e-82	274.2	2.6	1	1	2.2e-81	2.7e-80	268.8	2.6	56	353	11	333	4	361	0.88	Mitogen-activated protein kinase 13 (DB05157; DB12010)
drugbank_target|O15264	-	365	sp|Q8IBS5|CDPK4_PL	-	528	6.7e-82	274.2	2.6	1	1	2.2e-81	2.7e-80	268.8	2.6	56	353	11	333	4	361	0.88	Mitogen-activated protein kinase 13 (DB01017)
drugbank_target|Q05397	-	1052	sp|Q8IBS5|CDPK4_PL	-	528	7e-82	274.1	0.0	1	1	8.9e-83	1.1e-81	273.4	0.0	26	344	378	696	359	710	0.88	Focal adhesion kinase 1 (DB06423; DB07248; DB07460; DB12010)
drugbank_target|P28482	-	360	sp|Q8IBS5|CDPK4_PL	-	528	9.7e-82	273.6	0.0	1	1	1.8e-82	2.2e-81	272.4	0.0	64	338	19	323	8	344	0.90	Mitogen-activated protein kinase 1 (DB01064; DB01169; DB02116; DB02482; DB02733; DB04338; DB06195; DB06641; DB06877; DB07010; DB07264; DB07788; DB07794; DB07905; DB08513; DB08521; DB11120; DB13930)
drugbank_target|P28482	-	360	sp|Q8IBS5|CDPK4_PL	-	528	9.7e-82	273.6	0.0	1	1	1.8e-82	2.2e-81	272.4	0.0	64	338	19	323	8	344	0.90	Mitogen-activated protein kinase 1 (DB00945)
drugbank_target|P28482	-	360	sp|Q8IBS5|CDPK4_PL	-	528	9.7e-82	273.6	0.0	1	1	1.8e-82	2.2e-81	272.4	0.0	64	338	19	323	8	344	0.90	Mitogen-activated protein kinase 1 (DB01017)
drugbank_target|Q16512	-	942	sp|Q8IBS5|CDPK4_PL	-	528	1.2e-81	273.3	0.0	1	1	1.6e-82	2e-81	272.6	0.0	65	333	610	879	554	889	0.91	Serine/threonine-protein kinase N1 (DB12010)
drugbank_target|Q9BUB5	-	465	sp|Q8IBS5|CDPK4_PL	-	528	1.3e-81	273.3	0.0	1	1	6.9e-82	8.8e-81	270.5	0.0	45	357	23	404	4	428	0.89	MAP kinase-interacting serine/threonine-protein kinase 1 (DB12010)
drugbank_target|Q8TD08	-	544	sp|Q8IBS5|CDPK4_PL	-	528	1.3e-81	273.2	0.0	1	1	2.4e-82	3.1e-81	272.0	0.0	67	336	10	312	4	359	0.88	Mitogen-activated protein kinase 15 (DB12010)
drugbank_target|Q8TD08	-	544	sp|Q8IBS5|CDPK4_PL	-	528	1.3e-81	273.2	0.0	1	1	2.4e-82	3.1e-81	272.0	0.0	67	336	10	312	4	359	0.88	Mitogen-activated protein kinase 15 (DB00945)
drugbank_target|Q8TD08	-	544	sp|Q8IBS5|CDPK4_PL	-	528	1.3e-81	273.2	0.0	1	1	2.4e-82	3.1e-81	272.0	0.0	67	336	10	312	4	359	0.88	Mitogen-activated protein kinase 15 (DB01017)
drugbank_target|P54762	-	984	sp|Q8IBS5|CDPK4_PL	-	528	1.8e-81	272.8	0.0	1	1	2.1e-82	2.6e-81	272.2	0.0	68	324	617	876	571	896	0.89	Ephrin type-B receptor 1 (DB12010)
drugbank_target|P16591	-	822	sp|Q8IBS5|CDPK4_PL	-	528	2.8e-81	272.1	0.1	1	1	2.2e-82	2.8e-81	272.1	0.1	60	325	553	813	529	820	0.91	Tyrosine-protein kinase Fer (DB12010)
drugbank_target|P06239	-	509	sp|Q8IBS5|CDPK4_PL	-	528	3e-81	272.0	0.0	1	1	3.4e-82	4.3e-81	271.5	0.0	51	323	226	491	207	506	0.92	Tyrosine-protein kinase Lck (DB01254; DB01830; DB02010; DB03023; DB04003; DB04395; DB06925; DB07146; DB07297; DB08055; DB08056; DB08057; DB08901; DB09079; DB12010; DB15035)
drugbank_target|P07947	-	543	sp|Q8IBS5|CDPK4_PL	-	528	3.9e-81	271.6	0.0	1	1	4e-82	5.1e-81	271.2	0.0	57	324	264	524	229	540	0.91	Tyrosine-protein kinase Yes (DB01254; DB12010)
drugbank_target|Q13882	-	451	sp|Q8IBS5|CDPK4_PL	-	528	4.7e-81	271.4	0.0	1	1	4.9e-82	6.2e-81	271.0	0.0	61	324	182	439	156	448	0.93	Protein-tyrosine kinase 6 (DB05294; DB12010; DB15035)
drugbank_target|P07948	-	512	sp|Q8IBS5|CDPK4_PL	-	528	5.9e-81	271.0	0.0	1	1	6.2e-82	7.9e-81	270.6	0.0	55	322	232	493	205	507	0.91	Tyrosine-protein kinase Lyn (DB01254; DB03023; DB06616; DB08901; DB09079; DB12010)
drugbank_target|P29320	-	983	sp|Q8IBS5|CDPK4_PL	-	528	6.3e-81	271.0	0.0	1	1	7.4e-82	9.4e-81	270.4	0.0	64	323	615	875	597	886	0.89	Ephrin type-A receptor 3 (DB12010)
drugbank_target|Q96RR4	-	588	sp|Q8IBS5|CDPK4_PL	-	528	9.9e-81	270.3	0.0	1	1	1.1e-81	1.4e-80	269.9	0.0	61	350	156	468	133	500	0.89	Calcium/calmodulin-dependent protein kinase kinase 2 (DB12010)
drugbank_target|P51955	-	445	sp|Q8IBS5|CDPK4_PL	-	528	1e-80	270.2	0.2	1	1	8.2e-82	1e-80	270.2	0.2	67	377	5	325	2	362	0.83	Serine/threonine-protein kinase Nek2 (DB07180; DB12010)
drugbank_target|Q9Y2H9	-	1570	sp|Q8IBS5|CDPK4_PL	-	528	1.2e-80	270.0	0.0	1	1	1.6e-81	2.1e-80	269.2	0.0	41	384	345	704	337	725	0.86	Microtubule-associated serine/threonine-protein kinase 1 (DB12010)
drugbank_target|P11362	-	822	sp|Q8IBS5|CDPK4_PL	-	528	1.4e-80	269.8	0.0	1	1	1.9e-81	2.4e-80	269.0	0.0	61	324	469	752	458	775	0.92	Fibroblast growth factor receptor 1 (DB00039; DB00398; DB01109; DB02058; DB05014; DB07525; DB07840; DB08577; DB08896; DB08901; DB09078; DB09079; DB12010; DB12147; DB15102; DB15685)
drugbank_target|P42680	-	631	sp|Q8IBS5|CDPK4_PL	-	528	1.4e-80	269.8	0.0	1	1	1.6e-81	2e-80	269.3	0.0	58	324	358	617	330	620	0.92	Tyrosine-protein kinase Tec (DB12010; DB15035)
drugbank_target|Q07785	-	288	sp|Q8IBS5|CDPK4_PL	-	528	1.5e-80	269.7	0.1	1	2	5.8e-73	7.4e-72	241.0	0.0	68	299	2	230	1	233	0.95	Cell division control protein 2 homolog (DB02519; DB02733)
drugbank_target|Q07785	-	288	sp|Q8IBS5|CDPK4_PL	-	528	1.5e-80	269.7	0.1	2	2	4.3e-08	5.5e-07	27.0	0.0	295	331	251	287	240	288	0.88	Cell division control protein 2 homolog (DB02519; DB02733)
drugbank_target|P27361	-	379	sp|Q8IBS5|CDPK4_PL	-	528	1.6e-80	269.7	0.1	1	1	3.9e-81	5e-80	268.0	0.1	60	336	32	338	26	359	0.90	Mitogen-activated protein kinase 3 (DB00605; DB01169; DB02733; DB04604; DB06195; DB08862; DB13930)
drugbank_target|P27361	-	379	sp|Q8IBS5|CDPK4_PL	-	528	1.6e-80	269.7	0.1	1	1	3.9e-81	5e-80	268.0	0.1	60	336	32	338	26	359	0.90	Mitogen-activated protein kinase 3 (DB00945)
drugbank_target|P27361	-	379	sp|Q8IBS5|CDPK4_PL	-	528	1.6e-80	269.7	0.1	1	1	3.9e-81	5e-80	268.0	0.1	60	336	32	338	26	359	0.90	Mitogen-activated protein kinase 3 (DB01017)
drugbank_target|Q9Y2U5	-	619	sp|Q8IBS5|CDPK4_PL	-	528	1.8e-80	269.4	0.0	1	1	2e-81	2.5e-80	269.0	0.0	67	329	353	617	330	619	0.92	Mitogen-activated protein kinase kinase kinase 2 (DB06616; DB12010)
drugbank_target|Q92918	-	833	sp|Q8IBS5|CDPK4_PL	-	528	1.9e-80	269.4	0.0	1	1	2e-81	2.6e-80	268.9	0.0	63	332	10	278	5	293	0.94	Mitogen-activated protein kinase kinase kinase kinase 1 (DB12010)
drugbank_target|P54756	-	1037	sp|Q8IBS5|CDPK4_PL	-	528	2.3e-80	269.1	0.0	1	1	2.6e-81	3.4e-80	268.6	0.0	59	324	663	930	624	955	0.87	Ephrin type-A receptor 5 (DB01254; DB12010)
drugbank_target|Q15375	-	998	sp|Q8IBS5|CDPK4_PL	-	528	2.4e-80	269.0	0.0	1	1	2.9e-81	3.7e-80	268.4	0.0	65	323	628	887	605	898	0.90	Ephrin type-A receptor 7 (DB07970; DB12010)
drugbank_target|O43283	-	966	sp|Q8IBS5|CDPK4_PL	-	528	2.9e-80	268.8	0.3	1	1	3.8e-81	4.8e-80	268.0	0.3	54	386	152	467	146	504	0.87	Mitogen-activated protein kinase kinase kinase 13 (DB12010)
drugbank_target|P54764	-	986	sp|Q8IBS5|CDPK4_PL	-	528	3.3e-80	268.6	0.0	1	1	4.1e-81	5.3e-80	267.9	0.0	23	324	577	876	563	899	0.83	Ephrin type-A receptor 4 (DB12010)
drugbank_target|P49759	-	484	sp|Q8IBS5|CDPK4_PL	-	528	4.5e-80	268.2	13.5	1	2	2.1e-75	2.6e-74	249.1	1.1	9	293	99	402	91	414	0.91	Dual specificity protein kinase CLK1 (DB04367; DB06376; DB08691; DB12010)
drugbank_target|P49759	-	484	sp|Q8IBS5|CDPK4_PL	-	528	4.5e-80	268.2	13.5	2	2	4.6e-08	5.9e-07	26.9	0.1	298	329	447	478	426	483	0.87	Dual specificity protein kinase CLK1 (DB04367; DB06376; DB08691; DB12010)
drugbank_target|P08631	-	526	sp|Q8IBS5|CDPK4_PL	-	528	4.9e-80	268.0	0.0	1	1	5e-81	6.3e-80	267.6	0.0	53	323	245	508	221	525	0.91	Tyrosine-protein kinase HCK (DB01809; DB01962; DB04216; DB06616; DB12010)
drugbank_target|P51813	-	675	sp|Q8IBS5|CDPK4_PL	-	528	6.5e-80	267.6	0.2	1	1	5.1e-81	6.5e-80	267.6	0.2	33	324	378	664	351	673	0.88	Cytoplasmic tyrosine-protein kinase BMX (DB12010; DB15035)
drugbank_target|P29323	-	1055	sp|Q8IBS5|CDPK4_PL	-	528	8.3e-80	267.3	0.0	1	1	1e-80	1.3e-79	266.6	0.0	69	324	620	878	599	896	0.90	Ephrin type-B receptor 2 (DB04395; DB12010)
drugbank_target|Q9BXA7	-	367	sp|Q8IBS5|CDPK4_PL	-	528	9e-80	267.1	0.0	1	1	8.6e-81	1.1e-79	266.9	0.0	67	335	9	279	2	336	0.88	Testis-specific serine/threonine-protein kinase 1 (DB12010)
drugbank_target|Q9HAZ1	-	481	sp|Q8IBS5|CDPK4_PL	-	528	1.7e-79	266.3	4.9	1	1	1.3e-80	1.7e-79	266.3	4.9	15	330	105	477	94	481	0.91	Dual specificity protein kinase CLK4 (DB12010)
drugbank_target|P07332	-	822	sp|Q8IBS5|CDPK4_PL	-	528	1.9e-79	266.1	2.9	1	1	2.3e-80	3e-79	265.4	0.0	59	324	550	812	532	819	0.92	Tyrosine-protein kinase Fes/Fps (DB12010)
drugbank_target|Q8WU08	-	396	sp|Q8IBS5|CDPK4_PL	-	528	2.3e-79	265.8	0.2	1	1	1.8e-80	2.3e-79	265.8	0.2	58	337	12	290	2	297	0.89	Serine/threonine-protein kinase 32A (DB12010)
drugbank_target|Q15759	-	364	sp|Q8IBS5|CDPK4_PL	-	528	3.6e-79	265.2	0.0	1	1	5.9e-78	7.6e-77	257.5	0.0	60	364	14	344	8	350	0.86	Mitogen-activated protein kinase 11 (DB05157; DB08896)
drugbank_target|Q15759	-	364	sp|Q8IBS5|CDPK4_PL	-	528	3.6e-79	265.2	0.0	1	1	5.9e-78	7.6e-77	257.5	0.0	60	364	14	344	8	350	0.86	Mitogen-activated protein kinase 11 (DB01017)
drugbank_target|Q8N5S9	-	505	sp|Q8IBS5|CDPK4_PL	-	528	5.4e-79	264.6	0.0	1	1	5.2e-80	6.7e-79	264.3	0.0	59	342	117	423	97	476	0.89	Calcium/calmodulin-dependent protein kinase kinase 1 (DB12010)
drugbank_target|P21802	-	821	sp|Q8IBS5|CDPK4_PL	-	528	5.4e-79	264.6	0.0	1	1	6e-80	7.6e-79	264.1	0.0	58	324	469	755	424	782	0.90	Fibroblast growth factor receptor 2 (DB00039; DB01041; DB01109; DB01901; DB02058; DB02491; DB08896; DB08901; DB09078; DB09079; DB10770; DB10772; DB12010; DB12147; DB15102; DB15685)
drugbank_target|P42681	-	527	sp|Q8IBS5|CDPK4_PL	-	528	9.9e-79	263.7	0.1	1	1	1.1e-79	1.4e-78	263.2	0.1	62	324	263	518	255	521	0.92	Tyrosine-protein kinase TXK (DB12010; DB15035)
drugbank_target|Q8IW41	-	473	sp|Q8IBS5|CDPK4_PL	-	528	1.2e-78	263.5	0.2	1	1	1.4e-79	1.8e-78	262.8	0.2	55	361	7	338	1	355	0.84	MAP kinase-activated protein kinase 5 (DB12010)
drugbank_target|O14578	-	2027	sp|Q8IBS5|CDPK4_PL	-	528	1.2e-78	263.5	0.0	1	1	9.3e-80	1.2e-78	263.5	0.0	64	335	91	367	61	398	0.91	Citron Rho-interacting kinase (DB12010)
drugbank_target|Q13164	-	816	sp|Q8IBS5|CDPK4_PL	-	528	1.5e-78	263.1	2.2	1	1	3e-79	3.8e-78	261.8	0.0	62	338	47	357	22	397	0.89	Mitogen-activated protein kinase 7 (DB12010)
drugbank_target|Q13164	-	816	sp|Q8IBS5|CDPK4_PL	-	528	1.5e-78	263.1	2.2	1	1	3e-79	3.8e-78	261.8	0.0	62	338	47	357	22	397	0.89	Mitogen-activated protein kinase 7 (DB00945)
drugbank_target|Q13164	-	816	sp|Q8IBS5|CDPK4_PL	-	528	1.5e-78	263.1	2.2	1	1	3e-79	3.8e-78	261.8	0.0	62	338	47	357	22	397	0.89	Mitogen-activated protein kinase 7 (DB01017)
drugbank_target|Q00535	-	292	sp|Q8IBS5|CDPK4_PL	-	528	1.6e-78	263.1	0.0	1	2	2.7e-72	3.4e-71	238.8	0.0	68	298	2	231	1	234	0.95	Cyclin-dependent-like kinase 5 (DB02052; DB02116; DB02950; DB03428; DB03496; DB04014; DB07364)
drugbank_target|Q00535	-	292	sp|Q8IBS5|CDPK4_PL	-	528	1.6e-78	263.1	0.0	2	2	1.1e-06	1.4e-05	22.3	0.0	294	330	252	288	244	290	0.90	Cyclin-dependent-like kinase 5 (DB02052; DB02116; DB02950; DB03428; DB03496; DB04014; DB07364)
drugbank_target|Q9Y6R4	-	1608	sp|Q8IBS5|CDPK4_PL	-	528	2.7e-78	262.2	0.3	1	1	4.3e-79	5.5e-78	261.3	0.3	55	334	1328	1607	1285	1608	0.89	Mitogen-activated protein kinase kinase kinase 4 (DB12010)
drugbank_target|Q02763	-	1124	sp|Q8IBS5|CDPK4_PL	-	528	3.5e-78	261.9	0.0	1	1	4e-79	5.1e-78	261.4	0.0	68	323	822	1089	776	1109	0.94	Angiopoietin-1 receptor (DB00415; DB05294; DB08221; DB08896; DB08901; DB12010; DB14840)
drugbank_target|Q6ZN16	-	1313	sp|Q8IBS5|CDPK4_PL	-	528	4.1e-78	261.7	0.0	1	1	5.4e-79	6.8e-78	260.9	0.0	75	339	657	919	638	927	0.94	Mitogen-activated protein kinase kinase kinase 15 (DB12010)
drugbank_target|Q16620	-	822	sp|Q8IBS5|CDPK4_PL	-	528	4.1e-78	261.7	0.1	1	1	4.8e-79	6.1e-78	261.1	0.1	50	321	521	802	510	811	0.90	BDNF/NT-3 growth factors receptor (DB00321; DB11823; DB11986; DB12010; DB14723)
drugbank_target|Q00534	-	326	sp|Q8IBS5|CDPK4_PL	-	528	5e-78	261.4	0.0	1	1	1.1e-78	1.4e-77	260.0	0.0	66	343	9	316	2	325	0.88	Cyclin-dependent kinase 6 (DB03496; DB07379; DB07795; DB09073; DB11730; DB12001)
drugbank_target|Q00537	-	523	sp|Q8IBS5|CDPK4_PL	-	528	8.1e-78	260.7	0.1	1	1	5.3e-78	6.8e-77	257.7	0.1	61	332	183	477	162	501	0.91	Cyclin-dependent kinase 17 (DB12010)
drugbank_target|P49761	-	638	sp|Q8IBS5|CDPK4_PL	-	528	1.3e-77	260.0	3.2	1	2	1.5e-71	1.9e-70	236.4	1.5	9	293	250	545	243	566	0.92	Dual specificity protein kinase CLK3 (DB07664; DB08691; DB12010)
drugbank_target|P49761	-	638	sp|Q8IBS5|CDPK4_PL	-	528	1.3e-77	260.0	3.2	2	2	5e-07	6.3e-06	23.5	0.0	300	336	592	628	567	637	0.87	Dual specificity protein kinase CLK3 (DB07664; DB08691; DB12010)
drugbank_target|P22607	-	806	sp|Q8IBS5|CDPK4_PL	-	528	1.3e-77	260.0	0.0	1	1	1.4e-78	1.7e-77	259.6	0.0	60	324	462	746	420	760	0.92	Fibroblast growth factor receptor 3 (DB00039; DB05014; DB06589; DB08901; DB09078; DB09079; DB12010; DB12147; DB15102; DB15685)
drugbank_target|Q8TD19	-	979	sp|Q8IBS5|CDPK4_PL	-	528	1.5e-77	259.8	0.0	1	1	1.8e-78	2.3e-77	259.2	0.0	67	341	49	321	35	348	0.92	Serine/threonine-protein kinase Nek9 (DB12010)
drugbank_target|P29317	-	976	sp|Q8IBS5|CDPK4_PL	-	528	1.9e-77	259.5	0.0	1	1	2.2e-78	2.8e-77	258.9	0.0	50	323	593	868	557	882	0.83	Ephrin type-A receptor 2 (DB01254; DB04395; DB08896; DB12010)
drugbank_target|P09769	-	529	sp|Q8IBS5|CDPK4_PL	-	528	2e-77	259.4	0.0	1	1	2.2e-78	2.8e-77	258.9	0.0	60	324	253	510	244	526	0.92	Tyrosine-protein kinase Fgr (DB01254; DB12010; DB15035)
drugbank_target|Q12852	-	859	sp|Q8IBS5|CDPK4_PL	-	528	2.9e-77	258.9	0.0	1	1	3.2e-78	4.1e-77	258.4	0.0	54	387	109	425	102	462	0.87	Mitogen-activated protein kinase kinase kinase 12 (DB12010)
drugbank_target|Q86UE8	-	772	sp|Q8IBS5|CDPK4_PL	-	528	4.3e-77	258.3	0.3	1	1	3.4e-78	4.3e-77	258.3	0.3	27	335	420	748	398	769	0.82	Serine/threonine-protein kinase tousled-like 2 (DB12010)
drugbank_target|P49760	-	499	sp|Q8IBS5|CDPK4_PL	-	528	4.8e-77	258.1	1.5	1	1	3.8e-78	4.8e-77	258.1	1.5	11	334	103	485	95	495	0.89	Dual specificity protein kinase CLK2 (DB12010)
drugbank_target|P51451	-	505	sp|Q8IBS5|CDPK4_PL	-	528	4.9e-77	258.1	0.0	1	1	5.3e-78	6.8e-77	257.7	0.0	58	321	229	485	222	504	0.91	Tyrosine-protein kinase Blk (DB12010; DB15035)
drugbank_target|P54760	-	987	sp|Q8IBS5|CDPK4_PL	-	528	5.2e-77	258.0	0.0	1	1	5.7e-78	7.2e-77	257.6	0.0	63	324	607	872	565	890	0.88	Ephrin type-B receptor 4 (DB01254; DB07249; DB07250; DB07251; DB07252; DB07253; DB07254; DB07255; DB07256; DB11973; DB12010)
drugbank_target|P07949	-	1114	sp|Q8IBS5|CDPK4_PL	-	528	7.6e-77	257.5	0.0	1	1	8.4e-78	1.1e-76	257.0	0.0	51	324	705	1003	670	1026	0.88	Proto-oncogene tyrosine-protein kinase receptor Ret (DB00398; DB01809; DB05294; DB08875; DB08896; DB08901; DB09078; DB12010; DB12742; DB15685)
drugbank_target|P35626	-	688	sp|Q8IBS5|CDPK4_PL	-	528	7.8e-77	257.4	0.5	1	1	6.1e-78	7.8e-77	257.4	0.5	53	335	175	460	113	468	0.89	Beta-adrenergic receptor kinase 2 (DB00171)
drugbank_target|P22455	-	802	sp|Q8IBS5|CDPK4_PL	-	528	9e-77	257.3	0.0	1	1	1e-77	1.3e-76	256.8	0.0	64	324	461	741	453	743	0.93	Fibroblast growth factor receptor 4 (DB00039; DB01109; DB08901; DB09078; DB12147; DB15102)
drugbank_target|Q06187	-	659	sp|Q8IBS5|CDPK4_PL	-	528	1.2e-76	256.8	0.2	1	1	1.4e-77	1.8e-76	256.3	0.2	59	324	391	649	356	656	0.89	Tyrosine-protein kinase BTK (DB01254; DB01863; DB05204; DB09053; DB11703; DB12010; DB15035)
drugbank_target|P80192	-	1104	sp|Q8IBS5|CDPK4_PL	-	528	1.4e-76	256.6	0.0	1	1	1.6e-77	2.1e-76	256.1	0.0	69	407	143	490	137	505	0.80	Mitogen-activated protein kinase kinase kinase 9 (DB08703; DB12010)
drugbank_target|Q6DT37	-	1551	sp|Q8IBS5|CDPK4_PL	-	528	1.7e-76	256.3	0.0	1	1	1.4e-77	1.7e-76	256.3	0.0	64	335	65	344	50	357	0.91	Serine/threonine-protein kinase MRCK gamma (DB12010)
drugbank_target|Q16584	-	847	sp|Q8IBS5|CDPK4_PL	-	528	2.3e-76	255.9	0.0	1	1	2.5e-77	3.2e-76	255.4	0.0	68	383	115	440	110	468	0.78	Mitogen-activated protein kinase kinase kinase 11 (DB12010)
drugbank_target|P21709	-	976	sp|Q8IBS5|CDPK4_PL	-	528	3e-76	255.5	0.0	1	1	3.3e-77	4.1e-76	255.1	0.0	71	325	625	879	569	894	0.88	Ephrin type-A receptor 1 (DB12010)
drugbank_target|Q13163	-	448	sp|Q8IBS5|CDPK4_PL	-	528	3.8e-76	255.2	0.0	1	1	4.1e-77	5.2e-76	254.7	0.0	19	334	116	425	109	445	0.93	Dual specificity mitogen-activated protein kinase kinase 5 (DB12010)
drugbank_target|Q08881	-	620	sp|Q8IBS5|CDPK4_PL	-	528	4.9e-76	254.8	0.0	1	1	5.8e-77	7.3e-76	254.2	0.0	68	324	361	610	348	613	0.91	Tyrosine-protein kinase ITK/TSK (DB02010; DB06589; DB12010; DB15035)
drugbank_target|Q16288	-	839	sp|Q8IBS5|CDPK4_PL	-	528	5.4e-76	254.7	0.0	1	1	6.2e-77	7.8e-76	254.1	0.0	63	324	531	822	512	826	0.89	NT-3 growth factor receptor (DB11986; DB12010; DB14723)
drugbank_target|P41240	-	450	sp|Q8IBS5|CDPK4_PL	-	528	6.9e-76	254.3	0.0	1	1	7.1e-77	9e-76	253.9	0.0	53	324	178	438	154	447	0.92	Tyrosine-protein kinase CSK (DB01254; DB02010; DB05075; DB12010)
drugbank_target|Q02779	-	954	sp|Q8IBS5|CDPK4_PL	-	528	7e-76	254.3	0.0	1	1	7.7e-77	9.7e-76	253.8	0.0	68	405	96	441	87	458	0.84	Mitogen-activated protein kinase kinase kinase 10 (DB12010)
drugbank_target|Q00536	-	496	sp|Q8IBS5|CDPK4_PL	-	528	7.2e-76	254.3	0.0	1	1	8e-76	1e-74	250.5	0.0	66	337	161	455	146	485	0.89	Cyclin-dependent kinase 16 (DB07766; DB12010)
drugbank_target|Q9UKI8	-	766	sp|Q8IBS5|CDPK4_PL	-	528	7.6e-76	254.2	0.5	1	1	6e-77	7.6e-76	254.2	0.5	25	336	412	742	390	753	0.83	Serine/threonine-protein kinase tousled-like 1 (DB12010)
drugbank_target|Q9H2X6	-	1198	sp|Q8IBS5|CDPK4_PL	-	528	8e-76	254.1	0.1	1	2	2.9e-66	3.7e-65	218.9	0.0	29	287	158	418	133	431	0.91	Homeodomain-interacting protein kinase 2 (DB12010)
drugbank_target|Q9H2X6	-	1198	sp|Q8IBS5|CDPK4_PL	-	528	8e-76	254.1	0.1	2	2	9.9e-10	1.3e-08	32.4	0.2	295	366	494	567	465	595	0.73	Homeodomain-interacting protein kinase 2 (DB12010)
drugbank_target|P25098	-	689	sp|Q8IBS5|CDPK4_PL	-	528	9.2e-76	253.9	0.0	1	1	1.4e-76	1.8e-75	253.0	0.0	65	334	186	459	154	468	0.91	Beta-adrenergic receptor kinase 1 (DB00171)
drugbank_target|O14757	-	476	sp|Q8IBS5|CDPK4_PL	-	528	9.9e-76	253.8	0.0	1	1	1.4e-76	1.7e-75	253.0	0.0	66	338	5	275	2	313	0.90	Serine/threonine-protein kinase Chk1 (DB05149; DB06486; DB06852; DB06876; DB07025; DB07034; DB07037; DB07038; DB07075; DB07078; DB07158; DB07213; DB07228; DB07243; DB07311; DB07314; DB07320; DB07336; DB07647; DB07648; DB07653; DB07654; DB07655; DB07959; DB08392; DB08393; DB08683; DB08774; DB08776; DB08777; DB08778; DB08779; DB08780; DB08781; DB12010)
drugbank_target|Q9UF33	-	1036	sp|Q8IBS5|CDPK4_PL	-	528	1.4e-75	253.3	0.0	1	1	4.9e-76	6.3e-75	251.2	0.0	65	323	626	927	579	939	0.83	Ephrin type-A receptor 6 (DB12010)
drugbank_target|P29322	-	1005	sp|Q8IBS5|CDPK4_PL	-	528	1.9e-75	252.9	0.0	1	1	2.1e-76	2.7e-75	252.4	0.0	65	323	630	889	611	897	0.91	Ephrin type-A receptor 8 (DB12010)
drugbank_target|P50750	-	372	sp|Q8IBS5|CDPK4_PL	-	528	2.4e-75	252.5	0.1	1	1	2.5e-75	3.2e-74	248.8	0.1	68	385	17	372	11	372	0.89	Cyclin-dependent kinase 9 (DB03496; DB06195)
drugbank_target|Q02750	-	393	sp|Q8IBS5|CDPK4_PL	-	528	2.6e-75	252.4	0.0	1	1	2.7e-76	3.5e-75	252.0	0.0	34	335	28	368	15	372	0.88	Dual specificity mitogen-activated protein kinase kinase 1 (DB02152; DB03115; DB05239; DB06616; DB06892; DB07046; DB07101; DB08130; DB08208; DB08911; DB11689)
drugbank_target|P15056	-	766	sp|Q8IBS5|CDPK4_PL	-	528	3.7e-75	251.9	0.0	1	1	4.2e-76	5.3e-75	251.4	0.0	35	324	423	712	408	734	0.86	Serine/threonine-protein kinase B-raf (DB00398; DB05190; DB05984; DB06999; DB07000; DB08553; DB08881; DB08896; DB08912; DB11718; DB12010; DB14840)
drugbank_target|P50613	-	346	sp|Q8IBS5|CDPK4_PL	-	528	4.9e-75	251.5	0.0	1	2	1.1e-72	1.4e-71	240.1	0.0	67	297	9	240	3	245	0.93	Cyclin-dependent kinase 7 (DB02482; DB03496; DB05969; DB06195)
drugbank_target|P50613	-	346	sp|Q8IBS5|CDPK4_PL	-	528	4.9e-75	251.5	0.0	2	2	0.0085	0.11	9.5	0.0	298	331	265	298	255	334	0.88	Cyclin-dependent kinase 7 (DB02482; DB03496; DB05969; DB06195)
drugbank_target|Q13233	-	1512	sp|Q8IBS5|CDPK4_PL	-	528	7.2e-75	251.0	0.0	1	1	1.6e-75	2e-74	249.5	0.0	53	329	1226	1509	1169	1511	0.87	Mitogen-activated protein kinase kinase kinase 1 (DB06061; DB11967; DB12010)
drugbank_target|P06213	-	1382	sp|Q8IBS5|CDPK4_PL	-	528	1.3e-74	250.1	0.0	1	1	1.6e-75	2e-74	249.5	0.0	59	324	1012	1288	1003	1339	0.90	Insulin receptor (DB00030; DB00046; DB00047; DB00071; DB01277; DB01306; DB01307; DB01309; DB03909; DB05115; DB05120; DB08513; DB09129; DB09564; DB12010; DB12267; DB14751)
drugbank_target|P35590	-	1138	sp|Q8IBS5|CDPK4_PL	-	528	1.5e-74	249.9	0.0	1	1	1.7e-75	2.1e-74	249.4	0.0	68	322	837	1103	829	1110	0.95	Tyrosine-protein kinase receptor Tie-1 (DB12010)
drugbank_target|Q9H3Y6	-	488	sp|Q8IBS5|CDPK4_PL	-	528	1.7e-74	249.7	0.0	1	1	1.8e-75	2.2e-74	249.3	0.0	55	324	215	478	200	482	0.92	Tyrosine-protein kinase Srms (DB12010)
drugbank_target|P04629	-	796	sp|Q8IBS5|CDPK4_PL	-	528	2.2e-74	249.3	0.0	1	1	2.5e-75	3.2e-74	248.8	0.0	64	322	504	777	490	782	0.92	High affinity nerve growth factor receptor (DB00321; DB00619; DB08896; DB11986; DB12010; DB13926; DB14723)
drugbank_target|Q14289	-	1009	sp|Q8IBS5|CDPK4_PL	-	528	3.2e-74	248.8	0.0	1	1	2.5e-75	3.2e-74	248.8	0.0	65	324	420	677	380	708	0.90	Protein-tyrosine kinase 2-beta (DB01097; DB01645; DB08341; DB11817; DB12010)
drugbank_target|O95382	-	1288	sp|Q8IBS5|CDPK4_PL	-	528	5.6e-74	248.0	0.0	1	1	6.5e-75	8.2e-74	247.5	0.0	75	339	653	917	626	954	0.89	Mitogen-activated protein kinase kinase kinase 6 (DB12010)
drugbank_target|Q9NYL2	-	800	sp|Q8IBS5|CDPK4_PL	-	528	7.8e-74	247.5	0.2	1	1	9.6e-75	1.2e-73	246.9	0.2	68	387	14	317	6	328	0.86	Mitogen-activated protein kinase kinase kinase MLT (DB01254; DB12010)
drugbank_target|P36507	-	400	sp|Q8IBS5|CDPK4_PL	-	528	1.1e-73	247.0	0.0	1	1	1.2e-74	1.5e-73	246.6	0.0	36	334	34	375	20	380	0.89	Dual specificity mitogen-activated protein kinase kinase 2 (DB06616; DB08911; DB11689; DB11967; DB12010)
drugbank_target|P08922	-	2347	sp|Q8IBS5|CDPK4_PL	-	528	2.4e-73	246.0	0.0	1	1	2.9e-74	3.7e-73	245.3	0.0	56	323	1931	2212	1913	2237	0.90	Proto-oncogene tyrosine-protein kinase ROS (DB11986; DB12010)
drugbank_target|Q09013	-	629	sp|Q8IBS5|CDPK4_PL	-	528	2.9e-73	245.7	0.0	1	1	4.1e-74	5.2e-73	244.8	0.0	63	328	64	339	49	345	0.91	Myotonin-protein kinase (DB01946)
drugbank_target|Q9H422	-	1215	sp|Q8IBS5|CDPK4_PL	-	528	3.9e-73	245.2	0.0	1	2	4.8e-64	6.1e-63	211.6	0.0	54	287	181	416	153	435	0.90	Homeodomain-interacting protein kinase 3 (DB12010)
drugbank_target|Q9H422	-	1215	sp|Q8IBS5|CDPK4_PL	-	528	3.9e-73	245.2	0.0	2	2	2.1e-09	2.6e-08	31.3	0.0	270	389	468	586	463	597	0.79	Homeodomain-interacting protein kinase 3 (DB12010)
drugbank_target|Q13627	-	763	sp|Q8IBS5|CDPK4_PL	-	528	8.4e-73	244.1	1.0	1	2	2.8e-67	3.5e-66	222.3	0.7	20	304	112	394	94	403	0.83	Dual specificity tyrosine-phosphorylation-regulated kinase 1A (DB07608; DB12010)
drugbank_target|Q13627	-	763	sp|Q8IBS5|CDPK4_PL	-	528	8.4e-73	244.1	1.0	2	2	1.1e-08	1.5e-07	28.9	0.0	300	376	451	524	448	543	0.77	Dual specificity tyrosine-phosphorylation-regulated kinase 1A (DB07608; DB12010)
drugbank_target|P43405	-	635	sp|Q8IBS5|CDPK4_PL	-	528	1e-72	243.9	0.2	1	1	1.3e-73	1.6e-72	243.2	0.2	73	321	374	621	349	625	0.92	Tyrosine-protein kinase SYK (DB02010; DB06834; DB07159; DB07194; DB08361; DB08846; DB12010)
drugbank_target|P10398	-	606	sp|Q8IBS5|CDPK4_PL	-	528	1.2e-72	243.7	0.0	1	1	1.2e-73	1.5e-72	243.3	0.0	24	325	265	566	256	593	0.88	Serine/threonine-protein kinase A-Raf (DB00171)
drugbank_target|Q9Y463	-	629	sp|Q8IBS5|CDPK4_PL	-	528	1.3e-72	243.5	0.0	1	2	2.1e-68	2.6e-67	226.0	0.2	20	292	64	335	46	350	0.83	Dual specificity tyrosine-phosphorylation-regulated kinase 1B (DB12010)
drugbank_target|Q9Y463	-	629	sp|Q8IBS5|CDPK4_PL	-	528	1.3e-72	243.5	0.0	2	2	0.00014	0.0018	15.3	0.0	301	338	404	441	396	485	0.82	Dual specificity tyrosine-phosphorylation-regulated kinase 1B (DB12010)
drugbank_target|Q9UM73	-	1620	sp|Q8IBS5|CDPK4_PL	-	528	1.5e-72	243.3	0.0	1	1	1.7e-73	2.2e-72	242.8	0.0	18	325	1064	1382	1054	1433	0.91	ALK tyrosine kinase receptor (DB00171; DB08865; DB09063; DB11363; DB12010; DB12130; DB12141; DB12267)
drugbank_target|O15146	-	869	sp|Q8IBS5|CDPK4_PL	-	528	1.8e-72	243.0	0.0	1	1	2.1e-73	2.6e-72	242.5	0.0	66	322	571	852	564	859	0.93	Muscle, skeletal receptor tyrosine-protein kinase (DB12010)
drugbank_target|P43403	-	619	sp|Q8IBS5|CDPK4_PL	-	528	2e-72	242.9	0.1	1	1	2.2e-73	2.8e-72	242.4	0.1	74	322	342	589	310	605	0.89	Tyrosine-protein kinase ZAP-70 (DB02010; DB12010)
drugbank_target|P08069	-	1367	sp|Q8IBS5|CDPK4_PL	-	528	2.5e-72	242.6	0.0	1	1	3.2e-73	4.1e-72	241.9	0.0	57	323	986	1263	964	1270	0.92	Insulin-like growth factor 1 receptor (DB00030; DB00046; DB00047; DB00071; DB01277; DB01306; DB01307; DB01309; DB04395; DB05023; DB05184; DB05897; DB06075; DB06343; DB07156; DB07474; DB09098; DB09564; DB12250; DB12267; DB14751)
drugbank_target|P42679	-	507	sp|Q8IBS5|CDPK4_PL	-	528	3.1e-72	242.3	0.0	1	1	3.4e-73	4.3e-72	241.8	0.0	40	324	205	476	187	481	0.90	Megakaryocyte-associated tyrosine-protein kinase (DB12010)
drugbank_target|P04049	-	648	sp|Q8IBS5|CDPK4_PL	-	528	4e-72	241.9	0.0	1	1	4.3e-73	5.5e-72	241.4	0.0	54	326	333	606	304	641	0.84	RAF proto-oncogene serine/threonine-protein kinase (DB00398; DB04973; DB05190; DB05268; DB08862; DB08896; DB08912; DB12010)
drugbank_target|Q15303	-	1308	sp|Q8IBS5|CDPK4_PL	-	528	5.9e-72	241.3	0.0	1	1	6.9e-73	8.8e-72	240.8	0.0	65	324	713	972	679	992	0.91	Receptor tyrosine-protein kinase erbB-4 (DB08916; DB12010; DB12267; DB15035)
drugbank_target|P10721	-	976	sp|Q8IBS5|CDPK4_PL	-	528	6.2e-72	241.3	0.0	1	2	2e-21	2.5e-20	71.0	0.0	58	164	577	687	550	703	0.89	Mast/stem cell growth factor receptor Kit (DB00398; DB00619; DB01254; DB01268; DB01962; DB04868; DB05146; DB05913; DB06080; DB06589; DB06595; DB08896; DB08901; DB09078; DB09103; DB12010; DB12147; DB12742; DB12978; DB14840; DB15233)
drugbank_target|P10721	-	976	sp|Q8IBS5|CDPK4_PL	-	528	6.2e-72	241.3	0.0	2	2	7.9e-51	1e-49	168.0	0.0	164	324	763	922	746	967	0.87	Mast/stem cell growth factor receptor Kit (DB00398; DB00619; DB01254; DB01268; DB01962; DB04868; DB05146; DB05913; DB06080; DB06589; DB06595; DB08896; DB08901; DB09078; DB09103; DB12010; DB12147; DB12742; DB12978; DB14840; DB15233)
drugbank_target|Q16659	-	721	sp|Q8IBS5|CDPK4_PL	-	528	6.5e-72	241.2	0.0	1	1	1.3e-72	1.6e-71	239.9	0.0	62	334	12	322	2	353	0.89	Mitogen-activated protein kinase 6 (DB00945)
drugbank_target|Q16659	-	721	sp|Q8IBS5|CDPK4_PL	-	528	6.5e-72	241.2	0.0	1	1	1.3e-72	1.6e-71	239.9	0.0	62	334	12	322	2	353	0.89	Mitogen-activated protein kinase 6 (DB01017)
drugbank_target|P11802	-	303	sp|Q8IBS5|CDPK4_PL	-	528	7.8e-72	241.0	0.0	1	1	5.8e-72	7.3e-71	237.7	0.0	67	332	3	299	1	303	0.88	Cyclin-dependent kinase 4 (DB02733; DB03496; DB09073; DB11730; DB12001; DB12010)
drugbank_target|P07333	-	972	sp|Q8IBS5|CDPK4_PL	-	528	9.8e-72	240.6	0.0	1	2	1.3e-24	1.6e-23	81.5	0.0	58	162	570	678	542	686	0.88	Macrophage colony-stimulating factor 1 receptor (DB00619; DB01268; DB06080; DB07167; DB07202; DB12010; DB12147; DB12978)
drugbank_target|P07333	-	972	sp|Q8IBS5|CDPK4_PL	-	528	9.8e-72	240.6	0.0	2	2	1.8e-47	2.3e-46	156.9	0.0	161	350	746	932	735	961	0.86	Macrophage colony-stimulating factor 1 receptor (DB00619; DB01268; DB06080; DB07167; DB07202; DB12010; DB12147; DB12978)
drugbank_target|P09619	-	1106	sp|Q8IBS5|CDPK4_PL	-	528	1.1e-71	240.4	0.0	1	2	4.1e-26	5.3e-25	86.4	0.0	60	164	590	698	564	707	0.88	Platelet-derived growth factor receptor beta (DB00102; DB00398; DB00619; DB01254; DB01268; DB05014; DB05146; DB06589; DB06595; DB08896; DB09079; DB09221; DB09283; DB10770; DB12010; DB12147; DB12978; DB14840)
drugbank_target|P09619	-	1106	sp|Q8IBS5|CDPK4_PL	-	528	1.1e-71	240.4	0.0	2	2	6.4e-46	8.2e-45	151.8	0.0	159	322	792	954	784	976	0.89	Platelet-derived growth factor receptor beta (DB00102; DB00398; DB00619; DB01254; DB01268; DB05014; DB05146; DB06589; DB06595; DB08896; DB09079; DB09221; DB09283; DB10770; DB12010; DB12147; DB12978; DB14840)
drugbank_target|Q16832	-	855	sp|Q8IBS5|CDPK4_PL	-	528	1.4e-71	240.1	0.0	1	1	1.6e-72	2.1e-71	239.5	0.0	65	322	558	845	547	848	0.89	Discoidin domain-containing receptor 2 (DB08896; DB12010)
drugbank_target|P36888	-	993	sp|Q8IBS5|CDPK4_PL	-	528	1.5e-71	240.0	0.5	1	2	2.4e-26	3.1e-25	87.2	0.2	59	166	599	711	563	726	0.80	Receptor-type tyrosine-protein kinase FLT3 (DB00398; DB01268; DB05014; DB05465; DB06080; DB06469; DB06595; DB08901; DB09079; DB12010; DB12141; DB12267; DB12500; DB12742; DB12874; DB12978)
drugbank_target|P36888	-	993	sp|Q8IBS5|CDPK4_PL	-	528	1.5e-71	240.0	0.5	2	2	1.3e-45	1.7e-44	150.8	0.0	162	323	777	940	766	973	0.88	Receptor-type tyrosine-protein kinase FLT3 (DB00398; DB01268; DB05014; DB05465; DB06080; DB06469; DB06595; DB08901; DB09079; DB12010; DB12141; DB12267; DB12500; DB12742; DB12874; DB12978)
drugbank_target|P16234	-	1089	sp|Q8IBS5|CDPK4_PL	-	528	1.6e-71	239.9	0.0	1	2	4.5e-23	5.7e-22	76.4	0.0	61	164	584	691	570	700	0.87	Platelet-derived growth factor receptor alpha (DB00102; DB00619; DB01268; DB05146; DB06043; DB06589; DB06595; DB08896; DB08901; DB09078; DB09079; DB10772; DB12010; DB12147; DB12742; DB14840)
drugbank_target|P16234	-	1089	sp|Q8IBS5|CDPK4_PL	-	528	1.6e-71	239.9	0.0	2	2	1.1e-48	1.4e-47	160.9	0.0	158	323	781	947	772	982	0.85	Platelet-derived growth factor receptor alpha (DB00102; DB00619; DB01268; DB05146; DB06043; DB06589; DB06595; DB08896; DB08901; DB09078; DB09079; DB10772; DB12010; DB12147; DB12742; DB14840)
drugbank_target|P30530	-	894	sp|Q8IBS5|CDPK4_PL	-	528	1.7e-71	239.8	0.0	1	1	1.9e-72	2.4e-71	239.3	0.0	38	324	503	801	475	805	0.86	Tyrosine-protein kinase receptor UFO (DB12010; DB12141)
drugbank_target|Q13546	-	671	sp|Q8IBS5|CDPK4_PL	-	528	2.2e-71	239.4	0.3	1	1	3.4e-72	4.4e-71	238.5	0.3	65	374	12	334	2	346	0.88	Receptor-interacting serine/threonine-protein kinase 1 (DB12010)
drugbank_target|Q07912	-	1038	sp|Q8IBS5|CDPK4_PL	-	528	3.5e-71	238.8	0.0	1	1	4e-72	5.1e-71	238.3	0.0	67	322	123	381	99	413	0.91	Activated CDC42 kinase 1 (DB00171; DB04367; DB11986; DB12010)
drugbank_target|P14616	-	1297	sp|Q8IBS5|CDPK4_PL	-	528	1.1e-70	237.2	0.0	1	1	1.2e-71	1.5e-70	236.7	0.0	54	324	963	1244	946	1247	0.91	Insulin receptor-related protein (DB12010)
drugbank_target|Q96Q40	-	435	sp|Q8IBS5|CDPK4_PL	-	528	1.7e-70	236.5	0.0	1	2	1.4e-67	1.8e-66	223.3	0.0	34	299	66	330	37	332	0.88	Cyclin-dependent kinase 15 (DB00171; DB06486; DB12010)
drugbank_target|Q96Q40	-	435	sp|Q8IBS5|CDPK4_PL	-	528	1.7e-70	236.5	0.0	2	2	0.0026	0.033	11.2	0.0	299	333	358	392	351	406	0.89	Cyclin-dependent kinase 15 (DB00171; DB06486; DB12010)
drugbank_target|Q08345	-	913	sp|Q8IBS5|CDPK4_PL	-	528	2.4e-70	236.0	0.0	1	1	2.6e-71	3.3e-70	235.6	0.0	66	323	606	902	602	911	0.90	Epithelial discoidin domain-containing receptor 1 (DB00619; DB12010)
drugbank_target|Q59H18	-	835	sp|Q8IBS5|CDPK4_PL	-	528	3.4e-70	235.5	0.0	1	1	4.2e-71	5.4e-70	234.9	0.0	17	323	412	716	399	719	0.91	Serine/threonine-protein kinase TNNI3K (DB12010)
drugbank_target|P31152	-	587	sp|Q8IBS5|CDPK4_PL	-	528	4.2e-70	235.2	0.1	1	1	2.9e-70	3.7e-69	232.1	0.1	68	338	18	322	12	356	0.84	Mitogen-activated protein kinase 4 (DB12010)
drugbank_target|P31152	-	587	sp|Q8IBS5|CDPK4_PL	-	528	4.2e-70	235.2	0.1	1	1	2.9e-70	3.7e-69	232.1	0.1	68	338	18	322	12	356	0.84	Mitogen-activated protein kinase 4 (DB00945)
drugbank_target|P31152	-	587	sp|Q8IBS5|CDPK4_PL	-	528	4.2e-70	235.2	0.1	1	1	2.9e-70	3.7e-69	232.1	0.1	68	338	18	322	12	356	0.84	Mitogen-activated protein kinase 4 (DB01017)
drugbank_target|P17948	-	1338	sp|Q8IBS5|CDPK4_PL	-	528	4.6e-70	235.1	0.1	1	2	5e-22	6.4e-21	72.9	0.0	58	164	815	926	781	938	0.84	Vascular endothelial growth factor receptor 1 (DB00398; DB01268; DB04879; DB05075; DB05913; DB05932; DB06080; DB06101; DB06589; DB06626; DB07288; DB08896; DB09078; DB09079; DB09221; DB10770; DB12010; DB15685)
drugbank_target|P17948	-	1338	sp|Q8IBS5|CDPK4_PL	-	528	4.6e-70	235.1	0.1	2	2	2.2e-48	2.8e-47	159.9	0.0	163	324	992	1152	973	1163	0.89	Vascular endothelial growth factor receptor 1 (DB00398; DB01268; DB04879; DB05075; DB05913; DB05932; DB06080; DB06101; DB06589; DB06626; DB07288; DB08896; DB09078; DB09079; DB09221; DB10770; DB12010; DB15685)
drugbank_target|Q06418	-	890	sp|Q8IBS5|CDPK4_PL	-	528	5.6e-70	234.8	0.0	1	1	6.1e-71	7.7e-70	234.4	0.0	65	322	513	782	477	786	0.87	Tyrosine-protein kinase receptor TYRO3 (DB12010)
drugbank_target|P52564	-	334	sp|Q8IBS5|CDPK4_PL	-	528	1.2e-69	233.7	0.0	1	1	1.1e-70	1.5e-69	233.5	0.0	48	334	30	320	2	328	0.87	Dual specificity mitogen-activated protein kinase kinase 6 (DB12010)
drugbank_target|P46734	-	347	sp|Q8IBS5|CDPK4_PL	-	528	7.1e-69	231.2	0.0	1	1	6.7e-70	8.6e-69	230.9	0.0	59	336	52	333	7	342	0.86	Dual specificity mitogen-activated protein kinase kinase 3 (DB12010)
drugbank_target|P35968	-	1356	sp|Q8IBS5|CDPK4_PL	-	528	9.7e-69	230.7	0.0	1	2	1.8e-20	2.3e-19	67.8	0.0	60	164	824	933	810	945	0.88	Vascular endothelial growth factor receptor 2 (DB00398; DB01268; DB04727; DB04849; DB04879; DB05014; DB05075; DB05146; DB05198; DB05578; DB05931; DB05984; DB06080; DB06101; DB06436; DB06589; DB06595; DB06626; DB06938; DB07183; DB07274; DB07326; DB07333; DB07334; DB07514; DB07528; DB07537; DB08042; DB08519; DB08875; DB08896; DB08901; DB09078; DB09079; DB12010; DB12147; DB12307; DB14840)
drugbank_target|P35968	-	1356	sp|Q8IBS5|CDPK4_PL	-	528	9.7e-69	230.7	0.0	2	2	1.4e-48	1.7e-47	160.6	0.0	150	325	978	1159	975	1178	0.86	Vascular endothelial growth factor receptor 2 (DB00398; DB01268; DB04727; DB04849; DB04879; DB05014; DB05075; DB05146; DB05198; DB05578; DB05931; DB05984; DB06080; DB06101; DB06436; DB06589; DB06595; DB06626; DB06938; DB07183; DB07274; DB07326; DB07333; DB07334; DB07514; DB07528; DB07537; DB08042; DB08519; DB08875; DB08896; DB08901; DB09078; DB09079; DB12010; DB12147; DB12307; DB14840)
drugbank_target|P33981	-	857	sp|Q8IBS5|CDPK4_PL	-	528	9.9e-69	230.7	1.3	1	1	7.8e-70	9.9e-69	230.7	1.3	40	341	495	804	488	850	0.88	Dual specificity protein kinase TTK (DB01782; DB12010; DB15498)
drugbank_target|P00533	-	1210	sp|Q8IBS5|CDPK4_PL	-	528	1.3e-68	230.3	0.0	1	1	1.6e-69	2e-68	229.7	0.0	66	323	708	965	693	982	0.91	Epidermal growth factor receptor (DB00002; DB00281; DB00317; DB00530; DB01259; DB01269; DB03496; DB04988; DB05101; DB05294; DB05374; DB05424; DB05524; DB05944; DB06021; DB07602; DB07662; DB08916; DB09330; DB09559; DB10772; DB11731; DB11737; DB11828; DB11963; DB12010; DB12202; DB12267; DB13164; DB15035)
drugbank_target|P04626	-	1255	sp|Q8IBS5|CDPK4_PL	-	528	1.4e-68	230.2	0.0	1	1	1.6e-69	2e-68	229.7	0.0	64	324	714	974	676	992	0.89	Receptor tyrosine-protein kinase erbB-2 (DB00072; DB01259; DB04988; DB05773; DB05944; DB06021; DB06366; DB08916; DB11652; DB11973; DB12010; DB12267; DB15035)
drugbank_target|Q8IIR9	-	335	sp|Q8IBS5|CDPK4_PL	-	528	1.8e-68	229.9	2.9	1	1	9.1e-69	1.2e-67	227.2	2.9	62	333	35	333	13	335	0.90	Casein kinase 2, alpha subunit (DB11638)
drugbank_target|Q04912	-	1400	sp|Q8IBS5|CDPK4_PL	-	528	2.9e-68	229.2	0.0	1	1	3.2e-69	4.1e-68	228.7	0.0	72	322	1084	1337	1060	1341	0.90	Macrophage-stimulating protein receptor (DB12010)
drugbank_target|Q59EB3	-	712	sp|Q8IBS5|CDPK4_PL	-	528	3.2e-68	229.0	0.0	1	1	3.7e-69	4.7e-68	228.5	0.0	71	323	401	656	389	660	0.90	Met proto-oncogene variant (DB08111)
drugbank_target|P08581	-	1390	sp|Q8IBS5|CDPK4_PL	-	528	1e-67	227.4	0.0	1	1	1.2e-68	1.6e-67	226.7	0.0	71	323	1079	1334	1068	1338	0.90	Hepatocyte growth factor receptor (DB02152; DB06314; DB06896; DB06995; DB06997; DB07369; DB07969; DB08079; DB08791; DB08865; DB08875; DB11791; DB12010; DB12200; DB12267; DB12742)
drugbank_target|P49841	-	420	sp|Q8IBS5|CDPK4_PL	-	528	1.4e-67	226.9	0.0	1	1	1.6e-67	2.1e-66	223.0	0.0	62	335	48	347	7	370	0.85	Glycogen synthase kinase-3 beta (DB01356; DB01772; DB01793; DB01950; DB02010; DB02052; DB03444; DB04014; DB04395; DB07014; DB07058; DB07149; DB07584; DB07585; DB07676; DB07812; DB07859; DB07947; DB08073; DB12010; DB12129; DB14507; DB14508; DB14509)
drugbank_target|P11309	-	404	sp|Q8IBS5|CDPK4_PL	-	528	3.8e-67	225.5	0.0	1	1	4.1e-68	5.2e-67	225.0	0.0	59	336	118	389	97	399	0.90	Serine/threonine-protein kinase pim-1 (DB01754; DB02010; DB02656; DB03366; DB03650; DB03777; DB04216; DB04395; DB04522; DB04530; DB04715; DB07151; DB07242; DB07524; DB08022; DB08166; DB08230; DB08705; DB08707; DB08708; DB08709; DB12010)
drugbank_target|Q12866	-	999	sp|Q8IBS5|CDPK4_PL	-	528	3.9e-67	225.5	0.1	1	1	4.2e-68	5.4e-67	225.0	0.1	69	320	586	848	550	873	0.87	Tyrosine-protein kinase Mer (DB08325; DB12010)
drugbank_target|P49840	-	483	sp|Q8IBS5|CDPK4_PL	-	528	4.8e-67	225.1	0.0	1	1	4.9e-67	6.2e-66	221.5	0.0	65	330	114	405	100	412	0.87	Glycogen synthase kinase-3 alpha (DB12010)
drugbank_target|P53667	-	647	sp|Q8IBS5|CDPK4_PL	-	528	1.1e-66	224.0	0.0	1	1	1.2e-67	1.5e-66	223.5	0.0	68	322	337	600	310	610	0.90	LIM domain kinase 1 (DB08912; DB12010)
drugbank_target|P29376	-	864	sp|Q8IBS5|CDPK4_PL	-	528	1.9e-66	223.2	0.0	1	1	2e-67	2.5e-66	222.8	0.0	68	325	508	776	501	789	0.92	Leukocyte tyrosine kinase receptor (DB12010)
drugbank_target|P68400	-	391	sp|Q8IBS5|CDPK4_PL	-	528	2.3e-66	222.9	3.7	1	1	1e-66	1.3e-65	220.4	3.7	63	333	32	329	8	339	0.89	Casein kinase II subunit alpha (DB00171; DB01765; DB02170; DB02709; DB03035; DB03127; DB03924; DB04216; DB04395; DB04462; DB04719; DB04720; DB04721; DB07715; DB07802; DB08338; DB08340; DB08345; DB08353; DB08354; DB08360; DB08362; DB08473; DB08660; DB08846; DB12010)
drugbank_target|P9WI81	-	626	sp|Q8IBS5|CDPK4_PL	-	528	3e-66	222.5	0.0	1	1	3.2e-67	4.1e-66	222.1	0.0	65	331	6	277	2	300	0.91	Serine/threonine-protein kinase PknB (DB02930; DB03909; DB12010)
drugbank_target|P35916	-	1363	sp|Q8IBS5|CDPK4_PL	-	528	3.5e-66	222.3	0.0	1	2	2.1e-20	2.6e-19	67.6	0.0	53	165	828	946	821	957	0.86	Vascular endothelial growth factor receptor 3 (DB00398; DB01268; DB04879; DB05075; DB05932; DB06080; DB06101; DB06589; DB06626; DB08896; DB09078; DB09079; DB12010; DB15685)
drugbank_target|P35916	-	1363	sp|Q8IBS5|CDPK4_PL	-	528	3.5e-66	222.3	0.0	2	2	4.1e-46	5.2e-45	152.4	0.0	164	324	1008	1167	997	1214	0.90	Vascular endothelial growth factor receptor 3 (DB00398; DB01268; DB04879; DB05075; DB05932; DB06080; DB06101; DB06589; DB06626; DB08896; DB09078; DB09079; DB12010; DB15685)
drugbank_target|P19784	-	350	sp|Q8IBS5|CDPK4_PL	-	528	1.1e-65	220.7	4.1	1	1	3.4e-66	4.3e-65	218.7	4.1	66	336	36	333	13	344	0.89	Casein kinase II subunit alpha' (DB07546; DB12010)
drugbank_target|P53671	-	638	sp|Q8IBS5|CDPK4_PL	-	528	2.2e-65	219.7	0.0	1	1	2.2e-66	2.8e-65	219.3	0.0	15	322	276	597	263	601	0.85	LIM domain kinase 2 (DB12010)
drugbank_target|P19525	-	551	sp|Q8IBS5|CDPK4_PL	-	528	3.4e-65	219.1	0.4	1	1	3.5e-66	4.5e-65	218.6	0.4	34	337	233	547	198	551	0.84	Interferon-induced, double-stranded RNA-activated protein kinase (DB12010)
drugbank_target|Q86V86	-	326	sp|Q8IBS5|CDPK4_PL	-	528	9.5e-65	217.6	0.0	1	1	9.6e-66	1.2e-64	217.2	0.0	59	329	29	294	19	305	0.93	Serine/threonine-protein kinase pim-3 (DB12010)
drugbank_target|Q9NWZ3	-	460	sp|Q8IBS5|CDPK4_PL	-	528	1.1e-64	217.4	0.1	1	1	1.1e-65	1.4e-64	217.0	0.1	63	323	177	451	119	457	0.80	Interleukin-1 receptor-associated kinase 4 (DB08590; DB12010)
drugbank_target|Q9BQI3	-	630	sp|Q8IBS5|CDPK4_PL	-	528	5.6e-64	215.0	1.4	1	2	8.6e-21	1.1e-19	68.9	0.2	27	142	123	238	109	241	0.86	Eukaryotic translation initiation factor 2-alpha kinase 1 (DB12010)
drugbank_target|Q9BQI3	-	630	sp|Q8IBS5|CDPK4_PL	-	528	5.6e-64	215.0	1.4	2	2	7.4e-44	9.4e-43	145.0	0.1	142	354	379	610	358	620	0.87	Eukaryotic translation initiation factor 2-alpha kinase 1 (DB12010)
drugbank_target|Q52WX2	-	424	sp|Q8IBS5|CDPK4_PL	-	528	6e-64	214.9	0.0	1	1	6.2e-65	7.8e-64	214.5	0.0	64	324	47	311	34	332	0.89	Serine/threonine-protein kinase SBK1 (DB12010)
drugbank_target|P49336	-	464	sp|Q8IBS5|CDPK4_PL	-	528	8.1e-64	214.5	0.1	1	1	9.6e-65	1.2e-63	213.9	0.1	62	365	12	377	3	396	0.81	Cyclin-dependent kinase 8 (DB03496)
drugbank_target|O14920	-	756	sp|Q8IBS5|CDPK4_PL	-	528	8.8e-63	211.1	0.0	1	1	1.4e-63	1.8e-62	210.0	0.0	69	285	14	238	5	290	0.88	Inhibitor of nuclear factor kappa-B kinase subunit beta (DB00244; DB00795; DB00945; DB00995; DB01169; DB05183; DB06151; DB06521; DB12010)
drugbank_target|Q15569	-	626	sp|Q8IBS5|CDPK4_PL	-	528	1.2e-62	210.6	0.0	1	1	1.3e-63	1.6e-62	210.2	0.0	67	332	54	318	40	338	0.87	Dual specificity testis-specific protein kinase 1 (DB12010)
drugbank_target|O15111	-	745	sp|Q8IBS5|CDPK4_PL	-	528	5.8e-62	208.4	0.0	1	1	7.3e-63	9.3e-62	207.7	0.0	70	278	15	244	12	298	0.81	Inhibitor of nuclear factor kappa-B kinase subunit alpha (DB00233; DB00244; DB00795; DB06151)
drugbank_target|Q13523	-	1007	sp|Q8IBS5|CDPK4_PL	-	528	1e-61	207.5	1.2	1	2	3.7e-58	4.7e-57	192.2	0.1	46	292	663	911	644	920	0.91	Serine/threonine-protein kinase PRP4 homolog (DB12010)
drugbank_target|Q13523	-	1007	sp|Q8IBS5|CDPK4_PL	-	528	1e-61	207.5	1.2	2	2	4.8e-07	6.2e-06	23.5	0.1	288	330	964	1005	944	1007	0.81	Serine/threonine-protein kinase PRP4 homolog (DB12010)
drugbank_target|Q8TDR2	-	534	sp|Q8IBS5|CDPK4_PL	-	528	2.5e-61	206.3	0.0	1	1	1e-61	1.3e-60	203.9	0.0	67	322	199	523	192	527	0.90	Serine/threonine-protein kinase 35 (DB12010)
drugbank_target|Q99640	-	499	sp|Q8IBS5|CDPK4_PL	-	528	3.8e-61	205.7	0.0	1	1	4e-62	5.1e-61	205.3	0.0	54	330	94	361	78	366	0.92	Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase (DB12010)
drugbank_target|O14976	-	1311	sp|Q8IBS5|CDPK4_PL	-	528	1.6e-60	203.6	0.0	1	1	2.1e-61	2.7e-60	202.9	0.0	61	325	31	312	20	335	0.84	Cyclin-G-associated kinase (DB12010)
drugbank_target|P21860	-	1342	sp|Q8IBS5|CDPK4_PL	-	528	4.1e-60	202.3	0.0	1	1	4.8e-61	6.1e-60	201.7	0.0	65	324	704	963	669	978	0.88	Receptor tyrosine-protein kinase erbB-3 (DB11652)
drugbank_target|P30291	-	646	sp|Q8IBS5|CDPK4_PL	-	528	7e-60	201.5	0.2	1	1	7e-61	8.9e-60	201.2	0.2	42	368	271	611	244	645	0.81	Wee1-like protein kinase (DB04608; DB07006; DB07226; DB07257; DB07265; DB08365; DB11740; DB12010)
drugbank_target|Q8NFD2	-	765	sp|Q8IBS5|CDPK4_PL	-	528	9.4e-60	201.1	0.0	1	1	9.9e-61	1.3e-59	200.7	0.0	74	322	26	281	13	346	0.88	Ankyrin repeat and protein kinase domain-containing protein 1 (DB12010)
drugbank_target|P57078	-	832	sp|Q8IBS5|CDPK4_PL	-	528	2.7e-59	199.6	0.0	1	1	2.9e-60	3.7e-59	199.1	0.0	69	320	21	277	15	288	0.90	Receptor-interacting serine/threonine-protein kinase 4 (DB12010)
drugbank_target|Q13470	-	666	sp|Q8IBS5|CDPK4_PL	-	528	6.7e-57	191.7	0.0	1	1	7.3e-58	9.3e-57	191.2	0.0	72	322	118	373	110	378	0.88	Non-receptor tyrosine-protein kinase TNK1 (DB12010)
drugbank_target|Q13873	-	1038	sp|Q8IBS5|CDPK4_PL	-	528	6.8e-57	191.6	0.0	1	1	7.8e-58	1e-56	191.1	0.0	65	395	198	573	176	598	0.86	Bone morphogenetic protein receptor type-2 (DB11639; DB12010)
drugbank_target|O15197	-	1021	sp|Q8IBS5|CDPK4_PL	-	528	7e-57	191.6	0.0	1	1	7.8e-58	1e-56	191.1	0.0	68	324	668	913	633	927	0.90	Ephrin type-B receptor 6 (DB12010)
drugbank_target|O43353	-	540	sp|Q8IBS5|CDPK4_PL	-	528	1.1e-56	191.0	0.0	1	1	1.3e-57	1.7e-56	190.3	0.0	70	351	18	317	8	346	0.84	Receptor-interacting serine/threonine-protein kinase 2 (DB12010)
drugbank_target|O75716	-	305	sp|Q8IBS5|CDPK4_PL	-	528	3.8e-56	189.2	0.0	1	1	3.9e-57	4.9e-56	188.8	0.0	67	323	17	287	9	294	0.87	Serine/threonine-protein kinase 16 (DB12010)
drugbank_target|Q14164	-	716	sp|Q8IBS5|CDPK4_PL	-	528	5.1e-56	188.8	0.0	1	1	9e-57	1.1e-55	187.6	0.0	70	286	9	241	2	245	0.89	Inhibitor of nuclear factor kappa-B kinase subunit epsilon (DB12010)
drugbank_target|Q9UHD2	-	729	sp|Q8IBS5|CDPK4_PL	-	528	1.2e-55	187.5	0.0	1	1	1.9e-56	2.4e-55	186.5	0.0	71	287	10	242	2	252	0.90	Serine/threonine-protein kinase TBK1 (DB12010)
drugbank_target|Q2M2I8	-	961	sp|Q8IBS5|CDPK4_PL	-	528	2.5e-55	186.5	0.0	1	1	1.9e-56	2.5e-55	186.5	0.0	67	326	43	311	35	365	0.85	AP2-associated protein kinase 1 (DB12010)
drugbank_target|O00238	-	502	sp|Q8IBS5|CDPK4_PL	-	528	5.4e-55	185.4	0.0	1	1	5.9e-56	7.5e-55	184.9	0.0	63	323	197	488	178	499	0.83	Bone morphogenetic protein receptor type-1B (DB12010)
drugbank_target|P36894	-	532	sp|Q8IBS5|CDPK4_PL	-	528	6.1e-55	185.2	0.0	1	1	6.5e-56	8.3e-55	184.8	0.0	62	324	226	519	171	530	0.78	Bone morphogenetic protein receptor type-1A (DB11639)
drugbank_target|O75460	-	977	sp|Q8IBS5|CDPK4_PL	-	528	1.9e-54	183.6	0.0	1	1	2.5e-55	3.2e-54	182.8	0.0	65	343	566	847	518	860	0.80	Serine/threonine-protein kinase/endoribonuclease IRE1 (DB07382; DB12010)
drugbank_target|Q9NSY1	-	1161	sp|Q8IBS5|CDPK4_PL	-	528	5.6e-54	182.0	0.0	1	1	4.4e-55	5.6e-54	182.0	0.0	67	326	48	315	42	375	0.82	BMP-2-inducible protein kinase (DB12010)
drugbank_target|Q5S007	-	2527	sp|Q8IBS5|CDPK4_PL	-	528	7.1e-54	181.7	0.0	1	2	5.9e-54	7.5e-53	178.3	0.0	75	322	1884	2128	1866	2133	0.88	Leucine-rich repeat serine/threonine-protein kinase 2 (DB12010)
drugbank_target|Q5S007	-	2527	sp|Q8IBS5|CDPK4_PL	-	528	7.1e-54	181.7	0.0	2	2	4.3	55	0.6	0.0	404	439	2465	2500	2454	2521	0.87	Leucine-rich repeat serine/threonine-protein kinase 2 (DB12010)
drugbank_target|Q04771	-	509	sp|Q8IBS5|CDPK4_PL	-	528	1.3e-53	180.8	0.0	1	1	1.5e-54	1.9e-53	180.3	0.0	63	324	201	493	197	504	0.84	Activin receptor type-1 (DB00171; DB08597; DB12010)
drugbank_target|P36897	-	503	sp|Q8IBS5|CDPK4_PL	-	528	3.8e-53	179.3	0.1	1	1	4.3e-54	5.5e-53	178.8	0.1	64	324	199	490	195	499	0.87	TGF-beta receptor type-1 (DB03921; DB04434; DB04480; DB07152; DB07267; DB08450; DB12010)
drugbank_target|P36896	-	505	sp|Q8IBS5|CDPK4_PL	-	528	4.7e-51	172.4	0.0	1	1	4.7e-52	6e-51	172.0	0.0	63	324	200	492	151	501	0.86	Activin receptor type-1B (DB00171; DB12010)
drugbank_target|P37173	-	567	sp|Q8IBS5|CDPK4_PL	-	528	5.7e-51	172.1	0.1	1	1	6.4e-52	8.2e-51	171.6	0.1	40	324	216	536	187	548	0.81	TGF-beta receptor type-2 (DB10770; DB10772; DB12010)
drugbank_target|P37023	-	503	sp|Q8IBS5|CDPK4_PL	-	528	5.2e-50	168.9	0.0	1	1	5.7e-51	7.3e-50	168.5	0.0	64	324	196	487	191	500	0.83	Serine/threonine-protein kinase receptor R3 (DB00171)
drugbank_target|P78362	-	688	sp|Q8IBS5|CDPK4_PL	-	528	4e-49	166.0	0.1	1	2	3.1e-32	4e-31	106.6	0.1	57	202	68	223	45	230	0.83	SRSF protein kinase 2 (DB00173; DB02733; DB04395)
drugbank_target|P78362	-	688	sp|Q8IBS5|CDPK4_PL	-	528	4e-49	166.0	0.1	2	2	6.4e-20	8.1e-19	66.0	0.0	204	329	519	687	511	688	0.92	SRSF protein kinase 2 (DB00173; DB02733; DB04395)
drugbank_target|P02585	-	160	sp|Q8IBS5|CDPK4_PL	-	528	6.7e-48	162.0	11.6	1	2	2.8e-19	3.5e-18	63.9	0.5	460	524	16	82	4	85	0.90	Troponin C, skeletal muscle (DB01023; DB01373; DB04682)
drugbank_target|P02585	-	160	sp|Q8IBS5|CDPK4_PL	-	528	6.7e-48	162.0	11.6	2	2	7.2e-33	9.2e-32	108.7	4.9	424	523	52	157	51	160	0.93	Troponin C, skeletal muscle (DB01023; DB01373; DB04682)
drugbank_target|P51617	-	712	sp|Q8IBS5|CDPK4_PL	-	528	8.4e-48	161.6	0.0	1	1	9.2e-49	1.2e-47	161.2	0.0	68	323	210	515	204	518	0.86	Interleukin-1 receptor-associated kinase 1 (DB12010)
drugbank_target|P27037	-	513	sp|Q8IBS5|CDPK4_PL	-	528	1.9e-47	160.5	0.1	1	1	2.1e-48	2.7e-47	160.0	0.1	70	320	192	473	187	494	0.83	Activin receptor type-2A (DB12118)
drugbank_target|P20594	-	1047	sp|Q8IBS5|CDPK4_PL	-	528	4e-47	159.4	0.0	1	1	4.7e-48	6e-47	158.8	0.0	91	324	543	784	534	845	0.84	Atrial natriuretic peptide receptor 2 (DB01613; DB04899)
drugbank_target|Q9Y616	-	596	sp|Q8IBS5|CDPK4_PL	-	528	1.8e-46	157.2	0.0	1	1	2e-47	2.6e-46	156.7	0.0	48	324	142	441	108	450	0.82	Interleukin-1 receptor-associated kinase 3 (DB12010)
drugbank_target|P0DP23	-	149	sp|Q8IBS5|CDPK4_PL	-	528	9.6e-46	154.8	8.2	1	1	2.3e-46	2.9e-45	153.3	8.2	371	523	3	147	1	148	0.93	Calmodulin (DB00477; DB00527; DB00622; DB00623; DB00753; DB00831; DB00836; DB00850; DB00925; DB01023; DB01065; DB01069; DB01100; DB01115; DB01244; DB01373; DB01429; DB02868; DB03900; DB03977; DB04513; DB04825; DB04841; DB08039; DB08231; DB11093; DB11348; DB13800; DB14481)
drugbank_target|P0DP24	-	149	sp|Q8IBS5|CDPK4_PL	-	528	9.6e-46	154.8	8.2	1	1	2.3e-46	2.9e-45	153.3	8.2	371	523	3	147	1	148	0.93	Calmodulin-2 (DB11093; DB11348; DB14481)
drugbank_target|P0DP25	-	149	sp|Q8IBS5|CDPK4_PL	-	528	9.6e-46	154.8	8.2	1	1	2.3e-46	2.9e-45	153.3	8.2	371	523	3	147	1	148	0.93	Calmodulin-3 (DB11093; DB11348; DB14481)
drugbank_target|P16066	-	1061	sp|Q8IBS5|CDPK4_PL	-	528	8.6e-45	151.7	0.0	1	1	9.4e-46	1.2e-44	151.2	0.0	83	358	551	834	546	864	0.80	Atrial natriuretic peptide receptor 1 (DB00325; DB00727; DB00883; DB01612; DB01613; DB04899; DB05034)
drugbank_target|Q9HCP0	-	422	sp|Q8IBS5|CDPK4_PL	-	528	4.3e-44	149.4	0.0	1	1	4.4e-45	5.6e-44	149.0	0.0	33	305	8	290	1	300	0.83	Casein kinase I isoform gamma-1 (DB08325)
drugbank_target|Q9Y6M4	-	447	sp|Q8IBS5|CDPK4_PL	-	528	1.2e-43	147.9	0.7	1	1	1.6e-44	2.1e-43	147.2	0.0	33	292	5	274	1	290	0.82	Casein kinase I isoform gamma-3 (DB04751; DB07488; DB07489; DB07664)
drugbank_target|P20807	-	821	sp|Q8IBS5|CDPK4_PL	-	528	1.9e-43	147.3	9.0	1	2	1.9e-44	2.4e-43	147.0	4.9	345	525	618	789	600	792	0.90	Calpain-3 (DB06124)
drugbank_target|P20807	-	821	sp|Q8IBS5|CDPK4_PL	-	528	1.9e-43	147.3	9.0	2	2	1.4	18	2.2	0.1	466	482	794	810	787	817	0.82	Calpain-3 (DB06124)
drugbank_target|P48729	-	337	sp|Q8IBS5|CDPK4_PL	-	528	4.6e-43	146.0	0.1	1	1	4.5e-44	5.7e-43	145.7	0.1	62	308	9	263	2	336	0.86	Casein kinase I isoform alpha (DB12010)
drugbank_target|P49674	-	416	sp|Q8IBS5|CDPK4_PL	-	528	8e-43	145.2	0.1	1	1	7.7e-44	9.8e-43	144.9	0.1	65	307	4	254	1	271	0.89	Casein kinase I isoform epsilon (DB06195)
drugbank_target|P78368	-	415	sp|Q8IBS5|CDPK4_PL	-	528	1.3e-41	141.2	0.0	1	1	1.3e-42	1.7e-41	140.9	0.0	65	305	41	291	9	299	0.87	Casein kinase I isoform gamma-2 (DB03083; DB03693; DB04604)
drugbank_target|P0C264	-	359	sp|Q8IBS5|CDPK4_PL	-	528	5.5e-41	139.2	0.0	1	1	5.5e-42	7e-41	138.8	0.0	64	317	37	295	3	304	0.86	Uncharacterized serine/threonine-protein kinase SBK3 (DB12010)
drugbank_target|P63098	-	170	sp|Q8IBS5|CDPK4_PL	-	528	1.7e-40	137.5	2.9	1	1	1.6e-41	2e-40	137.3	2.9	369	523	11	158	2	162	0.87	Calcineurin subunit B type 1 (DB08231; DB11693)
drugbank_target|Q96LZ3	-	170	sp|Q8IBS5|CDPK4_PL	-	528	2.3e-39	133.8	2.5	1	1	2.2e-40	2.8e-39	133.5	2.5	364	525	6	160	2	163	0.87	Calcineurin subunit B type 2 (DB00091; DB11693)
drugbank_target|P19105	-	171	sp|Q8IBS5|CDPK4_PL	-	528	4.9e-38	129.4	3.8	1	1	4.5e-39	5.7e-38	129.2	3.8	350	523	3	163	1	166	0.94	Myosin regulatory light chain 12A (DB08378)
drugbank_target|P04632	-	268	sp|Q8IBS5|CDPK4_PL	-	528	9.6e-38	128.5	0.5	1	2	6.2e-38	7.9e-37	125.4	0.1	369	525	89	236	71	239	0.87	Calpain small subunit 1 (DB02570)
drugbank_target|P04632	-	268	sp|Q8IBS5|CDPK4_PL	-	528	9.6e-38	128.5	0.5	2	2	1.9	24	1.7	0.0	466	481	241	256	235	264	0.75	Calpain small subunit 1 (DB02570)
drugbank_target|P9WI73	-	750	sp|Q8IBS5|CDPK4_PL	-	528	1.1e-37	128.3	0.0	1	1	1.3e-38	1.7e-37	127.6	0.0	65	320	146	385	139	395	0.85	Serine/threonine-protein kinase PknG (DB07398)
drugbank_target|Q16671	-	573	sp|Q8IBS5|CDPK4_PL	-	528	1.6e-37	127.7	0.0	1	1	1.7e-38	2.2e-37	127.3	0.0	70	324	203	503	187	515	0.83	Anti-Muellerian hormone type-2 receptor (DB00171)
drugbank_target|P25092	-	1073	sp|Q8IBS5|CDPK4_PL	-	528	2.3e-37	127.2	1.2	1	1	2.9e-38	3.6e-37	126.5	1.2	89	323	506	742	502	790	0.86	Heat-stable enterotoxin receptor (DB08890)
drugbank_target|O75746	-	678	sp|Q8IBS5|CDPK4_PL	-	528	1.5e-36	124.5	0.1	1	2	7.6e-34	9.7e-33	111.9	0.0	369	525	4	157	1	160	0.94	Calcium-binding mitochondrial carrier protein Aralar1 (DB00128)
drugbank_target|O75746	-	678	sp|Q8IBS5|CDPK4_PL	-	528	1.5e-36	124.5	0.1	2	2	0.01	0.13	9.2	0.0	380	516	161	287	158	291	0.74	Calcium-binding mitochondrial carrier protein Aralar1 (DB00128)
drugbank_target|P22676	-	271	sp|Q8IBS5|CDPK4_PL	-	528	9.4e-35	118.6	11.2	1	2	2.2e-13	2.8e-12	44.4	2.2	459	522	16	92	11	98	0.88	Calretinin (DB11093; DB11348; DB13800; DB14481)
drugbank_target|P22676	-	271	sp|Q8IBS5|CDPK4_PL	-	528	9.4e-35	118.6	11.2	2	2	1.2e-23	1.6e-22	78.2	1.8	377	498	108	235	103	252	0.84	Calretinin (DB11093; DB11348; DB13800; DB14481)
drugbank_target|Q9UJS0	-	675	sp|Q8IBS5|CDPK4_PL	-	528	2.3e-34	117.3	0.3	1	2	2e-33	2.6e-32	110.5	0.1	371	525	7	158	1	161	0.94	Calcium-binding mitochondrial carrier protein Aralar2 (DB00128)
drugbank_target|Q9UJS0	-	675	sp|Q8IBS5|CDPK4_PL	-	528	2.3e-34	117.3	0.3	2	2	0.18	2.3	5.1	0.0	438	507	210	278	159	289	0.72	Calcium-binding mitochondrial carrier protein Aralar2 (DB00128)
drugbank_target|P07384	-	714	sp|Q8IBS5|CDPK4_PL	-	528	2.6e-34	117.1	5.5	1	2	1.3e-16	1.7e-15	55.0	0.8	425	528	504	620	497	620	0.92	Calpain-1 catalytic subunit (DB04276; DB04653; DB07627)
drugbank_target|P07384	-	714	sp|Q8IBS5|CDPK4_PL	-	528	2.6e-34	117.1	5.5	2	2	4.5e-22	5.7e-21	73.1	0.3	381	526	547	683	546	685	0.89	Calpain-1 catalytic subunit (DB04276; DB04653; DB07627)
drugbank_target|P63316	-	161	sp|Q8IBS5|CDPK4_PL	-	528	3.5e-34	116.7	11.3	1	2	1.9e-17	2.4e-16	57.8	0.4	452	525	8	84	1	86	0.88	Troponin C, slow skeletal and cardiac muscles (DB00831; DB00922; DB01023; DB01244; DB01373; DB01375; DB03944; DB04513)
drugbank_target|P63316	-	161	sp|Q8IBS5|CDPK4_PL	-	528	3.5e-34	116.7	11.3	2	2	2.1e-19	2.7e-18	64.3	5.0	451	523	84	158	82	161	0.93	Troponin C, slow skeletal and cardiac muscles (DB00831; DB00922; DB01023; DB01244; DB01373; DB01375; DB03944; DB04513)
drugbank_target|P43080	-	201	sp|Q8IBS5|CDPK4_PL	-	528	2.7e-30	103.9	1.1	1	1	2.7e-31	3.4e-30	103.5	1.1	380	524	17	162	3	164	0.82	Guanylyl cyclase-activating protein 1 (DB08231)
drugbank_target|P30626	-	198	sp|Q8IBS5|CDPK4_PL	-	528	1.1e-29	101.8	0.0	1	1	1.3e-30	1.7e-29	101.3	0.0	385	526	39	167	30	169	0.90	Sorcin (DB11093; DB11348; DB14481)
drugbank_target|Q13938	-	189	sp|Q8IBS5|CDPK4_PL	-	528	2.4e-29	100.8	0.0	1	1	2.3e-30	2.9e-29	100.5	0.0	374	521	19	165	3	171	0.88	Calcyphosin (DB11093; DB11348; DB14481)
drugbank_target|P12814	-	892	sp|Q8IBS5|CDPK4_PL	-	528	2.6e-29	100.6	0.1	1	1	5.6e-30	7.1e-29	99.2	0.1	352	486	722	850	691	863	0.89	Alpha-actinin-1 (DB06773; DB09130)
drugbank_target|P62166	-	190	sp|Q8IBS5|CDPK4_PL	-	528	7.1e-29	99.2	2.0	1	1	6.4e-30	8.1e-29	99.0	2.0	375	520	24	171	2	175	0.78	Neuronal calcium sensor 1 (DB11093; DB11348; DB14481)
drugbank_target|O75340	-	191	sp|Q8IBS5|CDPK4_PL	-	528	3.6e-28	96.9	2.6	1	2	6.2e-27	7.9e-26	89.1	0.7	383	523	30	156	24	161	0.89	Programmed cell death protein 6 (DB01373; DB01593; DB11093; DB11348; DB14481; DB14487)
drugbank_target|O75340	-	191	sp|Q8IBS5|CDPK4_PL	-	528	3.6e-28	96.9	2.6	2	2	0.11	1.4	5.8	0.0	497	522	160	187	153	191	0.61	Programmed cell death protein 6 (DB01373; DB01593; DB11093; DB11348; DB14481; DB14487)
drugbank_target|Q9UBV8	-	284	sp|Q8IBS5|CDPK4_PL	-	528	1.1e-26	92.0	1.7	1	2	4.8e-22	6.2e-21	73.0	0.2	422	525	113	213	104	217	0.93	Peflin (DB11093; DB11348; DB14481)
drugbank_target|Q9UBV8	-	284	sp|Q8IBS5|CDPK4_PL	-	528	1.1e-26	92.0	1.7	2	2	9.9e-08	1.3e-06	25.8	0.1	462	525	184	250	182	281	0.84	Peflin (DB11093; DB11348; DB14481)
drugbank_target|P28676	-	217	sp|Q8IBS5|CDPK4_PL	-	528	2.1e-26	91.0	0.0	1	1	2e-27	2.6e-26	90.7	0.0	383	526	56	186	42	188	0.90	Grancalcin (DB11093; DB11348; DB14481)
drugbank_target|Q96KG9	-	808	sp|Q8IBS5|CDPK4_PL	-	528	6.1e-23	79.6	0.0	1	1	7.8e-24	1e-22	78.9	0.0	86	269	33	221	30	258	0.88	N-terminal kinase-like protein (DB05036)
drugbank_target|Q99653	-	195	sp|Q8IBS5|CDPK4_PL	-	528	1.4e-21	75.1	1.2	1	1	1.6e-22	2e-21	74.6	1.2	371	525	21	183	4	185	0.89	Calcineurin B homologous protein 1 (DB11093; DB11348; DB14481)
drugbank_target|Q99828	-	191	sp|Q8IBS5|CDPK4_PL	-	528	2.4e-21	74.4	0.5	1	1	4.7e-22	6e-21	73.0	0.3	380	457	107	182	93	189	0.92	Calcium and integrin-binding protein 1 (DB11093; DB11348; DB14481)
drugbank_target|P35243	-	200	sp|Q8IBS5|CDPK4_PL	-	528	3.3e-21	73.9	3.9	1	2	5.4e-22	6.9e-21	72.8	2.3	394	520	42	174	10	176	0.81	Recoverin (DB08231)
drugbank_target|P35243	-	200	sp|Q8IBS5|CDPK4_PL	-	528	3.3e-21	73.9	3.9	2	2	0.046	0.59	7.1	0.3	458	504	146	199	139	200	0.77	Recoverin (DB08231)
drugbank_target|P14649	-	208	sp|Q8IBS5|CDPK4_PL	-	528	2e-20	71.3	0.1	1	2	1.7e-10	2.1e-09	34.9	0.0	454	526	60	135	52	137	0.87	Myosin light chain 6B (DB08378)
drugbank_target|P14649	-	208	sp|Q8IBS5|CDPK4_PL	-	528	2e-20	71.3	0.1	2	2	9.5e-11	1.2e-09	35.7	0.0	455	521	137	204	132	208	0.85	Myosin light chain 6B (DB08378)
drugbank_target|O75838	-	187	sp|Q8IBS5|CDPK4_PL	-	528	8.7e-20	69.2	1.1	1	1	8.4e-21	1.1e-19	68.9	1.1	429	525	72	176	57	179	0.89	Calcium and integrin-binding family member 2 (DB11093; DB11348; DB14481)
drugbank_target|P29377	-	79	sp|Q8IBS5|CDPK4_PL	-	528	4.9e-16	56.8	0.2	1	1	4.1e-17	5.2e-16	56.7	0.2	457	526	3	78	1	79	0.91	Protein S100-G (DB04464)
drugbank_target|P20472	-	110	sp|Q8IBS5|CDPK4_PL	-	528	3.2e-15	54.1	1.5	1	1	2.9e-16	3.7e-15	53.9	1.5	446	523	28	108	21	110	0.87	Parvalbumin alpha (DB01942)
drugbank_target|P51178	-	756	sp|Q8IBS5|CDPK4_PL	-	528	4.7e-15	53.6	0.6	1	1	5.8e-16	7.3e-15	52.9	0.6	404	505	124	221	104	242	0.86	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase delta-1 (DB03401; DB03956)
drugbank_target|Q9Y6T7	-	804	sp|Q8IBS5|CDPK4_PL	-	528	5.4e-15	53.4	0.1	1	1	9.3e-16	1.2e-14	52.3	0.1	443	520	133	221	130	224	0.83	Diacylglycerol kinase beta (DB14001)
drugbank_target|P23297	-	94	sp|Q8IBS5|CDPK4_PL	-	528	6.4e-15	53.1	0.3	1	1	5.7e-16	7.3e-15	53.0	0.3	457	525	5	82	1	85	0.86	Protein S100-A1 (DB00768)
drugbank_target|P04271	-	92	sp|Q8IBS5|CDPK4_PL	-	528	1.7e-13	48.5	1.9	1	1	1.4e-14	1.7e-13	48.4	1.9	458	525	5	81	1	84	0.82	Protein S100-B (DB00768; DB01373; DB04464; DB05343; DB06941; DB07004; DB11093; DB11348; DB14481)
drugbank_target|P06703	-	90	sp|Q8IBS5|CDPK4_PL	-	528	4.2e-13	47.1	0.1	1	1	3.9e-14	5e-13	46.9	0.1	465	525	13	80	7	83	0.90	Protein S100-A6 (DB11093; DB11348; DB14481)
drugbank_target|P80511	-	92	sp|Q8IBS5|CDPK4_PL	-	528	8.5e-13	46.1	0.7	1	1	7.5e-14	9.6e-13	46.0	0.7	458	523	5	79	1	82	0.83	Protein S100-A12 (DB00768; DB01025)
drugbank_target|P60903	-	97	sp|Q8IBS5|CDPK4_PL	-	528	1.7e-12	45.1	0.2	1	1	1.5e-13	1.9e-12	44.9	0.2	457	525	5	79	1	82	0.88	Protein S100-A10 (DB12695)
drugbank_target|P31949	-	105	sp|Q8IBS5|CDPK4_PL	-	528	3.2e-12	44.2	0.1	1	1	2.8e-13	3.5e-12	44.1	0.1	454	523	7	85	1	89	0.81	Protein S100-A11 (DB02482)
drugbank_target|P23743	-	735	sp|Q8IBS5|CDPK4_PL	-	528	6e-12	43.3	0.0	1	1	7.7e-13	9.8e-12	42.6	0.0	456	520	107	182	91	186	0.84	Diacylglycerol kinase alpha (DB00163)
drugbank_target|P23743	-	735	sp|Q8IBS5|CDPK4_PL	-	528	6e-12	43.3	0.0	1	1	7.7e-13	9.8e-12	42.6	0.0	456	520	107	182	91	186	0.84	Diacylglycerol kinase alpha (DB14001)
drugbank_target|P26447	-	101	sp|Q8IBS5|CDPK4_PL	-	528	1.1e-11	42.5	0.2	1	1	9.2e-13	1.2e-11	42.4	0.2	462	526	10	83	2	87	0.83	Protein S100-A4 (DB00831; DB09130)
drugbank_target|P49619	-	791	sp|Q8IBS5|CDPK4_PL	-	528	1.2e-11	42.3	0.0	1	1	2.4e-12	3e-11	41.0	0.0	449	519	165	246	152	248	0.81	Diacylglycerol kinase gamma (DB00144)
drugbank_target|P49619	-	791	sp|Q8IBS5|CDPK4_PL	-	528	1.2e-11	42.3	0.0	1	1	2.4e-12	3e-11	41.0	0.0	449	519	165	246	152	248	0.81	Diacylglycerol kinase gamma (DB14001)
drugbank_target|P06702	-	114	sp|Q8IBS5|CDPK4_PL	-	528	1.3e-11	42.2	2.1	1	1	1.2e-12	1.6e-11	41.9	2.1	454	525	5	86	1	88	0.85	Protein S100-A9 (DB01373; DB01593; DB14487; DB14533; DB14548)
drugbank_target|P25815	-	95	sp|Q8IBS5|CDPK4_PL	-	528	3.7e-11	40.7	0.1	1	1	3.4e-12	4.3e-11	40.5	0.1	463	526	10	82	2	84	0.84	Protein S100-P (DB01003)
drugbank_target|P16788	-	707	sp|Q8IBS5|CDPK4_PL	-	528	4.2e-10	37.2	0.0	1	1	5.1e-11	6.5e-10	36.6	0.0	75	228	336	494	328	507	0.85	Serine/threonine protein kinase UL97 (DB06234)
drugbank_target|Q68101	-	707	sp|Q8IBS5|CDPK4_PL	-	528	4.2e-10	37.2	0.0	1	1	5.1e-11	6.5e-10	36.6	0.0	75	228	336	494	328	507	0.85	Serine/threonine protein kinase UL97 (DB06234)
drugbank_target|Q8NI22	-	146	sp|Q8IBS5|CDPK4_PL	-	528	5.8e-10	36.8	0.2	1	1	5.5e-11	7e-10	36.5	0.2	446	522	53	145	49	146	0.83	Multiple coagulation factor deficiency protein 2 (DB00025; DB13998; DB13999)
drugbank_target|P29034	-	98	sp|Q8IBS5|CDPK4_PL	-	528	6.1e-10	36.7	0.2	1	1	5.2e-11	6.6e-10	36.6	0.2	462	525	11	83	1	86	0.82	Protein S100-A2 (DB00768; DB01373; DB01593; DB09130; DB14487; DB14533; DB14548)
drugbank_target|Q8TF76	-	798	sp|Q8IBS5|CDPK4_PL	-	528	1.6e-09	35.3	3.1	1	1	2.5e-10	3.2e-09	34.3	0.1	41	207	455	663	447	697	0.78	Serine/threonine-protein kinase haspin (DB04604; DB07698; DB07995; DB08004)
drugbank_target|P31151	-	101	sp|Q8IBS5|CDPK4_PL	-	528	4.3e-09	33.9	1.3	1	1	3.5e-10	4.5e-09	33.8	1.3	453	526	2	83	1	86	0.79	Protein S100-A7 (DB01050; DB01593; DB04474; DB09213; DB14487; DB14533; DB14548)
drugbank_target|Q96FQ6	-	103	sp|Q8IBS5|CDPK4_PL	-	528	1.5e-08	32.2	0.0	1	1	1.3e-09	1.6e-08	32.0	0.0	475	525	30	86	10	88	0.78	Protein S100-A16 (DB11093; DB11348; DB14481)
drugbank_target|Q99584	-	98	sp|Q8IBS5|CDPK4_PL	-	528	2.8e-08	31.2	0.2	1	1	2.5e-09	3.2e-08	31.0	0.2	457	526	9	84	3	86	0.81	Protein S100-A13 (DB00768; DB01025; DB01164; DB01373; DB11093; DB11348; DB14481)
drugbank_target|P05109	-	93	sp|Q8IBS5|CDPK4_PL	-	528	4.3e-08	30.6	0.1	1	1	3.8e-09	4.8e-08	30.4	0.1	458	525	6	78	1	80	0.85	Protein S100-A8 (DB01373; DB01593; DB09130; DB14487; DB14533; DB14548)
drugbank_target|Q86YZ3	-	2850	sp|Q8IBS5|CDPK4_PL	-	528	1.9e-07	28.4	0.5	1	1	1.5e-08	1.9e-07	28.4	0.5	465	526	12	82	9	84	0.79	Hornerin (DB01593; DB14487)
drugbank_target|Q9NXG6	-	502	sp|Q8IBS5|CDPK4_PL	-	528	1.2e-05	22.5	0.0	1	1	1.4e-06	1.8e-05	22.0	0.0	466	521	192	252	172	256	0.88	Transmembrane prolyl 4-hydroxylase (DB00126)
drugbank_target|Q8IJN7	-	446	sp|Q8IJN7|ENO_PLAF	-	446	1.8e-274	908.5	3.9	1	1	3.4e-277	2e-274	908.4	3.9	1	446	1	446	1	446	1.00	Enolase (DB11638)
drugbank_target|P09104	-	434	sp|Q8IJN7|ENO_PLAF	-	446	3.6e-260	861.4	0.1	1	1	7e-263	4.1e-260	861.2	0.1	4	444	2	431	1	433	0.99	Gamma-enolase (DB02726)
drugbank_target|P06733	-	434	sp|Q8IJN7|ENO_PLAF	-	446	2e-259	858.9	0.4	1	1	3.8e-262	2.2e-259	858.8	0.4	5	445	3	432	1	433	0.99	Alpha-enolase (DB01593; DB09130; DB11638; DB14487; DB14533; DB14548)
drugbank_target|P13929	-	434	sp|Q8IJN7|ENO_PLAF	-	446	7.4e-258	853.8	0.3	1	1	1.4e-260	8.3e-258	853.6	0.3	4	444	2	431	1	433	0.99	Beta-enolase (DB01709; DB01819; DB02726; DB03645)
drugbank_target|Q27655	-	431	sp|Q8IJN7|ENO_PLAF	-	446	4.1e-248	821.6	0.3	1	1	7.8e-251	4.6e-248	821.5	0.3	4	443	2	430	1	431	0.99	Enolase (DB12245)
drugbank_target|P11444	-	359	sp|Q8IJN7|ENO_PLAF	-	446	2.3e-29	100.6	0.0	1	1	6.1e-32	3.5e-29	100.0	0.0	293	395	210	308	189	313	0.95	Mandelate racemase (DB02280; DB03357; DB07381)
drugbank_target|Q9RYA6	-	375	sp|Q8IJN7|ENO_PLAF	-	446	6.1e-21	72.9	0.0	1	1	1.3e-23	7.8e-21	72.6	0.0	293	379	209	290	140	298	0.91	o-succinylbenzoate synthase (DB04167)
drugbank_target|Q44244	-	368	sp|Q8IJN7|ENO_PLAF	-	446	2.4e-10	38.0	0.0	1	2	0.033	19	2.1	0.0	26	63	119	156	109	165	0.76	o-succinylbenzoate synthase (DB01646; DB02251; DB03299; DB04511)
drugbank_target|Q44244	-	368	sp|Q8IJN7|ENO_PLAF	-	446	2.4e-10	38.0	0.0	2	2	7.9e-12	4.6e-09	33.7	0.0	295	377	205	284	188	304	0.90	o-succinylbenzoate synthase (DB01646; DB02251; DB03299; DB04511)
drugbank_target|Q47Q21	-	317	sp|Q8IJN7|ENO_PLAF	-	446	0.014	12.4	0.2	1	2	1.5	8.7e+02	-3.4	0.1	336	361	77	102	70	112	0.78	o-succinylbenzoate synthase (DB02251)
drugbank_target|Q47Q21	-	317	sp|Q8IJN7|ENO_PLAF	-	446	0.014	12.4	0.2	2	2	4.2e-05	0.025	11.6	0.0	292	384	142	226	133	242	0.84	o-succinylbenzoate synthase (DB02251)
drugbank_target|Q9Y5K3	-	369	sp|Q8IIT5|PTKL_PLA	-	1501	5.9e-62	207.8	9.0	1	1	5.3e-63	7.8e-62	207.4	9.0	451	595	224	363	212	367	0.97	Choline-phosphate cytidylyltransferase B (DB00122; DB14006)
drugbank_target|O60674	-	1132	sp|Q8IIT5|PTKL_PLA	-	1501	2.3e-59	199.2	1.5	1	6	4.6e-09	6.7e-08	28.6	0.2	854	925	571	643	546	651	0.87	Tyrosine-protein kinase JAK2 (DB04716; DB05243; DB07161; DB07162; DB08067; DB08877; DB08895; DB11817; DB11986; DB12010; DB12500; DB15035)
drugbank_target|O60674	-	1132	sp|Q8IIT5|PTKL_PLA	-	1501	2.3e-59	199.2	1.5	2	6	0.024	0.34	6.4	0.0	1269	1311	652	702	645	712	0.76	Tyrosine-protein kinase JAK2 (DB04716; DB05243; DB07161; DB07162; DB08067; DB08877; DB08895; DB11817; DB11986; DB12010; DB12500; DB15035)
drugbank_target|O60674	-	1132	sp|Q8IIT5|PTKL_PLA	-	1501	2.3e-59	199.2	1.5	3	6	3.2e-12	4.6e-11	39.1	0.0	1386	1484	713	810	703	825	0.88	Tyrosine-protein kinase JAK2 (DB04716; DB05243; DB07161; DB07162; DB08067; DB08877; DB08895; DB11817; DB11986; DB12010; DB12500; DB15035)
drugbank_target|O60674	-	1132	sp|Q8IIT5|PTKL_PLA	-	1501	2.3e-59	199.2	1.5	4	6	3.1e-12	4.5e-11	39.1	0.2	852	930	871	951	851	955	0.78	Tyrosine-protein kinase JAK2 (DB04716; DB05243; DB07161; DB07162; DB08067; DB08877; DB08895; DB11817; DB11986; DB12010; DB12500; DB15035)
drugbank_target|O60674	-	1132	sp|Q8IIT5|PTKL_PLA	-	1501	2.3e-59	199.2	1.5	5	6	4.3e-12	6.3e-11	38.6	0.1	1257	1314	943	1000	942	1004	0.94	Tyrosine-protein kinase JAK2 (DB04716; DB05243; DB07161; DB07162; DB08067; DB08877; DB08895; DB11817; DB11986; DB12010; DB12500; DB15035)
drugbank_target|O60674	-	1132	sp|Q8IIT5|PTKL_PLA	-	1501	2.3e-59	199.2	1.5	6	6	7.2e-14	1e-12	44.5	0.0	1369	1483	1000	1127	998	1131	0.73	Tyrosine-protein kinase JAK2 (DB04716; DB05243; DB07161; DB07162; DB08067; DB08877; DB08895; DB11817; DB11986; DB12010; DB12500; DB15035)
drugbank_target|P51812	-	740	sp|Q8IIT5|PTKL_PLA	-	1501	2.9e-59	198.8	0.0	1	6	0.00022	0.0032	13.1	0.0	849	922	85	161	66	165	0.76	Ribosomal protein S6 kinase alpha-3 (DB00945; DB12010)
drugbank_target|P51812	-	740	sp|Q8IIT5|PTKL_PLA	-	1501	2.9e-59	198.8	0.0	2	6	1.8e-12	2.7e-11	39.9	0.0	1260	1315	163	218	159	228	0.88	Ribosomal protein S6 kinase alpha-3 (DB00945; DB12010)
drugbank_target|P51812	-	740	sp|Q8IIT5|PTKL_PLA	-	1501	2.9e-59	198.8	0.0	3	6	1.7e-15	2.4e-14	49.9	0.0	1379	1470	222	311	216	315	0.90	Ribosomal protein S6 kinase alpha-3 (DB00945; DB12010)
drugbank_target|P51812	-	740	sp|Q8IIT5|PTKL_PLA	-	1501	2.9e-59	198.8	0.0	4	6	1.5e-06	2.3e-05	20.2	0.0	841	922	430	507	417	511	0.76	Ribosomal protein S6 kinase alpha-3 (DB00945; DB12010)
drugbank_target|P51812	-	740	sp|Q8IIT5|PTKL_PLA	-	1501	2.9e-59	198.8	0.0	5	6	2.3e-10	3.3e-09	32.9	0.0	1260	1315	509	568	506	581	0.82	Ribosomal protein S6 kinase alpha-3 (DB00945; DB12010)
drugbank_target|P51812	-	740	sp|Q8IIT5|PTKL_PLA	-	1501	2.9e-59	198.8	0.0	6	6	1.1e-11	1.7e-10	37.2	0.0	1387	1477	580	675	569	684	0.89	Ribosomal protein S6 kinase alpha-3 (DB00945; DB12010)
drugbank_target|Q15418	-	735	sp|Q8IIT5|PTKL_PLA	-	1501	7.4e-58	194.2	0.0	1	6	0.00092	0.013	11.0	0.0	852	922	82	155	63	158	0.75	Ribosomal protein S6 kinase alpha-1 (DB04751; DB12010)
drugbank_target|Q15418	-	735	sp|Q8IIT5|PTKL_PLA	-	1501	7.4e-58	194.2	0.0	2	6	3.1e-12	4.5e-11	39.1	0.0	1260	1314	157	211	153	221	0.90	Ribosomal protein S6 kinase alpha-1 (DB04751; DB12010)
drugbank_target|Q15418	-	735	sp|Q8IIT5|PTKL_PLA	-	1501	7.4e-58	194.2	0.0	3	6	6.6e-15	9.7e-14	48.0	0.0	1380	1470	217	305	211	309	0.91	Ribosomal protein S6 kinase alpha-1 (DB04751; DB12010)
drugbank_target|Q15418	-	735	sp|Q8IIT5|PTKL_PLA	-	1501	7.4e-58	194.2	0.0	4	6	1.9e-06	2.8e-05	19.9	0.0	837	922	422	503	410	508	0.77	Ribosomal protein S6 kinase alpha-1 (DB04751; DB12010)
drugbank_target|Q15418	-	735	sp|Q8IIT5|PTKL_PLA	-	1501	7.4e-58	194.2	0.0	5	6	1.8e-09	2.6e-08	30.0	0.0	1260	1315	505	564	502	573	0.84	Ribosomal protein S6 kinase alpha-1 (DB04751; DB12010)
drugbank_target|Q15418	-	735	sp|Q8IIT5|PTKL_PLA	-	1501	7.4e-58	194.2	0.0	6	6	2.1e-12	3.1e-11	39.7	0.0	1387	1478	576	672	571	690	0.87	Ribosomal protein S6 kinase alpha-1 (DB04751; DB12010)
drugbank_target|Q9UK32	-	745	sp|Q8IIT5|PTKL_PLA	-	1501	6.4e-57	191.1	0.0	1	6	0.0012	0.018	10.6	0.0	850	922	91	166	75	169	0.74	Ribosomal protein S6 kinase alpha-6 (DB12010)
drugbank_target|Q9UK32	-	745	sp|Q8IIT5|PTKL_PLA	-	1501	6.4e-57	191.1	0.0	2	6	1.6e-11	2.4e-10	36.7	0.0	1261	1315	169	223	162	231	0.90	Ribosomal protein S6 kinase alpha-6 (DB12010)
drugbank_target|Q9UK32	-	745	sp|Q8IIT5|PTKL_PLA	-	1501	6.4e-57	191.1	0.0	3	6	1.1e-15	1.6e-14	50.5	0.0	1379	1477	227	323	222	334	0.89	Ribosomal protein S6 kinase alpha-6 (DB12010)
drugbank_target|Q9UK32	-	745	sp|Q8IIT5|PTKL_PLA	-	1501	6.4e-57	191.1	0.0	4	6	8.4e-06	0.00012	17.8	0.0	840	923	433	512	404	515	0.73	Ribosomal protein S6 kinase alpha-6 (DB12010)
drugbank_target|Q9UK32	-	745	sp|Q8IIT5|PTKL_PLA	-	1501	6.4e-57	191.1	0.0	5	6	1.7e-09	2.5e-08	30.1	0.0	1259	1314	512	571	509	584	0.85	Ribosomal protein S6 kinase alpha-6 (DB12010)
drugbank_target|Q9UK32	-	745	sp|Q8IIT5|PTKL_PLA	-	1501	6.4e-57	191.1	0.0	6	6	2.8e-12	4.1e-11	39.3	0.0	1388	1478	585	680	580	700	0.88	Ribosomal protein S6 kinase alpha-6 (DB12010)
drugbank_target|P29317	-	976	sp|Q8IIT5|PTKL_PLA	-	1501	2e-55	186.1	0.2	1	3	4.6e-23	6.7e-22	75.0	0.0	818	923	597	707	591	709	0.89	Ephrin type-A receptor 2 (DB01254; DB04395; DB08896; DB12010)
drugbank_target|P29317	-	976	sp|Q8IIT5|PTKL_PLA	-	1501	2e-55	186.1	0.2	2	3	1.3e-11	1.8e-10	37.1	0.0	1258	1315	707	764	705	775	0.91	Ephrin type-A receptor 2 (DB01254; DB04395; DB08896; DB12010)
drugbank_target|P29317	-	976	sp|Q8IIT5|PTKL_PLA	-	1501	2e-55	186.1	0.2	3	3	6e-22	8.8e-21	71.3	0.0	1388	1485	780	877	768	885	0.92	Ephrin type-A receptor 2 (DB01254; DB04395; DB08896; DB12010)
drugbank_target|P23458	-	1154	sp|Q8IIT5|PTKL_PLA	-	1501	1.5e-54	183.2	10.8	1	6	8.9e-06	0.00013	17.7	0.1	856	923	614	682	599	688	0.83	Tyrosine-protein kinase JAK1 (DB02375; DB04716; DB08877; DB08895; DB11817; DB12010; DB12500; DB15091)
drugbank_target|P23458	-	1154	sp|Q8IIT5|PTKL_PLA	-	1501	1.5e-54	183.2	10.8	2	6	0.016	0.23	7.0	0.0	1259	1301	683	725	678	744	0.82	Tyrosine-protein kinase JAK1 (DB02375; DB04716; DB08877; DB08895; DB11817; DB12010; DB12500; DB15091)
drugbank_target|P23458	-	1154	sp|Q8IIT5|PTKL_PLA	-	1501	1.5e-54	183.2	10.8	3	6	9.5e-14	1.4e-12	44.1	0.0	1381	1489	748	855	742	868	0.83	Tyrosine-protein kinase JAK1 (DB02375; DB04716; DB08877; DB08895; DB11817; DB12010; DB12500; DB15091)
drugbank_target|P23458	-	1154	sp|Q8IIT5|PTKL_PLA	-	1501	1.5e-54	183.2	10.8	4	6	1.6e-10	2.3e-09	33.5	0.0	852	926	896	974	870	976	0.82	Tyrosine-protein kinase JAK1 (DB02375; DB04716; DB08877; DB08895; DB11817; DB12010; DB12500; DB15091)
drugbank_target|P23458	-	1154	sp|Q8IIT5|PTKL_PLA	-	1501	1.5e-54	183.2	10.8	5	6	6.5e-13	9.5e-12	41.4	0.1	1257	1316	970	1029	968	1033	0.94	Tyrosine-protein kinase JAK1 (DB02375; DB04716; DB08877; DB08895; DB11817; DB12010; DB12500; DB15091)
drugbank_target|P23458	-	1154	sp|Q8IIT5|PTKL_PLA	-	1501	1.5e-54	183.2	10.8	6	6	8.6e-14	1.3e-12	44.3	0.0	1372	1482	1030	1152	1027	1154	0.81	Tyrosine-protein kinase JAK1 (DB02375; DB04716; DB08877; DB08895; DB11817; DB12010; DB12500; DB15091)
drugbank_target|P49585	-	367	sp|Q8IIT5|PTKL_PLA	-	1501	2.3e-52	176.0	4.3	1	1	2.1e-53	3e-52	175.6	4.3	451	589	224	354	212	362	0.95	Choline-phosphate cytidylyltransferase A (DB00122; DB14006)
drugbank_target|P29597	-	1187	sp|Q8IIT5|PTKL_PLA	-	1501	3.7e-50	168.6	0.0	1	6	5e-05	0.00074	15.2	0.0	859	924	637	703	618	709	0.85	Non-receptor tyrosine-protein kinase TYK2 (DB04716; DB08895; DB12010)
drugbank_target|P29597	-	1187	sp|Q8IIT5|PTKL_PLA	-	1501	3.7e-50	168.6	0.0	2	6	0.0076	0.11	8.0	0.0	1265	1300	709	744	701	763	0.83	Non-receptor tyrosine-protein kinase TYK2 (DB04716; DB08895; DB12010)
drugbank_target|P29597	-	1187	sp|Q8IIT5|PTKL_PLA	-	1501	3.7e-50	168.6	0.0	3	6	2.6e-09	3.7e-08	29.4	0.0	1385	1485	772	872	764	880	0.85	Non-receptor tyrosine-protein kinase TYK2 (DB04716; DB08895; DB12010)
drugbank_target|P29597	-	1187	sp|Q8IIT5|PTKL_PLA	-	1501	3.7e-50	168.6	0.0	4	6	1.3e-07	1.8e-06	23.8	0.0	853	922	919	992	890	996	0.77	Non-receptor tyrosine-protein kinase TYK2 (DB04716; DB08895; DB12010)
drugbank_target|P29597	-	1187	sp|Q8IIT5|PTKL_PLA	-	1501	3.7e-50	168.6	0.0	5	6	3.8e-12	5.6e-11	38.8	0.0	1264	1314	997	1047	991	1053	0.92	Non-receptor tyrosine-protein kinase TYK2 (DB04716; DB08895; DB12010)
drugbank_target|P29597	-	1187	sp|Q8IIT5|PTKL_PLA	-	1501	3.7e-50	168.6	0.0	6	6	3e-14	4.4e-13	45.8	0.0	1375	1488	1053	1178	1047	1184	0.78	Non-receptor tyrosine-protein kinase TYK2 (DB04716; DB08895; DB12010)
drugbank_target|P54762	-	984	sp|Q8IIT5|PTKL_PLA	-	1501	5.7e-49	164.7	0.0	1	3	5.6e-17	8.2e-16	54.8	0.0	818	929	603	718	590	722	0.82	Ephrin type-B receptor 1 (DB12010)
drugbank_target|P54762	-	984	sp|Q8IIT5|PTKL_PLA	-	1501	5.7e-49	164.7	0.0	2	3	1.6e-11	2.3e-10	36.7	0.0	1258	1316	712	770	710	782	0.88	Ephrin type-B receptor 1 (DB12010)
drugbank_target|P54762	-	984	sp|Q8IIT5|PTKL_PLA	-	1501	5.7e-49	164.7	0.0	3	3	3.6e-22	5.2e-21	72.1	0.0	1380	1486	777	885	769	897	0.88	Ephrin type-B receptor 1 (DB12010)
drugbank_target|Q06187	-	659	sp|Q8IIT5|PTKL_PLA	-	1501	8.2e-49	164.2	1.8	1	3	2e-18	2.9e-17	59.6	0.2	853	926	418	492	406	494	0.84	Tyrosine-protein kinase BTK (DB01254; DB01863; DB05204; DB09053; DB11703; DB12010; DB15035)
drugbank_target|Q06187	-	659	sp|Q8IIT5|PTKL_PLA	-	1501	8.2e-49	164.2	1.8	2	3	1.8e-13	2.6e-12	43.2	0.0	1260	1314	491	545	488	552	0.94	Tyrosine-protein kinase BTK (DB01254; DB01863; DB05204; DB09053; DB11703; DB12010; DB15035)
drugbank_target|Q06187	-	659	sp|Q8IIT5|PTKL_PLA	-	1501	8.2e-49	164.2	1.8	3	3	5.5e-19	8e-18	61.5	0.0	1383	1485	557	657	545	659	0.89	Tyrosine-protein kinase BTK (DB01254; DB01863; DB05204; DB09053; DB11703; DB12010; DB15035)
drugbank_target|P29323	-	1055	sp|Q8IIT5|PTKL_PLA	-	1501	9.1e-49	164.1	0.0	1	3	1.3e-16	1.9e-15	53.6	0.0	818	929	605	720	591	724	0.82	Ephrin type-B receptor 2 (DB04395; DB12010)
drugbank_target|P29323	-	1055	sp|Q8IIT5|PTKL_PLA	-	1501	9.1e-49	164.1	0.0	2	3	3.1e-11	4.6e-10	35.8	0.0	1260	1316	716	772	713	784	0.88	Ephrin type-B receptor 2 (DB04395; DB12010)
drugbank_target|P29323	-	1055	sp|Q8IIT5|PTKL_PLA	-	1501	9.1e-49	164.1	0.0	3	3	1.7e-22	2.4e-21	73.2	0.0	1388	1488	789	889	770	898	0.90	Ephrin type-B receptor 2 (DB04395; DB12010)
drugbank_target|O75676	-	772	sp|Q8IIT5|PTKL_PLA	-	1501	7e-48	161.1	0.0	1	6	0.015	0.23	7.0	0.0	840	925	40	132	30	140	0.77	Ribosomal protein S6 kinase alpha-4 (DB03247)
drugbank_target|O75676	-	772	sp|Q8IIT5|PTKL_PLA	-	1501	7e-48	161.1	0.0	2	6	9.4e-10	1.4e-08	30.9	0.0	1259	1316	130	187	128	197	0.88	Ribosomal protein S6 kinase alpha-4 (DB03247)
drugbank_target|O75676	-	772	sp|Q8IIT5|PTKL_PLA	-	1501	7e-48	161.1	0.0	3	6	7.2e-12	1e-10	37.9	0.0	1380	1470	192	285	185	289	0.88	Ribosomal protein S6 kinase alpha-4 (DB03247)
drugbank_target|O75676	-	772	sp|Q8IIT5|PTKL_PLA	-	1501	7e-48	161.1	0.0	4	6	1e-05	0.00015	17.5	0.0	849	924	425	499	415	501	0.82	Ribosomal protein S6 kinase alpha-4 (DB03247)
drugbank_target|O75676	-	772	sp|Q8IIT5|PTKL_PLA	-	1501	7e-48	161.1	0.0	5	6	1.7e-09	2.5e-08	30.0	0.0	1258	1314	497	557	493	562	0.87	Ribosomal protein S6 kinase alpha-4 (DB03247)
drugbank_target|O75676	-	772	sp|Q8IIT5|PTKL_PLA	-	1501	7e-48	161.1	0.0	6	6	8.8e-11	1.3e-09	34.3	0.0	1386	1475	570	668	563	675	0.86	Ribosomal protein S6 kinase alpha-4 (DB03247)
drugbank_target|P52333	-	1124	sp|Q8IIT5|PTKL_PLA	-	1501	8.6e-48	160.8	0.0	1	6	3.2e-06	4.7e-05	19.2	0.1	844	923	536	615	524	627	0.86	Tyrosine-protein kinase JAK3 (DB04716; DB06321; DB08895; DB11817; DB12010; DB15035)
drugbank_target|P52333	-	1124	sp|Q8IIT5|PTKL_PLA	-	1501	8.6e-48	160.8	0.0	2	6	0.15	2.3	3.7	0.0	1268	1321	625	684	619	688	0.84	Tyrosine-protein kinase JAK3 (DB04716; DB06321; DB08895; DB11817; DB12010; DB15035)
drugbank_target|P52333	-	1124	sp|Q8IIT5|PTKL_PLA	-	1501	8.6e-48	160.8	0.0	3	6	2e-10	3e-09	33.1	0.0	1386	1485	685	783	677	791	0.88	Tyrosine-protein kinase JAK3 (DB04716; DB06321; DB08895; DB11817; DB12010; DB15035)
drugbank_target|P52333	-	1124	sp|Q8IIT5|PTKL_PLA	-	1501	8.6e-48	160.8	0.0	4	6	2.2e-07	3.2e-06	23.1	0.0	854	925	845	919	813	923	0.77	Tyrosine-protein kinase JAK3 (DB04716; DB06321; DB08895; DB11817; DB12010; DB15035)
drugbank_target|P52333	-	1124	sp|Q8IIT5|PTKL_PLA	-	1501	8.6e-48	160.8	0.0	5	6	1.8e-12	2.7e-11	39.9	0.0	1257	1314	916	973	914	981	0.93	Tyrosine-protein kinase JAK3 (DB04716; DB06321; DB08895; DB11817; DB12010; DB15035)
drugbank_target|P52333	-	1124	sp|Q8IIT5|PTKL_PLA	-	1501	8.6e-48	160.8	0.0	6	6	1.9e-11	2.8e-10	36.5	0.0	1380	1483	984	1099	974	1112	0.74	Tyrosine-protein kinase JAK3 (DB04716; DB06321; DB08895; DB11817; DB12010; DB15035)
drugbank_target|Q05397	-	1052	sp|Q8IIT5|PTKL_PLA	-	1501	1e-47	160.6	0.0	1	2	1.1e-10	1.7e-09	33.9	0.0	843	926	432	517	423	523	0.77	Focal adhesion kinase 1 (DB06423; DB07248; DB07460; DB12010)
drugbank_target|Q05397	-	1052	sp|Q8IIT5|PTKL_PLA	-	1501	1e-47	160.6	0.0	2	2	4.1e-38	6e-37	124.9	0.0	1319	1494	521	691	517	695	0.95	Focal adhesion kinase 1 (DB06423; DB07248; DB07460; DB12010)
drugbank_target|P54764	-	986	sp|Q8IIT5|PTKL_PLA	-	1501	1.1e-47	160.5	0.0	1	3	3.9e-17	5.7e-16	55.4	0.0	818	928	605	719	593	724	0.85	Ephrin type-A receptor 4 (DB12010)
drugbank_target|P54764	-	986	sp|Q8IIT5|PTKL_PLA	-	1501	1.1e-47	160.5	0.0	2	3	9.6e-11	1.4e-09	34.2	0.0	1258	1315	714	771	712	780	0.92	Ephrin type-A receptor 4 (DB12010)
drugbank_target|P54764	-	986	sp|Q8IIT5|PTKL_PLA	-	1501	1.1e-47	160.5	0.0	3	3	2.1e-21	3.1e-20	69.5	0.0	1385	1488	786	887	769	895	0.92	Ephrin type-A receptor 4 (DB12010)
drugbank_target|P29320	-	983	sp|Q8IIT5|PTKL_PLA	-	1501	1.2e-47	160.3	0.0	1	3	7.3e-17	1.1e-15	54.5	0.0	836	930	624	721	604	726	0.84	Ephrin type-A receptor 3 (DB12010)
drugbank_target|P29320	-	983	sp|Q8IIT5|PTKL_PLA	-	1501	1.2e-47	160.3	0.0	2	3	4.7e-11	6.8e-10	35.2	0.0	1260	1315	716	771	713	782	0.91	Ephrin type-A receptor 3 (DB12010)
drugbank_target|P29320	-	983	sp|Q8IIT5|PTKL_PLA	-	1501	1.2e-47	160.3	0.0	3	3	2.3e-21	3.4e-20	69.4	0.0	1389	1485	788	884	775	890	0.93	Ephrin type-A receptor 3 (DB12010)
drugbank_target|P54756	-	1037	sp|Q8IIT5|PTKL_PLA	-	1501	2.1e-47	159.5	0.0	1	3	2.7e-16	4e-15	52.6	0.0	818	927	659	772	614	777	0.85	Ephrin type-A receptor 5 (DB01254; DB12010)
drugbank_target|P54756	-	1037	sp|Q8IIT5|PTKL_PLA	-	1501	2.1e-47	159.5	0.0	2	3	9.6e-11	1.4e-09	34.2	0.0	1258	1315	768	825	766	836	0.91	Ephrin type-A receptor 5 (DB01254; DB12010)
drugbank_target|P54756	-	1037	sp|Q8IIT5|PTKL_PLA	-	1501	2.1e-47	159.5	0.0	3	3	6.4e-22	9.3e-21	71.2	0.0	1386	1485	841	938	825	948	0.92	Ephrin type-A receptor 5 (DB01254; DB12010)
drugbank_target|P42685	-	505	sp|Q8IIT5|PTKL_PLA	-	1501	2.5e-47	159.3	0.0	1	3	2.2e-13	3.2e-12	42.9	0.0	852	924	249	322	232	328	0.84	Tyrosine-protein kinase FRK (DB01254; DB08896; DB12010; DB15035)
drugbank_target|P42685	-	505	sp|Q8IIT5|PTKL_PLA	-	1501	2.5e-47	159.3	0.0	2	3	1.4e-12	2e-11	40.3	0.0	1256	1322	320	386	319	390	0.91	Tyrosine-protein kinase FRK (DB01254; DB08896; DB12010; DB15035)
drugbank_target|P42685	-	505	sp|Q8IIT5|PTKL_PLA	-	1501	2.5e-47	159.3	0.0	3	3	2.7e-23	3.9e-22	75.8	0.0	1373	1487	383	495	377	503	0.88	Tyrosine-protein kinase FRK (DB01254; DB08896; DB12010; DB15035)
drugbank_target|P07948	-	512	sp|Q8IIT5|PTKL_PLA	-	1501	3.3e-47	158.9	0.2	1	3	1.5e-14	2.2e-13	46.8	0.1	851	928	261	339	248	346	0.82	Tyrosine-protein kinase Lyn (DB01254; DB03023; DB06616; DB08901; DB09079; DB12010)
drugbank_target|P07948	-	512	sp|Q8IIT5|PTKL_PLA	-	1501	3.3e-47	158.9	0.2	2	3	2.1e-12	3e-11	39.7	0.0	1262	1316	339	393	333	400	0.89	Tyrosine-protein kinase Lyn (DB01254; DB03023; DB06616; DB08901; DB09079; DB12010)
drugbank_target|P07948	-	512	sp|Q8IIT5|PTKL_PLA	-	1501	3.3e-47	158.9	0.2	3	3	1.2e-21	1.7e-20	70.4	0.0	1381	1490	401	508	391	511	0.90	Tyrosine-protein kinase Lyn (DB01254; DB03023; DB06616; DB08901; DB09079; DB12010)
drugbank_target|P42680	-	631	sp|Q8IIT5|PTKL_PLA	-	1501	4.6e-47	158.4	0.1	1	3	3.7e-15	5.5e-14	48.8	0.1	854	924	387	458	382	462	0.88	Tyrosine-protein kinase Tec (DB12010; DB15035)
drugbank_target|P42680	-	631	sp|Q8IIT5|PTKL_PLA	-	1501	4.6e-47	158.4	0.1	2	3	2.5e-12	3.6e-11	39.4	0.0	1259	1314	458	513	456	522	0.92	Tyrosine-protein kinase Tec (DB12010; DB15035)
drugbank_target|P42680	-	631	sp|Q8IIT5|PTKL_PLA	-	1501	4.6e-47	158.4	0.1	3	3	6.2e-21	9e-20	68.0	0.0	1375	1488	518	628	512	630	0.90	Tyrosine-protein kinase Tec (DB12010; DB15035)
drugbank_target|P42681	-	527	sp|Q8IIT5|PTKL_PLA	-	1501	8.4e-47	157.5	0.6	1	3	6.5e-17	9.5e-16	54.6	0.2	855	926	289	361	274	364	0.86	Tyrosine-protein kinase TXK (DB12010; DB15035)
drugbank_target|P42681	-	527	sp|Q8IIT5|PTKL_PLA	-	1501	8.4e-47	157.5	0.6	2	3	1.7e-12	2.5e-11	40.0	0.0	1258	1314	358	414	356	421	0.93	Tyrosine-protein kinase TXK (DB12010; DB15035)
drugbank_target|P42681	-	527	sp|Q8IIT5|PTKL_PLA	-	1501	8.4e-47	157.5	0.6	3	3	2.7e-19	4e-18	62.5	0.0	1384	1483	427	524	412	526	0.90	Tyrosine-protein kinase TXK (DB12010; DB15035)
drugbank_target|P42684	-	1182	sp|Q8IIT5|PTKL_PLA	-	1501	8.9e-47	157.5	0.0	1	3	9.6e-17	1.4e-15	54.1	0.0	842	933	297	386	289	389	0.88	Abelson tyrosine-protein kinase 2 (DB00171; DB01254; DB05184; DB07664; DB12010)
drugbank_target|P42684	-	1182	sp|Q8IIT5|PTKL_PLA	-	1501	8.9e-47	157.5	0.0	2	3	9.8e-12	1.4e-10	37.5	0.1	1262	1315	381	434	377	440	0.90	Abelson tyrosine-protein kinase 2 (DB00171; DB01254; DB05184; DB07664; DB12010)
drugbank_target|P42684	-	1182	sp|Q8IIT5|PTKL_PLA	-	1501	8.9e-47	157.5	0.0	3	3	9.3e-20	1.4e-18	64.0	0.0	1383	1488	445	548	434	556	0.90	Abelson tyrosine-protein kinase 2 (DB00171; DB01254; DB05184; DB07664; DB12010)
drugbank_target|P00521	-	746	sp|Q8IIT5|PTKL_PLA	-	1501	9.8e-47	157.3	16.8	1	3	2.1e-17	3e-16	56.3	0.0	842	932	137	225	127	229	0.88	Tyrosine-protein kinase transforming protein Abl (DB02567; DB03814; DB03878; DB05489)
drugbank_target|P00521	-	746	sp|Q8IIT5|PTKL_PLA	-	1501	9.8e-47	157.3	16.8	2	3	5.7e-12	8.4e-11	38.2	0.0	1260	1315	219	274	216	282	0.91	Tyrosine-protein kinase transforming protein Abl (DB02567; DB03814; DB03878; DB05489)
drugbank_target|P00521	-	746	sp|Q8IIT5|PTKL_PLA	-	1501	9.8e-47	157.3	16.8	3	3	9.7e-23	1.4e-21	73.9	0.0	1383	1488	285	388	274	397	0.90	Tyrosine-protein kinase transforming protein Abl (DB02567; DB03814; DB03878; DB05489)
drugbank_target|P41240	-	450	sp|Q8IIT5|PTKL_PLA	-	1501	2.2e-46	156.1	0.0	1	3	1.1e-15	1.6e-14	50.6	0.0	851	922	209	280	197	286	0.91	Tyrosine-protein kinase CSK (DB01254; DB02010; DB05075; DB12010)
drugbank_target|P41240	-	450	sp|Q8IIT5|PTKL_PLA	-	1501	2.2e-46	156.1	0.0	2	3	1.3e-11	1.9e-10	37.1	0.0	1266	1317	290	341	281	347	0.90	Tyrosine-protein kinase CSK (DB01254; DB02010; DB05075; DB12010)
drugbank_target|P41240	-	450	sp|Q8IIT5|PTKL_PLA	-	1501	2.2e-46	156.1	0.0	3	3	3.3e-20	4.9e-19	65.5	0.0	1388	1484	349	445	339	449	0.93	Tyrosine-protein kinase CSK (DB01254; DB02010; DB05075; DB12010)
drugbank_target|P11362	-	822	sp|Q8IIT5|PTKL_PLA	-	1501	2.6e-46	155.9	0.7	1	4	1.5	22	0.4	0.1	1364	1401	128	165	112	172	0.81	Fibroblast growth factor receptor 1 (DB00039; DB00398; DB01109; DB02058; DB05014; DB07525; DB07840; DB08577; DB08896; DB08901; DB09078; DB09079; DB12010; DB12147; DB15102; DB15685)
drugbank_target|P11362	-	822	sp|Q8IIT5|PTKL_PLA	-	1501	2.6e-46	155.9	0.7	2	4	1.1e-11	1.6e-10	37.3	0.1	858	923	508	576	498	583	0.86	Fibroblast growth factor receptor 1 (DB00039; DB00398; DB01109; DB02058; DB05014; DB07525; DB07840; DB08577; DB08896; DB08901; DB09078; DB09079; DB12010; DB12147; DB15102; DB15685)
drugbank_target|P11362	-	822	sp|Q8IIT5|PTKL_PLA	-	1501	2.6e-46	155.9	0.7	3	4	5.2e-14	7.7e-13	45.0	0.0	1257	1317	590	650	580	655	0.90	Fibroblast growth factor receptor 1 (DB00039; DB00398; DB01109; DB02058; DB05014; DB07525; DB07840; DB08577; DB08896; DB08901; DB09078; DB09079; DB12010; DB12147; DB15102; DB15685)
drugbank_target|P11362	-	822	sp|Q8IIT5|PTKL_PLA	-	1501	2.6e-46	155.9	0.7	4	4	2.8e-21	4.1e-20	69.1	0.0	1374	1485	651	760	647	771	0.93	Fibroblast growth factor receptor 1 (DB00039; DB00398; DB01109; DB02058; DB05014; DB07525; DB07840; DB08577; DB08896; DB08901; DB09078; DB09079; DB12010; DB12147; DB15102; DB15685)
drugbank_target|P54760	-	987	sp|Q8IIT5|PTKL_PLA	-	1501	3.2e-46	155.6	0.0	1	3	1e-15	1.5e-14	50.6	0.0	819	928	600	713	587	718	0.82	Ephrin type-B receptor 4 (DB01254; DB07249; DB07250; DB07251; DB07252; DB07253; DB07254; DB07255; DB07256; DB11973; DB12010)
drugbank_target|P54760	-	987	sp|Q8IIT5|PTKL_PLA	-	1501	3.2e-46	155.6	0.0	2	3	2.6e-11	3.9e-10	36.0	0.0	1261	1320	711	770	707	781	0.87	Ephrin type-B receptor 4 (DB01254; DB07249; DB07250; DB07251; DB07252; DB07253; DB07254; DB07255; DB07256; DB11973; DB12010)
drugbank_target|P54760	-	987	sp|Q8IIT5|PTKL_PLA	-	1501	3.2e-46	155.6	0.0	3	3	8.4e-21	1.2e-19	67.5	0.0	1381	1485	774	880	765	887	0.89	Ephrin type-B receptor 4 (DB01254; DB07249; DB07250; DB07251; DB07252; DB07253; DB07254; DB07255; DB07256; DB11973; DB12010)
drugbank_target|P06239	-	509	sp|Q8IIT5|PTKL_PLA	-	1501	6e-46	154.7	0.1	1	3	1.2e-13	1.8e-12	43.8	0.1	851	927	259	335	251	342	0.80	Tyrosine-protein kinase Lck (DB01254; DB01830; DB02010; DB03023; DB04003; DB04395; DB06925; DB07146; DB07297; DB08055; DB08056; DB08057; DB08901; DB09079; DB12010; DB15035)
drugbank_target|P06239	-	509	sp|Q8IIT5|PTKL_PLA	-	1501	6e-46	154.7	0.1	2	3	1.3e-12	1.9e-11	40.4	0.1	1261	1316	335	390	330	397	0.93	Tyrosine-protein kinase Lck (DB01254; DB01830; DB02010; DB03023; DB04003; DB04395; DB06925; DB07146; DB07297; DB08055; DB08056; DB08057; DB08901; DB09079; DB12010; DB15035)
drugbank_target|P06239	-	509	sp|Q8IIT5|PTKL_PLA	-	1501	6e-46	154.7	0.1	3	3	3.4e-21	4.9e-20	68.8	0.0	1381	1487	398	502	388	508	0.89	Tyrosine-protein kinase Lck (DB01254; DB01830; DB02010; DB03023; DB04003; DB04395; DB06925; DB07146; DB07297; DB08055; DB08056; DB08057; DB08901; DB09079; DB12010; DB15035)
drugbank_target|P10721	-	976	sp|Q8IIT5|PTKL_PLA	-	1501	6.1e-46	154.7	0.0	1	3	1e-11	1.5e-10	37.4	0.0	840	945	599	711	586	724	0.79	Mast/stem cell growth factor receptor Kit (DB00398; DB00619; DB01254; DB01268; DB01962; DB04868; DB05146; DB05913; DB06080; DB06589; DB06595; DB08896; DB08901; DB09078; DB09103; DB12010; DB12147; DB12742; DB12978; DB14840; DB15233)
drugbank_target|P10721	-	976	sp|Q8IIT5|PTKL_PLA	-	1501	6.1e-46	154.7	0.0	2	3	7.9e-15	1.2e-13	47.7	0.0	1226	1314	729	816	716	826	0.87	Mast/stem cell growth factor receptor Kit (DB00398; DB00619; DB01254; DB01268; DB01962; DB04868; DB05146; DB05913; DB06080; DB06589; DB06595; DB08896; DB08901; DB09078; DB09103; DB12010; DB12147; DB12742; DB12978; DB14840; DB15233)
drugbank_target|P10721	-	976	sp|Q8IIT5|PTKL_PLA	-	1501	6.1e-46	154.7	0.0	3	3	1.3e-20	1.9e-19	66.8	0.0	1375	1490	821	935	815	942	0.87	Mast/stem cell growth factor receptor Kit (DB00398; DB00619; DB01254; DB01268; DB01962; DB04868; DB05146; DB05913; DB06080; DB06589; DB06595; DB08896; DB08901; DB09078; DB09103; DB12010; DB12147; DB12742; DB12978; DB14840; DB15233)
drugbank_target|P07949	-	1114	sp|Q8IIT5|PTKL_PLA	-	1501	6.8e-46	154.5	0.0	1	3	2.6e-14	3.8e-13	46.0	0.0	840	924	734	820	728	823	0.92	Proto-oncogene tyrosine-protein kinase receptor Ret (DB00398; DB01809; DB05294; DB08875; DB08896; DB08901; DB09078; DB12010; DB12742; DB15685)
drugbank_target|P07949	-	1114	sp|Q8IIT5|PTKL_PLA	-	1501	6.8e-46	154.5	0.0	2	3	8.1e-13	1.2e-11	41.1	0.0	1243	1315	826	899	818	910	0.82	Proto-oncogene tyrosine-protein kinase receptor Ret (DB00398; DB01809; DB05294; DB08875; DB08896; DB08901; DB09078; DB12010; DB12742; DB15685)
drugbank_target|P07949	-	1114	sp|Q8IIT5|PTKL_PLA	-	1501	6.8e-46	154.5	0.0	3	3	4.3e-20	6.3e-19	65.2	0.0	1377	1487	905	1013	898	1022	0.89	Proto-oncogene tyrosine-protein kinase receptor Ret (DB00398; DB01809; DB05294; DB08875; DB08896; DB08901; DB09078; DB12010; DB12742; DB15685)
drugbank_target|Q16620	-	822	sp|Q8IIT5|PTKL_PLA	-	1501	1.5e-45	153.4	0.1	1	3	2.5e-14	3.7e-13	46.0	0.0	858	928	566	637	542	642	0.85	BDNF/NT-3 growth factors receptor (DB00321; DB11823; DB11986; DB12010; DB14723)
drugbank_target|Q16620	-	822	sp|Q8IIT5|PTKL_PLA	-	1501	1.5e-45	153.4	0.1	2	3	1.8e-11	2.7e-10	36.6	0.0	1260	1313	646	699	640	703	0.95	BDNF/NT-3 growth factors receptor (DB00321; DB11823; DB11986; DB12010; DB14723)
drugbank_target|Q16620	-	822	sp|Q8IIT5|PTKL_PLA	-	1501	1.5e-45	153.4	0.1	3	3	7.3e-21	1.1e-19	67.7	0.0	1372	1485	702	813	699	819	0.95	BDNF/NT-3 growth factors receptor (DB00321; DB11823; DB11986; DB12010; DB14723)
drugbank_target|Q15375	-	998	sp|Q8IIT5|PTKL_PLA	-	1501	1.5e-45	153.4	0.0	1	3	2.3e-14	3.3e-13	46.2	0.0	821	928	620	731	613	735	0.81	Ephrin type-A receptor 7 (DB07970; DB12010)
drugbank_target|Q15375	-	998	sp|Q8IIT5|PTKL_PLA	-	1501	1.5e-45	153.4	0.0	2	3	6.3e-11	9.1e-10	34.8	0.0	1259	1315	727	783	724	792	0.91	Ephrin type-A receptor 7 (DB07970; DB12010)
drugbank_target|Q15375	-	998	sp|Q8IIT5|PTKL_PLA	-	1501	1.5e-45	153.4	0.0	3	3	9.2e-22	1.3e-20	70.7	0.0	1385	1487	798	898	784	903	0.92	Ephrin type-A receptor 7 (DB07970; DB12010)
drugbank_target|Q02763	-	1124	sp|Q8IIT5|PTKL_PLA	-	1501	2.8e-45	152.5	0.0	1	3	4.3e-11	6.2e-10	35.3	0.0	833	925	824	919	817	925	0.89	Angiopoietin-1 receptor (DB00415; DB05294; DB08221; DB08896; DB08901; DB12010; DB14840)
drugbank_target|Q02763	-	1124	sp|Q8IIT5|PTKL_PLA	-	1501	2.8e-45	152.5	0.0	2	3	4.3e-14	6.3e-13	45.3	0.0	1255	1317	929	991	919	997	0.91	Angiopoietin-1 receptor (DB00415; DB05294; DB08221; DB08896; DB08901; DB12010; DB14840)
drugbank_target|Q02763	-	1124	sp|Q8IIT5|PTKL_PLA	-	1501	2.8e-45	152.5	0.0	3	3	3.5e-21	5.1e-20	68.8	0.0	1384	1494	999	1107	988	1112	0.92	Angiopoietin-1 receptor (DB00415; DB05294; DB08221; DB08896; DB08901; DB12010; DB14840)
drugbank_target|P21802	-	821	sp|Q8IIT5|PTKL_PLA	-	1501	3.1e-45	152.3	0.1	1	3	4.4e-12	6.4e-11	38.6	0.1	858	924	511	580	491	593	0.82	Fibroblast growth factor receptor 2 (DB00039; DB01041; DB01109; DB01901; DB02058; DB02491; DB08896; DB08901; DB09078; DB09079; DB10770; DB10772; DB12010; DB12147; DB15102; DB15685)
drugbank_target|P21802	-	821	sp|Q8IIT5|PTKL_PLA	-	1501	3.1e-45	152.3	0.1	2	3	2.9e-13	4.2e-12	42.5	0.1	1259	1319	595	655	583	656	0.90	Fibroblast growth factor receptor 2 (DB00039; DB01041; DB01109; DB01901; DB02058; DB02491; DB08896; DB08901; DB09078; DB09079; DB10770; DB10772; DB12010; DB12147; DB15102; DB15685)
drugbank_target|P21802	-	821	sp|Q8IIT5|PTKL_PLA	-	1501	3.1e-45	152.3	0.1	3	3	1.7e-21	2.5e-20	69.8	0.0	1373	1484	653	762	650	773	0.94	Fibroblast growth factor receptor 2 (DB00039; DB01041; DB01109; DB01901; DB02058; DB02491; DB08896; DB08901; DB09078; DB09079; DB10770; DB10772; DB12010; DB12147; DB15102; DB15685)
drugbank_target|P00519	-	1130	sp|Q8IIT5|PTKL_PLA	-	1501	9.4e-45	150.8	0.4	1	3	3.7e-17	5.4e-16	55.4	0.0	842	932	251	339	241	342	0.88	Tyrosine-protein kinase ABL1 (DB00171; DB00619; DB01254; DB03878; DB04868; DB05184; DB06616; DB07831; DB08043; DB08231; DB08339; DB08350; DB08583; DB08896; DB08901; DB12010; DB12267; DB12323)
drugbank_target|P00519	-	1130	sp|Q8IIT5|PTKL_PLA	-	1501	9.4e-45	150.8	0.4	2	3	1.3e-11	1.8e-10	37.1	0.0	1261	1315	334	388	330	398	0.89	Tyrosine-protein kinase ABL1 (DB00171; DB00619; DB01254; DB03878; DB04868; DB05184; DB06616; DB07831; DB08043; DB08231; DB08339; DB08350; DB08583; DB08896; DB08901; DB12010; DB12267; DB12323)
drugbank_target|P00519	-	1130	sp|Q8IIT5|PTKL_PLA	-	1501	9.4e-45	150.8	0.4	3	3	1.7e-22	2.5e-21	73.1	0.0	1383	1488	399	502	388	511	0.90	Tyrosine-protein kinase ABL1 (DB00171; DB00619; DB01254; DB03878; DB04868; DB05184; DB06616; DB07831; DB08043; DB08231; DB08339; DB08350; DB08583; DB08896; DB08901; DB12010; DB12267; DB12323)
drugbank_target|P08631	-	526	sp|Q8IIT5|PTKL_PLA	-	1501	9.9e-45	150.7	0.7	1	3	6.5e-12	9.5e-11	38.1	0.3	853	923	278	348	261	353	0.80	Tyrosine-protein kinase HCK (DB01809; DB01962; DB04216; DB06616; DB12010)
drugbank_target|P08631	-	526	sp|Q8IIT5|PTKL_PLA	-	1501	9.9e-45	150.7	0.7	2	3	1.1e-11	1.5e-10	37.4	0.0	1264	1316	355	407	347	414	0.89	Tyrosine-protein kinase HCK (DB01809; DB01962; DB04216; DB06616; DB12010)
drugbank_target|P08631	-	526	sp|Q8IIT5|PTKL_PLA	-	1501	9.9e-45	150.7	0.7	3	3	1.9e-22	2.8e-21	72.9	0.0	1382	1491	416	523	406	525	0.91	Tyrosine-protein kinase HCK (DB01809; DB01962; DB04216; DB06616; DB12010)
drugbank_target|Q08881	-	620	sp|Q8IIT5|PTKL_PLA	-	1501	1.9e-44	149.7	0.1	1	3	3.9e-15	5.8e-14	48.7	0.0	857	924	384	451	372	456	0.89	Tyrosine-protein kinase ITK/TSK (DB02010; DB06589; DB12010; DB15035)
drugbank_target|Q08881	-	620	sp|Q8IIT5|PTKL_PLA	-	1501	1.9e-44	149.7	0.1	2	3	1.2e-10	1.7e-09	33.9	0.0	1262	1314	454	506	448	511	0.90	Tyrosine-protein kinase ITK/TSK (DB02010; DB06589; DB12010; DB15035)
drugbank_target|Q08881	-	620	sp|Q8IIT5|PTKL_PLA	-	1501	1.9e-44	149.7	0.1	3	3	6e-20	8.7e-19	64.7	0.0	1375	1484	511	617	505	619	0.90	Tyrosine-protein kinase ITK/TSK (DB02010; DB06589; DB12010; DB15035)
drugbank_target|P21709	-	976	sp|Q8IIT5|PTKL_PLA	-	1501	2.5e-44	149.3	0.0	1	3	1.4e-12	2e-11	40.3	0.0	838	925	629	719	612	723	0.82	Ephrin type-A receptor 1 (DB12010)
drugbank_target|P21709	-	976	sp|Q8IIT5|PTKL_PLA	-	1501	2.5e-44	149.3	0.0	2	3	3.2e-11	4.7e-10	35.7	0.0	1261	1318	720	777	716	783	0.89	Ephrin type-A receptor 1 (DB12010)
drugbank_target|P21709	-	976	sp|Q8IIT5|PTKL_PLA	-	1501	2.5e-44	149.3	0.0	3	3	1.1e-21	1.5e-20	70.5	0.0	1388	1485	789	886	776	894	0.92	Ephrin type-A receptor 1 (DB12010)
drugbank_target|P22607	-	806	sp|Q8IIT5|PTKL_PLA	-	1501	3e-44	149.1	0.0	1	3	2.3e-10	3.4e-09	32.9	0.0	859	923	503	570	482	578	0.84	Fibroblast growth factor receptor 3 (DB00039; DB05014; DB06589; DB08901; DB09078; DB09079; DB12010; DB12147; DB15102; DB15685)
drugbank_target|P22607	-	806	sp|Q8IIT5|PTKL_PLA	-	1501	3e-44	149.1	0.0	2	3	1.3e-13	1.9e-12	43.7	0.0	1257	1318	584	645	573	647	0.90	Fibroblast growth factor receptor 3 (DB00039; DB05014; DB06589; DB08901; DB09078; DB09079; DB12010; DB12147; DB15102; DB15685)
drugbank_target|P22607	-	806	sp|Q8IIT5|PTKL_PLA	-	1501	3e-44	149.1	0.0	3	3	9.9e-22	1.4e-20	70.6	0.0	1372	1488	643	757	640	767	0.94	Fibroblast growth factor receptor 3 (DB00039; DB05014; DB06589; DB08901; DB09078; DB09079; DB12010; DB12147; DB15102; DB15685)
drugbank_target|P06241	-	537	sp|Q8IIT5|PTKL_PLA	-	1501	3.1e-44	149.0	0.0	1	3	1.2e-13	1.8e-12	43.8	0.0	850	922	284	356	269	361	0.84	Tyrosine-protein kinase Fyn (DB01254; DB02078; DB12010)
drugbank_target|P06241	-	537	sp|Q8IIT5|PTKL_PLA	-	1501	3.1e-44	149.0	0.0	2	3	1.6e-11	2.4e-10	36.7	0.0	1260	1315	360	415	356	420	0.92	Tyrosine-protein kinase Fyn (DB01254; DB02078; DB12010)
drugbank_target|P06241	-	537	sp|Q8IIT5|PTKL_PLA	-	1501	3.1e-44	149.0	0.0	3	3	3.3e-20	4.9e-19	65.5	0.0	1380	1485	423	526	415	533	0.89	Tyrosine-protein kinase Fyn (DB01254; DB02078; DB12010)
drugbank_target|P12931	-	536	sp|Q8IIT5|PTKL_PLA	-	1501	4.9e-44	148.4	0.0	1	3	7e-14	1e-12	44.6	0.0	851	926	284	359	277	366	0.83	Proto-oncogene tyrosine-protein kinase Src (DB01254; DB01678; DB01866; DB01893; DB01908; DB01947; DB01962; DB02175; DB02336; DB02432; DB02762; DB02908; DB03023; DB03078; DB03104; DB03114; DB03217; DB03268; DB03298; DB03306; DB03525; DB03591; DB03628; DB03712; DB03828; DB03902; DB04080; DB04272; DB04495; DB04739; DB04751; DB05184; DB06137; DB06616; DB06882; DB06883; DB07335; DB07662; DB07966; DB08052; DB08053; DB08054; DB08192; DB08462; DB08564; DB08901; DB09079; DB12010)
drugbank_target|P12931	-	536	sp|Q8IIT5|PTKL_PLA	-	1501	4.9e-44	148.4	0.0	2	3	5.9e-12	8.6e-11	38.2	0.0	1260	1316	359	415	355	422	0.91	Proto-oncogene tyrosine-protein kinase Src (DB01254; DB01678; DB01866; DB01893; DB01908; DB01947; DB01962; DB02175; DB02336; DB02432; DB02762; DB02908; DB03023; DB03078; DB03104; DB03114; DB03217; DB03268; DB03298; DB03306; DB03525; DB03591; DB03628; DB03712; DB03828; DB03902; DB04080; DB04272; DB04495; DB04739; DB04751; DB05184; DB06137; DB06616; DB06882; DB06883; DB07335; DB07662; DB07966; DB08052; DB08053; DB08054; DB08192; DB08462; DB08564; DB08901; DB09079; DB12010)
drugbank_target|P12931	-	536	sp|Q8IIT5|PTKL_PLA	-	1501	4.9e-44	148.4	0.0	3	3	1.1e-19	1.6e-18	63.8	0.0	1379	1486	421	526	412	532	0.89	Proto-oncogene tyrosine-protein kinase Src (DB01254; DB01678; DB01866; DB01893; DB01908; DB01947; DB01962; DB02175; DB02336; DB02432; DB02762; DB02908; DB03023; DB03078; DB03104; DB03114; DB03217; DB03268; DB03298; DB03306; DB03525; DB03591; DB03628; DB03712; DB03828; DB03902; DB04080; DB04272; DB04495; DB04739; DB04751; DB05184; DB06137; DB06616; DB06882; DB06883; DB07335; DB07662; DB07966; DB08052; DB08053; DB08054; DB08192; DB08462; DB08564; DB08901; DB09079; DB12010)
drugbank_target|P42679	-	507	sp|Q8IIT5|PTKL_PLA	-	1501	5.8e-44	148.1	0.1	1	3	3.1e-13	4.6e-12	42.4	0.4	851	935	249	331	243	332	0.92	Megakaryocyte-associated tyrosine-protein kinase (DB12010)
drugbank_target|P42679	-	507	sp|Q8IIT5|PTKL_PLA	-	1501	5.8e-44	148.1	0.1	2	3	5.1e-13	7.5e-12	41.7	0.0	1262	1316	324	378	319	385	0.91	Megakaryocyte-associated tyrosine-protein kinase (DB12010)
drugbank_target|P42679	-	507	sp|Q8IIT5|PTKL_PLA	-	1501	5.8e-44	148.1	0.1	3	3	2.8e-19	4.1e-18	62.5	0.0	1389	1483	388	482	381	491	0.93	Megakaryocyte-associated tyrosine-protein kinase (DB12010)
drugbank_target|P51813	-	675	sp|Q8IIT5|PTKL_PLA	-	1501	9.5e-44	147.4	12.9	1	3	6.7e-16	9.8e-15	51.3	0.0	853	922	433	503	412	507	0.87	Cytoplasmic tyrosine-protein kinase BMX (DB12010; DB15035)
drugbank_target|P51813	-	675	sp|Q8IIT5|PTKL_PLA	-	1501	9.5e-44	147.4	12.9	2	3	6.1e-12	9e-11	38.1	0.0	1260	1314	506	560	502	566	0.92	Cytoplasmic tyrosine-protein kinase BMX (DB12010; DB15035)
drugbank_target|P51813	-	675	sp|Q8IIT5|PTKL_PLA	-	1501	9.5e-44	147.4	12.9	3	3	9.2e-21	1.3e-19	67.4	0.0	1370	1487	560	674	557	675	0.90	Cytoplasmic tyrosine-protein kinase BMX (DB12010; DB15035)
drugbank_target|P63185	-	526	sp|Q8IIT5|PTKL_PLA	-	1501	1.8e-43	146.5	0.0	1	3	1.5e-13	2.1e-12	43.5	0.0	851	923	281	353	274	360	0.83	Tyrosine-protein kinase transforming protein Src (DB01773)
drugbank_target|P63185	-	526	sp|Q8IIT5|PTKL_PLA	-	1501	1.8e-43	146.5	0.0	2	3	6.9e-12	1e-10	38.0	0.0	1261	1315	357	411	352	418	0.91	Tyrosine-protein kinase transforming protein Src (DB01773)
drugbank_target|P63185	-	526	sp|Q8IIT5|PTKL_PLA	-	1501	1.8e-43	146.5	0.0	3	3	2.7e-19	3.9e-18	62.5	0.0	1380	1479	419	516	411	521	0.90	Tyrosine-protein kinase transforming protein Src (DB01773)
drugbank_target|P35590	-	1138	sp|Q8IIT5|PTKL_PLA	-	1501	2.6e-43	145.9	0.0	1	3	1.5e-11	2.2e-10	36.8	0.0	838	924	844	933	837	938	0.88	Tyrosine-protein kinase receptor Tie-1 (DB12010)
drugbank_target|P35590	-	1138	sp|Q8IIT5|PTKL_PLA	-	1501	2.6e-43	145.9	0.0	2	3	3.5e-12	5.1e-11	38.9	0.0	1258	1317	947	1006	935	1012	0.91	Tyrosine-protein kinase receptor Tie-1 (DB12010)
drugbank_target|P35590	-	1138	sp|Q8IIT5|PTKL_PLA	-	1501	2.6e-43	145.9	0.0	3	3	1e-20	1.5e-19	67.2	0.0	1385	1494	1015	1122	1004	1127	0.91	Tyrosine-protein kinase receptor Tie-1 (DB12010)
drugbank_target|P00524	-	526	sp|Q8IIT5|PTKL_PLA	-	1501	3e-43	145.7	0.0	1	3	9.5e-14	1.4e-12	44.1	0.0	851	923	281	353	274	360	0.83	Tyrosine-protein kinase transforming protein Src (DB08434)
drugbank_target|P00524	-	526	sp|Q8IIT5|PTKL_PLA	-	1501	3e-43	145.7	0.0	2	3	6.9e-12	1e-10	38.0	0.0	1261	1315	357	411	352	418	0.91	Tyrosine-protein kinase transforming protein Src (DB08434)
drugbank_target|P00524	-	526	sp|Q8IIT5|PTKL_PLA	-	1501	3e-43	145.7	0.0	3	3	6.8e-19	1e-17	61.2	0.0	1380	1479	419	516	411	521	0.90	Tyrosine-protein kinase transforming protein Src (DB08434)
drugbank_target|P16234	-	1089	sp|Q8IIT5|PTKL_PLA	-	1501	4.1e-43	145.3	0.1	1	3	3.1e-13	4.5e-12	42.4	0.0	841	925	604	691	597	699	0.83	Platelet-derived growth factor receptor alpha (DB00102; DB00619; DB01268; DB05146; DB06043; DB06589; DB06595; DB08896; DB08901; DB09078; DB09079; DB10772; DB12010; DB12147; DB12742; DB14840)
drugbank_target|P16234	-	1089	sp|Q8IIT5|PTKL_PLA	-	1501	4.1e-43	145.3	0.1	2	3	1e-12	1.5e-11	40.7	0.1	1221	1313	748	841	720	850	0.73	Platelet-derived growth factor receptor alpha (DB00102; DB00619; DB01268; DB05146; DB06043; DB06589; DB06595; DB08896; DB08901; DB09078; DB09079; DB10772; DB12010; DB12147; DB12742; DB14840)
drugbank_target|P16234	-	1089	sp|Q8IIT5|PTKL_PLA	-	1501	4.1e-43	145.3	0.1	3	3	4.1e-18	6e-17	58.6	0.0	1384	1490	854	961	842	972	0.85	Platelet-derived growth factor receptor alpha (DB00102; DB00619; DB01268; DB05146; DB06043; DB06589; DB06595; DB08896; DB08901; DB09078; DB09079; DB10772; DB12010; DB12147; DB12742; DB14840)
drugbank_target|Q13882	-	451	sp|Q8IIT5|PTKL_PLA	-	1501	5.2e-43	145.0	0.0	1	3	8.2e-13	1.2e-11	41.0	0.2	851	934	205	290	199	291	0.90	Protein-tyrosine kinase 6 (DB05294; DB12010; DB15035)
drugbank_target|Q13882	-	451	sp|Q8IIT5|PTKL_PLA	-	1501	5.2e-43	145.0	0.0	2	3	1.7e-12	2.4e-11	40.0	0.0	1258	1315	280	337	277	350	0.91	Protein-tyrosine kinase 6 (DB05294; DB12010; DB15035)
drugbank_target|Q13882	-	451	sp|Q8IIT5|PTKL_PLA	-	1501	5.2e-43	145.0	0.0	3	3	5.9e-20	8.6e-19	64.7	0.0	1388	1486	350	448	337	451	0.91	Protein-tyrosine kinase 6 (DB05294; DB12010; DB15035)
drugbank_target|Q9NYL2	-	800	sp|Q8IIT5|PTKL_PLA	-	1501	1.1e-42	143.8	0.2	1	4	1.3e-08	1.9e-07	27.1	0.1	858	928	39	102	26	105	0.83	Mitogen-activated protein kinase kinase kinase MLT (DB01254; DB12010)
drugbank_target|Q9NYL2	-	800	sp|Q8IIT5|PTKL_PLA	-	1501	1.1e-42	143.8	0.2	2	4	1.7e-12	2.5e-11	40.0	0.0	1258	1318	98	161	95	164	0.90	Mitogen-activated protein kinase kinase kinase MLT (DB01254; DB12010)
drugbank_target|Q9NYL2	-	800	sp|Q8IIT5|PTKL_PLA	-	1501	1.1e-42	143.8	0.2	3	4	1.1e-22	1.6e-21	73.8	0.0	1378	1498	159	277	157	280	0.89	Mitogen-activated protein kinase kinase kinase MLT (DB01254; DB12010)
drugbank_target|Q9NYL2	-	800	sp|Q8IIT5|PTKL_PLA	-	1501	1.1e-42	143.8	0.2	4	4	0.89	13	1.1	0.0	323	363	368	407	346	419	0.86	Mitogen-activated protein kinase kinase kinase MLT (DB01254; DB12010)
drugbank_target|Q16288	-	839	sp|Q8IIT5|PTKL_PLA	-	1501	1.3e-42	143.7	1.3	1	3	9.3e-13	1.4e-11	40.8	0.0	855	923	563	632	546	640	0.85	NT-3 growth factor receptor (DB11986; DB12010; DB14723)
drugbank_target|Q16288	-	839	sp|Q8IIT5|PTKL_PLA	-	1501	1.3e-42	143.7	1.3	2	3	3.8e-11	5.6e-10	35.5	0.0	1256	1315	645	704	635	714	0.90	NT-3 growth factor receptor (DB11986; DB12010; DB14723)
drugbank_target|Q16288	-	839	sp|Q8IIT5|PTKL_PLA	-	1501	1.3e-42	143.7	1.3	3	3	8.6e-20	1.3e-18	64.2	0.0	1388	1483	733	828	722	834	0.93	NT-3 growth factor receptor (DB11986; DB12010; DB14723)
drugbank_target|P22455	-	802	sp|Q8IIT5|PTKL_PLA	-	1501	1.3e-42	143.6	0.0	1	3	3.1e-10	4.6e-09	32.5	0.0	858	923	497	565	479	568	0.88	Fibroblast growth factor receptor 4 (DB00039; DB01109; DB08901; DB09078; DB12147; DB15102)
drugbank_target|P22455	-	802	sp|Q8IIT5|PTKL_PLA	-	1501	1.3e-42	143.6	0.0	2	3	1.9e-12	2.8e-11	39.8	0.0	1261	1315	583	637	577	641	0.90	Fibroblast growth factor receptor 4 (DB00039; DB01109; DB08901; DB09078; DB12147; DB15102)
drugbank_target|P22455	-	802	sp|Q8IIT5|PTKL_PLA	-	1501	1.3e-42	143.6	0.0	3	3	6.2e-21	9.1e-20	67.9	0.0	1374	1484	640	748	636	761	0.93	Fibroblast growth factor receptor 4 (DB00039; DB01109; DB08901; DB09078; DB12147; DB15102)
drugbank_target|P51451	-	505	sp|Q8IIT5|PTKL_PLA	-	1501	2.7e-42	142.6	0.0	1	3	3.4e-13	4.9e-12	42.3	0.1	851	922	255	326	243	330	0.82	Tyrosine-protein kinase Blk (DB12010; DB15035)
drugbank_target|P51451	-	505	sp|Q8IIT5|PTKL_PLA	-	1501	2.7e-42	142.6	0.0	2	3	7.7e-13	1.1e-11	41.1	0.0	1257	1317	327	387	325	393	0.93	Tyrosine-protein kinase Blk (DB12010; DB15035)
drugbank_target|P51451	-	505	sp|Q8IIT5|PTKL_PLA	-	1501	2.7e-42	142.6	0.0	3	3	1.1e-17	1.7e-16	57.1	0.0	1383	1490	395	501	385	504	0.89	Tyrosine-protein kinase Blk (DB12010; DB15035)
drugbank_target|P17948	-	1338	sp|Q8IIT5|PTKL_PLA	-	1501	3.3e-42	142.3	0.0	1	3	3.3e-13	4.9e-12	42.3	0.0	840	924	837	925	831	935	0.90	Vascular endothelial growth factor receptor 1 (DB00398; DB01268; DB04879; DB05075; DB05913; DB05932; DB06080; DB06101; DB06589; DB06626; DB07288; DB08896; DB09078; DB09079; DB09221; DB10770; DB12010; DB15685)
drugbank_target|P17948	-	1338	sp|Q8IIT5|PTKL_PLA	-	1501	3.3e-42	142.3	0.0	2	3	3.6e-12	5.3e-11	38.9	0.0	1260	1313	992	1045	978	1056	0.91	Vascular endothelial growth factor receptor 1 (DB00398; DB01268; DB04879; DB05075; DB05913; DB05932; DB06080; DB06101; DB06589; DB06626; DB07288; DB08896; DB09078; DB09079; DB09221; DB10770; DB12010; DB15685)
drugbank_target|P17948	-	1338	sp|Q8IIT5|PTKL_PLA	-	1501	3.3e-42	142.3	0.0	3	3	8.8e-18	1.3e-16	57.5	0.0	1385	1488	1061	1163	1046	1172	0.88	Vascular endothelial growth factor receptor 1 (DB00398; DB01268; DB04879; DB05075; DB05913; DB05932; DB06080; DB06101; DB06589; DB06626; DB07288; DB08896; DB09078; DB09079; DB09221; DB10770; DB12010; DB15685)
drugbank_target|P09619	-	1106	sp|Q8IIT5|PTKL_PLA	-	1501	8.8e-42	140.9	0.0	1	3	6.3e-15	9.2e-14	48.0	0.0	841	927	611	700	606	708	0.88	Platelet-derived growth factor receptor beta (DB00102; DB00398; DB00619; DB01254; DB01268; DB05014; DB05146; DB06589; DB06595; DB08896; DB09079; DB09221; DB09283; DB10770; DB12010; DB12147; DB12978; DB14840)
drugbank_target|P09619	-	1106	sp|Q8IIT5|PTKL_PLA	-	1501	8.8e-42	140.9	0.0	2	3	5.7e-11	8.3e-10	34.9	0.0	1257	1313	793	849	784	859	0.89	Platelet-derived growth factor receptor beta (DB00102; DB00398; DB00619; DB01254; DB01268; DB05014; DB05146; DB06589; DB06595; DB08896; DB09079; DB09221; DB09283; DB10770; DB12010; DB12147; DB12978; DB14840)
drugbank_target|P09619	-	1106	sp|Q8IIT5|PTKL_PLA	-	1501	8.8e-42	140.9	0.0	3	3	7.8e-17	1.1e-15	54.4	0.0	1385	1486	863	965	851	979	0.85	Platelet-derived growth factor receptor beta (DB00102; DB00398; DB00619; DB01254; DB01268; DB05014; DB05146; DB06589; DB06595; DB08896; DB09079; DB09221; DB09283; DB10770; DB12010; DB12147; DB12978; DB14840)
drugbank_target|P29322	-	1005	sp|Q8IIT5|PTKL_PLA	-	1501	1.1e-41	140.6	0.0	1	3	1.3e-12	2e-11	40.3	0.0	858	925	661	730	625	737	0.76	Ephrin type-A receptor 8 (DB12010)
drugbank_target|P29322	-	1005	sp|Q8IIT5|PTKL_PLA	-	1501	1.1e-41	140.6	0.0	2	3	8.4e-10	1.2e-08	31.1	0.0	1259	1315	729	785	725	794	0.90	Ephrin type-A receptor 8 (DB12010)
drugbank_target|P29322	-	1005	sp|Q8IIT5|PTKL_PLA	-	1501	1.1e-41	140.6	0.0	3	3	9.3e-21	1.4e-19	67.4	0.0	1386	1491	801	904	785	911	0.90	Ephrin type-A receptor 8 (DB12010)
drugbank_target|P07333	-	972	sp|Q8IIT5|PTKL_PLA	-	1501	1.1e-41	140.5	0.0	1	3	3.6e-13	5.2e-12	42.2	0.0	841	923	593	678	580	684	0.85	Macrophage colony-stimulating factor 1 receptor (DB00619; DB01268; DB06080; DB07167; DB07202; DB12010; DB12147; DB12978)
drugbank_target|P07333	-	972	sp|Q8IIT5|PTKL_PLA	-	1501	1.1e-41	140.5	0.0	2	3	3.2e-11	4.7e-10	35.7	0.0	1250	1314	737	802	728	811	0.85	Macrophage colony-stimulating factor 1 receptor (DB00619; DB01268; DB06080; DB07167; DB07202; DB12010; DB12147; DB12978)
drugbank_target|P07333	-	972	sp|Q8IIT5|PTKL_PLA	-	1501	1.1e-41	140.5	0.0	3	3	2.4e-18	3.4e-17	59.4	0.0	1376	1488	808	919	801	928	0.88	Macrophage colony-stimulating factor 1 receptor (DB00619; DB01268; DB06080; DB07167; DB07202; DB12010; DB12147; DB12978)
drugbank_target|P43403	-	619	sp|Q8IIT5|PTKL_PLA	-	1501	1.3e-41	140.3	0.4	1	3	7.2e-10	1.1e-08	31.3	0.1	841	922	346	428	339	433	0.86	Tyrosine-protein kinase ZAP-70 (DB02010; DB12010)
drugbank_target|P43403	-	619	sp|Q8IIT5|PTKL_PLA	-	1501	1.3e-41	140.3	0.4	2	3	9.4e-13	1.4e-11	40.8	0.0	1259	1317	430	488	426	494	0.91	Tyrosine-protein kinase ZAP-70 (DB02010; DB12010)
drugbank_target|P43403	-	619	sp|Q8IIT5|PTKL_PLA	-	1501	1.3e-41	140.3	0.4	3	3	2.1e-20	3e-19	66.2	0.0	1375	1491	491	605	487	608	0.93	Tyrosine-protein kinase ZAP-70 (DB02010; DB12010)
drugbank_target|O15146	-	869	sp|Q8IIT5|PTKL_PLA	-	1501	1.9e-41	139.8	7.2	1	3	3.2e-11	4.7e-10	35.7	0.0	860	927	605	674	586	681	0.89	Muscle, skeletal receptor tyrosine-protein kinase (DB12010)
drugbank_target|O15146	-	869	sp|Q8IIT5|PTKL_PLA	-	1501	1.9e-41	139.8	7.2	2	3	2.1e-11	3.1e-10	36.3	0.0	1259	1314	694	749	673	754	0.84	Muscle, skeletal receptor tyrosine-protein kinase (DB12010)
drugbank_target|O15146	-	869	sp|Q8IIT5|PTKL_PLA	-	1501	1.9e-41	139.8	7.2	3	3	6.2e-22	9.1e-21	71.3	0.0	1372	1489	751	866	748	868	0.95	Muscle, skeletal receptor tyrosine-protein kinase (DB12010)
drugbank_target|P43405	-	635	sp|Q8IIT5|PTKL_PLA	-	1501	3.5e-41	138.9	1.6	1	3	2.3e-10	3.4e-09	32.9	0.3	841	924	379	464	372	468	0.88	Tyrosine-protein kinase SYK (DB02010; DB06834; DB07159; DB07194; DB08361; DB08846; DB12010)
drugbank_target|P43405	-	635	sp|Q8IIT5|PTKL_PLA	-	1501	3.5e-41	138.9	1.6	2	3	7.7e-13	1.1e-11	41.1	0.2	1258	1315	462	519	461	524	0.94	Tyrosine-protein kinase SYK (DB02010; DB06834; DB07159; DB07194; DB08361; DB08846; DB12010)
drugbank_target|P43405	-	635	sp|Q8IIT5|PTKL_PLA	-	1501	3.5e-41	138.9	1.6	3	3	3.1e-20	4.5e-19	65.6	0.0	1372	1483	521	630	518	633	0.95	Tyrosine-protein kinase SYK (DB02010; DB06834; DB07159; DB07194; DB08361; DB08846; DB12010)
drugbank_target|P04629	-	796	sp|Q8IIT5|PTKL_PLA	-	1501	4e-41	138.7	0.0	1	3	1.4e-12	2.1e-11	40.2	0.0	852	923	532	604	518	611	0.84	High affinity nerve growth factor receptor (DB00321; DB00619; DB08896; DB11986; DB12010; DB13926; DB14723)
drugbank_target|P04629	-	796	sp|Q8IIT5|PTKL_PLA	-	1501	4e-41	138.7	0.0	2	3	3.6e-08	5.2e-07	25.7	0.0	1265	1313	625	673	618	676	0.93	High affinity nerve growth factor receptor (DB00321; DB00619; DB08896; DB11986; DB12010; DB13926; DB14723)
drugbank_target|P04629	-	796	sp|Q8IIT5|PTKL_PLA	-	1501	4e-41	138.7	0.0	3	3	2.2e-21	3.2e-20	69.4	0.0	1372	1485	676	787	673	792	0.95	High affinity nerve growth factor receptor (DB00321; DB00619; DB08896; DB11986; DB12010; DB13926; DB14723)
drugbank_target|P09769	-	529	sp|Q8IIT5|PTKL_PLA	-	1501	7.2e-41	137.9	0.0	1	3	1e-11	1.5e-10	37.4	0.0	853	923	279	349	273	357	0.82	Tyrosine-protein kinase Fgr (DB01254; DB12010; DB15035)
drugbank_target|P09769	-	529	sp|Q8IIT5|PTKL_PLA	-	1501	7.2e-41	137.9	0.0	2	3	1.1e-12	1.6e-11	40.6	0.0	1259	1315	351	407	348	413	0.92	Tyrosine-protein kinase Fgr (DB01254; DB12010; DB15035)
drugbank_target|P09769	-	529	sp|Q8IIT5|PTKL_PLA	-	1501	7.2e-41	137.9	0.0	3	3	9.9e-18	1.4e-16	57.3	0.0	1384	1487	419	520	407	525	0.91	Tyrosine-protein kinase Fgr (DB01254; DB12010; DB15035)
drugbank_target|P35968	-	1356	sp|Q8IIT5|PTKL_PLA	-	1501	1e-40	137.4	0.0	1	3	5.4e-12	7.9e-11	38.3	0.0	841	937	845	945	842	950	0.85	Vascular endothelial growth factor receptor 2 (DB00398; DB01268; DB04727; DB04849; DB04879; DB05014; DB05075; DB05146; DB05198; DB05578; DB05931; DB05984; DB06080; DB06101; DB06436; DB06589; DB06595; DB06626; DB06938; DB07183; DB07274; DB07326; DB07333; DB07334; DB07514; DB07528; DB07537; DB08042; DB08519; DB08875; DB08896; DB08901; DB09078; DB09079; DB12010; DB12147; DB12307; DB14840)
drugbank_target|P35968	-	1356	sp|Q8IIT5|PTKL_PLA	-	1501	1e-40	137.4	0.0	2	3	5e-12	7.4e-11	38.4	0.0	1260	1313	998	1051	984	1062	0.91	Vascular endothelial growth factor receptor 2 (DB00398; DB01268; DB04727; DB04849; DB04879; DB05014; DB05075; DB05146; DB05198; DB05578; DB05931; DB05984; DB06080; DB06101; DB06436; DB06589; DB06595; DB06626; DB06938; DB07183; DB07274; DB07326; DB07333; DB07334; DB07514; DB07528; DB07537; DB08042; DB08519; DB08875; DB08896; DB08901; DB09078; DB09079; DB12010; DB12147; DB12307; DB14840)
drugbank_target|P35968	-	1356	sp|Q8IIT5|PTKL_PLA	-	1501	1e-40	137.4	0.0	3	3	1.4e-17	2e-16	56.8	0.0	1388	1489	1068	1170	1052	1179	0.88	Vascular endothelial growth factor receptor 2 (DB00398; DB01268; DB04727; DB04849; DB04879; DB05014; DB05075; DB05146; DB05198; DB05578; DB05931; DB05984; DB06080; DB06101; DB06436; DB06589; DB06595; DB06626; DB06938; DB07183; DB07274; DB07326; DB07333; DB07334; DB07514; DB07528; DB07537; DB08042; DB08519; DB08875; DB08896; DB08901; DB09078; DB09079; DB12010; DB12147; DB12307; DB14840)
drugbank_target|P07947	-	543	sp|Q8IIT5|PTKL_PLA	-	1501	1.1e-40	137.2	13.1	1	3	1.1e-12	1.5e-11	40.7	0.0	851	927	291	367	284	373	0.83	Tyrosine-protein kinase Yes (DB01254; DB12010)
drugbank_target|P07947	-	543	sp|Q8IIT5|PTKL_PLA	-	1501	1.1e-40	137.2	13.1	2	3	1.5e-12	2.1e-11	40.2	0.0	1260	1316	366	422	362	431	0.91	Tyrosine-protein kinase Yes (DB01254; DB12010)
drugbank_target|P07947	-	543	sp|Q8IIT5|PTKL_PLA	-	1501	1.1e-40	137.2	13.1	3	3	2.3e-19	3.4e-18	62.7	0.0	1380	1486	429	533	420	539	0.89	Tyrosine-protein kinase Yes (DB01254; DB12010)
drugbank_target|P07332	-	822	sp|Q8IIT5|PTKL_PLA	-	1501	1.3e-40	137.0	0.0	1	3	3.9e-11	5.7e-10	35.5	0.0	856	935	582	662	565	662	0.79	Tyrosine-protein kinase Fes/Fps (DB12010)
drugbank_target|P07332	-	822	sp|Q8IIT5|PTKL_PLA	-	1501	1.3e-40	137.0	0.0	2	3	7.7e-12	1.1e-10	37.8	0.0	1259	1315	652	708	649	715	0.94	Tyrosine-protein kinase Fes/Fps (DB12010)
drugbank_target|P07332	-	822	sp|Q8IIT5|PTKL_PLA	-	1501	1.3e-40	137.0	0.0	3	3	2e-19	2.9e-18	62.9	0.0	1388	1485	723	820	709	822	0.94	Tyrosine-protein kinase Fes/Fps (DB12010)
drugbank_target|P16591	-	822	sp|Q8IIT5|PTKL_PLA	-	1501	2.5e-40	136.1	0.6	1	3	3.1e-13	4.6e-12	42.4	0.0	850	925	576	654	566	656	0.83	Tyrosine-protein kinase Fer (DB12010)
drugbank_target|P16591	-	822	sp|Q8IIT5|PTKL_PLA	-	1501	2.5e-40	136.1	0.6	2	3	1.4e-12	2.1e-11	40.2	0.0	1257	1316	651	710	649	717	0.95	Tyrosine-protein kinase Fer (DB12010)
drugbank_target|P16591	-	822	sp|Q8IIT5|PTKL_PLA	-	1501	2.5e-40	136.1	0.6	3	3	8.1e-21	1.2e-19	67.6	0.0	1388	1485	723	820	710	822	0.93	Tyrosine-protein kinase Fer (DB12010)
drugbank_target|O43283	-	966	sp|Q8IIT5|PTKL_PLA	-	1501	3.6e-40	135.5	7.6	1	3	4e-11	5.9e-10	35.4	0.0	850	923	181	248	174	254	0.88	Mitogen-activated protein kinase kinase kinase 13 (DB12010)
drugbank_target|O43283	-	966	sp|Q8IIT5|PTKL_PLA	-	1501	3.6e-40	135.5	7.6	2	3	6e-11	8.7e-10	34.9	0.0	1263	1314	252	303	247	306	0.90	Mitogen-activated protein kinase kinase kinase 13 (DB12010)
drugbank_target|O43283	-	966	sp|Q8IIT5|PTKL_PLA	-	1501	3.6e-40	135.5	7.6	3	3	3.5e-21	5e-20	68.8	0.0	1377	1480	305	408	302	421	0.91	Mitogen-activated protein kinase kinase kinase 13 (DB12010)
drugbank_target|Q9H3Y6	-	488	sp|Q8IIT5|PTKL_PLA	-	1501	3.9e-40	135.5	0.0	1	3	4.1e-11	6e-10	35.4	0.0	852	922	245	316	238	328	0.89	Tyrosine-protein kinase Srms (DB12010)
drugbank_target|Q9H3Y6	-	488	sp|Q8IIT5|PTKL_PLA	-	1501	3.9e-40	135.5	0.0	2	3	2.5e-11	3.6e-10	36.1	0.0	1264	1314	324	374	317	381	0.89	Tyrosine-protein kinase Srms (DB12010)
drugbank_target|Q9H3Y6	-	488	sp|Q8IIT5|PTKL_PLA	-	1501	3.9e-40	135.5	0.0	3	3	8.2e-19	1.2e-17	60.9	0.0	1383	1483	386	484	376	487	0.92	Tyrosine-protein kinase Srms (DB12010)
drugbank_target|Q9UF33	-	1036	sp|Q8IIT5|PTKL_PLA	-	1501	4.1e-40	135.4	0.0	1	4	3.7e-07	5.3e-06	22.3	0.0	824	909	621	710	611	729	0.78	Ephrin type-A receptor 6 (DB12010)
drugbank_target|Q9UF33	-	1036	sp|Q8IIT5|PTKL_PLA	-	1501	4.1e-40	135.4	0.0	2	4	0.015	0.23	7.0	0.0	902	927	745	770	741	776	0.84	Ephrin type-A receptor 6 (DB12010)
drugbank_target|Q9UF33	-	1036	sp|Q8IIT5|PTKL_PLA	-	1501	4.1e-40	135.4	0.0	3	4	4.9e-11	7.1e-10	35.2	0.0	1260	1315	768	823	764	832	0.91	Ephrin type-A receptor 6 (DB12010)
drugbank_target|Q9UF33	-	1036	sp|Q8IIT5|PTKL_PLA	-	1501	4.1e-40	135.4	0.0	4	4	9.6e-21	1.4e-19	67.3	0.0	1385	1487	838	938	822	951	0.88	Ephrin type-A receptor 6 (DB12010)
drugbank_target|Q12852	-	859	sp|Q8IIT5|PTKL_PLA	-	1501	6.5e-40	134.7	0.0	1	3	2.9e-09	4.2e-08	29.3	0.0	850	922	138	204	131	210	0.87	Mitogen-activated protein kinase kinase kinase 12 (DB12010)
drugbank_target|Q12852	-	859	sp|Q8IIT5|PTKL_PLA	-	1501	6.5e-40	134.7	0.0	2	3	2.8e-09	4.1e-08	29.3	0.0	1268	1314	214	260	206	263	0.91	Mitogen-activated protein kinase kinase kinase 12 (DB12010)
drugbank_target|Q12852	-	859	sp|Q8IIT5|PTKL_PLA	-	1501	6.5e-40	134.7	0.0	3	3	1.5e-22	2.3e-21	73.3	0.0	1375	1480	260	365	257	378	0.91	Mitogen-activated protein kinase kinase kinase 12 (DB12010)
drugbank_target|P08069	-	1367	sp|Q8IIT5|PTKL_PLA	-	1501	7.7e-40	134.5	0.1	1	3	4.8e-11	7e-10	35.2	0.0	843	924	1009	1095	1002	1103	0.78	Insulin-like growth factor 1 receptor (DB00030; DB00046; DB00047; DB00071; DB01277; DB01306; DB01307; DB01309; DB04395; DB05023; DB05184; DB05897; DB06075; DB06343; DB07156; DB07474; DB09098; DB09564; DB12250; DB12267; DB14751)
drugbank_target|P08069	-	1367	sp|Q8IIT5|PTKL_PLA	-	1501	7.7e-40	134.5	0.1	2	3	1.1e-09	1.6e-08	30.7	0.0	1264	1313	1109	1158	1098	1163	0.93	Insulin-like growth factor 1 receptor (DB00030; DB00046; DB00047; DB00071; DB01277; DB01306; DB01307; DB01309; DB04395; DB05023; DB05184; DB05897; DB06075; DB06343; DB07156; DB07474; DB09098; DB09564; DB12250; DB12267; DB14751)
drugbank_target|P08069	-	1367	sp|Q8IIT5|PTKL_PLA	-	1501	7.7e-40	134.5	0.1	3	3	6.1e-20	8.9e-19	64.7	0.0	1372	1481	1161	1268	1157	1277	0.94	Insulin-like growth factor 1 receptor (DB00030; DB00046; DB00047; DB00071; DB01277; DB01306; DB01307; DB01309; DB04395; DB05023; DB05184; DB05897; DB06075; DB06343; DB07156; DB07474; DB09098; DB09564; DB12250; DB12267; DB14751)
drugbank_target|Q14289	-	1009	sp|Q8IIT5|PTKL_PLA	-	1501	8.5e-40	134.3	0.1	1	3	1.8e-11	2.6e-10	36.6	0.1	841	927	433	521	426	529	0.81	Protein-tyrosine kinase 2-beta (DB01097; DB01645; DB08341; DB11817; DB12010)
drugbank_target|Q14289	-	1009	sp|Q8IIT5|PTKL_PLA	-	1501	8.5e-40	134.3	0.1	2	3	1.3e-10	1.9e-09	33.7	0.1	1256	1316	515	575	513	582	0.93	Protein-tyrosine kinase 2-beta (DB01097; DB01645; DB08341; DB11817; DB12010)
drugbank_target|Q14289	-	1009	sp|Q8IIT5|PTKL_PLA	-	1501	8.5e-40	134.3	0.1	3	3	2.1e-20	3.1e-19	66.2	0.0	1369	1488	572	688	570	696	0.91	Protein-tyrosine kinase 2-beta (DB01097; DB01645; DB08341; DB11817; DB12010)
drugbank_target|P27448	-	753	sp|Q8IIT5|PTKL_PLA	-	1501	1.3e-39	133.7	10.3	1	3	1e-15	1.5e-14	50.6	0.2	839	921	60	145	52	148	0.90	MAP/microtubule affinity-regulating kinase 3 (DB12010)
drugbank_target|P27448	-	753	sp|Q8IIT5|PTKL_PLA	-	1501	1.3e-39	133.7	10.3	2	3	6.1e-14	8.8e-13	44.8	0.1	1259	1313	147	201	145	207	0.95	MAP/microtubule affinity-regulating kinase 3 (DB12010)
drugbank_target|P27448	-	753	sp|Q8IIT5|PTKL_PLA	-	1501	1.3e-39	133.7	10.3	3	3	2.5e-13	3.6e-12	42.7	0.0	1384	1478	211	304	206	319	0.93	MAP/microtubule affinity-regulating kinase 3 (DB12010)
drugbank_target|P06213	-	1382	sp|Q8IIT5|PTKL_PLA	-	1501	5.1e-39	131.7	0.0	1	3	8.1e-10	1.2e-08	31.1	0.0	851	924	1045	1119	1029	1125	0.78	Insulin receptor (DB00030; DB00046; DB00047; DB00071; DB01277; DB01306; DB01307; DB01309; DB03909; DB05115; DB05120; DB08513; DB09129; DB09564; DB12010; DB12267; DB14751)
drugbank_target|P06213	-	1382	sp|Q8IIT5|PTKL_PLA	-	1501	5.1e-39	131.7	0.0	2	3	5e-10	7.2e-09	31.8	0.1	1264	1313	1133	1182	1128	1191	0.93	Insulin receptor (DB00030; DB00046; DB00047; DB00071; DB01277; DB01306; DB01307; DB01309; DB03909; DB05115; DB05120; DB08513; DB09129; DB09564; DB12010; DB12267; DB14751)
drugbank_target|P06213	-	1382	sp|Q8IIT5|PTKL_PLA	-	1501	5.1e-39	131.7	0.0	3	3	3e-20	4.4e-19	65.7	0.0	1372	1480	1185	1291	1182	1297	0.94	Insulin receptor (DB00030; DB00046; DB00047; DB00071; DB01277; DB01306; DB01307; DB01309; DB03909; DB05115; DB05120; DB08513; DB09129; DB09564; DB12010; DB12267; DB14751)
drugbank_target|P35916	-	1363	sp|Q8IIT5|PTKL_PLA	-	1501	9.7e-39	130.8	0.0	1	3	4.4e-11	6.4e-10	35.3	0.0	840	924	855	943	849	950	0.86	Vascular endothelial growth factor receptor 3 (DB00398; DB01268; DB04879; DB05075; DB05932; DB06080; DB06101; DB06589; DB06626; DB08896; DB09078; DB09079; DB12010; DB15685)
drugbank_target|P35916	-	1363	sp|Q8IIT5|PTKL_PLA	-	1501	9.7e-39	130.8	0.0	2	3	1e-11	1.5e-10	37.4	0.0	1261	1313	1008	1060	995	1076	0.92	Vascular endothelial growth factor receptor 3 (DB00398; DB01268; DB04879; DB05075; DB05932; DB06080; DB06101; DB06589; DB06626; DB08896; DB09078; DB09079; DB12010; DB15685)
drugbank_target|P35916	-	1363	sp|Q8IIT5|PTKL_PLA	-	1501	9.7e-39	130.8	0.0	3	3	6.7e-17	9.8e-16	54.6	0.0	1384	1493	1073	1183	1061	1187	0.89	Vascular endothelial growth factor receptor 3 (DB00398; DB01268; DB04879; DB05075; DB05932; DB06080; DB06101; DB06589; DB06626; DB08896; DB09078; DB09079; DB12010; DB15685)
drugbank_target|P36888	-	993	sp|Q8IIT5|PTKL_PLA	-	1501	1e-38	130.8	0.0	1	3	7.2e-14	1.1e-12	44.5	0.0	841	928	621	711	613	725	0.83	Receptor-type tyrosine-protein kinase FLT3 (DB00398; DB01268; DB05014; DB05465; DB06080; DB06469; DB06595; DB08901; DB09079; DB12010; DB12141; DB12267; DB12500; DB12742; DB12874; DB12978)
drugbank_target|P36888	-	993	sp|Q8IIT5|PTKL_PLA	-	1501	1e-38	130.8	0.0	2	3	1e-11	1.5e-10	37.4	0.0	1253	1314	772	835	759	844	0.83	Receptor-type tyrosine-protein kinase FLT3 (DB00398; DB01268; DB05014; DB05465; DB06080; DB06469; DB06595; DB08901; DB09079; DB12010; DB12141; DB12267; DB12500; DB12742; DB12874; DB12978)
drugbank_target|P36888	-	993	sp|Q8IIT5|PTKL_PLA	-	1501	1e-38	130.8	0.0	3	3	3.7e-14	5.4e-13	45.5	0.0	1380	1483	845	947	834	961	0.84	Receptor-type tyrosine-protein kinase FLT3 (DB00398; DB01268; DB05014; DB05465; DB06080; DB06469; DB06595; DB08901; DB09079; DB12010; DB12141; DB12267; DB12500; DB12742; DB12874; DB12978)
drugbank_target|Q13131	-	559	sp|Q8IIT5|PTKL_PLA	-	1501	1.2e-38	130.4	4.8	1	3	1.1e-13	1.5e-12	44.0	0.1	842	921	36	117	30	121	0.86	5'-AMP-activated protein kinase catalytic subunit alpha-1 (DB00131; DB00171; DB00914; DB12010)
drugbank_target|Q13131	-	559	sp|Q8IIT5|PTKL_PLA	-	1501	1.2e-38	130.4	4.8	2	3	7.9e-15	1.2e-13	47.7	0.0	1259	1315	119	175	116	181	0.94	5'-AMP-activated protein kinase catalytic subunit alpha-1 (DB00131; DB00171; DB00914; DB12010)
drugbank_target|Q13131	-	559	sp|Q8IIT5|PTKL_PLA	-	1501	1.2e-38	130.4	4.8	3	3	4.5e-12	6.5e-11	38.6	0.0	1384	1477	183	275	175	282	0.92	5'-AMP-activated protein kinase catalytic subunit alpha-1 (DB00131; DB00171; DB00914; DB12010)
drugbank_target|Q13131	-	559	sp|Q8IIT5|PTKL_PLA	-	1501	1.2e-38	130.4	4.8	1	3	1.1e-13	1.5e-12	44.0	0.1	842	921	36	117	30	121	0.86	5'-AMP-activated protein kinase catalytic subunit alpha-1 (DB00131; DB00945; DB12010)
drugbank_target|Q13131	-	559	sp|Q8IIT5|PTKL_PLA	-	1501	1.2e-38	130.4	4.8	2	3	7.9e-15	1.2e-13	47.7	0.0	1259	1315	119	175	116	181	0.94	5'-AMP-activated protein kinase catalytic subunit alpha-1 (DB00131; DB00945; DB12010)
drugbank_target|Q13131	-	559	sp|Q8IIT5|PTKL_PLA	-	1501	1.2e-38	130.4	4.8	3	3	4.5e-12	6.5e-11	38.6	0.0	1384	1477	183	275	175	282	0.92	5'-AMP-activated protein kinase catalytic subunit alpha-1 (DB00131; DB00945; DB12010)
drugbank_target|Q9P289	-	416	sp|Q8IIT5|PTKL_PLA	-	1501	1.6e-38	130.1	0.0	1	3	3.2e-11	4.6e-10	35.8	0.0	855	935	44	126	25	127	0.87	Serine/threonine-protein kinase 26 (DB07853; DB12010)
drugbank_target|Q9P289	-	416	sp|Q8IIT5|PTKL_PLA	-	1501	1.6e-38	130.1	0.0	2	3	5.6e-12	8.2e-11	38.3	0.0	1265	1313	119	167	116	174	0.92	Serine/threonine-protein kinase 26 (DB07853; DB12010)
drugbank_target|Q9P289	-	416	sp|Q8IIT5|PTKL_PLA	-	1501	1.6e-38	130.1	0.0	3	3	5.4e-18	7.9e-17	58.2	0.0	1380	1495	174	288	167	292	0.93	Serine/threonine-protein kinase 26 (DB07853; DB12010)
drugbank_target|Q96L34	-	752	sp|Q8IIT5|PTKL_PLA	-	1501	2.4e-38	129.5	17.6	1	3	1.2e-15	1.8e-14	50.4	0.1	839	921	63	148	55	152	0.90	MAP/microtubule affinity-regulating kinase 4 (DB12010)
drugbank_target|Q96L34	-	752	sp|Q8IIT5|PTKL_PLA	-	1501	2.4e-38	129.5	17.6	2	3	7.9e-14	1.2e-12	44.4	0.1	1259	1313	150	204	148	214	0.94	MAP/microtubule affinity-regulating kinase 4 (DB12010)
drugbank_target|Q96L34	-	752	sp|Q8IIT5|PTKL_PLA	-	1501	2.4e-38	129.5	17.6	3	3	1e-13	1.5e-12	44.0	0.0	1383	1478	213	307	208	318	0.94	MAP/microtubule affinity-regulating kinase 4 (DB12010)
drugbank_target|Q9Y6E0	-	443	sp|Q8IIT5|PTKL_PLA	-	1501	4.6e-38	128.6	0.0	1	3	4.7e-10	6.9e-09	31.9	0.0	854	934	55	137	35	138	0.85	Serine/threonine-protein kinase 24 (DB12010)
drugbank_target|Q9Y6E0	-	443	sp|Q8IIT5|PTKL_PLA	-	1501	4.6e-38	128.6	0.0	2	3	6.5e-13	9.5e-12	41.4	0.0	1262	1313	128	179	124	186	0.93	Serine/threonine-protein kinase 24 (DB12010)
drugbank_target|Q9Y6E0	-	443	sp|Q8IIT5|PTKL_PLA	-	1501	4.6e-38	128.6	0.0	3	3	1.2e-17	1.8e-16	57.0	0.0	1380	1495	186	300	179	304	0.93	Serine/threonine-protein kinase 24 (DB12010)
drugbank_target|Q13546	-	671	sp|Q8IIT5|PTKL_PLA	-	1501	5.1e-38	128.4	3.6	1	3	1.2e-09	1.8e-08	30.5	0.8	868	923	52	107	26	116	0.86	Receptor-interacting serine/threonine-protein kinase 1 (DB12010)
drugbank_target|Q13546	-	671	sp|Q8IIT5|PTKL_PLA	-	1501	5.1e-38	128.4	3.6	2	3	2.7e-11	3.9e-10	36.0	0.1	1269	1315	117	163	106	170	0.90	Receptor-interacting serine/threonine-protein kinase 1 (DB12010)
drugbank_target|Q13546	-	671	sp|Q8IIT5|PTKL_PLA	-	1501	5.1e-38	128.4	3.6	3	3	4.5e-19	6.6e-18	61.8	0.0	1367	1496	169	303	162	306	0.80	Receptor-interacting serine/threonine-protein kinase 1 (DB12010)
drugbank_target|P30530	-	894	sp|Q8IIT5|PTKL_PLA	-	1501	9.6e-38	127.5	0.0	1	3	2.6e-06	3.9e-05	19.5	0.0	842	923	545	635	536	643	0.76	Tyrosine-protein kinase receptor UFO (DB12010; DB12141)
drugbank_target|P30530	-	894	sp|Q8IIT5|PTKL_PLA	-	1501	9.6e-38	127.5	0.0	2	3	3e-12	4.4e-11	39.2	0.0	1255	1314	637	696	633	699	0.93	Tyrosine-protein kinase receptor UFO (DB12010; DB12141)
drugbank_target|P30530	-	894	sp|Q8IIT5|PTKL_PLA	-	1501	9.6e-38	127.5	0.0	3	3	1.9e-20	2.8e-19	66.3	0.0	1372	1486	698	810	696	826	0.90	Tyrosine-protein kinase receptor UFO (DB12010; DB12141)
drugbank_target|Q9H0K1	-	926	sp|Q8IIT5|PTKL_PLA	-	1501	1.4e-37	127.0	0.2	1	3	8.7e-14	1.3e-12	44.3	2.2	841	921	26	109	21	111	0.87	Serine/threonine-protein kinase SIK2 (DB12010)
drugbank_target|Q9H0K1	-	926	sp|Q8IIT5|PTKL_PLA	-	1501	1.4e-37	127.0	0.2	2	3	5.2e-13	7.6e-12	41.7	0.0	1258	1314	110	166	109	174	0.94	Serine/threonine-protein kinase SIK2 (DB12010)
drugbank_target|Q9H0K1	-	926	sp|Q8IIT5|PTKL_PLA	-	1501	1.4e-37	127.0	0.2	3	3	2.6e-11	3.8e-10	36.0	0.0	1385	1479	176	269	169	278	0.91	Serine/threonine-protein kinase SIK2 (DB12010)
drugbank_target|P08922	-	2347	sp|Q8IIT5|PTKL_PLA	-	1501	3.2e-37	125.8	0.0	1	3	2.1e-11	3.1e-10	36.3	0.1	859	929	1975	2047	1954	2053	0.82	Proto-oncogene tyrosine-protein kinase ROS (DB11986; DB12010)
drugbank_target|P08922	-	2347	sp|Q8IIT5|PTKL_PLA	-	1501	3.2e-37	125.8	0.0	2	3	6.9e-07	1e-05	21.4	0.0	1263	1313	2052	2107	2047	2114	0.82	Proto-oncogene tyrosine-protein kinase ROS (DB11986; DB12010)
drugbank_target|P08922	-	2347	sp|Q8IIT5|PTKL_PLA	-	1501	3.2e-37	125.8	0.0	3	3	5.6e-20	8.2e-19	64.8	0.0	1373	1481	2111	2217	2108	2226	0.92	Proto-oncogene tyrosine-protein kinase ROS (DB11986; DB12010)
drugbank_target|Q7KZI7	-	788	sp|Q8IIT5|PTKL_PLA	-	1501	4.5e-37	125.3	0.2	1	3	7.2e-16	1e-14	51.2	0.6	838	921	56	142	45	145	0.90	Serine/threonine-protein kinase MARK2 (DB12010)
drugbank_target|Q7KZI7	-	788	sp|Q8IIT5|PTKL_PLA	-	1501	4.5e-37	125.3	0.2	2	3	2.9e-13	4.2e-12	42.5	0.1	1259	1313	144	198	142	207	0.94	Serine/threonine-protein kinase MARK2 (DB12010)
drugbank_target|Q7KZI7	-	788	sp|Q8IIT5|PTKL_PLA	-	1501	4.5e-37	125.3	0.2	3	3	7.2e-14	1.1e-12	44.5	0.0	1383	1478	207	301	200	314	0.93	Serine/threonine-protein kinase MARK2 (DB12010)
drugbank_target|Q9P0L2	-	795	sp|Q8IIT5|PTKL_PLA	-	1501	4.6e-37	125.3	15.3	1	3	2.4e-15	3.5e-14	49.4	0.2	840	921	65	149	56	153	0.88	Serine/threonine-protein kinase MARK1 (DB12010)
drugbank_target|Q9P0L2	-	795	sp|Q8IIT5|PTKL_PLA	-	1501	4.6e-37	125.3	15.3	2	3	2.7e-13	4e-12	42.6	0.0	1259	1314	151	206	149	215	0.93	Serine/threonine-protein kinase MARK1 (DB12010)
drugbank_target|Q9P0L2	-	795	sp|Q8IIT5|PTKL_PLA	-	1501	4.6e-37	125.3	15.3	3	3	2e-13	2.9e-12	43.1	0.0	1383	1478	214	308	206	321	0.92	Serine/threonine-protein kinase MARK1 (DB12010)
drugbank_target|Q16832	-	855	sp|Q8IIT5|PTKL_PLA	-	1501	5.9e-37	124.9	4.1	1	4	8	1.2e+02	-2.0	1.0	580	612	445	477	425	489	0.71	Discoidin domain-containing receptor 2 (DB08896; DB12010)
drugbank_target|Q16832	-	855	sp|Q8IIT5|PTKL_PLA	-	1501	5.9e-37	124.9	4.1	2	4	8e-13	1.2e-11	41.1	0.0	857	923	601	669	574	677	0.76	Discoidin domain-containing receptor 2 (DB08896; DB12010)
drugbank_target|Q16832	-	855	sp|Q8IIT5|PTKL_PLA	-	1501	5.9e-37	124.9	4.1	3	4	2.5e-11	3.6e-10	36.1	0.0	1258	1314	678	734	668	743	0.91	Discoidin domain-containing receptor 2 (DB08896; DB12010)
drugbank_target|Q16832	-	855	sp|Q8IIT5|PTKL_PLA	-	1501	5.9e-37	124.9	4.1	4	4	9.4e-15	1.4e-13	47.5	0.0	1374	1476	738	846	733	853	0.84	Discoidin domain-containing receptor 2 (DB08896; DB12010)
drugbank_target|Q12866	-	999	sp|Q8IIT5|PTKL_PLA	-	1501	1.1e-36	124.1	0.0	1	3	9.2e-09	1.3e-07	27.6	0.0	839	923	593	686	588	690	0.74	Tyrosine-protein kinase Mer (DB08325; DB12010)
drugbank_target|Q12866	-	999	sp|Q8IIT5|PTKL_PLA	-	1501	1.1e-36	124.1	0.0	2	3	3.7e-11	5.5e-10	35.5	0.0	1256	1314	689	747	684	754	0.91	Tyrosine-protein kinase Mer (DB08325; DB12010)
drugbank_target|Q12866	-	999	sp|Q8IIT5|PTKL_PLA	-	1501	1.1e-36	124.1	0.0	3	3	6.7e-18	9.8e-17	57.9	0.0	1374	1486	751	861	747	875	0.89	Tyrosine-protein kinase Mer (DB08325; DB12010)
drugbank_target|P54646	-	552	sp|Q8IIT5|PTKL_PLA	-	1501	1.1e-36	124.0	7.6	1	3	5.8e-13	8.4e-12	41.5	0.2	843	921	26	106	20	108	0.85	5'-AMP-activated protein kinase catalytic subunit alpha-2 (DB00131; DB00945; DB12010)
drugbank_target|P54646	-	552	sp|Q8IIT5|PTKL_PLA	-	1501	1.1e-36	124.0	7.6	2	3	8.1e-15	1.2e-13	47.7	0.0	1258	1315	107	164	105	172	0.94	5'-AMP-activated protein kinase catalytic subunit alpha-2 (DB00131; DB00945; DB12010)
drugbank_target|P54646	-	552	sp|Q8IIT5|PTKL_PLA	-	1501	1.1e-36	124.0	7.6	3	3	1.7e-11	2.4e-10	36.7	0.0	1384	1477	172	264	164	270	0.92	5'-AMP-activated protein kinase catalytic subunit alpha-2 (DB00131; DB00945; DB12010)
drugbank_target|P14616	-	1297	sp|Q8IIT5|PTKL_PLA	-	1501	1.2e-36	123.9	0.0	1	3	3.5e-08	5.2e-07	25.7	0.0	844	924	990	1075	978	1082	0.77	Insulin receptor-related protein (DB12010)
drugbank_target|P14616	-	1297	sp|Q8IIT5|PTKL_PLA	-	1501	1.2e-36	123.9	0.0	2	3	3.7e-09	5.4e-08	28.9	0.0	1266	1313	1091	1138	1085	1146	0.92	Insulin receptor-related protein (DB12010)
drugbank_target|P14616	-	1297	sp|Q8IIT5|PTKL_PLA	-	1501	1.2e-36	123.9	0.0	3	3	1.7e-20	2.5e-19	66.5	0.0	1371	1481	1140	1248	1137	1253	0.94	Insulin receptor-related protein (DB12010)
drugbank_target|Q08345	-	913	sp|Q8IIT5|PTKL_PLA	-	1501	1.7e-36	123.4	0.0	1	3	1.5e-12	2.2e-11	40.1	0.0	860	925	651	718	642	724	0.84	Epithelial discoidin domain-containing receptor 1 (DB00619; DB12010)
drugbank_target|Q08345	-	913	sp|Q8IIT5|PTKL_PLA	-	1501	1.7e-36	123.4	0.0	2	3	1.6e-10	2.3e-09	33.4	0.0	1261	1314	737	790	730	795	0.91	Epithelial discoidin domain-containing receptor 1 (DB00619; DB12010)
drugbank_target|Q08345	-	913	sp|Q8IIT5|PTKL_PLA	-	1501	1.7e-36	123.4	0.0	3	3	1.7e-14	2.4e-13	46.6	0.0	1373	1479	793	905	789	911	0.83	Epithelial discoidin domain-containing receptor 1 (DB00619; DB12010)
drugbank_target|Q59EB3	-	712	sp|Q8IIT5|PTKL_PLA	-	1501	2.2e-36	123.0	0.0	1	3	6.1e-06	8.9e-05	18.3	0.0	840	924	407	495	396	500	0.77	Met proto-oncogene variant (DB08111)
drugbank_target|Q59EB3	-	712	sp|Q8IIT5|PTKL_PLA	-	1501	2.2e-36	123.0	0.0	2	3	2.9e-11	4.2e-10	35.9	0.0	1263	1313	499	549	493	551	0.91	Met proto-oncogene variant (DB08111)
drugbank_target|Q59EB3	-	712	sp|Q8IIT5|PTKL_PLA	-	1501	2.2e-36	123.0	0.0	3	3	2.2e-20	3.3e-19	66.1	0.0	1371	1483	551	663	549	669	0.95	Met proto-oncogene variant (DB08111)
drugbank_target|Q9H093	-	628	sp|Q8IIT5|PTKL_PLA	-	1501	3e-36	122.5	0.0	1	3	1.6e-12	2.4e-11	40.0	0.4	842	923	62	144	50	146	0.81	NUAK family SNF1-like kinase 2 (DB12010)
drugbank_target|Q9H093	-	628	sp|Q8IIT5|PTKL_PLA	-	1501	3e-36	122.5	0.0	2	3	6.1e-15	8.8e-14	48.1	0.0	1258	1314	143	199	141	205	0.94	NUAK family SNF1-like kinase 2 (DB12010)
drugbank_target|Q9H093	-	628	sp|Q8IIT5|PTKL_PLA	-	1501	3e-36	122.5	0.0	3	3	3.9e-10	5.6e-09	32.2	0.0	1381	1477	205	299	198	304	0.90	NUAK family SNF1-like kinase 2 (DB12010)
drugbank_target|Q15303	-	1308	sp|Q8IIT5|PTKL_PLA	-	1501	1e-35	120.8	0.0	1	3	9.5e-10	1.4e-08	30.9	0.0	834	925	719	813	706	817	0.81	Receptor tyrosine-protein kinase erbB-4 (DB08916; DB12010; DB12267; DB15035)
drugbank_target|Q15303	-	1308	sp|Q8IIT5|PTKL_PLA	-	1501	1e-35	120.8	0.0	2	3	1.3e-11	1.9e-10	37.0	0.0	1259	1317	812	870	809	879	0.89	Receptor tyrosine-protein kinase erbB-4 (DB08916; DB12010; DB12267; DB15035)
drugbank_target|Q15303	-	1308	sp|Q8IIT5|PTKL_PLA	-	1501	1e-35	120.8	0.0	3	3	9.6e-16	1.4e-14	50.7	0.0	1388	1485	883	980	871	986	0.93	Receptor tyrosine-protein kinase erbB-4 (DB08916; DB12010; DB12267; DB15035)
drugbank_target|P15056	-	766	sp|Q8IIT5|PTKL_PLA	-	1501	1.3e-35	120.4	0.3	1	3	4.6e-10	6.8e-09	31.9	0.0	851	931	471	552	462	554	0.86	Serine/threonine-protein kinase B-raf (DB00398; DB05190; DB05984; DB06999; DB07000; DB08553; DB08881; DB08896; DB08912; DB11718; DB12010; DB14840)
drugbank_target|P15056	-	766	sp|Q8IIT5|PTKL_PLA	-	1501	1.3e-35	120.4	0.3	2	3	5.6e-13	8.1e-12	41.6	0.1	1261	1316	547	602	544	608	0.92	Serine/threonine-protein kinase B-raf (DB00398; DB05190; DB05984; DB06999; DB07000; DB08553; DB08881; DB08896; DB08912; DB11718; DB12010; DB14840)
drugbank_target|P15056	-	766	sp|Q8IIT5|PTKL_PLA	-	1501	1.3e-35	120.4	0.3	3	3	1.1e-18	1.6e-17	60.5	0.0	1383	1484	611	719	601	728	0.85	Serine/threonine-protein kinase B-raf (DB00398; DB05190; DB05984; DB06999; DB07000; DB08553; DB08881; DB08896; DB08912; DB11718; DB12010; DB14840)
drugbank_target|O60285	-	661	sp|Q8IIT5|PTKL_PLA	-	1501	1.3e-35	120.4	16.5	1	3	2.5e-14	3.7e-13	46.0	0.7	837	923	59	147	48	149	0.82	NUAK family SNF1-like kinase 1 (DB12010)
drugbank_target|O60285	-	661	sp|Q8IIT5|PTKL_PLA	-	1501	1.3e-35	120.4	16.5	2	3	2.1e-15	3.1e-14	49.6	0.0	1258	1315	146	203	144	209	0.94	NUAK family SNF1-like kinase 1 (DB12010)
drugbank_target|O60285	-	661	sp|Q8IIT5|PTKL_PLA	-	1501	1.3e-35	120.4	16.5	3	3	2.9e-11	4.3e-10	35.9	0.0	1378	1478	205	303	201	312	0.91	NUAK family SNF1-like kinase 1 (DB12010)
drugbank_target|O95747	-	527	sp|Q8IIT5|PTKL_PLA	-	1501	2.3e-35	119.7	0.3	1	3	4.2e-08	6.2e-07	25.4	0.3	855	929	37	113	14	119	0.80	Serine/threonine-protein kinase OSR1 (DB12010)
drugbank_target|O95747	-	527	sp|Q8IIT5|PTKL_PLA	-	1501	2.3e-35	119.7	0.3	2	3	1.4e-12	2e-11	40.3	0.0	1257	1313	113	169	108	174	0.92	Serine/threonine-protein kinase OSR1 (DB12010)
drugbank_target|O95747	-	527	sp|Q8IIT5|PTKL_PLA	-	1501	2.3e-35	119.7	0.3	3	3	5.7e-16	8.3e-15	51.5	0.0	1378	1487	179	295	172	306	0.78	Serine/threonine-protein kinase OSR1 (DB12010)
drugbank_target|Q14680	-	651	sp|Q8IIT5|PTKL_PLA	-	1501	2.5e-35	119.5	0.0	1	3	8e-12	1.2e-10	37.8	0.0	842	921	18	99	12	103	0.86	Maternal embryonic leucine zipper kinase (DB12010)
drugbank_target|Q14680	-	651	sp|Q8IIT5|PTKL_PLA	-	1501	2.5e-35	119.5	0.0	2	3	3e-12	4.4e-11	39.2	0.0	1259	1313	101	155	99	166	0.92	Maternal embryonic leucine zipper kinase (DB12010)
drugbank_target|Q14680	-	651	sp|Q8IIT5|PTKL_PLA	-	1501	2.5e-35	119.5	0.0	3	3	1.9e-12	2.7e-11	39.8	0.0	1382	1478	165	260	157	272	0.90	Maternal embryonic leucine zipper kinase (DB12010)
drugbank_target|P08581	-	1390	sp|Q8IIT5|PTKL_PLA	-	1501	2.5e-35	119.5	0.0	1	3	1.3e-05	0.00019	17.1	0.0	840	924	1085	1173	1074	1180	0.77	Hepatocyte growth factor receptor (DB02152; DB06314; DB06896; DB06995; DB06997; DB07369; DB07969; DB08079; DB08791; DB08865; DB08875; DB11791; DB12010; DB12200; DB12267; DB12742)
drugbank_target|P08581	-	1390	sp|Q8IIT5|PTKL_PLA	-	1501	2.5e-35	119.5	0.0	2	3	5.8e-11	8.5e-10	34.9	0.0	1263	1313	1177	1227	1171	1230	0.91	Hepatocyte growth factor receptor (DB02152; DB06314; DB06896; DB06995; DB06997; DB07369; DB07969; DB08079; DB08791; DB08865; DB08875; DB11791; DB12010; DB12200; DB12267; DB12742)
drugbank_target|P08581	-	1390	sp|Q8IIT5|PTKL_PLA	-	1501	2.5e-35	119.5	0.0	3	3	4.6e-20	6.6e-19	65.1	0.0	1371	1483	1229	1341	1226	1348	0.95	Hepatocyte growth factor receptor (DB02152; DB06314; DB06896; DB06995; DB06997; DB07369; DB07969; DB08079; DB08791; DB08865; DB08875; DB11791; DB12010; DB12200; DB12267; DB12742)
drugbank_target|P51956	-	506	sp|Q8IIT5|PTKL_PLA	-	1501	3.9e-35	118.9	0.5	1	3	1.1e-08	1.6e-07	27.3	0.1	849	926	18	97	6	100	0.89	Serine/threonine-protein kinase Nek3 (DB12010)
drugbank_target|P51956	-	506	sp|Q8IIT5|PTKL_PLA	-	1501	3.9e-35	118.9	0.5	2	3	1.1e-12	1.7e-11	40.6	0.1	1253	1314	89	151	88	162	0.87	Serine/threonine-protein kinase Nek3 (DB12010)
drugbank_target|P51956	-	506	sp|Q8IIT5|PTKL_PLA	-	1501	3.9e-35	118.9	0.5	3	3	5.1e-16	7.4e-15	51.7	0.0	1384	1477	161	253	155	264	0.94	Serine/threonine-protein kinase Nek3 (DB12010)
drugbank_target|Q06418	-	890	sp|Q8IIT5|PTKL_PLA	-	1501	4.1e-35	118.8	0.0	1	3	3.3e-06	4.8e-05	19.1	0.0	842	923	527	618	518	625	0.75	Tyrosine-protein kinase receptor TYRO3 (DB12010)
drugbank_target|Q06418	-	890	sp|Q8IIT5|PTKL_PLA	-	1501	4.1e-35	118.8	0.0	2	3	2.4e-11	3.5e-10	36.2	0.0	1255	1314	620	679	616	686	0.91	Tyrosine-protein kinase receptor TYRO3 (DB12010)
drugbank_target|Q06418	-	890	sp|Q8IIT5|PTKL_PLA	-	1501	4.1e-35	118.8	0.0	3	3	6.7e-19	9.8e-18	61.2	0.0	1372	1483	681	790	678	800	0.93	Tyrosine-protein kinase receptor TYRO3 (DB12010)
drugbank_target|P57059	-	783	sp|Q8IIT5|PTKL_PLA	-	1501	4.9e-35	118.5	14.9	1	3	3.4e-14	5e-13	45.6	1.7	841	922	33	117	28	120	0.88	Serine/threonine-protein kinase SIK1 (DB08912; DB12010)
drugbank_target|P57059	-	783	sp|Q8IIT5|PTKL_PLA	-	1501	4.9e-35	118.5	14.9	2	3	4.5e-12	6.6e-11	38.6	0.0	1259	1314	118	173	116	180	0.93	Serine/threonine-protein kinase SIK1 (DB08912; DB12010)
drugbank_target|P57059	-	783	sp|Q8IIT5|PTKL_PLA	-	1501	4.9e-35	118.5	14.9	3	3	8e-12	1.2e-10	37.8	0.0	1384	1478	182	275	172	280	0.93	Serine/threonine-protein kinase SIK1 (DB08912; DB12010)
drugbank_target|P04049	-	648	sp|Q8IIT5|PTKL_PLA	-	1501	5.1e-35	118.5	0.4	1	3	5.5e-10	8e-09	31.7	0.0	851	927	363	440	355	444	0.89	RAF proto-oncogene serine/threonine-protein kinase (DB00398; DB04973; DB05190; DB05268; DB08862; DB08896; DB08912; DB12010)
drugbank_target|P04049	-	648	sp|Q8IIT5|PTKL_PLA	-	1501	5.1e-35	118.5	0.4	2	3	8.7e-13	1.3e-11	40.9	0.1	1258	1315	436	493	435	499	0.93	RAF proto-oncogene serine/threonine-protein kinase (DB00398; DB04973; DB05190; DB05268; DB08862; DB08896; DB08912; DB12010)
drugbank_target|P04049	-	648	sp|Q8IIT5|PTKL_PLA	-	1501	5.1e-35	118.5	0.4	3	3	3e-18	4.4e-17	59.0	0.0	1384	1484	504	611	495	620	0.85	RAF proto-oncogene serine/threonine-protein kinase (DB00398; DB04973; DB05190; DB05268; DB08862; DB08896; DB08912; DB12010)
drugbank_target|Q9UM73	-	1620	sp|Q8IIT5|PTKL_PLA	-	1501	5.7e-35	118.3	0.0	1	3	1.3e-08	1.9e-07	27.1	0.0	859	924	1145	1212	1122	1222	0.80	ALK tyrosine kinase receptor (DB00171; DB08865; DB09063; DB11363; DB12010; DB12130; DB12141; DB12267)
drugbank_target|Q9UM73	-	1620	sp|Q8IIT5|PTKL_PLA	-	1501	5.7e-35	118.3	0.0	2	3	3.6e-08	5.3e-07	25.6	0.0	1260	1313	1219	1275	1214	1280	0.88	ALK tyrosine kinase receptor (DB00171; DB08865; DB09063; DB11363; DB12010; DB12130; DB12141; DB12267)
drugbank_target|Q9UM73	-	1620	sp|Q8IIT5|PTKL_PLA	-	1501	5.7e-35	118.3	0.0	3	3	3.3e-19	4.8e-18	62.2	0.0	1384	1485	1290	1389	1275	1397	0.90	ALK tyrosine kinase receptor (DB00171; DB08865; DB09063; DB11363; DB12010; DB12130; DB12141; DB12267)
drugbank_target|Q9NWZ3	-	460	sp|Q8IIT5|PTKL_PLA	-	1501	1.6e-34	116.8	0.7	1	3	1.7e-11	2.5e-10	36.6	0.0	851	923	200	277	190	281	0.87	Interleukin-1 receptor-associated kinase 4 (DB08590; DB12010)
drugbank_target|Q9NWZ3	-	460	sp|Q8IIT5|PTKL_PLA	-	1501	1.6e-34	116.8	0.7	2	3	1.6e-12	2.3e-11	40.1	0.0	1262	1322	283	343	278	347	0.90	Interleukin-1 receptor-associated kinase 4 (DB08590; DB12010)
drugbank_target|Q9NWZ3	-	460	sp|Q8IIT5|PTKL_PLA	-	1501	1.6e-34	116.8	0.7	3	3	3.7e-12	5.4e-11	38.9	0.0	1378	1483	341	458	335	460	0.82	Interleukin-1 receptor-associated kinase 4 (DB08590; DB12010)
drugbank_target|Q9UEW8	-	545	sp|Q8IIT5|PTKL_PLA	-	1501	1.7e-34	116.8	0.1	1	3	1.2e-07	1.7e-06	23.9	0.1	837	923	67	153	60	159	0.81	STE20/SPS1-related proline-alanine-rich protein kinase (DB12010)
drugbank_target|Q9UEW8	-	545	sp|Q8IIT5|PTKL_PLA	-	1501	1.7e-34	116.8	0.1	2	3	2.3e-12	3.4e-11	39.5	0.0	1256	1313	158	215	150	220	0.90	STE20/SPS1-related proline-alanine-rich protein kinase (DB12010)
drugbank_target|Q9UEW8	-	545	sp|Q8IIT5|PTKL_PLA	-	1501	1.7e-34	116.8	0.1	3	3	1.3e-15	1.9e-14	50.3	0.0	1377	1479	224	335	217	353	0.77	STE20/SPS1-related proline-alanine-rich protein kinase (DB12010)
drugbank_target|Q02779	-	954	sp|Q8IIT5|PTKL_PLA	-	1501	8.3e-34	114.5	1.9	1	3	2.1e-08	3.1e-07	26.4	0.0	838	921	103	187	92	195	0.80	Mitogen-activated protein kinase kinase kinase 10 (DB12010)
drugbank_target|Q02779	-	954	sp|Q8IIT5|PTKL_PLA	-	1501	8.3e-34	114.5	1.9	2	3	7.2e-07	1e-05	21.3	0.0	1262	1314	191	254	186	261	0.79	Mitogen-activated protein kinase kinase kinase 10 (DB12010)
drugbank_target|Q02779	-	954	sp|Q8IIT5|PTKL_PLA	-	1501	8.3e-34	114.5	1.9	3	3	1.2e-19	1.7e-18	63.7	0.0	1378	1486	256	364	253	373	0.89	Mitogen-activated protein kinase kinase kinase 10 (DB12010)
drugbank_target|Q13177	-	524	sp|Q8IIT5|PTKL_PLA	-	1501	8.9e-34	114.4	0.1	1	3	2.3e-10	3.4e-09	32.9	0.2	850	931	264	346	242	348	0.85	Serine/threonine-protein kinase PAK 2 (DB12010)
drugbank_target|Q13177	-	524	sp|Q8IIT5|PTKL_PLA	-	1501	8.9e-34	114.4	0.1	2	3	1.2e-10	1.7e-09	33.9	0.0	1261	1313	339	391	335	398	0.92	Serine/threonine-protein kinase PAK 2 (DB12010)
drugbank_target|Q13177	-	524	sp|Q8IIT5|PTKL_PLA	-	1501	8.9e-34	114.4	0.1	3	3	1.1e-14	1.7e-13	47.2	0.0	1379	1478	397	497	391	505	0.86	Serine/threonine-protein kinase PAK 2 (DB12010)
drugbank_target|P62344	-	524	sp|Q8IIT5|PTKL_PLA	-	1501	1.3e-33	113.8	8.4	1	3	2.2e-07	3.2e-06	23.0	1.0	852	920	88	157	8	166	0.70	Calcium-dependent protein kinase 1 (DB12010)
drugbank_target|P62344	-	524	sp|Q8IIT5|PTKL_PLA	-	1501	1.3e-33	113.8	8.4	2	3	4.2e-13	6.1e-12	42.0	0.4	1260	1314	161	218	155	225	0.86	Calcium-dependent protein kinase 1 (DB12010)
drugbank_target|P62344	-	524	sp|Q8IIT5|PTKL_PLA	-	1501	1.3e-33	113.8	8.4	3	3	1.4e-16	2.1e-15	53.5	0.0	1384	1488	227	334	219	346	0.84	Calcium-dependent protein kinase 1 (DB12010)
drugbank_target|P00533	-	1210	sp|Q8IIT5|PTKL_PLA	-	1501	1.8e-33	113.4	0.3	1	3	2.2e-07	3.2e-06	23.0	0.0	834	925	713	807	700	810	0.80	Epidermal growth factor receptor (DB00002; DB00281; DB00317; DB00530; DB01259; DB01269; DB03496; DB04988; DB05101; DB05294; DB05374; DB05424; DB05524; DB05944; DB06021; DB07602; DB07662; DB08916; DB09330; DB09559; DB10772; DB11731; DB11737; DB11828; DB11963; DB12010; DB12202; DB12267; DB13164; DB15035)
drugbank_target|P00533	-	1210	sp|Q8IIT5|PTKL_PLA	-	1501	1.8e-33	113.4	0.3	2	3	9.8e-12	1.4e-10	37.5	0.0	1260	1316	807	863	804	872	0.90	Epidermal growth factor receptor (DB00002; DB00281; DB00317; DB00530; DB01259; DB01269; DB03496; DB04988; DB05101; DB05294; DB05374; DB05424; DB05524; DB05944; DB06021; DB07602; DB07662; DB08916; DB09330; DB09559; DB10772; DB11731; DB11737; DB11828; DB11963; DB12010; DB12202; DB12267; DB13164; DB15035)
drugbank_target|P00533	-	1210	sp|Q8IIT5|PTKL_PLA	-	1501	1.8e-33	113.4	0.3	3	3	1.5e-15	2.3e-14	50.1	0.0	1388	1485	877	974	863	980	0.92	Epidermal growth factor receptor (DB00002; DB00281; DB00317; DB00530; DB01259; DB01269; DB03496; DB04988; DB05101; DB05294; DB05374; DB05424; DB05524; DB05944; DB06021; DB07602; DB07662; DB08916; DB09330; DB09559; DB10772; DB11731; DB11737; DB11828; DB11963; DB12010; DB12202; DB12267; DB13164; DB15035)
drugbank_target|Q14012	-	370	sp|Q8IIT5|PTKL_PLA	-	1501	2.6e-33	112.8	0.0	1	3	1.9e-08	2.8e-07	26.6	0.0	851	920	36	107	19	114	0.85	Calcium/calmodulin-dependent protein kinase type 1 (DB12010)
drugbank_target|Q14012	-	370	sp|Q8IIT5|PTKL_PLA	-	1501	2.6e-33	112.8	0.0	2	3	9.3e-12	1.4e-10	37.5	0.0	1263	1316	114	170	108	177	0.90	Calcium/calmodulin-dependent protein kinase type 1 (DB12010)
drugbank_target|Q14012	-	370	sp|Q8IIT5|PTKL_PLA	-	1501	2.6e-33	112.8	0.0	3	3	3.2e-14	4.7e-13	45.7	0.0	1384	1478	177	273	172	292	0.90	Calcium/calmodulin-dependent protein kinase type 1 (DB12010)
drugbank_target|P51955	-	445	sp|Q8IIT5|PTKL_PLA	-	1501	3e-33	112.6	0.0	1	3	2.1e-08	3.1e-07	26.4	0.0	849	929	22	107	8	112	0.79	Serine/threonine-protein kinase Nek2 (DB07180; DB12010)
drugbank_target|P51955	-	445	sp|Q8IIT5|PTKL_PLA	-	1501	3e-33	112.6	0.0	2	3	3.3e-10	4.8e-09	32.4	0.0	1257	1317	103	168	99	173	0.89	Serine/threonine-protein kinase Nek2 (DB07180; DB12010)
drugbank_target|P51955	-	445	sp|Q8IIT5|PTKL_PLA	-	1501	3e-33	112.6	0.0	3	3	2.1e-16	3e-15	52.9	0.0	1378	1478	169	268	166	286	0.91	Serine/threonine-protein kinase Nek2 (DB07180; DB12010)
drugbank_target|Q04912	-	1400	sp|Q8IIT5|PTKL_PLA	-	1501	3.3e-33	112.5	0.0	1	3	0.0011	0.016	10.8	0.0	837	923	1086	1176	1079	1182	0.80	Macrophage-stimulating protein receptor (DB12010)
drugbank_target|Q04912	-	1400	sp|Q8IIT5|PTKL_PLA	-	1501	3.3e-33	112.5	0.0	2	3	2.8e-11	4e-10	36.0	0.0	1261	1313	1179	1231	1173	1235	0.91	Macrophage-stimulating protein receptor (DB12010)
drugbank_target|Q04912	-	1400	sp|Q8IIT5|PTKL_PLA	-	1501	3.3e-33	112.5	0.0	3	3	1.8e-19	2.7e-18	63.1	0.0	1373	1483	1235	1345	1232	1352	0.94	Macrophage-stimulating protein receptor (DB12010)
drugbank_target|Q96NX5	-	476	sp|Q8IIT5|PTKL_PLA	-	1501	3.7e-33	112.3	0.3	1	3	2.1e-08	3.1e-07	26.4	0.1	826	920	16	109	6	115	0.82	Calcium/calmodulin-dependent protein kinase type 1G (DB08009; DB12010)
drugbank_target|Q96NX5	-	476	sp|Q8IIT5|PTKL_PLA	-	1501	3.7e-33	112.3	0.3	2	3	3.8e-12	5.5e-11	38.8	0.0	1263	1317	116	173	111	179	0.86	Calcium/calmodulin-dependent protein kinase type 1G (DB08009; DB12010)
drugbank_target|Q96NX5	-	476	sp|Q8IIT5|PTKL_PLA	-	1501	3.7e-33	112.3	0.3	3	3	8.6e-14	1.3e-12	44.3	0.0	1383	1476	177	272	172	275	0.91	Calcium/calmodulin-dependent protein kinase type 1G (DB08009; DB12010)
drugbank_target|Q6P3R8	-	708	sp|Q8IIT5|PTKL_PLA	-	1501	4.6e-33	112.0	6.2	1	3	1.3e-09	2e-08	30.4	0.2	837	922	6	94	2	98	0.89	Serine/threonine-protein kinase Nek5 (DB12010)
drugbank_target|Q6P3R8	-	708	sp|Q8IIT5|PTKL_PLA	-	1501	4.6e-33	112.0	6.2	2	3	3.1e-11	4.5e-10	35.8	0.0	1254	1317	91	156	88	161	0.85	Serine/threonine-protein kinase Nek5 (DB12010)
drugbank_target|Q6P3R8	-	708	sp|Q8IIT5|PTKL_PLA	-	1501	4.6e-33	112.0	6.2	3	3	2.6e-15	3.7e-14	49.3	0.0	1382	1478	161	256	156	270	0.94	Serine/threonine-protein kinase Nek5 (DB12010)
drugbank_target|P29376	-	864	sp|Q8IIT5|PTKL_PLA	-	1501	6e-33	111.6	0.3	1	3	3.6e-07	5.2e-06	22.3	0.0	857	924	537	606	517	609	0.81	Leukocyte tyrosine kinase receptor (DB12010)
drugbank_target|P29376	-	864	sp|Q8IIT5|PTKL_PLA	-	1501	6e-33	111.6	0.3	2	3	2.6e-09	3.8e-08	29.4	0.0	1261	1313	614	669	608	676	0.88	Leukocyte tyrosine kinase receptor (DB12010)
drugbank_target|P29376	-	864	sp|Q8IIT5|PTKL_PLA	-	1501	6e-33	111.6	0.3	3	3	3.9e-17	5.6e-16	55.4	0.0	1377	1485	677	783	670	789	0.90	Leukocyte tyrosine kinase receptor (DB12010)
drugbank_target|Q6PHR2	-	472	sp|Q8IIT5|PTKL_PLA	-	1501	6.7e-33	111.5	0.0	1	3	5.8e-11	8.4e-10	34.9	0.1	842	924	23	107	18	109	0.84	Serine/threonine-protein kinase ULK3 (DB12010)
drugbank_target|Q6PHR2	-	472	sp|Q8IIT5|PTKL_PLA	-	1501	6.7e-33	111.5	0.0	2	3	2.3e-11	3.3e-10	36.2	0.0	1260	1317	107	166	104	172	0.87	Serine/threonine-protein kinase ULK3 (DB12010)
drugbank_target|Q6PHR2	-	472	sp|Q8IIT5|PTKL_PLA	-	1501	6.7e-33	111.5	0.0	3	3	6.8e-12	1e-10	38.0	0.0	1383	1475	171	264	163	268	0.88	Serine/threonine-protein kinase ULK3 (DB12010)
drugbank_target|Q13153	-	545	sp|Q8IIT5|PTKL_PLA	-	1501	7.4e-33	111.3	0.1	1	3	5e-09	7.3e-08	28.5	0.1	841	932	276	368	260	372	0.82	Serine/threonine-protein kinase PAK 1 (DB12010)
drugbank_target|Q13153	-	545	sp|Q8IIT5|PTKL_PLA	-	1501	7.4e-33	111.3	0.1	2	3	8.2e-11	1.2e-09	34.4	0.0	1261	1313	360	412	356	418	0.92	Serine/threonine-protein kinase PAK 1 (DB12010)
drugbank_target|Q13153	-	545	sp|Q8IIT5|PTKL_PLA	-	1501	7.4e-33	111.3	0.1	3	3	9.2e-15	1.3e-13	47.5	0.0	1379	1478	418	518	412	529	0.85	Serine/threonine-protein kinase PAK 1 (DB12010)
drugbank_target|Q8IY84	-	436	sp|Q8IIT5|PTKL_PLA	-	1501	8.2e-33	111.2	0.1	1	3	2.9e-11	4.3e-10	35.9	0.3	850	918	89	160	77	165	0.81	Serine/threonine-protein kinase NIM1 (DB12010)
drugbank_target|Q8IY84	-	436	sp|Q8IIT5|PTKL_PLA	-	1501	8.2e-33	111.2	0.1	2	3	1.3e-11	2e-10	37.0	0.0	1259	1320	165	226	160	231	0.91	Serine/threonine-protein kinase NIM1 (DB12010)
drugbank_target|Q8IY84	-	436	sp|Q8IIT5|PTKL_PLA	-	1501	8.2e-33	111.2	0.1	3	3	3e-11	4.3e-10	35.9	0.0	1382	1476	227	320	222	325	0.93	Serine/threonine-protein kinase NIM1 (DB12010)
drugbank_target|P53350	-	603	sp|Q8IIT5|PTKL_PLA	-	1501	2e-32	109.9	0.0	1	3	0.00041	0.006	12.2	0.0	857	920	80	142	59	147	0.79	Serine/threonine-protein kinase PLK1 (DB06897; DB06963; DB07186; DB07789; DB08059; DB12010)
drugbank_target|P53350	-	603	sp|Q8IIT5|PTKL_PLA	-	1501	2e-32	109.9	0.0	2	3	7.7e-13	1.1e-11	41.1	0.0	1255	1314	141	200	137	203	0.93	Serine/threonine-protein kinase PLK1 (DB06897; DB06963; DB07186; DB07789; DB08059; DB12010)
drugbank_target|P53350	-	603	sp|Q8IIT5|PTKL_PLA	-	1501	2e-32	109.9	0.0	3	3	5.2e-17	7.6e-16	54.9	0.0	1377	1477	203	301	200	306	0.93	Serine/threonine-protein kinase PLK1 (DB06897; DB06963; DB07186; DB07789; DB08059; DB12010)
drugbank_target|Q9NRH2	-	765	sp|Q8IIT5|PTKL_PLA	-	1501	2.3e-32	109.7	12.1	1	3	1.6e-10	2.4e-09	33.4	0.0	842	923	23	107	19	110	0.85	SNF-related serine/threonine-protein kinase (DB12010)
drugbank_target|Q9NRH2	-	765	sp|Q8IIT5|PTKL_PLA	-	1501	2.3e-32	109.7	12.1	2	3	7.9e-11	1.2e-09	34.5	0.0	1257	1314	106	164	104	170	0.89	SNF-related serine/threonine-protein kinase (DB12010)
drugbank_target|Q9NRH2	-	765	sp|Q8IIT5|PTKL_PLA	-	1501	2.3e-32	109.7	12.1	3	3	7.4e-16	1.1e-14	51.1	0.0	1383	1478	172	266	164	289	0.89	SNF-related serine/threonine-protein kinase (DB12010)
drugbank_target|O14965	-	403	sp|Q8IIT5|PTKL_PLA	-	1501	3.1e-32	109.2	0.0	1	3	1e-06	1.5e-05	20.8	0.0	844	922	142	224	133	228	0.78	Aurora kinase A (DB02482; DB05169; DB05198; DB05220; DB06134; DB06347; DB06486; DB07186; DB07266; DB07360; DB07362; DB07545; DB07801; DB08065; DB08066; DB12010; DB13061)
drugbank_target|O14965	-	403	sp|Q8IIT5|PTKL_PLA	-	1501	3.1e-32	109.2	0.0	2	3	9.2e-13	1.3e-11	40.9	0.0	1259	1313	225	279	220	286	0.92	Aurora kinase A (DB02482; DB05169; DB05198; DB05220; DB06134; DB06347; DB06486; DB07186; DB07266; DB07360; DB07362; DB07545; DB07801; DB08065; DB08066; DB12010; DB13061)
drugbank_target|O14965	-	403	sp|Q8IIT5|PTKL_PLA	-	1501	3.1e-32	109.2	0.0	3	3	4.7e-14	6.9e-13	45.1	0.0	1381	1478	285	380	278	398	0.90	Aurora kinase A (DB02482; DB05169; DB05198; DB05220; DB06134; DB06347; DB06486; DB07186; DB07266; DB07360; DB07362; DB07545; DB07801; DB08065; DB08066; DB12010; DB13061)
drugbank_target|Q59H18	-	835	sp|Q8IIT5|PTKL_PLA	-	1501	3.3e-32	109.2	0.0	1	3	1.1e-09	1.5e-08	30.7	0.0	850	924	476	555	461	558	0.83	Serine/threonine-protein kinase TNNI3K (DB12010)
drugbank_target|Q59H18	-	835	sp|Q8IIT5|PTKL_PLA	-	1501	3.3e-32	109.2	0.0	2	3	1e-10	1.5e-09	34.1	0.1	1256	1320	552	618	551	622	0.91	Serine/threonine-protein kinase TNNI3K (DB12010)
drugbank_target|Q59H18	-	835	sp|Q8IIT5|PTKL_PLA	-	1501	3.3e-32	109.2	0.0	3	3	4.5e-14	6.6e-13	45.2	0.0	1376	1483	615	723	613	731	0.92	Serine/threonine-protein kinase TNNI3K (DB12010)
drugbank_target|Q9UQB9	-	309	sp|Q8IIT5|PTKL_PLA	-	1501	3.3e-32	109.2	0.0	1	3	5.7e-08	8.3e-07	25.0	0.1	842	923	52	135	48	137	0.77	Aurora kinase C (DB06134; DB12010)
drugbank_target|Q9UQB9	-	309	sp|Q8IIT5|PTKL_PLA	-	1501	3.3e-32	109.2	0.0	2	3	8.8e-14	1.3e-12	44.2	0.0	1257	1315	133	191	130	197	0.92	Aurora kinase C (DB06134; DB12010)
drugbank_target|Q9UQB9	-	309	sp|Q8IIT5|PTKL_PLA	-	1501	3.3e-32	109.2	0.0	3	3	4.5e-12	6.5e-11	38.6	0.0	1382	1478	196	290	191	299	0.93	Aurora kinase C (DB06134; DB12010)
drugbank_target|Q13188	-	491	sp|Q8IIT5|PTKL_PLA	-	1501	4.9e-32	108.6	0.1	1	3	3e-08	4.3e-07	25.9	0.1	850	923	44	114	28	119	0.83	Serine/threonine-protein kinase 3 (DB12010)
drugbank_target|Q13188	-	491	sp|Q8IIT5|PTKL_PLA	-	1501	4.9e-32	108.6	0.1	2	3	1e-10	1.5e-09	34.1	0.1	1259	1313	115	169	111	176	0.92	Serine/threonine-protein kinase 3 (DB12010)
drugbank_target|Q13188	-	491	sp|Q8IIT5|PTKL_PLA	-	1501	4.9e-32	108.6	0.1	3	3	1.7e-14	2.5e-13	46.6	0.0	1379	1478	175	275	169	295	0.88	Serine/threonine-protein kinase 3 (DB12010)
drugbank_target|P10398	-	606	sp|Q8IIT5|PTKL_PLA	-	1501	4.9e-32	108.6	12.0	1	3	7.3e-09	1.1e-07	27.9	0.0	851	926	324	400	315	405	0.86	Serine/threonine-protein kinase A-Raf (DB00171)
drugbank_target|P10398	-	606	sp|Q8IIT5|PTKL_PLA	-	1501	4.9e-32	108.6	12.0	2	3	7.6e-13	1.1e-11	41.1	0.0	1260	1315	399	454	396	459	0.93	Serine/threonine-protein kinase A-Raf (DB00171)
drugbank_target|P10398	-	606	sp|Q8IIT5|PTKL_PLA	-	1501	4.9e-32	108.6	12.0	3	3	1e-14	1.5e-13	47.4	0.0	1387	1484	468	572	460	582	0.84	Serine/threonine-protein kinase A-Raf (DB00171)
drugbank_target|Q8IBS5	-	528	sp|Q8IIT5|PTKL_PLA	-	1501	6.1e-32	108.3	8.8	1	3	6.8e-08	9.9e-07	24.7	3.3	804	922	40	161	15	168	0.77	Calcium-dependent protein kinase 4 (DB11638)
drugbank_target|Q8IBS5	-	528	sp|Q8IIT5|PTKL_PLA	-	1501	6.1e-32	108.3	8.8	2	3	7.9e-13	1.2e-11	41.1	0.4	1261	1316	164	223	160	230	0.82	Calcium-dependent protein kinase 4 (DB11638)
drugbank_target|Q8IBS5	-	528	sp|Q8IIT5|PTKL_PLA	-	1501	6.1e-32	108.3	8.8	3	3	3.3e-14	4.9e-13	45.6	0.0	1381	1487	227	336	220	343	0.83	Calcium-dependent protein kinase 4 (DB11638)
drugbank_target|Q86YV6	-	388	sp|Q8IIT5|PTKL_PLA	-	1501	7.1e-32	108.1	0.9	1	3	5.5e-13	8e-12	41.6	0.2	828	934	101	206	95	207	0.89	Myosin light chain kinase family member 4 (DB12010)
drugbank_target|Q86YV6	-	388	sp|Q8IIT5|PTKL_PLA	-	1501	7.1e-32	108.1	0.9	2	3	3.1e-11	4.5e-10	35.8	0.1	1255	1315	192	254	190	264	0.87	Myosin light chain kinase family member 4 (DB12010)
drugbank_target|Q86YV6	-	388	sp|Q8IIT5|PTKL_PLA	-	1501	7.1e-32	108.1	0.9	3	3	3.6e-10	5.3e-09	32.3	0.0	1384	1478	262	358	253	376	0.86	Myosin light chain kinase family member 4 (DB12010)
drugbank_target|O75914	-	559	sp|Q8IIT5|PTKL_PLA	-	1501	9.4e-32	107.7	0.0	1	3	1.2e-08	1.8e-07	27.2	0.1	850	931	298	380	272	383	0.82	Serine/threonine-protein kinase PAK 3 (DB12010)
drugbank_target|O75914	-	559	sp|Q8IIT5|PTKL_PLA	-	1501	9.4e-32	107.7	0.0	2	3	1.3e-10	1.9e-09	33.7	0.0	1261	1313	373	425	370	431	0.92	Serine/threonine-protein kinase PAK 3 (DB12010)
drugbank_target|O75914	-	559	sp|Q8IIT5|PTKL_PLA	-	1501	9.4e-32	107.7	0.0	3	3	4.4e-14	6.4e-13	45.2	0.0	1379	1478	431	531	426	539	0.86	Serine/threonine-protein kinase PAK 3 (DB12010)
drugbank_target|Q96GD4	-	344	sp|Q8IIT5|PTKL_PLA	-	1501	1e-31	107.5	0.0	1	3	5.4e-08	7.9e-07	25.1	0.1	841	922	83	168	58	171	0.81	Aurora kinase B (DB04703; DB05169; DB06486; DB07340; DB12010)
drugbank_target|Q96GD4	-	344	sp|Q8IIT5|PTKL_PLA	-	1501	1e-31	107.5	0.0	2	3	7.2e-12	1.1e-10	37.9	0.0	1260	1315	170	225	166	231	0.91	Aurora kinase B (DB04703; DB05169; DB06486; DB07340; DB12010)
drugbank_target|Q96GD4	-	344	sp|Q8IIT5|PTKL_PLA	-	1501	1e-31	107.5	0.0	3	3	3.4e-13	5e-12	42.3	0.0	1382	1476	230	322	225	331	0.92	Aurora kinase B (DB04703; DB05169; DB06486; DB07340; DB12010)
drugbank_target|Q8IU85	-	385	sp|Q8IIT5|PTKL_PLA	-	1501	1.4e-31	107.1	6.3	1	3	2.9e-08	4.2e-07	26.0	0.1	849	920	37	110	8	116	0.85	Calcium/calmodulin-dependent protein kinase type 1D (DB08454; DB12010)
drugbank_target|Q8IU85	-	385	sp|Q8IIT5|PTKL_PLA	-	1501	1.4e-31	107.1	6.3	2	3	9.6e-12	1.4e-10	37.5	0.0	1262	1317	116	174	111	180	0.87	Calcium/calmodulin-dependent protein kinase type 1D (DB08454; DB12010)
drugbank_target|Q8IU85	-	385	sp|Q8IIT5|PTKL_PLA	-	1501	1.4e-31	107.1	6.3	3	3	2.2e-14	3.2e-13	46.2	0.0	1383	1477	179	275	174	295	0.90	Calcium/calmodulin-dependent protein kinase type 1D (DB08454; DB12010)
drugbank_target|Q9P286	-	719	sp|Q8IIT5|PTKL_PLA	-	1501	1.8e-31	106.7	15.9	1	3	4.5e-11	6.5e-10	35.3	0.2	840	933	454	548	446	549	0.90	Serine/threonine-protein kinase PAK 5 (DB12010)
drugbank_target|Q9P286	-	719	sp|Q8IIT5|PTKL_PLA	-	1501	1.8e-31	106.7	15.9	2	3	5.8e-12	8.4e-11	38.2	0.0	1258	1313	536	591	534	596	0.94	Serine/threonine-protein kinase PAK 5 (DB12010)
drugbank_target|Q9P286	-	719	sp|Q8IIT5|PTKL_PLA	-	1501	1.8e-31	106.7	15.9	3	3	1e-12	1.5e-11	40.7	0.0	1378	1476	596	695	591	699	0.90	Serine/threonine-protein kinase PAK 5 (DB12010)
drugbank_target|Q9BXA7	-	367	sp|Q8IIT5|PTKL_PLA	-	1501	1.8e-31	106.7	1.1	1	3	8.9e-08	1.3e-06	24.3	0.2	842	922	21	104	15	109	0.78	Testis-specific serine/threonine-protein kinase 1 (DB12010)
drugbank_target|Q9BXA7	-	367	sp|Q8IIT5|PTKL_PLA	-	1501	1.8e-31	106.7	1.1	2	3	2.8e-11	4.2e-10	35.9	0.1	1258	1314	104	160	100	167	0.92	Testis-specific serine/threonine-protein kinase 1 (DB12010)
drugbank_target|Q9BXA7	-	367	sp|Q8IIT5|PTKL_PLA	-	1501	1.8e-31	106.7	1.1	3	3	4.7e-14	6.9e-13	45.1	0.0	1381	1478	171	269	163	279	0.89	Testis-specific serine/threonine-protein kinase 1 (DB12010)
drugbank_target|O15197	-	1021	sp|Q8IIT5|PTKL_PLA	-	1501	1.9e-31	106.6	0.8	1	3	1e-09	1.5e-08	30.7	0.0	834	924	671	764	656	773	0.81	Ephrin type-B receptor 6 (DB12010)
drugbank_target|O15197	-	1021	sp|Q8IIT5|PTKL_PLA	-	1501	1.9e-31	106.6	0.8	2	3	0.00015	0.0022	13.6	0.0	1259	1312	764	817	761	824	0.91	Ephrin type-B receptor 6 (DB12010)
drugbank_target|O15197	-	1021	sp|Q8IIT5|PTKL_PLA	-	1501	1.9e-31	106.6	0.8	3	3	3.9e-18	5.8e-17	58.7	0.0	1389	1488	825	924	819	928	0.95	Ephrin type-B receptor 6 (DB12010)
drugbank_target|Q32MK0	-	819	sp|Q8IIT5|PTKL_PLA	-	1501	2.1e-31	106.5	0.1	1	3	1.2e-11	1.8e-10	37.1	0.1	835	927	517	608	502	614	0.86	Myosin light chain kinase 3 (DB12010)
drugbank_target|Q32MK0	-	819	sp|Q8IIT5|PTKL_PLA	-	1501	2.1e-31	106.5	0.1	2	3	2.7e-12	4e-11	39.3	0.0	1254	1315	600	663	599	673	0.89	Myosin light chain kinase 3 (DB12010)
drugbank_target|Q32MK0	-	819	sp|Q8IIT5|PTKL_PLA	-	1501	2.1e-31	106.5	0.1	3	3	6.7e-10	9.8e-09	31.4	0.0	1385	1478	672	767	662	789	0.83	Myosin light chain kinase 3 (DB12010)
drugbank_target|O43293	-	454	sp|Q8IIT5|PTKL_PLA	-	1501	3e-31	106.0	0.0	1	3	5.7e-09	8.3e-08	28.3	0.0	842	923	20	108	14	110	0.82	Death-associated protein kinase 3 (DB04716; DB07125; DB07242; DB12010)
drugbank_target|O43293	-	454	sp|Q8IIT5|PTKL_PLA	-	1501	3e-31	106.0	0.0	2	3	1.5e-11	2.2e-10	36.8	0.0	1259	1315	108	168	106	174	0.85	Death-associated protein kinase 3 (DB04716; DB07125; DB07242; DB12010)
drugbank_target|O43293	-	454	sp|Q8IIT5|PTKL_PLA	-	1501	3e-31	106.0	0.0	3	3	4.1e-12	6e-11	38.7	0.0	1383	1478	175	272	167	289	0.82	Death-associated protein kinase 3 (DB04716; DB07125; DB07242; DB12010)
drugbank_target|Q16584	-	847	sp|Q8IIT5|PTKL_PLA	-	1501	4.9e-31	105.3	0.0	1	3	1.1e-08	1.6e-07	27.4	0.0	850	921	130	206	112	214	0.83	Mitogen-activated protein kinase kinase kinase 11 (DB12010)
drugbank_target|Q16584	-	847	sp|Q8IIT5|PTKL_PLA	-	1501	4.9e-31	105.3	0.0	2	3	1.3e-07	1.9e-06	23.8	0.0	1263	1314	211	273	206	281	0.79	Mitogen-activated protein kinase kinase kinase 11 (DB12010)
drugbank_target|Q16584	-	847	sp|Q8IIT5|PTKL_PLA	-	1501	4.9e-31	105.3	0.0	3	3	7e-21	1e-19	67.8	0.0	1378	1485	275	382	272	398	0.87	Mitogen-activated protein kinase kinase kinase 11 (DB12010)
drugbank_target|P53667	-	647	sp|Q8IIT5|PTKL_PLA	-	1501	5.9e-31	105.0	5.6	1	3	8.5e-08	1.2e-06	24.4	0.1	852	924	356	429	341	434	0.79	LIM domain kinase 1 (DB08912; DB12010)
drugbank_target|P53667	-	647	sp|Q8IIT5|PTKL_PLA	-	1501	5.9e-31	105.0	5.6	2	3	1.1e-11	1.5e-10	37.4	0.1	1259	1314	429	484	424	493	0.89	LIM domain kinase 1 (DB08912; DB12010)
drugbank_target|P53667	-	647	sp|Q8IIT5|PTKL_PLA	-	1501	5.9e-31	105.0	5.6	3	3	5.7e-13	8.3e-12	41.6	0.0	1378	1483	502	608	493	614	0.92	LIM domain kinase 1 (DB08912; DB12010)
drugbank_target|Q9NQU5	-	681	sp|Q8IIT5|PTKL_PLA	-	1501	5.9e-31	105.0	0.3	1	3	1.3e-10	1.8e-09	33.8	0.3	850	933	422	506	409	507	0.91	Serine/threonine-protein kinase PAK 6 (DB12010)
drugbank_target|Q9NQU5	-	681	sp|Q8IIT5|PTKL_PLA	-	1501	5.9e-31	105.0	0.3	2	3	4.3e-11	6.2e-10	35.3	0.0	1260	1313	496	549	493	554	0.93	Serine/threonine-protein kinase PAK 6 (DB12010)
drugbank_target|Q9NQU5	-	681	sp|Q8IIT5|PTKL_PLA	-	1501	5.9e-31	105.0	0.3	3	3	3.2e-15	4.6e-14	49.0	0.0	1378	1477	554	654	549	661	0.90	Serine/threonine-protein kinase PAK 6 (DB12010)
drugbank_target|P80192	-	1104	sp|Q8IIT5|PTKL_PLA	-	1501	6.2e-31	104.9	20.9	1	3	2.7e-09	3.9e-08	29.4	0.0	839	922	150	234	138	241	0.81	Mitogen-activated protein kinase kinase kinase 9 (DB08703; DB12010)
drugbank_target|P80192	-	1104	sp|Q8IIT5|PTKL_PLA	-	1501	6.2e-31	104.9	20.9	2	3	1.9e-07	2.8e-06	23.2	0.1	1264	1314	239	300	233	308	0.77	Mitogen-activated protein kinase kinase kinase 9 (DB08703; DB12010)
drugbank_target|P80192	-	1104	sp|Q8IIT5|PTKL_PLA	-	1501	6.2e-31	104.9	20.9	3	3	6.7e-20	9.8e-19	64.5	0.0	1379	1484	303	408	299	418	0.90	Mitogen-activated protein kinase kinase kinase 9 (DB08703; DB12010)
drugbank_target|Q9UIK4	-	370	sp|Q8IIT5|PTKL_PLA	-	1501	8.2e-31	104.5	0.1	1	3	1.5e-08	2.2e-07	26.9	0.0	842	923	30	118	10	120	0.80	Death-associated protein kinase 2 (DB12010)
drugbank_target|Q9UIK4	-	370	sp|Q8IIT5|PTKL_PLA	-	1501	8.2e-31	104.5	0.1	2	3	2.4e-12	3.4e-11	39.5	0.0	1258	1314	117	177	115	185	0.85	Death-associated protein kinase 2 (DB12010)
drugbank_target|Q9UIK4	-	370	sp|Q8IIT5|PTKL_PLA	-	1501	8.2e-31	104.5	0.1	3	3	1.5e-11	2.3e-10	36.8	0.0	1383	1478	185	282	177	303	0.85	Death-associated protein kinase 2 (DB12010)
drugbank_target|Q9Y2K2	-	1321	sp|Q8IIT5|PTKL_PLA	-	1501	9.7e-31	104.3	16.5	1	3	1.7e-11	2.4e-10	36.7	1.6	841	920	72	154	67	157	0.84	Serine/threonine-protein kinase SIK3 (DB12010)
drugbank_target|Q9Y2K2	-	1321	sp|Q8IIT5|PTKL_PLA	-	1501	9.7e-31	104.3	16.5	2	3	3.7e-12	5.4e-11	38.9	0.1	1259	1314	157	212	153	218	0.94	Serine/threonine-protein kinase SIK3 (DB12010)
drugbank_target|Q9Y2K2	-	1321	sp|Q8IIT5|PTKL_PLA	-	1501	9.7e-31	104.3	16.5	3	3	2.8e-12	4.1e-11	39.3	0.0	1384	1478	221	314	216	330	0.92	Serine/threonine-protein kinase SIK3 (DB12010)
drugbank_target|O00444	-	970	sp|Q8IIT5|PTKL_PLA	-	1501	1.3e-30	103.9	1.3	1	3	8.2e-08	1.2e-06	24.5	1.1	852	922	29	103	9	107	0.82	Serine/threonine-protein kinase PLK4 (DB12010)
drugbank_target|O00444	-	970	sp|Q8IIT5|PTKL_PLA	-	1501	1.3e-30	103.9	1.3	2	3	4.2e-12	6.1e-11	38.7	0.2	1260	1314	106	160	102	167	0.92	Serine/threonine-protein kinase PLK4 (DB12010)
drugbank_target|O00444	-	970	sp|Q8IIT5|PTKL_PLA	-	1501	1.3e-30	103.9	1.3	3	3	7e-12	1e-10	37.9	0.0	1379	1478	165	262	159	285	0.84	Serine/threonine-protein kinase PLK4 (DB12010)
drugbank_target|Q56UN5	-	1328	sp|Q8IIT5|PTKL_PLA	-	1501	1.3e-30	103.9	4.2	1	3	8.3e-08	1.2e-06	24.4	0.1	838	921	1066	1153	1013	1157	0.73	Mitogen-activated protein kinase kinase kinase 19 (DB12010)
drugbank_target|Q56UN5	-	1328	sp|Q8IIT5|PTKL_PLA	-	1501	1.3e-30	103.9	4.2	2	3	1.4e-09	2.1e-08	30.3	0.0	1261	1314	1157	1210	1149	1221	0.89	Mitogen-activated protein kinase kinase kinase 19 (DB12010)
drugbank_target|Q56UN5	-	1328	sp|Q8IIT5|PTKL_PLA	-	1501	1.3e-30	103.9	4.2	3	3	4e-15	5.8e-14	48.7	0.0	1381	1478	1223	1321	1214	1326	0.91	Mitogen-activated protein kinase kinase kinase 19 (DB12010)
drugbank_target|Q96PY6	-	1258	sp|Q8IIT5|PTKL_PLA	-	1501	1.5e-30	103.6	9.4	1	3	6.6e-09	9.7e-08	28.1	0.1	839	924	8	96	2	99	0.78	Serine/threonine-protein kinase Nek1 (DB12010)
drugbank_target|Q96PY6	-	1258	sp|Q8IIT5|PTKL_PLA	-	1501	1.5e-30	103.6	9.4	2	3	2.6e-12	3.8e-11	39.4	0.1	1255	1317	92	155	90	160	0.88	Serine/threonine-protein kinase Nek1 (DB12010)
drugbank_target|Q96PY6	-	1258	sp|Q8IIT5|PTKL_PLA	-	1501	1.5e-30	103.6	9.4	3	3	3e-13	4.3e-12	42.5	0.0	1381	1478	159	255	155	267	0.93	Serine/threonine-protein kinase Nek1 (DB12010)
drugbank_target|P04626	-	1255	sp|Q8IIT5|PTKL_PLA	-	1501	1.6e-30	103.6	0.0	1	3	9.9e-05	0.0015	14.2	0.0	838	924	725	814	714	817	0.79	Receptor tyrosine-protein kinase erbB-2 (DB00072; DB01259; DB04988; DB05773; DB05944; DB06021; DB06366; DB08916; DB11652; DB11973; DB12010; DB12267; DB15035)
drugbank_target|P04626	-	1255	sp|Q8IIT5|PTKL_PLA	-	1501	1.6e-30	103.6	0.0	2	3	2.2e-12	3.3e-11	39.6	0.0	1255	1317	810	872	808	879	0.92	Receptor tyrosine-protein kinase erbB-2 (DB00072; DB01259; DB04988; DB05773; DB05944; DB06021; DB06366; DB08916; DB11652; DB11973; DB12010; DB12267; DB15035)
drugbank_target|P04626	-	1255	sp|Q8IIT5|PTKL_PLA	-	1501	1.6e-30	103.6	0.0	3	3	4.1e-15	6e-14	48.7	0.0	1388	1485	885	982	873	990	0.93	Receptor tyrosine-protein kinase erbB-2 (DB00072; DB01259; DB04988; DB05773; DB05944; DB06021; DB06366; DB08916; DB11652; DB11973; DB12010; DB12267; DB15035)
drugbank_target|O75385	-	1050	sp|Q8IIT5|PTKL_PLA	-	1501	2.9e-30	102.7	0.3	1	3	2.1e-13	3e-12	43.0	0.7	851	924	30	108	15	109	0.81	Serine/threonine-protein kinase ULK1 (DB12010)
drugbank_target|O75385	-	1050	sp|Q8IIT5|PTKL_PLA	-	1501	2.9e-30	102.7	0.3	2	3	3.4e-11	5e-10	35.7	0.0	1260	1318	108	175	106	179	0.85	Serine/threonine-protein kinase ULK1 (DB12010)
drugbank_target|O75385	-	1050	sp|Q8IIT5|PTKL_PLA	-	1501	2.9e-30	102.7	0.3	3	3	6.6e-12	9.7e-11	38.0	0.0	1381	1475	177	272	171	276	0.89	Serine/threonine-protein kinase ULK1 (DB12010)
drugbank_target|Q8NG66	-	645	sp|Q8IIT5|PTKL_PLA	-	1501	2.9e-30	102.7	0.1	1	3	2.3e-06	3.3e-05	19.7	0.0	858	925	60	125	28	130	0.72	Serine/threonine-protein kinase Nek11 (DB08912; DB12010)
drugbank_target|Q8NG66	-	645	sp|Q8IIT5|PTKL_PLA	-	1501	2.9e-30	102.7	0.1	2	3	1.3e-10	1.9e-09	33.7	0.0	1253	1314	121	181	117	189	0.91	Serine/threonine-protein kinase Nek11 (DB08912; DB12010)
drugbank_target|Q8NG66	-	645	sp|Q8IIT5|PTKL_PLA	-	1501	2.9e-30	102.7	0.1	3	3	8.4e-15	1.2e-13	47.6	0.0	1383	1477	190	283	184	297	0.93	Serine/threonine-protein kinase Nek11 (DB08912; DB12010)
drugbank_target|Q9NYY3	-	685	sp|Q8IIT5|PTKL_PLA	-	1501	4e-30	102.3	0.1	1	3	9.5e-06	0.00014	17.6	1.2	847	924	94	175	82	177	0.81	Serine/threonine-protein kinase PLK2 (DB12010)
drugbank_target|Q9NYY3	-	685	sp|Q8IIT5|PTKL_PLA	-	1501	4e-30	102.3	0.1	2	3	5.6e-11	8.2e-10	34.9	0.0	1258	1317	173	232	170	238	0.91	Serine/threonine-protein kinase PLK2 (DB12010)
drugbank_target|Q9NYY3	-	685	sp|Q8IIT5|PTKL_PLA	-	1501	4e-30	102.3	0.1	3	3	1.3e-14	1.9e-13	47.0	0.0	1382	1477	237	330	231	336	0.92	Serine/threonine-protein kinase PLK2 (DB12010)
drugbank_target|Q9C098	-	648	sp|Q8IIT5|PTKL_PLA	-	1501	4.6e-30	102.1	0.1	1	3	6.3e-09	9.2e-08	28.2	0.1	840	920	363	443	347	449	0.78	Serine/threonine-protein kinase DCLK3 (DB12010)
drugbank_target|Q9C098	-	648	sp|Q8IIT5|PTKL_PLA	-	1501	4.6e-30	102.1	0.1	2	3	9.6e-10	1.4e-08	30.9	0.1	1262	1314	449	505	444	510	0.85	Serine/threonine-protein kinase DCLK3 (DB12010)
drugbank_target|Q9C098	-	648	sp|Q8IIT5|PTKL_PLA	-	1501	4.6e-30	102.1	0.1	3	3	2.2e-12	3.2e-11	39.6	0.0	1384	1483	512	617	507	632	0.83	Serine/threonine-protein kinase DCLK3 (DB12010)
drugbank_target|O75716	-	305	sp|Q8IIT5|PTKL_PLA	-	1501	4.8e-30	102.0	0.0	1	2	1.7e-19	2.5e-18	63.2	0.0	1206	1313	63	171	47	183	0.91	Serine/threonine-protein kinase 16 (DB12010)
drugbank_target|O75716	-	305	sp|Q8IIT5|PTKL_PLA	-	1501	4.8e-30	102.0	0.0	2	2	1.3e-11	1.9e-10	37.1	0.0	1385	1483	192	294	177	304	0.84	Serine/threonine-protein kinase 16 (DB12010)
drugbank_target|O94768	-	372	sp|Q8IIT5|PTKL_PLA	-	1501	4.9e-30	102.0	0.9	1	3	3.5e-05	0.00051	15.7	0.0	839	918	37	120	16	127	0.77	Serine/threonine-protein kinase 17B (DB04216; DB12010)
drugbank_target|O94768	-	372	sp|Q8IIT5|PTKL_PLA	-	1501	4.9e-30	102.0	0.9	2	3	1.1e-12	1.7e-11	40.6	0.0	1260	1314	128	185	121	193	0.89	Serine/threonine-protein kinase 17B (DB04216; DB12010)
drugbank_target|O94768	-	372	sp|Q8IIT5|PTKL_PLA	-	1501	4.9e-30	102.0	0.9	3	3	1.8e-13	2.6e-12	43.2	0.0	1383	1477	193	289	187	299	0.87	Serine/threonine-protein kinase 17B (DB04216; DB12010)
drugbank_target|Q9H1R3	-	596	sp|Q8IIT5|PTKL_PLA	-	1501	6.1e-30	101.7	0.5	1	3	1e-09	1.5e-08	30.8	0.1	839	921	291	372	269	377	0.76	Myosin light chain kinase 2, skeletal/cardiac muscle (DB04825; DB12010)
drugbank_target|Q9H1R3	-	596	sp|Q8IIT5|PTKL_PLA	-	1501	6.1e-30	101.7	0.5	2	3	2.1e-11	3e-10	36.4	0.0	1254	1318	370	436	368	443	0.87	Myosin light chain kinase 2, skeletal/cardiac muscle (DB04825; DB12010)
drugbank_target|Q9H1R3	-	596	sp|Q8IIT5|PTKL_PLA	-	1501	6.1e-30	101.7	0.5	3	3	1.6e-10	2.3e-09	33.5	0.0	1384	1487	441	548	432	558	0.86	Myosin light chain kinase 2, skeletal/cardiac muscle (DB04825; DB12010)
drugbank_target|O14757	-	476	sp|Q8IIT5|PTKL_PLA	-	1501	6.5e-30	101.6	1.2	1	3	1.7e-07	2.5e-06	23.4	0.1	848	920	22	96	10	99	0.83	Serine/threonine-protein kinase Chk1 (DB05149; DB06486; DB06852; DB06876; DB07025; DB07034; DB07037; DB07038; DB07075; DB07078; DB07158; DB07213; DB07228; DB07243; DB07311; DB07314; DB07320; DB07336; DB07647; DB07648; DB07653; DB07654; DB07655; DB07959; DB08392; DB08393; DB08683; DB08774; DB08776; DB08777; DB08778; DB08779; DB08780; DB08781; DB12010)
drugbank_target|O14757	-	476	sp|Q8IIT5|PTKL_PLA	-	1501	6.5e-30	101.6	1.2	2	3	3.7e-11	5.4e-10	35.5	0.0	1263	1314	103	154	97	161	0.91	Serine/threonine-protein kinase Chk1 (DB05149; DB06486; DB06852; DB06876; DB07025; DB07034; DB07037; DB07038; DB07075; DB07078; DB07158; DB07213; DB07228; DB07243; DB07311; DB07314; DB07320; DB07336; DB07647; DB07648; DB07653; DB07654; DB07655; DB07959; DB08392; DB08393; DB08683; DB08774; DB08776; DB08777; DB08778; DB08779; DB08780; DB08781; DB12010)
drugbank_target|O14757	-	476	sp|Q8IIT5|PTKL_PLA	-	1501	6.5e-30	101.6	1.2	3	3	1.6e-12	2.4e-11	40.0	0.0	1382	1478	164	262	154	275	0.85	Serine/threonine-protein kinase Chk1 (DB05149; DB06486; DB06852; DB06876; DB07025; DB07034; DB07037; DB07038; DB07075; DB07078; DB07158; DB07213; DB07228; DB07243; DB07311; DB07314; DB07320; DB07336; DB07647; DB07648; DB07653; DB07654; DB07655; DB07959; DB08392; DB08393; DB08683; DB08774; DB08776; DB08777; DB08778; DB08779; DB08780; DB08781; DB12010)
drugbank_target|P53671	-	638	sp|Q8IIT5|PTKL_PLA	-	1501	9e-30	101.1	2.6	1	3	4e-10	5.9e-09	32.1	0.2	851	923	347	420	322	422	0.85	LIM domain kinase 2 (DB12010)
drugbank_target|P53671	-	638	sp|Q8IIT5|PTKL_PLA	-	1501	9e-30	101.1	2.6	2	3	2.1e-09	3.1e-08	29.7	0.0	1264	1314	425	475	420	486	0.92	LIM domain kinase 2 (DB12010)
drugbank_target|P53671	-	638	sp|Q8IIT5|PTKL_PLA	-	1501	9e-30	101.1	2.6	3	3	1e-11	1.5e-10	37.4	0.0	1372	1482	493	604	483	607	0.88	LIM domain kinase 2 (DB12010)
drugbank_target|Q9NRP7	-	1315	sp|Q8IIT5|PTKL_PLA	-	1501	1.5e-29	100.4	0.0	1	3	2.7e-08	4e-07	26.1	0.0	852	920	21	91	5	94	0.83	Serine/threonine-protein kinase 36 (DB12010)
drugbank_target|Q9NRP7	-	1315	sp|Q8IIT5|PTKL_PLA	-	1501	1.5e-29	100.4	0.0	2	3	8.8e-14	1.3e-12	44.2	0.0	1254	1320	89	155	86	160	0.92	Serine/threonine-protein kinase 36 (DB12010)
drugbank_target|Q9NRP7	-	1315	sp|Q8IIT5|PTKL_PLA	-	1501	1.5e-29	100.4	0.0	3	3	4.9e-09	7.2e-08	28.5	0.0	1383	1475	158	248	152	253	0.90	Serine/threonine-protein kinase 36 (DB12010)
drugbank_target|Q8NFD2	-	765	sp|Q8IIT5|PTKL_PLA	-	1501	3.4e-29	99.2	0.1	1	3	6.4e-06	9.3e-05	18.2	0.0	859	923	46	113	30	119	0.78	Ankyrin repeat and protein kinase domain-containing protein 1 (DB12010)
drugbank_target|Q8NFD2	-	765	sp|Q8IIT5|PTKL_PLA	-	1501	3.4e-29	99.2	0.1	2	3	1.7e-10	2.5e-09	33.3	0.0	1267	1317	120	172	111	179	0.86	Ankyrin repeat and protein kinase domain-containing protein 1 (DB12010)
drugbank_target|Q8NFD2	-	765	sp|Q8IIT5|PTKL_PLA	-	1501	3.4e-29	99.2	0.1	3	3	3.2e-14	4.7e-13	45.7	0.0	1374	1482	173	288	169	300	0.77	Ankyrin repeat and protein kinase domain-containing protein 1 (DB12010)
drugbank_target|Q9UEE5	-	414	sp|Q8IIT5|PTKL_PLA	-	1501	3.8e-29	99.0	0.1	1	3	0.00042	0.0061	12.2	0.0	841	918	67	148	64	151	0.75	Serine/threonine-protein kinase 17A (DB12010)
drugbank_target|Q9UEE5	-	414	sp|Q8IIT5|PTKL_PLA	-	1501	3.8e-29	99.0	0.1	2	3	9.4e-14	1.4e-12	44.1	0.0	1253	1316	149	215	147	222	0.89	Serine/threonine-protein kinase 17A (DB12010)
drugbank_target|Q9UEE5	-	414	sp|Q8IIT5|PTKL_PLA	-	1501	3.8e-29	99.0	0.1	3	3	1.2e-12	1.8e-11	40.5	0.0	1383	1478	221	318	215	339	0.85	Serine/threonine-protein kinase 17A (DB12010)
drugbank_target|Q8IYT8	-	1036	sp|Q8IIT5|PTKL_PLA	-	1501	4.3e-29	98.8	0.4	1	3	9e-13	1.3e-11	40.9	0.1	852	922	24	99	9	102	0.80	Serine/threonine-protein kinase ULK2 (DB12010)
drugbank_target|Q8IYT8	-	1036	sp|Q8IIT5|PTKL_PLA	-	1501	4.3e-29	98.8	0.4	2	3	3.8e-11	5.5e-10	35.5	0.0	1259	1318	100	168	98	173	0.80	Serine/threonine-protein kinase ULK2 (DB12010)
drugbank_target|Q8IYT8	-	1036	sp|Q8IIT5|PTKL_PLA	-	1501	4.3e-29	98.8	0.4	3	3	1.4e-11	2e-10	37.0	0.0	1381	1475	170	265	165	272	0.88	Serine/threonine-protein kinase ULK2 (DB12010)
drugbank_target|P21860	-	1342	sp|Q8IIT5|PTKL_PLA	-	1501	4.6e-29	98.8	0.0	1	3	0.00025	0.0036	12.9	0.0	837	924	713	803	696	806	0.78	Receptor tyrosine-protein kinase erbB-3 (DB11652)
drugbank_target|P21860	-	1342	sp|Q8IIT5|PTKL_PLA	-	1501	4.6e-29	98.8	0.0	2	3	2.5e-11	3.7e-10	36.1	0.0	1257	1325	801	869	798	873	0.91	Receptor tyrosine-protein kinase erbB-3 (DB11652)
drugbank_target|P21860	-	1342	sp|Q8IIT5|PTKL_PLA	-	1501	4.6e-29	98.8	0.0	3	3	6.8e-15	1e-13	47.9	0.0	1387	1484	873	970	868	974	0.94	Receptor tyrosine-protein kinase erbB-3 (DB11652)
drugbank_target|Q16816	-	387	sp|Q8IIT5|PTKL_PLA	-	1501	5.1e-29	98.6	0.0	1	3	5e-06	7.4e-05	18.5	0.0	854	922	39	118	21	122	0.71	Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform (DB12010)
drugbank_target|Q16816	-	387	sp|Q8IIT5|PTKL_PLA	-	1501	5.1e-29	98.6	0.0	2	3	3.9e-13	5.8e-12	42.1	0.1	1259	1314	119	174	116	181	0.93	Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform (DB12010)
drugbank_target|Q16816	-	387	sp|Q8IIT5|PTKL_PLA	-	1501	5.1e-29	98.6	0.0	3	3	3.8e-11	5.5e-10	35.5	0.0	1383	1477	182	284	178	295	0.85	Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform (DB12010)
drugbank_target|Q8IVH8	-	894	sp|Q8IIT5|PTKL_PLA	-	1501	6.6e-29	98.2	0.0	1	3	4.4e-08	6.5e-07	25.3	0.0	852	922	33	104	16	107	0.86	Mitogen-activated protein kinase kinase kinase kinase 3 (DB12010)
drugbank_target|Q8IVH8	-	894	sp|Q8IIT5|PTKL_PLA	-	1501	6.6e-29	98.2	0.0	2	3	2.5e-10	3.6e-09	32.8	0.0	1261	1314	107	160	101	166	0.91	Mitogen-activated protein kinase kinase kinase kinase 3 (DB12010)
drugbank_target|Q8IVH8	-	894	sp|Q8IIT5|PTKL_PLA	-	1501	6.6e-29	98.2	0.0	3	3	1.1e-11	1.7e-10	37.2	0.0	1379	1478	165	270	160	286	0.83	Mitogen-activated protein kinase kinase kinase kinase 3 (DB12010)
drugbank_target|Q13555	-	558	sp|Q8IIT5|PTKL_PLA	-	1501	7.4e-29	98.1	0.0	1	3	3.1e-07	4.5e-06	22.6	0.0	836	921	15	103	5	109	0.83	Calcium/calmodulin-dependent protein kinase type II subunit gamma (DB06616; DB08699; DB12010)
drugbank_target|Q13555	-	558	sp|Q8IIT5|PTKL_PLA	-	1501	7.4e-29	98.1	0.0	2	3	5.7e-10	8.3e-09	31.6	0.1	1262	1313	108	162	103	171	0.86	Calcium/calmodulin-dependent protein kinase type II subunit gamma (DB06616; DB08699; DB12010)
drugbank_target|Q13555	-	558	sp|Q8IIT5|PTKL_PLA	-	1501	7.4e-29	98.1	0.0	3	3	9.9e-13	1.5e-11	40.7	0.0	1385	1478	174	269	163	284	0.88	Calcium/calmodulin-dependent protein kinase type II subunit gamma (DB06616; DB08699; DB12010)
drugbank_target|Q9UKE5	-	1360	sp|Q8IIT5|PTKL_PLA	-	1501	1e-28	97.6	22.6	1	3	7.2e-06	0.00011	18.0	0.0	846	924	38	121	28	123	0.82	TRAF2 and NCK-interacting protein kinase (DB12010)
drugbank_target|Q9UKE5	-	1360	sp|Q8IIT5|PTKL_PLA	-	1501	1e-28	97.6	22.6	2	3	7.4e-13	1.1e-11	41.2	0.0	1256	1314	119	177	117	183	0.93	TRAF2 and NCK-interacting protein kinase (DB12010)
drugbank_target|Q9UKE5	-	1360	sp|Q8IIT5|PTKL_PLA	-	1501	1e-28	97.6	22.6	3	3	5.2e-15	7.6e-14	48.3	0.0	1380	1495	183	303	176	309	0.82	TRAF2 and NCK-interacting protein kinase (DB12010)
drugbank_target|P51957	-	841	sp|Q8IIT5|PTKL_PLA	-	1501	1.1e-28	97.5	0.4	1	3	1.7e-06	2.5e-05	20.1	0.0	842	924	13	99	8	103	0.83	Serine/threonine-protein kinase Nek4 (DB12010)
drugbank_target|P51957	-	841	sp|Q8IIT5|PTKL_PLA	-	1501	1.1e-28	97.5	0.4	2	3	1.3e-12	1.8e-11	40.4	0.2	1256	1320	97	162	93	166	0.88	Serine/threonine-protein kinase Nek4 (DB12010)
drugbank_target|P51957	-	841	sp|Q8IIT5|PTKL_PLA	-	1501	1.1e-28	97.5	0.4	3	3	8.7e-16	1.3e-14	50.9	0.0	1381	1478	162	258	157	282	0.92	Serine/threonine-protein kinase Nek4 (DB12010)
drugbank_target|Q8N4C8	-	1332	sp|Q8IIT5|PTKL_PLA	-	1501	1.2e-28	97.3	0.0	1	3	2.4e-06	3.4e-05	19.6	0.0	842	925	34	122	26	126	0.81	Misshapen-like kinase 1 (DB12010)
drugbank_target|Q8N4C8	-	1332	sp|Q8IIT5|PTKL_PLA	-	1501	1.2e-28	97.3	0.0	2	3	1.4e-12	2.1e-11	40.2	0.1	1256	1314	119	177	116	182	0.93	Misshapen-like kinase 1 (DB12010)
drugbank_target|Q8N4C8	-	1332	sp|Q8IIT5|PTKL_PLA	-	1501	1.2e-28	97.3	0.0	3	3	3.8e-11	5.6e-10	35.5	0.0	1380	1478	183	286	178	308	0.83	Misshapen-like kinase 1 (DB12010)
drugbank_target|P53355	-	1430	sp|Q8IIT5|PTKL_PLA	-	1501	1.4e-28	97.1	0.1	1	3	4.1e-08	6e-07	25.5	0.1	844	923	22	108	13	110	0.81	Death-associated protein kinase 1 (DB04069; DB04395; DB07444; DB12010)
drugbank_target|P53355	-	1430	sp|Q8IIT5|PTKL_PLA	-	1501	1.4e-28	97.1	0.1	2	3	2.6e-10	3.8e-09	32.7	0.0	1259	1314	108	167	106	174	0.86	Death-associated protein kinase 1 (DB04069; DB04395; DB07444; DB12010)
drugbank_target|P53355	-	1430	sp|Q8IIT5|PTKL_PLA	-	1501	1.4e-28	97.1	0.1	3	3	2.1e-11	3e-10	36.4	0.0	1383	1477	175	271	170	289	0.87	Death-associated protein kinase 1 (DB04069; DB04395; DB07444; DB12010)
drugbank_target|O43353	-	540	sp|Q8IIT5|PTKL_PLA	-	1501	1.5e-28	97.0	0.0	1	3	5.6e-08	8.2e-07	25.0	0.0	858	923	41	110	29	120	0.83	Receptor-interacting serine/threonine-protein kinase 2 (DB12010)
drugbank_target|O43353	-	540	sp|Q8IIT5|PTKL_PLA	-	1501	1.5e-28	97.0	0.0	2	3	1.7e-10	2.5e-09	33.3	0.0	1269	1315	123	171	114	184	0.90	Receptor-interacting serine/threonine-protein kinase 2 (DB12010)
drugbank_target|O43353	-	540	sp|Q8IIT5|PTKL_PLA	-	1501	1.5e-28	97.0	0.0	3	3	3.8e-11	5.6e-10	35.5	0.0	1385	1484	186	295	171	310	0.76	Receptor-interacting serine/threonine-protein kinase 2 (DB12010)
drugbank_target|Q9Y4K4	-	846	sp|Q8IIT5|PTKL_PLA	-	1501	2.4e-28	96.4	0.0	1	3	1e-07	1.5e-06	24.2	0.0	844	921	31	107	8	110	0.83	Mitogen-activated protein kinase kinase kinase kinase 5 (DB12010)
drugbank_target|Q9Y4K4	-	846	sp|Q8IIT5|PTKL_PLA	-	1501	2.4e-28	96.4	0.0	2	3	2e-10	2.9e-09	33.1	0.0	1261	1314	111	164	105	172	0.89	Mitogen-activated protein kinase kinase kinase kinase 5 (DB12010)
drugbank_target|Q9Y4K4	-	846	sp|Q8IIT5|PTKL_PLA	-	1501	2.4e-28	96.4	0.0	3	3	2.2e-11	3.3e-10	36.3	0.0	1379	1478	169	274	163	281	0.85	Mitogen-activated protein kinase kinase kinase kinase 5 (DB12010)
drugbank_target|Q15139	-	912	sp|Q8IIT5|PTKL_PLA	-	1501	4.1e-28	95.6	0.0	1	3	5.8e-07	8.5e-06	21.6	0.0	853	924	601	675	565	678	0.84	Serine/threonine-protein kinase D1 (DB11752; DB12010)
drugbank_target|Q15139	-	912	sp|Q8IIT5|PTKL_PLA	-	1501	4.1e-28	95.6	0.0	2	3	7.2e-11	1.1e-09	34.6	0.0	1255	1314	671	733	666	738	0.88	Serine/threonine-protein kinase D1 (DB11752; DB12010)
drugbank_target|Q15139	-	912	sp|Q8IIT5|PTKL_PLA	-	1501	4.1e-28	95.6	0.0	3	3	7.9e-12	1.2e-10	37.8	0.0	1381	1477	739	835	733	844	0.85	Serine/threonine-protein kinase D1 (DB11752; DB12010)
drugbank_target|O96013	-	591	sp|Q8IIT5|PTKL_PLA	-	1501	4.4e-28	95.5	0.0	1	3	4.3e-09	6.3e-08	28.7	0.1	844	924	330	411	318	413	0.86	Serine/threonine-protein kinase PAK 4 (DB12010)
drugbank_target|O96013	-	591	sp|Q8IIT5|PTKL_PLA	-	1501	4.4e-28	95.5	0.0	2	3	4.7e-11	6.9e-10	35.2	0.0	1258	1313	408	463	405	470	0.94	Serine/threonine-protein kinase PAK 4 (DB12010)
drugbank_target|O96013	-	591	sp|Q8IIT5|PTKL_PLA	-	1501	4.4e-28	95.5	0.0	3	3	9.5e-14	1.4e-12	44.1	0.0	1379	1478	469	569	464	574	0.91	Serine/threonine-protein kinase PAK 4 (DB12010)
drugbank_target|P17612	-	351	sp|Q8IIT5|PTKL_PLA	-	1501	4.8e-28	95.4	0.1	1	3	3.9e-07	5.6e-06	22.2	0.5	837	923	46	136	35	139	0.81	cAMP-dependent protein kinase catalytic subunit alpha (DB01919; DB01940; DB02155; DB02482; DB02611; DB03374; DB04098; DB04522; DB04530; DB04707; DB06959; DB06977; DB07107; DB07124; DB07204; DB07235; DB07458; DB07583; DB07854; DB07855; DB07856; DB07857; DB07858; DB07859; DB07860; DB07876; DB07947; DB07995; DB07996; DB07997; DB08070; DB08073; DB08113; DB08114; DB08148; DB08149; DB08150; DB08162; DB08231; DB08568; DB08569; DB08756; DB08846; DB12010)
drugbank_target|P17612	-	351	sp|Q8IIT5|PTKL_PLA	-	1501	4.8e-28	95.4	0.1	2	3	1.2e-10	1.7e-09	33.9	0.0	1261	1315	138	192	135	198	0.93	cAMP-dependent protein kinase catalytic subunit alpha (DB01919; DB01940; DB02155; DB02482; DB02611; DB03374; DB04098; DB04522; DB04530; DB04707; DB06959; DB06977; DB07107; DB07124; DB07204; DB07235; DB07458; DB07583; DB07854; DB07855; DB07856; DB07857; DB07858; DB07859; DB07860; DB07876; DB07947; DB07995; DB07996; DB07997; DB08070; DB08073; DB08113; DB08114; DB08148; DB08149; DB08150; DB08162; DB08231; DB08568; DB08569; DB08756; DB08846; DB12010)
drugbank_target|P17612	-	351	sp|Q8IIT5|PTKL_PLA	-	1501	4.8e-28	95.4	0.1	3	3	2.5e-11	3.7e-10	36.1	0.0	1384	1470	198	282	191	303	0.90	cAMP-dependent protein kinase catalytic subunit alpha (DB01919; DB01940; DB02155; DB02482; DB02611; DB03374; DB04098; DB04522; DB04530; DB04707; DB06959; DB06977; DB07107; DB07124; DB07204; DB07235; DB07458; DB07583; DB07854; DB07855; DB07856; DB07857; DB07858; DB07859; DB07860; DB07876; DB07947; DB07995; DB07996; DB07997; DB08070; DB08073; DB08113; DB08114; DB08148; DB08149; DB08150; DB08162; DB08231; DB08568; DB08569; DB08756; DB08846; DB12010)
drugbank_target|Q9UQM7	-	478	sp|Q8IIT5|PTKL_PLA	-	1501	4.9e-28	95.3	0.0	1	3	5.5e-07	8e-06	21.7	0.0	836	922	14	103	3	110	0.83	Calcium/calmodulin-dependent protein kinase type II subunit alpha (DB04119; DB04447; DB07766; DB12010)
drugbank_target|Q9UQM7	-	478	sp|Q8IIT5|PTKL_PLA	-	1501	4.9e-28	95.3	0.0	2	3	5.3e-10	7.7e-09	31.7	0.0	1262	1313	107	161	101	171	0.86	Calcium/calmodulin-dependent protein kinase type II subunit alpha (DB04119; DB04447; DB07766; DB12010)
drugbank_target|Q9UQM7	-	478	sp|Q8IIT5|PTKL_PLA	-	1501	4.9e-28	95.3	0.0	3	3	3.8e-12	5.5e-11	38.8	0.0	1385	1478	173	268	164	283	0.88	Calcium/calmodulin-dependent protein kinase type II subunit alpha (DB04119; DB04447; DB07766; DB12010)
drugbank_target|P20594	-	1047	sp|Q8IIT5|PTKL_PLA	-	1501	5.1e-28	95.3	0.0	1	3	1.3e-09	1.9e-08	30.4	0.0	851	923	538	611	522	620	0.86	Atrial natriuretic peptide receptor 2 (DB01613; DB04899)
drugbank_target|P20594	-	1047	sp|Q8IIT5|PTKL_PLA	-	1501	5.1e-28	95.3	0.0	2	3	5.7e-06	8.3e-05	18.3	0.0	1268	1318	621	672	609	685	0.83	Atrial natriuretic peptide receptor 2 (DB01613; DB04899)
drugbank_target|P20594	-	1047	sp|Q8IIT5|PTKL_PLA	-	1501	5.1e-28	95.3	0.0	3	3	9.6e-14	1.4e-12	44.1	0.0	1384	1499	679	806	670	808	0.85	Atrial natriuretic peptide receptor 2 (DB01613; DB04899)
drugbank_target|Q13557	-	499	sp|Q8IIT5|PTKL_PLA	-	1501	9.2e-28	94.4	0.0	1	3	5.7e-07	8.3e-06	21.7	0.0	836	921	15	103	4	109	0.84	Calcium/calmodulin-dependent protein kinase type II subunit delta (DB07853; DB08039; DB12010)
drugbank_target|Q13557	-	499	sp|Q8IIT5|PTKL_PLA	-	1501	9.2e-28	94.4	0.0	2	3	1.7e-09	2.5e-08	30.1	0.0	1262	1313	108	162	102	174	0.86	Calcium/calmodulin-dependent protein kinase type II subunit delta (DB07853; DB08039; DB12010)
drugbank_target|Q13557	-	499	sp|Q8IIT5|PTKL_PLA	-	1501	9.2e-28	94.4	0.0	3	3	2e-12	2.9e-11	39.8	0.0	1385	1478	174	269	163	286	0.87	Calcium/calmodulin-dependent protein kinase type II subunit delta (DB07853; DB08039; DB12010)
drugbank_target|P22694	-	351	sp|Q8IIT5|PTKL_PLA	-	1501	9.6e-28	94.4	0.1	1	3	8.9e-07	1.3e-05	21.0	0.7	848	923	57	136	41	139	0.79	cAMP-dependent protein kinase catalytic subunit beta (DB02482; DB12010)
drugbank_target|P22694	-	351	sp|Q8IIT5|PTKL_PLA	-	1501	9.6e-28	94.4	0.1	2	3	1.4e-10	2.1e-09	33.6	0.0	1261	1314	138	191	135	197	0.93	cAMP-dependent protein kinase catalytic subunit beta (DB02482; DB12010)
drugbank_target|P22694	-	351	sp|Q8IIT5|PTKL_PLA	-	1501	9.6e-28	94.4	0.1	3	3	2.4e-11	3.5e-10	36.2	0.0	1384	1470	198	282	192	303	0.89	cAMP-dependent protein kinase catalytic subunit beta (DB02482; DB12010)
drugbank_target|O15530	-	556	sp|Q8IIT5|PTKL_PLA	-	1501	1e-27	94.2	0.0	1	3	2.4e-05	0.00034	16.3	0.0	851	923	98	174	83	182	0.82	3-phosphoinositide-dependent protein kinase 1 (DB00482; DB01863; DB01933; DB01946; DB02010; DB03777; DB04522; DB06932; DB07033; DB07132; DB07300; DB07456; DB07457; DB12010)
drugbank_target|O15530	-	556	sp|Q8IIT5|PTKL_PLA	-	1501	1e-27	94.2	0.0	2	3	1.4e-13	2e-12	43.6	0.0	1263	1315	178	230	172	237	0.90	3-phosphoinositide-dependent protein kinase 1 (DB00482; DB01863; DB01933; DB01946; DB02010; DB03777; DB04522; DB06932; DB07033; DB07132; DB07300; DB07456; DB07457; DB12010)
drugbank_target|O15530	-	556	sp|Q8IIT5|PTKL_PLA	-	1501	1e-27	94.2	0.0	3	3	6.6e-10	9.7e-09	31.4	0.0	1378	1475	235	330	231	333	0.91	3-phosphoinositide-dependent protein kinase 1 (DB00482; DB01863; DB01933; DB01946; DB02010; DB03777; DB04522; DB06932; DB07033; DB07132; DB07300; DB07456; DB07457; DB12010)
drugbank_target|Q9UL54	-	1235	sp|Q8IIT5|PTKL_PLA	-	1501	1.1e-27	94.2	6.2	1	3	5.1e-06	7.4e-05	18.5	0.0	853	913	46	110	29	121	0.77	Serine/threonine-protein kinase TAO2 (DB04522; DB12010)
drugbank_target|Q9UL54	-	1235	sp|Q8IIT5|PTKL_PLA	-	1501	1.1e-27	94.2	6.2	2	3	4.9e-11	7.2e-10	35.1	0.0	1255	1315	116	176	109	180	0.91	Serine/threonine-protein kinase TAO2 (DB04522; DB12010)
drugbank_target|Q9UL54	-	1235	sp|Q8IIT5|PTKL_PLA	-	1501	1.1e-27	94.2	6.2	3	3	1.9e-13	2.7e-12	43.2	0.0	1382	1490	179	290	176	300	0.82	Serine/threonine-protein kinase TAO2 (DB04522; DB12010)
drugbank_target|P31751	-	481	sp|Q8IIT5|PTKL_PLA	-	1501	1.2e-27	94.1	0.0	1	3	1.6e-05	0.00023	16.9	0.0	841	923	158	244	145	250	0.80	RAC-beta serine/threonine-protein kinase (DB07812; DB07859; DB07947; DB08073)
drugbank_target|P31751	-	481	sp|Q8IIT5|PTKL_PLA	-	1501	1.2e-27	94.1	0.0	2	3	8.7e-11	1.3e-09	34.3	0.0	1260	1313	245	298	242	307	0.91	RAC-beta serine/threonine-protein kinase (DB07812; DB07859; DB07947; DB08073)
drugbank_target|P31751	-	481	sp|Q8IIT5|PTKL_PLA	-	1501	1.2e-27	94.1	0.0	3	3	1.3e-12	1.9e-11	40.4	0.0	1379	1470	304	393	299	399	0.92	RAC-beta serine/threonine-protein kinase (DB07812; DB07859; DB07947; DB08073)
drugbank_target|P24941	-	298	sp|Q8IIT5|PTKL_PLA	-	1501	1.3e-27	94.0	0.2	1	3	2.6e-09	3.8e-08	29.4	0.1	836	920	5	91	2	98	0.80	Cyclin-dependent kinase 2 (DB01888; DB02010; DB02052; DB02091; DB02116; DB02197; DB02297; DB02407; DB02538; DB02603; DB02647; DB02733; DB02833; DB02898; DB02915; DB02950; DB02963; DB02973; DB03019; DB03307; DB03365; DB03428; DB03490; DB03496; DB03583; DB03663; DB03737; DB03801; DB04006; DB04101; DB04186; DB04288; DB04407; DB04518; DB04607; DB04662; DB04669; DB06195; DB06616; DB06844; DB06888; DB06944; DB06948; DB06976; DB06983; DB07024; DB07054; DB07065; DB07126; DB07137; DB07163; DB07164; DB07179; DB07203; DB07210; DB07220; DB07431; DB07471; DB07493; DB07501; DB07504; DB07529; DB07531; DB07533; DB07534; DB07538; DB07539; DB07540; DB07562; DB07595; DB07606; DB07612; DB07618; DB07622; DB07685; DB07686; DB07687; DB07688; DB07731; DB07750; DB07751; DB07755; DB07761; DB07790; DB07791; DB07852; DB07889; DB07936; DB07982; DB08066; DB08094; DB08122; DB08123; DB08124; DB08125; DB08126; DB08132; DB08133; DB08134; DB08135; DB08136; DB08137; DB08138; DB08139; DB08140; DB08141; DB08142; DB08178; DB08182; DB08218; DB08219; DB08233; DB08241; DB08247; DB08248; DB08285; DB08309; DB08312; DB08355; DB08441; DB08463; DB08527; DB08531; DB08532; DB08533; DB08534; DB08535; DB08536; DB08537; DB08538; DB08539; DB08572; DB08673; DB08677; DB08694; DB08768)
drugbank_target|P24941	-	298	sp|Q8IIT5|PTKL_PLA	-	1501	1.3e-27	94.0	0.2	2	3	2.3e-11	3.4e-10	36.2	0.0	1266	1314	103	151	93	156	0.92	Cyclin-dependent kinase 2 (DB01888; DB02010; DB02052; DB02091; DB02116; DB02197; DB02297; DB02407; DB02538; DB02603; DB02647; DB02733; DB02833; DB02898; DB02915; DB02950; DB02963; DB02973; DB03019; DB03307; DB03365; DB03428; DB03490; DB03496; DB03583; DB03663; DB03737; DB03801; DB04006; DB04101; DB04186; DB04288; DB04407; DB04518; DB04607; DB04662; DB04669; DB06195; DB06616; DB06844; DB06888; DB06944; DB06948; DB06976; DB06983; DB07024; DB07054; DB07065; DB07126; DB07137; DB07163; DB07164; DB07179; DB07203; DB07210; DB07220; DB07431; DB07471; DB07493; DB07501; DB07504; DB07529; DB07531; DB07533; DB07534; DB07538; DB07539; DB07540; DB07562; DB07595; DB07606; DB07612; DB07618; DB07622; DB07685; DB07686; DB07687; DB07688; DB07731; DB07750; DB07751; DB07755; DB07761; DB07790; DB07791; DB07852; DB07889; DB07936; DB07982; DB08066; DB08094; DB08122; DB08123; DB08124; DB08125; DB08126; DB08132; DB08133; DB08134; DB08135; DB08136; DB08137; DB08138; DB08139; DB08140; DB08141; DB08142; DB08178; DB08182; DB08218; DB08219; DB08233; DB08241; DB08247; DB08248; DB08285; DB08309; DB08312; DB08355; DB08441; DB08463; DB08527; DB08531; DB08532; DB08533; DB08534; DB08535; DB08536; DB08537; DB08538; DB08539; DB08572; DB08673; DB08677; DB08694; DB08768)
drugbank_target|P24941	-	298	sp|Q8IIT5|PTKL_PLA	-	1501	1.3e-27	94.0	0.2	3	3	4.7e-08	6.8e-07	25.3	0.0	1381	1433	159	210	153	280	0.88	Cyclin-dependent kinase 2 (DB01888; DB02010; DB02052; DB02091; DB02116; DB02197; DB02297; DB02407; DB02538; DB02603; DB02647; DB02733; DB02833; DB02898; DB02915; DB02950; DB02963; DB02973; DB03019; DB03307; DB03365; DB03428; DB03490; DB03496; DB03583; DB03663; DB03737; DB03801; DB04006; DB04101; DB04186; DB04288; DB04407; DB04518; DB04607; DB04662; DB04669; DB06195; DB06616; DB06844; DB06888; DB06944; DB06948; DB06976; DB06983; DB07024; DB07054; DB07065; DB07126; DB07137; DB07163; DB07164; DB07179; DB07203; DB07210; DB07220; DB07431; DB07471; DB07493; DB07501; DB07504; DB07529; DB07531; DB07533; DB07534; DB07538; DB07539; DB07540; DB07562; DB07595; DB07606; DB07612; DB07618; DB07622; DB07685; DB07686; DB07687; DB07688; DB07731; DB07750; DB07751; DB07755; DB07761; DB07790; DB07791; DB07852; DB07889; DB07936; DB07982; DB08066; DB08094; DB08122; DB08123; DB08124; DB08125; DB08126; DB08132; DB08133; DB08134; DB08135; DB08136; DB08137; DB08138; DB08139; DB08140; DB08141; DB08142; DB08178; DB08182; DB08218; DB08219; DB08233; DB08241; DB08247; DB08248; DB08285; DB08309; DB08312; DB08355; DB08441; DB08463; DB08527; DB08531; DB08532; DB08533; DB08534; DB08535; DB08536; DB08537; DB08538; DB08539; DB08572; DB08673; DB08677; DB08694; DB08768)
drugbank_target|Q9BYT3	-	514	sp|Q8IIT5|PTKL_PLA	-	1501	1.9e-27	93.4	19.7	1	3	1.9e-08	2.7e-07	26.6	0.9	853	921	134	205	114	208	0.84	Serine/threonine-protein kinase 33 (DB12010)
drugbank_target|Q9BYT3	-	514	sp|Q8IIT5|PTKL_PLA	-	1501	1.9e-27	93.4	19.7	2	3	5.5e-11	8.1e-10	35.0	0.8	1254	1317	202	274	201	282	0.84	Serine/threonine-protein kinase 33 (DB12010)
drugbank_target|Q9BYT3	-	514	sp|Q8IIT5|PTKL_PLA	-	1501	1.9e-27	93.4	19.7	3	3	5.6e-15	8.2e-14	48.2	0.0	1380	1478	278	378	271	399	0.86	Serine/threonine-protein kinase 33 (DB12010)
drugbank_target|Q07912	-	1038	sp|Q8IIT5|PTKL_PLA	-	1501	2e-27	93.3	0.0	1	3	1.1e-06	1.6e-05	20.7	0.0	859	927	153	223	135	234	0.78	Activated CDC42 kinase 1 (DB00171; DB04367; DB11986; DB12010)
drugbank_target|Q07912	-	1038	sp|Q8IIT5|PTKL_PLA	-	1501	2e-27	93.3	0.0	2	3	3e-09	4.4e-08	29.2	0.0	1266	1314	228	276	221	284	0.90	Activated CDC42 kinase 1 (DB00171; DB04367; DB11986; DB12010)
drugbank_target|Q07912	-	1038	sp|Q8IIT5|PTKL_PLA	-	1501	2e-27	93.3	0.0	3	3	7.9e-18	1.1e-16	57.7	0.0	1373	1479	280	385	275	399	0.86	Activated CDC42 kinase 1 (DB00171; DB04367; DB11986; DB12010)
drugbank_target|Q7L7X3	-	1001	sp|Q8IIT5|PTKL_PLA	-	1501	2.2e-27	93.2	0.1	1	3	2.8e-05	0.00041	16.1	0.1	852	913	45	110	29	121	0.77	Serine/threonine-protein kinase TAO1 (DB12010)
drugbank_target|Q7L7X3	-	1001	sp|Q8IIT5|PTKL_PLA	-	1501	2.2e-27	93.2	0.1	2	3	3.5e-12	5.1e-11	38.9	0.0	1255	1314	116	175	109	179	0.92	Serine/threonine-protein kinase TAO1 (DB12010)
drugbank_target|Q7L7X3	-	1001	sp|Q8IIT5|PTKL_PLA	-	1501	2.2e-27	93.2	0.1	3	3	3.3e-16	4.8e-15	52.3	0.0	1382	1492	179	292	176	300	0.85	Serine/threonine-protein kinase TAO1 (DB12010)
drugbank_target|Q04759	-	706	sp|Q8IIT5|PTKL_PLA	-	1501	2.3e-27	93.1	0.1	1	3	0.016	0.24	6.9	0.1	848	932	393	482	377	485	0.68	Protein kinase C theta type (DB02010; DB02482; DB04522; DB12010)
drugbank_target|Q04759	-	706	sp|Q8IIT5|PTKL_PLA	-	1501	2.3e-27	93.1	0.1	2	3	7.9e-12	1.2e-10	37.8	0.1	1260	1315	474	529	469	535	0.90	Protein kinase C theta type (DB02010; DB02482; DB04522; DB12010)
drugbank_target|Q04759	-	706	sp|Q8IIT5|PTKL_PLA	-	1501	2.3e-27	93.1	0.1	3	3	8.2e-15	1.2e-13	47.7	0.0	1379	1471	533	623	526	631	0.91	Protein kinase C theta type (DB02010; DB02482; DB04522; DB12010)
drugbank_target|Q04759	-	706	sp|Q8IIT5|PTKL_PLA	-	1501	2.3e-27	93.1	0.1	1	3	0.016	0.24	6.9	0.1	848	932	393	482	377	485	0.68	Protein kinase C theta type (DB00675)
drugbank_target|Q04759	-	706	sp|Q8IIT5|PTKL_PLA	-	1501	2.3e-27	93.1	0.1	2	3	7.9e-12	1.2e-10	37.8	0.1	1260	1315	474	529	469	535	0.90	Protein kinase C theta type (DB00675)
drugbank_target|Q04759	-	706	sp|Q8IIT5|PTKL_PLA	-	1501	2.3e-27	93.1	0.1	3	3	8.2e-15	1.2e-13	47.7	0.0	1379	1471	533	623	526	631	0.91	Protein kinase C theta type (DB00675)
drugbank_target|P31749	-	480	sp|Q8IIT5|PTKL_PLA	-	1501	2.6e-27	93.0	0.0	1	3	1.2e-05	0.00017	17.3	0.1	841	923	156	242	145	246	0.79	RAC-alpha serine/threonine-protein kinase (DB00171; DB01169; DB01645; DB01863; DB02709; DB05971; DB06486; DB06641; DB07584; DB07585)
drugbank_target|P31749	-	480	sp|Q8IIT5|PTKL_PLA	-	1501	2.6e-27	93.0	0.0	2	3	1.6e-10	2.3e-09	33.5	0.0	1259	1313	242	297	238	303	0.91	RAC-alpha serine/threonine-protein kinase (DB00171; DB01169; DB01645; DB01863; DB02709; DB05971; DB06486; DB06641; DB07584; DB07585)
drugbank_target|P31749	-	480	sp|Q8IIT5|PTKL_PLA	-	1501	2.6e-27	93.0	0.0	3	3	2e-12	3e-11	39.7	0.0	1380	1470	304	392	298	405	0.91	RAC-alpha serine/threonine-protein kinase (DB00171; DB01169; DB01645; DB01863; DB02709; DB05971; DB06486; DB06641; DB07584; DB07585)
drugbank_target|Q92772	-	493	sp|Q8IIT5|PTKL_PLA	-	1501	2.7e-27	92.9	5.8	1	3	1.8e-09	2.6e-08	30.0	0.8	849	918	18	90	2	94	0.76	Cyclin-dependent kinase-like 2 (DB12010)
drugbank_target|Q92772	-	493	sp|Q8IIT5|PTKL_PLA	-	1501	2.7e-27	92.9	5.8	2	3	4.4e-13	6.4e-12	41.9	0.0	1260	1314	96	150	90	154	0.94	Cyclin-dependent kinase-like 2 (DB12010)
drugbank_target|Q92772	-	493	sp|Q8IIT5|PTKL_PLA	-	1501	2.7e-27	92.9	5.8	3	3	7e-07	1e-05	21.4	0.0	1383	1476	159	282	153	300	0.68	Cyclin-dependent kinase-like 2 (DB12010)
drugbank_target|Q13163	-	448	sp|Q8IIT5|PTKL_PLA	-	1501	5.3e-27	91.9	0.0	1	3	1.1e-05	0.00016	17.4	0.0	857	920	188	253	178	258	0.86	Dual specificity mitogen-activated protein kinase kinase 5 (DB12010)
drugbank_target|Q13163	-	448	sp|Q8IIT5|PTKL_PLA	-	1501	5.3e-27	91.9	0.0	2	3	8e-11	1.2e-09	34.4	0.0	1261	1314	254	307	250	314	0.90	Dual specificity mitogen-activated protein kinase kinase 5 (DB12010)
drugbank_target|Q13163	-	448	sp|Q8IIT5|PTKL_PLA	-	1501	5.3e-27	91.9	0.0	3	3	7.7e-12	1.1e-10	37.8	0.0	1380	1476	311	414	305	426	0.83	Dual specificity mitogen-activated protein kinase kinase 5 (DB12010)
drugbank_target|Q99759	-	626	sp|Q8IIT5|PTKL_PLA	-	1501	5.9e-27	91.8	10.7	1	3	8.9e-06	0.00013	17.7	0.0	868	922	401	457	369	460	0.79	Mitogen-activated protein kinase kinase kinase 3 (DB12010)
drugbank_target|Q99759	-	626	sp|Q8IIT5|PTKL_PLA	-	1501	5.9e-27	91.8	10.7	2	3	3.2e-12	4.7e-11	39.1	0.0	1261	1319	460	518	456	522	0.92	Mitogen-activated protein kinase kinase kinase 3 (DB12010)
drugbank_target|Q99759	-	626	sp|Q8IIT5|PTKL_PLA	-	1501	5.9e-27	91.8	10.7	3	3	1.2e-12	1.8e-11	40.5	0.0	1380	1478	522	619	515	625	0.83	Mitogen-activated protein kinase kinase kinase 3 (DB12010)
drugbank_target|P16066	-	1061	sp|Q8IIT5|PTKL_PLA	-	1501	6.2e-27	91.7	0.0	1	3	1e-08	1.5e-07	27.5	0.0	853	923	556	627	539	637	0.87	Atrial natriuretic peptide receptor 1 (DB00325; DB00727; DB00883; DB01612; DB01613; DB04899; DB05034)
drugbank_target|P16066	-	1061	sp|Q8IIT5|PTKL_PLA	-	1501	6.2e-27	91.7	0.0	2	3	2.7e-05	0.0004	16.1	0.0	1269	1314	638	684	626	691	0.87	Atrial natriuretic peptide receptor 1 (DB00325; DB00727; DB00883; DB01612; DB01613; DB04899; DB05034)
drugbank_target|P16066	-	1061	sp|Q8IIT5|PTKL_PLA	-	1501	6.2e-27	91.7	0.0	3	3	5e-14	7.3e-13	45.1	0.0	1382	1499	692	821	685	823	0.84	Atrial natriuretic peptide receptor 1 (DB00325; DB00727; DB00883; DB01612; DB01613; DB04899; DB05034)
drugbank_target|Q92918	-	833	sp|Q8IIT5|PTKL_PLA	-	1501	7e-27	91.5	0.0	1	3	2.4e-07	3.4e-06	22.9	0.0	852	920	34	103	24	108	0.88	Mitogen-activated protein kinase kinase kinase kinase 1 (DB12010)
drugbank_target|Q92918	-	833	sp|Q8IIT5|PTKL_PLA	-	1501	7e-27	91.5	0.0	2	3	8.3e-12	1.2e-10	37.7	0.0	1255	1314	102	161	100	171	0.90	Mitogen-activated protein kinase kinase kinase kinase 1 (DB12010)
drugbank_target|Q92918	-	833	sp|Q8IIT5|PTKL_PLA	-	1501	7e-27	91.5	0.0	3	3	5.5e-09	8e-08	28.3	0.0	1382	1478	169	271	161	277	0.78	Mitogen-activated protein kinase kinase kinase kinase 1 (DB12010)
drugbank_target|Q9P2K8	-	1649	sp|Q8IIT5|PTKL_PLA	-	1501	9.3e-27	91.1	8.9	1	4	1.2e-11	1.7e-10	37.2	0.3	1223	1315	357	450	327	471	0.81	eIF-2-alpha kinase GCN2 (DB12010)
drugbank_target|Q9P2K8	-	1649	sp|Q8IIT5|PTKL_PLA	-	1501	9.3e-27	91.1	8.9	2	4	0.45	6.5	2.1	0.0	852	901	607	658	588	661	0.80	eIF-2-alpha kinase GCN2 (DB12010)
drugbank_target|Q9P2K8	-	1649	sp|Q8IIT5|PTKL_PLA	-	1501	9.3e-27	91.1	8.9	3	4	1.5e-11	2.2e-10	36.8	0.0	1263	1314	821	872	789	883	0.78	eIF-2-alpha kinase GCN2 (DB12010)
drugbank_target|Q9P2K8	-	1649	sp|Q8IIT5|PTKL_PLA	-	1501	9.3e-27	91.1	8.9	4	4	1.9e-05	0.00028	16.6	0.0	1384	1478	900	998	877	1020	0.75	eIF-2-alpha kinase GCN2 (DB12010)
drugbank_target|Q8TD19	-	979	sp|Q8IIT5|PTKL_PLA	-	1501	9.3e-27	91.1	0.4	1	3	0.00041	0.006	12.2	0.1	867	923	89	143	55	146	0.74	Serine/threonine-protein kinase Nek9 (DB12010)
drugbank_target|Q8TD19	-	979	sp|Q8IIT5|PTKL_PLA	-	1501	9.3e-27	91.1	0.4	2	3	1.2e-09	1.8e-08	30.5	0.1	1255	1317	141	203	137	208	0.90	Serine/threonine-protein kinase Nek9 (DB12010)
drugbank_target|Q8TD19	-	979	sp|Q8IIT5|PTKL_PLA	-	1501	9.3e-27	91.1	0.4	3	3	1e-14	1.5e-13	47.3	0.0	1380	1490	206	315	201	323	0.84	Serine/threonine-protein kinase Nek9 (DB12010)
drugbank_target|P27361	-	379	sp|Q8IIT5|PTKL_PLA	-	1501	1.4e-26	90.6	0.8	1	3	0.00056	0.0082	11.7	0.1	852	921	59	134	40	137	0.71	Mitogen-activated protein kinase 3 (DB00605; DB01169; DB02733; DB04604; DB06195; DB08862; DB13930)
drugbank_target|P27361	-	379	sp|Q8IIT5|PTKL_PLA	-	1501	1.4e-26	90.6	0.8	2	3	1.3e-15	1.9e-14	50.3	0.1	1239	1317	120	193	112	200	0.83	Mitogen-activated protein kinase 3 (DB00605; DB01169; DB02733; DB04604; DB06195; DB08862; DB13930)
drugbank_target|P27361	-	379	sp|Q8IIT5|PTKL_PLA	-	1501	1.4e-26	90.6	0.8	3	3	6.5e-09	9.5e-08	28.1	0.0	1383	1438	202	257	192	345	0.74	Mitogen-activated protein kinase 3 (DB00605; DB01169; DB02733; DB04604; DB06195; DB08862; DB13930)
drugbank_target|P27361	-	379	sp|Q8IIT5|PTKL_PLA	-	1501	1.4e-26	90.6	0.8	1	3	0.00056	0.0082	11.7	0.1	852	921	59	134	40	137	0.71	Mitogen-activated protein kinase 3 (DB01017)
drugbank_target|P27361	-	379	sp|Q8IIT5|PTKL_PLA	-	1501	1.4e-26	90.6	0.8	2	3	1.3e-15	1.9e-14	50.3	0.1	1239	1317	120	193	112	200	0.83	Mitogen-activated protein kinase 3 (DB01017)
drugbank_target|P27361	-	379	sp|Q8IIT5|PTKL_PLA	-	1501	1.4e-26	90.6	0.8	3	3	6.5e-09	9.5e-08	28.1	0.0	1383	1438	202	257	192	345	0.74	Mitogen-activated protein kinase 3 (DB01017)
drugbank_target|P27361	-	379	sp|Q8IIT5|PTKL_PLA	-	1501	1.4e-26	90.6	0.8	1	3	0.00056	0.0082	11.7	0.1	852	921	59	134	40	137	0.71	Mitogen-activated protein kinase 3 (DB00945)
drugbank_target|P27361	-	379	sp|Q8IIT5|PTKL_PLA	-	1501	1.4e-26	90.6	0.8	2	3	1.3e-15	1.9e-14	50.3	0.1	1239	1317	120	193	112	200	0.83	Mitogen-activated protein kinase 3 (DB00945)
drugbank_target|P27361	-	379	sp|Q8IIT5|PTKL_PLA	-	1501	1.4e-26	90.6	0.8	3	3	6.5e-09	9.5e-08	28.1	0.0	1383	1438	202	257	192	345	0.74	Mitogen-activated protein kinase 3 (DB00945)
drugbank_target|Q16566	-	473	sp|Q8IIT5|PTKL_PLA	-	1501	1.4e-26	90.5	0.0	1	3	1.2e-06	1.7e-05	20.6	0.0	850	921	61	131	48	137	0.85	Calcium/calmodulin-dependent protein kinase type IV (DB07664; DB07676)
drugbank_target|Q16566	-	473	sp|Q8IIT5|PTKL_PLA	-	1501	1.4e-26	90.5	0.0	2	3	2.9e-11	4.2e-10	35.9	0.0	1262	1316	136	193	129	200	0.87	Calcium/calmodulin-dependent protein kinase type IV (DB07664; DB07676)
drugbank_target|Q16566	-	473	sp|Q8IIT5|PTKL_PLA	-	1501	1.4e-26	90.5	0.0	3	3	8.1e-10	1.2e-08	31.1	0.0	1382	1477	198	296	193	313	0.82	Calcium/calmodulin-dependent protein kinase type IV (DB07664; DB07676)
drugbank_target|Q6ZN16	-	1313	sp|Q8IIT5|PTKL_PLA	-	1501	1.6e-26	90.3	0.0	1	3	3.7e-05	0.00054	15.7	0.0	856	922	673	740	649	743	0.85	Mitogen-activated protein kinase kinase kinase 15 (DB12010)
drugbank_target|Q6ZN16	-	1313	sp|Q8IIT5|PTKL_PLA	-	1501	1.6e-26	90.3	0.0	2	3	3.6e-11	5.3e-10	35.6	0.0	1262	1314	745	798	739	806	0.90	Mitogen-activated protein kinase kinase kinase 15 (DB12010)
drugbank_target|Q6ZN16	-	1313	sp|Q8IIT5|PTKL_PLA	-	1501	1.6e-26	90.3	0.0	3	3	3.2e-11	4.7e-10	35.8	0.0	1383	1478	807	905	802	921	0.82	Mitogen-activated protein kinase kinase kinase 15 (DB12010)
drugbank_target|P36894	-	532	sp|Q8IIT5|PTKL_PLA	-	1501	1.8e-26	90.1	0.1	1	3	3.2e-10	4.6e-09	32.5	0.0	836	926	235	327	228	334	0.87	Bone morphogenetic protein receptor type-1A (DB11639)
drugbank_target|P36894	-	532	sp|Q8IIT5|PTKL_PLA	-	1501	1.8e-26	90.1	0.1	2	3	3.2e-06	4.7e-05	19.2	0.0	1263	1323	327	395	324	398	0.76	Bone morphogenetic protein receptor type-1A (DB11639)
drugbank_target|P36894	-	532	sp|Q8IIT5|PTKL_PLA	-	1501	1.8e-26	90.1	0.1	3	3	5.1e-12	7.5e-11	38.4	0.0	1371	1489	388	531	384	532	0.72	Bone morphogenetic protein receptor type-1A (DB11639)
drugbank_target|P28482	-	360	sp|Q8IIT5|PTKL_PLA	-	1501	2e-26	90.0	1.2	1	3	0.00059	0.0087	11.7	0.3	854	920	44	116	22	119	0.72	Mitogen-activated protein kinase 1 (DB01064; DB01169; DB02116; DB02482; DB02733; DB04338; DB06195; DB06641; DB06877; DB07010; DB07264; DB07788; DB07794; DB07905; DB08513; DB08521; DB11120; DB13930)
drugbank_target|P28482	-	360	sp|Q8IIT5|PTKL_PLA	-	1501	2e-26	90.0	1.2	2	3	2.2e-15	3.2e-14	49.6	0.1	1257	1316	116	175	99	183	0.86	Mitogen-activated protein kinase 1 (DB01064; DB01169; DB02116; DB02482; DB02733; DB04338; DB06195; DB06641; DB06877; DB07010; DB07264; DB07788; DB07794; DB07905; DB08513; DB08521; DB11120; DB13930)
drugbank_target|P28482	-	360	sp|Q8IIT5|PTKL_PLA	-	1501	2e-26	90.0	1.2	3	3	7.9e-09	1.2e-07	27.8	0.0	1383	1437	185	239	177	327	0.76	Mitogen-activated protein kinase 1 (DB01064; DB01169; DB02116; DB02482; DB02733; DB04338; DB06195; DB06641; DB06877; DB07010; DB07264; DB07788; DB07794; DB07905; DB08513; DB08521; DB11120; DB13930)
drugbank_target|P28482	-	360	sp|Q8IIT5|PTKL_PLA	-	1501	2e-26	90.0	1.2	1	3	0.00059	0.0087	11.7	0.3	854	920	44	116	22	119	0.72	Mitogen-activated protein kinase 1 (DB01017)
drugbank_target|P28482	-	360	sp|Q8IIT5|PTKL_PLA	-	1501	2e-26	90.0	1.2	2	3	2.2e-15	3.2e-14	49.6	0.1	1257	1316	116	175	99	183	0.86	Mitogen-activated protein kinase 1 (DB01017)
drugbank_target|P28482	-	360	sp|Q8IIT5|PTKL_PLA	-	1501	2e-26	90.0	1.2	3	3	7.9e-09	1.2e-07	27.8	0.0	1383	1437	185	239	177	327	0.76	Mitogen-activated protein kinase 1 (DB01017)
drugbank_target|P28482	-	360	sp|Q8IIT5|PTKL_PLA	-	1501	2e-26	90.0	1.2	1	3	0.00059	0.0087	11.7	0.3	854	920	44	116	22	119	0.72	Mitogen-activated protein kinase 1 (DB00945)
drugbank_target|P28482	-	360	sp|Q8IIT5|PTKL_PLA	-	1501	2e-26	90.0	1.2	2	3	2.2e-15	3.2e-14	49.6	0.1	1257	1316	116	175	99	183	0.86	Mitogen-activated protein kinase 1 (DB00945)
drugbank_target|P28482	-	360	sp|Q8IIT5|PTKL_PLA	-	1501	2e-26	90.0	1.2	3	3	7.9e-09	1.2e-07	27.8	0.0	1383	1437	185	239	177	327	0.76	Mitogen-activated protein kinase 1 (DB00945)
drugbank_target|Q00532	-	358	sp|Q8IIT5|PTKL_PLA	-	1501	3.7e-26	89.1	0.0	1	3	1.1e-08	1.5e-07	27.4	0.1	837	918	7	91	2	97	0.77	Cyclin-dependent kinase-like 1 (DB12010)
drugbank_target|Q00532	-	358	sp|Q8IIT5|PTKL_PLA	-	1501	3.7e-26	89.1	0.0	2	3	7e-13	1e-11	41.3	0.0	1254	1314	91	151	86	157	0.91	Cyclin-dependent kinase-like 1 (DB12010)
drugbank_target|Q00532	-	358	sp|Q8IIT5|PTKL_PLA	-	1501	3.7e-26	89.1	0.0	3	3	1.5e-05	0.00022	16.9	0.0	1381	1476	158	283	154	305	0.71	Cyclin-dependent kinase-like 1 (DB12010)
drugbank_target|Q05655	-	676	sp|Q8IIT5|PTKL_PLA	-	1501	6.4e-26	88.3	0.0	1	3	0.056	0.81	5.1	0.0	829	933	337	452	332	455	0.64	Protein kinase C delta type (DB04376; DB05013; DB12010)
drugbank_target|Q05655	-	676	sp|Q8IIT5|PTKL_PLA	-	1501	6.4e-26	88.3	0.0	2	3	3.6e-11	5.2e-10	35.6	0.0	1259	1314	442	497	437	503	0.91	Protein kinase C delta type (DB04376; DB05013; DB12010)
drugbank_target|Q05655	-	676	sp|Q8IIT5|PTKL_PLA	-	1501	6.4e-26	88.3	0.0	3	3	1.7e-14	2.5e-13	46.6	0.0	1380	1472	503	593	496	600	0.91	Protein kinase C delta type (DB04376; DB05013; DB12010)
drugbank_target|Q05655	-	676	sp|Q8IIT5|PTKL_PLA	-	1501	6.4e-26	88.3	0.0	1	3	0.056	0.81	5.1	0.0	829	933	337	452	332	455	0.64	Protein kinase C delta type (DB00675)
drugbank_target|Q05655	-	676	sp|Q8IIT5|PTKL_PLA	-	1501	6.4e-26	88.3	0.0	2	3	3.6e-11	5.2e-10	35.6	0.0	1259	1314	442	497	437	503	0.91	Protein kinase C delta type (DB00675)
drugbank_target|Q05655	-	676	sp|Q8IIT5|PTKL_PLA	-	1501	6.4e-26	88.3	0.0	3	3	1.7e-14	2.5e-13	46.6	0.0	1380	1472	503	593	496	600	0.91	Protein kinase C delta type (DB00675)
drugbank_target|Q9H4B4	-	646	sp|Q8IIT5|PTKL_PLA	-	1501	7.1e-26	88.2	0.0	1	3	0.00054	0.0078	11.8	0.0	853	920	80	151	66	156	0.80	Serine/threonine-protein kinase PLK3 (DB12010)
drugbank_target|Q9H4B4	-	646	sp|Q8IIT5|PTKL_PLA	-	1501	7.1e-26	88.2	0.0	2	3	2.4e-10	3.5e-09	32.8	0.0	1257	1314	152	209	148	217	0.90	Serine/threonine-protein kinase PLK3 (DB12010)
drugbank_target|Q9H4B4	-	646	sp|Q8IIT5|PTKL_PLA	-	1501	7.1e-26	88.2	0.0	3	3	8.1e-13	1.2e-11	41.1	0.0	1380	1477	215	310	211	316	0.94	Serine/threonine-protein kinase PLK3 (DB12010)
drugbank_target|Q04771	-	509	sp|Q8IIT5|PTKL_PLA	-	1501	7.5e-26	88.1	0.0	1	3	2.2e-10	3.2e-09	33.0	0.0	849	929	220	304	206	321	0.84	Activin receptor type-1 (DB00171; DB08597; DB12010)
drugbank_target|Q04771	-	509	sp|Q8IIT5|PTKL_PLA	-	1501	7.5e-26	88.1	0.0	2	3	5.5e-07	8.1e-06	21.7	0.1	1262	1323	300	369	298	372	0.79	Activin receptor type-1 (DB00171; DB08597; DB12010)
drugbank_target|Q04771	-	509	sp|Q8IIT5|PTKL_PLA	-	1501	7.5e-26	88.1	0.0	3	3	2e-10	2.9e-09	33.1	0.0	1373	1485	364	501	360	508	0.72	Activin receptor type-1 (DB00171; DB08597; DB12010)
drugbank_target|P52564	-	334	sp|Q8IIT5|PTKL_PLA	-	1501	8.1e-26	88.0	0.0	1	3	0.042	0.62	5.5	0.0	838	913	56	134	34	140	0.75	Dual specificity mitogen-activated protein kinase kinase 6 (DB12010)
drugbank_target|P52564	-	334	sp|Q8IIT5|PTKL_PLA	-	1501	8.1e-26	88.0	0.0	2	3	1.4e-13	2e-12	43.6	0.0	1238	1323	126	213	122	217	0.89	Dual specificity mitogen-activated protein kinase kinase 6 (DB12010)
drugbank_target|P52564	-	334	sp|Q8IIT5|PTKL_PLA	-	1501	8.1e-26	88.0	0.0	3	3	6e-13	8.8e-12	41.5	0.0	1386	1490	214	324	203	332	0.82	Dual specificity mitogen-activated protein kinase kinase 6 (DB12010)
drugbank_target|Q9H2K8	-	898	sp|Q8IIT5|PTKL_PLA	-	1501	9.4e-26	87.8	0.2	1	3	1.6e-06	2.3e-05	20.2	0.2	853	912	42	105	27	116	0.79	Serine/threonine-protein kinase TAO3 (DB12010)
drugbank_target|Q9H2K8	-	898	sp|Q8IIT5|PTKL_PLA	-	1501	9.4e-26	87.8	0.2	2	3	2e-11	2.9e-10	36.5	0.0	1255	1314	112	171	105	175	0.92	Serine/threonine-protein kinase TAO3 (DB12010)
drugbank_target|Q9H2K8	-	898	sp|Q8IIT5|PTKL_PLA	-	1501	9.4e-26	87.8	0.2	3	3	5.4e-14	7.8e-13	44.9	0.0	1382	1477	175	273	170	280	0.85	Serine/threonine-protein kinase TAO3 (DB12010)
drugbank_target|Q8N568	-	766	sp|Q8IIT5|PTKL_PLA	-	1501	1e-25	87.6	21.4	1	3	1.8e-08	2.6e-07	26.6	0.1	842	922	403	483	387	490	0.80	Serine/threonine-protein kinase DCLK2 (DB12010)
drugbank_target|Q8N568	-	766	sp|Q8IIT5|PTKL_PLA	-	1501	1e-25	87.6	21.4	2	3	5.2e-08	7.6e-07	25.1	0.0	1261	1315	486	544	481	550	0.87	Serine/threonine-protein kinase DCLK2 (DB12010)
drugbank_target|Q8N568	-	766	sp|Q8IIT5|PTKL_PLA	-	1501	1e-25	87.6	21.4	3	3	1.5e-11	2.2e-10	36.8	0.0	1384	1478	550	648	544	667	0.85	Serine/threonine-protein kinase DCLK2 (DB12010)
drugbank_target|P46734	-	347	sp|Q8IIT5|PTKL_PLA	-	1501	1.1e-25	87.6	0.1	1	3	0.0037	0.053	9.0	0.0	837	927	66	158	43	161	0.74	Dual specificity mitogen-activated protein kinase kinase 3 (DB12010)
drugbank_target|P46734	-	347	sp|Q8IIT5|PTKL_PLA	-	1501	1.1e-25	87.6	0.1	2	3	3.3e-13	4.8e-12	42.4	0.0	1238	1313	137	213	129	225	0.91	Dual specificity mitogen-activated protein kinase kinase 3 (DB12010)
drugbank_target|P46734	-	347	sp|Q8IIT5|PTKL_PLA	-	1501	1.1e-25	87.6	0.1	3	3	1.2e-12	1.8e-11	40.5	0.0	1383	1490	222	335	214	343	0.81	Dual specificity mitogen-activated protein kinase kinase 3 (DB12010)
drugbank_target|P06493	-	297	sp|Q8IIT5|PTKL_PLA	-	1501	1.2e-25	87.4	0.0	1	3	3.8e-09	5.6e-08	28.9	0.0	840	923	9	94	2	105	0.76	Cyclin-dependent kinase 1 (DB02052; DB02116; DB02950; DB03428; DB03496; DB04014; DB06195; DB08142; DB12010)
drugbank_target|P06493	-	297	sp|Q8IIT5|PTKL_PLA	-	1501	1.2e-25	87.4	0.0	2	3	4.8e-12	7e-11	38.5	0.0	1262	1314	100	152	96	159	0.92	Cyclin-dependent kinase 1 (DB02052; DB02116; DB02950; DB03428; DB03496; DB04014; DB06195; DB08142; DB12010)
drugbank_target|P06493	-	297	sp|Q8IIT5|PTKL_PLA	-	1501	1.2e-25	87.4	0.0	3	3	1.4e-05	0.0002	17.1	0.0	1386	1439	164	217	155	238	0.80	Cyclin-dependent kinase 1 (DB02052; DB02116; DB02950; DB03428; DB03496; DB04014; DB06195; DB08142; DB12010)
drugbank_target|Q12851	-	820	sp|Q8IIT5|PTKL_PLA	-	1501	1.3e-25	87.3	4.2	1	3	5.4e-08	7.8e-07	25.1	0.0	852	922	33	104	19	106	0.86	Mitogen-activated protein kinase kinase kinase kinase 2 (DB12010)
drugbank_target|Q12851	-	820	sp|Q8IIT5|PTKL_PLA	-	1501	1.3e-25	87.3	4.2	2	3	2.4e-09	3.6e-08	29.5	0.0	1253	1312	99	158	97	163	0.93	Mitogen-activated protein kinase kinase kinase kinase 2 (DB12010)
drugbank_target|Q12851	-	820	sp|Q8IIT5|PTKL_PLA	-	1501	1.3e-25	87.3	4.2	3	3	5.2e-11	7.5e-10	35.1	0.0	1378	1482	164	274	159	288	0.78	Mitogen-activated protein kinase kinase kinase kinase 2 (DB12010)
drugbank_target|Q96BR1	-	496	sp|Q8IIT5|PTKL_PLA	-	1501	1.4e-25	87.2	0.0	1	3	1.1e-05	0.00016	17.4	0.4	841	923	168	255	160	258	0.78	Serine/threonine-protein kinase Sgk3 (DB12010)
drugbank_target|Q96BR1	-	496	sp|Q8IIT5|PTKL_PLA	-	1501	1.4e-25	87.2	0.0	2	3	3.4e-11	4.9e-10	35.7	0.0	1259	1314	255	310	253	316	0.92	Serine/threonine-protein kinase Sgk3 (DB12010)
drugbank_target|Q96BR1	-	496	sp|Q8IIT5|PTKL_PLA	-	1501	1.4e-25	87.2	0.0	3	3	7e-10	1e-08	31.3	0.0	1381	1474	317	408	311	417	0.89	Serine/threonine-protein kinase Sgk3 (DB12010)
drugbank_target|Q00537	-	523	sp|Q8IIT5|PTKL_PLA	-	1501	1.4e-25	87.2	0.1	1	3	1.1e-06	1.6e-05	20.8	0.0	845	920	202	278	188	282	0.76	Cyclin-dependent kinase 17 (DB12010)
drugbank_target|Q00537	-	523	sp|Q8IIT5|PTKL_PLA	-	1501	1.4e-25	87.2	0.1	2	3	1.4e-14	2e-13	46.9	0.0	1252	1316	275	339	272	344	0.93	Cyclin-dependent kinase 17 (DB12010)
drugbank_target|Q00537	-	523	sp|Q8IIT5|PTKL_PLA	-	1501	1.4e-25	87.2	0.1	3	3	5.2e-06	7.6e-05	18.5	0.0	1379	1438	343	401	337	473	0.76	Cyclin-dependent kinase 17 (DB12010)
drugbank_target|Q9Y6R4	-	1608	sp|Q8IIT5|PTKL_PLA	-	1501	1.6e-25	87.0	18.3	1	3	1.8e-08	2.6e-07	26.7	0.0	837	923	1345	1434	1332	1440	0.79	Mitogen-activated protein kinase kinase kinase 4 (DB12010)
drugbank_target|Q9Y6R4	-	1608	sp|Q8IIT5|PTKL_PLA	-	1501	1.6e-25	87.0	18.3	2	3	3.4e-09	4.9e-08	29.0	0.1	1261	1314	1434	1487	1429	1495	0.89	Mitogen-activated protein kinase kinase kinase 4 (DB12010)
drugbank_target|Q9Y6R4	-	1608	sp|Q8IIT5|PTKL_PLA	-	1501	1.6e-25	87.0	18.3	3	3	1.9e-14	2.8e-13	46.4	0.0	1371	1478	1489	1598	1486	1607	0.86	Mitogen-activated protein kinase kinase kinase 4 (DB12010)
drugbank_target|O00238	-	502	sp|Q8IIT5|PTKL_PLA	-	1501	2e-25	86.7	0.0	1	3	3.8e-10	5.6e-09	32.2	0.0	836	925	205	296	196	302	0.87	Bone morphogenetic protein receptor type-1B (DB12010)
drugbank_target|O00238	-	502	sp|Q8IIT5|PTKL_PLA	-	1501	2e-25	86.7	0.0	2	3	3.1e-06	4.5e-05	19.2	0.1	1260	1314	294	356	292	367	0.78	Bone morphogenetic protein receptor type-1B (DB12010)
drugbank_target|O00238	-	502	sp|Q8IIT5|PTKL_PLA	-	1501	2e-25	86.7	0.0	3	3	1e-10	1.5e-09	34.1	0.0	1373	1489	360	501	355	502	0.75	Bone morphogenetic protein receptor type-1B (DB12010)
drugbank_target|O00141	-	431	sp|Q8IIT5|PTKL_PLA	-	1501	2e-25	86.7	10.1	1	3	3.2e-05	0.00047	15.9	0.5	842	923	105	191	98	195	0.74	Serine/threonine-protein kinase Sgk1 (DB03247; DB07837; DB08191)
drugbank_target|O00141	-	431	sp|Q8IIT5|PTKL_PLA	-	1501	2e-25	86.7	10.1	2	3	3e-11	4.4e-10	35.8	0.0	1265	1314	197	246	189	253	0.89	Serine/threonine-protein kinase Sgk1 (DB03247; DB07837; DB08191)
drugbank_target|O00141	-	431	sp|Q8IIT5|PTKL_PLA	-	1501	2e-25	86.7	10.1	3	3	9.5e-13	1.4e-11	40.8	0.0	1379	1474	251	344	245	356	0.89	Serine/threonine-protein kinase Sgk1 (DB03247; DB07837; DB08191)
drugbank_target|Q07785	-	288	sp|Q8IIT5|PTKL_PLA	-	1501	3.1e-25	86.1	0.5	1	3	1.3e-06	1.9e-05	20.5	0.5	855	917	23	87	8	94	0.75	Cell division control protein 2 homolog (DB02519; DB02733)
drugbank_target|Q07785	-	288	sp|Q8IIT5|PTKL_PLA	-	1501	3.1e-25	86.1	0.5	2	3	4.2e-12	6.2e-11	38.7	0.0	1261	1314	96	149	87	154	0.91	Cell division control protein 2 homolog (DB02519; DB02733)
drugbank_target|Q07785	-	288	sp|Q8IIT5|PTKL_PLA	-	1501	3.1e-25	86.1	0.5	3	3	1.2e-07	1.7e-06	23.9	0.0	1383	1440	158	215	150	281	0.83	Cell division control protein 2 homolog (DB02519; DB02733)
drugbank_target|Q00536	-	496	sp|Q8IIT5|PTKL_PLA	-	1501	3.3e-25	86.0	0.2	1	3	2.4e-07	3.5e-06	22.9	0.1	845	921	175	252	162	256	0.77	Cyclin-dependent kinase 16 (DB07766; DB12010)
drugbank_target|Q00536	-	496	sp|Q8IIT5|PTKL_PLA	-	1501	3.3e-25	86.0	0.2	2	3	1.5e-13	2.2e-12	43.5	0.0	1252	1316	248	312	245	317	0.93	Cyclin-dependent kinase 16 (DB07766; DB12010)
drugbank_target|Q00536	-	496	sp|Q8IIT5|PTKL_PLA	-	1501	3.3e-25	86.0	0.2	3	3	3.4e-06	4.9e-05	19.1	0.0	1379	1437	316	373	309	393	0.84	Cyclin-dependent kinase 16 (DB07766; DB12010)
drugbank_target|Q9Y2H1	-	464	sp|Q8IIT5|PTKL_PLA	-	1501	3.4e-25	85.9	0.5	1	3	0.0011	0.016	10.8	0.0	839	922	94	181	66	184	0.79	Serine/threonine-protein kinase 38-like (DB12010)
drugbank_target|Q9Y2H1	-	464	sp|Q8IIT5|PTKL_PLA	-	1501	3.4e-25	85.9	0.5	2	3	7.3e-11	1.1e-09	34.6	0.0	1258	1313	181	236	178	252	0.92	Serine/threonine-protein kinase 38-like (DB12010)
drugbank_target|Q9Y2H1	-	464	sp|Q8IIT5|PTKL_PLA	-	1501	3.4e-25	85.9	0.5	3	3	4e-12	5.9e-11	38.7	0.0	1363	1462	261	362	239	377	0.82	Serine/threonine-protein kinase 38-like (DB12010)
drugbank_target|Q15569	-	626	sp|Q8IIT5|PTKL_PLA	-	1501	4.7e-25	85.5	0.0	1	3	2.7e-09	3.9e-08	29.4	0.0	852	921	74	142	60	146	0.82	Dual specificity testis-specific protein kinase 1 (DB12010)
drugbank_target|Q15569	-	626	sp|Q8IIT5|PTKL_PLA	-	1501	4.7e-25	85.5	0.0	2	3	4.8e-07	7e-06	21.9	0.0	1267	1314	152	202	143	210	0.84	Dual specificity testis-specific protein kinase 1 (DB12010)
drugbank_target|Q15569	-	626	sp|Q8IIT5|PTKL_PLA	-	1501	4.7e-25	85.5	0.0	3	3	1.4e-09	2.1e-08	30.3	0.0	1384	1484	216	316	206	321	0.83	Dual specificity testis-specific protein kinase 1 (DB12010)
drugbank_target|Q8NEV4	-	1616	sp|Q8IIT5|PTKL_PLA	-	1501	7.3e-25	84.8	1.8	1	3	7.9e-05	0.0012	14.6	0.0	841	921	27	113	14	118	0.81	Myosin-IIIa (DB12010)
drugbank_target|Q8NEV4	-	1616	sp|Q8IIT5|PTKL_PLA	-	1501	7.3e-25	84.8	1.8	2	3	4.5e-10	6.6e-09	31.9	0.0	1258	1314	118	174	113	182	0.92	Myosin-IIIa (DB12010)
drugbank_target|Q8NEV4	-	1616	sp|Q8IIT5|PTKL_PLA	-	1501	7.3e-25	84.8	1.8	3	3	3.5e-11	5.1e-10	35.6	0.0	1380	1494	180	301	174	307	0.78	Myosin-IIIa (DB12010)
drugbank_target|Q96RR4	-	588	sp|Q8IIT5|PTKL_PLA	-	1501	8.4e-25	84.6	5.2	1	3	0.0053	0.077	8.5	0.1	874	917	231	276	225	280	0.85	Calcium/calmodulin-dependent protein kinase kinase 2 (DB12010)
drugbank_target|Q96RR4	-	588	sp|Q8IIT5|PTKL_PLA	-	1501	8.4e-25	84.6	5.2	2	3	1.5e-13	2.2e-12	43.5	0.0	1261	1317	283	339	278	347	0.91	Calcium/calmodulin-dependent protein kinase kinase 2 (DB12010)
drugbank_target|Q96RR4	-	588	sp|Q8IIT5|PTKL_PLA	-	1501	8.4e-25	84.6	5.2	3	3	1.4e-10	2e-09	33.7	0.0	1384	1476	346	441	338	450	0.87	Calcium/calmodulin-dependent protein kinase kinase 2 (DB12010)
drugbank_target|Q16513	-	984	sp|Q8IIT5|PTKL_PLA	-	1501	9.4e-25	84.5	5.3	1	3	4.9e-05	0.00071	15.3	0.1	850	922	672	751	655	756	0.76	Serine/threonine-protein kinase N2 (DB12010)
drugbank_target|Q16513	-	984	sp|Q8IIT5|PTKL_PLA	-	1501	9.4e-25	84.5	5.3	2	3	3.8e-10	5.6e-09	32.2	0.0	1262	1313	754	805	750	809	0.92	Serine/threonine-protein kinase N2 (DB12010)
drugbank_target|Q16513	-	984	sp|Q8IIT5|PTKL_PLA	-	1501	9.4e-25	84.5	5.3	3	3	5.3e-12	7.8e-11	38.3	0.0	1382	1472	814	902	807	911	0.91	Serine/threonine-protein kinase N2 (DB12010)
drugbank_target|Q16539	-	360	sp|Q8IIT5|PTKL_PLA	-	1501	1.6e-24	83.7	0.1	1	3	0.0021	0.03	9.9	0.0	833	901	22	93	10	109	0.75	Mitogen-activated protein kinase 14 (DB01254; DB01761; DB01807; DB01948; DB01953; DB01988; DB02195; DB02277; DB02352; DB02873; DB02984; DB03044; DB03110; DB03980; DB04338; DB04632; DB04797; DB05157; DB05412; DB05470; DB06518; DB06882; DB06940; DB06991; DB07138; DB07307; DB07459; DB07607; DB07811; DB07829; DB07832; DB07833; DB07834; DB07835; DB07941; DB07942; DB07943; DB08064; DB08068; DB08091; DB08092; DB08093; DB08095; DB08096; DB08097; DB08242; DB08349; DB08351; DB08352; DB08395; DB08423; DB08424; DB08521; DB08522; DB08730; DB12010)
drugbank_target|Q16539	-	360	sp|Q8IIT5|PTKL_PLA	-	1501	1.6e-24	83.7	0.1	2	3	3.1e-14	4.6e-13	45.7	0.1	1243	1316	103	176	99	180	0.90	Mitogen-activated protein kinase 14 (DB01254; DB01761; DB01807; DB01948; DB01953; DB01988; DB02195; DB02277; DB02352; DB02873; DB02984; DB03044; DB03110; DB03980; DB04338; DB04632; DB04797; DB05157; DB05412; DB05470; DB06518; DB06882; DB06940; DB06991; DB07138; DB07307; DB07459; DB07607; DB07811; DB07829; DB07832; DB07833; DB07834; DB07835; DB07941; DB07942; DB07943; DB08064; DB08068; DB08091; DB08092; DB08093; DB08095; DB08096; DB08097; DB08242; DB08349; DB08351; DB08352; DB08395; DB08423; DB08424; DB08521; DB08522; DB08730; DB12010)
drugbank_target|Q16539	-	360	sp|Q8IIT5|PTKL_PLA	-	1501	1.6e-24	83.7	0.1	3	3	4.6e-08	6.8e-07	25.3	0.0	1382	1459	179	260	174	272	0.72	Mitogen-activated protein kinase 14 (DB01254; DB01761; DB01807; DB01948; DB01953; DB01988; DB02195; DB02277; DB02352; DB02873; DB02984; DB03044; DB03110; DB03980; DB04338; DB04632; DB04797; DB05157; DB05412; DB05470; DB06518; DB06882; DB06940; DB06991; DB07138; DB07307; DB07459; DB07607; DB07811; DB07829; DB07832; DB07833; DB07834; DB07835; DB07941; DB07942; DB07943; DB08064; DB08068; DB08091; DB08092; DB08093; DB08095; DB08096; DB08097; DB08242; DB08349; DB08351; DB08352; DB08395; DB08423; DB08424; DB08521; DB08522; DB08730; DB12010)
drugbank_target|Q16539	-	360	sp|Q8IIT5|PTKL_PLA	-	1501	1.6e-24	83.7	0.1	1	3	0.0021	0.03	9.9	0.0	833	901	22	93	10	109	0.75	Mitogen-activated protein kinase 14 (DB01017)
drugbank_target|Q16539	-	360	sp|Q8IIT5|PTKL_PLA	-	1501	1.6e-24	83.7	0.1	2	3	3.1e-14	4.6e-13	45.7	0.1	1243	1316	103	176	99	180	0.90	Mitogen-activated protein kinase 14 (DB01017)
drugbank_target|Q16539	-	360	sp|Q8IIT5|PTKL_PLA	-	1501	1.6e-24	83.7	0.1	3	3	4.6e-08	6.8e-07	25.3	0.0	1382	1459	179	260	174	272	0.72	Mitogen-activated protein kinase 14 (DB01017)
drugbank_target|Q15208	-	465	sp|Q8IIT5|PTKL_PLA	-	1501	1.7e-24	83.6	2.2	1	3	0.0036	0.052	9.1	0.0	839	922	93	180	64	183	0.79	Serine/threonine-protein kinase 38 (DB12010)
drugbank_target|Q15208	-	465	sp|Q8IIT5|PTKL_PLA	-	1501	1.7e-24	83.6	2.2	2	3	8.3e-11	1.2e-09	34.4	0.0	1259	1313	181	235	179	247	0.92	Serine/threonine-protein kinase 38 (DB12010)
drugbank_target|Q15208	-	465	sp|Q8IIT5|PTKL_PLA	-	1501	1.7e-24	83.6	2.2	3	3	3.1e-12	4.5e-11	39.1	0.0	1362	1461	259	360	237	379	0.81	Serine/threonine-protein kinase 38 (DB12010)
drugbank_target|P36897	-	503	sp|Q8IIT5|PTKL_PLA	-	1501	1.9e-24	83.5	0.0	1	3	6.3e-10	9.2e-09	31.5	0.0	850	925	218	297	208	317	0.88	TGF-beta receptor type-1 (DB03921; DB04434; DB04480; DB07152; DB07267; DB08450; DB12010)
drugbank_target|P36897	-	503	sp|Q8IIT5|PTKL_PLA	-	1501	1.9e-24	83.5	0.0	2	3	4.6e-07	6.7e-06	22.0	0.1	1263	1324	298	367	294	371	0.79	TGF-beta receptor type-1 (DB03921; DB04434; DB04480; DB07152; DB07267; DB08450; DB12010)
drugbank_target|P36897	-	503	sp|Q8IIT5|PTKL_PLA	-	1501	1.9e-24	83.5	0.0	3	3	1.9e-09	2.7e-08	29.9	0.0	1373	1488	361	501	356	503	0.73	TGF-beta receptor type-1 (DB03921; DB04434; DB04480; DB07152; DB07267; DB08450; DB12010)
drugbank_target|P41743	-	596	sp|Q8IIT5|PTKL_PLA	-	1501	2e-24	83.4	0.0	1	3	0.0057	0.084	8.4	0.0	840	923	261	347	253	349	0.71	Protein kinase C iota type (DB03777; DB12010)
drugbank_target|P41743	-	596	sp|Q8IIT5|PTKL_PLA	-	1501	2e-24	83.4	0.0	2	3	3.1e-11	4.6e-10	35.8	0.0	1257	1313	345	401	342	405	0.95	Protein kinase C iota type (DB03777; DB12010)
drugbank_target|P41743	-	596	sp|Q8IIT5|PTKL_PLA	-	1501	2e-24	83.4	0.0	3	3	1.2e-11	1.8e-10	37.1	0.0	1382	1470	410	505	404	511	0.87	Protein kinase C iota type (DB03777; DB12010)
drugbank_target|P41743	-	596	sp|Q8IIT5|PTKL_PLA	-	1501	2e-24	83.4	0.0	1	3	0.0057	0.084	8.4	0.0	840	923	261	347	253	349	0.71	Protein kinase C iota type (DB00675)
drugbank_target|P41743	-	596	sp|Q8IIT5|PTKL_PLA	-	1501	2e-24	83.4	0.0	2	3	3.1e-11	4.6e-10	35.8	0.0	1257	1313	345	401	342	405	0.95	Protein kinase C iota type (DB00675)
drugbank_target|P41743	-	596	sp|Q8IIT5|PTKL_PLA	-	1501	2e-24	83.4	0.0	3	3	1.2e-11	1.8e-10	37.1	0.0	1382	1470	410	505	404	511	0.87	Protein kinase C iota type (DB00675)
drugbank_target|O15264	-	365	sp|Q8IIT5|PTKL_PLA	-	1501	2e-24	83.4	0.1	1	3	0.0011	0.016	10.8	0.0	854	911	44	110	29	119	0.70	Mitogen-activated protein kinase 13 (DB01017)
drugbank_target|O15264	-	365	sp|Q8IIT5|PTKL_PLA	-	1501	2e-24	83.4	0.1	2	3	2.4e-13	3.4e-12	42.8	0.0	1259	1317	119	177	104	182	0.88	Mitogen-activated protein kinase 13 (DB01017)
drugbank_target|O15264	-	365	sp|Q8IIT5|PTKL_PLA	-	1501	2e-24	83.4	0.1	3	3	7.3e-09	1.1e-07	27.9	0.0	1382	1442	179	239	173	299	0.75	Mitogen-activated protein kinase 13 (DB01017)
drugbank_target|O15264	-	365	sp|Q8IIT5|PTKL_PLA	-	1501	2e-24	83.4	0.1	1	3	0.0011	0.016	10.8	0.0	854	911	44	110	29	119	0.70	Mitogen-activated protein kinase 13 (DB05157; DB12010)
drugbank_target|O15264	-	365	sp|Q8IIT5|PTKL_PLA	-	1501	2e-24	83.4	0.1	2	3	2.4e-13	3.4e-12	42.8	0.0	1259	1317	119	177	104	182	0.88	Mitogen-activated protein kinase 13 (DB05157; DB12010)
drugbank_target|O15264	-	365	sp|Q8IIT5|PTKL_PLA	-	1501	2e-24	83.4	0.1	3	3	7.3e-09	1.1e-07	27.9	0.0	1382	1442	179	239	173	299	0.75	Mitogen-activated protein kinase 13 (DB05157; DB12010)
drugbank_target|Q9H2G2	-	1235	sp|Q8IIT5|PTKL_PLA	-	1501	3.4e-24	82.6	0.5	1	3	1.1e-05	0.00016	17.4	0.0	851	919	50	119	32	125	0.77	STE20-like serine/threonine-protein kinase (DB07664; DB07853; DB12010)
drugbank_target|Q9H2G2	-	1235	sp|Q8IIT5|PTKL_PLA	-	1501	3.4e-24	82.6	0.5	2	3	1.2e-11	1.7e-10	37.2	0.1	1259	1315	124	180	118	186	0.92	STE20-like serine/threonine-protein kinase (DB07664; DB07853; DB12010)
drugbank_target|Q9H2G2	-	1235	sp|Q8IIT5|PTKL_PLA	-	1501	3.4e-24	82.6	0.5	3	3	1.8e-13	2.6e-12	43.2	0.0	1379	1478	184	289	178	305	0.84	STE20-like serine/threonine-protein kinase (DB07664; DB07853; DB12010)
drugbank_target|Q8N5S9	-	505	sp|Q8IIT5|PTKL_PLA	-	1501	3.5e-24	82.6	0.0	1	3	0.068	0.99	4.8	0.0	874	916	194	238	186	242	0.82	Calcium/calmodulin-dependent protein kinase kinase 1 (DB12010)
drugbank_target|Q8N5S9	-	505	sp|Q8IIT5|PTKL_PLA	-	1501	3.5e-24	82.6	0.0	2	3	1.4e-13	2e-12	43.6	0.0	1261	1320	246	305	242	309	0.92	Calcium/calmodulin-dependent protein kinase kinase 1 (DB12010)
drugbank_target|Q8N5S9	-	505	sp|Q8IIT5|PTKL_PLA	-	1501	3.5e-24	82.6	0.0	3	3	7.8e-10	1.1e-08	31.1	0.0	1383	1476	308	404	302	415	0.86	Calcium/calmodulin-dependent protein kinase kinase 1 (DB12010)
drugbank_target|P53778	-	367	sp|Q8IIT5|PTKL_PLA	-	1501	4.1e-24	82.4	0.0	1	3	0.0038	0.055	9.0	0.0	856	903	48	98	31	119	0.76	Mitogen-activated protein kinase 12 (DB01017)
drugbank_target|P53778	-	367	sp|Q8IIT5|PTKL_PLA	-	1501	4.1e-24	82.4	0.0	2	3	5.8e-13	8.4e-12	41.5	0.0	1258	1316	121	179	107	183	0.93	Mitogen-activated protein kinase 12 (DB01017)
drugbank_target|P53778	-	367	sp|Q8IIT5|PTKL_PLA	-	1501	4.1e-24	82.4	0.0	3	3	3.1e-09	4.6e-08	29.2	0.0	1382	1463	182	267	177	291	0.75	Mitogen-activated protein kinase 12 (DB01017)
drugbank_target|P53778	-	367	sp|Q8IIT5|PTKL_PLA	-	1501	4.1e-24	82.4	0.0	1	3	0.0038	0.055	9.0	0.0	856	903	48	98	31	119	0.76	Mitogen-activated protein kinase 12 (DB02482; DB04395; DB05157; DB05403)
drugbank_target|P53778	-	367	sp|Q8IIT5|PTKL_PLA	-	1501	4.1e-24	82.4	0.0	2	3	5.8e-13	8.4e-12	41.5	0.0	1258	1316	121	179	107	183	0.93	Mitogen-activated protein kinase 12 (DB02482; DB04395; DB05157; DB05403)
drugbank_target|P53778	-	367	sp|Q8IIT5|PTKL_PLA	-	1501	4.1e-24	82.4	0.0	3	3	3.1e-09	4.6e-08	29.2	0.0	1382	1463	182	267	177	291	0.75	Mitogen-activated protein kinase 12 (DB02482; DB04395; DB05157; DB05403)
drugbank_target|P17252	-	672	sp|Q8IIT5|PTKL_PLA	-	1501	4.5e-24	82.2	0.0	1	3	0.093	1.4	4.4	0.0	844	922	348	431	338	436	0.70	Protein kinase C alpha type (DB00144; DB00163; DB05013; DB06451; DB06595; DB06641; DB08846; DB11752; DB14001; DB14002)
drugbank_target|P17252	-	672	sp|Q8IIT5|PTKL_PLA	-	1501	4.5e-24	82.2	0.0	2	3	3.6e-11	5.2e-10	35.6	0.0	1193	1315	370	488	360	493	0.71	Protein kinase C alpha type (DB00144; DB00163; DB05013; DB06451; DB06595; DB06641; DB08846; DB11752; DB14001; DB14002)
drugbank_target|P17252	-	672	sp|Q8IIT5|PTKL_PLA	-	1501	4.5e-24	82.2	0.0	3	3	2.6e-13	3.8e-12	42.7	0.0	1376	1470	489	581	486	584	0.93	Protein kinase C alpha type (DB00144; DB00163; DB05013; DB06451; DB06595; DB06641; DB08846; DB11752; DB14001; DB14002)
drugbank_target|P17252	-	672	sp|Q8IIT5|PTKL_PLA	-	1501	4.5e-24	82.2	0.0	1	3	0.093	1.4	4.4	0.0	844	922	348	431	338	436	0.70	Protein kinase C alpha type (DB00675)
drugbank_target|P17252	-	672	sp|Q8IIT5|PTKL_PLA	-	1501	4.5e-24	82.2	0.0	2	3	3.6e-11	5.2e-10	35.6	0.0	1193	1315	370	488	360	493	0.71	Protein kinase C alpha type (DB00675)
drugbank_target|P17252	-	672	sp|Q8IIT5|PTKL_PLA	-	1501	4.5e-24	82.2	0.0	3	3	2.6e-13	3.8e-12	42.7	0.0	1376	1470	489	581	486	584	0.93	Protein kinase C alpha type (DB00675)
drugbank_target|P50613	-	346	sp|Q8IIT5|PTKL_PLA	-	1501	6.5e-24	81.7	0.0	1	3	6.1e-07	9e-06	21.6	0.0	837	913	14	96	2	100	0.76	Cyclin-dependent kinase 7 (DB02482; DB03496; DB05969; DB06195)
drugbank_target|P50613	-	346	sp|Q8IIT5|PTKL_PLA	-	1501	6.5e-24	81.7	0.0	2	3	3.7e-13	5.3e-12	42.2	0.0	1254	1314	101	161	96	167	0.93	Cyclin-dependent kinase 7 (DB02482; DB03496; DB05969; DB06195)
drugbank_target|P50613	-	346	sp|Q8IIT5|PTKL_PLA	-	1501	6.5e-24	81.7	0.0	3	3	7.5e-05	0.0011	14.6	0.0	1383	1428	171	215	164	243	0.75	Cyclin-dependent kinase 7 (DB02482; DB03496; DB05969; DB06195)
drugbank_target|P25092	-	1073	sp|Q8IIT5|PTKL_PLA	-	1501	6.9e-24	81.6	2.6	1	3	1.8e-05	0.00026	16.7	0.2	845	922	497	575	475	581	0.86	Heat-stable enterotoxin receptor (DB08890)
drugbank_target|P25092	-	1073	sp|Q8IIT5|PTKL_PLA	-	1501	6.9e-24	81.6	2.6	2	3	1.8e-07	2.6e-06	23.3	0.0	1268	1314	591	638	581	645	0.89	Heat-stable enterotoxin receptor (DB08890)
drugbank_target|P25092	-	1073	sp|Q8IIT5|PTKL_PLA	-	1501	6.9e-24	81.6	2.6	3	3	1.3e-12	1.8e-11	40.4	0.0	1390	1487	645	753	639	769	0.77	Heat-stable enterotoxin receptor (DB08890)
drugbank_target|Q13237	-	762	sp|Q8IIT5|PTKL_PLA	-	1501	8.1e-24	81.4	0.0	1	3	0.0031	0.045	9.3	0.1	840	922	458	544	403	548	0.77	cGMP-dependent protein kinase 2 (DB12010)
drugbank_target|Q13237	-	762	sp|Q8IIT5|PTKL_PLA	-	1501	8.1e-24	81.4	0.0	2	3	3.4e-09	4.9e-08	29.0	0.0	1266	1314	552	600	544	605	0.89	cGMP-dependent protein kinase 2 (DB12010)
drugbank_target|Q13237	-	762	sp|Q8IIT5|PTKL_PLA	-	1501	8.1e-24	81.4	0.0	3	3	2.8e-12	4.2e-11	39.2	0.0	1382	1470	607	695	601	709	0.90	cGMP-dependent protein kinase 2 (DB12010)
drugbank_target|O94804	-	968	sp|Q8IIT5|PTKL_PLA	-	1501	8.2e-24	81.3	0.0	1	3	4.4e-06	6.5e-05	18.7	0.0	846	919	47	121	29	126	0.82	Serine/threonine-protein kinase 10 (DB12010)
drugbank_target|O94804	-	968	sp|Q8IIT5|PTKL_PLA	-	1501	8.2e-24	81.3	0.0	2	3	7.3e-11	1.1e-09	34.6	0.0	1260	1314	127	181	120	188	0.91	Serine/threonine-protein kinase 10 (DB12010)
drugbank_target|O94804	-	968	sp|Q8IIT5|PTKL_PLA	-	1501	8.2e-24	81.3	0.0	3	3	3.9e-13	5.7e-12	42.1	0.0	1380	1478	187	291	181	310	0.85	Serine/threonine-protein kinase 10 (DB12010)
drugbank_target|Q16512	-	942	sp|Q8IIT5|PTKL_PLA	-	1501	9.6e-24	81.1	5.7	1	3	0.0021	0.03	9.9	0.0	857	922	637	709	616	714	0.75	Serine/threonine-protein kinase N1 (DB12010)
drugbank_target|Q16512	-	942	sp|Q8IIT5|PTKL_PLA	-	1501	9.6e-24	81.1	5.7	2	3	9.3e-10	1.4e-08	30.9	0.0	1262	1313	712	763	706	768	0.91	Serine/threonine-protein kinase N1 (DB12010)
drugbank_target|Q16512	-	942	sp|Q8IIT5|PTKL_PLA	-	1501	9.6e-24	81.1	5.7	3	3	2e-11	3e-10	36.4	0.0	1382	1471	772	859	763	868	0.91	Serine/threonine-protein kinase N1 (DB12010)
drugbank_target|P45983	-	427	sp|Q8IIT5|PTKL_PLA	-	1501	1e-23	81.1	10.8	1	3	3.7e-06	5.4e-05	19.0	0.2	818	913	8	113	3	122	0.81	Mitogen-activated protein kinase 8 (DB00675; DB01782; DB07218; DB07268; DB07272; DB07276; DB07845)
drugbank_target|P45983	-	427	sp|Q8IIT5|PTKL_PLA	-	1501	1e-23	81.1	10.8	2	3	7.5e-13	1.1e-11	41.1	0.0	1259	1320	120	181	114	186	0.90	Mitogen-activated protein kinase 8 (DB00675; DB01782; DB07218; DB07268; DB07272; DB07276; DB07845)
drugbank_target|P45983	-	427	sp|Q8IIT5|PTKL_PLA	-	1501	1e-23	81.1	10.8	3	3	5.9e-09	8.6e-08	28.3	0.0	1384	1475	184	274	178	301	0.81	Mitogen-activated protein kinase 8 (DB00675; DB01782; DB07218; DB07268; DB07272; DB07276; DB07845)
drugbank_target|P45983	-	427	sp|Q8IIT5|PTKL_PLA	-	1501	1e-23	81.1	10.8	1	3	3.7e-06	5.4e-05	19.0	0.2	818	913	8	113	3	122	0.81	Mitogen-activated protein kinase 8 (DB01017)
drugbank_target|P45983	-	427	sp|Q8IIT5|PTKL_PLA	-	1501	1e-23	81.1	10.8	2	3	7.5e-13	1.1e-11	41.1	0.0	1259	1320	120	181	114	186	0.90	Mitogen-activated protein kinase 8 (DB01017)
drugbank_target|P45983	-	427	sp|Q8IIT5|PTKL_PLA	-	1501	1e-23	81.1	10.8	3	3	5.9e-09	8.6e-08	28.3	0.0	1384	1475	184	274	178	301	0.81	Mitogen-activated protein kinase 8 (DB01017)
drugbank_target|P45983	-	427	sp|Q8IIT5|PTKL_PLA	-	1501	1e-23	81.1	10.8	1	3	3.7e-06	5.4e-05	19.0	0.2	818	913	8	113	3	122	0.81	Mitogen-activated protein kinase 8 (DB15624)
drugbank_target|P45983	-	427	sp|Q8IIT5|PTKL_PLA	-	1501	1e-23	81.1	10.8	2	3	7.5e-13	1.1e-11	41.1	0.0	1259	1320	120	181	114	186	0.90	Mitogen-activated protein kinase 8 (DB15624)
drugbank_target|P45983	-	427	sp|Q8IIT5|PTKL_PLA	-	1501	1e-23	81.1	10.8	3	3	5.9e-09	8.6e-08	28.3	0.0	1384	1475	184	274	178	301	0.81	Mitogen-activated protein kinase 8 (DB15624)
drugbank_target|Q13470	-	666	sp|Q8IIT5|PTKL_PLA	-	1501	1e-23	81.0	0.0	1	3	0.014	0.2	7.1	0.0	860	920	144	208	124	214	0.77	Non-receptor tyrosine-protein kinase TNK1 (DB12010)
drugbank_target|Q13470	-	666	sp|Q8IIT5|PTKL_PLA	-	1501	1e-23	81.0	0.0	2	3	2.7e-07	3.9e-06	22.8	0.0	1267	1313	222	268	214	272	0.91	Non-receptor tyrosine-protein kinase TNK1 (DB12010)
drugbank_target|Q13470	-	666	sp|Q8IIT5|PTKL_PLA	-	1501	1e-23	81.0	0.0	3	3	1.1e-14	1.6e-13	47.3	0.0	1389	1481	287	379	281	392	0.92	Non-receptor tyrosine-protein kinase TNK1 (DB12010)
drugbank_target|Q86UE8	-	772	sp|Q8IIT5|PTKL_PLA	-	1501	1.2e-23	80.8	0.2	1	3	0.0001	0.0015	14.2	0.1	857	924	484	560	468	563	0.72	Serine/threonine-protein kinase tousled-like 2 (DB12010)
drugbank_target|Q86UE8	-	772	sp|Q8IIT5|PTKL_PLA	-	1501	1.2e-23	80.8	0.2	2	3	6.4e-12	9.4e-11	38.1	0.1	1258	1319	558	624	557	637	0.86	Serine/threonine-protein kinase tousled-like 2 (DB12010)
drugbank_target|Q86UE8	-	772	sp|Q8IIT5|PTKL_PLA	-	1501	1.2e-23	80.8	0.2	3	3	6.4e-09	9.3e-08	28.1	0.0	1383	1476	635	736	622	750	0.75	Serine/threonine-protein kinase tousled-like 2 (DB12010)
drugbank_target|Q9UPZ9	-	632	sp|Q8IIT5|PTKL_PLA	-	1501	1.2e-23	80.7	12.8	1	3	9.1e-08	1.3e-06	24.3	1.0	855	914	24	85	2	88	0.79	Serine/threonine-protein kinase ICK (DB12010)
drugbank_target|Q9UPZ9	-	632	sp|Q8IIT5|PTKL_PLA	-	1501	1.2e-23	80.7	12.8	2	3	1.7e-12	2.4e-11	40.0	0.0	1252	1315	87	150	84	159	0.91	Serine/threonine-protein kinase ICK (DB12010)
drugbank_target|Q9UPZ9	-	632	sp|Q8IIT5|PTKL_PLA	-	1501	1.2e-23	80.7	12.8	3	3	2.3e-07	3.3e-06	23.0	0.0	1383	1473	157	276	152	282	0.66	Serine/threonine-protein kinase ICK (DB12010)
drugbank_target|Q13554	-	666	sp|Q8IIT5|PTKL_PLA	-	1501	1.4e-23	80.6	0.0	1	3	9e-07	1.3e-05	21.0	0.0	838	921	17	103	5	110	0.83	Calcium/calmodulin-dependent protein kinase type II subunit beta (DB07168; DB12010)
drugbank_target|Q13554	-	666	sp|Q8IIT5|PTKL_PLA	-	1501	1.4e-23	80.6	0.0	2	3	8.4e-10	1.2e-08	31.1	0.0	1262	1313	108	162	102	173	0.86	Calcium/calmodulin-dependent protein kinase type II subunit beta (DB07168; DB12010)
drugbank_target|Q13554	-	666	sp|Q8IIT5|PTKL_PLA	-	1501	1.4e-23	80.6	0.0	3	3	6e-13	8.7e-12	41.5	0.0	1385	1478	174	269	163	286	0.87	Calcium/calmodulin-dependent protein kinase type II subunit beta (DB07168; DB12010)
drugbank_target|Q02156	-	737	sp|Q8IIT5|PTKL_PLA	-	1501	1.5e-23	80.5	4.3	1	3	0.0073	0.11	8.0	0.0	843	921	416	499	407	506	0.65	Protein kinase C epsilon type (DB06064; DB11752; DB12010)
drugbank_target|Q02156	-	737	sp|Q8IIT5|PTKL_PLA	-	1501	1.5e-23	80.5	4.3	2	3	6.7e-11	9.8e-10	34.7	0.0	1258	1313	500	555	495	562	0.92	Protein kinase C epsilon type (DB06064; DB11752; DB12010)
drugbank_target|Q02156	-	737	sp|Q8IIT5|PTKL_PLA	-	1501	1.5e-23	80.5	4.3	3	3	3.5e-12	5.1e-11	39.0	0.0	1381	1471	563	651	556	665	0.91	Protein kinase C epsilon type (DB06064; DB11752; DB12010)
drugbank_target|Q02156	-	737	sp|Q8IIT5|PTKL_PLA	-	1501	1.5e-23	80.5	4.3	1	3	0.0073	0.11	8.0	0.0	843	921	416	499	407	506	0.65	Protein kinase C epsilon type (DB00675)
drugbank_target|Q02156	-	737	sp|Q8IIT5|PTKL_PLA	-	1501	1.5e-23	80.5	4.3	2	3	6.7e-11	9.8e-10	34.7	0.0	1258	1313	500	555	495	562	0.92	Protein kinase C epsilon type (DB00675)
drugbank_target|Q02156	-	737	sp|Q8IIT5|PTKL_PLA	-	1501	1.5e-23	80.5	4.3	3	3	3.5e-12	5.1e-11	39.0	0.0	1381	1471	563	651	556	665	0.91	Protein kinase C epsilon type (DB00675)
drugbank_target|Q9Y2U5	-	619	sp|Q8IIT5|PTKL_PLA	-	1501	1.5e-23	80.4	0.0	1	3	5.3e-06	7.7e-05	18.5	0.0	857	922	378	451	362	454	0.85	Mitogen-activated protein kinase kinase kinase 2 (DB06616; DB12010)
drugbank_target|Q9Y2U5	-	619	sp|Q8IIT5|PTKL_PLA	-	1501	1.5e-23	80.4	0.0	2	3	4.3e-12	6.2e-11	38.7	0.0	1260	1316	453	509	447	515	0.92	Mitogen-activated protein kinase kinase kinase 2 (DB06616; DB12010)
drugbank_target|Q9Y2U5	-	619	sp|Q8IIT5|PTKL_PLA	-	1501	1.5e-23	80.4	0.0	3	3	2.5e-11	3.7e-10	36.1	0.0	1380	1479	516	614	507	619	0.84	Mitogen-activated protein kinase kinase kinase 2 (DB06616; DB12010)
drugbank_target|Q8WU08	-	396	sp|Q8IIT5|PTKL_PLA	-	1501	1.7e-23	80.3	13.3	1	3	5.1e-05	0.00074	15.2	0.5	840	922	28	114	10	119	0.81	Serine/threonine-protein kinase 32A (DB12010)
drugbank_target|Q8WU08	-	396	sp|Q8IIT5|PTKL_PLA	-	1501	1.7e-23	80.3	13.3	2	3	2.2e-12	3.3e-11	39.6	0.3	1258	1314	114	170	111	179	0.92	Serine/threonine-protein kinase 32A (DB12010)
drugbank_target|Q8WU08	-	396	sp|Q8IIT5|PTKL_PLA	-	1501	1.7e-23	80.3	13.3	3	3	3e-11	4.4e-10	35.8	0.0	1380	1471	175	270	169	283	0.81	Serine/threonine-protein kinase 32A (DB12010)
drugbank_target|Q9Y463	-	629	sp|Q8IIT5|PTKL_PLA	-	1501	2.4e-23	79.8	1.1	1	2	1.1e-20	1.5e-19	67.2	1.4	1197	1313	142	264	127	271	0.89	Dual specificity tyrosine-phosphorylation-regulated kinase 1B (DB12010)
drugbank_target|Q9Y463	-	629	sp|Q8IIT5|PTKL_PLA	-	1501	2.4e-23	79.8	1.1	2	2	4.2e-06	6.1e-05	18.8	0.0	1384	1438	272	325	265	333	0.89	Dual specificity tyrosine-phosphorylation-regulated kinase 1B (DB12010)
drugbank_target|O95819	-	1239	sp|Q8IIT5|PTKL_PLA	-	1501	2.5e-23	79.7	0.0	1	3	1.5e-05	0.00022	17.0	0.0	842	926	34	123	24	126	0.81	Mitogen-activated protein kinase kinase kinase kinase 4 (DB12010)
drugbank_target|O95819	-	1239	sp|Q8IIT5|PTKL_PLA	-	1501	2.5e-23	79.7	0.0	2	3	1.4e-11	2e-10	37.0	0.0	1256	1314	119	177	116	183	0.93	Mitogen-activated protein kinase kinase kinase kinase 4 (DB12010)
drugbank_target|O95819	-	1239	sp|Q8IIT5|PTKL_PLA	-	1501	2.5e-23	79.7	0.0	3	3	1.1e-12	1.7e-11	40.6	0.0	1380	1495	183	303	178	309	0.82	Mitogen-activated protein kinase kinase kinase kinase 4 (DB12010)
drugbank_target|Q13627	-	763	sp|Q8IIT5|PTKL_PLA	-	1501	2.5e-23	79.7	1.6	1	3	7.3e-21	1.1e-19	67.7	1.7	1197	1313	190	312	177	320	0.90	Dual specificity tyrosine-phosphorylation-regulated kinase 1A (DB07608; DB12010)
drugbank_target|Q13627	-	763	sp|Q8IIT5|PTKL_PLA	-	1501	2.5e-23	79.7	1.6	2	3	5.1e-06	7.4e-05	18.5	0.0	1384	1439	320	374	314	409	0.87	Dual specificity tyrosine-phosphorylation-regulated kinase 1A (DB07608; DB12010)
drugbank_target|Q13627	-	763	sp|Q8IIT5|PTKL_PLA	-	1501	2.5e-23	79.7	1.6	3	3	0.95	14	1.0	6.7	534	594	613	673	596	687	0.75	Dual specificity tyrosine-phosphorylation-regulated kinase 1A (DB07608; DB12010)
drugbank_target|P05771	-	671	sp|Q8IIT5|PTKL_PLA	-	1501	3e-23	79.5	0.0	1	3	0.81	12	1.3	0.0	843	922	350	434	321	438	0.70	Protein kinase C beta type (DB00163; DB01738; DB06486; DB08846; DB08862; DB14001; DB14002)
drugbank_target|P05771	-	671	sp|Q8IIT5|PTKL_PLA	-	1501	3e-23	79.5	0.0	2	3	1.4e-10	2.1e-09	33.6	0.0	1256	1314	432	490	364	497	0.76	Protein kinase C beta type (DB00163; DB01738; DB06486; DB08846; DB08862; DB14001; DB14002)
drugbank_target|P05771	-	671	sp|Q8IIT5|PTKL_PLA	-	1501	3e-23	79.5	0.0	3	3	1.6e-13	2.3e-12	43.4	0.0	1378	1470	494	584	489	588	0.92	Protein kinase C beta type (DB00163; DB01738; DB06486; DB08846; DB08862; DB14001; DB14002)
drugbank_target|P05771	-	671	sp|Q8IIT5|PTKL_PLA	-	1501	3e-23	79.5	0.0	1	3	0.81	12	1.3	0.0	843	922	350	434	321	438	0.70	Protein kinase C beta type (DB00675)
drugbank_target|P05771	-	671	sp|Q8IIT5|PTKL_PLA	-	1501	3e-23	79.5	0.0	2	3	1.4e-10	2.1e-09	33.6	0.0	1256	1314	432	490	364	497	0.76	Protein kinase C beta type (DB00675)
drugbank_target|P05771	-	671	sp|Q8IIT5|PTKL_PLA	-	1501	3e-23	79.5	0.0	3	3	1.6e-13	2.3e-12	43.4	0.0	1378	1470	494	584	489	588	0.92	Protein kinase C beta type (DB00675)
drugbank_target|Q16644	-	382	sp|Q8IIT5|PTKL_PLA	-	1501	4.6e-23	78.9	0.0	1	3	0.05	0.73	5.3	0.0	854	922	63	132	45	136	0.73	MAP kinase-activated protein kinase 3 (DB07728; DB08358)
drugbank_target|Q16644	-	382	sp|Q8IIT5|PTKL_PLA	-	1501	4.6e-23	78.9	0.0	2	3	8.1e-11	1.2e-09	34.4	0.0	1259	1316	135	195	128	202	0.83	MAP kinase-activated protein kinase 3 (DB07728; DB08358)
drugbank_target|Q16644	-	382	sp|Q8IIT5|PTKL_PLA	-	1501	4.6e-23	78.9	0.0	3	3	1.3e-11	1.9e-10	37.1	0.0	1384	1477	201	300	193	313	0.83	MAP kinase-activated protein kinase 3 (DB07728; DB08358)
drugbank_target|Q00534	-	326	sp|Q8IIT5|PTKL_PLA	-	1501	5.1e-23	78.7	0.0	1	3	0.0046	0.068	8.7	0.0	853	922	32	111	9	118	0.66	Cyclin-dependent kinase 6 (DB03496; DB07379; DB07795; DB09073; DB11730; DB12001)
drugbank_target|Q00534	-	326	sp|Q8IIT5|PTKL_PLA	-	1501	5.1e-23	78.7	0.0	2	3	1.3e-15	1.8e-14	50.4	0.0	1235	1316	92	171	86	177	0.88	Cyclin-dependent kinase 6 (DB03496; DB07379; DB07795; DB09073; DB11730; DB12001)
drugbank_target|Q00534	-	326	sp|Q8IIT5|PTKL_PLA	-	1501	5.1e-23	78.7	0.0	3	3	1.2e-06	1.7e-05	20.6	0.0	1383	1435	177	228	170	297	0.81	Cyclin-dependent kinase 6 (DB03496; DB07379; DB07795; DB09073; DB11730; DB12001)
drugbank_target|O96017	-	543	sp|Q8IIT5|PTKL_PLA	-	1501	5.2e-23	78.7	24.9	1	3	6e-06	8.8e-05	18.3	0.1	853	919	238	312	222	317	0.75	Serine/threonine-protein kinase Chk2 (DB05149; DB06486; DB12010)
drugbank_target|O96017	-	543	sp|Q8IIT5|PTKL_PLA	-	1501	5.2e-23	78.7	24.9	2	3	5.4e-13	8e-12	41.6	0.1	1259	1315	316	375	313	382	0.88	Serine/threonine-protein kinase Chk2 (DB05149; DB06486; DB12010)
drugbank_target|O96017	-	543	sp|Q8IIT5|PTKL_PLA	-	1501	5.2e-23	78.7	24.9	3	3	2.1e-09	3.1e-08	29.7	0.0	1382	1479	381	484	376	502	0.77	Serine/threonine-protein kinase Chk2 (DB05149; DB06486; DB12010)
drugbank_target|Q15759	-	364	sp|Q8IIT5|PTKL_PLA	-	1501	5.5e-23	78.6	0.2	1	3	0.0058	0.085	8.4	0.0	857	902	46	94	25	119	0.75	Mitogen-activated protein kinase 11 (DB01017)
drugbank_target|Q15759	-	364	sp|Q8IIT5|PTKL_PLA	-	1501	5.5e-23	78.6	0.2	2	3	4.1e-13	6e-12	42.0	0.0	1257	1316	117	176	99	181	0.87	Mitogen-activated protein kinase 11 (DB01017)
drugbank_target|Q15759	-	364	sp|Q8IIT5|PTKL_PLA	-	1501	5.5e-23	78.6	0.2	3	3	2.3e-08	3.4e-07	26.3	0.0	1381	1451	178	252	173	268	0.75	Mitogen-activated protein kinase 11 (DB01017)
drugbank_target|Q15759	-	364	sp|Q8IIT5|PTKL_PLA	-	1501	5.5e-23	78.6	0.2	1	3	0.0058	0.085	8.4	0.0	857	902	46	94	25	119	0.75	Mitogen-activated protein kinase 11 (DB05157; DB08896)
drugbank_target|Q15759	-	364	sp|Q8IIT5|PTKL_PLA	-	1501	5.5e-23	78.6	0.2	2	3	4.1e-13	6e-12	42.0	0.0	1257	1316	117	176	99	181	0.87	Mitogen-activated protein kinase 11 (DB05157; DB08896)
drugbank_target|Q15759	-	364	sp|Q8IIT5|PTKL_PLA	-	1501	5.5e-23	78.6	0.2	3	3	2.3e-08	3.4e-07	26.3	0.0	1381	1451	178	252	173	268	0.75	Mitogen-activated protein kinase 11 (DB05157; DB08896)
drugbank_target|Q02750	-	393	sp|Q8IIT5|PTKL_PLA	-	1501	6.2e-23	78.4	0.0	1	4	0.00016	0.0023	13.6	0.0	853	922	86	157	66	161	0.81	Dual specificity mitogen-activated protein kinase kinase 1 (DB02152; DB03115; DB05239; DB06616; DB06892; DB07046; DB07101; DB08130; DB08208; DB08911; DB11689)
drugbank_target|Q02750	-	393	sp|Q8IIT5|PTKL_PLA	-	1501	6.2e-23	78.4	0.0	2	4	1.5e-11	2.2e-10	36.8	0.0	1255	1312	154	212	152	219	0.89	Dual specificity mitogen-activated protein kinase kinase 1 (DB02152; DB03115; DB05239; DB06616; DB06892; DB07046; DB07101; DB08130; DB08208; DB08911; DB11689)
drugbank_target|Q02750	-	393	sp|Q8IIT5|PTKL_PLA	-	1501	6.2e-23	78.4	0.0	3	4	3e-08	4.4e-07	25.9	0.0	1380	1437	218	274	213	289	0.86	Dual specificity mitogen-activated protein kinase kinase 1 (DB02152; DB03115; DB05239; DB06616; DB06892; DB07046; DB07101; DB08130; DB08208; DB08911; DB11689)
drugbank_target|Q02750	-	393	sp|Q8IIT5|PTKL_PLA	-	1501	6.2e-23	78.4	0.0	4	4	6.1	89	-1.6	0.0	1450	1477	330	357	312	370	0.81	Dual specificity mitogen-activated protein kinase kinase 1 (DB02152; DB03115; DB05239; DB06616; DB06892; DB07046; DB07101; DB08130; DB08208; DB08911; DB11689)
drugbank_target|Q15746	-	1914	sp|Q8IIT5|PTKL_PLA	-	1501	8.8e-23	77.9	17.1	1	3	6.5e-06	9.5e-05	18.2	0.2	842	919	1473	1549	1447	1553	0.77	Myosin light chain kinase, smooth muscle (DB12010)
drugbank_target|Q15746	-	1914	sp|Q8IIT5|PTKL_PLA	-	1501	8.8e-23	77.9	17.1	2	3	4.6e-12	6.8e-11	38.5	0.0	1254	1315	1549	1612	1546	1621	0.87	Myosin light chain kinase, smooth muscle (DB12010)
drugbank_target|Q15746	-	1914	sp|Q8IIT5|PTKL_PLA	-	1501	8.8e-23	77.9	17.1	3	3	5e-11	7.3e-10	35.1	0.0	1385	1489	1621	1727	1614	1741	0.86	Myosin light chain kinase, smooth muscle (DB12010)
drugbank_target|Q05513	-	592	sp|Q8IIT5|PTKL_PLA	-	1501	9.5e-23	77.8	0.0	1	3	0.028	0.41	6.1	0.1	840	923	259	345	252	347	0.69	Protein kinase C zeta type (DB00675)
drugbank_target|Q05513	-	592	sp|Q8IIT5|PTKL_PLA	-	1501	9.5e-23	77.8	0.0	2	3	5.3e-11	7.7e-10	35.0	0.0	1257	1313	343	399	340	402	0.95	Protein kinase C zeta type (DB00675)
drugbank_target|Q05513	-	592	sp|Q8IIT5|PTKL_PLA	-	1501	9.5e-23	77.8	0.0	3	3	7.9e-11	1.2e-09	34.5	0.0	1382	1470	408	501	404	509	0.86	Protein kinase C zeta type (DB00675)
drugbank_target|P49137	-	400	sp|Q8IIT5|PTKL_PLA	-	1501	1e-22	77.7	0.0	1	3	0.15	2.2	3.7	0.0	853	921	82	151	49	156	0.72	MAP kinase-activated protein kinase 2 (DB02010; DB07234; DB07406; DB07430; DB07431; DB07728; DB08358)
drugbank_target|P49137	-	400	sp|Q8IIT5|PTKL_PLA	-	1501	1e-22	77.7	0.0	2	3	3.1e-10	4.6e-09	32.5	0.0	1259	1319	155	218	148	226	0.84	MAP kinase-activated protein kinase 2 (DB02010; DB07234; DB07406; DB07430; DB07431; DB07728; DB08358)
drugbank_target|P49137	-	400	sp|Q8IIT5|PTKL_PLA	-	1501	1e-22	77.7	0.0	3	3	2.1e-12	3.1e-11	39.7	0.0	1384	1478	222	322	213	334	0.78	MAP kinase-activated protein kinase 2 (DB02010; DB07234; DB07406; DB07430; DB07431; DB07728; DB08358)
drugbank_target|P9WI81	-	626	sp|Q8IIT5|PTKL_PLA	-	1501	1.4e-22	77.3	0.0	1	3	0.0025	0.036	9.6	0.0	851	922	27	106	8	110	0.77	Serine/threonine-protein kinase PknB (DB02930; DB03909; DB12010)
drugbank_target|P9WI81	-	626	sp|Q8IIT5|PTKL_PLA	-	1501	1.4e-22	77.3	0.0	2	3	6.5e-11	9.5e-10	34.7	0.1	1262	1314	110	162	105	169	0.91	Serine/threonine-protein kinase PknB (DB02930; DB03909; DB12010)
drugbank_target|P9WI81	-	626	sp|Q8IIT5|PTKL_PLA	-	1501	1.4e-22	77.3	0.0	3	3	2e-09	2.9e-08	29.8	0.0	1378	1473	169	266	163	280	0.82	Serine/threonine-protein kinase PknB (DB02930; DB03909; DB12010)
drugbank_target|Q96Q40	-	435	sp|Q8IIT5|PTKL_PLA	-	1501	1.4e-22	77.3	0.1	1	3	4.8e-07	7e-06	21.9	0.1	847	921	117	190	99	193	0.77	Cyclin-dependent kinase 15 (DB00171; DB06486; DB12010)
drugbank_target|Q96Q40	-	435	sp|Q8IIT5|PTKL_PLA	-	1501	1.4e-22	77.3	0.1	2	3	3.2e-12	4.7e-11	39.1	0.0	1253	1316	187	250	182	256	0.90	Cyclin-dependent kinase 15 (DB00171; DB06486; DB12010)
drugbank_target|Q96Q40	-	435	sp|Q8IIT5|PTKL_PLA	-	1501	1.4e-22	77.3	0.1	3	3	5.3e-05	0.00077	15.1	0.0	1379	1430	254	304	247	318	0.82	Cyclin-dependent kinase 15 (DB00171; DB06486; DB12010)
drugbank_target|O14936	-	926	sp|Q8IIT5|PTKL_PLA	-	1501	2e-22	76.8	1.3	1	3	8.7e-06	0.00013	17.7	0.0	850	929	27	113	13	121	0.78	Peripheral plasma membrane protein CASK (DB01942; DB12010)
drugbank_target|O14936	-	926	sp|Q8IIT5|PTKL_PLA	-	1501	2e-22	76.8	1.3	2	3	1e-07	1.5e-06	24.1	0.0	1261	1312	112	166	98	172	0.83	Peripheral plasma membrane protein CASK (DB01942; DB12010)
drugbank_target|O14936	-	926	sp|Q8IIT5|PTKL_PLA	-	1501	2e-22	76.8	1.3	3	3	3.3e-10	4.8e-09	32.4	0.0	1386	1476	180	271	175	280	0.85	Peripheral plasma membrane protein CASK (DB01942; DB12010)
drugbank_target|P36896	-	505	sp|Q8IIT5|PTKL_PLA	-	1501	2e-22	76.7	0.0	1	3	5.5e-09	8.1e-08	28.3	0.0	837	925	211	299	199	321	0.86	Activin receptor type-1B (DB00171; DB12010)
drugbank_target|P36896	-	505	sp|Q8IIT5|PTKL_PLA	-	1501	2e-22	76.7	0.0	2	3	6e-07	8.8e-06	21.6	0.1	1266	1324	303	369	295	372	0.76	Activin receptor type-1B (DB00171; DB12010)
drugbank_target|P36896	-	505	sp|Q8IIT5|PTKL_PLA	-	1501	2e-22	76.7	0.0	3	3	2.6e-08	3.7e-07	26.1	0.0	1375	1489	365	504	361	505	0.73	Activin receptor type-1B (DB00171; DB12010)
drugbank_target|P36507	-	400	sp|Q8IIT5|PTKL_PLA	-	1501	2.9e-22	76.2	0.0	1	3	7.5e-05	0.0011	14.6	0.0	857	924	94	163	71	170	0.81	Dual specificity mitogen-activated protein kinase kinase 2 (DB06616; DB08911; DB11689; DB11967; DB12010)
drugbank_target|P36507	-	400	sp|Q8IIT5|PTKL_PLA	-	1501	2.9e-22	76.2	0.0	2	3	1.5e-10	2.2e-09	33.5	0.0	1259	1312	162	216	160	222	0.88	Dual specificity mitogen-activated protein kinase kinase 2 (DB06616; DB08911; DB11689; DB11967; DB12010)
drugbank_target|P36507	-	400	sp|Q8IIT5|PTKL_PLA	-	1501	2.9e-22	76.2	0.0	3	3	3.2e-08	4.6e-07	25.8	0.0	1380	1437	222	278	216	293	0.88	Dual specificity mitogen-activated protein kinase kinase 2 (DB06616; DB08911; DB11689; DB11967; DB12010)
drugbank_target|O15075	-	740	sp|Q8IIT5|PTKL_PLA	-	1501	5.3e-22	75.3	24.1	1	3	6.1e-08	8.9e-07	24.9	0.1	848	923	403	480	381	485	0.80	Serine/threonine-protein kinase DCLK1 (DB12010)
drugbank_target|O15075	-	740	sp|Q8IIT5|PTKL_PLA	-	1501	5.3e-22	75.3	24.1	2	3	1.6e-09	2.3e-08	30.1	0.0	1259	1316	480	541	478	546	0.88	Serine/threonine-protein kinase DCLK1 (DB12010)
drugbank_target|O15075	-	740	sp|Q8IIT5|PTKL_PLA	-	1501	5.3e-22	75.3	24.1	3	3	9.6e-09	1.4e-07	27.5	0.0	1384	1477	546	643	541	648	0.83	Serine/threonine-protein kinase DCLK1 (DB12010)
drugbank_target|Q00535	-	292	sp|Q8IIT5|PTKL_PLA	-	1501	5.3e-22	75.3	0.0	1	3	4e-07	5.8e-06	22.2	0.0	838	921	7	92	1	98	0.73	Cyclin-dependent-like kinase 5 (DB02052; DB02116; DB02950; DB03428; DB03496; DB04014; DB07364)
drugbank_target|Q00535	-	292	sp|Q8IIT5|PTKL_PLA	-	1501	5.3e-22	75.3	0.0	2	3	1.6e-11	2.4e-10	36.7	0.0	1258	1314	94	150	87	157	0.90	Cyclin-dependent-like kinase 5 (DB02052; DB02116; DB02950; DB03428; DB03496; DB04014; DB07364)
drugbank_target|Q00535	-	292	sp|Q8IIT5|PTKL_PLA	-	1501	5.3e-22	75.3	0.0	3	3	9.9e-05	0.0014	14.2	0.0	1386	1438	162	215	152	282	0.77	Cyclin-dependent-like kinase 5 (DB02052; DB02116; DB02950; DB03428; DB03496; DB04014; DB07364)
drugbank_target|P53779	-	464	sp|Q8IIT5|PTKL_PLA	-	1501	7.2e-22	74.9	16.7	1	3	1.1e-05	0.00017	17.4	0.4	821	913	49	151	29	159	0.76	Mitogen-activated protein kinase 10 (DB01017)
drugbank_target|P53779	-	464	sp|Q8IIT5|PTKL_PLA	-	1501	7.2e-22	74.9	16.7	2	3	9.1e-13	1.3e-11	40.9	0.0	1260	1320	159	219	153	224	0.90	Mitogen-activated protein kinase 10 (DB01017)
drugbank_target|P53779	-	464	sp|Q8IIT5|PTKL_PLA	-	1501	7.2e-22	74.9	16.7	3	3	5.7e-09	8.3e-08	28.3	0.0	1384	1466	222	302	216	328	0.84	Mitogen-activated protein kinase 10 (DB01017)
drugbank_target|P53779	-	464	sp|Q8IIT5|PTKL_PLA	-	1501	7.2e-22	74.9	16.7	1	3	1.1e-05	0.00017	17.4	0.4	821	913	49	151	29	159	0.76	Mitogen-activated protein kinase 10 (DB15624)
drugbank_target|P53779	-	464	sp|Q8IIT5|PTKL_PLA	-	1501	7.2e-22	74.9	16.7	2	3	9.1e-13	1.3e-11	40.9	0.0	1260	1320	159	219	153	224	0.90	Mitogen-activated protein kinase 10 (DB15624)
drugbank_target|P53779	-	464	sp|Q8IIT5|PTKL_PLA	-	1501	7.2e-22	74.9	16.7	3	3	5.7e-09	8.3e-08	28.3	0.0	1384	1466	222	302	216	328	0.84	Mitogen-activated protein kinase 10 (DB15624)
drugbank_target|P53779	-	464	sp|Q8IIT5|PTKL_PLA	-	1501	7.2e-22	74.9	16.7	1	3	1.1e-05	0.00017	17.4	0.4	821	913	49	151	29	159	0.76	Mitogen-activated protein kinase 10 (DB01782; DB02388; DB03084; DB03623; DB04395; DB06933; DB07010; DB07217; DB08005; DB08010; DB08011; DB08015; DB08021; DB08023; DB08025; DB08026; DB08555; DB12010)
drugbank_target|P53779	-	464	sp|Q8IIT5|PTKL_PLA	-	1501	7.2e-22	74.9	16.7	2	3	9.1e-13	1.3e-11	40.9	0.0	1260	1320	159	219	153	224	0.90	Mitogen-activated protein kinase 10 (DB01782; DB02388; DB03084; DB03623; DB04395; DB06933; DB07010; DB07217; DB08005; DB08010; DB08011; DB08015; DB08021; DB08023; DB08025; DB08026; DB08555; DB12010)
drugbank_target|P53779	-	464	sp|Q8IIT5|PTKL_PLA	-	1501	7.2e-22	74.9	16.7	3	3	5.7e-09	8.3e-08	28.3	0.0	1384	1466	222	302	216	328	0.84	Mitogen-activated protein kinase 10 (DB01782; DB02388; DB03084; DB03623; DB04395; DB06933; DB07010; DB07217; DB08005; DB08010; DB08011; DB08015; DB08021; DB08023; DB08025; DB08026; DB08555; DB12010)
drugbank_target|O95382	-	1288	sp|Q8IIT5|PTKL_PLA	-	1501	7.8e-22	74.8	19.0	1	3	2.2e-05	0.00033	16.4	0.0	853	922	666	736	651	739	0.86	Mitogen-activated protein kinase kinase kinase 6 (DB12010)
drugbank_target|O95382	-	1288	sp|Q8IIT5|PTKL_PLA	-	1501	7.8e-22	74.8	19.0	2	3	1.7e-09	2.5e-08	30.0	0.0	1264	1314	745	796	739	803	0.91	Mitogen-activated protein kinase kinase kinase 6 (DB12010)
drugbank_target|O95382	-	1288	sp|Q8IIT5|PTKL_PLA	-	1501	7.8e-22	74.8	19.0	3	3	1e-09	1.5e-08	30.8	0.0	1383	1476	805	901	800	904	0.84	Mitogen-activated protein kinase kinase kinase 6 (DB12010)
drugbank_target|P31152	-	587	sp|Q8IIT5|PTKL_PLA	-	1501	1.1e-21	74.3	0.6	1	3	0.0021	0.031	9.8	0.3	857	901	42	87	35	117	0.71	Mitogen-activated protein kinase 4 (DB01017)
drugbank_target|P31152	-	587	sp|Q8IIT5|PTKL_PLA	-	1501	1.1e-21	74.3	0.6	2	3	7.9e-13	1.2e-11	41.1	0.0	1239	1317	103	177	91	187	0.82	Mitogen-activated protein kinase 4 (DB01017)
drugbank_target|P31152	-	587	sp|Q8IIT5|PTKL_PLA	-	1501	1.1e-21	74.3	0.6	3	3	4.5e-07	6.6e-06	22.0	0.0	1375	1480	178	286	175	305	0.80	Mitogen-activated protein kinase 4 (DB01017)
drugbank_target|P31152	-	587	sp|Q8IIT5|PTKL_PLA	-	1501	1.1e-21	74.3	0.6	1	3	0.0021	0.031	9.8	0.3	857	901	42	87	35	117	0.71	Mitogen-activated protein kinase 4 (DB12010)
drugbank_target|P31152	-	587	sp|Q8IIT5|PTKL_PLA	-	1501	1.1e-21	74.3	0.6	2	3	7.9e-13	1.2e-11	41.1	0.0	1239	1317	103	177	91	187	0.82	Mitogen-activated protein kinase 4 (DB12010)
drugbank_target|P31152	-	587	sp|Q8IIT5|PTKL_PLA	-	1501	1.1e-21	74.3	0.6	3	3	4.5e-07	6.6e-06	22.0	0.0	1375	1480	178	286	175	305	0.80	Mitogen-activated protein kinase 4 (DB12010)
drugbank_target|P31152	-	587	sp|Q8IIT5|PTKL_PLA	-	1501	1.1e-21	74.3	0.6	1	3	0.0021	0.031	9.8	0.3	857	901	42	87	35	117	0.71	Mitogen-activated protein kinase 4 (DB00945)
drugbank_target|P31152	-	587	sp|Q8IIT5|PTKL_PLA	-	1501	1.1e-21	74.3	0.6	2	3	7.9e-13	1.2e-11	41.1	0.0	1239	1317	103	177	91	187	0.82	Mitogen-activated protein kinase 4 (DB00945)
drugbank_target|P31152	-	587	sp|Q8IIT5|PTKL_PLA	-	1501	1.1e-21	74.3	0.6	3	3	4.5e-07	6.6e-06	22.0	0.0	1375	1480	178	286	175	305	0.80	Mitogen-activated protein kinase 4 (DB00945)
drugbank_target|Q9HAZ1	-	481	sp|Q8IIT5|PTKL_PLA	-	1501	1.2e-21	74.2	1.0	1	3	0.15	2.2	3.7	0.0	851	911	176	242	160	255	0.76	Dual specificity protein kinase CLK4 (DB12010)
drugbank_target|Q9HAZ1	-	481	sp|Q8IIT5|PTKL_PLA	-	1501	1.2e-21	74.2	1.0	2	3	3e-07	4.4e-06	22.6	0.3	1262	1301	258	297	246	304	0.86	Dual specificity protein kinase CLK4 (DB12010)
drugbank_target|Q9HAZ1	-	481	sp|Q8IIT5|PTKL_PLA	-	1501	1.2e-21	74.2	1.0	3	3	5e-14	7.3e-13	45.1	0.0	1349	1440	301	391	296	410	0.92	Dual specificity protein kinase CLK4 (DB12010)
drugbank_target|P37023	-	503	sp|Q8IIT5|PTKL_PLA	-	1501	1.3e-21	74.0	0.0	1	3	8.6e-09	1.3e-07	27.7	0.0	849	924	214	293	199	303	0.86	Serine/threonine-protein kinase receptor R3 (DB00171)
drugbank_target|P37023	-	503	sp|Q8IIT5|PTKL_PLA	-	1501	1.3e-21	74.0	0.0	2	3	6.3e-05	0.00092	14.9	0.0	1283	1316	323	356	291	367	0.76	Serine/threonine-protein kinase receptor R3 (DB00171)
drugbank_target|P37023	-	503	sp|Q8IIT5|PTKL_PLA	-	1501	1.3e-21	74.0	0.0	3	3	3e-09	4.4e-08	29.2	0.0	1374	1485	359	495	353	501	0.70	Serine/threonine-protein kinase receptor R3 (DB00171)
drugbank_target|P57078	-	832	sp|Q8IIT5|PTKL_PLA	-	1501	1.4e-21	74.0	8.5	1	3	0.0025	0.036	9.6	0.0	857	921	44	109	25	114	0.77	Receptor-interacting serine/threonine-protein kinase 4 (DB12010)
drugbank_target|P57078	-	832	sp|Q8IIT5|PTKL_PLA	-	1501	1.4e-21	74.0	8.5	2	3	2.1e-09	3e-08	29.8	0.0	1267	1315	118	168	109	178	0.86	Receptor-interacting serine/threonine-protein kinase 4 (DB12010)
drugbank_target|P57078	-	832	sp|Q8IIT5|PTKL_PLA	-	1501	1.4e-21	74.0	8.5	3	3	9.3e-12	1.4e-10	37.5	0.0	1385	1473	181	277	171	282	0.82	Receptor-interacting serine/threonine-protein kinase 4 (DB12010)
drugbank_target|P05129	-	697	sp|Q8IIT5|PTKL_PLA	-	1501	2.4e-21	73.1	3.4	1	2	3.5e-10	5.1e-09	32.3	0.0	1258	1314	448	504	429	510	0.90	Protein kinase C gamma type (DB00675)
drugbank_target|P05129	-	697	sp|Q8IIT5|PTKL_PLA	-	1501	2.4e-21	73.1	3.4	2	2	7.8e-13	1.1e-11	41.1	0.0	1380	1470	510	598	503	601	0.91	Protein kinase C gamma type (DB00675)
drugbank_target|P05129	-	697	sp|Q8IIT5|PTKL_PLA	-	1501	2.4e-21	73.1	3.4	1	2	3.5e-10	5.1e-09	32.3	0.0	1258	1314	448	504	429	510	0.90	Protein kinase C gamma type (DB12010)
drugbank_target|P05129	-	697	sp|Q8IIT5|PTKL_PLA	-	1501	2.4e-21	73.1	3.4	2	2	7.8e-13	1.1e-11	41.1	0.0	1380	1470	510	598	503	601	0.91	Protein kinase C gamma type (DB12010)
drugbank_target|P50750	-	372	sp|Q8IIT5|PTKL_PLA	-	1501	3.2e-21	72.8	1.0	1	3	0.00012	0.0017	14.0	0.4	837	912	21	107	13	120	0.70	Cyclin-dependent kinase 9 (DB03496; DB06195)
drugbank_target|P50750	-	372	sp|Q8IIT5|PTKL_PLA	-	1501	3.2e-21	72.8	1.0	2	3	8.3e-12	1.2e-10	37.7	0.1	1239	1315	101	174	92	185	0.83	Cyclin-dependent kinase 9 (DB03496; DB06195)
drugbank_target|P50750	-	372	sp|Q8IIT5|PTKL_PLA	-	1501	3.2e-21	72.8	1.0	3	3	3e-06	4.4e-05	19.3	0.0	1380	1470	184	274	177	288	0.78	Cyclin-dependent kinase 9 (DB03496; DB06195)
drugbank_target|Q5S007	-	2527	sp|Q8IIT5|PTKL_PLA	-	1501	3.2e-21	72.8	0.0	1	3	3.9e-06	5.7e-05	18.9	0.0	851	925	1893	1964	1887	1969	0.89	Leucine-rich repeat serine/threonine-protein kinase 2 (DB12010)
drugbank_target|Q5S007	-	2527	sp|Q8IIT5|PTKL_PLA	-	1501	3.2e-21	72.8	0.0	2	3	2.3e-08	3.4e-07	26.3	0.0	1257	1322	1961	2029	1959	2034	0.83	Leucine-rich repeat serine/threonine-protein kinase 2 (DB12010)
drugbank_target|Q5S007	-	2527	sp|Q8IIT5|PTKL_PLA	-	1501	3.2e-21	72.8	0.0	3	3	3e-08	4.4e-07	25.9	0.0	1383	1480	2030	2133	2022	2138	0.71	Leucine-rich repeat serine/threonine-protein kinase 2 (DB12010)
drugbank_target|Q8TD08	-	544	sp|Q8IIT5|PTKL_PLA	-	1501	3.3e-21	72.7	4.4	1	3	0.00045	0.0066	12.1	0.0	855	913	33	97	19	105	0.75	Mitogen-activated protein kinase 15 (DB01017)
drugbank_target|Q8TD08	-	544	sp|Q8IIT5|PTKL_PLA	-	1501	3.3e-21	72.7	4.4	2	3	3.1e-13	4.6e-12	42.4	0.0	1235	1314	86	161	84	166	0.92	Mitogen-activated protein kinase 15 (DB01017)
drugbank_target|Q8TD08	-	544	sp|Q8IIT5|PTKL_PLA	-	1501	3.3e-21	72.7	4.4	3	3	7.1e-07	1e-05	21.3	0.0	1381	1439	173	231	167	245	0.87	Mitogen-activated protein kinase 15 (DB01017)
drugbank_target|Q8TD08	-	544	sp|Q8IIT5|PTKL_PLA	-	1501	3.3e-21	72.7	4.4	1	3	0.00045	0.0066	12.1	0.0	855	913	33	97	19	105	0.75	Mitogen-activated protein kinase 15 (DB12010)
drugbank_target|Q8TD08	-	544	sp|Q8IIT5|PTKL_PLA	-	1501	3.3e-21	72.7	4.4	2	3	3.1e-13	4.6e-12	42.4	0.0	1235	1314	86	161	84	166	0.92	Mitogen-activated protein kinase 15 (DB12010)
drugbank_target|Q8TD08	-	544	sp|Q8IIT5|PTKL_PLA	-	1501	3.3e-21	72.7	4.4	3	3	7.1e-07	1e-05	21.3	0.0	1381	1439	173	231	167	245	0.87	Mitogen-activated protein kinase 15 (DB12010)
drugbank_target|Q8TD08	-	544	sp|Q8IIT5|PTKL_PLA	-	1501	3.3e-21	72.7	4.4	1	3	0.00045	0.0066	12.1	0.0	855	913	33	97	19	105	0.75	Mitogen-activated protein kinase 15 (DB00945)
drugbank_target|Q8TD08	-	544	sp|Q8IIT5|PTKL_PLA	-	1501	3.3e-21	72.7	4.4	2	3	3.1e-13	4.6e-12	42.4	0.0	1235	1314	86	161	84	166	0.92	Mitogen-activated protein kinase 15 (DB00945)
drugbank_target|Q8TD08	-	544	sp|Q8IIT5|PTKL_PLA	-	1501	3.3e-21	72.7	4.4	3	3	7.1e-07	1e-05	21.3	0.0	1381	1439	173	231	167	245	0.87	Mitogen-activated protein kinase 15 (DB00945)
drugbank_target|P45984	-	424	sp|Q8IIT5|PTKL_PLA	-	1501	4.4e-21	72.3	13.9	1	3	0.0002	0.0028	13.3	0.2	836	914	27	114	5	122	0.74	Mitogen-activated protein kinase 9 (DB07020; DB12010)
drugbank_target|P45984	-	424	sp|Q8IIT5|PTKL_PLA	-	1501	4.4e-21	72.3	13.9	2	3	5.2e-13	7.5e-12	41.7	0.1	1259	1317	120	178	114	185	0.90	Mitogen-activated protein kinase 9 (DB07020; DB12010)
drugbank_target|P45984	-	424	sp|Q8IIT5|PTKL_PLA	-	1501	4.4e-21	72.3	13.9	3	3	4.9e-09	7.1e-08	28.5	0.0	1383	1467	183	265	175	301	0.82	Mitogen-activated protein kinase 9 (DB07020; DB12010)
drugbank_target|P45984	-	424	sp|Q8IIT5|PTKL_PLA	-	1501	4.4e-21	72.3	13.9	1	3	0.0002	0.0028	13.3	0.2	836	914	27	114	5	122	0.74	Mitogen-activated protein kinase 9 (DB01017)
drugbank_target|P45984	-	424	sp|Q8IIT5|PTKL_PLA	-	1501	4.4e-21	72.3	13.9	2	3	5.2e-13	7.5e-12	41.7	0.1	1259	1317	120	178	114	185	0.90	Mitogen-activated protein kinase 9 (DB01017)
drugbank_target|P45984	-	424	sp|Q8IIT5|PTKL_PLA	-	1501	4.4e-21	72.3	13.9	3	3	4.9e-09	7.1e-08	28.5	0.0	1383	1467	183	265	175	301	0.82	Mitogen-activated protein kinase 9 (DB01017)
drugbank_target|P45984	-	424	sp|Q8IIT5|PTKL_PLA	-	1501	4.4e-21	72.3	13.9	1	3	0.0002	0.0028	13.3	0.2	836	914	27	114	5	122	0.74	Mitogen-activated protein kinase 9 (DB15624)
drugbank_target|P45984	-	424	sp|Q8IIT5|PTKL_PLA	-	1501	4.4e-21	72.3	13.9	2	3	5.2e-13	7.5e-12	41.7	0.1	1259	1317	120	178	114	185	0.90	Mitogen-activated protein kinase 9 (DB15624)
drugbank_target|P45984	-	424	sp|Q8IIT5|PTKL_PLA	-	1501	4.4e-21	72.3	13.9	3	3	4.9e-09	7.1e-08	28.5	0.0	1383	1467	183	265	175	301	0.82	Mitogen-activated protein kinase 9 (DB15624)
drugbank_target|P35626	-	688	sp|Q8IIT5|PTKL_PLA	-	1501	5.7e-21	71.9	0.0	1	3	1.6	23	0.3	0.0	825	921	186	284	164	286	0.61	Beta-adrenergic receptor kinase 2 (DB00171)
drugbank_target|P35626	-	688	sp|Q8IIT5|PTKL_PLA	-	1501	5.7e-21	71.9	0.0	2	3	3.5e-11	5.1e-10	35.6	0.0	1257	1313	284	340	278	346	0.94	Beta-adrenergic receptor kinase 2 (DB00171)
drugbank_target|P35626	-	688	sp|Q8IIT5|PTKL_PLA	-	1501	5.7e-21	71.9	0.0	3	3	2.3e-10	3.3e-09	32.9	0.0	1382	1470	347	437	340	441	0.87	Beta-adrenergic receptor kinase 2 (DB00171)
drugbank_target|Q9HBH9	-	465	sp|Q8IIT5|PTKL_PLA	-	1501	9.4e-21	71.2	0.0	1	3	4.5e-06	6.6e-05	18.7	0.1	841	924	90	175	73	181	0.84	MAP kinase-interacting serine/threonine-protein kinase 2 (DB12010)
drugbank_target|Q9HBH9	-	465	sp|Q8IIT5|PTKL_PLA	-	1501	9.4e-21	71.2	0.0	2	3	1.7e-09	2.5e-08	30.0	0.0	1259	1312	174	230	172	240	0.85	MAP kinase-interacting serine/threonine-protein kinase 2 (DB12010)
drugbank_target|Q9HBH9	-	465	sp|Q8IIT5|PTKL_PLA	-	1501	9.4e-21	71.2	0.0	3	3	1.4e-06	2e-05	20.4	0.0	1386	1477	251	364	231	370	0.72	MAP kinase-interacting serine/threonine-protein kinase 2 (DB12010)
drugbank_target|Q13233	-	1512	sp|Q8IIT5|PTKL_PLA	-	1501	9.6e-21	71.2	0.0	1	3	3e-06	4.4e-05	19.3	0.0	858	922	1266	1337	1247	1343	0.78	Mitogen-activated protein kinase kinase kinase 1 (DB06061; DB11967; DB12010)
drugbank_target|Q13233	-	1512	sp|Q8IIT5|PTKL_PLA	-	1501	9.6e-21	71.2	0.0	2	3	6.5e-09	9.5e-08	28.1	0.0	1260	1313	1339	1393	1333	1400	0.88	Mitogen-activated protein kinase kinase kinase 1 (DB06061; DB11967; DB12010)
drugbank_target|Q13233	-	1512	sp|Q8IIT5|PTKL_PLA	-	1501	9.6e-21	71.2	0.0	3	3	3.2e-12	4.6e-11	39.1	0.0	1383	1478	1407	1505	1396	1509	0.84	Mitogen-activated protein kinase kinase kinase 1 (DB06061; DB11967; DB12010)
drugbank_target|O14920	-	756	sp|Q8IIT5|PTKL_PLA	-	1501	1e-20	71.1	0.0	1	3	2.8e-05	0.00041	16.1	0.0	852	923	32	111	18	115	0.80	Inhibitor of nuclear factor kappa-B kinase subunit beta (DB00244; DB00795; DB00945; DB00995; DB01169; DB05183; DB06151; DB06521; DB12010)
drugbank_target|O14920	-	756	sp|Q8IIT5|PTKL_PLA	-	1501	1e-20	71.1	0.0	2	3	2.4e-10	3.4e-09	32.9	0.0	1262	1314	117	172	111	178	0.87	Inhibitor of nuclear factor kappa-B kinase subunit beta (DB00244; DB00795; DB00945; DB00995; DB01169; DB05183; DB06151; DB06521; DB12010)
drugbank_target|O14920	-	756	sp|Q8IIT5|PTKL_PLA	-	1501	1e-20	71.1	0.0	3	3	6.3e-06	9.2e-05	18.2	0.0	1383	1428	180	224	175	249	0.82	Inhibitor of nuclear factor kappa-B kinase subunit beta (DB00244; DB00795; DB00945; DB00995; DB01169; DB05183; DB06151; DB06521; DB12010)
drugbank_target|P49336	-	464	sp|Q8IIT5|PTKL_PLA	-	1501	1.3e-20	70.7	0.0	1	3	0.00052	0.0077	11.8	0.0	842	914	30	103	25	115	0.85	Cyclin-dependent kinase 8 (DB03496)
drugbank_target|P49336	-	464	sp|Q8IIT5|PTKL_PLA	-	1501	1.3e-20	70.7	0.0	2	3	6.8e-13	9.9e-12	41.3	0.0	1233	1316	89	181	87	190	0.83	Cyclin-dependent kinase 8 (DB03496)
drugbank_target|P49336	-	464	sp|Q8IIT5|PTKL_PLA	-	1501	1.3e-20	70.7	0.0	3	3	2.5e-06	3.7e-05	19.5	0.0	1385	1431	193	239	187	259	0.85	Cyclin-dependent kinase 8 (DB03496)
drugbank_target|P11802	-	303	sp|Q8IIT5|PTKL_PLA	-	1501	1.4e-20	70.6	0.0	1	3	0.052	0.76	5.2	0.0	880	921	60	105	24	108	0.84	Cyclin-dependent kinase 4 (DB02733; DB03496; DB09073; DB11730; DB12001; DB12010)
drugbank_target|P11802	-	303	sp|Q8IIT5|PTKL_PLA	-	1501	1.4e-20	70.6	0.0	2	3	1.9e-14	2.8e-13	46.4	0.0	1234	1316	86	166	64	172	0.80	Cyclin-dependent kinase 4 (DB02733; DB03496; DB09073; DB11730; DB12001; DB12010)
drugbank_target|P11802	-	303	sp|Q8IIT5|PTKL_PLA	-	1501	1.4e-20	70.6	0.0	3	3	1.9e-06	2.8e-05	19.9	0.0	1385	1435	174	223	165	243	0.86	Cyclin-dependent kinase 4 (DB02733; DB03496; DB09073; DB11730; DB12001; DB12010)
drugbank_target|Q8IW41	-	473	sp|Q8IIT5|PTKL_PLA	-	1501	1.5e-20	70.5	0.1	1	3	0.0037	0.054	9.0	0.0	850	923	37	117	14	119	0.80	MAP kinase-activated protein kinase 5 (DB12010)
drugbank_target|Q8IW41	-	473	sp|Q8IIT5|PTKL_PLA	-	1501	1.5e-20	70.5	0.1	2	3	6.5e-12	9.5e-11	38.0	0.0	1257	1325	115	186	112	211	0.82	MAP kinase-activated protein kinase 5 (DB12010)
drugbank_target|Q8IW41	-	473	sp|Q8IIT5|PTKL_PLA	-	1501	1.5e-20	70.5	0.1	3	3	5.3e-07	7.7e-06	21.8	0.0	1404	1478	219	301	209	322	0.78	MAP kinase-activated protein kinase 5 (DB12010)
drugbank_target|Q9BQI3	-	630	sp|Q8IIT5|PTKL_PLA	-	1501	3.1e-20	69.5	0.0	1	3	0.057	0.84	5.1	0.1	843	901	175	236	156	241	0.70	Eukaryotic translation initiation factor 2-alpha kinase 1 (DB12010)
drugbank_target|Q9BQI3	-	630	sp|Q8IIT5|PTKL_PLA	-	1501	3.1e-20	69.5	0.0	2	3	3.7e-11	5.4e-10	35.6	0.0	1264	1325	416	477	402	484	0.88	Eukaryotic translation initiation factor 2-alpha kinase 1 (DB12010)
drugbank_target|Q9BQI3	-	630	sp|Q8IIT5|PTKL_PLA	-	1501	3.1e-20	69.5	0.0	3	3	3.1e-08	4.5e-07	25.9	0.0	1376	1478	481	580	471	598	0.79	Eukaryotic translation initiation factor 2-alpha kinase 1 (DB12010)
drugbank_target|O15111	-	745	sp|Q8IIT5|PTKL_PLA	-	1501	3.8e-20	69.2	0.3	1	3	3.3e-05	0.00048	15.8	0.0	853	922	33	109	21	113	0.79	Inhibitor of nuclear factor kappa-B kinase subunit alpha (DB00233; DB00244; DB00795; DB06151)
drugbank_target|O15111	-	745	sp|Q8IIT5|PTKL_PLA	-	1501	3.8e-20	69.2	0.3	2	3	2.4e-10	3.4e-09	32.9	0.0	1261	1314	115	171	110	178	0.90	Inhibitor of nuclear factor kappa-B kinase subunit alpha (DB00233; DB00244; DB00795; DB06151)
drugbank_target|O15111	-	745	sp|Q8IIT5|PTKL_PLA	-	1501	3.8e-20	69.2	0.3	3	3	1.8e-05	0.00026	16.7	0.0	1383	1431	179	226	173	252	0.83	Inhibitor of nuclear factor kappa-B kinase subunit alpha (DB00233; DB00244; DB00795; DB06151)
drugbank_target|Q9UKI8	-	766	sp|Q8IIT5|PTKL_PLA	-	1501	7.7e-20	68.2	12.3	1	3	0.00031	0.0045	12.6	0.1	859	924	480	554	461	557	0.68	Serine/threonine-protein kinase tousled-like 1 (DB12010)
drugbank_target|Q9UKI8	-	766	sp|Q8IIT5|PTKL_PLA	-	1501	7.7e-20	68.2	12.3	2	3	2e-11	2.9e-10	36.4	0.0	1258	1318	552	617	551	631	0.87	Serine/threonine-protein kinase tousled-like 1 (DB12010)
drugbank_target|Q9UKI8	-	766	sp|Q8IIT5|PTKL_PLA	-	1501	7.7e-20	68.2	12.3	3	3	1e-08	1.5e-07	27.5	0.0	1384	1477	629	730	615	747	0.75	Serine/threonine-protein kinase tousled-like 1 (DB12010)
drugbank_target|O14578	-	2027	sp|Q8IIT5|PTKL_PLA	-	1501	1.2e-19	67.6	4.2	1	3	0.0012	0.017	10.7	0.0	828	923	89	189	68	192	0.78	Citron Rho-interacting kinase (DB12010)
drugbank_target|O14578	-	2027	sp|Q8IIT5|PTKL_PLA	-	1501	1.2e-19	67.6	4.2	2	3	8.5e-11	1.2e-09	34.4	0.1	1256	1320	187	251	185	256	0.93	Citron Rho-interacting kinase (DB12010)
drugbank_target|O14578	-	2027	sp|Q8IIT5|PTKL_PLA	-	1501	1.2e-19	67.6	4.2	3	3	1.2e-07	1.8e-06	23.9	0.0	1386	1473	258	352	248	358	0.80	Citron Rho-interacting kinase (DB12010)
drugbank_target|P49759	-	484	sp|Q8IIT5|PTKL_PLA	-	1501	1.2e-19	67.6	5.1	1	3	0.036	0.53	5.8	0.0	845	911	173	244	155	256	0.78	Dual specificity protein kinase CLK1 (DB04367; DB06376; DB08691; DB12010)
drugbank_target|P49759	-	484	sp|Q8IIT5|PTKL_PLA	-	1501	1.2e-19	67.6	5.1	2	3	1.9e-07	2.8e-06	23.2	0.1	1262	1301	260	299	247	309	0.89	Dual specificity protein kinase CLK1 (DB04367; DB06376; DB08691; DB12010)
drugbank_target|P49759	-	484	sp|Q8IIT5|PTKL_PLA	-	1501	1.2e-19	67.6	5.1	3	3	6.2e-12	9e-11	38.1	0.0	1354	1441	308	394	296	410	0.91	Dual specificity protein kinase CLK1 (DB04367; DB06376; DB08691; DB12010)
drugbank_target|P25098	-	689	sp|Q8IIT5|PTKL_PLA	-	1501	2.5e-19	66.5	0.0	1	2	1.3e-10	1.9e-09	33.7	0.0	1257	1313	284	340	278	346	0.94	Beta-adrenergic receptor kinase 1 (DB00171)
drugbank_target|P25098	-	689	sp|Q8IIT5|PTKL_PLA	-	1501	2.5e-19	66.5	0.0	2	2	1.4e-09	2.1e-08	30.3	0.0	1382	1470	347	437	341	441	0.87	Beta-adrenergic receptor kinase 1 (DB00171)
drugbank_target|P49841	-	420	sp|Q8IIT5|PTKL_PLA	-	1501	2.5e-19	66.5	0.0	1	3	0.13	1.9	3.9	0.1	856	895	77	113	54	128	0.72	Glycogen synthase kinase-3 beta (DB01356; DB01772; DB01793; DB01950; DB02010; DB02052; DB03444; DB04014; DB04395; DB07014; DB07058; DB07149; DB07584; DB07585; DB07676; DB07812; DB07859; DB07947; DB08073; DB12010; DB12129; DB14507; DB14508; DB14509)
drugbank_target|P49841	-	420	sp|Q8IIT5|PTKL_PLA	-	1501	2.5e-19	66.5	0.0	2	3	3.8e-13	5.6e-12	42.1	0.1	1201	1324	91	216	86	217	0.75	Glycogen synthase kinase-3 beta (DB01356; DB01772; DB01793; DB01950; DB02010; DB02052; DB03444; DB04014; DB04395; DB07014; DB07058; DB07149; DB07584; DB07585; DB07676; DB07812; DB07859; DB07947; DB08073; DB12010; DB12129; DB14507; DB14508; DB14509)
drugbank_target|P49841	-	420	sp|Q8IIT5|PTKL_PLA	-	1501	2.5e-19	66.5	0.0	3	3	1.2e-06	1.8e-05	20.6	0.0	1379	1433	210	264	205	315	0.77	Glycogen synthase kinase-3 beta (DB01356; DB01772; DB01793; DB01950; DB02010; DB02052; DB03444; DB04014; DB04395; DB07014; DB07058; DB07149; DB07584; DB07585; DB07676; DB07812; DB07859; DB07947; DB08073; DB12010; DB12129; DB14507; DB14508; DB14509)
drugbank_target|Q9Y616	-	596	sp|Q8IIT5|PTKL_PLA	-	1501	3.6e-19	66.0	0.1	1	3	8.1e-08	1.2e-06	24.5	0.1	852	923	180	256	174	261	0.80	Interleukin-1 receptor-associated kinase 3 (DB12010)
drugbank_target|Q9Y616	-	596	sp|Q8IIT5|PTKL_PLA	-	1501	3.6e-19	66.0	0.1	2	3	0.00039	0.0057	12.3	0.0	1269	1319	269	322	258	327	0.87	Interleukin-1 receptor-associated kinase 3 (DB12010)
drugbank_target|Q9Y616	-	596	sp|Q8IIT5|PTKL_PLA	-	1501	3.6e-19	66.0	0.1	3	3	3.1e-08	4.5e-07	25.9	0.0	1374	1482	323	446	318	455	0.77	Interleukin-1 receptor-associated kinase 3 (DB12010)
drugbank_target|Q8TDR2	-	534	sp|Q8IIT5|PTKL_PLA	-	1501	4.5e-19	65.6	0.0	1	3	3.3	48	-0.7	0.0	857	903	224	273	209	295	0.73	Serine/threonine-protein kinase 35 (DB12010)
drugbank_target|Q8TDR2	-	534	sp|Q8IIT5|PTKL_PLA	-	1501	4.5e-19	65.6	0.0	2	3	3.2e-11	4.7e-10	35.7	0.0	1268	1316	338	389	322	394	0.86	Serine/threonine-protein kinase 35 (DB12010)
drugbank_target|Q8TDR2	-	534	sp|Q8IIT5|PTKL_PLA	-	1501	4.5e-19	65.6	0.0	3	3	2.7e-08	4e-07	26.0	0.0	1381	1482	411	530	394	534	0.78	Serine/threonine-protein kinase 35 (DB12010)
drugbank_target|P27037	-	513	sp|Q8IIT5|PTKL_PLA	-	1501	8.3e-19	64.7	0.0	1	3	3.3e-06	4.9e-05	19.1	0.0	851	923	206	282	197	290	0.89	Activin receptor type-2A (DB12118)
drugbank_target|P27037	-	513	sp|Q8IIT5|PTKL_PLA	-	1501	8.3e-19	64.7	0.0	2	3	9.6e-08	1.4e-06	24.2	0.0	1260	1313	282	345	280	353	0.78	Activin receptor type-2A (DB12118)
drugbank_target|P27037	-	513	sp|Q8IIT5|PTKL_PLA	-	1501	8.3e-19	64.7	0.0	3	3	3.7e-06	5.4e-05	19.0	0.0	1385	1495	359	495	348	500	0.67	Activin receptor type-2A (DB12118)
drugbank_target|Q8IIR9	-	335	sp|Q8IIT5|PTKL_PLA	-	1501	1.1e-18	64.4	0.2	1	3	0.0022	0.033	9.8	0.0	852	915	60	124	33	131	0.72	Casein kinase 2, alpha subunit (DB11638)
drugbank_target|Q8IIR9	-	335	sp|Q8IIT5|PTKL_PLA	-	1501	1.1e-18	64.4	0.2	2	3	9.9e-12	1.4e-10	37.4	0.0	1261	1315	131	186	124	198	0.88	Casein kinase 2, alpha subunit (DB11638)
drugbank_target|Q8IIR9	-	335	sp|Q8IIT5|PTKL_PLA	-	1501	1.1e-18	64.4	0.2	3	3	8.4e-05	0.0012	14.5	0.0	1383	1432	193	243	185	299	0.76	Casein kinase 2, alpha subunit (DB11638)
drugbank_target|P49840	-	483	sp|Q8IIT5|PTKL_PLA	-	1501	1.1e-18	64.4	0.0	1	3	0.21	3	3.2	0.1	856	895	140	176	118	186	0.72	Glycogen synthase kinase-3 alpha (DB12010)
drugbank_target|P49840	-	483	sp|Q8IIT5|PTKL_PLA	-	1501	1.1e-18	64.4	0.0	2	3	1.2e-12	1.7e-11	40.5	0.2	1199	1324	152	279	148	282	0.76	Glycogen synthase kinase-3 alpha (DB12010)
drugbank_target|P49840	-	483	sp|Q8IIT5|PTKL_PLA	-	1501	1.1e-18	64.4	0.0	3	3	1e-06	1.5e-05	20.8	0.0	1379	1441	273	339	268	388	0.72	Glycogen synthase kinase-3 alpha (DB12010)
drugbank_target|P11309	-	404	sp|Q8IIT5|PTKL_PLA	-	1501	1.4e-18	64.0	11.6	1	2	1e-08	1.5e-07	27.4	0.0	1258	1312	226	281	217	289	0.89	Serine/threonine-protein kinase pim-1 (DB01754; DB02010; DB02656; DB03366; DB03650; DB03777; DB04216; DB04395; DB04522; DB04530; DB04715; DB07151; DB07242; DB07524; DB08022; DB08166; DB08230; DB08705; DB08707; DB08708; DB08709; DB12010)
drugbank_target|P11309	-	404	sp|Q8IIT5|PTKL_PLA	-	1501	1.4e-18	64.0	11.6	2	2	3.9e-12	5.7e-11	38.8	0.0	1379	1478	286	378	281	394	0.85	Serine/threonine-protein kinase pim-1 (DB01754; DB02010; DB02656; DB03366; DB03650; DB03777; DB04216; DB04395; DB04522; DB04530; DB04715; DB07151; DB07242; DB07524; DB08022; DB08166; DB08230; DB08705; DB08707; DB08708; DB08709; DB12010)
drugbank_target|P19525	-	551	sp|Q8IIT5|PTKL_PLA	-	1501	1.8e-18	63.6	11.8	1	3	0.45	6.5	2.1	0.0	850	896	282	325	264	329	0.74	Interferon-induced, double-stranded RNA-activated protein kinase (DB12010)
drugbank_target|P19525	-	551	sp|Q8IIT5|PTKL_PLA	-	1501	1.8e-18	63.6	11.8	2	3	2.7e-13	4e-12	42.6	0.1	1245	1313	368	437	342	444	0.77	Interferon-induced, double-stranded RNA-activated protein kinase (DB12010)
drugbank_target|P19525	-	551	sp|Q8IIT5|PTKL_PLA	-	1501	1.8e-18	63.6	11.8	3	3	3e-08	4.3e-07	25.9	0.0	1381	1485	444	542	436	550	0.79	Interferon-induced, double-stranded RNA-activated protein kinase (DB12010)
drugbank_target|P37173	-	567	sp|Q8IIT5|PTKL_PLA	-	1501	3.4e-18	62.7	0.1	1	3	8.4e-06	0.00012	17.8	0.2	824	922	236	339	219	345	0.81	TGF-beta receptor type-2 (DB10770; DB10772; DB12010)
drugbank_target|P37173	-	567	sp|Q8IIT5|PTKL_PLA	-	1501	3.4e-18	62.7	0.1	2	3	1e-06	1.5e-05	20.8	0.0	1262	1313	342	402	338	410	0.82	TGF-beta receptor type-2 (DB10770; DB10772; DB12010)
drugbank_target|P37173	-	567	sp|Q8IIT5|PTKL_PLA	-	1501	3.4e-18	62.7	0.1	3	3	8e-07	1.2e-05	21.2	0.0	1377	1483	410	542	405	550	0.66	TGF-beta receptor type-2 (DB10770; DB10772; DB12010)
drugbank_target|Q52WX2	-	424	sp|Q8IIT5|PTKL_PLA	-	1501	5.2e-18	62.1	0.0	1	3	0.00016	0.0024	13.5	0.0	838	920	56	140	40	145	0.79	Serine/threonine-protein kinase SBK1 (DB12010)
drugbank_target|Q52WX2	-	424	sp|Q8IIT5|PTKL_PLA	-	1501	5.2e-18	62.1	0.0	2	3	1.5e-09	2.3e-08	30.2	0.0	1262	1318	146	204	141	209	0.86	Serine/threonine-protein kinase SBK1 (DB12010)
drugbank_target|Q52WX2	-	424	sp|Q8IIT5|PTKL_PLA	-	1501	5.2e-18	62.1	0.0	3	3	3.7e-05	0.00054	15.7	0.0	1384	1479	207	313	204	324	0.69	Serine/threonine-protein kinase SBK1 (DB12010)
drugbank_target|Q9Y2H9	-	1570	sp|Q8IIT5|PTKL_PLA	-	1501	5.5e-18	62.0	0.0	1	2	2.7e-12	3.9e-11	39.3	0.0	1232	1315	442	522	394	538	0.73	Microtubule-associated serine/threonine-protein kinase 1 (DB12010)
drugbank_target|Q9Y2H9	-	1570	sp|Q8IIT5|PTKL_PLA	-	1501	5.5e-18	62.0	0.0	2	2	1.3e-09	1.9e-08	30.4	0.0	1381	1470	543	633	523	641	0.87	Microtubule-associated serine/threonine-protein kinase 1 (DB12010)
drugbank_target|Q86V86	-	326	sp|Q8IIT5|PTKL_PLA	-	1501	9.7e-18	61.2	0.0	1	2	5e-08	7.3e-07	25.2	0.0	1259	1312	139	193	131	201	0.88	Serine/threonine-protein kinase pim-3 (DB12010)
drugbank_target|Q86V86	-	326	sp|Q8IIT5|PTKL_PLA	-	1501	9.7e-18	61.2	0.0	2	2	7.3e-11	1.1e-09	34.6	0.0	1379	1477	198	289	193	296	0.87	Serine/threonine-protein kinase pim-3 (DB12010)
drugbank_target|O95835	-	1130	sp|Q8IIT5|PTKL_PLA	-	1501	1.5e-17	60.6	10.5	1	3	0.08	1.2	4.6	0.0	838	921	713	795	690	799	0.70	Serine/threonine-protein kinase LATS1 (DB12010)
drugbank_target|O95835	-	1130	sp|Q8IIT5|PTKL_PLA	-	1501	1.5e-17	60.6	10.5	2	3	1e-09	1.5e-08	30.7	0.0	1265	1313	803	851	796	864	0.89	Serine/threonine-protein kinase LATS1 (DB12010)
drugbank_target|O95835	-	1130	sp|Q8IIT5|PTKL_PLA	-	1501	1.5e-17	60.6	10.5	3	3	8e-10	1.2e-08	31.1	0.0	1379	1462	904	989	888	1003	0.78	Serine/threonine-protein kinase LATS1 (DB12010)
drugbank_target|P19784	-	350	sp|Q8IIT5|PTKL_PLA	-	1501	1.9e-17	60.3	2.0	1	3	0.00027	0.004	12.8	0.5	836	919	41	125	22	132	0.77	Casein kinase II subunit alpha' (DB07546; DB12010)
drugbank_target|P19784	-	350	sp|Q8IIT5|PTKL_PLA	-	1501	1.9e-17	60.3	2.0	2	3	4.4e-10	6.4e-09	32.0	0.0	1260	1315	127	183	120	193	0.86	Casein kinase II subunit alpha' (DB07546; DB12010)
drugbank_target|P19784	-	350	sp|Q8IIT5|PTKL_PLA	-	1501	1.9e-17	60.3	2.0	3	3	4.9e-05	0.00071	15.3	0.0	1382	1433	189	241	181	321	0.76	Casein kinase II subunit alpha' (DB07546; DB12010)
drugbank_target|Q13164	-	816	sp|Q8IIT5|PTKL_PLA	-	1501	2.4e-17	59.9	0.1	1	3	0.0012	0.017	10.7	0.1	848	898	68	121	49	127	0.77	Mitogen-activated protein kinase 7 (DB01017)
drugbank_target|Q13164	-	816	sp|Q8IIT5|PTKL_PLA	-	1501	2.4e-17	59.9	0.1	2	3	6.5e-15	9.4e-14	48.0	0.0	1238	1313	134	205	126	218	0.88	Mitogen-activated protein kinase 7 (DB01017)
drugbank_target|Q13164	-	816	sp|Q8IIT5|PTKL_PLA	-	1501	2.4e-17	59.9	0.1	3	3	4.5e-06	6.5e-05	18.7	0.0	1382	1441	218	277	209	306	0.81	Mitogen-activated protein kinase 7 (DB01017)
drugbank_target|Q13164	-	816	sp|Q8IIT5|PTKL_PLA	-	1501	2.4e-17	59.9	0.1	1	3	0.0012	0.017	10.7	0.1	848	898	68	121	49	127	0.77	Mitogen-activated protein kinase 7 (DB12010)
drugbank_target|Q13164	-	816	sp|Q8IIT5|PTKL_PLA	-	1501	2.4e-17	59.9	0.1	2	3	6.5e-15	9.4e-14	48.0	0.0	1238	1313	134	205	126	218	0.88	Mitogen-activated protein kinase 7 (DB12010)
drugbank_target|Q13164	-	816	sp|Q8IIT5|PTKL_PLA	-	1501	2.4e-17	59.9	0.1	3	3	4.5e-06	6.5e-05	18.7	0.0	1382	1441	218	277	209	306	0.81	Mitogen-activated protein kinase 7 (DB12010)
drugbank_target|Q13164	-	816	sp|Q8IIT5|PTKL_PLA	-	1501	2.4e-17	59.9	0.1	1	3	0.0012	0.017	10.7	0.1	848	898	68	121	49	127	0.77	Mitogen-activated protein kinase 7 (DB00945)
drugbank_target|Q13164	-	816	sp|Q8IIT5|PTKL_PLA	-	1501	2.4e-17	59.9	0.1	2	3	6.5e-15	9.4e-14	48.0	0.0	1238	1313	134	205	126	218	0.88	Mitogen-activated protein kinase 7 (DB00945)
drugbank_target|Q13164	-	816	sp|Q8IIT5|PTKL_PLA	-	1501	2.4e-17	59.9	0.1	3	3	4.5e-06	6.5e-05	18.7	0.0	1382	1441	218	277	209	306	0.81	Mitogen-activated protein kinase 7 (DB00945)
drugbank_target|Q6DT37	-	1551	sp|Q8IIT5|PTKL_PLA	-	1501	3.7e-17	59.3	0.0	1	3	0.26	3.8	2.9	0.0	848	922	84	162	70	167	0.81	Serine/threonine-protein kinase MRCK gamma (DB12010)
drugbank_target|Q6DT37	-	1551	sp|Q8IIT5|PTKL_PLA	-	1501	3.7e-17	59.3	0.0	2	3	2.1e-08	3.1e-07	26.4	0.0	1260	1317	165	222	160	230	0.88	Serine/threonine-protein kinase MRCK gamma (DB12010)
drugbank_target|Q6DT37	-	1551	sp|Q8IIT5|PTKL_PLA	-	1501	3.7e-17	59.3	0.0	3	3	1.4e-08	2.1e-07	27.0	0.0	1384	1467	230	321	221	325	0.85	Serine/threonine-protein kinase MRCK gamma (DB12010)
drugbank_target|O14976	-	1311	sp|Q8IIT5|PTKL_PLA	-	1501	3.8e-17	59.3	0.0	1	3	0.52	7.6	1.9	0.0	857	924	62	138	53	141	0.71	Cyclin-G-associated kinase (DB12010)
drugbank_target|O14976	-	1311	sp|Q8IIT5|PTKL_PLA	-	1501	3.8e-17	59.3	0.0	2	3	3.4e-11	5e-10	35.7	0.0	1252	1315	134	198	116	215	0.81	Cyclin-G-associated kinase (DB12010)
drugbank_target|O14976	-	1311	sp|Q8IIT5|PTKL_PLA	-	1501	3.8e-17	59.3	0.0	3	3	8.3e-10	1.2e-08	31.1	0.0	1382	1489	217	323	203	333	0.82	Cyclin-G-associated kinase (DB12010)
drugbank_target|O75460	-	977	sp|Q8IIT5|PTKL_PLA	-	1501	9e-17	58.0	12.7	1	3	0.21	3.1	3.2	0.0	851	929	586	662	579	670	0.83	Serine/threonine-protein kinase/endoribonuclease IRE1 (DB07382; DB12010)
drugbank_target|O75460	-	977	sp|Q8IIT5|PTKL_PLA	-	1501	9e-17	58.0	12.7	2	3	1.5e-08	2.1e-07	26.9	0.2	1267	1314	665	717	632	726	0.76	Serine/threonine-protein kinase/endoribonuclease IRE1 (DB07382; DB12010)
drugbank_target|O75460	-	977	sp|Q8IIT5|PTKL_PLA	-	1501	9e-17	58.0	12.7	3	3	1.1e-08	1.5e-07	27.4	0.0	1381	1478	727	829	719	841	0.79	Serine/threonine-protein kinase/endoribonuclease IRE1 (DB07382; DB12010)
drugbank_target|P49760	-	499	sp|Q8IIT5|PTKL_PLA	-	1501	1.2e-16	57.6	0.2	1	3	6.6	96	-1.7	0.0	852	889	181	218	170	259	0.69	Dual specificity protein kinase CLK2 (DB12010)
drugbank_target|P49760	-	499	sp|Q8IIT5|PTKL_PLA	-	1501	1.2e-16	57.6	0.2	2	3	9.9e-07	1.4e-05	20.9	0.2	1262	1301	262	301	199	308	0.87	Dual specificity protein kinase CLK2 (DB12010)
drugbank_target|P49760	-	499	sp|Q8IIT5|PTKL_PLA	-	1501	1.2e-16	57.6	0.2	3	3	1.2e-10	1.8e-09	33.8	0.0	1355	1440	311	395	303	411	0.92	Dual specificity protein kinase CLK2 (DB12010)
drugbank_target|Q13464	-	1354	sp|Q8IIT5|PTKL_PLA	-	1501	1.5e-16	57.3	0.0	1	3	0.00066	0.0097	11.5	0.0	840	922	81	167	54	173	0.83	Rho-associated protein kinase 1 (DB04707; DB07876; DB08162; DB08756; DB13165; DB13931)
drugbank_target|Q13464	-	1354	sp|Q8IIT5|PTKL_PLA	-	1501	1.5e-16	57.3	0.0	2	3	9.4e-10	1.4e-08	30.9	0.0	1264	1317	172	225	166	232	0.88	Rho-associated protein kinase 1 (DB04707; DB07876; DB08162; DB08756; DB13165; DB13931)
drugbank_target|Q13464	-	1354	sp|Q8IIT5|PTKL_PLA	-	1501	1.5e-16	57.3	0.0	3	3	1.9e-09	2.7e-08	29.9	0.0	1383	1478	232	335	221	348	0.83	Rho-associated protein kinase 1 (DB04707; DB07876; DB08162; DB08756; DB13165; DB13931)
drugbank_target|Q9BUB5	-	465	sp|Q8IIT5|PTKL_PLA	-	1501	5e-16	55.5	0.0	1	3	4.7e-05	0.00068	15.3	0.1	842	925	58	141	49	167	0.80	MAP kinase-interacting serine/threonine-protein kinase 1 (DB12010)
drugbank_target|Q9BUB5	-	465	sp|Q8IIT5|PTKL_PLA	-	1501	5e-16	55.5	0.0	2	3	0.00079	0.012	11.3	0.0	1281	1312	202	236	195	246	0.75	MAP kinase-interacting serine/threonine-protein kinase 1 (DB12010)
drugbank_target|Q9BUB5	-	465	sp|Q8IIT5|PTKL_PLA	-	1501	5e-16	55.5	0.0	3	3	4.6e-08	6.8e-07	25.3	0.0	1384	1478	255	371	240	381	0.74	MAP kinase-interacting serine/threonine-protein kinase 1 (DB12010)
drugbank_target|Q09013	-	629	sp|Q8IIT5|PTKL_PLA	-	1501	8.2e-16	54.8	0.0	1	3	0.012	0.18	7.3	0.0	842	922	78	162	70	167	0.83	Myotonin-protein kinase (DB01946)
drugbank_target|Q09013	-	629	sp|Q8IIT5|PTKL_PLA	-	1501	8.2e-16	54.8	0.0	2	3	2.2e-08	3.2e-07	26.4	0.0	1260	1312	165	217	161	227	0.91	Myotonin-protein kinase (DB01946)
drugbank_target|Q09013	-	629	sp|Q8IIT5|PTKL_PLA	-	1501	8.2e-16	54.8	0.0	3	3	7.3e-06	0.00011	18.0	0.0	1385	1462	231	318	220	325	0.78	Myotonin-protein kinase (DB01946)
drugbank_target|Q2M2I8	-	961	sp|Q8IIT5|PTKL_PLA	-	1501	1.9e-15	53.6	7.3	1	3	0.076	1.1	4.7	0.0	856	921	66	139	57	145	0.83	AP2-associated protein kinase 1 (DB12010)
drugbank_target|Q2M2I8	-	961	sp|Q8IIT5|PTKL_PLA	-	1501	1.9e-15	53.6	7.3	2	3	4.5e-09	6.5e-08	28.6	0.0	1259	1314	143	200	136	209	0.89	AP2-associated protein kinase 1 (DB12010)
drugbank_target|Q2M2I8	-	961	sp|Q8IIT5|PTKL_PLA	-	1501	1.9e-15	53.6	7.3	3	3	1.4e-07	2e-06	23.7	0.0	1381	1485	215	317	199	323	0.79	AP2-associated protein kinase 1 (DB12010)
drugbank_target|P51617	-	712	sp|Q8IIT5|PTKL_PLA	-	1501	4.5e-15	52.4	18.6	1	3	3.2e-08	4.6e-07	25.8	0.0	855	924	230	304	223	311	0.80	Interleukin-1 receptor-associated kinase 1 (DB12010)
drugbank_target|P51617	-	712	sp|Q8IIT5|PTKL_PLA	-	1501	4.5e-15	52.4	18.6	2	3	1.4e-07	2e-06	23.7	0.0	1262	1315	310	365	305	371	0.88	Interleukin-1 receptor-associated kinase 1 (DB12010)
drugbank_target|P51617	-	712	sp|Q8IIT5|PTKL_PLA	-	1501	4.5e-15	52.4	18.6	3	3	0.00031	0.0045	12.6	0.0	1375	1466	374	464	365	479	0.71	Interleukin-1 receptor-associated kinase 1 (DB12010)
drugbank_target|O75116	-	1388	sp|Q8IIT5|PTKL_PLA	-	1501	5.2e-15	52.2	0.0	1	3	0.00069	0.01	11.4	0.0	840	922	97	183	77	191	0.83	Rho-associated protein kinase 2 (DB08162; DB08756; DB12010; DB13165; DB13931)
drugbank_target|O75116	-	1388	sp|Q8IIT5|PTKL_PLA	-	1501	5.2e-15	52.2	0.0	2	3	2.7e-09	3.9e-08	29.4	0.0	1264	1316	188	240	182	246	0.87	Rho-associated protein kinase 2 (DB08162; DB08756; DB12010; DB13165; DB13931)
drugbank_target|O75116	-	1388	sp|Q8IIT5|PTKL_PLA	-	1501	5.2e-15	52.2	0.0	3	3	2.1e-08	3e-07	26.4	0.0	1383	1466	248	337	238	354	0.81	Rho-associated protein kinase 2 (DB08162; DB08756; DB12010; DB13165; DB13931)
drugbank_target|Q13873	-	1038	sp|Q8IIT5|PTKL_PLA	-	1501	5.5e-15	52.1	0.0	1	3	0.00064	0.0093	11.6	0.0	850	926	216	297	209	301	0.76	Bone morphogenetic protein receptor type-2 (DB11639; DB12010)
drugbank_target|Q13873	-	1038	sp|Q8IIT5|PTKL_PLA	-	1501	5.5e-15	52.1	0.0	2	3	3.7e-06	5.5e-05	19.0	0.0	1269	1313	303	356	297	363	0.82	Bone morphogenetic protein receptor type-2 (DB11639; DB12010)
drugbank_target|Q13873	-	1038	sp|Q8IIT5|PTKL_PLA	-	1501	5.5e-15	52.1	0.0	3	3	9.5e-06	0.00014	17.6	0.0	1384	1483	375	505	367	519	0.64	Bone morphogenetic protein receptor type-2 (DB11639; DB12010)
drugbank_target|Q14164	-	716	sp|Q8IIT5|PTKL_PLA	-	1501	8e-15	51.5	0.0	1	3	1e-07	1.5e-06	24.2	0.1	849	922	23	100	13	105	0.78	Inhibitor of nuclear factor kappa-B kinase subunit epsilon (DB12010)
drugbank_target|Q14164	-	716	sp|Q8IIT5|PTKL_PLA	-	1501	8e-15	51.5	0.0	2	3	1.5e-06	2.1e-05	20.3	0.0	1261	1316	106	165	99	174	0.82	Inhibitor of nuclear factor kappa-B kinase subunit epsilon (DB12010)
drugbank_target|Q14164	-	716	sp|Q8IIT5|PTKL_PLA	-	1501	8e-15	51.5	0.0	3	3	0.15	2.2	3.7	0.0	1400	1441	195	240	164	251	0.63	Inhibitor of nuclear factor kappa-B kinase subunit epsilon (DB12010)
drugbank_target|P68400	-	391	sp|Q8IIT5|PTKL_PLA	-	1501	1.2e-14	51.0	11.1	1	3	0.0031	0.046	9.3	0.5	836	917	40	122	14	127	0.74	Casein kinase II subunit alpha (DB00171; DB01765; DB02170; DB02709; DB03035; DB03127; DB03924; DB04216; DB04395; DB04462; DB04719; DB04720; DB04721; DB07715; DB07802; DB08338; DB08340; DB08345; DB08353; DB08354; DB08360; DB08362; DB08473; DB08660; DB08846; DB12010)
drugbank_target|P68400	-	391	sp|Q8IIT5|PTKL_PLA	-	1501	1.2e-14	51.0	11.1	2	3	4e-11	5.9e-10	35.4	0.0	1249	1314	115	181	110	187	0.90	Casein kinase II subunit alpha (DB00171; DB01765; DB02170; DB02709; DB03035; DB03127; DB03924; DB04216; DB04395; DB04462; DB04719; DB04720; DB04721; DB07715; DB07802; DB08338; DB08340; DB08345; DB08353; DB08354; DB08360; DB08362; DB08473; DB08660; DB08846; DB12010)
drugbank_target|P68400	-	391	sp|Q8IIT5|PTKL_PLA	-	1501	1.2e-14	51.0	11.1	3	3	5.8e-05	0.00085	15.0	0.0	1383	1432	189	239	179	291	0.72	Casein kinase II subunit alpha (DB00171; DB01765; DB02170; DB02709; DB03035; DB03127; DB03924; DB04216; DB04395; DB04462; DB04719; DB04720; DB04721; DB07715; DB07802; DB08338; DB08340; DB08345; DB08353; DB08354; DB08360; DB08362; DB08473; DB08660; DB08846; DB12010)
drugbank_target|Q16659	-	721	sp|Q8IIT5|PTKL_PLA	-	1501	9.7e-14	48.0	17.2	1	3	0.009	0.13	7.7	0.3	858	898	43	84	34	121	0.69	Mitogen-activated protein kinase 6 (DB01017)
drugbank_target|Q16659	-	721	sp|Q8IIT5|PTKL_PLA	-	1501	9.7e-14	48.0	17.2	2	3	1.1e-11	1.6e-10	37.3	0.0	1239	1316	106	179	97	187	0.82	Mitogen-activated protein kinase 6 (DB01017)
drugbank_target|Q16659	-	721	sp|Q8IIT5|PTKL_PLA	-	1501	9.7e-14	48.0	17.2	3	3	2.9e-05	0.00042	16.0	0.0	1386	1441	192	247	179	276	0.80	Mitogen-activated protein kinase 6 (DB01017)
drugbank_target|Q16659	-	721	sp|Q8IIT5|PTKL_PLA	-	1501	9.7e-14	48.0	17.2	1	3	0.009	0.13	7.7	0.3	858	898	43	84	34	121	0.69	Mitogen-activated protein kinase 6 (DB00945)
drugbank_target|Q16659	-	721	sp|Q8IIT5|PTKL_PLA	-	1501	9.7e-14	48.0	17.2	2	3	1.1e-11	1.6e-10	37.3	0.0	1239	1316	106	179	97	187	0.82	Mitogen-activated protein kinase 6 (DB00945)
drugbank_target|Q16659	-	721	sp|Q8IIT5|PTKL_PLA	-	1501	9.7e-14	48.0	17.2	3	3	2.9e-05	0.00042	16.0	0.0	1386	1441	192	247	179	276	0.80	Mitogen-activated protein kinase 6 (DB00945)
drugbank_target|P49761	-	638	sp|Q8IIT5|PTKL_PLA	-	1501	1.3e-13	47.6	8.7	1	2	1.2e-07	1.8e-06	23.9	0.4	1201	1301	340	442	323	449	0.73	Dual specificity protein kinase CLK3 (DB07664; DB08691; DB12010)
drugbank_target|P49761	-	638	sp|Q8IIT5|PTKL_PLA	-	1501	1.3e-13	47.6	8.7	2	2	3.1e-09	4.5e-08	29.2	0.0	1360	1440	457	536	445	552	0.89	Dual specificity protein kinase CLK3 (DB07664; DB08691; DB12010)
drugbank_target|Q13523	-	1007	sp|Q8IIT5|PTKL_PLA	-	1501	2.1e-13	46.9	1.3	1	3	2.2	32	-0.2	0.1	854	889	707	742	685	768	0.63	Serine/threonine-protein kinase PRP4 homolog (DB12010)
drugbank_target|Q13523	-	1007	sp|Q8IIT5|PTKL_PLA	-	1501	2.1e-13	46.9	1.3	2	3	3.7e-10	5.3e-09	32.2	1.0	1228	1314	753	840	712	847	0.78	Serine/threonine-protein kinase PRP4 homolog (DB12010)
drugbank_target|Q13523	-	1007	sp|Q8IIT5|PTKL_PLA	-	1501	2.1e-13	46.9	1.3	3	3	4.4e-07	6.4e-06	22.0	0.0	1385	1445	849	908	839	919	0.84	Serine/threonine-protein kinase PRP4 homolog (DB12010)
drugbank_target|Q9H422	-	1215	sp|Q8IIT5|PTKL_PLA	-	1501	2.9e-13	46.4	17.2	1	2	1.1e-11	1.6e-10	37.3	0.1	1199	1314	230	350	210	356	0.80	Homeodomain-interacting protein kinase 3 (DB12010)
drugbank_target|Q9H422	-	1215	sp|Q8IIT5|PTKL_PLA	-	1501	2.9e-13	46.4	17.2	2	2	0.00014	0.0021	13.7	0.0	1379	1442	353	415	349	441	0.85	Homeodomain-interacting protein kinase 3 (DB12010)
drugbank_target|Q9NSY1	-	1161	sp|Q8IIT5|PTKL_PLA	-	1501	8.7e-13	44.8	0.0	1	3	0.082	1.2	4.6	0.1	860	921	75	143	62	148	0.78	BMP-2-inducible protein kinase (DB12010)
drugbank_target|Q9NSY1	-	1161	sp|Q8IIT5|PTKL_PLA	-	1501	8.7e-13	44.8	0.0	2	3	1.1e-09	1.7e-08	30.6	0.0	1239	1314	128	204	125	215	0.84	BMP-2-inducible protein kinase (DB12010)
drugbank_target|Q9NSY1	-	1161	sp|Q8IIT5|PTKL_PLA	-	1501	8.7e-13	44.8	0.0	3	3	6.6e-07	9.6e-06	21.5	0.0	1382	1479	220	315	204	330	0.79	BMP-2-inducible protein kinase (DB12010)
drugbank_target|Q9UHD2	-	729	sp|Q8IIT5|PTKL_PLA	-	1501	1.3e-12	44.2	0.0	1	3	4.3e-05	0.00063	15.4	0.1	853	922	27	100	13	105	0.76	Serine/threonine-protein kinase TBK1 (DB12010)
drugbank_target|Q9UHD2	-	729	sp|Q8IIT5|PTKL_PLA	-	1501	1.3e-12	44.2	0.0	2	3	8.9e-07	1.3e-05	21.0	0.0	1261	1315	106	164	100	176	0.82	Serine/threonine-protein kinase TBK1 (DB12010)
drugbank_target|Q9UHD2	-	729	sp|Q8IIT5|PTKL_PLA	-	1501	1.3e-12	44.2	0.0	3	3	0.11	1.6	4.2	0.0	1400	1438	195	237	163	252	0.62	Serine/threonine-protein kinase TBK1 (DB12010)
drugbank_target|Q9H2X6	-	1198	sp|Q8IIT5|PTKL_PLA	-	1501	7.3e-12	41.7	0.0	1	2	5.9e-11	8.7e-10	34.9	0.1	1200	1314	233	352	219	358	0.77	Homeodomain-interacting protein kinase 2 (DB12010)
drugbank_target|Q9H2X6	-	1198	sp|Q8IIT5|PTKL_PLA	-	1501	7.3e-12	41.7	0.0	2	2	0.0001	0.0015	14.2	0.0	1382	1442	358	417	351	431	0.87	Homeodomain-interacting protein kinase 2 (DB12010)
drugbank_target|Q99640	-	499	sp|Q8IIT5|PTKL_PLA	-	1501	1.3e-11	40.9	0.6	1	2	9.4e-09	1.4e-07	27.6	0.0	1252	1311	195	254	181	262	0.87	Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase (DB12010)
drugbank_target|Q99640	-	499	sp|Q8IIT5|PTKL_PLA	-	1501	1.3e-11	40.9	0.6	2	2	0.0015	0.022	10.3	0.0	1387	1476	269	354	260	361	0.77	Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase (DB12010)
drugbank_target|Q16671	-	573	sp|Q8IIT5|PTKL_PLA	-	1501	6.2e-11	38.7	0.0	1	3	0.0012	0.018	10.6	0.0	851	923	217	294	211	300	0.84	Anti-Muellerian hormone type-2 receptor (DB00171)
drugbank_target|Q16671	-	573	sp|Q8IIT5|PTKL_PLA	-	1501	6.2e-11	38.7	0.0	2	3	0.00048	0.0071	12.0	0.0	1269	1314	303	357	297	363	0.81	Anti-Muellerian hormone type-2 receptor (DB00171)
drugbank_target|Q16671	-	573	sp|Q8IIT5|PTKL_PLA	-	1501	6.2e-11	38.7	0.0	3	3	0.0004	0.0059	12.2	0.0	1387	1486	382	512	375	516	0.70	Anti-Muellerian hormone type-2 receptor (DB00171)
drugbank_target|P30291	-	646	sp|Q8IIT5|PTKL_PLA	-	1501	8.6e-10	34.9	0.0	1	3	0.014	0.2	7.2	0.0	864	922	332	390	296	399	0.80	Wee1-like protein kinase (DB04608; DB07006; DB07226; DB07257; DB07265; DB08365; DB11740; DB12010)
drugbank_target|P30291	-	646	sp|Q8IIT5|PTKL_PLA	-	1501	8.6e-10	34.9	0.0	2	3	5.1e-05	0.00074	15.2	0.0	1262	1301	398	437	392	443	0.90	Wee1-like protein kinase (DB04608; DB07006; DB07226; DB07257; DB07265; DB08365; DB11740; DB12010)
drugbank_target|P30291	-	646	sp|Q8IIT5|PTKL_PLA	-	1501	8.6e-10	34.9	0.0	3	3	0.004	0.059	8.9	0.0	1388	1485	479	573	463	585	0.80	Wee1-like protein kinase (DB04608; DB07006; DB07226; DB07257; DB07265; DB08365; DB11740; DB12010)
drugbank_target|Q9HCP0	-	422	sp|Q8IIT5|PTKL_PLA	-	1501	2e-09	33.6	0.0	1	2	1.3e-08	1.9e-07	27.1	0.1	1259	1314	133	193	117	205	0.84	Casein kinase I isoform gamma-1 (DB08325)
drugbank_target|Q9HCP0	-	422	sp|Q8IIT5|PTKL_PLA	-	1501	2e-09	33.6	0.0	2	2	0.069	1	4.8	0.0	1375	1485	201	317	194	325	0.76	Casein kinase I isoform gamma-1 (DB08325)
drugbank_target|P78362	-	688	sp|Q8IIT5|PTKL_PLA	-	1501	1.1e-08	31.3	6.6	1	2	7e-07	1e-05	21.4	6.3	1238	1300	163	224	152	315	0.86	SRSF protein kinase 2 (DB00173; DB02733; DB04395)
drugbank_target|P78362	-	688	sp|Q8IIT5|PTKL_PLA	-	1501	1.1e-08	31.3	6.6	2	2	0.019	0.28	6.7	0.0	1385	1432	544	590	521	611	0.85	SRSF protein kinase 2 (DB00173; DB02733; DB04395)
drugbank_target|P78368	-	415	sp|Q8IIT5|PTKL_PLA	-	1501	1.3e-08	30.9	0.0	1	2	3.3e-08	4.8e-07	25.8	0.0	1259	1314	134	194	117	206	0.85	Casein kinase I isoform gamma-2 (DB03083; DB03693; DB04604)
drugbank_target|P78368	-	415	sp|Q8IIT5|PTKL_PLA	-	1501	1.3e-08	30.9	0.0	2	2	0.16	2.4	3.6	0.0	1375	1460	202	293	194	319	0.72	Casein kinase I isoform gamma-2 (DB03083; DB03693; DB04604)
drugbank_target|Q9Y6M4	-	447	sp|Q8IIT5|PTKL_PLA	-	1501	1.7e-08	30.5	0.0	1	2	1.5e-08	2.2e-07	26.9	0.0	1259	1314	131	191	121	204	0.84	Casein kinase I isoform gamma-3 (DB04751; DB07488; DB07489; DB07664)
drugbank_target|Q9Y6M4	-	447	sp|Q8IIT5|PTKL_PLA	-	1501	1.7e-08	30.5	0.0	2	2	0.59	8.5	1.7	0.0	1375	1447	199	270	191	296	0.79	Casein kinase I isoform gamma-3 (DB04751; DB07488; DB07489; DB07664)
drugbank_target|P9WI73	-	750	sp|Q8IIT5|PTKL_PLA	-	1501	2.2e-08	30.2	0.0	1	2	0.13	1.9	3.9	0.0	855	917	172	241	166	243	0.78	Serine/threonine-protein kinase PknG (DB07398)
drugbank_target|P9WI73	-	750	sp|Q8IIT5|PTKL_PLA	-	1501	2.2e-08	30.2	0.0	2	2	5e-08	7.3e-07	25.2	0.0	1256	1315	242	300	229	307	0.86	Serine/threonine-protein kinase PknG (DB07398)
drugbank_target|P49674	-	416	sp|Q8IIT5|PTKL_PLA	-	1501	3.5e-08	29.5	0.0	1	2	7.1e-09	1e-07	28.0	0.0	1256	1317	94	158	79	174	0.81	Casein kinase I isoform epsilon (DB06195)
drugbank_target|P49674	-	416	sp|Q8IIT5|PTKL_PLA	-	1501	3.5e-08	29.5	0.0	2	2	2.4	36	-0.3	0.0	1374	1448	162	235	156	281	0.71	Casein kinase I isoform epsilon (DB06195)
drugbank_target|P48729	-	337	sp|Q8IIT5|PTKL_PLA	-	1501	8.6e-08	28.3	0.1	1	1	1.3e-08	1.8e-07	27.1	0.0	1255	1316	101	165	83	181	0.80	Casein kinase I isoform alpha (DB12010)
drugbank_target|P0C264	-	359	sp|Q8IIT5|PTKL_PLA	-	1501	5.2e-05	19.0	0.0	1	1	5e-06	7.3e-05	18.5	0.0	1259	1314	132	189	126	193	0.86	Uncharacterized serine/threonine-protein kinase SBK3 (DB12010)
drugbank_target|Q8WTS6	-	366	sp|Q8IIT5|PTKL_PLA	-	1501	0.11	8.0	0.1	1	1	0.013	0.19	7.2	0.1	23	61	14	52	9	81	0.83	Histone-lysine N-methyltransferase SETD7 (DB01752)
drugbank_target|Q99814	-	870	sp|Q8IIT5|PTKL_PLA	-	1501	1.8	4.0	6.4	1	1	0.23	3.4	3.1	6.4	537	608	422	493	413	525	0.69	Endothelial PAS domain-containing protein 1 (DB15463)
drugbank_target|P50250	-	479	sp|P50250|SAHH_PLA	-	479	1.5e-296	981.8	3.2	1	1	1.4e-298	1.7e-296	981.6	3.2	1	479	1	479	1	479	1.00	Adenosylhomocysteinase (DB11638)
drugbank_target|P9WGV3	-	495	sp|P50250|SAHH_PLA	-	479	9.7e-259	857.1	0.0	1	1	1e-260	1.2e-258	856.8	0.0	5	479	20	495	16	495	0.99	Adenosylhomocysteinase (DB07052)
drugbank_target|P23526	-	432	sp|P50250|SAHH_PLA	-	479	1.9e-234	776.9	1.9	1	2	4.5e-84	5.2e-82	274.3	0.2	6	143	7	140	2	141	0.98	Adenosylhomocysteinase (DB03216; DB03273; DB03769; DB09130)
drugbank_target|P23526	-	432	sp|P50250|SAHH_PLA	-	479	1.9e-234	776.9	1.9	2	2	1.5e-153	1.7e-151	503.4	0.1	185	479	141	432	140	432	0.99	Adenosylhomocysteinase (DB03216; DB03273; DB03769; DB09130)
drugbank_target|P28845	-	292	sp|P50250|SAHH_PLA	-	479	2.1e-18	64.5	0.3	1	1	2.7e-20	3.1e-18	64.0	0.3	254	355	31	145	26	157	0.92	Corticosteroid 11-beta-dehydrogenase isozyme 1 (DB00157; DB02329; DB03461; DB03814; DB04652; DB05064; DB06992; DB07017; DB07049; DB07056; DB07310; DB07316; DB07619; DB07624; DB07866; DB08277; DB08280; DB08771; DB13751)
drugbank_target|P46736	-	316	sp|P50250|SAHH_PLA	-	479	1.2e-15	55.4	0.3	1	1	1.6e-17	1.8e-15	54.8	0.3	323	387	18	83	3	86	0.90	Lys-63-specific deubiquitinase BRCC36 (DB01593; DB14487; DB14533; DB14548)
drugbank_target|P30901	-	337	sp|P50250|SAHH_PLA	-	479	1.1e-14	52.2	0.1	1	1	1.6e-16	1.8e-14	51.5	0.1	254	343	143	234	116	249	0.92	D-lactate dehydrogenase (DB03940)
drugbank_target|Q96NR8	-	316	sp|P50250|SAHH_PLA	-	479	6e-14	49.8	0.1	1	1	7.3e-16	8.4e-14	49.3	0.1	238	305	21	87	13	127	0.83	Retinol dehydrogenase 12 (DB00162)
drugbank_target|Q8TC12	-	318	sp|P50250|SAHH_PLA	-	479	5.7e-13	46.6	0.3	1	1	6.7e-15	7.7e-13	46.2	0.3	239	307	24	91	18	131	0.80	Retinol dehydrogenase 11 (DB00162)
drugbank_target|Q59771	-	356	sp|P50250|SAHH_PLA	-	479	1.3e-12	45.4	0.1	1	1	1.6e-14	1.8e-12	44.9	0.1	233	347	152	266	130	283	0.85	Phenylalanine dehydrogenase (DB02494; DB03884)
drugbank_target|P17584	-	333	sp|P50250|SAHH_PLA	-	479	2.9e-12	44.3	0.0	1	1	3.8e-14	4.4e-12	43.7	0.0	254	343	142	232	128	252	0.90	D-2-hydroxyisocaproate dehydrogenase (DB03229)
drugbank_target|P9WNX3	-	528	sp|P50250|SAHH_PLA	-	479	3.5e-12	44.0	0.0	1	1	5.2e-14	5.9e-12	43.2	0.0	253	343	137	230	127	252	0.87	D-3-phosphoglycerate dehydrogenase (DB01694)
drugbank_target|P0AET8	-	255	sp|P50250|SAHH_PLA	-	479	2.4e-11	41.2	0.7	1	2	2.1e-13	2.4e-11	41.2	0.7	250	329	4	95	1	97	0.86	7-alpha-hydroxysteroid dehydrogenase (DB02123)
drugbank_target|P0AET8	-	255	sp|P50250|SAHH_PLA	-	479	2.4e-11	41.2	0.7	2	2	5.3	6.1e+02	-3.0	0.0	270	295	127	152	121	174	0.66	7-alpha-hydroxysteroid dehydrogenase (DB02123)
drugbank_target|Q9BTZ2	-	278	sp|P50250|SAHH_PLA	-	479	1.7e-08	31.8	0.5	1	1	1.9e-10	2.2e-08	31.5	0.5	254	344	29	131	14	167	0.76	Dehydrogenase/reductase SDR family member 4 (DB00162)
drugbank_target|Q8NBN7	-	331	sp|P50250|SAHH_PLA	-	479	2e-08	31.6	0.2	1	1	2.4e-10	2.7e-08	31.1	0.2	251	313	32	94	16	130	0.73	Retinol dehydrogenase 13 (DB00162)
drugbank_target|O43175	-	533	sp|P50250|SAHH_PLA	-	479	8.8e-08	29.5	0.1	1	2	6.6	7.6e+02	-3.3	0.2	239	317	19	96	18	104	0.65	D-3-phosphoglycerate dehydrogenase (DB00157)
drugbank_target|O43175	-	533	sp|P50250|SAHH_PLA	-	479	8.8e-08	29.5	0.1	2	2	1.6e-09	1.8e-07	28.4	0.0	252	342	140	233	124	244	0.84	D-3-phosphoglycerate dehydrogenase (DB00157)
drugbank_target|Q9WYS2	-	255	sp|P50250|SAHH_PLA	-	479	2.6e-07	27.9	0.1	1	1	3.3e-09	3.8e-07	27.4	0.1	253	315	5	68	2	102	0.88	Oxidoreductase, short chain dehydrogenase/reductase family (DB03461)
drugbank_target|Q9HBH5	-	336	sp|P50250|SAHH_PLA	-	479	2.7e-07	27.9	0.2	1	2	6.5e-09	7.4e-07	26.4	0.0	253	297	39	84	29	97	0.89	Retinol dehydrogenase 14 (DB00162)
drugbank_target|Q9HBH5	-	336	sp|P50250|SAHH_PLA	-	479	2.7e-07	27.9	0.2	2	2	2.8	3.2e+02	-2.0	0.0	432	444	311	323	307	330	0.86	Retinol dehydrogenase 14 (DB00162)
drugbank_target|P55818	-	288	sp|P50250|SAHH_PLA	-	479	6.4e-07	26.6	0.7	1	1	7.5e-09	8.6e-07	26.2	0.7	247	313	110	181	98	209	0.78	Bifunctional protein MdtA (DB03461)
drugbank_target|Q7Z4W1	-	244	sp|P50250|SAHH_PLA	-	479	8.1e-07	26.3	0.0	1	1	9e-09	1e-06	26.0	0.0	253	352	3	106	1	125	0.75	L-xylulose reductase (DB02831; DB03461)
drugbank_target|P0CG22	-	281	sp|P50250|SAHH_PLA	-	479	2e-06	25.0	0.1	1	1	2.1e-08	2.4e-06	24.7	0.1	254	328	29	115	16	155	0.77	Putative dehydrogenase/reductase SDR family member 4-like 1 (DB02532; DB03461; DB03541; DB07689; DB07765)
drugbank_target|P0AEK2	-	244	sp|P50250|SAHH_PLA	-	479	3.5e-06	24.2	0.4	1	1	3.3e-08	3.8e-06	24.1	0.4	255	332	3	89	1	172	0.65	3-oxoacyl-[acyl-carrier-protein] reductase FabG (DB03461)
drugbank_target|Q16698	-	335	sp|P50250|SAHH_PLA	-	479	4.1e-06	24.0	0.0	1	1	4.8e-08	5.5e-06	23.6	0.0	232	310	32	112	27	186	0.77	2,4-dienoyl-CoA reductase, mitochondrial (DB03461; DB08605)
drugbank_target|Q13363	-	440	sp|P50250|SAHH_PLA	-	479	4.7e-06	23.8	0.0	1	1	7.6e-08	8.7e-06	22.9	0.0	252	343	169	264	150	288	0.84	C-terminal-binding protein 1 (DB01942)
drugbank_target|Q6PKH6	-	230	sp|P50250|SAHH_PLA	-	479	5e-06	23.7	0.1	1	1	5.1e-08	5.8e-06	23.5	0.1	254	332	27	117	10	158	0.77	Dehydrogenase/reductase SDR family member 4-like 2 (DB04200)
drugbank_target|Q9BY49	-	303	sp|P50250|SAHH_PLA	-	479	8.2e-06	23.0	0.0	1	1	9.2e-08	1e-05	22.6	0.0	253	299	14	61	3	105	0.90	Peroxisomal trans-2-enoyl-CoA reductase (DB00173)
drugbank_target|Q84EX5	-	252	sp|P50250|SAHH_PLA	-	479	2e-05	21.7	0.1	1	1	2.5e-07	2.9e-05	21.2	0.1	254	298	4	49	1	65	0.88	R-specific alcohol dehydrogenase (DB04619; DB04784)
drugbank_target|P19992	-	255	sp|P50250|SAHH_PLA	-	479	3.7e-05	20.8	0.1	1	1	4.2e-07	4.8e-05	20.4	0.1	255	300	4	51	2	114	0.78	3-alpha-(or 20-beta)-hydroxysteroid dehydrogenase (DB02329)
drugbank_target|Q00796	-	357	sp|P50250|SAHH_PLA	-	479	0.00013	19.0	0.2	1	1	1.6e-06	0.00019	18.5	0.2	256	304	172	221	154	240	0.86	Sorbitol dehydrogenase (DB00157; DB04478)
drugbank_target|P15428	-	266	sp|P50250|SAHH_PLA	-	479	0.00016	18.7	0.1	1	1	1.8e-06	0.00021	18.4	0.1	254	302	2	54	1	107	0.66	15-hydroxyprostaglandin dehydrogenase [NAD(+)] (DB00157)
drugbank_target|O75911	-	302	sp|P50250|SAHH_PLA	-	479	0.0002	18.4	0.1	1	1	2.4e-06	0.00027	18.0	0.1	254	330	35	124	20	150	0.72	Short-chain dehydrogenase/reductase 3 (DB00162)
drugbank_target|Q48436	-	256	sp|P50250|SAHH_PLA	-	479	0.0003	17.8	1.5	1	1	3.2e-06	0.00036	17.5	1.5	258	329	3	86	1	123	0.72	Diacetyl reductase [(S)-acetoin forming] (DB02379)
drugbank_target|P9WGT1	-	260	sp|P50250|SAHH_PLA	-	479	0.0012	15.8	0.4	1	1	1.4e-05	0.0016	15.4	0.4	254	329	4	88	1	102	0.77	3-alpha-(or 20-beta)-hydroxysteroid dehydrogenase (DB02854)
drugbank_target|P9WGR1	-	269	sp|P50250|SAHH_PLA	-	479	0.0039	14.1	0.0	1	1	4.7e-05	0.0053	13.7	0.0	254	300	4	53	1	83	0.86	Enoyl-[acyl-carrier-protein] reductase [NADH] (DB00609; DB00951; DB02990; DB04289; DB05154; DB07090; DB07123; DB07155; DB07178; DB07188; DB07192; DB07222; DB07287; DB08604)
drugbank_target|P16544	-	261	sp|P50250|SAHH_PLA	-	479	0.0044	14.0	0.1	1	1	6.2e-05	0.0071	13.3	0.1	258	329	7	90	2	93	0.78	Putative ketoacyl reductase (DB01942; DB03461; DB07715)
drugbank_target|Q92506	-	261	sp|P50250|SAHH_PLA	-	479	0.0045	14.0	0.1	1	1	3.9e-05	0.0045	14.0	0.1	255	297	9	52	2	56	0.89	Estradiol 17-beta-dehydrogenase 8 (DB00157; DB03461)
drugbank_target|P37058	-	310	sp|P50250|SAHH_PLA	-	479	0.0055	13.7	0.0	1	1	6.7e-05	0.0077	13.2	0.0	257	305	48	96	41	167	0.80	Testosterone 17-beta-dehydrogenase 3 (DB00157)
drugbank_target|Q8I814	-	276	sp|P50250|SAHH_PLA	-	479	0.0071	13.3	0.0	1	1	9.9e-05	0.011	12.6	0.0	260	315	14	71	6	101	0.77	Putative pteridine reductase 2 (DB02015; DB03461)
drugbank_target|Q6ZMR3	-	332	sp|P50250|SAHH_PLA	-	479	0.0085	13.0	0.1	1	1	0.00012	0.014	12.3	0.1	250	330	13	98	4	144	0.81	L-lactate dehydrogenase A-like 6A (DB00157)
drugbank_target|P37062	-	447	sp|P50250|SAHH_PLA	-	479	0.0086	13.0	0.4	1	2	0.00014	0.016	12.1	0.1	233	308	125	200	56	219	0.78	NADH peroxidase (DB03147; DB03382)
drugbank_target|P37062	-	447	sp|P50250|SAHH_PLA	-	479	0.0086	13.0	0.4	2	2	5.1	5.9e+02	-2.9	0.0	279	336	387	445	383	446	0.66	NADH peroxidase (DB03147; DB03382)
drugbank_target|Q9BYZ2	-	381	sp|P50250|SAHH_PLA	-	479	0.012	12.6	0.0	1	1	0.00015	0.017	12.0	0.0	255	347	67	167	53	219	0.71	L-lactate dehydrogenase A-like 6B (DB00157)
drugbank_target|Q99714	-	261	sp|P50250|SAHH_PLA	-	479	0.022	11.7	0.3	1	1	0.00031	0.035	11.0	0.2	253	315	6	71	1	93	0.74	3-hydroxyacyl-CoA dehydrogenase type-2 (DB00157; DB02820; DB09568)
drugbank_target|Q6UWP2	-	260	sp|P50250|SAHH_PLA	-	479	0.023	11.6	0.0	1	1	0.00024	0.028	11.3	0.0	257	299	11	54	4	161	0.73	Dehydrogenase/reductase SDR family member 11 (DB03461)
drugbank_target|Q52437	-	408	sp|P50250|SAHH_PLA	-	479	0.024	11.5	0.0	1	1	0.00032	0.037	10.9	0.0	259	349	147	241	134	255	0.83	Ferredoxin reductase (DB03147)
drugbank_target|P42328	-	339	sp|P50250|SAHH_PLA	-	479	0.028	11.3	0.4	1	1	0.00037	0.043	10.7	0.4	257	324	165	232	148	247	0.83	Alcohol dehydrogenase (DB03226)
drugbank_target|Q16836	-	314	sp|P50250|SAHH_PLA	-	479	0.03	11.2	1.8	1	1	0.00044	0.05	10.5	1.8	248	321	18	98	5	160	0.64	Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial (DB00157; DB03059; DB03612; DB09568)
drugbank_target|Q92206	-	496	sp|P50250|SAHH_PLA	-	479	0.039	10.9	0.1	1	1	0.00049	0.056	10.3	0.1	260	297	8	45	4	75	0.84	Squalene monooxygenase (DB00525; DB00857)
drugbank_target|Q15418	-	735	sp|Q8ICR0|CDPK2_PL	-	509	2.6e-178	592.0	0.0	1	2	5e-89	6.4e-88	293.8	0.0	59	333	48	328	21	339	0.91	Ribosomal protein S6 kinase alpha-1 (DB04751; DB12010)
drugbank_target|Q15418	-	735	sp|Q8ICR0|CDPK2_PL	-	509	2.6e-178	592.0	0.0	2	2	1e-89	1.3e-88	296.1	0.0	64	338	410	687	395	715	0.90	Ribosomal protein S6 kinase alpha-1 (DB04751; DB12010)
drugbank_target|P51812	-	740	sp|Q8ICR0|CDPK2_PL	-	509	4.9e-178	591.1	0.0	1	2	2.2e-91	2.7e-90	301.6	0.0	41	333	37	334	9	344	0.86	Ribosomal protein S6 kinase alpha-3 (DB00945; DB12010)
drugbank_target|P51812	-	740	sp|Q8ICR0|CDPK2_PL	-	509	4.9e-178	591.1	0.0	2	2	4.5e-87	5.7e-86	287.4	0.0	59	334	409	687	389	715	0.91	Ribosomal protein S6 kinase alpha-3 (DB00945; DB12010)
drugbank_target|Q9UK32	-	745	sp|Q8ICR0|CDPK2_PL	-	509	7.1e-176	584.0	0.1	1	2	4.1e-89	5.2e-88	294.1	0.1	66	333	66	337	30	348	0.91	Ribosomal protein S6 kinase alpha-6 (DB12010)
drugbank_target|Q9UK32	-	745	sp|Q8ICR0|CDPK2_PL	-	509	7.1e-176	584.0	0.1	2	2	3.5e-87	4.5e-86	287.7	0.0	63	341	417	698	405	723	0.92	Ribosomal protein S6 kinase alpha-6 (DB12010)
drugbank_target|O75676	-	772	sp|Q8ICR0|CDPK2_PL	-	509	2.8e-159	529.2	0.0	1	2	1.7e-80	2.2e-79	265.7	0.0	62	331	22	306	5	317	0.87	Ribosomal protein S6 kinase alpha-4 (DB03247)
drugbank_target|O75676	-	772	sp|Q8ICR0|CDPK2_PL	-	509	2.8e-159	529.2	0.0	2	2	3.2e-79	4.1e-78	261.5	0.0	76	333	415	681	391	694	0.91	Ribosomal protein S6 kinase alpha-4 (DB03247)
drugbank_target|Q8IBS5	-	528	sp|Q8ICR0|CDPK2_PL	-	509	8.7e-155	514.4	16.4	1	1	8.3e-156	1.1e-154	514.1	16.4	4	504	5	517	1	521	0.93	Calcium-dependent protein kinase 4 (DB11638)
drugbank_target|P62344	-	524	sp|Q8ICR0|CDPK2_PL	-	509	1.2e-149	497.5	23.2	1	2	4.8e-150	6.2e-149	495.1	23.1	11	503	13	509	3	515	0.89	Calcium-dependent protein kinase 1 (DB12010)
drugbank_target|P62344	-	524	sp|Q8ICR0|CDPK2_PL	-	509	1.2e-149	497.5	23.2	2	2	0.00066	0.0083	13.0	0.1	412	439	492	519	488	523	0.85	Calcium-dependent protein kinase 1 (DB12010)
drugbank_target|O60674	-	1132	sp|Q8ICR0|CDPK2_PL	-	509	4.7e-120	399.8	0.1	1	2	4.2e-49	5.3e-48	162.1	0.0	63	322	535	803	512	814	0.88	Tyrosine-protein kinase JAK2 (DB04716; DB05243; DB07161; DB07162; DB08067; DB08877; DB08895; DB11817; DB11986; DB12010; DB12500; DB15035)
drugbank_target|O60674	-	1132	sp|Q8ICR0|CDPK2_PL	-	509	4.7e-120	399.8	0.1	2	2	2.7e-71	3.4e-70	235.3	0.2	69	320	846	1119	836	1123	0.84	Tyrosine-protein kinase JAK2 (DB04716; DB05243; DB07161; DB07162; DB08067; DB08877; DB08895; DB11817; DB11986; DB12010; DB12500; DB15035)
drugbank_target|P23458	-	1154	sp|Q8ICR0|CDPK2_PL	-	509	6.6e-114	379.6	7.7	1	2	2.1e-46	2.7e-45	153.2	0.0	65	322	576	843	547	854	0.87	Tyrosine-protein kinase JAK1 (DB02375; DB04716; DB08877; DB08895; DB11817; DB12010; DB12500; DB15091)
drugbank_target|P23458	-	1154	sp|Q8ICR0|CDPK2_PL	-	509	6.6e-114	379.6	7.7	2	2	8.4e-70	1.1e-68	230.4	0.1	53	321	855	1146	842	1148	0.84	Tyrosine-protein kinase JAK1 (DB02375; DB04716; DB08877; DB08895; DB11817; DB12010; DB12500; DB15091)
drugbank_target|P29597	-	1187	sp|Q8ICR0|CDPK2_PL	-	509	1.9e-111	371.4	0.0	1	2	4.7e-43	6e-42	142.2	0.0	59	323	575	865	557	876	0.90	Non-receptor tyrosine-protein kinase TYK2 (DB04716; DB08895; DB12010)
drugbank_target|P29597	-	1187	sp|Q8ICR0|CDPK2_PL	-	509	1.9e-111	371.4	0.0	2	2	1e-68	1.3e-67	226.8	0.0	70	320	895	1165	879	1177	0.88	Non-receptor tyrosine-protein kinase TYK2 (DB04716; DB08895; DB12010)
drugbank_target|Q8IU85	-	385	sp|Q8ICR0|CDPK2_PL	-	509	8.4e-109	362.7	0.1	1	1	7.8e-110	9.9e-109	362.5	0.1	55	370	6	322	1	326	0.96	Calcium/calmodulin-dependent protein kinase type 1D (DB08454; DB12010)
drugbank_target|P52333	-	1124	sp|Q8ICR0|CDPK2_PL	-	509	7.6e-108	359.5	0.0	1	2	6.6e-42	8.4e-41	138.4	0.0	50	321	498	774	478	779	0.88	Tyrosine-protein kinase JAK3 (DB04716; DB06321; DB08895; DB11817; DB12010; DB15035)
drugbank_target|P52333	-	1124	sp|Q8ICR0|CDPK2_PL	-	509	7.6e-108	359.5	0.0	2	2	2.4e-66	3.1e-65	219.0	0.0	69	319	819	1090	806	1094	0.86	Tyrosine-protein kinase JAK3 (DB04716; DB06321; DB08895; DB11817; DB12010; DB15035)
drugbank_target|Q96NX5	-	476	sp|Q8ICR0|CDPK2_PL	-	509	1.9e-106	355.0	0.2	1	1	1.8e-107	2.3e-106	354.7	0.2	53	372	4	322	1	325	0.96	Calcium/calmodulin-dependent protein kinase type 1G (DB08009; DB12010)
drugbank_target|Q14012	-	370	sp|Q8ICR0|CDPK2_PL	-	509	2.3e-106	354.6	0.0	1	1	2.5e-107	3.1e-106	354.2	0.0	63	372	11	321	6	325	0.96	Calcium/calmodulin-dependent protein kinase type 1 (DB12010)
drugbank_target|Q9BYT3	-	514	sp|Q8ICR0|CDPK2_PL	-	509	9e-104	346.1	6.6	1	1	8.8e-105	1.1e-103	345.8	6.6	5	374	52	427	48	455	0.88	Serine/threonine-protein kinase 33 (DB12010)
drugbank_target|Q13557	-	499	sp|Q8ICR0|CDPK2_PL	-	509	1e-102	342.7	0.0	1	1	1.1e-103	1.4e-102	342.2	0.0	66	366	8	311	2	363	0.94	Calcium/calmodulin-dependent protein kinase type II subunit delta (DB07853; DB08039; DB12010)
drugbank_target|O14965	-	403	sp|Q8ICR0|CDPK2_PL	-	509	2.4e-102	341.4	0.0	1	1	2.2e-103	2.8e-102	341.2	0.0	2	344	66	401	65	403	0.93	Aurora kinase A (DB02482; DB05169; DB05198; DB05220; DB06134; DB06347; DB06486; DB07186; DB07266; DB07360; DB07362; DB07545; DB07801; DB08065; DB08066; DB12010; DB13061)
drugbank_target|Q9UQM7	-	478	sp|Q8ICR0|CDPK2_PL	-	509	2.5e-101	338.1	0.2	1	1	3e-102	3.8e-101	337.5	0.0	66	364	7	308	1	315	0.96	Calcium/calmodulin-dependent protein kinase type II subunit alpha (DB04119; DB04447; DB07766; DB12010)
drugbank_target|Q13555	-	558	sp|Q8ICR0|CDPK2_PL	-	509	2.5e-101	338.0	0.0	1	1	2.9e-102	3.7e-101	337.5	0.0	66	364	8	309	2	322	0.95	Calcium/calmodulin-dependent protein kinase type II subunit gamma (DB06616; DB08699; DB12010)
drugbank_target|Q13554	-	666	sp|Q8ICR0|CDPK2_PL	-	509	5.1e-100	333.7	0.0	1	1	5.5e-101	7.1e-100	333.3	0.0	66	364	8	309	2	315	0.96	Calcium/calmodulin-dependent protein kinase type II subunit beta (DB07168; DB12010)
drugbank_target|P27448	-	753	sp|Q8ICR0|CDPK2_PL	-	509	9.5e-100	332.8	0.0	1	1	1.2e-100	1.5e-99	332.2	0.0	26	334	11	315	2	369	0.88	MAP/microtubule affinity-regulating kinase 3 (DB12010)
drugbank_target|Q9C098	-	648	sp|Q8ICR0|CDPK2_PL	-	509	6.3e-99	330.1	0.0	1	1	7e-100	8.9e-99	329.6	0.0	16	355	299	642	285	648	0.87	Serine/threonine-protein kinase DCLK3 (DB12010)
drugbank_target|Q9P0L2	-	795	sp|Q8ICR0|CDPK2_PL	-	509	1.1e-98	329.3	0.0	1	1	1.4e-99	1.7e-98	328.7	0.0	38	334	25	319	4	337	0.91	Serine/threonine-protein kinase MARK1 (DB12010)
drugbank_target|Q9UIK4	-	370	sp|Q8ICR0|CDPK2_PL	-	509	2.8e-98	328.0	0.1	1	1	2.9e-99	3.7e-98	327.6	0.1	55	371	6	328	2	338	0.91	Death-associated protein kinase 2 (DB12010)
drugbank_target|Q7KZI7	-	788	sp|Q8ICR0|CDPK2_PL	-	509	2.9e-98	328.0	0.0	1	1	4.2e-99	5.3e-98	327.1	0.0	46	333	27	311	9	325	0.92	Serine/threonine-protein kinase MARK2 (DB12010)
drugbank_target|O43293	-	454	sp|Q8ICR0|CDPK2_PL	-	509	5.8e-98	326.9	0.1	1	1	1.1e-98	1.4e-97	325.7	0.0	62	341	3	290	1	314	0.92	Death-associated protein kinase 3 (DB04716; DB07125; DB07242; DB12010)
drugbank_target|Q96L34	-	752	sp|Q8ICR0|CDPK2_PL	-	509	1.1e-97	326.1	0.0	1	1	1.1e-98	1.4e-97	325.7	0.0	55	331	41	315	6	370	0.90	MAP/microtubule affinity-regulating kinase 4 (DB12010)
drugbank_target|P53355	-	1430	sp|Q8ICR0|CDPK2_PL	-	509	1.7e-97	325.4	0.1	1	1	1.9e-98	2.4e-97	324.9	0.1	62	370	3	321	1	341	0.92	Death-associated protein kinase 1 (DB04069; DB04395; DB07444; DB12010)
drugbank_target|O60285	-	661	sp|Q8ICR0|CDPK2_PL	-	509	5.8e-96	320.3	0.1	1	1	6.3e-97	8e-96	319.9	0.1	60	332	43	312	29	404	0.93	NUAK family SNF1-like kinase 1 (DB12010)
drugbank_target|Q9P2K8	-	1649	sp|Q8ICR0|CDPK2_PL	-	509	7.1e-96	320.1	16.9	1	3	3.1e-38	4e-37	126.3	0.2	103	333	333	546	328	585	0.87	eIF-2-alpha kinase GCN2 (DB12010)
drugbank_target|Q9P2K8	-	1649	sp|Q8ICR0|CDPK2_PL	-	509	7.1e-96	320.1	16.9	2	3	1.3e-14	1.6e-13	48.3	0.0	62	139	580	658	549	662	0.85	eIF-2-alpha kinase GCN2 (DB12010)
drugbank_target|Q9P2K8	-	1649	sp|Q8ICR0|CDPK2_PL	-	509	7.1e-96	320.1	16.9	3	3	2.4e-46	3.1e-45	153.0	0.0	139	347	795	1023	789	1043	0.86	eIF-2-alpha kinase GCN2 (DB12010)
drugbank_target|Q9NRH2	-	765	sp|Q8ICR0|CDPK2_PL	-	509	1.3e-95	319.2	0.0	1	1	1.8e-96	2.2e-95	318.4	0.0	66	361	10	305	5	324	0.93	SNF-related serine/threonine-protein kinase (DB12010)
drugbank_target|Q16566	-	473	sp|Q8ICR0|CDPK2_PL	-	509	1.8e-95	318.8	0.0	1	1	1.9e-96	2.5e-95	318.3	0.0	64	358	38	332	31	351	0.93	Calcium/calmodulin-dependent protein kinase type IV (DB07664; DB07676)
drugbank_target|P31751	-	481	sp|Q8ICR0|CDPK2_PL	-	509	4.8e-95	317.3	0.0	1	1	4.8e-96	6.1e-95	317.0	0.0	43	334	123	417	89	438	0.91	RAC-beta serine/threonine-protein kinase (DB07812; DB07859; DB07947; DB08073)
drugbank_target|P31749	-	480	sp|Q8ICR0|CDPK2_PL	-	509	6.4e-95	316.9	0.1	1	1	6.5e-96	8.3e-95	316.5	0.1	33	335	111	417	87	449	0.88	RAC-alpha serine/threonine-protein kinase (DB00171; DB01169; DB01645; DB01863; DB02709; DB05971; DB06486; DB06641; DB07584; DB07585)
drugbank_target|O96017	-	543	sp|Q8ICR0|CDPK2_PL	-	509	9.1e-95	316.4	0.0	1	1	1.1e-95	1.4e-94	315.7	0.0	64	338	212	498	170	522	0.90	Serine/threonine-protein kinase Chk2 (DB05149; DB06486; DB12010)
drugbank_target|Q15746	-	1914	sp|Q8ICR0|CDPK2_PL	-	509	9.2e-95	316.4	0.9	1	1	1.3e-95	1.6e-94	315.6	0.9	34	358	1426	1751	1397	1765	0.91	Myosin light chain kinase, smooth muscle (DB12010)
drugbank_target|O15075	-	740	sp|Q8ICR0|CDPK2_PL	-	509	1.2e-94	316.0	0.0	1	1	1.5e-95	1.9e-94	315.4	0.0	36	369	354	692	328	700	0.84	Serine/threonine-protein kinase DCLK1 (DB12010)
drugbank_target|Q13131	-	559	sp|Q8ICR0|CDPK2_PL	-	509	1.5e-94	315.7	0.0	1	1	1.6e-95	2.1e-94	315.2	0.0	58	335	12	288	2	321	0.91	5'-AMP-activated protein kinase catalytic subunit alpha-1 (DB00131; DB00171; DB00914; DB12010)
drugbank_target|Q13131	-	559	sp|Q8ICR0|CDPK2_PL	-	509	1.5e-94	315.7	0.0	1	1	1.6e-95	2.1e-94	315.2	0.0	58	335	12	288	2	321	0.91	5'-AMP-activated protein kinase catalytic subunit alpha-1 (DB00131; DB00945; DB12010)
drugbank_target|Q9Y2K2	-	1321	sp|Q8ICR0|CDPK2_PL	-	509	2e-94	315.3	0.1	1	1	1.5e-95	2e-94	315.3	0.1	71	370	65	361	60	373	0.94	Serine/threonine-protein kinase SIK3 (DB12010)
drugbank_target|Q9H093	-	628	sp|Q8ICR0|CDPK2_PL	-	509	4e-94	314.3	0.0	1	1	4.4e-95	5.6e-94	313.8	0.0	54	328	35	305	14	319	0.93	NUAK family SNF1-like kinase 2 (DB12010)
drugbank_target|Q8N568	-	766	sp|Q8ICR0|CDPK2_PL	-	509	8.8e-94	313.2	0.0	1	1	1e-94	1.3e-93	312.6	0.0	61	370	383	698	349	702	0.90	Serine/threonine-protein kinase DCLK2 (DB12010)
drugbank_target|P57059	-	783	sp|Q8ICR0|CDPK2_PL	-	509	9.9e-93	309.7	0.0	1	1	1.1e-93	1.3e-92	309.2	0.0	71	328	26	280	8	338	0.95	Serine/threonine-protein kinase SIK1 (DB08912; DB12010)
drugbank_target|Q32MK0	-	819	sp|Q8ICR0|CDPK2_PL	-	509	1.8e-92	308.8	0.4	1	1	2.1e-93	2.6e-92	308.3	0.4	62	366	503	811	496	815	0.91	Myosin light chain kinase 3 (DB12010)
drugbank_target|Q9Y6E0	-	443	sp|Q8ICR0|CDPK2_PL	-	509	1.8e-92	308.8	0.0	1	1	1.9e-93	2.4e-92	308.4	0.0	65	355	29	315	13	346	0.93	Serine/threonine-protein kinase 24 (DB12010)
drugbank_target|Q86YV6	-	388	sp|Q8ICR0|CDPK2_PL	-	509	2.2e-92	308.6	0.2	1	1	2.1e-93	2.6e-92	308.3	0.2	58	341	90	377	31	387	0.92	Myosin light chain kinase family member 4 (DB12010)
drugbank_target|P54646	-	552	sp|Q8ICR0|CDPK2_PL	-	509	6.9e-92	306.9	0.0	1	1	7.8e-93	9.9e-92	306.4	0.0	63	332	6	274	2	311	0.93	5'-AMP-activated protein kinase catalytic subunit alpha-2 (DB00131; DB00945; DB12010)
drugbank_target|Q16816	-	387	sp|Q8ICR0|CDPK2_PL	-	509	7.2e-92	306.8	0.0	1	1	7.4e-93	9.4e-92	306.5	0.0	63	333	11	295	2	308	0.93	Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform (DB12010)
drugbank_target|Q13188	-	491	sp|Q8ICR0|CDPK2_PL	-	509	1.3e-91	306.0	1.0	1	1	1.6e-92	2.1e-91	305.3	0.0	62	371	17	325	3	329	0.91	Serine/threonine-protein kinase 3 (DB12010)
drugbank_target|P05771	-	671	sp|Q8ICR0|CDPK2_PL	-	509	1.6e-91	305.7	0.0	1	1	1.8e-92	2.3e-91	305.2	0.0	23	341	293	615	280	648	0.92	Protein kinase C beta type (DB00163; DB01738; DB06486; DB08846; DB08862; DB14001; DB14002)
drugbank_target|P05771	-	671	sp|Q8ICR0|CDPK2_PL	-	509	1.6e-91	305.7	0.0	1	1	1.8e-92	2.3e-91	305.2	0.0	23	341	293	615	280	648	0.92	Protein kinase C beta type (DB00675)
drugbank_target|Q9H0K1	-	926	sp|Q8ICR0|CDPK2_PL	-	509	2.2e-91	305.2	0.0	1	1	3.3e-92	4.2e-91	304.3	0.0	71	335	19	280	8	337	0.89	Serine/threonine-protein kinase SIK2 (DB12010)
drugbank_target|Q9P289	-	416	sp|Q8ICR0|CDPK2_PL	-	509	3.2e-91	304.7	0.1	1	1	6.6e-92	8.4e-91	303.3	0.0	62	353	14	301	8	334	0.92	Serine/threonine-protein kinase 26 (DB07853; DB12010)
drugbank_target|Q14680	-	651	sp|Q8ICR0|CDPK2_PL	-	509	8.7e-91	303.3	0.7	1	1	1e-91	1.3e-90	302.7	0.7	67	344	6	281	2	317	0.91	Maternal embryonic leucine zipper kinase (DB12010)
drugbank_target|O75914	-	559	sp|Q8ICR0|CDPK2_PL	-	509	1.1e-90	303.0	0.0	1	2	1.7	22	1.8	0.0	399	437	122	158	116	171	0.87	Serine/threonine-protein kinase PAK 3 (DB12010)
drugbank_target|O75914	-	559	sp|Q8ICR0|CDPK2_PL	-	509	1.1e-90	303.0	0.0	2	2	1.3e-90	1.7e-89	299.0	0.0	30	335	241	543	223	559	0.90	Serine/threonine-protein kinase PAK 3 (DB12010)
drugbank_target|P17612	-	351	sp|Q8ICR0|CDPK2_PL	-	509	1.2e-90	302.8	0.0	1	1	1.1e-91	1.5e-90	302.5	0.0	38	331	11	303	2	342	0.91	cAMP-dependent protein kinase catalytic subunit alpha (DB01919; DB01940; DB02155; DB02482; DB02611; DB03374; DB04098; DB04522; DB04530; DB04707; DB06959; DB06977; DB07107; DB07124; DB07204; DB07235; DB07458; DB07583; DB07854; DB07855; DB07856; DB07857; DB07858; DB07859; DB07860; DB07876; DB07947; DB07995; DB07996; DB07997; DB08070; DB08073; DB08113; DB08114; DB08148; DB08149; DB08150; DB08162; DB08231; DB08568; DB08569; DB08756; DB08846; DB12010)
drugbank_target|P22694	-	351	sp|Q8ICR0|CDPK2_PL	-	509	1.4e-90	302.6	0.0	1	1	1.2e-91	1.5e-90	302.5	0.0	38	332	11	304	2	351	0.89	cAMP-dependent protein kinase catalytic subunit beta (DB02482; DB12010)
drugbank_target|P17252	-	672	sp|Q8ICR0|CDPK2_PL	-	509	1.8e-90	302.2	0.0	1	1	2.1e-91	2.7e-90	301.7	0.0	55	335	322	606	286	624	0.89	Protein kinase C alpha type (DB00144; DB00163; DB05013; DB06451; DB06595; DB06641; DB08846; DB11752; DB14001; DB14002)
drugbank_target|P17252	-	672	sp|Q8ICR0|CDPK2_PL	-	509	1.8e-90	302.2	0.0	1	1	2.1e-91	2.7e-90	301.7	0.0	55	335	322	606	286	624	0.89	Protein kinase C alpha type (DB00675)
drugbank_target|Q9H1R3	-	596	sp|Q8ICR0|CDPK2_PL	-	509	2e-90	302.1	0.3	1	1	2.1e-91	2.6e-90	301.7	0.3	62	369	273	584	268	589	0.93	Myosin light chain kinase 2, skeletal/cardiac muscle (DB04825; DB12010)
drugbank_target|O14936	-	926	sp|Q8ICR0|CDPK2_PL	-	509	2.4e-90	301.8	0.0	1	1	3.8e-91	4.8e-90	300.8	0.0	68	366	8	315	2	319	0.94	Peripheral plasma membrane protein CASK (DB01942; DB12010)
drugbank_target|Q9UQB9	-	309	sp|Q8ICR0|CDPK2_PL	-	509	3.1e-90	301.5	0.0	1	1	3e-91	3.9e-90	301.1	0.0	64	331	34	298	8	305	0.91	Aurora kinase C (DB06134; DB12010)
drugbank_target|Q02156	-	737	sp|Q8ICR0|CDPK2_PL	-	509	3.6e-90	301.3	0.0	1	1	4e-91	5e-90	300.8	0.0	54	375	389	728	340	733	0.85	Protein kinase C epsilon type (DB06064; DB11752; DB12010)
drugbank_target|Q02156	-	737	sp|Q8ICR0|CDPK2_PL	-	509	3.6e-90	301.3	0.0	1	1	4e-91	5e-90	300.8	0.0	54	375	389	728	340	733	0.85	Protein kinase C epsilon type (DB00675)
drugbank_target|Q00532	-	358	sp|Q8ICR0|CDPK2_PL	-	509	7.8e-90	300.1	0.0	1	1	7.5e-91	9.5e-90	299.9	0.0	69	371	2	334	1	336	0.93	Cyclin-dependent kinase-like 1 (DB12010)
drugbank_target|Q13153	-	545	sp|Q8ICR0|CDPK2_PL	-	509	1.4e-89	299.3	0.0	1	1	1.8e-90	2.2e-89	298.6	0.0	38	334	236	529	214	545	0.89	Serine/threonine-protein kinase PAK 1 (DB12010)
drugbank_target|Q9HBH9	-	465	sp|Q8ICR0|CDPK2_PL	-	509	1.8e-89	299.0	0.0	1	1	1.9e-90	2.4e-89	298.5	0.0	50	372	61	418	46	420	0.90	MAP kinase-interacting serine/threonine-protein kinase 2 (DB12010)
drugbank_target|Q16644	-	382	sp|Q8ICR0|CDPK2_PL	-	509	1.8e-89	298.9	0.0	1	1	1.8e-90	2.3e-89	298.6	0.0	64	377	35	356	29	367	0.93	MAP kinase-activated protein kinase 3 (DB07728; DB08358)
drugbank_target|Q9H2G2	-	1235	sp|Q8ICR0|CDPK2_PL	-	509	1.9e-89	298.8	0.1	1	1	1.5e-90	1.9e-89	298.8	0.1	52	357	14	326	6	337	0.90	STE20-like serine/threonine-protein kinase (DB07664; DB07853; DB12010)
drugbank_target|Q13177	-	524	sp|Q8ICR0|CDPK2_PL	-	509	2e-89	298.8	0.2	1	1	4.5e-90	5.8e-89	297.3	0.0	42	335	219	509	207	524	0.90	Serine/threonine-protein kinase PAK 2 (DB12010)
drugbank_target|O00444	-	970	sp|Q8ICR0|CDPK2_PL	-	509	3.5e-89	298.0	1.5	1	1	3.9e-90	4.9e-89	297.5	0.0	70	334	10	273	2	308	0.93	Serine/threonine-protein kinase PLK4 (DB12010)
drugbank_target|Q04759	-	706	sp|Q8ICR0|CDPK2_PL	-	509	3.9e-89	297.8	0.2	1	1	4.4e-90	5.6e-89	297.3	0.2	67	337	376	645	351	694	0.92	Protein kinase C theta type (DB02010; DB02482; DB04522; DB12010)
drugbank_target|Q04759	-	706	sp|Q8ICR0|CDPK2_PL	-	509	3.9e-89	297.8	0.2	1	1	4.4e-90	5.6e-89	297.3	0.2	67	337	376	645	351	694	0.92	Protein kinase C theta type (DB00675)
drugbank_target|P49137	-	400	sp|Q8ICR0|CDPK2_PL	-	509	5.3e-89	297.4	0.2	1	1	5.2e-90	6.6e-89	297.1	0.2	61	374	52	374	41	378	0.92	MAP kinase-activated protein kinase 2 (DB02010; DB07234; DB07406; DB07430; DB07431; DB07728; DB08358)
drugbank_target|O00141	-	431	sp|Q8ICR0|CDPK2_PL	-	509	2.3e-88	295.3	0.0	1	1	2.2e-89	2.8e-88	295.0	0.0	64	330	90	359	40	370	0.92	Serine/threonine-protein kinase Sgk1 (DB03247; DB07837; DB08191)
drugbank_target|Q8IY84	-	436	sp|Q8ICR0|CDPK2_PL	-	509	3.2e-88	294.8	0.0	1	1	3.2e-89	4.1e-88	294.4	0.0	28	359	30	360	15	375	0.90	Serine/threonine-protein kinase NIM1 (DB12010)
drugbank_target|Q9UEE5	-	414	sp|Q8ICR0|CDPK2_PL	-	509	4.2e-88	294.4	0.0	1	1	4.4e-89	5.7e-88	294.0	0.0	69	367	56	361	44	371	0.90	Serine/threonine-protein kinase 17A (DB12010)
drugbank_target|Q16513	-	984	sp|Q8ICR0|CDPK2_PL	-	509	5.3e-88	294.1	0.0	1	1	8.3e-89	1.1e-87	293.1	0.0	27	332	613	922	599	940	0.91	Serine/threonine-protein kinase N2 (DB12010)
drugbank_target|Q96GD4	-	344	sp|Q8ICR0|CDPK2_PL	-	509	1e-87	293.1	0.0	1	1	1e-88	1.3e-87	292.8	0.0	67	331	72	332	42	341	0.93	Aurora kinase B (DB04703; DB05169; DB06486; DB07340; DB12010)
drugbank_target|Q96BR1	-	496	sp|Q8ICR0|CDPK2_PL	-	509	1.1e-87	293.1	0.0	1	1	1.2e-88	1.5e-87	292.6	0.0	33	331	123	424	99	434	0.90	Serine/threonine-protein kinase Sgk3 (DB12010)
drugbank_target|Q8IVH8	-	894	sp|Q8ICR0|CDPK2_PL	-	509	2.2e-87	292.1	0.0	1	1	2.5e-88	3.2e-87	291.5	0.0	65	337	9	284	4	299	0.94	Mitogen-activated protein kinase kinase kinase kinase 3 (DB12010)
drugbank_target|Q9NRP7	-	1315	sp|Q8ICR0|CDPK2_PL	-	509	3e-87	291.6	0.0	1	1	3.9e-88	5e-87	290.9	0.0	70	329	2	257	1	264	0.96	Serine/threonine-protein kinase 36 (DB12010)
drugbank_target|Q92772	-	493	sp|Q8ICR0|CDPK2_PL	-	509	3.2e-87	291.5	0.4	1	1	3.3e-88	4.2e-87	291.1	0.4	70	362	2	324	1	337	0.91	Cyclin-dependent kinase-like 2 (DB12010)
drugbank_target|P24941	-	298	sp|Q8ICR0|CDPK2_PL	-	509	3.3e-87	291.4	0.0	1	1	3e-88	3.9e-87	291.2	0.0	70	334	2	294	1	298	0.95	Cyclin-dependent kinase 2 (DB01888; DB02010; DB02052; DB02091; DB02116; DB02197; DB02297; DB02407; DB02538; DB02603; DB02647; DB02733; DB02833; DB02898; DB02915; DB02950; DB02963; DB02973; DB03019; DB03307; DB03365; DB03428; DB03490; DB03496; DB03583; DB03663; DB03737; DB03801; DB04006; DB04101; DB04186; DB04288; DB04407; DB04518; DB04607; DB04662; DB04669; DB06195; DB06616; DB06844; DB06888; DB06944; DB06948; DB06976; DB06983; DB07024; DB07054; DB07065; DB07126; DB07137; DB07163; DB07164; DB07179; DB07203; DB07210; DB07220; DB07431; DB07471; DB07493; DB07501; DB07504; DB07529; DB07531; DB07533; DB07534; DB07538; DB07539; DB07540; DB07562; DB07595; DB07606; DB07612; DB07618; DB07622; DB07685; DB07686; DB07687; DB07688; DB07731; DB07750; DB07751; DB07755; DB07761; DB07790; DB07791; DB07852; DB07889; DB07936; DB07982; DB08066; DB08094; DB08122; DB08123; DB08124; DB08125; DB08126; DB08132; DB08133; DB08134; DB08135; DB08136; DB08137; DB08138; DB08139; DB08140; DB08141; DB08142; DB08178; DB08182; DB08218; DB08219; DB08233; DB08241; DB08247; DB08248; DB08285; DB08309; DB08312; DB08355; DB08441; DB08463; DB08527; DB08531; DB08532; DB08533; DB08534; DB08535; DB08536; DB08537; DB08538; DB08539; DB08572; DB08673; DB08677; DB08694; DB08768)
drugbank_target|O75385	-	1050	sp|Q8ICR0|CDPK2_PL	-	509	1.4e-86	289.4	0.0	1	1	1.6e-87	2e-86	288.9	0.0	71	330	15	282	6	296	0.93	Serine/threonine-protein kinase ULK1 (DB12010)
drugbank_target|O94804	-	968	sp|Q8ICR0|CDPK2_PL	-	509	1.9e-86	288.9	0.0	1	1	1.5e-87	1.9e-86	288.9	0.0	52	366	16	336	7	345	0.88	Serine/threonine-protein kinase 10 (DB12010)
drugbank_target|Q9UKE5	-	1360	sp|Q8ICR0|CDPK2_PL	-	509	2.2e-86	288.8	0.1	1	1	1.7e-87	2.2e-86	288.8	0.1	70	358	23	321	9	333	0.89	TRAF2 and NCK-interacting protein kinase (DB12010)
drugbank_target|Q6PHR2	-	472	sp|Q8ICR0|CDPK2_PL	-	509	2.7e-86	288.4	0.0	1	1	3.1e-87	4e-86	287.9	0.0	71	349	13	295	9	312	0.89	Serine/threonine-protein kinase ULK3 (DB12010)
drugbank_target|Q8IYT8	-	1036	sp|Q8ICR0|CDPK2_PL	-	509	4.2e-86	287.8	0.0	1	1	5.3e-87	6.8e-86	287.1	0.0	71	330	8	275	3	282	0.94	Serine/threonine-protein kinase ULK2 (DB12010)
drugbank_target|Q05655	-	676	sp|Q8ICR0|CDPK2_PL	-	509	8e-86	286.9	0.0	1	1	8.6e-87	1.1e-85	286.4	0.0	50	332	326	609	281	660	0.86	Protein kinase C delta type (DB04376; DB05013; DB12010)
drugbank_target|Q05655	-	676	sp|Q8ICR0|CDPK2_PL	-	509	8e-86	286.9	0.0	1	1	8.6e-87	1.1e-85	286.4	0.0	50	332	326	609	281	660	0.86	Protein kinase C delta type (DB00675)
drugbank_target|Q9H4B4	-	646	sp|Q8ICR0|CDPK2_PL	-	509	8.7e-86	286.8	0.0	1	1	9.5e-87	1.2e-85	286.3	0.0	69	332	59	320	50	340	0.94	Serine/threonine-protein kinase PLK3 (DB12010)
drugbank_target|Q9NYY3	-	685	sp|Q8ICR0|CDPK2_PL	-	509	1.4e-85	286.1	0.0	1	1	1.8e-86	2.3e-85	285.4	0.0	60	341	70	349	21	373	0.87	Serine/threonine-protein kinase PLK2 (DB12010)
drugbank_target|Q13237	-	762	sp|Q8ICR0|CDPK2_PL	-	509	2.2e-85	285.4	0.0	1	2	0.86	11	2.7	0.0	108	209	271	379	250	383	0.63	cGMP-dependent protein kinase 2 (DB12010)
drugbank_target|Q13237	-	762	sp|Q8ICR0|CDPK2_PL	-	509	2.2e-85	285.4	0.0	2	2	7e-85	8.9e-84	280.2	0.0	20	334	401	719	387	733	0.94	cGMP-dependent protein kinase 2 (DB12010)
drugbank_target|Q9Y2H1	-	464	sp|Q8ICR0|CDPK2_PL	-	509	3.7e-85	284.7	0.2	1	1	4.4e-86	5.7e-85	284.1	0.2	24	335	42	392	18	423	0.89	Serine/threonine-protein kinase 38-like (DB12010)
drugbank_target|Q13627	-	763	sp|Q8ICR0|CDPK2_PL	-	509	3.9e-85	284.6	1.1	1	1	2.6e-85	3.3e-84	281.6	1.1	4	357	95	510	93	519	0.91	Dual specificity tyrosine-phosphorylation-regulated kinase 1A (DB07608; DB12010)
drugbank_target|P51956	-	506	sp|Q8ICR0|CDPK2_PL	-	509	4.7e-85	284.4	0.1	1	1	5.2e-86	6.6e-85	283.9	0.1	70	368	2	303	1	312	0.93	Serine/threonine-protein kinase Nek3 (DB12010)
drugbank_target|P53350	-	603	sp|Q8ICR0|CDPK2_PL	-	509	6.4e-85	283.9	0.0	1	1	7.3e-86	9.3e-85	283.4	0.0	68	328	49	307	41	315	0.96	Serine/threonine-protein kinase PLK1 (DB06897; DB06963; DB07186; DB07789; DB08059; DB12010)
drugbank_target|P53779	-	464	sp|Q8ICR0|CDPK2_PL	-	509	8.1e-85	283.6	1.1	1	1	3.2e-85	4.1e-84	281.3	1.1	37	354	29	386	22	406	0.89	Mitogen-activated protein kinase 10 (DB01017)
drugbank_target|P53779	-	464	sp|Q8ICR0|CDPK2_PL	-	509	8.1e-85	283.6	1.1	1	1	3.2e-85	4.1e-84	281.3	1.1	37	354	29	386	22	406	0.89	Mitogen-activated protein kinase 10 (DB15624)
drugbank_target|P53779	-	464	sp|Q8ICR0|CDPK2_PL	-	509	8.1e-85	283.6	1.1	1	1	3.2e-85	4.1e-84	281.3	1.1	37	354	29	386	22	406	0.89	Mitogen-activated protein kinase 10 (DB01782; DB02388; DB03084; DB03623; DB04395; DB06933; DB07010; DB07217; DB08005; DB08010; DB08011; DB08015; DB08021; DB08023; DB08025; DB08026; DB08555; DB12010)
drugbank_target|O94768	-	372	sp|Q8ICR0|CDPK2_PL	-	509	1e-84	283.3	0.0	1	1	1e-85	1.3e-84	282.9	0.0	64	357	24	324	15	340	0.89	Serine/threonine-protein kinase 17B (DB04216; DB12010)
drugbank_target|Q15139	-	912	sp|Q8ICR0|CDPK2_PL	-	509	1.1e-84	283.2	0.0	1	1	1.2e-85	1.6e-84	282.6	0.0	53	331	562	844	548	871	0.92	Serine/threonine-protein kinase D1 (DB11752; DB12010)
drugbank_target|P51957	-	841	sp|Q8ICR0|CDPK2_PL	-	509	1.2e-84	283.0	0.0	1	1	9.8e-86	1.2e-84	283.0	0.0	72	354	6	289	2	302	0.93	Serine/threonine-protein kinase Nek4 (DB12010)
drugbank_target|Q9UPZ9	-	632	sp|Q8ICR0|CDPK2_PL	-	509	2.4e-84	282.0	0.0	1	1	2.4e-85	3.1e-84	281.7	0.0	70	340	2	298	1	311	0.93	Serine/threonine-protein kinase ICK (DB12010)
drugbank_target|Q8TD08	-	544	sp|Q8ICR0|CDPK2_PL	-	509	3.8e-84	281.4	0.0	1	1	4.1e-85	5.3e-84	280.9	0.0	68	339	9	317	3	329	0.93	Mitogen-activated protein kinase 15 (DB01017)
drugbank_target|Q8TD08	-	544	sp|Q8ICR0|CDPK2_PL	-	509	3.8e-84	281.4	0.0	1	1	4.1e-85	5.3e-84	280.9	0.0	68	339	9	317	3	329	0.93	Mitogen-activated protein kinase 15 (DB12010)
drugbank_target|Q8TD08	-	544	sp|Q8ICR0|CDPK2_PL	-	509	3.8e-84	281.4	0.0	1	1	4.1e-85	5.3e-84	280.9	0.0	68	339	9	317	3	329	0.93	Mitogen-activated protein kinase 15 (DB00945)
drugbank_target|Q9BUB5	-	465	sp|Q8ICR0|CDPK2_PL	-	509	5.7e-84	280.8	0.0	1	1	2.5e-84	3.2e-83	278.3	0.0	51	376	27	421	4	423	0.89	MAP kinase-interacting serine/threonine-protein kinase 1 (DB12010)
drugbank_target|Q6P3R8	-	708	sp|Q8ICR0|CDPK2_PL	-	509	7.3e-84	280.4	0.0	1	1	5.8e-85	7.3e-84	280.4	0.0	70	332	2	265	1	296	0.94	Serine/threonine-protein kinase Nek5 (DB12010)
drugbank_target|O95819	-	1239	sp|Q8ICR0|CDPK2_PL	-	509	7.5e-84	280.4	0.0	1	1	5.9e-85	7.5e-84	280.4	0.0	69	357	22	320	9	332	0.89	Mitogen-activated protein kinase kinase kinase kinase 4 (DB12010)
drugbank_target|P28482	-	360	sp|Q8ICR0|CDPK2_PL	-	509	8e-84	280.3	0.0	1	1	8e-85	1e-83	280.0	0.0	62	336	15	323	6	350	0.92	Mitogen-activated protein kinase 1 (DB01064; DB01169; DB02116; DB02482; DB02733; DB04338; DB06195; DB06641; DB06877; DB07010; DB07264; DB07788; DB07794; DB07905; DB08513; DB08521; DB11120; DB13930)
drugbank_target|P28482	-	360	sp|Q8ICR0|CDPK2_PL	-	509	8e-84	280.3	0.0	1	1	8e-85	1e-83	280.0	0.0	62	336	15	323	6	350	0.92	Mitogen-activated protein kinase 1 (DB01017)
drugbank_target|P28482	-	360	sp|Q8ICR0|CDPK2_PL	-	509	8e-84	280.3	0.0	1	1	8e-85	1e-83	280.0	0.0	62	336	15	323	6	350	0.92	Mitogen-activated protein kinase 1 (DB00945)
drugbank_target|P41743	-	596	sp|Q8ICR0|CDPK2_PL	-	509	1.4e-83	279.5	0.0	1	1	3.9e-84	5e-83	277.7	0.0	42	337	223	533	197	546	0.87	Protein kinase C iota type (DB03777; DB12010)
drugbank_target|P41743	-	596	sp|Q8ICR0|CDPK2_PL	-	509	1.4e-83	279.5	0.0	1	1	3.9e-84	5e-83	277.7	0.0	42	337	223	533	197	546	0.87	Protein kinase C iota type (DB00675)
drugbank_target|O95747	-	527	sp|Q8ICR0|CDPK2_PL	-	509	1.4e-83	279.5	0.0	1	1	1.6e-84	2e-83	279.0	0.0	69	346	14	311	3	328	0.87	Serine/threonine-protein kinase OSR1 (DB12010)
drugbank_target|P54764	-	986	sp|Q8ICR0|CDPK2_PL	-	509	1.9e-83	279.1	0.0	1	1	2.2e-84	2.8e-83	278.5	0.0	26	322	573	876	565	936	0.82	Ephrin type-A receptor 4 (DB12010)
drugbank_target|P45983	-	427	sp|Q8ICR0|CDPK2_PL	-	509	2.4e-83	278.7	0.7	1	1	5.4e-84	6.9e-83	277.2	0.7	51	339	5	334	1	369	0.89	Mitogen-activated protein kinase 8 (DB00675; DB01782; DB07218; DB07268; DB07272; DB07276; DB07845)
drugbank_target|P45983	-	427	sp|Q8ICR0|CDPK2_PL	-	509	2.4e-83	278.7	0.7	1	1	5.4e-84	6.9e-83	277.2	0.7	51	339	5	334	1	369	0.89	Mitogen-activated protein kinase 8 (DB01017)
drugbank_target|P45983	-	427	sp|Q8ICR0|CDPK2_PL	-	509	2.4e-83	278.7	0.7	1	1	5.4e-84	6.9e-83	277.2	0.7	51	339	5	334	1	369	0.89	Mitogen-activated protein kinase 8 (DB15624)
drugbank_target|P53778	-	367	sp|Q8ICR0|CDPK2_PL	-	509	2.6e-83	278.6	0.0	1	1	3.9e-84	4.9e-83	277.7	0.0	58	340	13	325	7	351	0.91	Mitogen-activated protein kinase 12 (DB01017)
drugbank_target|P53778	-	367	sp|Q8ICR0|CDPK2_PL	-	509	2.6e-83	278.6	0.0	1	1	3.9e-84	4.9e-83	277.7	0.0	58	340	13	325	7	351	0.91	Mitogen-activated protein kinase 12 (DB02482; DB04395; DB05157; DB05403)
drugbank_target|Q15208	-	465	sp|Q8ICR0|CDPK2_PL	-	509	2.9e-83	278.5	0.8	1	1	3.5e-84	4.5e-83	277.8	0.8	22	337	39	393	13	427	0.86	Serine/threonine-protein kinase 38 (DB12010)
drugbank_target|Q96RR4	-	588	sp|Q8ICR0|CDPK2_PL	-	509	5.3e-83	277.6	0.0	1	1	6e-84	7.6e-83	277.1	0.0	57	364	150	484	129	511	0.89	Calcium/calmodulin-dependent protein kinase kinase 2 (DB12010)
drugbank_target|P54762	-	984	sp|Q8ICR0|CDPK2_PL	-	509	6.3e-83	277.3	0.0	1	1	7e-84	8.9e-83	276.8	0.0	54	322	601	876	563	932	0.88	Ephrin type-B receptor 1 (DB12010)
drugbank_target|Q8NEV4	-	1616	sp|Q8ICR0|CDPK2_PL	-	509	6.4e-83	277.3	0.6	1	2	4.9e-83	6.3e-82	274.1	0.0	64	357	13	318	6	340	0.86	Myosin-IIIa (DB12010)
drugbank_target|Q8NEV4	-	1616	sp|Q8ICR0|CDPK2_PL	-	509	6.4e-83	277.3	0.6	2	2	8.7	1.1e+02	-0.6	1.0	335	403	1395	1463	1366	1475	0.82	Myosin-IIIa (DB12010)
drugbank_target|O15264	-	365	sp|Q8ICR0|CDPK2_PL	-	509	6.4e-83	277.3	0.1	1	1	7.3e-84	9.2e-83	276.8	0.1	58	354	11	336	4	351	0.91	Mitogen-activated protein kinase 13 (DB01017)
drugbank_target|O15264	-	365	sp|Q8ICR0|CDPK2_PL	-	509	6.4e-83	277.3	0.1	1	1	7.3e-84	9.2e-83	276.8	0.1	58	354	11	336	4	351	0.91	Mitogen-activated protein kinase 13 (DB05157; DB12010)
drugbank_target|P06493	-	297	sp|Q8ICR0|CDPK2_PL	-	509	6.5e-83	277.3	0.0	1	1	6.1e-84	7.8e-83	277.0	0.0	70	335	2	296	1	297	0.94	Cyclin-dependent kinase 1 (DB02052; DB02116; DB02950; DB03428; DB03496; DB04014; DB06195; DB08142; DB12010)
drugbank_target|Q7L7X3	-	1001	sp|Q8ICR0|CDPK2_PL	-	509	6.7e-83	277.3	0.0	1	1	5.3e-84	6.7e-83	277.3	0.0	65	361	21	316	4	322	0.93	Serine/threonine-protein kinase TAO1 (DB12010)
drugbank_target|Q9P286	-	719	sp|Q8ICR0|CDPK2_PL	-	509	6.9e-83	277.2	0.0	1	1	8.1e-84	1e-82	276.6	0.0	50	328	427	702	407	711	0.92	Serine/threonine-protein kinase PAK 5 (DB12010)
drugbank_target|P27361	-	379	sp|Q8ICR0|CDPK2_PL	-	509	8.7e-83	276.9	0.0	1	1	8.8e-84	1.1e-82	276.5	0.0	60	337	30	341	26	368	0.91	Mitogen-activated protein kinase 3 (DB00605; DB01169; DB02733; DB04604; DB06195; DB08862; DB13930)
drugbank_target|P27361	-	379	sp|Q8ICR0|CDPK2_PL	-	509	8.7e-83	276.9	0.0	1	1	8.8e-84	1.1e-82	276.5	0.0	60	337	30	341	26	368	0.91	Mitogen-activated protein kinase 3 (DB01017)
drugbank_target|P27361	-	379	sp|Q8ICR0|CDPK2_PL	-	509	8.7e-83	276.9	0.0	1	1	8.8e-84	1.1e-82	276.5	0.0	60	337	30	341	26	368	0.91	Mitogen-activated protein kinase 3 (DB00945)
drugbank_target|P05129	-	697	sp|Q8ICR0|CDPK2_PL	-	509	1.2e-82	276.4	0.0	1	1	1.3e-83	1.7e-82	276.0	0.0	70	317	349	600	335	626	0.92	Protein kinase C gamma type (DB00675)
drugbank_target|P05129	-	697	sp|Q8ICR0|CDPK2_PL	-	509	1.2e-82	276.4	0.0	1	1	1.3e-83	1.7e-82	276.0	0.0	70	317	349	600	335	626	0.92	Protein kinase C gamma type (DB12010)
drugbank_target|O15530	-	556	sp|Q8ICR0|CDPK2_PL	-	509	1.2e-82	276.4	0.0	1	1	1.3e-83	1.6e-82	276.0	0.0	65	349	75	365	57	390	0.90	3-phosphoinositide-dependent protein kinase 1 (DB00482; DB01863; DB01933; DB01946; DB02010; DB03777; DB04522; DB06932; DB07033; DB07132; DB07300; DB07456; DB07457; DB12010)
drugbank_target|Q9NQU5	-	681	sp|Q8ICR0|CDPK2_PL	-	509	1.8e-82	275.8	0.0	1	1	2e-83	2.5e-82	275.4	0.0	74	329	409	661	384	678	0.94	Serine/threonine-protein kinase PAK 6 (DB12010)
drugbank_target|P29320	-	983	sp|Q8ICR0|CDPK2_PL	-	509	2.3e-82	275.5	0.0	1	1	2.8e-83	3.6e-82	274.9	0.0	61	321	610	875	594	879	0.89	Ephrin type-A receptor 3 (DB12010)
drugbank_target|Q12851	-	820	sp|Q8ICR0|CDPK2_PL	-	509	2.3e-82	275.5	0.0	1	1	2.6e-83	3.4e-82	274.9	0.0	66	332	10	279	4	291	0.95	Mitogen-activated protein kinase kinase kinase kinase 2 (DB12010)
drugbank_target|Q15375	-	998	sp|Q8ICR0|CDPK2_PL	-	509	4e-82	274.7	0.0	1	1	4.6e-83	5.9e-82	274.2	0.0	58	322	619	888	599	955	0.85	Ephrin type-A receptor 7 (DB07970; DB12010)
drugbank_target|P54756	-	1037	sp|Q8ICR0|CDPK2_PL	-	509	4.6e-82	274.5	0.0	1	1	5.2e-83	6.6e-82	274.0	0.0	55	333	658	943	623	1013	0.82	Ephrin type-A receptor 5 (DB01254; DB12010)
drugbank_target|P00521	-	746	sp|Q8ICR0|CDPK2_PL	-	509	5.2e-82	274.3	0.1	1	1	5.8e-83	7.4e-82	273.8	0.1	66	323	121	378	106	399	0.91	Tyrosine-protein kinase transforming protein Abl (DB02567; DB03814; DB03878; DB05489)
drugbank_target|P45984	-	424	sp|Q8ICR0|CDPK2_PL	-	509	5.6e-82	274.2	0.8	1	1	1.6e-82	2.1e-81	272.3	0.8	57	338	11	333	1	366	0.90	Mitogen-activated protein kinase 9 (DB07020; DB12010)
drugbank_target|P45984	-	424	sp|Q8ICR0|CDPK2_PL	-	509	5.6e-82	274.2	0.8	1	1	1.6e-82	2.1e-81	272.3	0.8	57	338	11	333	1	366	0.90	Mitogen-activated protein kinase 9 (DB01017)
drugbank_target|P45984	-	424	sp|Q8ICR0|CDPK2_PL	-	509	5.6e-82	274.2	0.8	1	1	1.6e-82	2.1e-81	272.3	0.8	57	338	11	333	1	366	0.90	Mitogen-activated protein kinase 9 (DB15624)
drugbank_target|Q9Y4K4	-	846	sp|Q8ICR0|CDPK2_PL	-	509	5.9e-82	274.1	0.0	1	1	7e-83	8.9e-82	273.6	0.0	66	332	14	283	8	311	0.93	Mitogen-activated protein kinase kinase kinase kinase 5 (DB12010)
drugbank_target|P12931	-	536	sp|Q8ICR0|CDPK2_PL	-	509	6.1e-82	274.1	0.0	1	1	6e-83	7.7e-82	273.8	0.0	54	321	251	516	197	534	0.85	Proto-oncogene tyrosine-protein kinase Src (DB01254; DB01678; DB01866; DB01893; DB01908; DB01947; DB01962; DB02175; DB02336; DB02432; DB02762; DB02908; DB03023; DB03078; DB03104; DB03114; DB03217; DB03268; DB03298; DB03306; DB03525; DB03591; DB03628; DB03712; DB03828; DB03902; DB04080; DB04272; DB04495; DB04739; DB04751; DB05184; DB06137; DB06616; DB06882; DB06883; DB07335; DB07662; DB07966; DB08052; DB08053; DB08054; DB08192; DB08462; DB08564; DB08901; DB09079; DB12010)
drugbank_target|O96013	-	591	sp|Q8ICR0|CDPK2_PL	-	509	7.2e-82	273.9	0.0	1	1	7.7e-83	9.8e-82	273.4	0.0	60	333	309	579	290	589	0.92	Serine/threonine-protein kinase PAK 4 (DB12010)
drugbank_target|Q99759	-	626	sp|Q8ICR0|CDPK2_PL	-	509	7.5e-82	273.8	0.0	1	1	8e-83	1e-81	273.4	0.0	58	327	348	623	320	626	0.90	Mitogen-activated protein kinase kinase kinase 3 (DB12010)
drugbank_target|Q9Y463	-	629	sp|Q8ICR0|CDPK2_PL	-	509	8.4e-82	273.6	0.0	1	1	1.9e-82	2.5e-81	272.1	0.0	4	336	47	441	45	452	0.93	Dual specificity tyrosine-phosphorylation-regulated kinase 1B (DB12010)
drugbank_target|Q8N4C8	-	1332	sp|Q8ICR0|CDPK2_PL	-	509	8.9e-82	273.6	0.0	1	1	7e-83	8.9e-82	273.6	0.0	70	358	23	321	13	330	0.89	Misshapen-like kinase 1 (DB12010)
drugbank_target|Q96PY6	-	1258	sp|Q8ICR0|CDPK2_PL	-	509	1.1e-81	273.3	0.0	1	1	8.3e-83	1.1e-81	273.3	0.0	70	333	2	265	1	292	0.94	Serine/threonine-protein kinase Nek1 (DB12010)
drugbank_target|P29323	-	1055	sp|Q8ICR0|CDPK2_PL	-	509	1.1e-81	273.2	0.0	1	1	1.3e-82	1.7e-81	272.6	0.0	59	322	608	878	571	903	0.88	Ephrin type-B receptor 2 (DB04395; DB12010)
drugbank_target|P06241	-	537	sp|Q8ICR0|CDPK2_PL	-	509	1.1e-81	273.2	0.0	1	1	1.2e-82	1.5e-81	272.8	0.0	63	321	261	517	247	533	0.91	Tyrosine-protein kinase Fyn (DB01254; DB02078; DB12010)
drugbank_target|Q16512	-	942	sp|Q8ICR0|CDPK2_PL	-	509	1.3e-81	273.0	0.0	1	1	1.8e-82	2.3e-81	272.2	0.0	66	331	609	879	547	886	0.90	Serine/threonine-protein kinase N1 (DB12010)
drugbank_target|P00519	-	1130	sp|Q8ICR0|CDPK2_PL	-	509	1.5e-81	272.8	0.1	1	1	1.8e-82	2.3e-81	272.2	0.1	66	323	235	492	219	520	0.91	Tyrosine-protein kinase ABL1 (DB00171; DB00619; DB01254; DB03878; DB04868; DB05184; DB06616; DB07831; DB08043; DB08231; DB08339; DB08350; DB08583; DB08896; DB08901; DB12010; DB12267; DB12323)
drugbank_target|Q13464	-	1354	sp|Q8ICR0|CDPK2_PL	-	509	2e-81	272.4	0.0	1	1	1.5e-82	2e-81	272.4	0.0	60	336	63	348	45	361	0.89	Rho-associated protein kinase 1 (DB04707; DB07876; DB08162; DB08756; DB13165; DB13931)
drugbank_target|Q9H2K8	-	898	sp|Q8ICR0|CDPK2_PL	-	509	2.1e-81	272.3	0.0	1	1	1.6e-82	2.1e-81	272.3	0.0	66	361	18	312	8	325	0.93	Serine/threonine-protein kinase TAO3 (DB12010)
drugbank_target|Q13164	-	816	sp|Q8ICR0|CDPK2_PL	-	509	2.1e-81	272.3	1.3	1	1	4.3e-82	5.4e-81	271.0	0.0	65	337	48	358	22	391	0.90	Mitogen-activated protein kinase 7 (DB01017)
drugbank_target|Q13164	-	816	sp|Q8ICR0|CDPK2_PL	-	509	2.1e-81	272.3	1.3	1	1	4.3e-82	5.4e-81	271.0	0.0	65	337	48	358	22	391	0.90	Mitogen-activated protein kinase 7 (DB12010)
drugbank_target|Q13164	-	816	sp|Q8ICR0|CDPK2_PL	-	509	2.1e-81	272.3	1.3	1	1	4.3e-82	5.4e-81	271.0	0.0	65	337	48	358	22	391	0.90	Mitogen-activated protein kinase 7 (DB00945)
drugbank_target|Q13882	-	451	sp|Q8ICR0|CDPK2_PL	-	509	2.4e-81	272.1	0.0	1	1	2.5e-82	3.2e-81	271.7	0.0	66	322	185	439	171	449	0.95	Protein-tyrosine kinase 6 (DB05294; DB12010; DB15035)
drugbank_target|P00524	-	526	sp|Q8ICR0|CDPK2_PL	-	509	2.6e-81	272.0	0.0	1	1	2.6e-82	3.3e-81	271.7	0.0	53	321	247	513	194	517	0.88	Tyrosine-protein kinase transforming protein Src (DB08434)
drugbank_target|P63185	-	526	sp|Q8ICR0|CDPK2_PL	-	509	2.8e-81	271.9	0.0	1	1	2.7e-82	3.5e-81	271.6	0.0	53	321	247	513	194	517	0.88	Tyrosine-protein kinase transforming protein Src (DB01773)
drugbank_target|O75116	-	1388	sp|Q8ICR0|CDPK2_PL	-	509	2.8e-81	271.9	0.0	1	1	2.2e-82	2.8e-81	271.9	0.0	65	339	85	367	61	382	0.89	Rho-associated protein kinase 2 (DB08162; DB08756; DB12010; DB13165; DB13931)
drugbank_target|Q86UE8	-	772	sp|Q8ICR0|CDPK2_PL	-	509	3e-81	271.8	0.2	1	1	2.4e-82	3e-81	271.8	0.2	14	338	404	753	390	771	0.88	Serine/threonine-protein kinase tousled-like 2 (DB12010)
drugbank_target|Q07785	-	288	sp|Q8ICR0|CDPK2_PL	-	509	4.6e-81	271.2	0.0	1	1	4.6e-82	5.8e-81	270.9	0.0	70	329	2	287	1	288	0.95	Cell division control protein 2 homolog (DB02519; DB02733)
drugbank_target|Q9UEW8	-	545	sp|Q8ICR0|CDPK2_PL	-	509	5.1e-81	271.1	0.0	1	1	6e-82	7.7e-81	270.5	0.0	69	348	60	359	51	372	0.89	STE20/SPS1-related proline-alanine-rich protein kinase (DB12010)
drugbank_target|Q16539	-	360	sp|Q8ICR0|CDPK2_PL	-	509	8.7e-81	270.3	0.0	1	1	2.6e-81	3.3e-80	268.4	0.0	58	335	10	317	2	332	0.93	Mitogen-activated protein kinase 14 (DB01254; DB01761; DB01807; DB01948; DB01953; DB01988; DB02195; DB02277; DB02352; DB02873; DB02984; DB03044; DB03110; DB03980; DB04338; DB04632; DB04797; DB05157; DB05412; DB05470; DB06518; DB06882; DB06940; DB06991; DB07138; DB07307; DB07459; DB07607; DB07811; DB07829; DB07832; DB07833; DB07834; DB07835; DB07941; DB07942; DB07943; DB08064; DB08068; DB08091; DB08092; DB08093; DB08095; DB08096; DB08097; DB08242; DB08349; DB08351; DB08352; DB08395; DB08423; DB08424; DB08521; DB08522; DB08730; DB12010)
drugbank_target|Q16539	-	360	sp|Q8ICR0|CDPK2_PL	-	509	8.7e-81	270.3	0.0	1	1	2.6e-81	3.3e-80	268.4	0.0	58	335	10	317	2	332	0.93	Mitogen-activated protein kinase 14 (DB01017)
drugbank_target|Q9UL54	-	1235	sp|Q8ICR0|CDPK2_PL	-	509	9e-81	270.2	0.0	1	1	7.1e-82	9e-81	270.2	0.0	66	360	22	315	10	320	0.93	Serine/threonine-protein kinase TAO2 (DB04522; DB12010)
drugbank_target|Q56UN5	-	1328	sp|Q8ICR0|CDPK2_PL	-	509	1.3e-80	269.7	0.0	1	1	1.1e-81	1.3e-80	269.7	0.0	48	329	1035	1327	985	1328	0.87	Mitogen-activated protein kinase kinase kinase 19 (DB12010)
drugbank_target|P42684	-	1182	sp|Q8ICR0|CDPK2_PL	-	509	1.4e-80	269.6	0.0	1	1	1.7e-81	2.2e-80	269.0	0.0	65	322	280	537	267	562	0.91	Abelson tyrosine-protein kinase 2 (DB00171; DB01254; DB05184; DB07664; DB12010)
drugbank_target|P42685	-	505	sp|Q8ICR0|CDPK2_PL	-	509	1.6e-80	269.4	0.0	1	1	1.7e-81	2.2e-80	269.0	0.0	64	320	225	483	217	499	0.91	Tyrosine-protein kinase FRK (DB01254; DB08896; DB12010; DB15035)
drugbank_target|O95835	-	1130	sp|Q8ICR0|CDPK2_PL	-	509	2e-80	269.1	0.0	1	1	1.5e-81	2e-80	269.1	0.0	19	348	650	1032	632	1049	0.88	Serine/threonine-protein kinase LATS1 (DB12010)
drugbank_target|P16591	-	822	sp|Q8ICR0|CDPK2_PL	-	509	2.5e-80	268.8	0.1	1	1	2e-81	2.5e-80	268.8	0.1	69	323	560	813	531	820	0.92	Tyrosine-protein kinase Fer (DB12010)
drugbank_target|P07947	-	543	sp|Q8ICR0|CDPK2_PL	-	509	3e-80	268.5	0.0	1	1	3e-81	3.9e-80	268.1	0.0	59	321	263	523	206	539	0.87	Tyrosine-protein kinase Yes (DB01254; DB12010)
drugbank_target|Q00535	-	292	sp|Q8ICR0|CDPK2_PL	-	509	3.7e-80	268.2	0.0	1	1	3.6e-81	4.6e-80	267.9	0.0	70	328	2	288	1	291	0.96	Cyclin-dependent-like kinase 5 (DB02052; DB02116; DB02950; DB03428; DB03496; DB04014; DB07364)
drugbank_target|Q9Y6R4	-	1608	sp|Q8ICR0|CDPK2_PL	-	509	4.5e-80	267.9	0.2	1	1	3.6e-81	4.5e-80	267.9	0.2	34	332	1305	1607	1280	1608	0.91	Mitogen-activated protein kinase kinase kinase 4 (DB12010)
drugbank_target|P07948	-	512	sp|Q8ICR0|CDPK2_PL	-	509	5.1e-80	267.7	0.0	1	1	6e-81	7.7e-80	267.2	0.0	60	320	234	493	207	507	0.91	Tyrosine-protein kinase Lyn (DB01254; DB03023; DB06616; DB08901; DB09079; DB12010)
drugbank_target|Q8N5S9	-	505	sp|Q8ICR0|CDPK2_PL	-	509	6.3e-80	267.4	0.0	1	1	7.1e-81	9.1e-80	266.9	0.0	62	356	118	439	94	476	0.89	Calcium/calmodulin-dependent protein kinase kinase 1 (DB12010)
drugbank_target|Q05397	-	1052	sp|Q8ICR0|CDPK2_PL	-	509	7.9e-80	267.1	0.0	1	1	1e-80	1.3e-79	266.4	0.0	40	334	389	688	359	706	0.82	Focal adhesion kinase 1 (DB06423; DB07248; DB07460; DB12010)
drugbank_target|Q9HAZ1	-	481	sp|Q8ICR0|CDPK2_PL	-	509	9.3e-80	266.9	3.9	1	1	7.3e-81	9.3e-80	266.9	3.9	16	329	102	478	88	481	0.92	Dual specificity protein kinase CLK4 (DB12010)
drugbank_target|Q15759	-	364	sp|Q8ICR0|CDPK2_PL	-	509	1.1e-79	266.6	0.0	1	1	1.3e-80	1.6e-79	266.1	0.0	59	354	11	339	5	349	0.91	Mitogen-activated protein kinase 11 (DB01017)
drugbank_target|Q15759	-	364	sp|Q8ICR0|CDPK2_PL	-	509	1.1e-79	266.6	0.0	1	1	1.3e-80	1.6e-79	266.1	0.0	59	354	11	339	5	349	0.91	Mitogen-activated protein kinase 11 (DB05157; DB08896)
drugbank_target|P49759	-	484	sp|Q8ICR0|CDPK2_PL	-	509	1.3e-79	266.4	1.5	1	1	1e-80	1.3e-79	266.4	1.5	16	330	103	481	87	484	0.90	Dual specificity protein kinase CLK1 (DB04367; DB06376; DB08691; DB12010)
drugbank_target|P06239	-	509	sp|Q8ICR0|CDPK2_PL	-	509	1.4e-79	266.3	0.0	1	1	1.5e-80	1.9e-79	265.8	0.0	53	320	226	490	208	506	0.90	Tyrosine-protein kinase Lck (DB01254; DB01830; DB02010; DB03023; DB04003; DB04395; DB06925; DB07146; DB07297; DB08055; DB08056; DB08057; DB08901; DB09079; DB12010; DB15035)
drugbank_target|Q9Y2U5	-	619	sp|Q8ICR0|CDPK2_PL	-	509	1.5e-79	266.3	0.0	1	1	1.6e-80	2e-79	265.8	0.0	67	327	351	617	340	619	0.94	Mitogen-activated protein kinase kinase kinase 2 (DB06616; DB12010)
drugbank_target|Q8NG66	-	645	sp|Q8ICR0|CDPK2_PL	-	509	1.5e-79	266.2	0.5	1	1	1.2e-80	1.5e-79	266.2	0.5	65	368	22	326	4	346	0.83	Serine/threonine-protein kinase Nek11 (DB08912; DB12010)
drugbank_target|Q05513	-	592	sp|Q8ICR0|CDPK2_PL	-	509	2.1e-79	265.7	0.0	1	1	2.7e-80	3.5e-79	265.0	0.0	62	333	242	525	199	549	0.89	Protein kinase C zeta type (DB00675)
drugbank_target|Q00537	-	523	sp|Q8ICR0|CDPK2_PL	-	509	2.9e-79	265.3	0.0	1	1	5e-80	6.3e-79	264.1	0.0	53	339	174	486	158	502	0.90	Cyclin-dependent kinase 17 (DB12010)
drugbank_target|Q00534	-	326	sp|Q8ICR0|CDPK2_PL	-	509	3.2e-79	265.1	0.0	1	1	2.9e-80	3.7e-79	264.9	0.0	68	347	9	321	2	326	0.92	Cyclin-dependent kinase 6 (DB03496; DB07379; DB07795; DB09073; DB11730; DB12001)
drugbank_target|P08631	-	526	sp|Q8ICR0|CDPK2_PL	-	509	3.3e-79	265.1	0.0	1	1	3.4e-80	4.4e-79	264.7	0.0	58	321	247	508	217	524	0.92	Tyrosine-protein kinase HCK (DB01809; DB01962; DB04216; DB06616; DB12010)
drugbank_target|P51955	-	445	sp|Q8ICR0|CDPK2_PL	-	509	3.5e-79	265.0	0.0	1	2	2.7e-80	3.5e-79	265.0	0.0	69	340	5	285	2	319	0.88	Serine/threonine-protein kinase Nek2 (DB07180; DB12010)
drugbank_target|P51955	-	445	sp|Q8ICR0|CDPK2_PL	-	509	3.5e-79	265.0	0.0	2	2	9.6	1.2e+02	-0.7	0.6	25	75	388	437	372	443	0.54	Serine/threonine-protein kinase Nek2 (DB07180; DB12010)
drugbank_target|P42680	-	631	sp|Q8ICR0|CDPK2_PL	-	509	4.1e-79	264.8	0.0	1	1	4.7e-80	6e-79	264.2	0.0	65	322	362	617	339	619	0.93	Tyrosine-protein kinase Tec (DB12010; DB15035)
drugbank_target|Q92918	-	833	sp|Q8ICR0|CDPK2_PL	-	509	4.4e-79	264.7	0.0	1	1	4.9e-80	6.2e-79	264.2	0.0	66	328	11	276	6	286	0.95	Mitogen-activated protein kinase kinase kinase kinase 1 (DB12010)
drugbank_target|Q8WU08	-	396	sp|Q8ICR0|CDPK2_PL	-	509	5.1e-79	264.5	0.3	1	2	4e-80	5.1e-79	264.5	0.3	60	332	11	287	2	295	0.91	Serine/threonine-protein kinase 32A (DB12010)
drugbank_target|Q8WU08	-	396	sp|Q8ICR0|CDPK2_PL	-	509	5.1e-79	264.5	0.3	2	2	9.1	1.2e+02	-0.6	1.0	25	74	325	373	310	376	0.61	Serine/threonine-protein kinase 32A (DB12010)
drugbank_target|Q9UKI8	-	766	sp|Q8ICR0|CDPK2_PL	-	509	6.3e-79	264.2	0.3	1	1	4.9e-80	6.3e-79	264.2	0.3	15	335	399	743	390	753	0.89	Serine/threonine-protein kinase tousled-like 1 (DB12010)
drugbank_target|P54760	-	987	sp|Q8ICR0|CDPK2_PL	-	509	9.5e-79	263.6	0.0	1	1	1e-79	1.3e-78	263.1	0.0	38	321	581	871	562	882	0.87	Ephrin type-B receptor 4 (DB01254; DB07249; DB07250; DB07251; DB07252; DB07253; DB07254; DB07255; DB07256; DB11973; DB12010)
drugbank_target|P29317	-	976	sp|Q8ICR0|CDPK2_PL	-	509	1.2e-78	263.3	0.0	1	1	1.2e-79	1.6e-78	262.9	0.0	48	321	589	868	557	927	0.85	Ephrin type-A receptor 2 (DB01254; DB04395; DB08896; DB12010)
drugbank_target|O43283	-	966	sp|Q8ICR0|CDPK2_PL	-	509	1.4e-78	263.0	0.1	1	1	1.8e-79	2.3e-78	262.3	0.1	57	371	152	454	143	483	0.87	Mitogen-activated protein kinase kinase kinase 13 (DB12010)
drugbank_target|P07332	-	822	sp|Q8ICR0|CDPK2_PL	-	509	2.1e-78	262.5	0.2	1	1	8.7e-79	1.1e-77	260.0	0.0	66	322	554	812	534	820	0.92	Tyrosine-protein kinase Fes/Fps (DB12010)
drugbank_target|Q00536	-	496	sp|Q8ICR0|CDPK2_PL	-	509	2.1e-78	262.4	0.0	1	1	2.5e-79	3.1e-78	261.9	0.0	66	350	160	469	133	481	0.90	Cyclin-dependent kinase 16 (DB07766; DB12010)
drugbank_target|Q9Y2H9	-	1570	sp|Q8ICR0|CDPK2_PL	-	509	2.2e-78	262.3	0.0	1	1	2.9e-79	3.7e-78	261.6	0.0	52	335	354	656	338	718	0.85	Microtubule-associated serine/threonine-protein kinase 1 (DB12010)
drugbank_target|Q9BXA7	-	367	sp|Q8ICR0|CDPK2_PL	-	509	4.4e-78	261.4	0.1	1	1	4.7e-79	6e-78	260.9	0.1	71	336	11	282	3	295	0.91	Testis-specific serine/threonine-protein kinase 1 (DB12010)
drugbank_target|Q8IW41	-	473	sp|Q8ICR0|CDPK2_PL	-	509	4.9e-78	261.2	0.2	1	1	6.7e-79	8.5e-78	260.4	0.2	64	345	12	323	1	350	0.84	MAP kinase-activated protein kinase 5 (DB12010)
drugbank_target|O14578	-	2027	sp|Q8ICR0|CDPK2_PL	-	509	6.6e-78	260.8	0.0	1	1	5.2e-79	6.6e-78	260.8	0.0	60	334	84	368	61	398	0.90	Citron Rho-interacting kinase (DB12010)
drugbank_target|P42681	-	527	sp|Q8ICR0|CDPK2_PL	-	509	7.4e-78	260.6	0.0	1	1	8.7e-79	1.1e-77	260.0	0.0	69	322	268	518	256	521	0.94	Tyrosine-protein kinase TXK (DB12010; DB15035)
drugbank_target|P51813	-	675	sp|Q8ICR0|CDPK2_PL	-	509	1.2e-77	259.9	0.1	1	1	9.7e-79	1.2e-77	259.9	0.1	66	322	410	664	368	672	0.91	Cytoplasmic tyrosine-protein kinase BMX (DB12010; DB15035)
drugbank_target|P11362	-	822	sp|Q8ICR0|CDPK2_PL	-	509	1.4e-77	259.7	0.0	1	1	1.9e-78	2.4e-77	259.0	0.0	68	322	473	752	458	767	0.91	Fibroblast growth factor receptor 1 (DB00039; DB00398; DB01109; DB02058; DB05014; DB07525; DB07840; DB08577; DB08896; DB08901; DB09078; DB09079; DB12010; DB12147; DB15102; DB15685)
drugbank_target|Q6ZN16	-	1313	sp|Q8ICR0|CDPK2_PL	-	509	1.5e-77	259.6	0.0	1	1	1.9e-78	2.5e-77	258.9	0.0	77	335	657	917	637	924	0.92	Mitogen-activated protein kinase kinase kinase 15 (DB12010)
drugbank_target|Q16620	-	822	sp|Q8ICR0|CDPK2_PL	-	509	1.7e-77	259.4	0.1	1	1	1.9e-78	2.4e-77	258.9	0.1	69	319	535	802	518	811	0.92	BDNF/NT-3 growth factors receptor (DB00321; DB11823; DB11986; DB12010; DB14723)
drugbank_target|Q9UF33	-	1036	sp|Q8ICR0|CDPK2_PL	-	509	4.9e-77	257.9	0.0	1	1	2.5e-77	3.2e-76	255.2	0.0	64	321	623	927	576	946	0.88	Ephrin type-A receptor 6 (DB12010)
drugbank_target|P50613	-	346	sp|Q8ICR0|CDPK2_PL	-	509	5.1e-77	257.9	0.0	1	1	5e-78	6.3e-77	257.5	0.0	68	338	8	307	2	337	0.90	Cyclin-dependent kinase 7 (DB02482; DB03496; DB05969; DB06195)
drugbank_target|P21709	-	976	sp|Q8ICR0|CDPK2_PL	-	509	5.4e-77	257.8	0.0	1	1	5.7e-78	7.3e-77	257.3	0.0	72	323	624	879	567	892	0.86	Ephrin type-A receptor 1 (DB12010)
drugbank_target|P35626	-	688	sp|Q8ICR0|CDPK2_PL	-	509	9.9e-77	256.9	0.1	1	1	7.8e-78	9.9e-77	256.9	0.1	30	337	149	464	120	468	0.89	Beta-adrenergic receptor kinase 2 (DB00171)
drugbank_target|P21802	-	821	sp|Q8ICR0|CDPK2_PL	-	509	1e-76	256.9	0.0	1	1	1.1e-77	1.4e-76	256.4	0.0	62	322	470	755	415	777	0.89	Fibroblast growth factor receptor 2 (DB00039; DB01041; DB01109; DB01901; DB02058; DB02491; DB08896; DB08901; DB09078; DB09079; DB10770; DB10772; DB12010; DB12147; DB15102; DB15685)
drugbank_target|Q8TD19	-	979	sp|Q8ICR0|CDPK2_PL	-	509	1.1e-76	256.7	0.0	1	1	1.3e-77	1.7e-76	256.1	0.0	69	343	49	322	39	349	0.90	Serine/threonine-protein kinase Nek9 (DB12010)
drugbank_target|P29322	-	1005	sp|Q8ICR0|CDPK2_PL	-	509	1.3e-76	256.5	0.0	1	1	1.5e-77	1.9e-76	256.0	0.0	69	321	632	889	608	894	0.92	Ephrin type-A receptor 8 (DB12010)
drugbank_target|Q9H422	-	1215	sp|Q8ICR0|CDPK2_PL	-	509	2.6e-76	255.5	0.0	1	1	3.7e-77	4.7e-76	254.7	0.0	57	392	182	595	156	597	0.92	Homeodomain-interacting protein kinase 3 (DB12010)
drugbank_target|Q13163	-	448	sp|Q8ICR0|CDPK2_PL	-	509	3.3e-76	255.2	0.0	1	1	3.6e-77	4.5e-76	254.7	0.0	25	336	120	429	107	445	0.91	Dual specificity mitogen-activated protein kinase kinase 5 (DB12010)
drugbank_target|Q16659	-	721	sp|Q8ICR0|CDPK2_PL	-	509	6e-76	254.3	0.5	1	2	8e-76	1e-74	250.3	0.0	58	330	6	320	1	346	0.93	Mitogen-activated protein kinase 6 (DB01017)
drugbank_target|Q16659	-	721	sp|Q8ICR0|CDPK2_PL	-	509	6e-76	254.3	0.5	2	2	1.4	18	2.0	0.3	415	483	514	577	474	585	0.70	Mitogen-activated protein kinase 6 (DB01017)
drugbank_target|Q16659	-	721	sp|Q8ICR0|CDPK2_PL	-	509	6e-76	254.3	0.5	1	2	8e-76	1e-74	250.3	0.0	58	330	6	320	1	346	0.93	Mitogen-activated protein kinase 6 (DB00945)
drugbank_target|Q16659	-	721	sp|Q8ICR0|CDPK2_PL	-	509	6e-76	254.3	0.5	2	2	1.4	18	2.0	0.3	415	483	514	577	474	585	0.70	Mitogen-activated protein kinase 6 (DB00945)
drugbank_target|Q06187	-	659	sp|Q8ICR0|CDPK2_PL	-	509	7.5e-76	254.0	0.2	1	1	9e-77	1.2e-75	253.4	0.2	65	322	394	649	360	655	0.90	Tyrosine-protein kinase BTK (DB01254; DB01863; DB05204; DB09053; DB11703; DB12010; DB15035)
drugbank_target|Q08881	-	620	sp|Q8ICR0|CDPK2_PL	-	509	1.2e-75	253.3	0.0	1	1	1.5e-76	1.9e-75	252.7	0.0	70	322	361	610	351	613	0.94	Tyrosine-protein kinase ITK/TSK (DB02010; DB06589; DB12010; DB15035)
drugbank_target|Q6DT37	-	1551	sp|Q8ICR0|CDPK2_PL	-	509	1.4e-75	253.1	0.0	1	1	1.1e-76	1.4e-75	253.1	0.0	63	334	61	345	42	356	0.90	Serine/threonine-protein kinase MRCK gamma (DB12010)
drugbank_target|P51451	-	505	sp|Q8ICR0|CDPK2_PL	-	509	1.4e-75	253.1	0.0	1	1	1.6e-76	2e-75	252.6	0.0	64	318	232	484	223	502	0.92	Tyrosine-protein kinase Blk (DB12010; DB15035)
drugbank_target|Q12852	-	859	sp|Q8ICR0|CDPK2_PL	-	509	2.7e-75	252.2	0.0	1	1	3e-76	3.8e-75	251.7	0.0	57	351	109	391	99	451	0.86	Mitogen-activated protein kinase kinase kinase 12 (DB12010)
drugbank_target|Q9H2X6	-	1198	sp|Q8ICR0|CDPK2_PL	-	509	2.9e-75	252.0	0.1	1	1	6.4e-76	8.2e-75	250.6	0.1	39	380	165	585	130	594	0.88	Homeodomain-interacting protein kinase 2 (DB12010)
drugbank_target|O14757	-	476	sp|Q8ICR0|CDPK2_PL	-	509	4.5e-75	251.4	0.0	1	1	9e-76	1.1e-74	250.1	0.0	70	332	7	271	3	297	0.92	Serine/threonine-protein kinase Chk1 (DB05149; DB06486; DB06852; DB06876; DB07025; DB07034; DB07037; DB07038; DB07075; DB07078; DB07158; DB07213; DB07228; DB07243; DB07311; DB07314; DB07320; DB07336; DB07647; DB07648; DB07653; DB07654; DB07655; DB07959; DB08392; DB08393; DB08683; DB08774; DB08776; DB08777; DB08778; DB08779; DB08780; DB08781; DB12010)
drugbank_target|P49760	-	499	sp|Q8ICR0|CDPK2_PL	-	509	4.6e-75	251.4	0.7	1	1	3.6e-76	4.6e-75	251.4	0.7	13	333	102	486	93	497	0.90	Dual specificity protein kinase CLK2 (DB12010)
drugbank_target|P09769	-	529	sp|Q8ICR0|CDPK2_PL	-	509	4.8e-75	251.3	0.0	1	1	5.1e-76	6.6e-75	250.9	0.0	67	321	257	509	243	525	0.91	Tyrosine-protein kinase Fgr (DB01254; DB12010; DB15035)
drugbank_target|P22607	-	806	sp|Q8ICR0|CDPK2_PL	-	509	7.8e-75	250.6	0.0	1	1	8.9e-76	1.1e-74	250.1	0.0	69	322	469	746	448	756	0.91	Fibroblast growth factor receptor 3 (DB00039; DB05014; DB06589; DB08901; DB09078; DB09079; DB12010; DB12147; DB15102; DB15685)
drugbank_target|P25098	-	689	sp|Q8ICR0|CDPK2_PL	-	509	9.5e-75	250.4	0.0	1	1	1.5e-75	1.9e-74	249.3	0.0	40	333	159	460	147	467	0.91	Beta-adrenergic receptor kinase 1 (DB00171)
drugbank_target|P80192	-	1104	sp|Q8ICR0|CDPK2_PL	-	509	1e-74	250.3	0.0	1	1	1.2e-75	1.5e-74	249.7	0.0	71	402	143	491	138	507	0.82	Mitogen-activated protein kinase kinase kinase 9 (DB08703; DB12010)
drugbank_target|Q16288	-	839	sp|Q8ICR0|CDPK2_PL	-	509	1.1e-74	250.1	0.0	1	1	1.4e-75	1.7e-74	249.5	0.0	69	322	535	822	514	825	0.90	NT-3 growth factor receptor (DB11986; DB12010; DB14723)
drugbank_target|Q02763	-	1124	sp|Q8ICR0|CDPK2_PL	-	509	3.4e-74	248.5	0.0	1	1	3.9e-75	5e-74	248.0	0.0	70	321	822	1089	772	1107	0.91	Angiopoietin-1 receptor (DB00415; DB05294; DB08221; DB08896; DB08901; DB12010; DB14840)
drugbank_target|P50750	-	372	sp|Q8ICR0|CDPK2_PL	-	509	3.5e-74	248.5	0.0	1	1	6.6e-75	8.4e-74	247.2	0.0	69	346	16	335	2	372	0.86	Cyclin-dependent kinase 9 (DB03496; DB06195)
drugbank_target|Q16584	-	847	sp|Q8ICR0|CDPK2_PL	-	509	5.2e-74	247.9	0.0	1	1	5.3e-75	6.8e-74	247.5	0.0	70	323	115	375	109	441	0.87	Mitogen-activated protein kinase kinase kinase 11 (DB12010)
drugbank_target|P07949	-	1114	sp|Q8ICR0|CDPK2_PL	-	509	6.9e-74	247.5	0.0	1	1	7.9e-75	1e-73	247.0	0.0	47	322	698	1003	677	1017	0.90	Proto-oncogene tyrosine-protein kinase receptor Ret (DB00398; DB01809; DB05294; DB08875; DB08896; DB08901; DB09078; DB12010; DB12742; DB15685)
drugbank_target|P04629	-	796	sp|Q8ICR0|CDPK2_PL	-	509	1.2e-73	246.7	0.0	1	1	1.4e-74	1.8e-73	246.2	0.0	69	320	507	777	489	783	0.93	High affinity nerve growth factor receptor (DB00321; DB00619; DB08896; DB11986; DB12010; DB13926; DB14723)
drugbank_target|Q14289	-	1009	sp|Q8ICR0|CDPK2_PL	-	509	1.3e-73	246.7	1.6	1	1	1.9e-74	2.4e-73	245.7	0.0	69	322	422	677	402	704	0.91	Protein-tyrosine kinase 2-beta (DB01097; DB01645; DB08341; DB11817; DB12010)
drugbank_target|P22455	-	802	sp|Q8ICR0|CDPK2_PL	-	509	1.3e-73	246.6	0.0	1	1	1.5e-74	1.9e-73	246.1	0.0	69	322	464	741	459	744	0.93	Fibroblast growth factor receptor 4 (DB00039; DB01109; DB08901; DB09078; DB12147; DB15102)
drugbank_target|Q02750	-	393	sp|Q8ICR0|CDPK2_PL	-	509	1.4e-73	246.5	0.0	1	1	2.1e-74	2.7e-73	245.6	0.0	29	334	24	369	14	374	0.89	Dual specificity mitogen-activated protein kinase kinase 1 (DB02152; DB03115; DB05239; DB06616; DB06892; DB07046; DB07101; DB08130; DB08208; DB08911; DB11689)
drugbank_target|P43405	-	635	sp|Q8ICR0|CDPK2_PL	-	509	2.8e-73	245.5	0.3	1	1	3.3e-74	4.3e-73	244.9	0.3	75	319	374	621	352	625	0.92	Tyrosine-protein kinase SYK (DB02010; DB06834; DB07159; DB07194; DB08361; DB08846; DB12010)
drugbank_target|O95382	-	1288	sp|Q8ICR0|CDPK2_PL	-	509	2.9e-73	245.5	0.0	1	1	3.5e-74	4.4e-73	244.9	0.0	77	334	653	914	626	939	0.91	Mitogen-activated protein kinase kinase kinase 6 (DB12010)
drugbank_target|P06213	-	1382	sp|Q8ICR0|CDPK2_PL	-	509	4.4e-73	244.9	0.0	1	1	5.2e-74	6.6e-73	244.3	0.0	67	322	1017	1288	1008	1332	0.89	Insulin receptor (DB00030; DB00046; DB00047; DB00071; DB01277; DB01306; DB01307; DB01309; DB03909; DB05115; DB05120; DB08513; DB09129; DB09564; DB12010; DB12267; DB14751)
drugbank_target|P49761	-	638	sp|Q8ICR0|CDPK2_PL	-	509	5.1e-73	244.7	1.2	1	1	5.9e-74	7.5e-73	244.1	1.2	22	339	253	633	235	637	0.90	Dual specificity protein kinase CLK3 (DB07664; DB08691; DB12010)
drugbank_target|Q02779	-	954	sp|Q8ICR0|CDPK2_PL	-	509	5.2e-73	244.6	0.0	1	1	7e-74	9e-73	243.8	0.0	70	359	96	404	87	452	0.81	Mitogen-activated protein kinase kinase kinase 10 (DB12010)
drugbank_target|P31152	-	587	sp|Q8ICR0|CDPK2_PL	-	509	6.1e-73	244.4	0.0	1	1	6.8e-74	8.6e-73	243.9	0.0	70	339	18	325	8	351	0.90	Mitogen-activated protein kinase 4 (DB01017)
drugbank_target|P31152	-	587	sp|Q8ICR0|CDPK2_PL	-	509	6.1e-73	244.4	0.0	1	1	6.8e-74	8.6e-73	243.9	0.0	70	339	18	325	8	351	0.90	Mitogen-activated protein kinase 4 (DB12010)
drugbank_target|P31152	-	587	sp|Q8ICR0|CDPK2_PL	-	509	6.1e-73	244.4	0.0	1	1	6.8e-74	8.6e-73	243.9	0.0	70	339	18	325	8	351	0.90	Mitogen-activated protein kinase 4 (DB00945)
drugbank_target|Q9H3Y6	-	488	sp|Q8ICR0|CDPK2_PL	-	509	6.3e-73	244.4	0.0	1	1	6.6e-74	8.4e-73	243.9	0.0	66	321	224	477	210	482	0.93	Tyrosine-protein kinase Srms (DB12010)
drugbank_target|P43403	-	619	sp|Q8ICR0|CDPK2_PL	-	509	6.4e-73	244.3	0.1	1	1	6.8e-74	8.7e-73	243.9	0.1	74	320	340	589	308	603	0.89	Tyrosine-protein kinase ZAP-70 (DB02010; DB12010)
drugbank_target|P11802	-	303	sp|Q8ICR0|CDPK2_PL	-	509	6.4e-73	244.3	0.0	1	1	5.7e-74	7.3e-73	244.1	0.0	69	330	3	299	1	303	0.93	Cyclin-dependent kinase 4 (DB02733; DB03496; DB09073; DB11730; DB12001; DB12010)
drugbank_target|Q13233	-	1512	sp|Q8ICR0|CDPK2_PL	-	509	1.5e-72	243.1	0.0	1	1	2.1e-73	2.7e-72	242.3	0.0	65	327	1236	1509	1168	1511	0.85	Mitogen-activated protein kinase kinase kinase 1 (DB06061; DB11967; DB12010)
drugbank_target|Q9NYL2	-	800	sp|Q8ICR0|CDPK2_PL	-	509	2e-72	242.7	0.2	1	1	2.5e-73	3.1e-72	242.1	0.2	70	369	14	303	6	320	0.89	Mitogen-activated protein kinase kinase kinase MLT (DB01254; DB12010)
drugbank_target|P41240	-	450	sp|Q8ICR0|CDPK2_PL	-	509	2.8e-72	242.2	0.0	1	1	2.9e-73	3.7e-72	241.8	0.0	64	322	186	438	165	447	0.91	Tyrosine-protein kinase CSK (DB01254; DB02010; DB05075; DB12010)
drugbank_target|P36507	-	400	sp|Q8ICR0|CDPK2_PL	-	509	1.4e-71	239.9	0.0	1	1	4.6e-72	5.9e-71	237.9	0.0	34	333	33	376	19	381	0.86	Dual specificity mitogen-activated protein kinase kinase 2 (DB06616; DB08911; DB11689; DB11967; DB12010)
drugbank_target|Q16832	-	855	sp|Q8ICR0|CDPK2_PL	-	509	1.8e-71	239.6	0.0	1	1	2e-72	2.6e-71	239.1	0.0	69	320	560	845	549	848	0.89	Discoidin domain-containing receptor 2 (DB08896; DB12010)
drugbank_target|Q09013	-	629	sp|Q8ICR0|CDPK2_PL	-	509	3.9e-71	238.5	0.0	1	1	6.6e-72	8.4e-71	237.3	0.0	67	327	65	340	51	348	0.89	Myotonin-protein kinase (DB01946)
drugbank_target|O15146	-	869	sp|Q8ICR0|CDPK2_PL	-	509	4e-71	238.4	0.0	1	1	4.8e-72	6.1e-71	237.8	0.0	68	320	571	852	564	859	0.92	Muscle, skeletal receptor tyrosine-protein kinase (DB12010)
drugbank_target|P08922	-	2347	sp|Q8ICR0|CDPK2_PL	-	509	6.3e-71	237.8	0.0	1	1	7.5e-72	9.6e-71	237.2	0.0	68	322	1941	2213	1925	2247	0.86	Proto-oncogene tyrosine-protein kinase ROS (DB11986; DB12010)
drugbank_target|Q96Q40	-	435	sp|Q8ICR0|CDPK2_PL	-	509	7e-71	237.6	0.0	1	1	7.6e-72	9.7e-71	237.1	0.0	38	334	71	395	37	410	0.85	Cyclin-dependent kinase 15 (DB00171; DB06486; DB12010)
drugbank_target|P35590	-	1138	sp|Q8ICR0|CDPK2_PL	-	509	8e-71	237.4	0.0	1	1	9.1e-72	1.2e-70	236.9	0.0	70	320	837	1103	829	1109	0.93	Tyrosine-protein kinase receptor Tie-1 (DB12010)
drugbank_target|P15056	-	766	sp|Q8ICR0|CDPK2_PL	-	509	1.1e-70	237.0	0.0	1	1	1.2e-71	1.6e-70	236.5	0.0	38	323	423	713	404	738	0.82	Serine/threonine-protein kinase B-raf (DB00398; DB05190; DB05984; DB06999; DB07000; DB08553; DB08881; DB08896; DB08912; DB11718; DB12010; DB14840)
drugbank_target|P08069	-	1367	sp|Q8ICR0|CDPK2_PL	-	509	2.1e-70	236.0	0.0	1	1	2.6e-71	3.3e-70	235.4	0.0	66	321	992	1263	977	1269	0.90	Insulin-like growth factor 1 receptor (DB00030; DB00046; DB00047; DB00071; DB01277; DB01306; DB01307; DB01309; DB04395; DB05023; DB05184; DB05897; DB06075; DB06343; DB07156; DB07474; DB09098; DB09564; DB12250; DB12267; DB14751)
drugbank_target|P30530	-	894	sp|Q8ICR0|CDPK2_PL	-	509	2.5e-70	235.8	0.0	1	1	2.7e-71	3.4e-70	235.3	0.0	61	322	524	801	473	807	0.85	Tyrosine-protein kinase receptor UFO (DB12010; DB12141)
drugbank_target|Q15303	-	1308	sp|Q8ICR0|CDPK2_PL	-	509	2.6e-70	235.7	0.0	1	1	3.1e-71	3.9e-70	235.1	0.0	69	322	715	972	686	988	0.91	Receptor tyrosine-protein kinase erbB-4 (DB08916; DB12010; DB12267; DB15035)
drugbank_target|P42679	-	507	sp|Q8ICR0|CDPK2_PL	-	509	6.2e-70	234.5	0.0	1	1	6.8e-71	8.7e-70	234.0	0.0	49	322	211	476	189	481	0.89	Megakaryocyte-associated tyrosine-protein kinase (DB12010)
drugbank_target|P49841	-	420	sp|Q8ICR0|CDPK2_PL	-	509	8.6e-70	234.0	0.0	1	1	8.7e-71	1.1e-69	233.7	0.0	69	339	53	353	17	375	0.89	Glycogen synthase kinase-3 beta (DB01356; DB01772; DB01793; DB01950; DB02010; DB02052; DB03444; DB04014; DB04395; DB07014; DB07058; DB07149; DB07584; DB07585; DB07676; DB07812; DB07859; DB07947; DB08073; DB12010; DB12129; DB14507; DB14508; DB14509)
drugbank_target|Q08345	-	913	sp|Q8ICR0|CDPK2_PL	-	509	1e-69	233.8	0.0	1	1	1.1e-70	1.4e-69	233.3	0.0	69	321	607	902	602	911	0.90	Epithelial discoidin domain-containing receptor 1 (DB00619; DB12010)
drugbank_target|P68400	-	391	sp|Q8ICR0|CDPK2_PL	-	509	1.3e-69	233.4	0.6	1	1	1.5e-70	1.9e-69	232.9	0.6	65	339	32	337	9	344	0.92	Casein kinase II subunit alpha (DB00171; DB01765; DB02170; DB02709; DB03035; DB03127; DB03924; DB04216; DB04395; DB04462; DB04719; DB04720; DB04721; DB07715; DB07802; DB08338; DB08340; DB08345; DB08353; DB08354; DB08360; DB08362; DB08473; DB08660; DB08846; DB12010)
drugbank_target|P52564	-	334	sp|Q8ICR0|CDPK2_PL	-	509	1.5e-69	233.2	0.0	1	1	1.3e-70	1.6e-69	233.1	0.0	54	336	34	324	1	331	0.84	Dual specificity mitogen-activated protein kinase kinase 6 (DB12010)
drugbank_target|Q8IIR9	-	335	sp|Q8ICR0|CDPK2_PL	-	509	1.8e-69	233.0	2.1	1	1	1.7e-70	2.2e-69	232.7	2.1	65	332	36	334	17	335	0.93	Casein kinase 2, alpha subunit (DB11638)
drugbank_target|Q07912	-	1038	sp|Q8ICR0|CDPK2_PL	-	509	3.1e-69	232.2	0.0	1	1	3.8e-70	4.8e-69	231.5	0.0	69	319	123	380	113	404	0.91	Activated CDC42 kinase 1 (DB00171; DB04367; DB11986; DB12010)
drugbank_target|P09619	-	1106	sp|Q8ICR0|CDPK2_PL	-	509	3.3e-69	232.1	0.0	1	2	7.5e-25	9.5e-24	82.1	0.0	67	163	594	698	577	707	0.87	Platelet-derived growth factor receptor beta (DB00102; DB00398; DB00619; DB01254; DB01268; DB05014; DB05146; DB06589; DB06595; DB08896; DB09079; DB09221; DB09283; DB10770; DB12010; DB12147; DB12978; DB14840)
drugbank_target|P09619	-	1106	sp|Q8ICR0|CDPK2_PL	-	509	3.3e-69	232.1	0.0	2	2	9.2e-45	1.2e-43	147.8	0.0	158	321	792	955	784	980	0.86	Platelet-derived growth factor receptor beta (DB00102; DB00398; DB00619; DB01254; DB01268; DB05014; DB05146; DB06589; DB06595; DB08896; DB09079; DB09221; DB09283; DB10770; DB12010; DB12147; DB12978; DB14840)
drugbank_target|P16234	-	1089	sp|Q8ICR0|CDPK2_PL	-	509	3.5e-69	232.0	0.0	1	2	2e-22	2.5e-21	74.1	0.0	69	163	590	691	578	700	0.86	Platelet-derived growth factor receptor alpha (DB00102; DB00619; DB01268; DB05146; DB06043; DB06589; DB06595; DB08896; DB08901; DB09078; DB09079; DB10772; DB12010; DB12147; DB12742; DB14840)
drugbank_target|P16234	-	1089	sp|Q8ICR0|CDPK2_PL	-	509	3.5e-69	232.0	0.0	2	2	4.2e-47	5.4e-46	155.5	0.0	155	320	779	946	772	986	0.84	Platelet-derived growth factor receptor alpha (DB00102; DB00619; DB01268; DB05146; DB06043; DB06589; DB06595; DB08896; DB08901; DB09078; DB09079; DB10772; DB12010; DB12147; DB12742; DB14840)
drugbank_target|P46734	-	347	sp|Q8ICR0|CDPK2_PL	-	509	3.6e-69	232.0	0.0	1	1	3.4e-70	4.4e-69	231.7	0.0	63	336	54	335	7	343	0.88	Dual specificity mitogen-activated protein kinase kinase 3 (DB12010)
drugbank_target|P10721	-	976	sp|Q8ICR0|CDPK2_PL	-	509	4.4e-69	231.7	0.0	1	2	2.8e-20	3.5e-19	67.0	0.0	64	162	580	686	556	703	0.89	Mast/stem cell growth factor receptor Kit (DB00398; DB00619; DB01254; DB01268; DB01962; DB04868; DB05146; DB05913; DB06080; DB06589; DB06595; DB08896; DB08901; DB09078; DB09103; DB12010; DB12147; DB12742; DB12978; DB14840; DB15233)
drugbank_target|P10721	-	976	sp|Q8ICR0|CDPK2_PL	-	509	4.4e-69	231.7	0.0	2	2	3.6e-49	4.5e-48	162.3	0.0	163	322	763	922	746	956	0.85	Mast/stem cell growth factor receptor Kit (DB00398; DB00619; DB01254; DB01268; DB01962; DB04868; DB05146; DB05913; DB06080; DB06589; DB06595; DB08896; DB08901; DB09078; DB09103; DB12010; DB12147; DB12742; DB12978; DB14840; DB15233)
drugbank_target|P49840	-	483	sp|Q8ICR0|CDPK2_PL	-	509	5.3e-69	231.4	0.0	1	1	5.5e-70	7e-69	231.0	0.0	69	329	116	406	97	417	0.91	Glycogen synthase kinase-3 alpha (DB12010)
drugbank_target|Q06418	-	890	sp|Q8ICR0|CDPK2_PL	-	509	5.4e-69	231.4	0.0	1	1	5.8e-70	7.3e-69	230.9	0.0	66	319	512	781	457	786	0.89	Tyrosine-protein kinase receptor TYRO3 (DB12010)
drugbank_target|P04049	-	648	sp|Q8ICR0|CDPK2_PL	-	509	5.4e-69	231.4	0.0	1	1	5.8e-70	7.4e-69	230.9	0.0	66	342	342	624	300	641	0.83	RAF proto-oncogene serine/threonine-protein kinase (DB00398; DB04973; DB05190; DB05268; DB08862; DB08896; DB08912; DB12010)
drugbank_target|Q59EB3	-	712	sp|Q8ICR0|CDPK2_PL	-	509	6.1e-69	231.2	0.0	1	1	6.9e-70	8.8e-69	230.7	0.0	73	322	401	657	392	662	0.92	Met proto-oncogene variant (DB08111)
drugbank_target|P07333	-	972	sp|Q8ICR0|CDPK2_PL	-	509	1.2e-68	230.2	0.0	1	2	7.3e-24	9.3e-23	78.8	0.0	64	161	573	678	540	686	0.86	Macrophage colony-stimulating factor 1 receptor (DB00619; DB01268; DB06080; DB07167; DB07202; DB12010; DB12147; DB12978)
drugbank_target|P07333	-	972	sp|Q8ICR0|CDPK2_PL	-	509	1.2e-68	230.2	0.0	2	2	3.4e-45	4.3e-44	149.2	0.0	160	334	746	918	735	955	0.85	Macrophage colony-stimulating factor 1 receptor (DB00619; DB01268; DB06080; DB07167; DB07202; DB12010; DB12147; DB12978)
drugbank_target|P19784	-	350	sp|Q8ICR0|CDPK2_PL	-	509	1.5e-68	229.9	1.0	1	1	1.7e-69	2.2e-68	229.4	1.0	65	335	33	334	9	347	0.91	Casein kinase II subunit alpha' (DB07546; DB12010)
drugbank_target|P11309	-	404	sp|Q8ICR0|CDPK2_PL	-	509	1.7e-68	229.8	0.0	1	1	1.9e-69	2.4e-68	229.2	0.0	63	337	120	392	103	400	0.91	Serine/threonine-protein kinase pim-1 (DB01754; DB02010; DB02656; DB03366; DB03650; DB03777; DB04216; DB04395; DB04522; DB04530; DB04715; DB07151; DB07242; DB07524; DB08022; DB08166; DB08230; DB08705; DB08707; DB08708; DB08709; DB12010)
drugbank_target|P36888	-	993	sp|Q8ICR0|CDPK2_PL	-	509	1.7e-68	229.7	0.4	1	2	2.2e-25	2.8e-24	83.9	0.2	46	165	584	711	562	726	0.77	Receptor-type tyrosine-protein kinase FLT3 (DB00398; DB01268; DB05014; DB05465; DB06080; DB06469; DB06595; DB08901; DB09079; DB12010; DB12141; DB12267; DB12500; DB12742; DB12874; DB12978)
drugbank_target|P36888	-	993	sp|Q8ICR0|CDPK2_PL	-	509	1.7e-68	229.7	0.4	2	2	1.6e-43	2e-42	143.7	0.0	162	321	781	940	766	973	0.87	Receptor-type tyrosine-protein kinase FLT3 (DB00398; DB01268; DB05014; DB05465; DB06080; DB06469; DB06595; DB08901; DB09079; DB12010; DB12141; DB12267; DB12500; DB12742; DB12874; DB12978)
drugbank_target|P08581	-	1390	sp|Q8ICR0|CDPK2_PL	-	509	1.9e-68	229.6	0.0	1	1	2.3e-69	3e-68	228.9	0.0	73	322	1079	1335	1071	1340	0.92	Hepatocyte growth factor receptor (DB02152; DB06314; DB06896; DB06995; DB06997; DB07369; DB07969; DB08079; DB08791; DB08865; DB08875; DB11791; DB12010; DB12200; DB12267; DB12742)
drugbank_target|Q13546	-	671	sp|Q8ICR0|CDPK2_PL	-	509	2.2e-68	229.4	0.5	1	1	3.9e-69	5e-68	228.2	0.5	69	347	14	312	2	338	0.83	Receptor-interacting serine/threonine-protein kinase 1 (DB12010)
drugbank_target|P17948	-	1338	sp|Q8ICR0|CDPK2_PL	-	509	3.9e-68	228.5	0.1	1	2	8.6e-21	1.1e-19	68.7	0.0	64	163	818	926	783	938	0.87	Vascular endothelial growth factor receptor 1 (DB00398; DB01268; DB04879; DB05075; DB05913; DB05932; DB06080; DB06101; DB06589; DB06626; DB07288; DB08896; DB09078; DB09079; DB09221; DB10770; DB12010; DB15685)
drugbank_target|P17948	-	1338	sp|Q8ICR0|CDPK2_PL	-	509	3.9e-68	228.5	0.1	2	2	9.9e-48	1.3e-46	157.6	0.0	161	322	991	1152	973	1160	0.88	Vascular endothelial growth factor receptor 1 (DB00398; DB01268; DB04879; DB05075; DB05913; DB05932; DB06080; DB06101; DB06589; DB06626; DB07288; DB08896; DB09078; DB09079; DB09221; DB10770; DB12010; DB15685)
drugbank_target|Q9UM73	-	1620	sp|Q8ICR0|CDPK2_PL	-	509	1.3e-67	226.8	0.0	1	1	1.4e-68	1.8e-67	226.4	0.0	59	323	1103	1382	1058	1396	0.87	ALK tyrosine kinase receptor (DB00171; DB08865; DB09063; DB11363; DB12010; DB12130; DB12141; DB12267)
drugbank_target|P14616	-	1297	sp|Q8ICR0|CDPK2_PL	-	509	1.4e-67	226.7	0.0	1	1	1.5e-68	1.9e-67	226.2	0.0	64	322	970	1244	946	1247	0.88	Insulin receptor-related protein (DB12010)
drugbank_target|P10398	-	606	sp|Q8ICR0|CDPK2_PL	-	509	1.4e-67	226.7	0.0	1	1	1.6e-68	2e-67	226.2	0.0	33	330	271	573	257	594	0.84	Serine/threonine-protein kinase A-Raf (DB00171)
drugbank_target|P00533	-	1210	sp|Q8ICR0|CDPK2_PL	-	509	2.8e-67	225.7	0.0	1	1	3.3e-68	4.3e-67	225.1	0.0	69	321	709	965	692	978	0.93	Epidermal growth factor receptor (DB00002; DB00281; DB00317; DB00530; DB01259; DB01269; DB03496; DB04988; DB05101; DB05294; DB05374; DB05424; DB05524; DB05944; DB06021; DB07602; DB07662; DB08916; DB09330; DB09559; DB10772; DB11731; DB11737; DB11828; DB11963; DB12010; DB12202; DB12267; DB13164; DB15035)
drugbank_target|P04626	-	1255	sp|Q8ICR0|CDPK2_PL	-	509	4.5e-67	225.0	0.0	1	1	5.1e-68	6.5e-67	224.5	0.0	69	322	717	974	676	991	0.90	Receptor tyrosine-protein kinase erbB-2 (DB00072; DB01259; DB04988; DB05773; DB05944; DB06021; DB06366; DB08916; DB11652; DB11973; DB12010; DB12267; DB15035)
drugbank_target|P53667	-	647	sp|Q8ICR0|CDPK2_PL	-	509	1.2e-66	223.7	0.0	1	1	1.3e-67	1.6e-66	223.2	0.0	69	320	336	600	309	610	0.87	LIM domain kinase 1 (DB08912; DB12010)
drugbank_target|P35968	-	1356	sp|Q8ICR0|CDPK2_PL	-	509	1.4e-66	223.4	0.0	1	2	2.8e-19	3.6e-18	63.7	0.0	65	163	826	933	814	945	0.87	Vascular endothelial growth factor receptor 2 (DB00398; DB01268; DB04727; DB04849; DB04879; DB05014; DB05075; DB05146; DB05198; DB05578; DB05931; DB05984; DB06080; DB06101; DB06436; DB06589; DB06595; DB06626; DB06938; DB07183; DB07274; DB07326; DB07333; DB07334; DB07514; DB07528; DB07537; DB08042; DB08519; DB08875; DB08896; DB08901; DB09078; DB09079; DB12010; DB12147; DB12307; DB14840)
drugbank_target|P35968	-	1356	sp|Q8ICR0|CDPK2_PL	-	509	1.4e-66	223.4	0.0	2	2	1.1e-47	1.4e-46	157.4	0.0	150	323	979	1159	975	1174	0.86	Vascular endothelial growth factor receptor 2 (DB00398; DB01268; DB04727; DB04849; DB04879; DB05014; DB05075; DB05146; DB05198; DB05578; DB05931; DB05984; DB06080; DB06101; DB06436; DB06589; DB06595; DB06626; DB06938; DB07183; DB07274; DB07326; DB07333; DB07334; DB07514; DB07528; DB07537; DB08042; DB08519; DB08875; DB08896; DB08901; DB09078; DB09079; DB12010; DB12147; DB12307; DB14840)
drugbank_target|P33981	-	857	sp|Q8ICR0|CDPK2_PL	-	509	1.5e-66	223.4	1.7	1	1	1.2e-67	1.5e-66	223.4	1.7	70	341	523	806	492	817	0.89	Dual specificity protein kinase TTK (DB01782; DB12010; DB15498)
drugbank_target|Q12866	-	999	sp|Q8ICR0|CDPK2_PL	-	509	1.9e-66	223.0	0.1	1	1	2.1e-67	2.6e-66	222.5	0.1	69	318	584	848	548	867	0.87	Tyrosine-protein kinase Mer (DB08325; DB12010)
drugbank_target|Q04912	-	1400	sp|Q8ICR0|CDPK2_PL	-	509	4.2e-66	221.8	0.0	1	1	4.7e-67	6e-66	221.3	0.0	74	320	1084	1337	1069	1343	0.90	Macrophage-stimulating protein receptor (DB12010)
drugbank_target|P9WI81	-	626	sp|Q8ICR0|CDPK2_PL	-	509	1.9e-65	219.6	0.0	1	1	1.9e-66	2.5e-65	219.3	0.0	66	330	5	278	1	297	0.90	Serine/threonine-protein kinase PknB (DB02930; DB03909; DB12010)
drugbank_target|P53671	-	638	sp|Q8ICR0|CDPK2_PL	-	509	2.3e-65	219.4	0.0	1	1	2.4e-66	3.1e-65	219.0	0.0	69	320	328	597	265	601	0.89	LIM domain kinase 2 (DB12010)
drugbank_target|Q86V86	-	326	sp|Q8ICR0|CDPK2_PL	-	509	3.3e-65	218.9	0.0	1	1	3.3e-66	4.2e-65	218.5	0.0	62	328	30	295	24	313	0.92	Serine/threonine-protein kinase pim-3 (DB12010)
drugbank_target|Q52WX2	-	424	sp|Q8ICR0|CDPK2_PL	-	509	7.5e-65	217.7	0.0	1	1	7.8e-66	9.9e-65	217.3	0.0	61	326	42	318	33	332	0.88	Serine/threonine-protein kinase SBK1 (DB12010)
drugbank_target|Q9NWZ3	-	460	sp|Q8ICR0|CDPK2_PL	-	509	1.1e-64	217.2	0.1	1	1	1.1e-65	1.4e-64	216.8	0.1	74	321	188	451	119	457	0.83	Interleukin-1 receptor-associated kinase 4 (DB08590; DB12010)
drugbank_target|P35916	-	1363	sp|Q8ICR0|CDPK2_PL	-	509	4.4e-64	215.2	0.0	1	2	3.7e-19	4.8e-18	63.3	0.0	62	162	834	943	822	955	0.85	Vascular endothelial growth factor receptor 3 (DB00398; DB01268; DB04879; DB05075; DB05932; DB06080; DB06101; DB06589; DB06626; DB08896; DB09078; DB09079; DB12010; DB15685)
drugbank_target|P35916	-	1363	sp|Q8ICR0|CDPK2_PL	-	509	4.4e-64	215.2	0.0	2	2	2.6e-45	3.3e-44	149.6	0.0	163	322	1008	1167	998	1214	0.88	Vascular endothelial growth factor receptor 3 (DB00398; DB01268; DB04879; DB05075; DB05932; DB06080; DB06101; DB06589; DB06626; DB08896; DB09078; DB09079; DB12010; DB15685)
drugbank_target|Q13523	-	1007	sp|Q8ICR0|CDPK2_PL	-	509	6.2e-64	214.7	1.2	1	1	4.9e-65	6.2e-64	214.7	1.2	61	328	676	1005	654	1007	0.92	Serine/threonine-protein kinase PRP4 homolog (DB12010)
drugbank_target|P29376	-	864	sp|Q8ICR0|CDPK2_PL	-	509	1.2e-63	213.8	0.0	1	1	1.3e-64	1.6e-63	213.3	0.0	71	323	509	776	502	789	0.91	Leukocyte tyrosine kinase receptor (DB12010)
drugbank_target|O15111	-	745	sp|Q8ICR0|CDPK2_PL	-	509	3.5e-63	212.2	0.0	1	1	4.3e-64	5.5e-63	211.6	0.0	72	316	15	289	11	300	0.90	Inhibitor of nuclear factor kappa-B kinase subunit alpha (DB00233; DB00244; DB00795; DB06151)
drugbank_target|P19525	-	551	sp|Q8ICR0|CDPK2_PL	-	509	3.8e-63	212.1	0.3	1	1	4.6e-64	5.9e-63	211.5	0.3	59	337	254	549	206	551	0.86	Interferon-induced, double-stranded RNA-activated protein kinase (DB12010)
drugbank_target|O14920	-	756	sp|Q8ICR0|CDPK2_PL	-	509	8.4e-63	210.9	0.0	1	1	1.5e-63	1.9e-62	209.8	0.0	71	283	14	238	6	349	0.83	Inhibitor of nuclear factor kappa-B kinase subunit beta (DB00244; DB00795; DB00945; DB00995; DB01169; DB05183; DB06151; DB06521; DB12010)
drugbank_target|Q59H18	-	835	sp|Q8ICR0|CDPK2_PL	-	509	9.3e-63	210.8	0.2	1	1	2e-63	2.5e-62	209.4	0.0	70	321	461	716	436	720	0.92	Serine/threonine-protein kinase TNNI3K (DB12010)
drugbank_target|P49336	-	464	sp|Q8ICR0|CDPK2_PL	-	509	1.5e-62	210.1	0.2	1	1	3.5e-63	4.4e-62	208.6	0.2	62	332	10	341	3	377	0.88	Cyclin-dependent kinase 8 (DB03496)
drugbank_target|Q15569	-	626	sp|Q8ICR0|CDPK2_PL	-	509	1e-61	207.4	0.0	1	1	1.1e-62	1.4e-61	206.9	0.0	68	336	53	324	38	337	0.87	Dual specificity testis-specific protein kinase 1 (DB12010)
drugbank_target|Q8TDR2	-	534	sp|Q8ICR0|CDPK2_PL	-	509	3.4e-61	205.7	0.0	1	1	1.6e-61	2e-60	203.1	0.0	68	320	198	523	190	527	0.90	Serine/threonine-protein kinase 35 (DB12010)
drugbank_target|O14976	-	1311	sp|Q8ICR0|CDPK2_PL	-	509	1.1e-60	203.9	0.0	1	1	1.6e-61	2.1e-60	203.0	0.0	69	322	37	311	19	330	0.87	Cyclin-G-associated kinase (DB12010)
drugbank_target|P21860	-	1342	sp|Q8ICR0|CDPK2_PL	-	509	2.7e-60	202.7	0.0	1	1	3.1e-61	3.9e-60	202.1	0.0	69	323	706	964	669	979	0.90	Receptor tyrosine-protein kinase erbB-3 (DB11652)
drugbank_target|Q99640	-	499	sp|Q8ICR0|CDPK2_PL	-	509	1.9e-59	199.8	0.0	1	1	2e-60	2.6e-59	199.4	0.0	66	328	103	361	76	366	0.91	Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase (DB12010)
drugbank_target|Q8NFD2	-	765	sp|Q8ICR0|CDPK2_PL	-	509	3.6e-59	199.0	0.0	1	1	3.8e-60	4.8e-59	198.6	0.0	76	320	26	281	15	346	0.87	Ankyrin repeat and protein kinase domain-containing protein 1 (DB12010)
drugbank_target|Q9BQI3	-	630	sp|Q8ICR0|CDPK2_PL	-	509	6.4e-59	198.1	2.2	1	2	1.9e-18	2.5e-17	60.9	0.2	48	139	144	236	111	241	0.76	Eukaryotic translation initiation factor 2-alpha kinase 1 (DB12010)
drugbank_target|Q9BQI3	-	630	sp|Q8ICR0|CDPK2_PL	-	509	6.4e-59	198.1	2.2	2	2	2.1e-41	2.7e-40	136.7	0.1	141	351	379	609	350	619	0.82	Eukaryotic translation initiation factor 2-alpha kinase 1 (DB12010)
drugbank_target|P30291	-	646	sp|Q8ICR0|CDPK2_PL	-	509	3.1e-57	192.6	0.1	1	1	3.3e-58	4.3e-57	192.1	0.1	40	365	267	608	244	615	0.87	Wee1-like protein kinase (DB04608; DB07006; DB07226; DB07257; DB07265; DB08365; DB11740; DB12010)
drugbank_target|P57078	-	832	sp|Q8ICR0|CDPK2_PL	-	509	3.2e-57	192.5	0.0	1	1	3.6e-58	4.5e-57	192.0	0.0	71	318	21	277	15	290	0.89	Receptor-interacting serine/threonine-protein kinase 4 (DB12010)
drugbank_target|O15197	-	1021	sp|Q8ICR0|CDPK2_PL	-	509	4.5e-57	192.0	0.0	1	1	5.1e-58	6.4e-57	191.5	0.0	70	322	668	913	642	926	0.91	Ephrin type-B receptor 6 (DB12010)
drugbank_target|Q2M2I8	-	961	sp|Q8ICR0|CDPK2_PL	-	509	9.4e-56	187.7	0.0	1	1	7.4e-57	9.4e-56	187.7	0.0	69	320	43	307	35	349	0.87	AP2-associated protein kinase 1 (DB12010)
drugbank_target|Q14164	-	716	sp|Q8ICR0|CDPK2_PL	-	509	1.3e-55	187.2	0.0	1	1	2e-56	2.5e-55	186.3	0.0	72	284	9	241	2	245	0.90	Inhibitor of nuclear factor kappa-B kinase subunit epsilon (DB12010)
drugbank_target|O75716	-	305	sp|Q8ICR0|CDPK2_PL	-	509	1.5e-55	187.0	0.0	1	1	1.5e-56	1.9e-55	186.7	0.0	69	321	17	287	6	300	0.89	Serine/threonine-protein kinase 16 (DB12010)
drugbank_target|Q9UHD2	-	729	sp|Q8ICR0|CDPK2_PL	-	509	2.4e-55	186.4	0.0	1	1	3.9e-56	5e-55	185.3	0.0	72	285	9	242	2	252	0.90	Serine/threonine-protein kinase TBK1 (DB12010)
drugbank_target|O43353	-	540	sp|Q8ICR0|CDPK2_PL	-	509	2.4e-55	186.3	0.0	1	1	2.7e-56	3.4e-55	185.9	0.0	74	321	20	287	12	334	0.85	Receptor-interacting serine/threonine-protein kinase 2 (DB12010)
drugbank_target|Q13470	-	666	sp|Q8ICR0|CDPK2_PL	-	509	2.5e-55	186.3	0.0	1	1	2.7e-56	3.4e-55	185.9	0.0	74	319	118	372	111	378	0.89	Non-receptor tyrosine-protein kinase TNK1 (DB12010)
drugbank_target|O00238	-	502	sp|Q8ICR0|CDPK2_PL	-	509	1.6e-54	183.7	0.0	1	1	1.7e-55	2.1e-54	183.2	0.0	63	322	195	489	170	498	0.83	Bone morphogenetic protein receptor type-1B (DB12010)
drugbank_target|P36894	-	532	sp|Q8ICR0|CDPK2_PL	-	509	3.5e-54	182.5	0.0	1	1	3.5e-55	4.4e-54	182.2	0.0	53	322	215	519	176	529	0.80	Bone morphogenetic protein receptor type-1A (DB11639)
drugbank_target|Q04771	-	509	sp|Q8ICR0|CDPK2_PL	-	509	7.6e-54	181.4	0.0	1	1	8.1e-55	1e-53	181.0	0.0	65	322	201	493	186	505	0.85	Activin receptor type-1 (DB00171; DB08597; DB12010)
drugbank_target|Q9NSY1	-	1161	sp|Q8ICR0|CDPK2_PL	-	509	9.7e-54	181.1	0.0	1	1	7.6e-55	9.7e-54	181.1	0.0	69	321	48	312	37	360	0.85	BMP-2-inducible protein kinase (DB12010)
drugbank_target|P0DP23	-	149	sp|Q8ICR0|CDPK2_PL	-	509	2.1e-53	179.9	7.4	1	1	2e-54	2.5e-53	179.7	7.4	363	503	1	140	1	145	0.98	Calmodulin (DB00477; DB00527; DB00622; DB00623; DB00753; DB00831; DB00836; DB00850; DB00925; DB01023; DB01065; DB01069; DB01100; DB01115; DB01244; DB01373; DB01429; DB02868; DB03900; DB03977; DB04513; DB04825; DB04841; DB08039; DB08231; DB11093; DB11348; DB13800; DB14481)
drugbank_target|P0DP24	-	149	sp|Q8ICR0|CDPK2_PL	-	509	2.1e-53	179.9	7.4	1	1	2e-54	2.5e-53	179.7	7.4	363	503	1	140	1	145	0.98	Calmodulin-2 (DB11093; DB11348; DB14481)
drugbank_target|P0DP25	-	149	sp|Q8ICR0|CDPK2_PL	-	509	2.1e-53	179.9	7.4	1	1	2e-54	2.5e-53	179.7	7.4	363	503	1	140	1	145	0.98	Calmodulin-3 (DB11093; DB11348; DB14481)
drugbank_target|O75460	-	977	sp|Q8ICR0|CDPK2_PL	-	509	6.6e-53	178.3	0.0	1	1	8.6e-54	1.1e-52	177.6	0.0	71	341	570	847	518	856	0.80	Serine/threonine-protein kinase/endoribonuclease IRE1 (DB07382; DB12010)
drugbank_target|Q5S007	-	2527	sp|Q8ICR0|CDPK2_PL	-	509	1.3e-52	177.3	0.0	1	1	1.9e-53	2.4e-52	176.4	0.0	76	321	1883	2129	1864	2134	0.89	Leucine-rich repeat serine/threonine-protein kinase 2 (DB12010)
drugbank_target|P36897	-	503	sp|Q8ICR0|CDPK2_PL	-	509	2.1e-51	173.4	0.0	1	1	2.2e-52	2.8e-51	172.9	0.0	65	322	198	490	178	499	0.83	TGF-beta receptor type-1 (DB03921; DB04434; DB04480; DB07152; DB07267; DB08450; DB12010)
drugbank_target|P37023	-	503	sp|Q8ICR0|CDPK2_PL	-	509	1.2e-50	170.8	0.0	1	1	1.3e-51	1.6e-50	170.4	0.0	65	322	195	487	178	500	0.85	Serine/threonine-protein kinase receptor R3 (DB00171)
drugbank_target|P78362	-	688	sp|Q8ICR0|CDPK2_PL	-	509	1.5e-48	163.9	0.2	1	2	2e-31	2.5e-30	103.8	0.1	68	202	76	224	47	230	0.87	SRSF protein kinase 2 (DB00173; DB02733; DB04395)
drugbank_target|P78362	-	688	sp|Q8ICR0|CDPK2_PL	-	509	1.5e-48	163.9	0.2	2	2	3.4e-20	4.4e-19	66.7	0.0	206	327	523	687	511	688	0.90	SRSF protein kinase 2 (DB00173; DB02733; DB04395)
drugbank_target|P36896	-	505	sp|Q8ICR0|CDPK2_PL	-	509	2.7e-48	163.1	0.0	1	1	2.7e-49	3.5e-48	162.7	0.0	63	322	198	492	153	501	0.82	Activin receptor type-1B (DB00171; DB12010)
drugbank_target|P20594	-	1047	sp|Q8ICR0|CDPK2_PL	-	509	3.2e-48	162.8	0.0	1	1	3.6e-49	4.6e-48	162.3	0.0	92	321	542	783	531	832	0.84	Atrial natriuretic peptide receptor 2 (DB01613; DB04899)
drugbank_target|Q13873	-	1038	sp|Q8ICR0|CDPK2_PL	-	509	4.8e-48	162.3	0.0	1	1	6.1e-49	7.8e-48	161.6	0.0	69	354	200	536	176	542	0.80	Bone morphogenetic protein receptor type-2 (DB11639; DB12010)
drugbank_target|Q9HCP0	-	422	sp|Q8ICR0|CDPK2_PL	-	509	6.9e-47	158.4	0.0	1	1	7.6e-48	9.7e-47	158.0	0.0	34	303	6	290	2	303	0.87	Casein kinase I isoform gamma-1 (DB08325)
drugbank_target|P37173	-	567	sp|Q8ICR0|CDPK2_PL	-	509	7.1e-47	158.4	0.1	1	1	8.4e-48	1.1e-46	157.8	0.1	63	321	236	535	190	546	0.75	TGF-beta receptor type-2 (DB10770; DB10772; DB12010)
drugbank_target|P27037	-	513	sp|Q8ICR0|CDPK2_PL	-	509	1.7e-46	157.2	0.1	1	1	1.8e-47	2.3e-46	156.7	0.1	72	318	192	473	188	502	0.80	Activin receptor type-2A (DB12118)
drugbank_target|Q9Y6M4	-	447	sp|Q8ICR0|CDPK2_PL	-	509	4.7e-46	155.7	0.5	1	1	5.6e-47	7.1e-46	155.1	0.0	32	290	4	274	1	307	0.85	Casein kinase I isoform gamma-3 (DB04751; DB07488; DB07489; DB07664)
drugbank_target|Q9Y616	-	596	sp|Q8ICR0|CDPK2_PL	-	509	6e-46	155.3	0.1	1	1	6.8e-47	8.7e-46	154.8	0.1	60	322	153	441	129	451	0.84	Interleukin-1 receptor-associated kinase 3 (DB12010)
drugbank_target|P51617	-	712	sp|Q8ICR0|CDPK2_PL	-	509	9.5e-46	154.7	0.0	1	1	1.1e-46	1.4e-45	154.1	0.0	69	273	209	429	202	517	0.79	Interleukin-1 receptor-associated kinase 1 (DB12010)
drugbank_target|P16066	-	1061	sp|Q8ICR0|CDPK2_PL	-	509	6.4e-45	151.9	0.0	1	1	7.3e-46	9.3e-45	151.4	0.0	85	322	551	799	546	851	0.80	Atrial natriuretic peptide receptor 1 (DB00325; DB00727; DB00883; DB01612; DB01613; DB04899; DB05034)
drugbank_target|P48729	-	337	sp|Q8ICR0|CDPK2_PL	-	509	3.7e-44	149.5	0.1	1	1	3.2e-45	4.1e-44	149.3	0.1	67	305	12	262	2	333	0.88	Casein kinase I isoform alpha (DB12010)
drugbank_target|P49674	-	416	sp|Q8ICR0|CDPK2_PL	-	509	5e-44	149.0	0.0	1	1	5.2e-45	6.7e-44	148.6	0.0	67	303	4	252	2	271	0.86	Casein kinase I isoform epsilon (DB06195)
drugbank_target|P78368	-	415	sp|Q8ICR0|CDPK2_PL	-	509	5.7e-44	148.8	0.0	1	1	5.8e-45	7.4e-44	148.5	0.0	65	302	39	290	6	302	0.86	Casein kinase I isoform gamma-2 (DB03083; DB03693; DB04604)
drugbank_target|P02585	-	160	sp|Q8ICR0|CDPK2_PL	-	509	3.8e-43	146.1	7.9	1	1	3.4e-44	4.3e-43	145.9	7.9	360	503	5	150	1	156	0.94	Troponin C, skeletal muscle (DB01023; DB01373; DB04682)
drugbank_target|P63098	-	170	sp|Q8ICR0|CDPK2_PL	-	509	9.5e-43	144.8	4.8	1	1	9.3e-44	1.2e-42	144.5	4.8	361	503	9	151	3	156	0.94	Calcineurin subunit B type 1 (DB08231; DB11693)
drugbank_target|Q96LZ3	-	170	sp|Q8ICR0|CDPK2_PL	-	509	6.1e-41	138.8	3.2	1	1	6e-42	7.6e-41	138.5	3.2	361	503	9	151	3	156	0.94	Calcineurin subunit B type 2 (DB00091; DB11693)
drugbank_target|P0C264	-	359	sp|Q8ICR0|CDPK2_PL	-	509	1.1e-40	138.0	0.0	1	1	1.1e-41	1.4e-40	137.6	0.0	62	315	33	295	3	307	0.86	Uncharacterized serine/threonine-protein kinase SBK3 (DB12010)
drugbank_target|P63316	-	161	sp|Q8ICR0|CDPK2_PL	-	509	2.3e-40	136.9	11.4	1	1	2.3e-41	2.9e-40	136.6	11.4	361	504	6	152	2	157	0.94	Troponin C, slow skeletal and cardiac muscles (DB00831; DB00922; DB01023; DB01244; DB01373; DB01375; DB03944; DB04513)
drugbank_target|P62166	-	190	sp|Q8ICR0|CDPK2_PL	-	509	7.4e-39	132.0	2.2	1	1	6.4e-40	8.2e-39	131.8	2.2	358	506	13	170	1	173	0.88	Neuronal calcium sensor 1 (DB11093; DB11348; DB14481)
drugbank_target|P22676	-	271	sp|Q8ICR0|CDPK2_PL	-	509	8e-39	131.9	9.8	1	2	5.6e-33	7.2e-32	108.9	2.3	366	503	12	174	9	178	0.92	Calretinin (DB11093; DB11348; DB13800; DB14481)
drugbank_target|P22676	-	271	sp|Q8ICR0|CDPK2_PL	-	509	8e-39	131.9	9.8	2	2	2.7e-08	3.5e-07	27.5	0.9	371	414	196	240	184	247	0.83	Calretinin (DB11093; DB11348; DB13800; DB14481)
drugbank_target|P25092	-	1073	sp|Q8ICR0|CDPK2_PL	-	509	8.1e-39	131.8	0.9	1	1	9.9e-40	1.3e-38	131.2	0.9	92	320	507	741	502	777	0.90	Heat-stable enterotoxin receptor (DB08890)
drugbank_target|P19105	-	171	sp|Q8ICR0|CDPK2_PL	-	509	1e-38	131.5	5.5	1	1	9.7e-40	1.2e-38	131.2	5.5	345	502	3	155	1	160	0.93	Myosin regulatory light chain 12A (DB08378)
drugbank_target|P43080	-	201	sp|Q8ICR0|CDPK2_PL	-	509	3.8e-38	129.6	0.3	1	1	3.9e-39	5e-38	129.2	0.3	362	504	8	155	2	159	0.92	Guanylyl cyclase-activating protein 1 (DB08231)
drugbank_target|O75340	-	191	sp|Q8ICR0|CDPK2_PL	-	509	8.2e-38	128.5	2.2	1	2	8.8e-13	1.1e-11	42.3	0.0	375	432	28	86	24	90	0.93	Programmed cell death protein 6 (DB01373; DB01593; DB11093; DB11348; DB14481; DB14487)
drugbank_target|O75340	-	191	sp|Q8ICR0|CDPK2_PL	-	509	8.2e-38	128.5	2.2	2	2	7.8e-26	9.9e-25	85.3	1.3	372	464	92	178	89	185	0.97	Programmed cell death protein 6 (DB01373; DB01593; DB11093; DB11348; DB14481; DB14487)
drugbank_target|P9WI73	-	750	sp|Q8ICR0|CDPK2_PL	-	509	2e-37	127.2	0.0	1	1	2.6e-38	3.3e-37	126.5	0.0	68	319	147	386	138	395	0.85	Serine/threonine-protein kinase PknG (DB07398)
drugbank_target|Q16671	-	573	sp|Q8ICR0|CDPK2_PL	-	509	2e-36	123.9	0.0	1	1	2.1e-37	2.7e-36	123.5	0.0	72	322	203	503	192	520	0.80	Anti-Muellerian hormone type-2 receptor (DB00171)
drugbank_target|P14649	-	208	sp|Q8ICR0|CDPK2_PL	-	509	7.6e-34	115.4	0.0	1	1	7.4e-35	9.4e-34	115.1	0.0	345	504	39	200	22	204	0.92	Myosin light chain 6B (DB08378)
drugbank_target|Q99653	-	195	sp|Q8ICR0|CDPK2_PL	-	509	1.7e-31	107.7	0.8	1	1	1.6e-32	2.1e-31	107.4	0.8	360	503	16	174	4	180	0.89	Calcineurin B homologous protein 1 (DB11093; DB11348; DB14481)
drugbank_target|Q13938	-	189	sp|Q8ICR0|CDPK2_PL	-	509	1.9e-31	107.5	0.0	1	1	1.9e-32	2.4e-31	107.2	0.0	370	503	21	160	7	166	0.95	Calcyphosin (DB11093; DB11348; DB14481)
drugbank_target|Q9UBV8	-	284	sp|Q8ICR0|CDPK2_PL	-	509	3e-30	103.6	0.2	1	2	8.2e-12	1e-10	39.1	0.1	376	433	120	178	117	182	0.90	Peflin (DB11093; DB11348; DB14481)
drugbank_target|Q9UBV8	-	284	sp|Q8ICR0|CDPK2_PL	-	509	3e-30	103.6	0.2	2	2	5.9e-19	7.5e-18	62.7	0.0	372	462	183	268	180	274	0.96	Peflin (DB11093; DB11348; DB14481)
drugbank_target|P35243	-	200	sp|Q8ICR0|CDPK2_PL	-	509	4.3e-30	103.1	1.3	1	1	5.3e-31	6.7e-30	102.4	1.3	360	501	16	168	3	176	0.88	Recoverin (DB08231)
drugbank_target|P12814	-	892	sp|Q8ICR0|CDPK2_PL	-	509	1.5e-28	98.0	0.1	1	1	2.5e-29	3.2e-28	96.9	0.1	346	473	722	854	692	866	0.83	Alpha-actinin-1 (DB06773; DB09130)
drugbank_target|P20807	-	821	sp|Q8ICR0|CDPK2_PL	-	509	1.8e-27	94.4	10.0	1	2	2.6e-05	0.00033	17.7	2.0	354	432	633	718	595	723	0.67	Calpain-3 (DB06124)
drugbank_target|P20807	-	821	sp|Q8ICR0|CDPK2_PL	-	509	1.8e-27	94.4	10.0	2	2	1.1e-24	1.5e-23	81.5	1.3	371	468	723	813	719	819	0.95	Calpain-3 (DB06124)
drugbank_target|P04632	-	268	sp|Q8ICR0|CDPK2_PL	-	509	4.1e-26	89.9	0.4	1	2	0.002	0.026	11.4	0.0	368	431	94	164	83	170	0.80	Calpain small subunit 1 (DB02570)
drugbank_target|P04632	-	268	sp|Q8ICR0|CDPK2_PL	-	509	4.1e-26	89.9	0.4	2	2	2.6e-23	3.4e-22	77.0	0.1	371	465	170	257	165	264	0.96	Calpain small subunit 1 (DB02570)
drugbank_target|O75746	-	678	sp|Q8ICR0|CDPK2_PL	-	509	1.2e-25	88.3	0.4	1	2	3.1e-20	3.9e-19	66.9	0.0	372	479	13	123	2	134	0.85	Calcium-binding mitochondrial carrier protein Aralar1 (DB00128)
drugbank_target|O75746	-	678	sp|Q8ICR0|CDPK2_PL	-	509	1.2e-25	88.3	0.4	2	2	6.4e-06	8.1e-05	19.7	0.2	419	486	138	199	125	206	0.86	Calcium-binding mitochondrial carrier protein Aralar1 (DB00128)
drugbank_target|P30626	-	198	sp|Q8ICR0|CDPK2_PL	-	509	1.6e-25	88.0	0.0	1	2	9e-05	0.0011	15.9	0.0	385	434	44	98	35	103	0.81	Sorcin (DB11093; DB11348; DB14481)
drugbank_target|P30626	-	198	sp|Q8ICR0|CDPK2_PL	-	509	1.6e-25	88.0	0.0	2	2	2.4e-21	3e-20	70.6	0.0	372	463	102	185	99	188	0.97	Sorcin (DB11093; DB11348; DB14481)
drugbank_target|Q96KG9	-	808	sp|Q8ICR0|CDPK2_PL	-	509	1.4e-22	78.2	0.0	1	1	1.8e-23	2.3e-22	77.5	0.0	88	267	33	221	30	244	0.86	N-terminal kinase-like protein (DB05036)
drugbank_target|Q99828	-	191	sp|Q8ICR0|CDPK2_PL	-	509	1.6e-22	78.1	0.2	1	1	1.6e-23	2e-22	77.7	0.2	401	504	63	172	52	177	0.88	Calcium and integrin-binding protein 1 (DB11093; DB11348; DB14481)
drugbank_target|Q9UJS0	-	675	sp|Q8ICR0|CDPK2_PL	-	509	3.1e-22	77.1	0.3	1	2	3.2e-21	4e-20	70.1	0.1	371	480	13	125	2	130	0.88	Calcium-binding mitochondrial carrier protein Aralar2 (DB00128)
drugbank_target|Q9UJS0	-	675	sp|Q8ICR0|CDPK2_PL	-	509	3.1e-22	77.1	0.3	2	2	0.22	2.8	4.7	0.0	360	431	148	220	128	239	0.58	Calcium-binding mitochondrial carrier protein Aralar2 (DB00128)
drugbank_target|P07384	-	714	sp|Q8ICR0|CDPK2_PL	-	509	1.7e-21	74.7	6.1	1	2	0.0082	0.1	9.4	0.3	365	431	536	610	515	614	0.77	Calpain-1 catalytic subunit (DB04276; DB04653; DB07627)
drugbank_target|P07384	-	714	sp|Q8ICR0|CDPK2_PL	-	509	1.7e-21	74.7	6.1	2	2	2.5e-20	3.2e-19	67.2	0.9	371	465	616	703	611	712	0.95	Calpain-1 catalytic subunit (DB04276; DB04653; DB07627)
drugbank_target|O75838	-	187	sp|Q8ICR0|CDPK2_PL	-	509	1.8e-21	74.6	1.7	1	1	1.9e-22	2.4e-21	74.2	1.7	399	503	62	167	56	172	0.87	Calcium and integrin-binding family member 2 (DB11093; DB11348; DB14481)
drugbank_target|Q9Y6T7	-	804	sp|Q8ICR0|CDPK2_PL	-	509	8e-21	72.5	0.2	1	1	1.5e-21	1.9e-20	71.2	0.0	425	503	132	217	127	223	0.94	Diacylglycerol kinase beta (DB14001)
drugbank_target|P28676	-	217	sp|Q8ICR0|CDPK2_PL	-	509	2.8e-20	70.6	0.0	1	2	0.0073	0.093	9.6	0.0	385	431	63	114	53	120	0.69	Grancalcin (DB11093; DB11348; DB14481)
drugbank_target|P28676	-	217	sp|Q8ICR0|CDPK2_PL	-	509	2.8e-20	70.6	0.0	2	2	6.3e-18	8.1e-17	59.2	0.0	372	458	121	199	118	205	0.94	Grancalcin (DB11093; DB11348; DB14481)
drugbank_target|P49619	-	791	sp|Q8ICR0|CDPK2_PL	-	509	1.6e-18	64.9	0.0	1	1	3e-19	3.8e-18	63.6	0.0	425	504	158	244	148	249	0.86	Diacylglycerol kinase gamma (DB14001)
drugbank_target|P49619	-	791	sp|Q8ICR0|CDPK2_PL	-	509	1.6e-18	64.9	0.0	1	1	3e-19	3.8e-18	63.6	0.0	425	504	158	244	148	249	0.86	Diacylglycerol kinase gamma (DB00144)
drugbank_target|P20472	-	110	sp|Q8ICR0|CDPK2_PL	-	509	1.9e-17	61.3	4.0	1	1	1.7e-18	2.1e-17	61.2	4.0	406	503	7	101	1	105	0.91	Parvalbumin alpha (DB01942)
drugbank_target|P23743	-	735	sp|Q8ICR0|CDPK2_PL	-	509	4.6e-17	60.1	0.1	1	1	5.9e-18	7.5e-17	59.4	0.1	433	502	101	177	88	183	0.93	Diacylglycerol kinase alpha (DB14001)
drugbank_target|P23743	-	735	sp|Q8ICR0|CDPK2_PL	-	509	4.6e-17	60.1	0.1	1	1	5.9e-18	7.5e-17	59.4	0.1	433	502	101	177	88	183	0.93	Diacylglycerol kinase alpha (DB00163)
drugbank_target|P60903	-	97	sp|Q8ICR0|CDPK2_PL	-	509	5.1e-13	46.7	0.3	1	1	4.4e-14	5.6e-13	46.6	0.3	441	504	6	71	1	75	0.89	Protein S100-A10 (DB12695)
drugbank_target|P31949	-	105	sp|Q8ICR0|CDPK2_PL	-	509	8.5e-13	46.0	0.1	1	1	7.4e-14	9.5e-13	45.8	0.1	369	436	11	85	3	99	0.86	Protein S100-A11 (DB02482)
drugbank_target|Q8NI22	-	146	sp|Q8ICR0|CDPK2_PL	-	509	6.2e-12	43.1	0.3	1	1	5.9e-13	7.5e-12	42.9	0.3	441	503	67	139	52	144	0.89	Multiple coagulation factor deficiency protein 2 (DB00025; DB13998; DB13999)
drugbank_target|P23297	-	94	sp|Q8ICR0|CDPK2_PL	-	509	9.1e-12	42.6	0.2	1	1	7.5e-13	9.6e-12	42.5	0.2	370	439	7	83	1	90	0.86	Protein S100-A1 (DB00768)
drugbank_target|P06703	-	90	sp|Q8ICR0|CDPK2_PL	-	509	1.4e-11	42.0	0.1	1	1	1.2e-12	1.6e-11	41.8	0.1	375	437	12	79	5	87	0.87	Protein S100-A6 (DB11093; DB11348; DB14481)
drugbank_target|P29377	-	79	sp|Q8ICR0|CDPK2_PL	-	509	5.9e-11	39.9	0.4	1	1	4.7e-12	6e-11	39.9	0.4	368	436	3	75	1	79	0.84	Protein S100-G (DB04464)
drugbank_target|P06702	-	114	sp|Q8ICR0|CDPK2_PL	-	509	1e-10	39.1	1.2	1	1	8.4e-12	1.1e-10	39.0	1.2	388	448	30	95	2	97	0.71	Protein S100-A9 (DB01373; DB01593; DB14487; DB14533; DB14548)
drugbank_target|P80511	-	92	sp|Q8ICR0|CDPK2_PL	-	509	1.3e-10	38.8	0.3	1	1	1.1e-11	1.5e-10	38.6	0.3	372	436	8	79	2	91	0.78	Protein S100-A12 (DB00768; DB01025)
drugbank_target|P16788	-	707	sp|Q8ICR0|CDPK2_PL	-	509	1.5e-10	38.6	0.0	1	1	1.9e-11	2.4e-10	37.9	0.0	77	222	336	490	329	506	0.87	Serine/threonine protein kinase UL97 (DB06234)
drugbank_target|Q68101	-	707	sp|Q8ICR0|CDPK2_PL	-	509	1.5e-10	38.6	0.0	1	1	1.9e-11	2.4e-10	37.9	0.0	77	222	336	490	329	506	0.87	Serine/threonine protein kinase UL97 (DB06234)
drugbank_target|P04271	-	92	sp|Q8ICR0|CDPK2_PL	-	509	2.7e-10	37.7	1.3	1	1	2.5e-11	3.1e-10	37.5	1.3	374	440	10	83	2	90	0.79	Protein S100-B (DB00768; DB01373; DB04464; DB05343; DB06941; DB07004; DB11093; DB11348; DB14481)
drugbank_target|Q8TF76	-	798	sp|Q8ICR0|CDPK2_PL	-	509	2.7e-09	34.4	1.5	1	1	1.2e-09	1.5e-08	31.9	0.0	61	218	473	692	445	702	0.78	Serine/threonine-protein kinase haspin (DB04604; DB07698; DB07995; DB08004)
drugbank_target|P25815	-	95	sp|Q8ICR0|CDPK2_PL	-	509	7.1e-09	33.0	0.1	1	1	6e-10	7.7e-09	32.9	0.1	387	439	25	82	11	92	0.81	Protein S100-P (DB01003)
drugbank_target|P26447	-	101	sp|Q8ICR0|CDPK2_PL	-	509	7.2e-09	33.0	0.9	1	1	6.2e-10	7.8e-09	32.9	0.9	379	436	16	80	10	97	0.85	Protein S100-A4 (DB00831; DB09130)
drugbank_target|P31151	-	101	sp|Q8ICR0|CDPK2_PL	-	509	5.2e-08	30.2	0.3	1	1	4.3e-09	5.5e-08	30.1	0.3	388	442	33	86	6	93	0.84	Protein S100-A7 (DB01050; DB01593; DB04474; DB09213; DB14487; DB14533; DB14548)
drugbank_target|Q9NXG6	-	502	sp|Q8ICR0|CDPK2_PL	-	509	5.3e-08	30.2	0.1	1	1	5.7e-09	7.3e-08	29.7	0.1	346	436	162	255	151	277	0.80	Transmembrane prolyl 4-hydroxylase (DB00126)
drugbank_target|Q96FQ6	-	103	sp|Q8ICR0|CDPK2_PL	-	509	7.7e-08	29.6	0.0	1	1	6.1e-09	7.7e-08	29.6	0.0	388	435	39	83	15	101	0.85	Protein S100-A16 (DB11093; DB11348; DB14481)
drugbank_target|P29034	-	98	sp|Q8ICR0|CDPK2_PL	-	509	4e-07	27.3	0.5	1	1	3.1e-08	4e-07	27.3	0.5	372	437	10	82	1	92	0.79	Protein S100-A2 (DB00768; DB01373; DB01593; DB09130; DB14487; DB14533; DB14548)
drugbank_target|P05109	-	93	sp|Q8ICR0|CDPK2_PL	-	509	1.2e-06	25.7	0.0	1	1	1.1e-07	1.4e-06	25.5	0.0	462	503	29	69	15	73	0.94	Protein S100-A8 (DB01373; DB01593; DB09130; DB14487; DB14533; DB14548)
drugbank_target|Q86YZ3	-	2850	sp|Q8ICR0|CDPK2_PL	-	509	6.9e-06	23.2	0.4	1	1	5.5e-07	6.9e-06	23.2	0.4	388	440	26	83	12	91	0.75	Hornerin (DB01593; DB14487)
drugbank_target|P51178	-	756	sp|Q8ICR0|CDPK2_PL	-	509	0.00026	18.0	1.0	1	1	3e-05	0.00038	17.4	1.0	408	477	142	209	125	241	0.80	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase delta-1 (DB03401; DB03956)
drugbank_target|Q99584	-	98	sp|Q8ICR0|CDPK2_PL	-	509	0.00039	17.4	0.3	1	1	3.3e-05	0.00042	17.3	0.3	377	443	18	88	2	96	0.75	Protein S100-A13 (DB00768; DB01025; DB01164; DB01373; DB11093; DB11348; DB14481)
drugbank_target|Q8WWQ8	-	2551	sp|Q8IL04|HDP_PLAF	-	205	3.3e-151	498.9	32.3	1	9	6e-33	3.2e-29	100.5	0.1	84	203	402	505	385	506	0.96	Stabilin-2 (DB08818)
drugbank_target|Q8WWQ8	-	2551	sp|Q8IL04|HDP_PLAF	-	205	3.3e-151	498.9	32.3	2	9	8.8e-27	4.6e-23	80.4	0.1	51	158	520	631	511	653	0.73	Stabilin-2 (DB08818)
drugbank_target|Q8WWQ8	-	2551	sp|Q8IL04|HDP_PLAF	-	205	3.3e-151	498.9	32.3	3	9	2.8e-24	1.5e-20	72.2	0.6	125	204	1047	1128	1000	1129	0.91	Stabilin-2 (DB08818)
drugbank_target|Q8WWQ8	-	2551	sp|Q8IL04|HDP_PLAF	-	205	3.3e-151	498.9	32.3	4	9	9.7e-23	5.1e-19	67.2	0.6	55	143	1144	1224	1138	1229	0.93	Stabilin-2 (DB08818)
drugbank_target|Q8WWQ8	-	2551	sp|Q8IL04|HDP_PLAF	-	205	3.3e-151	498.9	32.3	5	9	0.0093	49	1.9	0.1	171	203	1234	1265	1228	1267	0.89	Stabilin-2 (DB08818)
drugbank_target|Q8WWQ8	-	2551	sp|Q8IL04|HDP_PLAF	-	205	3.3e-151	498.9	32.3	6	9	0.012	61	1.6	0.0	81	127	1624	1667	1614	1678	0.68	Stabilin-2 (DB08818)
drugbank_target|Q8WWQ8	-	2551	sp|Q8IL04|HDP_PLAF	-	205	3.3e-151	498.9	32.3	7	9	1.5e-13	8.1e-10	37.1	2.5	154	203	1671	1724	1650	1725	0.87	Stabilin-2 (DB08818)
drugbank_target|Q8WWQ8	-	2551	sp|Q8IL04|HDP_PLAF	-	205	3.3e-151	498.9	32.3	8	9	1.6e-28	8.5e-25	86.1	0.0	52	133	1744	1826	1736	1841	0.89	Stabilin-2 (DB08818)
drugbank_target|Q8WWQ8	-	2551	sp|Q8IL04|HDP_PLAF	-	205	3.3e-151	498.9	32.3	9	9	1.5e-21	7.8e-18	63.3	0.0	129	203	2372	2446	2367	2448	0.93	Stabilin-2 (DB08818)
drugbank_target|P35579	-	1960	sp|Q8IDR3|MYOA_PLA	-	818	0	1144.4	5.6	1	2	0	0	1144.4	5.6	96	809	80	811	47	820	0.94	Myosin-9 (DB11638)
drugbank_target|P35579	-	1960	sp|Q8IDR3|MYOA_PLA	-	818	0	1144.4	5.6	2	2	6	5.3e+03	-8.0	4.1	329	412	1040	1125	1009	1144	0.54	Myosin-9 (DB11638)
drugbank_target|P35749	-	1972	sp|Q8IDR3|MYOA_PLA	-	818	0	1139.6	7.3	1	1	0	0	1138.3	7.3	96	810	84	819	46	828	0.93	Myosin-11 (DB04444)
drugbank_target|Q7Z406	-	1995	sp|Q8IDR3|MYOA_PLA	-	818	0	1103.2	0.0	1	1	0	0	1102.5	0.0	98	810	106	839	94	845	0.95	Myosin-14 (DB01944; DB03126; DB04444; DB07468; DB07469; DB07470; DB08276)
drugbank_target|P12883	-	1935	sp|Q8IDR3|MYOA_PLA	-	818	0	1090.9	2.5	1	2	0	0	1090.9	2.5	98	816	86	823	41	825	0.94	Myosin-7 (DB08378)
drugbank_target|P12883	-	1935	sp|Q8IDR3|MYOA_PLA	-	818	0	1090.9	2.5	2	2	0.84	7.4e+02	-4.1	2.4	720	781	960	1021	958	1045	0.79	Myosin-7 (DB08378)
drugbank_target|Q12965	-	1108	sp|Q8IDR3|MYOA_PLA	-	818	0	1024.6	10.0	1	1	0	0	1024.1	10.0	92	807	14	729	5	738	0.95	Unconventional myosin-Ie (DB03366)
drugbank_target|Q8NEV4	-	1616	sp|Q8IDR3|MYOA_PLA	-	818	5.7e-304	1008.5	15.8	1	1	2.8e-306	2.5e-303	1006.3	15.7	96	816	337	1098	299	1100	0.94	Myosin-IIIa (DB12010)
drugbank_target|P07771	-	348	sp|Q8IED5|FER_PLAF	-	194	2.2e-45	152.8	1.1	1	1	6.2e-49	3.3e-45	152.3	1.1	99	191	14	111	5	114	0.97	Benzoate 1,2-dioxygenase electron transfer component (DB03147)
drugbank_target|P0DP23	-	149	sp|P62203|CALM_PLA	-	149	6e-64	213.1	6.6	1	1	1e-65	6.6e-64	213.0	6.6	1	149	1	149	1	149	0.99	Calmodulin (DB00477; DB00527; DB00622; DB00623; DB00753; DB00831; DB00836; DB00850; DB00925; DB01023; DB01065; DB01069; DB01100; DB01115; DB01244; DB01373; DB01429; DB02868; DB03900; DB03977; DB04513; DB04825; DB04841; DB08039; DB08231; DB11093; DB11348; DB13800; DB14481)
drugbank_target|P0DP24	-	149	sp|P62203|CALM_PLA	-	149	6e-64	213.1	6.6	1	1	1e-65	6.6e-64	213.0	6.6	1	149	1	149	1	149	0.99	Calmodulin-2 (DB11093; DB11348; DB14481)
drugbank_target|P0DP25	-	149	sp|P62203|CALM_PLA	-	149	6e-64	213.1	6.6	1	1	1e-65	6.6e-64	213.0	6.6	1	149	1	149	1	149	0.99	Calmodulin-3 (DB11093; DB11348; DB14481)
drugbank_target|P02585	-	160	sp|P62203|CALM_PLA	-	149	4.2e-49	164.9	5.2	1	1	8.4e-51	5.4e-49	164.6	5.2	5	146	12	156	9	158	0.96	Troponin C, skeletal muscle (DB01023; DB01373; DB04682)
drugbank_target|P63316	-	161	sp|P62203|CALM_PLA	-	149	6.8e-46	154.5	8.6	1	1	1.3e-47	8.3e-46	154.2	8.6	3	146	10	157	8	159	0.96	Troponin C, slow skeletal and cardiac muscles (DB00831; DB00922; DB01023; DB01244; DB01373; DB01375; DB03944; DB04513)
drugbank_target|P63098	-	170	sp|P62203|CALM_PLA	-	149	1.4e-43	147.0	2.6	1	1	2.5e-45	1.6e-43	146.8	2.6	1	146	11	157	11	159	0.96	Calcineurin subunit B type 1 (DB08231; DB11693)
drugbank_target|Q96LZ3	-	170	sp|P62203|CALM_PLA	-	149	4.8e-42	142.0	2.6	1	1	8.6e-44	5.6e-42	141.8	2.6	1	146	11	157	11	159	0.97	Calcineurin subunit B type 2 (DB00091; DB11693)
drugbank_target|P19105	-	171	sp|P62203|CALM_PLA	-	149	2.2e-39	133.4	3.4	1	1	4.3e-41	2.8e-39	133.0	3.4	4	146	24	162	10	164	0.98	Myosin regulatory light chain 12A (DB08378)
drugbank_target|P22676	-	271	sp|P62203|CALM_PLA	-	149	2.5e-39	133.2	8.3	1	2	1.6e-32	1.1e-30	105.2	2.3	4	146	12	180	11	183	0.92	Calretinin (DB11093; DB11348; DB13800; DB14481)
drugbank_target|P22676	-	271	sp|P62203|CALM_PLA	-	149	2.5e-39	133.2	8.3	2	2	8e-10	5.2e-08	31.6	0.4	9	54	196	242	191	249	0.87	Calretinin (DB11093; DB11348; DB13800; DB14481)
drugbank_target|O75340	-	191	sp|P62203|CALM_PLA	-	149	6.5e-38	128.6	0.8	1	2	7.3e-37	4.8e-35	119.3	0.1	15	145	30	154	25	158	0.96	Programmed cell death protein 6 (DB01373; DB01593; DB11093; DB11348; DB14481; DB14487)
drugbank_target|O75340	-	191	sp|P62203|CALM_PLA	-	149	6.5e-38	128.6	0.8	2	2	0.012	0.8	8.2	0.1	85	102	160	177	156	189	0.67	Programmed cell death protein 6 (DB01373; DB01593; DB11093; DB11348; DB14481; DB14487)
drugbank_target|P43080	-	201	sp|P62203|CALM_PLA	-	149	3.1e-36	123.1	0.5	1	1	6.8e-38	4.4e-36	122.7	0.5	3	146	11	160	9	162	0.90	Guanylyl cyclase-activating protein 1 (DB08231)
drugbank_target|P62344	-	524	sp|P62203|CALM_PLA	-	149	4.1e-36	122.8	19.5	1	2	1e-07	6.5e-06	24.8	0.8	24	107	310	398	293	404	0.80	Calcium-dependent protein kinase 1 (DB12010)
drugbank_target|P62344	-	524	sp|P62203|CALM_PLA	-	149	4.1e-36	122.8	19.5	2	2	2.8e-34	1.8e-32	110.9	11.9	6	146	370	515	364	517	0.89	Calcium-dependent protein kinase 1 (DB12010)
drugbank_target|P62166	-	190	sp|P62203|CALM_PLA	-	149	4.7e-35	119.3	2.7	1	1	1e-36	6.6e-35	118.9	2.7	4	144	21	171	19	174	0.89	Neuronal calcium sensor 1 (DB11093; DB11348; DB14481)
drugbank_target|P14649	-	208	sp|P62203|CALM_PLA	-	149	8.9e-35	118.4	0.1	1	1	1.6e-36	1e-34	118.2	0.1	4	147	60	206	57	208	0.94	Myosin light chain 6B (DB08378)
drugbank_target|P20807	-	821	sp|P62203|CALM_PLA	-	149	2.2e-34	117.2	10.1	1	2	3.9e-15	2.6e-13	48.8	0.9	6	75	647	723	643	726	0.85	Calpain-3 (DB06124)
drugbank_target|P20807	-	821	sp|P62203|CALM_PLA	-	149	2.2e-34	117.2	10.1	2	2	3.5e-23	2.3e-21	74.9	0.9	9	108	723	814	722	820	0.94	Calpain-3 (DB06124)
drugbank_target|P35243	-	200	sp|P62203|CALM_PLA	-	149	4e-34	116.3	1.3	1	1	9.5e-36	6.2e-34	115.7	1.3	3	145	21	175	19	179	0.90	Recoverin (DB08231)
drugbank_target|P04632	-	268	sp|P62203|CALM_PLA	-	149	1.6e-33	114.3	0.2	1	2	3e-14	1.9e-12	45.9	0.0	6	74	94	169	90	171	0.88	Calpain small subunit 1 (DB02570)
drugbank_target|P04632	-	268	sp|P62203|CALM_PLA	-	149	1.6e-33	114.3	0.2	2	2	5.5e-21	3.6e-19	67.8	0.1	9	103	170	256	168	265	0.95	Calpain small subunit 1 (DB02570)
drugbank_target|Q8IBS5	-	528	sp|P62203|CALM_PLA	-	149	1.2e-32	111.5	5.6	1	1	4.6e-34	3e-32	110.2	5.6	6	147	374	523	368	524	0.90	Calcium-dependent protein kinase 4 (DB11638)
drugbank_target|Q99653	-	195	sp|P62203|CALM_PLA	-	149	1.5e-31	107.9	0.4	1	1	3.7e-33	2.4e-31	107.3	0.4	4	146	22	180	19	182	0.90	Calcineurin B homologous protein 1 (DB11093; DB11348; DB14481)
drugbank_target|Q9UBV8	-	284	sp|P62203|CALM_PLA	-	149	4.3e-30	103.2	0.1	1	1	3.5e-31	2.3e-29	100.9	0.1	14	146	120	247	117	282	0.95	Peflin (DB11093; DB11348; DB14481)
drugbank_target|P30626	-	198	sp|P62203|CALM_PLA	-	149	1.7e-29	101.3	0.0	1	1	7.2e-31	4.6e-29	99.9	0.0	13	147	35	164	26	166	0.93	Sorcin (DB11093; DB11348; DB14481)
drugbank_target|O75746	-	678	sp|P62203|CALM_PLA	-	149	1.4e-28	98.3	2.2	1	3	3.6e-09	2.3e-07	29.5	0.0	74	145	4	80	1	82	0.90	Calcium-binding mitochondrial carrier protein Aralar1 (DB00128)
drugbank_target|O75746	-	678	sp|P62203|CALM_PLA	-	149	1.4e-28	98.3	2.2	2	3	1.4e-19	9.3e-18	63.2	2.8	13	141	91	218	88	257	0.84	Calcium-binding mitochondrial carrier protein Aralar1 (DB00128)
drugbank_target|O75746	-	678	sp|P62203|CALM_PLA	-	149	1.4e-28	98.3	2.2	3	3	0.56	37	2.8	0.0	62	140	212	287	200	289	0.73	Calcium-binding mitochondrial carrier protein Aralar1 (DB00128)
drugbank_target|Q13938	-	189	sp|P62203|CALM_PLA	-	149	2.9e-27	94.1	0.0	1	1	8.3e-29	5.4e-27	93.2	0.0	10	144	23	164	19	167	0.88	Calcyphosin (DB11093; DB11348; DB14481)
drugbank_target|P07384	-	714	sp|P62203|CALM_PLA	-	149	3.5e-27	93.8	3.4	1	2	8.8e-28	5.7e-26	89.9	0.5	5	147	538	680	535	682	0.90	Calpain-1 catalytic subunit (DB04276; DB04653; DB07627)
drugbank_target|P07384	-	714	sp|P62203|CALM_PLA	-	149	3.5e-27	93.8	3.4	2	2	0.00035	0.023	13.3	0.1	49	106	655	705	653	713	0.85	Calpain-1 catalytic subunit (DB04276; DB04653; DB07627)
drugbank_target|P28676	-	217	sp|P62203|CALM_PLA	-	149	4.8e-26	90.1	0.0	1	1	1.1e-27	7.2e-26	89.5	0.0	16	146	57	182	49	184	0.90	Grancalcin (DB11093; DB11348; DB14481)
drugbank_target|Q9UJS0	-	675	sp|P62203|CALM_PLA	-	149	7.4e-25	86.2	0.3	1	2	6.2e-21	4e-19	67.6	0.4	17	147	24	156	10	158	0.92	Calcium-binding mitochondrial carrier protein Aralar2 (DB00128)
drugbank_target|Q9UJS0	-	675	sp|P62203|CALM_PLA	-	149	7.4e-25	86.2	0.3	2	2	2.9e-05	0.0019	16.8	0.0	9	131	159	279	155	289	0.80	Calcium-binding mitochondrial carrier protein Aralar2 (DB00128)
drugbank_target|O75838	-	187	sp|P62203|CALM_PLA	-	149	6.6e-24	83.2	0.8	1	1	1.6e-25	1e-23	82.5	0.8	37	146	62	173	57	175	0.94	Calcium and integrin-binding family member 2 (DB11093; DB11348; DB14481)
drugbank_target|P12814	-	892	sp|P62203|CALM_PLA	-	149	1.6e-23	81.9	0.0	1	1	6.1e-25	3.9e-23	80.6	0.0	2	108	740	850	739	858	0.95	Alpha-actinin-1 (DB06773; DB09130)
drugbank_target|Q99828	-	191	sp|P62203|CALM_PLA	-	149	1.6e-19	68.9	0.1	1	1	3.7e-21	2.4e-19	68.4	0.1	37	146	61	177	52	179	0.88	Calcium and integrin-binding protein 1 (DB11093; DB11348; DB14481)
drugbank_target|Q9Y6T7	-	804	sp|P62203|CALM_PLA	-	149	8.1e-19	66.6	1.0	1	2	0.23	15	4.1	0.2	60	93	54	87	5	90	0.78	Diacylglycerol kinase beta (DB14001)
drugbank_target|Q9Y6T7	-	804	sp|P62203|CALM_PLA	-	149	8.1e-19	66.6	1.0	2	2	9.3e-19	6.1e-17	60.6	0.0	67	144	136	221	126	224	0.83	Diacylglycerol kinase beta (DB14001)
drugbank_target|P20472	-	110	sp|P62203|CALM_PLA	-	149	3.3e-18	64.7	2.0	1	1	6.1e-20	4e-18	64.4	2.0	61	146	22	107	4	109	0.89	Parvalbumin alpha (DB01942)
drugbank_target|P23297	-	94	sp|P62203|CALM_PLA	-	149	8.4e-17	60.1	0.9	1	1	1.4e-18	9.1e-17	60.0	0.9	81	147	7	80	1	82	0.90	Protein S100-A1 (DB00768)
drugbank_target|Q9NXG6	-	502	sp|P62203|CALM_PLA	-	149	2.7e-15	55.2	0.0	1	1	7.1e-17	4.6e-15	54.5	0.0	19	145	126	252	124	255	0.93	Transmembrane prolyl 4-hydroxylase (DB00126)
drugbank_target|P29377	-	79	sp|P62203|CALM_PLA	-	149	2.8e-15	55.1	0.3	1	1	4.9e-17	3.2e-15	55.0	0.3	79	146	3	74	1	76	0.92	Protein S100-G (DB04464)
drugbank_target|P06703	-	90	sp|P62203|CALM_PLA	-	149	5.6e-15	54.2	0.3	1	1	9.9e-17	6.4e-15	54.0	0.3	86	146	12	77	6	80	0.91	Protein S100-A6 (DB11093; DB11348; DB14481)
drugbank_target|P60903	-	97	sp|P62203|CALM_PLA	-	149	6.6e-15	53.9	0.3	1	1	1.2e-16	7.8e-15	53.7	0.3	80	146	6	76	1	78	0.92	Protein S100-A10 (DB12695)
drugbank_target|P04271	-	92	sp|P62203|CALM_PLA	-	149	7.9e-15	53.7	2.5	1	1	1.4e-16	8.8e-15	53.5	2.5	81	146	6	78	1	81	0.83	Protein S100-B (DB00768; DB01373; DB04464; DB05343; DB06941; DB07004; DB11093; DB11348; DB14481)
drugbank_target|P31949	-	105	sp|P62203|CALM_PLA	-	149	2e-14	52.4	0.1	1	1	3.7e-16	2.4e-14	52.1	0.1	80	146	11	84	2	86	0.88	Protein S100-A11 (DB02482)
drugbank_target|P23743	-	735	sp|P62203|CALM_PLA	-	149	2.8e-14	51.9	0.1	1	2	9.1	5.9e+02	-1.1	0.0	99	146	6	57	2	80	0.55	Diacylglycerol kinase alpha (DB00163)
drugbank_target|P23743	-	735	sp|P62203|CALM_PLA	-	149	2.8e-14	51.9	0.1	2	2	1.8e-15	1.2e-13	49.9	0.0	74	144	103	182	83	184	0.84	Diacylglycerol kinase alpha (DB00163)
drugbank_target|P23743	-	735	sp|P62203|CALM_PLA	-	149	2.8e-14	51.9	0.1	1	2	9.1	5.9e+02	-1.1	0.0	99	146	6	57	2	80	0.55	Diacylglycerol kinase alpha (DB14001)
drugbank_target|P23743	-	735	sp|P62203|CALM_PLA	-	149	2.8e-14	51.9	0.1	2	2	1.8e-15	1.2e-13	49.9	0.0	74	144	103	182	83	184	0.84	Diacylglycerol kinase alpha (DB14001)
drugbank_target|P49619	-	791	sp|P62203|CALM_PLA	-	149	4.3e-14	51.3	0.0	1	1	1.4e-15	9.1e-14	50.2	0.0	70	144	165	247	152	250	0.83	Diacylglycerol kinase gamma (DB00144)
drugbank_target|P49619	-	791	sp|P62203|CALM_PLA	-	149	4.3e-14	51.3	0.0	1	1	1.4e-15	9.1e-14	50.2	0.0	70	144	165	247	152	250	0.83	Diacylglycerol kinase gamma (DB14001)
drugbank_target|P26447	-	101	sp|P62203|CALM_PLA	-	149	6.1e-14	50.8	0.1	1	1	1.3e-15	8.5e-14	50.3	0.1	82	146	8	79	2	81	0.84	Protein S100-A4 (DB00831; DB09130)
drugbank_target|P29034	-	98	sp|P62203|CALM_PLA	-	149	4e-13	48.2	0.3	1	1	7.1e-15	4.6e-13	48.0	0.3	83	146	10	80	1	82	0.85	Protein S100-A2 (DB00768; DB01373; DB01593; DB09130; DB14487; DB14533; DB14548)
drugbank_target|P80511	-	92	sp|P62203|CALM_PLA	-	149	4.6e-13	48.0	0.8	1	1	7.8e-15	5.1e-13	47.8	0.8	81	146	6	78	1	81	0.80	Protein S100-A12 (DB00768; DB01025)
drugbank_target|O60840	-	1977	sp|P62203|CALM_PLA	-	149	1.1e-12	46.8	0.0	1	1	3.8e-14	2.5e-12	45.6	0.0	8	89	1457	1546	1453	1574	0.96	Voltage-dependent L-type calcium channel subunit alpha-1F (DB00393; DB00568; DB01388; DB04855; DB04920; DB09229)
drugbank_target|O60840	-	1977	sp|P62203|CALM_PLA	-	149	1.1e-12	46.8	0.0	1	1	3.8e-14	2.5e-12	45.6	0.0	8	89	1457	1546	1453	1574	0.96	Voltage-dependent L-type calcium channel subunit alpha-1F (DB00153; DB00228; DB00421; DB11148; DB13746)
drugbank_target|O60840	-	1977	sp|P62203|CALM_PLA	-	149	1.1e-12	46.8	0.0	1	1	3.8e-14	2.5e-12	45.6	0.0	8	89	1457	1546	1453	1574	0.96	Voltage-dependent L-type calcium channel subunit alpha-1F (DB00252; DB00653; DB00825; DB09089; DB09231; DB09232; DB09236; DB09238; DB13746)
drugbank_target|O60840	-	1977	sp|P62203|CALM_PLA	-	149	1.1e-12	46.8	0.0	1	1	3.8e-14	2.5e-12	45.6	0.0	8	89	1457	1546	1453	1574	0.96	Voltage-dependent L-type calcium channel subunit alpha-1F (DB00243; DB00273; DB01110; DB01118; DB13961)
drugbank_target|P05109	-	93	sp|P62203|CALM_PLA	-	149	2.2e-12	45.7	0.1	1	1	3.8e-14	2.5e-12	45.6	0.1	81	147	7	76	1	78	0.90	Protein S100-A8 (DB01373; DB01593; DB09130; DB14487; DB14533; DB14548)
drugbank_target|Q8NI22	-	146	sp|P62203|CALM_PLA	-	149	4.2e-12	44.8	0.4	1	1	7.7e-14	5e-12	44.6	0.4	79	146	66	145	41	146	0.86	Multiple coagulation factor deficiency protein 2 (DB00025; DB13998; DB13999)
drugbank_target|P51178	-	756	sp|P62203|CALM_PLA	-	149	6e-12	44.3	1.3	1	1	1.8e-13	1.2e-11	43.4	1.3	41	129	137	221	123	237	0.88	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase delta-1 (DB03401; DB03956)
drugbank_target|P25815	-	95	sp|P62203|CALM_PLA	-	149	1.3e-11	43.3	0.2	1	1	2.1e-13	1.4e-11	43.2	0.2	85	147	10	79	1	81	0.85	Protein S100-P (DB01003)
drugbank_target|P80303	-	420	sp|P62203|CALM_PLA	-	149	1.8e-11	42.8	18.3	1	1	2.7e-13	1.8e-11	42.8	18.3	27	145	182	321	167	325	0.83	Nucleobindin-2 (DB11093; DB11348; DB14481)
drugbank_target|Q01668	-	2161	sp|P62203|CALM_PLA	-	149	1.9e-11	42.7	0.0	1	1	8.3e-13	5.4e-11	41.3	0.0	8	89	1480	1569	1476	1593	0.95	Voltage-dependent L-type calcium channel subunit alpha-1D (DB00270; DB00393; DB00401; DB00568; DB00622; DB00898; DB01023; DB01054; DB01115; DB01388; DB04855; DB04920; DB06712; DB09229; DB09237)
drugbank_target|Q01668	-	2161	sp|P62203|CALM_PLA	-	149	1.9e-11	42.7	0.0	1	1	8.3e-13	5.4e-11	41.3	0.0	8	89	1480	1569	1476	1593	0.95	Voltage-dependent L-type calcium channel subunit alpha-1D (DB00153; DB00228; DB00421; DB11148; DB13746)
drugbank_target|Q01668	-	2161	sp|P62203|CALM_PLA	-	149	1.9e-11	42.7	0.0	1	1	8.3e-13	5.4e-11	41.3	0.0	8	89	1480	1569	1476	1593	0.95	Voltage-dependent L-type calcium channel subunit alpha-1D (DB00252; DB00653; DB00825; DB09089; DB09231; DB09232; DB09236; DB09238; DB13746)
drugbank_target|Q01668	-	2161	sp|P62203|CALM_PLA	-	149	1.9e-11	42.7	0.0	1	1	8.3e-13	5.4e-11	41.3	0.0	8	89	1480	1569	1476	1593	0.95	Voltage-dependent L-type calcium channel subunit alpha-1D (DB00243; DB00273; DB01110; DB01118; DB13961)
drugbank_target|Q92736	-	4967	sp|P62203|CALM_PLA	-	149	2.1e-11	42.6	0.9	1	2	6.3	4.1e+02	-0.5	0.0	48	76	77	105	62	113	0.82	Ryanodine receptor 2 (DB01195; DB09085)
drugbank_target|Q92736	-	4967	sp|P62203|CALM_PLA	-	149	2.1e-11	42.6	0.9	2	2	3e-12	2e-10	39.4	0.3	15	78	4030	4092	4025	4098	0.93	Ryanodine receptor 2 (DB01195; DB09085)
drugbank_target|Q13698	-	1873	sp|P62203|CALM_PLA	-	149	2.4e-11	42.4	0.0	1	1	8.7e-13	5.6e-11	41.2	0.0	8	89	1397	1486	1393	1510	0.95	Voltage-dependent L-type calcium channel subunit alpha-1S (DB00270; DB00393; DB00401; DB00568; DB00898; DB01023; DB01054; DB01115; DB01388; DB04855; DB04920; DB06712; DB09090; DB09229)
drugbank_target|Q13698	-	1873	sp|P62203|CALM_PLA	-	149	2.4e-11	42.4	0.0	1	1	8.7e-13	5.6e-11	41.2	0.0	8	89	1397	1486	1393	1510	0.95	Voltage-dependent L-type calcium channel subunit alpha-1S (DB00153; DB00228; DB00421; DB11148; DB13746)
drugbank_target|Q13698	-	1873	sp|P62203|CALM_PLA	-	149	2.4e-11	42.4	0.0	1	1	8.7e-13	5.6e-11	41.2	0.0	8	89	1397	1486	1393	1510	0.95	Voltage-dependent L-type calcium channel subunit alpha-1S (DB00252; DB00653; DB00825; DB09089; DB09231; DB09232; DB09236; DB09238; DB13746)
drugbank_target|Q13698	-	1873	sp|P62203|CALM_PLA	-	149	2.4e-11	42.4	0.0	1	1	8.7e-13	5.6e-11	41.2	0.0	8	89	1397	1486	1393	1510	0.95	Voltage-dependent L-type calcium channel subunit alpha-1S (DB00243; DB00273; DB01110; DB01118; DB13961)
drugbank_target|Q13936	-	2221	sp|P62203|CALM_PLA	-	149	6.6e-11	41.0	0.0	1	1	2.6e-12	1.7e-10	39.6	0.0	8	89	1540	1629	1536	1652	0.95	Voltage-dependent L-type calcium channel subunit alpha-1C (DB00153; DB00228; DB00421; DB11148; DB13746)
drugbank_target|Q13936	-	2221	sp|P62203|CALM_PLA	-	149	6.6e-11	41.0	0.0	1	1	2.6e-12	1.7e-10	39.6	0.0	8	89	1540	1629	1536	1652	0.95	Voltage-dependent L-type calcium channel subunit alpha-1C (DB00252; DB00653; DB00825; DB09089; DB09231; DB09232; DB09236; DB09238; DB13746)
drugbank_target|Q13936	-	2221	sp|P62203|CALM_PLA	-	149	6.6e-11	41.0	0.0	1	1	2.6e-12	1.7e-10	39.6	0.0	8	89	1540	1629	1536	1652	0.95	Voltage-dependent L-type calcium channel subunit alpha-1C (DB00270; DB00308; DB00343; DB00381; DB00393; DB00401; DB00568; DB00622; DB00661; DB00898; DB01023; DB01054; DB01115; DB01373; DB01388; DB04855; DB04920; DB06712; DB06751; DB09227; DB09229; DB09235; DB09237; DB11633; DB12278)
drugbank_target|Q13936	-	2221	sp|P62203|CALM_PLA	-	149	6.6e-11	41.0	0.0	1	1	2.6e-12	1.7e-10	39.6	0.0	8	89	1540	1629	1536	1652	0.95	Voltage-dependent L-type calcium channel subunit alpha-1C (DB00243; DB00273; DB01110; DB01118; DB13961)
drugbank_target|P06702	-	114	sp|P62203|CALM_PLA	-	149	6.9e-11	40.9	4.0	1	1	1.7e-12	1.1e-10	40.2	2.9	19	87	31	95	26	97	0.90	Protein S100-A9 (DB01373; DB01593; DB14487; DB14533; DB14548)
drugbank_target|P31151	-	101	sp|P62203|CALM_PLA	-	149	1.8e-10	39.6	1.0	1	1	3e-12	2e-10	39.4	1.0	81	146	8	79	1	81	0.85	Protein S100-A7 (DB01050; DB01593; DB04474; DB09213; DB14487; DB14533; DB14548)
drugbank_target|Q02818	-	461	sp|P62203|CALM_PLA	-	149	2e-10	39.4	9.1	1	2	9.2	6e+02	-1.1	0.1	14	40	135	161	130	178	0.68	Nucleobindin-1 (DB11093; DB11348; DB14481)
drugbank_target|Q02818	-	461	sp|P62203|CALM_PLA	-	149	2e-10	39.4	9.1	2	2	3.1e-12	2e-10	39.4	9.1	27	144	181	319	166	323	0.83	Nucleobindin-1 (DB11093; DB11348; DB14481)
drugbank_target|Q96FQ6	-	103	sp|P62203|CALM_PLA	-	149	6e-10	37.9	0.1	1	1	1.1e-11	6.9e-10	37.6	0.1	98	146	30	83	6	85	0.84	Protein S100-A16 (DB11093; DB11348; DB14481)
drugbank_target|Q99584	-	98	sp|P62203|CALM_PLA	-	149	7.2e-10	37.6	0.3	1	1	1.3e-11	8.3e-10	37.4	0.3	80	146	10	80	1	85	0.84	Protein S100-A13 (DB00768; DB01025; DB01164; DB01373; DB11093; DB11348; DB14481)
drugbank_target|P21817	-	5038	sp|P62203|CALM_PLA	-	149	1.8e-08	33.1	0.3	1	1	7.7e-10	5e-08	31.6	0.3	15	77	4074	4135	4073	4141	0.93	Ryanodine receptor 1 (DB00201; DB01219; DB04786; DB09085)
drugbank_target|Q86YZ3	-	2850	sp|P62203|CALM_PLA	-	149	1.7e-07	29.9	0.3	1	1	3.9e-09	2.5e-07	29.3	0.3	16	78	24	83	17	89	0.89	Hornerin (DB01593; DB14487)
drugbank_target|P42971	-	668	sp|P62203|CALM_PLA	-	149	0.0018	16.8	3.3	1	1	2.8e-05	0.0018	16.8	3.3	11	101	41	152	33	159	0.83	Penicillin-binding protein 3 (DB00355; DB00493; DB01598; DB04570)
drugbank_target|Q00975	-	2339	sp|P62203|CALM_PLA	-	149	0.0023	16.5	0.0	1	1	8.7e-05	0.0056	15.2	0.0	8	76	1724	1801	1719	1812	0.90	Voltage-dependent N-type calcium channel subunit alpha-1B (DB00381; DB00661; DB01202; DB05885; DB05950; DB06283; DB08838; DB09231; DB09232)
drugbank_target|Q00975	-	2339	sp|P62203|CALM_PLA	-	149	0.0023	16.5	0.0	1	1	8.7e-05	0.0056	15.2	0.0	8	76	1724	1801	1719	1812	0.90	Voltage-dependent N-type calcium channel subunit alpha-1B (DB00153; DB00228; DB00421; DB11148; DB13746)
drugbank_target|Q00975	-	2339	sp|P62203|CALM_PLA	-	149	0.0023	16.5	0.0	1	1	8.7e-05	0.0056	15.2	0.0	8	76	1724	1801	1719	1812	0.90	Voltage-dependent N-type calcium channel subunit alpha-1B (DB00381; DB00996)
drugbank_target|Q15878	-	2313	sp|P62203|CALM_PLA	-	149	0.03	12.9	0.0	1	1	0.001	0.067	11.7	0.0	8	77	1739	1816	1734	1827	0.89	Voltage-dependent R-type calcium channel subunit alpha-1E (DB00153; DB00228; DB00421; DB11148; DB13746)
drugbank_target|Q15878	-	2313	sp|P62203|CALM_PLA	-	149	0.03	12.9	0.0	1	1	0.001	0.067	11.7	0.0	8	77	1739	1816	1734	1827	0.89	Voltage-dependent R-type calcium channel subunit alpha-1E (DB00273)
drugbank_target|Q15878	-	2313	sp|P62203|CALM_PLA	-	149	0.03	12.9	0.0	1	1	0.001	0.067	11.7	0.0	8	77	1739	1816	1734	1827	0.89	Voltage-dependent R-type calcium channel subunit alpha-1E (DB00555)
drugbank_target|P0DP23	-	149	sp|P24044|CALM_PLA	-	149	6e-64	213.1	6.6	1	1	1e-65	6.6e-64	213.0	6.6	1	149	1	149	1	149	0.99	Calmodulin (DB00477; DB00527; DB00622; DB00623; DB00753; DB00831; DB00836; DB00850; DB00925; DB01023; DB01065; DB01069; DB01100; DB01115; DB01244; DB01373; DB01429; DB02868; DB03900; DB03977; DB04513; DB04825; DB04841; DB08039; DB08231; DB11093; DB11348; DB13800; DB14481)
drugbank_target|P0DP24	-	149	sp|P24044|CALM_PLA	-	149	6e-64	213.1	6.6	1	1	1e-65	6.6e-64	213.0	6.6	1	149	1	149	1	149	0.99	Calmodulin-2 (DB11093; DB11348; DB14481)
drugbank_target|P0DP25	-	149	sp|P24044|CALM_PLA	-	149	6e-64	213.1	6.6	1	1	1e-65	6.6e-64	213.0	6.6	1	149	1	149	1	149	0.99	Calmodulin-3 (DB11093; DB11348; DB14481)
drugbank_target|P02585	-	160	sp|P24044|CALM_PLA	-	149	4.2e-49	164.9	5.2	1	1	8.4e-51	5.4e-49	164.6	5.2	5	146	12	156	9	158	0.96	Troponin C, skeletal muscle (DB01023; DB01373; DB04682)
drugbank_target|P63316	-	161	sp|P24044|CALM_PLA	-	149	6.8e-46	154.5	8.6	1	1	1.3e-47	8.3e-46	154.2	8.6	3	146	10	157	8	159	0.96	Troponin C, slow skeletal and cardiac muscles (DB00831; DB00922; DB01023; DB01244; DB01373; DB01375; DB03944; DB04513)
drugbank_target|P63098	-	170	sp|P24044|CALM_PLA	-	149	1.4e-43	147.0	2.6	1	1	2.5e-45	1.6e-43	146.8	2.6	1	146	11	157	11	159	0.96	Calcineurin subunit B type 1 (DB08231; DB11693)
drugbank_target|Q96LZ3	-	170	sp|P24044|CALM_PLA	-	149	4.8e-42	142.0	2.6	1	1	8.6e-44	5.6e-42	141.8	2.6	1	146	11	157	11	159	0.97	Calcineurin subunit B type 2 (DB00091; DB11693)
drugbank_target|P19105	-	171	sp|P24044|CALM_PLA	-	149	2.2e-39	133.4	3.4	1	1	4.3e-41	2.8e-39	133.0	3.4	4	146	24	162	10	164	0.98	Myosin regulatory light chain 12A (DB08378)
drugbank_target|P22676	-	271	sp|P24044|CALM_PLA	-	149	2.5e-39	133.2	8.3	1	2	1.6e-32	1.1e-30	105.2	2.3	4	146	12	180	11	183	0.92	Calretinin (DB11093; DB11348; DB13800; DB14481)
drugbank_target|P22676	-	271	sp|P24044|CALM_PLA	-	149	2.5e-39	133.2	8.3	2	2	8e-10	5.2e-08	31.6	0.4	9	54	196	242	191	249	0.87	Calretinin (DB11093; DB11348; DB13800; DB14481)
drugbank_target|O75340	-	191	sp|P24044|CALM_PLA	-	149	6.5e-38	128.6	0.8	1	2	7.3e-37	4.8e-35	119.3	0.1	15	145	30	154	25	158	0.96	Programmed cell death protein 6 (DB01373; DB01593; DB11093; DB11348; DB14481; DB14487)
drugbank_target|O75340	-	191	sp|P24044|CALM_PLA	-	149	6.5e-38	128.6	0.8	2	2	0.012	0.8	8.2	0.1	85	102	160	177	156	189	0.67	Programmed cell death protein 6 (DB01373; DB01593; DB11093; DB11348; DB14481; DB14487)
drugbank_target|P43080	-	201	sp|P24044|CALM_PLA	-	149	3.1e-36	123.1	0.5	1	1	6.8e-38	4.4e-36	122.7	0.5	3	146	11	160	9	162	0.90	Guanylyl cyclase-activating protein 1 (DB08231)
drugbank_target|P62344	-	524	sp|P24044|CALM_PLA	-	149	4.1e-36	122.8	19.5	1	2	1e-07	6.5e-06	24.8	0.8	24	107	310	398	293	404	0.80	Calcium-dependent protein kinase 1 (DB12010)
drugbank_target|P62344	-	524	sp|P24044|CALM_PLA	-	149	4.1e-36	122.8	19.5	2	2	2.8e-34	1.8e-32	110.9	11.9	6	146	370	515	364	517	0.89	Calcium-dependent protein kinase 1 (DB12010)
drugbank_target|P62166	-	190	sp|P24044|CALM_PLA	-	149	4.7e-35	119.3	2.7	1	1	1e-36	6.6e-35	118.9	2.7	4	144	21	171	19	174	0.89	Neuronal calcium sensor 1 (DB11093; DB11348; DB14481)
drugbank_target|P14649	-	208	sp|P24044|CALM_PLA	-	149	8.9e-35	118.4	0.1	1	1	1.6e-36	1e-34	118.2	0.1	4	147	60	206	57	208	0.94	Myosin light chain 6B (DB08378)
drugbank_target|P20807	-	821	sp|P24044|CALM_PLA	-	149	2.2e-34	117.2	10.1	1	2	3.9e-15	2.6e-13	48.8	0.9	6	75	647	723	643	726	0.85	Calpain-3 (DB06124)
drugbank_target|P20807	-	821	sp|P24044|CALM_PLA	-	149	2.2e-34	117.2	10.1	2	2	3.5e-23	2.3e-21	74.9	0.9	9	108	723	814	722	820	0.94	Calpain-3 (DB06124)
drugbank_target|P35243	-	200	sp|P24044|CALM_PLA	-	149	4e-34	116.3	1.3	1	1	9.5e-36	6.2e-34	115.7	1.3	3	145	21	175	19	179	0.90	Recoverin (DB08231)
drugbank_target|P04632	-	268	sp|P24044|CALM_PLA	-	149	1.6e-33	114.3	0.2	1	2	3e-14	1.9e-12	45.9	0.0	6	74	94	169	90	171	0.88	Calpain small subunit 1 (DB02570)
drugbank_target|P04632	-	268	sp|P24044|CALM_PLA	-	149	1.6e-33	114.3	0.2	2	2	5.5e-21	3.6e-19	67.8	0.1	9	103	170	256	168	265	0.95	Calpain small subunit 1 (DB02570)
drugbank_target|Q8IBS5	-	528	sp|P24044|CALM_PLA	-	149	1.2e-32	111.5	5.6	1	1	4.6e-34	3e-32	110.2	5.6	6	147	374	523	368	524	0.90	Calcium-dependent protein kinase 4 (DB11638)
drugbank_target|Q99653	-	195	sp|P24044|CALM_PLA	-	149	1.5e-31	107.9	0.4	1	1	3.7e-33	2.4e-31	107.3	0.4	4	146	22	180	19	182	0.90	Calcineurin B homologous protein 1 (DB11093; DB11348; DB14481)
drugbank_target|Q9UBV8	-	284	sp|P24044|CALM_PLA	-	149	4.3e-30	103.2	0.1	1	1	3.5e-31	2.3e-29	100.9	0.1	14	146	120	247	117	282	0.95	Peflin (DB11093; DB11348; DB14481)
drugbank_target|P30626	-	198	sp|P24044|CALM_PLA	-	149	1.7e-29	101.3	0.0	1	1	7.2e-31	4.6e-29	99.9	0.0	13	147	35	164	26	166	0.93	Sorcin (DB11093; DB11348; DB14481)
drugbank_target|O75746	-	678	sp|P24044|CALM_PLA	-	149	1.4e-28	98.3	2.2	1	3	3.6e-09	2.3e-07	29.5	0.0	74	145	4	80	1	82	0.90	Calcium-binding mitochondrial carrier protein Aralar1 (DB00128)
drugbank_target|O75746	-	678	sp|P24044|CALM_PLA	-	149	1.4e-28	98.3	2.2	2	3	1.4e-19	9.3e-18	63.2	2.8	13	141	91	218	88	257	0.84	Calcium-binding mitochondrial carrier protein Aralar1 (DB00128)
drugbank_target|O75746	-	678	sp|P24044|CALM_PLA	-	149	1.4e-28	98.3	2.2	3	3	0.56	37	2.8	0.0	62	140	212	287	200	289	0.73	Calcium-binding mitochondrial carrier protein Aralar1 (DB00128)
drugbank_target|Q13938	-	189	sp|P24044|CALM_PLA	-	149	2.9e-27	94.1	0.0	1	1	8.3e-29	5.4e-27	93.2	0.0	10	144	23	164	19	167	0.88	Calcyphosin (DB11093; DB11348; DB14481)
drugbank_target|P07384	-	714	sp|P24044|CALM_PLA	-	149	3.5e-27	93.8	3.4	1	2	8.8e-28	5.7e-26	89.9	0.5	5	147	538	680	535	682	0.90	Calpain-1 catalytic subunit (DB04276; DB04653; DB07627)
drugbank_target|P07384	-	714	sp|P24044|CALM_PLA	-	149	3.5e-27	93.8	3.4	2	2	0.00035	0.023	13.3	0.1	49	106	655	705	653	713	0.85	Calpain-1 catalytic subunit (DB04276; DB04653; DB07627)
drugbank_target|P28676	-	217	sp|P24044|CALM_PLA	-	149	4.8e-26	90.1	0.0	1	1	1.1e-27	7.2e-26	89.5	0.0	16	146	57	182	49	184	0.90	Grancalcin (DB11093; DB11348; DB14481)
drugbank_target|Q9UJS0	-	675	sp|P24044|CALM_PLA	-	149	7.4e-25	86.2	0.3	1	2	6.2e-21	4e-19	67.6	0.4	17	147	24	156	10	158	0.92	Calcium-binding mitochondrial carrier protein Aralar2 (DB00128)
drugbank_target|Q9UJS0	-	675	sp|P24044|CALM_PLA	-	149	7.4e-25	86.2	0.3	2	2	2.9e-05	0.0019	16.8	0.0	9	131	159	279	155	289	0.80	Calcium-binding mitochondrial carrier protein Aralar2 (DB00128)
drugbank_target|O75838	-	187	sp|P24044|CALM_PLA	-	149	6.6e-24	83.2	0.8	1	1	1.6e-25	1e-23	82.5	0.8	37	146	62	173	57	175	0.94	Calcium and integrin-binding family member 2 (DB11093; DB11348; DB14481)
drugbank_target|P12814	-	892	sp|P24044|CALM_PLA	-	149	1.6e-23	81.9	0.0	1	1	6.1e-25	3.9e-23	80.6	0.0	2	108	740	850	739	858	0.95	Alpha-actinin-1 (DB06773; DB09130)
drugbank_target|Q99828	-	191	sp|P24044|CALM_PLA	-	149	1.6e-19	68.9	0.1	1	1	3.7e-21	2.4e-19	68.4	0.1	37	146	61	177	52	179	0.88	Calcium and integrin-binding protein 1 (DB11093; DB11348; DB14481)
drugbank_target|Q9Y6T7	-	804	sp|P24044|CALM_PLA	-	149	8.1e-19	66.6	1.0	1	2	0.23	15	4.1	0.2	60	93	54	87	5	90	0.78	Diacylglycerol kinase beta (DB14001)
drugbank_target|Q9Y6T7	-	804	sp|P24044|CALM_PLA	-	149	8.1e-19	66.6	1.0	2	2	9.3e-19	6.1e-17	60.6	0.0	67	144	136	221	126	224	0.83	Diacylglycerol kinase beta (DB14001)
drugbank_target|P20472	-	110	sp|P24044|CALM_PLA	-	149	3.3e-18	64.7	2.0	1	1	6.1e-20	4e-18	64.4	2.0	61	146	22	107	4	109	0.89	Parvalbumin alpha (DB01942)
drugbank_target|P23297	-	94	sp|P24044|CALM_PLA	-	149	8.4e-17	60.1	0.9	1	1	1.4e-18	9.1e-17	60.0	0.9	81	147	7	80	1	82	0.90	Protein S100-A1 (DB00768)
drugbank_target|Q9NXG6	-	502	sp|P24044|CALM_PLA	-	149	2.7e-15	55.2	0.0	1	1	7.1e-17	4.6e-15	54.5	0.0	19	145	126	252	124	255	0.93	Transmembrane prolyl 4-hydroxylase (DB00126)
drugbank_target|P29377	-	79	sp|P24044|CALM_PLA	-	149	2.8e-15	55.1	0.3	1	1	4.9e-17	3.2e-15	55.0	0.3	79	146	3	74	1	76	0.92	Protein S100-G (DB04464)
drugbank_target|P06703	-	90	sp|P24044|CALM_PLA	-	149	5.6e-15	54.2	0.3	1	1	9.9e-17	6.4e-15	54.0	0.3	86	146	12	77	6	80	0.91	Protein S100-A6 (DB11093; DB11348; DB14481)
drugbank_target|P60903	-	97	sp|P24044|CALM_PLA	-	149	6.6e-15	53.9	0.3	1	1	1.2e-16	7.8e-15	53.7	0.3	80	146	6	76	1	78	0.92	Protein S100-A10 (DB12695)
drugbank_target|P04271	-	92	sp|P24044|CALM_PLA	-	149	7.9e-15	53.7	2.5	1	1	1.4e-16	8.8e-15	53.5	2.5	81	146	6	78	1	81	0.83	Protein S100-B (DB00768; DB01373; DB04464; DB05343; DB06941; DB07004; DB11093; DB11348; DB14481)
drugbank_target|P31949	-	105	sp|P24044|CALM_PLA	-	149	2e-14	52.4	0.1	1	1	3.7e-16	2.4e-14	52.1	0.1	80	146	11	84	2	86	0.88	Protein S100-A11 (DB02482)
drugbank_target|P23743	-	735	sp|P24044|CALM_PLA	-	149	2.8e-14	51.9	0.1	1	2	9.1	5.9e+02	-1.1	0.0	99	146	6	57	2	80	0.55	Diacylglycerol kinase alpha (DB14001)
drugbank_target|P23743	-	735	sp|P24044|CALM_PLA	-	149	2.8e-14	51.9	0.1	2	2	1.8e-15	1.2e-13	49.9	0.0	74	144	103	182	83	184	0.84	Diacylglycerol kinase alpha (DB14001)
drugbank_target|P23743	-	735	sp|P24044|CALM_PLA	-	149	2.8e-14	51.9	0.1	1	2	9.1	5.9e+02	-1.1	0.0	99	146	6	57	2	80	0.55	Diacylglycerol kinase alpha (DB00163)
drugbank_target|P23743	-	735	sp|P24044|CALM_PLA	-	149	2.8e-14	51.9	0.1	2	2	1.8e-15	1.2e-13	49.9	0.0	74	144	103	182	83	184	0.84	Diacylglycerol kinase alpha (DB00163)
drugbank_target|P49619	-	791	sp|P24044|CALM_PLA	-	149	4.3e-14	51.3	0.0	1	1	1.4e-15	9.1e-14	50.2	0.0	70	144	165	247	152	250	0.83	Diacylglycerol kinase gamma (DB14001)
drugbank_target|P49619	-	791	sp|P24044|CALM_PLA	-	149	4.3e-14	51.3	0.0	1	1	1.4e-15	9.1e-14	50.2	0.0	70	144	165	247	152	250	0.83	Diacylglycerol kinase gamma (DB00144)
drugbank_target|P26447	-	101	sp|P24044|CALM_PLA	-	149	6.1e-14	50.8	0.1	1	1	1.3e-15	8.5e-14	50.3	0.1	82	146	8	79	2	81	0.84	Protein S100-A4 (DB00831; DB09130)
drugbank_target|P29034	-	98	sp|P24044|CALM_PLA	-	149	4e-13	48.2	0.3	1	1	7.1e-15	4.6e-13	48.0	0.3	83	146	10	80	1	82	0.85	Protein S100-A2 (DB00768; DB01373; DB01593; DB09130; DB14487; DB14533; DB14548)
drugbank_target|P80511	-	92	sp|P24044|CALM_PLA	-	149	4.6e-13	48.0	0.8	1	1	7.8e-15	5.1e-13	47.8	0.8	81	146	6	78	1	81	0.80	Protein S100-A12 (DB00768; DB01025)
drugbank_target|O60840	-	1977	sp|P24044|CALM_PLA	-	149	1.1e-12	46.8	0.0	1	1	3.8e-14	2.5e-12	45.6	0.0	8	89	1457	1546	1453	1574	0.96	Voltage-dependent L-type calcium channel subunit alpha-1F (DB00243; DB00273; DB01110; DB01118; DB13961)
drugbank_target|O60840	-	1977	sp|P24044|CALM_PLA	-	149	1.1e-12	46.8	0.0	1	1	3.8e-14	2.5e-12	45.6	0.0	8	89	1457	1546	1453	1574	0.96	Voltage-dependent L-type calcium channel subunit alpha-1F (DB00393; DB00568; DB01388; DB04855; DB04920; DB09229)
drugbank_target|O60840	-	1977	sp|P24044|CALM_PLA	-	149	1.1e-12	46.8	0.0	1	1	3.8e-14	2.5e-12	45.6	0.0	8	89	1457	1546	1453	1574	0.96	Voltage-dependent L-type calcium channel subunit alpha-1F (DB00153; DB00228; DB00421; DB11148; DB13746)
drugbank_target|O60840	-	1977	sp|P24044|CALM_PLA	-	149	1.1e-12	46.8	0.0	1	1	3.8e-14	2.5e-12	45.6	0.0	8	89	1457	1546	1453	1574	0.96	Voltage-dependent L-type calcium channel subunit alpha-1F (DB00252; DB00653; DB00825; DB09089; DB09231; DB09232; DB09236; DB09238; DB13746)
drugbank_target|P05109	-	93	sp|P24044|CALM_PLA	-	149	2.2e-12	45.7	0.1	1	1	3.8e-14	2.5e-12	45.6	0.1	81	147	7	76	1	78	0.90	Protein S100-A8 (DB01373; DB01593; DB09130; DB14487; DB14533; DB14548)
drugbank_target|Q8NI22	-	146	sp|P24044|CALM_PLA	-	149	4.2e-12	44.8	0.4	1	1	7.7e-14	5e-12	44.6	0.4	79	146	66	145	41	146	0.86	Multiple coagulation factor deficiency protein 2 (DB00025; DB13998; DB13999)
drugbank_target|P51178	-	756	sp|P24044|CALM_PLA	-	149	6e-12	44.3	1.3	1	1	1.8e-13	1.2e-11	43.4	1.3	41	129	137	221	123	237	0.88	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase delta-1 (DB03401; DB03956)
drugbank_target|P25815	-	95	sp|P24044|CALM_PLA	-	149	1.3e-11	43.3	0.2	1	1	2.1e-13	1.4e-11	43.2	0.2	85	147	10	79	1	81	0.85	Protein S100-P (DB01003)
drugbank_target|P80303	-	420	sp|P24044|CALM_PLA	-	149	1.8e-11	42.8	18.3	1	1	2.7e-13	1.8e-11	42.8	18.3	27	145	182	321	167	325	0.83	Nucleobindin-2 (DB11093; DB11348; DB14481)
drugbank_target|Q01668	-	2161	sp|P24044|CALM_PLA	-	149	1.9e-11	42.7	0.0	1	1	8.3e-13	5.4e-11	41.3	0.0	8	89	1480	1569	1476	1593	0.95	Voltage-dependent L-type calcium channel subunit alpha-1D (DB00243; DB00273; DB01110; DB01118; DB13961)
drugbank_target|Q01668	-	2161	sp|P24044|CALM_PLA	-	149	1.9e-11	42.7	0.0	1	1	8.3e-13	5.4e-11	41.3	0.0	8	89	1480	1569	1476	1593	0.95	Voltage-dependent L-type calcium channel subunit alpha-1D (DB00270; DB00393; DB00401; DB00568; DB00622; DB00898; DB01023; DB01054; DB01115; DB01388; DB04855; DB04920; DB06712; DB09229; DB09237)
drugbank_target|Q01668	-	2161	sp|P24044|CALM_PLA	-	149	1.9e-11	42.7	0.0	1	1	8.3e-13	5.4e-11	41.3	0.0	8	89	1480	1569	1476	1593	0.95	Voltage-dependent L-type calcium channel subunit alpha-1D (DB00153; DB00228; DB00421; DB11148; DB13746)
drugbank_target|Q01668	-	2161	sp|P24044|CALM_PLA	-	149	1.9e-11	42.7	0.0	1	1	8.3e-13	5.4e-11	41.3	0.0	8	89	1480	1569	1476	1593	0.95	Voltage-dependent L-type calcium channel subunit alpha-1D (DB00252; DB00653; DB00825; DB09089; DB09231; DB09232; DB09236; DB09238; DB13746)
drugbank_target|Q92736	-	4967	sp|P24044|CALM_PLA	-	149	2.1e-11	42.6	0.9	1	2	6.3	4.1e+02	-0.5	0.0	48	76	77	105	62	113	0.82	Ryanodine receptor 2 (DB01195; DB09085)
drugbank_target|Q92736	-	4967	sp|P24044|CALM_PLA	-	149	2.1e-11	42.6	0.9	2	2	3e-12	2e-10	39.4	0.3	15	78	4030	4092	4025	4098	0.93	Ryanodine receptor 2 (DB01195; DB09085)
drugbank_target|Q13698	-	1873	sp|P24044|CALM_PLA	-	149	2.4e-11	42.4	0.0	1	1	8.7e-13	5.6e-11	41.2	0.0	8	89	1397	1486	1393	1510	0.95	Voltage-dependent L-type calcium channel subunit alpha-1S (DB00243; DB00273; DB01110; DB01118; DB13961)
drugbank_target|Q13698	-	1873	sp|P24044|CALM_PLA	-	149	2.4e-11	42.4	0.0	1	1	8.7e-13	5.6e-11	41.2	0.0	8	89	1397	1486	1393	1510	0.95	Voltage-dependent L-type calcium channel subunit alpha-1S (DB00270; DB00393; DB00401; DB00568; DB00898; DB01023; DB01054; DB01115; DB01388; DB04855; DB04920; DB06712; DB09090; DB09229)
drugbank_target|Q13698	-	1873	sp|P24044|CALM_PLA	-	149	2.4e-11	42.4	0.0	1	1	8.7e-13	5.6e-11	41.2	0.0	8	89	1397	1486	1393	1510	0.95	Voltage-dependent L-type calcium channel subunit alpha-1S (DB00153; DB00228; DB00421; DB11148; DB13746)
drugbank_target|Q13698	-	1873	sp|P24044|CALM_PLA	-	149	2.4e-11	42.4	0.0	1	1	8.7e-13	5.6e-11	41.2	0.0	8	89	1397	1486	1393	1510	0.95	Voltage-dependent L-type calcium channel subunit alpha-1S (DB00252; DB00653; DB00825; DB09089; DB09231; DB09232; DB09236; DB09238; DB13746)
drugbank_target|Q13936	-	2221	sp|P24044|CALM_PLA	-	149	6.6e-11	41.0	0.0	1	1	2.6e-12	1.7e-10	39.6	0.0	8	89	1540	1629	1536	1652	0.95	Voltage-dependent L-type calcium channel subunit alpha-1C (DB00270; DB00308; DB00343; DB00381; DB00393; DB00401; DB00568; DB00622; DB00661; DB00898; DB01023; DB01054; DB01115; DB01373; DB01388; DB04855; DB04920; DB06712; DB06751; DB09227; DB09229; DB09235; DB09237; DB11633; DB12278)
drugbank_target|Q13936	-	2221	sp|P24044|CALM_PLA	-	149	6.6e-11	41.0	0.0	1	1	2.6e-12	1.7e-10	39.6	0.0	8	89	1540	1629	1536	1652	0.95	Voltage-dependent L-type calcium channel subunit alpha-1C (DB00243; DB00273; DB01110; DB01118; DB13961)
drugbank_target|Q13936	-	2221	sp|P24044|CALM_PLA	-	149	6.6e-11	41.0	0.0	1	1	2.6e-12	1.7e-10	39.6	0.0	8	89	1540	1629	1536	1652	0.95	Voltage-dependent L-type calcium channel subunit alpha-1C (DB00153; DB00228; DB00421; DB11148; DB13746)
drugbank_target|Q13936	-	2221	sp|P24044|CALM_PLA	-	149	6.6e-11	41.0	0.0	1	1	2.6e-12	1.7e-10	39.6	0.0	8	89	1540	1629	1536	1652	0.95	Voltage-dependent L-type calcium channel subunit alpha-1C (DB00252; DB00653; DB00825; DB09089; DB09231; DB09232; DB09236; DB09238; DB13746)
drugbank_target|P06702	-	114	sp|P24044|CALM_PLA	-	149	6.9e-11	40.9	4.0	1	1	1.7e-12	1.1e-10	40.2	2.9	19	87	31	95	26	97	0.90	Protein S100-A9 (DB01373; DB01593; DB14487; DB14533; DB14548)
drugbank_target|P31151	-	101	sp|P24044|CALM_PLA	-	149	1.8e-10	39.6	1.0	1	1	3e-12	2e-10	39.4	1.0	81	146	8	79	1	81	0.85	Protein S100-A7 (DB01050; DB01593; DB04474; DB09213; DB14487; DB14533; DB14548)
drugbank_target|Q02818	-	461	sp|P24044|CALM_PLA	-	149	2e-10	39.4	9.1	1	2	9.2	6e+02	-1.1	0.1	14	40	135	161	130	178	0.68	Nucleobindin-1 (DB11093; DB11348; DB14481)
drugbank_target|Q02818	-	461	sp|P24044|CALM_PLA	-	149	2e-10	39.4	9.1	2	2	3.1e-12	2e-10	39.4	9.1	27	144	181	319	166	323	0.83	Nucleobindin-1 (DB11093; DB11348; DB14481)
drugbank_target|Q96FQ6	-	103	sp|P24044|CALM_PLA	-	149	6e-10	37.9	0.1	1	1	1.1e-11	6.9e-10	37.6	0.1	98	146	30	83	6	85	0.84	Protein S100-A16 (DB11093; DB11348; DB14481)
drugbank_target|Q99584	-	98	sp|P24044|CALM_PLA	-	149	7.2e-10	37.6	0.3	1	1	1.3e-11	8.3e-10	37.4	0.3	80	146	10	80	1	85	0.84	Protein S100-A13 (DB00768; DB01025; DB01164; DB01373; DB11093; DB11348; DB14481)
drugbank_target|P21817	-	5038	sp|P24044|CALM_PLA	-	149	1.8e-08	33.1	0.3	1	1	7.7e-10	5e-08	31.6	0.3	15	77	4074	4135	4073	4141	0.93	Ryanodine receptor 1 (DB00201; DB01219; DB04786; DB09085)
drugbank_target|Q86YZ3	-	2850	sp|P24044|CALM_PLA	-	149	1.7e-07	29.9	0.3	1	1	3.9e-09	2.5e-07	29.3	0.3	16	78	24	83	17	89	0.89	Hornerin (DB01593; DB14487)
drugbank_target|P42971	-	668	sp|P24044|CALM_PLA	-	149	0.0018	16.8	3.3	1	1	2.8e-05	0.0018	16.8	3.3	11	101	41	152	33	159	0.83	Penicillin-binding protein 3 (DB00355; DB00493; DB01598; DB04570)
drugbank_target|Q00975	-	2339	sp|P24044|CALM_PLA	-	149	0.0023	16.5	0.0	1	1	8.7e-05	0.0056	15.2	0.0	8	76	1724	1801	1719	1812	0.90	Voltage-dependent N-type calcium channel subunit alpha-1B (DB00381; DB00661; DB01202; DB05885; DB05950; DB06283; DB08838; DB09231; DB09232)
drugbank_target|Q00975	-	2339	sp|P24044|CALM_PLA	-	149	0.0023	16.5	0.0	1	1	8.7e-05	0.0056	15.2	0.0	8	76	1724	1801	1719	1812	0.90	Voltage-dependent N-type calcium channel subunit alpha-1B (DB00153; DB00228; DB00421; DB11148; DB13746)
drugbank_target|Q00975	-	2339	sp|P24044|CALM_PLA	-	149	0.0023	16.5	0.0	1	1	8.7e-05	0.0056	15.2	0.0	8	76	1724	1801	1719	1812	0.90	Voltage-dependent N-type calcium channel subunit alpha-1B (DB00381; DB00996)
drugbank_target|Q15878	-	2313	sp|P24044|CALM_PLA	-	149	0.03	12.9	0.0	1	1	0.001	0.067	11.7	0.0	8	77	1739	1816	1734	1827	0.89	Voltage-dependent R-type calcium channel subunit alpha-1E (DB00153; DB00228; DB00421; DB11148; DB13746)
drugbank_target|Q15878	-	2313	sp|P24044|CALM_PLA	-	149	0.03	12.9	0.0	1	1	0.001	0.067	11.7	0.0	8	77	1739	1816	1734	1827	0.89	Voltage-dependent R-type calcium channel subunit alpha-1E (DB00273)
drugbank_target|Q15878	-	2313	sp|P24044|CALM_PLA	-	149	0.03	12.9	0.0	1	1	0.001	0.067	11.7	0.0	8	77	1739	1816	1734	1827	0.89	Voltage-dependent R-type calcium channel subunit alpha-1E (DB00555)
drugbank_target|Q15418	-	735	sp|P61075|CDC2H_PL	-	288	1.4e-148	492.1	1.5	1	4	5.3e-75	7.7e-74	246.8	0.1	3	217	61	278	60	292	0.95	Ribosomal protein S6 kinase alpha-1 (DB04751; DB12010)
drugbank_target|Q15418	-	735	sp|P61075|CDC2H_PL	-	288	1.4e-148	492.1	1.5	2	4	7.7	1.1e+02	0.1	0.0	253	273	285	305	279	322	0.86	Ribosomal protein S6 kinase alpha-1 (DB04751; DB12010)
drugbank_target|Q15418	-	735	sp|P61075|CDC2H_PL	-	288	1.4e-148	492.1	1.5	3	4	1.5e-60	2.2e-59	199.4	0.0	3	213	417	625	415	637	0.89	Ribosomal protein S6 kinase alpha-1 (DB04751; DB12010)
drugbank_target|Q15418	-	735	sp|P61075|CDC2H_PL	-	288	1.4e-148	492.1	1.5	4	4	1.5e-12	2.2e-11	41.8	0.1	249	287	640	678	635	679	0.94	Ribosomal protein S6 kinase alpha-1 (DB04751; DB12010)
drugbank_target|P51812	-	740	sp|P61075|CDC2H_PL	-	288	2e-147	488.3	0.5	1	4	1.1e-74	1.6e-73	245.8	0.1	3	217	67	284	66	290	0.95	Ribosomal protein S6 kinase alpha-3 (DB00945; DB12010)
drugbank_target|P51812	-	740	sp|P61075|CDC2H_PL	-	288	2e-147	488.3	0.5	2	4	0.59	8.5	3.8	0.0	253	285	291	328	286	331	0.80	Ribosomal protein S6 kinase alpha-3 (DB00945; DB12010)
drugbank_target|P51812	-	740	sp|P61075|CDC2H_PL	-	288	2e-147	488.3	0.5	3	4	1.7e-60	2.4e-59	199.2	0.0	3	213	421	629	419	641	0.89	Ribosomal protein S6 kinase alpha-3 (DB00945; DB12010)
drugbank_target|P51812	-	740	sp|P61075|CDC2H_PL	-	288	2e-147	488.3	0.5	4	4	2e-10	2.9e-09	34.9	0.1	249	285	644	680	635	683	0.93	Ribosomal protein S6 kinase alpha-3 (DB00945; DB12010)
drugbank_target|Q9UK32	-	745	sp|P61075|CDC2H_PL	-	288	1.2e-145	482.4	1.3	1	4	2.8e-73	4e-72	241.2	0.1	3	217	72	289	71	295	0.95	Ribosomal protein S6 kinase alpha-6 (DB12010)
drugbank_target|Q9UK32	-	745	sp|P61075|CDC2H_PL	-	288	1.2e-145	482.4	1.3	2	4	1.2	17	2.8	0.0	253	286	296	332	292	334	0.80	Ribosomal protein S6 kinase alpha-6 (DB12010)
drugbank_target|Q9UK32	-	745	sp|P61075|CDC2H_PL	-	288	1.2e-145	482.4	1.3	3	4	1.9e-59	2.7e-58	195.8	0.0	3	206	425	627	424	645	0.90	Ribosomal protein S6 kinase alpha-6 (DB12010)
drugbank_target|Q9UK32	-	745	sp|P61075|CDC2H_PL	-	288	1.2e-145	482.4	1.3	4	4	1.4e-11	2e-10	38.7	0.1	249	286	648	685	641	687	0.94	Ribosomal protein S6 kinase alpha-6 (DB12010)
drugbank_target|O75676	-	772	sp|P61075|CDC2H_PL	-	288	1e-132	440.0	0.0	1	3	2.5e-63	3.6e-62	208.5	0.0	2	220	31	257	30	265	0.92	Ribosomal protein S6 kinase alpha-4 (DB03247)
drugbank_target|O75676	-	772	sp|P61075|CDC2H_PL	-	288	1e-132	440.0	0.0	2	3	0.0025	0.036	11.6	0.0	252	285	264	302	256	305	0.82	Ribosomal protein S6 kinase alpha-4 (DB03247)
drugbank_target|O75676	-	772	sp|P61075|CDC2H_PL	-	288	1e-132	440.0	0.0	3	3	1e-63	1.5e-62	209.7	0.0	9	286	416	676	406	678	0.88	Ribosomal protein S6 kinase alpha-4 (DB03247)
drugbank_target|O60674	-	1132	sp|P61075|CDC2H_PL	-	288	1.5e-105	350.8	0.1	1	2	4e-44	5.7e-43	145.5	0.0	6	245	547	797	543	816	0.86	Tyrosine-protein kinase JAK2 (DB04716; DB05243; DB07161; DB07162; DB08067; DB08877; DB08895; DB11817; DB11986; DB12010; DB12500; DB15035)
drugbank_target|O60674	-	1132	sp|P61075|CDC2H_PL	-	288	1.5e-105	350.8	0.1	2	2	2.1e-61	3.1e-60	202.1	0.1	4	196	849	1049	847	1072	0.91	Tyrosine-protein kinase JAK2 (DB04716; DB05243; DB07161; DB07162; DB08067; DB08877; DB08895; DB11817; DB11986; DB12010; DB12500; DB15035)
drugbank_target|Q07785	-	288	sp|P61075|CDC2H_PL	-	288	2.4e-104	346.9	0.0	1	1	1.9e-105	2.7e-104	346.7	0.0	1	288	1	288	1	288	0.99	Cell division control protein 2 homolog (DB02519; DB02733)
drugbank_target|P23458	-	1154	sp|P61075|CDC2H_PL	-	288	1.1e-102	341.5	2.5	1	2	1.9e-43	2.8e-42	143.2	0.0	5	261	584	856	580	859	0.84	Tyrosine-protein kinase JAK1 (DB02375; DB04716; DB08877; DB08895; DB11817; DB12010; DB12500; DB15091)
drugbank_target|P23458	-	1154	sp|P61075|CDC2H_PL	-	288	1.1e-102	341.5	2.5	2	2	1.3e-59	1.9e-58	196.3	0.0	5	278	876	1145	872	1148	0.83	Tyrosine-protein kinase JAK1 (DB02375; DB04716; DB08877; DB08895; DB11817; DB12010; DB12500; DB15091)
drugbank_target|P24941	-	298	sp|P61075|CDC2H_PL	-	288	6.4e-101	335.7	0.0	1	1	5e-102	7.2e-101	335.5	0.0	1	286	1	288	1	290	0.98	Cyclin-dependent kinase 2 (DB01888; DB02010; DB02052; DB02091; DB02116; DB02197; DB02297; DB02407; DB02538; DB02603; DB02647; DB02733; DB02833; DB02898; DB02915; DB02950; DB02963; DB02973; DB03019; DB03307; DB03365; DB03428; DB03490; DB03496; DB03583; DB03663; DB03737; DB03801; DB04006; DB04101; DB04186; DB04288; DB04407; DB04518; DB04607; DB04662; DB04669; DB06195; DB06616; DB06844; DB06888; DB06944; DB06948; DB06976; DB06983; DB07024; DB07054; DB07065; DB07126; DB07137; DB07163; DB07164; DB07179; DB07203; DB07210; DB07220; DB07431; DB07471; DB07493; DB07501; DB07504; DB07529; DB07531; DB07533; DB07534; DB07538; DB07539; DB07540; DB07562; DB07595; DB07606; DB07612; DB07618; DB07622; DB07685; DB07686; DB07687; DB07688; DB07731; DB07750; DB07751; DB07755; DB07761; DB07790; DB07791; DB07852; DB07889; DB07936; DB07982; DB08066; DB08094; DB08122; DB08123; DB08124; DB08125; DB08126; DB08132; DB08133; DB08134; DB08135; DB08136; DB08137; DB08138; DB08139; DB08140; DB08141; DB08142; DB08178; DB08182; DB08218; DB08219; DB08233; DB08241; DB08247; DB08248; DB08285; DB08309; DB08312; DB08355; DB08441; DB08463; DB08527; DB08531; DB08532; DB08533; DB08534; DB08535; DB08536; DB08537; DB08538; DB08539; DB08572; DB08673; DB08677; DB08694; DB08768)
drugbank_target|P29597	-	1187	sp|P61075|CDC2H_PL	-	288	5.2e-100	332.7	0.0	1	2	1.1e-42	1.6e-41	140.7	0.0	5	286	590	899	586	901	0.91	Non-receptor tyrosine-protein kinase TYK2 (DB04716; DB08895; DB12010)
drugbank_target|P29597	-	1187	sp|P61075|CDC2H_PL	-	288	5.2e-100	332.7	0.0	2	2	5.5e-58	8e-57	190.9	0.0	5	200	898	1100	897	1165	0.88	Non-receptor tyrosine-protein kinase TYK2 (DB04716; DB08895; DB12010)
drugbank_target|P06493	-	297	sp|P61075|CDC2H_PL	-	288	8.5e-98	325.4	0.0	1	1	6.8e-99	9.8e-98	325.2	0.0	1	286	1	289	1	291	0.98	Cyclin-dependent kinase 1 (DB02052; DB02116; DB02950; DB03428; DB03496; DB04014; DB06195; DB08142; DB12010)
drugbank_target|Q00535	-	292	sp|P61075|CDC2H_PL	-	288	5.2e-96	319.6	0.0	1	1	4e-97	5.8e-96	319.4	0.0	1	286	1	288	1	290	0.99	Cyclin-dependent-like kinase 5 (DB02052; DB02116; DB02950; DB03428; DB03496; DB04014; DB07364)
drugbank_target|P52333	-	1124	sp|P61075|CDC2H_PL	-	288	8.7e-94	312.2	0.0	1	2	4.9e-37	7.1e-36	122.2	0.0	4	254	521	778	518	786	0.88	Tyrosine-protein kinase JAK3 (DB04716; DB06321; DB08895; DB11817; DB12010; DB15035)
drugbank_target|P52333	-	1124	sp|P61075|CDC2H_PL	-	288	8.7e-94	312.2	0.0	2	2	5.5e-57	8e-56	187.7	0.0	5	198	823	1024	820	1046	0.91	Tyrosine-protein kinase JAK3 (DB04716; DB06321; DB08895; DB11817; DB12010; DB15035)
drugbank_target|P28482	-	360	sp|P61075|CDC2H_PL	-	288	1.4e-93	311.6	0.0	1	1	1.2e-94	1.7e-93	311.3	0.0	3	286	24	315	23	317	0.95	Mitogen-activated protein kinase 1 (DB01064; DB01169; DB02116; DB02482; DB02733; DB04338; DB06195; DB06641; DB06877; DB07010; DB07264; DB07788; DB07794; DB07905; DB08513; DB08521; DB11120; DB13930)
drugbank_target|P28482	-	360	sp|P61075|CDC2H_PL	-	288	1.4e-93	311.6	0.0	1	1	1.2e-94	1.7e-93	311.3	0.0	3	286	24	315	23	317	0.95	Mitogen-activated protein kinase 1 (DB01017)
drugbank_target|P28482	-	360	sp|P61075|CDC2H_PL	-	288	1.4e-93	311.6	0.0	1	1	1.2e-94	1.7e-93	311.3	0.0	3	286	24	315	23	317	0.95	Mitogen-activated protein kinase 1 (DB00945)
drugbank_target|P27361	-	379	sp|P61075|CDC2H_PL	-	288	2.3e-93	310.9	0.0	1	1	2e-94	2.8e-93	310.6	0.0	3	286	41	332	40	334	0.95	Mitogen-activated protein kinase 3 (DB00605; DB01169; DB02733; DB04604; DB06195; DB08862; DB13930)
drugbank_target|P27361	-	379	sp|P61075|CDC2H_PL	-	288	2.3e-93	310.9	0.0	1	1	2e-94	2.8e-93	310.6	0.0	3	286	41	332	40	334	0.95	Mitogen-activated protein kinase 3 (DB01017)
drugbank_target|P27361	-	379	sp|P61075|CDC2H_PL	-	288	2.3e-93	310.9	0.0	1	1	2e-94	2.8e-93	310.6	0.0	3	286	41	332	40	334	0.95	Mitogen-activated protein kinase 3 (DB00945)
drugbank_target|P53778	-	367	sp|P61075|CDC2H_PL	-	288	8e-93	309.1	0.0	1	1	7.4e-94	1.1e-92	308.7	0.0	4	286	27	313	25	315	0.96	Mitogen-activated protein kinase 12 (DB01017)
drugbank_target|P53778	-	367	sp|P61075|CDC2H_PL	-	288	8e-93	309.1	0.0	1	1	7.4e-94	1.1e-92	308.7	0.0	4	286	27	313	25	315	0.96	Mitogen-activated protein kinase 12 (DB02482; DB04395; DB05157; DB05403)
drugbank_target|O15264	-	365	sp|P61075|CDC2H_PL	-	288	1.9e-92	307.8	0.0	1	1	1.7e-93	2.5e-92	307.4	0.0	4	285	25	309	23	312	0.96	Mitogen-activated protein kinase 13 (DB01017)
drugbank_target|O15264	-	365	sp|P61075|CDC2H_PL	-	288	1.9e-92	307.8	0.0	1	1	1.7e-93	2.5e-92	307.4	0.0	4	285	25	309	23	312	0.96	Mitogen-activated protein kinase 13 (DB05157; DB12010)
drugbank_target|Q00537	-	523	sp|P61075|CDC2H_PL	-	288	3.2e-91	303.8	0.0	1	1	3.2e-92	4.6e-91	303.3	0.0	1	286	189	475	189	477	0.98	Cyclin-dependent kinase 17 (DB12010)
drugbank_target|Q16539	-	360	sp|P61075|CDC2H_PL	-	288	4.9e-91	303.2	0.0	1	1	4e-92	5.8e-91	303.0	0.0	2	286	22	310	21	312	0.96	Mitogen-activated protein kinase 14 (DB01254; DB01761; DB01807; DB01948; DB01953; DB01988; DB02195; DB02277; DB02352; DB02873; DB02984; DB03044; DB03110; DB03980; DB04338; DB04632; DB04797; DB05157; DB05412; DB05470; DB06518; DB06882; DB06940; DB06991; DB07138; DB07307; DB07459; DB07607; DB07811; DB07829; DB07832; DB07833; DB07834; DB07835; DB07941; DB07942; DB07943; DB08064; DB08068; DB08091; DB08092; DB08093; DB08095; DB08096; DB08097; DB08242; DB08349; DB08351; DB08352; DB08395; DB08423; DB08424; DB08521; DB08522; DB08730; DB12010)
drugbank_target|Q16539	-	360	sp|P61075|CDC2H_PL	-	288	4.9e-91	303.2	0.0	1	1	4e-92	5.8e-91	303.0	0.0	2	286	22	310	21	312	0.96	Mitogen-activated protein kinase 14 (DB01017)
drugbank_target|Q9UPZ9	-	632	sp|P61075|CDC2H_PL	-	288	9.1e-91	302.3	0.0	1	1	8e-92	1.2e-90	302.0	0.0	1	285	1	285	1	288	0.97	Serine/threonine-protein kinase ICK (DB12010)
drugbank_target|P53779	-	464	sp|P61075|CDC2H_PL	-	288	1.5e-90	301.6	0.0	1	1	1.4e-91	2e-90	301.2	0.0	1	285	61	360	61	363	0.93	Mitogen-activated protein kinase 10 (DB01017)
drugbank_target|P53779	-	464	sp|P61075|CDC2H_PL	-	288	1.5e-90	301.6	0.0	1	1	1.4e-91	2e-90	301.2	0.0	1	285	61	360	61	363	0.93	Mitogen-activated protein kinase 10 (DB15624)
drugbank_target|P53779	-	464	sp|P61075|CDC2H_PL	-	288	1.5e-90	301.6	0.0	1	1	1.4e-91	2e-90	301.2	0.0	1	285	61	360	61	363	0.93	Mitogen-activated protein kinase 10 (DB01782; DB02388; DB03084; DB03623; DB04395; DB06933; DB07010; DB07217; DB08005; DB08010; DB08011; DB08015; DB08021; DB08023; DB08025; DB08026; DB08555; DB12010)
drugbank_target|Q00532	-	358	sp|P61075|CDC2H_PL	-	288	2.9e-90	300.7	0.0	1	1	2.7e-91	3.9e-90	300.3	0.0	1	286	2	290	2	292	0.95	Cyclin-dependent kinase-like 1 (DB12010)
drugbank_target|P45983	-	427	sp|P61075|CDC2H_PL	-	288	5.3e-90	299.8	0.1	1	1	4.6e-91	6.6e-90	299.5	0.1	1	285	23	322	23	325	0.91	Mitogen-activated protein kinase 8 (DB00675; DB01782; DB07218; DB07268; DB07272; DB07276; DB07845)
drugbank_target|P45983	-	427	sp|P61075|CDC2H_PL	-	288	5.3e-90	299.8	0.1	1	1	4.6e-91	6.6e-90	299.5	0.1	1	285	23	322	23	325	0.91	Mitogen-activated protein kinase 8 (DB01017)
drugbank_target|P45983	-	427	sp|P61075|CDC2H_PL	-	288	5.3e-90	299.8	0.1	1	1	4.6e-91	6.6e-90	299.5	0.1	1	285	23	322	23	325	0.91	Mitogen-activated protein kinase 8 (DB15624)
drugbank_target|Q00536	-	496	sp|P61075|CDC2H_PL	-	288	6.3e-90	299.6	0.0	1	1	7e-91	1e-89	298.9	0.0	1	284	162	446	162	449	0.97	Cyclin-dependent kinase 16 (DB07766; DB12010)
drugbank_target|P45984	-	424	sp|P61075|CDC2H_PL	-	288	2.6e-89	297.6	0.1	1	1	2.4e-90	3.4e-89	297.2	0.1	1	285	23	322	23	325	0.92	Mitogen-activated protein kinase 9 (DB07020; DB12010)
drugbank_target|P45984	-	424	sp|P61075|CDC2H_PL	-	288	2.6e-89	297.6	0.1	1	1	2.4e-90	3.4e-89	297.2	0.1	1	285	23	322	23	325	0.92	Mitogen-activated protein kinase 9 (DB01017)
drugbank_target|P45984	-	424	sp|P61075|CDC2H_PL	-	288	2.6e-89	297.6	0.1	1	1	2.4e-90	3.4e-89	297.2	0.1	1	285	23	322	23	325	0.92	Mitogen-activated protein kinase 9 (DB15624)
drugbank_target|Q15759	-	364	sp|P61075|CDC2H_PL	-	288	7e-89	296.2	0.0	1	1	6.3e-90	9.1e-89	295.8	0.0	3	286	23	310	22	312	0.95	Mitogen-activated protein kinase 11 (DB01017)
drugbank_target|Q15759	-	364	sp|P61075|CDC2H_PL	-	288	7e-89	296.2	0.0	1	1	6.3e-90	9.1e-89	295.8	0.0	3	286	23	310	22	312	0.95	Mitogen-activated protein kinase 11 (DB05157; DB08896)
drugbank_target|Q92772	-	493	sp|P61075|CDC2H_PL	-	288	7.4e-89	296.1	0.0	1	1	7.5e-90	1.1e-88	295.5	0.0	1	286	1	289	1	291	0.96	Cyclin-dependent kinase-like 2 (DB12010)
drugbank_target|Q13164	-	816	sp|P61075|CDC2H_PL	-	288	7.6e-89	296.0	0.0	1	1	7.1e-90	1e-88	295.6	0.0	2	286	53	349	52	351	0.95	Mitogen-activated protein kinase 7 (DB01017)
drugbank_target|Q13164	-	816	sp|P61075|CDC2H_PL	-	288	7.6e-89	296.0	0.0	1	1	7.1e-90	1e-88	295.6	0.0	2	286	53	349	52	351	0.95	Mitogen-activated protein kinase 7 (DB12010)
drugbank_target|Q13164	-	816	sp|P61075|CDC2H_PL	-	288	7.6e-89	296.0	0.0	1	1	7.1e-90	1e-88	295.6	0.0	2	286	53	349	52	351	0.95	Mitogen-activated protein kinase 7 (DB00945)
drugbank_target|P50613	-	346	sp|P61075|CDC2H_PL	-	288	1.8e-88	294.8	0.0	1	1	1.5e-89	2.2e-88	294.5	0.0	2	286	10	297	9	299	0.97	Cyclin-dependent kinase 7 (DB02482; DB03496; DB05969; DB06195)
drugbank_target|Q8TD08	-	544	sp|P61075|CDC2H_PL	-	288	2.3e-88	294.5	0.0	1	1	1.9e-89	2.8e-88	294.2	0.0	2	286	11	306	10	308	0.93	Mitogen-activated protein kinase 15 (DB01017)
drugbank_target|Q8TD08	-	544	sp|P61075|CDC2H_PL	-	288	2.3e-88	294.5	0.0	1	1	1.9e-89	2.8e-88	294.2	0.0	2	286	11	306	10	308	0.93	Mitogen-activated protein kinase 15 (DB12010)
drugbank_target|Q8TD08	-	544	sp|P61075|CDC2H_PL	-	288	2.3e-88	294.5	0.0	1	1	1.9e-89	2.8e-88	294.2	0.0	2	286	11	306	10	308	0.93	Mitogen-activated protein kinase 15 (DB00945)
drugbank_target|Q00534	-	326	sp|P61075|CDC2H_PL	-	288	1.1e-87	292.2	0.0	1	1	9.3e-89	1.3e-87	291.9	0.0	2	286	11	302	10	304	0.94	Cyclin-dependent kinase 6 (DB03496; DB07379; DB07795; DB09073; DB11730; DB12001)
drugbank_target|P50750	-	372	sp|P61075|CDC2H_PL	-	288	2.4e-84	281.2	0.0	1	1	2.1e-85	3e-84	280.9	0.0	2	284	17	315	16	319	0.94	Cyclin-dependent kinase 9 (DB03496; DB06195)
drugbank_target|Q96Q40	-	435	sp|P61075|CDC2H_PL	-	288	1.3e-82	275.5	0.0	1	1	1.2e-83	1.7e-82	275.2	0.0	3	286	102	389	100	391	0.96	Cyclin-dependent kinase 15 (DB00171; DB06486; DB12010)
drugbank_target|P11802	-	303	sp|P61075|CDC2H_PL	-	288	3e-81	271.1	0.0	1	1	2.5e-82	3.5e-81	270.9	0.0	2	287	4	298	3	299	0.93	Cyclin-dependent kinase 4 (DB02733; DB03496; DB09073; DB11730; DB12001; DB12010)
drugbank_target|P62344	-	524	sp|P61075|CDC2H_PL	-	288	4.4e-81	270.6	5.3	1	2	3.6e-73	5.2e-72	240.8	1.9	2	227	54	293	53	294	0.93	Calcium-dependent protein kinase 1 (DB12010)
drugbank_target|P62344	-	524	sp|P61075|CDC2H_PL	-	288	4.4e-81	270.6	5.3	2	2	3.7e-10	5.4e-09	34.0	0.1	249	287	290	328	284	329	0.94	Calcium-dependent protein kinase 1 (DB12010)
drugbank_target|Q96L34	-	752	sp|P61075|CDC2H_PL	-	288	8.6e-81	269.6	0.1	1	2	1.3e-76	1.9e-75	252.0	0.0	3	219	58	274	56	281	0.96	MAP/microtubule affinity-regulating kinase 4 (DB12010)
drugbank_target|Q96L34	-	752	sp|P61075|CDC2H_PL	-	288	8.6e-81	269.6	0.1	2	2	0.00013	0.0018	15.8	0.0	253	285	279	311	277	314	0.93	MAP/microtubule affinity-regulating kinase 4 (DB12010)
drugbank_target|Q13557	-	499	sp|P61075|CDC2H_PL	-	288	1.4e-80	268.9	0.0	1	2	5.9e-70	8.5e-69	230.2	0.0	2	228	12	241	11	243	0.96	Calcium/calmodulin-dependent protein kinase type II subunit delta (DB07853; DB08039; DB12010)
drugbank_target|Q13557	-	499	sp|P61075|CDC2H_PL	-	288	1.4e-80	268.9	0.0	2	2	7.5e-12	1.1e-10	39.6	0.0	249	286	237	274	235	276	0.93	Calcium/calmodulin-dependent protein kinase type II subunit delta (DB07853; DB08039; DB12010)
drugbank_target|Q9UQM7	-	478	sp|P61075|CDC2H_PL	-	288	2.2e-80	268.3	0.1	1	2	3e-69	4.3e-68	227.9	0.0	2	228	11	240	10	242	0.96	Calcium/calmodulin-dependent protein kinase type II subunit alpha (DB04119; DB04447; DB07766; DB12010)
drugbank_target|Q9UQM7	-	478	sp|P61075|CDC2H_PL	-	288	2.2e-80	268.3	0.1	2	2	2.4e-12	3.4e-11	41.2	0.0	249	286	236	273	232	275	0.93	Calcium/calmodulin-dependent protein kinase type II subunit alpha (DB04119; DB04447; DB07766; DB12010)
drugbank_target|Q9P2K8	-	1649	sp|P61075|CDC2H_PL	-	288	2.4e-80	268.1	17.8	1	5	1.1e-28	1.6e-27	94.7	0.0	40	198	336	495	327	502	0.86	eIF-2-alpha kinase GCN2 (DB12010)
drugbank_target|Q9P2K8	-	1649	sp|P61075|CDC2H_PL	-	288	2.4e-80	268.1	17.8	2	5	0.00093	0.013	13.0	0.0	252	285	507	540	498	543	0.90	eIF-2-alpha kinase GCN2 (DB12010)
drugbank_target|Q9P2K8	-	1649	sp|P61075|CDC2H_PL	-	288	2.4e-80	268.1	17.8	3	5	2.5e-13	3.6e-12	44.4	0.0	3	72	589	658	587	662	0.91	eIF-2-alpha kinase GCN2 (DB12010)
drugbank_target|Q9P2K8	-	1649	sp|P61075|CDC2H_PL	-	288	2.4e-80	268.1	17.8	4	5	1.7e-35	2.4e-34	117.2	0.0	73	199	796	941	788	974	0.88	eIF-2-alpha kinase GCN2 (DB12010)
drugbank_target|Q9P2K8	-	1649	sp|P61075|CDC2H_PL	-	288	2.4e-80	268.1	17.8	5	5	0.049	0.71	7.3	0.0	255	281	972	998	945	1002	0.81	eIF-2-alpha kinase GCN2 (DB12010)
drugbank_target|P27448	-	753	sp|P61075|CDC2H_PL	-	288	2.8e-80	267.9	0.0	1	2	1.7e-76	2.5e-75	251.7	0.0	3	220	55	272	53	278	0.96	MAP/microtubule affinity-regulating kinase 3 (DB12010)
drugbank_target|P27448	-	753	sp|P61075|CDC2H_PL	-	288	2.8e-80	267.9	0.0	2	2	0.00037	0.0053	14.3	0.0	253	286	276	309	274	311	0.93	MAP/microtubule affinity-regulating kinase 3 (DB12010)
drugbank_target|Q8IU85	-	385	sp|P61075|CDC2H_PL	-	288	3.1e-80	267.8	0.1	1	2	1.7e-70	2.4e-69	232.0	0.0	4	226	23	246	20	247	0.94	Calcium/calmodulin-dependent protein kinase type 1D (DB08454; DB12010)
drugbank_target|Q8IU85	-	385	sp|P61075|CDC2H_PL	-	288	3.1e-80	267.8	0.1	2	2	1.2e-10	1.7e-09	35.6	0.0	249	285	244	280	240	283	0.94	Calcium/calmodulin-dependent protein kinase type 1D (DB08454; DB12010)
drugbank_target|Q7KZI7	-	788	sp|P61075|CDC2H_PL	-	288	3.3e-80	267.7	0.1	1	2	2.7e-76	3.9e-75	251.1	0.0	3	219	52	268	50	273	0.96	Serine/threonine-protein kinase MARK2 (DB12010)
drugbank_target|Q7KZI7	-	788	sp|P61075|CDC2H_PL	-	288	3.3e-80	267.7	0.1	2	2	0.00028	0.0041	14.7	0.0	253	285	273	305	269	308	0.93	Serine/threonine-protein kinase MARK2 (DB12010)
drugbank_target|Q14012	-	370	sp|P61075|CDC2H_PL	-	288	3.4e-80	267.6	0.0	1	2	2.7e-69	3.9e-68	228.1	0.0	4	226	20	243	17	244	0.95	Calcium/calmodulin-dependent protein kinase type 1 (DB12010)
drugbank_target|Q14012	-	370	sp|P61075|CDC2H_PL	-	288	3.4e-80	267.6	0.0	2	2	7.7e-12	1.1e-10	39.5	0.0	249	285	241	277	236	280	0.93	Calcium/calmodulin-dependent protein kinase type 1 (DB12010)
drugbank_target|Q16659	-	721	sp|P61075|CDC2H_PL	-	288	6.2e-80	266.8	0.0	1	1	6.3e-81	9.1e-80	266.2	0.0	3	285	19	317	17	320	0.93	Mitogen-activated protein kinase 6 (DB01017)
drugbank_target|Q16659	-	721	sp|P61075|CDC2H_PL	-	288	6.2e-80	266.8	0.0	1	1	6.3e-81	9.1e-80	266.2	0.0	3	285	19	317	17	320	0.93	Mitogen-activated protein kinase 6 (DB00945)
drugbank_target|Q9P0L2	-	795	sp|P61075|CDC2H_PL	-	288	9.9e-80	266.1	0.1	1	2	1e-75	1.5e-74	249.1	0.0	3	219	59	275	57	280	0.96	Serine/threonine-protein kinase MARK1 (DB12010)
drugbank_target|Q9P0L2	-	795	sp|P61075|CDC2H_PL	-	288	9.9e-80	266.1	0.1	2	2	0.00022	0.0032	15.0	0.0	253	285	280	312	278	315	0.93	Serine/threonine-protein kinase MARK1 (DB12010)
drugbank_target|Q9BYT3	-	514	sp|P61075|CDC2H_PL	-	288	1.1e-79	266.0	2.6	1	2	1.3e-72	1.9e-71	238.9	0.7	4	225	116	347	113	348	0.93	Serine/threonine-protein kinase 33 (DB12010)
drugbank_target|Q9BYT3	-	514	sp|P61075|CDC2H_PL	-	288	1.1e-79	266.0	2.6	2	2	2.8e-08	4.1e-07	27.8	0.1	248	286	345	383	341	385	0.93	Serine/threonine-protein kinase 33 (DB12010)
drugbank_target|Q13555	-	558	sp|P61075|CDC2H_PL	-	288	1.1e-79	266.0	0.1	1	2	7.1e-70	1e-68	230.0	0.0	2	228	12	241	11	243	0.96	Calcium/calmodulin-dependent protein kinase type II subunit gamma (DB06616; DB08699; DB12010)
drugbank_target|Q13555	-	558	sp|P61075|CDC2H_PL	-	288	1.1e-79	266.0	0.1	2	2	3.8e-11	5.5e-10	37.2	0.0	249	286	237	274	233	276	0.93	Calcium/calmodulin-dependent protein kinase type II subunit gamma (DB06616; DB08699; DB12010)
drugbank_target|Q9NRH2	-	765	sp|P61075|CDC2H_PL	-	288	1.3e-79	265.7	0.6	1	2	6.8e-71	9.9e-70	233.3	0.1	4	222	16	236	14	238	0.96	SNF-related serine/threonine-protein kinase (DB12010)
drugbank_target|Q9NRH2	-	765	sp|P61075|CDC2H_PL	-	288	1.3e-79	265.7	0.6	2	2	1.5e-09	2.2e-08	32.0	0.1	250	286	235	271	232	273	0.92	SNF-related serine/threonine-protein kinase (DB12010)
drugbank_target|Q9NRP7	-	1315	sp|P61075|CDC2H_PL	-	288	1.7e-79	265.4	0.0	1	2	1.1e-74	1.6e-73	245.7	0.0	1	214	1	213	1	218	0.96	Serine/threonine-protein kinase 36 (DB12010)
drugbank_target|Q9NRP7	-	1315	sp|P61075|CDC2H_PL	-	288	1.7e-79	265.4	0.0	2	2	5.5e-05	0.00079	17.0	0.0	251	285	221	255	216	258	0.92	Serine/threonine-protein kinase 36 (DB12010)
drugbank_target|Q96NX5	-	476	sp|P61075|CDC2H_PL	-	288	2.8e-79	264.6	0.9	1	2	1.5e-69	2.2e-68	228.9	0.0	2	226	21	244	20	245	0.94	Calcium/calmodulin-dependent protein kinase type 1G (DB08009; DB12010)
drugbank_target|Q96NX5	-	476	sp|P61075|CDC2H_PL	-	288	2.8e-79	264.6	0.9	2	2	7.7e-11	1.1e-09	36.2	0.0	249	286	242	279	238	281	0.93	Calcium/calmodulin-dependent protein kinase type 1G (DB08009; DB12010)
drugbank_target|Q13131	-	559	sp|P61075|CDC2H_PL	-	288	3.8e-79	264.2	0.1	1	2	1e-71	1.5e-70	236.0	0.0	3	217	26	241	24	248	0.96	5'-AMP-activated protein kinase catalytic subunit alpha-1 (DB00131; DB00171; DB00914; DB12010)
drugbank_target|Q13131	-	559	sp|P61075|CDC2H_PL	-	288	3.8e-79	264.2	0.1	2	2	7.9e-08	1.1e-06	26.3	0.1	253	286	248	281	243	283	0.92	5'-AMP-activated protein kinase catalytic subunit alpha-1 (DB00131; DB00171; DB00914; DB12010)
drugbank_target|Q13131	-	559	sp|P61075|CDC2H_PL	-	288	3.8e-79	264.2	0.1	1	2	1e-71	1.5e-70	236.0	0.0	3	217	26	241	24	248	0.96	5'-AMP-activated protein kinase catalytic subunit alpha-1 (DB00131; DB00945; DB12010)
drugbank_target|Q13131	-	559	sp|P61075|CDC2H_PL	-	288	3.8e-79	264.2	0.1	2	2	7.9e-08	1.1e-06	26.3	0.1	253	286	248	281	243	283	0.92	5'-AMP-activated protein kinase catalytic subunit alpha-1 (DB00131; DB00945; DB12010)
drugbank_target|Q8IBS5	-	528	sp|P61075|CDC2H_PL	-	288	4.2e-79	264.1	5.8	1	2	3.8e-72	5.5e-71	237.4	1.7	2	227	68	296	67	297	0.94	Calcium-dependent protein kinase 4 (DB11638)
drugbank_target|Q8IBS5	-	528	sp|P61075|CDC2H_PL	-	288	4.2e-79	264.1	5.8	2	2	4.2e-09	6e-08	30.5	0.1	250	286	294	330	289	332	0.94	Calcium-dependent protein kinase 4 (DB11638)
drugbank_target|P31152	-	587	sp|P61075|CDC2H_PL	-	288	4.7e-79	263.9	0.0	1	1	4.3e-80	6.2e-79	263.5	0.0	3	285	19	313	18	316	0.93	Mitogen-activated protein kinase 4 (DB01017)
drugbank_target|P31152	-	587	sp|P61075|CDC2H_PL	-	288	4.7e-79	263.9	0.0	1	1	4.3e-80	6.2e-79	263.5	0.0	3	285	19	313	18	316	0.93	Mitogen-activated protein kinase 4 (DB12010)
drugbank_target|P31152	-	587	sp|P61075|CDC2H_PL	-	288	4.7e-79	263.9	0.0	1	1	4.3e-80	6.2e-79	263.5	0.0	3	285	19	313	18	316	0.93	Mitogen-activated protein kinase 4 (DB00945)
drugbank_target|O43293	-	454	sp|P61075|CDC2H_PL	-	288	4.9e-79	263.9	0.6	1	3	1.9e-69	2.8e-68	228.5	0.0	2	225	11	241	10	243	0.92	Death-associated protein kinase 3 (DB04716; DB07125; DB07242; DB12010)
drugbank_target|O43293	-	454	sp|P61075|CDC2H_PL	-	288	4.9e-79	263.9	0.6	2	3	4.3e-10	6.2e-09	33.8	0.1	247	286	238	277	237	279	0.94	Death-associated protein kinase 3 (DB04716; DB07125; DB07242; DB12010)
drugbank_target|O43293	-	454	sp|P61075|CDC2H_PL	-	288	4.9e-79	263.9	0.6	3	3	8.1	1.2e+02	0.1	0.1	43	75	334	366	316	401	0.58	Death-associated protein kinase 3 (DB04716; DB07125; DB07242; DB12010)
drugbank_target|Q9H093	-	628	sp|P61075|CDC2H_PL	-	288	8e-79	263.1	0.4	1	2	1.2e-76	1.8e-75	252.2	0.0	2	223	51	272	50	278	0.95	NUAK family SNF1-like kinase 2 (DB12010)
drugbank_target|Q9H093	-	628	sp|P61075|CDC2H_PL	-	288	8e-79	263.1	0.4	2	2	0.01	0.14	9.6	0.0	257	285	276	304	273	307	0.91	NUAK family SNF1-like kinase 2 (DB12010)
drugbank_target|P57059	-	783	sp|P61075|CDC2H_PL	-	288	1.2e-78	262.5	0.2	1	2	7.1e-71	1e-69	233.3	0.0	4	215	27	238	25	245	0.95	Serine/threonine-protein kinase SIK1 (DB08912; DB12010)
drugbank_target|P57059	-	783	sp|P61075|CDC2H_PL	-	288	1.2e-78	262.5	0.2	2	2	4.3e-08	6.2e-07	27.2	0.1	253	286	247	280	243	282	0.94	Serine/threonine-protein kinase SIK1 (DB08912; DB12010)
drugbank_target|Q13554	-	666	sp|P61075|CDC2H_PL	-	288	1.6e-78	262.1	0.1	1	2	5.5e-69	8e-68	227.0	0.0	2	228	12	241	11	243	0.97	Calcium/calmodulin-dependent protein kinase type II subunit beta (DB07168; DB12010)
drugbank_target|Q13554	-	666	sp|P61075|CDC2H_PL	-	288	1.6e-78	262.1	0.1	2	2	7.5e-11	1.1e-09	36.3	0.0	249	286	237	274	235	276	0.93	Calcium/calmodulin-dependent protein kinase type II subunit beta (DB07168; DB12010)
drugbank_target|Q13153	-	545	sp|P61075|CDC2H_PL	-	288	1.8e-78	262.0	0.1	1	2	2.2e-71	3.2e-70	234.9	0.0	2	220	268	482	267	491	0.94	Serine/threonine-protein kinase PAK 1 (DB12010)
drugbank_target|Q13153	-	545	sp|P61075|CDC2H_PL	-	288	1.8e-78	262.0	0.1	2	2	1.6e-07	2.2e-06	25.4	0.0	250	285	487	522	481	525	0.91	Serine/threonine-protein kinase PAK 1 (DB12010)
drugbank_target|Q13177	-	524	sp|P61075|CDC2H_PL	-	288	2.2e-78	261.7	0.0	1	2	1.2e-70	1.7e-69	232.5	0.0	2	220	247	461	246	470	0.94	Serine/threonine-protein kinase PAK 2 (DB12010)
drugbank_target|Q13177	-	524	sp|P61075|CDC2H_PL	-	288	2.2e-78	261.7	0.0	2	2	2.9e-08	4.3e-07	27.8	0.0	250	285	466	501	460	504	0.91	Serine/threonine-protein kinase PAK 2 (DB12010)
drugbank_target|O60285	-	661	sp|P61075|CDC2H_PL	-	288	2.7e-78	261.4	0.3	1	2	2.7e-74	3.9e-73	244.5	0.1	2	220	53	272	52	277	0.95	NUAK family SNF1-like kinase 1 (DB12010)
drugbank_target|O60285	-	661	sp|P61075|CDC2H_PL	-	288	2.7e-78	261.4	0.3	2	2	0.00017	0.0025	15.4	0.0	255	285	277	307	271	310	0.92	NUAK family SNF1-like kinase 1 (DB12010)
drugbank_target|Q9P289	-	416	sp|P61075|CDC2H_PL	-	288	2.9e-78	261.3	0.0	1	2	4.5e-72	6.5e-71	237.2	0.0	4	217	24	235	21	243	0.96	Serine/threonine-protein kinase 26 (DB07853; DB12010)
drugbank_target|Q9P289	-	416	sp|P61075|CDC2H_PL	-	288	2.9e-78	261.3	0.0	2	2	1.1e-06	1.6e-05	22.6	0.0	249	287	239	277	232	278	0.88	Serine/threonine-protein kinase 26 (DB07853; DB12010)
drugbank_target|Q9Y6E0	-	443	sp|P61075|CDC2H_PL	-	288	4.2e-78	260.8	0.0	1	2	3.1e-73	4.5e-72	241.0	0.0	4	217	36	247	33	254	0.96	Serine/threonine-protein kinase 24 (DB12010)
drugbank_target|Q9Y6E0	-	443	sp|P61075|CDC2H_PL	-	288	4.2e-78	260.8	0.0	2	2	2.4e-05	0.00035	18.2	0.0	252	286	254	288	245	290	0.90	Serine/threonine-protein kinase 24 (DB12010)
drugbank_target|O75914	-	559	sp|P61075|CDC2H_PL	-	288	5.2e-78	260.5	0.0	1	2	4.5e-71	6.5e-70	233.9	0.0	2	216	281	492	280	503	0.95	Serine/threonine-protein kinase PAK 3 (DB12010)
drugbank_target|O75914	-	559	sp|P61075|CDC2H_PL	-	288	5.2e-78	260.5	0.0	2	2	2.3e-07	3.4e-06	24.8	0.0	251	285	501	535	494	538	0.90	Serine/threonine-protein kinase PAK 3 (DB12010)
drugbank_target|O00444	-	970	sp|P61075|CDC2H_PL	-	288	7.4e-78	260.0	1.4	1	2	1.1e-71	1.6e-70	235.9	0.3	1	216	9	226	9	233	0.96	Serine/threonine-protein kinase PLK4 (DB12010)
drugbank_target|O00444	-	970	sp|P61075|CDC2H_PL	-	288	7.4e-78	260.0	1.4	2	2	1.1e-06	1.5e-05	22.7	0.0	253	287	234	268	226	269	0.91	Serine/threonine-protein kinase PLK4 (DB12010)
drugbank_target|Q13188	-	491	sp|P61075|CDC2H_PL	-	288	1.4e-77	259.1	3.4	1	2	3.2e-69	4.7e-68	227.8	0.0	3	213	26	233	24	244	0.95	Serine/threonine-protein kinase 3 (DB12010)
drugbank_target|Q13188	-	491	sp|P61075|CDC2H_PL	-	288	1.4e-77	259.1	3.4	2	2	2.5e-09	3.7e-08	31.2	0.0	253	287	247	281	236	282	0.91	Serine/threonine-protein kinase 3 (DB12010)
drugbank_target|Q9C098	-	648	sp|P61075|CDC2H_PL	-	288	1.4e-77	259.0	0.1	1	2	5.4e-66	7.8e-65	217.2	0.0	2	215	354	568	353	576	0.91	Serine/threonine-protein kinase DCLK3 (DB12010)
drugbank_target|Q9C098	-	648	sp|P61075|CDC2H_PL	-	288	1.4e-77	259.0	0.1	2	2	6.6e-12	9.6e-11	39.7	0.0	249	286	578	615	571	617	0.93	Serine/threonine-protein kinase DCLK3 (DB12010)
drugbank_target|P54646	-	552	sp|P61075|CDC2H_PL	-	288	1.9e-77	258.6	0.3	1	2	4.7e-71	6.8e-70	233.8	0.0	3	215	15	228	13	237	0.96	5'-AMP-activated protein kinase catalytic subunit alpha-2 (DB00131; DB00945; DB12010)
drugbank_target|P54646	-	552	sp|P61075|CDC2H_PL	-	288	1.9e-77	258.6	0.3	2	2	9.3e-07	1.3e-05	22.8	0.1	253	286	237	270	230	272	0.91	5'-AMP-activated protein kinase catalytic subunit alpha-2 (DB00131; DB00945; DB12010)
drugbank_target|O14965	-	403	sp|P61075|CDC2H_PL	-	288	7e-77	256.8	0.0	1	2	3.6e-69	5.2e-68	227.6	0.0	1	220	130	348	130	354	0.95	Aurora kinase A (DB02482; DB05169; DB05198; DB05220; DB06134; DB06347; DB06486; DB07186; DB07266; DB07360; DB07362; DB07545; DB07801; DB08065; DB08066; DB12010; DB13061)
drugbank_target|O14965	-	403	sp|P61075|CDC2H_PL	-	288	7e-77	256.8	0.0	2	2	3.8e-08	5.5e-07	27.4	0.0	253	287	352	386	347	387	0.91	Aurora kinase A (DB02482; DB05169; DB05198; DB05220; DB06134; DB06347; DB06486; DB07186; DB07266; DB07360; DB07362; DB07545; DB07801; DB08065; DB08066; DB12010; DB13061)
drugbank_target|Q9H0K1	-	926	sp|P61075|CDC2H_PL	-	288	8.9e-77	256.4	0.5	1	2	1.7e-69	2.5e-68	228.7	0.0	4	207	20	223	18	237	0.95	Serine/threonine-protein kinase SIK2 (DB12010)
drugbank_target|Q9H0K1	-	926	sp|P61075|CDC2H_PL	-	288	8.9e-77	256.4	0.5	2	2	1.3e-07	1.9e-06	25.6	0.2	253	284	240	271	234	274	0.95	Serine/threonine-protein kinase SIK2 (DB12010)
drugbank_target|P31751	-	481	sp|P61075|CDC2H_PL	-	288	3.3e-76	254.5	0.0	1	2	3.4e-73	5e-72	240.9	0.1	1	216	149	365	149	372	0.96	RAC-beta serine/threonine-protein kinase (DB07812; DB07859; DB07947; DB08073)
drugbank_target|P31751	-	481	sp|P61075|CDC2H_PL	-	288	3.3e-76	254.5	0.0	2	2	0.0016	0.023	12.3	0.0	251	285	371	410	364	413	0.85	RAC-beta serine/threonine-protein kinase (DB07812; DB07859; DB07947; DB08073)
drugbank_target|Q14680	-	651	sp|P61075|CDC2H_PL	-	288	3.7e-76	254.4	2.2	1	2	9e-69	1.3e-67	226.4	0.2	1	221	8	229	8	234	0.95	Maternal embryonic leucine zipper kinase (DB12010)
drugbank_target|Q14680	-	651	sp|P61075|CDC2H_PL	-	288	3.7e-76	254.4	2.2	2	2	2.1e-08	3e-07	28.2	0.1	253	286	232	265	227	267	0.90	Maternal embryonic leucine zipper kinase (DB12010)
drugbank_target|Q9UIK4	-	370	sp|P61075|CDC2H_PL	-	288	8.4e-76	253.2	0.1	1	2	4.1e-67	6e-66	220.9	0.0	4	227	23	253	20	255	0.92	Death-associated protein kinase 2 (DB12010)
drugbank_target|Q9UIK4	-	370	sp|P61075|CDC2H_PL	-	288	8.4e-76	253.2	0.1	2	2	4.5e-10	6.5e-09	33.7	0.1	247	285	248	286	244	289	0.94	Death-associated protein kinase 2 (DB12010)
drugbank_target|Q9UQB9	-	309	sp|P61075|CDC2H_PL	-	288	9.6e-76	253.0	0.1	1	2	2.3e-69	3.4e-68	228.3	0.0	2	218	41	256	40	263	0.95	Aurora kinase C (DB06134; DB12010)
drugbank_target|Q9UQB9	-	309	sp|P61075|CDC2H_PL	-	288	9.6e-76	253.0	0.1	2	2	7.4e-07	1.1e-05	23.2	0.1	257	286	266	295	259	297	0.93	Aurora kinase C (DB06134; DB12010)
drugbank_target|P31749	-	480	sp|P61075|CDC2H_PL	-	288	1.3e-75	252.6	0.0	1	2	1.8e-72	2.6e-71	238.5	0.2	1	216	147	364	147	372	0.95	RAC-alpha serine/threonine-protein kinase (DB00171; DB01169; DB01645; DB01863; DB02709; DB05971; DB06486; DB06641; DB07584; DB07585)
drugbank_target|P31749	-	480	sp|P61075|CDC2H_PL	-	288	1.3e-75	252.6	0.0	2	2	0.0014	0.02	12.4	0.0	251	285	370	409	363	412	0.86	RAC-alpha serine/threonine-protein kinase (DB00171; DB01169; DB01645; DB01863; DB02709; DB05971; DB06486; DB06641; DB07584; DB07585)
drugbank_target|O95747	-	527	sp|P61075|CDC2H_PL	-	288	1.9e-75	252.1	0.3	1	2	2.1e-67	3e-66	221.9	0.0	2	216	15	242	14	253	0.91	Serine/threonine-protein kinase OSR1 (DB12010)
drugbank_target|O95747	-	527	sp|P61075|CDC2H_PL	-	288	1.9e-75	252.1	0.3	2	2	1.6e-08	2.2e-07	28.7	0.1	245	287	252	294	241	295	0.90	Serine/threonine-protein kinase OSR1 (DB12010)
drugbank_target|P53355	-	1430	sp|P61075|CDC2H_PL	-	288	4e-75	251.0	0.1	1	2	4.6e-66	6.6e-65	217.5	0.0	3	225	12	241	10	244	0.92	Death-associated protein kinase 1 (DB04069; DB04395; DB07444; DB12010)
drugbank_target|P53355	-	1430	sp|P61075|CDC2H_PL	-	288	4e-75	251.0	0.1	2	2	7.6e-10	1.1e-08	33.0	0.1	248	286	239	277	237	279	0.93	Death-associated protein kinase 1 (DB04069; DB04395; DB07444; DB12010)
drugbank_target|Q16816	-	387	sp|P61075|CDC2H_PL	-	288	7.2e-75	250.2	0.0	1	2	9.9e-67	1.4e-65	219.7	0.0	2	228	18	257	17	259	0.92	Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform (DB12010)
drugbank_target|Q16816	-	387	sp|P61075|CDC2H_PL	-	288	7.2e-75	250.2	0.0	2	2	1.8e-09	2.5e-08	31.8	0.0	249	286	253	290	250	292	0.94	Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform (DB12010)
drugbank_target|Q32MK0	-	819	sp|P61075|CDC2H_PL	-	288	1.1e-74	249.6	0.5	1	2	9.6e-67	1.4e-65	219.7	0.1	7	222	518	733	513	737	0.94	Myosin light chain kinase 3 (DB12010)
drugbank_target|Q32MK0	-	819	sp|P61075|CDC2H_PL	-	288	1.1e-74	249.6	0.5	2	2	1.3e-08	1.8e-07	29.0	0.0	249	286	735	772	730	774	0.93	Myosin light chain kinase 3 (DB12010)
drugbank_target|Q86YV6	-	388	sp|P61075|CDC2H_PL	-	288	1.3e-74	249.3	0.8	1	2	2.3e-66	3.3e-65	218.4	0.1	6	227	108	329	104	330	0.94	Myosin light chain kinase family member 4 (DB12010)
drugbank_target|Q86YV6	-	388	sp|P61075|CDC2H_PL	-	288	1.3e-74	249.3	0.8	2	2	1e-09	1.5e-08	32.5	0.1	247	286	324	363	319	365	0.93	Myosin light chain kinase family member 4 (DB12010)
drugbank_target|Q9H4B4	-	646	sp|P61075|CDC2H_PL	-	288	2e-74	248.7	0.0	1	2	2.6e-71	3.8e-70	234.7	0.0	3	221	61	280	60	284	0.97	Serine/threonine-protein kinase PLK3 (DB12010)
drugbank_target|Q9H4B4	-	646	sp|P61075|CDC2H_PL	-	288	2e-74	248.7	0.0	2	2	0.0013	0.019	12.5	0.0	253	286	283	316	278	318	0.90	Serine/threonine-protein kinase PLK3 (DB12010)
drugbank_target|O96017	-	543	sp|P61075|CDC2H_PL	-	288	2.5e-74	248.4	0.1	1	2	2.1e-63	3.1e-62	208.7	0.0	2	212	218	438	217	449	0.89	Serine/threonine-protein kinase Chk2 (DB05149; DB06486; DB12010)
drugbank_target|O96017	-	543	sp|P61075|CDC2H_PL	-	288	2.5e-74	248.4	0.1	2	2	2e-11	2.8e-10	38.2	0.1	244	287	446	489	436	490	0.88	Serine/threonine-protein kinase Chk2 (DB05149; DB06486; DB12010)
drugbank_target|Q9NQU5	-	681	sp|P61075|CDC2H_PL	-	288	2.7e-74	248.3	0.2	1	2	6e-66	8.6e-65	217.1	0.0	9	215	412	615	407	622	0.95	Serine/threonine-protein kinase PAK 6 (DB12010)
drugbank_target|Q9NQU5	-	681	sp|P61075|CDC2H_PL	-	288	2.7e-74	248.3	0.2	2	2	7.9e-09	1.1e-07	29.6	0.0	248	285	622	659	614	662	0.89	Serine/threonine-protein kinase PAK 6 (DB12010)
drugbank_target|Q9Y2K2	-	1321	sp|P61075|CDC2H_PL	-	288	3.1e-74	248.1	12.1	1	2	2.2e-69	3.1e-68	228.4	0.0	4	215	66	277	63	284	0.95	Serine/threonine-protein kinase SIK3 (DB12010)
drugbank_target|Q9Y2K2	-	1321	sp|P61075|CDC2H_PL	-	288	3.1e-74	248.1	12.1	2	2	4.1e-08	5.9e-07	27.3	0.2	253	285	286	318	284	321	0.94	Serine/threonine-protein kinase SIK3 (DB12010)
drugbank_target|O15075	-	740	sp|P61075|CDC2H_PL	-	288	3.2e-74	248.0	0.0	1	2	1.3e-65	1.9e-64	216.0	0.0	2	216	388	604	387	613	0.90	Serine/threonine-protein kinase DCLK1 (DB12010)
drugbank_target|O15075	-	740	sp|P61075|CDC2H_PL	-	288	3.2e-74	248.0	0.0	2	2	5.2e-09	7.5e-08	30.2	0.0	249	286	612	649	605	651	0.94	Serine/threonine-protein kinase DCLK1 (DB12010)
drugbank_target|P49840	-	483	sp|P61075|CDC2H_PL	-	288	3.3e-74	248.0	0.0	1	1	2.9e-75	4.2e-74	247.6	0.0	4	286	119	405	117	407	0.89	Glycogen synthase kinase-3 alpha (DB12010)
drugbank_target|Q96GD4	-	344	sp|P61075|CDC2H_PL	-	288	3.5e-74	247.9	0.1	1	2	6.3e-68	9.1e-67	223.6	0.0	1	218	74	290	74	296	0.95	Aurora kinase B (DB04703; DB05169; DB06486; DB07340; DB12010)
drugbank_target|Q96GD4	-	344	sp|P61075|CDC2H_PL	-	288	3.5e-74	247.9	0.1	2	2	9.3e-07	1.3e-05	22.8	0.0	254	287	297	330	291	331	0.89	Aurora kinase B (DB04703; DB05169; DB06486; DB07340; DB12010)
drugbank_target|Q9P286	-	719	sp|P61075|CDC2H_PL	-	288	4.6e-74	247.5	0.0	1	2	2.2e-68	3.2e-67	225.1	0.0	9	217	454	659	447	671	0.94	Serine/threonine-protein kinase PAK 5 (DB12010)
drugbank_target|Q9P286	-	719	sp|P61075|CDC2H_PL	-	288	4.6e-74	247.5	0.0	2	2	2.8e-06	4e-05	21.3	0.0	249	285	665	701	660	704	0.92	Serine/threonine-protein kinase PAK 5 (DB12010)
drugbank_target|Q8IVH8	-	894	sp|P61075|CDC2H_PL	-	288	5.3e-74	247.3	0.1	1	2	2.9e-68	4.2e-67	224.7	0.0	2	221	14	234	13	240	0.95	Mitogen-activated protein kinase kinase kinase kinase 3 (DB12010)
drugbank_target|Q8IVH8	-	894	sp|P61075|CDC2H_PL	-	288	5.3e-74	247.3	0.1	2	2	3e-06	4.4e-05	21.2	0.1	252	286	241	275	229	277	0.87	Mitogen-activated protein kinase kinase kinase kinase 3 (DB12010)
drugbank_target|Q8IYT8	-	1036	sp|P61075|CDC2H_PL	-	288	6.8e-74	247.0	0.1	1	2	2.4e-71	3.4e-70	234.8	0.0	3	218	8	231	7	236	0.92	Serine/threonine-protein kinase ULK2 (DB12010)
drugbank_target|Q8IYT8	-	1036	sp|P61075|CDC2H_PL	-	288	6.8e-74	247.0	0.1	2	2	0.0044	0.064	10.8	0.0	244	286	231	273	223	275	0.86	Serine/threonine-protein kinase ULK2 (DB12010)
drugbank_target|P49841	-	420	sp|P61075|CDC2H_PL	-	288	9.4e-74	246.5	0.0	1	1	8.5e-75	1.2e-73	246.1	0.0	3	286	55	342	54	344	0.90	Glycogen synthase kinase-3 beta (DB01356; DB01772; DB01793; DB01950; DB02010; DB02052; DB03444; DB04014; DB04395; DB07014; DB07058; DB07149; DB07584; DB07585; DB07676; DB07812; DB07859; DB07947; DB08073; DB12010; DB12129; DB14507; DB14508; DB14509)
drugbank_target|Q6PHR2	-	472	sp|P61075|CDC2H_PL	-	288	1e-73	246.4	0.1	1	2	8.9e-67	1.3e-65	219.8	0.0	2	214	12	226	11	237	0.93	Serine/threonine-protein kinase ULK3 (DB12010)
drugbank_target|Q6PHR2	-	472	sp|P61075|CDC2H_PL	-	288	1e-73	246.4	0.1	2	2	2.7e-07	3.9e-06	24.6	0.0	253	285	239	271	227	274	0.92	Serine/threonine-protein kinase ULK3 (DB12010)
drugbank_target|O75385	-	1050	sp|P61075|CDC2H_PL	-	288	1.8e-73	245.6	0.4	1	2	1.3e-70	1.8e-69	232.4	0.0	3	217	15	237	14	242	0.91	Serine/threonine-protein kinase ULK1 (DB12010)
drugbank_target|O75385	-	1050	sp|P61075|CDC2H_PL	-	288	1.8e-73	245.6	0.4	2	2	0.0018	0.026	12.0	0.1	246	286	240	280	230	282	0.85	Serine/threonine-protein kinase ULK1 (DB12010)
drugbank_target|P51957	-	841	sp|P61075|CDC2H_PL	-	288	1.8e-73	245.6	2.2	1	2	2e-69	2.9e-68	228.5	0.2	2	224	4	229	3	231	0.95	Serine/threonine-protein kinase Nek4 (DB12010)
drugbank_target|P51957	-	841	sp|P61075|CDC2H_PL	-	288	1.8e-73	245.6	2.2	2	2	5e-05	0.00072	17.2	0.0	251	286	228	263	222	265	0.92	Serine/threonine-protein kinase Nek4 (DB12010)
drugbank_target|O96013	-	591	sp|P61075|CDC2H_PL	-	288	1.8e-73	245.6	0.0	1	2	2.9e-65	4.1e-64	214.9	0.0	9	216	326	530	320	538	0.95	Serine/threonine-protein kinase PAK 4 (DB12010)
drugbank_target|O96013	-	591	sp|P61075|CDC2H_PL	-	288	1.8e-73	245.6	0.0	2	2	1.2e-08	1.7e-07	29.0	0.0	248	286	536	574	531	576	0.92	Serine/threonine-protein kinase PAK 4 (DB12010)
drugbank_target|P53350	-	603	sp|P61075|CDC2H_PL	-	288	2.7e-73	245.0	0.0	1	2	2e-67	2.9e-66	221.9	0.0	3	221	52	271	50	274	0.96	Serine/threonine-protein kinase PLK1 (DB06897; DB06963; DB07186; DB07789; DB08059; DB12010)
drugbank_target|P53350	-	603	sp|P61075|CDC2H_PL	-	288	2.7e-73	245.0	0.0	2	2	9.2e-07	1.3e-05	22.9	0.0	248	286	269	307	264	309	0.90	Serine/threonine-protein kinase PLK1 (DB06897; DB06963; DB07186; DB07789; DB08059; DB12010)
drugbank_target|O00141	-	431	sp|P61075|CDC2H_PL	-	288	3e-73	244.9	0.1	1	2	5.9e-72	8.5e-71	236.8	0.0	3	218	97	314	96	320	0.95	Serine/threonine-protein kinase Sgk1 (DB03247; DB07837; DB08191)
drugbank_target|O00141	-	431	sp|P61075|CDC2H_PL	-	288	3e-73	244.9	0.1	2	2	0.065	0.94	6.9	0.0	249	277	316	344	310	358	0.81	Serine/threonine-protein kinase Sgk1 (DB03247; DB07837; DB08191)
drugbank_target|O14936	-	926	sp|P61075|CDC2H_PL	-	288	4.3e-73	244.3	0.0	1	2	1e-62	1.4e-61	206.5	0.0	3	228	11	245	9	246	0.91	Peripheral plasma membrane protein CASK (DB01942; DB12010)
drugbank_target|O14936	-	926	sp|P61075|CDC2H_PL	-	288	4.3e-73	244.3	0.0	2	2	6.1e-12	8.8e-11	39.8	0.1	248	287	240	279	234	280	0.92	Peripheral plasma membrane protein CASK (DB01942; DB12010)
drugbank_target|Q9UEW8	-	545	sp|P61075|CDC2H_PL	-	288	4.8e-73	244.2	0.1	1	2	4.5e-66	6.5e-65	217.5	0.0	2	216	61	288	60	299	0.90	STE20/SPS1-related proline-alanine-rich protein kinase (DB12010)
drugbank_target|Q9UEW8	-	545	sp|P61075|CDC2H_PL	-	288	4.8e-73	244.2	0.1	2	2	2e-07	2.9e-06	25.0	0.0	245	287	298	340	287	341	0.90	STE20/SPS1-related proline-alanine-rich protein kinase (DB12010)
drugbank_target|Q9NYY3	-	685	sp|P61075|CDC2H_PL	-	288	5.4e-73	244.0	0.5	1	2	1.9e-69	2.8e-68	228.5	0.2	2	222	80	301	79	306	0.96	Serine/threonine-protein kinase PLK2 (DB12010)
drugbank_target|Q9NYY3	-	685	sp|P61075|CDC2H_PL	-	288	5.4e-73	244.0	0.5	2	2	0.00042	0.0061	14.1	0.0	256	285	306	335	299	338	0.90	Serine/threonine-protein kinase PLK2 (DB12010)
drugbank_target|Q8IIR9	-	335	sp|P61075|CDC2H_PL	-	288	6.1e-73	243.8	0.3	1	1	4.9e-74	7.1e-73	243.6	0.3	2	286	41	330	40	332	0.92	Casein kinase 2, alpha subunit (DB11638)
drugbank_target|Q8N568	-	766	sp|P61075|CDC2H_PL	-	288	1.8e-72	242.3	0.0	1	2	5.1e-63	7.4e-62	207.5	0.0	1	216	391	608	391	615	0.91	Serine/threonine-protein kinase DCLK2 (DB12010)
drugbank_target|Q8N568	-	766	sp|P61075|CDC2H_PL	-	288	1.8e-72	242.3	0.0	2	2	8.8e-10	1.3e-08	32.8	0.0	249	287	616	654	610	655	0.94	Serine/threonine-protein kinase DCLK2 (DB12010)
drugbank_target|P17252	-	672	sp|P61075|CDC2H_PL	-	288	3.1e-72	241.5	0.0	1	1	4e-73	5.7e-72	240.6	0.0	2	232	337	569	336	597	0.93	Protein kinase C alpha type (DB00144; DB00163; DB05013; DB06451; DB06595; DB06641; DB08846; DB11752; DB14001; DB14002)
drugbank_target|P17252	-	672	sp|P61075|CDC2H_PL	-	288	3.1e-72	241.5	0.0	1	1	4e-73	5.7e-72	240.6	0.0	2	232	337	569	336	597	0.93	Protein kinase C alpha type (DB00675)
drugbank_target|P51956	-	506	sp|P61075|CDC2H_PL	-	288	3.2e-72	241.5	0.1	1	2	3.7e-71	5.4e-70	234.2	0.0	1	222	1	223	1	228	0.95	Serine/threonine-protein kinase Nek3 (DB12010)
drugbank_target|P51956	-	506	sp|P61075|CDC2H_PL	-	288	3.2e-72	241.5	0.1	2	2	0.13	1.8	6.0	0.0	251	280	224	253	218	259	0.89	Serine/threonine-protein kinase Nek3 (DB12010)
drugbank_target|Q9UEE5	-	414	sp|P61075|CDC2H_PL	-	288	3.3e-72	241.4	0.1	1	2	1.6e-63	2.3e-62	209.1	0.0	7	227	64	289	59	292	0.93	Serine/threonine-protein kinase 17A (DB12010)
drugbank_target|Q9UEE5	-	414	sp|P61075|CDC2H_PL	-	288	3.3e-72	241.4	0.1	2	2	5.6e-10	8.1e-09	33.4	0.0	247	287	284	324	280	325	0.93	Serine/threonine-protein kinase 17A (DB12010)
drugbank_target|Q15139	-	912	sp|P61075|CDC2H_PL	-	288	4e-72	241.2	0.0	1	2	1.2e-63	1.7e-62	209.6	0.0	8	211	587	794	581	804	0.93	Serine/threonine-protein kinase D1 (DB11752; DB12010)
drugbank_target|Q15139	-	912	sp|P61075|CDC2H_PL	-	288	4e-72	241.2	0.0	2	2	8.2e-09	1.2e-07	29.6	0.1	248	287	803	842	790	843	0.90	Serine/threonine-protein kinase D1 (DB11752; DB12010)
drugbank_target|Q15746	-	1914	sp|P61075|CDC2H_PL	-	288	4.2e-72	241.1	0.5	1	2	3.4e-63	4.9e-62	208.0	0.0	4	227	1464	1687	1461	1688	0.94	Myosin light chain kinase, smooth muscle (DB12010)
drugbank_target|Q15746	-	1914	sp|P61075|CDC2H_PL	-	288	4.2e-72	241.1	0.5	2	2	5e-10	7.3e-09	33.6	0.1	247	286	1682	1721	1674	1723	0.92	Myosin light chain kinase, smooth muscle (DB12010)
drugbank_target|P49759	-	484	sp|P61075|CDC2H_PL	-	288	4.5e-72	241.0	0.2	1	1	4.4e-73	6.4e-72	240.5	0.2	3	285	160	478	158	481	0.90	Dual specificity protein kinase CLK1 (DB04367; DB06376; DB08691; DB12010)
drugbank_target|Q16566	-	473	sp|P61075|CDC2H_PL	-	288	7e-72	240.4	0.0	1	2	9.6e-63	1.4e-61	206.6	0.0	4	210	46	250	43	262	0.91	Calcium/calmodulin-dependent protein kinase type IV (DB07664; DB07676)
drugbank_target|Q16566	-	473	sp|P61075|CDC2H_PL	-	288	7e-72	240.4	0.0	2	2	1.9e-09	2.7e-08	31.7	0.0	249	285	265	301	256	304	0.92	Calcium/calmodulin-dependent protein kinase type IV (DB07664; DB07676)
drugbank_target|Q04759	-	706	sp|P61075|CDC2H_PL	-	288	7.5e-72	240.3	0.5	1	2	1.6e-70	2.3e-69	232.1	0.3	1	215	377	593	377	600	0.93	Protein kinase C theta type (DB02010; DB02482; DB04522; DB12010)
drugbank_target|Q04759	-	706	sp|P61075|CDC2H_PL	-	288	7.5e-72	240.3	0.5	2	2	0.099	1.4	6.3	0.0	253	286	602	636	595	638	0.86	Protein kinase C theta type (DB02010; DB02482; DB04522; DB12010)
drugbank_target|Q04759	-	706	sp|P61075|CDC2H_PL	-	288	7.5e-72	240.3	0.5	1	2	1.6e-70	2.3e-69	232.1	0.3	1	215	377	593	377	600	0.93	Protein kinase C theta type (DB00675)
drugbank_target|Q04759	-	706	sp|P61075|CDC2H_PL	-	288	7.5e-72	240.3	0.5	2	2	0.099	1.4	6.3	0.0	253	286	602	636	595	638	0.86	Protein kinase C theta type (DB00675)
drugbank_target|P42685	-	505	sp|P61075|CDC2H_PL	-	288	1.1e-71	239.7	0.0	1	1	1e-72	1.5e-71	239.3	0.0	3	234	233	468	231	496	0.89	Tyrosine-protein kinase FRK (DB01254; DB08896; DB12010; DB15035)
drugbank_target|P22694	-	351	sp|P61075|CDC2H_PL	-	288	1.1e-71	239.7	0.1	1	2	1.1e-69	1.6e-68	229.3	0.0	1	220	41	258	41	261	0.95	cAMP-dependent protein kinase catalytic subunit beta (DB02482; DB12010)
drugbank_target|P22694	-	351	sp|P61075|CDC2H_PL	-	288	1.1e-71	239.7	0.1	2	2	0.012	0.18	9.3	0.0	251	285	260	299	255	302	0.78	cAMP-dependent protein kinase catalytic subunit beta (DB02482; DB12010)
drugbank_target|P17612	-	351	sp|P61075|CDC2H_PL	-	288	1.1e-71	239.7	0.0	1	2	2.2e-69	3.1e-68	228.4	0.0	1	221	41	259	41	262	0.95	cAMP-dependent protein kinase catalytic subunit alpha (DB01919; DB01940; DB02155; DB02482; DB02611; DB03374; DB04098; DB04522; DB04530; DB04707; DB06959; DB06977; DB07107; DB07124; DB07204; DB07235; DB07458; DB07583; DB07854; DB07855; DB07856; DB07857; DB07858; DB07859; DB07860; DB07876; DB07947; DB07995; DB07996; DB07997; DB08070; DB08073; DB08113; DB08114; DB08148; DB08149; DB08150; DB08162; DB08231; DB08568; DB08569; DB08756; DB08846; DB12010)
drugbank_target|P17612	-	351	sp|P61075|CDC2H_PL	-	288	1.1e-71	239.7	0.0	2	2	0.0057	0.082	10.4	0.0	251	286	260	300	255	302	0.80	cAMP-dependent protein kinase catalytic subunit alpha (DB01919; DB01940; DB02155; DB02482; DB02611; DB03374; DB04098; DB04522; DB04530; DB04707; DB06959; DB06977; DB07107; DB07124; DB07204; DB07235; DB07458; DB07583; DB07854; DB07855; DB07856; DB07857; DB07858; DB07859; DB07860; DB07876; DB07947; DB07995; DB07996; DB07997; DB08070; DB08073; DB08113; DB08114; DB08148; DB08149; DB08150; DB08162; DB08231; DB08568; DB08569; DB08756; DB08846; DB12010)
drugbank_target|Q9H1R3	-	596	sp|P61075|CDC2H_PL	-	288	1.7e-71	239.1	0.5	1	2	1.4e-63	2e-62	209.3	0.1	7	226	288	507	284	509	0.95	Myosin light chain kinase 2, skeletal/cardiac muscle (DB04825; DB12010)
drugbank_target|Q9H1R3	-	596	sp|P61075|CDC2H_PL	-	288	1.7e-71	239.1	0.5	2	2	3.9e-09	5.6e-08	30.7	0.0	247	286	503	542	500	544	0.94	Myosin light chain kinase 2, skeletal/cardiac muscle (DB04825; DB12010)
drugbank_target|P54762	-	984	sp|P61075|CDC2H_PL	-	288	1.8e-71	239.0	0.0	1	1	2.8e-72	4.1e-71	237.9	0.0	6	251	621	876	618	886	0.86	Ephrin type-B receptor 1 (DB12010)
drugbank_target|P68400	-	391	sp|P61075|CDC2H_PL	-	288	2.8e-71	238.4	0.7	1	1	2.3e-72	3.3e-71	238.2	0.7	2	285	37	325	36	328	0.92	Casein kinase II subunit alpha (DB00171; DB01765; DB02170; DB02709; DB03035; DB03127; DB03924; DB04216; DB04395; DB04462; DB04719; DB04720; DB04721; DB07715; DB07802; DB08338; DB08340; DB08345; DB08353; DB08354; DB08360; DB08362; DB08473; DB08660; DB08846; DB12010)
drugbank_target|P06241	-	537	sp|P61075|CDC2H_PL	-	288	3.5e-71	238.1	0.0	1	2	1.9e-71	2.7e-70	235.1	0.0	3	226	270	492	268	510	0.94	Tyrosine-protein kinase Fyn (DB01254; DB02078; DB12010)
drugbank_target|P06241	-	537	sp|P61075|CDC2H_PL	-	288	3.5e-71	238.1	0.0	2	2	4	57	1.1	0.0	257	277	495	515	493	526	0.84	Tyrosine-protein kinase Fyn (DB01254; DB02078; DB12010)
drugbank_target|P19784	-	350	sp|P61075|CDC2H_PL	-	288	9.5e-71	236.6	1.3	1	1	8.3e-72	1.2e-70	236.3	1.3	2	284	38	325	37	328	0.93	Casein kinase II subunit alpha' (DB07546; DB12010)
drugbank_target|Q96BR1	-	496	sp|P61075|CDC2H_PL	-	288	1.1e-70	236.5	0.0	1	2	4.7e-70	6.8e-69	230.6	0.0	3	216	161	376	160	382	0.95	Serine/threonine-protein kinase Sgk3 (DB12010)
drugbank_target|Q96BR1	-	496	sp|P61075|CDC2H_PL	-	288	1.1e-70	236.5	0.0	2	2	0.49	7	4.1	0.0	252	286	383	421	375	423	0.80	Serine/threonine-protein kinase Sgk3 (DB12010)
drugbank_target|Q56UN5	-	1328	sp|P61075|CDC2H_PL	-	288	1.3e-70	236.2	1.3	1	3	3.4	49	1.3	0.1	24	58	409	444	398	447	0.85	Mitogen-activated protein kinase kinase kinase 19 (DB12010)
drugbank_target|Q56UN5	-	1328	sp|P61075|CDC2H_PL	-	288	1.3e-70	236.2	1.3	2	3	4.6e-64	6.7e-63	210.9	0.0	4	219	1061	1285	1060	1290	0.93	Mitogen-activated protein kinase kinase kinase 19 (DB12010)
drugbank_target|Q56UN5	-	1328	sp|P61075|CDC2H_PL	-	288	1.3e-70	236.2	1.3	3	3	4.6e-06	6.6e-05	20.6	0.1	251	286	1291	1326	1286	1328	0.93	Mitogen-activated protein kinase kinase kinase 19 (DB12010)
drugbank_target|Q9HAZ1	-	481	sp|P61075|CDC2H_PL	-	288	1.5e-70	236.0	1.6	1	1	1.5e-71	2.1e-70	235.5	1.6	3	285	158	476	156	479	0.88	Dual specificity protein kinase CLK4 (DB12010)
drugbank_target|Q9H2G2	-	1235	sp|P61075|CDC2H_PL	-	288	1.6e-70	235.9	0.1	1	2	1.3e-66	1.8e-65	219.3	0.0	4	217	34	251	31	260	0.95	STE20-like serine/threonine-protein kinase (DB07664; DB07853; DB12010)
drugbank_target|Q9H2G2	-	1235	sp|P61075|CDC2H_PL	-	288	1.6e-70	235.9	0.1	2	2	4.2e-07	6.1e-06	24.0	0.0	251	285	259	293	248	296	0.88	STE20-like serine/threonine-protein kinase (DB07664; DB07853; DB12010)
drugbank_target|P42681	-	527	sp|P61075|CDC2H_PL	-	288	1.7e-70	235.8	0.0	1	1	2.1e-71	3.1e-70	235.0	0.0	5	230	272	497	269	526	0.89	Tyrosine-protein kinase TXK (DB12010; DB15035)
drugbank_target|P29320	-	983	sp|P61075|CDC2H_PL	-	288	1.7e-70	235.8	0.0	1	1	2e-71	2.9e-70	235.0	0.0	6	230	623	854	619	884	0.87	Ephrin type-A receptor 3 (DB12010)
drugbank_target|Q9UKE5	-	1360	sp|P61075|CDC2H_PL	-	288	1.7e-70	235.8	0.2	1	2	6.5e-68	9.4e-67	223.5	0.0	4	214	25	246	23	254	0.92	TRAF2 and NCK-interacting protein kinase (DB12010)
drugbank_target|Q9UKE5	-	1360	sp|P61075|CDC2H_PL	-	288	1.7e-70	235.8	0.2	2	2	7e-06	0.0001	20.0	0.1	250	286	255	291	244	293	0.89	TRAF2 and NCK-interacting protein kinase (DB12010)
drugbank_target|Q6P3R8	-	708	sp|P61075|CDC2H_PL	-	288	1.9e-70	235.7	10.8	1	2	2.4e-69	3.4e-68	228.3	0.1	1	218	1	221	1	228	0.96	Serine/threonine-protein kinase Nek5 (DB12010)
drugbank_target|Q6P3R8	-	708	sp|P61075|CDC2H_PL	-	288	1.9e-70	235.7	10.8	2	2	0.00061	0.0088	13.6	0.0	251	286	226	261	219	263	0.90	Serine/threonine-protein kinase Nek5 (DB12010)
drugbank_target|P54756	-	1037	sp|P61075|CDC2H_PL	-	288	2.1e-70	235.5	0.0	1	1	2.4e-71	3.5e-70	234.8	0.0	6	251	677	930	674	947	0.87	Ephrin type-A receptor 5 (DB01254; DB12010)
drugbank_target|Q02156	-	737	sp|P61075|CDC2H_PL	-	288	2.4e-70	235.3	0.0	1	2	2.4e-70	3.5e-69	231.5	0.0	1	215	405	621	405	628	0.95	Protein kinase C epsilon type (DB06064; DB11752; DB12010)
drugbank_target|Q02156	-	737	sp|P61075|CDC2H_PL	-	288	2.4e-70	235.3	0.0	2	2	3	43	1.5	0.0	253	286	630	670	622	672	0.77	Protein kinase C epsilon type (DB06064; DB11752; DB12010)
drugbank_target|Q02156	-	737	sp|P61075|CDC2H_PL	-	288	2.4e-70	235.3	0.0	1	2	2.4e-70	3.5e-69	231.5	0.0	1	215	405	621	405	628	0.95	Protein kinase C epsilon type (DB00675)
drugbank_target|Q02156	-	737	sp|P61075|CDC2H_PL	-	288	2.4e-70	235.3	0.0	2	2	3	43	1.5	0.0	253	286	630	670	622	672	0.77	Protein kinase C epsilon type (DB00675)
drugbank_target|Q15375	-	998	sp|P61075|CDC2H_PL	-	288	2.5e-70	235.3	0.0	1	1	3.1e-71	4.5e-70	234.4	0.0	6	230	635	866	632	896	0.88	Ephrin type-A receptor 7 (DB07970; DB12010)
drugbank_target|P42680	-	631	sp|P61075|CDC2H_PL	-	288	2.6e-70	235.2	0.0	1	1	3e-71	4.3e-70	234.5	0.0	4	230	370	595	368	624	0.90	Tyrosine-protein kinase Tec (DB12010; DB15035)
drugbank_target|P07948	-	512	sp|P61075|CDC2H_PL	-	288	2.9e-70	235.0	0.0	1	1	2.8e-71	4e-70	234.6	0.0	3	240	246	484	244	503	0.91	Tyrosine-protein kinase Lyn (DB01254; DB03023; DB06616; DB08901; DB09079; DB12010)
drugbank_target|P16591	-	822	sp|P61075|CDC2H_PL	-	288	4.3e-70	234.5	0.0	1	1	3e-71	4.3e-70	234.5	0.0	6	252	565	813	561	821	0.91	Tyrosine-protein kinase Fer (DB12010)
drugbank_target|P29323	-	1055	sp|P61075|CDC2H_PL	-	288	4.7e-70	234.4	0.0	1	1	6.4e-71	9.3e-70	233.4	0.0	6	231	623	857	620	887	0.87	Ephrin type-B receptor 2 (DB04395; DB12010)
drugbank_target|P49336	-	464	sp|P61075|CDC2H_PL	-	288	5.1e-70	234.2	0.0	1	1	4.5e-71	6.5e-70	233.9	0.0	9	286	26	337	19	339	0.86	Cyclin-dependent kinase 8 (DB03496)
drugbank_target|P00521	-	746	sp|P61075|CDC2H_PL	-	288	6.3e-70	233.9	0.0	1	1	8.5e-71	1.2e-69	233.0	0.0	4	253	128	379	125	397	0.91	Tyrosine-protein kinase transforming protein Abl (DB02567; DB03814; DB03878; DB05489)
drugbank_target|Q96PY6	-	1258	sp|P61075|CDC2H_PL	-	288	6.4e-70	233.9	8.1	1	2	5.5e-70	7.9e-69	230.3	0.1	1	216	1	218	1	225	0.97	Serine/threonine-protein kinase Nek1 (DB12010)
drugbank_target|Q96PY6	-	1258	sp|P61075|CDC2H_PL	-	288	6.4e-70	233.9	8.1	2	2	0.044	0.63	7.5	0.0	252	286	226	260	220	262	0.91	Serine/threonine-protein kinase Nek1 (DB12010)
drugbank_target|P07332	-	822	sp|P61075|CDC2H_PL	-	288	1e-69	233.2	0.0	1	2	3.8	54	1.2	1.4	204	259	114	170	102	186	0.66	Tyrosine-protein kinase Fes/Fps (DB12010)
drugbank_target|P07332	-	822	sp|P61075|CDC2H_PL	-	288	1e-69	233.2	0.0	2	2	2.6e-69	3.7e-68	228.1	0.0	3	253	560	814	558	820	0.91	Tyrosine-protein kinase Fes/Fps (DB12010)
drugbank_target|P12931	-	536	sp|P61075|CDC2H_PL	-	288	1e-69	233.2	0.0	1	1	4.3e-70	6.2e-69	230.7	0.0	7	230	273	495	268	520	0.91	Proto-oncogene tyrosine-protein kinase Src (DB01254; DB01678; DB01866; DB01893; DB01908; DB01947; DB01962; DB02175; DB02336; DB02432; DB02762; DB02908; DB03023; DB03078; DB03104; DB03114; DB03217; DB03268; DB03298; DB03306; DB03525; DB03591; DB03628; DB03712; DB03828; DB03902; DB04080; DB04272; DB04495; DB04739; DB04751; DB05184; DB06137; DB06616; DB06882; DB06883; DB07335; DB07662; DB07966; DB08052; DB08053; DB08054; DB08192; DB08462; DB08564; DB08901; DB09079; DB12010)
drugbank_target|P05771	-	671	sp|P61075|CDC2H_PL	-	288	1.1e-69	233.2	0.0	1	1	1.2e-70	1.7e-69	232.5	0.0	2	229	340	569	339	588	0.91	Protein kinase C beta type (DB00163; DB01738; DB06486; DB08846; DB08862; DB14001; DB14002)
drugbank_target|P05771	-	671	sp|P61075|CDC2H_PL	-	288	1.1e-69	233.2	0.0	1	1	1.2e-70	1.7e-69	232.5	0.0	2	229	340	569	339	588	0.91	Protein kinase C beta type (DB00675)
drugbank_target|Q99759	-	626	sp|P61075|CDC2H_PL	-	288	1.2e-69	233.0	0.0	1	2	2.5e-68	3.6e-67	224.9	0.0	4	221	362	587	360	590	0.92	Mitogen-activated protein kinase kinase kinase 3 (DB12010)
drugbank_target|Q99759	-	626	sp|P61075|CDC2H_PL	-	288	1.2e-69	233.0	0.0	2	2	0.078	1.1	6.7	0.0	249	284	588	622	582	625	0.87	Mitogen-activated protein kinase kinase kinase 3 (DB12010)
drugbank_target|Q9Y4K4	-	846	sp|P61075|CDC2H_PL	-	288	1.3e-69	232.9	0.1	1	2	4.4e-66	6.4e-65	217.5	0.0	2	221	18	238	17	244	0.95	Mitogen-activated protein kinase kinase kinase kinase 5 (DB12010)
drugbank_target|Q9Y4K4	-	846	sp|P61075|CDC2H_PL	-	288	1.3e-69	232.9	0.1	2	2	0.00044	0.0064	14.0	0.0	250	286	243	279	231	281	0.86	Mitogen-activated protein kinase kinase kinase kinase 5 (DB12010)
drugbank_target|P54764	-	986	sp|P61075|CDC2H_PL	-	288	2e-69	232.3	0.0	1	1	2.7e-70	3.8e-69	231.4	0.0	6	228	623	852	619	884	0.89	Ephrin type-A receptor 4 (DB12010)
drugbank_target|P00519	-	1130	sp|P61075|CDC2H_PL	-	288	2.1e-69	232.2	0.1	1	1	2.7e-70	3.9e-69	231.3	0.1	4	253	242	493	239	508	0.91	Tyrosine-protein kinase ABL1 (DB00171; DB00619; DB01254; DB03878; DB04868; DB05184; DB06616; DB07831; DB08043; DB08231; DB08339; DB08350; DB08583; DB08896; DB08901; DB12010; DB12267; DB12323)
drugbank_target|Q9HBH9	-	465	sp|P61075|CDC2H_PL	-	288	2.3e-69	232.1	0.0	1	1	2.5e-70	3.6e-69	231.4	0.0	8	286	88	370	81	372	0.89	MAP kinase-interacting serine/threonine-protein kinase 2 (DB12010)
drugbank_target|P29317	-	976	sp|P61075|CDC2H_PL	-	288	2.4e-69	232.1	0.0	1	1	2.7e-70	3.9e-69	231.3	0.0	7	254	616	872	613	896	0.85	Ephrin type-A receptor 2 (DB01254; DB04395; DB08896; DB12010)
drugbank_target|Q12851	-	820	sp|P61075|CDC2H_PL	-	288	2.8e-69	231.8	0.0	1	2	1e-64	1.5e-63	213.0	0.0	2	221	14	234	13	240	0.95	Mitogen-activated protein kinase kinase kinase kinase 2 (DB12010)
drugbank_target|Q12851	-	820	sp|P61075|CDC2H_PL	-	288	2.8e-69	231.8	0.0	2	2	6.9e-05	0.001	16.7	0.1	253	286	242	275	235	277	0.89	Mitogen-activated protein kinase kinase kinase kinase 2 (DB12010)
drugbank_target|Q13882	-	451	sp|P61075|CDC2H_PL	-	288	2.8e-69	231.8	0.0	1	1	3e-70	4.4e-69	231.2	0.0	2	228	189	415	188	444	0.93	Protein-tyrosine kinase 6 (DB05294; DB12010; DB15035)
drugbank_target|P63185	-	526	sp|P61075|CDC2H_PL	-	288	3e-69	231.7	0.0	1	2	1.6e-68	2.4e-67	225.5	0.0	7	227	270	489	265	492	0.94	Tyrosine-protein kinase transforming protein Src (DB01773)
drugbank_target|P63185	-	526	sp|P61075|CDC2H_PL	-	288	3e-69	231.7	0.0	2	2	0.15	2.2	5.7	0.0	253	277	487	511	485	515	0.86	Tyrosine-protein kinase transforming protein Src (DB01773)
drugbank_target|Q05655	-	676	sp|P61075|CDC2H_PL	-	288	4e-69	231.3	0.0	1	2	8.3e-68	1.2e-66	223.2	0.0	2	215	347	562	346	570	0.92	Protein kinase C delta type (DB04376; DB05013; DB12010)
drugbank_target|Q05655	-	676	sp|P61075|CDC2H_PL	-	288	4e-69	231.3	0.0	2	2	0.11	1.6	6.2	0.0	253	286	571	605	562	607	0.84	Protein kinase C delta type (DB04376; DB05013; DB12010)
drugbank_target|Q05655	-	676	sp|P61075|CDC2H_PL	-	288	4e-69	231.3	0.0	1	2	8.3e-68	1.2e-66	223.2	0.0	2	215	347	562	346	570	0.92	Protein kinase C delta type (DB00675)
drugbank_target|Q05655	-	676	sp|P61075|CDC2H_PL	-	288	4e-69	231.3	0.0	2	2	0.11	1.6	6.2	0.0	253	286	571	605	562	607	0.84	Protein kinase C delta type (DB00675)
drugbank_target|P00524	-	526	sp|P61075|CDC2H_PL	-	288	4.1e-69	231.3	0.0	1	2	4.9e-69	7.1e-68	227.2	0.0	7	227	270	489	265	495	0.94	Tyrosine-protein kinase transforming protein Src (DB08434)
drugbank_target|P00524	-	526	sp|P61075|CDC2H_PL	-	288	4.1e-69	231.3	0.0	2	2	0.78	11	3.4	0.0	255	277	489	511	486	515	0.87	Tyrosine-protein kinase transforming protein Src (DB08434)
drugbank_target|P42684	-	1182	sp|P61075|CDC2H_PL	-	288	4.5e-69	231.1	0.0	1	1	6.2e-70	9e-69	230.2	0.0	4	253	288	539	285	554	0.90	Abelson tyrosine-protein kinase 2 (DB00171; DB01254; DB05184; DB07664; DB12010)
drugbank_target|P07947	-	543	sp|P61075|CDC2H_PL	-	288	5e-69	231.0	0.0	1	1	1.9e-69	2.7e-68	228.6	0.0	7	235	280	508	275	532	0.90	Tyrosine-protein kinase Yes (DB01254; DB12010)
drugbank_target|Q8IY84	-	436	sp|P61075|CDC2H_PL	-	288	5.3e-69	230.9	0.0	1	2	6.6e-68	9.5e-67	223.5	0.0	4	223	74	293	71	296	0.96	Serine/threonine-protein kinase NIM1 (DB12010)
drugbank_target|Q8IY84	-	436	sp|P61075|CDC2H_PL	-	288	5.3e-69	230.9	0.0	2	2	0.062	0.9	7.0	0.0	250	285	291	326	288	329	0.92	Serine/threonine-protein kinase NIM1 (DB12010)
drugbank_target|Q9UL54	-	1235	sp|P61075|CDC2H_PL	-	288	6.4e-69	230.6	3.3	1	2	3e-67	4.3e-66	221.4	0.0	4	218	28	242	26	252	0.95	Serine/threonine-protein kinase TAO2 (DB04522; DB12010)
drugbank_target|Q9UL54	-	1235	sp|P61075|CDC2H_PL	-	288	6.4e-69	230.6	3.3	2	2	0.0093	0.13	9.7	0.0	253	285	250	282	244	285	0.91	Serine/threonine-protein kinase TAO2 (DB04522; DB12010)
drugbank_target|O94768	-	372	sp|P61075|CDC2H_PL	-	288	6.4e-69	230.6	0.1	1	2	2.8e-61	4.1e-60	201.8	0.0	7	228	36	262	30	263	0.93	Serine/threonine-protein kinase 17B (DB04216; DB12010)
drugbank_target|O94768	-	372	sp|P61075|CDC2H_PL	-	288	6.4e-69	230.6	0.1	2	2	3.2e-09	4.6e-08	30.9	0.0	246	286	255	295	251	297	0.93	Serine/threonine-protein kinase 17B (DB04216; DB12010)
drugbank_target|Q7L7X3	-	1001	sp|P61075|CDC2H_PL	-	288	7.2e-69	230.5	0.1	1	3	2.3e-68	3.4e-67	225.0	0.0	4	218	28	242	26	250	0.95	Serine/threonine-protein kinase TAO1 (DB12010)
drugbank_target|Q7L7X3	-	1001	sp|P61075|CDC2H_PL	-	288	7.2e-69	230.5	0.1	2	3	0.0012	0.018	12.6	0.0	250	284	247	281	239	285	0.87	Serine/threonine-protein kinase TAO1 (DB12010)
drugbank_target|Q7L7X3	-	1001	sp|P61075|CDC2H_PL	-	288	7.2e-69	230.5	0.1	3	3	8.4	1.2e+02	0.0	4.0	204	271	684	751	669	756	0.86	Serine/threonine-protein kinase TAO1 (DB12010)
drugbank_target|P06239	-	509	sp|P61075|CDC2H_PL	-	288	1.1e-68	229.9	0.0	1	1	1e-69	1.5e-68	229.5	0.0	3	234	244	475	242	499	0.91	Tyrosine-protein kinase Lck (DB01254; DB01830; DB02010; DB03023; DB04003; DB04395; DB06925; DB07146; DB07297; DB08055; DB08056; DB08057; DB08901; DB09079; DB12010; DB15035)
drugbank_target|Q16513	-	984	sp|P61075|CDC2H_PL	-	288	1.4e-68	229.5	1.6	1	2	9.3e-68	1.3e-66	223.0	0.0	1	217	654	873	654	879	0.95	Serine/threonine-protein kinase N2 (DB12010)
drugbank_target|Q16513	-	984	sp|P61075|CDC2H_PL	-	288	1.4e-68	229.5	1.6	2	2	0.22	3.2	5.2	0.0	253	285	880	917	873	920	0.80	Serine/threonine-protein kinase N2 (DB12010)
drugbank_target|Q9H2X6	-	1198	sp|P61075|CDC2H_PL	-	288	1.8e-68	229.1	0.0	1	1	3.7e-69	5.4e-68	227.6	0.0	2	286	197	529	196	531	0.91	Homeodomain-interacting protein kinase 2 (DB12010)
drugbank_target|Q9H2K8	-	898	sp|P61075|CDC2H_PL	-	288	1.9e-68	229.1	0.3	1	2	9.4e-68	1.4e-66	223.0	0.1	4	218	24	238	22	247	0.94	Serine/threonine-protein kinase TAO3 (DB12010)
drugbank_target|Q9H2K8	-	898	sp|P61075|CDC2H_PL	-	288	1.9e-68	229.1	0.3	2	2	0.00079	0.011	13.2	0.0	251	286	244	279	237	281	0.90	Serine/threonine-protein kinase TAO3 (DB12010)
drugbank_target|P08631	-	526	sp|P61075|CDC2H_PL	-	288	2.3e-68	228.8	0.0	1	1	2.2e-69	3.1e-68	228.4	0.0	4	235	262	493	259	519	0.89	Tyrosine-protein kinase HCK (DB01809; DB01962; DB04216; DB06616; DB12010)
drugbank_target|P05129	-	697	sp|P61075|CDC2H_PL	-	288	2.5e-68	228.7	0.0	1	1	2.4e-69	3.4e-68	228.3	0.0	2	227	349	581	348	597	0.90	Protein kinase C gamma type (DB00675)
drugbank_target|P05129	-	697	sp|P61075|CDC2H_PL	-	288	2.5e-68	228.7	0.0	1	1	2.4e-69	3.4e-68	228.3	0.0	2	227	349	581	348	597	0.90	Protein kinase C gamma type (DB12010)
drugbank_target|P51451	-	505	sp|P61075|CDC2H_PL	-	288	2.5e-68	228.7	0.0	1	1	2.5e-69	3.6e-68	228.2	0.0	4	227	241	462	238	494	0.93	Tyrosine-protein kinase Blk (DB12010; DB15035)
drugbank_target|O95819	-	1239	sp|P61075|CDC2H_PL	-	288	3.2e-68	228.4	0.0	1	2	6.2e-66	8.9e-65	217.0	0.0	4	214	25	246	23	253	0.92	Mitogen-activated protein kinase kinase kinase kinase 4 (DB12010)
drugbank_target|O95819	-	1239	sp|P61075|CDC2H_PL	-	288	3.2e-68	228.4	0.0	2	2	1.7e-05	0.00024	18.7	0.0	250	286	255	291	244	293	0.89	Mitogen-activated protein kinase kinase kinase kinase 4 (DB12010)
drugbank_target|Q08881	-	620	sp|P61075|CDC2H_PL	-	288	4.4e-68	227.9	0.0	1	1	4.9e-69	7.1e-68	227.2	0.0	4	253	363	612	361	619	0.90	Tyrosine-protein kinase ITK/TSK (DB02010; DB06589; DB12010; DB15035)
drugbank_target|Q06187	-	659	sp|P61075|CDC2H_PL	-	288	4.9e-68	227.7	0.3	1	1	5.8e-69	8.3e-68	227.0	0.3	3	229	401	626	400	656	0.90	Tyrosine-protein kinase BTK (DB01254; DB01863; DB05204; DB09053; DB11703; DB12010; DB15035)
drugbank_target|O15530	-	556	sp|P61075|CDC2H_PL	-	288	7.6e-68	227.1	0.0	1	2	2e-66	2.9e-65	218.7	0.0	2	227	80	308	79	310	0.95	3-phosphoinositide-dependent protein kinase 1 (DB00482; DB01863; DB01933; DB01946; DB02010; DB03777; DB04522; DB06932; DB07033; DB07132; DB07300; DB07456; DB07457; DB12010)
drugbank_target|O15530	-	556	sp|P61075|CDC2H_PL	-	288	7.6e-68	227.1	0.0	2	2	0.016	0.23	8.9	0.0	252	278	304	330	300	346	0.76	3-phosphoinositide-dependent protein kinase 1 (DB00482; DB01863; DB01933; DB01946; DB02010; DB03777; DB04522; DB06932; DB07033; DB07132; DB07300; DB07456; DB07457; DB12010)
drugbank_target|Q8NEV4	-	1616	sp|P61075|CDC2H_PL	-	288	9e-68	226.9	0.1	1	2	9.1e-61	1.3e-59	200.1	0.0	2	216	19	245	18	255	0.91	Myosin-IIIa (DB12010)
drugbank_target|Q8NEV4	-	1616	sp|P61075|CDC2H_PL	-	288	9e-68	226.9	0.1	2	2	5.8e-07	8.4e-06	23.5	0.0	253	286	256	289	243	291	0.89	Myosin-IIIa (DB12010)
drugbank_target|Q13237	-	762	sp|P61075|CDC2H_PL	-	288	1.2e-67	226.4	0.1	1	2	0.0028	0.04	11.4	0.0	33	141	265	380	245	386	0.74	cGMP-dependent protein kinase 2 (DB12010)
drugbank_target|Q13237	-	762	sp|P61075|CDC2H_PL	-	288	1.2e-67	226.4	0.1	2	2	5.3e-64	7.7e-63	210.7	0.0	2	222	451	671	450	708	0.92	cGMP-dependent protein kinase 2 (DB12010)
drugbank_target|P09769	-	529	sp|P61075|CDC2H_PL	-	288	1.3e-67	226.4	0.0	1	1	1.3e-68	1.9e-67	225.8	0.0	5	245	264	504	261	520	0.91	Tyrosine-protein kinase Fgr (DB01254; DB12010; DB15035)
drugbank_target|O94804	-	968	sp|P61075|CDC2H_PL	-	288	1.5e-67	226.1	0.0	1	2	1.9e-65	2.7e-64	215.5	0.0	3	216	35	252	33	257	0.95	Serine/threonine-protein kinase 10 (DB12010)
drugbank_target|O94804	-	968	sp|P61075|CDC2H_PL	-	288	1.5e-67	226.1	0.0	2	2	3.4e-05	0.00049	17.7	0.0	251	286	261	296	255	298	0.91	Serine/threonine-protein kinase 10 (DB12010)
drugbank_target|Q9Y2U5	-	619	sp|P61075|CDC2H_PL	-	288	1.5e-67	226.1	0.0	1	2	6.9e-67	9.9e-66	220.2	0.0	3	220	355	580	354	585	0.92	Mitogen-activated protein kinase kinase kinase 2 (DB06616; DB12010)
drugbank_target|Q9Y2U5	-	619	sp|P61075|CDC2H_PL	-	288	1.5e-67	226.1	0.0	2	2	0.45	6.5	4.2	0.0	249	285	582	617	577	619	0.87	Mitogen-activated protein kinase kinase kinase 2 (DB06616; DB12010)
drugbank_target|Q16620	-	822	sp|P61075|CDC2H_PL	-	288	2e-67	225.7	0.0	1	1	2.3e-68	3.3e-67	225.0	0.0	6	230	540	784	536	815	0.87	BDNF/NT-3 growth factors receptor (DB00321; DB11823; DB11986; DB12010; DB14723)
drugbank_target|P41743	-	596	sp|P61075|CDC2H_PL	-	288	3e-67	225.2	0.0	1	2	1e-66	1.5e-65	219.6	0.0	1	204	251	456	251	470	0.94	Protein kinase C iota type (DB03777; DB12010)
drugbank_target|P41743	-	596	sp|P61075|CDC2H_PL	-	288	3e-67	225.2	0.0	2	2	0.65	9.4	3.6	0.0	248	276	480	508	459	526	0.73	Protein kinase C iota type (DB03777; DB12010)
drugbank_target|P41743	-	596	sp|P61075|CDC2H_PL	-	288	3e-67	225.2	0.0	1	2	1e-66	1.5e-65	219.6	0.0	1	204	251	456	251	470	0.94	Protein kinase C iota type (DB00675)
drugbank_target|P41743	-	596	sp|P61075|CDC2H_PL	-	288	3e-67	225.2	0.0	2	2	0.65	9.4	3.6	0.0	248	276	480	508	459	526	0.73	Protein kinase C iota type (DB00675)
drugbank_target|Q02750	-	393	sp|P61075|CDC2H_PL	-	288	3.2e-67	225.1	0.0	1	1	4.5e-68	6.5e-67	224.1	0.0	2	287	66	364	65	365	0.86	Dual specificity mitogen-activated protein kinase kinase 1 (DB02152; DB03115; DB05239; DB06616; DB06892; DB07046; DB07101; DB08130; DB08208; DB08911; DB11689)
drugbank_target|P51955	-	445	sp|P61075|CDC2H_PL	-	288	3.9e-67	224.8	3.9	1	2	1.3e-65	1.8e-64	216.0	0.0	2	217	6	232	5	237	0.93	Serine/threonine-protein kinase Nek2 (DB07180; DB12010)
drugbank_target|P51955	-	445	sp|P61075|CDC2H_PL	-	288	3.9e-67	224.8	3.9	2	2	0.012	0.18	9.3	0.0	248	285	235	272	229	275	0.87	Serine/threonine-protein kinase Nek2 (DB07180; DB12010)
drugbank_target|Q96RR4	-	588	sp|P61075|CDC2H_PL	-	288	4.4e-67	224.6	0.5	1	2	1.1e-59	1.5e-58	196.6	0.1	1	213	162	402	162	413	0.92	Calcium/calmodulin-dependent protein kinase kinase 2 (DB12010)
drugbank_target|Q96RR4	-	588	sp|P61075|CDC2H_PL	-	288	4.4e-67	224.6	0.5	2	2	4.1e-07	5.9e-06	24.0	0.0	251	286	413	448	399	450	0.89	Calcium/calmodulin-dependent protein kinase kinase 2 (DB12010)
drugbank_target|Q13464	-	1354	sp|P61075|CDC2H_PL	-	288	4.4e-67	224.6	0.0	1	1	3.1e-68	4.4e-67	224.6	0.0	2	233	74	310	73	355	0.91	Rho-associated protein kinase 1 (DB04707; DB07876; DB08162; DB08756; DB13165; DB13931)
drugbank_target|P11362	-	822	sp|P61075|CDC2H_PL	-	288	4.6e-67	224.5	0.1	1	1	9.3e-68	1.3e-66	223.0	0.0	4	254	478	755	475	763	0.90	Fibroblast growth factor receptor 1 (DB00039; DB00398; DB01109; DB02058; DB05014; DB07525; DB07840; DB08577; DB08896; DB08901; DB09078; DB09079; DB12010; DB12147; DB15102; DB15685)
drugbank_target|Q8N4C8	-	1332	sp|P61075|CDC2H_PL	-	288	4.7e-67	224.5	14.3	1	3	1e-67	1.5e-66	222.9	0.0	4	214	25	246	23	253	0.92	Misshapen-like kinase 1 (DB12010)
drugbank_target|Q8N4C8	-	1332	sp|P61075|CDC2H_PL	-	288	4.7e-67	224.5	14.3	2	3	0.032	0.46	7.9	0.0	250	286	255	291	244	293	0.89	Misshapen-like kinase 1 (DB12010)
drugbank_target|Q8N4C8	-	1332	sp|P61075|CDC2H_PL	-	288	4.7e-67	224.5	14.3	3	3	8.6	1.2e+02	-0.0	2.9	24	60	446	482	439	489	0.87	Misshapen-like kinase 1 (DB12010)
drugbank_target|P21709	-	976	sp|P61075|CDC2H_PL	-	288	5.1e-67	224.4	0.0	1	1	5.4e-68	7.8e-67	223.8	0.0	8	252	628	879	624	898	0.89	Ephrin type-A receptor 1 (DB12010)
drugbank_target|P51813	-	675	sp|P61075|CDC2H_PL	-	288	6.1e-67	224.2	0.7	1	1	8.8e-68	1.3e-66	223.1	0.1	3	232	416	644	414	671	0.88	Cytoplasmic tyrosine-protein kinase BMX (DB12010; DB15035)
drugbank_target|Q9Y6R4	-	1608	sp|P61075|CDC2H_PL	-	288	6.2e-67	224.1	5.9	1	2	9.2e-62	1.3e-60	203.3	0.2	3	217	1342	1562	1341	1570	0.90	Mitogen-activated protein kinase kinase kinase 4 (DB12010)
drugbank_target|Q9Y6R4	-	1608	sp|P61075|CDC2H_PL	-	288	6.2e-67	224.1	5.9	2	2	5.1e-07	7.4e-06	23.7	0.0	251	285	1568	1602	1563	1605	0.92	Mitogen-activated protein kinase kinase kinase 4 (DB12010)
drugbank_target|P54760	-	987	sp|P61075|CDC2H_PL	-	288	7.5e-67	223.9	0.0	1	1	8.1e-68	1.2e-66	223.2	0.0	6	230	617	850	613	881	0.86	Ephrin type-B receptor 4 (DB01254; DB07249; DB07250; DB07251; DB07252; DB07253; DB07254; DB07255; DB07256; DB11973; DB12010)
drugbank_target|Q16512	-	942	sp|P61075|CDC2H_PL	-	288	7.8e-67	223.8	0.0	1	3	2.3	33	1.8	0.0	171	227	451	507	438	520	0.82	Serine/threonine-protein kinase N1 (DB12010)
drugbank_target|Q16512	-	942	sp|P61075|CDC2H_PL	-	288	7.8e-67	223.8	0.0	2	3	5.5e-66	8e-65	217.2	0.0	1	217	612	831	612	837	0.95	Serine/threonine-protein kinase N1 (DB12010)
drugbank_target|Q16512	-	942	sp|P61075|CDC2H_PL	-	288	7.8e-67	223.8	0.0	3	3	7	1e+02	0.3	0.0	253	275	838	860	833	877	0.74	Serine/threonine-protein kinase N1 (DB12010)
drugbank_target|P49760	-	499	sp|P61075|CDC2H_PL	-	288	9.6e-67	223.5	0.2	1	1	1e-67	1.5e-66	222.9	0.2	2	286	161	481	160	483	0.90	Dual specificity protein kinase CLK2 (DB12010)
drugbank_target|Q9BXA7	-	367	sp|P61075|CDC2H_PL	-	288	1.3e-66	223.1	0.4	1	2	1.2e-59	1.7e-58	196.4	0.1	4	217	12	231	10	238	0.89	Testis-specific serine/threonine-protein kinase 1 (DB12010)
drugbank_target|Q9BXA7	-	367	sp|P61075|CDC2H_PL	-	288	1.3e-66	223.1	0.4	2	2	1.4e-07	2e-06	25.5	0.1	250	286	238	274	226	276	0.87	Testis-specific serine/threonine-protein kinase 1 (DB12010)
drugbank_target|Q9BUB5	-	465	sp|P61075|CDC2H_PL	-	288	2.6e-66	222.1	0.1	1	2	2.8e-25	4e-24	83.6	0.4	8	120	53	165	46	174	0.91	MAP kinase-interacting serine/threonine-protein kinase 1 (DB12010)
drugbank_target|Q9BUB5	-	465	sp|P61075|CDC2H_PL	-	288	2.6e-66	222.1	0.1	2	2	2.9e-41	4.3e-40	136.1	0.0	119	286	205	376	196	378	0.87	MAP kinase-interacting serine/threonine-protein kinase 1 (DB12010)
drugbank_target|Q9UF33	-	1036	sp|P61075|CDC2H_PL	-	288	3.1e-66	221.8	0.0	1	1	5.3e-67	7.7e-66	220.5	0.0	5	235	632	912	629	951	0.84	Ephrin type-A receptor 6 (DB12010)
drugbank_target|P36507	-	400	sp|P61075|CDC2H_PL	-	288	3.2e-66	221.8	0.0	1	1	5.4e-67	7.8e-66	220.5	0.0	2	286	70	371	69	373	0.89	Dual specificity mitogen-activated protein kinase kinase 2 (DB06616; DB08911; DB11689; DB11967; DB12010)
drugbank_target|Q6ZN16	-	1313	sp|P61075|CDC2H_PL	-	288	3.8e-66	221.5	0.0	1	2	6.7e-63	9.7e-62	207.1	0.0	9	208	657	858	654	871	0.94	Mitogen-activated protein kinase kinase kinase 15 (DB12010)
drugbank_target|Q6ZN16	-	1313	sp|P61075|CDC2H_PL	-	288	3.8e-66	221.5	0.0	2	2	0.0022	0.031	11.8	0.0	249	287	873	911	864	912	0.89	Mitogen-activated protein kinase kinase kinase 15 (DB12010)
drugbank_target|Q16644	-	382	sp|P61075|CDC2H_PL	-	288	3.9e-66	221.5	0.2	1	2	1.3e-56	1.9e-55	186.4	0.0	3	208	42	249	40	266	0.89	MAP kinase-activated protein kinase 3 (DB07728; DB08358)
drugbank_target|Q16644	-	382	sp|P61075|CDC2H_PL	-	288	3.9e-66	221.5	0.2	2	2	6.9e-10	1e-08	33.1	0.1	249	286	269	306	263	308	0.94	MAP kinase-activated protein kinase 3 (DB07728; DB08358)
drugbank_target|O75116	-	1388	sp|P61075|CDC2H_PL	-	288	4.3e-66	221.4	0.0	1	1	2.9e-67	4.3e-66	221.4	0.0	2	234	90	327	89	372	0.89	Rho-associated protein kinase 2 (DB08162; DB08756; DB12010; DB13165; DB13931)
drugbank_target|Q92918	-	833	sp|P61075|CDC2H_PL	-	288	6.5e-66	220.8	0.0	1	2	4e-64	5.8e-63	211.1	0.0	2	221	15	235	14	242	0.95	Mitogen-activated protein kinase kinase kinase kinase 1 (DB12010)
drugbank_target|Q92918	-	833	sp|P61075|CDC2H_PL	-	288	6.5e-66	220.8	0.0	2	2	0.029	0.42	8.1	0.0	252	285	242	275	233	278	0.87	Mitogen-activated protein kinase kinase kinase kinase 1 (DB12010)
drugbank_target|Q9Y2H1	-	464	sp|P61075|CDC2H_PL	-	288	8.8e-66	220.4	1.1	1	1	4.7e-66	6.7e-65	217.4	1.5	1	219	87	341	87	355	0.94	Serine/threonine-protein kinase 38-like (DB12010)
drugbank_target|Q05397	-	1052	sp|P61075|CDC2H_PL	-	288	8.8e-66	220.3	0.0	1	1	2.7e-66	4e-65	218.2	0.0	2	248	420	671	419	693	0.88	Focal adhesion kinase 1 (DB06423; DB07248; DB07460; DB12010)
drugbank_target|Q13627	-	763	sp|P61075|CDC2H_PL	-	288	1e-65	220.1	0.1	1	1	6.2e-66	8.9e-65	217.0	0.1	1	287	156	482	156	483	0.83	Dual specificity tyrosine-phosphorylation-regulated kinase 1A (DB07608; DB12010)
drugbank_target|Q9H422	-	1215	sp|P61075|CDC2H_PL	-	288	1.1e-65	220.1	0.0	1	1	3.5e-66	5e-65	217.9	0.0	2	286	195	527	194	529	0.89	Homeodomain-interacting protein kinase 3 (DB12010)
drugbank_target|P49137	-	400	sp|P61075|CDC2H_PL	-	288	1.1e-65	220.1	0.1	1	2	1.7e-56	2.4e-55	186.1	0.0	2	206	61	268	60	286	0.89	MAP kinase-activated protein kinase 2 (DB02010; DB07234; DB07406; DB07430; DB07431; DB07728; DB08358)
drugbank_target|P49137	-	400	sp|P61075|CDC2H_PL	-	288	1.1e-65	220.1	0.1	2	2	1.3e-09	1.9e-08	32.2	0.1	247	286	288	327	270	329	0.88	MAP kinase-activated protein kinase 2 (DB02010; DB07234; DB07406; DB07430; DB07431; DB07728; DB08358)
drugbank_target|P21802	-	821	sp|P61075|CDC2H_PL	-	288	1.4e-65	219.7	0.0	1	1	1.6e-66	2.3e-65	219.0	0.0	3	254	480	758	478	773	0.88	Fibroblast growth factor receptor 2 (DB00039; DB01041; DB01109; DB01901; DB02058; DB02491; DB08896; DB08901; DB09078; DB09079; DB10770; DB10772; DB12010; DB12147; DB15102; DB15685)
drugbank_target|Q05513	-	592	sp|P61075|CDC2H_PL	-	288	2.4e-65	218.9	0.0	1	2	1.3e-65	1.9e-64	216.0	0.0	1	206	249	456	249	469	0.94	Protein kinase C zeta type (DB00675)
drugbank_target|Q05513	-	592	sp|P61075|CDC2H_PL	-	288	2.4e-65	218.9	0.0	2	2	8	1.2e+02	0.1	0.0	253	275	481	503	459	520	0.84	Protein kinase C zeta type (DB00675)
drugbank_target|Q9Y463	-	629	sp|P61075|CDC2H_PL	-	288	4.5e-65	218.0	0.0	1	1	4.1e-65	5.9e-64	214.4	0.0	1	286	108	433	108	435	0.85	Dual specificity tyrosine-phosphorylation-regulated kinase 1B (DB12010)
drugbank_target|Q8WU08	-	396	sp|P61075|CDC2H_PL	-	288	4.8e-65	217.9	7.7	1	2	7e-65	1e-63	213.6	0.6	2	206	21	228	20	241	0.93	Serine/threonine-protein kinase 32A (DB12010)
drugbank_target|Q8WU08	-	396	sp|P61075|CDC2H_PL	-	288	4.8e-65	217.9	7.7	2	2	0.016	0.23	8.9	0.0	244	286	240	283	229	285	0.77	Serine/threonine-protein kinase 32A (DB12010)
drugbank_target|P29322	-	1005	sp|P61075|CDC2H_PL	-	288	5.9e-65	217.6	0.0	1	1	6e-66	8.7e-65	217.1	0.0	3	230	634	868	632	898	0.88	Ephrin type-A receptor 8 (DB12010)
drugbank_target|O14757	-	476	sp|P61075|CDC2H_PL	-	288	6e-65	217.6	0.0	1	2	1.1e-61	1.5e-60	203.1	0.0	2	206	7	213	6	219	0.94	Serine/threonine-protein kinase Chk1 (DB05149; DB06486; DB06852; DB06876; DB07025; DB07034; DB07037; DB07038; DB07075; DB07078; DB07158; DB07213; DB07228; DB07243; DB07311; DB07314; DB07320; DB07336; DB07647; DB07648; DB07653; DB07654; DB07655; DB07959; DB08392; DB08393; DB08683; DB08774; DB08776; DB08777; DB08778; DB08779; DB08780; DB08781; DB12010)
drugbank_target|O14757	-	476	sp|P61075|CDC2H_PL	-	288	6e-65	217.6	0.0	2	2	0.00095	0.014	13.0	0.0	239	285	220	266	210	269	0.85	Serine/threonine-protein kinase Chk1 (DB05149; DB06486; DB06852; DB06876; DB07025; DB07034; DB07037; DB07038; DB07075; DB07078; DB07158; DB07213; DB07228; DB07243; DB07311; DB07314; DB07320; DB07336; DB07647; DB07648; DB07653; DB07654; DB07655; DB07959; DB08392; DB08393; DB08683; DB08774; DB08776; DB08777; DB08778; DB08779; DB08780; DB08781; DB12010)
drugbank_target|P49761	-	638	sp|P61075|CDC2H_PL	-	288	1e-64	216.9	0.5	1	1	9.5e-66	1.4e-64	216.4	0.5	2	285	302	621	301	624	0.90	Dual specificity protein kinase CLK3 (DB07664; DB08691; DB12010)
drugbank_target|Q9H3Y6	-	488	sp|P61075|CDC2H_PL	-	288	1.1e-64	216.7	0.0	1	1	1e-65	1.5e-64	216.3	0.0	3	228	229	454	227	483	0.92	Tyrosine-protein kinase Srms (DB12010)
drugbank_target|Q15208	-	465	sp|P61075|CDC2H_PL	-	288	1.3e-64	216.5	1.9	1	1	3.6e-65	5.2e-64	214.5	1.9	1	221	86	342	86	358	0.93	Serine/threonine-protein kinase 38 (DB12010)
drugbank_target|Q8N5S9	-	505	sp|P61075|CDC2H_PL	-	288	1.3e-64	216.5	0.1	1	2	1.3e-56	1.9e-55	186.4	0.0	1	204	125	356	125	375	0.90	Calcium/calmodulin-dependent protein kinase kinase 1 (DB12010)
drugbank_target|Q8N5S9	-	505	sp|P61075|CDC2H_PL	-	288	1.3e-64	216.5	0.1	2	2	1.6e-07	2.4e-06	25.3	0.0	251	287	376	412	360	413	0.90	Calcium/calmodulin-dependent protein kinase kinase 1 (DB12010)
drugbank_target|Q13523	-	1007	sp|P61075|CDC2H_PL	-	288	1.4e-64	216.4	2.0	1	1	9.4e-66	1.4e-64	216.4	2.0	2	287	685	1006	684	1007	0.88	Serine/threonine-protein kinase PRP4 homolog (DB12010)
drugbank_target|Q8TD19	-	979	sp|P61075|CDC2H_PL	-	288	1.5e-64	216.3	0.6	1	2	6e-62	8.7e-61	204.0	0.1	4	222	52	272	50	278	0.95	Serine/threonine-protein kinase Nek9 (DB12010)
drugbank_target|Q8TD19	-	979	sp|P61075|CDC2H_PL	-	288	1.5e-64	216.3	0.6	2	2	0.0029	0.042	11.4	0.1	251	286	275	310	269	312	0.87	Serine/threonine-protein kinase Nek9 (DB12010)
drugbank_target|P22607	-	806	sp|P61075|CDC2H_PL	-	288	2e-64	215.9	0.0	1	1	2.5e-65	3.6e-64	215.1	0.0	4	254	472	749	470	755	0.87	Fibroblast growth factor receptor 3 (DB00039; DB05014; DB06589; DB08901; DB09078; DB09079; DB12010; DB12147; DB15102; DB15685)
drugbank_target|Q8NG66	-	645	sp|P61075|CDC2H_PL	-	288	4.4e-64	214.8	7.9	1	3	5.4e-63	7.8e-62	207.4	0.1	2	223	27	254	26	259	0.91	Serine/threonine-protein kinase Nek11 (DB08912; DB12010)
drugbank_target|Q8NG66	-	645	sp|P61075|CDC2H_PL	-	288	4.4e-64	214.8	7.9	2	3	0.011	0.16	9.4	0.0	252	286	255	289	248	291	0.88	Serine/threonine-protein kinase Nek11 (DB08912; DB12010)
drugbank_target|Q8NG66	-	645	sp|P61075|CDC2H_PL	-	288	4.4e-64	214.8	7.9	3	3	7.9	1.1e+02	0.1	0.8	201	234	351	384	310	409	0.71	Serine/threonine-protein kinase Nek11 (DB08912; DB12010)
drugbank_target|P41240	-	450	sp|P61075|CDC2H_PL	-	288	4.4e-64	214.8	0.0	1	1	4.3e-65	6.2e-64	214.3	0.0	1	241	192	428	192	448	0.89	Tyrosine-protein kinase CSK (DB01254; DB02010; DB05075; DB12010)
drugbank_target|Q16288	-	839	sp|P61075|CDC2H_PL	-	288	7.2e-64	214.1	0.0	1	1	1.5e-64	2.2e-63	212.5	0.0	6	229	540	800	536	825	0.87	NT-3 growth factor receptor (DB11986; DB12010; DB14723)
drugbank_target|Q9Y2H9	-	1570	sp|P61075|CDC2H_PL	-	288	2e-63	212.6	0.0	1	2	2.6e-63	3.8e-62	208.4	0.0	2	214	372	600	371	611	0.93	Microtubule-associated serine/threonine-protein kinase 1 (DB12010)
drugbank_target|Q9Y2H9	-	1570	sp|P61075|CDC2H_PL	-	288	2e-63	212.6	0.0	2	2	2.9	41	1.5	0.0	253	286	613	649	604	651	0.81	Microtubule-associated serine/threonine-protein kinase 1 (DB12010)
drugbank_target|P35626	-	688	sp|P61075|CDC2H_PL	-	288	2e-63	212.6	0.0	1	2	1.7e-61	2.4e-60	202.5	0.1	1	209	188	399	188	410	0.91	Beta-adrenergic receptor kinase 2 (DB00171)
drugbank_target|P35626	-	688	sp|P61075|CDC2H_PL	-	288	2e-63	212.6	0.0	2	2	0.042	0.6	7.6	0.0	248	285	412	454	396	457	0.76	Beta-adrenergic receptor kinase 2 (DB00171)
drugbank_target|Q15303	-	1308	sp|P61075|CDC2H_PL	-	288	3.7e-63	211.7	0.0	1	1	3.9e-64	5.6e-63	211.1	0.0	4	286	718	1006	716	1008	0.91	Receptor tyrosine-protein kinase erbB-4 (DB08916; DB12010; DB12267; DB15035)
drugbank_target|Q13233	-	1512	sp|P61075|CDC2H_PL	-	288	4.1e-63	211.6	0.0	1	2	2.9e-61	4.2e-60	201.7	0.0	4	225	1243	1473	1241	1478	0.90	Mitogen-activated protein kinase kinase kinase 1 (DB06061; DB11967; DB12010)
drugbank_target|Q13233	-	1512	sp|P61075|CDC2H_PL	-	288	4.1e-63	211.6	0.0	2	2	0.016	0.23	8.9	0.0	248	285	1472	1509	1463	1512	0.87	Mitogen-activated protein kinase kinase kinase 1 (DB06061; DB11967; DB12010)
drugbank_target|O43283	-	966	sp|P61075|CDC2H_PL	-	288	4.5e-63	211.5	0.0	1	1	8.9e-64	1.3e-62	210.0	0.0	3	254	167	408	165	417	0.87	Mitogen-activated protein kinase kinase kinase 13 (DB12010)
drugbank_target|O14920	-	756	sp|P61075|CDC2H_PL	-	288	6.8e-63	210.9	0.0	1	1	1.5e-63	2.1e-62	209.2	0.0	4	274	15	290	13	294	0.93	Inhibitor of nuclear factor kappa-B kinase subunit beta (DB00244; DB00795; DB00945; DB00995; DB01169; DB05183; DB06151; DB06521; DB12010)
drugbank_target|P22455	-	802	sp|P61075|CDC2H_PL	-	288	7.1e-63	210.8	0.0	1	1	8.4e-64	1.2e-62	210.0	0.0	4	255	467	745	464	758	0.88	Fibroblast growth factor receptor 4 (DB00039; DB01109; DB08901; DB09078; DB12147; DB15102)
drugbank_target|O15111	-	745	sp|P61075|CDC2H_PL	-	288	7.4e-63	210.7	0.0	1	1	1.3e-63	1.9e-62	209.4	0.0	4	272	15	287	14	296	0.92	Inhibitor of nuclear factor kappa-B kinase subunit alpha (DB00233; DB00244; DB00795; DB06151)
drugbank_target|P06213	-	1382	sp|P61075|CDC2H_PL	-	288	1e-62	210.3	0.0	1	1	1.5e-63	2.1e-62	209.3	0.0	3	252	1022	1289	1020	1296	0.88	Insulin receptor (DB00030; DB00046; DB00047; DB00071; DB01277; DB01306; DB01307; DB01309; DB03909; DB05115; DB05120; DB08513; DB09129; DB09564; DB12010; DB12267; DB14751)
drugbank_target|P43403	-	619	sp|P61075|CDC2H_PL	-	288	1e-62	210.3	0.0	1	1	1.1e-63	1.6e-62	209.7	0.0	9	226	343	565	340	595	0.91	Tyrosine-protein kinase ZAP-70 (DB02010; DB12010)
drugbank_target|P04629	-	796	sp|P61075|CDC2H_PL	-	288	1.4e-62	209.8	0.0	1	1	1.5e-63	2.2e-62	209.2	0.0	9	253	515	781	508	787	0.88	High affinity nerve growth factor receptor (DB00321; DB00619; DB08896; DB11986; DB12010; DB13926; DB14723)
drugbank_target|Q8IW41	-	473	sp|P61075|CDC2H_PL	-	288	1.5e-62	209.8	0.0	1	2	5e-53	7.2e-52	174.7	0.0	7	217	25	257	17	267	0.87	MAP kinase-activated protein kinase 5 (DB12010)
drugbank_target|Q8IW41	-	473	sp|P61075|CDC2H_PL	-	288	1.5e-62	209.8	0.0	2	2	6.3e-10	9.2e-09	33.2	0.0	247	286	267	306	256	308	0.91	MAP kinase-activated protein kinase 5 (DB12010)
drugbank_target|Q86UE8	-	772	sp|P61075|CDC2H_PL	-	288	2.1e-62	209.2	1.5	1	2	1.4e-59	2e-58	196.2	0.1	2	212	460	692	459	710	0.86	Serine/threonine-protein kinase tousled-like 2 (DB12010)
drugbank_target|Q86UE8	-	772	sp|P61075|CDC2H_PL	-	288	2.1e-62	209.2	1.5	2	2	0.0032	0.046	11.2	0.0	253	284	710	741	692	744	0.90	Serine/threonine-protein kinase tousled-like 2 (DB12010)
drugbank_target|P43405	-	635	sp|P61075|CDC2H_PL	-	288	2.3e-62	209.1	0.3	1	1	2.9e-63	4.2e-62	208.3	0.3	8	233	375	606	372	625	0.91	Tyrosine-protein kinase SYK (DB02010; DB06834; DB07159; DB07194; DB08361; DB08846; DB12010)
drugbank_target|Q14289	-	1009	sp|P61075|CDC2H_PL	-	288	2.3e-62	209.1	0.1	1	1	7.4e-63	1.1e-61	206.9	0.0	7	254	428	680	423	708	0.88	Protein-tyrosine kinase 2-beta (DB01097; DB01645; DB08341; DB11817; DB12010)
drugbank_target|P04049	-	648	sp|P61075|CDC2H_PL	-	288	2.5e-62	209.0	0.1	1	1	3e-63	4.3e-62	208.2	0.1	8	239	353	585	348	616	0.86	RAF proto-oncogene serine/threonine-protein kinase (DB00398; DB04973; DB05190; DB05268; DB08862; DB08896; DB08912; DB12010)
drugbank_target|P42679	-	507	sp|P61075|CDC2H_PL	-	288	4.2e-62	208.3	0.0	1	1	4.2e-63	6.1e-62	207.7	0.0	2	258	233	483	232	485	0.92	Megakaryocyte-associated tyrosine-protein kinase (DB12010)
drugbank_target|P25098	-	689	sp|P61075|CDC2H_PL	-	288	4.7e-62	208.1	0.5	1	3	2e-60	2.9e-59	198.9	0.1	1	210	188	400	188	410	0.91	Beta-adrenergic receptor kinase 1 (DB00171)
drugbank_target|P25098	-	689	sp|P61075|CDC2H_PL	-	288	4.7e-62	208.1	0.5	2	3	0.42	6.1	4.3	0.0	245	275	409	439	397	456	0.73	Beta-adrenergic receptor kinase 1 (DB00171)
drugbank_target|P25098	-	689	sp|P61075|CDC2H_PL	-	288	4.7e-62	208.1	0.5	3	3	2.5	36	1.7	0.1	208	285	604	682	588	685	0.72	Beta-adrenergic receptor kinase 1 (DB00171)
drugbank_target|P15056	-	766	sp|P61075|CDC2H_PL	-	288	7.1e-62	207.5	0.1	1	1	1.3e-62	1.8e-61	206.2	0.1	5	237	458	691	455	721	0.86	Serine/threonine-protein kinase B-raf (DB00398; DB05190; DB05984; DB06999; DB07000; DB08553; DB08881; DB08896; DB08912; DB11718; DB12010; DB14840)
drugbank_target|Q59EB3	-	712	sp|P61075|CDC2H_PL	-	288	8.1e-62	207.3	0.0	1	1	8.3e-63	1.2e-61	206.8	0.0	6	261	402	667	400	675	0.90	Met proto-oncogene variant (DB08111)
drugbank_target|O14578	-	2027	sp|P61075|CDC2H_PL	-	288	8.4e-62	207.3	0.0	1	2	5.8e-63	8.4e-62	207.3	0.0	2	222	95	324	94	332	0.93	Citron Rho-interacting kinase (DB12010)
drugbank_target|O14578	-	2027	sp|P61075|CDC2H_PL	-	288	8.4e-62	207.3	0.0	2	2	0.91	13	3.2	0.0	252	286	329	362	325	364	0.89	Citron Rho-interacting kinase (DB12010)
drugbank_target|Q6DT37	-	1551	sp|P61075|CDC2H_PL	-	288	9.1e-62	207.2	0.2	1	2	1.2e-61	1.7e-60	203.0	0.0	2	219	69	294	68	300	0.94	Serine/threonine-protein kinase MRCK gamma (DB12010)
drugbank_target|Q6DT37	-	1551	sp|P61075|CDC2H_PL	-	288	9.1e-62	207.2	0.2	2	2	4.6	66	0.9	0.0	250	285	301	338	295	341	0.85	Serine/threonine-protein kinase MRCK gamma (DB12010)
drugbank_target|Q9NYL2	-	800	sp|P61075|CDC2H_PL	-	288	1.8e-61	206.2	0.1	1	1	1.4e-61	2e-60	202.8	0.1	2	279	14	291	13	292	0.85	Mitogen-activated protein kinase kinase kinase MLT (DB01254; DB12010)
drugbank_target|P07949	-	1114	sp|P61075|CDC2H_PL	-	288	2e-61	206.0	0.0	1	1	2.6e-62	3.8e-61	205.1	0.0	6	257	726	1005	722	1014	0.85	Proto-oncogene tyrosine-protein kinase receptor Ret (DB00398; DB01809; DB05294; DB08875; DB08896; DB08901; DB09078; DB12010; DB12742; DB15685)
drugbank_target|Q9UKI8	-	766	sp|P61075|CDC2H_PL	-	288	2.1e-61	206.0	0.2	1	2	8.5e-58	1.2e-56	190.3	0.1	2	211	454	684	453	697	0.86	Serine/threonine-protein kinase tousled-like 1 (DB12010)
drugbank_target|Q9UKI8	-	766	sp|P61075|CDC2H_PL	-	288	2.1e-61	206.0	0.2	2	2	0.001	0.015	12.8	0.0	251	284	701	734	687	737	0.90	Serine/threonine-protein kinase tousled-like 1 (DB12010)
drugbank_target|O95382	-	1288	sp|P61075|CDC2H_PL	-	288	2.2e-61	205.9	0.0	1	2	3.2e-60	4.6e-59	198.3	0.0	9	207	653	855	648	870	0.93	Mitogen-activated protein kinase kinase kinase 6 (DB12010)
drugbank_target|O95382	-	1288	sp|P61075|CDC2H_PL	-	288	2.2e-61	205.9	0.0	2	2	0.2	2.9	5.3	0.0	251	285	873	907	864	910	0.91	Mitogen-activated protein kinase kinase kinase 6 (DB12010)
drugbank_target|P08581	-	1390	sp|P61075|CDC2H_PL	-	288	2.4e-61	205.8	0.0	1	1	2.8e-62	4.1e-61	205.0	0.0	6	261	1080	1345	1078	1353	0.90	Hepatocyte growth factor receptor (DB02152; DB06314; DB06896; DB06995; DB06997; DB07369; DB07969; DB08079; DB08791; DB08865; DB08875; DB11791; DB12010; DB12200; DB12267; DB12742)
drugbank_target|Q02763	-	1124	sp|P61075|CDC2H_PL	-	288	4.3e-61	205.0	0.0	1	1	6.1e-62	8.9e-61	203.9	0.0	3	253	823	1092	821	1107	0.86	Angiopoietin-1 receptor (DB00415; DB05294; DB08221; DB08896; DB08901; DB12010; DB14840)
drugbank_target|P08069	-	1367	sp|P61075|CDC2H_PL	-	288	5.1e-61	204.7	0.0	1	1	5.7e-62	8.2e-61	204.0	0.0	3	257	998	1270	996	1274	0.89	Insulin-like growth factor 1 receptor (DB00030; DB00046; DB00047; DB00071; DB01277; DB01306; DB01307; DB01309; DB04395; DB05023; DB05184; DB05897; DB06075; DB06343; DB07156; DB07474; DB09098; DB09564; DB12250; DB12267; DB14751)
drugbank_target|O15146	-	869	sp|P61075|CDC2H_PL	-	288	5.6e-61	204.6	0.0	1	1	8.7e-62	1.3e-60	203.4	0.0	3	230	574	833	572	863	0.87	Muscle, skeletal receptor tyrosine-protein kinase (DB12010)
drugbank_target|P36888	-	993	sp|P61075|CDC2H_PL	-	288	8.4e-61	204.0	0.0	1	2	4.5e-23	6.4e-22	76.4	0.1	3	99	609	712	607	719	0.88	Receptor-type tyrosine-protein kinase FLT3 (DB00398; DB01268; DB05014; DB05465; DB06080; DB06469; DB06595; DB08901; DB09079; DB12010; DB12141; DB12267; DB12500; DB12742; DB12874; DB12978)
drugbank_target|P36888	-	993	sp|P61075|CDC2H_PL	-	288	8.4e-61	204.0	0.0	2	2	8e-38	1.2e-36	124.8	0.0	95	224	781	912	766	946	0.86	Receptor-type tyrosine-protein kinase FLT3 (DB00398; DB01268; DB05014; DB05465; DB06080; DB06469; DB06595; DB08901; DB09079; DB12010; DB12141; DB12267; DB12500; DB12742; DB12874; DB12978)
drugbank_target|Q12852	-	859	sp|P61075|CDC2H_PL	-	288	9.8e-61	203.8	0.0	1	2	3.5e-60	5.1e-59	198.1	0.0	6	207	127	316	122	325	0.93	Mitogen-activated protein kinase kinase kinase 12 (DB12010)
drugbank_target|Q12852	-	859	sp|P61075|CDC2H_PL	-	288	9.8e-61	203.8	0.0	2	2	0.85	12	3.3	0.0	253	281	335	363	322	368	0.89	Mitogen-activated protein kinase kinase kinase 12 (DB12010)
drugbank_target|Q9NWZ3	-	460	sp|P61075|CDC2H_PL	-	288	1e-60	203.7	0.1	1	1	1.2e-61	1.7e-60	203.0	0.1	8	247	190	433	187	459	0.84	Interleukin-1 receptor-associated kinase 4 (DB08590; DB12010)
drugbank_target|P09619	-	1106	sp|P61075|CDC2H_PL	-	288	1.3e-60	203.3	0.0	1	2	2.3e-22	3.3e-21	74.1	0.1	4	99	600	702	597	707	0.89	Platelet-derived growth factor receptor beta (DB00102; DB00398; DB00619; DB01254; DB01268; DB05014; DB05146; DB06589; DB06595; DB08896; DB09079; DB09221; DB09283; DB10770; DB12010; DB12147; DB12978; DB14840)
drugbank_target|P09619	-	1106	sp|P61075|CDC2H_PL	-	288	1.3e-60	203.3	0.0	2	2	1.7e-38	2.5e-37	127.0	0.0	93	230	794	935	783	964	0.83	Platelet-derived growth factor receptor beta (DB00102; DB00398; DB00619; DB01254; DB01268; DB05014; DB05146; DB06589; DB06595; DB08896; DB09079; DB09221; DB09283; DB10770; DB12010; DB12147; DB12978; DB14840)
drugbank_target|Q07912	-	1038	sp|P61075|CDC2H_PL	-	288	1.6e-60	203.1	0.0	1	1	1.8e-61	2.6e-60	202.4	0.0	3	232	125	364	123	390	0.90	Activated CDC42 kinase 1 (DB00171; DB04367; DB11986; DB12010)
drugbank_target|P16234	-	1089	sp|P61075|CDC2H_PL	-	288	1.7e-60	203.0	0.0	1	2	1.1e-20	1.6e-19	68.5	0.0	6	98	595	694	591	700	0.87	Platelet-derived growth factor receptor alpha (DB00102; DB00619; DB01268; DB05146; DB06043; DB06589; DB06595; DB08896; DB08901; DB09078; DB09079; DB10772; DB12010; DB12147; DB12742; DB14840)
drugbank_target|P16234	-	1089	sp|P61075|CDC2H_PL	-	288	1.7e-60	203.0	0.0	2	2	5e-40	7.2e-39	132.0	0.0	85	234	777	931	771	956	0.77	Platelet-derived growth factor receptor alpha (DB00102; DB00619; DB01268; DB05146; DB06043; DB06589; DB06595; DB08896; DB08901; DB09078; DB09079; DB10772; DB12010; DB12147; DB12742; DB14840)
drugbank_target|P00533	-	1210	sp|P61075|CDC2H_PL	-	288	1.8e-60	202.9	0.0	1	1	1.9e-61	2.8e-60	202.3	0.0	3	274	711	988	709	999	0.88	Epidermal growth factor receptor (DB00002; DB00281; DB00317; DB00530; DB01259; DB01269; DB03496; DB04988; DB05101; DB05294; DB05374; DB05424; DB05524; DB05944; DB06021; DB07602; DB07662; DB08916; DB09330; DB09559; DB10772; DB11731; DB11737; DB11828; DB11963; DB12010; DB12202; DB12267; DB13164; DB15035)
drugbank_target|P80192	-	1104	sp|P61075|CDC2H_PL	-	288	2e-60	202.7	0.1	1	1	1.2e-60	1.7e-59	199.7	0.0	4	237	144	387	141	408	0.83	Mitogen-activated protein kinase kinase kinase 9 (DB08703; DB12010)
drugbank_target|Q16584	-	847	sp|P61075|CDC2H_PL	-	288	2.2e-60	202.7	0.0	1	1	3.7e-61	5.4e-60	201.4	0.0	3	262	116	385	114	444	0.84	Mitogen-activated protein kinase kinase kinase 11 (DB12010)
drugbank_target|Q16832	-	855	sp|P61075|CDC2H_PL	-	288	3.8e-60	201.9	0.0	1	1	4.5e-61	6.5e-60	201.1	0.0	5	218	564	806	561	845	0.89	Discoidin domain-containing receptor 2 (DB08896; DB12010)
drugbank_target|P53667	-	647	sp|P61075|CDC2H_PL	-	288	5.4e-60	201.4	0.0	1	1	5.7e-61	8.2e-60	200.8	0.0	7	195	342	543	337	550	0.95	LIM domain kinase 1 (DB08912; DB12010)
drugbank_target|P46734	-	347	sp|P61075|CDC2H_PL	-	288	7e-60	201.0	0.1	1	2	1.8e-54	2.5e-53	179.5	0.0	5	216	65	284	61	292	0.90	Dual specificity mitogen-activated protein kinase kinase 3 (DB12010)
drugbank_target|P46734	-	347	sp|P61075|CDC2H_PL	-	288	7e-60	201.0	0.1	2	2	3.3e-06	4.8e-05	21.0	0.0	250	285	291	326	275	329	0.82	Dual specificity mitogen-activated protein kinase kinase 3 (DB12010)
drugbank_target|Q09013	-	629	sp|P61075|CDC2H_PL	-	288	8.2e-60	200.8	0.0	1	1	1.4e-60	2.1e-59	199.4	0.0	2	224	69	301	68	317	0.93	Myotonin-protein kinase (DB01946)
drugbank_target|Q13163	-	448	sp|P61075|CDC2H_PL	-	288	9.3e-60	200.6	0.0	1	2	6.8e-56	9.9e-55	184.1	0.0	6	208	168	363	164	381	0.93	Dual specificity mitogen-activated protein kinase kinase 5 (DB12010)
drugbank_target|Q13163	-	448	sp|P61075|CDC2H_PL	-	288	9.3e-60	200.6	0.0	2	2	0.0003	0.0044	14.6	0.0	252	286	387	421	370	423	0.91	Dual specificity mitogen-activated protein kinase kinase 5 (DB12010)
drugbank_target|P30530	-	894	sp|P61075|CDC2H_PL	-	288	9.8e-60	200.5	0.0	1	1	1.6e-60	2.3e-59	199.3	0.0	6	258	538	808	534	810	0.87	Tyrosine-protein kinase receptor UFO (DB12010; DB12141)
drugbank_target|O95835	-	1130	sp|P61075|CDC2H_PL	-	288	1.1e-59	200.4	0.0	1	1	7.3e-61	1.1e-59	200.4	0.0	4	218	705	967	702	981	0.93	Serine/threonine-protein kinase LATS1 (DB12010)
drugbank_target|P52564	-	334	sp|P61075|CDC2H_PL	-	288	1.5e-59	199.9	0.0	1	2	7.4e-54	1.1e-52	177.4	0.0	3	216	52	273	50	281	0.90	Dual specificity mitogen-activated protein kinase kinase 6 (DB12010)
drugbank_target|P52564	-	334	sp|P61075|CDC2H_PL	-	288	1.5e-59	199.9	0.0	2	2	1.6e-06	2.2e-05	22.1	0.0	249	285	279	315	263	318	0.82	Dual specificity mitogen-activated protein kinase kinase 6 (DB12010)
drugbank_target|P10398	-	606	sp|P61075|CDC2H_PL	-	288	1.9e-59	199.6	0.0	1	2	2.6e-59	3.7e-58	195.3	0.0	5	215	311	523	308	537	0.92	Serine/threonine-protein kinase A-Raf (DB00171)
drugbank_target|P10398	-	606	sp|P61075|CDC2H_PL	-	288	1.9e-59	199.6	0.0	2	2	1.6	23	2.4	0.0	246	280	531	565	526	567	0.86	Serine/threonine-protein kinase A-Raf (DB00171)
drugbank_target|Q04912	-	1400	sp|P61075|CDC2H_PL	-	288	2.3e-59	199.3	0.0	1	1	2.4e-60	3.5e-59	198.7	0.0	8	254	1086	1342	1083	1354	0.86	Macrophage-stimulating protein receptor (DB12010)
drugbank_target|Q02779	-	954	sp|P61075|CDC2H_PL	-	288	2.3e-59	199.3	0.0	1	1	5e-60	7.2e-59	197.7	0.0	3	227	97	330	95	423	0.82	Mitogen-activated protein kinase kinase kinase 10 (DB12010)
drugbank_target|P35590	-	1138	sp|P61075|CDC2H_PL	-	288	3.7e-59	198.6	0.0	1	1	3.7e-60	5.3e-59	198.1	0.0	3	245	838	1099	836	1113	0.86	Tyrosine-protein kinase receptor Tie-1 (DB12010)
drugbank_target|P04626	-	1255	sp|P61075|CDC2H_PL	-	288	4.1e-59	198.5	0.0	1	1	4.5e-60	6.5e-59	197.8	0.0	4	259	720	982	718	985	0.90	Receptor tyrosine-protein kinase erbB-2 (DB00072; DB01259; DB04988; DB05773; DB05944; DB06021; DB06366; DB08916; DB11652; DB11973; DB12010; DB12267; DB15035)
drugbank_target|P17948	-	1338	sp|P61075|CDC2H_PL	-	288	4.1e-59	198.4	0.1	1	2	8.1e-19	1.2e-17	62.4	0.1	2	95	825	926	824	938	0.87	Vascular endothelial growth factor receptor 1 (DB00398; DB01268; DB04879; DB05075; DB05913; DB05932; DB06080; DB06101; DB06589; DB06626; DB07288; DB08896; DB09078; DB09079; DB09221; DB10770; DB12010; DB15685)
drugbank_target|P17948	-	1338	sp|P61075|CDC2H_PL	-	288	4.1e-59	198.4	0.1	2	2	1.7e-40	2.4e-39	133.6	0.0	94	254	991	1155	974	1176	0.78	Vascular endothelial growth factor receptor 1 (DB00398; DB01268; DB04879; DB05075; DB05913; DB05932; DB06080; DB06101; DB06589; DB06626; DB07288; DB08896; DB09078; DB09079; DB09221; DB10770; DB12010; DB15685)
drugbank_target|Q08345	-	913	sp|P61075|CDC2H_PL	-	288	5e-59	198.2	0.0	1	1	5.5e-60	7.9e-59	197.5	0.0	4	215	610	859	608	895	0.88	Epithelial discoidin domain-containing receptor 1 (DB00619; DB12010)
drugbank_target|P10721	-	976	sp|P61075|CDC2H_PL	-	288	7e-59	197.7	0.0	1	2	4.3e-18	6.2e-17	60.0	0.0	3	97	588	689	586	706	0.90	Mast/stem cell growth factor receptor Kit (DB00398; DB00619; DB01254; DB01268; DB01962; DB04868; DB05146; DB05913; DB06080; DB06589; DB06595; DB08896; DB08901; DB09078; DB09103; DB12010; DB12147; DB12742; DB12978; DB14840; DB15233)
drugbank_target|P10721	-	976	sp|P61075|CDC2H_PL	-	288	7e-59	197.7	0.0	2	2	7.7e-41	1.1e-39	134.7	0.0	81	257	747	928	736	946	0.81	Mast/stem cell growth factor receptor Kit (DB00398; DB00619; DB01254; DB01268; DB01962; DB04868; DB05146; DB05913; DB06080; DB06589; DB06595; DB08896; DB08901; DB09078; DB09103; DB12010; DB12147; DB12742; DB12978; DB14840; DB15233)
drugbank_target|P08922	-	2347	sp|P61075|CDC2H_PL	-	288	8e-59	197.5	0.0	1	1	9.6e-60	1.4e-58	196.7	0.0	8	242	1949	2204	1943	2230	0.84	Proto-oncogene tyrosine-protein kinase ROS (DB11986; DB12010)
drugbank_target|P33981	-	857	sp|P61075|CDC2H_PL	-	288	8.3e-59	197.4	6.8	1	2	3e-54	4.4e-53	178.7	0.7	4	222	525	756	523	762	0.90	Dual specificity protein kinase TTK (DB01782; DB12010; DB15498)
drugbank_target|P33981	-	857	sp|P61075|CDC2H_PL	-	288	8.3e-59	197.4	6.8	2	2	8.7e-07	1.3e-05	22.9	0.0	254	285	761	792	739	795	0.82	Dual specificity protein kinase TTK (DB01782; DB12010; DB15498)
drugbank_target|P07333	-	972	sp|P61075|CDC2H_PL	-	288	1e-58	197.2	0.0	1	2	3.7e-21	5.3e-20	70.1	0.0	3	95	581	680	579	687	0.89	Macrophage colony-stimulating factor 1 receptor (DB00619; DB01268; DB06080; DB07167; DB07202; DB12010; DB12147; DB12978)
drugbank_target|P07333	-	972	sp|P61075|CDC2H_PL	-	288	1e-58	197.2	0.0	2	2	7.9e-38	1.1e-36	124.8	0.0	91	258	744	915	716	917	0.86	Macrophage colony-stimulating factor 1 receptor (DB00619; DB01268; DB06080; DB07167; DB07202; DB12010; DB12147; DB12978)
drugbank_target|Q12866	-	999	sp|P61075|CDC2H_PL	-	288	1e-58	197.1	0.0	1	1	1.1e-59	1.6e-58	196.5	0.0	6	227	589	827	586	867	0.87	Tyrosine-protein kinase Mer (DB08325; DB12010)
drugbank_target|P14616	-	1297	sp|P61075|CDC2H_PL	-	288	1.3e-58	196.8	0.0	1	1	1.5e-59	2.1e-58	196.1	0.0	3	257	978	1250	976	1257	0.87	Insulin receptor-related protein (DB12010)
drugbank_target|Q59H18	-	835	sp|P61075|CDC2H_PL	-	288	2.5e-58	195.9	0.0	1	1	2.7e-59	4e-58	195.2	0.0	2	211	461	675	460	691	0.93	Serine/threonine-protein kinase TNNI3K (DB12010)
drugbank_target|P9WI81	-	626	sp|P61075|CDC2H_PL	-	288	3.7e-58	195.3	0.0	1	1	4.2e-59	6e-58	194.6	0.0	2	230	9	245	8	275	0.89	Serine/threonine-protein kinase PknB (DB02930; DB03909; DB12010)
drugbank_target|P53671	-	638	sp|P61075|CDC2H_PL	-	288	4.2e-58	195.2	0.2	1	1	4.7e-59	6.8e-58	194.5	0.2	7	195	334	540	330	546	0.95	LIM domain kinase 2 (DB12010)
drugbank_target|P35968	-	1356	sp|P61075|CDC2H_PL	-	288	1.4e-57	193.4	0.0	1	2	5.5e-18	8e-17	59.7	0.0	2	97	832	935	831	944	0.89	Vascular endothelial growth factor receptor 2 (DB00398; DB01268; DB04727; DB04849; DB04879; DB05014; DB05075; DB05146; DB05198; DB05578; DB05931; DB05984; DB06080; DB06101; DB06436; DB06589; DB06595; DB06626; DB06938; DB07183; DB07274; DB07326; DB07333; DB07334; DB07514; DB07528; DB07537; DB08042; DB08519; DB08875; DB08896; DB08901; DB09078; DB09079; DB12010; DB12147; DB12307; DB14840)
drugbank_target|P35968	-	1356	sp|P61075|CDC2H_PL	-	288	1.4e-57	193.4	0.0	2	2	1.2e-39	1.7e-38	130.8	0.0	95	234	998	1139	977	1170	0.81	Vascular endothelial growth factor receptor 2 (DB00398; DB01268; DB04727; DB04849; DB04879; DB05014; DB05075; DB05146; DB05198; DB05578; DB05931; DB05984; DB06080; DB06101; DB06436; DB06589; DB06595; DB06626; DB06938; DB07183; DB07274; DB07326; DB07333; DB07334; DB07514; DB07528; DB07537; DB08042; DB08519; DB08875; DB08896; DB08901; DB09078; DB09079; DB12010; DB12147; DB12307; DB14840)
drugbank_target|Q06418	-	890	sp|P61075|CDC2H_PL	-	288	2.1e-57	192.8	0.0	1	1	3.3e-58	4.7e-57	191.7	0.0	2	235	516	768	515	793	0.85	Tyrosine-protein kinase receptor TYRO3 (DB12010)
drugbank_target|Q13546	-	671	sp|P61075|CDC2H_PL	-	288	3.4e-57	192.2	0.2	1	1	5.4e-58	7.8e-57	191.0	0.2	3	231	16	258	14	300	0.86	Receptor-interacting serine/threonine-protein kinase 1 (DB12010)
drugbank_target|P11309	-	404	sp|P61075|CDC2H_PL	-	288	6.1e-57	191.3	0.0	1	2	1.3e-50	1.8e-49	166.8	0.0	3	206	128	338	126	347	0.92	Serine/threonine-protein kinase pim-1 (DB01754; DB02010; DB02656; DB03366; DB03650; DB03777; DB04216; DB04395; DB04522; DB04530; DB04715; DB07151; DB07242; DB07524; DB08022; DB08166; DB08230; DB08705; DB08707; DB08708; DB08709; DB12010)
drugbank_target|P11309	-	404	sp|P61075|CDC2H_PL	-	288	6.1e-57	191.3	0.0	2	2	9.9e-07	1.4e-05	22.7	0.0	251	286	348	383	341	385	0.93	Serine/threonine-protein kinase pim-1 (DB01754; DB02010; DB02656; DB03366; DB03650; DB03777; DB04216; DB04395; DB04522; DB04530; DB04715; DB07151; DB07242; DB07524; DB08022; DB08166; DB08230; DB08705; DB08707; DB08708; DB08709; DB12010)
drugbank_target|Q8TDR2	-	534	sp|P61075|CDC2H_PL	-	288	1.5e-56	190.0	0.0	1	1	9.9e-57	1.4e-55	186.8	0.0	3	277	201	522	200	526	0.87	Serine/threonine-protein kinase 35 (DB12010)
drugbank_target|P35916	-	1363	sp|P61075|CDC2H_PL	-	288	1.6e-56	189.9	0.0	1	2	3.4e-17	4.9e-16	57.1	0.0	2	98	843	947	842	953	0.89	Vascular endothelial growth factor receptor 3 (DB00398; DB01268; DB04879; DB05075; DB05932; DB06080; DB06101; DB06589; DB06626; DB08896; DB09078; DB09079; DB12010; DB15685)
drugbank_target|P35916	-	1363	sp|P61075|CDC2H_PL	-	288	1.6e-56	189.9	0.0	2	2	1.5e-39	2.2e-38	130.5	0.0	96	223	1008	1137	999	1173	0.87	Vascular endothelial growth factor receptor 3 (DB00398; DB01268; DB04879; DB05075; DB05932; DB06080; DB06101; DB06589; DB06626; DB08896; DB09078; DB09079; DB12010; DB15685)
drugbank_target|P36894	-	532	sp|P61075|CDC2H_PL	-	288	5.7e-56	188.1	0.0	1	1	5.9e-57	8.5e-56	187.6	0.0	2	278	232	517	231	520	0.90	Bone morphogenetic protein receptor type-1A (DB11639)
drugbank_target|Q15569	-	626	sp|P61075|CDC2H_PL	-	288	1e-55	187.3	0.0	1	1	1.1e-56	1.6e-55	186.6	0.0	2	198	55	254	54	260	0.90	Dual specificity testis-specific protein kinase 1 (DB12010)
drugbank_target|Q9UM73	-	1620	sp|P61075|CDC2H_PL	-	288	1.1e-55	187.2	0.0	1	1	1.1e-56	1.6e-55	186.7	0.0	3	249	1115	1379	1113	1398	0.87	ALK tyrosine kinase receptor (DB00171; DB08865; DB09063; DB11363; DB12010; DB12130; DB12141; DB12267)
drugbank_target|O00238	-	502	sp|P61075|CDC2H_PL	-	288	1.6e-55	186.7	0.0	1	1	1.4e-56	2.1e-55	186.3	0.0	2	278	202	487	201	490	0.90	Bone morphogenetic protein receptor type-1B (DB12010)
drugbank_target|Q86V86	-	326	sp|P61075|CDC2H_PL	-	288	3e-55	185.8	0.0	1	2	9.8e-50	1.4e-48	163.9	0.0	2	206	38	250	37	258	0.91	Serine/threonine-protein kinase pim-3 (DB12010)
drugbank_target|Q86V86	-	326	sp|P61075|CDC2H_PL	-	288	3e-55	185.8	0.0	2	2	6e-06	8.7e-05	20.2	0.0	251	284	260	293	253	297	0.92	Serine/threonine-protein kinase pim-3 (DB12010)
drugbank_target|P19525	-	551	sp|P61075|CDC2H_PL	-	288	1.8e-54	183.2	5.2	1	2	1.6e-54	2.3e-53	179.6	0.5	3	201	266	489	265	500	0.90	Interferon-induced, double-stranded RNA-activated protein kinase (DB12010)
drugbank_target|P19525	-	551	sp|P61075|CDC2H_PL	-	288	1.8e-54	183.2	5.2	2	2	0.27	3.9	4.9	0.1	254	280	508	534	502	536	0.88	Interferon-induced, double-stranded RNA-activated protein kinase (DB12010)
drugbank_target|P29376	-	864	sp|P61075|CDC2H_PL	-	288	7.3e-54	181.2	0.0	1	1	7e-55	1e-53	180.8	0.0	5	265	511	791	508	795	0.88	Leukocyte tyrosine kinase receptor (DB12010)
drugbank_target|P36897	-	503	sp|P61075|CDC2H_PL	-	288	2.8e-53	179.3	0.0	1	1	1.9e-54	2.8e-53	179.3	0.0	6	276	207	486	203	491	0.87	TGF-beta receptor type-1 (DB03921; DB04434; DB04480; DB07152; DB07267; DB08450; DB12010)
drugbank_target|Q99640	-	499	sp|P61075|CDC2H_PL	-	288	3.2e-53	179.1	0.0	1	2	2.1e-51	3e-50	169.4	0.0	2	210	108	315	107	320	0.94	Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase (DB12010)
drugbank_target|Q99640	-	499	sp|P61075|CDC2H_PL	-	288	3.2e-53	179.1	0.0	2	2	0.034	0.5	7.8	0.0	249	282	324	357	316	362	0.88	Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase (DB12010)
drugbank_target|Q04771	-	509	sp|P61075|CDC2H_PL	-	288	5.2e-53	178.4	0.0	1	1	4.8e-54	6.9e-53	178.0	0.0	3	278	207	491	205	494	0.89	Activin receptor type-1 (DB00171; DB08597; DB12010)
drugbank_target|Q52WX2	-	424	sp|P61075|CDC2H_PL	-	288	1.2e-52	177.3	0.0	1	2	2.4e-52	3.4e-51	172.5	0.0	2	210	51	262	50	270	0.89	Serine/threonine-protein kinase SBK1 (DB12010)
drugbank_target|Q52WX2	-	424	sp|P61075|CDC2H_PL	-	288	1.2e-52	177.3	0.0	2	2	1.1	16	2.9	0.0	247	279	278	310	263	316	0.87	Serine/threonine-protein kinase SBK1 (DB12010)
drugbank_target|O14976	-	1311	sp|P61075|CDC2H_PL	-	288	3.2e-52	175.8	0.0	1	2	3.3e-50	4.7e-49	165.4	0.0	5	206	41	268	38	287	0.84	Cyclin-G-associated kinase (DB12010)
drugbank_target|O14976	-	1311	sp|P61075|CDC2H_PL	-	288	3.2e-52	175.8	0.0	2	2	0.024	0.35	8.3	0.0	257	280	288	311	279	313	0.88	Cyclin-G-associated kinase (DB12010)
drugbank_target|Q14164	-	716	sp|P61075|CDC2H_PL	-	288	7.3e-52	174.7	0.0	1	1	1.6e-52	2.3e-51	173.0	0.0	6	227	11	247	8	301	0.85	Inhibitor of nuclear factor kappa-B kinase subunit epsilon (DB12010)
drugbank_target|P78362	-	688	sp|P61075|CDC2H_PL	-	288	2.5e-51	172.9	4.0	1	2	1.8e-29	2.6e-28	97.4	0.2	3	134	80	223	78	230	0.86	SRSF protein kinase 2 (DB00173; DB02733; DB04395)
drugbank_target|P78362	-	688	sp|P61075|CDC2H_PL	-	288	2.5e-51	172.9	4.0	2	2	4.3e-23	6.2e-22	76.4	0.0	137	285	524	687	511	688	0.80	SRSF protein kinase 2 (DB00173; DB02733; DB04395)
drugbank_target|P21860	-	1342	sp|P61075|CDC2H_PL	-	288	3.2e-51	172.6	0.0	1	1	4.5e-52	6.5e-51	171.6	0.0	4	257	709	969	707	974	0.87	Receptor tyrosine-protein kinase erbB-3 (DB11652)
drugbank_target|Q9UHD2	-	729	sp|P61075|CDC2H_PL	-	288	2.3e-50	169.8	0.8	1	2	8.8e-51	1.3e-49	167.3	0.0	7	220	12	244	8	329	0.84	Serine/threonine-protein kinase TBK1 (DB12010)
drugbank_target|Q9UHD2	-	729	sp|P61075|CDC2H_PL	-	288	2.3e-50	169.8	0.8	2	2	9	1.3e+02	-0.1	0.7	220	268	577	627	552	667	0.60	Serine/threonine-protein kinase TBK1 (DB12010)
drugbank_target|P27037	-	513	sp|P61075|CDC2H_PL	-	288	4.4e-50	168.8	0.0	1	1	4e-51	5.8e-50	168.4	0.0	4	275	192	472	189	477	0.87	Activin receptor type-2A (DB12118)
drugbank_target|O15197	-	1021	sp|P61075|CDC2H_PL	-	288	8.5e-50	167.9	0.0	1	1	8.5e-51	1.2e-49	167.4	0.0	5	227	671	888	668	921	0.92	Ephrin type-B receptor 6 (DB12010)
drugbank_target|P36896	-	505	sp|P61075|CDC2H_PL	-	288	9.5e-50	167.7	0.0	1	1	9.2e-51	1.3e-49	167.3	0.0	6	275	209	487	205	493	0.86	Activin receptor type-1B (DB00171; DB12010)
drugbank_target|P57078	-	832	sp|P61075|CDC2H_PL	-	288	1e-49	167.6	0.0	1	1	1.2e-50	1.8e-49	166.8	0.0	3	227	21	250	19	278	0.89	Receptor-interacting serine/threonine-protein kinase 4 (DB12010)
drugbank_target|Q13873	-	1038	sp|P61075|CDC2H_PL	-	288	1.1e-49	167.5	0.0	1	1	1.3e-50	1.9e-49	166.7	0.0	2	277	201	496	200	500	0.85	Bone morphogenetic protein receptor type-2 (DB11639; DB12010)
drugbank_target|Q8NFD2	-	765	sp|P61075|CDC2H_PL	-	288	2.2e-49	166.5	0.0	1	2	2.6e-48	3.8e-47	159.2	0.0	8	214	26	239	19	248	0.88	Ankyrin repeat and protein kinase domain-containing protein 1 (DB12010)
drugbank_target|Q8NFD2	-	765	sp|P61075|CDC2H_PL	-	288	2.2e-49	166.5	0.0	2	2	0.19	2.8	5.4	0.0	244	273	247	276	240	282	0.87	Ankyrin repeat and protein kinase domain-containing protein 1 (DB12010)
drugbank_target|P37023	-	503	sp|P61075|CDC2H_PL	-	288	2.6e-49	166.3	0.0	1	1	2.5e-50	3.7e-49	165.8	0.0	6	278	204	485	200	489	0.88	Serine/threonine-protein kinase receptor R3 (DB00171)
drugbank_target|O75716	-	305	sp|P61075|CDC2H_PL	-	288	1.2e-48	164.1	0.1	1	2	8.5e-47	1.2e-45	154.2	0.0	2	202	18	236	17	257	0.87	Serine/threonine-protein kinase 16 (DB12010)
drugbank_target|O75716	-	305	sp|P61075|CDC2H_PL	-	288	1.2e-48	164.1	0.1	2	2	0.025	0.37	8.3	0.0	251	279	259	287	239	289	0.84	Serine/threonine-protein kinase 16 (DB12010)
drugbank_target|O43353	-	540	sp|P61075|CDC2H_PL	-	288	2.6e-48	163.0	0.0	1	1	2.7e-49	3.9e-48	162.4	0.0	5	220	19	249	15	295	0.87	Receptor-interacting serine/threonine-protein kinase 2 (DB12010)
drugbank_target|Q13470	-	666	sp|P61075|CDC2H_PL	-	288	1.1e-47	161.0	0.0	1	1	1.1e-48	1.6e-47	160.4	0.0	7	227	119	350	117	373	0.89	Non-receptor tyrosine-protein kinase TNK1 (DB12010)
drugbank_target|Q9BQI3	-	630	sp|P61075|CDC2H_PL	-	288	1.2e-47	160.8	1.8	1	3	9.7e-17	1.4e-15	55.6	0.2	1	72	164	236	164	242	0.93	Eukaryotic translation initiation factor 2-alpha kinase 1 (DB12010)
drugbank_target|Q9BQI3	-	630	sp|P61075|CDC2H_PL	-	288	1.2e-47	160.8	1.8	2	3	1.4e-30	2e-29	101.0	0.0	63	196	366	525	344	546	0.80	Eukaryotic translation initiation factor 2-alpha kinase 1 (DB12010)
drugbank_target|Q9BQI3	-	630	sp|P61075|CDC2H_PL	-	288	1.2e-47	160.8	1.8	3	3	2.7	39	1.6	0.0	252	286	551	585	525	587	0.81	Eukaryotic translation initiation factor 2-alpha kinase 1 (DB12010)
drugbank_target|O75460	-	977	sp|P61075|CDC2H_PL	-	288	1.9e-47	160.2	0.0	1	2	4e-41	5.8e-40	135.6	0.0	7	204	574	778	570	789	0.85	Serine/threonine-protein kinase/endoribonuclease IRE1 (DB07382; DB12010)
drugbank_target|O75460	-	977	sp|P61075|CDC2H_PL	-	288	1.9e-47	160.2	0.0	2	2	2e-06	2.9e-05	21.7	0.1	256	284	804	832	792	836	0.90	Serine/threonine-protein kinase/endoribonuclease IRE1 (DB07382; DB12010)
drugbank_target|Q5S007	-	2527	sp|P61075|CDC2H_PL	-	288	7.4e-46	154.9	0.0	1	2	3.9e-45	5.6e-44	148.8	0.0	10	219	1885	2092	1881	2102	0.91	Leucine-rich repeat serine/threonine-protein kinase 2 (DB12010)
drugbank_target|Q5S007	-	2527	sp|P61075|CDC2H_PL	-	288	7.4e-46	154.9	0.0	2	2	0.77	11	3.4	0.0	257	279	2107	2129	2094	2131	0.90	Leucine-rich repeat serine/threonine-protein kinase 2 (DB12010)
drugbank_target|P37173	-	567	sp|P61075|CDC2H_PL	-	288	9.7e-46	154.6	0.0	1	1	1.1e-46	1.6e-45	153.8	0.0	7	278	247	534	243	538	0.80	TGF-beta receptor type-2 (DB10770; DB10772; DB12010)
drugbank_target|P51617	-	712	sp|P61075|CDC2H_PL	-	288	2.7e-45	153.1	0.0	1	1	2.5e-46	3.7e-45	152.7	0.0	3	210	211	433	209	481	0.87	Interleukin-1 receptor-associated kinase 1 (DB12010)
drugbank_target|Q2M2I8	-	961	sp|P61075|CDC2H_PL	-	288	4.4e-45	152.4	0.2	1	2	3e-46	4.4e-45	152.4	0.2	5	204	47	265	44	269	0.87	AP2-associated protein kinase 1 (DB12010)
drugbank_target|Q2M2I8	-	961	sp|P61075|CDC2H_PL	-	288	4.4e-45	152.4	0.2	2	2	0.35	5	4.6	0.0	252	278	281	307	275	312	0.88	AP2-associated protein kinase 1 (DB12010)
drugbank_target|Q9NSY1	-	1161	sp|P61075|CDC2H_PL	-	288	2.8e-44	149.8	0.1	1	2	1.9e-45	2.8e-44	149.8	0.1	6	204	53	269	49	274	0.86	BMP-2-inducible protein kinase (DB12010)
drugbank_target|Q9NSY1	-	1161	sp|P61075|CDC2H_PL	-	288	2.8e-44	149.8	0.1	2	2	4.9	71	0.8	0.0	252	278	285	311	279	316	0.86	BMP-2-inducible protein kinase (DB12010)
drugbank_target|P30291	-	646	sp|P61075|CDC2H_PL	-	288	3.1e-43	146.3	0.0	1	2	4.4e-41	6.4e-40	135.5	0.0	3	212	298	525	296	532	0.90	Wee1-like protein kinase (DB04608; DB07006; DB07226; DB07257; DB07265; DB08365; DB11740; DB12010)
drugbank_target|P30291	-	646	sp|P61075|CDC2H_PL	-	288	3.1e-43	146.3	0.0	2	2	0.011	0.16	9.4	0.0	242	282	527	567	518	572	0.85	Wee1-like protein kinase (DB04608; DB07006; DB07226; DB07257; DB07265; DB08365; DB11740; DB12010)
drugbank_target|Q9Y6M4	-	447	sp|P61075|CDC2H_PL	-	288	2.6e-42	143.3	0.0	1	1	2.7e-43	3.9e-42	142.7	0.0	3	223	42	270	41	311	0.85	Casein kinase I isoform gamma-3 (DB04751; DB07488; DB07489; DB07664)
drugbank_target|Q9Y616	-	596	sp|P61075|CDC2H_PL	-	288	6.1e-42	142.1	0.1	1	1	6.7e-43	9.6e-42	141.5	0.1	3	217	164	390	162	408	0.89	Interleukin-1 receptor-associated kinase 3 (DB12010)
drugbank_target|Q9HCP0	-	422	sp|P61075|CDC2H_PL	-	288	6.2e-42	142.1	0.0	1	1	5.7e-43	8.3e-42	141.7	0.0	3	227	43	277	42	314	0.85	Casein kinase I isoform gamma-1 (DB08325)
drugbank_target|P48729	-	337	sp|P61075|CDC2H_PL	-	288	1.5e-41	140.8	0.1	1	1	1.4e-42	2.1e-41	140.3	0.1	3	220	16	240	15	262	0.87	Casein kinase I isoform alpha (DB12010)
drugbank_target|P78368	-	415	sp|P61075|CDC2H_PL	-	288	2.3e-41	140.2	0.0	1	1	2.1e-42	3e-41	139.8	0.0	3	223	45	273	44	312	0.87	Casein kinase I isoform gamma-2 (DB03083; DB03693; DB04604)
drugbank_target|P49674	-	416	sp|P61075|CDC2H_PL	-	288	4.7e-41	139.2	0.0	1	1	4.3e-42	6.2e-41	138.8	0.0	2	222	7	234	6	261	0.87	Casein kinase I isoform epsilon (DB06195)
drugbank_target|P20594	-	1047	sp|P61075|CDC2H_PL	-	288	1.1e-39	134.7	0.0	1	1	4.2e-40	6.1e-39	132.3	0.0	19	223	538	746	528	788	0.82	Atrial natriuretic peptide receptor 2 (DB01613; DB04899)
drugbank_target|Q16671	-	573	sp|P61075|CDC2H_PL	-	288	2.9e-39	133.3	0.0	1	1	2.6e-40	3.7e-39	133.0	0.0	7	278	206	501	200	505	0.86	Anti-Muellerian hormone type-2 receptor (DB00171)
drugbank_target|P16066	-	1061	sp|P61075|CDC2H_PL	-	288	6.7e-39	132.1	0.0	1	1	1.9e-39	2.7e-38	130.1	0.0	12	220	547	762	544	826	0.83	Atrial natriuretic peptide receptor 1 (DB00325; DB00727; DB00883; DB01612; DB01613; DB04899; DB05034)
drugbank_target|P9WI73	-	750	sp|P61075|CDC2H_PL	-	288	1.6e-35	121.0	0.0	1	1	2.6e-36	3.7e-35	119.8	0.0	3	195	150	339	148	351	0.92	Serine/threonine-protein kinase PknG (DB07398)
drugbank_target|P0C264	-	359	sp|P61075|CDC2H_PL	-	288	1.8e-33	114.3	0.0	1	2	1.3e-33	1.9e-32	110.9	0.0	2	202	41	243	40	246	0.90	Uncharacterized serine/threonine-protein kinase SBK3 (DB12010)
drugbank_target|P0C264	-	359	sp|P61075|CDC2H_PL	-	288	1.8e-33	114.3	0.0	2	2	3.8	55	1.1	0.0	250	274	272	296	253	303	0.82	Uncharacterized serine/threonine-protein kinase SBK3 (DB12010)
drugbank_target|P25092	-	1073	sp|P61075|CDC2H_PL	-	288	3.1e-33	113.5	0.2	1	1	1.1e-33	1.6e-32	111.2	0.2	23	220	505	699	499	744	0.86	Heat-stable enterotoxin receptor (DB08890)
drugbank_target|Q96KG9	-	808	sp|P61075|CDC2H_PL	-	288	3e-24	84.1	0.0	1	1	3.8e-25	5.5e-24	83.2	0.0	20	200	33	221	30	232	0.88	N-terminal kinase-like protein (DB05036)
drugbank_target|P16788	-	707	sp|P61075|CDC2H_PL	-	288	1.1e-12	46.1	0.0	1	1	1.4e-13	2.1e-12	45.2	0.0	9	156	336	494	332	506	0.88	Serine/threonine protein kinase UL97 (DB06234)
drugbank_target|Q68101	-	707	sp|P61075|CDC2H_PL	-	288	1.1e-12	46.1	0.0	1	1	1.4e-13	2.1e-12	45.2	0.0	9	156	336	494	332	506	0.88	Serine/threonine protein kinase UL97 (DB06234)
drugbank_target|Q8TF76	-	798	sp|P61075|CDC2H_PL	-	288	4.8e-11	40.7	0.3	1	2	5.1e-05	0.00074	17.1	0.0	2	50	482	531	481	545	0.73	Serine/threonine-protein kinase haspin (DB04604; DB07698; DB07995; DB08004)
drugbank_target|Q8TF76	-	798	sp|P61075|CDC2H_PL	-	288	4.8e-11	40.7	0.3	2	2	3.2e-06	4.6e-05	21.1	0.0	71	148	595	692	582	700	0.80	Serine/threonine-protein kinase haspin (DB04604; DB07698; DB07995; DB08004)
drugbank_target|Q9BVS4	-	552	sp|P61075|CDC2H_PL	-	288	2.4e-09	35.1	0.1	1	1	3.8e-10	5.4e-09	34.0	0.1	7	145	98	248	96	267	0.83	Serine/threonine-protein kinase RIO2 (DB12010)
drugbank_target|O14730	-	519	sp|P61075|CDC2H_PL	-	288	5.3e-08	30.7	0.4	1	1	1e-08	1.5e-07	29.2	0.1	10	140	257	420	252	433	0.72	Serine/threonine-protein kinase RIO3 (DB12010)
drugbank_target|Q9BRS2	-	568	sp|P61075|CDC2H_PL	-	288	8.5e-06	23.5	0.2	1	1	5.9e-07	8.5e-06	23.5	0.2	9	144	185	342	181	356	0.78	Serine/threonine-protein kinase RIO1 (DB12010)
drugbank_target|Q9N623	-	424	sp|Q8IBZ9|CRT_PLAF	-	424	7.6e-301	995.2	30.0	1	1	1.6e-304	8.5e-301	995.0	30.0	1	424	1	424	1	424	1.00	Chloroquine resistance transporter (DB11638)
drugbank_target|P60709	-	375	sp|Q8I4X0|ACT1_PLA	-	376	5.7e-230	760.9	0.0	1	1	8.5e-233	6.4e-230	760.8	0.0	3	376	2	375	1	375	1.00	Actin, cytoplasmic 1 (DB04216; DB12695)
drugbank_target|P63261	-	375	sp|Q8I4X0|ACT1_PLA	-	376	9.1e-230	760.3	0.0	1	1	1.4e-232	1e-229	760.1	0.0	3	376	2	375	1	375	1.00	Actin, cytoplasmic 2 (DB09130; DB11638)
drugbank_target|P68133	-	377	sp|Q8I4X0|ACT1_PLA	-	376	2.4e-229	758.9	0.0	1	1	3.9e-232	2.9e-229	758.6	0.0	3	376	4	377	2	377	1.00	Actin, alpha skeletal muscle (DB02621; DB02772; DB03021; DB03616; DB03850; DB03903; DB04151; DB04395; DB04629; DB04774; DB04775; DB04783; DB08080)
drugbank_target|P62736	-	377	sp|Q8I4X0|ACT1_PLA	-	376	5.9e-229	757.6	0.0	1	1	9.5e-232	7.1e-229	757.3	0.0	3	376	4	377	2	377	1.00	Actin, aortic smooth muscle (DB12695)
drugbank_target|P86287	-	376	sp|Q8I4X0|ACT1_PLA	-	376	5.4e-226	747.9	0.0	1	1	8e-229	6e-226	747.7	0.0	1	376	1	376	1	376	1.00	Actin-1 (DB11638)
drugbank_target|P61160	-	394	sp|Q8I4X0|ACT1_PLA	-	376	2.5e-186	617.3	0.0	1	1	4e-189	3e-186	617.0	0.0	5	372	5	387	1	390	0.98	Actin-related protein 2 (DB08235; DB08236)
drugbank_target|P61158	-	418	sp|Q8I4X0|ACT1_PLA	-	376	1.5e-175	581.8	0.0	1	1	2.4e-178	1.8e-175	581.5	0.0	7	373	6	410	2	413	0.98	Actin-related protein 3 (DB08235; DB08236)
drugbank_target|Q07412	-	248	sp|Q7KQM0|TPIS_PLA	-	248	9.9e-130	429.8	0.7	1	1	1.3e-132	1.1e-129	429.6	0.7	1	248	1	248	1	248	1.00	Triosephosphate isomerase (DB01709; DB01779; DB02515; DB02726; DB02951; DB04510)
drugbank_target|P60174	-	286	sp|Q7KQM0|TPIS_PLA	-	248	1.3e-116	386.7	0.1	1	1	1.8e-119	1.6e-116	386.5	0.1	2	246	41	284	40	286	0.99	Triosephosphate isomerase (DB01593; DB01695; DB02726; DB03026; DB03132; DB03135; DB03314; DB03379; DB03900; DB04326; DB04447; DB04510; DB07387; DB11638; DB14487; DB14533; DB14548)
drugbank_target|P36204	-	654	sp|Q7KQM0|TPIS_PLA	-	248	2.8e-113	375.9	0.1	1	1	6.1e-116	5.3e-113	375.0	0.1	2	245	401	647	400	649	0.98	Bifunctional PGK/TIM (DB04510)
drugbank_target|P52270	-	251	sp|Q7KQM0|TPIS_PLA	-	248	3.5e-112	372.3	0.3	1	1	4.7e-115	4.1e-112	372.1	0.3	5	246	7	249	2	251	0.98	Triosephosphate isomerase, glycosomal (DB03132)
drugbank_target|P00943	-	253	sp|Q7KQM0|TPIS_PLA	-	248	3.8e-107	355.8	0.0	1	1	4.9e-110	4.3e-107	355.6	0.0	3	246	2	249	1	251	0.92	Triosephosphate isomerase (DB02726)
drugbank_target|P50921	-	256	sp|Q7KQM0|TPIS_PLA	-	248	5.4e-107	355.3	0.5	1	1	7e-110	6.1e-107	355.1	0.5	3	247	2	251	1	252	0.97	Triosephosphate isomerase (DB02726)
drugbank_target|P06727	-	396	sp|Q8IIG7|YPF05_PL	-	1070	1.4e-76	256.2	27.0	1	2	2.9e-60	1.3e-57	193.5	14.6	428	683	35	288	31	290	0.98	Apolipoprotein A-IV (DB01593; DB09130; DB14487)
drugbank_target|P06727	-	396	sp|Q8IIG7|YPF05_PL	-	1070	1.4e-76	256.2	27.0	2	2	6.5e-25	2.9e-22	76.4	4.5	585	719	260	391	259	394	0.95	Apolipoprotein A-IV (DB01593; DB09130; DB14487)
drugbank_target|P02649	-	317	sp|Q8IIG7|YPF05_PL	-	1070	6.2e-33	111.7	13.1	1	2	2.8e-25	1.2e-22	77.7	4.2	576	720	57	196	17	215	0.91	Apolipoprotein E (DB01593; DB09130; DB14487; DB14533; DB14548)
drugbank_target|P02649	-	317	sp|Q8IIG7|YPF05_PL	-	1070	6.2e-33	111.7	13.1	2	2	7.4e-14	3.2e-11	39.8	1.5	516	601	222	307	212	314	0.95	Apolipoprotein E (DB01593; DB09130; DB14487; DB14533; DB14548)
drugbank_target|P02647	-	267	sp|Q8IIG7|YPF05_PL	-	1070	1.1e-32	111.0	2.4	1	1	2.9e-35	1.3e-32	110.7	2.4	496	685	73	265	65	267	0.97	Apolipoprotein A-I (DB01593; DB09130; DB14487; DB14533; DB14548)
drugbank_target|P49257	-	510	sp|Q8IIG7|YPF05_PL	-	1070	2.3e-19	66.8	10.1	1	1	6.9e-22	3e-19	66.4	10.1	490	629	279	418	275	462	0.88	Protein ERGIC-53 (DB00025; DB13998; DB13999)
drugbank_target|O75348	-	118	sp|Q8IIG7|YPF05_PL	-	1070	9.7e-14	48.2	10.7	1	1	2.6e-16	1.1e-13	48.0	10.7	489	591	11	113	2	116	0.95	V-type proton ATPase subunit G 1 (DB01133)
drugbank_target|O95670	-	118	sp|Q8IIG7|YPF05_PL	-	1070	2.6e-12	43.5	8.6	1	1	6.7e-15	2.9e-12	43.3	8.6	489	589	11	111	2	116	0.93	V-type proton ATPase subunit G 2 (DB01133)
drugbank_target|P29590	-	882	sp|Q8IIG7|YPF05_PL	-	1070	5.2e-11	39.1	1.1	1	1	1.6e-13	6.9e-11	38.7	1.1	528	622	220	317	216	380	0.88	Protein PML (DB01169)
drugbank_target|Q96LB4	-	118	sp|Q8IIG7|YPF05_PL	-	1070	9.3e-07	25.1	9.5	1	1	2.5e-09	1.1e-06	24.8	9.5	490	589	12	111	3	117	0.93	V-type proton ATPase subunit G 3 (DB01133)
drugbank_target|O60664	-	434	sp|Q8IIG7|YPF05_PL	-	1070	0.0072	12.2	2.2	1	2	0.0046	2	4.1	0.0	537	621	85	169	44	194	0.58	Perilipin-3 (DB01271; DB01279)
drugbank_target|O60664	-	434	sp|Q8IIG7|YPF05_PL	-	1070	0.0072	12.2	2.2	2	2	0.00094	0.41	6.4	2.0	504	641	239	375	222	412	0.67	Perilipin-3 (DB01271; DB01279)
drugbank_target|P52732	-	1056	sp|Q8IIG7|YPF05_PL	-	1070	0.69	5.6	44.4	1	2	0.00086	0.38	6.5	21.6	534	692	368	532	341	582	0.35	Kinesin-like protein KIF11 (DB03996; DB04331; DB06040; DB07064; DB08032; DB08033; DB08037; DB08198; DB08239; DB08244; DB08246; DB08250)
drugbank_target|P52732	-	1056	sp|Q8IIG7|YPF05_PL	-	1070	0.69	5.6	44.4	2	2	0.0026	1.1	4.9	14.8	419	694	670	871	644	962	0.49	Kinesin-like protein KIF11 (DB03996; DB04331; DB06040; DB07064; DB08032; DB08033; DB08037; DB08198; DB08239; DB08244; DB08246; DB08250)
drugbank_target|Q8TF61	-	875	sp|Q8IIG7|YPF05_PL	-	1070	1.2	4.8	14.9	1	1	0.0038	1.7	4.4	14.9	484	603	214	336	201	351	0.61	F-box only protein 41 (DB12695)
drugbank_target|O14964	-	777	sp|Q8IIG7|YPF05_PL	-	1070	2	4.1	18.7	1	2	0.072	32	0.1	1.0	625	676	46	99	17	136	0.46	Hepatocyte growth factor-regulated tyrosine kinase substrate (DB04272)
drugbank_target|O14964	-	777	sp|Q8IIG7|YPF05_PL	-	1070	2	4.1	18.7	2	2	0.0002	0.089	8.6	10.8	636	738	450	555	398	573	0.70	Hepatocyte growth factor-regulated tyrosine kinase substrate (DB04272)
drugbank_target|O97313	-	262	sp|O97313|RS3A_PLA	-	262	3.5e-184	608.3	19.6	1	1	7.4e-188	3.9e-184	608.2	19.6	1	262	1	262	1	262	1.00	40S ribosomal protein S3a (DB11638)
drugbank_target|Q8IXJ6	-	389	sp|Q8IKW2|SIR2B_PL	-	1304	3.2e-53	179.1	0.0	1	2	7.4e-12	9.8e-09	31.7	0.0	43	76	74	108	61	114	0.88	NAD-dependent protein deacetylase sirtuin-2 (DB15493)
drugbank_target|Q8IXJ6	-	389	sp|Q8IKW2|SIR2B_PL	-	1304	3.2e-53	179.1	0.0	2	2	4.1e-46	5.3e-43	145.2	0.0	252	386	145	276	137	289	0.97	NAD-dependent protein deacetylase sirtuin-2 (DB15493)
drugbank_target|Q9NTG7	-	399	sp|Q8IKW2|SIR2B_PL	-	1304	9.1e-52	174.3	0.0	1	2	5.4e-15	7.1e-12	42.1	0.0	33	80	126	173	117	177	0.90	NAD-dependent protein deacetylase sirtuin-3, mitochondrial (DB02059)
drugbank_target|Q9NTG7	-	399	sp|Q8IKW2|SIR2B_PL	-	1304	9.1e-52	174.3	0.0	2	2	1.5e-41	1.9e-38	130.1	0.0	252	383	206	331	198	337	0.96	NAD-dependent protein deacetylase sirtuin-3, mitochondrial (DB02059)
drugbank_target|Q96EB6	-	747	sp|Q8IKW2|SIR2B_PL	-	1304	3.7e-50	168.9	0.1	1	2	2.7e-15	3.5e-12	43.1	0.0	31	74	239	282	232	289	0.90	NAD-dependent protein deacetylase sirtuin-1 (DB02709; DB13978; DB15493)
drugbank_target|Q96EB6	-	747	sp|Q8IKW2|SIR2B_PL	-	1304	3.7e-50	168.9	0.1	2	2	1.3e-39	1.8e-36	123.6	0.0	251	385	322	454	309	458	0.95	NAD-dependent protein deacetylase sirtuin-1 (DB02709; DB13978; DB15493)
drugbank_target|Q9NXA8	-	310	sp|Q8IKW2|SIR2B_PL	-	1304	2.2e-26	90.2	0.0	1	2	1.6e-14	2.1e-11	40.6	0.0	42	81	47	86	37	100	0.89	NAD-dependent protein deacylase sirtuin-5, mitochondrial (DB02059; DB02701; DB03478; DB04786; DB15493)
drugbank_target|Q9NXA8	-	310	sp|Q8IKW2|SIR2B_PL	-	1304	2.2e-26	90.2	0.0	2	2	1.2e-16	1.6e-13	47.6	0.0	269	383	135	261	112	267	0.77	NAD-dependent protein deacylase sirtuin-5, mitochondrial (DB02059; DB02701; DB03478; DB04786; DB15493)
drugbank_target|P03277	-	968	sp|Q6LFN2|ZNRF1_PL	-	1103	2e-09	34.0	2.5	1	1	1.2e-12	3.2e-09	33.4	2.5	186	218	144	176	96	181	0.90	Hexon protein (DB04272)
drugbank_target|Q9UL54	-	1235	sp|Q6LFN2|ZNRF1_PL	-	1103	9.9	2.0	14.1	1	1	0.0064	17	1.2	14.1	186	210	373	397	366	413	0.68	Serine/threonine-protein kinase TAO2 (DB04522; DB12010)
drugbank_target|Q969G3	-	411	sp|Q8I659|YPF11_PL	-	1383	1e-53	180.6	27.2	1	2	0.44	7.7e+02	-4.5	0.9	231	250	114	133	104	164	0.55	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily E member 1 (DB12695)
drugbank_target|Q969G3	-	411	sp|Q8I659|YPF11_PL	-	1383	1e-53	180.6	27.2	2	2	5.7e-57	1e-53	180.6	27.2	1057	1254	190	395	186	399	0.97	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily E member 1 (DB12695)
drugbank_target|P29973	-	690	sp|Q8I659|YPF11_PL	-	1383	2.1e-18	63.6	28.8	1	1	2e-21	3.5e-18	62.9	28.8	1096	1198	48	154	5	157	0.88	cGMP-gated cation channel alpha-1 (DB04209)
drugbank_target|Q9NRF9	-	147	sp|Q8I659|YPF11_PL	-	1383	7.2e-09	32.0	23.5	1	1	4.4e-12	7.6e-09	31.9	23.5	1148	1210	85	145	47	147	0.82	DNA polymerase epsilon subunit 3 (DB00242)
drugbank_target|P31948	-	543	sp|Q8ILC1|STI1L_PL	-	564	6.8e-264	875.0	45.2	1	3	8.7e-71	7.6e-68	227.8	4.7	5	120	2	117	1	127	0.97	Stress-induced-phosphoprotein 1 (DB09130)
drugbank_target|P31948	-	543	sp|Q8ILC1|STI1L_PL	-	564	6.8e-264	875.0	45.2	2	3	1e-20	8.9e-18	62.5	0.1	505	560	132	187	126	190	0.95	Stress-induced-phosphoprotein 1 (DB09130)
drugbank_target|P31948	-	543	sp|Q8ILC1|STI1L_PL	-	564	6.8e-264	875.0	45.2	3	3	2.6e-181	2.3e-178	592.7	29.3	208	564	190	543	188	543	1.00	Stress-induced-phosphoprotein 1 (DB09130)
drugbank_target|P53041	-	499	sp|Q8ILC1|STI1L_PL	-	564	8.5e-61	204.5	8.6	1	1	1.4e-63	1.2e-60	204.0	8.6	376	519	26	170	17	178	0.97	Serine/threonine-protein phosphatase 5 (DB00171)
drugbank_target|Q8IVL5	-	708	sp|Q8ILC1|STI1L_PL	-	564	2.9e-34	117.0	5.7	1	3	0.2	1.7e+02	-1.1	0.0	276	309	45	76	39	87	0.54	Prolyl 3-hydroxylase 2 (DB00126; DB00172)
drugbank_target|Q8IVL5	-	708	sp|Q8ILC1|STI1L_PL	-	564	2.9e-34	117.0	5.7	2	3	2.5e-35	2.2e-32	110.8	4.8	307	406	138	238	132	243	0.97	Prolyl 3-hydroxylase 2 (DB00126; DB00172)
drugbank_target|Q8IVL5	-	708	sp|Q8ILC1|STI1L_PL	-	564	2.9e-34	117.0	5.7	3	3	0.0075	6.6	3.5	0.0	320	354	308	342	287	366	0.86	Prolyl 3-hydroxylase 2 (DB00126; DB00172)
drugbank_target|Q32P28	-	736	sp|Q8ILC1|STI1L_PL	-	564	1.3e-18	65.3	3.1	1	2	1.4e-15	1.2e-12	45.6	0.3	308	406	134	233	119	244	0.91	Prolyl 3-hydroxylase 1 (DB00126; DB00172)
drugbank_target|Q32P28	-	736	sp|Q8ILC1|STI1L_PL	-	564	1.3e-18	65.3	3.1	2	2	7.8e-08	6.8e-05	20.0	0.2	313	382	298	366	266	370	0.83	Prolyl 3-hydroxylase 1 (DB00126; DB00172)
drugbank_target|P19878	-	526	sp|Q8ILC1|STI1L_PL	-	564	2.7e-15	54.4	1.7	1	2	3.1e-18	2.7e-15	54.3	0.2	388	442	47	102	32	113	0.89	Neutrophil cytosol factor 2 (DB00514)
drugbank_target|P19878	-	526	sp|Q8ILC1|STI1L_PL	-	564	2.7e-15	54.4	1.7	2	2	0.42	3.7e+02	-2.2	0.1	43	73	124	153	121	169	0.65	Neutrophil cytosol factor 2 (DB00514)
drugbank_target|Q8IVL6	-	736	sp|Q8ILC1|STI1L_PL	-	564	4.6e-08	30.5	0.0	1	2	5.3e-11	4.6e-08	30.5	0.0	306	368	143	204	138	245	0.88	Prolyl 3-hydroxylase 3 (DB00126; DB00172)
drugbank_target|Q8IVL6	-	736	sp|Q8ILC1|STI1L_PL	-	564	4.6e-08	30.5	0.0	2	2	6	5.3e+03	-7.6	7.3	203	222	693	713	678	732	0.44	Prolyl 3-hydroxylase 3 (DB00126; DB00172)
drugbank_target|P09429	-	215	sp|Q8IDG7|YPF01_PL	-	2068	7.8	1.8	18.4	1	1	0.0014	7.1	2.0	18.4	957	1018	145	206	19	215	0.58	High mobility group protein B1 (DB00608; DB05869)
drugbank_target|P07814	-	1512	sp|Q8I5R7|SYP_PLAF	-	746	9.4e-291	964.5	0.0	1	1	2.9e-293	1.4e-290	964.0	0.0	171	746	933	1512	926	1512	0.99	Bifunctional glutamate/proline--tRNA ligase (DB00142; DB00172; DB02510; DB02684; DB03376)
drugbank_target|P26639	-	723	sp|Q8I5R7|SYP_PLAF	-	746	1.7e-102	342.0	0.1	1	2	4e-56	1.9e-53	179.9	0.0	273	454	330	505	323	518	0.92	Threonine--tRNA ligase, cytoplasmic (DB00156)
drugbank_target|P26639	-	723	sp|Q8I5R7|SYP_PLAF	-	746	1.7e-102	342.0	0.1	2	2	3.7e-50	1.8e-47	160.1	0.0	462	636	543	711	525	718	0.92	Threonine--tRNA ligase, cytoplasmic (DB00156)
drugbank_target|Q7L3T8	-	475	sp|Q8I5R7|SYP_PLAF	-	746	5.1e-93	310.7	0.0	1	2	1.2e-53	5.6e-51	171.7	0.0	249	451	54	249	33	262	0.91	Probable proline--tRNA ligase, mitochondrial (DB00172)
drugbank_target|Q7L3T8	-	475	sp|Q8I5R7|SYP_PLAF	-	746	5.1e-93	310.7	0.0	2	2	3.9e-43	1.9e-40	136.9	0.0	472	630	303	466	300	472	0.97	Probable proline--tRNA ligase, mitochondrial (DB00172)
drugbank_target|Q9BW92	-	718	sp|Q8I5R7|SYP_PLAF	-	746	3.8e-92	307.8	0.0	1	2	9.5e-56	4.5e-53	178.6	0.0	273	440	309	487	301	503	0.94	Threonine--tRNA ligase, mitochondrial (DB00156)
drugbank_target|Q9BW92	-	718	sp|Q8I5R7|SYP_PLAF	-	746	3.8e-92	307.8	0.0	2	2	3.8e-40	1.8e-37	127.1	0.0	469	633	547	703	530	715	0.89	Threonine--tRNA ligase, mitochondrial (DB00156)
drugbank_target|Q8IIA4	-	1013	sp|Q8I5R7|SYP_PLAF	-	746	4.9e-90	300.9	5.3	1	2	1.1e-51	5.5e-49	165.1	0.2	275	437	542	698	534	722	0.94	Threonine--tRNA ligase (DB11638)
drugbank_target|Q8IIA4	-	1013	sp|Q8I5R7|SYP_PLAF	-	746	4.9e-90	300.9	5.3	2	2	4e-46	1.9e-43	146.8	1.2	499	650	866	1006	844	1012	0.94	Threonine--tRNA ligase (DB11638)
drugbank_target|P0A8M5	-	642	sp|Q8I5R7|SYP_PLAF	-	746	3.1e-89	298.2	0.0	1	2	3.6e-49	1.7e-46	156.9	0.0	279	437	258	415	247	444	0.90	Threonine--tRNA ligase (DB03355; DB03869; DB04024)
drugbank_target|P0A8M5	-	642	sp|Q8I5R7|SYP_PLAF	-	746	3.1e-89	298.2	0.0	2	2	7.6e-44	3.6e-41	139.3	0.0	472	637	476	632	452	639	0.92	Threonine--tRNA ligase (DB03355; DB03869; DB04024)
drugbank_target|Q8NW68	-	645	sp|Q8I5R7|SYP_PLAF	-	746	2.9e-86	288.4	0.9	1	2	2.3e-47	1.1e-44	150.9	0.1	283	438	262	418	246	449	0.92	Threonine--tRNA ligase (DB03355)
drugbank_target|Q8NW68	-	645	sp|Q8I5R7|SYP_PLAF	-	746	2.9e-86	288.4	0.9	2	2	7e-43	3.4e-40	136.1	0.1	480	633	493	635	468	641	0.92	Threonine--tRNA ligase (DB03355)
drugbank_target|P49591	-	514	sp|Q8I5R7|SYP_PLAF	-	746	3.3e-69	232.0	0.0	1	1	1e-71	4.9e-69	231.4	0.0	285	536	194	457	186	464	0.96	Serine--tRNA ligase, cytoplasmic (DB00133)
drugbank_target|P41250	-	739	sp|Q8I5R7|SYP_PLAF	-	746	2.4e-20	70.4	0.0	1	3	0.00076	0.36	7.0	0.0	278	347	141	210	134	229	0.83	Glycine--tRNA ligase (DB00145)
drugbank_target|P41250	-	739	sp|Q8I5R7|SYP_PLAF	-	746	2.4e-20	70.4	0.0	2	3	7.2e-17	3.4e-14	50.1	0.0	357	437	297	378	292	395	0.85	Glycine--tRNA ligase (DB00145)
drugbank_target|P41250	-	739	sp|Q8I5R7|SYP_PLAF	-	746	2.4e-20	70.4	0.0	3	3	0.00014	0.065	9.5	0.0	530	624	606	697	544	711	0.84	Glycine--tRNA ligase (DB00145)
drugbank_target|P60906	-	424	sp|Q8I5R7|SYP_PLAF	-	746	0.0037	13.6	0.0	1	2	0.00062	0.3	7.3	0.0	280	358	7	82	4	185	0.86	Histidine--tRNA ligase (DB03811; DB04201)
drugbank_target|P60906	-	424	sp|Q8I5R7|SYP_PLAF	-	746	0.0037	13.6	0.0	2	2	0.0041	1.9	4.6	0.0	556	636	345	422	327	424	0.75	Histidine--tRNA ligase (DB03811; DB04201)
drugbank_target|P12081	-	509	sp|Q8I5R7|SYP_PLAF	-	746	0.0097	12.2	0.2	1	2	0.083	40	0.3	0.0	283	328	61	106	54	113	0.87	Histidine--tRNA ligase, cytoplasmic (DB00117)
drugbank_target|P12081	-	509	sp|Q8I5R7|SYP_PLAF	-	746	0.0097	12.2	0.2	2	2	0.00014	0.069	9.4	0.2	553	633	419	498	403	502	0.85	Histidine--tRNA ligase, cytoplasmic (DB00117)
drugbank_target|P28720	-	386	sp|Q8ILC2|TGTL_PLA	-	407	1.3e-60	203.7	0.4	1	2	1e-34	5.5e-31	106.1	0.0	210	284	223	296	215	306	0.95	Queuine tRNA-ribosyltransferase (DB01825; DB02041; DB02441; DB02599; DB03074; DB03304; DB03505; DB03780; DB04004; DB04169; DB04239; DB04543; DB07012; DB07452; DB07481; DB07564; DB07704; DB08267; DB08268; DB08511; DB08512; DB08514)
drugbank_target|P28720	-	386	sp|Q8ILC2|TGTL_PLA	-	407	1.3e-60	203.7	0.4	2	2	1.5e-31	8e-28	95.6	0.3	334	396	315	377	299	382	0.91	Queuine tRNA-ribosyltransferase (DB01825; DB02041; DB02441; DB02599; DB03074; DB03304; DB03505; DB03780; DB04004; DB04169; DB04239; DB04543; DB07012; DB07452; DB07481; DB07564; DB07704; DB08267; DB08268; DB08511; DB08512; DB08514)
drugbank_target|P04179	-	222	sp|Q9TW89|SODF_PLA	-	198	5.1e-110	364.3	1.3	1	1	1.2e-113	6.2e-110	364.0	1.3	4	192	27	217	25	222	0.98	Superoxide dismutase [Mn], mitochondrial (DB03297; DB04436)
drugbank_target|C0H4Y6	-	483	sp|Q7KQL8|THIO_PLA	-	104	7.9e-59	194.5	0.8	1	3	1.3e-29	5.7e-27	92.2	0.0	8	89	38	123	34	134	0.91	Protein disulfide-isomerase (DB11638)
drugbank_target|C0H4Y6	-	483	sp|Q7KQL8|THIO_PLA	-	104	7.9e-59	194.5	0.8	2	3	0.41	1.8e+02	0.6	0.1	17	56	153	192	143	231	0.75	Protein disulfide-isomerase (DB11638)
drugbank_target|C0H4Y6	-	483	sp|Q7KQL8|THIO_PLA	-	104	7.9e-59	194.5	0.8	3	3	2.7e-31	1.2e-28	97.6	0.0	2	85	356	442	355	459	0.93	Protein disulfide-isomerase (DB11638)
drugbank_target|P07237	-	508	sp|Q7KQL8|THIO_PLA	-	104	5.2e-56	185.5	0.2	1	4	1.7e-29	7.4e-27	91.8	0.0	5	84	28	111	26	127	0.91	Protein disulfide-isomerase (DB01593; DB03615; DB09130; DB11638; DB14487; DB14533; DB14548)
drugbank_target|P07237	-	508	sp|Q7KQL8|THIO_PLA	-	104	5.2e-56	185.5	0.2	2	4	3.6	1.6e+03	-2.4	0.0	46	75	178	204	145	231	0.54	Protein disulfide-isomerase (DB01593; DB03615; DB09130; DB11638; DB14487; DB14533; DB14548)
drugbank_target|P07237	-	508	sp|Q7KQL8|THIO_PLA	-	104	5.2e-56	185.5	0.2	3	4	7.5	3.3e+03	-3.4	0.0	42	61	277	297	273	324	0.62	Protein disulfide-isomerase (DB01593; DB03615; DB09130; DB11638; DB14487; DB14533; DB14548)
drugbank_target|P07237	-	508	sp|Q7KQL8|THIO_PLA	-	104	5.2e-56	185.5	0.2	4	4	4.9e-29	2.1e-26	90.3	0.1	2	82	369	450	368	466	0.90	Protein disulfide-isomerase (DB01593; DB03615; DB09130; DB11638; DB14487; DB14533; DB14548)
drugbank_target|P30101	-	505	sp|Q7KQL8|THIO_PLA	-	104	6.6e-56	185.2	0.1	1	3	1.3e-28	5.8e-26	88.9	0.0	9	91	33	119	27	132	0.89	Protein disulfide-isomerase A3 (DB01593; DB09130; DB14487; DB14533; DB14548)
drugbank_target|P30101	-	505	sp|Q7KQL8|THIO_PLA	-	104	6.6e-56	185.2	0.1	2	3	0.16	68	2.0	0.0	7	31	141	165	138	208	0.70	Protein disulfide-isomerase A3 (DB01593; DB09130; DB14487; DB14533; DB14548)
drugbank_target|P30101	-	505	sp|Q7KQL8|THIO_PLA	-	104	6.6e-56	185.2	0.1	3	3	5.3e-29	2.3e-26	90.2	0.1	2	85	378	463	377	479	0.90	Protein disulfide-isomerase A3 (DB01593; DB09130; DB14487; DB14533; DB14548)
drugbank_target|P10599	-	105	sp|Q7KQL8|THIO_PLA	-	104	8.3e-42	139.8	1.3	1	1	2.1e-44	9.1e-42	139.7	1.3	1	101	1	103	1	105	0.98	Thioredoxin (DB12695)
drugbank_target|Q8IKL4	-	121	sp|Q7KQL8|THIO_PLA	-	104	1.5e-27	94.0	4.1	1	1	4.5e-30	2e-27	93.7	4.1	5	101	12	113	9	116	0.93	Thioredoxin-like protein (DB11638)
drugbank_target|Q8IDH5	-	208	sp|Q7KQL8|THIO_PLA	-	104	6.2e-25	85.6	0.2	1	1	2.2e-27	9.8e-25	85.0	0.2	17	86	44	114	25	131	0.82	Thioredoxin-related protein, putative (DB11638)
drugbank_target|Q8IB72	-	655	sp|Q7KQL8|THIO_PLA	-	104	5.4e-19	66.5	0.8	1	5	0.089	39	2.7	0.3	32	51	145	164	126	181	0.85	DnaJ protein, putative (DB11638)
drugbank_target|Q8IB72	-	655	sp|Q7KQL8|THIO_PLA	-	104	5.4e-19	66.5	0.8	2	5	1.2e-21	5.4e-19	66.5	0.8	6	88	191	277	188	292	0.92	DnaJ protein, putative (DB11638)
drugbank_target|Q8IB72	-	655	sp|Q7KQL8|THIO_PLA	-	104	5.4e-19	66.5	0.8	3	5	1.7	7.3e+02	-1.3	0.2	37	61	350	369	341	413	0.51	DnaJ protein, putative (DB11638)
drugbank_target|Q8IB72	-	655	sp|Q7KQL8|THIO_PLA	-	104	5.4e-19	66.5	0.8	4	5	2.4	1e+03	-1.8	0.0	36	63	418	444	407	470	0.62	DnaJ protein, putative (DB11638)
drugbank_target|Q8IB72	-	655	sp|Q7KQL8|THIO_PLA	-	104	5.4e-19	66.5	0.8	5	5	2.4	1e+03	-1.8	0.1	45	81	471	508	462	526	0.55	DnaJ protein, putative (DB11638)
drugbank_target|P08319	-	380	sp|Q7KQL8|THIO_PLA	-	104	8.8e-17	59.4	0.2	1	1	4.3e-19	1.9e-16	58.4	0.2	18	85	87	154	80	171	0.87	Alcohol dehydrogenase 4 (DB00157; DB03559)
drugbank_target|P11766	-	374	sp|Q7KQL8|THIO_PLA	-	104	0.0013	17.1	0.0	1	1	6.8e-06	0.003	16.0	0.0	17	48	84	115	72	156	0.79	Alcohol dehydrogenase class-3 (DB00157; DB03017; DB03704; DB04153)
drugbank_target|P00325	-	375	sp|Q7KQL8|THIO_PLA	-	104	0.0038	15.6	0.1	1	1	2.9e-05	0.013	13.9	0.1	17	83	85	147	74	163	0.73	Alcohol dehydrogenase 1B (DB00157; DB01213; DB02481; DB02721; DB03461; DB03703; DB04105; DB09462)
drugbank_target|P00326	-	375	sp|Q7KQL8|THIO_PLA	-	104	0.014	13.8	0.1	1	1	9.7e-05	0.043	12.3	0.1	17	79	85	143	74	163	0.70	Alcohol dehydrogenase 1C (DB00157; DB01213; DB01711; DB02131; DB02249; DB02659; DB02721; DB02757; DB02822; DB02871; DB03020; DB03061; DB03226; DB03559; DB04071; DB04113; DB04312; DB04448)
drugbank_target|P0AEG4	-	208	sp|Q7KQL8|THIO_PLA	-	104	0.024	13.0	0.7	1	2	0.0038	1.7	7.1	0.2	22	49	41	68	36	124	0.84	Thiol:disulfide interchange protein DsbA (DB08689)
drugbank_target|P0AEG4	-	208	sp|Q7KQL8|THIO_PLA	-	104	0.024	13.0	0.7	2	2	0.029	13	4.3	0.0	52	103	149	198	125	199	0.81	Thiol:disulfide interchange protein DsbA (DB08689)
drugbank_target|O15511	-	151	sp|O96133|YB145_PL	-	1979	2.9e-43	145.5	0.0	1	1	6.5e-47	3.4e-43	145.3	0.0	1789	1913	12	134	2	141	0.95	Actin-related protein 2/3 complex subunit 5 (DB08235; DB08236)
drugbank_target|P04179	-	222	sp|Q8IAY6|SODF_PLA	-	198	5.1e-110	364.3	1.3	1	1	1.2e-113	6.2e-110	364.0	1.3	4	192	27	217	25	222	0.98	Superoxide dismutase [Mn], mitochondrial (DB03297; DB04436)
drugbank_target|P08865	-	295	sp|Q8IJD4|RSSA_PLA	-	263	4.1e-133	440.6	0.1	1	1	3.5e-136	6.2e-133	440.0	0.1	8	249	9	251	4	276	0.97	40S ribosomal protein SA (DB04985; DB09130)
drugbank_target|P62662	-	256	sp|Q8IJD4|RSSA_PLA	-	263	8e-87	288.9	2.2	1	2	2.3e-52	4.1e-49	165.3	0.1	9	111	2	106	1	139	0.88	30S ribosomal protein S2 (DB08185)
drugbank_target|P62662	-	256	sp|Q8IJD4|RSSA_PLA	-	263	8e-87	288.9	2.2	2	2	1.2e-39	2.1e-36	123.6	0.3	116	198	157	239	152	249	0.96	30S ribosomal protein S2 (DB08185)
drugbank_target|P80371	-	256	sp|Q8IJD4|RSSA_PLA	-	263	8e-87	288.9	2.2	1	2	2.3e-52	4.1e-49	165.3	0.1	9	111	2	106	1	139	0.88	30S ribosomal protein S2 (DB08185)
drugbank_target|P80371	-	256	sp|Q8IJD4|RSSA_PLA	-	263	8e-87	288.9	2.2	2	2	1.2e-39	2.1e-36	123.6	0.3	116	198	157	239	152	249	0.96	30S ribosomal protein S2 (DB08185)
drugbank_target|Q9NNW7	-	524	sp|P61076|TRXR2_PL	-	617	2.5e-197	655.4	0.0	1	1	3.6e-199	2.9e-197	655.1	0.0	111	612	33	524	16	524	0.98	Thioredoxin reductase 2, mitochondrial (DB05428)
drugbank_target|Q16881	-	649	sp|P61076|TRXR2_PL	-	617	1.1e-194	646.6	0.0	1	1	1.6e-196	1.3e-194	646.3	0.0	114	612	159	649	143	649	0.96	Thioredoxin reductase 1, cytoplasmic (DB01169; DB02338; DB03147; DB03566; DB04106; DB05428; DB05448)
drugbank_target|P06715	-	450	sp|P61076|TRXR2_PL	-	617	1.1e-166	554.1	1.0	1	1	1.5e-168	1.3e-166	553.9	1.0	115	595	2	449	1	450	0.98	Glutathione reductase (DB00336; DB03147)
drugbank_target|P00390	-	522	sp|P61076|TRXR2_PL	-	617	2.5e-163	543.0	1.9	1	1	3.7e-165	3e-163	542.7	1.9	116	595	63	521	58	522	0.97	Glutathione reductase, mitochondrial (DB00143; DB00157; DB00262; DB01644; DB02153; DB02553; DB02895; DB03147; DB03310; DB03867; DB07393; DB07714; DB09061; DB09130; DB14009; DB14011)
drugbank_target|P14218	-	478	sp|P61076|TRXR2_PL	-	617	1.3e-158	527.5	12.5	1	1	1.8e-160	1.5e-158	527.3	12.5	115	601	2	467	1	475	0.97	Dihydrolipoyl dehydrogenase (DB03147)
drugbank_target|Q94655	-	500	sp|P61076|TRXR2_PL	-	617	2e-158	526.8	0.1	1	1	5e-160	4.1e-158	525.8	0.1	118	595	3	495	1	497	0.96	Glutathione reductase (DB03147)
drugbank_target|P18925	-	477	sp|P61076|TRXR2_PL	-	617	1e-155	517.9	13.6	1	1	1.5e-157	1.3e-155	517.6	13.6	115	601	2	467	1	474	0.96	Dihydrolipoyl dehydrogenase (DB03147)
drugbank_target|P09622	-	509	sp|P61076|TRXR2_PL	-	617	1.1e-155	517.8	8.0	1	1	1.6e-157	1.3e-155	517.6	8.0	112	605	36	507	27	509	0.94	Dihydrolipoyl dehydrogenase, mitochondrial (DB00157; DB03147)
drugbank_target|P28593	-	492	sp|P61076|TRXR2_PL	-	617	3.4e-152	506.3	0.0	1	1	5.2e-154	4.3e-152	505.9	0.0	116	596	4	472	2	482	0.95	Trypanothione reductase (DB02240; DB03147; DB03470; DB04299)
drugbank_target|Q51225	-	594	sp|P61076|TRXR2_PL	-	617	7.7e-138	458.8	2.0	1	1	1.4e-139	1.1e-137	458.3	2.0	114	595	114	577	104	587	0.93	Dihydrolipoyl dehydrogenase (DB03147)
drugbank_target|P09063	-	459	sp|P61076|TRXR2_PL	-	617	2.3e-133	444.0	0.4	1	1	3.5e-135	2.9e-133	443.7	0.4	113	597	2	450	1	456	0.96	Dihydrolipoyl dehydrogenase (DB03147)
drugbank_target|P9WHH7	-	493	sp|P61076|TRXR2_PL	-	617	1.8e-119	398.2	0.5	1	1	2.7e-121	2.2e-119	397.9	0.5	120	595	5	460	2	473	0.95	NAD(P)H dehydrogenase (quinone) (DB03147)
drugbank_target|Q56839	-	523	sp|P61076|TRXR2_PL	-	617	4.5e-119	396.8	0.0	1	1	7.1e-121	5.9e-119	396.5	0.0	99	581	25	497	8	515	0.95	2-oxopropyl-CoM reductase, carboxylating (DB03147; DB03163)
drugbank_target|P19480	-	521	sp|P61076|TRXR2_PL	-	617	1.6e-59	200.2	6.3	1	2	2.6e-08	2.1e-06	24.7	0.5	108	145	203	240	193	249	0.85	Alkyl hydroperoxide reductase subunit F (DB03147)
drugbank_target|P19480	-	521	sp|P61076|TRXR2_PL	-	617	1.6e-59	200.2	6.3	2	2	6.8e-55	5.6e-53	178.5	0.8	200	457	252	512	244	518	0.94	Alkyl hydroperoxide reductase subunit F (DB03147)
drugbank_target|P35340	-	521	sp|P61076|TRXR2_PL	-	617	8.1e-59	197.8	6.6	1	2	1.3e-08	1.1e-06	25.7	0.4	108	145	203	240	192	248	0.84	Alkyl hydroperoxide reductase subunit F (DB03147)
drugbank_target|P35340	-	521	sp|P61076|TRXR2_PL	-	617	8.1e-59	197.8	6.6	2	2	7e-54	5.8e-52	175.2	1.2	200	457	252	512	243	518	0.94	Alkyl hydroperoxide reductase subunit F (DB03147)
drugbank_target|P37062	-	447	sp|P61076|TRXR2_PL	-	617	2.6e-58	196.2	3.5	1	1	8.5e-60	6.9e-58	194.7	3.5	203	579	44	418	27	422	0.89	NADH peroxidase (DB03147; DB03382)
drugbank_target|P66010	-	311	sp|P61076|TRXR2_PL	-	617	2.6e-53	179.6	3.6	1	2	5.1e-10	4.2e-08	30.3	0.1	115	156	3	44	1	48	0.89	Thioredoxin reductase (DB00548)
drugbank_target|P66010	-	311	sp|P61076|TRXR2_PL	-	617	2.6e-53	179.6	3.6	2	2	2.1e-46	1.7e-44	150.5	0.6	246	460	93	304	62	311	0.87	Thioredoxin reductase (DB00548)
drugbank_target|P0A9P4	-	321	sp|P61076|TRXR2_PL	-	617	1.1e-46	157.7	0.9	1	2	3.5e-07	2.8e-05	21.0	0.1	115	157	4	46	2	49	0.89	Thioredoxin reductase (DB03147)
drugbank_target|P0A9P4	-	321	sp|P61076|TRXR2_PL	-	617	1.1e-46	157.7	0.9	2	2	7.5e-42	6.2e-40	135.5	0.1	249	454	97	308	67	318	0.88	Thioredoxin reductase (DB03147)
drugbank_target|P16640	-	422	sp|P61076|TRXR2_PL	-	617	6.6e-43	145.3	0.7	1	2	0.022	1.8	5.1	0.5	119	140	6	27	2	38	0.83	Putidaredoxin reductase (DB03147)
drugbank_target|P16640	-	422	sp|P61076|TRXR2_PL	-	617	6.6e-43	145.3	0.7	2	2	9.5e-43	7.8e-41	138.4	0.0	253	442	95	293	56	345	0.82	Putidaredoxin reductase (DB03147)
drugbank_target|O95831	-	613	sp|P61076|TRXR2_PL	-	617	2.6e-41	140.0	0.0	1	2	0.022	1.8	5.1	0.0	97	148	114	164	85	171	0.74	Apoptosis-inducing factor 1, mitochondrial (DB03147; DB05282)
drugbank_target|O95831	-	613	sp|P61076|TRXR2_PL	-	617	2.6e-41	140.0	0.0	2	2	4.9e-41	4e-39	132.8	0.0	234	461	223	474	211	501	0.90	Apoptosis-inducing factor 1, mitochondrial (DB03147; DB05282)
drugbank_target|Q52437	-	408	sp|P61076|TRXR2_PL	-	617	3.8e-39	132.8	0.0	1	2	0.44	36	0.8	0.0	300	352	9	63	2	76	0.67	Ferredoxin reductase (DB03147)
drugbank_target|Q52437	-	408	sp|P61076|TRXR2_PL	-	617	3.8e-39	132.8	0.0	2	2	3.6e-40	3e-38	129.9	0.0	237	457	82	306	68	311	0.86	Ferredoxin reductase (DB03147)
drugbank_target|Q14534	-	574	sp|P61076|TRXR2_PL	-	617	9.5e-26	88.6	0.0	1	2	3.8e-27	3.1e-25	86.9	0.0	63	149	66	155	58	165	0.93	Squalene monooxygenase (DB00735; DB00857; DB01091; DB08846)
drugbank_target|Q14534	-	574	sp|P61076|TRXR2_PL	-	617	9.5e-26	88.6	0.0	2	2	2.2	1.8e+02	-1.5	0.0	346	382	236	272	230	320	0.74	Squalene monooxygenase (DB00735; DB00857; DB01091; DB08846)
drugbank_target|P37747	-	367	sp|P61076|TRXR2_PL	-	617	1.6e-16	58.1	0.0	1	1	2.5e-18	2.1e-16	57.7	0.0	118	203	2	75	1	130	0.91	UDP-galactopyranose mutase (DB03147)
drugbank_target|P0C278	-	571	sp|P61076|TRXR2_PL	-	617	7.4e-15	52.6	1.3	1	2	3.9e-16	3.2e-14	50.5	0.4	99	163	108	172	98	176	0.96	Fumarate reductase flavoprotein subunit (DB01677; DB03147; DB03343; DB04734)
drugbank_target|P0C278	-	571	sp|P61076|TRXR2_PL	-	617	7.4e-15	52.6	1.3	2	2	0.73	60	0.1	0.0	240	272	283	317	237	337	0.63	Fumarate reductase flavoprotein subunit (DB01677; DB03147; DB03343; DB04734)
drugbank_target|P42593	-	672	sp|P61076|TRXR2_PL	-	617	1.2e-14	51.9	0.6	1	3	1e-08	8.4e-07	26.0	0.2	117	162	374	411	370	422	0.85	2,4-dienoyl-CoA reductase [NADPH] (DB03147; DB03247; DB03461; DB03698)
drugbank_target|P42593	-	672	sp|P61076|TRXR2_PL	-	617	1.2e-14	51.9	0.6	2	3	4.4e-06	0.00036	17.3	0.0	245	326	441	523	427	554	0.81	2,4-dienoyl-CoA reductase [NADPH] (DB03147; DB03247; DB03461; DB03698)
drugbank_target|P42593	-	672	sp|P61076|TRXR2_PL	-	617	1.2e-14	51.9	0.6	3	3	0.02	1.6	5.3	0.0	223	396	582	631	556	655	0.66	2,4-dienoyl-CoA reductase [NADPH] (DB03147; DB03247; DB03461; DB03698)
drugbank_target|P83223	-	596	sp|P61076|TRXR2_PL	-	617	4.3e-12	43.5	4.7	1	3	4.6e-13	3.8e-11	40.4	2.3	105	163	138	196	129	201	0.91	Fumarate reductase flavoprotein subunit (DB00518; DB01677; DB03147)
drugbank_target|P83223	-	596	sp|P61076|TRXR2_PL	-	617	4.3e-12	43.5	4.7	2	3	0.34	28	1.2	0.0	328	392	269	339	250	351	0.67	Fumarate reductase flavoprotein subunit (DB00518; DB01677; DB03147)
drugbank_target|P83223	-	596	sp|P61076|TRXR2_PL	-	617	4.3e-12	43.5	4.7	3	3	1.1	88	-0.5	0.0	564	589	369	393	363	408	0.85	Fumarate reductase flavoprotein subunit (DB00518; DB01677; DB03147)
drugbank_target|Q9Z4P0	-	588	sp|P61076|TRXR2_PL	-	617	4.9e-12	43.3	2.1	1	2	1.2e-12	9.7e-11	39.0	0.2	100	163	126	189	109	193	0.89	Fumarate reductase flavoprotein subunit (DB03147)
drugbank_target|Q9Z4P0	-	588	sp|P61076|TRXR2_PL	-	617	4.9e-12	43.3	2.1	2	2	0.076	6.2	3.3	0.1	321	552	255	310	244	358	0.67	Fumarate reductase flavoprotein subunit (DB03147)
drugbank_target|P0AC41	-	588	sp|P61076|TRXR2_PL	-	617	1.1e-11	42.2	0.8	1	2	3.2e-13	2.6e-11	40.9	0.3	116	167	6	57	3	59	0.95	Succinate dehydrogenase flavoprotein subunit (DB04631; DB07671; DB08690)
drugbank_target|P0AC41	-	588	sp|P61076|TRXR2_PL	-	617	1.1e-11	42.2	0.8	2	2	7.1	5.9e+02	-3.2	0.0	542	563	171	192	159	211	0.73	Succinate dehydrogenase flavoprotein subunit (DB04631; DB07671; DB08690)
drugbank_target|P00363	-	602	sp|P61076|TRXR2_PL	-	617	2.2e-11	41.1	1.4	1	2	4.6e-10	3.8e-08	30.5	0.9	114	164	2	54	1	58	0.92	Fumarate reductase flavoprotein subunit (DB00730; DB07490; DB07918)
drugbank_target|P00363	-	602	sp|P61076|TRXR2_PL	-	617	2.2e-11	41.1	1.4	2	2	0.0016	0.13	8.9	0.0	411	436	358	383	333	420	0.79	Fumarate reductase flavoprotein subunit (DB00730; DB07490; DB07918)
drugbank_target|Q6NUM9	-	610	sp|P61076|TRXR2_PL	-	617	2.3e-11	41.1	0.6	1	1	4.2e-13	3.4e-11	40.5	0.6	103	166	52	108	45	111	0.85	All-trans-retinol 13,14-reductase (DB00162)
drugbank_target|Q47PU3	-	542	sp|P61076|TRXR2_PL	-	617	1.5e-10	38.4	0.0	1	3	7.8e-08	6.4e-06	23.1	0.0	111	149	10	48	2	59	0.86	Phenylacetone monooxygenase (DB03147)
drugbank_target|Q47PU3	-	542	sp|P61076|TRXR2_PL	-	617	1.5e-10	38.4	0.0	2	3	0.00012	0.0097	12.6	0.0	191	330	71	218	60	275	0.78	Phenylacetone monooxygenase (DB03147)
drugbank_target|Q47PU3	-	542	sp|P61076|TRXR2_PL	-	617	1.5e-10	38.4	0.0	3	3	4.2	3.5e+02	-2.4	0.0	220	269	343	388	340	392	0.71	Phenylacetone monooxygenase (DB03147)
drugbank_target|B7JBP8	-	434	sp|P61076|TRXR2_PL	-	617	3.8e-10	37.0	0.4	1	3	0.00028	0.023	11.4	0.1	119	148	3	35	1	40	0.82	Sulfide-quinone reductase (DB07640)
drugbank_target|B7JBP8	-	434	sp|P61076|TRXR2_PL	-	617	3.8e-10	37.0	0.4	2	3	0.00066	0.054	10.1	0.0	217	284	58	120	52	154	0.82	Sulfide-quinone reductase (DB07640)
drugbank_target|B7JBP8	-	434	sp|P61076|TRXR2_PL	-	617	3.8e-10	37.0	0.4	3	3	0.00017	0.014	12.1	0.0	344	432	211	301	206	322	0.82	Sulfide-quinone reductase (DB07640)
drugbank_target|P40859	-	390	sp|P61076|TRXR2_PL	-	617	4.1e-10	37.0	0.0	1	2	6.4e-11	5.3e-09	33.3	0.1	116	156	3	43	1	48	0.88	Monomeric sarcosine oxidase (DB01918; DB02083; DB02543; DB03098; DB03147; DB03366; DB03517)
drugbank_target|P40859	-	390	sp|P61076|TRXR2_PL	-	617	4.1e-10	37.0	0.0	2	2	0.31	25	1.3	0.0	336	406	149	215	139	221	0.76	Monomeric sarcosine oxidase (DB01918; DB02083; DB02543; DB03098; DB03147; DB03366; DB03517)
drugbank_target|Q16134	-	617	sp|P61076|TRXR2_PL	-	617	5.4e-10	36.5	0.1	1	2	2.7e-11	2.2e-09	34.5	0.0	111	168	62	122	49	124	0.83	Electron transfer flavoprotein-ubiquinone oxidoreductase, mitochondrial (DB00331; DB04141)
drugbank_target|Q16134	-	617	sp|P61076|TRXR2_PL	-	617	5.4e-10	36.5	0.1	2	2	1.5	1.2e+02	-0.9	0.0	442	468	400	427	395	432	0.79	Electron transfer flavoprotein-ubiquinone oxidoreductase, mitochondrial (DB00331; DB04141)
drugbank_target|O31616	-	369	sp|P61076|TRXR2_PL	-	617	1.9e-09	34.8	0.1	1	1	3.1e-11	2.5e-09	34.3	0.1	115	178	2	65	1	79	0.87	Glycine oxidase (DB02713; DB03147)
drugbank_target|P31040	-	664	sp|P61076|TRXR2_PL	-	617	2.3e-09	34.5	0.6	1	1	4.9e-11	4e-09	33.7	0.6	115	163	59	107	36	112	0.87	Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial (DB04141; DB04657; DB04795; DB08689; DB09270)
drugbank_target|P16099	-	730	sp|P61076|TRXR2_PL	-	617	6.4e-09	33.0	0.0	1	2	7.9e-06	0.00065	16.5	0.0	113	163	386	428	372	437	0.80	Trimethylamine dehydrogenase (DB03247)
drugbank_target|P16099	-	730	sp|P61076|TRXR2_PL	-	617	6.4e-09	33.0	0.0	2	2	4e-05	0.0033	14.1	0.0	257	461	477	701	446	712	0.72	Trimethylamine dehydrogenase (DB03247)
drugbank_target|P10902	-	540	sp|P61076|TRXR2_PL	-	617	7.3e-09	32.8	0.3	1	3	1.7e-07	1.4e-05	22.0	0.1	115	164	6	54	1	58	0.90	L-aspartate oxidase (DB03147)
drugbank_target|P10902	-	540	sp|P61076|TRXR2_PL	-	617	7.3e-09	32.8	0.3	2	3	1	86	-0.4	0.0	250	273	186	209	146	223	0.74	L-aspartate oxidase (DB03147)
drugbank_target|P10902	-	540	sp|P61076|TRXR2_PL	-	617	7.3e-09	32.8	0.3	3	3	0.0052	0.43	7.2	0.0	413	436	355	378	350	413	0.82	L-aspartate oxidase (DB03147)
drugbank_target|P27338	-	520	sp|P61076|TRXR2_PL	-	617	4.6e-08	30.2	0.4	1	1	7.8e-10	6.4e-08	29.7	0.4	115	162	2	41	1	46	0.86	Amine oxidase [flavin-containing] B (DB00182; DB00721; DB01168; DB01171)
drugbank_target|P27338	-	520	sp|P61076|TRXR2_PL	-	617	4.6e-08	30.2	0.4	1	1	7.8e-10	6.4e-08	29.7	0.4	115	162	2	41	1	46	0.86	Amine oxidase [flavin-containing] B (DB00182; DB00191; DB00752; DB00780; DB00909; DB01037; DB01132; DB01171; DB01247; DB01363; DB01367; DB01442; DB01472; DB01577; DB01626; DB02095; DB02211; DB02509; DB02643; DB03147; DB03894; DB04147; DB04307; DB04677; DB04820; DB04821; DB04832; DB06654; DB07512; DB07513; DB08082; DB08176; DB08480; DB08516; DB14914)
drugbank_target|Q92206	-	496	sp|P61076|TRXR2_PL	-	617	7.4e-08	29.5	0.0	1	2	1.5e-08	1.2e-06	25.4	0.1	115	149	3	37	1	46	0.90	Squalene monooxygenase (DB00525; DB00857)
drugbank_target|Q92206	-	496	sp|P61076|TRXR2_PL	-	617	7.4e-08	29.5	0.0	2	2	0.26	22	1.5	0.0	323	367	276	320	270	339	0.84	Squalene monooxygenase (DB00525; DB00857)
drugbank_target|P00338	-	332	sp|P61076|TRXR2_PL	-	617	1.6e-07	28.4	0.0	1	1	2.8e-09	2.3e-07	27.9	0.0	100	154	2	59	1	65	0.87	L-lactate dehydrogenase A chain (DB00157; DB02483; DB02701; DB03940; DB09118; DB09130; DB11638)
drugbank_target|Q9P0Z9	-	390	sp|P61076|TRXR2_PL	-	617	2.2e-07	27.9	0.0	1	2	9.5e-08	7.8e-06	22.8	0.0	114	150	4	40	1	52	0.84	Peroxisomal sarcosine oxidase (DB00145)
drugbank_target|Q9P0Z9	-	390	sp|P61076|TRXR2_PL	-	617	2.2e-07	27.9	0.0	2	2	0.1	8.4	2.9	0.0	114	129	333	348	321	354	0.87	Peroxisomal sarcosine oxidase (DB00145)
drugbank_target|O67931	-	430	sp|P61076|TRXR2_PL	-	617	3.3e-07	27.4	0.2	1	2	0.00035	0.029	11.0	0.1	119	139	4	24	2	38	0.78	Sulfide-quinone reductase (DB07640)
drugbank_target|O67931	-	430	sp|P61076|TRXR2_PL	-	617	3.3e-07	27.4	0.2	2	2	4.1e-05	0.0034	14.1	0.0	224	297	65	135	54	154	0.72	Sulfide-quinone reductase (DB07640)
drugbank_target|P21397	-	527	sp|P61076|TRXR2_PL	-	617	5.7e-07	26.6	0.3	1	1	1.2e-08	9.7e-07	25.8	0.3	116	163	12	51	3	56	0.85	Amine oxidase [flavin-containing] A (DB00182; DB00721; DB01168; DB01171)
drugbank_target|P21397	-	527	sp|P61076|TRXR2_PL	-	617	5.7e-07	26.6	0.3	1	1	1.2e-08	9.7e-07	25.8	0.3	116	163	12	51	3	56	0.85	Amine oxidase [flavin-containing] A (DB00191; DB00752; DB00780; DB00805; DB00909; DB01037; DB01171; DB01247; DB01363; DB01442; DB01472; DB01577; DB01626; DB03147; DB04017; DB04820; DB04821; DB04832; DB04850; DB05205; DB07641; DB07919; DB09244; DB09245; DB13876; DB14914)
drugbank_target|Q96RQ9	-	567	sp|P61076|TRXR2_PL	-	617	8.7e-07	26.0	0.3	1	1	1.5e-08	1.3e-06	25.4	0.3	120	162	62	96	53	100	0.87	L-amino-acid oxidase (DB03147; DB03214; DB04166; DB04272)
drugbank_target|Q6ZMR3	-	332	sp|P61076|TRXR2_PL	-	617	2.3e-06	24.6	0.1	1	1	3.7e-08	3.1e-06	24.2	0.1	100	151	2	56	1	66	0.83	L-lactate dehydrogenase A-like 6A (DB00157)
drugbank_target|Q8KI25	-	529	sp|P61076|TRXR2_PL	-	617	5.7e-06	23.3	0.1	1	1	9.5e-08	7.8e-06	22.8	0.1	114	151	3	40	1	51	0.85	Putative FAD-monooxygenase (DB07241; DB08036)
drugbank_target|Q12882	-	1025	sp|P61076|TRXR2_PL	-	617	7.4e-06	22.9	0.0	1	2	0.47	39	0.7	0.0	299	336	188	226	179	298	0.59	Dihydropyrimidine dehydrogenase [NADP(+)] (DB02303; DB02338; DB03048; DB03147; DB03247; DB03419; DB03516; DB03554; DB09257; DB09327)
drugbank_target|Q12882	-	1025	sp|P61076|TRXR2_PL	-	617	7.4e-06	22.9	0.0	2	2	8.4e-07	6.9e-05	19.7	0.0	299	453	333	500	318	517	0.76	Dihydropyrimidine dehydrogenase [NADP(+)] (DB02303; DB02338; DB03048; DB03147; DB03247; DB03419; DB03516; DB03554; DB09257; DB09327)
drugbank_target|Q16836	-	314	sp|P61076|TRXR2_PL	-	617	8.4e-06	22.7	1.4	1	2	1e-07	8.4e-06	22.7	1.4	108	159	18	69	8	71	0.82	Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial (DB00157; DB03059; DB03612; DB09568)
drugbank_target|Q16836	-	314	sp|P61076|TRXR2_PL	-	617	8.4e-06	22.7	1.4	2	2	1.4	1.1e+02	-0.8	0.1	475	587	102	209	78	213	0.64	Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial (DB00157; DB03059; DB03612; DB09568)
drugbank_target|P17412	-	656	sp|P61076|TRXR2_PL	-	617	1.1e-05	22.4	0.7	1	1	3.2e-07	2.7e-05	21.1	0.7	118	163	6	51	2	56	0.94	Fumarate reductase flavoprotein subunit (DB07669)
drugbank_target|P9WIQ1	-	399	sp|P61076|TRXR2_PL	-	617	1.5e-05	21.9	0.0	1	1	2.6e-07	2.1e-05	21.4	0.0	115	203	5	84	2	103	0.75	UDP-galactopyranose mutase (DB03147; DB03709)
drugbank_target|Q9BYZ2	-	381	sp|P61076|TRXR2_PL	-	617	3.5e-05	20.7	0.0	1	1	6.1e-07	5e-05	20.1	0.0	99	152	50	106	47	116	0.82	L-lactate dehydrogenase A-like 6B (DB00157)
drugbank_target|P22637	-	552	sp|P61076|TRXR2_PL	-	617	5.6e-05	20.0	1.6	1	2	1.5e-05	0.0013	15.5	0.1	120	148	59	87	41	98	0.89	Cholesterol oxidase (DB03147)
drugbank_target|P22637	-	552	sp|P61076|TRXR2_PL	-	617	5.6e-05	20.0	1.6	2	2	0.064	5.3	3.6	0.2	334	399	271	343	244	351	0.66	Cholesterol oxidase (DB03147)
drugbank_target|Q888A4	-	328	sp|P61076|TRXR2_PL	-	617	6.3e-05	19.8	0.2	1	1	1.1e-06	9.1e-05	19.3	0.2	120	153	5	38	2	46	0.86	Amine oxidase, flavin-containing protein (DB03147)
drugbank_target|P07864	-	332	sp|P61076|TRXR2_PL	-	617	0.0001	19.1	0.0	1	1	1.7e-06	0.00014	18.6	0.0	103	150	5	55	1	65	0.78	L-lactate dehydrogenase C chain (DB00157)
drugbank_target|Q9NWM0	-	555	sp|P61076|TRXR2_PL	-	617	0.00013	18.8	0.4	1	1	2.6e-06	0.00021	18.1	0.4	117	162	24	62	20	71	0.83	Spermine oxidase (DB00127; DB04188)
drugbank_target|Q6A8X5	-	424	sp|P61076|TRXR2_PL	-	617	0.0017	15.1	0.0	1	1	3.4e-05	0.0028	14.4	0.0	116	165	5	47	2	50	0.86	Putative aminooxidase (DB04746; DB04747)
drugbank_target|P07195	-	334	sp|P61076|TRXR2_PL	-	617	0.0034	14.1	0.1	1	1	6.4e-05	0.0053	13.5	0.1	101	153	3	59	1	66	0.74	L-lactate dehydrogenase B chain (DB00157; DB02401; DB03940; DB09118; DB11638)
drugbank_target|P56601	-	471	sp|P61076|TRXR2_PL	-	617	0.0041	13.8	1.3	1	1	7.2e-05	0.006	13.3	1.3	117	162	9	46	4	61	0.79	Protoporphyrinogen oxidase (DB07338)
drugbank_target|P32397	-	470	sp|P61076|TRXR2_PL	-	617	0.0069	13.1	0.3	1	2	0.00035	0.029	11.0	0.1	118	139	6	27	2	51	0.79	Protoporphyrinogen oxidase (DB07338)
drugbank_target|P32397	-	470	sp|P61076|TRXR2_PL	-	617	0.0069	13.1	0.3	2	2	1.1	91	-0.5	0.0	343	390	240	285	211	296	0.75	Protoporphyrinogen oxidase (DB07338)
drugbank_target|Q13423	-	1086	sp|P61076|TRXR2_PL	-	617	0.016	11.9	0.7	1	2	0.00041	0.033	10.8	0.3	298	338	227	268	182	283	0.67	NAD(P) transhydrogenase, mitochondrial (DB00157; DB01763; DB03461; DB09092)
drugbank_target|Q13423	-	1086	sp|P61076|TRXR2_PL	-	617	0.016	11.9	0.7	2	2	3.7	3.1e+02	-2.3	0.0	444	540	335	428	330	435	0.73	NAD(P) transhydrogenase, mitochondrial (DB00157; DB01763; DB03461; DB09092)
drugbank_target|Q00796	-	357	sp|P61076|TRXR2_PL	-	617	0.026	11.2	1.3	1	1	0.00045	0.037	10.7	1.3	118	161	174	217	161	221	0.87	Sorbitol dehydrogenase (DB00157; DB04478)
drugbank_target|P13830	-	1073	sp|Q8IM77|YPFJ1_PL	-	492	6.3e-157	521.3	15.5	1	3	0.3	8e+02	-3.5	0.7	137	286	415	452	380	477	0.59	Ring-infected erythrocyte surface antigen (DB11638)
drugbank_target|P13830	-	1073	sp|Q8IM77|YPFJ1_PL	-	492	6.3e-157	521.3	15.5	2	3	2.4e-160	6.3e-157	521.3	15.5	143	486	522	841	498	845	0.99	Ring-infected erythrocyte surface antigen (DB11638)
drugbank_target|P13830	-	1073	sp|Q8IM77|YPFJ1_PL	-	492	6.3e-157	521.3	15.5	3	3	2	5.3e+03	-23.1	27.9	354	462	931	1044	892	1060	0.52	Ring-infected erythrocyte surface antigen (DB11638)
drugbank_target|Q8IL88	-	424	sp|Q8IM77|YPFJ1_PL	-	492	2.8e-26	90.4	1.5	1	1	2.2e-29	5.7e-26	89.3	1.5	139	215	22	93	17	96	0.95	HSP40, subfamily A, putative (DB11638)
drugbank_target|Q08289	-	660	sp|O96185|YPF08_PL	-	2573	6.1e-32	107.8	28.3	1	1	6.3e-35	8.2e-32	107.4	28.3	510	618	525	630	501	657	0.89	Voltage-dependent L-type calcium channel subunit beta-2 (DB00270; DB00393; DB00401; DB00622; DB01023; DB01054; DB01115; DB01388; DB04855; DB06712)
drugbank_target|Q08289	-	660	sp|O96185|YPF08_PL	-	2573	6.1e-32	107.8	28.3	1	1	6.3e-35	8.2e-32	107.4	28.3	510	618	525	630	501	657	0.89	Voltage-dependent L-type calcium channel subunit beta-2 (DB00153; DB00228; DB00421; DB11148; DB13746)
drugbank_target|Q08289	-	660	sp|O96185|YPF08_PL	-	2573	6.1e-32	107.8	28.3	1	1	6.3e-35	8.2e-32	107.4	28.3	510	618	525	630	501	657	0.89	Voltage-dependent L-type calcium channel subunit beta-2 (DB00252; DB00653; DB00825; DB09089; DB09231; DB09232; DB09236; DB09238; DB13746)
drugbank_target|Q08289	-	660	sp|O96185|YPF08_PL	-	2573	6.1e-32	107.8	28.3	1	1	6.3e-35	8.2e-32	107.4	28.3	510	618	525	630	501	657	0.89	Voltage-dependent L-type calcium channel subunit beta-2 (DB00243; DB00273; DB01110; DB01118; DB13961)
drugbank_target|P0A8T7	-	1407	sp|P21422|RPOC1_PL	-	575	4.3e-246	816.3	0.0	1	1	4.3e-249	7.5e-246	815.5	0.0	35	510	34	512	13	539	0.95	DNA-directed RNA polymerase subunit beta' (DB00615; DB11753)
drugbank_target|P9WGY7	-	1316	sp|P21422|RPOC1_PL	-	575	5.7e-229	759.8	0.0	1	2	3.6e-60	6.4e-57	191.7	0.0	35	153	24	140	5	187	0.91	DNA-directed RNA polymerase subunit beta' (DB01201)
drugbank_target|P9WGY7	-	1316	sp|P21422|RPOC1_PL	-	575	5.7e-229	759.8	0.0	2	2	1.7e-173	3e-170	565.9	0.0	133	510	210	587	200	592	0.94	DNA-directed RNA polymerase subunit beta' (DB01201)
drugbank_target|Q8RQE8	-	1524	sp|P21422|RPOC1_PL	-	575	1.9e-217	721.8	0.0	1	3	1.3e-57	2.3e-54	183.3	0.0	35	149	22	141	5	167	0.87	DNA-directed RNA polymerase subunit beta' (DB04788; DB08226; DB08266)
drugbank_target|Q8RQE8	-	1524	sp|P21422|RPOC1_PL	-	575	1.9e-217	721.8	0.0	2	3	2.7e-164	4.7e-161	535.6	0.0	177	511	451	792	434	811	0.94	DNA-directed RNA polymerase subunit beta' (DB04788; DB08226; DB08266)
drugbank_target|Q8RQE8	-	1524	sp|P21422|RPOC1_PL	-	575	1.9e-217	721.8	0.0	3	3	0.34	5.9e+02	-3.0	0.0	360	393	1107	1141	1093	1160	0.73	DNA-directed RNA polymerase subunit beta' (DB04788; DB08226; DB08266)
drugbank_target|P84077	-	181	sp|Q7KQL3|ARF1_PLA	-	181	4.7e-74	245.9	0.0	1	1	6.2e-76	5.2e-74	245.8	0.0	1	181	1	181	1	181	0.99	ADP-ribosylation factor 1 (DB02774; DB04121; DB04137; DB04315; DB07348; DB08231; DB09462)
drugbank_target|P18085	-	180	sp|Q7KQL3|ARF1_PLA	-	181	1.7e-72	240.8	0.1	1	1	2.2e-74	1.9e-72	240.7	0.1	1	178	1	178	1	180	0.99	ADP-ribosylation factor 4 (DB04315)
drugbank_target|P62330	-	175	sp|Q7KQL3|ARF1_PLA	-	181	3.8e-69	229.9	0.0	1	1	5e-71	4.2e-69	229.8	0.0	6	178	2	174	1	175	0.98	ADP-ribosylation factor 6 (DB01864; DB04315; DB08231)
drugbank_target|P40616	-	181	sp|Q7KQL3|ARF1_PLA	-	181	1.6e-68	227.9	0.0	1	1	2e-70	1.7e-68	227.8	0.0	1	179	1	179	1	181	0.99	ADP-ribosylation factor-like protein 1 (DB04315)
drugbank_target|Q9Y689	-	179	sp|Q7KQL3|ARF1_PLA	-	181	6.6e-68	225.9	0.4	1	1	8.6e-70	7.3e-68	225.8	0.4	1	178	1	177	1	179	0.99	ADP-ribosylation factor-like protein 5A (DB04315)
drugbank_target|Q96KC2	-	179	sp|Q7KQL3|ARF1_PLA	-	181	5.7e-67	222.8	0.1	1	1	8.1e-69	6.9e-67	222.6	0.1	1	177	1	176	1	178	0.99	ADP-ribosylation factor-like protein 5B (DB04315)
drugbank_target|P36405	-	182	sp|Q7KQL3|ARF1_PLA	-	181	1.5e-62	208.5	0.0	1	1	1.9e-64	1.6e-62	208.3	0.0	6	180	4	180	1	181	0.97	ADP-ribosylation factor-like protein 3 (DB03814; DB04315)
drugbank_target|P36404	-	184	sp|Q7KQL3|ARF1_PLA	-	181	2.3e-59	198.0	0.0	1	1	3.3e-61	2.8e-59	197.8	0.0	6	178	4	177	1	179	0.98	ADP-ribosylation factor-like protein 2 (DB14731)
drugbank_target|P01112	-	189	sp|Q7KQL3|ARF1_PLA	-	181	4.7e-50	167.7	0.1	1	1	6.3e-52	5.3e-50	167.6	0.1	17	180	3	166	1	167	0.95	GTPase HRas (DB02210; DB03226; DB04137; DB04315; DB08751)
drugbank_target|P01116	-	189	sp|Q7KQL3|ARF1_PLA	-	181	7.8e-50	167.0	0.0	1	1	1.1e-51	9.2e-50	166.8	0.0	17	179	3	165	1	167	0.95	GTPase KRas (DB07771; DB07780; DB15568; DB15569)
drugbank_target|Q92930	-	207	sp|Q7KQL3|ARF1_PLA	-	181	2.4e-49	165.4	0.4	1	1	4.1e-51	3.5e-49	164.9	0.4	18	178	9	170	3	172	0.91	Ras-related protein Rab-8B (DB02082; DB04315)
drugbank_target|P11233	-	206	sp|Q7KQL3|ARF1_PLA	-	181	4.3e-49	164.6	0.1	1	1	6.6e-51	5.6e-49	164.2	0.1	18	180	15	178	9	179	0.93	Ras-related protein Ral-A (DB04315)
drugbank_target|P38545	-	214	sp|Q7KQL3|ARF1_PLA	-	181	1e-48	163.4	0.0	1	1	1.6e-50	1.3e-48	163.0	0.0	17	179	9	169	4	171	0.94	GTP-binding nuclear protein Ran (DB11638)
drugbank_target|P62826	-	216	sp|Q7KQL3|ARF1_PLA	-	181	1.1e-47	160.0	0.0	1	1	1.8e-49	1.6e-47	159.5	0.0	16	177	9	168	6	170	0.94	GTP-binding nuclear protein Ran (DB04315)
drugbank_target|P10114	-	183	sp|Q7KQL3|ARF1_PLA	-	181	4.8e-47	157.9	0.0	1	1	6.8e-49	5.8e-47	157.7	0.0	16	178	2	165	1	167	0.94	Ras-related protein Rap-2a (DB04137; DB04315)
drugbank_target|P20339	-	215	sp|Q7KQL3|ARF1_PLA	-	181	7.7e-47	157.3	0.1	1	1	1.1e-48	9.4e-47	157.0	0.1	17	177	20	181	15	185	0.94	Ras-related protein Rab-5A (DB02467; DB04137; DB04315)
drugbank_target|Q26000	-	207	sp|Q7KQL3|ARF1_PLA	-	181	2.4e-46	155.7	0.1	1	1	3.9e-48	3.3e-46	155.2	0.1	16	177	10	172	3	175	0.93	GTPase (Rab6) (DB04315)
drugbank_target|P51149	-	207	sp|Q7KQL3|ARF1_PLA	-	181	4.4e-46	154.8	0.1	1	1	6.5e-48	5.5e-46	154.5	0.1	16	176	7	172	2	177	0.90	Ras-related protein Rab-7a (DB04315)
drugbank_target|Q9Y6B6	-	198	sp|Q7KQL3|ARF1_PLA	-	181	1.1e-45	153.4	0.0	1	1	1.6e-47	1.4e-45	153.2	0.0	13	177	21	197	10	198	0.96	GTP-binding protein SAR1b (DB04315)
drugbank_target|P62745	-	196	sp|Q7KQL3|ARF1_PLA	-	181	6.2e-45	151.0	0.0	1	1	1e-46	8.9e-45	150.5	0.0	18	175	6	176	2	181	0.90	Rho-related GTP-binding protein RhoB (DB00083)
drugbank_target|P62491	-	216	sp|Q7KQL3|ARF1_PLA	-	181	9e-45	150.5	0.0	1	1	1.5e-46	1.3e-44	150.0	0.0	18	177	12	172	8	174	0.93	Ras-related protein Rab-11A (DB01864; DB04315)
drugbank_target|P61586	-	193	sp|Q7KQL3|ARF1_PLA	-	181	9.2e-45	150.5	0.0	1	1	1.6e-46	1.4e-44	149.9	0.0	18	174	6	175	2	181	0.88	Transforming protein RhoA (DB04315)
drugbank_target|Q9X1F8	-	439	sp|Q7KQL3|ARF1_PLA	-	181	8.2e-44	147.4	0.4	1	2	7.3e-23	6.2e-21	72.8	0.2	20	179	4	166	1	168	0.86	GTPase Der (DB04315)
drugbank_target|Q9X1F8	-	439	sp|Q7KQL3|ARF1_PLA	-	181	8.2e-44	147.4	0.4	2	2	8.3e-23	7.1e-21	72.7	0.0	16	173	179	349	173	354	0.81	GTPase Der (DB04315)
drugbank_target|P51151	-	201	sp|Q7KQL3|ARF1_PLA	-	181	2.4e-43	145.9	0.0	1	1	3.8e-45	3.2e-43	145.5	0.0	16	177	6	172	2	175	0.88	Ras-related protein Rab-9A (DB04315)
drugbank_target|P63000	-	192	sp|Q7KQL3|ARF1_PLA	-	181	2.8e-43	145.6	0.0	1	1	4.2e-45	3.6e-43	145.3	0.0	16	174	2	173	1	177	0.91	Ras-related C3 botulinum toxin substrate 1 (DB00514)
drugbank_target|P63000	-	192	sp|Q7KQL3|ARF1_PLA	-	181	2.8e-43	145.6	0.0	1	1	4.2e-45	3.6e-43	145.3	0.0	16	174	2	173	1	177	0.91	Ras-related C3 botulinum toxin substrate 1 (DB00993; DB04315)
drugbank_target|P15153	-	192	sp|Q7KQL3|ARF1_PLA	-	181	1.9e-42	142.9	0.0	1	1	2.9e-44	2.5e-42	142.6	0.0	16	174	2	173	1	177	0.91	Ras-related C3 botulinum toxin substrate 2 (DB00514)
drugbank_target|P60953	-	191	sp|Q7KQL3|ARF1_PLA	-	181	2.4e-40	136.1	0.0	1	1	3.7e-42	3.2e-40	135.7	0.0	16	172	2	171	1	177	0.91	Cell division control protein 42 homolog (DB02623; DB04315)
drugbank_target|Q15382	-	184	sp|Q7KQL3|ARF1_PLA	-	181	6.3e-38	128.2	0.1	1	1	8.8e-40	7.5e-38	128.0	0.1	14	174	3	164	1	170	0.92	GTP-binding protein Rheb (DB04137; DB04315)
drugbank_target|P61587	-	244	sp|Q7KQL3|ARF1_PLA	-	181	5.2e-34	115.4	0.0	1	1	1.1e-35	9.2e-34	114.6	0.0	14	167	20	186	12	200	0.86	Rho-related GTP-binding protein RhoE (DB04137)
drugbank_target|Q8I4W4	-	261	sp|Q7KQL3|ARF1_PLA	-	181	7.6e-34	114.9	1.8	1	1	1.7e-35	1.4e-33	114.0	1.8	5	158	49	204	46	261	0.88	Signal recognition particle receptor, beta subunit (DB11638)
drugbank_target|P63096	-	354	sp|Q7KQL3|ARF1_PLA	-	181	4.3e-29	99.4	2.8	1	2	9.9e-07	8.4e-05	20.3	0.0	15	38	31	54	27	77	0.92	Guanine nucleotide-binding protein G(i) subunit alpha-1 (DB04315; DB04444)
drugbank_target|P63096	-	354	sp|Q7KQL3|ARF1_PLA	-	181	4.3e-29	99.4	2.8	2	2	4.1e-24	3.5e-22	76.9	0.8	38	175	171	341	168	346	0.86	Guanine nucleotide-binding protein G(i) subunit alpha-1 (DB04315; DB04444)
drugbank_target|Q5S007	-	2527	sp|Q7KQL3|ARF1_PLA	-	181	4.9e-28	96.0	0.1	1	1	1.8e-29	1.5e-27	94.4	0.1	9	154	1326	1480	1318	1495	0.86	Leucine-rich repeat serine/threonine-protein kinase 2 (DB12010)
drugbank_target|P63092	-	394	sp|Q7KQL3|ARF1_PLA	-	181	8.1e-27	92.0	0.6	1	2	6.2e-06	0.00053	17.7	0.1	14	37	37	60	24	67	0.87	Guanine nucleotide-binding protein G(s) subunit alpha isoforms short (DB02587; DB06843)
drugbank_target|P63092	-	394	sp|Q7KQL3|ARF1_PLA	-	181	8.1e-27	92.0	0.6	2	2	1.8e-22	1.5e-20	71.6	0.1	45	136	201	302	192	317	0.92	Guanine nucleotide-binding protein G(s) subunit alpha isoforms short (DB02587; DB06843)
drugbank_target|P11488	-	350	sp|Q7KQL3|ARF1_PLA	-	181	1.2e-25	88.2	1.5	1	2	1.1e-06	9.7e-05	20.1	0.0	14	38	26	50	16	106	0.91	Guanine nucleotide-binding protein G(t) subunit alpha-1 (DB02994; DB04315; DB04444)
drugbank_target|P11488	-	350	sp|Q7KQL3|ARF1_PLA	-	181	1.2e-25	88.2	1.5	2	2	3.5e-20	3e-18	64.1	0.5	39	174	168	336	164	342	0.81	Guanine nucleotide-binding protein G(t) subunit alpha-1 (DB02994; DB04315; DB04444)
drugbank_target|P15170	-	499	sp|Q7KQL3|ARF1_PLA	-	181	2.5e-24	83.9	0.0	1	2	0.004	0.34	8.5	0.0	15	39	72	96	69	121	0.79	Eukaryotic peptide chain release factor GTP-binding subunit ERF3A (DB04315)
drugbank_target|P15170	-	499	sp|Q7KQL3|ARF1_PLA	-	181	2.5e-24	83.9	0.0	2	2	6e-23	5.1e-21	73.1	0.0	44	169	135	272	122	276	0.84	Eukaryotic peptide chain release factor GTP-binding subunit ERF3A (DB04315)
drugbank_target|P68104	-	462	sp|Q7KQL3|ARF1_PLA	-	181	5.8e-24	82.7	0.5	1	2	0.019	1.6	6.3	0.3	14	50	4	40	2	48	0.78	Elongation factor 1-alpha 1 (DB01593; DB04315; DB09130; DB11638; DB14487; DB14533; DB14548)
drugbank_target|P68104	-	462	sp|Q7KQL3|ARF1_PLA	-	181	5.8e-24	82.7	0.5	2	2	1.9e-23	1.6e-21	74.7	0.0	27	147	48	173	46	208	0.86	Elongation factor 1-alpha 1 (DB01593; DB04315; DB09130; DB11638; DB14487; DB14533; DB14548)
drugbank_target|Q00080	-	443	sp|Q7KQL3|ARF1_PLA	-	181	1.3e-23	81.5	0.6	1	2	0.066	5.6	4.6	0.2	14	36	4	26	2	48	0.77	Elongation factor 1-alpha (DB11638)
drugbank_target|Q00080	-	443	sp|Q7KQL3|ARF1_PLA	-	181	1.3e-23	81.5	0.6	2	2	1.4e-23	1.2e-21	75.2	0.0	27	168	48	201	45	206	0.84	Elongation factor 1-alpha (DB11638)
drugbank_target|P20964	-	428	sp|Q7KQL3|ARF1_PLA	-	181	4.1e-23	79.9	0.0	1	1	7.7e-25	6.6e-23	79.3	0.0	22	179	163	330	153	331	0.89	GTPase Obg (DB04022)
drugbank_target|Q83JC4	-	394	sp|Q7KQL3|ARF1_PLA	-	181	2.4e-19	67.6	0.0	1	1	8.3e-21	7.1e-19	66.1	0.0	22	153	17	163	5	181	0.81	Elongation factor Tu (DB02975; DB04315)
drugbank_target|Q01698	-	406	sp|Q7KQL3|ARF1_PLA	-	181	3.2e-19	67.2	0.0	1	1	1.6e-20	1.4e-18	65.2	0.0	22	149	17	160	6	183	0.81	Elongation factor Tu (DB04315; DB08185)
drugbank_target|P60339	-	406	sp|Q7KQL3|ARF1_PLA	-	181	5.1e-19	66.6	0.0	1	1	2.8e-20	2.4e-18	64.4	0.0	23	149	18	160	6	179	0.78	Elongation factor Tu-B (DB04124; DB04315)
drugbank_target|Q9X242	-	295	sp|Q7KQL3|ARF1_PLA	-	181	2.8e-18	64.2	1.0	1	2	1.6e-17	1.4e-15	55.4	0.1	77	178	71	166	66	169	0.90	Putative ribosome biogenesis GTPase RsgA (DB04315)
drugbank_target|Q9X242	-	295	sp|Q7KQL3|ARF1_PLA	-	181	2.8e-18	64.2	1.0	2	2	0.0084	0.71	7.5	0.1	22	40	168	186	167	234	0.59	Putative ribosome biogenesis GTPase RsgA (DB04315)
drugbank_target|Q96RE1	-	398	sp|Q7KQL3|ARF1_PLA	-	181	2.1e-17	61.3	0.0	1	1	3.7e-19	3.1e-17	60.8	0.0	44	147	4	109	1	144	0.86	Translation elongation factor 1 alpha 1-like 14 (DB09130)
drugbank_target|P13551	-	691	sp|Q7KQL3|ARF1_PLA	-	181	2.3e-16	58.0	0.0	1	2	9.6e-18	8.2e-16	56.2	0.1	43	133	59	144	50	160	0.89	Elongation factor G (DB02703; DB04315)
drugbank_target|P13551	-	691	sp|Q7KQL3|ARF1_PLA	-	181	2.3e-16	58.0	0.0	2	2	8.8	7.5e+02	-2.4	0.0	143	177	246	280	235	281	0.73	Elongation factor G (DB02703; DB04315)
drugbank_target|P49411	-	452	sp|Q7KQL3|ARF1_PLA	-	181	6.6e-14	50.0	0.0	1	1	2.1e-15	1.8e-13	48.5	0.0	22	140	62	195	50	222	0.82	Elongation factor Tu, mitochondrial (DB01593; DB04315; DB14487; DB14533; DB14548)
drugbank_target|Q7Z2Z2	-	1120	sp|Q7KQL3|ARF1_PLA	-	181	7.8e-13	46.4	0.4	1	2	2e-13	1.7e-11	42.1	0.0	58	130	83	150	53	169	0.83	Elongation factor Tu GTP-binding domain-containing protein 1 (DB02750; DB03619; DB04315)
drugbank_target|Q7Z2Z2	-	1120	sp|Q7KQL3|ARF1_PLA	-	181	7.8e-13	46.4	0.4	2	2	0.62	52	1.4	0.1	5	46	264	306	261	322	0.81	Elongation factor Tu GTP-binding domain-containing protein 1 (DB02750; DB03619; DB04315)
drugbank_target|P13639	-	858	sp|Q7KQL3|ARF1_PLA	-	181	2.6e-11	41.5	0.0	1	1	7.2e-13	6.1e-11	40.3	0.0	51	131	88	163	71	190	0.85	Elongation factor 2 (DB02059; DB03223; DB04315; DB08348; DB11823; DB12688)
drugbank_target|P41091	-	472	sp|Q7KQL3|ARF1_PLA	-	181	1.9e-10	38.7	0.0	1	2	0.86	73	0.9	0.1	15	39	39	63	31	91	0.75	Eukaryotic translation initiation factor 2 subunit 3 (DB04315)
drugbank_target|P41091	-	472	sp|Q7KQL3|ARF1_PLA	-	181	1.9e-10	38.7	0.0	2	2	2.5e-11	2.1e-09	35.3	0.0	61	177	128	243	109	245	0.86	Eukaryotic translation initiation factor 2 subunit 3 (DB04315)
drugbank_target|Q8IKW5	-	832	sp|Q7KQL3|ARF1_PLA	-	181	2.1e-08	32.0	0.1	1	1	8.2e-10	7e-08	30.3	0.1	59	131	90	157	7	187	0.81	Elongation factor 2 (DB11638)
drugbank_target|P38424	-	195	sp|Q7KQL3|ARF1_PLA	-	181	2.1e-06	25.5	0.0	1	1	3e-08	2.5e-06	25.2	0.0	20	143	26	159	24	195	0.65	Probable GTP-binding protein EngB (DB04137; DB04315)
drugbank_target|Q9RA63	-	854	sp|Q7KQL3|ARF1_PLA	-	181	0.00076	17.2	0.0	1	2	0.0025	0.21	9.2	0.0	7	39	181	213	177	223	0.82	Chaperone protein ClpB (DB04395)
drugbank_target|Q9RA63	-	854	sp|Q7KQL3|ARF1_PLA	-	181	0.00076	17.2	0.0	2	2	0.037	3.2	5.4	0.0	21	55	592	626	590	636	0.83	Chaperone protein ClpB (DB04395)
drugbank_target|P13568	-	1419	sp|Q7KQL3|ARF1_PLA	-	181	0.0019	15.8	0.0	1	2	0.012	1	6.9	0.0	17	36	405	425	393	453	0.77	Multidrug resistance protein (DB11638)
drugbank_target|P13568	-	1419	sp|Q7KQL3|ARF1_PLA	-	181	0.0019	15.8	0.0	2	2	0.027	2.3	5.8	0.0	19	37	1156	1174	1142	1198	0.81	Multidrug resistance protein (DB11638)
drugbank_target|Q16774	-	197	sp|Q7KQL3|ARF1_PLA	-	181	0.0021	15.7	0.0	1	1	5.3e-05	0.0045	14.6	0.0	20	41	7	28	5	55	0.89	Guanylate kinase (DB01972)
drugbank_target|P33527	-	1531	sp|Q7KQL3|ARF1_PLA	-	181	0.0045	14.6	1.8	1	3	0.033	2.8	5.5	0.1	20	39	674	693	669	708	0.85	Multidrug resistance-associated protein 1 (DB00171; DB01138; DB04851; DB06176; DB08855)
drugbank_target|P33527	-	1531	sp|Q7KQL3|ARF1_PLA	-	181	0.0045	14.6	1.8	2	3	6	5.1e+02	-1.8	0.0	69	90	770	791	769	791	0.94	Multidrug resistance-associated protein 1 (DB00171; DB01138; DB04851; DB06176; DB08855)
drugbank_target|P33527	-	1531	sp|Q7KQL3|ARF1_PLA	-	181	0.0045	14.6	1.8	3	3	0.013	1.1	6.8	0.1	19	65	1322	1370	1314	1373	0.78	Multidrug resistance-associated protein 1 (DB00171; DB01138; DB04851; DB06176; DB08855)
drugbank_target|O15439	-	1325	sp|Q7KQL3|ARF1_PLA	-	181	0.0046	14.6	0.5	1	2	0.15	13	3.4	0.1	20	38	441	459	438	468	0.88	Multidrug resistance-associated protein 4 (DB00171)
drugbank_target|O15439	-	1325	sp|Q7KQL3|ARF1_PLA	-	181	0.0046	14.6	0.5	2	2	0.0039	0.33	8.6	0.1	15	37	1066	1088	1054	1112	0.82	Multidrug resistance-associated protein 4 (DB00171)
drugbank_target|Q96MA6	-	479	sp|Q7KQL3|ARF1_PLA	-	181	0.0091	13.6	0.0	1	2	0.0012	0.1	10.2	0.0	18	35	58	75	46	99	0.83	Adenylate kinase 8 (DB01717)
drugbank_target|Q96MA6	-	479	sp|Q7KQL3|ARF1_PLA	-	181	0.0091	13.6	0.0	2	2	1	87	0.7	0.0	19	31	270	282	264	291	0.90	Adenylate kinase 8 (DB01717)
drugbank_target|P13569	-	1480	sp|Q7KQL3|ARF1_PLA	-	181	0.019	12.6	1.6	1	2	0.19	16	3.1	0.1	20	38	454	472	440	481	0.83	Cystic fibrosis transmembrane conductance regulator (DB00171; DB00887; DB01016; DB01050; DB02587; DB04395; DB04522; DB04941; DB06266; DB08820; DB09213; DB09280; DB11712; DB15444)
drugbank_target|P13569	-	1480	sp|Q7KQL3|ARF1_PLA	-	181	0.019	12.6	1.6	2	2	0.011	0.95	7.1	0.2	19	38	1239	1258	1234	1270	0.89	Cystic fibrosis transmembrane conductance regulator (DB00171; DB00887; DB01016; DB01050; DB02587; DB04395; DB04522; DB04941; DB06266; DB08820; DB09213; DB09280; DB11712; DB15444)
drugbank_target|P08183	-	1280	sp|Q7KQL3|ARF1_PLA	-	181	0.021	12.5	1.4	1	2	0.036	3.1	5.4	0.1	16	35	419	438	407	464	0.77	Multidrug resistance protein 1 (DB00171; DB00603; DB00778; DB00813; DB04877; DB04881; DB04905; DB05449; DB06191; DB06240; DB09031; DB11635; DB14061; DB14062; DB14063; DB14064; DB14065; DB14066; DB14067; DB14068; DB14069; DB14070; DB14071; DB14072)
drugbank_target|P08183	-	1280	sp|Q7KQL3|ARF1_PLA	-	181	0.021	12.5	1.4	2	2	0.04	3.4	5.3	0.1	16	35	1062	1081	1054	1087	0.81	Multidrug resistance protein 1 (DB00171; DB00603; DB00778; DB00813; DB04877; DB04881; DB04905; DB05449; DB06191; DB06240; DB09031; DB11635; DB14061; DB14062; DB14063; DB14064; DB14065; DB14066; DB14067; DB14068; DB14069; DB14070; DB14071; DB14072)
drugbank_target|P08690	-	583	sp|Q7KQL3|ARF1_PLA	-	181	0.026	12.2	0.2	1	2	0.65	55	1.3	0.0	22	34	13	25	6	37	0.88	Arsenical pump-driving ATPase (DB02453; DB04395; DB04456)
drugbank_target|P08690	-	583	sp|Q7KQL3|ARF1_PLA	-	181	0.026	12.2	0.2	2	2	0.0053	0.45	8.1	0.0	8	35	318	345	314	358	0.80	Arsenical pump-driving ATPase (DB02453; DB04395; DB04456)
drugbank_target|Q9HC29	-	1040	sp|Q7KQL3|ARF1_PLA	-	181	0.053	11.1	0.0	1	1	0.0015	0.13	9.9	0.0	20	37	295	312	287	317	0.90	Nucleotide-binding oligomerization domain-containing protein 2 (DB13615)
drugbank_target|O95255	-	1503	sp|Q7KQL3|ARF1_PLA	-	181	0.06	11.0	0.9	1	2	0.067	5.7	4.5	0.1	20	38	659	677	649	691	0.85	Multidrug resistance-associated protein 6 (DB00171)
drugbank_target|O95255	-	1503	sp|Q7KQL3|ARF1_PLA	-	181	0.06	11.0	0.9	2	2	0.079	6.7	4.3	0.1	19	35	1294	1310	1285	1318	0.83	Multidrug resistance-associated protein 6 (DB00171)
drugbank_target|P23528	-	166	sp|Q8ID92|CADF2_PL	-	143	1e-39	134.0	4.1	1	1	1.5e-42	3.9e-39	132.1	4.1	1	135	1	146	1	151	0.81	Cofilin-1 (DB04147; DB09130; DB11638)
drugbank_target|P60981	-	165	sp|Q8ID92|CADF2_PL	-	143	1.1e-34	117.7	1.4	1	1	1.1e-37	2.9e-34	116.3	1.4	1	133	1	144	1	150	0.78	Destrin (DB04147)
drugbank_target|O75762	-	1119	sp|C6KTB7|ALTH1_PL	-	10287	8.4e-35	115.5	3.9	1	5	1.9e-14	4.8e-12	39.9	0.3	7778	7922	62	198	47	203	0.84	Transient receptor potential cation channel subfamily A member 1 (DB00825; DB01744; DB09061; DB11148; DB11345; DB11755; DB14009; DB14011; DB14050)
drugbank_target|O75762	-	1119	sp|C6KTB7|ALTH1_PL	-	10287	8.4e-35	115.5	3.9	2	5	1.3e-09	3.3e-07	23.8	0.0	7804	7888	233	317	223	326	0.87	Transient receptor potential cation channel subfamily A member 1 (DB00825; DB01744; DB09061; DB11148; DB11345; DB11755; DB14009; DB14011; DB14050)
drugbank_target|O75762	-	1119	sp|C6KTB7|ALTH1_PL	-	10287	8.4e-35	115.5	3.9	3	5	0.001	0.25	4.3	0.0	7809	7889	308	384	301	403	0.81	Transient receptor potential cation channel subfamily A member 1 (DB00825; DB01744; DB09061; DB11148; DB11345; DB11755; DB14009; DB14011; DB14050)
drugbank_target|O75762	-	1119	sp|C6KTB7|ALTH1_PL	-	10287	8.4e-35	115.5	3.9	4	5	1.4e-06	0.00035	13.8	0.0	7794	7868	397	468	377	474	0.87	Transient receptor potential cation channel subfamily A member 1 (DB00825; DB01744; DB09061; DB11148; DB11345; DB11755; DB14009; DB14011; DB14050)
drugbank_target|O75762	-	1119	sp|C6KTB7|ALTH1_PL	-	10287	8.4e-35	115.5	3.9	5	5	8.7e-13	2.2e-10	34.4	0.1	7804	7922	476	580	467	599	0.86	Transient receptor potential cation channel subfamily A member 1 (DB00825; DB01744; DB09061; DB11148; DB11345; DB11755; DB14009; DB14011; DB14050)
drugbank_target|P57078	-	832	sp|C6KTB7|ALTH1_PL	-	10287	1.2e-28	95.0	0.1	1	4	3.1e-10	7.9e-08	25.9	0.0	7807	7892	483	564	462	569	0.84	Receptor-interacting serine/threonine-protein kinase 4 (DB12010)
drugbank_target|P57078	-	832	sp|C6KTB7|ALTH1_PL	-	10287	1.2e-28	95.0	0.1	2	4	5.3e-16	1.3e-13	45.1	0.0	7785	7887	557	659	556	680	0.93	Receptor-interacting serine/threonine-protein kinase 4 (DB12010)
drugbank_target|P57078	-	832	sp|C6KTB7|ALTH1_PL	-	10287	1.2e-28	95.0	0.1	3	4	1.2e-05	0.003	10.7	0.0	7809	7867	651	706	647	713	0.89	Receptor-interacting serine/threonine-protein kinase 4 (DB12010)
drugbank_target|P57078	-	832	sp|C6KTB7|ALTH1_PL	-	10287	1.2e-28	95.0	0.1	4	4	8.5e-10	2.1e-07	24.5	0.2	7802	7916	710	810	690	818	0.79	Receptor-interacting serine/threonine-protein kinase 4 (DB12010)
drugbank_target|Q8NFD2	-	765	sp|C6KTB7|ALTH1_PL	-	10287	5.1e-28	93.0	0.0	1	4	1.5e-08	3.7e-06	20.3	0.0	7804	7891	356	439	323	445	0.84	Ankyrin repeat and protein kinase domain-containing protein 1 (DB12010)
drugbank_target|Q8NFD2	-	765	sp|C6KTB7|ALTH1_PL	-	10287	5.1e-28	93.0	0.0	2	4	6e-14	1.5e-11	38.3	0.0	7785	7889	433	536	432	552	0.88	Ankyrin repeat and protein kinase domain-containing protein 1 (DB12010)
drugbank_target|Q8NFD2	-	765	sp|C6KTB7|ALTH1_PL	-	10287	5.1e-28	93.0	0.0	3	4	1.3e-06	0.00033	13.9	0.0	7804	7888	554	634	536	651	0.76	Ankyrin repeat and protein kinase domain-containing protein 1 (DB12010)
drugbank_target|Q8NFD2	-	765	sp|C6KTB7|ALTH1_PL	-	10287	5.1e-28	93.0	0.0	4	4	1.3e-08	3.3e-06	20.5	0.0	7803	7889	652	734	636	745	0.89	Ankyrin repeat and protein kinase domain-containing protein 1 (DB12010)
drugbank_target|P53355	-	1430	sp|C6KTB7|ALTH1_PL	-	10287	3.8e-22	73.4	0.0	1	3	4e-08	1e-05	18.9	0.0	7771	7887	330	452	280	462	0.78	Death-associated protein kinase 1 (DB04069; DB04395; DB07444; DB12010)
drugbank_target|P53355	-	1430	sp|C6KTB7|ALTH1_PL	-	10287	3.8e-22	73.4	0.0	2	3	2.5e-11	6.2e-09	29.6	0.0	7801	7890	469	554	453	563	0.90	Death-associated protein kinase 1 (DB04069; DB04395; DB07444; DB12010)
drugbank_target|P53355	-	1430	sp|C6KTB7|ALTH1_PL	-	10287	3.8e-22	73.4	0.0	3	3	5.9e-09	1.5e-06	21.7	0.0	7804	7883	571	646	555	657	0.87	Death-associated protein kinase 1 (DB04069; DB04395; DB07444; DB12010)
drugbank_target|Q59H18	-	835	sp|C6KTB7|ALTH1_PL	-	10287	2.5e-20	67.4	0.0	1	3	1.9e-08	4.8e-06	20.0	0.0	7793	7885	115	205	93	205	0.83	Serine/threonine-protein kinase TNNI3K (DB12010)
drugbank_target|Q59H18	-	835	sp|C6KTB7|ALTH1_PL	-	10287	2.5e-20	67.4	0.0	2	3	8e-07	0.0002	14.6	0.0	7808	7869	198	258	193	271	0.86	Serine/threonine-protein kinase TNNI3K (DB12010)
drugbank_target|Q59H18	-	835	sp|C6KTB7|ALTH1_PL	-	10287	2.5e-20	67.4	0.0	3	3	8.4e-13	2.1e-10	34.4	0.0	7806	7917	266	368	259	373	0.90	Serine/threonine-protein kinase TNNI3K (DB12010)
drugbank_target|O60733	-	806	sp|C6KTB7|ALTH1_PL	-	10287	2.4e-15	50.9	0.0	1	3	1.7e-09	4.3e-07	23.5	0.0	7796	7879	138	219	121	220	0.90	85/88 kDa calcium-independent phospholipase A2 (DB01103)
drugbank_target|O60733	-	806	sp|C6KTB7|ALTH1_PL	-	10287	2.4e-15	50.9	0.0	2	3	2e-07	5e-05	16.6	0.0	7804	7887	214	294	208	306	0.84	85/88 kDa calcium-independent phospholipase A2 (DB01103)
drugbank_target|O60733	-	806	sp|C6KTB7|ALTH1_PL	-	10287	2.4e-15	50.9	0.0	3	3	1.7e-05	0.0043	10.2	0.0	7803	7883	310	386	294	424	0.82	85/88 kDa calcium-independent phospholipase A2 (DB01103)
drugbank_target|Q00653	-	900	sp|C6KTB7|ALTH1_PL	-	10287	8.2e-15	49.1	0.0	1	2	3.9e-09	9.8e-07	22.3	0.0	7804	7889	482	569	465	578	0.86	Nuclear factor NF-kappa-B p100 subunit (DB01296; DB05212; DB05451; DB05464; DB05471; DB05487; DB05767)
drugbank_target|Q00653	-	900	sp|C6KTB7|ALTH1_PL	-	10287	8.2e-15	49.1	0.0	2	2	6.5e-10	1.6e-07	24.9	0.0	7806	7916	596	695	583	703	0.82	Nuclear factor NF-kappa-B p100 subunit (DB01296; DB05212; DB05451; DB05464; DB05471; DB05487; DB05767)
drugbank_target|Q00653	-	900	sp|C6KTB7|ALTH1_PL	-	10287	8.2e-15	49.1	0.0	1	2	3.9e-09	9.8e-07	22.3	0.0	7804	7889	482	569	465	578	0.86	Nuclear factor NF-kappa-B p100 subunit (DB00843; DB05559; DB13751; DB13961)
drugbank_target|Q00653	-	900	sp|C6KTB7|ALTH1_PL	-	10287	8.2e-15	49.1	0.0	2	2	6.5e-10	1.6e-07	24.9	0.0	7806	7916	596	695	583	703	0.82	Nuclear factor NF-kappa-B p100 subunit (DB00843; DB05559; DB13751; DB13961)
drugbank_target|Q00653	-	900	sp|C6KTB7|ALTH1_PL	-	10287	8.2e-15	49.1	0.0	1	2	3.9e-09	9.8e-07	22.3	0.0	7804	7889	482	569	465	578	0.86	Nuclear factor NF-kappa-B p100 subunit (DB14059)
drugbank_target|Q00653	-	900	sp|C6KTB7|ALTH1_PL	-	10287	8.2e-15	49.1	0.0	2	2	6.5e-10	1.6e-07	24.9	0.0	7806	7916	596	695	583	703	0.82	Nuclear factor NF-kappa-B p100 subunit (DB14059)
drugbank_target|Q8NER1	-	839	sp|C6KTB7|ALTH1_PL	-	10287	2.7e-13	44.0	0.0	1	1	1.5e-15	3.7e-13	43.6	0.0	7791	7916	183	321	177	341	0.85	Transient receptor potential cation channel subfamily V member 1 (DB00132; DB00159; DB00168; DB00193; DB00316; DB01744; DB02955; DB06515; DB06774; DB09061; DB09120; DB09288; DB11131; DB11324; DB11345; DB14009; DB14011; DB14050)
drugbank_target|P25963	-	317	sp|C6KTB7|ALTH1_PL	-	10287	1.2e-10	35.3	0.0	1	2	0.0021	0.53	3.2	0.0	7803	7869	67	133	35	145	0.83	NF-kappa-B inhibitor alpha (DB00945; DB05983; DB06543)
drugbank_target|P25963	-	317	sp|C6KTB7|ALTH1_PL	-	10287	1.2e-10	35.3	0.0	2	2	1e-11	2.5e-09	30.9	0.0	7806	7922	140	250	134	258	0.83	NF-kappa-B inhibitor alpha (DB00945; DB05983; DB06543)
drugbank_target|Q9Y5S1	-	764	sp|C6KTB7|ALTH1_PL	-	10287	5.2e-10	33.1	0.0	1	1	2.8e-12	7e-10	32.7	0.0	7794	7941	147	309	134	317	0.84	Transient receptor potential cation channel subfamily V member 2 (DB09061; DB11755; DB14009; DB14011; DB14050)
drugbank_target|Q9HBA0	-	871	sp|C6KTB7|ALTH1_PL	-	10287	9.7e-10	32.2	0.0	1	1	5.3e-12	1.3e-09	31.8	0.0	7796	7915	224	356	212	404	0.86	Transient receptor potential cation channel subfamily V member 4 (DB09061; DB11148; DB14009; DB14011)
drugbank_target|Q8NET8	-	790	sp|C6KTB7|ALTH1_PL	-	10287	6.2e-09	29.6	0.0	1	1	3.4e-11	8.5e-09	29.1	0.0	7774	7927	179	346	171	371	0.80	Transient receptor potential cation channel subfamily V member 3 (DB00825; DB01744; DB09061; DB09086; DB11345; DB14009; DB14011)
drugbank_target|P19838	-	968	sp|C6KTB7|ALTH1_PL	-	10287	9.2e-09	29.0	0.0	1	2	2.2e-09	5.4e-07	23.1	0.1	7793	7890	564	661	524	664	0.84	Nuclear factor NF-kappa-B p105 subunit (DB00852; DB01041; DB01411; DB05212; DB05451; DB05464; DB05471; DB05487; DB05767; DB08814)
drugbank_target|P19838	-	968	sp|C6KTB7|ALTH1_PL	-	10287	9.2e-09	29.0	0.0	2	2	0.0034	0.85	2.5	0.0	7803	7865	678	738	669	750	0.81	Nuclear factor NF-kappa-B p105 subunit (DB00852; DB01041; DB01411; DB05212; DB05451; DB05464; DB05471; DB05487; DB05767; DB08814)
drugbank_target|P19838	-	968	sp|C6KTB7|ALTH1_PL	-	10287	9.2e-09	29.0	0.0	1	2	2.2e-09	5.4e-07	23.1	0.1	7793	7890	564	661	524	664	0.84	Nuclear factor NF-kappa-B p105 subunit (DB00843; DB05559; DB13751; DB13961)
drugbank_target|P19838	-	968	sp|C6KTB7|ALTH1_PL	-	10287	9.2e-09	29.0	0.0	2	2	0.0034	0.85	2.5	0.0	7803	7865	678	738	669	750	0.81	Nuclear factor NF-kappa-B p105 subunit (DB00843; DB05559; DB13751; DB13961)
drugbank_target|P19838	-	968	sp|C6KTB7|ALTH1_PL	-	10287	9.2e-09	29.0	0.0	1	2	2.2e-09	5.4e-07	23.1	0.1	7793	7890	564	661	524	664	0.84	Nuclear factor NF-kappa-B p105 subunit (DB14059)
drugbank_target|P19838	-	968	sp|C6KTB7|ALTH1_PL	-	10287	9.2e-09	29.0	0.0	2	2	0.0034	0.85	2.5	0.0	7803	7865	678	738	669	750	0.81	Nuclear factor NF-kappa-B p105 subunit (DB14059)
drugbank_target|Q9UI32	-	602	sp|C6KTB7|ALTH1_PL	-	10287	1.2e-06	22.0	0.0	1	1	5.8e-09	1.4e-06	21.7	0.0	7798	7880	506	586	467	600	0.77	Glutaminase liver isoform, mitochondrial (DB00142)
drugbank_target|O94925	-	669	sp|C6KTB7|ALTH1_PL	-	10287	1.4e-06	21.8	0.0	1	1	6.9e-09	1.7e-06	21.5	0.0	7799	7887	574	664	551	668	0.80	Glutaminase kidney isoform, mitochondrial (DB00142)
drugbank_target|O75912	-	1065	sp|C6KTB7|ALTH1_PL	-	10287	2.9e-05	17.4	0.0	1	1	1.5e-07	3.8e-05	17.0	0.0	7807	7884	956	1032	920	1040	0.85	Diacylglycerol kinase iota (DB14001)
drugbank_target|Q86U10	-	573	sp|C6KTB7|ALTH1_PL	-	10287	0.00049	13.3	0.0	1	1	2.6e-06	0.00065	12.9	0.0	7816	7886	407	473	385	481	0.84	60 kDa lysophospholipase (DB00721)
drugbank_target|Q01698	-	406	sp|Q25820|EFTU_PLA	-	410	1.1e-188	625.5	0.2	1	1	3.7e-191	1.2e-188	625.3	0.2	1	408	1	404	1	406	0.99	Elongation factor Tu (DB04315; DB08185)
drugbank_target|P60339	-	406	sp|Q25820|EFTU_PLA	-	410	7.4e-188	622.7	0.1	1	1	2.5e-190	8.3e-188	622.5	0.1	1	408	1	404	1	406	0.99	Elongation factor Tu-B (DB04124; DB04315)
drugbank_target|Q83JC4	-	394	sp|Q25820|EFTU_PLA	-	410	1.5e-175	582.2	0.0	1	1	5.6e-178	1.8e-175	581.9	0.0	1	408	1	392	1	393	0.99	Elongation factor Tu (DB02975; DB04315)
drugbank_target|P68104	-	462	sp|Q25820|EFTU_PLA	-	410	2.1e-166	552.0	0.0	1	1	7.5e-169	2.5e-166	551.8	0.0	6	408	1	441	1	443	0.97	Elongation factor 1-alpha 1 (DB01593; DB04315; DB09130; DB11638; DB14487; DB14533; DB14548)
drugbank_target|P49411	-	452	sp|Q25820|EFTU_PLA	-	410	6.9e-166	550.4	0.0	1	1	2.6e-168	8.4e-166	550.1	0.0	2	407	47	438	46	440	0.97	Elongation factor Tu, mitochondrial (DB01593; DB04315; DB14487; DB14533; DB14548)
drugbank_target|Q00080	-	443	sp|Q25820|EFTU_PLA	-	410	1.9e-161	535.7	0.6	1	1	6.6e-164	2.2e-161	535.5	0.6	6	409	1	428	1	429	0.96	Elongation factor 1-alpha (DB11638)
drugbank_target|Q96RE1	-	398	sp|Q25820|EFTU_PLA	-	410	1.2e-144	480.3	0.0	1	1	4.4e-147	1.4e-144	480.1	0.0	58	408	4	377	1	379	0.98	Translation elongation factor 1 alpha 1-like 14 (DB09130)
drugbank_target|P15170	-	499	sp|Q25820|EFTU_PLA	-	410	8.5e-142	471.0	0.0	1	1	3.5e-144	1.2e-141	470.6	0.0	9	408	71	494	69	495	0.95	Eukaryotic peptide chain release factor GTP-binding subunit ERF3A (DB04315)
drugbank_target|P41091	-	472	sp|Q25820|EFTU_PLA	-	410	2.1e-82	275.4	0.0	1	1	9.2e-85	3e-82	274.9	0.0	5	393	34	443	31	461	0.90	Eukaryotic translation initiation factor 2 subunit 3 (DB04315)
drugbank_target|Q8IKW5	-	832	sp|Q25820|EFTU_PLA	-	410	9.2e-52	174.5	4.1	1	2	6.2e-54	2.1e-51	173.3	2.1	3	172	10	183	8	198	0.92	Elongation factor 2 (DB11638)
drugbank_target|Q8IKW5	-	832	sp|Q25820|EFTU_PLA	-	410	9.2e-52	174.5	4.1	2	2	0.18	58	0.6	0.0	218	257	365	405	351	460	0.81	Elongation factor 2 (DB11638)
drugbank_target|P13639	-	858	sp|Q25820|EFTU_PLA	-	410	1.2e-50	170.8	0.4	1	2	1e-52	3.3e-50	169.3	0.4	5	156	12	184	9	196	0.90	Elongation factor 2 (DB02059; DB03223; DB04315; DB08348; DB11823; DB12688)
drugbank_target|P13639	-	858	sp|Q25820|EFTU_PLA	-	410	1.2e-50	170.8	0.4	2	2	1.5	4.8e+02	-2.5	0.0	220	257	393	431	389	446	0.80	Elongation factor 2 (DB02059; DB03223; DB04315; DB08348; DB11823; DB12688)
drugbank_target|Q7Z2Z2	-	1120	sp|Q25820|EFTU_PLA	-	410	2.5e-48	163.2	0.1	1	1	1.3e-50	4.2e-48	162.4	0.1	7	161	14	173	9	209	0.87	Elongation factor Tu GTP-binding domain-containing protein 1 (DB02750; DB03619; DB04315)
drugbank_target|P13551	-	691	sp|Q25820|EFTU_PLA	-	410	6.8e-47	158.4	0.5	1	1	3.5e-49	1.1e-46	157.7	0.5	10	141	10	142	1	156	0.94	Elongation factor G (DB02703; DB04315)
drugbank_target|Q9X1F8	-	439	sp|Q25820|EFTU_PLA	-	410	1.1e-22	78.6	0.4	1	3	2.7e-05	0.009	13.1	0.1	93	163	76	139	3	185	0.74	GTPase Der (DB04315)
drugbank_target|Q9X1F8	-	439	sp|Q25820|EFTU_PLA	-	410	1.1e-22	78.6	0.4	2	3	0.42	1.4e+02	-0.7	0.0	13	36	181	204	174	211	0.86	GTPase Der (DB04315)
drugbank_target|Q9X1F8	-	439	sp|Q25820|EFTU_PLA	-	410	1.1e-22	78.6	0.4	3	3	5e-20	1.6e-17	61.7	0.0	92	199	257	359	251	380	0.85	GTPase Der (DB04315)
drugbank_target|P20964	-	428	sp|Q25820|EFTU_PLA	-	410	0.0037	14.4	0.0	1	1	3e-05	0.0098	13.0	0.0	128	231	275	381	266	386	0.82	GTPase Obg (DB04022)
drugbank_target|Q9X242	-	295	sp|Q25820|EFTU_PLA	-	410	0.0047	14.0	0.1	1	1	2.1e-05	0.007	13.5	0.1	96	180	76	153	68	215	0.77	Putative ribosome biogenesis GTPase RsgA (DB04315)
drugbank_target|P55072	-	806	sp|P46468|CDAT_PLA	-	1229	0	1301.2	0.6	1	2	3.1e-245	5.5e-243	807.7	2.0	320	758	4	435	1	437	0.99	Transitional endoplasmic reticulum ATPase (DB04395; DB12695)
drugbank_target|P55072	-	806	sp|P46468|CDAT_PLA	-	1229	0	1301.2	0.6	2	2	5.5e-152	9.6e-150	498.9	0.0	885	1225	428	763	428	766	0.99	Transitional endoplasmic reticulum ATPase (DB04395; DB12695)
drugbank_target|C6KT34	-	828	sp|P46468|CDAT_PLA	-	1229	0	1275.5	1.6	1	2	3.2e-242	5.5e-240	797.8	4.6	333	758	20	438	2	439	0.98	Cell division cycle protein 48 homologue,putative (DB11638)
drugbank_target|C6KT34	-	828	sp|P46468|CDAT_PLA	-	1229	0	1275.5	1.6	2	2	5.6e-146	9.8e-144	479.0	0.0	888	1224	434	789	434	792	0.97	Cell division cycle protein 48 homologue,putative (DB11638)
drugbank_target|P17980	-	439	sp|P46468|CDAT_PLA	-	1229	6.6e-142	472.9	3.3	1	1	4.4e-144	7.8e-142	472.7	3.3	465	775	117	435	37	438	0.93	26S protease regulatory subunit 6A (DB12695)
drugbank_target|P46459	-	744	sp|P46468|CDAT_PLA	-	1229	5.5e-110	367.2	0.4	1	2	5.1e-88	8.9e-86	287.0	0.2	897	1169	177	468	167	492	0.93	Vesicle-fusing ATPase (DB01902)
drugbank_target|P46459	-	744	sp|P46468|CDAT_PLA	-	1229	5.5e-110	367.2	0.4	2	2	5.7e-25	1e-22	78.1	0.0	959	1086	527	654	517	663	0.91	Vesicle-fusing ATPase (DB01902)
drugbank_target|Q9Y4W6	-	797	sp|P46468|CDAT_PLA	-	1229	2.7e-81	272.1	0.0	1	1	2.1e-83	3.7e-81	271.7	0.0	929	1172	303	551	290	571	0.95	AFG3-like protein 2 (DB00171)
drugbank_target|Q56313	-	334	sp|P46468|CDAT_PLA	-	1229	3.7e-37	125.9	0.7	1	1	2.7e-39	4.7e-37	125.6	0.7	947	1136	30	214	22	239	0.96	Holliday junction ATP-dependent DNA helicase RuvB (DB02210)
drugbank_target|Q5SL87	-	324	sp|P46468|CDAT_PLA	-	1229	7.8e-32	108.3	0.0	1	1	5.9e-34	1e-31	107.9	0.0	947	1127	17	194	11	204	0.92	Holliday junction ATP-dependent DNA helicase RuvB (DB00173)
drugbank_target|P0A6H7	-	443	sp|P46468|CDAT_PLA	-	1229	2.8e-22	76.6	0.5	1	2	3.2e-19	5.6e-17	59.1	0.1	934	1025	15	109	4	118	0.91	ATP-dependent protease ATPase subunit HslU (DB04395)
drugbank_target|P0A6H7	-	443	sp|P46468|CDAT_PLA	-	1229	2.8e-22	76.6	0.5	2	2	3.8e-06	0.00067	15.8	0.0	1003	1067	220	289	178	309	0.70	ATP-dependent protease ATPase subunit HslU (DB04395)
drugbank_target|Q9RA63	-	854	sp|P46468|CDAT_PLA	-	1229	1.5e-19	67.6	0.0	1	2	3.1e-12	5.5e-10	35.9	0.0	965	1044	188	280	168	358	0.91	Chaperone protein ClpB (DB04395)
drugbank_target|Q9RA63	-	854	sp|P46468|CDAT_PLA	-	1229	1.5e-19	67.6	0.0	2	2	2.8e-10	4.8e-08	29.5	0.0	936	1038	560	671	543	679	0.78	Chaperone protein ClpB (DB04395)
drugbank_target|O25926	-	446	sp|P46468|CDAT_PLA	-	1229	2.1e-19	67.1	0.4	1	1	1.7e-21	3e-19	66.6	0.4	942	1063	116	244	90	249	0.80	ATP-dependent Clp protease ATP-binding subunit ClpX (DB09275)
drugbank_target|Q9Y230	-	463	sp|P46468|CDAT_PLA	-	1229	4.8e-15	52.7	2.1	1	2	5.7e-17	1e-14	51.6	0.9	560	615	69	125	63	129	0.94	RuvB-like 2 (DB04216)
drugbank_target|Q9Y230	-	463	sp|P46468|CDAT_PLA	-	1229	4.8e-15	52.7	2.1	2	2	0.31	55	-0.5	0.0	1006	1053	270	318	256	336	0.66	RuvB-like 2 (DB04216)
drugbank_target|Q94M05	-	331	sp|P46468|CDAT_PLA	-	1229	1.6e-14	51.0	0.0	1	1	1.2e-16	2.1e-14	50.6	0.0	969	1079	124	234	112	247	0.93	NTPase P4 (DB02596)
drugbank_target|Q96MA6	-	479	sp|P46468|CDAT_PLA	-	1229	5.7e-12	42.5	0.0	1	2	1.5e-06	0.00026	17.1	0.0	966	1014	55	103	29	130	0.79	Adenylate kinase 8 (DB01717)
drugbank_target|Q96MA6	-	479	sp|P46468|CDAT_PLA	-	1229	5.7e-12	42.5	0.0	2	2	1.9e-08	3.3e-06	23.4	0.0	950	1013	250	311	217	333	0.87	Adenylate kinase 8 (DB01717)
drugbank_target|P03302	-	2206	sp|P46468|CDAT_PLA	-	1229	5.9e-07	25.9	0.0	1	1	5.1e-09	8.9e-07	25.3	0.0	558	592	1243	1281	1222	1283	0.80	Genome polyprotein (DB03203; DB08012; DB08013; DB08014; DB08231; DB08726)
drugbank_target|P06210	-	2207	sp|P46468|CDAT_PLA	-	1229	6.2e-07	25.8	0.0	1	1	5.2e-09	9.1e-07	25.3	0.0	555	592	1241	1282	1223	1284	0.81	Genome polyprotein (DB08231)
drugbank_target|P03300	-	2209	sp|P46468|CDAT_PLA	-	1229	1.1e-06	25.0	0.0	1	1	9.2e-09	1.6e-06	24.4	0.0	558	592	1246	1284	1225	1286	0.80	Genome polyprotein (DB03203; DB03963; DB04137; DB08012; DB08013; DB08014; DB08231)
drugbank_target|P16384	-	316	sp|P46468|CDAT_PLA	-	1229	1.4e-06	24.7	0.0	1	1	9.8e-09	1.7e-06	24.4	0.0	965	1021	7	64	2	72	0.91	tRNA dimethylallyltransferase (DB02270)
drugbank_target|Q71LY2	-	2207	sp|P46468|CDAT_PLA	-	1229	5.6e-05	19.3	0.0	1	1	4.9e-07	8.6e-05	18.7	0.0	559	591	1245	1281	1225	1284	0.86	Genome polyprotein (DB08231)
drugbank_target|P22055	-	2206	sp|P46468|CDAT_PLA	-	1229	0.00032	16.8	0.0	1	1	2.8e-06	0.00049	16.2	0.0	559	591	1245	1281	1229	1284	0.87	Genome polyprotein (DB08231)
drugbank_target|P03303	-	2179	sp|P46468|CDAT_PLA	-	1229	0.00058	16.0	0.0	1	1	4.9e-06	0.00087	15.4	0.0	553	591	1214	1256	1198	1259	0.75	Genome polyprotein (DB03203; DB05102; DB08017; DB08509; DB08540; DB08543; DB08719; DB08720; DB08721; DB08722; DB08723; DB08724; DB08725; DB08726; DB08727; DB08728)
drugbank_target|P58758	-	243	sp|P46468|CDAT_PLA	-	1229	0.00071	15.7	0.0	1	1	5.3e-06	0.00093	15.3	0.0	972	1005	5	38	3	59	0.83	Adenylate dimethylallyltransferase (DB02270)
drugbank_target|Q8V397	-	2178	sp|P46468|CDAT_PLA	-	1229	0.00076	15.6	0.0	1	1	6.3e-06	0.0011	15.1	0.0	553	591	1209	1251	1198	1254	0.84	Genome polyprotein (DB05105)
drugbank_target|P23008	-	2157	sp|P46468|CDAT_PLA	-	1229	0.0028	13.7	0.0	1	1	2.4e-05	0.0041	13.2	0.0	559	588	1209	1242	1194	1245	0.88	Genome polyprotein (DB03017; DB08017; DB08231; DB08723; DB08728)
drugbank_target|Q82122	-	2153	sp|P46468|CDAT_PLA	-	1229	0.0032	13.5	0.0	1	1	2.6e-05	0.0045	13.0	0.0	559	588	1205	1238	1189	1241	0.87	Genome polyprotein (DB03017; DB08231; DB08713; DB08714; DB08715)
drugbank_target|P08690	-	583	sp|P46468|CDAT_PLA	-	1229	0.0049	12.9	0.1	1	2	0.19	33	0.3	0.0	963	992	3	32	1	57	0.77	Arsenical pump-driving ATPase (DB02453; DB04395; DB04456)
drugbank_target|P08690	-	583	sp|P46468|CDAT_PLA	-	1229	0.0049	12.9	0.1	2	2	0.00017	0.03	10.3	0.0	962	993	321	352	312	376	0.82	Arsenical pump-driving ATPase (DB02453; DB04395; DB04456)
drugbank_target|P29813	-	2195	sp|P46468|CDAT_PLA	-	1229	0.0094	12.0	0.0	1	1	7.9e-05	0.014	11.4	0.0	559	592	1230	1267	1216	1270	0.87	Genome polyprotein (DB08231)
drugbank_target|P13900	-	2185	sp|P46468|CDAT_PLA	-	1229	0.011	11.8	0.0	1	1	9.9e-05	0.017	11.1	0.0	559	591	1220	1256	1205	1259	0.87	Genome polyprotein (DB03203; DB08231)
drugbank_target|P21404	-	2201	sp|P46468|CDAT_PLA	-	1229	0.011	11.7	0.0	1	1	0.0001	0.018	11.1	0.0	559	591	1236	1272	1222	1275	0.87	Genome polyprotein (DB08231; DB08726)
drugbank_target|Q66282	-	2185	sp|P46468|CDAT_PLA	-	1229	0.011	11.7	0.0	1	1	0.0001	0.018	11.1	0.0	559	591	1220	1256	1206	1259	0.87	Genome polyprotein (DB08231)
drugbank_target|O91734	-	2184	sp|P46468|CDAT_PLA	-	1229	0.012	11.7	0.0	1	1	0.0001	0.018	11.1	0.0	559	591	1219	1255	1205	1258	0.87	Genome polyprotein (DB08231)
drugbank_target|Q9NRF9	-	147	sp|Q8I5D2|ABRA_PLA	-	743	1.6e-23	80.8	18.3	1	1	9.7e-27	1.7e-23	80.8	18.3	626	732	53	145	15	147	0.83	DNA polymerase epsilon subunit 3 (DB00242)
drugbank_target|P27797	-	417	sp|Q8I5D2|ABRA_PLA	-	743	2.7e-11	40.4	41.5	1	2	3	5.3e+03	-9.8	6.1	696	717	220	241	203	262	0.35	Calreticulin (DB00025; DB00031; DB01065; DB06245; DB09130; DB11093; DB11348; DB13998; DB13999; DB14481)
drugbank_target|P27797	-	417	sp|Q8I5D2|ABRA_PLA	-	743	2.7e-11	40.4	41.5	2	2	1.6e-14	2.7e-11	40.4	41.5	668	732	345	409	329	415	0.91	Calreticulin (DB00025; DB00031; DB01065; DB06245; DB09130; DB11093; DB11348; DB13998; DB13999; DB14481)
drugbank_target|Q9Y2I1	-	1504	sp|Q8I5D2|ABRA_PLA	-	743	8	2.5	21.8	1	1	0.007	12	1.9	21.8	651	731	603	687	595	698	0.58	Nischarin (DB00697; DB08838; DB09242)
drugbank_target|P14223	-	369	sp|Q7KQL9|ALF_PLAF	-	369	6.6e-228	753.8	0.4	1	1	4.2e-231	7.4e-228	753.6	0.4	1	369	1	369	1	369	1.00	Fructose-bisphosphate aldolase (DB11638)
drugbank_target|P04075	-	364	sp|Q7KQL9|ALF_PLAF	-	369	2.9e-208	689.2	0.0	1	1	2e-211	3.5e-208	688.9	0.0	14	369	8	364	3	364	0.99	Fructose-bisphosphate aldolase A (DB01593; DB02512; DB04326; DB04733; DB08240; DB11638; DB14487; DB14533; DB14548)
drugbank_target|P05062	-	364	sp|Q7KQL9|ALF_PLAF	-	369	7.3e-208	687.9	0.7	1	1	4.9e-211	8.6e-208	687.6	0.7	14	369	8	364	2	364	0.99	Fructose-bisphosphate aldolase B (DB02512; DB02515; DB04326)
dgbank_trgt|A0A144A2G5	-	700	sp|Q8IIJ9|CATC_PLA	-	700	0	1571.5	31.9	1	1	0	0	1571.3	31.9	1	700	1	700	1	700	1.00	Dipeptidyl aminopeptidase 1 (DB11638)
drugbank_target|P07858	-	339	sp|Q8IIJ9|CATC_PLA	-	700	7.9e-92	307.0	7.9	1	2	1.9e-55	9.8e-53	177.8	0.0	318	493	20	195	5	197	0.95	Cathepsin B (DB02108; DB02148; DB02685; DB02855; DB03329; DB03588; DB04126; DB04579; DB07160; DB07219; DB07223; DB07224; DB07225; DB07231)
drugbank_target|P07858	-	339	sp|Q8IIJ9|CATC_PLA	-	700	7.9e-92	307.0	7.9	2	2	3.1e-40	1.6e-37	127.5	7.1	542	676	218	326	209	334	0.95	Cathepsin B (DB02108; DB02148; DB02685; DB02855; DB03329; DB03588; DB04126; DB04579; DB07160; DB07219; DB07223; DB07224; DB07225; DB07231)
drugbank_target|O60911	-	334	sp|Q8IIJ9|CATC_PLA	-	700	1.6e-69	233.3	8.0	1	2	1e-37	5.4e-35	119.2	0.6	367	486	111	219	76	229	0.85	Cathepsin L2 (DB02869; DB04451)
drugbank_target|O60911	-	334	sp|Q8IIJ9|CATC_PLA	-	700	1.6e-69	233.3	8.0	2	2	1.9e-37	9.7e-35	118.3	1.8	558	675	229	329	217	333	0.93	Cathepsin L2 (DB02869; DB04451)
drugbank_target|P07711	-	333	sp|Q8IIJ9|CATC_PLA	-	700	5.1e-69	231.6	7.1	1	2	3.3e-37	1.8e-34	117.5	0.9	374	487	114	220	57	228	0.80	Cathepsin L1 (DB03661; DB07477; DB12010)
drugbank_target|P07711	-	333	sp|Q8IIJ9|CATC_PLA	-	700	5.1e-69	231.6	7.1	2	2	2.3e-37	1.2e-34	118.0	0.8	558	675	228	328	217	331	0.94	Cathepsin L1 (DB03661; DB07477; DB12010)
drugbank_target|P09668	-	335	sp|Q8IIJ9|CATC_PLA	-	700	2.3e-65	219.6	6.6	1	2	2.7e-34	1.4e-31	107.9	0.8	374	495	116	231	60	234	0.83	Pro-cathepsin H (DB02140; DB03120; DB04126; DB08526)
drugbank_target|P09668	-	335	sp|Q8IIJ9|CATC_PLA	-	700	2.3e-65	219.6	6.6	2	2	1.6e-36	8.5e-34	115.2	0.7	561	673	235	326	228	333	0.94	Pro-cathepsin H (DB02140; DB03120; DB04126; DB08526)
drugbank_target|P43235	-	329	sp|Q8IIJ9|CATC_PLA	-	700	1.2e-61	207.3	12.6	1	2	3.5e-38	1.8e-35	120.7	2.1	377	498	118	230	104	232	0.92	Cathepsin K (DB01858; DB02679; DB02869; DB03405; DB03456; DB03642; DB03891; DB04234; DB04244; DB04523; DB05736; DB06367; DB06670; DB07563; DB07592; DB07593; DB07965; DB07967; DB08270; DB08287; DB08594; DB15599)
drugbank_target|P43235	-	329	sp|Q8IIJ9|CATC_PLA	-	700	1.2e-61	207.3	12.6	2	2	1.4e-29	7.6e-27	92.2	2.9	561	675	231	324	228	328	0.93	Cathepsin K (DB01858; DB02679; DB02869; DB03405; DB03456; DB03642; DB03891; DB04234; DB04244; DB04523; DB05736; DB06367; DB06670; DB07563; DB07592; DB07593; DB07965; DB07967; DB08270; DB08287; DB08594; DB15599)
drugbank_target|P25774	-	331	sp|Q8IIJ9|CATC_PLA	-	700	2.2e-59	199.8	12.5	1	2	3.7e-36	1.9e-33	114.0	3.7	363	495	103	230	72	234	0.85	Cathepsin S (DB03767; DB03837; DB03984; DB07520; DB07587; DB07589; DB07839; DB07878; DB08195; DB08611; DB08752; DB08755; DB12010)
drugbank_target|P25774	-	331	sp|Q8IIJ9|CATC_PLA	-	700	2.2e-59	199.8	12.5	2	2	5.2e-29	2.7e-26	90.4	2.4	561	673	234	324	224	330	0.92	Cathepsin S (DB03767; DB03837; DB03984; DB07520; DB07587; DB07589; DB07839; DB07878; DB08195; DB08611; DB08752; DB08755; DB12010)
drugbank_target|Q24940	-	326	sp|Q8IIJ9|CATC_PLA	-	700	1.5e-58	197.1	11.4	1	2	4.9e-34	2.6e-31	107.0	4.0	376	492	110	218	51	223	0.85	Cathepsin L-like proteinase (DB12245)
drugbank_target|Q24940	-	326	sp|Q8IIJ9|CATC_PLA	-	700	1.5e-58	197.1	11.4	2	2	1.5e-30	7.7e-28	95.5	1.2	552	674	217	316	211	324	0.90	Cathepsin L-like proteinase (DB12245)
drugbank_target|Q9UBX1	-	484	sp|Q8IIJ9|CATC_PLA	-	700	7.7e-51	171.5	7.7	1	2	1.2e-35	6.2e-33	112.4	1.1	377	497	274	385	219	390	0.86	Cathepsin F (DB01810; DB01871; DB02243; DB03536; DB03573; DB03691; DB07913; DB08775)
drugbank_target|Q9UBX1	-	484	sp|Q8IIJ9|CATC_PLA	-	700	7.7e-51	171.5	7.7	2	2	7.2e-21	3.8e-18	63.5	0.9	560	674	385	477	383	482	0.83	Cathepsin F (DB01810; DB01871; DB02243; DB03536; DB03573; DB03691; DB07913; DB08775)
drugbank_target|P25779	-	467	sp|Q8IIJ9|CATC_PLA	-	700	1.2e-47	161.0	6.9	1	2	9.9e-29	5.2e-26	89.5	0.6	376	479	125	221	116	249	0.86	Cruzipain (DB01810; DB01871; DB02051; DB02128; DB02200; DB03536; DB03573; DB03691; DB04427; DB04502)
drugbank_target|P25779	-	467	sp|Q8IIJ9|CATC_PLA	-	700	1.2e-47	161.0	6.9	2	2	3.1e-24	1.6e-21	74.6	0.9	610	675	270	331	237	336	0.93	Cruzipain (DB01810; DB01871; DB02051; DB02128; DB02200; DB03536; DB03573; DB03691; DB04427; DB04502)
drugbank_target|Q15418	-	735	sp|Q9NJU9|CDPK3_PL	-	562	7.2e-174	577.5	0.0	1	2	1.1e-85	1.3e-84	282.8	0.0	108	394	54	342	30	362	0.91	Ribosomal protein S6 kinase alpha-1 (DB04751; DB12010)
drugbank_target|Q15418	-	735	sp|Q9NJU9|CDPK3_PL	-	562	7.2e-174	577.5	0.0	2	2	1.1e-88	1.4e-87	292.6	0.0	110	387	411	689	400	712	0.92	Ribosomal protein S6 kinase alpha-1 (DB04751; DB12010)
drugbank_target|Q9UK32	-	745	sp|Q9NJU9|CDPK3_PL	-	562	8.7e-172	570.6	0.0	1	2	2.6e-85	3.3e-84	281.5	0.0	114	388	71	345	44	360	0.93	Ribosomal protein S6 kinase alpha-6 (DB12010)
drugbank_target|Q9UK32	-	745	sp|Q9NJU9|CDPK3_PL	-	562	8.7e-172	570.6	0.0	2	2	5.6e-87	7.1e-86	287.0	0.0	109	385	418	695	400	724	0.92	Ribosomal protein S6 kinase alpha-6 (DB12010)
drugbank_target|P51812	-	740	sp|Q9NJU9|CDPK3_PL	-	562	1.1e-171	570.3	0.0	1	2	2.3e-87	2.9e-86	288.3	0.0	91	386	43	340	24	354	0.90	Ribosomal protein S6 kinase alpha-3 (DB00945; DB12010)
drugbank_target|P51812	-	740	sp|Q9NJU9|CDPK3_PL	-	562	1.1e-171	570.3	0.0	2	2	7.4e-85	9.4e-84	280.0	0.0	106	384	411	690	390	719	0.91	Ribosomal protein S6 kinase alpha-3 (DB00945; DB12010)
drugbank_target|O75676	-	772	sp|Q9NJU9|CDPK3_PL	-	562	4.5e-154	512.2	0.0	1	2	6.3e-76	7.9e-75	250.5	0.0	108	396	25	324	6	337	0.88	Ribosomal protein S6 kinase alpha-4 (DB03247)
drugbank_target|O75676	-	772	sp|Q9NJU9|CDPK3_PL	-	562	4.5e-154	512.2	0.0	2	2	1.2e-78	1.5e-77	259.5	0.0	119	378	412	679	393	690	0.93	Ribosomal protein S6 kinase alpha-4 (DB03247)
drugbank_target|Q8IBS5	-	528	sp|Q9NJU9|CDPK3_PL	-	562	1.3e-151	504.1	18.0	1	1	1.3e-152	1.7e-151	503.7	18.0	63	558	15	522	7	525	0.92	Calcium-dependent protein kinase 4 (DB11638)
drugbank_target|P62344	-	524	sp|Q9NJU9|CDPK3_PL	-	562	2.9e-150	499.6	20.3	1	1	3e-151	3.8e-150	499.2	20.3	75	559	14	516	4	518	0.93	Calcium-dependent protein kinase 1 (DB12010)
drugbank_target|O60674	-	1132	sp|Q9NJU9|CDPK3_PL	-	562	3e-113	377.4	0.2	1	2	1.5e-45	1.9e-44	150.3	0.0	112	368	539	802	521	805	0.87	Tyrosine-protein kinase JAK2 (DB04716; DB05243; DB07161; DB07162; DB08067; DB08877; DB08895; DB11817; DB11986; DB12010; DB12500; DB15035)
drugbank_target|O60674	-	1132	sp|Q9NJU9|CDPK3_PL	-	562	3e-113	377.4	0.2	2	2	4.6e-68	5.8e-67	224.6	0.2	109	367	840	1119	817	1123	0.85	Tyrosine-protein kinase JAK2 (DB04716; DB05243; DB07161; DB07162; DB08067; DB08877; DB08895; DB11817; DB11986; DB12010; DB12500; DB15035)
drugbank_target|P23458	-	1154	sp|Q9NJU9|CDPK3_PL	-	562	4.8e-108	360.2	3.9	1	2	3.8e-43	4.8e-42	142.3	0.0	105	369	571	843	541	851	0.87	Tyrosine-protein kinase JAK1 (DB02375; DB04716; DB08877; DB08895; DB11817; DB12010; DB12500; DB15091)
drugbank_target|P23458	-	1154	sp|Q9NJU9|CDPK3_PL	-	562	4.8e-108	360.2	3.9	2	2	3.1e-66	3.9e-65	218.6	0.1	110	368	867	1146	844	1148	0.85	Tyrosine-protein kinase JAK1 (DB02375; DB04716; DB08877; DB08895; DB11817; DB12010; DB12500; DB15091)
drugbank_target|P29597	-	1187	sp|Q9NJU9|CDPK3_PL	-	562	1.5e-104	348.7	0.0	1	2	4.3e-39	5.4e-38	128.9	0.0	114	369	585	864	564	876	0.88	Non-receptor tyrosine-protein kinase TYK2 (DB04716; DB08895; DB12010)
drugbank_target|P29597	-	1187	sp|Q9NJU9|CDPK3_PL	-	562	1.5e-104	348.7	0.0	2	2	5.6e-66	7.1e-65	217.7	0.0	110	367	889	1165	866	1179	0.88	Non-receptor tyrosine-protein kinase TYK2 (DB04716; DB08895; DB12010)
drugbank_target|Q8IU85	-	385	sp|Q9NJU9|CDPK3_PL	-	562	1.7e-103	345.2	0.1	1	1	1.7e-104	2.2e-103	344.8	0.1	105	414	11	321	2	327	0.94	Calcium/calmodulin-dependent protein kinase type 1D (DB08454; DB12010)
drugbank_target|Q14012	-	370	sp|Q9NJU9|CDPK3_PL	-	562	3.6e-102	340.8	0.0	1	1	3.7e-103	4.7e-102	340.4	0.0	108	416	11	320	5	328	0.95	Calcium/calmodulin-dependent protein kinase type 1 (DB12010)
drugbank_target|Q13557	-	499	sp|Q9NJU9|CDPK3_PL	-	562	4e-102	340.7	0.0	1	1	4.5e-103	5.7e-102	340.1	0.0	111	422	8	319	2	367	0.93	Calcium/calmodulin-dependent protein kinase type II subunit delta (DB07853; DB08039; DB12010)
drugbank_target|P52333	-	1124	sp|Q9NJU9|CDPK3_PL	-	562	8.1e-101	336.3	0.0	1	2	3.1e-38	3.9e-37	126.1	0.0	105	368	509	774	491	778	0.88	Tyrosine-protein kinase JAK3 (DB04716; DB06321; DB08895; DB11817; DB12010; DB15035)
drugbank_target|P52333	-	1124	sp|Q9NJU9|CDPK3_PL	-	562	8.1e-101	336.3	0.0	2	2	4.6e-63	5.9e-62	208.1	0.0	115	366	819	1090	806	1094	0.90	Tyrosine-protein kinase JAK3 (DB04716; DB06321; DB08895; DB11817; DB12010; DB15035)
drugbank_target|Q13555	-	558	sp|Q9NJU9|CDPK3_PL	-	562	1.5e-100	335.5	0.1	1	1	2.9e-101	3.6e-100	334.2	0.0	111	415	8	312	2	322	0.95	Calcium/calmodulin-dependent protein kinase type II subunit gamma (DB06616; DB08699; DB12010)
drugbank_target|Q9UQM7	-	478	sp|Q9NJU9|CDPK3_PL	-	562	3.9e-100	334.1	0.0	1	1	5.1e-101	6.5e-100	333.4	0.0	112	415	8	311	3	375	0.88	Calcium/calmodulin-dependent protein kinase type II subunit alpha (DB04119; DB04447; DB07766; DB12010)
drugbank_target|Q96NX5	-	476	sp|Q9NJU9|CDPK3_PL	-	562	6.5e-100	333.4	0.2	1	1	7.4e-101	9.3e-100	332.8	0.2	106	414	12	319	3	324	0.95	Calcium/calmodulin-dependent protein kinase type 1G (DB08009; DB12010)
drugbank_target|Q13554	-	666	sp|Q9NJU9|CDPK3_PL	-	562	1.7e-98	328.7	0.0	1	1	1.8e-99	2.3e-98	328.2	0.0	112	414	9	311	2	319	0.96	Calcium/calmodulin-dependent protein kinase type II subunit beta (DB07168; DB12010)
drugbank_target|P53355	-	1430	sp|Q9NJU9|CDPK3_PL	-	562	7.2e-96	320.0	0.1	1	1	7.9e-97	1e-95	319.5	0.1	109	409	5	311	1	327	0.94	Death-associated protein kinase 1 (DB04069; DB04395; DB07444; DB12010)
drugbank_target|Q9UIK4	-	370	sp|Q9NJU9|CDPK3_PL	-	562	1.1e-94	316.2	0.1	1	1	1.1e-95	1.3e-94	315.8	0.1	108	422	14	335	2	349	0.91	Death-associated protein kinase 2 (DB12010)
drugbank_target|Q9BYT3	-	514	sp|Q9NJU9|CDPK3_PL	-	562	3.2e-94	314.6	5.6	1	1	3.2e-95	4.1e-94	314.2	5.6	79	449	77	454	47	476	0.79	Serine/threonine-protein kinase 33 (DB12010)
drugbank_target|P17612	-	351	sp|Q9NJU9|CDPK3_PL	-	562	1e-93	312.9	0.0	1	1	9.4e-95	1.2e-93	312.7	0.0	86	425	12	350	2	351	0.93	cAMP-dependent protein kinase catalytic subunit alpha (DB01919; DB01940; DB02155; DB02482; DB02611; DB03374; DB04098; DB04522; DB04530; DB04707; DB06959; DB06977; DB07107; DB07124; DB07204; DB07235; DB07458; DB07583; DB07854; DB07855; DB07856; DB07857; DB07858; DB07859; DB07860; DB07876; DB07947; DB07995; DB07996; DB07997; DB08070; DB08073; DB08113; DB08114; DB08148; DB08149; DB08150; DB08162; DB08231; DB08568; DB08569; DB08756; DB08846; DB12010)
drugbank_target|P22694	-	351	sp|Q9NJU9|CDPK3_PL	-	562	1e-93	312.9	0.0	1	1	9.5e-95	1.2e-93	312.7	0.0	94	424	22	349	2	351	0.93	cAMP-dependent protein kinase catalytic subunit beta (DB02482; DB12010)
drugbank_target|Q9P2K8	-	1649	sp|Q9NJU9|CDPK3_PL	-	562	3.7e-93	311.1	10.1	1	3	4.6e-36	5.9e-35	118.9	0.1	151	379	335	545	328	564	0.90	eIF-2-alpha kinase GCN2 (DB12010)
drugbank_target|Q9P2K8	-	1649	sp|Q9NJU9|CDPK3_PL	-	562	3.7e-93	311.1	10.1	2	3	1.6e-14	2.1e-13	47.8	0.0	105	184	579	657	568	661	0.90	eIF-2-alpha kinase GCN2 (DB12010)
drugbank_target|Q9P2K8	-	1649	sp|Q9NJU9|CDPK3_PL	-	562	3.7e-93	311.1	10.1	3	3	1.8e-44	2.3e-43	146.7	0.0	184	410	794	1038	788	1057	0.85	eIF-2-alpha kinase GCN2 (DB12010)
drugbank_target|Q16566	-	473	sp|Q9NJU9|CDPK3_PL	-	562	5.4e-93	310.5	0.0	1	1	5.8e-94	7.4e-93	310.1	0.0	108	410	37	336	29	361	0.91	Calcium/calmodulin-dependent protein kinase type IV (DB07664; DB07676)
drugbank_target|O43293	-	454	sp|Q9NJU9|CDPK3_PL	-	562	6.4e-93	310.3	0.1	1	1	1.2e-93	1.5e-92	309.0	0.0	109	379	5	281	1	313	0.92	Death-associated protein kinase 3 (DB04716; DB07125; DB07242; DB12010)
drugbank_target|Q9C098	-	648	sp|Q9NJU9|CDPK3_PL	-	562	2e-92	308.7	0.0	1	1	2.1e-93	2.7e-92	308.2	0.0	107	389	346	629	284	647	0.83	Serine/threonine-protein kinase DCLK3 (DB12010)
drugbank_target|P31749	-	480	sp|Q9NJU9|CDPK3_PL	-	562	4.3e-92	307.5	0.0	1	1	4.5e-93	5.7e-92	307.1	0.0	82	412	112	447	102	459	0.91	RAC-alpha serine/threonine-protein kinase (DB00171; DB01169; DB01645; DB01863; DB02709; DB05971; DB06486; DB06641; DB07584; DB07585)
drugbank_target|P31751	-	481	sp|Q9NJU9|CDPK3_PL	-	562	8e-92	306.6	0.0	1	1	8.3e-93	1e-91	306.3	0.0	98	403	131	439	106	452	0.91	RAC-beta serine/threonine-protein kinase (DB07812; DB07859; DB07947; DB08073)
drugbank_target|O15075	-	740	sp|Q9NJU9|CDPK3_PL	-	562	9.5e-92	306.4	0.0	1	1	1.1e-92	1.3e-91	305.9	0.0	108	424	381	698	342	703	0.90	Serine/threonine-protein kinase DCLK1 (DB12010)
drugbank_target|Q8N568	-	766	sp|Q9NJU9|CDPK3_PL	-	562	1.9e-91	305.4	0.0	1	1	2.3e-92	2.9e-91	304.8	0.0	106	419	383	698	375	706	0.93	Serine/threonine-protein kinase DCLK2 (DB12010)
drugbank_target|P27448	-	753	sp|Q9NJU9|CDPK3_PL	-	562	2.5e-91	305.0	0.0	1	1	2.9e-92	3.7e-91	304.5	0.0	102	430	41	364	8	376	0.86	MAP/microtubule affinity-regulating kinase 3 (DB12010)
drugbank_target|Q15746	-	1914	sp|Q9NJU9|CDPK3_PL	-	562	3.5e-91	304.5	1.0	1	1	5e-92	6.3e-91	303.7	1.0	94	407	1441	1749	1419	1764	0.92	Myosin light chain kinase, smooth muscle (DB12010)
drugbank_target|Q7KZI7	-	788	sp|Q9NJU9|CDPK3_PL	-	562	5e-91	304.0	0.0	1	1	5.9e-92	7.5e-91	303.4	0.0	93	380	29	311	10	339	0.91	Serine/threonine-protein kinase MARK2 (DB12010)
drugbank_target|Q9P0L2	-	795	sp|Q9NJU9|CDPK3_PL	-	562	5.2e-91	304.0	0.1	1	1	5.7e-92	7.3e-91	303.5	0.1	90	383	32	321	13	362	0.92	Serine/threonine-protein kinase MARK1 (DB12010)
drugbank_target|Q9NRH2	-	765	sp|Q9NJU9|CDPK3_PL	-	562	5.4e-91	303.9	0.0	1	1	5.8e-92	7.3e-91	303.5	0.0	105	411	4	307	1	324	0.93	SNF-related serine/threonine-protein kinase (DB12010)
drugbank_target|Q96L34	-	752	sp|Q9NJU9|CDPK3_PL	-	562	1.7e-90	302.3	0.0	1	1	1.7e-91	2.2e-90	301.9	0.0	115	379	57	316	25	373	0.88	MAP/microtubule affinity-regulating kinase 4 (DB12010)
drugbank_target|Q86YV6	-	388	sp|Q9NJU9|CDPK3_PL	-	562	1.7e-90	302.3	0.2	1	1	1.6e-91	2e-90	302.0	0.2	105	390	92	378	31	387	0.94	Myosin light chain kinase family member 4 (DB12010)
drugbank_target|Q13131	-	559	sp|Q9NJU9|CDPK3_PL	-	562	4.3e-90	300.9	0.0	1	1	4.6e-91	5.9e-90	300.5	0.0	108	428	17	336	3	356	0.89	5'-AMP-activated protein kinase catalytic subunit alpha-1 (DB00131; DB00171; DB00914; DB12010)
drugbank_target|Q13131	-	559	sp|Q9NJU9|CDPK3_PL	-	562	4.3e-90	300.9	0.0	1	1	4.6e-91	5.9e-90	300.5	0.0	108	428	17	336	3	356	0.89	5'-AMP-activated protein kinase catalytic subunit alpha-1 (DB00131; DB00945; DB12010)
drugbank_target|O96017	-	543	sp|Q9NJU9|CDPK3_PL	-	562	6e-90	300.5	0.0	1	1	6.3e-91	8e-90	300.1	0.0	111	387	214	500	177	519	0.91	Serine/threonine-protein kinase Chk2 (DB05149; DB06486; DB12010)
drugbank_target|P54646	-	552	sp|Q9NJU9|CDPK3_PL	-	562	2.5e-89	298.4	0.0	1	1	2.7e-90	3.4e-89	298.0	0.0	116	431	15	328	2	344	0.92	5'-AMP-activated protein kinase catalytic subunit alpha-2 (DB00131; DB00945; DB12010)
drugbank_target|O60285	-	661	sp|Q9NJU9|CDPK3_PL	-	562	3.8e-89	297.8	0.2	1	1	4.1e-90	5.2e-89	297.4	0.2	107	376	45	309	33	378	0.93	NUAK family SNF1-like kinase 1 (DB12010)
drugbank_target|Q9Y2K2	-	1321	sp|Q9NJU9|CDPK3_PL	-	562	6.2e-89	297.1	0.1	1	3	4.9e-90	6.2e-89	297.1	0.1	117	412	66	357	62	377	0.92	Serine/threonine-protein kinase SIK3 (DB12010)
drugbank_target|Q9Y2K2	-	1321	sp|Q9NJU9|CDPK3_PL	-	562	6.2e-89	297.1	0.1	2	3	5.6	71	-0.2	3.7	384	465	612	693	597	697	0.78	Serine/threonine-protein kinase SIK3 (DB12010)
drugbank_target|Q9Y2K2	-	1321	sp|Q9NJU9|CDPK3_PL	-	562	6.2e-89	297.1	0.1	3	3	8.3	1.1e+02	-0.8	0.4	405	439	997	1031	989	1049	0.79	Serine/threonine-protein kinase SIK3 (DB12010)
drugbank_target|Q32MK0	-	819	sp|Q9NJU9|CDPK3_PL	-	562	8.2e-89	296.7	0.4	1	1	9e-90	1.1e-88	296.2	0.4	110	411	506	807	495	815	0.91	Myosin light chain kinase 3 (DB12010)
drugbank_target|Q9H2G2	-	1235	sp|Q9NJU9|CDPK3_PL	-	562	1.8e-88	295.6	0.0	1	1	1.4e-89	1.8e-88	295.6	0.0	92	405	9	326	5	342	0.93	STE20-like serine/threonine-protein kinase (DB07664; DB07853; DB12010)
drugbank_target|Q13177	-	524	sp|Q9NJU9|CDPK3_PL	-	562	3e-88	294.9	0.0	1	1	3.4e-89	4.3e-88	294.3	0.0	86	379	218	506	209	523	0.92	Serine/threonine-protein kinase PAK 2 (DB12010)
drugbank_target|Q13188	-	491	sp|Q9NJU9|CDPK3_PL	-	562	5.2e-88	294.1	0.1	1	1	7e-89	8.9e-88	293.3	0.0	106	407	16	313	6	380	0.86	Serine/threonine-protein kinase 3 (DB12010)
drugbank_target|Q9HBH9	-	465	sp|Q9NJU9|CDPK3_PL	-	562	6.4e-88	293.8	0.0	1	1	6.4e-89	8.1e-88	293.4	0.0	95	413	61	408	50	419	0.91	MAP kinase-interacting serine/threonine-protein kinase 2 (DB12010)
drugbank_target|O00141	-	431	sp|Q9NJU9|CDPK3_PL	-	562	7.5e-88	293.5	0.0	1	1	8.7e-89	1.1e-87	293.0	0.0	107	396	89	378	69	393	0.93	Serine/threonine-protein kinase Sgk1 (DB03247; DB07837; DB08191)
drugbank_target|Q16816	-	387	sp|Q9NJU9|CDPK3_PL	-	562	1.4e-87	292.6	0.0	1	1	1.4e-88	1.8e-87	292.3	0.0	108	379	11	294	2	309	0.92	Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform (DB12010)
drugbank_target|Q14680	-	651	sp|Q9NJU9|CDPK3_PL	-	562	1.7e-87	292.3	0.8	1	1	1.8e-88	2.3e-87	292.0	0.8	112	379	6	268	1	324	0.90	Maternal embryonic leucine zipper kinase (DB12010)
drugbank_target|Q16644	-	382	sp|Q9NJU9|CDPK3_PL	-	562	2.9e-87	291.6	0.0	1	1	3e-88	3.8e-87	291.2	0.0	110	426	36	357	29	372	0.91	MAP kinase-activated protein kinase 3 (DB07728; DB08358)
drugbank_target|Q13153	-	545	sp|Q9NJU9|CDPK3_PL	-	562	3.5e-87	291.3	0.0	1	1	4.4e-88	5.5e-87	290.7	0.0	85	378	239	526	229	544	0.90	Serine/threonine-protein kinase PAK 1 (DB12010)
drugbank_target|O75914	-	559	sp|Q9NJU9|CDPK3_PL	-	562	4.8e-87	290.9	0.0	1	1	5.9e-88	7.4e-87	290.2	0.0	84	379	252	540	233	558	0.89	Serine/threonine-protein kinase PAK 3 (DB12010)
drugbank_target|Q9Y6E0	-	443	sp|Q9NJU9|CDPK3_PL	-	562	9.8e-87	289.9	0.0	1	1	9.2e-88	1.2e-86	289.6	0.0	110	388	29	301	11	370	0.89	Serine/threonine-protein kinase 24 (DB12010)
drugbank_target|O00444	-	970	sp|Q9NJU9|CDPK3_PL	-	562	1e-86	289.8	0.1	1	1	1.8e-87	2.3e-86	288.6	0.1	111	387	7	279	2	310	0.93	Serine/threonine-protein kinase PLK4 (DB12010)
drugbank_target|Q9H093	-	628	sp|Q9NJU9|CDPK3_PL	-	562	1.1e-86	289.7	0.1	1	1	1.2e-87	1.5e-86	289.2	0.1	104	374	40	304	27	318	0.92	NUAK family SNF1-like kinase 2 (DB12010)
drugbank_target|O14936	-	926	sp|Q9NJU9|CDPK3_PL	-	562	1.4e-86	289.3	0.0	1	1	2.1e-87	2.7e-86	288.4	0.0	113	411	8	312	2	321	0.90	Peripheral plasma membrane protein CASK (DB01942; DB12010)
drugbank_target|P49137	-	400	sp|Q9NJU9|CDPK3_PL	-	562	1.7e-86	289.0	0.1	1	1	1.8e-87	2.3e-86	288.6	0.1	107	425	53	377	42	387	0.91	MAP kinase-activated protein kinase 2 (DB02010; DB07234; DB07406; DB07430; DB07431; DB07728; DB08358)
drugbank_target|Q9H1R3	-	596	sp|Q9NJU9|CDPK3_PL	-	562	1.9e-86	288.9	0.4	1	1	2.1e-87	2.6e-86	288.4	0.4	110	410	277	576	266	588	0.90	Myosin light chain kinase 2, skeletal/cardiac muscle (DB04825; DB12010)
drugbank_target|Q04759	-	706	sp|Q9NJU9|CDPK3_PL	-	562	2.1e-86	288.7	0.0	1	1	2.7e-87	3.4e-86	288.1	0.0	99	407	363	668	344	681	0.93	Protein kinase C theta type (DB02010; DB02482; DB04522; DB12010)
drugbank_target|Q04759	-	706	sp|Q9NJU9|CDPK3_PL	-	562	2.1e-86	288.7	0.0	1	1	2.7e-87	3.4e-86	288.1	0.0	99	407	363	668	344	681	0.93	Protein kinase C theta type (DB00675)
drugbank_target|P57059	-	783	sp|Q9NJU9|CDPK3_PL	-	562	2.2e-86	288.7	0.0	1	1	2.5e-87	3.2e-86	288.2	0.0	115	375	25	280	5	295	0.96	Serine/threonine-protein kinase SIK1 (DB08912; DB12010)
drugbank_target|Q9P289	-	416	sp|Q9NJU9|CDPK3_PL	-	562	8.1e-86	286.8	0.1	1	1	1.1e-86	1.4e-85	286.0	0.0	115	386	22	287	4	333	0.89	Serine/threonine-protein kinase 26 (DB07853; DB12010)
drugbank_target|Q9H0K1	-	926	sp|Q9NJU9|CDPK3_PL	-	562	8.6e-86	286.7	0.0	1	1	1e-86	1.3e-85	286.2	0.0	116	374	19	272	10	330	0.93	Serine/threonine-protein kinase SIK2 (DB12010)
drugbank_target|P17252	-	672	sp|Q9NJU9|CDPK3_PL	-	562	1.8e-85	285.7	0.0	1	1	2.1e-86	2.6e-85	285.2	0.0	105	390	328	614	301	629	0.92	Protein kinase C alpha type (DB00144; DB00163; DB05013; DB06451; DB06595; DB06641; DB08846; DB11752; DB14001; DB14002)
drugbank_target|P17252	-	672	sp|Q9NJU9|CDPK3_PL	-	562	1.8e-85	285.7	0.0	1	1	2.1e-86	2.6e-85	285.2	0.0	105	390	328	614	301	629	0.92	Protein kinase C alpha type (DB00675)
drugbank_target|O14965	-	403	sp|Q9NJU9|CDPK3_PL	-	562	2.7e-85	285.1	0.0	1	1	2.5e-86	3.1e-85	284.9	0.0	98	387	115	398	69	403	0.89	Aurora kinase A (DB02482; DB05169; DB05198; DB05220; DB06134; DB06347; DB06486; DB07186; DB07266; DB07360; DB07362; DB07545; DB07801; DB08065; DB08066; DB12010; DB13061)
drugbank_target|Q96BR1	-	496	sp|Q9NJU9|CDPK3_PL	-	562	3.7e-85	284.6	0.0	1	1	4.1e-86	5.2e-85	284.2	0.0	76	395	124	441	116	458	0.89	Serine/threonine-protein kinase Sgk3 (DB12010)
drugbank_target|Q92772	-	493	sp|Q9NJU9|CDPK3_PL	-	562	5e-85	284.2	2.4	1	1	8e-86	1e-84	283.2	2.3	116	445	3	355	1	372	0.87	Cyclin-dependent kinase-like 2 (DB12010)
drugbank_target|Q16513	-	984	sp|Q9NJU9|CDPK3_PL	-	562	7.1e-85	283.7	0.0	1	1	1e-85	1.3e-84	282.8	0.0	98	406	639	949	609	978	0.92	Serine/threonine-protein kinase N2 (DB12010)
drugbank_target|Q8IVH8	-	894	sp|Q9NJU9|CDPK3_PL	-	562	7.1e-85	283.7	0.0	1	1	7.5e-86	9.5e-85	283.3	0.0	105	378	5	278	1	299	0.93	Mitogen-activated protein kinase kinase kinase kinase 3 (DB12010)
drugbank_target|P05771	-	671	sp|Q9NJU9|CDPK3_PL	-	562	1.1e-84	283.1	0.0	1	1	1.3e-85	1.6e-84	282.5	0.0	90	408	318	635	294	646	0.90	Protein kinase C beta type (DB00163; DB01738; DB06486; DB08846; DB08862; DB14001; DB14002)
drugbank_target|P05771	-	671	sp|Q9NJU9|CDPK3_PL	-	562	1.1e-84	283.1	0.0	1	1	1.3e-85	1.6e-84	282.5	0.0	90	408	318	635	294	646	0.90	Protein kinase C beta type (DB00675)
drugbank_target|Q02156	-	737	sp|Q9NJU9|CDPK3_PL	-	562	1.9e-84	282.3	0.0	1	1	2.1e-85	2.6e-84	281.8	0.0	109	406	401	701	354	729	0.90	Protein kinase C epsilon type (DB06064; DB11752; DB12010)
drugbank_target|Q02156	-	737	sp|Q9NJU9|CDPK3_PL	-	562	1.9e-84	282.3	0.0	1	1	2.1e-85	2.6e-84	281.8	0.0	109	406	401	701	354	729	0.90	Protein kinase C epsilon type (DB00675)
drugbank_target|Q9H4B4	-	646	sp|Q9NJU9|CDPK3_PL	-	562	2.6e-84	281.9	0.0	1	1	2.6e-85	3.3e-84	281.5	0.0	118	381	62	322	53	363	0.94	Serine/threonine-protein kinase PLK3 (DB12010)
drugbank_target|Q9UEE5	-	414	sp|Q9NJU9|CDPK3_PL	-	562	9.1e-84	280.0	0.1	1	1	8.9e-85	1.1e-83	279.8	0.1	110	391	52	340	44	396	0.90	Serine/threonine-protein kinase 17A (DB12010)
drugbank_target|Q9UKE5	-	1360	sp|Q9NJU9|CDPK3_PL	-	562	2e-83	278.9	0.0	1	1	1.6e-84	2e-83	278.9	0.0	110	403	18	319	1	336	0.90	TRAF2 and NCK-interacting protein kinase (DB12010)
drugbank_target|Q9UQB9	-	309	sp|Q9NJU9|CDPK3_PL	-	562	2.6e-83	278.5	0.0	1	1	2.6e-84	3.3e-83	278.2	0.0	97	377	24	297	9	305	0.92	Aurora kinase C (DB06134; DB12010)
drugbank_target|O75385	-	1050	sp|Q9NJU9|CDPK3_PL	-	562	3.1e-83	278.3	0.0	1	1	3.4e-84	4.3e-83	277.8	0.0	111	376	9	281	5	288	0.93	Serine/threonine-protein kinase ULK1 (DB12010)
drugbank_target|Q8IYT8	-	1036	sp|Q9NJU9|CDPK3_PL	-	562	4.4e-83	277.8	0.0	1	1	5.5e-84	6.9e-83	277.1	0.0	115	381	6	279	2	287	0.92	Serine/threonine-protein kinase ULK2 (DB12010)
drugbank_target|Q9Y2H1	-	464	sp|Q9NJU9|CDPK3_PL	-	562	4.5e-83	277.8	0.1	1	1	5.3e-84	6.7e-83	277.2	0.1	79	389	51	399	28	441	0.88	Serine/threonine-protein kinase 38-like (DB12010)
drugbank_target|Q9NYY3	-	685	sp|Q9NJU9|CDPK3_PL	-	562	4.7e-83	277.7	0.1	1	1	5.1e-84	6.4e-83	277.3	0.1	114	415	79	375	57	442	0.88	Serine/threonine-protein kinase PLK2 (DB12010)
drugbank_target|Q9NRP7	-	1315	sp|Q9NJU9|CDPK3_PL	-	562	5.2e-83	277.6	0.0	1	1	6.2e-84	7.9e-83	277.0	0.0	115	375	2	256	1	264	0.96	Serine/threonine-protein kinase 36 (DB12010)
drugbank_target|Q05655	-	676	sp|Q9NJU9|CDPK3_PL	-	562	5.7e-83	277.4	0.0	1	1	6.8e-84	8.6e-83	276.8	0.0	107	410	340	640	269	658	0.92	Protein kinase C delta type (DB04376; DB05013; DB12010)
drugbank_target|Q05655	-	676	sp|Q9NJU9|CDPK3_PL	-	562	5.7e-83	277.4	0.0	1	1	6.8e-84	8.6e-83	276.8	0.0	107	410	340	640	269	658	0.92	Protein kinase C delta type (DB00675)
drugbank_target|Q00532	-	358	sp|Q9NJU9|CDPK3_PL	-	562	6.3e-83	277.3	0.0	1	1	1.9e-83	2.5e-82	275.3	0.0	115	415	3	330	1	336	0.89	Cyclin-dependent kinase-like 1 (DB12010)
drugbank_target|Q9BUB5	-	465	sp|Q9NJU9|CDPK3_PL	-	562	7.2e-83	277.1	0.0	1	2	8.3e-33	1e-31	108.2	0.1	99	236	29	171	18	173	0.92	MAP kinase-interacting serine/threonine-protein kinase 1 (DB12010)
drugbank_target|Q9BUB5	-	465	sp|Q9NJU9|CDPK3_PL	-	562	7.2e-83	277.1	0.0	2	2	1.4e-50	1.8e-49	166.8	0.0	232	392	205	390	197	423	0.84	MAP kinase-interacting serine/threonine-protein kinase 1 (DB12010)
drugbank_target|O94768	-	372	sp|Q9NJU9|CDPK3_PL	-	562	2e-82	275.6	0.0	1	1	2e-83	2.6e-82	275.3	0.0	109	407	24	326	15	345	0.90	Serine/threonine-protein kinase 17B (DB04216; DB12010)
drugbank_target|Q8NEV4	-	1616	sp|Q9NJU9|CDPK3_PL	-	562	3.1e-82	275.0	0.0	1	1	2.5e-83	3.1e-82	275.0	0.0	113	425	17	339	7	362	0.93	Myosin-IIIa (DB12010)
drugbank_target|P51956	-	506	sp|Q9NJU9|CDPK3_PL	-	562	8e-82	273.6	0.1	1	1	8.2e-83	1e-81	273.3	0.1	115	414	2	301	1	322	0.94	Serine/threonine-protein kinase Nek3 (DB12010)
drugbank_target|Q6PHR2	-	472	sp|Q9NJU9|CDPK3_PL	-	562	9.3e-82	273.4	0.0	1	1	1.1e-82	1.4e-81	272.9	0.0	119	380	16	277	10	312	0.90	Serine/threonine-protein kinase ULK3 (DB12010)
drugbank_target|Q13237	-	762	sp|Q9NJU9|CDPK3_PL	-	562	9.4e-82	273.4	0.1	1	2	0.39	4.9	3.6	0.0	152	252	272	376	246	384	0.65	cGMP-dependent protein kinase 2 (DB12010)
drugbank_target|Q13237	-	762	sp|Q9NJU9|CDPK3_PL	-	562	9.4e-82	273.4	0.1	2	2	4.6e-81	5.8e-80	267.5	0.0	72	380	409	718	395	743	0.94	cGMP-dependent protein kinase 2 (DB12010)
drugbank_target|O94804	-	968	sp|Q9NJU9|CDPK3_PL	-	562	1.1e-81	273.2	0.0	1	2	8.6e-83	1.1e-81	273.2	0.0	100	398	19	322	5	347	0.89	Serine/threonine-protein kinase 10 (DB12010)
drugbank_target|O94804	-	968	sp|Q9NJU9|CDPK3_PL	-	562	1.1e-81	273.2	0.0	2	2	1.3	16	1.9	7.8	26	122	677	771	657	775	0.70	Serine/threonine-protein kinase 10 (DB12010)
drugbank_target|O95819	-	1239	sp|Q9NJU9|CDPK3_PL	-	562	1.6e-81	272.6	0.0	1	1	1.3e-82	1.6e-81	272.6	0.0	115	403	23	319	2	333	0.91	Mitogen-activated protein kinase kinase kinase kinase 4 (DB12010)
drugbank_target|P51957	-	841	sp|Q9NJU9|CDPK3_PL	-	562	1.8e-81	272.5	0.1	1	1	2.6e-82	3.3e-81	271.6	0.1	120	402	9	289	3	307	0.90	Serine/threonine-protein kinase Nek4 (DB12010)
drugbank_target|P53350	-	603	sp|Q9NJU9|CDPK3_PL	-	562	2.3e-81	272.1	0.0	1	1	2.6e-82	3.3e-81	271.6	0.0	116	375	52	307	44	316	0.96	Serine/threonine-protein kinase PLK1 (DB06897; DB06963; DB07186; DB07789; DB08059; DB12010)
drugbank_target|Q15139	-	912	sp|Q9NJU9|CDPK3_PL	-	562	2.8e-81	271.8	0.0	1	1	3.2e-82	4.1e-81	271.3	0.0	98	379	562	845	546	873	0.91	Serine/threonine-protein kinase D1 (DB11752; DB12010)
drugbank_target|Q15208	-	465	sp|Q9NJU9|CDPK3_PL	-	562	3.6e-81	271.5	1.2	1	1	4.1e-82	5.2e-81	271.0	1.2	67	390	39	399	16	443	0.85	Serine/threonine-protein kinase 38 (DB12010)
drugbank_target|Q96GD4	-	344	sp|Q9NJU9|CDPK3_PL	-	562	6.4e-81	270.6	0.0	1	1	6.4e-82	8.1e-81	270.3	0.0	106	377	67	331	44	339	0.93	Aurora kinase B (DB04703; DB05169; DB06486; DB07340; DB12010)
drugbank_target|Q9Y4K4	-	846	sp|Q9NJU9|CDPK3_PL	-	562	6.7e-81	270.6	0.0	1	1	7.9e-82	1e-80	270.0	0.0	111	391	14	295	7	329	0.93	Mitogen-activated protein kinase kinase kinase kinase 5 (DB12010)
drugbank_target|Q8IY84	-	436	sp|Q9NJU9|CDPK3_PL	-	562	9e-81	270.2	0.0	1	1	8.8e-82	1.1e-80	269.9	0.0	99	406	56	359	22	382	0.84	Serine/threonine-protein kinase NIM1 (DB12010)
drugbank_target|P00521	-	746	sp|Q9NJU9|CDPK3_PL	-	562	2.4e-80	268.8	0.0	1	1	2.7e-81	3.4e-80	268.2	0.0	112	370	122	378	111	406	0.91	Tyrosine-protein kinase transforming protein Abl (DB02567; DB03814; DB03878; DB05489)
drugbank_target|P54764	-	986	sp|Q9NJU9|CDPK3_PL	-	562	6.4e-80	267.4	0.0	1	1	1e-80	1.3e-79	266.3	0.0	66	369	569	876	563	892	0.91	Ephrin type-A receptor 4 (DB12010)
drugbank_target|P00519	-	1130	sp|Q9NJU9|CDPK3_PL	-	562	6.8e-80	267.3	0.0	1	1	7.9e-81	1e-79	266.7	0.0	112	377	236	501	224	530	0.91	Tyrosine-protein kinase ABL1 (DB00171; DB00619; DB01254; DB03878; DB04868; DB05184; DB06616; DB07831; DB08043; DB08231; DB08339; DB08350; DB08583; DB08896; DB08901; DB12010; DB12267; DB12323)
drugbank_target|P24941	-	298	sp|Q9NJU9|CDPK3_PL	-	562	1e-79	266.7	0.0	1	1	3.2e-80	4.1e-79	264.7	0.0	114	377	2	290	1	295	0.88	Cyclin-dependent kinase 2 (DB01888; DB02010; DB02052; DB02091; DB02116; DB02197; DB02297; DB02407; DB02538; DB02603; DB02647; DB02733; DB02833; DB02898; DB02915; DB02950; DB02963; DB02973; DB03019; DB03307; DB03365; DB03428; DB03490; DB03496; DB03583; DB03663; DB03737; DB03801; DB04006; DB04101; DB04186; DB04288; DB04407; DB04518; DB04607; DB04662; DB04669; DB06195; DB06616; DB06844; DB06888; DB06944; DB06948; DB06976; DB06983; DB07024; DB07054; DB07065; DB07126; DB07137; DB07163; DB07164; DB07179; DB07203; DB07210; DB07220; DB07431; DB07471; DB07493; DB07501; DB07504; DB07529; DB07531; DB07533; DB07534; DB07538; DB07539; DB07540; DB07562; DB07595; DB07606; DB07612; DB07618; DB07622; DB07685; DB07686; DB07687; DB07688; DB07731; DB07750; DB07751; DB07755; DB07761; DB07790; DB07791; DB07852; DB07889; DB07936; DB07982; DB08066; DB08094; DB08122; DB08123; DB08124; DB08125; DB08126; DB08132; DB08133; DB08134; DB08135; DB08136; DB08137; DB08138; DB08139; DB08140; DB08141; DB08142; DB08178; DB08182; DB08218; DB08219; DB08233; DB08241; DB08247; DB08248; DB08285; DB08309; DB08312; DB08355; DB08441; DB08463; DB08527; DB08531; DB08532; DB08533; DB08534; DB08535; DB08536; DB08537; DB08538; DB08539; DB08572; DB08673; DB08677; DB08694; DB08768)
drugbank_target|Q12851	-	820	sp|Q9NJU9|CDPK3_PL	-	562	1.1e-79	266.6	0.0	1	1	1.2e-80	1.5e-79	266.1	0.0	112	377	11	277	5	293	0.95	Mitogen-activated protein kinase kinase kinase kinase 2 (DB12010)
drugbank_target|Q56UN5	-	1328	sp|Q9NJU9|CDPK3_PL	-	562	1.1e-79	266.6	1.3	1	2	9.9	1.2e+02	-1.0	2.4	413	544	879	998	856	1003	0.65	Mitogen-activated protein kinase kinase kinase 19 (DB12010)
drugbank_target|Q56UN5	-	1328	sp|Q9NJU9|CDPK3_PL	-	562	1.1e-79	266.6	1.3	2	2	3.6e-80	4.5e-79	264.6	0.0	56	375	998	1326	987	1328	0.85	Mitogen-activated protein kinase kinase kinase 19 (DB12010)
drugbank_target|Q9NQU5	-	681	sp|Q9NJU9|CDPK3_PL	-	562	2e-79	265.7	0.0	1	1	2.2e-80	2.8e-79	265.2	0.0	123	376	412	661	382	668	0.95	Serine/threonine-protein kinase PAK 6 (DB12010)
drugbank_target|Q9P286	-	719	sp|Q9NJU9|CDPK3_PL	-	562	2e-79	265.7	0.0	1	1	2.2e-80	2.8e-79	265.2	0.0	122	374	453	701	419	709	0.95	Serine/threonine-protein kinase PAK 5 (DB12010)
drugbank_target|Q8N4C8	-	1332	sp|Q9NJU9|CDPK3_PL	-	562	2.3e-79	265.5	0.0	1	1	1.8e-80	2.3e-79	265.5	0.0	117	403	25	319	10	333	0.92	Misshapen-like kinase 1 (DB12010)
drugbank_target|Q13464	-	1354	sp|Q9NJU9|CDPK3_PL	-	562	2.7e-79	265.3	0.0	1	1	2.1e-80	2.7e-79	265.3	0.0	92	402	49	367	40	379	0.87	Rho-associated protein kinase 1 (DB04707; DB07876; DB08162; DB08756; DB13165; DB13931)
drugbank_target|P41743	-	596	sp|Q9NJU9|CDPK3_PL	-	562	4e-79	264.7	0.0	1	1	9.9e-80	1.3e-78	263.1	0.0	87	395	224	544	204	573	0.87	Protein kinase C iota type (DB03777; DB12010)
drugbank_target|P41743	-	596	sp|Q9NJU9|CDPK3_PL	-	562	4e-79	264.7	0.0	1	1	9.9e-80	1.3e-78	263.1	0.0	87	395	224	544	204	573	0.87	Protein kinase C iota type (DB00675)
drugbank_target|O43283	-	966	sp|Q9NJU9|CDPK3_PL	-	562	4.9e-79	264.4	0.1	1	1	5.6e-80	7e-79	263.9	0.1	111	426	163	465	147	494	0.93	Mitogen-activated protein kinase kinase kinase 13 (DB12010)
drugbank_target|Q96RR4	-	588	sp|Q9NJU9|CDPK3_PL	-	562	6.1e-79	264.1	0.0	1	1	6.4e-80	8.1e-79	263.7	0.0	115	395	163	468	142	495	0.88	Calcium/calmodulin-dependent protein kinase kinase 2 (DB12010)
drugbank_target|P54762	-	984	sp|Q9NJU9|CDPK3_PL	-	562	6.8e-79	264.0	0.0	1	1	7.8e-80	9.8e-79	263.4	0.0	97	369	597	876	565	888	0.88	Ephrin type-B receptor 1 (DB12010)
drugbank_target|O96013	-	591	sp|Q9NJU9|CDPK3_PL	-	562	1.1e-78	263.3	0.0	1	1	1.1e-79	1.4e-78	262.9	0.0	123	376	326	575	303	589	0.96	Serine/threonine-protein kinase PAK 4 (DB12010)
drugbank_target|O15530	-	556	sp|Q9NJU9|CDPK3_PL	-	562	1.1e-78	263.3	0.0	1	1	1.2e-79	1.5e-78	262.9	0.0	111	383	77	352	66	368	0.92	3-phosphoinositide-dependent protein kinase 1 (DB00482; DB01863; DB01933; DB01946; DB02010; DB03777; DB04522; DB06932; DB07033; DB07132; DB07300; DB07456; DB07457; DB12010)
drugbank_target|Q6P3R8	-	708	sp|Q9NJU9|CDPK3_PL	-	562	1.4e-78	262.9	0.1	1	1	1.1e-79	1.4e-78	262.9	0.1	115	376	2	262	1	285	0.95	Serine/threonine-protein kinase Nek5 (DB12010)
drugbank_target|O95747	-	527	sp|Q9NJU9|CDPK3_PL	-	562	1.5e-78	262.8	0.0	1	1	1.6e-79	2.1e-78	262.4	0.0	114	389	14	307	10	326	0.88	Serine/threonine-protein kinase OSR1 (DB12010)
drugbank_target|O75116	-	1388	sp|Q9NJU9|CDPK3_PL	-	562	1.9e-78	262.5	0.0	1	1	1.5e-79	1.9e-78	262.5	0.0	91	393	64	374	57	388	0.87	Rho-associated protein kinase 2 (DB08162; DB08756; DB12010; DB13165; DB13931)
drugbank_target|P42684	-	1182	sp|Q9NJU9|CDPK3_PL	-	562	2.5e-78	262.1	0.0	1	1	3e-79	3.8e-78	261.5	0.0	110	369	280	537	270	564	0.92	Abelson tyrosine-protein kinase 2 (DB00171; DB01254; DB05184; DB07664; DB12010)
drugbank_target|P29320	-	983	sp|Q9NJU9|CDPK3_PL	-	562	2.6e-78	262.0	0.0	1	1	3.2e-79	4e-78	261.4	0.0	102	368	605	875	571	879	0.90	Ephrin type-A receptor 3 (DB12010)
drugbank_target|Q8IW41	-	473	sp|Q9NJU9|CDPK3_PL	-	562	3.9e-78	261.4	0.1	1	1	4.6e-79	5.8e-78	260.9	0.1	106	408	10	339	1	352	0.87	MAP kinase-activated protein kinase 5 (DB12010)
drugbank_target|P51955	-	445	sp|Q9NJU9|CDPK3_PL	-	562	5.6e-78	260.9	0.0	1	1	4.4e-79	5.6e-78	260.9	0.0	115	422	6	315	3	332	0.87	Serine/threonine-protein kinase Nek2 (DB07180; DB12010)
drugbank_target|P05129	-	697	sp|Q9NJU9|CDPK3_PL	-	562	7e-78	260.6	0.0	1	1	8e-79	1e-77	260.1	0.0	112	380	347	621	340	630	0.93	Protein kinase C gamma type (DB00675)
drugbank_target|P05129	-	697	sp|Q9NJU9|CDPK3_PL	-	562	7e-78	260.6	0.0	1	1	8e-79	1e-77	260.1	0.0	112	380	347	621	340	630	0.93	Protein kinase C gamma type (DB12010)
drugbank_target|P12931	-	536	sp|Q9NJU9|CDPK3_PL	-	562	1.1e-77	260.0	0.0	1	1	1.1e-78	1.4e-77	259.6	0.0	113	375	266	525	209	533	0.91	Proto-oncogene tyrosine-protein kinase Src (DB01254; DB01678; DB01866; DB01893; DB01908; DB01947; DB01962; DB02175; DB02336; DB02432; DB02762; DB02908; DB03023; DB03078; DB03104; DB03114; DB03217; DB03268; DB03298; DB03306; DB03525; DB03591; DB03628; DB03712; DB03828; DB03902; DB04080; DB04272; DB04495; DB04739; DB04751; DB05184; DB06137; DB06616; DB06882; DB06883; DB07335; DB07662; DB07966; DB08052; DB08053; DB08054; DB08192; DB08462; DB08564; DB08901; DB09079; DB12010)
drugbank_target|Q96PY6	-	1258	sp|Q9NJU9|CDPK3_PL	-	562	1.6e-77	259.5	0.0	1	1	1.2e-78	1.6e-77	259.5	0.0	117	382	4	267	1	292	0.92	Serine/threonine-protein kinase Nek1 (DB12010)
drugbank_target|Q8N5S9	-	505	sp|Q9NJU9|CDPK3_PL	-	562	1.6e-77	259.4	0.0	1	1	1.7e-78	2.1e-77	259.0	0.0	114	396	125	432	101	458	0.90	Calcium/calmodulin-dependent protein kinase kinase 1 (DB12010)
drugbank_target|P42685	-	505	sp|Q9NJU9|CDPK3_PL	-	562	2.1e-77	259.1	0.0	1	1	2.3e-78	2.9e-77	258.6	0.0	116	367	233	483	219	500	0.92	Tyrosine-protein kinase FRK (DB01254; DB08896; DB12010; DB15035)
drugbank_target|O95835	-	1130	sp|Q9NJU9|CDPK3_PL	-	562	2.3e-77	258.9	0.0	1	1	4.3e-78	5.5e-77	257.7	0.0	75	389	659	1025	640	1058	0.88	Serine/threonine-protein kinase LATS1 (DB12010)
drugbank_target|P16591	-	822	sp|Q9NJU9|CDPK3_PL	-	562	2.8e-77	258.7	0.1	1	1	2.2e-78	2.8e-77	258.7	0.1	113	373	558	816	529	822	0.91	Tyrosine-protein kinase Fer (DB12010)
drugbank_target|Q92918	-	833	sp|Q9NJU9|CDPK3_PL	-	562	4.7e-77	257.9	0.0	1	1	5.2e-78	6.6e-77	257.4	0.0	109	376	9	277	6	291	0.96	Mitogen-activated protein kinase kinase kinase kinase 1 (DB12010)
drugbank_target|P63185	-	526	sp|Q9NJU9|CDPK3_PL	-	562	4.8e-77	257.9	0.0	1	1	5.1e-78	6.4e-77	257.4	0.0	114	367	264	512	224	517	0.93	Tyrosine-protein kinase transforming protein Src (DB01773)
drugbank_target|Q15375	-	998	sp|Q9NJU9|CDPK3_PL	-	562	5.1e-77	257.8	0.0	1	1	6e-78	7.6e-77	257.2	0.0	103	368	618	887	604	891	0.91	Ephrin type-A receptor 7 (DB07970; DB12010)
drugbank_target|P00524	-	526	sp|Q9NJU9|CDPK3_PL	-	562	5.5e-77	257.7	0.0	1	1	5.9e-78	7.4e-77	257.2	0.0	114	367	264	512	224	517	0.93	Tyrosine-protein kinase transforming protein Src (DB08434)
drugbank_target|Q99759	-	626	sp|Q9NJU9|CDPK3_PL	-	562	8.2e-77	257.1	0.0	1	1	9.4e-78	1.2e-76	256.6	0.0	121	374	365	623	331	625	0.89	Mitogen-activated protein kinase kinase kinase 3 (DB12010)
drugbank_target|P54756	-	1037	sp|Q9NJU9|CDPK3_PL	-	562	9.5e-77	256.9	0.0	1	1	1.1e-77	1.4e-76	256.4	0.0	101	369	658	930	624	947	0.90	Ephrin type-A receptor 5 (DB01254; DB12010)
drugbank_target|P29323	-	1055	sp|Q9NJU9|CDPK3_PL	-	562	9.5e-77	256.9	0.0	1	1	1.1e-77	1.4e-76	256.3	0.0	98	369	600	878	577	894	0.89	Ephrin type-B receptor 2 (DB04395; DB12010)
drugbank_target|P06241	-	537	sp|Q9NJU9|CDPK3_PL	-	562	1.3e-76	256.4	0.0	1	1	1.4e-77	1.8e-76	256.0	0.0	114	368	268	517	255	532	0.92	Tyrosine-protein kinase Fyn (DB01254; DB02078; DB12010)
drugbank_target|P07947	-	543	sp|Q9NJU9|CDPK3_PL	-	562	1.7e-76	256.0	0.0	1	1	1.7e-77	2.2e-76	255.7	0.0	100	368	260	523	197	538	0.86	Tyrosine-protein kinase Yes (DB01254; DB12010)
drugbank_target|Q9UEW8	-	545	sp|Q9NJU9|CDPK3_PL	-	562	1.8e-76	256.0	0.0	1	1	2e-77	2.5e-76	255.5	0.0	114	392	60	356	57	377	0.88	STE20/SPS1-related proline-alanine-rich protein kinase (DB12010)
drugbank_target|Q16512	-	942	sp|Q9NJU9|CDPK3_PL	-	562	2.3e-76	255.6	0.0	1	1	3e-77	3.9e-76	254.9	0.0	110	382	609	883	602	907	0.94	Serine/threonine-protein kinase N1 (DB12010)
drugbank_target|P07948	-	512	sp|Q9NJU9|CDPK3_PL	-	562	3.3e-76	255.1	0.0	1	1	3.6e-77	4.6e-76	254.6	0.0	114	367	244	493	209	507	0.94	Tyrosine-protein kinase Lyn (DB01254; DB03023; DB06616; DB08901; DB09079; DB12010)
drugbank_target|Q7L7X3	-	1001	sp|Q9NJU9|CDPK3_PL	-	562	3.3e-76	255.1	0.0	1	1	2.6e-77	3.3e-76	255.1	0.0	117	402	28	309	6	334	0.87	Serine/threonine-protein kinase TAO1 (DB12010)
drugbank_target|Q9H2K8	-	898	sp|Q9NJU9|CDPK3_PL	-	562	3.4e-76	255.1	0.0	1	1	2.7e-77	3.4e-76	255.1	0.0	121	401	27	304	11	333	0.87	Serine/threonine-protein kinase TAO3 (DB12010)
drugbank_target|Q8NG66	-	645	sp|Q9NJU9|CDPK3_PL	-	562	3.6e-76	255.0	0.3	1	1	2.9e-77	3.6e-76	255.0	0.3	113	400	25	317	5	344	0.84	Serine/threonine-protein kinase Nek11 (DB08912; DB12010)
drugbank_target|P06493	-	297	sp|Q9NJU9|CDPK3_PL	-	562	4.5e-76	254.7	0.0	1	1	7.2e-77	9.1e-76	253.6	0.0	116	379	3	293	1	297	0.91	Cyclin-dependent kinase 1 (DB02052; DB02116; DB02950; DB03428; DB03496; DB04014; DB06195; DB08142; DB12010)
drugbank_target|P08631	-	526	sp|Q9NJU9|CDPK3_PL	-	562	4.8e-76	254.6	0.0	1	1	5.1e-77	6.4e-76	254.1	0.0	114	368	259	508	234	524	0.92	Tyrosine-protein kinase HCK (DB01809; DB01962; DB04216; DB06616; DB12010)
drugbank_target|Q07785	-	288	sp|Q9NJU9|CDPK3_PL	-	562	5.7e-76	254.3	0.0	1	2	4.8e-69	6.1e-68	227.8	0.0	116	344	3	230	1	233	0.94	Cell division control protein 2 homolog (DB02519; DB02733)
drugbank_target|Q07785	-	288	sp|Q9NJU9|CDPK3_PL	-	562	5.7e-76	254.3	0.0	2	2	1.6e-07	2e-06	24.8	0.0	340	376	251	287	241	288	0.89	Cell division control protein 2 homolog (DB02519; DB02733)
drugbank_target|P35626	-	688	sp|Q9NJU9|CDPK3_PL	-	562	8.4e-76	253.8	0.1	1	1	1.2e-76	1.5e-75	252.9	0.1	80	385	153	465	113	473	0.88	Beta-adrenergic receptor kinase 2 (DB00171)
drugbank_target|Q8WU08	-	396	sp|Q9NJU9|CDPK3_PL	-	562	8.8e-76	253.7	1.2	1	1	9.4e-77	1.2e-75	253.3	0.9	101	393	8	301	2	343	0.89	Serine/threonine-protein kinase 32A (DB12010)
drugbank_target|Q12852	-	859	sp|Q9NJU9|CDPK3_PL	-	562	9.3e-76	253.6	0.0	1	1	1e-76	1.3e-75	253.1	0.0	113	427	122	423	102	455	0.92	Mitogen-activated protein kinase kinase kinase 12 (DB12010)
drugbank_target|Q05513	-	592	sp|Q9NJU9|CDPK3_PL	-	562	1e-75	253.5	0.0	1	1	1.2e-76	1.5e-75	253.0	0.0	103	403	239	548	214	574	0.86	Protein kinase C zeta type (DB00675)
drugbank_target|P29317	-	976	sp|Q9NJU9|CDPK3_PL	-	562	1.5e-75	252.9	0.0	1	1	1.7e-76	2.1e-75	252.4	0.0	91	368	586	868	558	872	0.87	Ephrin type-A receptor 2 (DB01254; DB04395; DB08896; DB12010)
drugbank_target|P53778	-	367	sp|Q9NJU9|CDPK3_PL	-	562	1.6e-75	252.9	0.0	1	2	4.5e-69	5.7e-68	227.9	0.0	107	356	17	268	8	272	0.90	Mitogen-activated protein kinase 12 (DB01017)
drugbank_target|P53778	-	367	sp|Q9NJU9|CDPK3_PL	-	562	1.6e-75	252.9	0.0	2	2	4.5e-07	5.7e-06	23.2	0.0	339	382	277	320	266	348	0.77	Mitogen-activated protein kinase 12 (DB01017)
drugbank_target|P53778	-	367	sp|Q9NJU9|CDPK3_PL	-	562	1.6e-75	252.9	0.0	1	2	4.5e-69	5.7e-68	227.9	0.0	107	356	17	268	8	272	0.90	Mitogen-activated protein kinase 12 (DB02482; DB04395; DB05157; DB05403)
drugbank_target|P53778	-	367	sp|Q9NJU9|CDPK3_PL	-	562	1.6e-75	252.9	0.0	2	2	4.5e-07	5.7e-06	23.2	0.0	339	382	277	320	266	348	0.77	Mitogen-activated protein kinase 12 (DB02482; DB04395; DB05157; DB05403)
drugbank_target|Q13882	-	451	sp|Q9NJU9|CDPK3_PL	-	562	1.8e-75	252.6	0.0	1	1	2e-76	2.6e-75	252.2	0.0	114	368	188	438	180	445	0.93	Protein-tyrosine kinase 6 (DB05294; DB12010; DB15035)
drugbank_target|Q9BXA7	-	367	sp|Q9NJU9|CDPK3_PL	-	562	2.7e-75	252.1	0.1	1	1	2.8e-76	3.6e-75	251.7	0.1	120	377	14	276	3	291	0.91	Testis-specific serine/threonine-protein kinase 1 (DB12010)
drugbank_target|Q16539	-	360	sp|Q9NJU9|CDPK3_PL	-	562	3.9e-75	251.6	0.0	1	1	2.1e-75	2.6e-74	248.8	0.0	107	378	14	313	1	329	0.87	Mitogen-activated protein kinase 14 (DB01254; DB01761; DB01807; DB01948; DB01953; DB01988; DB02195; DB02277; DB02352; DB02873; DB02984; DB03044; DB03110; DB03980; DB04338; DB04632; DB04797; DB05157; DB05412; DB05470; DB06518; DB06882; DB06940; DB06991; DB07138; DB07307; DB07459; DB07607; DB07811; DB07829; DB07832; DB07833; DB07834; DB07835; DB07941; DB07942; DB07943; DB08064; DB08068; DB08091; DB08092; DB08093; DB08095; DB08096; DB08097; DB08242; DB08349; DB08351; DB08352; DB08395; DB08423; DB08424; DB08521; DB08522; DB08730; DB12010)
drugbank_target|Q16539	-	360	sp|Q9NJU9|CDPK3_PL	-	562	3.9e-75	251.6	0.0	1	1	2.1e-75	2.6e-74	248.8	0.0	107	378	14	313	1	329	0.87	Mitogen-activated protein kinase 14 (DB01017)
drugbank_target|P42680	-	631	sp|Q9NJU9|CDPK3_PL	-	562	4.2e-75	251.5	0.0	1	1	4.9e-76	6.2e-75	250.9	0.0	119	369	371	617	346	619	0.93	Tyrosine-protein kinase Tec (DB12010; DB15035)
drugbank_target|Q6ZN16	-	1313	sp|Q9NJU9|CDPK3_PL	-	562	4.5e-75	251.4	0.0	1	1	5.6e-76	7.1e-75	250.7	0.0	120	380	654	915	624	924	0.91	Mitogen-activated protein kinase kinase kinase 15 (DB12010)
drugbank_target|Q8TD08	-	544	sp|Q9NJU9|CDPK3_PL	-	562	4.6e-75	251.3	0.0	1	1	7.8e-76	9.9e-75	250.2	0.0	115	376	11	307	5	321	0.90	Mitogen-activated protein kinase 15 (DB01017)
drugbank_target|Q8TD08	-	544	sp|Q9NJU9|CDPK3_PL	-	562	4.6e-75	251.3	0.0	1	1	7.8e-76	9.9e-75	250.2	0.0	115	376	11	307	5	321	0.90	Mitogen-activated protein kinase 15 (DB12010)
drugbank_target|Q8TD08	-	544	sp|Q9NJU9|CDPK3_PL	-	562	4.6e-75	251.3	0.0	1	1	7.8e-76	9.9e-75	250.2	0.0	115	376	11	307	5	321	0.90	Mitogen-activated protein kinase 15 (DB00945)
drugbank_target|P28482	-	360	sp|Q9NJU9|CDPK3_PL	-	562	5.1e-75	251.2	0.0	1	1	5.5e-76	7e-75	250.7	0.0	115	377	23	317	10	352	0.91	Mitogen-activated protein kinase 1 (DB01064; DB01169; DB02116; DB02482; DB02733; DB04338; DB06195; DB06641; DB06877; DB07010; DB07264; DB07788; DB07794; DB07905; DB08513; DB08521; DB11120; DB13930)
drugbank_target|P28482	-	360	sp|Q9NJU9|CDPK3_PL	-	562	5.1e-75	251.2	0.0	1	1	5.5e-76	7e-75	250.7	0.0	115	377	23	317	10	352	0.91	Mitogen-activated protein kinase 1 (DB01017)
drugbank_target|P28482	-	360	sp|Q9NJU9|CDPK3_PL	-	562	5.1e-75	251.2	0.0	1	1	5.5e-76	7e-75	250.7	0.0	115	377	23	317	10	352	0.91	Mitogen-activated protein kinase 1 (DB00945)
drugbank_target|Q9Y2U5	-	619	sp|Q9NJU9|CDPK3_PL	-	562	7.2e-75	250.7	0.0	1	1	7.5e-76	9.5e-75	250.3	0.0	117	374	356	617	326	619	0.92	Mitogen-activated protein kinase kinase kinase 2 (DB06616; DB12010)
drugbank_target|P06239	-	509	sp|Q9NJU9|CDPK3_PL	-	562	8.7e-75	250.4	0.0	1	1	9.2e-76	1.2e-74	250.0	0.0	113	367	241	490	220	506	0.91	Tyrosine-protein kinase Lck (DB01254; DB01830; DB02010; DB03023; DB04003; DB04395; DB06925; DB07146; DB07297; DB08055; DB08056; DB08057; DB08901; DB09079; DB12010; DB15035)
drugbank_target|Q9UPZ9	-	632	sp|Q9NJU9|CDPK3_PL	-	562	1.1e-74	250.1	0.0	1	1	9e-75	1.1e-73	246.7	0.0	115	377	2	288	1	306	0.87	Serine/threonine-protein kinase ICK (DB12010)
drugbank_target|Q9Y2H9	-	1570	sp|Q9NJU9|CDPK3_PL	-	562	1.3e-74	249.8	0.0	1	1	1.5e-75	2e-74	249.2	0.0	113	387	371	661	341	703	0.87	Microtubule-associated serine/threonine-protein kinase 1 (DB12010)
drugbank_target|Q86UE8	-	772	sp|Q9NJU9|CDPK3_PL	-	562	1.8e-74	249.4	0.1	1	2	8.3	1.1e+02	-0.8	5.0	73	171	242	346	194	352	0.80	Serine/threonine-protein kinase tousled-like 2 (DB12010)
drugbank_target|Q86UE8	-	772	sp|Q9NJU9|CDPK3_PL	-	562	1.8e-74	249.4	0.1	2	2	1.4e-75	1.8e-74	249.4	0.1	81	375	424	743	408	760	0.85	Serine/threonine-protein kinase tousled-like 2 (DB12010)
drugbank_target|O14578	-	2027	sp|Q9NJU9|CDPK3_PL	-	562	2e-74	249.2	0.0	1	1	1.6e-75	2e-74	249.2	0.0	104	380	84	367	60	392	0.89	Citron Rho-interacting kinase (DB12010)
drugbank_target|Q9UL54	-	1235	sp|Q9NJU9|CDPK3_PL	-	562	2.7e-74	248.8	0.0	1	1	2.1e-75	2.7e-74	248.8	0.0	119	403	31	310	14	321	0.89	Serine/threonine-protein kinase TAO2 (DB04522; DB12010)
drugbank_target|O15264	-	365	sp|Q9NJU9|CDPK3_PL	-	562	3.1e-74	248.6	0.6	1	1	8.9e-75	1.1e-73	246.7	0.6	108	392	16	326	4	355	0.84	Mitogen-activated protein kinase 13 (DB01017)
drugbank_target|O15264	-	365	sp|Q9NJU9|CDPK3_PL	-	562	3.1e-74	248.6	0.6	1	1	8.9e-75	1.1e-73	246.7	0.6	108	392	16	326	4	355	0.84	Mitogen-activated protein kinase 13 (DB05157; DB12010)
drugbank_target|P07332	-	822	sp|Q9NJU9|CDPK3_PL	-	562	4.7e-74	248.0	0.0	1	1	1.8e-74	2.3e-73	245.7	0.0	113	369	556	812	533	819	0.92	Tyrosine-protein kinase Fes/Fps (DB12010)
drugbank_target|P21709	-	976	sp|Q9NJU9|CDPK3_PL	-	562	5.2e-74	247.8	0.0	1	1	5.8e-75	7.4e-74	247.3	0.0	64	370	568	879	560	887	0.86	Ephrin type-A receptor 1 (DB12010)
drugbank_target|P53779	-	464	sp|Q9NJU9|CDPK3_PL	-	562	6.7e-74	247.5	1.7	1	2	3.3e-67	4.2e-66	221.7	0.4	91	350	35	298	17	303	0.88	Mitogen-activated protein kinase 10 (DB01017)
drugbank_target|P53779	-	464	sp|Q9NJU9|CDPK3_PL	-	562	6.7e-74	247.5	1.7	2	2	1.3e-07	1.7e-06	25.0	0.0	343	383	329	369	314	409	0.72	Mitogen-activated protein kinase 10 (DB01017)
drugbank_target|P53779	-	464	sp|Q9NJU9|CDPK3_PL	-	562	6.7e-74	247.5	1.7	1	2	3.3e-67	4.2e-66	221.7	0.4	91	350	35	298	17	303	0.88	Mitogen-activated protein kinase 10 (DB15624)
drugbank_target|P53779	-	464	sp|Q9NJU9|CDPK3_PL	-	562	6.7e-74	247.5	1.7	2	2	1.3e-07	1.7e-06	25.0	0.0	343	383	329	369	314	409	0.72	Mitogen-activated protein kinase 10 (DB15624)
drugbank_target|P53779	-	464	sp|Q9NJU9|CDPK3_PL	-	562	6.7e-74	247.5	1.7	1	2	3.3e-67	4.2e-66	221.7	0.4	91	350	35	298	17	303	0.88	Mitogen-activated protein kinase 10 (DB01782; DB02388; DB03084; DB03623; DB04395; DB06933; DB07010; DB07217; DB08005; DB08010; DB08011; DB08015; DB08021; DB08023; DB08025; DB08026; DB08555; DB12010)
drugbank_target|P53779	-	464	sp|Q9NJU9|CDPK3_PL	-	562	6.7e-74	247.5	1.7	2	2	1.3e-07	1.7e-06	25.0	0.0	343	383	329	369	314	409	0.72	Mitogen-activated protein kinase 10 (DB01782; DB02388; DB03084; DB03623; DB04395; DB06933; DB07010; DB07217; DB08005; DB08010; DB08011; DB08015; DB08021; DB08023; DB08025; DB08026; DB08555; DB12010)
drugbank_target|P54760	-	987	sp|Q9NJU9|CDPK3_PL	-	562	1.1e-73	246.8	0.0	1	1	1.2e-74	1.5e-73	246.3	0.0	95	368	591	871	565	878	0.89	Ephrin type-B receptor 4 (DB01254; DB07249; DB07250; DB07251; DB07252; DB07253; DB07254; DB07255; DB07256; DB11973; DB12010)
drugbank_target|P80192	-	1104	sp|Q9NJU9|CDPK3_PL	-	562	1.1e-73	246.8	0.0	1	1	1.2e-74	1.5e-73	246.3	0.0	118	450	145	491	138	501	0.84	Mitogen-activated protein kinase kinase kinase 9 (DB08703; DB12010)
drugbank_target|Q05397	-	1052	sp|Q9NJU9|CDPK3_PL	-	562	1.3e-73	246.6	0.0	1	1	1.5e-74	1.9e-73	246.0	0.0	113	389	418	696	375	705	0.86	Focal adhesion kinase 1 (DB06423; DB07248; DB07460; DB12010)
drugbank_target|Q8TD19	-	979	sp|Q9NJU9|CDPK3_PL	-	562	1.4e-73	246.4	0.0	1	1	1.6e-74	2e-73	245.9	0.0	118	385	52	320	42	348	0.91	Serine/threonine-protein kinase Nek9 (DB12010)
drugbank_target|P45984	-	424	sp|Q9NJU9|CDPK3_PL	-	562	1.6e-73	246.3	1.6	1	2	7.9e-67	1e-65	220.5	0.3	107	350	16	260	2	266	0.91	Mitogen-activated protein kinase 9 (DB07020; DB12010)
drugbank_target|P45984	-	424	sp|Q9NJU9|CDPK3_PL	-	562	1.6e-73	246.3	1.6	2	2	1.3e-07	1.6e-06	25.0	0.0	342	375	290	323	275	365	0.83	Mitogen-activated protein kinase 9 (DB07020; DB12010)
drugbank_target|P45984	-	424	sp|Q9NJU9|CDPK3_PL	-	562	1.6e-73	246.3	1.6	1	2	7.9e-67	1e-65	220.5	0.3	107	350	16	260	2	266	0.91	Mitogen-activated protein kinase 9 (DB01017)
drugbank_target|P45984	-	424	sp|Q9NJU9|CDPK3_PL	-	562	1.6e-73	246.3	1.6	2	2	1.3e-07	1.6e-06	25.0	0.0	342	375	290	323	275	365	0.83	Mitogen-activated protein kinase 9 (DB01017)
drugbank_target|P45984	-	424	sp|Q9NJU9|CDPK3_PL	-	562	1.6e-73	246.3	1.6	1	2	7.9e-67	1e-65	220.5	0.3	107	350	16	260	2	266	0.91	Mitogen-activated protein kinase 9 (DB15624)
drugbank_target|P45984	-	424	sp|Q9NJU9|CDPK3_PL	-	562	1.6e-73	246.3	1.6	2	2	1.3e-07	1.6e-06	25.0	0.0	342	375	290	323	275	365	0.83	Mitogen-activated protein kinase 9 (DB15624)
drugbank_target|P25098	-	689	sp|Q9NJU9|CDPK3_PL	-	562	2.1e-73	245.9	0.2	1	1	3.3e-74	4.2e-73	244.8	0.0	85	384	158	464	89	472	0.89	Beta-adrenergic receptor kinase 1 (DB00171)
drugbank_target|P27361	-	379	sp|Q9NJU9|CDPK3_PL	-	562	2.2e-73	245.8	0.0	1	1	2.7e-74	3.5e-73	245.1	0.0	115	376	40	333	28	362	0.89	Mitogen-activated protein kinase 3 (DB00605; DB01169; DB02733; DB04604; DB06195; DB08862; DB13930)
drugbank_target|P27361	-	379	sp|Q9NJU9|CDPK3_PL	-	562	2.2e-73	245.8	0.0	1	1	2.7e-74	3.5e-73	245.1	0.0	115	376	40	333	28	362	0.89	Mitogen-activated protein kinase 3 (DB01017)
drugbank_target|P27361	-	379	sp|Q9NJU9|CDPK3_PL	-	562	2.2e-73	245.8	0.0	1	1	2.7e-74	3.5e-73	245.1	0.0	115	376	40	333	28	362	0.89	Mitogen-activated protein kinase 3 (DB00945)
drugbank_target|P45983	-	427	sp|Q9NJU9|CDPK3_PL	-	562	2.6e-73	245.5	0.7	1	2	9.1e-67	1.1e-65	220.3	0.1	108	350	17	260	2	266	0.91	Mitogen-activated protein kinase 8 (DB00675; DB01782; DB07218; DB07268; DB07272; DB07276; DB07845)
drugbank_target|P45983	-	427	sp|Q9NJU9|CDPK3_PL	-	562	2.6e-73	245.5	0.7	2	2	3e-07	3.8e-06	23.8	0.0	343	375	291	323	275	363	0.84	Mitogen-activated protein kinase 8 (DB00675; DB01782; DB07218; DB07268; DB07272; DB07276; DB07845)
drugbank_target|P45983	-	427	sp|Q9NJU9|CDPK3_PL	-	562	2.6e-73	245.5	0.7	1	2	9.1e-67	1.1e-65	220.3	0.1	108	350	17	260	2	266	0.91	Mitogen-activated protein kinase 8 (DB01017)
drugbank_target|P45983	-	427	sp|Q9NJU9|CDPK3_PL	-	562	2.6e-73	245.5	0.7	2	2	3e-07	3.8e-06	23.8	0.0	343	375	291	323	275	363	0.84	Mitogen-activated protein kinase 8 (DB01017)
drugbank_target|P45983	-	427	sp|Q9NJU9|CDPK3_PL	-	562	2.6e-73	245.5	0.7	1	2	9.1e-67	1.1e-65	220.3	0.1	108	350	17	260	2	266	0.91	Mitogen-activated protein kinase 8 (DB15624)
drugbank_target|P45983	-	427	sp|Q9NJU9|CDPK3_PL	-	562	2.6e-73	245.5	0.7	2	2	3e-07	3.8e-06	23.8	0.0	343	375	291	323	275	363	0.84	Mitogen-activated protein kinase 8 (DB15624)
drugbank_target|Q00537	-	523	sp|Q9NJU9|CDPK3_PL	-	562	4e-73	244.9	0.0	1	1	8.3e-74	1.1e-72	243.5	0.0	112	376	188	476	168	501	0.88	Cyclin-dependent kinase 17 (DB12010)
drugbank_target|Q9Y6R4	-	1608	sp|Q9NJU9|CDPK3_PL	-	562	4.6e-73	244.7	0.3	1	1	7.3e-74	9.2e-73	243.7	0.3	117	375	1343	1603	1295	1608	0.90	Mitogen-activated protein kinase kinase kinase 4 (DB12010)
drugbank_target|Q9UKI8	-	766	sp|Q9NJU9|CDPK3_PL	-	562	4.7e-73	244.7	6.3	1	2	1.1	14	2.2	1.8	73	171	246	350	207	355	0.82	Serine/threonine-protein kinase tousled-like 1 (DB12010)
drugbank_target|Q9UKI8	-	766	sp|Q9NJU9|CDPK3_PL	-	562	4.7e-73	244.7	6.3	2	2	4e-74	5e-73	244.6	0.2	80	381	417	742	402	753	0.84	Serine/threonine-protein kinase tousled-like 1 (DB12010)
drugbank_target|Q16620	-	822	sp|Q9NJU9|CDPK3_PL	-	562	6.7e-73	244.2	0.1	1	1	7.7e-74	9.8e-73	243.6	0.1	109	366	529	802	516	812	0.89	BDNF/NT-3 growth factors receptor (DB00321; DB11823; DB11986; DB12010; DB14723)
drugbank_target|P11362	-	822	sp|Q9NJU9|CDPK3_PL	-	562	1.1e-72	243.4	0.0	1	1	1.6e-73	2e-72	242.6	0.0	115	369	476	752	461	771	0.90	Fibroblast growth factor receptor 1 (DB00039; DB00398; DB01109; DB02058; DB05014; DB07525; DB07840; DB08577; DB08896; DB08901; DB09078; DB09079; DB12010; DB12147; DB15102; DB15685)
drugbank_target|P42681	-	527	sp|Q9NJU9|CDPK3_PL	-	562	1.3e-72	243.3	0.0	1	1	1.6e-73	2e-72	242.6	0.0	121	369	274	518	258	521	0.93	Tyrosine-protein kinase TXK (DB12010; DB15035)
drugbank_target|Q00534	-	326	sp|Q9NJU9|CDPK3_PL	-	562	1.4e-72	243.1	0.0	1	1	2.2e-73	2.8e-72	242.1	0.0	114	379	10	306	4	324	0.87	Cyclin-dependent kinase 6 (DB03496; DB07379; DB07795; DB09073; DB11730; DB12001)
drugbank_target|P51813	-	675	sp|Q9NJU9|CDPK3_PL	-	562	2.7e-72	242.2	0.2	1	1	4.8e-73	6e-72	241.0	0.1	115	369	415	664	378	666	0.93	Cytoplasmic tyrosine-protein kinase BMX (DB12010; DB15035)
drugbank_target|O14757	-	476	sp|Q9NJU9|CDPK3_PL	-	562	2.8e-72	242.1	0.0	1	2	8.9e-73	1.1e-71	240.1	0.0	116	377	8	269	3	313	0.92	Serine/threonine-protein kinase Chk1 (DB05149; DB06486; DB06852; DB06876; DB07025; DB07034; DB07037; DB07038; DB07075; DB07078; DB07158; DB07213; DB07228; DB07243; DB07311; DB07314; DB07320; DB07336; DB07647; DB07648; DB07653; DB07654; DB07655; DB07959; DB08392; DB08393; DB08683; DB08774; DB08776; DB08777; DB08778; DB08779; DB08780; DB08781; DB12010)
drugbank_target|O14757	-	476	sp|Q9NJU9|CDPK3_PL	-	562	2.8e-72	242.1	0.0	2	2	8	1e+02	-0.7	0.0	419	449	373	403	361	427	0.71	Serine/threonine-protein kinase Chk1 (DB05149; DB06486; DB06852; DB06876; DB07025; DB07034; DB07037; DB07038; DB07075; DB07078; DB07158; DB07213; DB07228; DB07243; DB07311; DB07314; DB07320; DB07336; DB07647; DB07648; DB07653; DB07654; DB07655; DB07959; DB08392; DB08393; DB08683; DB08774; DB08776; DB08777; DB08778; DB08779; DB08780; DB08781; DB12010)
drugbank_target|Q13164	-	816	sp|Q9NJU9|CDPK3_PL	-	562	3.3e-72	241.9	0.0	1	1	6.1e-73	7.8e-72	240.7	0.0	108	377	46	351	24	363	0.87	Mitogen-activated protein kinase 7 (DB01017)
drugbank_target|Q13164	-	816	sp|Q9NJU9|CDPK3_PL	-	562	3.3e-72	241.9	0.0	1	1	6.1e-73	7.8e-72	240.7	0.0	108	377	46	351	24	363	0.87	Mitogen-activated protein kinase 7 (DB12010)
drugbank_target|Q13164	-	816	sp|Q9NJU9|CDPK3_PL	-	562	3.3e-72	241.9	0.0	1	1	6.1e-73	7.8e-72	240.7	0.0	108	377	46	351	24	363	0.87	Mitogen-activated protein kinase 7 (DB00945)
drugbank_target|Q15759	-	364	sp|Q9NJU9|CDPK3_PL	-	562	5.5e-72	241.2	0.0	1	1	5.5e-72	7e-71	237.5	0.0	114	397	21	334	8	348	0.85	Mitogen-activated protein kinase 11 (DB01017)
drugbank_target|Q15759	-	364	sp|Q9NJU9|CDPK3_PL	-	562	5.5e-72	241.2	0.0	1	1	5.5e-72	7e-71	237.5	0.0	114	397	21	334	8	348	0.85	Mitogen-activated protein kinase 11 (DB05157; DB08896)
drugbank_target|Q00535	-	292	sp|Q9NJU9|CDPK3_PL	-	562	6.8e-72	240.8	0.0	1	2	4.7e-66	6e-65	217.9	0.0	116	343	3	231	1	234	0.94	Cyclin-dependent-like kinase 5 (DB02052; DB02116; DB02950; DB03428; DB03496; DB04014; DB07364)
drugbank_target|Q00535	-	292	sp|Q9NJU9|CDPK3_PL	-	562	6.8e-72	240.8	0.0	2	2	2.1e-06	2.6e-05	21.0	0.0	340	374	253	287	242	289	0.90	Cyclin-dependent-like kinase 5 (DB02052; DB02116; DB02950; DB03428; DB03496; DB04014; DB07364)
drugbank_target|Q16584	-	847	sp|Q9NJU9|CDPK3_PL	-	562	1.1e-71	240.1	0.0	1	1	1.2e-72	1.5e-71	239.7	0.0	118	392	118	397	109	437	0.87	Mitogen-activated protein kinase kinase kinase 11 (DB12010)
drugbank_target|Q9HAZ1	-	481	sp|Q9NJU9|CDPK3_PL	-	562	1.5e-71	239.8	4.5	1	1	2e-70	2.5e-69	232.4	4.5	74	376	115	478	97	481	0.85	Dual specificity protein kinase CLK4 (DB12010)
drugbank_target|Q9UF33	-	1036	sp|Q9NJU9|CDPK3_PL	-	562	1.5e-71	239.7	0.0	1	1	9.3e-72	1.2e-70	236.8	0.0	105	368	618	927	578	932	0.88	Ephrin type-A receptor 6 (DB12010)
drugbank_target|Q16288	-	839	sp|Q9NJU9|CDPK3_PL	-	562	1.8e-71	239.4	0.0	1	1	2.1e-72	2.6e-71	238.9	0.0	112	369	532	822	515	827	0.90	NT-3 growth factor receptor (DB11986; DB12010; DB14723)
drugbank_target|P29322	-	1005	sp|Q9NJU9|CDPK3_PL	-	562	2.1e-71	239.2	0.0	1	1	2.3e-72	3e-71	238.8	0.0	105	368	622	889	608	892	0.90	Ephrin type-A receptor 8 (DB12010)
drugbank_target|Q08881	-	620	sp|Q9NJU9|CDPK3_PL	-	562	2.5e-71	239.0	0.0	1	1	3.4e-72	4.3e-71	238.2	0.0	121	369	366	610	357	613	0.93	Tyrosine-protein kinase ITK/TSK (DB02010; DB06589; DB12010; DB15035)
drugbank_target|O95382	-	1288	sp|Q9NJU9|CDPK3_PL	-	562	3.8e-71	238.4	0.0	1	1	4.4e-72	5.6e-71	237.8	0.0	113	379	645	912	625	924	0.90	Mitogen-activated protein kinase kinase kinase 6 (DB12010)
drugbank_target|Q6DT37	-	1551	sp|Q9NJU9|CDPK3_PL	-	562	4.3e-71	238.2	0.2	1	1	1.4e-71	1.7e-70	236.2	0.0	113	381	68	345	48	356	0.90	Serine/threonine-protein kinase MRCK gamma (DB12010)
drugbank_target|P09769	-	529	sp|Q9NJU9|CDPK3_PL	-	562	6.3e-71	237.7	0.0	1	1	6.7e-72	8.4e-71	237.2	0.0	115	368	260	509	244	525	0.91	Tyrosine-protein kinase Fgr (DB01254; DB12010; DB15035)
drugbank_target|Q06187	-	659	sp|Q9NJU9|CDPK3_PL	-	562	6.9e-71	237.5	0.1	1	1	8.1e-72	1e-70	237.0	0.1	117	369	403	649	378	652	0.93	Tyrosine-protein kinase BTK (DB01254; DB01863; DB05204; DB09053; DB11703; DB12010; DB15035)
drugbank_target|Q00536	-	496	sp|Q9NJU9|CDPK3_PL	-	562	7.1e-71	237.5	0.0	1	1	2.6e-71	3.3e-70	235.3	0.0	112	379	161	452	145	481	0.88	Cyclin-dependent kinase 16 (DB07766; DB12010)
drugbank_target|P21802	-	821	sp|Q9NJU9|CDPK3_PL	-	562	7.6e-71	237.4	0.0	1	1	8.8e-72	1.1e-70	236.9	0.0	114	369	478	755	461	767	0.89	Fibroblast growth factor receptor 2 (DB00039; DB01041; DB01109; DB01901; DB02058; DB02491; DB08896; DB08901; DB09078; DB09079; DB10770; DB10772; DB12010; DB12147; DB15102; DB15685)
drugbank_target|Q14289	-	1009	sp|Q9NJU9|CDPK3_PL	-	562	8.3e-71	237.3	0.0	1	1	1.4e-71	1.8e-70	236.1	0.0	117	369	425	677	416	704	0.90	Protein-tyrosine kinase 2-beta (DB01097; DB01645; DB08341; DB11817; DB12010)
drugbank_target|Q13233	-	1512	sp|Q9NJU9|CDPK3_PL	-	562	8.6e-71	237.2	0.0	1	1	1.1e-71	1.3e-70	236.6	0.0	104	375	1229	1510	1211	1512	0.89	Mitogen-activated protein kinase kinase kinase 1 (DB06061; DB11967; DB12010)
drugbank_target|P49759	-	484	sp|Q9NJU9|CDPK3_PL	-	562	1e-70	236.9	11.5	1	2	1.1e-66	1.3e-65	220.1	0.4	72	338	120	402	94	415	0.86	Dual specificity protein kinase CLK1 (DB04367; DB06376; DB08691; DB12010)
drugbank_target|P49759	-	484	sp|Q9NJU9|CDPK3_PL	-	562	1e-70	236.9	11.5	2	2	1.1e-07	1.4e-06	25.3	0.1	344	375	448	479	429	483	0.88	Dual specificity protein kinase CLK1 (DB04367; DB06376; DB08691; DB12010)
drugbank_target|Q02779	-	954	sp|Q9NJU9|CDPK3_PL	-	562	2.2e-70	235.9	0.0	1	1	2.5e-71	3.1e-70	235.4	0.0	118	409	99	394	89	455	0.81	Mitogen-activated protein kinase kinase kinase 10 (DB12010)
drugbank_target|Q13627	-	763	sp|Q9NJU9|CDPK3_PL	-	562	3.4e-70	235.2	0.5	1	2	5.1e-64	6.4e-63	211.2	0.9	69	335	108	380	94	402	0.84	Dual specificity tyrosine-phosphorylation-regulated kinase 1A (DB07608; DB12010)
drugbank_target|Q13627	-	763	sp|Q9NJU9|CDPK3_PL	-	562	3.4e-70	235.2	0.5	2	2	1.7e-06	2.1e-05	21.3	0.0	345	387	451	494	449	519	0.73	Dual specificity tyrosine-phosphorylation-regulated kinase 1A (DB07608; DB12010)
drugbank_target|P51451	-	505	sp|Q9NJU9|CDPK3_PL	-	562	3.9e-70	235.1	0.0	1	1	4.2e-71	5.3e-70	234.6	0.0	116	366	240	485	227	503	0.91	Tyrosine-protein kinase Blk (DB12010; DB15035)
drugbank_target|P50750	-	372	sp|Q9NJU9|CDPK3_PL	-	562	4.4e-70	234.9	0.0	1	1	1.1e-70	1.4e-69	233.3	0.0	114	415	17	357	4	372	0.86	Cyclin-dependent kinase 9 (DB03496; DB06195)
drugbank_target|P50613	-	346	sp|Q9NJU9|CDPK3_PL	-	562	7.8e-70	234.1	0.0	1	2	4.4e-68	5.6e-67	224.6	0.0	114	342	9	240	3	244	0.93	Cyclin-dependent kinase 7 (DB02482; DB03496; DB05969; DB06195)
drugbank_target|P50613	-	346	sp|Q9NJU9|CDPK3_PL	-	562	7.8e-70	234.1	0.0	2	2	0.027	0.34	7.5	0.0	343	376	265	298	255	330	0.91	Cyclin-dependent kinase 7 (DB02482; DB03496; DB05969; DB06195)
drugbank_target|P43405	-	635	sp|Q9NJU9|CDPK3_PL	-	562	1.2e-69	233.4	0.2	1	1	1.5e-70	1.9e-69	232.8	0.2	118	366	371	621	351	625	0.91	Tyrosine-protein kinase SYK (DB02010; DB06834; DB07159; DB07194; DB08361; DB08846; DB12010)
drugbank_target|P22455	-	802	sp|Q9NJU9|CDPK3_PL	-	562	1.4e-69	233.2	0.0	1	1	1.6e-70	2e-69	232.7	0.0	115	369	465	741	461	743	0.91	Fibroblast growth factor receptor 4 (DB00039; DB01109; DB08901; DB09078; DB12147; DB15102)
drugbank_target|P22607	-	806	sp|Q9NJU9|CDPK3_PL	-	562	1.4e-69	233.2	0.0	1	1	1.6e-70	2e-69	232.7	0.0	116	369	471	746	453	749	0.89	Fibroblast growth factor receptor 3 (DB00039; DB05014; DB06589; DB08901; DB09078; DB09079; DB12010; DB12147; DB15102; DB15685)
drugbank_target|P49761	-	638	sp|Q9NJU9|CDPK3_PL	-	562	2.3e-69	232.5	2.8	1	2	5.6e-64	7.2e-63	211.1	0.9	67	337	251	544	238	566	0.89	Dual specificity protein kinase CLK3 (DB07664; DB08691; DB12010)
drugbank_target|P49761	-	638	sp|Q9NJU9|CDPK3_PL	-	562	2.3e-69	232.5	2.8	2	2	1.7e-06	2.2e-05	21.3	0.0	345	379	592	626	570	636	0.86	Dual specificity protein kinase CLK3 (DB07664; DB08691; DB12010)
drugbank_target|P06213	-	1382	sp|Q9NJU9|CDPK3_PL	-	562	4.8e-69	231.5	0.0	1	1	5.5e-70	7e-69	230.9	0.0	114	369	1020	1288	1009	1326	0.89	Insulin receptor (DB00030; DB00046; DB00047; DB00071; DB01277; DB01306; DB01307; DB01309; DB03909; DB05115; DB05120; DB08513; DB09129; DB09564; DB12010; DB12267; DB14751)
drugbank_target|Q16659	-	721	sp|Q9NJU9|CDPK3_PL	-	562	6e-69	231.1	0.1	1	2	8.6e-68	1.1e-66	223.7	0.0	115	377	18	320	4	352	0.86	Mitogen-activated protein kinase 6 (DB01017)
drugbank_target|Q16659	-	721	sp|Q9NJU9|CDPK3_PL	-	562	6e-69	231.1	0.1	2	2	0.27	3.4	4.2	0.4	446	528	499	576	445	591	0.74	Mitogen-activated protein kinase 6 (DB01017)
drugbank_target|Q16659	-	721	sp|Q9NJU9|CDPK3_PL	-	562	6e-69	231.1	0.1	1	2	8.6e-68	1.1e-66	223.7	0.0	115	377	18	320	4	352	0.86	Mitogen-activated protein kinase 6 (DB00945)
drugbank_target|Q16659	-	721	sp|Q9NJU9|CDPK3_PL	-	562	6e-69	231.1	0.1	2	2	0.27	3.4	4.2	0.4	446	528	499	576	445	591	0.74	Mitogen-activated protein kinase 6 (DB00945)
drugbank_target|Q9H2X6	-	1198	sp|Q9NJU9|CDPK3_PL	-	562	7.8e-69	230.8	0.2	1	2	2.1e-60	2.6e-59	199.3	0.0	93	332	175	418	126	430	0.87	Homeodomain-interacting protein kinase 2 (DB12010)
drugbank_target|Q9H2X6	-	1198	sp|Q9NJU9|CDPK3_PL	-	562	7.8e-69	230.8	0.2	2	2	6.9e-09	8.8e-08	29.2	0.2	343	408	497	559	466	586	0.82	Homeodomain-interacting protein kinase 2 (DB12010)
drugbank_target|Q02763	-	1124	sp|Q9NJU9|CDPK3_PL	-	562	1.1e-68	230.3	0.0	1	1	1.3e-69	1.7e-68	229.7	0.0	118	368	825	1089	797	1109	0.91	Angiopoietin-1 receptor (DB00415; DB05294; DB08221; DB08896; DB08901; DB12010; DB14840)
drugbank_target|Q9H3Y6	-	488	sp|Q9NJU9|CDPK3_PL	-	562	1.8e-68	229.5	0.0	1	1	1.9e-69	2.4e-68	229.2	0.0	117	369	230	478	215	482	0.93	Tyrosine-protein kinase Srms (DB12010)
drugbank_target|Q9NYL2	-	800	sp|Q9NJU9|CDPK3_PL	-	562	2.1e-68	229.3	0.2	1	1	2.4e-69	3.1e-68	228.8	0.2	117	369	17	258	7	325	0.87	Mitogen-activated protein kinase kinase kinase MLT (DB01254; DB12010)
drugbank_target|P41240	-	450	sp|Q9NJU9|CDPK3_PL	-	562	2.9e-68	228.9	0.0	1	1	3.1e-69	3.9e-68	228.4	0.0	114	369	193	438	168	447	0.90	Tyrosine-protein kinase CSK (DB01254; DB02010; DB05075; DB12010)
drugbank_target|P36888	-	993	sp|Q9NJU9|CDPK3_PL	-	562	3.2e-68	228.8	0.1	1	2	5.5e-24	7e-23	79.1	0.1	94	212	586	712	559	721	0.73	Receptor-type tyrosine-protein kinase FLT3 (DB00398; DB01268; DB05014; DB05465; DB06080; DB06469; DB06595; DB08901; DB09079; DB12010; DB12141; DB12267; DB12500; DB12742; DB12874; DB12978)
drugbank_target|P36888	-	993	sp|Q9NJU9|CDPK3_PL	-	562	3.2e-68	228.8	0.1	2	2	1.1e-44	1.4e-43	147.4	0.0	208	404	781	976	766	986	0.89	Receptor-type tyrosine-protein kinase FLT3 (DB00398; DB01268; DB05014; DB05465; DB06080; DB06469; DB06595; DB08901; DB09079; DB12010; DB12141; DB12267; DB12500; DB12742; DB12874; DB12978)
drugbank_target|P04629	-	796	sp|Q9NJU9|CDPK3_PL	-	562	3.5e-68	228.6	0.0	1	1	4e-69	5.1e-68	228.1	0.0	111	367	503	777	486	783	0.89	High affinity nerve growth factor receptor (DB00321; DB00619; DB08896; DB11986; DB12010; DB13926; DB14723)
drugbank_target|P43403	-	619	sp|Q9NJU9|CDPK3_PL	-	562	4.9e-68	228.1	0.1	1	1	5.3e-69	6.7e-68	227.7	0.1	121	367	341	589	315	599	0.88	Tyrosine-protein kinase ZAP-70 (DB02010; DB12010)
drugbank_target|P15056	-	766	sp|Q9NJU9|CDPK3_PL	-	562	5.8e-68	227.9	0.0	1	1	6.5e-69	8.3e-68	227.4	0.0	89	369	427	712	410	728	0.86	Serine/threonine-protein kinase B-raf (DB00398; DB05190; DB05984; DB06999; DB07000; DB08553; DB08881; DB08896; DB08912; DB11718; DB12010; DB14840)
drugbank_target|P07949	-	1114	sp|Q9NJU9|CDPK3_PL	-	562	5.8e-68	227.9	0.0	1	1	7.1e-69	8.9e-68	227.3	0.0	107	369	713	1003	688	1023	0.87	Proto-oncogene tyrosine-protein kinase receptor Ret (DB00398; DB01809; DB05294; DB08875; DB08896; DB08901; DB09078; DB12010; DB12742; DB15685)
drugbank_target|Q09013	-	629	sp|Q9NJU9|CDPK3_PL	-	562	1.2e-67	226.9	0.0	1	1	1.4e-68	1.8e-67	226.3	0.0	114	378	68	344	43	351	0.89	Myotonin-protein kinase (DB01946)
drugbank_target|P04049	-	648	sp|Q9NJU9|CDPK3_PL	-	562	1.9e-67	226.1	0.0	1	1	2.1e-68	2.7e-67	225.7	0.0	105	372	336	607	314	637	0.86	RAF proto-oncogene serine/threonine-protein kinase (DB00398; DB04973; DB05190; DB05268; DB08862; DB08896; DB08912; DB12010)
drugbank_target|P49760	-	499	sp|Q9NJU9|CDPK3_PL	-	562	2.1e-67	226.0	1.3	1	2	2.1e-61	2.6e-60	202.6	0.4	67	340	111	406	97	425	0.84	Dual specificity protein kinase CLK2 (DB12010)
drugbank_target|P49760	-	499	sp|Q9NJU9|CDPK3_PL	-	562	2.1e-67	226.0	1.3	2	2	8.9e-07	1.1e-05	22.2	0.0	343	378	449	484	426	495	0.86	Dual specificity protein kinase CLK2 (DB12010)
drugbank_target|Q13163	-	448	sp|Q9NJU9|CDPK3_PL	-	562	3.1e-67	225.5	0.0	1	1	3.7e-68	4.7e-67	224.9	0.0	91	376	138	422	115	445	0.90	Dual specificity mitogen-activated protein kinase kinase 5 (DB12010)
drugbank_target|Q9H422	-	1215	sp|Q9NJU9|CDPK3_PL	-	562	4.7e-67	224.9	0.1	1	2	3.3e-59	4.1e-58	195.4	0.0	108	335	188	418	164	442	0.88	Homeodomain-interacting protein kinase 3 (DB12010)
drugbank_target|Q9H422	-	1215	sp|Q9NJU9|CDPK3_PL	-	562	4.7e-67	224.9	0.1	2	2	2.5e-08	3.1e-07	27.4	0.0	343	440	495	595	463	599	0.88	Homeodomain-interacting protein kinase 3 (DB12010)
drugbank_target|P08922	-	2347	sp|Q9NJU9|CDPK3_PL	-	562	5.7e-67	224.6	0.0	1	1	6.9e-68	8.8e-67	224.0	0.0	117	369	1945	2213	1929	2240	0.87	Proto-oncogene tyrosine-protein kinase ROS (DB11986; DB12010)
drugbank_target|Q16832	-	855	sp|Q9NJU9|CDPK3_PL	-	562	5.7e-67	224.6	0.0	1	1	6.5e-68	8.2e-67	224.1	0.0	119	367	564	845	549	849	0.87	Discoidin domain-containing receptor 2 (DB08896; DB12010)
drugbank_target|Q9Y463	-	629	sp|Q9NJU9|CDPK3_PL	-	562	6.1e-67	224.5	0.0	1	2	8.1e-64	1e-62	210.6	0.2	69	331	60	329	46	350	0.86	Dual specificity tyrosine-phosphorylation-regulated kinase 1B (DB12010)
drugbank_target|Q9Y463	-	629	sp|Q9NJU9|CDPK3_PL	-	562	6.1e-67	224.5	0.0	2	2	0.0014	0.017	11.7	0.0	346	379	404	437	397	448	0.90	Dual specificity tyrosine-phosphorylation-regulated kinase 1B (DB12010)
drugbank_target|P31152	-	587	sp|Q9NJU9|CDPK3_PL	-	562	1e-66	223.8	0.0	1	1	2e-66	2.6e-65	219.1	0.0	122	380	24	319	17	348	0.86	Mitogen-activated protein kinase 4 (DB01017)
drugbank_target|P31152	-	587	sp|Q9NJU9|CDPK3_PL	-	562	1e-66	223.8	0.0	1	1	2e-66	2.6e-65	219.1	0.0	122	380	24	319	17	348	0.86	Mitogen-activated protein kinase 4 (DB12010)
drugbank_target|P31152	-	587	sp|Q9NJU9|CDPK3_PL	-	562	1e-66	223.8	0.0	1	1	2e-66	2.6e-65	219.1	0.0	122	380	24	319	17	348	0.86	Mitogen-activated protein kinase 4 (DB00945)
drugbank_target|Q02750	-	393	sp|Q9NJU9|CDPK3_PL	-	562	2e-66	222.8	0.0	1	1	2.3e-67	2.9e-66	222.3	0.0	86	379	33	367	20	373	0.88	Dual specificity mitogen-activated protein kinase kinase 1 (DB02152; DB03115; DB05239; DB06616; DB06892; DB07046; DB07101; DB08130; DB08208; DB08911; DB11689)
drugbank_target|Q15303	-	1308	sp|Q9NJU9|CDPK3_PL	-	562	2.3e-66	222.6	0.0	1	1	2.7e-67	3.4e-66	222.1	0.0	115	368	715	971	676	988	0.89	Receptor tyrosine-protein kinase erbB-4 (DB08916; DB12010; DB12267; DB15035)
drugbank_target|P08069	-	1367	sp|Q9NJU9|CDPK3_PL	-	562	2.8e-66	222.3	0.0	1	1	3.4e-67	4.3e-66	221.7	0.0	113	368	995	1263	972	1268	0.87	Insulin-like growth factor 1 receptor (DB00030; DB00046; DB00047; DB00071; DB01277; DB01306; DB01307; DB01309; DB04395; DB05023; DB05184; DB05897; DB06075; DB06343; DB07156; DB07474; DB09098; DB09564; DB12250; DB12267; DB14751)
drugbank_target|P11802	-	303	sp|Q9NJU9|CDPK3_PL	-	562	3.7e-66	221.9	0.0	1	1	1.8e-66	2.3e-65	219.3	0.0	116	377	5	299	2	303	0.85	Cyclin-dependent kinase 4 (DB02733; DB03496; DB09073; DB11730; DB12001; DB12010)
drugbank_target|Q13546	-	671	sp|Q9NJU9|CDPK3_PL	-	562	4.1e-66	221.8	0.4	1	1	4.9e-67	6.2e-66	221.2	0.4	114	410	13	327	4	346	0.84	Receptor-interacting serine/threonine-protein kinase 1 (DB12010)
drugbank_target|P35590	-	1138	sp|Q9NJU9|CDPK3_PL	-	562	8.5e-66	220.7	0.0	1	1	9.5e-67	1.2e-65	220.2	0.0	119	368	841	1104	829	1121	0.90	Tyrosine-protein kinase receptor Tie-1 (DB12010)
drugbank_target|Q59EB3	-	712	sp|Q9NJU9|CDPK3_PL	-	562	1e-65	220.4	0.0	1	1	1.2e-66	1.5e-65	219.9	0.0	121	369	403	657	393	664	0.91	Met proto-oncogene variant (DB08111)
drugbank_target|P10398	-	606	sp|Q9NJU9|CDPK3_PL	-	562	1.1e-65	220.4	0.0	1	1	1.2e-66	1.5e-65	219.9	0.0	75	370	266	566	257	592	0.89	Serine/threonine-protein kinase A-Raf (DB00171)
drugbank_target|P09619	-	1106	sp|Q9NJU9|CDPK3_PL	-	562	3.1e-65	218.9	0.0	1	2	3.7e-23	4.7e-22	76.3	0.0	114	209	597	698	570	707	0.84	Platelet-derived growth factor receptor beta (DB00102; DB00398; DB00619; DB01254; DB01268; DB05014; DB05146; DB06589; DB06595; DB08896; DB09079; DB09221; DB09283; DB10770; DB12010; DB12147; DB12978; DB14840)
drugbank_target|P09619	-	1106	sp|Q9NJU9|CDPK3_PL	-	562	3.1e-65	218.9	0.0	2	2	1.5e-42	1.9e-41	140.4	0.0	204	368	792	955	785	973	0.88	Platelet-derived growth factor receptor beta (DB00102; DB00398; DB00619; DB01254; DB01268; DB05014; DB05146; DB06589; DB06595; DB08896; DB09079; DB09221; DB09283; DB10770; DB12010; DB12147; DB12978; DB14840)
drugbank_target|P08581	-	1390	sp|Q9NJU9|CDPK3_PL	-	562	3.2e-65	218.8	0.0	1	1	4.1e-66	5.2e-65	218.1	0.0	121	369	1081	1335	1072	1341	0.91	Hepatocyte growth factor receptor (DB02152; DB06314; DB06896; DB06995; DB06997; DB07369; DB07969; DB08079; DB08791; DB08865; DB08875; DB11791; DB12010; DB12200; DB12267; DB12742)
drugbank_target|P10721	-	976	sp|Q9NJU9|CDPK3_PL	-	562	3.7e-65	218.6	0.0	1	2	4.1e-18	5.2e-17	59.7	0.0	117	208	589	686	567	704	0.87	Mast/stem cell growth factor receptor Kit (DB00398; DB00619; DB01254; DB01268; DB01962; DB04868; DB05146; DB05913; DB06080; DB06589; DB06595; DB08896; DB08901; DB09078; DB09103; DB12010; DB12147; DB12742; DB12978; DB14840; DB15233)
drugbank_target|P10721	-	976	sp|Q9NJU9|CDPK3_PL	-	562	3.7e-65	218.6	0.0	2	2	1.6e-47	2.1e-46	156.7	0.0	209	369	763	922	746	948	0.88	Mast/stem cell growth factor receptor Kit (DB00398; DB00619; DB01254; DB01268; DB01962; DB04868; DB05146; DB05913; DB06080; DB06589; DB06595; DB08896; DB08901; DB09078; DB09103; DB12010; DB12147; DB12742; DB12978; DB14840; DB15233)
drugbank_target|O15146	-	869	sp|Q9NJU9|CDPK3_PL	-	562	3.9e-65	218.6	0.0	1	1	5.5e-66	6.9e-65	217.7	0.0	116	367	574	852	564	858	0.87	Muscle, skeletal receptor tyrosine-protein kinase (DB12010)
drugbank_target|Q08345	-	913	sp|Q9NJU9|CDPK3_PL	-	562	4e-65	218.5	0.0	1	1	4.3e-66	5.4e-65	218.1	0.0	118	371	611	903	604	912	0.88	Epithelial discoidin domain-containing receptor 1 (DB00619; DB12010)
drugbank_target|P30530	-	894	sp|Q9NJU9|CDPK3_PL	-	562	4.3e-65	218.4	0.0	1	1	4.6e-66	5.9e-65	218.0	0.0	112	369	530	801	496	806	0.83	Tyrosine-protein kinase receptor UFO (DB12010; DB12141)
drugbank_target|Q96Q40	-	435	sp|Q9NJU9|CDPK3_PL	-	562	4.5e-65	218.3	0.0	1	1	3.8e-65	4.8e-64	214.9	0.0	114	376	100	390	61	403	0.85	Cyclin-dependent kinase 15 (DB00171; DB06486; DB12010)
drugbank_target|P16234	-	1089	sp|Q9NJU9|CDPK3_PL	-	562	4.6e-65	218.3	0.0	1	2	8.1e-21	1e-19	68.6	0.0	118	208	594	690	579	700	0.86	Platelet-derived growth factor receptor alpha (DB00102; DB00619; DB01268; DB05146; DB06043; DB06589; DB06595; DB08896; DB08901; DB09078; DB09079; DB10772; DB12010; DB12147; DB12742; DB14840)
drugbank_target|P16234	-	1089	sp|Q9NJU9|CDPK3_PL	-	562	4.6e-65	218.3	0.0	2	2	1.1e-44	1.4e-43	147.4	0.0	203	367	781	946	771	977	0.86	Platelet-derived growth factor receptor alpha (DB00102; DB00619; DB01268; DB05146; DB06043; DB06589; DB06595; DB08896; DB08901; DB09078; DB09079; DB10772; DB12010; DB12147; DB12742; DB14840)
drugbank_target|P46734	-	347	sp|Q9NJU9|CDPK3_PL	-	562	5e-65	218.2	0.0	1	1	4.7e-66	5.9e-65	217.9	0.0	109	380	55	332	15	343	0.88	Dual specificity mitogen-activated protein kinase kinase 3 (DB12010)
drugbank_target|Q07912	-	1038	sp|Q9NJU9|CDPK3_PL	-	562	7.5e-65	217.6	0.0	1	1	9.3e-66	1.2e-64	217.0	0.0	116	366	125	380	98	408	0.91	Activated CDC42 kinase 1 (DB00171; DB04367; DB11986; DB12010)
drugbank_target|P36507	-	400	sp|Q9NJU9|CDPK3_PL	-	562	2.1e-64	216.1	0.0	1	1	2.6e-65	3.3e-64	215.5	0.0	88	379	39	375	28	386	0.88	Dual specificity mitogen-activated protein kinase kinase 2 (DB06616; DB08911; DB11689; DB11967; DB12010)
drugbank_target|P07333	-	972	sp|Q9NJU9|CDPK3_PL	-	562	2.7e-64	215.8	0.0	1	2	3.3e-21	4.2e-20	69.9	0.0	115	208	580	679	546	686	0.86	Macrophage colony-stimulating factor 1 receptor (DB00619; DB01268; DB06080; DB07167; DB07202; DB12010; DB12147; DB12978)
drugbank_target|P07333	-	972	sp|Q9NJU9|CDPK3_PL	-	562	2.7e-64	215.8	0.0	2	2	1.6e-43	2e-42	143.5	0.0	207	376	747	913	734	945	0.87	Macrophage colony-stimulating factor 1 receptor (DB00619; DB01268; DB06080; DB07167; DB07202; DB12010; DB12147; DB12978)
drugbank_target|P53667	-	647	sp|Q9NJU9|CDPK3_PL	-	562	3e-64	215.6	0.0	1	1	3.3e-65	4.2e-64	215.1	0.0	116	367	337	600	313	611	0.88	LIM domain kinase 1 (DB08912; DB12010)
drugbank_target|P42679	-	507	sp|Q9NJU9|CDPK3_PL	-	562	5e-64	214.9	0.0	1	1	5.2e-65	6.7e-64	214.5	0.0	116	369	233	476	176	481	0.86	Megakaryocyte-associated tyrosine-protein kinase (DB12010)
drugbank_target|P17948	-	1338	sp|Q9NJU9|CDPK3_PL	-	562	6e-64	214.6	0.0	1	2	8.4e-19	1.1e-17	61.9	0.0	111	209	821	926	783	938	0.85	Vascular endothelial growth factor receptor 1 (DB00398; DB01268; DB04879; DB05075; DB05913; DB05932; DB06080; DB06101; DB06589; DB06626; DB07288; DB08896; DB09078; DB09079; DB09221; DB10770; DB12010; DB15685)
drugbank_target|P17948	-	1338	sp|Q9NJU9|CDPK3_PL	-	562	6e-64	214.6	0.0	2	2	1.3e-45	1.7e-44	150.4	0.0	207	369	991	1152	971	1155	0.89	Vascular endothelial growth factor receptor 1 (DB00398; DB01268; DB04879; DB05075; DB05913; DB05932; DB06080; DB06101; DB06589; DB06626; DB07288; DB08896; DB09078; DB09079; DB09221; DB10770; DB12010; DB15685)
drugbank_target|P14616	-	1297	sp|Q9NJU9|CDPK3_PL	-	562	7.4e-64	214.3	0.0	1	1	8.1e-65	1e-63	213.9	0.0	111	369	973	1244	945	1247	0.86	Insulin receptor-related protein (DB12010)
drugbank_target|P52564	-	334	sp|Q9NJU9|CDPK3_PL	-	562	9.3e-64	214.0	0.0	1	1	8.8e-65	1.1e-63	213.7	0.0	107	378	44	319	5	328	0.87	Dual specificity mitogen-activated protein kinase kinase 6 (DB12010)
drugbank_target|Q06418	-	890	sp|Q9NJU9|CDPK3_PL	-	562	1.9e-63	213.0	0.0	1	1	2e-64	2.6e-63	212.6	0.0	113	366	514	781	484	786	0.87	Tyrosine-protein kinase receptor TYRO3 (DB12010)
drugbank_target|Q9UM73	-	1620	sp|Q9NJU9|CDPK3_PL	-	562	3.6e-63	212.1	0.0	1	1	4e-64	5e-63	211.6	0.0	105	369	1104	1381	1059	1400	0.87	ALK tyrosine kinase receptor (DB00171; DB08865; DB09063; DB11363; DB12010; DB12130; DB12141; DB12267)
drugbank_target|Q12866	-	999	sp|Q9NJU9|CDPK3_PL	-	562	5.5e-63	211.5	0.0	1	1	6.1e-64	7.7e-63	211.0	0.0	112	366	581	849	551	858	0.86	Tyrosine-protein kinase Mer (DB08325; DB12010)
drugbank_target|P00533	-	1210	sp|Q9NJU9|CDPK3_PL	-	562	6.6e-63	211.2	0.0	1	1	8e-64	1e-62	210.6	0.0	114	368	710	965	696	976	0.90	Epidermal growth factor receptor (DB00002; DB00281; DB00317; DB00530; DB01259; DB01269; DB03496; DB04988; DB05101; DB05294; DB05374; DB05424; DB05524; DB05944; DB06021; DB07602; DB07662; DB08916; DB09330; DB09559; DB10772; DB11731; DB11737; DB11828; DB11963; DB12010; DB12202; DB12267; DB13164; DB15035)
drugbank_target|P33981	-	857	sp|Q9NJU9|CDPK3_PL	-	562	7.2e-63	211.1	1.2	1	1	9.5e-64	1.2e-62	210.3	1.2	116	387	524	805	494	834	0.88	Dual specificity protein kinase TTK (DB01782; DB12010; DB15498)
drugbank_target|P35968	-	1356	sp|Q9NJU9|CDPK3_PL	-	562	7.4e-63	211.0	0.0	1	2	1e-17	1.3e-16	58.4	0.0	113	210	830	935	814	945	0.85	Vascular endothelial growth factor receptor 2 (DB00398; DB01268; DB04727; DB04849; DB04879; DB05014; DB05075; DB05146; DB05198; DB05578; DB05931; DB05984; DB06080; DB06101; DB06436; DB06589; DB06595; DB06626; DB06938; DB07183; DB07274; DB07326; DB07333; DB07334; DB07514; DB07528; DB07537; DB08042; DB08519; DB08875; DB08896; DB08901; DB09078; DB09079; DB12010; DB12147; DB12307; DB14840)
drugbank_target|P35968	-	1356	sp|Q9NJU9|CDPK3_PL	-	562	7.4e-63	211.0	0.0	2	2	1.8e-45	2.3e-44	150.0	0.0	207	370	997	1159	976	1173	0.88	Vascular endothelial growth factor receptor 2 (DB00398; DB01268; DB04727; DB04849; DB04879; DB05014; DB05075; DB05146; DB05198; DB05578; DB05931; DB05984; DB06080; DB06101; DB06436; DB06589; DB06595; DB06626; DB06938; DB07183; DB07274; DB07326; DB07333; DB07334; DB07514; DB07528; DB07537; DB08042; DB08519; DB08875; DB08896; DB08901; DB09078; DB09079; DB12010; DB12147; DB12307; DB14840)
drugbank_target|Q9NWZ3	-	460	sp|Q9NJU9|CDPK3_PL	-	562	1.1e-62	210.4	0.1	1	1	1.2e-63	1.5e-62	210.0	0.1	88	369	153	452	136	457	0.80	Interleukin-1 receptor-associated kinase 4 (DB08590; DB12010)
drugbank_target|P11309	-	404	sp|Q9NJU9|CDPK3_PL	-	562	1.4e-62	210.1	0.0	1	1	1.5e-63	1.9e-62	209.7	0.0	108	377	120	385	104	399	0.91	Serine/threonine-protein kinase pim-1 (DB01754; DB02010; DB02656; DB03366; DB03650; DB03777; DB04216; DB04395; DB04522; DB04530; DB04715; DB07151; DB07242; DB07524; DB08022; DB08166; DB08230; DB08705; DB08707; DB08708; DB08709; DB12010)
drugbank_target|P9WI81	-	626	sp|Q9NJU9|CDPK3_PL	-	562	1.8e-62	209.8	0.0	1	1	1.9e-63	2.4e-62	209.3	0.0	112	368	6	269	2	291	0.91	Serine/threonine-protein kinase PknB (DB02930; DB03909; DB12010)
drugbank_target|P53671	-	638	sp|Q9NJU9|CDPK3_PL	-	562	1.8e-62	209.8	0.0	1	1	1.9e-63	2.4e-62	209.4	0.0	113	367	326	597	267	601	0.85	LIM domain kinase 2 (DB12010)
drugbank_target|Q8IIR9	-	335	sp|Q9NJU9|CDPK3_PL	-	562	2e-62	209.6	2.0	1	1	5.5e-63	7e-62	207.8	2.0	110	377	36	332	17	335	0.89	Casein kinase 2, alpha subunit (DB11638)
drugbank_target|P68400	-	391	sp|Q9NJU9|CDPK3_PL	-	562	2.3e-62	209.4	1.5	1	1	3.7e-63	4.7e-62	208.4	1.5	114	377	36	328	27	339	0.91	Casein kinase II subunit alpha (DB00171; DB01765; DB02170; DB02709; DB03035; DB03127; DB03924; DB04216; DB04395; DB04462; DB04719; DB04720; DB04721; DB07715; DB07802; DB08338; DB08340; DB08345; DB08353; DB08354; DB08360; DB08362; DB08473; DB08660; DB08846; DB12010)
drugbank_target|Q04912	-	1400	sp|Q9NJU9|CDPK3_PL	-	562	3.7e-62	208.7	0.0	1	1	4.1e-63	5.2e-62	208.2	0.0	120	367	1084	1337	1067	1344	0.90	Macrophage-stimulating protein receptor (DB12010)
drugbank_target|P19784	-	350	sp|Q9NJU9|CDPK3_PL	-	562	9.8e-62	207.3	2.7	1	1	1.4e-62	1.7e-61	206.5	2.7	114	378	37	330	19	344	0.90	Casein kinase II subunit alpha' (DB07546; DB12010)
drugbank_target|P04626	-	1255	sp|Q9NJU9|CDPK3_PL	-	562	1.1e-61	207.2	0.0	1	1	1.2e-62	1.5e-61	206.7	0.0	113	369	715	974	676	987	0.88	Receptor tyrosine-protein kinase erbB-2 (DB00072; DB01259; DB04988; DB05773; DB05944; DB06021; DB06366; DB08916; DB11652; DB11973; DB12010; DB12267; DB15035)
drugbank_target|P49841	-	420	sp|Q9NJU9|CDPK3_PL	-	562	1.7e-61	206.5	0.0	1	1	3.1e-62	3.9e-61	205.3	0.0	117	377	56	344	45	371	0.83	Glycogen synthase kinase-3 beta (DB01356; DB01772; DB01793; DB01950; DB02010; DB02052; DB03444; DB04014; DB04395; DB07014; DB07058; DB07149; DB07584; DB07585; DB07676; DB07812; DB07859; DB07947; DB08073; DB12010; DB12129; DB14507; DB14508; DB14509)
drugbank_target|P49840	-	483	sp|Q9NJU9|CDPK3_PL	-	562	2.2e-61	206.1	0.0	1	1	3.6e-62	4.5e-61	205.1	0.0	118	375	120	405	106	414	0.83	Glycogen synthase kinase-3 alpha (DB12010)
drugbank_target|Q52WX2	-	424	sp|Q9NJU9|CDPK3_PL	-	562	1.1e-60	203.8	0.0	1	1	1.1e-61	1.4e-60	203.5	0.0	110	368	46	310	33	329	0.91	Serine/threonine-protein kinase SBK1 (DB12010)
drugbank_target|Q86V86	-	326	sp|Q9NJU9|CDPK3_PL	-	562	4.1e-60	202.0	0.0	1	1	4.3e-61	5.4e-60	201.6	0.0	108	374	31	294	21	307	0.93	Serine/threonine-protein kinase pim-3 (DB12010)
drugbank_target|P49336	-	464	sp|Q9NJU9|CDPK3_PL	-	562	6.2e-60	201.4	0.1	1	1	1.3e-60	1.7e-59	199.9	0.1	107	376	10	338	2	344	0.86	Cyclin-dependent kinase 8 (DB03496)
drugbank_target|O15111	-	745	sp|Q9NJU9|CDPK3_PL	-	562	2e-59	199.7	0.0	1	1	2.5e-60	3.2e-59	199.0	0.0	119	334	17	241	14	298	0.81	Inhibitor of nuclear factor kappa-B kinase subunit alpha (DB00233; DB00244; DB00795; DB06151)
drugbank_target|P29376	-	864	sp|Q9NJU9|CDPK3_PL	-	562	2.3e-59	199.5	0.0	1	1	2.5e-60	3.1e-59	199.1	0.0	118	370	511	776	503	794	0.89	Leukocyte tyrosine kinase receptor (DB12010)
drugbank_target|P35916	-	1363	sp|Q9NJU9|CDPK3_PL	-	562	2.9e-59	199.2	0.0	1	2	9.3e-17	1.2e-15	55.2	0.0	113	208	841	943	802	953	0.86	Vascular endothelial growth factor receptor 3 (DB00398; DB01268; DB04879; DB05075; DB05932; DB06080; DB06101; DB06589; DB06626; DB08896; DB09078; DB09079; DB12010; DB15685)
drugbank_target|P35916	-	1363	sp|Q9NJU9|CDPK3_PL	-	562	2.9e-59	199.2	0.0	2	2	5.7e-43	7.3e-42	141.7	0.0	209	369	1008	1167	1000	1216	0.89	Vascular endothelial growth factor receptor 3 (DB00398; DB01268; DB04879; DB05075; DB05932; DB06080; DB06101; DB06589; DB06626; DB08896; DB09078; DB09079; DB12010; DB15685)
drugbank_target|Q59H18	-	835	sp|Q9NJU9|CDPK3_PL	-	562	3.1e-59	199.1	0.0	1	1	3.6e-60	4.6e-59	198.5	0.0	101	368	448	716	432	719	0.89	Serine/threonine-protein kinase TNNI3K (DB12010)
drugbank_target|O14920	-	756	sp|Q9NJU9|CDPK3_PL	-	562	1.1e-58	197.2	0.0	1	1	8.7e-60	1.1e-58	197.2	0.0	118	328	16	236	6	291	0.86	Inhibitor of nuclear factor kappa-B kinase subunit beta (DB00244; DB00795; DB00945; DB00995; DB01169; DB05183; DB06151; DB06521; DB12010)
drugbank_target|P19525	-	551	sp|Q9NJU9|CDPK3_PL	-	562	2.8e-58	195.9	0.5	1	1	2.2e-59	2.8e-58	195.9	0.5	101	383	253	548	223	551	0.88	Interferon-induced, double-stranded RNA-activated protein kinase (DB12010)
drugbank_target|Q15569	-	626	sp|Q9NJU9|CDPK3_PL	-	562	7.4e-58	194.5	0.0	1	1	7.9e-59	1e-57	194.1	0.0	109	373	50	314	39	333	0.88	Dual specificity testis-specific protein kinase 1 (DB12010)
drugbank_target|Q8TDR2	-	534	sp|Q9NJU9|CDPK3_PL	-	562	1.4e-57	193.6	0.0	1	1	7e-58	8.9e-57	191.0	0.0	114	367	199	523	192	527	0.88	Serine/threonine-protein kinase 35 (DB12010)
drugbank_target|Q9BQI3	-	630	sp|Q9NJU9|CDPK3_PL	-	562	1.4e-57	193.6	1.8	1	2	1.4e-17	1.8e-16	57.9	0.2	93	185	144	236	117	241	0.79	Eukaryotic translation initiation factor 2-alpha kinase 1 (DB12010)
drugbank_target|Q9BQI3	-	630	sp|Q9NJU9|CDPK3_PL	-	562	1.4e-57	193.6	1.8	2	2	6.2e-41	7.9e-40	135.0	0.1	175	404	365	611	339	621	0.79	Eukaryotic translation initiation factor 2-alpha kinase 1 (DB12010)
drugbank_target|Q13523	-	1007	sp|Q9NJU9|CDPK3_PL	-	562	3.7e-57	192.2	1.8	1	2	1.7e-54	2.1e-53	179.8	0.3	95	338	665	912	654	919	0.90	Serine/threonine-protein kinase PRP4 homolog (DB12010)
drugbank_target|Q13523	-	1007	sp|Q9NJU9|CDPK3_PL	-	562	3.7e-57	192.2	1.8	2	2	2.1e-06	2.7e-05	21.0	0.1	334	376	965	1006	948	1007	0.85	Serine/threonine-protein kinase PRP4 homolog (DB12010)
drugbank_target|O14976	-	1311	sp|Q9NJU9|CDPK3_PL	-	562	4.7e-57	191.9	0.0	1	1	6.8e-58	8.6e-57	191.0	0.0	118	369	41	311	22	334	0.86	Cyclin-G-associated kinase (DB12010)
drugbank_target|Q8NFD2	-	765	sp|Q9NJU9|CDPK3_PL	-	562	8.1e-56	187.8	0.0	1	1	8.6e-57	1.1e-55	187.4	0.0	122	371	26	285	15	348	0.83	Ankyrin repeat and protein kinase domain-containing protein 1 (DB12010)
drugbank_target|P21860	-	1342	sp|Q9NJU9|CDPK3_PL	-	562	5.2e-55	185.1	0.0	1	1	6.1e-56	7.7e-55	184.6	0.0	115	369	706	963	670	971	0.88	Receptor tyrosine-protein kinase erbB-3 (DB11652)
drugbank_target|Q99640	-	499	sp|Q9NJU9|CDPK3_PL	-	562	5.4e-54	181.8	0.0	1	1	5.7e-55	7.2e-54	181.4	0.0	115	375	109	361	85	369	0.90	Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase (DB12010)
drugbank_target|P57078	-	832	sp|Q9NJU9|CDPK3_PL	-	562	1.4e-53	180.4	0.0	1	1	1.5e-54	1.9e-53	179.9	0.0	121	365	25	277	12	289	0.87	Receptor-interacting serine/threonine-protein kinase 4 (DB12010)
drugbank_target|P30291	-	646	sp|Q9NJU9|CDPK3_PL	-	562	2.9e-53	179.4	0.1	1	1	3e-54	3.9e-53	178.9	0.1	106	414	289	609	248	621	0.83	Wee1-like protein kinase (DB04608; DB07006; DB07226; DB07257; DB07265; DB08365; DB11740; DB12010)
drugbank_target|O15197	-	1021	sp|Q9NJU9|CDPK3_PL	-	562	1e-52	177.5	0.0	1	1	1.2e-53	1.5e-52	177.0	0.0	105	368	657	912	643	923	0.91	Ephrin type-B receptor 6 (DB12010)
drugbank_target|Q13470	-	666	sp|Q9NJU9|CDPK3_PL	-	562	2.6e-52	176.2	0.0	1	1	2.8e-53	3.6e-52	175.8	0.0	121	367	119	373	111	378	0.90	Non-receptor tyrosine-protein kinase TNK1 (DB12010)
drugbank_target|O75460	-	977	sp|Q9NJU9|CDPK3_PL	-	562	7.6e-52	174.7	0.0	1	1	9.8e-53	1.2e-51	174.0	0.0	120	390	573	849	541	872	0.84	Serine/threonine-protein kinase/endoribonuclease IRE1 (DB07382; DB12010)
drugbank_target|Q14164	-	716	sp|Q9NJU9|CDPK3_PL	-	562	8.2e-52	174.6	0.0	1	1	1.1e-52	1.4e-51	173.8	0.0	121	331	12	241	2	246	0.88	Inhibitor of nuclear factor kappa-B kinase subunit epsilon (DB12010)
drugbank_target|P0DP23	-	149	sp|Q9NJU9|CDPK3_PL	-	562	1.1e-51	174.1	7.7	1	1	9.8e-53	1.2e-51	174.0	7.7	411	561	1	149	1	149	0.96	Calmodulin (DB00477; DB00527; DB00622; DB00623; DB00753; DB00831; DB00836; DB00850; DB00925; DB01023; DB01065; DB01069; DB01100; DB01115; DB01244; DB01373; DB01429; DB02868; DB03900; DB03977; DB04513; DB04825; DB04841; DB08039; DB08231; DB11093; DB11348; DB13800; DB14481)
drugbank_target|P0DP24	-	149	sp|Q9NJU9|CDPK3_PL	-	562	1.1e-51	174.1	7.7	1	1	9.8e-53	1.2e-51	174.0	7.7	411	561	1	149	1	149	0.96	Calmodulin-2 (DB11093; DB11348; DB14481)
drugbank_target|P0DP25	-	149	sp|Q9NJU9|CDPK3_PL	-	562	1.1e-51	174.1	7.7	1	1	9.8e-53	1.2e-51	174.0	7.7	411	561	1	149	1	149	0.96	Calmodulin-3 (DB11093; DB11348; DB14481)
drugbank_target|Q9UHD2	-	729	sp|Q9NJU9|CDPK3_PL	-	562	1.1e-51	174.1	1.3	1	1	9.6e-53	1.2e-51	174.0	0.0	119	332	10	242	2	252	0.88	Serine/threonine-protein kinase TBK1 (DB12010)
drugbank_target|Q5S007	-	2527	sp|Q9NJU9|CDPK3_PL	-	562	1.3e-51	173.9	0.0	1	1	1.8e-52	2.2e-51	173.1	0.0	113	367	1877	2128	1863	2134	0.87	Leucine-rich repeat serine/threonine-protein kinase 2 (DB12010)
drugbank_target|O00238	-	502	sp|Q9NJU9|CDPK3_PL	-	562	2.1e-51	173.2	0.0	1	1	2.4e-52	3e-51	172.7	0.0	101	368	188	488	173	498	0.83	Bone morphogenetic protein receptor type-1B (DB12010)
drugbank_target|O43353	-	540	sp|Q9NJU9|CDPK3_PL	-	562	3.1e-51	172.6	0.0	1	1	3.5e-52	4.5e-51	172.1	0.0	122	368	22	287	14	329	0.89	Receptor-interacting serine/threonine-protein kinase 2 (DB12010)
drugbank_target|Q2M2I8	-	961	sp|Q9NJU9|CDPK3_PL	-	562	3.9e-51	172.3	0.0	1	1	3.1e-52	3.9e-51	172.3	0.0	117	368	46	308	38	348	0.86	AP2-associated protein kinase 1 (DB12010)
drugbank_target|Q9NSY1	-	1161	sp|Q9NJU9|CDPK3_PL	-	562	1e-50	170.9	0.0	1	2	8.1e-52	1e-50	170.9	0.0	116	369	50	313	44	361	0.84	BMP-2-inducible protein kinase (DB12010)
drugbank_target|Q9NSY1	-	1161	sp|Q9NJU9|CDPK3_PL	-	562	1e-50	170.9	0.0	2	2	5.6	71	-0.2	6.5	388	428	461	501	432	641	0.67	BMP-2-inducible protein kinase (DB12010)
drugbank_target|O75716	-	305	sp|Q9NJU9|CDPK3_PL	-	562	1.4e-50	170.5	0.0	1	1	1.4e-51	1.8e-50	170.1	0.0	115	368	18	287	7	295	0.86	Serine/threonine-protein kinase 16 (DB12010)
drugbank_target|P36894	-	532	sp|Q9NJU9|CDPK3_PL	-	562	2.3e-50	169.8	0.0	1	1	2.6e-51	3.3e-50	169.3	0.0	95	369	212	519	173	529	0.80	Bone morphogenetic protein receptor type-1A (DB11639)
drugbank_target|P36897	-	503	sp|Q9NJU9|CDPK3_PL	-	562	1.4e-49	167.2	0.0	1	1	1.6e-50	2e-49	166.7	0.0	101	369	189	490	171	499	0.85	TGF-beta receptor type-1 (DB03921; DB04434; DB04480; DB07152; DB07267; DB08450; DB12010)
drugbank_target|Q04771	-	509	sp|Q9NJU9|CDPK3_PL	-	562	3.5e-49	165.9	0.0	1	1	3.7e-50	4.7e-49	165.5	0.0	110	369	201	493	178	501	0.85	Activin receptor type-1 (DB00171; DB08597; DB12010)
drugbank_target|P20594	-	1047	sp|Q9NJU9|CDPK3_PL	-	562	1.6e-46	157.1	0.0	1	1	1.8e-47	2.3e-46	156.6	0.0	138	368	542	783	530	856	0.84	Atrial natriuretic peptide receptor 2 (DB01613; DB04899)
drugbank_target|P37023	-	503	sp|Q9NJU9|CDPK3_PL	-	562	2.5e-45	153.2	0.0	1	1	2.6e-46	3.3e-45	152.8	0.0	106	369	191	487	163	496	0.83	Serine/threonine-protein kinase receptor R3 (DB00171)
drugbank_target|P36896	-	505	sp|Q9NJU9|CDPK3_PL	-	562	2.6e-45	153.1	0.0	1	1	2.8e-46	3.5e-45	152.7	0.0	109	369	199	492	168	501	0.84	Activin receptor type-1B (DB00171; DB12010)
drugbank_target|Q13873	-	1038	sp|Q9NJU9|CDPK3_PL	-	562	7.7e-45	151.6	0.0	1	1	9.3e-46	1.2e-44	150.9	0.0	115	370	201	500	179	541	0.81	Bone morphogenetic protein receptor type-2 (DB11639; DB12010)
drugbank_target|P27037	-	513	sp|Q9NJU9|CDPK3_PL	-	562	8.4e-45	151.4	0.1	1	1	9.1e-46	1.1e-44	151.0	0.1	125	365	199	473	192	501	0.85	Activin receptor type-2A (DB12118)
drugbank_target|P16066	-	1061	sp|Q9NJU9|CDPK3_PL	-	562	1.8e-44	150.3	0.0	1	1	2e-45	2.5e-44	149.8	0.0	131	377	551	808	545	862	0.84	Atrial natriuretic peptide receptor 1 (DB00325; DB00727; DB00883; DB01612; DB01613; DB04899; DB05034)
drugbank_target|P78362	-	688	sp|Q9NJU9|CDPK3_PL	-	562	2.1e-44	150.1	7.2	1	2	4.3e-29	5.4e-28	95.9	0.1	113	247	77	223	55	229	0.84	SRSF protein kinase 2 (DB00173; DB02733; DB04395)
drugbank_target|P78362	-	688	sp|Q9NJU9|CDPK3_PL	-	562	2.1e-44	150.1	7.2	2	2	2e-17	2.5e-16	57.4	0.0	253	374	524	687	511	688	0.87	SRSF protein kinase 2 (DB00173; DB02733; DB04395)
drugbank_target|Q9HCP0	-	422	sp|Q9NJU9|CDPK3_PL	-	562	5.2e-44	148.8	0.0	1	1	6.7e-45	8.5e-44	148.1	0.0	82	351	7	291	2	322	0.86	Casein kinase I isoform gamma-1 (DB08325)
drugbank_target|P51617	-	712	sp|Q9NJU9|CDPK3_PL	-	562	5.3e-44	148.8	0.0	1	1	5.9e-45	7.5e-44	148.3	0.0	122	368	216	515	204	518	0.83	Interleukin-1 receptor-associated kinase 1 (DB12010)
drugbank_target|P37173	-	567	sp|Q9NJU9|CDPK3_PL	-	562	1.5e-43	147.2	0.1	1	1	1.8e-44	2.3e-43	146.7	0.1	105	367	227	534	189	543	0.78	TGF-beta receptor type-2 (DB10770; DB10772; DB12010)
drugbank_target|Q9Y616	-	596	sp|Q9NJU9|CDPK3_PL	-	562	2.2e-43	146.7	0.1	1	1	2.3e-44	2.9e-43	146.3	0.1	108	370	154	442	131	465	0.82	Interleukin-1 receptor-associated kinase 3 (DB12010)
drugbank_target|P02585	-	160	sp|Q9NJU9|CDPK3_PL	-	562	9.4e-43	144.7	7.3	1	1	8.7e-44	1.1e-42	144.4	7.3	412	559	9	157	2	159	0.95	Troponin C, skeletal muscle (DB01023; DB01373; DB04682)
drugbank_target|P48729	-	337	sp|Q9NJU9|CDPK3_PL	-	562	1.3e-42	144.2	0.2	1	1	1.2e-43	1.5e-42	144.0	0.2	114	353	14	263	3	334	0.84	Casein kinase I isoform alpha (DB12010)
drugbank_target|P49674	-	416	sp|Q9NJU9|CDPK3_PL	-	562	5.1e-42	142.2	0.0	1	1	5.4e-43	6.8e-42	141.8	0.0	113	353	5	255	2	279	0.86	Casein kinase I isoform epsilon (DB06195)
drugbank_target|Q9Y6M4	-	447	sp|Q9NJU9|CDPK3_PL	-	562	9.2e-42	141.4	0.0	1	1	1e-42	1.3e-41	140.9	0.0	82	337	6	274	1	289	0.80	Casein kinase I isoform gamma-3 (DB04751; DB07488; DB07489; DB07664)
drugbank_target|P63098	-	170	sp|Q9NJU9|CDPK3_PL	-	562	1.1e-41	141.1	3.0	1	1	1.1e-42	1.4e-41	140.8	3.0	410	557	10	156	3	159	0.94	Calcineurin subunit B type 1 (DB08231; DB11693)
drugbank_target|Q96LZ3	-	170	sp|Q9NJU9|CDPK3_PL	-	562	3.4e-41	139.5	2.3	1	1	3.3e-42	4.1e-41	139.2	2.3	409	558	9	157	3	160	0.94	Calcineurin subunit B type 2 (DB00091; DB11693)
drugbank_target|P78368	-	415	sp|Q9NJU9|CDPK3_PL	-	562	2e-40	137.0	0.0	1	1	2e-41	2.5e-40	136.6	0.0	118	350	47	291	8	304	0.86	Casein kinase I isoform gamma-2 (DB03083; DB03693; DB04604)
drugbank_target|P63316	-	161	sp|Q9NJU9|CDPK3_PL	-	562	1.5e-39	134.1	10.7	1	1	1.4e-40	1.8e-39	133.8	10.7	410	559	7	158	2	160	0.94	Troponin C, slow skeletal and cardiac muscles (DB00831; DB00922; DB01023; DB01244; DB01373; DB01375; DB03944; DB04513)
drugbank_target|P22676	-	271	sp|Q9NJU9|CDPK3_PL	-	562	2.1e-36	123.7	10.4	1	3	3.4e-14	4.3e-13	46.7	2.0	485	557	13	91	10	95	0.82	Calretinin (DB11093; DB11348; DB13800; DB14481)
drugbank_target|P22676	-	271	sp|Q9NJU9|CDPK3_PL	-	562	2.1e-36	123.7	10.4	2	3	2.7e-16	3.4e-15	53.7	0.0	477	558	97	180	94	184	0.87	Calretinin (DB11093; DB11348; DB13800; DB14481)
drugbank_target|P22676	-	271	sp|Q9NJU9|CDPK3_PL	-	562	2.1e-36	123.7	10.4	3	3	2.7e-08	3.5e-07	27.2	1.2	485	534	193	240	184	252	0.77	Calretinin (DB11093; DB11348; DB13800; DB14481)
drugbank_target|P0C264	-	359	sp|Q9NJU9|CDPK3_PL	-	562	3e-36	123.2	0.0	1	1	3.1e-37	3.9e-36	122.8	0.0	110	362	36	295	6	306	0.87	Uncharacterized serine/threonine-protein kinase SBK3 (DB12010)
drugbank_target|P25092	-	1073	sp|Q9NJU9|CDPK3_PL	-	562	4.3e-36	122.7	1.3	1	1	5.4e-37	6.8e-36	122.0	1.3	138	367	507	741	501	788	0.85	Heat-stable enterotoxin receptor (DB08890)
drugbank_target|O75340	-	191	sp|Q9NJU9|CDPK3_PL	-	562	3e-35	119.9	0.6	1	2	3.6e-11	4.6e-10	36.7	0.0	494	558	29	89	20	91	0.89	Programmed cell death protein 6 (DB01373; DB01593; DB11093; DB11348; DB14481; DB14487)
drugbank_target|O75340	-	191	sp|Q9NJU9|CDPK3_PL	-	562	3e-35	119.9	0.6	2	2	1e-24	1.3e-23	81.4	0.7	420	510	92	178	89	185	0.93	Programmed cell death protein 6 (DB01373; DB01593; DB11093; DB11348; DB14481; DB14487)
drugbank_target|P62166	-	190	sp|Q9NJU9|CDPK3_PL	-	562	6e-35	118.9	2.7	1	1	5.6e-36	7.1e-35	118.6	2.7	417	560	21	175	2	176	0.84	Neuronal calcium sensor 1 (DB11093; DB11348; DB14481)
drugbank_target|P9WI73	-	750	sp|Q9NJU9|CDPK3_PL	-	562	8.8e-35	118.3	0.0	1	1	1e-35	1.3e-34	117.8	0.0	114	314	148	344	140	392	0.85	Serine/threonine-protein kinase PknG (DB07398)
drugbank_target|P43080	-	201	sp|Q9NJU9|CDPK3_PL	-	562	3.6e-34	116.3	0.8	1	1	3.6e-35	4.5e-34	116.0	0.8	415	558	10	160	3	163	0.89	Guanylyl cyclase-activating protein 1 (DB08231)
drugbank_target|P20807	-	821	sp|Q9NJU9|CDPK3_PL	-	562	1.1e-33	114.7	8.0	1	2	6.8e-12	8.7e-11	39.1	1.1	485	557	646	720	642	723	0.87	Calpain-3 (DB06124)
drugbank_target|P20807	-	821	sp|Q9NJU9|CDPK3_PL	-	562	1.1e-33	114.7	8.0	2	2	4.4e-24	5.6e-23	79.4	0.9	419	513	723	812	721	819	0.94	Calpain-3 (DB06124)
drugbank_target|Q16671	-	573	sp|Q9NJU9|CDPK3_PL	-	562	2.5e-33	113.5	0.0	1	1	2.7e-34	3.5e-33	113.1	0.0	121	369	206	503	192	513	0.82	Anti-Muellerian hormone type-2 receptor (DB00171)
drugbank_target|P19105	-	171	sp|Q9NJU9|CDPK3_PL	-	562	5e-33	112.6	4.6	1	1	4.7e-34	5.9e-33	112.3	4.6	393	559	3	163	1	165	0.94	Myosin regulatory light chain 12A (DB08378)
drugbank_target|P07384	-	714	sp|Q9NJU9|CDPK3_PL	-	562	5.7e-32	109.1	7.5	1	2	7.1e-16	9e-15	52.3	1.0	454	555	503	611	495	616	0.88	Calpain-1 catalytic subunit (DB04276; DB04653; DB07627)
drugbank_target|P07384	-	714	sp|Q9NJU9|CDPK3_PL	-	562	5.7e-32	109.1	7.5	2	2	2.1e-18	2.7e-17	60.6	0.7	420	514	617	705	611	713	0.92	Calpain-1 catalytic subunit (DB04276; DB04653; DB07627)
drugbank_target|P35243	-	200	sp|Q9NJU9|CDPK3_PL	-	562	9.9e-32	108.3	1.5	1	1	9.9e-33	1.3e-31	107.9	1.5	415	557	20	175	4	179	0.90	Recoverin (DB08231)
drugbank_target|Q99653	-	195	sp|Q9NJU9|CDPK3_PL	-	562	1.4e-30	104.5	0.6	1	1	1.3e-31	1.7e-30	104.2	0.6	404	558	12	180	3	183	0.91	Calcineurin B homologous protein 1 (DB11093; DB11348; DB14481)
drugbank_target|Q9UBV8	-	284	sp|Q9NJU9|CDPK3_PL	-	562	1.5e-29	101.1	0.2	1	2	4.9e-13	6.3e-12	42.9	0.0	423	480	119	178	116	181	0.94	Peflin (DB11093; DB11348; DB14481)
drugbank_target|Q9UBV8	-	284	sp|Q9NJU9|CDPK3_PL	-	562	1.5e-29	101.1	0.2	2	2	4.2e-17	5.3e-16	56.3	0.0	420	508	183	268	180	282	0.87	Peflin (DB11093; DB11348; DB14481)
drugbank_target|P14649	-	208	sp|Q9NJU9|CDPK3_PL	-	562	3.3e-29	99.9	0.0	1	1	3.1e-30	3.9e-29	99.7	0.0	401	556	47	203	26	207	0.90	Myosin light chain 6B (DB08378)
drugbank_target|P04632	-	268	sp|Q9NJU9|CDPK3_PL	-	562	6e-29	99.1	0.8	1	2	5.1e-07	6.5e-06	23.0	0.1	491	555	99	165	87	169	0.80	Calpain small subunit 1 (DB02570)
drugbank_target|P04632	-	268	sp|Q9NJU9|CDPK3_PL	-	562	6e-29	99.1	0.8	2	2	8.8e-23	1.1e-21	75.1	0.1	419	511	170	257	165	266	0.94	Calpain small subunit 1 (DB02570)
drugbank_target|P30626	-	198	sp|Q9NJU9|CDPK3_PL	-	562	4.4e-28	96.2	0.0	1	2	4.8e-11	6e-10	36.4	0.0	491	557	33	98	28	103	0.89	Sorcin (DB11093; DB11348; DB14481)
drugbank_target|P30626	-	198	sp|Q9NJU9|CDPK3_PL	-	562	4.4e-28	96.2	0.0	2	2	1.2e-17	1.5e-16	58.2	0.0	421	509	103	185	100	188	0.91	Sorcin (DB11093; DB11348; DB14481)
drugbank_target|Q13938	-	189	sp|Q9NJU9|CDPK3_PL	-	562	5.8e-28	95.8	0.0	1	1	5.8e-29	7.3e-28	95.5	0.0	418	557	21	165	4	168	0.86	Calcyphosin (DB11093; DB11348; DB14481)
drugbank_target|P28676	-	217	sp|Q9NJU9|CDPK3_PL	-	562	4.1e-25	86.4	0.0	1	2	1e-10	1.3e-09	35.3	0.0	493	557	54	117	42	121	0.89	Grancalcin (DB11093; DB11348; DB14481)
drugbank_target|P28676	-	217	sp|Q9NJU9|CDPK3_PL	-	562	4.1e-25	86.4	0.0	2	2	4.7e-15	6e-14	49.6	0.0	421	501	122	196	118	204	0.88	Grancalcin (DB11093; DB11348; DB14481)
drugbank_target|O75746	-	678	sp|Q9NJU9|CDPK3_PL	-	562	4.5e-25	86.3	0.2	1	2	8.2e-23	1e-21	75.2	0.0	410	558	3	154	1	156	0.91	Calcium-binding mitochondrial carrier protein Aralar1 (DB00128)
drugbank_target|O75746	-	678	sp|Q9NJU9|CDPK3_PL	-	562	4.5e-25	86.3	0.2	2	2	0.0004	0.0051	13.5	0.2	402	515	141	255	134	262	0.77	Calcium-binding mitochondrial carrier protein Aralar1 (DB00128)
drugbank_target|O75838	-	187	sp|Q9NJU9|CDPK3_PL	-	562	3.5e-23	80.1	2.1	1	1	3.1e-24	3.9e-23	79.9	2.1	441	558	54	173	3	176	0.80	Calcium and integrin-binding family member 2 (DB11093; DB11348; DB14481)
drugbank_target|Q9UJS0	-	675	sp|Q9NJU9|CDPK3_PL	-	562	2.1e-22	77.5	0.2	1	2	1.2e-20	1.5e-19	68.1	0.1	415	557	9	154	2	156	0.87	Calcium-binding mitochondrial carrier protein Aralar2 (DB00128)
drugbank_target|Q9UJS0	-	675	sp|Q9NJU9|CDPK3_PL	-	562	2.1e-22	77.5	0.2	2	2	0.0093	0.12	9.0	0.0	405	516	145	257	135	278	0.79	Calcium-binding mitochondrial carrier protein Aralar2 (DB00128)
drugbank_target|P12814	-	892	sp|Q9NJU9|CDPK3_PL	-	562	3.8e-21	73.3	0.2	1	1	5.8e-22	7.4e-21	72.4	0.2	400	515	728	850	692	858	0.84	Alpha-actinin-1 (DB06773; DB09130)
drugbank_target|Q96KG9	-	808	sp|Q9NJU9|CDPK3_PL	-	562	4.5e-21	73.1	0.0	1	1	5.2e-22	6.6e-21	72.5	0.0	134	314	33	221	30	244	0.89	N-terminal kinase-like protein (DB05036)
drugbank_target|Q99828	-	191	sp|Q9NJU9|CDPK3_PL	-	562	2.6e-20	70.6	0.1	1	1	2.4e-21	3e-20	70.4	0.1	443	558	55	177	30	180	0.89	Calcium and integrin-binding protein 1 (DB11093; DB11348; DB14481)
drugbank_target|Q9Y6T7	-	804	sp|Q9NJU9|CDPK3_PL	-	562	1.7e-18	64.6	0.0	1	1	2.4e-19	3.1e-18	63.7	0.0	476	556	136	221	125	226	0.86	Diacylglycerol kinase beta (DB14001)
drugbank_target|P49619	-	791	sp|Q9NJU9|CDPK3_PL	-	562	4.9e-16	56.5	0.0	1	1	9.2e-17	1.2e-15	55.2	0.0	478	556	164	247	150	252	0.83	Diacylglycerol kinase gamma (DB14001)
drugbank_target|P49619	-	791	sp|Q9NJU9|CDPK3_PL	-	562	4.9e-16	56.5	0.0	1	1	9.2e-17	1.2e-15	55.2	0.0	478	556	164	247	150	252	0.83	Diacylglycerol kinase gamma (DB00144)
drugbank_target|P23297	-	94	sp|Q9NJU9|CDPK3_PL	-	562	1.4e-15	54.9	1.0	1	1	1.2e-16	1.5e-15	54.8	1.0	491	558	10	79	1	82	0.88	Protein S100-A1 (DB00768)
drugbank_target|P23743	-	735	sp|Q9NJU9|CDPK3_PL	-	562	1.2e-14	51.9	0.0	1	1	1.9e-15	2.4e-14	50.9	0.0	485	556	107	182	97	186	0.90	Diacylglycerol kinase alpha (DB14001)
drugbank_target|P23743	-	735	sp|Q9NJU9|CDPK3_PL	-	562	1.2e-14	51.9	0.0	1	1	1.9e-15	2.4e-14	50.9	0.0	485	556	107	182	97	186	0.90	Diacylglycerol kinase alpha (DB00163)
drugbank_target|P31949	-	105	sp|Q9NJU9|CDPK3_PL	-	562	1.2e-13	48.5	0.1	1	1	1.1e-14	1.4e-13	48.3	0.1	491	557	15	83	5	86	0.92	Protein S100-A11 (DB02482)
drugbank_target|P60903	-	97	sp|Q9NJU9|CDPK3_PL	-	562	1.3e-13	48.5	0.4	1	1	1.1e-14	1.4e-13	48.3	0.4	490	557	9	75	1	78	0.92	Protein S100-A10 (DB12695)
drugbank_target|P29377	-	79	sp|Q9NJU9|CDPK3_PL	-	562	6.5e-13	46.1	0.3	1	1	5.7e-14	7.2e-13	46.0	0.3	487	559	4	75	1	77	0.89	Protein S100-G (DB04464)
drugbank_target|P04271	-	92	sp|Q9NJU9|CDPK3_PL	-	562	8.2e-13	45.8	2.8	1	1	7.7e-14	9.8e-13	45.6	2.8	493	558	11	78	2	81	0.90	Protein S100-B (DB00768; DB01373; DB04464; DB05343; DB06941; DB07004; DB11093; DB11348; DB14481)
drugbank_target|P20472	-	110	sp|Q9NJU9|CDPK3_PL	-	562	2.4e-12	44.3	2.1	1	1	1.9e-13	2.5e-12	44.2	2.1	473	557	25	106	4	110	0.66	Parvalbumin alpha (DB01942)
drugbank_target|P26447	-	101	sp|Q9NJU9|CDPK3_PL	-	562	1.4e-11	41.7	0.2	1	1	1.2e-12	1.5e-11	41.7	0.2	493	558	12	79	1	82	0.90	Protein S100-A4 (DB00831; DB09130)
drugbank_target|Q8NI22	-	146	sp|Q9NJU9|CDPK3_PL	-	562	2.9e-11	40.7	0.2	1	1	2.6e-12	3.3e-11	40.5	0.2	487	557	67	144	51	146	0.80	Multiple coagulation factor deficiency protein 2 (DB00025; DB13998; DB13999)
drugbank_target|P25815	-	95	sp|Q9NJU9|CDPK3_PL	-	562	3.8e-11	40.3	0.1	1	1	3.4e-12	4.4e-11	40.1	0.1	492	558	10	78	2	81	0.87	Protein S100-P (DB01003)
drugbank_target|Q92736	-	4967	sp|Q9NJU9|CDPK3_PL	-	562	4.9e-11	40.0	1.4	1	1	3.9e-12	4.9e-11	40.0	1.4	424	480	4029	4085	3998	4093	0.90	Ryanodine receptor 2 (DB01195; DB09085)
drugbank_target|P80511	-	92	sp|Q9NJU9|CDPK3_PL	-	562	5.1e-11	39.9	0.7	1	1	4.1e-12	5.2e-11	39.9	0.7	493	559	11	79	1	82	0.78	Protein S100-A12 (DB00768; DB01025)
drugbank_target|P06703	-	90	sp|Q9NJU9|CDPK3_PL	-	562	6e-11	39.7	0.1	1	1	5.3e-12	6.8e-11	39.5	0.1	494	558	13	77	3	80	0.83	Protein S100-A6 (DB11093; DB11348; DB14481)
drugbank_target|P29034	-	98	sp|Q9NJU9|CDPK3_PL	-	562	1.3e-10	38.5	0.3	1	1	1.2e-11	1.5e-10	38.4	0.3	482	558	3	80	1	83	0.86	Protein S100-A2 (DB00768; DB01373; DB01593; DB09130; DB14487; DB14533; DB14548)
drugbank_target|Q68101	-	707	sp|Q9NJU9|CDPK3_PL	-	562	1e-09	35.6	0.0	1	1	1.1e-10	1.4e-09	35.1	0.0	122	272	335	494	316	508	0.84	Serine/threonine protein kinase UL97 (DB06234)
drugbank_target|P16788	-	707	sp|Q9NJU9|CDPK3_PL	-	562	1e-09	35.6	0.0	1	1	1.1e-10	1.4e-09	35.1	0.0	122	272	335	494	316	508	0.84	Serine/threonine protein kinase UL97 (DB06234)
drugbank_target|Q9NXG6	-	502	sp|Q9NJU9|CDPK3_PL	-	562	1.1e-09	35.5	0.0	1	1	1.2e-10	1.5e-09	35.1	0.0	433	557	130	252	124	257	0.77	Transmembrane prolyl 4-hydroxylase (DB00126)
drugbank_target|P80303	-	420	sp|Q9NJU9|CDPK3_PL	-	562	1.9e-09	34.7	7.1	1	1	1.5e-10	1.9e-09	34.7	7.1	495	560	248	324	240	327	0.82	Nucleobindin-2 (DB11093; DB11348; DB14481)
drugbank_target|P06702	-	114	sp|Q9NJU9|CDPK3_PL	-	562	2.2e-09	34.5	2.9	1	1	1.9e-10	2.5e-09	34.3	2.9	490	559	12	84	1	86	0.79	Protein S100-A9 (DB01373; DB01593; DB14487; DB14533; DB14548)
drugbank_target|Q02818	-	461	sp|Q9NJU9|CDPK3_PL	-	562	8.3e-09	32.6	4.8	1	2	9.1	1.2e+02	-0.9	1.0	332	404	117	186	94	237	0.58	Nucleobindin-1 (DB11093; DB11348; DB14481)
drugbank_target|Q02818	-	461	sp|Q9NJU9|CDPK3_PL	-	562	8.3e-09	32.6	4.8	2	2	6.5e-10	8.3e-09	32.6	4.8	495	559	247	322	240	325	0.79	Nucleobindin-1 (DB11093; DB11348; DB14481)
drugbank_target|Q96FQ6	-	103	sp|Q9NJU9|CDPK3_PL	-	562	8.6e-09	32.5	0.1	1	1	8e-10	1e-08	32.3	0.1	506	556	31	81	15	84	0.91	Protein S100-A16 (DB11093; DB11348; DB14481)
drugbank_target|P31151	-	101	sp|Q9NJU9|CDPK3_PL	-	562	3.6e-08	30.5	1.4	1	1	3.2e-09	4.1e-08	30.3	1.4	493	557	13	78	2	81	0.87	Protein S100-A7 (DB01050; DB01593; DB04474; DB09213; DB14487; DB14533; DB14548)
drugbank_target|Q86YZ3	-	2850	sp|Q9NJU9|CDPK3_PL	-	562	7.2e-08	29.5	0.3	1	1	8.4e-09	1.1e-07	28.9	0.3	427	491	25	87	15	91	0.88	Hornerin (DB01593; DB14487)
drugbank_target|Q8TF76	-	798	sp|Q9NJU9|CDPK3_PL	-	562	1.5e-07	28.4	0.1	1	1	1.4e-07	1.7e-06	25.0	0.1	116	264	483	692	453	698	0.77	Serine/threonine-protein kinase haspin (DB04604; DB07698; DB07995; DB08004)
drugbank_target|Q99584	-	98	sp|Q9NJU9|CDPK3_PL	-	562	6.6e-07	26.3	0.3	1	1	6.1e-08	7.8e-07	26.1	0.3	496	557	20	79	4	82	0.79	Protein S100-A13 (DB00768; DB01025; DB01164; DB01373; DB11093; DB11348; DB14481)
drugbank_target|P05109	-	93	sp|Q9NJU9|CDPK3_PL	-	562	1.2e-06	25.4	0.1	1	1	1e-07	1.3e-06	25.4	0.1	507	555	28	72	4	78	0.88	Protein S100-A8 (DB01373; DB01593; DB09130; DB14487; DB14533; DB14548)
drugbank_target|P60709	-	375	sp|Q8ILW9|ACT2_PLA	-	376	4.6e-229	758.0	0.0	1	1	6.9e-232	5.2e-229	757.8	0.0	1	376	1	375	1	375	1.00	Actin, cytoplasmic 1 (DB04216; DB12695)
drugbank_target|P63261	-	375	sp|Q8ILW9|ACT2_PLA	-	376	7.9e-229	757.2	0.0	1	1	1.2e-231	8.8e-229	757.1	0.0	1	376	1	375	1	375	1.00	Actin, cytoplasmic 2 (DB09130; DB11638)
drugbank_target|P68133	-	377	sp|Q8ILW9|ACT2_PLA	-	376	7.2e-228	754.1	0.0	1	1	1.1e-230	8.5e-228	753.8	0.0	2	376	4	377	3	377	0.99	Actin, alpha skeletal muscle (DB02621; DB02772; DB03021; DB03616; DB03850; DB03903; DB04151; DB04395; DB04629; DB04774; DB04775; DB04783; DB08080)
drugbank_target|P62736	-	377	sp|Q8ILW9|ACT2_PLA	-	376	2.1e-227	752.5	0.0	1	1	3.3e-230	2.5e-227	752.3	0.0	2	376	4	377	3	377	0.99	Actin, aortic smooth muscle (DB12695)
drugbank_target|P86287	-	376	sp|Q8ILW9|ACT2_PLA	-	376	2.7e-221	732.4	0.0	1	1	4.3e-224	3.2e-221	732.2	0.0	2	376	3	376	2	376	0.99	Actin-1 (DB11638)
drugbank_target|P61160	-	394	sp|Q8ILW9|ACT2_PLA	-	376	1.6e-182	604.8	0.0	1	1	2.8e-185	2.1e-182	604.4	0.0	5	372	6	387	2	390	0.98	Actin-related protein 2 (DB08235; DB08236)
drugbank_target|P61158	-	418	sp|Q8ILW9|ACT2_PLA	-	376	1.2e-172	572.3	0.0	1	1	1.8e-175	1.4e-172	572.1	0.0	5	373	5	410	1	413	0.98	Actin-related protein 3 (DB08235; DB08236)
drugbank_target|P12004	-	261	sp|P61074|PCNA_PLA	-	274	5e-147	486.6	1.4	1	1	1e-150	5.5e-147	486.5	1.4	1	269	1	258	1	261	1.00	Proliferating cell nuclear antigen (DB00279; DB00945)
drugbank_target|O77323	-	539	sp|O77323|TCPH_PLA	-	539	0	1046.4	11.5	1	1	0	0	1046.2	11.5	1	539	1	539	1	539	1.00	T-complex protein 1 subunit eta (DB11638)
drugbank_target|P49368	-	545	sp|O77323|TCPH_PLA	-	539	9.1e-268	887.3	10.3	1	1	6.3e-271	1.1e-267	887.1	10.3	6	530	4	529	1	536	0.99	T-complex protein 1 subunit gamma (DB04395; DB11638)
drugbank_target|P10809	-	573	sp|O77323|TCPH_PLA	-	539	5.4e-97	323.7	15.1	1	2	1.2e-49	2.2e-46	156.7	3.3	21	150	33	167	19	225	0.89	60 kDa heat shock protein, mitochondrial (DB09130)
drugbank_target|P10809	-	573	sp|O77323|TCPH_PLA	-	539	5.4e-97	323.7	15.1	2	2	1.9e-54	3.3e-51	172.6	4.1	369	525	398	547	363	553	0.94	60 kDa heat shock protein, mitochondrial (DB09130)
drugbank_target|Q76NM6	-	611	sp|Q76NM6|VATA_PLA	-	611	0	1166.9	0.0	1	1	0	0	1166.8	0.0	1	611	1	611	1	611	1.00	V-type proton ATPase catalytic subunit A (DB11638)
drugbank_target|P38606	-	617	sp|Q76NM6|VATA_PLA	-	611	0	1116.1	0.0	1	1	0	0	1115.9	0.0	8	608	15	615	10	617	0.99	V-type proton ATPase catalytic subunit A (DB01133)
drugbank_target|P38606	-	617	sp|Q76NM6|VATA_PLA	-	611	0	1116.1	0.0	1	1	0	0	1115.9	0.0	8	608	15	615	10	617	0.99	V-type proton ATPase catalytic subunit A (DB00630; DB01077; DB06733; DB06734)
drugbank_target|P21281	-	511	sp|Q76NM6|VATA_PLA	-	611	3.9e-167	555.4	0.0	1	2	2.6e-38	1.3e-35	121.1	0.0	10	110	46	150	39	157	0.96	V-type proton ATPase subunit B, brain isoform (DB01133)
drugbank_target|P21281	-	511	sp|Q76NM6|VATA_PLA	-	611	3.9e-167	555.4	0.0	2	2	1.3e-132	6.4e-130	432.5	0.0	214	540	163	489	153	502	0.97	V-type proton ATPase subunit B, brain isoform (DB01133)
drugbank_target|P21281	-	511	sp|Q76NM6|VATA_PLA	-	611	3.9e-167	555.4	0.0	1	2	2.6e-38	1.3e-35	121.1	0.0	10	110	46	150	39	157	0.96	V-type proton ATPase subunit B, brain isoform (DB05260; DB07347)
drugbank_target|P21281	-	511	sp|Q76NM6|VATA_PLA	-	611	3.9e-167	555.4	0.0	2	2	1.3e-132	6.4e-130	432.5	0.0	214	540	163	489	153	502	0.97	V-type proton ATPase subunit B, brain isoform (DB05260; DB07347)
drugbank_target|P15313	-	513	sp|Q76NM6|VATA_PLA	-	611	2.2e-164	546.4	0.0	1	2	1.3e-37	6.4e-35	118.7	0.0	10	110	40	144	33	150	0.96	V-type proton ATPase subunit B, kidney isoform (DB01133)
drugbank_target|P15313	-	513	sp|Q76NM6|VATA_PLA	-	611	2.2e-164	546.4	0.0	2	2	1.5e-130	7.3e-128	425.7	0.0	214	540	157	483	148	501	0.97	V-type proton ATPase subunit B, kidney isoform (DB01133)
drugbank_target|P06576	-	529	sp|Q76NM6|VATA_PLA	-	611	2.2e-142	473.7	1.9	1	2	7.2e-20	3.4e-17	60.2	0.6	39	102	91	155	57	162	0.82	ATP synthase subunit beta, mitochondrial (DB04216; DB07384; DB07394; DB08399; DB08629; DB12695)
drugbank_target|P06576	-	529	sp|Q76NM6|VATA_PLA	-	611	2.2e-142	473.7	1.9	2	2	1e-126	4.9e-124	413.1	0.0	201	544	162	501	155	507	0.97	ATP synthase subunit beta, mitochondrial (DB04216; DB07384; DB07394; DB08399; DB08629; DB12695)
drugbank_target|P25705	-	553	sp|Q76NM6|VATA_PLA	-	611	7.8e-121	402.5	7.1	1	2	1.9e-32	9.2e-30	101.7	1.7	4	100	64	159	62	167	0.97	ATP synthase subunit alpha, mitochondrial (DB04216; DB07384; DB07394; DB08399; DB08629; DB11638)
drugbank_target|P25705	-	553	sp|Q76NM6|VATA_PLA	-	611	7.8e-121	402.5	7.1	2	2	1.2e-93	5.6e-91	303.9	0.3	209	520	176	477	170	493	0.92	ATP synthase subunit alpha, mitochondrial (DB04216; DB07384; DB07394; DB08399; DB08629; DB11638)
drugbank_target|P08183	-	1280	sp|Q76NM6|VATA_PLA	-	611	1.6e-07	28.2	0.1	1	2	0.0002	0.096	9.2	0.1	234	262	417	445	407	473	0.79	Multidrug resistance protein 1 (DB00171; DB00603; DB00778; DB00813; DB04877; DB04881; DB04905; DB05449; DB06191; DB06240; DB09031; DB11635; DB14061; DB14062; DB14063; DB14064; DB14065; DB14066; DB14067; DB14068; DB14069; DB14070; DB14071; DB14072)
drugbank_target|P08183	-	1280	sp|Q76NM6|VATA_PLA	-	611	1.6e-07	28.2	0.1	2	2	1.2e-06	0.00057	16.5	0.0	233	261	1059	1087	1012	1095	0.91	Multidrug resistance protein 1 (DB00171; DB00603; DB00778; DB00813; DB04877; DB04881; DB04905; DB05449; DB06191; DB06240; DB09031; DB11635; DB14061; DB14062; DB14063; DB14064; DB14065; DB14066; DB14067; DB14068; DB14069; DB14070; DB14071; DB14072)
drugbank_target|Q2M3G0	-	1257	sp|Q76NM6|VATA_PLA	-	611	0.00093	15.8	0.0	1	2	0.0032	1.5	5.2	0.0	233	262	410	439	391	449	0.81	ATP-binding cassette sub-family B member 5 (DB04851; DB14067)
drugbank_target|Q2M3G0	-	1257	sp|Q76NM6|VATA_PLA	-	611	0.00093	15.8	0.0	2	2	0.00041	0.19	8.1	0.0	233	262	1039	1068	1035	1093	0.81	ATP-binding cassette sub-family B member 5 (DB04851; DB14067)
drugbank_target|O95342	-	1321	sp|Q76NM6|VATA_PLA	-	611	0.0022	14.6	0.1	1	2	0.052	25	1.2	0.0	233	262	444	473	434	482	0.78	Bile salt export pump (DB00171; DB01016)
drugbank_target|O95342	-	1321	sp|Q76NM6|VATA_PLA	-	611	0.0022	14.6	0.1	2	2	6.4e-05	0.031	10.8	0.0	232	266	1101	1138	1093	1158	0.82	Bile salt export pump (DB00171; DB01016)
drugbank_target|P49591	-	514	sp|Q8I5P7|SYSC_PLA	-	618	3.3e-203	674.7	0.0	1	1	4.9e-206	4.3e-203	674.3	0.0	170	608	32	460	18	467	0.98	Serine--tRNA ligase, cytoplasmic (DB00133)
drugbank_target|P0A8M5	-	642	sp|Q8I5P7|SYSC_PLA	-	618	4.5e-36	122.6	0.0	1	1	7.8e-39	6.9e-36	122.0	0.0	359	470	278	381	268	420	0.93	Threonine--tRNA ligase (DB03355; DB03869; DB04024)
drugbank_target|P26639	-	723	sp|Q8I5P7|SYSC_PLA	-	618	1.7e-14	51.4	0.0	1	2	4.8e-17	4.2e-14	50.0	0.0	351	470	350	460	339	475	0.89	Threonine--tRNA ligase, cytoplasmic (DB00156)
drugbank_target|P26639	-	723	sp|Q8I5P7|SYSC_PLA	-	618	1.7e-14	51.4	0.0	2	2	0.55	4.8e+02	-3.0	0.0	544	585	563	608	555	611	0.73	Threonine--tRNA ligase, cytoplasmic (DB00156)
drugbank_target|Q8NW68	-	645	sp|Q8I5P7|SYSC_PLA	-	618	9.1e-14	49.0	0.0	1	2	0.94	8.3e+02	-3.8	0.9	208	232	123	147	108	171	0.47	Threonine--tRNA ligase (DB03355)
drugbank_target|Q8NW68	-	645	sp|Q8I5P7|SYSC_PLA	-	618	9.1e-14	49.0	0.0	2	2	1e-16	9.1e-14	49.0	0.0	346	500	266	413	193	422	0.78	Threonine--tRNA ligase (DB03355)
drugbank_target|Q9BW92	-	718	sp|Q8I5P7|SYSC_PLA	-	618	1.2e-12	45.3	0.0	1	1	1.8e-15	1.6e-12	44.8	0.0	355	472	333	458	321	494	0.85	Threonine--tRNA ligase, mitochondrial (DB00156)
drugbank_target|Q7L3T8	-	475	sp|Q8I5P7|SYSC_PLA	-	618	2e-05	21.4	0.0	1	1	3.1e-08	2.7e-05	21.0	0.0	362	511	105	248	83	268	0.80	Probable proline--tRNA ligase, mitochondrial (DB00172)
drugbank_target|Q8I3Z5	-	171	sp|Q8I3Z5|TCTP_PLA	-	171	3.1e-102	338.0	10.3	1	1	1.3e-105	3.4e-102	337.8	10.3	1	171	1	171	1	171	1.00	Translationally-controlled tumor protein homolog (DB11638)
drugbank_target|P13693	-	172	sp|Q8I3Z5|TCTP_PLA	-	171	4.5e-89	295.1	1.8	1	1	1.9e-92	5e-89	295.0	1.8	1	170	1	171	1	172	0.99	Translationally-controlled tumor protein (DB11093; DB11348; DB14481)
drugbank_target|P68371	-	445	sp|Q7KQL5|TBB_PLAF	-	445	2.9e-247	819.0	0.0	1	1	1.4e-249	3.2e-247	818.9	0.0	1	442	1	442	1	445	0.99	Tubulin beta-4B chain (DB00518; DB00643; DB01873; DB03010; DB04910; DB05147; DB12695)
drugbank_target|Q9BVA1	-	445	sp|Q7KQL5|TBB_PLAF	-	445	7.6e-247	817.7	0.0	1	1	3.7e-249	8.4e-247	817.5	0.0	1	444	1	444	1	445	1.00	Tubulin beta-2B chain (DB05147; DB07574)
drugbank_target|Q13885	-	445	sp|Q7KQL5|TBB_PLAF	-	445	6.8e-246	814.5	0.0	1	1	3.3e-248	7.6e-246	814.4	0.0	1	444	1	444	1	445	1.00	Tubulin beta-2A chain (DB05147; DB12695)
drugbank_target|P07437	-	444	sp|Q7KQL5|TBB_PLAF	-	445	8.5e-246	814.2	0.0	1	1	4.1e-248	9.5e-246	814.0	0.0	1	442	1	442	1	444	0.99	Tubulin beta chain (DB00361; DB00541; DB00570; DB01179; DB01394; DB01873; DB03010; DB05147; DB05284; DB06042; DB09130; DB11638; DB11641; DB11731; DB12334; DB15534)
drugbank_target|P04350	-	444	sp|Q7KQL5|TBB_PLAF	-	445	6.2e-244	808.0	0.0	1	1	3e-246	6.9e-244	807.9	0.0	1	442	1	441	1	444	0.98	Tubulin beta-4A chain (DB01873; DB03010; DB05147; DB06042; DB11638)
drugbank_target|Q13509	-	450	sp|Q7KQL5|TBB_PLAF	-	445	4.5e-243	805.2	0.0	1	1	2.2e-245	5.1e-243	805.0	0.0	1	442	1	442	1	446	0.99	Tubulin beta-3 chain (DB01873; DB03010; DB04845; DB05147; DB06042; DB12695)
drugbank_target|Q7KQL5	-	445	sp|Q7KQL5|TBB_PLAF	-	445	1.3e-242	803.7	0.0	1	1	6.5e-245	1.5e-242	803.5	0.0	1	444	1	444	1	445	1.00	Tubulin beta chain (DB11638)
drugbank_target|F1L7U3	-	455	sp|Q7KQL5|TBB_PLAF	-	445	2e-241	799.8	0.0	1	1	1e-243	2.4e-241	799.5	0.0	1	440	1	440	1	445	0.99	Tubulin beta-2 chain (DB00518)
drugbank_target|Q9BUF5	-	446	sp|Q7KQL5|TBB_PLAF	-	445	9.3e-241	797.6	0.0	1	1	4.5e-243	1e-240	797.4	0.0	1	443	1	444	1	446	0.99	Tubulin beta-6 chain (DB05147; DB11638)
drugbank_target|P68363	-	451	sp|Q7KQL5|TBB_PLAF	-	445	7.2e-228	755.1	0.0	1	1	3.5e-230	8e-228	754.9	0.0	1	440	1	450	1	451	0.99	Tubulin alpha-1B chain (DB01873; DB03010; DB05147; DB07574)
drugbank_target|Q9H4B7	-	451	sp|Q7KQL5|TBB_PLAF	-	445	2e-227	753.7	0.0	1	1	1e-229	2.3e-227	753.4	0.0	1	443	1	444	1	446	0.99	Tubulin beta-1 chain (DB00309; DB01229; DB01248; DB01873; DB03010; DB05147; DB06042; DB06772; DB08871; DB12334; DB12695)
drugbank_target|P10875	-	449	sp|Q7KQL5|TBB_PLAF	-	445	2e-227	753.6	0.0	1	1	1e-229	2.4e-227	753.4	0.0	1	438	1	438	1	445	0.99	Tubulin beta chain (DB00400)
drugbank_target|Q9BQE3	-	449	sp|Q7KQL5|TBB_PLAF	-	445	4e-227	752.7	0.0	1	1	1.9e-229	4.5e-227	752.5	0.0	1	438	1	448	1	449	0.99	Tubulin alpha-1C chain (DB01873; DB03010; DB05147; DB07574)
drugbank_target|Q71U36	-	451	sp|Q7KQL5|TBB_PLAF	-	445	4.5e-227	752.5	0.0	1	1	2.2e-229	5e-227	752.3	0.0	1	440	1	450	1	451	0.99	Tubulin alpha-1A chain (DB00518; DB00570; DB00643; DB01873; DB03010; DB05147; DB07574; DB11638; DB12695; DB15534)
drugbank_target|P68366	-	448	sp|Q7KQL5|TBB_PLAF	-	445	3.2e-225	746.4	0.0	1	1	1.5e-227	3.5e-225	746.2	0.0	1	438	1	448	1	448	0.99	Tubulin alpha-4A chain (DB00541; DB01179; DB01873; DB03010; DB05147; DB06772; DB12695)
drugbank_target|Q13748	-	450	sp|Q7KQL5|TBB_PLAF	-	445	3.5e-225	746.3	0.0	1	1	1.7e-227	3.9e-225	746.1	0.0	1	439	1	449	1	450	0.98	Tubulin alpha-3C/D chain (DB01873; DB03010; DB05147; DB09130; DB12695)
drugbank_target|Q6PEY2	-	450	sp|Q7KQL5|TBB_PLAF	-	445	1.1e-222	738.0	0.0	1	1	5.6e-225	1.3e-222	737.8	0.0	1	438	1	448	1	450	0.98	Tubulin alpha-3E chain (DB05147)
drugbank_target|Q9NY65	-	449	sp|Q7KQL5|TBB_PLAF	-	445	1e-220	731.5	0.0	1	1	5e-223	1.1e-220	731.4	0.0	1	438	1	448	1	449	0.98	Tubulin alpha-8 chain (DB01873; DB03010)
drugbank_target|P14642	-	453	sp|Q7KQL5|TBB_PLAF	-	445	3.8e-217	719.8	0.0	1	1	1.9e-219	4.3e-217	719.6	0.0	1	442	1	452	1	453	0.98	Tubulin alpha chain (DB11638)
drugbank_target|P23258	-	451	sp|Q7KQL5|TBB_PLAF	-	445	7.1e-179	593.6	0.0	1	1	4e-181	9.1e-179	593.3	0.0	2	430	3	440	2	450	0.98	Tubulin gamma-1 chain (DB00570)
drugbank_target|Q9UJT0	-	475	sp|Q7KQL5|TBB_PLAF	-	445	5.3e-164	544.6	2.1	1	2	6.7e-89	1.5e-86	289.3	0.2	1	213	1	220	1	230	0.96	Tubulin epsilon chain (DB00570)
drugbank_target|Q9UJT0	-	475	sp|Q7KQL5|TBB_PLAF	-	445	5.3e-164	544.6	2.1	2	2	1.6e-78	3.6e-76	255.1	0.1	219	428	252	460	237	467	0.95	Tubulin epsilon chain (DB00570)
drugbank_target|Q9UJT1	-	453	sp|Q7KQL5|TBB_PLAF	-	445	1.9e-133	443.9	3.5	1	2	7.8e-118	1.8e-115	384.7	0.5	4	293	3	299	1	317	0.96	Tubulin delta chain (DB00570)
drugbank_target|Q9UJT1	-	453	sp|Q7KQL5|TBB_PLAF	-	445	1.9e-133	443.9	3.5	2	2	1.9e-19	4.3e-17	60.4	0.1	336	422	362	450	328	453	0.76	Tubulin delta chain (DB00570)
drugbank_target|Q9H853	-	241	sp|Q7KQL5|TBB_PLAF	-	445	5.7e-94	313.8	0.0	1	1	3.1e-96	7e-94	313.5	0.0	76	260	17	201	11	223	0.97	Putative tubulin-like protein alpha-4B (DB05147)
drugbank_target|Q8IUR0	-	188	sp|Q7KQM2|TPPC5_PL	-	184	2.4e-76	253.8	0.0	1	1	2.2e-79	2.9e-76	253.5	0.0	5	182	10	183	7	185	0.98	Trafficking protein particle complex subunit 5 (DB08342)
drugbank_target|O43617	-	180	sp|Q7KQM2|TPPC5_PL	-	184	2.2e-51	172.4	0.0	1	1	1.9e-54	2.5e-51	172.2	0.0	16	159	11	152	1	172	0.90	Trafficking protein particle complex subunit 3 (DB03796; DB08231; DB08342)
drugbank_target|Q86SZ2	-	158	sp|Q7KQM2|TPPC5_PL	-	184	1.1e-49	166.8	0.3	1	1	1e-52	1.3e-49	166.6	0.3	22	157	5	143	2	156	0.94	Trafficking protein particle complex subunit 6B (DB08342)
drugbank_target|O75865	-	159	sp|Q7KQM2|TPPC5_PL	-	184	2.6e-39	133.0	0.0	1	1	2.6e-42	3.4e-39	132.6	0.0	23	156	6	143	2	151	0.89	Trafficking protein particle complex subunit 6A (DB08342)
drugbank_target|P23528	-	166	sp|Q8I467|CADF1_PL	-	122	1.3e-49	165.6	0.6	1	1	6.1e-53	1.6e-49	165.3	0.6	1	106	1	132	1	149	0.94	Cofilin-1 (DB04147; DB09130; DB11638)
drugbank_target|P60981	-	165	sp|Q8I467|CADF1_PL	-	122	6.7e-44	147.2	1.2	1	1	8.5e-47	2.2e-43	145.5	1.2	1	106	1	132	1	143	0.84	Destrin (DB04147)
drugbank_target|P00558	-	417	sp|P27362|PGK_PLAF	-	416	7.9e-240	793.9	5.5	1	1	3.5e-243	9.2e-240	793.7	5.5	2	415	3	416	2	417	1.00	Phosphoglycerate kinase 1 (DB03909; DB04510; DB09130; DB11638)
drugbank_target|P36204	-	654	sp|P27362|PGK_PLAF	-	416	2.9e-211	699.8	7.7	1	1	1.5e-214	3.9e-211	699.4	7.7	4	416	2	397	1	397	0.99	Bifunctional PGK/TIM (DB04510)
drugbank_target|P27696	-	559	sp|Q8I2J4|PROF_PLA	-	171	1.1e-29	101.7	0.0	1	1	1.7e-32	1.7e-29	101.0	0.0	91	169	429	507	411	509	0.93	Acetolactate synthase, catabolic (DB01987; DB02327; DB03361)
drugbank_target|Q9LCV9	-	573	sp|Q8I2J4|PROF_PLA	-	171	2.3e-24	84.3	0.0	1	1	3.5e-27	3.7e-24	83.7	0.0	90	169	444	525	436	527	0.94	N(2)-(2-carboxyethyl)arginine synthase (DB01987)
drugbank_target|P37063	-	603	sp|Q8I2J4|PROF_PLA	-	171	4.1e-06	24.9	0.0	1	1	8.9e-09	9.4e-06	23.7	0.0	91	164	429	504	390	509	0.86	Pyruvate oxidase (DB03147)
drugbank_target|P20906	-	528	sp|Q8I2J4|PROF_PLA	-	171	5.9e-05	21.1	0.0	1	1	9.8e-08	0.0001	20.4	0.0	90	162	409	483	404	490	0.75	Benzoylformate decarboxylase (DB02280)
drugbank_target|P06672	-	568	sp|Q8I2J4|PROF_PLA	-	171	6.3e-05	21.1	0.0	1	1	1.8e-07	0.00019	19.5	0.0	90	155	421	487	416	495	0.85	Pyruvate decarboxylase (DB04272)
drugbank_target|Q02779	-	954	sp|Q8IDX6|RBP2A_PL	-	3130	4.1e-26	88.4	13.4	1	1	7.5e-29	5.6e-26	87.9	13.4	2812	2903	378	469	368	487	0.93	Mitogen-activated protein kinase kinase kinase 10 (DB12010)
drugbank_target|P80192	-	1104	sp|Q8IDX6|RBP2A_PL	-	3130	6.4e-24	81.1	14.1	1	1	1.1e-26	8.4e-24	80.7	14.1	2812	2903	424	514	413	544	0.90	Mitogen-activated protein kinase kinase kinase 9 (DB08703; DB12010)
drugbank_target|Q16584	-	847	sp|Q8IDX6|RBP2A_PL	-	3130	2.4e-22	75.9	13.7	1	1	4.1e-25	3.1e-22	75.5	13.7	2801	2898	385	483	364	505	0.86	Mitogen-activated protein kinase kinase kinase 11 (DB12010)
drugbank_target|P51692	-	787	sp|Q8IDX6|RBP2A_PL	-	3130	4.4	2.0	12.6	1	1	0.0079	5.9	1.6	12.6	2745	2857	143	259	112	278	0.65	Signal transducer and activator of transcription 5B (DB01254)
drugbank_target|O75348	-	118	sp|Q8IDX6|RBP2A_PL	-	3130	5.5	1.7	16.4	1	1	0.0082	6.2	1.5	16.4	2709	2781	13	79	3	99	0.61	V-type proton ATPase subunit G 1 (DB01133)
drugbank_target|Q8TF61	-	875	sp|Q8IDX6|RBP2A_PL	-	3130	5.8	1.6	27.0	1	1	0.013	9.5	0.9	27.0	2709	2875	203	345	195	354	0.49	F-box only protein 41 (DB12695)
drugbank_target|P23246	-	707	sp|Q8IDX6|RBP2A_PL	-	3130	9	1.0	35.8	1	1	0.015	11	0.6	35.8	2713	2863	450	599	417	613	0.65	Splicing factor, proline- and glutamine-rich (DB09130; DB11638)
drugbank_target|Q3JUV5	-	175	sp|O77392|IPYR_PLA	-	380	1.6e-32	111.3	0.0	1	1	4.2e-36	2.2e-32	110.9	0.0	195	282	63	149	59	161	0.95	Inorganic pyrophosphatase (DB06851; DB07291)
drugbank_target|O75348	-	118	sp|C0H5F4|RBP2B_PL	-	3179	6.3e-25	84.4	13.7	1	1	5.6e-28	7.4e-25	84.2	13.7	2629	2728	8	100	2	108	0.94	V-type proton ATPase subunit G 1 (DB01133)
drugbank_target|Q96LB4	-	118	sp|C0H5F4|RBP2B_PL	-	3179	4.4e-22	75.0	12.4	1	1	3.7e-25	4.9e-22	74.8	12.4	2629	2711	8	89	2	106	0.91	V-type proton ATPase subunit G 3 (DB01133)
drugbank_target|O95670	-	118	sp|C0H5F4|RBP2B_PL	-	3179	1.3e-21	73.4	20.7	1	1	1.1e-24	1.5e-21	73.2	20.7	2629	2718	8	98	2	105	0.93	V-type proton ATPase subunit G 2 (DB01133)
drugbank_target|P0ABA0	-	156	sp|C0H5F4|RBP2B_PL	-	3179	7.2	1.3	15.4	1	1	0.0061	8	1.1	15.4	2623	2715	33	129	30	151	0.69	ATP synthase subunit b (DB03091)
drugbank_target|P49247	-	311	sp|Q8I3W2|RPIA_PLA	-	236	9.3e-105	347.4	0.1	1	1	8.2e-108	1.1e-104	347.2	0.1	2	233	79	308	78	311	0.98	Ribose-5-phosphate isomerase (DB01756)
drugbank_target|Q5SIR5	-	227	sp|Q8I3W2|RPIA_PLA	-	236	2.4e-92	306.8	0.0	1	1	2.2e-95	2.8e-92	306.6	0.0	2	227	6	222	5	226	0.97	Ribose-5-phosphate isomerase A (DB02053; DB03745)
drugbank_target|P0A7Z3	-	219	sp|Q8I3W2|RPIA_PLA	-	236	3.9e-91	302.8	4.4	1	1	3.4e-94	4.4e-91	302.7	4.4	2	230	4	216	3	219	0.94	Ribose-5-phosphate isomerase A (DB04127)
drugbank_target|P44725	-	219	sp|Q8I3W2|RPIA_PLA	-	236	7.9e-91	301.9	5.9	1	1	6.9e-94	9e-91	301.7	5.9	3	227	5	215	3	219	0.96	Ribose-5-phosphate isomerase A (DB04272)
drugbank_target|Q9U8D3	-	442	sp|Q8IDF6|PURA_PLA	-	442	1.3e-245	813.0	5.0	1	1	2.2e-248	1.5e-245	812.9	5.0	1	442	1	442	1	442	1.00	Adenylosuccinate synthetase (DB02109; DB03510; DB04315)
drugbank_target|Q8N142	-	457	sp|Q8IDF6|PURA_PLA	-	442	2.7e-228	756.0	0.1	1	1	5.1e-231	3.3e-228	755.7	0.1	12	434	29	454	22	457	0.98	Adenylosuccinate synthetase isozyme 1 (DB02109; DB03510; DB04137; DB04315; DB04418; DB04566; DB05540)
drugbank_target|Q8N142	-	457	sp|Q8IDF6|PURA_PLA	-	442	2.7e-228	756.0	0.1	1	1	5.1e-231	3.3e-228	755.7	0.1	12	434	29	454	22	457	0.98	Adenylosuccinate synthetase isozyme 1 (DB00128)
drugbank_target|P30520	-	456	sp|Q8IDF6|PURA_PLA	-	442	1.1e-227	753.9	0.1	1	1	2.1e-230	1.4e-227	753.6	0.1	14	434	28	453	23	456	0.98	Adenylosuccinate synthetase isozyme 2 (DB00128; DB05540)
drugbank_target|P30520	-	456	sp|Q8IDF6|PURA_PLA	-	442	1.1e-227	753.9	0.1	1	1	2.1e-230	1.4e-227	753.6	0.1	14	434	28	453	23	456	0.98	Adenylosuccinate synthetase isozyme 2 (DB00128)
drugbank_target|P0A7D4	-	432	sp|Q8IDF6|PURA_PLA	-	442	8.7e-219	724.6	0.1	1	1	1.5e-221	9.7e-219	724.5	0.1	14	439	2	430	1	432	0.98	Adenylosuccinate synthetase (DB02109; DB02493; DB02666; DB02836; DB02954; DB03146; DB04315; DB04460; DB04566)
drugbank_target|Q83P33	-	432	sp|Q8IDF6|PURA_PLA	-	442	2.9e-218	722.9	0.1	1	1	4.9e-221	3.2e-218	722.8	0.1	14	439	2	430	1	432	0.98	Adenylosuccinate synthetase (DB02954; DB04566)
drugbank_target|Q8ZIV7	-	432	sp|Q8IDF6|PURA_PLA	-	442	1.5e-216	717.3	0.2	1	1	2.5e-219	1.6e-216	717.1	0.2	14	439	2	430	1	432	0.98	Adenylosuccinate synthetase (DB02580)
drugbank_target|Q9NRF9	-	147	sp|Q8I3Z1|MLRR1_PL	-	10061	2.2e-28	94.2	15.2	1	1	1.3e-31	2.2e-28	94.2	15.2	7543	7629	59	144	3	147	0.84	DNA polymerase epsilon subunit 3 (DB00242)
drugbank_target|P06748	-	294	sp|Q8I3Z1|MLRR1_PL	-	10061	1.2e-17	58.6	27.1	1	1	9e-21	1.6e-17	58.2	27.1	8333	8409	160	233	154	238	0.95	Nucleophosmin (DB11638)
drugbank_target|P30419	-	496	sp|Q8I3Z1|MLRR1_PL	-	10061	5	0.1	6.2	1	1	0.0038	6.7	-0.4	6.2	5952	6002	27	77	19	96	0.74	Glycylpeptide N-tetradecanoyltransferase 1 (DB03062)
drugbank_target|Q15910	-	746	sp|C6KTD2|SET1_PLA	-	6753	3e-52	174.1	0.8	1	1	2.4e-55	4.2e-52	173.6	0.8	6606	6734	606	732	595	739	0.95	Histone-lysine N-methyltransferase EZH2 (DB12887; DB14581)
drugbank_target|Q92800	-	747	sp|C6KTD2|SET1_PLA	-	6753	6.7e-52	172.9	0.6	1	1	5.4e-55	9.5e-52	172.4	0.6	6607	6734	608	733	597	740	0.95	Histone-lysine N-methyltransferase EZH1 (DB12887)
drugbank_target|Q8WTS6	-	366	sp|C6KTD2|SET1_PLA	-	6753	1.8e-35	118.4	0.0	1	1	1.3e-38	2.3e-35	118.0	0.0	6609	6737	211	344	189	346	0.93	Histone-lysine N-methyltransferase SETD7 (DB01752)
drugbank_target|O60551	-	498	sp|Q8ILW6|NMT_PLAF	-	410	5.5e-224	741.7	0.0	1	1	6.6e-227	6.9e-224	741.3	0.0	17	409	108	497	98	498	0.99	Glycylpeptide N-tetradecanoyltransferase 2 (DB02180; DB02271; DB07061; DB07838)
drugbank_target|P30419	-	496	sp|Q8ILW6|NMT_PLAF	-	410	6.2e-223	738.2	0.0	1	1	7.3e-226	7.7e-223	737.9	0.0	17	409	106	495	94	496	0.99	Glycylpeptide N-tetradecanoyltransferase 1 (DB03062)
drugbank_target|P30418	-	451	sp|Q8ILW6|NMT_PLAF	-	410	3e-202	670.1	1.4	1	1	3.8e-205	4e-202	669.7	1.4	13	401	27	428	19	433	0.98	Glycylpeptide N-tetradecanoyltransferase (DB02180; DB02477; DB03062)
drugbank_target|Q7LG56	-	351	sp|Q8ILW6|NMT_PLAF	-	410	3.9e-32	109.8	0.1	1	1	6.1e-35	6.5e-32	109.1	0.1	47	143	98	193	89	199	0.95	Ribonucleoside-diphosphate reductase subunit M2 B (DB00242)
drugbank_target|P31350	-	389	sp|Q8ILW6|NMT_PLAF	-	410	1.4e-31	108.0	1.4	1	2	1.4e-34	1.5e-31	107.9	0.2	47	143	136	231	103	237	0.93	Ribonucleoside-diphosphate reductase subunit M2 (DB00242; DB05003; DB05260; DB05428; DB05801)
drugbank_target|P31350	-	389	sp|Q8ILW6|NMT_PLAF	-	410	1.4e-31	108.0	1.4	2	2	0.4	4.2e+02	-2.3	0.1	342	380	320	360	307	364	0.74	Ribonucleoside-diphosphate reductase subunit M2 (DB00242; DB05003; DB05260; DB05428; DB05801)
drugbank_target|O95342	-	1321	sp|Q8I1U7|SMC3_PLA	-	1193	1.7e-39	133.5	0.9	1	2	3.1e-19	1.1e-16	58.0	0.0	1086	1181	558	645	546	649	0.90	Bile salt export pump (DB00171; DB01016)
drugbank_target|O95342	-	1321	sp|Q8I1U7|SMC3_PLA	-	1193	1.7e-39	133.5	0.9	2	2	4.5e-24	1.6e-21	74.0	0.2	1081	1179	1213	1303	1197	1308	0.92	Bile salt export pump (DB00171; DB01016)
drugbank_target|P08183	-	1280	sp|Q8I1U7|SMC3_PLA	-	1193	2e-39	133.3	1.0	1	2	2.3e-21	8.2e-19	65.0	0.1	1083	1179	527	615	513	624	0.90	Multidrug resistance protein 1 (DB00171; DB00603; DB00778; DB00813; DB04877; DB04881; DB04905; DB05449; DB06191; DB06240; DB09031; DB11635; DB14061; DB14062; DB14063; DB14064; DB14065; DB14066; DB14067; DB14068; DB14069; DB14070; DB14071; DB14072)
drugbank_target|P08183	-	1280	sp|Q8I1U7|SMC3_PLA	-	1193	2e-39	133.3	1.0	2	2	6.9e-22	2.4e-19	66.8	0.1	1077	1162	1166	1246	1136	1262	0.82	Multidrug resistance protein 1 (DB00171; DB00603; DB00778; DB00813; DB04877; DB04881; DB04905; DB05449; DB06191; DB06240; DB09031; DB11635; DB14061; DB14062; DB14063; DB14064; DB14065; DB14066; DB14067; DB14068; DB14069; DB14070; DB14071; DB14072)
drugbank_target|Q2M3G0	-	1257	sp|Q8I1U7|SMC3_PLA	-	1193	7.4e-37	124.8	0.5	1	2	2.5e-20	8.8e-18	61.6	0.1	1083	1163	521	596	512	616	0.88	ATP-binding cassette sub-family B member 5 (DB04851; DB14067)
drugbank_target|Q2M3G0	-	1257	sp|Q8I1U7|SMC3_PLA	-	1193	7.4e-37	124.8	0.5	2	2	3.9e-20	1.4e-17	61.0	0.0	1082	1178	1151	1239	1133	1247	0.87	ATP-binding cassette sub-family B member 5 (DB04851; DB14067)
drugbank_target|O95477	-	2261	sp|Q8I1U7|SMC3_PLA	-	1193	1.2e-22	77.7	0.0	1	2	1.1e-13	3.8e-11	39.6	0.0	1078	1161	1024	1103	1014	1108	0.88	ATP-binding cassette sub-family A member 1 (DB00171; DB01016; DB01599)
drugbank_target|O95477	-	2261	sp|Q8I1U7|SMC3_PLA	-	1193	1.2e-22	77.7	0.0	2	2	1.6e-12	5.7e-10	35.7	0.0	1085	1156	2043	2110	2036	2122	0.90	ATP-binding cassette sub-family A member 1 (DB00171; DB01016; DB01599)
drugbank_target|O60706	-	1549	sp|Q8I1U7|SMC3_PLA	-	1193	6.1e-22	75.4	2.9	1	3	1.4	4.8e+02	-3.7	0.1	25	44	699	718	690	719	0.87	ATP-binding cassette sub-family C member 9 (DB00171; DB01016; DB09220)
drugbank_target|O60706	-	1549	sp|Q8I1U7|SMC3_PLA	-	1193	6.1e-22	75.4	2.9	2	3	2.5e-17	8.7e-15	51.7	0.0	1082	1163	807	886	797	909	0.86	ATP-binding cassette sub-family C member 9 (DB00171; DB01016; DB09220)
drugbank_target|O60706	-	1549	sp|Q8I1U7|SMC3_PLA	-	1193	6.1e-22	75.4	2.9	3	3	7.4e-09	2.6e-06	23.6	0.1	1077	1156	1439	1513	1420	1523	0.88	ATP-binding cassette sub-family C member 9 (DB00171; DB01016; DB09220)
drugbank_target|Q09428	-	1581	sp|Q8I1U7|SMC3_PLA	-	1193	6.3e-22	75.3	2.2	1	3	1.2	4.1e+02	-3.6	0.0	18	43	699	725	695	727	0.84	ATP-binding cassette sub-family C member 8 (DB00171; DB00222; DB00672; DB00731; DB00912; DB01067; DB01120; DB01124; DB01251; DB01252; DB01382)
drugbank_target|Q09428	-	1581	sp|Q8I1U7|SMC3_PLA	-	1193	6.3e-22	75.3	2.2	2	3	2.8e-15	9.7e-13	44.9	0.0	1076	1168	818	910	808	922	0.86	ATP-binding cassette sub-family C member 8 (DB00171; DB00222; DB00672; DB00731; DB00912; DB01067; DB01120; DB01124; DB01251; DB01252; DB01382)
drugbank_target|Q09428	-	1581	sp|Q8I1U7|SMC3_PLA	-	1193	6.3e-22	75.3	2.2	3	3	1.3e-10	4.7e-08	29.4	0.3	1079	1163	1473	1552	1452	1559	0.91	ATP-binding cassette sub-family C member 8 (DB00171; DB00222; DB00672; DB00731; DB00912; DB01067; DB01120; DB01124; DB01251; DB01252; DB01382)
drugbank_target|Q09428	-	1581	sp|Q8I1U7|SMC3_PLA	-	1193	6.3e-22	75.3	2.2	1	3	1.2	4.1e+02	-3.6	0.0	18	43	699	725	695	727	0.84	ATP-binding cassette sub-family C member 8 (DB00839; DB01016)
drugbank_target|Q09428	-	1581	sp|Q8I1U7|SMC3_PLA	-	1193	6.3e-22	75.3	2.2	2	3	2.8e-15	9.7e-13	44.9	0.0	1076	1168	818	910	808	922	0.86	ATP-binding cassette sub-family C member 8 (DB00839; DB01016)
drugbank_target|Q09428	-	1581	sp|Q8I1U7|SMC3_PLA	-	1193	6.3e-22	75.3	2.2	3	3	1.3e-10	4.7e-08	29.4	0.3	1079	1163	1473	1552	1452	1559	0.91	ATP-binding cassette sub-family C member 8 (DB00839; DB01016)
drugbank_target|O15440	-	1437	sp|Q8I1U7|SMC3_PLA	-	1193	5.1e-19	65.7	0.2	1	2	4.4e-12	1.5e-09	34.3	0.0	1075	1179	673	770	661	775	0.88	Multidrug resistance-associated protein 5 (DB11672; DB14635)
drugbank_target|O15440	-	1437	sp|Q8I1U7|SMC3_PLA	-	1193	5.1e-19	65.7	0.2	2	2	1.8e-10	6.2e-08	29.0	0.2	1083	1162	1326	1400	1317	1414	0.88	Multidrug resistance-associated protein 5 (DB11672; DB14635)
drugbank_target|Q9UNQ0	-	655	sp|Q8I1U7|SMC3_PLA	-	1193	1.5e-17	60.8	0.1	1	2	1.1e-19	3.9e-17	59.5	0.0	1075	1162	174	259	136	272	0.92	ATP-binding cassette sub-family G member 2 (DB04851; DB11995)
drugbank_target|Q9UNQ0	-	655	sp|Q8I1U7|SMC3_PLA	-	1193	1.5e-17	60.8	0.1	2	2	0.48	1.7e+02	-2.3	0.0	1062	1097	329	363	318	370	0.69	ATP-binding cassette sub-family G member 2 (DB04851; DB11995)
drugbank_target|P45844	-	678	sp|Q8I1U7|SMC3_PLA	-	1193	9e-17	58.3	0.0	1	1	3.7e-19	1.3e-16	57.7	0.0	1084	1162	214	290	208	300	0.93	ATP-binding cassette sub-family G member 1 (DB00171)
drugbank_target|Q92887	-	1545	sp|Q8I1U7|SMC3_PLA	-	1193	4.7e-16	55.9	0.0	1	2	6.3e-09	2.2e-06	23.8	0.0	1084	1171	758	846	748	857	0.84	Canalicular multispecific organic anion transporter 1 (DB00171; DB01138)
drugbank_target|Q92887	-	1545	sp|Q8I1U7|SMC3_PLA	-	1193	4.7e-16	55.9	0.0	2	2	1.1e-10	3.9e-08	29.7	0.1	1080	1178	1430	1520	1420	1525	0.84	Canalicular multispecific organic anion transporter 1 (DB00171; DB01138)
drugbank_target|P33527	-	1531	sp|Q8I1U7|SMC3_PLA	-	1193	5.6e-16	55.6	0.1	1	2	7.2e-10	2.5e-07	27.0	0.0	1074	1170	755	852	749	866	0.81	Multidrug resistance-associated protein 1 (DB00171; DB01138; DB04851; DB06176; DB08855)
drugbank_target|P33527	-	1531	sp|Q8I1U7|SMC3_PLA	-	1193	5.6e-16	55.6	0.1	2	2	1.1e-09	3.9e-07	26.3	0.1	1082	1160	1425	1498	1405	1510	0.84	Multidrug resistance-associated protein 1 (DB00171; DB01138; DB04851; DB06176; DB08855)
drugbank_target|O15439	-	1325	sp|Q8I1U7|SMC3_PLA	-	1193	2.3e-15	53.6	1.1	1	2	1.9e-10	6.8e-08	28.9	0.1	1084	1177	532	618	519	624	0.83	Multidrug resistance-associated protein 4 (DB00171)
drugbank_target|O15439	-	1325	sp|Q8I1U7|SMC3_PLA	-	1193	2.3e-15	53.6	1.1	2	2	9e-09	3.1e-06	23.3	0.1	1078	1162	1168	1247	1157	1256	0.89	Multidrug resistance-associated protein 4 (DB00171)
drugbank_target|O95255	-	1503	sp|Q8I1U7|SMC3_PLA	-	1193	1.7e-13	47.4	0.0	1	2	5.1e-09	1.8e-06	24.2	0.0	1085	1163	751	827	743	845	0.85	Multidrug resistance-associated protein 6 (DB00171)
drugbank_target|O95255	-	1503	sp|Q8I1U7|SMC3_PLA	-	1193	1.7e-13	47.4	0.0	2	2	4.5e-08	1.6e-05	21.0	0.0	1082	1159	1397	1469	1385	1484	0.81	Multidrug resistance-associated protein 6 (DB00171)
drugbank_target|P13569	-	1480	sp|Q8I1U7|SMC3_PLA	-	1193	9.2e-11	38.4	0.2	1	2	8.1e-08	2.9e-05	20.2	0.0	1085	1162	546	619	527	632	0.86	Cystic fibrosis transmembrane conductance regulator (DB00171; DB00887; DB01016; DB01050; DB02587; DB04395; DB04522; DB04941; DB06266; DB08820; DB09213; DB09280; DB11712; DB15444)
drugbank_target|P13569	-	1480	sp|Q8I1U7|SMC3_PLA	-	1193	9.2e-11	38.4	0.2	2	2	1.4e-06	0.00051	16.0	0.1	1087	1162	1346	1416	1339	1434	0.86	Cystic fibrosis transmembrane conductance regulator (DB00171; DB00887; DB01016; DB01050; DB02587; DB04395; DB04522; DB04941; DB06266; DB08820; DB09213; DB09280; DB11712; DB15444)
drugbank_target|Q6LFH8	-	414	sp|Q6LFH8|OAT_PLAF	-	414	1.9e-204	677.1	0.0	1	1	8.4e-207	2.1e-204	676.9	0.0	1	414	1	414	1	414	1.00	Ornithine aminotransferase (DB11638)
drugbank_target|P04181	-	439	sp|Q6LFH8|OAT_PLAF	-	414	4.2e-176	583.7	0.0	1	1	2.1e-178	5.2e-176	583.4	0.0	7	410	37	439	32	439	0.99	Ornithine aminotransferase, mitochondrial (DB00114; DB00129; DB02054; DB02821)
drugbank_target|Q9BYV1	-	514	sp|Q6LFH8|OAT_PLAF	-	414	6.1e-139	461.3	0.0	1	1	3.2e-141	7.9e-139	460.9	0.0	18	408	74	506	65	510	0.96	Alanine--glyoxylate aminotransferase 2, mitochondrial (DB00114; DB00119; DB00145; DB00160)
drugbank_target|P22256	-	426	sp|Q6LFH8|OAT_PLAF	-	414	1.1e-133	444.0	0.0	1	1	5.3e-136	1.3e-133	443.7	0.0	28	411	23	422	4	425	0.97	4-aminobutyrate aminotransferase GabT (DB02142; DB02783)
drugbank_target|P12995	-	429	sp|Q6LFH8|OAT_PLAF	-	414	2e-128	426.6	0.0	1	1	1e-130	2.5e-128	426.3	0.0	27	408	26	422	8	426	0.96	Adenosylmethionine-8-amino-7-oxononanoate aminotransferase (DB02274; DB02725; DB04083)
drugbank_target|Q8IUZ5	-	450	sp|Q6LFH8|OAT_PLAF	-	414	8.6e-120	398.2	0.0	1	1	4.4e-122	1.1e-119	397.8	0.0	25	406	27	429	22	435	0.95	5-phosphohydroxy-L-lysine phospho-lyase (DB00114; DB00160)
drugbank_target|P16932	-	433	sp|Q6LFH8|OAT_PLAF	-	414	9e-120	398.1	0.0	1	1	4.6e-122	1.2e-119	397.8	0.0	28	408	25	430	13	432	0.95	2,2-dialkylglycine decarboxylase (DB02038; DB02849; DB03787; DB04241)
drugbank_target|P9WQ77	-	449	sp|Q6LFH8|OAT_PLAF	-	414	1.8e-119	397.2	0.0	1	1	9.2e-122	2.3e-119	396.8	0.0	32	407	39	445	35	448	0.97	Probable L-lysine-epsilon aminotransferase (DB08071)
drugbank_target|P80404	-	500	sp|Q6LFH8|OAT_PLAF	-	414	8.1e-112	371.9	0.0	1	1	4e-114	1e-111	371.6	0.0	33	408	78	497	65	500	0.95	4-aminobutyrate aminotransferase, mitochondrial (DB00114; DB00119; DB00142; DB00160; DB00780; DB01080; DB01699; DB04235)
drugbank_target|P24630	-	433	sp|Q6LFH8|OAT_PLAF	-	414	6.5e-98	326.1	0.0	1	1	3.2e-100	7.9e-98	325.9	0.0	28	337	40	350	23	403	0.96	Glutamate-1-semialdehyde 2,1-aminomutase (DB02054; DB02142)
drugbank_target|Q9X266	-	343	sp|Q6LFH8|OAT_PLAF	-	414	2.9e-81	271.3	0.2	1	1	1.4e-83	3.5e-81	271.0	0.2	86	410	32	342	12	343	0.96	L-allo-threonine aldolase (DB02824; DB03576; DB04083)
drugbank_target|Q9KM65	-	389	sp|Q6LFH8|OAT_PLAF	-	414	9e-57	190.6	0.0	1	2	0.37	92	-0.5	0.0	63	117	54	113	53	129	0.68	CAI-1 autoinducer synthase (DB08364)
drugbank_target|Q9KM65	-	389	sp|Q6LFH8|OAT_PLAF	-	414	9e-57	190.6	0.0	2	2	1.7e-58	4.2e-56	188.4	0.0	173	409	144	383	132	387	0.95	CAI-1 autoinducer synthase (DB08364)
drugbank_target|P12998	-	384	sp|Q6LFH8|OAT_PLAF	-	414	9.1e-18	62.1	0.0	1	1	4.7e-18	1.2e-15	55.2	0.0	34	403	28	380	19	383	0.79	8-amino-7-oxononanoate synthase (DB03160)
drugbank_target|P0AB77	-	398	sp|Q6LFH8|OAT_PLAF	-	414	5.2e-13	46.5	0.1	1	2	0.011	2.8	4.5	0.0	62	111	56	110	22	117	0.76	2-amino-3-ketobutyrate coenzyme A ligase (DB03915)
drugbank_target|P0AB77	-	398	sp|Q6LFH8|OAT_PLAF	-	414	5.2e-13	46.5	0.1	2	2	2.1e-13	5.3e-11	39.9	0.0	171	405	147	389	123	393	0.74	2-amino-3-ketobutyrate coenzyme A ligase (DB03915)
drugbank_target|P22557	-	587	sp|Q6LFH8|OAT_PLAF	-	414	1.2e-09	35.4	0.0	1	1	1.5e-10	3.7e-08	30.5	0.0	176	356	297	482	190	534	0.75	5-aminolevulinate synthase, erythroid-specific, mitochondrial (DB00114; DB00145)
drugbank_target|P13196	-	640	sp|Q6LFH8|OAT_PLAF	-	414	2.2e-08	31.2	0.0	1	2	1.1	2.7e+02	-2.0	0.0	64	120	259	320	250	327	0.69	5-aminolevulinate synthase, nonspecific, mitochondrial (DB00114; DB00145)
drugbank_target|P13196	-	640	sp|Q6LFH8|OAT_PLAF	-	414	2.2e-08	31.2	0.0	2	2	2.3e-10	5.6e-08	29.9	0.0	173	387	352	574	310	584	0.73	5-aminolevulinate synthase, nonspecific, mitochondrial (DB00114; DB00145)
drugbank_target|Q5JAM2	-	640	sp|Q6LFH8|OAT_PLAF	-	414	2.2e-08	31.2	0.0	1	2	1.1	2.7e+02	-2.0	0.0	64	120	259	320	250	327	0.69	5-aminolevulinate synthase (DB00114)
drugbank_target|Q5JAM2	-	640	sp|Q6LFH8|OAT_PLAF	-	414	2.2e-08	31.2	0.0	2	2	2.3e-10	5.6e-08	29.9	0.0	173	387	352	574	310	584	0.73	5-aminolevulinate synthase (DB00114)
drugbank_target|O75600	-	419	sp|Q6LFH8|OAT_PLAF	-	414	1.9e-05	21.6	0.0	1	1	1.1e-07	2.7e-05	21.1	0.0	175	405	170	410	80	414	0.79	2-amino-3-ketobutyrate coenzyme A ligase, mitochondrial (DB00114; DB00145)
drugbank_target|Q56232	-	385	sp|Q6LFH8|OAT_PLAF	-	414	3.3e-05	20.8	0.0	1	1	1.8e-07	4.5e-05	20.3	0.0	176	405	150	380	126	383	0.77	Aspartate aminotransferase (DB02142; DB04299)
drugbank_target|Q16773	-	422	sp|Q6LFH8|OAT_PLAF	-	414	0.044	10.5	0.0	1	1	0.00034	0.086	9.5	0.0	211	303	191	288	184	298	0.70	Kynurenine--oxoglutarate transaminase 1 (DB00114; DB02142; DB02556; DB04083; DB07950)
drugbank_target|Q75WK2	-	381	sp|Q6LFH8|OAT_PLAF	-	414	0.051	10.3	0.0	1	1	0.00064	0.16	8.6	0.0	216	330	174	290	140	297	0.78	Aminotransferase (DB02024; DB02238)
drugbank_target|Q9Y3I0	-	505	sp|Q8IIU6|RTCB_PLA	-	506	0	1081.8	0.3	1	1	0	0	1081.5	0.3	11	506	10	505	4	505	1.00	tRNA-splicing ligase RtcB homolog (DB02772)
drugbank_target|Q9PM68	-	371	sp|P62368|ISPF_PLA	-	240	1.9e-77	258.2	0.1	1	1	3.8e-80	3.3e-77	257.4	0.1	65	235	191	363	151	365	0.96	Bifunctional enzyme IspD/IspF (DB02552; DB03403)
drugbank_target|P62617	-	159	sp|P62368|ISPF_PLA	-	240	1.6e-69	232.3	0.0	1	1	2.2e-72	1.9e-69	232.0	0.0	88	237	5	156	2	159	0.97	2-C-methyl-D-erythritol 2,4-cyclodiphosphate synthase (DB02552)
drugbank_target|P62619	-	159	sp|P62368|ISPF_PLA	-	240	1.6e-69	232.3	0.0	1	1	2.2e-72	1.9e-69	232.0	0.0	88	237	5	156	2	159	0.97	2-C-methyl-D-erythritol 2,4-cyclodiphosphate synthase (DB01859; DB02552; DB03403; DB03687; DB03961; DB04555)
drugbank_target|Q8EBR3	-	159	sp|P62368|ISPF_PLA	-	240	8.7e-68	226.6	0.1	1	1	1.2e-70	1e-67	226.4	0.1	86	236	5	157	1	159	0.96	2-C-methyl-D-erythritol 2,4-cyclodiphosphate synthase (DB07780)
drugbank_target|Q8RQP5	-	152	sp|P62368|ISPF_PLA	-	240	1.2e-47	160.7	0.0	1	1	1.6e-50	1.4e-47	160.5	0.0	97	219	15	138	4	151	0.92	2-C-methyl-D-erythritol 2,4-cyclodiphosphate synthase (DB03403; DB04555)
drugbank_target|A0R559	-	163	sp|P62368|ISPF_PLA	-	240	1.1e-46	157.5	0.0	1	1	1.5e-49	1.3e-46	157.3	0.0	111	235	33	154	9	158	0.93	2-C-methyl-D-erythritol 2,4-cyclodiphosphate synthase (DB04714)
drugbank_target|P22459	-	653	sp|P68874|P230_PLA	-	3135	1.6e-10	36.4	11.3	1	1	8.4e-14	2.2e-10	36.0	11.3	279	321	113	155	99	185	0.80	Potassium voltage-gated channel subfamily A member 4 (DB02299; DB06637)
drugbank_target|P22459	-	653	sp|P68874|P230_PLA	-	3135	1.6e-10	36.4	11.3	1	1	8.4e-14	2.2e-10	36.0	11.3	279	321	113	155	99	185	0.80	Potassium voltage-gated channel subfamily A member 4 (DB00228; DB01069; DB01110)
drugbank_target|Q9NYK1	-	1049	sp|Q8ILI6|AN32_PLA	-	281	1.1e-62	210.2	48.7	1	8	0.86	2e+02	-0.6	0.0	101	141	64	100	39	112	0.72	Toll-like receptor 7 (DB00724; DB01611; DB04860; DB05127; DB05475; DB06530)
drugbank_target|Q9NYK1	-	1049	sp|Q8ILI6|AN32_PLA	-	281	1.1e-62	210.2	48.7	2	8	1e-05	0.0023	15.5	0.1	49	118	119	185	104	194	0.79	Toll-like receptor 7 (DB00724; DB01611; DB04860; DB05127; DB05475; DB06530)
drugbank_target|Q9NYK1	-	1049	sp|Q8ILI6|AN32_PLA	-	281	1.1e-62	210.2	48.7	3	8	5e-11	1.1e-08	33.0	0.2	48	144	195	288	187	291	0.91	Toll-like receptor 7 (DB00724; DB01611; DB04860; DB05127; DB05475; DB06530)
drugbank_target|Q9NYK1	-	1049	sp|Q8ILI6|AN32_PLA	-	281	1.1e-62	210.2	48.7	4	8	2.9e-09	6.5e-07	27.2	0.6	73	140	284	350	280	354	0.91	Toll-like receptor 7 (DB00724; DB01611; DB04860; DB05127; DB05475; DB06530)
drugbank_target|Q9NYK1	-	1049	sp|Q8ILI6|AN32_PLA	-	281	1.1e-62	210.2	48.7	5	8	3.3e-09	7.5e-07	27.0	1.2	62	144	353	435	351	449	0.87	Toll-like receptor 7 (DB00724; DB01611; DB04860; DB05127; DB05475; DB06530)
drugbank_target|Q9NYK1	-	1049	sp|Q8ILI6|AN32_PLA	-	281	1.1e-62	210.2	48.7	6	8	5e-21	1.1e-18	65.7	6.0	60	176	496	612	476	618	0.92	Toll-like receptor 7 (DB00724; DB01611; DB04860; DB05127; DB05475; DB06530)
drugbank_target|Q9NYK1	-	1049	sp|Q8ILI6|AN32_PLA	-	281	1.1e-62	210.2	48.7	7	8	2.5e-14	5.8e-12	43.8	1.4	26	122	615	716	607	723	0.83	Toll-like receptor 7 (DB00724; DB01611; DB04860; DB05127; DB05475; DB06530)
drugbank_target|Q9NYK1	-	1049	sp|Q8ILI6|AN32_PLA	-	281	1.1e-62	210.2	48.7	8	8	1e-09	2.3e-07	28.6	1.9	56	135	722	803	715	810	0.87	Toll-like receptor 7 (DB00724; DB01611; DB04860; DB05127; DB05475; DB06530)
drugbank_target|Q9NR97	-	1041	sp|Q8ILI6|AN32_PLA	-	281	8.5e-55	184.3	48.4	1	8	7.2e-15	1.7e-12	45.5	8.4	31	163	64	207	58	214	0.92	Toll-like receptor 8 (DB00724; DB06530)
drugbank_target|Q9NR97	-	1041	sp|Q8ILI6|AN32_PLA	-	281	8.5e-55	184.3	48.4	2	8	7.5e-06	0.0017	16.0	0.2	50	121	194	262	193	268	0.86	Toll-like receptor 8 (DB00724; DB06530)
drugbank_target|Q9NR97	-	1041	sp|Q8ILI6|AN32_PLA	-	281	8.5e-55	184.3	48.4	3	8	5.8e-09	1.3e-06	26.2	0.1	74	143	282	350	272	355	0.88	Toll-like receptor 8 (DB00724; DB06530)
drugbank_target|Q9NR97	-	1041	sp|Q8ILI6|AN32_PLA	-	281	8.5e-55	184.3	48.4	4	8	2.7e-07	6.3e-05	20.7	0.5	68	144	356	432	353	443	0.88	Toll-like receptor 8 (DB00724; DB06530)
drugbank_target|Q9NR97	-	1041	sp|Q8ILI6|AN32_PLA	-	281	8.5e-55	184.3	48.4	5	8	2.3e-12	5.4e-10	37.3	1.6	61	163	485	587	482	591	0.90	Toll-like receptor 8 (DB00724; DB06530)
drugbank_target|Q9NR97	-	1041	sp|Q8ILI6|AN32_PLA	-	281	8.5e-55	184.3	48.4	6	8	0.0015	0.33	8.5	0.4	98	126	577	605	567	610	0.67	Toll-like receptor 8 (DB00724; DB06530)
drugbank_target|Q9NR97	-	1041	sp|Q8ILI6|AN32_PLA	-	281	8.5e-55	184.3	48.4	7	8	3.7e-12	8.4e-10	36.7	1.8	30	122	608	705	602	710	0.85	Toll-like receptor 8 (DB00724; DB06530)
drugbank_target|Q9NR97	-	1041	sp|Q8ILI6|AN32_PLA	-	281	8.5e-55	184.3	48.4	8	8	3.1e-11	7e-09	33.6	0.6	56	130	711	787	702	802	0.86	Toll-like receptor 8 (DB00724; DB06530)
drugbank_target|P35858	-	605	sp|Q8ILI6|AN32_PLA	-	281	2.3e-52	176.3	0.3	1	5	2.8e-14	6.3e-12	43.6	0.0	33	147	77	187	74	189	0.93	Insulin-like growth factor-binding protein complex acid labile subunit (DB01593; DB09130; DB14487; DB14533; DB14548)
drugbank_target|P35858	-	605	sp|Q8ILI6|AN32_PLA	-	281	2.3e-52	176.3	0.3	2	5	2.6e-12	5.9e-10	37.2	0.0	51	143	188	279	185	285	0.93	Insulin-like growth factor-binding protein complex acid labile subunit (DB01593; DB09130; DB14487; DB14533; DB14548)
drugbank_target|P35858	-	605	sp|Q8ILI6|AN32_PLA	-	281	2.3e-52	176.3	0.3	3	5	1.3e-15	2.9e-13	48.0	0.4	32	138	292	394	283	396	0.93	Insulin-like growth factor-binding protein complex acid labile subunit (DB01593; DB09130; DB14487; DB14533; DB14548)
drugbank_target|P35858	-	605	sp|Q8ILI6|AN32_PLA	-	281	2.3e-52	176.3	0.3	4	5	4.3e-15	9.7e-13	46.3	0.0	31	148	387	500	383	509	0.92	Insulin-like growth factor-binding protein complex acid labile subunit (DB01593; DB09130; DB14487; DB14533; DB14548)
drugbank_target|P35858	-	605	sp|Q8ILI6|AN32_PLA	-	281	2.3e-52	176.3	0.3	5	5	0.82	1.9e+02	-0.6	0.0	78	119	505	540	500	552	0.56	Insulin-like growth factor-binding protein complex acid labile subunit (DB01593; DB09130; DB14487; DB14533; DB14548)
drugbank_target|Q9NR96	-	1032	sp|Q8ILI6|AN32_PLA	-	281	1.7e-51	173.4	10.0	1	8	0.0038	0.87	7.1	0.0	105	140	63	97	43	101	0.65	Toll-like receptor 9 (DB00608; DB01611; DB05463; DB05475; DB05530)
drugbank_target|Q9NR96	-	1032	sp|Q8ILI6|AN32_PLA	-	281	1.7e-51	173.4	10.0	2	8	0.00016	0.036	11.6	0.0	49	119	115	181	103	192	0.84	Toll-like receptor 9 (DB00608; DB01611; DB05463; DB05475; DB05530)
drugbank_target|Q9NR96	-	1032	sp|Q8ILI6|AN32_PLA	-	281	1.7e-51	173.4	10.0	3	8	1.2e-05	0.0028	15.3	0.0	52	126	194	265	181	276	0.84	Toll-like receptor 9 (DB00608; DB01611; DB05463; DB05475; DB05530)
drugbank_target|Q9NR96	-	1032	sp|Q8ILI6|AN32_PLA	-	281	1.7e-51	173.4	10.0	4	8	1.5e-09	3.5e-07	28.1	0.1	74	143	279	347	270	357	0.89	Toll-like receptor 9 (DB00608; DB01611; DB05463; DB05475; DB05530)
drugbank_target|Q9NR96	-	1032	sp|Q8ILI6|AN32_PLA	-	281	1.7e-51	173.4	10.0	5	8	9.3e-05	0.021	12.4	0.0	77	147	362	432	350	441	0.49	Toll-like receptor 9 (DB00608; DB01611; DB05463; DB05475; DB05530)
drugbank_target|Q9NR96	-	1032	sp|Q8ILI6|AN32_PLA	-	281	1.7e-51	173.4	10.0	6	8	2.8e-13	6.4e-11	40.3	1.7	56	160	470	575	460	589	0.86	Toll-like receptor 9 (DB00608; DB01611; DB05463; DB05475; DB05530)
drugbank_target|Q9NR96	-	1032	sp|Q8ILI6|AN32_PLA	-	281	1.7e-51	173.4	10.0	7	8	3.1e-15	7.1e-13	46.7	0.0	28	144	596	715	584	720	0.86	Toll-like receptor 9 (DB00608; DB01611; DB05463; DB05475; DB05530)
drugbank_target|Q9NR96	-	1032	sp|Q8ILI6|AN32_PLA	-	281	1.7e-51	173.4	10.0	8	8	5.3e-06	0.0012	16.4	0.0	58	123	702	768	697	781	0.80	Toll-like receptor 9 (DB00608; DB01611; DB05463; DB05475; DB05530)
drugbank_target|O00206	-	839	sp|Q8ILI6|AN32_PLA	-	281	1.2e-37	128.0	37.0	1	6	3e-06	0.00068	17.3	0.0	33	93	57	116	32	120	0.54	Toll-like receptor 4 (DB00924; DB01183; DB02767; DB03017; DB04933; DB05475; DB06447; DB08231; DB11193; DB13615)
drugbank_target|O00206	-	839	sp|Q8ILI6|AN32_PLA	-	281	1.2e-37	128.0	37.0	2	6	1.4e-15	3.1e-13	47.9	5.8	29	144	98	217	95	232	0.86	Toll-like receptor 4 (DB00924; DB01183; DB02767; DB03017; DB04933; DB05475; DB06447; DB08231; DB11193; DB13615)
drugbank_target|O00206	-	839	sp|Q8ILI6|AN32_PLA	-	281	1.2e-37	128.0	37.0	3	6	0.029	6.5	4.2	0.3	62	159	208	310	207	317	0.77	Toll-like receptor 4 (DB00924; DB01183; DB02767; DB03017; DB04933; DB05475; DB06447; DB08231; DB11193; DB13615)
drugbank_target|O00206	-	839	sp|Q8ILI6|AN32_PLA	-	281	1.2e-37	128.0	37.0	4	6	2.4e-11	5.4e-09	34.0	0.6	34	141	347	458	336	464	0.83	Toll-like receptor 4 (DB00924; DB01183; DB02767; DB03017; DB04933; DB05475; DB06447; DB08231; DB11193; DB13615)
drugbank_target|O00206	-	839	sp|Q8ILI6|AN32_PLA	-	281	1.2e-37	128.0	37.0	5	6	1.4e-13	3.1e-11	41.4	1.6	29	145	398	511	388	514	0.90	Toll-like receptor 4 (DB00924; DB01183; DB02767; DB03017; DB04933; DB05475; DB06447; DB08231; DB11193; DB13615)
drugbank_target|O00206	-	839	sp|Q8ILI6|AN32_PLA	-	281	1.2e-37	128.0	37.0	6	6	1.1e-12	2.5e-10	38.4	5.4	32	150	498	615	498	641	0.82	Toll-like receptor 4 (DB00924; DB01183; DB02767; DB03017; DB04933; DB05475; DB06447; DB08231; DB11193; DB13615)
drugbank_target|P22792	-	545	sp|Q8ILI6|AN32_PLA	-	281	6.3e-37	125.7	18.2	1	3	4.9e-15	1.1e-12	46.1	6.6	34	147	101	210	91	216	0.89	Carboxypeptidase N subunit 2 (DB01593; DB12271; DB14487; DB14533; DB14548)
drugbank_target|P22792	-	545	sp|Q8ILI6|AN32_PLA	-	281	6.3e-37	125.7	18.2	2	3	9.7e-17	2.2e-14	51.7	0.2	30	147	217	330	212	333	0.94	Carboxypeptidase N subunit 2 (DB01593; DB12271; DB14487; DB14533; DB14548)
drugbank_target|P22792	-	545	sp|Q8ILI6|AN32_PLA	-	281	6.3e-37	125.7	18.2	3	3	6.3e-12	1.4e-09	35.9	0.2	52	151	332	432	326	461	0.90	Carboxypeptidase N subunit 2 (DB01593; DB12271; DB14487; DB14533; DB14548)
drugbank_target|O60603	-	784	sp|Q8ILI6|AN32_PLA	-	281	5.8e-36	122.5	33.7	1	5	2.2e-17	5.1e-15	53.8	2.3	30	139	52	158	45	170	0.92	Toll-like receptor 2 (DB00045; DB00210; DB03963; DB05475; DB11601)
drugbank_target|O60603	-	784	sp|Q8ILI6|AN32_PLA	-	281	5.8e-36	122.5	33.7	2	5	0.0005	0.11	10.0	3.7	31	133	175	277	157	298	0.73	Toll-like receptor 2 (DB00045; DB00210; DB03963; DB05475; DB11601)
drugbank_target|O60603	-	784	sp|Q8ILI6|AN32_PLA	-	281	5.8e-36	122.5	33.7	3	5	9e-12	2.1e-09	35.4	3.0	54	148	333	431	312	434	0.87	Toll-like receptor 2 (DB00045; DB00210; DB03963; DB05475; DB11601)
drugbank_target|O60603	-	784	sp|Q8ILI6|AN32_PLA	-	281	5.8e-36	122.5	33.7	4	5	0.086	20	2.6	0.1	57	93	436	471	431	475	0.80	Toll-like receptor 2 (DB00045; DB00210; DB03963; DB05475; DB11601)
drugbank_target|O60603	-	784	sp|Q8ILI6|AN32_PLA	-	281	5.8e-36	122.5	33.7	5	5	2.8e-13	6.4e-11	40.3	1.2	41	148	460	569	445	585	0.84	Toll-like receptor 2 (DB00045; DB00210; DB03963; DB05475; DB11601)
drugbank_target|P51884	-	338	sp|Q8ILI6|AN32_PLA	-	281	7.1e-27	92.7	13.6	1	2	2e-19	4.6e-17	60.5	5.6	21	147	81	201	72	204	0.87	Lumican (DB09130)
drugbank_target|P51884	-	338	sp|Q8ILI6|AN32_PLA	-	281	7.1e-27	92.7	13.6	2	2	3.3e-12	7.6e-10	36.8	1.0	31	145	206	319	202	331	0.87	Lumican (DB09130)
drugbank_target|Q5S007	-	2527	sp|Q8ILI6|AN32_PLA	-	281	4.6e-26	90.0	27.8	1	5	0.21	48	1.4	0.6	47	107	409	469	398	500	0.72	Leucine-rich repeat serine/threonine-protein kinase 2 (DB12010)
drugbank_target|Q5S007	-	2527	sp|Q8ILI6|AN32_PLA	-	281	4.6e-26	90.0	27.8	2	5	2.4e-14	5.5e-12	43.8	2.2	30	155	982	1108	967	1109	0.90	Leucine-rich repeat serine/threonine-protein kinase 2 (DB12010)
drugbank_target|Q5S007	-	2527	sp|Q8ILI6|AN32_PLA	-	281	4.6e-26	90.0	27.8	3	5	1.2e-07	2.8e-05	21.8	0.3	51	120	1101	1168	1099	1172	0.90	Leucine-rich repeat serine/threonine-protein kinase 2 (DB12010)
drugbank_target|Q5S007	-	2527	sp|Q8ILI6|AN32_PLA	-	281	4.6e-26	90.0	27.8	4	5	1.3e-13	3e-11	41.4	0.7	31	151	1174	1290	1171	1296	0.88	Leucine-rich repeat serine/threonine-protein kinase 2 (DB12010)
drugbank_target|Q5S007	-	2527	sp|Q8ILI6|AN32_PLA	-	281	4.6e-26	90.0	27.8	5	5	0.74	1.7e+02	-0.4	0.5	47	156	2402	2521	2389	2526	0.63	Leucine-rich repeat serine/threonine-protein kinase 2 (DB12010)
drugbank_target|Q9Y2I1	-	1504	sp|Q8ILI6|AN32_PLA	-	281	5.7e-26	89.7	4.3	1	2	4.4e-26	1e-23	82.3	2.5	9	145	265	392	261	394	0.92	Nischarin (DB00697; DB08838; DB09242)
drugbank_target|Q9Y2I1	-	1504	sp|Q8ILI6|AN32_PLA	-	281	5.7e-26	89.7	4.3	2	2	4.1e-06	0.00094	16.8	0.0	102	153	374	425	370	432	0.93	Nischarin (DB00697; DB08838; DB09242)
drugbank_target|P02750	-	347	sp|Q8ILI6|AN32_PLA	-	281	1.1e-25	88.8	0.7	1	2	1e-14	2.3e-12	45.0	0.1	38	146	76	180	52	183	0.88	Leucine-rich alpha-2-glycoprotein (DB09130)
drugbank_target|P02750	-	347	sp|Q8ILI6|AN32_PLA	-	281	1.1e-25	88.8	0.7	2	2	3.4e-16	7.8e-14	49.9	0.1	27	147	161	277	160	283	0.94	Leucine-rich alpha-2-glycoprotein (DB09130)
drugbank_target|Q92696	-	567	sp|Q8ILI6|AN32_PLA	-	281	4.8e-18	63.7	2.2	1	2	2.1	4.8e+02	-1.9	0.2	47	89	10	54	3	90	0.61	Geranylgeranyl transferase type-2 subunit alpha (DB04464; DB07780; DB07841)
drugbank_target|Q92696	-	567	sp|Q8ILI6|AN32_PLA	-	281	4.8e-18	63.7	2.2	2	2	2.1e-20	4.8e-18	63.7	2.2	26	160	437	563	432	566	0.91	Geranylgeranyl transferase type-2 subunit alpha (DB04464; DB07780; DB07841)
drugbank_target|P07359	-	652	sp|Q8ILI6|AN32_PLA	-	281	3.2e-17	61.0	7.4	1	2	2.1e-15	4.9e-13	47.3	2.2	28	151	69	185	63	195	0.90	Platelet glycoprotein Ib alpha chain (DB01050; DB05202; DB05391; DB09213)
drugbank_target|P07359	-	652	sp|Q8ILI6|AN32_PLA	-	281	3.2e-17	61.0	7.4	2	2	1.2e-08	2.6e-06	25.2	0.2	53	122	136	205	134	212	0.86	Platelet glycoprotein Ib alpha chain (DB01050; DB05202; DB05391; DB09213)
drugbank_target|Q6WRI0	-	2623	sp|Q8ILI6|AN32_PLA	-	281	4.7e-14	50.6	0.5	1	2	4.9e-13	1.1e-10	39.5	1.1	33	144	60	167	56	173	0.90	Immunoglobulin superfamily member 10 (DB00114)
drugbank_target|Q6WRI0	-	2623	sp|Q8ILI6|AN32_PLA	-	281	4.7e-14	50.6	0.5	2	2	0.0018	0.42	8.1	0.0	74	127	180	231	168	245	0.86	Immunoglobulin superfamily member 10 (DB00114)
drugbank_target|P23945	-	695	sp|Q8ILI6|AN32_PLA	-	281	2.4e-12	45.0	5.4	1	2	2.9e-11	6.7e-09	33.7	1.1	42	141	55	155	47	166	0.84	Follicle-stimulating hormone receptor (DB00032; DB00066; DB00094; DB00097; DB04786; DB09066)
drugbank_target|P23945	-	695	sp|Q8ILI6|AN32_PLA	-	281	2.4e-12	45.0	5.4	2	2	0.0001	0.024	12.2	0.3	62	134	175	246	157	269	0.78	Follicle-stimulating hormone receptor (DB00032; DB00066; DB00094; DB00097; DB04786; DB09066)
drugbank_target|P22888	-	699	sp|Q8ILI6|AN32_PLA	-	281	3.3e-08	31.4	0.5	1	2	3.1e-07	7.2e-05	20.5	0.1	42	140	61	158	48	167	0.79	Lutropin-choriogonadotropic hormone receptor (DB00014; DB00032; DB00044; DB00050; DB00097; DB06719; DB09126)
drugbank_target|P22888	-	699	sp|Q8ILI6|AN32_PLA	-	281	3.3e-08	31.4	0.5	2	2	0.00043	0.099	10.2	0.1	46	132	162	248	142	271	0.71	Lutropin-choriogonadotropic hormone receptor (DB00014; DB00032; DB00044; DB00050; DB00097; DB06719; DB09126)
drugbank_target|Q16288	-	839	sp|Q8ILI6|AN32_PLA	-	281	2.4e-07	28.6	0.8	1	1	1.7e-09	3.9e-07	27.9	0.8	18	143	57	188	54	208	0.75	NT-3 growth factor receptor (DB11986; DB12010; DB14723)
drugbank_target|P04629	-	796	sp|Q8ILI6|AN32_PLA	-	281	4.7e-07	27.6	0.0	1	1	3.2e-09	7.3e-07	27.0	0.0	30	129	66	162	51	176	0.87	High affinity nerve growth factor receptor (DB00321; DB00619; DB08896; DB11986; DB12010; DB13926; DB14723)
drugbank_target|Q9HC29	-	1040	sp|Q8ILI6|AN32_PLA	-	281	1.7e-05	22.5	0.8	1	2	0.025	5.7	4.4	0.0	74	122	810	860	763	901	0.50	Nucleotide-binding oligomerization domain-containing protein 2 (DB13615)
drugbank_target|Q9HC29	-	1040	sp|Q8ILI6|AN32_PLA	-	281	1.7e-05	22.5	0.8	2	2	5.7e-06	0.0013	16.4	0.2	28	117	925	1023	906	1032	0.73	Nucleotide-binding oligomerization domain-containing protein 2 (DB13615)
drugbank_target|Q16620	-	822	sp|Q8ILI6|AN32_PLA	-	281	7.1e-05	20.5	0.7	1	1	5.1e-07	0.00012	19.8	0.7	33	132	69	165	61	182	0.82	BDNF/NT-3 growth factors receptor (DB00321; DB11823; DB11986; DB12010; DB14723)
drugbank_target|P05154	-	406	sp|Q8ILI6|AN32_PLA	-	281	7.1e-05	20.5	0.2	1	1	5.1e-07	0.00012	19.8	0.2	30	149	85	203	80	211	0.90	Plasma serine protease inhibitor (DB00013; DB00055; DB05413; DB05961)
drugbank_target|P16473	-	764	sp|Q8ILI6|AN32_PLA	-	281	0.001	16.7	2.3	1	3	2.9e-05	0.0066	14.0	0.1	31	143	53	164	39	171	0.79	Thyrotropin receptor (DB00024)
drugbank_target|P16473	-	764	sp|Q8ILI6|AN32_PLA	-	281	0.001	16.7	2.3	2	3	0.00098	0.22	9.0	0.1	39	142	108	212	91	222	0.71	Thyrotropin receptor (DB00024)
drugbank_target|P16473	-	764	sp|Q8ILI6|AN32_PLA	-	281	0.001	16.7	2.3	3	3	1.1	2.4e+02	-0.9	0.1	31	83	266	320	249	350	0.73	Thyrotropin receptor (DB00024)
drugbank_target|P14770	-	177	sp|Q8ILI6|AN32_PLA	-	281	0.0061	14.2	0.0	1	1	3.4e-05	0.0077	13.8	0.0	79	125	51	95	34	104	0.82	Platelet glycoprotein IX (DB00468)
drugbank_target|Q94655	-	500	sp|O15770|GSHR_PLA	-	500	4.2e-237	785.9	0.3	1	1	6e-239	4.7e-237	785.7	0.3	1	500	1	500	1	500	1.00	Glutathione reductase (DB03147)
drugbank_target|P06715	-	450	sp|O15770|GSHR_PLA	-	500	4.1e-167	555.1	2.2	1	1	1.1e-168	9.1e-167	553.9	2.2	3	496	5	450	3	450	0.98	Glutathione reductase (DB00336; DB03147)
drugbank_target|P00390	-	522	sp|O15770|GSHR_PLA	-	500	1.3e-163	543.4	1.5	1	1	3e-165	2.4e-163	542.6	1.5	3	496	65	522	63	522	0.96	Glutathione reductase, mitochondrial (DB00143; DB00157; DB00262; DB01644; DB02153; DB02553; DB02895; DB03147; DB03310; DB03867; DB07393; DB07714; DB09061; DB09130; DB14009; DB14011)
drugbank_target|Q9NNW7	-	524	sp|O15770|GSHR_PLA	-	500	3.5e-159	528.9	0.0	1	1	8.2e-161	6.5e-159	528.0	0.0	3	496	40	508	39	511	0.95	Thioredoxin reductase 2, mitochondrial (DB05428)
drugbank_target|Q16881	-	649	sp|O15770|GSHR_PLA	-	500	5.1e-159	528.3	0.0	1	1	1.3e-160	1.1e-158	527.3	0.0	3	496	163	633	162	636	0.95	Thioredoxin reductase 1, cytoplasmic (DB01169; DB02338; DB03147; DB03566; DB04106; DB05428; DB05448)
drugbank_target|P14218	-	478	sp|O15770|GSHR_PLA	-	500	1.9e-154	513.2	13.4	1	1	5.9e-156	4.7e-154	511.9	13.4	3	493	5	459	4	463	0.96	Dihydrolipoyl dehydrogenase (DB03147)
drugbank_target|P28593	-	492	sp|O15770|GSHR_PLA	-	500	8.8e-154	511.1	0.0	1	1	2.2e-155	1.8e-153	510.1	0.0	2	496	5	472	4	475	0.96	Trypanothione reductase (DB02240; DB03147; DB03470; DB04299)
drugbank_target|P18925	-	477	sp|O15770|GSHR_PLA	-	500	3.3e-152	505.9	14.2	1	1	1e-153	8e-152	504.6	14.2	3	493	5	459	4	463	0.96	Dihydrolipoyl dehydrogenase (DB03147)
drugbank_target|P09622	-	509	sp|O15770|GSHR_PLA	-	500	6.3e-147	488.5	10.9	1	1	1.9e-148	1.5e-146	487.2	10.9	4	493	43	495	42	499	0.95	Dihydrolipoyl dehydrogenase, mitochondrial (DB00157; DB03147)
drugbank_target|Q51225	-	594	sp|O15770|GSHR_PLA	-	500	1.3e-141	470.9	1.6	1	1	3.6e-143	2.9e-141	469.8	1.6	3	492	118	574	117	579	0.93	Dihydrolipoyl dehydrogenase (DB03147)
drugbank_target|P09063	-	459	sp|O15770|GSHR_PLA	-	500	3.6e-134	446.4	0.9	1	1	1e-135	8.1e-134	445.2	0.9	5	493	9	446	6	451	0.96	Dihydrolipoyl dehydrogenase (DB03147)
drugbank_target|P9WHH7	-	493	sp|O15770|GSHR_PLA	-	500	6.1e-120	399.4	3.2	1	1	6.2e-121	5e-119	396.4	3.2	1	493	1	458	1	463	0.94	NAD(P)H dehydrogenase (quinone) (DB03147)
drugbank_target|Q56839	-	523	sp|O15770|GSHR_PLA	-	500	1.5e-106	355.2	0.0	1	1	1.1e-107	8.8e-106	352.7	0.0	3	481	44	497	43	514	0.94	2-oxopropyl-CoM reductase, carboxylating (DB03147; DB03163)
drugbank_target|P37062	-	447	sp|O15770|GSHR_PLA	-	500	3.4e-70	235.3	3.6	1	2	5e-68	4e-66	221.9	1.3	77	335	44	304	27	318	0.94	NADH peroxidase (DB03147; DB03382)
drugbank_target|P37062	-	447	sp|O15770|GSHR_PLA	-	500	3.4e-70	235.3	3.6	2	2	7.4e-05	0.0059	13.5	0.0	391	479	336	418	330	422	0.86	NADH peroxidase (DB03147; DB03382)
drugbank_target|P66010	-	311	sp|O15770|GSHR_PLA	-	500	4.7e-53	178.8	4.6	1	2	5.5e-13	4.3e-11	40.4	0.2	3	46	6	49	4	75	0.93	Thioredoxin reductase (DB00548)
drugbank_target|P66010	-	311	sp|O15770|GSHR_PLA	-	500	4.7e-53	178.8	4.6	2	2	2.4e-43	1.9e-41	140.5	0.7	117	315	79	280	57	292	0.84	Thioredoxin reductase (DB00548)
drugbank_target|P0A9P4	-	321	sp|O15770|GSHR_PLA	-	500	1.3e-51	174.0	0.3	1	2	9.6e-09	7.7e-07	26.3	0.0	5	46	9	50	8	54	0.94	Thioredoxin reductase (DB03147)
drugbank_target|P0A9P4	-	321	sp|O15770|GSHR_PLA	-	500	1.3e-51	174.0	0.3	2	2	5.1e-45	4.1e-43	146.0	0.1	134	337	98	314	58	319	0.87	Thioredoxin reductase (DB03147)
drugbank_target|P35340	-	521	sp|O15770|GSHR_PLA	-	500	1.9e-51	173.5	6.6	1	2	4.7e-09	3.7e-07	27.4	0.9	3	42	213	251	212	264	0.92	Alkyl hydroperoxide reductase subunit F (DB03147)
drugbank_target|P35340	-	521	sp|O15770|GSHR_PLA	-	500	1.9e-51	173.5	6.6	2	2	5.5e-46	4.4e-44	149.2	0.6	123	322	296	498	253	504	0.84	Alkyl hydroperoxide reductase subunit F (DB03147)
drugbank_target|P19480	-	521	sp|O15770|GSHR_PLA	-	500	2.8e-51	173.0	6.0	1	2	7.5e-09	6e-07	26.7	1.1	3	42	213	251	212	265	0.92	Alkyl hydroperoxide reductase subunit F (DB03147)
drugbank_target|P19480	-	521	sp|O15770|GSHR_PLA	-	500	2.8e-51	173.0	6.0	2	2	6.6e-46	5.3e-44	148.9	0.3	123	322	296	498	252	504	0.83	Alkyl hydroperoxide reductase subunit F (DB03147)
drugbank_target|P16640	-	422	sp|O15770|GSHR_PLA	-	500	5.7e-49	165.3	0.1	1	2	4.9e-08	3.9e-06	24.0	0.0	175	259	3	99	1	100	0.87	Putidaredoxin reductase (DB03147)
drugbank_target|P16640	-	422	sp|O15770|GSHR_PLA	-	500	5.7e-49	165.3	0.1	2	2	2.2e-45	1.8e-43	147.2	0.0	109	319	73	291	69	314	0.89	Putidaredoxin reductase (DB03147)
drugbank_target|Q47PU3	-	542	sp|O15770|GSHR_PLA	-	500	4e-42	142.7	0.0	1	2	1.8e-43	1.4e-41	140.9	0.0	4	241	18	252	17	279	0.89	Phenylacetone monooxygenase (DB03147)
drugbank_target|Q47PU3	-	542	sp|O15770|GSHR_PLA	-	500	4e-42	142.7	0.0	2	2	2.2	1.8e+02	-1.2	0.0	133	151	371	389	348	410	0.81	Phenylacetone monooxygenase (DB03147)
drugbank_target|Q52437	-	408	sp|O15770|GSHR_PLA	-	500	8.9e-37	125.1	0.0	1	2	0.042	3.4	4.4	0.0	178	234	9	66	2	75	0.82	Ferredoxin reductase (DB03147)
drugbank_target|Q52437	-	408	sp|O15770|GSHR_PLA	-	500	8.9e-37	125.1	0.0	2	2	1.1e-36	8.4e-35	118.6	0.0	127	315	87	276	79	305	0.87	Ferredoxin reductase (DB03147)
drugbank_target|O95831	-	613	sp|O15770|GSHR_PLA	-	500	1.7e-36	124.2	0.0	1	2	0.36	29	1.4	0.0	6	32	135	163	124	175	0.82	Apoptosis-inducing factor 1, mitochondrial (DB03147; DB05282)
drugbank_target|O95831	-	613	sp|O15770|GSHR_PLA	-	500	1.7e-36	124.2	0.0	2	2	3e-37	2.4e-35	120.4	0.1	113	314	228	440	214	454	0.87	Apoptosis-inducing factor 1, mitochondrial (DB03147; DB05282)
drugbank_target|P42593	-	672	sp|O15770|GSHR_PLA	-	500	1.1e-27	95.1	0.4	1	3	5.2e-12	4.1e-10	37.1	0.2	5	49	377	422	376	432	0.93	2,4-dienoyl-CoA reductase [NADPH] (DB03147; DB03247; DB03461; DB03698)
drugbank_target|P42593	-	672	sp|O15770|GSHR_PLA	-	500	1.1e-27	95.1	0.4	2	3	1.3e-15	1.1e-13	49.0	0.0	118	203	435	522	430	541	0.91	2,4-dienoyl-CoA reductase [NADPH] (DB03147; DB03247; DB03461; DB03698)
drugbank_target|P42593	-	672	sp|O15770|GSHR_PLA	-	500	1.1e-27	95.1	0.4	3	3	0.029	2.3	5.0	0.0	230	279	587	633	556	650	0.73	2,4-dienoyl-CoA reductase [NADPH] (DB03147; DB03247; DB03461; DB03698)
drugbank_target|Q12882	-	1025	sp|O15770|GSHR_PLA	-	500	6.8e-26	89.2	0.0	1	2	0.0082	0.65	6.8	0.0	173	280	184	293	162	304	0.74	Dihydropyrimidine dehydrogenase [NADP(+)] (DB02303; DB02338; DB03048; DB03147; DB03247; DB03419; DB03516; DB03554; DB09257; DB09327)
drugbank_target|Q12882	-	1025	sp|O15770|GSHR_PLA	-	500	6.8e-26	89.2	0.0	2	2	4.5e-25	3.6e-23	80.2	0.0	177	329	333	497	319	521	0.88	Dihydropyrimidine dehydrogenase [NADP(+)] (DB02303; DB02338; DB03048; DB03147; DB03247; DB03419; DB03516; DB03554; DB09257; DB09327)
drugbank_target|B7JBP8	-	434	sp|O15770|GSHR_PLA	-	500	2.5e-17	61.0	1.4	1	3	0.00025	0.02	11.8	0.1	4	33	3	35	1	40	0.89	Sulfide-quinone reductase (DB07640)
drugbank_target|B7JBP8	-	434	sp|O15770|GSHR_PLA	-	500	2.5e-17	61.0	1.4	2	3	0.0055	0.44	7.4	0.0	96	162	63	118	56	143	0.77	Sulfide-quinone reductase (DB07640)
drugbank_target|B7JBP8	-	434	sp|O15770|GSHR_PLA	-	500	2.5e-17	61.0	1.4	3	3	1.1e-12	8.6e-11	39.4	0.1	222	311	210	301	203	311	0.92	Sulfide-quinone reductase (DB07640)
drugbank_target|P16099	-	730	sp|O15770|GSHR_PLA	-	500	4.8e-15	53.4	0.0	1	1	1.2e-16	9.8e-15	52.4	0.0	168	280	382	497	362	502	0.92	Trimethylamine dehydrogenase (DB03247)
drugbank_target|P00363	-	602	sp|O15770|GSHR_PLA	-	500	1.4e-13	48.6	1.1	1	2	1e-05	0.00082	16.4	1.3	4	33	7	38	6	58	0.82	Fumarate reductase flavoprotein subunit (DB00730; DB07490; DB07918)
drugbank_target|P00363	-	602	sp|O15770|GSHR_PLA	-	500	1.4e-13	48.6	1.1	2	2	1e-09	8.3e-08	29.5	0.0	269	316	338	384	321	396	0.91	Fumarate reductase flavoprotein subunit (DB00730; DB07490; DB07918)
drugbank_target|P83223	-	596	sp|O15770|GSHR_PLA	-	500	3.9e-12	43.8	2.8	1	3	2.3e-10	1.8e-08	31.7	0.3	3	40	151	189	150	222	0.91	Fumarate reductase flavoprotein subunit (DB00518; DB01677; DB03147)
drugbank_target|P83223	-	596	sp|O15770|GSHR_PLA	-	500	3.9e-12	43.8	2.8	2	3	0.00098	0.078	9.8	0.0	207	273	267	339	249	355	0.74	Fumarate reductase flavoprotein subunit (DB00518; DB01677; DB03147)
drugbank_target|P83223	-	596	sp|O15770|GSHR_PLA	-	500	3.9e-12	43.8	2.8	3	3	1	82	-0.1	0.0	465	489	370	393	366	398	0.88	Fumarate reductase flavoprotein subunit (DB00518; DB01677; DB03147)
drugbank_target|P37747	-	367	sp|O15770|GSHR_PLA	-	500	1.5e-11	41.9	0.0	1	1	2.9e-13	2.3e-11	41.3	0.0	2	55	1	55	1	77	0.85	UDP-galactopyranose mutase (DB03147)
drugbank_target|P21397	-	527	sp|O15770|GSHR_PLA	-	500	1.5e-10	38.6	0.4	1	1	3e-12	2.4e-10	37.9	0.4	2	43	13	55	12	60	0.94	Amine oxidase [flavin-containing] A (DB00182; DB00721; DB01168; DB01171)
drugbank_target|P21397	-	527	sp|O15770|GSHR_PLA	-	500	1.5e-10	38.6	0.4	1	1	3e-12	2.4e-10	37.9	0.4	2	43	13	55	12	60	0.94	Amine oxidase [flavin-containing] A (DB00191; DB00752; DB00780; DB00805; DB00909; DB01037; DB01171; DB01247; DB01363; DB01442; DB01472; DB01577; DB01626; DB03147; DB04017; DB04820; DB04821; DB04832; DB04850; DB05205; DB07641; DB07919; DB09244; DB09245; DB13876; DB14914)
drugbank_target|P0C278	-	571	sp|O15770|GSHR_PLA	-	500	1.6e-10	38.5	2.9	1	3	4.1	3.3e+02	-2.1	0.0	391	435	37	78	35	83	0.73	Fumarate reductase flavoprotein subunit (DB01677; DB03147; DB03343; DB04734)
drugbank_target|P0C278	-	571	sp|O15770|GSHR_PLA	-	500	1.6e-10	38.5	2.9	2	3	8.5e-10	6.7e-08	29.8	0.3	4	40	128	165	126	205	0.91	Fumarate reductase flavoprotein subunit (DB01677; DB03147; DB03343; DB04734)
drugbank_target|P0C278	-	571	sp|O15770|GSHR_PLA	-	500	1.6e-10	38.5	2.9	3	3	0.0041	0.33	7.8	0.0	213	297	251	337	225	341	0.75	Fumarate reductase flavoprotein subunit (DB01677; DB03147; DB03343; DB04734)
drugbank_target|Q16836	-	314	sp|O15770|GSHR_PLA	-	500	3.8e-10	37.2	1.8	1	1	6.6e-12	5.2e-10	36.8	1.8	167	239	16	90	6	135	0.73	Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial (DB00157; DB03059; DB03612; DB09568)
drugbank_target|Q6NUM9	-	610	sp|O15770|GSHR_PLA	-	500	6.8e-10	36.4	2.5	1	1	1.4e-11	1.1e-09	35.7	2.5	4	44	69	110	68	113	0.93	All-trans-retinol 13,14-reductase (DB00162)
drugbank_target|P40859	-	390	sp|O15770|GSHR_PLA	-	500	2e-09	34.9	0.0	1	2	1.4e-09	1.1e-07	29.1	0.1	3	33	5	35	3	52	0.88	Monomeric sarcosine oxidase (DB01918; DB02083; DB02543; DB03098; DB03147; DB03366; DB03517)
drugbank_target|P40859	-	390	sp|O15770|GSHR_PLA	-	500	2e-09	34.9	0.0	2	2	0.078	6.2	3.6	0.0	220	282	154	212	141	226	0.78	Monomeric sarcosine oxidase (DB01918; DB02083; DB02543; DB03098; DB03147; DB03366; DB03517)
drugbank_target|P27338	-	520	sp|O15770|GSHR_PLA	-	500	2.4e-09	34.6	0.5	1	1	4.8e-11	3.9e-09	33.9	0.5	4	42	6	45	5	53	0.93	Amine oxidase [flavin-containing] B (DB00182; DB00721; DB01168; DB01171)
drugbank_target|P27338	-	520	sp|O15770|GSHR_PLA	-	500	2.4e-09	34.6	0.5	1	1	4.8e-11	3.9e-09	33.9	0.5	4	42	6	45	5	53	0.93	Amine oxidase [flavin-containing] B (DB00182; DB00191; DB00752; DB00780; DB00909; DB01037; DB01132; DB01171; DB01247; DB01363; DB01367; DB01442; DB01472; DB01577; DB01626; DB02095; DB02211; DB02509; DB02643; DB03147; DB03894; DB04147; DB04307; DB04677; DB04820; DB04821; DB04832; DB06654; DB07512; DB07513; DB08082; DB08176; DB08480; DB08516; DB14914)
drugbank_target|O31616	-	369	sp|O15770|GSHR_PLA	-	500	6.6e-09	33.2	1.3	1	1	1.6e-10	1.3e-08	32.2	1.3	3	42	5	44	4	55	0.95	Glycine oxidase (DB02713; DB03147)
drugbank_target|Q96RQ9	-	567	sp|O15770|GSHR_PLA	-	500	1.2e-08	32.3	0.1	1	1	2.1e-10	1.7e-08	31.8	0.1	5	42	62	100	60	161	0.86	L-amino-acid oxidase (DB03147; DB03214; DB04166; DB04272)
drugbank_target|Q92206	-	496	sp|O15770|GSHR_PLA	-	500	4.3e-08	30.5	0.1	1	2	2.6e-08	2.1e-06	24.9	0.1	3	34	6	39	4	54	0.86	Squalene monooxygenase (DB00525; DB00857)
drugbank_target|Q92206	-	496	sp|O15770|GSHR_PLA	-	500	4.3e-08	30.5	0.1	2	2	0.094	7.5	3.3	0.0	207	250	281	324	271	338	0.85	Squalene monooxygenase (DB00525; DB00857)
drugbank_target|P10902	-	540	sp|O15770|GSHR_PLA	-	500	4.6e-08	30.4	0.7	1	3	5.6e-05	0.0044	13.9	0.2	4	33	10	38	9	60	0.79	L-aspartate oxidase (DB03147)
drugbank_target|P10902	-	540	sp|O15770|GSHR_PLA	-	500	4.6e-08	30.4	0.7	2	3	3.5	2.8e+02	-1.9	0.0	137	155	192	210	160	224	0.80	L-aspartate oxidase (DB03147)
drugbank_target|P10902	-	540	sp|O15770|GSHR_PLA	-	500	4.6e-08	30.4	0.7	3	3	6.9e-05	0.0055	13.6	0.0	288	314	351	377	332	406	0.85	L-aspartate oxidase (DB03147)
drugbank_target|Q9P0Z9	-	390	sp|O15770|GSHR_PLA	-	500	7e-08	29.8	0.0	1	2	2.2e-08	1.8e-06	25.1	0.0	2	38	7	46	6	94	0.79	Peroxisomal sarcosine oxidase (DB00145)
drugbank_target|Q9P0Z9	-	390	sp|O15770|GSHR_PLA	-	500	7e-08	29.8	0.0	2	2	0.2	16	2.2	0.1	3	14	337	348	336	353	0.92	Peroxisomal sarcosine oxidase (DB00145)
drugbank_target|P28845	-	292	sp|O15770|GSHR_PLA	-	500	1.1e-07	29.1	0.0	1	1	1.9e-09	1.5e-07	28.7	0.0	164	215	20	74	5	91	0.86	Corticosteroid 11-beta-dehydrogenase isozyme 1 (DB00157; DB02329; DB03461; DB03814; DB04652; DB05064; DB06992; DB07017; DB07049; DB07056; DB07310; DB07316; DB07619; DB07624; DB07866; DB08277; DB08280; DB08771; DB13751)
drugbank_target|Q9Z4P0	-	588	sp|O15770|GSHR_PLA	-	500	2.4e-07	28.0	2.4	1	2	5.5e-08	4.4e-06	23.8	0.4	4	40	145	182	143	233	0.92	Fumarate reductase flavoprotein subunit (DB03147)
drugbank_target|Q9Z4P0	-	588	sp|O15770|GSHR_PLA	-	500	2.4e-07	28.0	2.4	2	2	0.099	7.9	3.2	0.1	213	272	268	331	250	369	0.69	Fumarate reductase flavoprotein subunit (DB03147)
drugbank_target|P9WIQ1	-	399	sp|O15770|GSHR_PLA	-	500	3.4e-07	27.5	0.0	1	1	6.2e-09	4.9e-07	27.0	0.0	3	44	8	51	7	84	0.88	UDP-galactopyranose mutase (DB03147; DB03709)
drugbank_target|Q6A8X5	-	424	sp|O15770|GSHR_PLA	-	500	7.4e-07	26.4	0.1	1	1	1.5e-08	1.2e-06	25.7	0.1	5	42	9	48	8	59	0.87	Putative aminooxidase (DB04746; DB04747)
drugbank_target|Q16134	-	617	sp|O15770|GSHR_PLA	-	500	7.5e-07	26.4	0.8	1	2	2.7e-08	2.2e-06	24.9	0.5	4	41	70	119	69	124	0.88	Electron transfer flavoprotein-ubiquinone oxidoreductase, mitochondrial (DB00331; DB04141)
drugbank_target|Q16134	-	617	sp|O15770|GSHR_PLA	-	500	7.5e-07	26.4	0.8	2	2	2.4	1.9e+02	-1.3	0.0	354	373	400	419	395	430	0.81	Electron transfer flavoprotein-ubiquinone oxidoreductase, mitochondrial (DB00331; DB04141)
drugbank_target|Q9NWM0	-	555	sp|O15770|GSHR_PLA	-	500	1.3e-06	25.6	1.6	1	1	3e-08	2.4e-06	24.7	1.6	5	44	27	68	26	72	0.90	Spermine oxidase (DB00127; DB04188)
drugbank_target|O67931	-	430	sp|O15770|GSHR_PLA	-	500	1.5e-06	25.4	0.1	1	2	4.1e-05	0.0033	14.4	0.0	4	32	4	34	1	42	0.86	Sulfide-quinone reductase (DB07640)
drugbank_target|O67931	-	430	sp|O15770|GSHR_PLA	-	500	1.5e-06	25.4	0.1	2	2	0.0023	0.18	8.6	0.0	103	155	70	111	57	150	0.69	Sulfide-quinone reductase (DB07640)
drugbank_target|P0AC41	-	588	sp|O15770|GSHR_PLA	-	500	3e-06	24.4	0.4	1	3	3.7e-08	3e-06	24.4	0.4	3	42	8	56	7	60	0.87	Succinate dehydrogenase flavoprotein subunit (DB04631; DB07671; DB08690)
drugbank_target|P0AC41	-	588	sp|O15770|GSHR_PLA	-	500	3e-06	24.4	0.4	2	3	3.3	2.6e+02	-1.8	0.0	92	151	147	204	134	217	0.60	Succinate dehydrogenase flavoprotein subunit (DB04631; DB07671; DB08690)
drugbank_target|P0AC41	-	588	sp|O15770|GSHR_PLA	-	500	3e-06	24.4	0.4	3	3	3.2	2.5e+02	-1.7	0.1	292	316	367	392	358	398	0.71	Succinate dehydrogenase flavoprotein subunit (DB04631; DB07671; DB08690)
drugbank_target|Q888A4	-	328	sp|O15770|GSHR_PLA	-	500	3.1e-06	24.4	0.2	1	1	5.7e-08	4.6e-06	23.8	0.2	5	41	5	42	1	48	0.89	Amine oxidase, flavin-containing protein (DB03147)
drugbank_target|P17412	-	656	sp|O15770|GSHR_PLA	-	500	8.2e-06	23.0	0.2	1	2	5e-06	0.0004	17.4	0.5	4	32	7	35	5	56	0.83	Fumarate reductase flavoprotein subunit (DB07669)
drugbank_target|P17412	-	656	sp|O15770|GSHR_PLA	-	500	8.2e-06	23.0	0.2	2	2	0.15	12	2.6	0.0	271	314	353	395	337	403	0.87	Fumarate reductase flavoprotein subunit (DB07669)
drugbank_target|P56601	-	471	sp|O15770|GSHR_PLA	-	500	9.1e-06	22.8	2.2	1	1	1.7e-07	1.4e-05	22.2	2.2	4	40	11	48	10	54	0.91	Protoporphyrinogen oxidase (DB07338)
drugbank_target|P32397	-	470	sp|O15770|GSHR_PLA	-	500	1.1e-05	22.6	0.3	1	2	4.7e-07	3.7e-05	20.8	0.1	5	44	8	54	7	57	0.79	Protoporphyrinogen oxidase (DB07338)
drugbank_target|P32397	-	470	sp|O15770|GSHR_PLA	-	500	1.1e-05	22.6	0.3	2	2	1.9	1.5e+02	-1.0	0.0	219	270	237	284	203	295	0.72	Protoporphyrinogen oxidase (DB07338)
drugbank_target|P22637	-	552	sp|O15770|GSHR_PLA	-	500	1.1e-05	22.6	0.3	1	2	1.7e-06	0.00013	18.9	0.0	5	34	59	91	58	139	0.73	Cholesterol oxidase (DB03147)
drugbank_target|P22637	-	552	sp|O15770|GSHR_PLA	-	500	1.1e-05	22.6	0.3	2	2	0.32	25	1.5	0.1	223	280	278	343	247	354	0.67	Cholesterol oxidase (DB03147)
drugbank_target|P31040	-	664	sp|O15770|GSHR_PLA	-	500	4.7e-05	20.5	0.7	1	2	5.8e-07	4.7e-05	20.5	0.7	3	33	62	92	61	112	0.85	Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial (DB04141; DB04657; DB04795; DB08689; DB09270)
drugbank_target|P31040	-	664	sp|O15770|GSHR_PLA	-	500	4.7e-05	20.5	0.7	2	2	7.7	6.1e+02	-3.0	0.0	269	314	389	442	385	447	0.66	Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial (DB04141; DB04657; DB04795; DB08689; DB09270)
drugbank_target|Q14534	-	574	sp|O15770|GSHR_PLA	-	500	4.9e-05	20.4	0.1	1	1	1.1e-06	8.6e-05	19.6	0.1	4	36	125	162	124	171	0.83	Squalene monooxygenase (DB00735; DB00857; DB01091; DB08846)
drugbank_target|Q8KI25	-	529	sp|O15770|GSHR_PLA	-	500	6.1e-05	20.1	0.0	1	1	1.1e-06	8.6e-05	19.6	0.0	3	35	7	39	5	77	0.87	Putative FAD-monooxygenase (DB07241; DB08036)
drugbank_target|Q13423	-	1086	sp|O15770|GSHR_PLA	-	500	0.0049	13.8	0.0	1	1	0.00011	0.0085	13.0	0.0	175	230	226	281	134	286	0.82	NAD(P) transhydrogenase, mitochondrial (DB00157; DB01763; DB03461; DB09092)
drugbank_target|P9WIQ3	-	456	sp|O15770|GSHR_PLA	-	500	0.0072	13.2	0.0	1	2	2.4	1.9e+02	-1.4	0.0	5	23	6	24	4	41	0.66	NADPH-ferredoxin reductase FprA (DB01753; DB03147)
drugbank_target|P9WIQ3	-	456	sp|O15770|GSHR_PLA	-	500	0.0072	13.2	0.0	2	2	0.00034	0.027	11.4	0.0	139	195	94	166	60	195	0.76	NADPH-ferredoxin reductase FprA (DB01753; DB03147)
drugbank_target|Q9AGP8	-	830	sp|O15770|GSHR_PLA	-	500	0.008	13.1	0.0	1	2	0.0029	0.23	8.3	0.0	5	57	7	68	6	82	0.77	Dimethylglycine oxidase (DB03147; DB03256)
drugbank_target|Q9AGP8	-	830	sp|O15770|GSHR_PLA	-	500	0.008	13.1	0.0	2	2	0.17	14	2.4	0.0	222	272	156	204	147	208	0.87	Dimethylglycine oxidase (DB03147; DB03256)
drugbank_target|P00438	-	394	sp|O15770|GSHR_PLA	-	500	0.012	12.5	0.1	1	1	0.00021	0.017	12.1	0.1	4	208	4	34	1	50	0.63	p-hydroxybenzoate hydroxylase (DB02362)
drugbank_target|P00438	-	394	sp|O15770|GSHR_PLA	-	500	0.012	12.5	0.1	1	1	0.00021	0.017	12.1	0.1	4	208	4	34	1	50	0.63	p-hydroxybenzoate hydroxylase (DB02059; DB02839; DB03147; DB04242)
drugbank_target|P20586	-	394	sp|O15770|GSHR_PLA	-	500	0.012	12.5	0.1	1	1	0.00021	0.017	12.1	0.1	4	208	4	34	1	50	0.63	p-hydroxybenzoate hydroxylase (DB02362)
drugbank_target|P20586	-	394	sp|O15770|GSHR_PLA	-	500	0.012	12.5	0.1	1	1	0.00021	0.017	12.1	0.1	4	208	4	34	1	50	0.63	p-hydroxybenzoate hydroxylase (DB02839; DB03147; DB03482; DB04242)
drugbank_target|Q08426	-	723	sp|O15770|GSHR_PLA	-	500	0.037	10.9	0.0	1	1	0.00071	0.056	10.3	0.0	174	229	295	350	278	355	0.89	Peroxisomal bifunctional enzyme (DB00157)
drugbank_target|Q9BY32	-	194	sp|Q8IBP3|ITPA_PLA	-	198	9.5e-96	317.6	0.0	1	1	2.2e-99	1.2e-95	317.3	0.0	2	187	9	189	8	192	0.99	Inosine triphosphate pyrophosphatase (DB04272)
drugbank_target|Q8I6U8	-	824	sp|Q8I6U8|GBP_PLAF	-	824	0	1927.7	87.3	1	1	0	0	1927.5	87.3	1	824	1	824	1	824	1.00	Glycophorin-binding protein (DB11638)
drugbank_target|Q8MU52	-	211	sp|Q8ILQ7|GST_PLAF	-	211	3.9e-81	269.9	1.4	1	1	3e-83	4.3e-81	269.8	1.4	1	211	1	211	1	211	1.00	Glutathione S-transferase (DB00608; DB01942; DB04132)
drugbank_target|P09488	-	218	sp|Q8ILQ7|GST_PLAF	-	211	7.5e-78	259.2	0.1	1	1	6.9e-80	9.8e-78	258.8	0.1	5	205	3	200	2	203	0.98	Glutathione S-transferase Mu 1 (DB03310)
drugbank_target|P09488	-	218	sp|Q8ILQ7|GST_PLAF	-	211	7.5e-78	259.2	0.1	1	1	6.9e-80	9.8e-78	258.8	0.1	5	205	3	200	2	203	0.98	Glutathione S-transferase Mu 1 (DB00143; DB00608; DB01834; DB02165; DB02458; DB03314; DB04187)
drugbank_target|Q03013	-	218	sp|Q8ILQ7|GST_PLAF	-	211	8.4e-78	259.1	0.0	1	1	7e-80	9.9e-78	258.8	0.0	4	205	2	200	1	203	0.98	Glutathione S-transferase Mu 4 (DB03310)
drugbank_target|Q03013	-	218	sp|Q8ILQ7|GST_PLAF	-	211	8.4e-78	259.1	0.0	1	1	7e-80	9.9e-78	258.8	0.0	4	205	2	200	1	203	0.98	Glutathione S-transferase Mu 4 (DB00143; DB03003; DB03032; DB03597; DB03706; DB04132)
drugbank_target|P28161	-	218	sp|Q8ILQ7|GST_PLAF	-	211	3.6e-77	257.0	0.1	1	1	3.3e-79	4.7e-77	256.6	0.1	5	205	3	200	2	203	0.98	Glutathione S-transferase Mu 2 (DB00143; DB02458; DB03310; DB04701)
drugbank_target|P28161	-	218	sp|Q8ILQ7|GST_PLAF	-	211	3.6e-77	257.0	0.1	1	1	3.3e-79	4.7e-77	256.6	0.1	5	205	3	200	2	203	0.98	Glutathione S-transferase Mu 2 (DB03310)
drugbank_target|P46439	-	218	sp|Q8ILQ7|GST_PLAF	-	211	1.3e-75	251.9	0.1	1	1	1.3e-77	1.8e-75	251.4	0.1	5	205	3	200	2	203	0.98	Glutathione S-transferase Mu 5 (DB00143)
drugbank_target|P46439	-	218	sp|Q8ILQ7|GST_PLAF	-	211	1.3e-75	251.9	0.1	1	1	1.3e-77	1.8e-75	251.4	0.1	5	205	3	200	2	203	0.98	Glutathione S-transferase Mu 5 (DB03310)
drugbank_target|P21266	-	225	sp|Q8ILQ7|GST_PLAF	-	211	6e-75	249.7	0.2	1	1	5.6e-77	7.9e-75	249.3	0.2	4	205	6	204	4	208	0.97	Glutathione S-transferase Mu 3 (DB03310)
drugbank_target|P21266	-	225	sp|Q8ILQ7|GST_PLAF	-	211	6e-75	249.7	0.2	1	1	5.6e-77	7.9e-75	249.3	0.2	4	205	6	204	4	208	0.97	Glutathione S-transferase Mu 3 (DB00143)
drugbank_target|P08263	-	222	sp|Q8ILQ7|GST_PLAF	-	211	1.9e-73	244.8	0.2	1	1	1.6e-75	2.3e-73	244.5	0.2	1	204	1	199	1	202	0.94	Glutathione S-transferase A1 (DB00143; DB01915; DB02486; DB02943; DB03003; DB03602; DB04132; DB13014)
drugbank_target|P08263	-	222	sp|Q8ILQ7|GST_PLAF	-	211	1.9e-73	244.8	0.2	1	1	1.6e-75	2.3e-73	244.5	0.2	1	204	1	199	1	202	0.94	Glutathione S-transferase A1 (DB03310)
drugbank_target|P09210	-	222	sp|Q8ILQ7|GST_PLAF	-	211	5.1e-73	243.4	0.4	1	1	4.5e-75	6.3e-73	243.1	0.4	1	204	1	199	1	202	0.94	Glutathione S-transferase A2 (DB00143; DB00608)
drugbank_target|P09210	-	222	sp|Q8ILQ7|GST_PLAF	-	211	5.1e-73	243.4	0.4	1	1	4.5e-75	6.3e-73	243.1	0.4	1	204	1	199	1	202	0.94	Glutathione S-transferase A2 (DB03310)
drugbank_target|Q16772	-	222	sp|Q8ILQ7|GST_PLAF	-	211	1e-71	239.1	0.0	1	1	9e-74	1.3e-71	238.8	0.0	1	204	1	199	1	202	0.94	Glutathione S-transferase A3 (DB00143; DB04521)
drugbank_target|Q7RTV2	-	222	sp|Q8ILQ7|GST_PLAF	-	211	1.5e-70	235.3	0.6	1	1	1.3e-72	1.9e-70	235.1	0.6	1	204	1	199	1	204	0.93	Glutathione S-transferase A5 (DB00143)
drugbank_target|O60760	-	199	sp|Q8ILQ7|GST_PLAF	-	211	3.3e-68	227.7	0.1	1	1	2.5e-70	3.6e-68	227.6	0.1	4	209	3	197	1	199	0.97	Hematopoietic prostaglandin D synthase (DB00143; DB00755; DB01897; DB07613; DB07614; DB07615; DB07616; DB07917; DB08313; DB08695; DB08790)
drugbank_target|O60760	-	199	sp|Q8ILQ7|GST_PLAF	-	211	3.3e-68	227.7	0.1	1	1	2.5e-70	3.6e-68	227.6	0.1	4	209	3	197	1	199	0.97	Hematopoietic prostaglandin D synthase (DB03310)
drugbank_target|O15217	-	222	sp|Q8ILQ7|GST_PLAF	-	211	1.6e-61	205.8	0.1	1	1	1.4e-63	1.9e-61	205.6	0.1	1	204	1	199	1	204	0.93	Glutathione S-transferase A4 (DB00143)
drugbank_target|P09211	-	210	sp|Q8ILQ7|GST_PLAF	-	211	6.2e-61	203.9	0.0	1	1	5.4e-63	7.7e-61	203.6	0.0	5	205	4	196	2	200	0.94	Glutathione S-transferase P (DB03310)
drugbank_target|P09211	-	210	sp|Q8ILQ7|GST_PLAF	-	211	6.2e-61	203.9	0.0	1	1	5.4e-63	7.7e-61	203.6	0.0	5	205	4	196	2	200	0.94	Glutathione S-transferase P (DB00143; DB00197; DB00363; DB00903; DB01242; DB01834; DB01915; DB02633; DB03003; DB03619; DB03686; DB03814; DB04132; DB04339; DB04972; DB05460; DB06246; DB07849; DB08370; DB11672; DB11831; DB13014; DB14635)
drugbank_target|P78417	-	241	sp|Q8ILQ7|GST_PLAF	-	211	8e-52	174.2	0.0	1	1	7.1e-54	1e-51	173.8	0.0	7	207	26	220	22	223	0.94	Glutathione S-transferase omega-1 (DB00143)
drugbank_target|O43708	-	216	sp|Q8ILQ7|GST_PLAF	-	211	1e-51	173.8	0.0	1	1	8.8e-54	1.3e-51	173.5	0.0	3	200	4	200	2	203	0.96	Maleylacetoacetate isomerase (DB00143; DB04447; DB08809; DB09462)
drugbank_target|Q9H4Y5	-	243	sp|Q8ILQ7|GST_PLAF	-	211	1.2e-47	160.5	0.0	1	1	1.1e-49	1.5e-47	160.2	0.0	8	205	27	219	23	223	0.93	Glutathione S-transferase omega-2 (DB00143)
drugbank_target|P0CG29	-	244	sp|Q8ILQ7|GST_PLAF	-	211	3.6e-45	152.4	0.0	1	1	3.4e-47	4.9e-45	152.0	0.0	24	195	22	199	12	205	0.92	Glutathione S-transferase theta-2 (DB04132)
drugbank_target|P0CG29	-	244	sp|Q8ILQ7|GST_PLAF	-	211	3.6e-45	152.4	0.0	1	1	3.4e-47	4.9e-45	152.0	0.0	24	195	22	199	12	205	0.92	Glutathione S-transferase theta-2 (DB03310)
drugbank_target|P0CG30	-	244	sp|Q8ILQ7|GST_PLAF	-	211	4.3e-45	152.2	0.0	1	1	4.1e-47	5.9e-45	151.7	0.0	24	195	22	199	12	205	0.92	Glutathione S-transferase theta-2B (DB03310)
drugbank_target|P30711	-	240	sp|Q8ILQ7|GST_PLAF	-	211	5.7e-41	138.7	0.0	1	1	5.3e-43	7.5e-41	138.3	0.0	24	195	22	200	9	209	0.91	Glutathione S-transferase theta-1 (DB03310)
drugbank_target|P30711	-	240	sp|Q8ILQ7|GST_PLAF	-	211	5.7e-41	138.7	0.0	1	1	5.3e-43	7.5e-41	138.3	0.0	24	195	22	200	9	209	0.91	Glutathione S-transferase theta-1 (DB00143)
drugbank_target|Q59721	-	203	sp|Q8ILQ7|GST_PLAF	-	211	6.3e-40	135.3	0.0	1	1	5.1e-42	7.2e-40	135.1	0.0	18	204	13	196	1	200	0.92	Glutathione S-transferase (DB07914)
drugbank_target|Q8IDV0	-	411	sp|Q8ILQ7|GST_PLAF	-	211	9e-36	121.7	0.6	1	1	1.1e-37	1.6e-35	120.9	0.6	34	201	32	192	11	201	0.90	Elongation factor 1-gamma, putative (DB11638)
drugbank_target|P0A9D2	-	201	sp|Q8ILQ7|GST_PLAF	-	211	1.8e-33	114.2	0.0	1	1	1.6e-35	2.3e-33	113.9	0.0	21	204	16	196	2	199	0.90	Glutathione S-transferase GstA (DB03003)
drugbank_target|K7YNB3	-	240	sp|Q8ILQ7|GST_PLAF	-	211	6.9e-31	105.8	0.0	1	1	6.4e-33	9.2e-31	105.4	0.0	5	173	17	171	14	214	0.88	Glutathione S-transferase omega class (DB12245)
dgbank_trgt|A0A384KMD8	-	213	sp|Q8ILQ7|GST_PLAF	-	211	4.4e-21	73.7	0.0	1	1	4.1e-23	5.9e-21	73.3	0.0	15	204	21	201	9	206	0.78	Putative stringent starvation protein A (DB04272)
drugbank_target|P07814	-	1512	sp|Q8ILQ7|GST_PLAF	-	211	8.2e-14	50.0	0.0	1	1	3.3e-15	4.7e-13	47.5	0.0	66	199	45	160	39	165	0.79	Bifunctional glutamate/proline--tRNA ligase (DB00142; DB00172; DB02510; DB02684; DB03376)
drugbank_target|O00299	-	241	sp|Q8ILQ7|GST_PLAF	-	211	1.1e-06	26.6	0.0	1	1	1.6e-08	2.2e-06	25.7	0.0	16	175	27	190	23	205	0.73	Chloride intracellular channel protein 1 (DB09130; DB11638)
drugbank_target|Q15418	-	735	sp|Q8IHZ9|KC1_PLAF	-	323	2.7e-157	521.4	0.0	1	2	2.6e-80	3.8e-79	264.6	0.0	7	264	60	305	55	309	0.94	Ribosomal protein S6 kinase alpha-1 (DB04751; DB12010)
drugbank_target|Q15418	-	735	sp|Q8IHZ9|KC1_PLAF	-	323	2.7e-157	521.4	0.0	2	2	2.5e-77	3.6e-76	254.8	0.0	5	277	414	674	410	713	0.90	Ribosomal protein S6 kinase alpha-1 (DB04751; DB12010)
drugbank_target|P51812	-	740	sp|Q8IHZ9|KC1_PLAF	-	323	3.8e-155	514.3	0.0	1	2	3.5e-80	5.1e-79	264.1	0.0	7	264	66	311	61	329	0.93	Ribosomal protein S6 kinase alpha-3 (DB00945; DB12010)
drugbank_target|P51812	-	740	sp|Q8IHZ9|KC1_PLAF	-	323	3.8e-155	514.3	0.0	2	2	2.7e-75	3.9e-74	248.1	0.0	3	269	416	673	414	698	0.94	Ribosomal protein S6 kinase alpha-3 (DB00945; DB12010)
drugbank_target|Q9UK32	-	745	sp|Q8IHZ9|KC1_PLAF	-	323	7.9e-155	513.3	0.1	1	2	9.6e-80	1.4e-78	262.7	0.1	7	280	71	332	66	345	0.92	Ribosomal protein S6 kinase alpha-6 (DB12010)
drugbank_target|Q9UK32	-	745	sp|Q8IHZ9|KC1_PLAF	-	323	7.9e-155	513.3	0.1	2	2	1.9e-75	2.8e-74	248.6	0.0	4	272	421	680	418	709	0.93	Ribosomal protein S6 kinase alpha-6 (DB12010)
drugbank_target|O75676	-	772	sp|Q8IHZ9|KC1_PLAF	-	323	1.7e-141	469.5	0.0	1	2	9.5e-69	1.4e-67	226.6	0.0	6	264	30	285	25	289	0.89	Ribosomal protein S6 kinase alpha-4 (DB03247)
drugbank_target|O75676	-	772	sp|Q8IHZ9|KC1_PLAF	-	323	1.7e-141	469.5	0.0	2	2	4.5e-73	6.5e-72	240.8	0.0	14	270	416	669	405	682	0.92	Ribosomal protein S6 kinase alpha-4 (DB03247)
drugbank_target|O60674	-	1132	sp|Q8IHZ9|KC1_PLAF	-	323	3.2e-123	409.4	0.4	1	2	1.6e-49	2.3e-48	163.4	0.0	7	279	543	811	538	827	0.87	Tyrosine-protein kinase JAK2 (DB04716; DB05243; DB07161; DB07162; DB08067; DB08877; DB08895; DB11817; DB11986; DB12010; DB12500; DB15035)
drugbank_target|O60674	-	1132	sp|Q8IHZ9|KC1_PLAF	-	323	3.2e-123	409.4	0.4	2	2	6.4e-74	9.2e-73	243.6	0.3	7	276	847	1126	843	1131	0.87	Tyrosine-protein kinase JAK2 (DB04716; DB05243; DB07161; DB07162; DB08067; DB08877; DB08895; DB11817; DB11986; DB12010; DB12500; DB15035)
drugbank_target|P23458	-	1154	sp|Q8IHZ9|KC1_PLAF	-	323	4.9e-118	392.4	0.1	1	2	3.1e-49	4.4e-48	162.5	0.0	5	281	579	853	575	874	0.85	Tyrosine-protein kinase JAK1 (DB02375; DB04716; DB08877; DB08895; DB11817; DB12010; DB12500; DB15091)
drugbank_target|P23458	-	1154	sp|Q8IHZ9|KC1_PLAF	-	323	4.9e-118	392.4	0.1	2	2	5.5e-72	8e-71	237.2	0.1	10	277	876	1153	868	1154	0.86	Tyrosine-protein kinase JAK1 (DB02375; DB04716; DB08877; DB08895; DB11817; DB12010; DB12500; DB15091)
drugbank_target|P29597	-	1187	sp|Q8IHZ9|KC1_PLAF	-	323	3.4e-116	386.3	0.0	1	2	4.6e-45	6.6e-44	148.8	0.0	7	280	587	873	582	883	0.88	Non-receptor tyrosine-protein kinase TYK2 (DB04716; DB08895; DB12010)
drugbank_target|P29597	-	1187	sp|Q8IHZ9|KC1_PLAF	-	323	3.4e-116	386.3	0.0	2	2	2.9e-71	4.1e-70	234.9	0.0	9	281	897	1177	890	1186	0.85	Non-receptor tyrosine-protein kinase TYK2 (DB04716; DB08895; DB12010)
drugbank_target|P52333	-	1124	sp|Q8IHZ9|KC1_PLAF	-	323	1.1e-111	371.4	0.0	1	2	2.8e-42	4.1e-41	139.6	0.0	7	279	519	783	514	790	0.89	Tyrosine-protein kinase JAK3 (DB04716; DB06321; DB08895; DB11817; DB12010; DB15035)
drugbank_target|P52333	-	1124	sp|Q8IHZ9|KC1_PLAF	-	323	1.1e-111	371.4	0.0	2	2	1.2e-69	1.8e-68	229.5	0.0	8	285	821	1107	816	1120	0.86	Tyrosine-protein kinase JAK3 (DB04716; DB06321; DB08895; DB11817; DB12010; DB15035)
drugbank_target|P49674	-	416	sp|Q8IHZ9|KC1_PLAF	-	323	3e-101	337.2	0.0	1	1	2.4e-102	3.5e-101	337.0	0.0	1	320	1	320	1	323	0.99	Casein kinase I isoform epsilon (DB06195)
drugbank_target|P48729	-	337	sp|Q8IHZ9|KC1_PLAF	-	323	3e-93	310.9	0.2	1	1	2.3e-94	3.4e-93	310.7	0.2	2	313	10	321	9	333	0.96	Casein kinase I isoform alpha (DB12010)
drugbank_target|P00521	-	746	sp|Q8IHZ9|KC1_PLAF	-	323	2.9e-90	301.1	0.0	1	1	3e-91	4.4e-90	300.5	0.0	7	287	126	393	122	414	0.94	Tyrosine-protein kinase transforming protein Abl (DB02567; DB03814; DB03878; DB05489)
drugbank_target|P00519	-	1130	sp|Q8IHZ9|KC1_PLAF	-	323	1e-89	299.3	0.1	1	1	1.1e-90	1.6e-89	298.7	0.1	7	288	240	508	236	542	0.93	Tyrosine-protein kinase ABL1 (DB00171; DB00619; DB01254; DB03878; DB04868; DB05184; DB06616; DB07831; DB08043; DB08231; DB08339; DB08350; DB08583; DB08896; DB08901; DB12010; DB12267; DB12323)
drugbank_target|P42685	-	505	sp|Q8IHZ9|KC1_PLAF	-	323	6.9e-89	296.6	0.0	1	1	6.7e-90	9.7e-89	296.1	0.0	7	284	232	498	228	503	0.93	Tyrosine-protein kinase FRK (DB01254; DB08896; DB12010; DB15035)
drugbank_target|Q13188	-	491	sp|Q8IHZ9|KC1_PLAF	-	323	5.3e-88	293.7	0.0	1	1	5.7e-89	8.2e-88	293.0	0.0	6	317	24	318	19	328	0.88	Serine/threonine-protein kinase 3 (DB12010)
drugbank_target|P42684	-	1182	sp|Q8IHZ9|KC1_PLAF	-	323	1.8e-87	291.9	0.0	1	1	2.2e-88	3.2e-87	291.1	0.0	7	288	286	554	282	566	0.93	Abelson tyrosine-protein kinase 2 (DB00171; DB01254; DB05184; DB07664; DB12010)
drugbank_target|Q9NYL2	-	800	sp|Q8IHZ9|KC1_PLAF	-	323	2.5e-87	291.5	0.1	1	1	3e-88	4.3e-87	290.7	0.1	7	317	14	310	10	317	0.93	Mitogen-activated protein kinase kinase kinase MLT (DB01254; DB12010)
drugbank_target|P06241	-	537	sp|Q8IHZ9|KC1_PLAF	-	323	5.1e-87	290.5	0.0	1	1	5.5e-88	7.9e-87	289.8	0.0	7	284	269	531	265	535	0.93	Tyrosine-protein kinase Fyn (DB01254; DB02078; DB12010)
drugbank_target|P12931	-	536	sp|Q8IHZ9|KC1_PLAF	-	323	1e-86	289.5	0.0	1	1	1.2e-87	1.7e-86	288.7	0.0	7	284	268	530	265	534	0.93	Proto-oncogene tyrosine-protein kinase Src (DB01254; DB01678; DB01866; DB01893; DB01908; DB01947; DB01962; DB02175; DB02336; DB02432; DB02762; DB02908; DB03023; DB03078; DB03104; DB03114; DB03217; DB03268; DB03298; DB03306; DB03525; DB03591; DB03628; DB03712; DB03828; DB03902; DB04080; DB04272; DB04495; DB04739; DB04751; DB05184; DB06137; DB06616; DB06882; DB06883; DB07335; DB07662; DB07966; DB08052; DB08053; DB08054; DB08192; DB08462; DB08564; DB08901; DB09079; DB12010)
drugbank_target|P07947	-	543	sp|Q8IHZ9|KC1_PLAF	-	323	3.5e-85	284.4	0.0	1	1	3.9e-86	5.7e-85	283.7	0.0	7	284	275	537	272	541	0.93	Tyrosine-protein kinase Yes (DB01254; DB12010)
drugbank_target|Q9Y6E0	-	443	sp|Q8IHZ9|KC1_PLAF	-	323	9.6e-85	283.0	0.0	1	1	8.4e-86	1.2e-84	282.6	0.0	6	319	33	327	28	331	0.87	Serine/threonine-protein kinase 24 (DB12010)
drugbank_target|P54762	-	984	sp|Q8IHZ9|KC1_PLAF	-	323	1e-84	282.9	0.0	1	1	1.3e-85	1.8e-84	282.0	0.0	10	284	620	889	615	903	0.92	Ephrin type-B receptor 1 (DB12010)
drugbank_target|P07948	-	512	sp|Q8IHZ9|KC1_PLAF	-	323	1.5e-84	282.3	0.0	1	1	1.6e-85	2.3e-84	281.7	0.0	7	284	245	508	242	511	0.93	Tyrosine-protein kinase Lyn (DB01254; DB03023; DB06616; DB08901; DB09079; DB12010)
drugbank_target|P63185	-	526	sp|Q8IHZ9|KC1_PLAF	-	323	2.4e-84	281.6	0.0	1	1	2.9e-85	4.3e-84	280.8	0.0	7	273	265	516	262	521	0.93	Tyrosine-protein kinase transforming protein Src (DB01773)
drugbank_target|P00524	-	526	sp|Q8IHZ9|KC1_PLAF	-	323	3.1e-84	281.3	0.0	1	1	3.8e-85	5.5e-84	280.5	0.0	7	273	265	516	262	521	0.93	Tyrosine-protein kinase transforming protein Src (DB08434)
drugbank_target|P27448	-	753	sp|Q8IHZ9|KC1_PLAF	-	323	3.3e-84	281.2	0.1	1	1	3.6e-85	5.3e-84	280.5	0.1	8	286	55	315	49	351	0.91	MAP/microtubule affinity-regulating kinase 3 (DB12010)
drugbank_target|P29320	-	983	sp|Q8IHZ9|KC1_PLAF	-	323	3.6e-84	281.1	0.0	1	1	3.9e-85	5.6e-84	280.4	0.0	7	283	619	888	615	909	0.91	Ephrin type-A receptor 3 (DB12010)
drugbank_target|P80192	-	1104	sp|Q8IHZ9|KC1_PLAF	-	323	3.6e-84	281.1	0.0	1	1	3.7e-85	5.4e-84	280.5	0.0	8	316	143	452	138	541	0.91	Mitogen-activated protein kinase kinase kinase 9 (DB08703; DB12010)
drugbank_target|P06239	-	509	sp|Q8IHZ9|KC1_PLAF	-	323	4.1e-84	280.9	0.0	1	1	3.9e-85	5.7e-84	280.4	0.0	7	284	243	505	239	508	0.93	Tyrosine-protein kinase Lck (DB01254; DB01830; DB02010; DB03023; DB04003; DB04395; DB06925; DB07146; DB07297; DB08055; DB08056; DB08057; DB08901; DB09079; DB12010; DB15035)
drugbank_target|P08631	-	526	sp|Q8IHZ9|KC1_PLAF	-	323	4.4e-84	280.8	0.0	1	1	4.5e-85	6.5e-84	280.2	0.0	7	285	260	523	257	525	0.93	Tyrosine-protein kinase HCK (DB01809; DB01962; DB04216; DB06616; DB12010)
drugbank_target|Q96L34	-	752	sp|Q8IHZ9|KC1_PLAF	-	323	5.4e-84	280.5	0.0	1	1	5.3e-85	7.7e-84	280.0	0.0	8	271	58	306	52	334	0.93	MAP/microtubule affinity-regulating kinase 4 (DB12010)
drugbank_target|P29323	-	1055	sp|Q8IHZ9|KC1_PLAF	-	323	6.6e-84	280.2	0.0	1	1	7.9e-85	1.1e-83	279.4	0.0	10	282	622	889	619	898	0.93	Ephrin type-B receptor 2 (DB04395; DB12010)
drugbank_target|Q7KZI7	-	788	sp|Q8IHZ9|KC1_PLAF	-	323	1e-83	279.6	0.1	1	1	1.1e-84	1.7e-83	278.9	0.1	8	271	52	300	46	318	0.93	Serine/threonine-protein kinase MARK2 (DB12010)
drugbank_target|Q02779	-	954	sp|Q8IHZ9|KC1_PLAF	-	323	1.1e-83	279.5	0.0	1	1	1.6e-84	2.3e-83	278.4	0.0	8	314	97	404	95	418	0.88	Mitogen-activated protein kinase kinase kinase 10 (DB12010)
drugbank_target|Q9Y6M4	-	447	sp|Q8IHZ9|KC1_PLAF	-	323	1.7e-83	278.8	0.0	1	1	1.6e-84	2.4e-83	278.4	0.0	4	315	38	350	36	362	0.93	Casein kinase I isoform gamma-3 (DB04751; DB07488; DB07489; DB07664)
drugbank_target|Q9P0L2	-	795	sp|Q8IHZ9|KC1_PLAF	-	323	2.3e-83	278.5	0.1	1	1	2.5e-84	3.6e-83	277.8	0.1	8	271	59	307	53	334	0.93	Serine/threonine-protein kinase MARK1 (DB12010)
drugbank_target|P54764	-	986	sp|Q8IHZ9|KC1_PLAF	-	323	3e-83	278.1	0.0	1	2	3.4	49	1.3	0.0	12	85	537	613	528	619	0.79	Ephrin type-A receptor 4 (DB12010)
drugbank_target|P54764	-	986	sp|Q8IHZ9|KC1_PLAF	-	323	3e-83	278.1	0.0	2	2	2.9e-83	4.2e-82	274.3	0.0	9	284	621	889	616	901	0.92	Ephrin type-A receptor 4 (DB12010)
drugbank_target|P09769	-	529	sp|Q8IHZ9|KC1_PLAF	-	323	6.6e-83	276.9	0.0	1	1	7.2e-84	1e-82	276.3	0.0	7	284	261	523	257	527	0.93	Tyrosine-protein kinase Fgr (DB01254; DB12010; DB15035)
drugbank_target|Q9HCP0	-	422	sp|Q8IHZ9|KC1_PLAF	-	323	6.7e-83	276.9	0.0	1	1	6.2e-84	9.1e-83	276.5	0.0	4	291	39	329	37	335	0.97	Casein kinase I isoform gamma-1 (DB08325)
drugbank_target|Q15375	-	998	sp|Q8IHZ9|KC1_PLAF	-	323	8.9e-83	276.5	0.0	1	1	1.1e-83	1.6e-82	275.7	0.0	9	282	633	899	629	909	0.92	Ephrin type-A receptor 7 (DB07970; DB12010)
drugbank_target|Q8IU85	-	385	sp|Q8IHZ9|KC1_PLAF	-	323	1e-82	276.3	0.1	1	1	8.5e-84	1.2e-82	276.0	0.1	4	275	18	276	15	318	0.89	Calcium/calmodulin-dependent protein kinase type 1D (DB08454; DB12010)
drugbank_target|P54756	-	1037	sp|Q8IHZ9|KC1_PLAF	-	323	1.1e-82	276.2	0.0	1	1	1.2e-83	1.7e-82	275.6	0.0	9	287	675	946	669	961	0.90	Ephrin type-A receptor 5 (DB01254; DB12010)
drugbank_target|Q9P289	-	416	sp|Q8IHZ9|KC1_PLAF	-	323	1.3e-82	276.0	0.0	1	1	1.5e-83	2.1e-82	275.3	0.0	7	306	22	303	18	322	0.83	Serine/threonine-protein kinase 26 (DB07853; DB12010)
drugbank_target|Q16584	-	847	sp|Q8IHZ9|KC1_PLAF	-	323	1.4e-82	275.9	0.0	1	1	1.3e-83	1.8e-82	275.5	0.0	7	314	115	423	109	435	0.88	Mitogen-activated protein kinase kinase kinase 11 (DB12010)
drugbank_target|Q13882	-	451	sp|Q8IHZ9|KC1_PLAF	-	323	1.5e-82	275.7	0.0	1	1	1.4e-83	2e-82	275.3	0.0	6	278	188	446	185	451	0.92	Protein-tyrosine kinase 6 (DB05294; DB12010; DB15035)
drugbank_target|Q16620	-	822	sp|Q8IHZ9|KC1_PLAF	-	323	4.3e-82	274.2	0.1	1	1	4.4e-83	6.4e-82	273.7	0.1	7	280	536	814	531	821	0.90	BDNF/NT-3 growth factors receptor (DB00321; DB11823; DB11986; DB12010; DB14723)
drugbank_target|P42680	-	631	sp|Q8IHZ9|KC1_PLAF	-	323	5e-82	274.1	0.1	1	1	5.4e-83	7.8e-82	273.4	0.1	8	279	369	625	365	629	0.93	Tyrosine-protein kinase Tec (DB12010; DB15035)
drugbank_target|O60285	-	661	sp|Q8IHZ9|KC1_PLAF	-	323	6.4e-82	273.7	0.1	1	1	6.9e-83	9.9e-82	273.1	0.1	3	271	49	302	47	324	0.93	NUAK family SNF1-like kinase 1 (DB12010)
drugbank_target|P16591	-	822	sp|Q8IHZ9|KC1_PLAF	-	323	6.4e-82	273.7	0.1	1	1	4.4e-83	6.4e-82	273.7	0.1	7	276	561	817	557	821	0.92	Tyrosine-protein kinase Fer (DB12010)
drugbank_target|P62344	-	524	sp|Q8IHZ9|KC1_PLAF	-	323	7.4e-82	273.5	3.9	1	1	8.1e-83	1.2e-81	272.8	3.9	3	287	50	334	48	360	0.87	Calcium-dependent protein kinase 1 (DB12010)
drugbank_target|P78368	-	415	sp|Q8IHZ9|KC1_PLAF	-	323	7.8e-82	273.4	0.0	1	1	7.2e-83	1e-81	273.0	0.0	4	291	41	330	39	336	0.97	Casein kinase I isoform gamma-2 (DB03083; DB03693; DB04604)
drugbank_target|P11362	-	822	sp|Q8IHZ9|KC1_PLAF	-	323	8.3e-82	273.3	0.1	1	2	7.7	1.1e+02	0.1	0.1	161	188	137	164	131	169	0.78	Fibroblast growth factor receptor 1 (DB00039; DB00398; DB01109; DB02058; DB05014; DB07525; DB07840; DB08577; DB08896; DB08901; DB09078; DB09079; DB12010; DB12147; DB15102; DB15685)
drugbank_target|P11362	-	822	sp|Q8IHZ9|KC1_PLAF	-	323	8.3e-82	273.3	0.1	2	2	4.3e-82	6.2e-81	270.4	0.0	7	283	476	764	473	780	0.88	Fibroblast growth factor receptor 1 (DB00039; DB00398; DB01109; DB02058; DB05014; DB07525; DB07840; DB08577; DB08896; DB08901; DB09078; DB09079; DB12010; DB12147; DB15102; DB15685)
drugbank_target|P07332	-	822	sp|Q8IHZ9|KC1_PLAF	-	323	8.6e-82	273.3	0.0	1	1	5.9e-83	8.6e-82	273.3	0.0	7	279	559	820	555	822	0.94	Tyrosine-protein kinase Fes/Fps (DB12010)
drugbank_target|Q13557	-	499	sp|Q8IHZ9|KC1_PLAF	-	323	1.3e-81	272.7	0.0	1	1	1.5e-82	2.2e-81	271.9	0.0	4	297	9	293	6	308	0.90	Calcium/calmodulin-dependent protein kinase type II subunit delta (DB07853; DB08039; DB12010)
drugbank_target|Q9P2K8	-	1649	sp|Q8IHZ9|KC1_PLAF	-	323	2.3e-81	271.8	13.0	1	3	6.9e-29	9.9e-28	95.6	0.2	38	273	332	534	328	556	0.83	eIF-2-alpha kinase GCN2 (DB12010)
drugbank_target|Q9P2K8	-	1649	sp|Q8IHZ9|KC1_PLAF	-	323	2.3e-81	271.8	13.0	2	3	5.3e-13	7.7e-12	43.4	0.0	8	75	589	658	584	661	0.86	eIF-2-alpha kinase GCN2 (DB12010)
drugbank_target|Q9P2K8	-	1649	sp|Q8IHZ9|KC1_PLAF	-	323	2.3e-81	271.8	13.0	3	3	4.9e-40	7.2e-39	132.2	0.0	76	271	796	997	785	1034	0.79	eIF-2-alpha kinase GCN2 (DB12010)
drugbank_target|P29317	-	976	sp|Q8IHZ9|KC1_PLAF	-	323	2.5e-81	271.8	0.0	1	1	2.7e-82	3.9e-81	271.1	0.0	11	280	615	878	611	892	0.90	Ephrin type-A receptor 2 (DB01254; DB04395; DB08896; DB12010)
drugbank_target|Q13555	-	558	sp|Q8IHZ9|KC1_PLAF	-	323	2.8e-81	271.6	0.0	1	1	3.2e-82	4.6e-81	270.9	0.0	4	296	9	292	6	306	0.90	Calcium/calmodulin-dependent protein kinase type II subunit gamma (DB06616; DB08699; DB12010)
drugbank_target|O43293	-	454	sp|Q8IHZ9|KC1_PLAF	-	323	2.8e-81	271.6	0.3	1	2	1.1e-81	1.6e-80	269.1	0.0	3	282	7	279	5	311	0.90	Death-associated protein kinase 3 (DB04716; DB07125; DB07242; DB12010)
drugbank_target|O43293	-	454	sp|Q8IHZ9|KC1_PLAF	-	323	2.8e-81	271.6	0.3	2	2	6.7	97	0.3	0.1	38	79	327	367	323	401	0.72	Death-associated protein kinase 3 (DB04716; DB07125; DB07242; DB12010)
drugbank_target|Q14012	-	370	sp|Q8IHZ9|KC1_PLAF	-	323	2.9e-81	271.5	0.0	1	1	2.7e-82	3.9e-81	271.1	0.0	5	304	16	304	13	320	0.89	Calcium/calmodulin-dependent protein kinase type 1 (DB12010)
drugbank_target|Q9NYY3	-	685	sp|Q8IHZ9|KC1_PLAF	-	323	5.8e-81	270.6	0.0	1	1	6.4e-82	9.2e-81	269.9	0.0	4	294	77	350	74	369	0.93	Serine/threonine-protein kinase PLK2 (DB12010)
drugbank_target|O95747	-	527	sp|Q8IHZ9|KC1_PLAF	-	323	5.8e-81	270.5	0.0	1	1	5.4e-82	7.8e-81	270.1	0.0	6	305	14	318	11	334	0.87	Serine/threonine-protein kinase OSR1 (DB12010)
drugbank_target|Q96NX5	-	476	sp|Q8IHZ9|KC1_PLAF	-	323	7.7e-81	270.1	0.1	1	1	7.4e-82	1.1e-80	269.7	0.1	4	302	18	303	15	324	0.91	Calcium/calmodulin-dependent protein kinase type 1G (DB08009; DB12010)
drugbank_target|Q13131	-	559	sp|Q8IHZ9|KC1_PLAF	-	323	1.1e-80	269.7	0.0	1	1	1.1e-81	1.6e-80	269.1	0.0	8	299	26	305	22	320	0.91	5'-AMP-activated protein kinase catalytic subunit alpha-1 (DB00131; DB00945; DB12010)
drugbank_target|Q13131	-	559	sp|Q8IHZ9|KC1_PLAF	-	323	1.1e-80	269.7	0.0	1	1	1.1e-81	1.6e-80	269.1	0.0	8	299	26	305	22	320	0.91	5'-AMP-activated protein kinase catalytic subunit alpha-1 (DB00131; DB00171; DB00914; DB12010)
drugbank_target|P42681	-	527	sp|Q8IHZ9|KC1_PLAF	-	323	1.5e-80	269.2	0.1	1	1	1.7e-81	2.4e-80	268.5	0.1	8	277	270	524	267	526	0.93	Tyrosine-protein kinase TXK (DB12010; DB15035)
drugbank_target|Q08881	-	620	sp|Q8IHZ9|KC1_PLAF	-	323	1.5e-80	269.2	0.0	1	1	1.9e-81	2.7e-80	268.4	0.0	8	278	362	617	360	619	0.94	Tyrosine-protein kinase ITK/TSK (DB02010; DB06589; DB12010; DB15035)
drugbank_target|Q9BYT3	-	514	sp|Q8IHZ9|KC1_PLAF	-	323	1.5e-80	269.2	2.2	1	1	1.6e-81	2.3e-80	268.6	2.2	5	307	112	418	109	429	0.81	Serine/threonine-protein kinase 33 (DB12010)
drugbank_target|O43283	-	966	sp|Q8IHZ9|KC1_PLAF	-	323	1.8e-80	268.9	0.0	1	1	2.2e-81	3.1e-80	268.1	0.0	8	304	167	443	164	460	0.91	Mitogen-activated protein kinase kinase kinase 13 (DB12010)
drugbank_target|O00444	-	970	sp|Q8IHZ9|KC1_PLAF	-	323	1.9e-80	268.8	0.1	1	1	1.3e-81	1.9e-80	268.8	0.1	7	284	10	271	7	288	0.93	Serine/threonine-protein kinase PLK4 (DB12010)
drugbank_target|Q9UQM7	-	478	sp|Q8IHZ9|KC1_PLAF	-	323	2e-80	268.8	0.0	1	1	2.3e-81	3.4e-80	268.0	0.0	4	291	8	286	5	306	0.90	Calcium/calmodulin-dependent protein kinase type II subunit alpha (DB04119; DB04447; DB07766; DB12010)
drugbank_target|Q13153	-	545	sp|Q8IHZ9|KC1_PLAF	-	323	2.3e-80	268.6	0.0	1	1	2.6e-81	3.8e-80	267.8	0.0	6	272	267	518	264	544	0.91	Serine/threonine-protein kinase PAK 1 (DB12010)
drugbank_target|Q05397	-	1052	sp|Q8IHZ9|KC1_PLAF	-	323	2.8e-80	268.3	0.0	1	1	3.6e-81	5.1e-80	267.4	0.0	6	291	419	694	415	705	0.90	Focal adhesion kinase 1 (DB06423; DB07248; DB07460; DB12010)
drugbank_target|P21802	-	821	sp|Q8IHZ9|KC1_PLAF	-	323	4.3e-80	267.7	0.0	1	1	4.9e-81	7.1e-80	267.0	0.0	7	282	479	766	476	783	0.87	Fibroblast growth factor receptor 2 (DB00039; DB01041; DB01109; DB01901; DB02058; DB02491; DB08896; DB08901; DB09078; DB09079; DB10770; DB10772; DB12010; DB12147; DB15102; DB15685)
drugbank_target|Q9H093	-	628	sp|Q8IHZ9|KC1_PLAF	-	323	4.8e-80	267.5	0.1	1	1	4.7e-81	6.8e-80	267.0	0.1	3	271	47	299	45	303	0.92	NUAK family SNF1-like kinase 2 (DB12010)
drugbank_target|P54760	-	987	sp|Q8IHZ9|KC1_PLAF	-	323	5e-80	267.5	0.0	1	1	5.2e-81	7.5e-80	266.9	0.0	10	281	616	882	609	897	0.92	Ephrin type-B receptor 4 (DB01254; DB07249; DB07250; DB07251; DB07252; DB07253; DB07254; DB07255; DB07256; DB11973; DB12010)
drugbank_target|Q14680	-	651	sp|Q8IHZ9|KC1_PLAF	-	323	5.2e-80	267.4	0.4	1	1	5.8e-81	8.4e-80	266.7	0.4	7	286	9	271	5	304	0.90	Maternal embryonic leucine zipper kinase (DB12010)
drugbank_target|Q13554	-	666	sp|Q8IHZ9|KC1_PLAF	-	323	5.5e-80	267.3	0.0	1	1	6e-81	8.8e-80	266.7	0.0	4	303	9	299	6	310	0.90	Calcium/calmodulin-dependent protein kinase type II subunit beta (DB07168; DB12010)
drugbank_target|P51451	-	505	sp|Q8IHZ9|KC1_PLAF	-	323	5.6e-80	267.3	0.0	1	1	5.8e-81	8.3e-80	266.7	0.0	7	285	239	502	235	504	0.91	Tyrosine-protein kinase Blk (DB12010; DB15035)
drugbank_target|P57059	-	783	sp|Q8IHZ9|KC1_PLAF	-	323	6e-80	267.2	0.0	1	1	6.5e-81	9.4e-80	266.6	0.0	9	271	27	274	24	278	0.95	Serine/threonine-protein kinase SIK1 (DB08912; DB12010)
drugbank_target|Q9NRH2	-	765	sp|Q8IHZ9|KC1_PLAF	-	323	8.3e-80	266.7	0.0	1	1	9.2e-81	1.3e-79	266.1	0.0	6	271	13	265	9	318	0.94	SNF-related serine/threonine-protein kinase (DB12010)
drugbank_target|Q8IBS5	-	528	sp|Q8IHZ9|KC1_PLAF	-	323	9.6e-80	266.5	2.5	1	1	9.8e-81	1.4e-79	266.0	2.5	4	291	65	341	62	366	0.88	Calcium-dependent protein kinase 4 (DB11638)
drugbank_target|O75914	-	559	sp|Q8IHZ9|KC1_PLAF	-	323	1.2e-79	266.2	0.0	1	1	1.5e-80	2.1e-79	265.4	0.0	6	277	280	533	277	558	0.90	Serine/threonine-protein kinase PAK 3 (DB12010)
drugbank_target|P31751	-	481	sp|Q8IHZ9|KC1_PLAF	-	323	1.3e-79	266.1	0.1	1	1	1.4e-80	2e-79	265.5	0.1	6	264	149	393	145	421	0.95	RAC-beta serine/threonine-protein kinase (DB07812; DB07859; DB07947; DB08073)
drugbank_target|Q9UKE5	-	1360	sp|Q8IHZ9|KC1_PLAF	-	323	1.4e-79	266.0	0.1	1	1	9.8e-81	1.4e-79	266.0	0.1	9	313	25	328	21	337	0.82	TRAF2 and NCK-interacting protein kinase (DB12010)
drugbank_target|P22607	-	806	sp|Q8IHZ9|KC1_PLAF	-	323	1.5e-79	265.9	0.0	1	1	1.6e-80	2.3e-79	265.3	0.0	7	281	470	756	466	770	0.88	Fibroblast growth factor receptor 3 (DB00039; DB05014; DB06589; DB08901; DB09078; DB09079; DB12010; DB12147; DB15102; DB15685)
drugbank_target|Q9H4B4	-	646	sp|Q8IHZ9|KC1_PLAF	-	323	1.6e-79	265.9	0.0	1	1	1.5e-80	2.1e-79	265.4	0.0	4	292	57	328	54	342	0.93	Serine/threonine-protein kinase PLK3 (DB12010)
drugbank_target|Q8IYT8	-	1036	sp|Q8IHZ9|KC1_PLAF	-	323	1.7e-79	265.7	0.0	1	1	2e-80	2.9e-79	265.0	0.0	6	280	6	273	1	281	0.90	Serine/threonine-protein kinase ULK2 (DB12010)
drugbank_target|Q13177	-	524	sp|Q8IHZ9|KC1_PLAF	-	323	1.7e-79	265.7	0.0	1	1	1.7e-80	2.5e-79	265.2	0.0	6	281	246	503	243	524	0.89	Serine/threonine-protein kinase PAK 2 (DB12010)
drugbank_target|P51957	-	841	sp|Q8IHZ9|KC1_PLAF	-	323	2.1e-79	265.4	0.4	1	1	4.7e-80	6.8e-79	263.7	0.1	8	297	5	280	3	302	0.88	Serine/threonine-protein kinase Nek4 (DB12010)
drugbank_target|Q9C098	-	648	sp|Q8IHZ9|KC1_PLAF	-	323	2.5e-79	265.2	0.0	1	1	2.6e-80	3.7e-79	264.6	0.0	3	297	350	632	348	647	0.88	Serine/threonine-protein kinase DCLK3 (DB12010)
drugbank_target|P51813	-	675	sp|Q8IHZ9|KC1_PLAF	-	323	3.1e-79	264.9	0.3	1	1	2.1e-80	3.1e-79	264.9	0.3	6	279	414	672	411	675	0.93	Cytoplasmic tyrosine-protein kinase BMX (DB12010; DB15035)
drugbank_target|P53355	-	1430	sp|Q8IHZ9|KC1_PLAF	-	323	3.9e-79	264.6	0.1	1	1	4.1e-80	6e-79	263.9	0.1	4	304	8	305	5	317	0.89	Death-associated protein kinase 1 (DB04069; DB04395; DB07444; DB12010)
drugbank_target|P17612	-	351	sp|Q8IHZ9|KC1_PLAF	-	323	4.2e-79	264.4	0.0	1	1	3.3e-80	4.8e-79	264.2	0.0	6	320	41	338	36	341	0.88	cAMP-dependent protein kinase catalytic subunit alpha (DB01919; DB01940; DB02155; DB02482; DB02611; DB03374; DB04098; DB04522; DB04530; DB04707; DB06959; DB06977; DB07107; DB07124; DB07204; DB07235; DB07458; DB07583; DB07854; DB07855; DB07856; DB07857; DB07858; DB07859; DB07860; DB07876; DB07947; DB07995; DB07996; DB07997; DB08070; DB08073; DB08113; DB08114; DB08148; DB08149; DB08150; DB08162; DB08231; DB08568; DB08569; DB08756; DB08846; DB12010)
drugbank_target|P22694	-	351	sp|Q8IHZ9|KC1_PLAF	-	323	4.8e-79	264.2	0.0	1	1	4.2e-80	6.1e-79	263.9	0.0	7	287	42	304	37	340	0.88	cAMP-dependent protein kinase catalytic subunit beta (DB02482; DB12010)
drugbank_target|O75385	-	1050	sp|Q8IHZ9|KC1_PLAF	-	323	6.3e-79	263.9	0.0	1	1	7.6e-80	1.1e-78	263.1	0.0	8	268	15	271	9	284	0.90	Serine/threonine-protein kinase ULK1 (DB12010)
drugbank_target|P17252	-	672	sp|Q8IHZ9|KC1_PLAF	-	323	6.9e-79	263.7	0.1	1	1	7.9e-80	1.1e-78	263.0	0.1	7	264	337	581	332	584	0.95	Protein kinase C alpha type (DB00144; DB00163; DB05013; DB06451; DB06595; DB06641; DB08846; DB11752; DB14001; DB14002)
drugbank_target|P17252	-	672	sp|Q8IHZ9|KC1_PLAF	-	323	6.9e-79	263.7	0.1	1	1	7.9e-80	1.1e-78	263.0	0.1	7	264	337	581	332	584	0.95	Protein kinase C alpha type (DB00675)
drugbank_target|P54646	-	552	sp|Q8IHZ9|KC1_PLAF	-	323	7.7e-79	263.6	0.2	1	1	1e-79	1.5e-78	262.6	0.0	8	298	15	293	11	311	0.89	5'-AMP-activated protein kinase catalytic subunit alpha-2 (DB00131; DB00945; DB12010)
drugbank_target|O00141	-	431	sp|Q8IHZ9|KC1_PLAF	-	323	8.4e-79	263.4	0.1	1	1	7.8e-80	1.1e-78	263.0	0.1	7	267	96	343	92	368	0.93	Serine/threonine-protein kinase Sgk1 (DB03247; DB07837; DB08191)
drugbank_target|P31749	-	480	sp|Q8IHZ9|KC1_PLAF	-	323	1.1e-78	263.1	0.2	1	1	7.6e-80	1.1e-78	263.1	0.2	6	264	147	392	142	428	0.93	RAC-alpha serine/threonine-protein kinase (DB00171; DB01169; DB01645; DB01863; DB02709; DB05971; DB06486; DB06641; DB07584; DB07585)
drugbank_target|Q8IVH8	-	894	sp|Q8IHZ9|KC1_PLAF	-	323	1.2e-78	262.9	0.0	1	1	1.3e-79	1.9e-78	262.2	0.0	6	288	13	283	9	300	0.92	Mitogen-activated protein kinase kinase kinase kinase 3 (DB12010)
drugbank_target|P29322	-	1005	sp|Q8IHZ9|KC1_PLAF	-	323	1.3e-78	262.8	0.0	1	1	1.6e-79	2.3e-78	262.0	0.0	7	283	633	902	629	912	0.92	Ephrin type-A receptor 8 (DB12010)
drugbank_target|Q9UF33	-	1036	sp|Q8IHZ9|KC1_PLAF	-	323	1.6e-78	262.5	0.0	1	2	2.6e-16	3.8e-15	54.3	0.0	8	80	630	707	626	723	0.85	Ephrin type-A receptor 6 (DB12010)
drugbank_target|Q9UF33	-	1036	sp|Q8IHZ9|KC1_PLAF	-	323	1.6e-78	262.5	0.0	2	2	1.9e-62	2.7e-61	205.9	0.0	75	286	744	943	740	954	0.92	Ephrin type-A receptor 6 (DB12010)
drugbank_target|Q9NRP7	-	1315	sp|Q8IHZ9|KC1_PLAF	-	323	1.6e-78	262.5	0.0	1	1	1.8e-79	2.6e-78	261.8	0.0	7	269	2	248	1	258	0.92	Serine/threonine-protein kinase 36 (DB12010)
drugbank_target|Q06187	-	659	sp|Q8IHZ9|KC1_PLAF	-	323	2e-78	262.2	0.6	1	1	2.4e-79	3.5e-78	261.4	0.6	7	278	400	656	397	659	0.93	Tyrosine-protein kinase BTK (DB01254; DB01863; DB05204; DB09053; DB11703; DB12010; DB15035)
drugbank_target|P21709	-	976	sp|Q8IHZ9|KC1_PLAF	-	323	4.3e-78	261.1	0.0	1	1	4.6e-79	6.6e-78	260.5	0.0	12	281	627	888	623	901	0.92	Ephrin type-A receptor 1 (DB12010)
drugbank_target|Q9Y2K2	-	1321	sp|Q8IHZ9|KC1_PLAF	-	323	4.6e-78	261.0	1.9	1	1	3.7e-79	5.3e-78	260.8	0.2	9	272	66	314	62	355	0.91	Serine/threonine-protein kinase SIK3 (DB12010)
drugbank_target|Q9H0K1	-	926	sp|Q8IHZ9|KC1_PLAF	-	323	6e-78	260.6	0.0	1	1	8.6e-79	1.3e-77	259.6	0.0	9	272	20	268	17	306	0.93	Serine/threonine-protein kinase SIK2 (DB12010)
drugbank_target|Q9UEW8	-	545	sp|Q8IHZ9|KC1_PLAF	-	323	6.4e-78	260.5	0.0	1	1	6.2e-79	9e-78	260.1	0.0	6	304	60	363	57	381	0.86	STE20/SPS1-related proline-alanine-rich protein kinase (DB12010)
drugbank_target|Q12852	-	859	sp|Q8IHZ9|KC1_PLAF	-	323	6.4e-78	260.5	0.0	1	1	6.6e-79	9.6e-78	260.0	0.0	12	303	128	399	122	417	0.91	Mitogen-activated protein kinase kinase kinase 12 (DB12010)
drugbank_target|P22455	-	802	sp|Q8IHZ9|KC1_PLAF	-	323	7.7e-78	260.3	0.0	1	1	7.9e-79	1.2e-77	259.7	0.0	7	278	465	748	462	758	0.89	Fibroblast growth factor receptor 4 (DB00039; DB01109; DB08901; DB09078; DB12147; DB15102)
drugbank_target|Q02763	-	1124	sp|Q8IHZ9|KC1_PLAF	-	323	8.4e-78	260.2	0.0	1	1	1e-78	1.5e-77	259.4	0.0	7	290	822	1110	821	1121	0.88	Angiopoietin-1 receptor (DB00415; DB05294; DB08221; DB08896; DB08901; DB12010; DB14840)
drugbank_target|P41240	-	450	sp|Q8IHZ9|KC1_PLAF	-	323	9.4e-78	260.0	0.0	1	1	1e-78	1.4e-77	259.4	0.0	7	279	193	446	190	449	0.93	Tyrosine-protein kinase CSK (DB01254; DB02010; DB05075; DB12010)
drugbank_target|Q16288	-	839	sp|Q8IHZ9|KC1_PLAF	-	323	1e-77	259.9	0.0	1	1	9.3e-79	1.4e-77	259.5	0.0	6	278	535	829	530	838	0.88	NT-3 growth factor receptor (DB11986; DB12010; DB14723)
drugbank_target|Q6P3R8	-	708	sp|Q8IHZ9|KC1_PLAF	-	323	1.3e-77	259.5	0.1	1	1	9.2e-79	1.3e-77	259.5	0.1	7	284	2	265	1	302	0.88	Serine/threonine-protein kinase Nek5 (DB12010)
drugbank_target|Q9H2G2	-	1235	sp|Q8IHZ9|KC1_PLAF	-	323	1.3e-77	259.5	0.0	1	1	9.2e-79	1.3e-77	259.5	0.0	6	310	31	327	27	334	0.89	STE20-like serine/threonine-protein kinase (DB07664; DB07853; DB12010)
drugbank_target|Q9H3Y6	-	488	sp|Q8IHZ9|KC1_PLAF	-	323	1.4e-77	259.5	0.0	1	1	1.3e-78	1.8e-77	259.0	0.0	7	276	228	483	224	487	0.93	Tyrosine-protein kinase Srms (DB12010)
drugbank_target|P51956	-	506	sp|Q8IHZ9|KC1_PLAF	-	323	1.5e-77	259.3	0.1	1	1	1.4e-78	2e-77	258.9	0.1	7	272	2	254	1	304	0.86	Serine/threonine-protein kinase Nek3 (DB12010)
drugbank_target|O95819	-	1239	sp|Q8IHZ9|KC1_PLAF	-	323	1.5e-77	259.3	0.0	1	1	1.1e-78	1.5e-77	259.3	0.0	9	309	25	322	21	343	0.82	Mitogen-activated protein kinase kinase kinase kinase 4 (DB12010)
drugbank_target|P06213	-	1382	sp|Q8IHZ9|KC1_PLAF	-	323	1.6e-77	259.2	0.0	1	1	1.8e-78	2.7e-77	258.5	0.0	6	302	1020	1318	1016	1343	0.84	Insulin receptor (DB00030; DB00046; DB00047; DB00071; DB01277; DB01306; DB01307; DB01309; DB03909; DB05115; DB05120; DB08513; DB09129; DB09564; DB12010; DB12267; DB14751)
drugbank_target|P04629	-	796	sp|Q8IHZ9|KC1_PLAF	-	323	2.4e-77	258.6	0.0	1	1	2.5e-78	3.6e-77	258.1	0.0	7	279	508	787	503	794	0.90	High affinity nerve growth factor receptor (DB00321; DB00619; DB08896; DB11986; DB12010; DB13926; DB14723)
drugbank_target|P53350	-	603	sp|Q8IHZ9|KC1_PLAF	-	323	2.8e-77	258.4	0.0	1	1	2.9e-78	4.1e-77	257.9	0.0	4	281	48	308	45	319	0.93	Serine/threonine-protein kinase PLK1 (DB06897; DB06963; DB07186; DB07789; DB08059; DB12010)
drugbank_target|O14965	-	403	sp|Q8IHZ9|KC1_PLAF	-	323	3.4e-77	258.2	0.0	1	1	3.4e-78	4.9e-77	257.6	0.0	7	286	131	391	125	403	0.91	Aurora kinase A (DB02482; DB05169; DB05198; DB05220; DB06134; DB06347; DB06486; DB07186; DB07266; DB07360; DB07362; DB07545; DB07801; DB08065; DB08066; DB12010; DB13061)
drugbank_target|P07949	-	1114	sp|Q8IHZ9|KC1_PLAF	-	323	4.3e-77	257.8	0.0	1	1	4.9e-78	7.1e-77	257.1	0.0	7	281	722	1013	719	1030	0.90	Proto-oncogene tyrosine-protein kinase receptor Ret (DB00398; DB01809; DB05294; DB08875; DB08896; DB08901; DB09078; DB12010; DB12742; DB15685)
drugbank_target|P09619	-	1106	sp|Q8IHZ9|KC1_PLAF	-	323	5.5e-77	257.5	0.0	1	2	5.8e-24	8.3e-23	79.4	0.0	7	100	598	700	595	706	0.87	Platelet-derived growth factor receptor beta (DB00102; DB00398; DB00619; DB01254; DB01268; DB05014; DB05146; DB06589; DB06595; DB08896; DB09079; DB09221; DB09283; DB10770; DB12010; DB12147; DB12978; DB14840)
drugbank_target|P09619	-	1106	sp|Q8IHZ9|KC1_PLAF	-	323	5.5e-77	257.5	0.0	2	2	2.8e-53	4.1e-52	175.7	0.0	95	286	793	971	784	993	0.88	Platelet-derived growth factor receptor beta (DB00102; DB00398; DB00619; DB01254; DB01268; DB05014; DB05146; DB06589; DB06595; DB08896; DB09079; DB09221; DB09283; DB10770; DB12010; DB12147; DB12978; DB14840)
drugbank_target|Q8N568	-	766	sp|Q8IHZ9|KC1_PLAF	-	323	8.8e-77	256.8	0.0	1	1	9.3e-78	1.4e-76	256.2	0.0	5	290	390	663	387	696	0.88	Serine/threonine-protein kinase DCLK2 (DB12010)
drugbank_target|Q04759	-	706	sp|Q8IHZ9|KC1_PLAF	-	323	9.2e-77	256.7	0.4	1	1	1.3e-77	1.9e-76	255.7	0.3	7	265	378	623	373	641	0.93	Protein kinase C theta type (DB02010; DB02482; DB04522; DB12010)
drugbank_target|Q04759	-	706	sp|Q8IHZ9|KC1_PLAF	-	323	9.2e-77	256.7	0.4	1	1	1.3e-77	1.9e-76	255.7	0.3	7	265	378	623	373	641	0.93	Protein kinase C theta type (DB00675)
drugbank_target|P16234	-	1089	sp|Q8IHZ9|KC1_PLAF	-	323	1.1e-76	256.5	0.0	1	2	2.4e-22	3.4e-21	74.1	0.0	9	100	593	693	589	698	0.86	Platelet-derived growth factor receptor alpha (DB00102; DB00619; DB01268; DB05146; DB06043; DB06589; DB06595; DB08896; DB08901; DB09078; DB09079; DB10772; DB12010; DB12147; DB12742; DB14840)
drugbank_target|P16234	-	1089	sp|Q8IHZ9|KC1_PLAF	-	323	1.1e-76	256.5	0.0	2	2	1.5e-54	2.2e-53	179.9	0.0	86	283	775	960	771	1001	0.87	Platelet-derived growth factor receptor alpha (DB00102; DB00619; DB01268; DB05146; DB06043; DB06589; DB06595; DB08896; DB08901; DB09078; DB09079; DB10772; DB12010; DB12147; DB12742; DB14840)
drugbank_target|Q9UIK4	-	370	sp|Q8IHZ9|KC1_PLAF	-	323	1.4e-76	256.2	0.1	1	1	1.3e-77	1.8e-76	255.8	0.1	3	296	17	303	15	320	0.89	Death-associated protein kinase 2 (DB12010)
drugbank_target|O15075	-	740	sp|Q8IHZ9|KC1_PLAF	-	323	1.5e-76	256.1	0.0	1	1	1.5e-77	2.1e-76	255.5	0.0	4	275	385	644	382	672	0.91	Serine/threonine-protein kinase DCLK1 (DB12010)
drugbank_target|Q16566	-	473	sp|Q8IHZ9|KC1_PLAF	-	323	1.5e-76	256.0	0.0	1	1	1.5e-77	2.1e-76	255.5	0.0	6	306	43	328	39	341	0.93	Calcium/calmodulin-dependent protein kinase type IV (DB07664; DB07676)
drugbank_target|Q8N4C8	-	1332	sp|Q8IHZ9|KC1_PLAF	-	323	1.9e-76	255.7	0.0	1	1	1.3e-77	1.9e-76	255.7	0.0	9	308	25	323	21	338	0.82	Misshapen-like kinase 1 (DB12010)
drugbank_target|O15146	-	869	sp|Q8IHZ9|KC1_PLAF	-	323	2.1e-76	255.6	0.0	1	1	2.2e-77	3.2e-76	254.9	0.0	6	281	572	864	569	869	0.91	Muscle, skeletal receptor tyrosine-protein kinase (DB12010)
drugbank_target|Q7L7X3	-	1001	sp|Q8IHZ9|KC1_PLAF	-	323	3.2e-76	254.9	0.0	1	1	2.2e-77	3.2e-76	254.9	0.0	7	305	26	308	21	328	0.86	Serine/threonine-protein kinase TAO1 (DB12010)
drugbank_target|P05771	-	671	sp|Q8IHZ9|KC1_PLAF	-	323	3.8e-76	254.7	0.1	1	1	4.1e-77	6e-76	254.1	0.1	7	264	340	584	335	632	0.95	Protein kinase C beta type (DB00675)
drugbank_target|P05771	-	671	sp|Q8IHZ9|KC1_PLAF	-	323	3.8e-76	254.7	0.1	1	1	4.1e-77	6e-76	254.1	0.1	7	264	340	584	335	632	0.95	Protein kinase C beta type (DB00163; DB01738; DB06486; DB08846; DB08862; DB14001; DB14002)
drugbank_target|Q14289	-	1009	sp|Q8IHZ9|KC1_PLAF	-	323	4.4e-76	254.5	0.8	1	2	8.5	1.2e+02	0.0	0.2	200	275	179	253	177	274	0.77	Protein-tyrosine kinase 2-beta (DB01097; DB01645; DB08341; DB11817; DB12010)
drugbank_target|Q14289	-	1009	sp|Q8IHZ9|KC1_PLAF	-	323	4.4e-76	254.5	0.8	2	2	1.8e-76	2.5e-75	252.0	0.0	7	283	423	689	420	708	0.91	Protein-tyrosine kinase 2-beta (DB01097; DB01645; DB08341; DB11817; DB12010)
drugbank_target|P10721	-	976	sp|Q8IHZ9|KC1_PLAF	-	323	5.1e-76	254.3	0.0	1	2	6.3e-20	9.1e-19	66.2	0.0	7	100	587	689	584	700	0.89	Mast/stem cell growth factor receptor Kit (DB00398; DB00619; DB01254; DB01268; DB01962; DB04868; DB05146; DB05913; DB06080; DB06589; DB06595; DB08896; DB08901; DB09078; DB09103; DB12010; DB12147; DB12742; DB12978; DB14840; DB15233)
drugbank_target|P10721	-	976	sp|Q8IHZ9|KC1_PLAF	-	323	5.1e-76	254.3	0.0	2	2	2.5e-56	3.6e-55	185.8	0.0	94	287	758	939	744	961	0.89	Mast/stem cell growth factor receptor Kit (DB00398; DB00619; DB01254; DB01268; DB01962; DB04868; DB05146; DB05913; DB06080; DB06589; DB06595; DB08896; DB08901; DB09078; DB09103; DB12010; DB12147; DB12742; DB12978; DB14840; DB15233)
drugbank_target|Q02156	-	737	sp|Q8IHZ9|KC1_PLAF	-	323	6.4e-76	254.0	0.0	1	1	6.6e-77	9.6e-76	253.4	0.0	7	267	406	653	402	708	0.87	Protein kinase C epsilon type (DB06064; DB11752; DB12010)
drugbank_target|Q02156	-	737	sp|Q8IHZ9|KC1_PLAF	-	323	6.4e-76	254.0	0.0	1	1	6.6e-77	9.6e-76	253.4	0.0	7	267	406	653	402	708	0.87	Protein kinase C epsilon type (DB00675)
drugbank_target|O96017	-	543	sp|Q8IHZ9|KC1_PLAF	-	323	9e-76	253.5	0.0	1	1	8.7e-77	1.3e-75	253.0	0.0	5	298	216	506	213	532	0.87	Serine/threonine-protein kinase Chk2 (DB05149; DB06486; DB12010)
drugbank_target|O94804	-	968	sp|Q8IHZ9|KC1_PLAF	-	323	1.1e-75	253.2	0.0	1	1	7.5e-77	1.1e-75	253.2	0.0	6	307	33	323	29	342	0.87	Serine/threonine-protein kinase 10 (DB12010)
drugbank_target|Q96BR1	-	496	sp|Q8IHZ9|KC1_PLAF	-	323	1.3e-75	252.9	0.0	1	1	1.3e-76	1.9e-75	252.4	0.0	7	277	160	418	156	433	0.90	Serine/threonine-protein kinase Sgk3 (DB12010)
drugbank_target|Q9UQB9	-	309	sp|Q8IHZ9|KC1_PLAF	-	323	1.4e-75	252.8	0.0	1	1	1.2e-76	1.7e-75	252.6	0.0	5	275	39	290	35	301	0.91	Aurora kinase C (DB06134; DB12010)
drugbank_target|P35590	-	1138	sp|Q8IHZ9|KC1_PLAF	-	323	2e-75	252.3	0.0	1	1	2.1e-76	3e-75	251.8	0.0	7	285	837	1120	835	1136	0.88	Tyrosine-protein kinase receptor Tie-1 (DB12010)
drugbank_target|Q16816	-	387	sp|Q8IHZ9|KC1_PLAF	-	323	2e-75	252.3	0.0	1	1	1.9e-76	2.8e-75	251.9	0.0	4	285	15	295	13	309	0.90	Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform (DB12010)
drugbank_target|P07333	-	972	sp|Q8IHZ9|KC1_PLAF	-	323	2.1e-75	252.3	0.0	1	2	6e-23	8.7e-22	76.1	0.0	7	98	580	680	577	687	0.85	Macrophage colony-stimulating factor 1 receptor (DB00619; DB01268; DB06080; DB07167; DB07202; DB12010; DB12147; DB12978)
drugbank_target|P07333	-	972	sp|Q8IHZ9|KC1_PLAF	-	323	2.1e-75	252.3	0.0	2	2	1e-52	1.5e-51	173.9	0.0	92	288	742	925	721	960	0.89	Macrophage colony-stimulating factor 1 receptor (DB00619; DB01268; DB06080; DB07167; DB07202; DB12010; DB12147; DB12978)
drugbank_target|Q9Y4K4	-	846	sp|Q8IHZ9|KC1_PLAF	-	323	3e-75	251.8	0.0	1	1	3.2e-76	4.6e-75	251.2	0.0	6	277	17	276	12	310	0.91	Mitogen-activated protein kinase kinase kinase kinase 5 (DB12010)
drugbank_target|P17948	-	1338	sp|Q8IHZ9|KC1_PLAF	-	323	3.6e-75	251.5	0.2	1	2	4.4e-21	6.4e-20	69.9	0.1	6	99	824	927	821	938	0.86	Vascular endothelial growth factor receptor 1 (DB00398; DB01268; DB04879; DB05075; DB05913; DB05932; DB06080; DB06101; DB06589; DB06626; DB07288; DB08896; DB09078; DB09079; DB09221; DB10770; DB12010; DB15685)
drugbank_target|P17948	-	1338	sp|Q8IHZ9|KC1_PLAF	-	323	3.6e-75	251.5	0.2	2	2	2.5e-54	3.6e-53	179.2	0.0	97	282	991	1163	973	1175	0.90	Vascular endothelial growth factor receptor 1 (DB00398; DB01268; DB04879; DB05075; DB05913; DB05932; DB06080; DB06101; DB06589; DB06626; DB07288; DB08896; DB09078; DB09079; DB09221; DB10770; DB12010; DB15685)
drugbank_target|Q9H2K8	-	898	sp|Q8IHZ9|KC1_PLAF	-	323	6.5e-75	250.7	0.0	1	1	4.5e-76	6.5e-75	250.7	0.0	12	305	27	304	19	321	0.87	Serine/threonine-protein kinase TAO3 (DB12010)
drugbank_target|Q99759	-	626	sp|Q8IHZ9|KC1_PLAF	-	323	6.5e-75	250.7	0.0	1	1	6.9e-76	1e-74	250.0	0.0	8	271	361	618	357	625	0.89	Mitogen-activated protein kinase kinase kinase 3 (DB12010)
drugbank_target|Q05655	-	676	sp|Q8IHZ9|KC1_PLAF	-	323	7.1e-75	250.5	0.0	1	1	8.3e-76	1.2e-74	249.8	0.0	7	265	347	592	343	605	0.94	Protein kinase C delta type (DB04376; DB05013; DB12010)
drugbank_target|Q05655	-	676	sp|Q8IHZ9|KC1_PLAF	-	323	7.1e-75	250.5	0.0	1	1	8.3e-76	1.2e-74	249.8	0.0	7	265	347	592	343	605	0.94	Protein kinase C delta type (DB00675)
drugbank_target|Q07912	-	1038	sp|Q8IHZ9|KC1_PLAF	-	323	8.1e-75	250.3	0.0	1	1	9e-76	1.3e-74	249.7	0.0	6	278	123	390	120	415	0.90	Activated CDC42 kinase 1 (DB00171; DB04367; DB11986; DB12010)
drugbank_target|P24941	-	298	sp|Q8IHZ9|KC1_PLAF	-	323	9.3e-75	250.1	0.0	1	1	5.4e-74	7.9e-73	243.8	0.0	7	267	2	278	1	293	0.84	Cyclin-dependent kinase 2 (DB01888; DB02010; DB02052; DB02091; DB02116; DB02197; DB02297; DB02407; DB02538; DB02603; DB02647; DB02733; DB02833; DB02898; DB02915; DB02950; DB02963; DB02973; DB03019; DB03307; DB03365; DB03428; DB03490; DB03496; DB03583; DB03663; DB03737; DB03801; DB04006; DB04101; DB04186; DB04288; DB04407; DB04518; DB04607; DB04662; DB04669; DB06195; DB06616; DB06844; DB06888; DB06944; DB06948; DB06976; DB06983; DB07024; DB07054; DB07065; DB07126; DB07137; DB07163; DB07164; DB07179; DB07203; DB07210; DB07220; DB07431; DB07471; DB07493; DB07501; DB07504; DB07529; DB07531; DB07533; DB07534; DB07538; DB07539; DB07540; DB07562; DB07595; DB07606; DB07612; DB07618; DB07622; DB07685; DB07686; DB07687; DB07688; DB07731; DB07750; DB07751; DB07755; DB07761; DB07790; DB07791; DB07852; DB07889; DB07936; DB07982; DB08066; DB08094; DB08122; DB08123; DB08124; DB08125; DB08126; DB08132; DB08133; DB08134; DB08135; DB08136; DB08137; DB08138; DB08139; DB08140; DB08141; DB08142; DB08178; DB08182; DB08218; DB08219; DB08233; DB08241; DB08247; DB08248; DB08285; DB08309; DB08312; DB08355; DB08441; DB08463; DB08527; DB08531; DB08532; DB08533; DB08534; DB08535; DB08536; DB08537; DB08538; DB08539; DB08572; DB08673; DB08677; DB08694; DB08768)
drugbank_target|P43405	-	635	sp|Q8IHZ9|KC1_PLAF	-	323	9.5e-75	250.1	0.6	1	1	1e-75	1.5e-74	249.5	0.6	13	277	375	630	370	634	0.92	Tyrosine-protein kinase SYK (DB02010; DB06834; DB07159; DB07194; DB08361; DB08846; DB12010)
drugbank_target|Q96PY6	-	1258	sp|Q8IHZ9|KC1_PLAF	-	323	1.3e-74	249.7	0.1	1	1	9.1e-76	1.3e-74	249.7	0.1	7	281	2	261	1	282	0.88	Serine/threonine-protein kinase Nek1 (DB12010)
drugbank_target|Q8NEV4	-	1616	sp|Q8IHZ9|KC1_PLAF	-	323	1.4e-74	249.6	0.0	1	1	2.7e-75	3.9e-74	248.1	0.0	7	309	19	318	16	331	0.87	Myosin-IIIa (DB12010)
drugbank_target|Q12851	-	820	sp|Q8IHZ9|KC1_PLAF	-	323	1.5e-74	249.5	0.0	1	1	1.6e-75	2.3e-74	248.8	0.0	6	286	13	281	10	292	0.93	Mitogen-activated protein kinase kinase kinase kinase 2 (DB12010)
drugbank_target|P08069	-	1367	sp|Q8IHZ9|KC1_PLAF	-	323	2e-74	249.1	0.0	1	1	2.2e-75	3.2e-74	248.4	0.0	6	280	996	1273	992	1300	0.87	Insulin-like growth factor 1 receptor (DB00030; DB00046; DB00047; DB00071; DB01277; DB01306; DB01307; DB01309; DB04395; DB05023; DB05184; DB05897; DB06075; DB06343; DB07156; DB07474; DB09098; DB09564; DB12250; DB12267; DB14751)
drugbank_target|P43403	-	619	sp|Q8IHZ9|KC1_PLAF	-	323	2e-74	249.0	0.1	1	1	2.2e-75	3.2e-74	248.4	0.1	14	277	343	597	336	606	0.91	Tyrosine-protein kinase ZAP-70 (DB02010; DB12010)
drugbank_target|Q16513	-	984	sp|Q8IHZ9|KC1_PLAF	-	323	2.3e-74	248.8	1.0	1	1	2.5e-75	3.7e-74	248.2	0.0	7	267	655	903	651	923	0.94	Serine/threonine-protein kinase N2 (DB12010)
drugbank_target|Q15303	-	1308	sp|Q8IHZ9|KC1_PLAF	-	323	2.5e-74	248.7	0.0	1	1	2.6e-75	3.7e-74	248.2	0.0	7	282	716	983	710	1020	0.90	Receptor tyrosine-protein kinase erbB-4 (DB08916; DB12010; DB12267; DB15035)
drugbank_target|Q32MK0	-	819	sp|Q8IHZ9|KC1_PLAF	-	323	2.6e-74	248.7	0.3	1	1	2.6e-75	3.7e-74	248.2	0.3	11	295	517	792	506	810	0.88	Myosin light chain kinase 3 (DB12010)
drugbank_target|P08922	-	2347	sp|Q8IHZ9|KC1_PLAF	-	323	3.1e-74	248.4	0.0	1	1	5.7e-75	8.3e-74	247.0	0.0	7	275	1943	2217	1940	2243	0.89	Proto-oncogene tyrosine-protein kinase ROS (DB11986; DB12010)
drugbank_target|Q8NG66	-	645	sp|Q8IHZ9|KC1_PLAF	-	323	3.8e-74	248.1	0.3	1	1	2.6e-75	3.8e-74	248.1	0.3	5	288	25	297	22	328	0.83	Serine/threonine-protein kinase Nek11 (DB08912; DB12010)
drugbank_target|Q08345	-	913	sp|Q8IHZ9|KC1_PLAF	-	323	4.2e-74	248.0	0.0	1	1	4.2e-75	6.1e-74	247.5	0.0	7	275	608	907	605	912	0.88	Epithelial discoidin domain-containing receptor 1 (DB00619; DB12010)
drugbank_target|Q56UN5	-	1328	sp|Q8IHZ9|KC1_PLAF	-	323	4.3e-74	248.0	0.0	1	1	9e-75	1.3e-73	246.4	0.0	9	271	1061	1320	1059	1327	0.91	Mitogen-activated protein kinase kinase kinase 19 (DB12010)
drugbank_target|Q9UPZ9	-	632	sp|Q8IHZ9|KC1_PLAF	-	323	4.8e-74	247.8	0.1	1	2	1.4e-70	2e-69	232.6	0.0	7	250	2	232	1	242	0.91	Serine/threonine-protein kinase ICK (DB12010)
drugbank_target|Q9UPZ9	-	632	sp|Q8IHZ9|KC1_PLAF	-	323	4.8e-74	247.8	0.1	2	2	0.00084	0.012	13.2	0.0	239	268	248	277	241	306	0.84	Serine/threonine-protein kinase ICK (DB12010)
drugbank_target|Q6PHR2	-	472	sp|Q8IHZ9|KC1_PLAF	-	323	4.8e-74	247.8	0.0	1	1	5.1e-75	7.4e-74	247.2	0.0	9	268	14	263	11	300	0.88	Serine/threonine-protein kinase ULK3 (DB12010)
drugbank_target|Q15746	-	1914	sp|Q8IHZ9|KC1_PLAF	-	323	5e-74	247.7	0.7	1	1	5.9e-75	8.6e-74	247.0	0.7	2	303	1457	1747	1456	1758	0.89	Myosin light chain kinase, smooth muscle (DB12010)
drugbank_target|Q92772	-	493	sp|Q8IHZ9|KC1_PLAF	-	323	6.8e-74	247.3	6.2	1	1	8.1e-73	1.2e-71	240.0	6.2	7	317	2	328	1	334	0.87	Cyclin-dependent kinase-like 2 (DB12010)
drugbank_target|Q9Y2U5	-	619	sp|Q8IHZ9|KC1_PLAF	-	323	7.4e-74	247.2	0.0	1	1	9.3e-75	1.3e-73	246.3	0.0	6	272	353	613	349	618	0.89	Mitogen-activated protein kinase kinase kinase 2 (DB06616; DB12010)
drugbank_target|Q16832	-	855	sp|Q8IHZ9|KC1_PLAF	-	323	8.4e-74	247.0	0.0	1	1	8.8e-75	1.3e-73	246.4	0.0	9	273	563	849	556	853	0.88	Discoidin domain-containing receptor 2 (DB08896; DB12010)
drugbank_target|Q96GD4	-	344	sp|Q8IHZ9|KC1_PLAF	-	323	1e-73	246.7	0.0	1	1	9.5e-75	1.4e-73	246.3	0.0	7	270	75	322	70	328	0.93	Aurora kinase B (DB04703; DB05169; DB06486; DB07340; DB12010)
drugbank_target|P36888	-	993	sp|Q8IHZ9|KC1_PLAF	-	323	1.2e-73	246.5	0.1	1	2	3.5e-24	5.1e-23	80.1	0.1	7	101	608	711	604	720	0.87	Receptor-type tyrosine-protein kinase FLT3 (DB00398; DB01268; DB05014; DB05465; DB06080; DB06469; DB06595; DB08901; DB09079; DB12010; DB12141; DB12267; DB12500; DB12742; DB12874; DB12978)
drugbank_target|P36888	-	993	sp|Q8IHZ9|KC1_PLAF	-	323	1.2e-73	246.5	0.1	2	2	9.6e-50	1.4e-48	164.1	0.0	98	286	781	957	766	981	0.85	Receptor-type tyrosine-protein kinase FLT3 (DB00398; DB01268; DB05014; DB05465; DB06080; DB06469; DB06595; DB08901; DB09079; DB12010; DB12141; DB12267; DB12500; DB12742; DB12874; DB12978)
drugbank_target|Q9NQU5	-	681	sp|Q8IHZ9|KC1_PLAF	-	323	1.5e-73	246.2	0.0	1	1	1.5e-74	2.1e-73	245.7	0.0	14	271	412	654	407	675	0.92	Serine/threonine-protein kinase PAK 6 (DB12010)
drugbank_target|O14936	-	926	sp|Q8IHZ9|KC1_PLAF	-	323	1.5e-73	246.1	0.0	1	1	2.6e-74	3.8e-73	244.8	0.0	5	302	8	302	5	313	0.87	Peripheral plasma membrane protein CASK (DB01942; DB12010)
drugbank_target|Q9UL54	-	1235	sp|Q8IHZ9|KC1_PLAF	-	323	1.7e-73	246.0	0.0	1	1	1.2e-74	1.7e-73	246.0	0.0	8	299	27	302	21	321	0.86	Serine/threonine-protein kinase TAO2 (DB04522; DB12010)
drugbank_target|P05129	-	697	sp|Q8IHZ9|KC1_PLAF	-	323	2.4e-73	245.5	0.0	1	1	2.5e-74	3.6e-73	244.9	0.0	8	264	350	598	347	600	0.93	Protein kinase C gamma type (DB00675)
drugbank_target|P05129	-	697	sp|Q8IHZ9|KC1_PLAF	-	323	2.4e-73	245.5	0.0	1	1	2.5e-74	3.6e-73	244.9	0.0	8	264	350	598	347	600	0.93	Protein kinase C gamma type (DB12010)
drugbank_target|P53779	-	464	sp|Q8IHZ9|KC1_PLAF	-	323	2.8e-73	245.3	0.3	1	2	1e-72	1.5e-71	239.7	0.1	3	291	58	327	56	332	0.90	Mitogen-activated protein kinase 10 (DB01782; DB02388; DB03084; DB03623; DB04395; DB06933; DB07010; DB07217; DB08005; DB08010; DB08011; DB08015; DB08021; DB08023; DB08025; DB08026; DB08555; DB12010)
drugbank_target|P53779	-	464	sp|Q8IHZ9|KC1_PLAF	-	323	2.8e-73	245.3	0.3	2	2	0.33	4.7	4.7	0.0	246	288	330	369	322	412	0.62	Mitogen-activated protein kinase 10 (DB01782; DB02388; DB03084; DB03623; DB04395; DB06933; DB07010; DB07217; DB08005; DB08010; DB08011; DB08015; DB08021; DB08023; DB08025; DB08026; DB08555; DB12010)
drugbank_target|P53779	-	464	sp|Q8IHZ9|KC1_PLAF	-	323	2.8e-73	245.3	0.3	1	2	1e-72	1.5e-71	239.7	0.1	3	291	58	327	56	332	0.90	Mitogen-activated protein kinase 10 (DB01017)
drugbank_target|P53779	-	464	sp|Q8IHZ9|KC1_PLAF	-	323	2.8e-73	245.3	0.3	2	2	0.33	4.7	4.7	0.0	246	288	330	369	322	412	0.62	Mitogen-activated protein kinase 10 (DB01017)
drugbank_target|P53779	-	464	sp|Q8IHZ9|KC1_PLAF	-	323	2.8e-73	245.3	0.3	1	2	1e-72	1.5e-71	239.7	0.1	3	291	58	327	56	332	0.90	Mitogen-activated protein kinase 10 (DB15624)
drugbank_target|P53779	-	464	sp|Q8IHZ9|KC1_PLAF	-	323	2.8e-73	245.3	0.3	2	2	0.33	4.7	4.7	0.0	246	288	330	369	322	412	0.62	Mitogen-activated protein kinase 10 (DB15624)
drugbank_target|P35968	-	1356	sp|Q8IHZ9|KC1_PLAF	-	323	3.1e-73	245.2	0.0	1	2	6.3e-20	9.1e-19	66.2	0.0	7	100	832	935	829	944	0.88	Vascular endothelial growth factor receptor 2 (DB00398; DB01268; DB04727; DB04849; DB04879; DB05014; DB05075; DB05146; DB05198; DB05578; DB05931; DB05984; DB06080; DB06101; DB06436; DB06589; DB06595; DB06626; DB06938; DB07183; DB07274; DB07326; DB07333; DB07334; DB07514; DB07528; DB07537; DB08042; DB08519; DB08875; DB08896; DB08901; DB09078; DB09079; DB12010; DB12147; DB12307; DB14840)
drugbank_target|P35968	-	1356	sp|Q8IHZ9|KC1_PLAF	-	323	3.1e-73	245.2	0.0	2	2	1.5e-53	2.2e-52	176.6	0.0	97	283	997	1170	976	1190	0.87	Vascular endothelial growth factor receptor 2 (DB00398; DB01268; DB04727; DB04849; DB04879; DB05014; DB05075; DB05146; DB05198; DB05578; DB05931; DB05984; DB06080; DB06101; DB06436; DB06589; DB06595; DB06626; DB06938; DB07183; DB07274; DB07326; DB07333; DB07334; DB07514; DB07528; DB07537; DB08042; DB08519; DB08875; DB08896; DB08901; DB09078; DB09079; DB12010; DB12147; DB12307; DB14840)
drugbank_target|Q9P286	-	719	sp|Q8IHZ9|KC1_PLAF	-	323	4e-73	244.8	0.0	1	1	4.1e-74	6e-73	244.2	0.0	14	270	454	695	446	702	0.92	Serine/threonine-protein kinase PAK 5 (DB12010)
drugbank_target|Q59EB3	-	712	sp|Q8IHZ9|KC1_PLAF	-	323	4.4e-73	244.7	0.0	1	1	4.3e-74	6.2e-73	244.2	0.0	10	280	401	666	399	702	0.88	Met proto-oncogene variant (DB08111)
drugbank_target|P53778	-	367	sp|Q8IHZ9|KC1_PLAF	-	323	5.5e-73	244.3	0.0	1	2	1.3e-72	1.8e-71	239.3	0.0	4	260	22	270	19	277	0.92	Mitogen-activated protein kinase 12 (DB02482; DB04395; DB05157; DB05403)
drugbank_target|P53778	-	367	sp|Q8IHZ9|KC1_PLAF	-	323	5.5e-73	244.3	0.0	2	2	0.76	11	3.5	0.0	241	281	277	314	269	348	0.72	Mitogen-activated protein kinase 12 (DB02482; DB04395; DB05157; DB05403)
drugbank_target|P53778	-	367	sp|Q8IHZ9|KC1_PLAF	-	323	5.5e-73	244.3	0.0	1	2	1.3e-72	1.8e-71	239.3	0.0	4	260	22	270	19	277	0.92	Mitogen-activated protein kinase 12 (DB01017)
drugbank_target|P53778	-	367	sp|Q8IHZ9|KC1_PLAF	-	323	5.5e-73	244.3	0.0	2	2	0.76	11	3.5	0.0	241	281	277	314	269	348	0.72	Mitogen-activated protein kinase 12 (DB01017)
drugbank_target|Q15139	-	912	sp|Q8IHZ9|KC1_PLAF	-	323	6.2e-73	244.1	0.0	1	1	7.1e-74	1e-72	243.4	0.0	12	284	586	845	575	876	0.89	Serine/threonine-protein kinase D1 (DB11752; DB12010)
drugbank_target|Q86YV6	-	388	sp|Q8IHZ9|KC1_PLAF	-	323	7.5e-73	243.9	0.2	1	1	7.8e-74	1.1e-72	243.3	0.2	11	288	108	371	99	385	0.92	Myosin light chain kinase family member 4 (DB12010)
drugbank_target|P30530	-	894	sp|Q8IHZ9|KC1_PLAF	-	323	9.8e-73	243.5	0.0	1	1	1e-73	1.5e-72	242.9	0.0	8	278	535	808	530	817	0.87	Tyrosine-protein kinase receptor UFO (DB12010; DB12141)
drugbank_target|P08581	-	1390	sp|Q8IHZ9|KC1_PLAF	-	323	1.2e-72	243.2	0.0	1	1	1.6e-73	2.2e-72	242.3	0.0	10	280	1079	1344	1077	1379	0.88	Hepatocyte growth factor receptor (DB02152; DB06314; DB06896; DB06995; DB06997; DB07369; DB07969; DB08079; DB08791; DB08865; DB08875; DB11791; DB12010; DB12200; DB12267; DB12742)
drugbank_target|Q92918	-	833	sp|Q8IHZ9|KC1_PLAF	-	323	1.4e-72	243.0	0.0	1	1	1.3e-73	1.9e-72	242.6	0.0	6	271	14	270	9	283	0.94	Mitogen-activated protein kinase kinase kinase kinase 1 (DB12010)
drugbank_target|Q00532	-	358	sp|Q8IHZ9|KC1_PLAF	-	323	2e-72	242.5	0.1	1	2	1.7e-69	2.4e-68	229.1	0.0	6	235	2	222	1	237	0.90	Cyclin-dependent kinase-like 1 (DB12010)
drugbank_target|Q00532	-	358	sp|Q8IHZ9|KC1_PLAF	-	323	2e-72	242.5	0.1	2	2	0.0026	0.037	11.6	0.0	236	302	249	313	239	326	0.69	Cyclin-dependent kinase-like 1 (DB12010)
drugbank_target|Q9UEE5	-	414	sp|Q8IHZ9|KC1_PLAF	-	323	2e-72	242.5	0.0	1	1	1.9e-73	2.8e-72	242.0	0.0	12	317	64	363	55	369	0.88	Serine/threonine-protein kinase 17A (DB12010)
drugbank_target|P51955	-	445	sp|Q8IHZ9|KC1_PLAF	-	323	2.3e-72	242.3	1.0	1	1	2.7e-73	3.9e-72	241.5	0.1	6	284	5	282	2	326	0.86	Serine/threonine-protein kinase Nek2 (DB07180; DB12010)
drugbank_target|Q16512	-	942	sp|Q8IHZ9|KC1_PLAF	-	323	2.6e-72	242.1	0.0	1	2	8	1.2e+02	0.1	0.0	185	234	453	499	449	526	0.70	Serine/threonine-protein kinase N1 (DB12010)
drugbank_target|Q16512	-	942	sp|Q8IHZ9|KC1_PLAF	-	323	2.6e-72	242.1	0.0	2	2	1.4e-72	2.1e-71	239.2	0.0	7	265	613	859	609	870	0.94	Serine/threonine-protein kinase N1 (DB12010)
drugbank_target|Q07785	-	288	sp|Q8IHZ9|KC1_PLAF	-	323	2.7e-72	242.0	0.1	1	1	2e-71	3e-70	235.4	0.1	7	233	2	234	1	288	0.82	Cell division control protein 2 homolog (DB02519; DB02733)
drugbank_target|P00533	-	1210	sp|Q8IHZ9|KC1_PLAF	-	323	4e-72	241.5	0.0	1	1	4.2e-73	6e-72	240.9	0.0	6	282	709	977	704	1012	0.91	Epidermal growth factor receptor (DB00002; DB00281; DB00317; DB00530; DB01259; DB01269; DB03496; DB04988; DB05101; DB05294; DB05374; DB05424; DB05524; DB05944; DB06021; DB07602; DB07662; DB08916; DB09330; DB09559; DB10772; DB11731; DB11737; DB11828; DB11963; DB12010; DB12202; DB12267; DB13164; DB15035)
drugbank_target|P42679	-	507	sp|Q8IHZ9|KC1_PLAF	-	323	4.1e-72	241.5	0.0	1	1	4.4e-73	6.4e-72	240.8	0.0	8	283	234	488	231	500	0.92	Megakaryocyte-associated tyrosine-protein kinase (DB12010)
drugbank_target|P45984	-	424	sp|Q8IHZ9|KC1_PLAF	-	323	4.1e-72	241.5	0.7	1	2	2.1e-71	3.1e-70	235.3	0.4	3	289	20	287	18	295	0.90	Mitogen-activated protein kinase 9 (DB07020; DB12010)
drugbank_target|P45984	-	424	sp|Q8IHZ9|KC1_PLAF	-	323	4.1e-72	241.5	0.7	2	2	0.14	2.1	5.8	0.0	244	282	290	325	271	374	0.67	Mitogen-activated protein kinase 9 (DB07020; DB12010)
drugbank_target|P45984	-	424	sp|Q8IHZ9|KC1_PLAF	-	323	4.1e-72	241.5	0.7	1	2	2.1e-71	3.1e-70	235.3	0.4	3	289	20	287	18	295	0.90	Mitogen-activated protein kinase 9 (DB01017)
drugbank_target|P45984	-	424	sp|Q8IHZ9|KC1_PLAF	-	323	4.1e-72	241.5	0.7	2	2	0.14	2.1	5.8	0.0	244	282	290	325	271	374	0.67	Mitogen-activated protein kinase 9 (DB01017)
drugbank_target|P45984	-	424	sp|Q8IHZ9|KC1_PLAF	-	323	4.1e-72	241.5	0.7	1	2	2.1e-71	3.1e-70	235.3	0.4	3	289	20	287	18	295	0.90	Mitogen-activated protein kinase 9 (DB15624)
drugbank_target|P45984	-	424	sp|Q8IHZ9|KC1_PLAF	-	323	4.1e-72	241.5	0.7	2	2	0.14	2.1	5.8	0.0	244	282	290	325	271	374	0.67	Mitogen-activated protein kinase 9 (DB15624)
drugbank_target|Q8WU08	-	396	sp|Q8IHZ9|KC1_PLAF	-	323	4.4e-72	241.4	0.5	1	1	3e-73	4.4e-72	241.4	0.5	7	269	21	272	16	295	0.89	Serine/threonine-protein kinase 32A (DB12010)
drugbank_target|Q8IY84	-	436	sp|Q8IHZ9|KC1_PLAF	-	323	4.4e-72	241.4	0.0	1	1	4.2e-73	6e-72	240.9	0.0	9	270	74	320	68	373	0.92	Serine/threonine-protein kinase NIM1 (DB12010)
drugbank_target|P45983	-	427	sp|Q8IHZ9|KC1_PLAF	-	323	4.9e-72	241.2	0.4	1	2	2.7e-72	4e-71	238.2	0.2	3	294	20	292	18	302	0.90	Mitogen-activated protein kinase 8 (DB00675; DB01782; DB07218; DB07268; DB07272; DB07276; DB07845)
drugbank_target|P45983	-	427	sp|Q8IHZ9|KC1_PLAF	-	323	4.9e-72	241.2	0.4	2	2	1.6	23	2.4	0.0	246	282	292	325	285	369	0.72	Mitogen-activated protein kinase 8 (DB00675; DB01782; DB07218; DB07268; DB07272; DB07276; DB07845)
drugbank_target|P45983	-	427	sp|Q8IHZ9|KC1_PLAF	-	323	4.9e-72	241.2	0.4	1	2	2.7e-72	4e-71	238.2	0.2	3	294	20	292	18	302	0.90	Mitogen-activated protein kinase 8 (DB01017)
drugbank_target|P45983	-	427	sp|Q8IHZ9|KC1_PLAF	-	323	4.9e-72	241.2	0.4	2	2	1.6	23	2.4	0.0	246	282	292	325	285	369	0.72	Mitogen-activated protein kinase 8 (DB01017)
drugbank_target|P45983	-	427	sp|Q8IHZ9|KC1_PLAF	-	323	4.9e-72	241.2	0.4	1	2	2.7e-72	4e-71	238.2	0.2	3	294	20	292	18	302	0.90	Mitogen-activated protein kinase 8 (DB15624)
drugbank_target|P45983	-	427	sp|Q8IHZ9|KC1_PLAF	-	323	4.9e-72	241.2	0.4	2	2	1.6	23	2.4	0.0	246	282	292	325	285	369	0.72	Mitogen-activated protein kinase 8 (DB15624)
drugbank_target|Q13464	-	1354	sp|Q8IHZ9|KC1_PLAF	-	323	5.2e-72	241.1	0.0	1	1	3.6e-73	5.2e-72	241.1	0.0	6	280	73	340	69	378	0.89	Rho-associated protein kinase 1 (DB04707; DB07876; DB08162; DB08756; DB13165; DB13931)
drugbank_target|P28482	-	360	sp|Q8IHZ9|KC1_PLAF	-	323	6.2e-72	240.9	0.3	1	2	1.5e-70	2.1e-69	232.5	0.1	4	253	20	265	18	272	0.89	Mitogen-activated protein kinase 1 (DB00945)
drugbank_target|P28482	-	360	sp|Q8IHZ9|KC1_PLAF	-	323	6.2e-72	240.9	0.3	2	2	0.048	0.7	7.4	0.0	230	282	268	317	256	355	0.74	Mitogen-activated protein kinase 1 (DB00945)
drugbank_target|P28482	-	360	sp|Q8IHZ9|KC1_PLAF	-	323	6.2e-72	240.9	0.3	1	2	1.5e-70	2.1e-69	232.5	0.1	4	253	20	265	18	272	0.89	Mitogen-activated protein kinase 1 (DB01064; DB01169; DB02116; DB02482; DB02733; DB04338; DB06195; DB06641; DB06877; DB07010; DB07264; DB07788; DB07794; DB07905; DB08513; DB08521; DB11120; DB13930)
drugbank_target|P28482	-	360	sp|Q8IHZ9|KC1_PLAF	-	323	6.2e-72	240.9	0.3	2	2	0.048	0.7	7.4	0.0	230	282	268	317	256	355	0.74	Mitogen-activated protein kinase 1 (DB01064; DB01169; DB02116; DB02482; DB02733; DB04338; DB06195; DB06641; DB06877; DB07010; DB07264; DB07788; DB07794; DB07905; DB08513; DB08521; DB11120; DB13930)
drugbank_target|P28482	-	360	sp|Q8IHZ9|KC1_PLAF	-	323	6.2e-72	240.9	0.3	1	2	1.5e-70	2.1e-69	232.5	0.1	4	253	20	265	18	272	0.89	Mitogen-activated protein kinase 1 (DB01017)
drugbank_target|P28482	-	360	sp|Q8IHZ9|KC1_PLAF	-	323	6.2e-72	240.9	0.3	2	2	0.048	0.7	7.4	0.0	230	282	268	317	256	355	0.74	Mitogen-activated protein kinase 1 (DB01017)
drugbank_target|P41743	-	596	sp|Q8IHZ9|KC1_PLAF	-	323	6.9e-72	240.7	0.0	1	1	8.8e-73	1.3e-71	239.8	0.0	7	264	252	505	249	520	0.88	Protein kinase C iota type (DB00675)
drugbank_target|P41743	-	596	sp|Q8IHZ9|KC1_PLAF	-	323	6.9e-72	240.7	0.0	1	1	8.8e-73	1.3e-71	239.8	0.0	7	264	252	505	249	520	0.88	Protein kinase C iota type (DB03777; DB12010)
drugbank_target|Q16644	-	382	sp|Q8IHZ9|KC1_PLAF	-	323	7.7e-72	240.6	0.1	1	1	6.5e-73	9.4e-72	240.3	0.1	3	300	37	327	35	356	0.86	MAP kinase-activated protein kinase 3 (DB07728; DB08358)
drugbank_target|Q6ZN16	-	1313	sp|Q8IHZ9|KC1_PLAF	-	323	9.5e-72	240.3	0.0	1	1	1.4e-72	2.1e-71	239.2	0.0	14	271	657	904	653	922	0.91	Mitogen-activated protein kinase kinase kinase 15 (DB12010)
drugbank_target|P49137	-	400	sp|Q8IHZ9|KC1_PLAF	-	323	1.1e-71	240.1	0.1	1	1	1e-72	1.5e-71	239.6	0.1	7	301	61	349	56	373	0.86	MAP kinase-activated protein kinase 2 (DB02010; DB07234; DB07406; DB07430; DB07431; DB07728; DB08358)
drugbank_target|Q06418	-	890	sp|Q8IHZ9|KC1_PLAF	-	323	1.2e-71	239.9	0.0	1	1	1.2e-72	1.8e-71	239.4	0.0	6	279	515	792	512	813	0.87	Tyrosine-protein kinase receptor TYRO3 (DB12010)
drugbank_target|P04049	-	648	sp|Q8IHZ9|KC1_PLAF	-	323	1.5e-71	239.6	0.1	1	1	1.6e-72	2.3e-71	239.0	0.1	10	294	350	627	345	640	0.87	RAF proto-oncogene serine/threonine-protein kinase (DB00398; DB04973; DB05190; DB05268; DB08862; DB08896; DB08912; DB12010)
drugbank_target|Q05513	-	592	sp|Q8IHZ9|KC1_PLAF	-	323	2e-71	239.2	0.0	1	2	4.7	68	0.9	0.0	40	96	31	86	10	95	0.71	Protein kinase C zeta type (DB00675)
drugbank_target|Q05513	-	592	sp|Q8IHZ9|KC1_PLAF	-	323	2e-71	239.2	0.0	2	2	1.3e-71	1.9e-70	236.0	0.0	7	265	250	502	248	519	0.92	Protein kinase C zeta type (DB00675)
drugbank_target|O96013	-	591	sp|Q8IHZ9|KC1_PLAF	-	323	2.7e-71	238.8	0.0	1	1	2.7e-72	3.8e-71	238.3	0.0	14	271	326	568	319	581	0.91	Serine/threonine-protein kinase PAK 4 (DB12010)
drugbank_target|Q9H1R3	-	596	sp|Q8IHZ9|KC1_PLAF	-	323	2.9e-71	238.7	0.5	1	1	2.8e-72	4e-71	238.2	0.5	11	299	287	566	278	587	0.89	Myosin light chain kinase 2, skeletal/cardiac muscle (DB04825; DB12010)
drugbank_target|Q9Y6R4	-	1608	sp|Q8IHZ9|KC1_PLAF	-	323	3.3e-71	238.5	0.5	1	1	9.1e-72	1.3e-70	236.5	0.1	4	271	1338	1597	1336	1607	0.89	Mitogen-activated protein kinase kinase kinase 4 (DB12010)
drugbank_target|P15056	-	766	sp|Q8IHZ9|KC1_PLAF	-	323	3.4e-71	238.4	0.0	1	1	4e-72	5.8e-71	237.7	0.0	8	278	456	719	453	737	0.90	Serine/threonine-protein kinase B-raf (DB00398; DB05190; DB05984; DB06999; DB07000; DB08553; DB08881; DB08896; DB08912; DB11718; DB12010; DB14840)
drugbank_target|Q8TD08	-	544	sp|Q8IHZ9|KC1_PLAF	-	323	3.8e-71	238.3	0.0	1	1	1.9e-70	2.7e-69	232.2	0.0	3	236	7	238	5	325	0.85	Mitogen-activated protein kinase 15 (DB12010)
drugbank_target|Q8TD08	-	544	sp|Q8IHZ9|KC1_PLAF	-	323	3.8e-71	238.3	0.0	1	1	1.9e-70	2.7e-69	232.2	0.0	3	236	7	238	5	325	0.85	Mitogen-activated protein kinase 15 (DB00945)
drugbank_target|Q8TD08	-	544	sp|Q8IHZ9|KC1_PLAF	-	323	3.8e-71	238.3	0.0	1	1	1.9e-70	2.7e-69	232.2	0.0	3	236	7	238	5	325	0.85	Mitogen-activated protein kinase 15 (DB01017)
drugbank_target|Q13237	-	762	sp|Q8IHZ9|KC1_PLAF	-	323	4.3e-71	238.1	0.4	1	2	1.2	18	2.8	0.0	43	140	274	376	248	383	0.70	cGMP-dependent protein kinase 2 (DB12010)
drugbank_target|Q13237	-	762	sp|Q8IHZ9|KC1_PLAF	-	323	4.3e-71	238.1	0.4	2	2	1.5e-70	2.1e-69	232.5	0.0	8	274	452	703	448	717	0.93	cGMP-dependent protein kinase 2 (DB12010)
drugbank_target|Q04912	-	1400	sp|Q8IHZ9|KC1_PLAF	-	323	8.4e-71	237.1	0.0	1	1	9e-72	1.3e-70	236.5	0.0	12	277	1085	1345	1082	1361	0.90	Macrophage-stimulating protein receptor (DB12010)
drugbank_target|P27361	-	379	sp|Q8IHZ9|KC1_PLAF	-	323	8.6e-71	237.1	0.3	1	2	7.3e-70	1.1e-68	230.2	0.1	4	255	37	284	35	291	0.90	Mitogen-activated protein kinase 3 (DB00945)
drugbank_target|P27361	-	379	sp|Q8IHZ9|KC1_PLAF	-	323	8.6e-71	237.1	0.3	2	2	0.11	1.6	6.2	0.0	229	282	284	334	273	375	0.70	Mitogen-activated protein kinase 3 (DB00945)
drugbank_target|P27361	-	379	sp|Q8IHZ9|KC1_PLAF	-	323	8.6e-71	237.1	0.3	1	2	7.3e-70	1.1e-68	230.2	0.1	4	255	37	284	35	291	0.90	Mitogen-activated protein kinase 3 (DB00605; DB01169; DB02733; DB04604; DB06195; DB08862; DB13930)
drugbank_target|P27361	-	379	sp|Q8IHZ9|KC1_PLAF	-	323	8.6e-71	237.1	0.3	2	2	0.11	1.6	6.2	0.0	229	282	284	334	273	375	0.70	Mitogen-activated protein kinase 3 (DB00605; DB01169; DB02733; DB04604; DB06195; DB08862; DB13930)
drugbank_target|P27361	-	379	sp|Q8IHZ9|KC1_PLAF	-	323	8.6e-71	237.1	0.3	1	2	7.3e-70	1.1e-68	230.2	0.1	4	255	37	284	35	291	0.90	Mitogen-activated protein kinase 3 (DB01017)
drugbank_target|P27361	-	379	sp|Q8IHZ9|KC1_PLAF	-	323	8.6e-71	237.1	0.3	2	2	0.11	1.6	6.2	0.0	229	282	284	334	273	375	0.70	Mitogen-activated protein kinase 3 (DB01017)
drugbank_target|P04626	-	1255	sp|Q8IHZ9|KC1_PLAF	-	323	9.4e-71	237.0	0.0	1	1	9.7e-72	1.4e-70	236.4	0.0	6	280	717	983	712	994	0.92	Receptor tyrosine-protein kinase erbB-2 (DB00072; DB01259; DB04988; DB05773; DB05944; DB06021; DB06366; DB08916; DB11652; DB11973; DB12010; DB12267; DB15035)
drugbank_target|Q16539	-	360	sp|Q8IHZ9|KC1_PLAF	-	323	9.5e-71	237.0	0.0	1	2	5.2e-71	7.5e-70	234.0	0.0	4	257	19	264	17	269	0.93	Mitogen-activated protein kinase 14 (DB01254; DB01761; DB01807; DB01948; DB01953; DB01988; DB02195; DB02277; DB02352; DB02873; DB02984; DB03044; DB03110; DB03980; DB04338; DB04632; DB04797; DB05157; DB05412; DB05470; DB06518; DB06882; DB06940; DB06991; DB07138; DB07307; DB07459; DB07607; DB07811; DB07829; DB07832; DB07833; DB07834; DB07835; DB07941; DB07942; DB07943; DB08064; DB08068; DB08091; DB08092; DB08093; DB08095; DB08096; DB08097; DB08242; DB08349; DB08351; DB08352; DB08395; DB08423; DB08424; DB08521; DB08522; DB08730; DB12010)
drugbank_target|Q16539	-	360	sp|Q8IHZ9|KC1_PLAF	-	323	9.5e-71	237.0	0.0	2	2	5.5	80	0.6	0.0	248	268	281	301	267	318	0.81	Mitogen-activated protein kinase 14 (DB01254; DB01761; DB01807; DB01948; DB01953; DB01988; DB02195; DB02277; DB02352; DB02873; DB02984; DB03044; DB03110; DB03980; DB04338; DB04632; DB04797; DB05157; DB05412; DB05470; DB06518; DB06882; DB06940; DB06991; DB07138; DB07307; DB07459; DB07607; DB07811; DB07829; DB07832; DB07833; DB07834; DB07835; DB07941; DB07942; DB07943; DB08064; DB08068; DB08091; DB08092; DB08093; DB08095; DB08096; DB08097; DB08242; DB08349; DB08351; DB08352; DB08395; DB08423; DB08424; DB08521; DB08522; DB08730; DB12010)
drugbank_target|Q16539	-	360	sp|Q8IHZ9|KC1_PLAF	-	323	9.5e-71	237.0	0.0	1	2	5.2e-71	7.5e-70	234.0	0.0	4	257	19	264	17	269	0.93	Mitogen-activated protein kinase 14 (DB01017)
drugbank_target|Q16539	-	360	sp|Q8IHZ9|KC1_PLAF	-	323	9.5e-71	237.0	0.0	2	2	5.5	80	0.6	0.0	248	268	281	301	267	318	0.81	Mitogen-activated protein kinase 14 (DB01017)
drugbank_target|Q12866	-	999	sp|Q8IHZ9|KC1_PLAF	-	323	9.5e-71	237.0	0.0	1	1	9.9e-72	1.4e-70	236.4	0.0	10	279	588	860	583	884	0.86	Tyrosine-protein kinase Mer (DB08325; DB12010)
drugbank_target|P35916	-	1363	sp|Q8IHZ9|KC1_PLAF	-	323	1.1e-70	236.7	0.0	1	2	1.5e-18	2.2e-17	61.6	0.0	7	101	843	947	840	962	0.88	Vascular endothelial growth factor receptor 3 (DB00398; DB01268; DB04879; DB05075; DB05932; DB06080; DB06101; DB06589; DB06626; DB08896; DB09078; DB09079; DB12010; DB15685)
drugbank_target|P35916	-	1363	sp|Q8IHZ9|KC1_PLAF	-	323	1.1e-70	236.7	0.0	2	2	2.3e-52	3.3e-51	172.7	0.0	99	288	1008	1184	998	1216	0.88	Vascular endothelial growth factor receptor 3 (DB00398; DB01268; DB04879; DB05075; DB05932; DB06080; DB06101; DB06589; DB06626; DB08896; DB09078; DB09079; DB12010; DB15685)
drugbank_target|O15264	-	365	sp|Q8IHZ9|KC1_PLAF	-	323	2e-70	235.9	2.3	1	1	5.9e-69	8.5e-68	227.3	2.3	7	281	23	311	18	349	0.83	Mitogen-activated protein kinase 13 (DB05157; DB12010)
drugbank_target|O15264	-	365	sp|Q8IHZ9|KC1_PLAF	-	323	2e-70	235.9	2.3	1	1	5.9e-69	8.5e-68	227.3	2.3	7	281	23	311	18	349	0.83	Mitogen-activated protein kinase 13 (DB01017)
drugbank_target|O15530	-	556	sp|Q8IHZ9|KC1_PLAF	-	323	2.2e-70	235.8	0.0	1	1	2.7e-71	4e-70	234.9	0.0	6	269	79	330	75	338	0.93	3-phosphoinositide-dependent protein kinase 1 (DB00482; DB01863; DB01933; DB01946; DB02010; DB03777; DB04522; DB06932; DB07033; DB07132; DB07300; DB07456; DB07457; DB12010)
drugbank_target|Q86UE8	-	772	sp|Q8IHZ9|KC1_PLAF	-	323	2.8e-70	235.4	0.1	1	1	1.9e-71	2.8e-70	235.4	0.1	4	270	457	736	455	748	0.88	Serine/threonine-protein kinase tousled-like 2 (DB12010)
drugbank_target|Q9BXA7	-	367	sp|Q8IHZ9|KC1_PLAF	-	323	3.5e-70	235.1	0.1	1	1	3.4e-71	5e-70	234.6	0.1	8	275	11	269	6	294	0.90	Testis-specific serine/threonine-protein kinase 1 (DB12010)
drugbank_target|P06493	-	297	sp|Q8IHZ9|KC1_PLAF	-	323	3.9e-70	235.0	0.0	1	1	1e-70	1.5e-69	233.0	0.0	7	250	2	236	1	248	0.91	Cyclin-dependent kinase 1 (DB02052; DB02116; DB02950; DB03428; DB03496; DB04014; DB06195; DB08142; DB12010)
drugbank_target|Q9UM73	-	1620	sp|Q8IHZ9|KC1_PLAF	-	323	4.1e-70	234.9	0.0	1	1	4e-71	5.8e-70	234.4	0.0	6	283	1113	1393	1108	1411	0.89	ALK tyrosine kinase receptor (DB00171; DB08865; DB09063; DB11363; DB12010; DB12130; DB12141; DB12267)
drugbank_target|P14616	-	1297	sp|Q8IHZ9|KC1_PLAF	-	323	4.8e-70	234.6	0.0	1	1	5.1e-71	7.4e-70	234.0	0.0	7	279	977	1252	973	1270	0.86	Insulin receptor-related protein (DB12010)
drugbank_target|O75116	-	1388	sp|Q8IHZ9|KC1_PLAF	-	323	5.2e-70	234.5	0.0	1	1	3.6e-71	5.2e-70	234.5	0.0	6	278	89	354	85	395	0.88	Rho-associated protein kinase 2 (DB08162; DB08756; DB12010; DB13165; DB13931)
drugbank_target|Q00535	-	292	sp|Q8IHZ9|KC1_PLAF	-	323	7.9e-70	234.0	0.0	1	2	6.5e-70	9.4e-69	230.4	0.0	7	244	2	230	1	236	0.93	Cyclin-dependent-like kinase 5 (DB02052; DB02116; DB02950; DB03428; DB03496; DB04014; DB07364)
drugbank_target|Q00535	-	292	sp|Q8IHZ9|KC1_PLAF	-	323	7.9e-70	234.0	0.0	2	2	3	43	1.5	0.0	242	269	253	280	243	288	0.80	Cyclin-dependent-like kinase 5 (DB02052; DB02116; DB02950; DB03428; DB03496; DB04014; DB07364)
drugbank_target|Q96RR4	-	588	sp|Q8IHZ9|KC1_PLAF	-	323	8.3e-70	233.9	0.0	1	1	8.9e-71	1.3e-69	233.3	0.0	7	270	163	441	157	477	0.86	Calcium/calmodulin-dependent protein kinase kinase 2 (DB12010)
drugbank_target|Q13233	-	1512	sp|Q8IHZ9|KC1_PLAF	-	323	8.3e-70	233.9	0.0	1	1	1.2e-70	1.8e-69	232.8	0.0	7	271	1241	1504	1237	1510	0.88	Mitogen-activated protein kinase kinase kinase 1 (DB06061; DB11967; DB12010)
drugbank_target|O14757	-	476	sp|Q8IHZ9|KC1_PLAF	-	323	9.2e-70	233.7	0.0	1	1	9.4e-71	1.4e-69	233.2	0.0	3	271	3	261	1	277	0.92	Serine/threonine-protein kinase Chk1 (DB05149; DB06486; DB06852; DB06876; DB07025; DB07034; DB07037; DB07038; DB07075; DB07078; DB07158; DB07213; DB07228; DB07243; DB07311; DB07314; DB07320; DB07336; DB07647; DB07648; DB07653; DB07654; DB07655; DB07959; DB08392; DB08393; DB08683; DB08774; DB08776; DB08777; DB08778; DB08779; DB08780; DB08781; DB12010)
drugbank_target|Q9HBH9	-	465	sp|Q8IHZ9|KC1_PLAF	-	323	1.1e-69	233.5	0.0	1	1	1.3e-70	1.9e-69	232.7	0.0	4	275	78	365	75	419	0.85	MAP kinase-interacting serine/threonine-protein kinase 2 (DB12010)
drugbank_target|O94768	-	372	sp|Q8IHZ9|KC1_PLAF	-	323	1.1e-69	233.5	0.0	1	1	9.4e-71	1.4e-69	233.2	0.0	11	307	35	324	25	342	0.83	Serine/threonine-protein kinase 17B (DB04216; DB12010)
drugbank_target|P53667	-	647	sp|Q8IHZ9|KC1_PLAF	-	323	2.6e-69	232.2	0.0	1	1	2.7e-70	3.9e-69	231.7	0.0	11	276	341	607	335	613	0.89	LIM domain kinase 1 (DB08912; DB12010)
drugbank_target|Q13164	-	816	sp|Q8IHZ9|KC1_PLAF	-	323	3.1e-69	232.0	2.1	1	1	3.6e-70	5.2e-69	231.3	0.0	3	254	49	300	47	307	0.90	Mitogen-activated protein kinase 7 (DB12010)
drugbank_target|Q13164	-	816	sp|Q8IHZ9|KC1_PLAF	-	323	3.1e-69	232.0	2.1	1	1	3.6e-70	5.2e-69	231.3	0.0	3	254	49	300	47	307	0.90	Mitogen-activated protein kinase 7 (DB00945)
drugbank_target|Q13164	-	816	sp|Q8IHZ9|KC1_PLAF	-	323	3.1e-69	232.0	2.1	1	1	3.6e-70	5.2e-69	231.3	0.0	3	254	49	300	47	307	0.90	Mitogen-activated protein kinase 7 (DB01017)
drugbank_target|Q15759	-	364	sp|Q8IHZ9|KC1_PLAF	-	323	6.9e-69	230.9	0.0	1	2	2.6e-69	3.8e-68	228.4	0.0	5	255	20	262	17	269	0.93	Mitogen-activated protein kinase 11 (DB05157; DB08896)
drugbank_target|Q15759	-	364	sp|Q8IHZ9|KC1_PLAF	-	323	6.9e-69	230.9	0.0	2	2	7.3	1.1e+02	0.2	0.0	242	286	275	316	264	345	0.63	Mitogen-activated protein kinase 11 (DB05157; DB08896)
drugbank_target|Q15759	-	364	sp|Q8IHZ9|KC1_PLAF	-	323	6.9e-69	230.9	0.0	1	2	2.6e-69	3.8e-68	228.4	0.0	5	255	20	262	17	269	0.93	Mitogen-activated protein kinase 11 (DB01017)
drugbank_target|Q15759	-	364	sp|Q8IHZ9|KC1_PLAF	-	323	6.9e-69	230.9	0.0	2	2	7.3	1.1e+02	0.2	0.0	242	286	275	316	264	345	0.63	Mitogen-activated protein kinase 11 (DB01017)
drugbank_target|Q8TD19	-	979	sp|Q8IHZ9|KC1_PLAF	-	323	8.3e-69	230.6	0.1	1	1	1.1e-69	1.6e-68	229.7	0.1	8	271	51	304	46	332	0.91	Serine/threonine-protein kinase Nek9 (DB12010)
drugbank_target|P10398	-	606	sp|Q8IHZ9|KC1_PLAF	-	323	9.3e-69	230.4	0.0	1	1	9.2e-70	1.3e-68	229.9	0.0	8	279	309	573	306	594	0.89	Serine/threonine-protein kinase A-Raf (DB00171)
drugbank_target|Q00537	-	523	sp|Q8IHZ9|KC1_PLAF	-	323	1.3e-68	230.0	0.1	1	3	8.8	1.3e+02	-0.0	0.0	243	274	115	146	92	153	0.82	Cyclin-dependent kinase 17 (DB12010)
drugbank_target|Q00537	-	523	sp|Q8IHZ9|KC1_PLAF	-	323	1.3e-68	230.0	0.1	2	3	4.6e-68	6.7e-67	224.3	0.0	7	245	190	417	186	426	0.90	Cyclin-dependent kinase 17 (DB12010)
drugbank_target|Q00537	-	523	sp|Q8IHZ9|KC1_PLAF	-	323	1.3e-68	230.0	0.1	3	3	1.7	25	2.3	0.0	235	269	433	467	410	477	0.67	Cyclin-dependent kinase 17 (DB12010)
drugbank_target|P29376	-	864	sp|Q8IHZ9|KC1_PLAF	-	323	2.1e-68	229.3	0.0	1	1	2e-69	3e-68	228.8	0.0	8	284	509	788	504	799	0.89	Leukocyte tyrosine kinase receptor (DB12010)
drugbank_target|Q9UKI8	-	766	sp|Q8IHZ9|KC1_PLAF	-	323	4.3e-68	228.2	0.1	1	1	3e-69	4.3e-68	228.2	0.1	4	271	451	730	449	749	0.87	Serine/threonine-protein kinase tousled-like 1 (DB12010)
drugbank_target|P50613	-	346	sp|Q8IHZ9|KC1_PLAF	-	323	1.2e-67	226.8	0.0	1	1	1.3e-68	1.9e-67	226.2	0.0	6	244	9	241	5	248	0.91	Cyclin-dependent kinase 7 (DB02482; DB03496; DB05969; DB06195)
drugbank_target|Q8N5S9	-	505	sp|Q8IHZ9|KC1_PLAF	-	323	1.3e-67	226.7	0.0	1	1	1.3e-68	1.9e-67	226.1	0.0	7	270	126	404	121	439	0.86	Calcium/calmodulin-dependent protein kinase kinase 1 (DB12010)
drugbank_target|Q9Y2H1	-	464	sp|Q8IHZ9|KC1_PLAF	-	323	1.4e-67	226.6	4.0	1	1	9.5e-69	1.4e-67	226.6	4.0	7	256	88	362	84	385	0.89	Serine/threonine-protein kinase 38-like (DB12010)
drugbank_target|Q00534	-	326	sp|Q8IHZ9|KC1_PLAF	-	323	1.9e-67	226.1	0.0	1	1	5e-67	7.3e-66	220.9	0.0	4	237	8	240	6	322	0.84	Cyclin-dependent kinase 6 (DB03496; DB07379; DB07795; DB09073; DB11730; DB12001)
drugbank_target|Q6DT37	-	1551	sp|Q8IHZ9|KC1_PLAF	-	323	2.9e-67	225.5	0.0	1	1	2e-68	2.9e-67	225.5	0.0	6	260	68	320	63	336	0.92	Serine/threonine-protein kinase MRCK gamma (DB12010)
drugbank_target|Q9Y2H9	-	1570	sp|Q8IHZ9|KC1_PLAF	-	323	3.3e-67	225.3	0.0	1	1	4.9e-68	7.1e-67	224.3	0.0	6	265	371	634	368	683	0.90	Microtubule-associated serine/threonine-protein kinase 1 (DB12010)
drugbank_target|Q13546	-	671	sp|Q8IHZ9|KC1_PLAF	-	323	3.3e-67	225.3	0.7	1	1	3.9e-68	5.7e-67	224.6	0.7	8	300	16	311	10	327	0.84	Receptor-interacting serine/threonine-protein kinase 1 (DB12010)
drugbank_target|O95382	-	1288	sp|Q8IHZ9|KC1_PLAF	-	323	3.4e-67	225.3	0.0	1	1	4e-68	5.7e-67	224.5	0.0	14	269	653	900	642	914	0.92	Mitogen-activated protein kinase kinase kinase 6 (DB12010)
drugbank_target|O95835	-	1130	sp|Q8IHZ9|KC1_PLAF	-	323	4.6e-67	224.9	0.8	1	2	4.4e-45	6.4e-44	148.8	0.1	8	163	704	860	698	871	0.92	Serine/threonine-protein kinase LATS1 (DB12010)
drugbank_target|O95835	-	1130	sp|Q8IHZ9|KC1_PLAF	-	323	4.6e-67	224.9	0.8	2	2	3.8e-22	5.5e-21	73.5	0.0	167	263	904	995	894	1032	0.84	Serine/threonine-protein kinase LATS1 (DB12010)
drugbank_target|Q15208	-	465	sp|Q8IHZ9|KC1_PLAF	-	323	5.5e-67	224.6	4.7	1	1	3.8e-68	5.5e-67	224.6	4.7	7	256	87	361	83	390	0.89	Serine/threonine-protein kinase 38 (DB12010)
drugbank_target|O14578	-	2027	sp|Q8IHZ9|KC1_PLAF	-	323	6.3e-67	224.4	0.0	1	2	4.4e-68	6.3e-67	224.4	0.0	6	267	94	352	90	357	0.91	Citron Rho-interacting kinase (DB12010)
drugbank_target|O14578	-	2027	sp|Q8IHZ9|KC1_PLAF	-	323	6.3e-67	224.4	0.0	2	2	5.1	73	0.7	4.3	258	311	630	683	624	693	0.84	Citron Rho-interacting kinase (DB12010)
drugbank_target|P35626	-	688	sp|Q8IHZ9|KC1_PLAF	-	323	2.8e-66	222.3	0.7	1	1	4.3e-67	6.2e-66	221.1	0.1	6	264	188	437	184	441	0.90	Beta-adrenergic receptor kinase 2 (DB00171)
drugbank_target|Q9BUB5	-	465	sp|Q8IHZ9|KC1_PLAF	-	323	4.7e-66	221.5	0.3	1	2	2.2e-27	3.2e-26	90.7	0.5	5	123	44	165	41	172	0.90	MAP kinase-interacting serine/threonine-protein kinase 1 (DB12010)
drugbank_target|Q9BUB5	-	465	sp|Q8IHZ9|KC1_PLAF	-	323	4.7e-66	221.5	0.3	2	2	7.9e-39	1.1e-37	128.3	0.0	122	275	205	371	197	423	0.80	MAP kinase-interacting serine/threonine-protein kinase 1 (DB12010)
drugbank_target|P53671	-	638	sp|Q8IHZ9|KC1_PLAF	-	323	4.9e-66	221.5	0.0	1	1	7.5e-67	1.1e-65	220.3	0.0	12	276	334	604	329	609	0.91	LIM domain kinase 2 (DB12010)
drugbank_target|Q00536	-	496	sp|Q8IHZ9|KC1_PLAF	-	323	5.5e-66	221.3	0.0	1	1	8.6e-67	1.3e-65	220.2	0.0	7	243	163	388	159	401	0.89	Cyclin-dependent kinase 16 (DB07766; DB12010)
drugbank_target|Q59H18	-	835	sp|Q8IHZ9|KC1_PLAF	-	323	5.6e-66	221.3	0.0	1	1	6.5e-67	9.4e-66	220.6	0.0	8	278	462	724	458	738	0.90	Serine/threonine-protein kinase TNNI3K (DB12010)
drugbank_target|P50750	-	372	sp|Q8IHZ9|KC1_PLAF	-	323	6.4e-66	221.1	0.0	1	2	2e-66	2.9e-65	218.9	0.0	7	252	17	265	14	285	0.86	Cyclin-dependent kinase 9 (DB03496; DB06195)
drugbank_target|P50750	-	372	sp|Q8IHZ9|KC1_PLAF	-	323	6.4e-66	221.1	0.0	2	2	1.8	25	2.3	0.0	213	267	253	307	250	356	0.81	Cyclin-dependent kinase 9 (DB03496; DB06195)
drugbank_target|Q9NWZ3	-	460	sp|Q8IHZ9|KC1_PLAF	-	323	1.7e-65	219.7	0.1	1	1	2.1e-66	3.1e-65	218.9	0.1	13	277	190	458	187	460	0.86	Interleukin-1 receptor-associated kinase 4 (DB08590; DB12010)
drugbank_target|Q09013	-	629	sp|Q8IHZ9|KC1_PLAF	-	323	1.8e-65	219.6	0.2	1	1	3e-66	4.3e-65	218.4	0.0	6	256	68	318	63	325	0.93	Myotonin-protein kinase (DB01946)
drugbank_target|Q9BQI3	-	630	sp|Q8IHZ9|KC1_PLAF	-	323	2e-65	219.5	3.0	1	2	4.2e-16	6.1e-15	53.6	0.5	4	76	162	237	159	241	0.84	Eukaryotic translation initiation factor 2-alpha kinase 1 (DB12010)
drugbank_target|Q9BQI3	-	630	sp|Q8IHZ9|KC1_PLAF	-	323	2e-65	219.5	3.0	2	2	2.5e-50	3.6e-49	166.1	0.1	77	319	379	625	348	628	0.88	Eukaryotic translation initiation factor 2-alpha kinase 1 (DB12010)
drugbank_target|Q13163	-	448	sp|Q8IHZ9|KC1_PLAF	-	323	4.6e-65	218.3	0.0	1	1	4.1e-66	6e-65	217.9	0.0	6	280	163	421	159	446	0.88	Dual specificity mitogen-activated protein kinase kinase 5 (DB12010)
drugbank_target|Q8IW41	-	473	sp|Q8IHZ9|KC1_PLAF	-	323	6.4e-65	217.8	0.4	1	1	1.4e-65	2.1e-64	216.1	0.1	9	285	22	311	13	348	0.83	MAP kinase-activated protein kinase 5 (DB12010)
drugbank_target|P25098	-	689	sp|Q8IHZ9|KC1_PLAF	-	323	8.9e-65	217.4	0.1	1	1	1.3e-65	1.9e-64	216.3	0.1	6	264	188	437	184	449	0.91	Beta-adrenergic receptor kinase 1 (DB00171)
drugbank_target|P9WI81	-	626	sp|Q8IHZ9|KC1_PLAF	-	323	2.1e-64	216.1	0.0	1	1	2e-65	3e-64	215.6	0.0	5	266	7	265	4	284	0.91	Serine/threonine-protein kinase PknB (DB02930; DB03909; DB12010)
drugbank_target|Q96Q40	-	435	sp|Q8IHZ9|KC1_PLAF	-	323	7e-64	214.4	0.0	1	1	1.1e-64	1.7e-63	213.2	0.0	6	245	100	329	96	333	0.92	Cyclin-dependent kinase 15 (DB00171; DB06486; DB12010)
drugbank_target|Q02750	-	393	sp|Q8IHZ9|KC1_PLAF	-	323	7.4e-64	214.3	0.0	1	2	3e-60	4.3e-59	198.7	0.0	6	226	65	276	62	306	0.90	Dual specificity mitogen-activated protein kinase kinase 1 (DB02152; DB03115; DB05239; DB06616; DB06892; DB07046; DB07101; DB08130; DB08208; DB08911; DB11689)
drugbank_target|Q02750	-	393	sp|Q8IHZ9|KC1_PLAF	-	323	7.4e-64	214.3	0.0	2	2	0.00056	0.0081	13.7	0.0	233	282	318	365	299	383	0.70	Dual specificity mitogen-activated protein kinase kinase 1 (DB02152; DB03115; DB05239; DB06616; DB06892; DB07046; DB07101; DB08130; DB08208; DB08911; DB11689)
drugbank_target|P33981	-	857	sp|Q8IHZ9|KC1_PLAF	-	323	9.7e-64	213.9	0.8	1	1	1.3e-64	1.8e-63	213.0	0.8	8	271	524	787	519	814	0.87	Dual specificity protein kinase TTK (DB01782; DB12010; DB15498)
drugbank_target|P11802	-	303	sp|Q8IHZ9|KC1_PLAF	-	323	9.8e-64	213.9	0.0	1	2	3.1e-63	4.5e-62	208.5	0.0	6	241	3	238	1	245	0.88	Cyclin-dependent kinase 4 (DB02733; DB03496; DB09073; DB11730; DB12001; DB12010)
drugbank_target|P11802	-	303	sp|Q8IHZ9|KC1_PLAF	-	323	9.8e-64	213.9	0.0	2	2	0.71	10	3.6	0.0	236	267	256	287	250	300	0.80	Cyclin-dependent kinase 4 (DB02733; DB03496; DB09073; DB11730; DB12001; DB12010)
drugbank_target|Q15569	-	626	sp|Q8IHZ9|KC1_PLAF	-	323	1.8e-63	213.0	0.0	1	1	1.8e-64	2.6e-63	212.5	0.0	7	279	55	317	50	335	0.90	Dual specificity testis-specific protein kinase 1 (DB12010)
drugbank_target|P36507	-	400	sp|Q8IHZ9|KC1_PLAF	-	323	6.4e-63	211.2	0.0	1	2	8.2e-60	1.2e-58	197.2	0.0	6	219	69	273	66	295	0.93	Dual specificity mitogen-activated protein kinase kinase 2 (DB06616; DB08911; DB11689; DB11967; DB12010)
drugbank_target|P36507	-	400	sp|Q8IHZ9|KC1_PLAF	-	323	6.4e-63	211.2	0.0	2	2	0.002	0.029	11.9	0.0	230	287	323	378	307	392	0.70	Dual specificity mitogen-activated protein kinase kinase 2 (DB06616; DB08911; DB11689; DB11967; DB12010)
drugbank_target|Q52WX2	-	424	sp|Q8IHZ9|KC1_PLAF	-	323	3.8e-62	208.7	0.0	1	1	3.3e-63	4.8e-62	208.4	0.0	4	280	48	320	45	330	0.89	Serine/threonine-protein kinase SBK1 (DB12010)
drugbank_target|P19525	-	551	sp|Q8IHZ9|KC1_PLAF	-	323	5.2e-62	208.3	0.9	1	1	9.9e-63	1.4e-61	206.8	0.9	2	277	260	540	259	550	0.89	Interferon-induced, double-stranded RNA-activated protein kinase (DB12010)
drugbank_target|P46734	-	347	sp|Q8IHZ9|KC1_PLAF	-	323	5.4e-62	208.2	0.0	1	1	4.9e-63	7.1e-62	207.8	0.0	7	278	62	325	57	343	0.87	Dual specificity mitogen-activated protein kinase kinase 3 (DB12010)
drugbank_target|P21860	-	1342	sp|Q8IHZ9|KC1_PLAF	-	323	6e-62	208.1	0.0	1	2	7.9	1.1e+02	0.1	0.0	201	249	653	701	650	708	0.75	Receptor tyrosine-protein kinase erbB-3 (DB11652)
drugbank_target|P21860	-	1342	sp|Q8IHZ9|KC1_PLAF	-	323	6e-62	208.1	0.0	2	2	2.2e-62	3.3e-61	205.6	0.0	7	278	707	970	701	977	0.90	Receptor tyrosine-protein kinase erbB-3 (DB11652)
drugbank_target|Q16659	-	721	sp|Q8IHZ9|KC1_PLAF	-	323	1e-61	207.3	0.1	1	1	1.5e-61	2.2e-60	202.9	0.0	5	232	16	248	13	318	0.84	Mitogen-activated protein kinase 6 (DB00945)
drugbank_target|Q16659	-	721	sp|Q8IHZ9|KC1_PLAF	-	323	1e-61	207.3	0.1	1	1	1.5e-61	2.2e-60	202.9	0.0	5	232	16	248	13	318	0.84	Mitogen-activated protein kinase 6 (DB01017)
drugbank_target|O00238	-	502	sp|Q8IHZ9|KC1_PLAF	-	323	1.1e-61	207.2	0.1	1	1	9.4e-63	1.4e-61	206.9	0.1	3	281	198	499	196	502	0.89	Bone morphogenetic protein receptor type-1B (DB12010)
drugbank_target|P52564	-	334	sp|Q8IHZ9|KC1_PLAF	-	323	1.6e-61	206.6	0.0	1	1	1.4e-62	2.1e-61	206.3	0.0	7	272	51	311	46	328	0.89	Dual specificity mitogen-activated protein kinase kinase 6 (DB12010)
drugbank_target|O14976	-	1311	sp|Q8IHZ9|KC1_PLAF	-	323	2.5e-61	206.0	0.0	1	1	3.1e-62	4.5e-61	205.2	0.0	9	284	40	324	36	336	0.84	Cyclin-G-associated kinase (DB12010)
drugbank_target|P36897	-	503	sp|Q8IHZ9|KC1_PLAF	-	323	2.9e-61	205.8	0.1	1	1	2.6e-62	3.7e-61	205.4	0.1	3	282	199	501	197	503	0.89	TGF-beta receptor type-1 (DB03921; DB04434; DB04480; DB07152; DB07267; DB08450; DB12010)
drugbank_target|P31152	-	587	sp|Q8IHZ9|KC1_PLAF	-	323	3.5e-61	205.5	0.1	1	1	2.3e-61	3.3e-60	202.3	0.1	7	264	18	276	13	322	0.85	Mitogen-activated protein kinase 4 (DB12010)
drugbank_target|P31152	-	587	sp|Q8IHZ9|KC1_PLAF	-	323	3.5e-61	205.5	0.1	1	1	2.3e-61	3.3e-60	202.3	0.1	7	264	18	276	13	322	0.85	Mitogen-activated protein kinase 4 (DB00945)
drugbank_target|P31152	-	587	sp|Q8IHZ9|KC1_PLAF	-	323	3.5e-61	205.5	0.1	1	1	2.3e-61	3.3e-60	202.3	0.1	7	264	18	276	13	322	0.85	Mitogen-activated protein kinase 4 (DB01017)
drugbank_target|Q8NFD2	-	765	sp|Q8IHZ9|KC1_PLAF	-	323	3.5e-61	205.5	0.0	1	1	3.6e-62	5.1e-61	205.0	0.0	14	271	27	283	17	335	0.84	Ankyrin repeat and protein kinase domain-containing protein 1 (DB12010)
drugbank_target|P49840	-	483	sp|Q8IHZ9|KC1_PLAF	-	323	1.1e-60	203.9	0.0	1	1	1e-61	1.5e-60	203.5	0.0	8	269	118	377	112	395	0.85	Glycogen synthase kinase-3 alpha (DB12010)
drugbank_target|P36894	-	532	sp|Q8IHZ9|KC1_PLAF	-	323	1.3e-60	203.7	0.1	1	1	1.2e-61	1.7e-60	203.3	0.1	3	281	228	529	226	532	0.89	Bone morphogenetic protein receptor type-1A (DB11639)
drugbank_target|Q13627	-	763	sp|Q8IHZ9|KC1_PLAF	-	323	1.7e-60	203.3	0.1	1	2	1.1e-59	1.6e-58	196.8	0.2	5	237	155	382	152	409	0.86	Dual specificity tyrosine-phosphorylation-regulated kinase 1A (DB07608; DB12010)
drugbank_target|Q13627	-	763	sp|Q8IHZ9|KC1_PLAF	-	323	1.7e-60	203.3	0.1	2	2	0.55	8	3.9	0.0	247	288	451	493	444	527	0.67	Dual specificity tyrosine-phosphorylation-regulated kinase 1A (DB07608; DB12010)
drugbank_target|O15111	-	745	sp|Q8IHZ9|KC1_PLAF	-	323	3.8e-60	202.1	0.2	1	1	7.6e-61	1.1e-59	200.6	0.2	9	247	15	251	10	301	0.81	Inhibitor of nuclear factor kappa-B kinase subunit alpha (DB00233; DB00244; DB00795; DB06151)
drugbank_target|Q9H2X6	-	1198	sp|Q8IHZ9|KC1_PLAF	-	323	5e-60	201.8	0.1	1	2	1.2e-59	1.7e-58	196.7	0.0	4	233	194	418	191	433	0.92	Homeodomain-interacting protein kinase 2 (DB12010)
drugbank_target|Q9H2X6	-	1198	sp|Q8IHZ9|KC1_PLAF	-	323	5e-60	201.8	0.1	2	2	1.3	19	2.7	0.1	245	291	497	540	466	567	0.64	Homeodomain-interacting protein kinase 2 (DB12010)
drugbank_target|O14920	-	756	sp|Q8IHZ9|KC1_PLAF	-	323	1.3e-59	200.4	0.0	1	1	8.9e-61	1.3e-59	200.4	0.0	8	218	14	228	7	279	0.88	Inhibitor of nuclear factor kappa-B kinase subunit beta (DB00244; DB00795; DB00945; DB00995; DB01169; DB05183; DB06151; DB06521; DB12010)
drugbank_target|P57078	-	832	sp|Q8IHZ9|KC1_PLAF	-	323	2e-59	199.7	0.0	1	1	2.2e-60	3.2e-59	199.1	0.0	8	267	21	277	17	289	0.89	Receptor-interacting serine/threonine-protein kinase 4 (DB12010)
drugbank_target|P49841	-	420	sp|Q8IHZ9|KC1_PLAF	-	323	2.5e-59	199.5	0.0	1	1	2.5e-60	3.6e-59	198.9	0.0	8	263	55	308	51	335	0.85	Glycogen synthase kinase-3 beta (DB01356; DB01772; DB01793; DB01950; DB02010; DB02052; DB03444; DB04014; DB04395; DB07014; DB07058; DB07149; DB07584; DB07585; DB07676; DB07812; DB07859; DB07947; DB08073; DB12010; DB12129; DB14507; DB14508; DB14509)
drugbank_target|Q9Y463	-	629	sp|Q8IHZ9|KC1_PLAF	-	323	2.8e-59	199.3	0.0	1	1	6.5e-60	9.4e-59	197.5	0.0	5	238	107	335	104	361	0.87	Dual specificity tyrosine-phosphorylation-regulated kinase 1B (DB12010)
drugbank_target|Q13470	-	666	sp|Q8IHZ9|KC1_PLAF	-	323	3.3e-59	199.0	0.0	1	1	3.3e-60	4.7e-59	198.5	0.0	12	282	119	386	114	414	0.88	Non-receptor tyrosine-protein kinase TNK1 (DB12010)
drugbank_target|Q04771	-	509	sp|Q8IHZ9|KC1_PLAF	-	323	4.8e-59	198.5	0.0	1	1	4.5e-60	6.5e-59	198.1	0.0	3	276	202	498	200	507	0.87	Activin receptor type-1 (DB00171; DB08597; DB12010)
drugbank_target|Q9H422	-	1215	sp|Q8IHZ9|KC1_PLAF	-	323	1.9e-58	196.5	0.0	1	1	3.1e-59	4.5e-58	195.3	0.0	4	233	192	416	189	432	0.92	Homeodomain-interacting protein kinase 3 (DB12010)
drugbank_target|P49759	-	484	sp|Q8IHZ9|KC1_PLAF	-	323	3.7e-58	195.6	1.0	1	2	1.8e-56	2.6e-55	186.3	0.1	6	229	158	395	155	413	0.87	Dual specificity protein kinase CLK1 (DB04367; DB06376; DB08691; DB12010)
drugbank_target|P49759	-	484	sp|Q8IHZ9|KC1_PLAF	-	323	3.7e-58	195.6	1.0	2	2	0.038	0.55	7.7	0.1	245	278	447	477	421	483	0.83	Dual specificity protein kinase CLK1 (DB04367; DB06376; DB08691; DB12010)
drugbank_target|P11309	-	404	sp|Q8IHZ9|KC1_PLAF	-	323	5.5e-58	195.0	0.0	1	1	5.2e-59	7.6e-58	194.6	0.0	5	271	125	377	122	394	0.91	Serine/threonine-protein kinase pim-1 (DB01754; DB02010; DB02656; DB03366; DB03650; DB03777; DB04216; DB04395; DB04522; DB04530; DB04715; DB07151; DB07242; DB07524; DB08022; DB08166; DB08230; DB08705; DB08707; DB08708; DB08709; DB12010)
drugbank_target|O75716	-	305	sp|Q8IHZ9|KC1_PLAF	-	323	1.5e-57	193.6	0.0	1	1	1.3e-58	1.9e-57	193.2	0.0	6	276	17	293	14	302	0.87	Serine/threonine-protein kinase 16 (DB12010)
drugbank_target|Q8TDR2	-	534	sp|Q8IHZ9|KC1_PLAF	-	323	3e-57	192.6	0.0	1	2	1.1e-13	1.6e-12	45.6	0.0	6	109	199	305	196	307	0.87	Serine/threonine-protein kinase 35 (DB12010)
drugbank_target|Q8TDR2	-	534	sp|Q8IHZ9|KC1_PLAF	-	323	3e-57	192.6	0.0	2	2	2.6e-44	3.8e-43	146.3	0.0	67	276	300	530	295	533	0.84	Serine/threonine-protein kinase 35 (DB12010)
drugbank_target|O15197	-	1021	sp|Q8IHZ9|KC1_PLAF	-	323	5.3e-57	191.8	0.0	1	1	6e-58	8.7e-57	191.1	0.0	9	280	670	922	664	927	0.91	Ephrin type-B receptor 6 (DB12010)
drugbank_target|Q86V86	-	326	sp|Q8IHZ9|KC1_PLAF	-	323	5.7e-57	191.7	0.0	1	1	4.9e-58	7.1e-57	191.4	0.0	4	270	35	288	32	296	0.91	Serine/threonine-protein kinase pim-3 (DB12010)
drugbank_target|P68400	-	391	sp|Q8IHZ9|KC1_PLAF	-	323	1.7e-56	190.2	1.7	1	2	6.6e-57	9.5e-56	187.7	0.8	5	263	35	280	31	293	0.88	Casein kinase II subunit alpha (DB00171; DB01765; DB02170; DB02709; DB03035; DB03127; DB03924; DB04216; DB04395; DB04462; DB04719; DB04720; DB04721; DB07715; DB07802; DB08338; DB08340; DB08345; DB08353; DB08354; DB08360; DB08362; DB08473; DB08660; DB08846; DB12010)
drugbank_target|P68400	-	391	sp|Q8IHZ9|KC1_PLAF	-	323	1.7e-56	190.2	1.7	2	2	3.4	50	1.3	0.0	242	268	291	317	282	334	0.83	Casein kinase II subunit alpha (DB00171; DB01765; DB02170; DB02709; DB03035; DB03127; DB03924; DB04216; DB04395; DB04462; DB04719; DB04720; DB04721; DB07715; DB07802; DB08338; DB08340; DB08345; DB08353; DB08354; DB08360; DB08362; DB08473; DB08660; DB08846; DB12010)
drugbank_target|P36896	-	505	sp|Q8IHZ9|KC1_PLAF	-	323	1.7e-56	190.1	0.0	1	1	1.6e-57	2.3e-56	189.7	0.0	3	280	201	501	199	504	0.88	Activin receptor type-1B (DB00171; DB12010)
drugbank_target|Q9HAZ1	-	481	sp|Q8IHZ9|KC1_PLAF	-	323	3.5e-56	189.1	3.6	1	1	1.7e-54	2.5e-53	179.7	3.6	6	230	156	394	153	481	0.86	Dual specificity protein kinase CLK4 (DB12010)
drugbank_target|P19784	-	350	sp|Q8IHZ9|KC1_PLAF	-	323	3.7e-56	189.0	2.7	1	2	5.7e-56	8.2e-55	184.6	1.2	6	233	37	251	34	284	0.87	Casein kinase II subunit alpha' (DB07546; DB12010)
drugbank_target|P19784	-	350	sp|Q8IHZ9|KC1_PLAF	-	323	3.7e-56	189.0	2.7	2	2	0.44	6.4	4.2	0.0	242	268	292	318	267	333	0.81	Casein kinase II subunit alpha' (DB07546; DB12010)
drugbank_target|Q8IIR9	-	335	sp|Q8IHZ9|KC1_PLAF	-	323	4.6e-56	188.7	0.5	1	1	8.1e-57	1.2e-55	187.4	0.4	6	236	40	257	35	278	0.88	Casein kinase 2, alpha subunit (DB11638)
drugbank_target|P37023	-	503	sp|Q8IHZ9|KC1_PLAF	-	323	4.6e-56	188.7	0.0	1	1	4.1e-57	6e-56	188.3	0.0	3	280	196	496	194	502	0.86	Serine/threonine-protein kinase receptor R3 (DB00171)
drugbank_target|O43353	-	540	sp|Q8IHZ9|KC1_PLAF	-	323	2.7e-55	186.2	0.0	1	1	3e-56	4.3e-55	185.5	0.0	11	280	20	297	15	334	0.82	Receptor-interacting serine/threonine-protein kinase 2 (DB12010)
drugbank_target|P49336	-	464	sp|Q8IHZ9|KC1_PLAF	-	323	7.3e-55	184.8	0.4	1	2	1.4e-54	2e-53	180.0	0.0	12	244	24	270	13	290	0.81	Cyclin-dependent kinase 8 (DB03496)
drugbank_target|P49336	-	464	sp|Q8IHZ9|KC1_PLAF	-	323	7.3e-55	184.8	0.4	2	2	0.9	13	3.2	0.2	240	307	303	373	276	387	0.54	Cyclin-dependent kinase 8 (DB03496)
drugbank_target|Q2M2I8	-	961	sp|Q8IHZ9|KC1_PLAF	-	323	8e-55	184.6	0.0	1	1	5.5e-56	8e-55	184.6	0.0	7	278	44	316	41	355	0.84	AP2-associated protein kinase 1 (DB12010)
drugbank_target|Q99640	-	499	sp|Q8IHZ9|KC1_PLAF	-	323	8.7e-55	184.5	0.0	1	1	8.5e-56	1.2e-54	184.0	0.0	5	270	106	354	103	360	0.91	Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase (DB12010)
drugbank_target|Q14164	-	716	sp|Q8IHZ9|KC1_PLAF	-	323	4.6e-54	182.1	0.6	1	1	7.9e-55	1.1e-53	180.9	0.0	5	232	5	241	1	249	0.86	Inhibitor of nuclear factor kappa-B kinase subunit epsilon (DB12010)
drugbank_target|Q5S007	-	2527	sp|Q8IHZ9|KC1_PLAF	-	323	6e-54	181.8	0.0	1	1	8.4e-55	1.2e-53	180.8	0.0	14	275	1884	2134	1877	2164	0.90	Leucine-rich repeat serine/threonine-protein kinase 2 (DB12010)
drugbank_target|P49760	-	499	sp|Q8IHZ9|KC1_PLAF	-	323	8.1e-54	181.3	0.8	1	2	7e-53	1e-51	174.5	0.2	6	229	160	397	157	416	0.87	Dual specificity protein kinase CLK2 (DB12010)
drugbank_target|P49760	-	499	sp|Q8IHZ9|KC1_PLAF	-	323	8.1e-54	181.3	0.8	2	2	0.24	3.5	5.1	0.0	241	279	446	480	412	493	0.71	Dual specificity protein kinase CLK2 (DB12010)
drugbank_target|Q9UHD2	-	729	sp|Q8IHZ9|KC1_PLAF	-	323	1.4e-53	180.5	0.0	1	1	9.9e-55	1.4e-53	180.5	0.0	3	234	3	243	1	253	0.87	Serine/threonine-protein kinase TBK1 (DB12010)
drugbank_target|Q13523	-	1007	sp|Q8IHZ9|KC1_PLAF	-	323	9.9e-53	177.8	0.4	1	2	6.8e-54	9.9e-53	177.8	0.4	6	239	684	912	680	923	0.91	Serine/threonine-protein kinase PRP4 homolog (DB12010)
drugbank_target|Q13523	-	1007	sp|Q8IHZ9|KC1_PLAF	-	323	9.9e-53	177.8	0.4	2	2	0.046	0.66	7.5	0.1	236	281	966	1006	946	1007	0.77	Serine/threonine-protein kinase PRP4 homolog (DB12010)
drugbank_target|Q9NSY1	-	1161	sp|Q8IHZ9|KC1_PLAF	-	323	1.3e-52	177.4	7.8	1	1	1.9e-53	2.7e-52	176.3	0.0	7	271	49	313	45	357	0.84	BMP-2-inducible protein kinase (DB12010)
drugbank_target|P37173	-	567	sp|Q8IHZ9|KC1_PLAF	-	323	2.1e-52	176.7	0.0	1	1	2.4e-53	3.5e-52	176.0	0.0	10	280	245	545	243	565	0.86	TGF-beta receptor type-2 (DB10770; DB10772; DB12010)
drugbank_target|P49761	-	638	sp|Q8IHZ9|KC1_PLAF	-	323	3.9e-52	175.8	1.8	1	2	1.8e-51	2.6e-50	169.8	0.5	5	229	300	538	297	558	0.85	Dual specificity protein kinase CLK3 (DB07664; DB08691; DB12010)
drugbank_target|P49761	-	638	sp|Q8IHZ9|KC1_PLAF	-	323	3.9e-52	175.8	1.8	2	2	0.22	3.2	5.2	0.0	238	274	585	616	553	634	0.69	Dual specificity protein kinase CLK3 (DB07664; DB08691; DB12010)
drugbank_target|P20594	-	1047	sp|Q8IHZ9|KC1_PLAF	-	323	6.2e-52	175.1	0.0	1	1	6.9e-53	1e-51	174.5	0.0	31	308	544	822	534	836	0.84	Atrial natriuretic peptide receptor 2 (DB01613; DB04899)
drugbank_target|P27037	-	513	sp|Q8IHZ9|KC1_PLAF	-	323	5.2e-51	172.1	0.0	1	1	4.9e-52	7e-51	171.7	0.0	10	286	193	494	189	510	0.84	Activin receptor type-2A (DB12118)
drugbank_target|P51617	-	712	sp|Q8IHZ9|KC1_PLAF	-	323	1e-50	171.2	0.0	1	2	8.9e-49	1.3e-47	161.0	0.0	6	230	209	439	205	458	0.87	Interleukin-1 receptor-associated kinase 1 (DB12010)
drugbank_target|P51617	-	712	sp|Q8IHZ9|KC1_PLAF	-	323	1e-50	171.2	0.0	2	2	0.027	0.4	8.2	0.0	226	277	471	522	461	537	0.91	Interleukin-1 receptor-associated kinase 1 (DB12010)
drugbank_target|Q9Y616	-	596	sp|Q8IHZ9|KC1_PLAF	-	323	6.3e-50	168.5	0.0	1	1	6.5e-51	9.5e-50	168.0	0.0	6	280	162	450	158	463	0.90	Interleukin-1 receptor-associated kinase 3 (DB12010)
drugbank_target|P16066	-	1061	sp|Q8IHZ9|KC1_PLAF	-	323	6.5e-50	168.5	0.0	1	1	6.5e-51	9.5e-50	168.0	0.0	22	314	551	843	546	851	0.84	Atrial natriuretic peptide receptor 1 (DB00325; DB00727; DB00883; DB01612; DB01613; DB04899; DB05034)
drugbank_target|P30291	-	646	sp|Q8IHZ9|KC1_PLAF	-	323	1e-49	167.8	0.0	1	1	9.8e-51	1.4e-49	167.4	0.0	1	315	291	609	291	617	0.87	Wee1-like protein kinase (DB04608; DB07006; DB07226; DB07257; DB07265; DB08365; DB11740; DB12010)
drugbank_target|O75460	-	977	sp|Q8IHZ9|KC1_PLAF	-	323	2.4e-47	160.1	0.0	1	1	3.6e-48	5.2e-47	159.0	0.0	11	280	573	834	568	867	0.83	Serine/threonine-protein kinase/endoribonuclease IRE1 (DB07382; DB12010)
drugbank_target|Q13873	-	1038	sp|Q8IHZ9|KC1_PLAF	-	323	9.2e-47	158.2	0.0	1	1	1.3e-47	1.9e-46	157.2	0.0	7	289	201	517	199	540	0.78	Bone morphogenetic protein receptor type-2 (DB11639; DB12010)
drugbank_target|P25092	-	1073	sp|Q8IHZ9|KC1_PLAF	-	323	9.2e-43	145.0	1.7	1	1	1.3e-43	1.9e-42	144.0	1.7	28	306	506	780	500	797	0.81	Heat-stable enterotoxin receptor (DB08890)
drugbank_target|P78362	-	688	sp|Q8IHZ9|KC1_PLAF	-	323	6.2e-42	142.3	10.6	1	2	5.9e-31	8.5e-30	102.4	0.2	6	140	78	226	74	230	0.88	SRSF protein kinase 2 (DB00173; DB02733; DB04395)
drugbank_target|P78362	-	688	sp|Q8IHZ9|KC1_PLAF	-	323	6.2e-42	142.3	10.6	2	2	6.5e-14	9.4e-13	46.4	0.0	142	236	523	610	511	625	0.80	SRSF protein kinase 2 (DB00173; DB02733; DB04395)
drugbank_target|P0C264	-	359	sp|Q8IHZ9|KC1_PLAF	-	323	1e-39	135.0	0.0	1	1	8.7e-41	1.3e-39	134.7	0.0	5	272	39	303	36	327	0.88	Uncharacterized serine/threonine-protein kinase SBK3 (DB12010)
drugbank_target|Q16671	-	573	sp|Q8IHZ9|KC1_PLAF	-	323	2.2e-39	133.9	0.0	1	1	2.1e-40	3.1e-39	133.4	0.0	9	281	203	513	195	519	0.80	Anti-Muellerian hormone type-2 receptor (DB00171)
drugbank_target|P9WI73	-	750	sp|Q8IHZ9|KC1_PLAF	-	323	9.4e-35	118.7	0.0	1	1	1.1e-35	1.6e-34	117.9	0.0	5	208	147	340	145	403	0.82	Serine/threonine-protein kinase PknG (DB07398)
drugbank_target|Q96KG9	-	808	sp|Q8IHZ9|KC1_PLAF	-	323	1.2e-20	72.3	0.0	1	1	1.4e-21	2e-20	71.6	0.0	25	212	33	221	30	298	0.86	N-terminal kinase-like protein (DB05036)
drugbank_target|Q8TF76	-	798	sp|Q8IHZ9|KC1_PLAF	-	323	2e-11	42.0	0.0	1	2	6.3e-05	0.00091	16.9	0.0	7	58	482	541	478	550	0.73	Serine/threonine-protein kinase haspin (DB04604; DB07698; DB07995; DB08004)
drugbank_target|Q8TF76	-	798	sp|Q8IHZ9|KC1_PLAF	-	323	2e-11	42.0	0.0	2	2	1.2e-06	1.7e-05	22.6	0.0	72	140	593	661	584	697	0.80	Serine/threonine-protein kinase haspin (DB04604; DB07698; DB07995; DB08004)
drugbank_target|P16788	-	707	sp|Q8IHZ9|KC1_PLAF	-	323	1.2e-10	39.5	0.0	1	1	1.4e-11	2.1e-10	38.7	0.0	14	161	336	493	332	509	0.82	Serine/threonine protein kinase UL97 (DB06234)
drugbank_target|Q68101	-	707	sp|Q8IHZ9|KC1_PLAF	-	323	1.2e-10	39.5	0.0	1	1	1.4e-11	2.1e-10	38.7	0.0	14	161	336	493	332	509	0.82	Serine/threonine protein kinase UL97 (DB06234)
drugbank_target|Q9BVS4	-	552	sp|Q8IHZ9|KC1_PLAF	-	323	0.023	12.2	0.9	1	1	0.0054	0.078	10.5	0.9	12	150	98	247	96	259	0.70	Serine/threonine-protein kinase RIO2 (DB12010)
drugbank_target|Q96D53	-	544	sp|Q8IHZ9|KC1_PLAF	-	323	0.034	11.7	0.0	1	2	6.4	93	0.4	0.0	20	42	220	241	219	262	0.73	Atypical kinase COQ8B, mitochondrial (DB12010)
drugbank_target|Q96D53	-	544	sp|Q8IHZ9|KC1_PLAF	-	323	0.034	11.7	0.0	2	2	0.031	0.44	8.0	0.0	130	160	369	397	322	408	0.85	Atypical kinase COQ8B, mitochondrial (DB12010)
drugbank_target|Q8RQE9	-	1119	sp|P21421|RPOB_PLA	-	1024	0	1109.1	0.0	1	2	1.6e-263	4.1e-260	864.1	0.0	303	834	371	902	365	910	0.99	DNA-directed RNA polymerase subunit beta (DB04788; DB08226; DB08266)
drugbank_target|Q8RQE9	-	1119	sp|P21421|RPOB_PLA	-	1024	0	1109.1	0.0	2	2	7.1e-76	1.9e-72	242.8	0.0	872	1007	969	1104	962	1117	0.95	DNA-directed RNA polymerase subunit beta (DB04788; DB08226; DB08266)
drugbank_target|P0A8V2	-	1342	sp|P21421|RPOB_PLA	-	1024	0	1014.2	0.0	1	3	1.6e-197	4.1e-194	645.6	0.0	304	748	492	944	477	958	0.98	DNA-directed RNA polymerase subunit beta (DB00615; DB01045; DB01220; DB04934; DB11753)
drugbank_target|P0A8V2	-	1342	sp|P21421|RPOB_PLA	-	1024	0	1014.2	0.0	2	3	2.2e-42	5.7e-39	132.0	0.3	742	828	1037	1123	1026	1152	0.91	DNA-directed RNA polymerase subunit beta (DB00615; DB01045; DB01220; DB04934; DB11753)
drugbank_target|P0A8V2	-	1342	sp|P21421|RPOB_PLA	-	1024	0	1014.2	0.0	3	3	1e-72	2.7e-69	232.4	0.0	874	1003	1209	1338	1205	1340	0.98	DNA-directed RNA polymerase subunit beta (DB00615; DB01045; DB01220; DB04934; DB11753)
drugbank_target|Q7KQM4	-	452	sp|Q7KQM4|PLM1_PLA	-	452	4.8e-247	818.5	14.1	1	1	9.3e-250	5.4e-247	818.4	14.1	1	452	1	452	1	452	1.00	Plasmepsin-1 (DB11638)
drugbank_target|P46925	-	453	sp|Q7KQM4|PLM1_PLA	-	452	9.4e-236	781.3	9.3	1	1	1.8e-238	1.1e-235	781.2	9.3	1	452	1	453	1	453	1.00	Plasmepsin-2 (DB01218; DB02505; DB03063; DB04373; DB04378; DB11638)
drugbank_target|Q8IM16	-	449	sp|Q7KQM4|PLM1_PLA	-	452	1.5e-227	754.3	7.4	1	1	2.8e-230	1.6e-227	754.2	7.4	1	450	1	448	1	449	1.00	Plasmepsin IV (DB11638)
drugbank_target|Q8IM15	-	451	sp|Q7KQM4|PLM1_PLA	-	452	5.9e-222	735.9	13.9	1	1	1.1e-224	6.6e-222	735.7	13.9	1	450	1	450	1	451	0.99	HAP protein (DB11638)
drugbank_target|P00797	-	406	sp|Q7KQM4|PLM1_PLA	-	452	9.8e-130	431.9	0.4	1	1	2.1e-132	1.2e-129	431.6	0.4	118	449	65	406	60	406	0.96	Renin (DB00212; DB00350; DB00722; DB01844; DB02296; DB02803; DB03024; DB03395; DB03736; DB03968; DB04379; DB04387; DB05203; DB06899; DB06967; DB07059; DB07113; DB07174; DB07244; DB08099; DB09026)
drugbank_target|P0DJD9	-	388	sp|Q7KQM4|PLM1_PLA	-	452	2.2e-127	424.1	1.2	1	1	4.5e-130	2.6e-127	423.9	1.2	126	447	63	386	38	388	0.97	Pepsin A-5 (DB00364)
drugbank_target|P07339	-	412	sp|Q7KQM4|PLM1_PLA	-	452	6.3e-126	419.3	0.0	1	1	1.4e-128	7.9e-126	419.0	0.0	131	449	71	410	67	412	0.91	Cathepsin D (DB00071; DB02216; DB03028; DB03096; DB07542; DB08740)
drugbank_target|P0DJ06	-	398	sp|Q7KQM4|PLM1_PLA	-	452	1.3e-99	332.6	10.9	1	1	2.8e-102	1.6e-99	332.3	10.9	128	449	60	387	45	389	0.96	Candidapepsin-2 (DB03090; DB03241; DB03659; DB04387; DB04451)
drugbank_target|P56817	-	501	sp|Q7KQM4|PLM1_PLA	-	452	5e-76	254.8	0.0	1	1	5.7e-78	3.3e-75	252.1	0.0	134	448	70	418	56	421	0.86	Beta-secretase 1 (DB02378; DB06073; DB06930; DB07019; DB07089; DB07110; DB07175; DB07206; DB07245; DB07281; DB07284; DB07303; DB07345; DB07346; DB07415; DB07519; DB07535; DB07573; DB07734; DB07735; DB07736; DB07737; DB07738; DB07874; DB07993; DB07994; DB08749; DB12285)
drugbank_target|P0A8T7	-	1407	sp|Q25802|RPOC2_PL	-	960	1.9e-149	497.8	0.1	1	2	2.9e-96	5.1e-93	311.0	0.0	101	339	704	941	677	979	0.92	DNA-directed RNA polymerase subunit beta' (DB00615; DB11753)
drugbank_target|P0A8T7	-	1407	sp|Q25802|RPOC2_PL	-	960	1.9e-149	497.8	0.1	2	2	4.4e-58	7.8e-55	184.6	0.0	820	955	1229	1364	1224	1367	0.98	DNA-directed RNA polymerase subunit beta' (DB00615; DB11753)
drugbank_target|Q8RQE8	-	1524	sp|Q25802|RPOC2_PL	-	960	5.5e-146	486.3	0.0	1	2	3.5e-92	6.2e-89	297.5	0.0	111	339	1012	1247	928	1254	0.93	DNA-directed RNA polymerase subunit beta' (DB04788; DB08226; DB08266)
drugbank_target|Q8RQE8	-	1524	sp|Q25802|RPOC2_PL	-	960	5.5e-146	486.3	0.0	2	2	1.1e-58	1.8e-55	186.7	0.0	820	954	1344	1478	1338	1484	0.98	DNA-directed RNA polymerase subunit beta' (DB04788; DB08226; DB08266)
drugbank_target|P9WGY7	-	1316	sp|Q25802|RPOC2_PL	-	960	1.1e-141	472.0	0.0	1	2	4.8e-88	8.3e-85	283.8	0.0	117	341	797	1023	777	1026	0.95	DNA-directed RNA polymerase subunit beta' (DB01201)
drugbank_target|P9WGY7	-	1316	sp|Q25802|RPOC2_PL	-	960	1.1e-141	472.0	0.0	2	2	1.6e-58	2.8e-55	186.1	0.0	821	957	1131	1267	1128	1270	0.98	DNA-directed RNA polymerase subunit beta' (DB01201)
drugbank_target|Q14103	-	355	sp|Q8I4V2|RBM22_PL	-	357	1.8e-52	177.2	0.1	1	2	6.5e-15	3.1e-12	44.8	0.0	214	282	89	163	80	165	0.83	Heterogeneous nuclear ribonucleoprotein D0 (DB11638)
drugbank_target|Q14103	-	355	sp|Q8I4V2|RBM22_PL	-	357	1.8e-52	177.2	0.1	2	2	2.4e-41	1.2e-38	131.7	0.1	202	335	162	300	161	313	0.96	Heterogeneous nuclear ribonucleoprotein D0 (DB11638)
drugbank_target|P22626	-	353	sp|Q8I4V2|RBM22_PL	-	357	2.1e-31	107.9	0.1	1	2	9e-15	4.3e-12	44.3	0.0	212	293	11	98	2	104	0.86	Heterogeneous nuclear ribonucleoproteins A2/B1 (DB09130; DB11638)
drugbank_target|P22626	-	353	sp|Q8I4V2|RBM22_PL	-	357	2.1e-31	107.9	0.1	2	2	4.8e-20	2.3e-17	61.7	0.2	219	304	109	200	94	208	0.90	Heterogeneous nuclear ribonucleoproteins A2/B1 (DB09130; DB11638)
drugbank_target|Q8I5H4	-	875	sp|Q8I4V2|RBM22_PL	-	357	2.8e-24	84.4	10.4	1	5	5.5e-06	0.0026	15.4	0.0	222	277	16	77	5	95	0.86	Polyadenylate-binding protein (DB11638)
drugbank_target|Q8I5H4	-	875	sp|Q8I4V2|RBM22_PL	-	357	2.8e-24	84.4	10.4	2	5	6.5e-10	3.1e-07	28.3	0.1	218	278	100	165	84	177	0.84	Polyadenylate-binding protein (DB11638)
drugbank_target|Q8I5H4	-	875	sp|Q8I4V2|RBM22_PL	-	357	2.8e-24	84.4	10.4	3	5	1.7e-11	8.1e-09	33.6	2.0	208	288	180	262	169	317	0.77	Polyadenylate-binding protein (DB11638)
drugbank_target|Q8I5H4	-	875	sp|Q8I4V2|RBM22_PL	-	357	2.8e-24	84.4	10.4	4	5	3.9e-12	1.8e-09	35.7	0.4	213	328	441	571	424	577	0.73	Polyadenylate-binding protein (DB11638)
drugbank_target|Q8I5H4	-	875	sp|Q8I4V2|RBM22_PL	-	357	2.8e-24	84.4	10.4	5	5	0.15	70	0.9	12.7	256	332	583	660	576	669	0.73	Polyadenylate-binding protein (DB11638)
drugbank_target|P23246	-	707	sp|Q8I4V2|RBM22_PL	-	357	5.1e-24	83.6	0.0	1	3	0.00012	0.056	11.1	0.0	216	277	291	352	279	368	0.78	Splicing factor, proline- and glutamine-rich (DB09130; DB11638)
drugbank_target|P23246	-	707	sp|Q8I4V2|RBM22_PL	-	357	5.1e-24	83.6	0.0	2	3	2.9e-22	1.4e-19	68.9	0.0	222	322	371	477	360	496	0.90	Splicing factor, proline- and glutamine-rich (DB09130; DB11638)
drugbank_target|P23246	-	707	sp|Q8I4V2|RBM22_PL	-	357	5.1e-24	83.6	0.0	3	3	1.1	5.4e+02	-2.1	1.3	288	323	553	589	501	608	0.48	Splicing factor, proline- and glutamine-rich (DB09130; DB11638)
drugbank_target|P31943	-	449	sp|Q8I4V2|RBM22_PL	-	357	2.8e-19	67.9	0.0	1	3	0.002	0.95	7.0	0.0	223	287	12	84	6	92	0.79	Heterogeneous nuclear ribonucleoprotein H (DB09130)
drugbank_target|P31943	-	449	sp|Q8I4V2|RBM22_PL	-	357	2.8e-19	67.9	0.0	2	3	4.7e-16	2.2e-13	48.6	0.0	204	288	93	183	86	197	0.93	Heterogeneous nuclear ribonucleoprotein H (DB09130)
drugbank_target|P31943	-	449	sp|Q8I4V2|RBM22_PL	-	357	2.8e-19	67.9	0.0	3	3	0.00058	0.28	8.8	0.0	222	287	289	358	281	365	0.85	Heterogeneous nuclear ribonucleoprotein H (DB09130)
drugbank_target|P52597	-	415	sp|Q8I4V2|RBM22_PL	-	357	5.9e-17	60.3	0.0	1	3	0.14	69	0.9	0.0	224	287	13	84	8	93	0.71	Heterogeneous nuclear ribonucleoprotein F (DB12695)
drugbank_target|P52597	-	415	sp|Q8I4V2|RBM22_PL	-	357	5.9e-17	60.3	0.0	2	3	2.4e-15	1.2e-12	46.2	0.0	205	291	94	186	88	197	0.93	Heterogeneous nuclear ribonucleoprotein F (DB12695)
drugbank_target|P52597	-	415	sp|Q8I4V2|RBM22_PL	-	357	5.9e-17	60.3	0.0	3	3	0.00035	0.17	9.5	0.0	221	288	288	359	278	411	0.81	Heterogeneous nuclear ribonucleoprotein F (DB12695)
drugbank_target|P14866	-	589	sp|Q8I4V2|RBM22_PL	-	357	1.2e-13	49.4	0.0	1	3	1.1e-11	5.1e-09	34.2	0.0	218	280	98	160	90	178	0.89	Heterogeneous nuclear ribonucleoprotein L (DB09130)
drugbank_target|P14866	-	589	sp|Q8I4V2|RBM22_PL	-	357	1.2e-13	49.4	0.0	2	3	0.0058	2.8	5.5	0.0	232	316	205	292	177	303	0.74	Heterogeneous nuclear ribonucleoprotein L (DB09130)
drugbank_target|P14866	-	589	sp|Q8I4V2|RBM22_PL	-	357	1.2e-13	49.4	0.0	3	3	0.0044	2.1	5.9	0.0	221	296	381	457	376	496	0.80	Heterogeneous nuclear ribonucleoprotein L (DB09130)
drugbank_target|P31942	-	346	sp|Q8I4V2|RBM22_PL	-	357	6.5e-13	47.0	0.0	1	2	8.1e-12	3.9e-09	34.6	0.0	206	287	3	87	1	95	0.90	Heterogeneous nuclear ribonucleoprotein H3 (DB09130)
drugbank_target|P31942	-	346	sp|Q8I4V2|RBM22_PL	-	357	6.5e-13	47.0	0.0	2	2	0.00018	0.086	10.4	0.0	223	287	196	264	189	270	0.90	Heterogeneous nuclear ribonucleoprotein H3 (DB09130)
drugbank_target|Q07955	-	248	sp|Q8I4V2|RBM22_PL	-	357	3e-11	41.5	0.0	1	2	4.8e-10	2.3e-07	28.8	0.0	219	274	13	71	9	88	0.89	Serine/arginine-rich splicing factor 1 (DB09130)
drugbank_target|Q07955	-	248	sp|Q8I4V2|RBM22_PL	-	357	3e-11	41.5	0.0	2	2	0.00013	0.062	10.9	0.0	219	282	118	180	114	240	0.77	Serine/arginine-rich splicing factor 1 (DB09130)
drugbank_target|Q86YN6	-	1023	sp|Q8I4V2|RBM22_PL	-	357	1.4e-09	36.1	0.0	1	1	4.5e-12	2.1e-09	35.4	0.0	212	272	892	956	885	968	0.86	Peroxisome proliferator-activated receptor gamma coactivator 1-beta (DB01118)
drugbank_target|P09012	-	282	sp|Q8I4V2|RBM22_PL	-	357	4.8e-08	31.0	0.0	1	2	2e-06	0.00094	16.9	0.1	219	276	7	71	2	91	0.81	U1 small nuclear ribonucleoprotein A (DB02175)
drugbank_target|P09012	-	282	sp|Q8I4V2|RBM22_PL	-	357	4.8e-08	31.0	0.0	2	2	5.2e-05	0.025	12.2	0.0	220	278	206	265	198	281	0.85	U1 small nuclear ribonucleoprotein A (DB02175)
drugbank_target|P09429	-	215	sp|O77384|LRR4_PLA	-	3394	6.1	1.0	19.9	1	1	0.0025	6.6	0.9	19.9	3334	3364	185	214	134	215	0.54	High mobility group protein B1 (DB00608; DB05869)
drugbank_target|P06748	-	294	sp|O77384|LRR4_PLA	-	3394	8.1	0.6	21.6	1	1	0.0038	9.9	0.3	21.6	3140	3178	154	186	114	215	0.45	Nucleophosmin (DB11638)
drugbank_target|O43766	-	372	sp|Q8IDQ0|LIPA_PLA	-	415	8.8e-187	619.3	0.0	1	1	4.1e-190	1.1e-186	619.1	0.0	117	411	70	369	59	372	0.98	Lipoyl synthase, mitochondrial (DB00166)
drugbank_target|P12996	-	346	sp|Q8IDQ0|LIPA_PLA	-	415	3.5e-20	70.6	0.0	1	1	2.1e-23	5.6e-20	69.9	0.0	264	329	138	200	125	209	0.93	Biotin synthase (DB03775)
drugbank_target|O43681	-	348	sp|Q8I1T8|ASNA_PLA	-	379	7.5e-168	556.5	0.4	1	2	1.4e-144	1.9e-141	469.6	0.0	17	284	16	287	9	294	0.97	ATPase ASNA1 (DB00171)
drugbank_target|O43681	-	348	sp|Q8I1T8|ASNA_PLA	-	379	7.5e-168	556.5	0.4	2	2	4.6e-28	6e-25	86.2	0.0	318	369	291	341	286	346	0.93	ATPase ASNA1 (DB00171)
drugbank_target|P08690	-	583	sp|Q8I1T8|ASNA_PLA	-	379	1.5e-113	377.8	0.0	1	4	6.4e-54	8.4e-51	171.3	0.0	40	178	10	158	4	163	0.95	Arsenical pump-driving ATPase (DB02453; DB04395; DB04456)
drugbank_target|P08690	-	583	sp|Q8I1T8|ASNA_PLA	-	379	1.5e-113	377.8	0.0	2	4	0.19	2.5e+02	-1.4	0.0	229	280	191	242	180	252	0.84	Arsenical pump-driving ATPase (DB02453; DB04395; DB04456)
drugbank_target|P08690	-	583	sp|Q8I1T8|ASNA_PLA	-	379	1.5e-113	377.8	0.0	3	4	8.1e-62	1.1e-58	197.3	0.0	12	189	297	474	289	485	0.94	Arsenical pump-driving ATPase (DB02453; DB04395; DB04456)
drugbank_target|P08690	-	583	sp|Q8I1T8|ASNA_PLA	-	379	1.5e-113	377.8	0.0	4	4	0.0029	3.8	4.6	0.0	231	279	485	533	477	562	0.78	Arsenical pump-driving ATPase (DB02453; DB04395; DB04456)
drugbank_target|Q9WZ40	-	294	sp|Q8I1T8|ASNA_PLA	-	379	2.9e-11	41.1	1.1	1	2	1.1e-12	1.4e-09	35.6	0.2	40	76	94	130	61	139	0.86	Signal recognition particle receptor FtsY (DB04272)
drugbank_target|Q9WZ40	-	294	sp|Q8I1T8|ASNA_PLA	-	379	2.9e-11	41.1	1.1	2	2	0.0031	4.1	4.4	0.0	136	171	155	190	136	210	0.76	Signal recognition particle receptor FtsY (DB04272)
drugbank_target|O07347	-	430	sp|Q8I1T8|ASNA_PLA	-	379	2e-10	38.4	0.0	1	1	3.2e-13	4.2e-10	37.3	0.0	37	76	97	136	92	154	0.92	Signal recognition particle protein (DB01942; DB04315)
drugbank_target|C0H4X5	-	266	sp|C0H4X5|DRE2_PLA	-	266	2.6e-183	605.6	38.9	1	1	5.6e-187	3e-183	605.5	38.9	1	266	1	266	1	266	1.00	Anamorsin homolog (DB11638)
drugbank_target|P39748	-	380	sp|Q7K734|FEN1_PLA	-	672	1.6e-211	702.6	0.2	1	1	1.4e-214	1.8e-211	702.4	0.2	1	397	1	378	1	380	0.99	Flap endonuclease 1 (DB01592; DB14488; DB14489; DB14490; DB14491; DB14501)
drugbank_target|P19821	-	832	sp|Q7K734|FEN1_PLA	-	672	2.7e-34	116.9	0.0	1	1	3.7e-37	4.8e-34	116.1	0.0	212	323	158	273	99	280	0.94	DNA polymerase I, thermostable (DB03152; DB03258)
drugbank_target|P52026	-	876	sp|Q7K734|FEN1_PLA	-	672	4.8e-27	93.0	0.1	1	1	5.6e-30	7.4e-27	92.3	0.1	206	291	145	235	120	269	0.86	DNA polymerase I (DB07435)
drugbank_target|P00582	-	928	sp|Q7K734|FEN1_PLA	-	672	9.3e-14	49.1	0.0	1	2	0.55	7.2e+02	-3.5	0.0	53	91	26	66	20	76	0.78	DNA polymerase I (DB00548; DB08432)
drugbank_target|P00582	-	928	sp|Q7K734|FEN1_PLA	-	672	9.3e-14	49.1	0.0	2	2	1.7e-16	2.2e-13	47.8	0.0	220	273	160	215	128	288	0.84	DNA polymerase I (DB00548; DB08432)
drugbank_target|O60264	-	1052	sp|C0H4W3|HEPF1_PL	-	2082	4.6e-287	954.2	12.0	1	2	8.3e-177	4.4e-173	576.2	2.9	650	962	167	473	130	478	0.94	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 5 (DB02379; DB02670)
drugbank_target|O60264	-	1052	sp|C0H4W3|HEPF1_PL	-	2082	4.6e-287	954.2	12.0	2	2	1e-118	5.4e-115	383.6	1.8	1762	1989	477	701	473	724	0.96	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 5 (DB02379; DB02670)
drugbank_target|Q8IKW5	-	832	sp|Q8I335|GUF1_PLA	-	1085	4.4e-102	340.7	6.2	1	3	1.2e-48	1.6e-46	156.7	1.7	218	394	3	190	1	204	0.96	Elongation factor 2 (DB11638)
drugbank_target|Q8IKW5	-	832	sp|Q8I335|GUF1_PLA	-	1085	4.4e-102	340.7	6.2	2	3	1.5e-37	2e-35	120.0	0.2	732	834	463	561	439	598	0.87	Elongation factor 2 (DB11638)
drugbank_target|Q8IKW5	-	832	sp|Q8I335|GUF1_PLA	-	1085	4.4e-102	340.7	6.2	3	3	9.5e-21	1.3e-18	64.3	0.0	886	953	714	782	708	816	0.91	Elongation factor 2 (DB11638)
drugbank_target|P13639	-	858	sp|Q8I335|GUF1_PLA	-	1085	3.6e-97	324.4	4.6	1	3	1.2e-48	1.6e-46	156.7	0.5	218	392	3	194	1	206	0.96	Elongation factor 2 (DB02059; DB03223; DB04315; DB08348; DB11823; DB12688)
drugbank_target|P13639	-	858	sp|Q8I335|GUF1_PLA	-	1085	3.6e-97	324.4	4.6	2	3	8.9e-33	1.2e-30	104.1	0.2	736	833	493	586	480	595	0.94	Elongation factor 2 (DB02059; DB03223; DB04315; DB08348; DB11823; DB12688)
drugbank_target|P13639	-	858	sp|Q8I335|GUF1_PLA	-	1085	3.6e-97	324.4	4.6	3	3	1.4e-20	1.9e-18	63.7	0.0	886	953	740	808	733	812	0.95	Elongation factor 2 (DB02059; DB03223; DB04315; DB08348; DB11823; DB12688)
drugbank_target|P13551	-	691	sp|Q8I335|GUF1_PLA	-	1085	1.1e-96	322.8	1.3	1	3	2e-40	2.7e-38	129.5	0.1	232	362	10	143	3	159	0.92	Elongation factor G (DB02703; DB04315)
drugbank_target|P13551	-	691	sp|Q8I335|GUF1_PLA	-	1085	1.1e-96	322.8	1.3	2	3	3.9e-35	5.3e-33	111.9	0.0	740	832	400	489	392	496	0.96	Elongation factor G (DB02703; DB04315)
drugbank_target|P13551	-	691	sp|Q8I335|GUF1_PLA	-	1085	1.1e-96	322.8	1.3	3	3	4.5e-25	6e-23	78.6	0.0	885	955	600	669	574	676	0.91	Elongation factor G (DB02703; DB04315)
drugbank_target|Q7Z2Z2	-	1120	sp|Q8I335|GUF1_PLA	-	1085	6.2e-75	250.8	2.9	1	3	4.4e-47	5.9e-45	151.5	0.2	219	387	4	177	1	202	0.94	Elongation factor Tu GTP-binding domain-containing protein 1 (DB02750; DB03619; DB04315)
drugbank_target|Q7Z2Z2	-	1120	sp|Q8I335|GUF1_PLA	-	1085	6.2e-75	250.8	2.9	2	3	2.2e-16	2.9e-14	49.9	0.2	743	833	613	699	609	730	0.87	Elongation factor Tu GTP-binding domain-containing protein 1 (DB02750; DB03619; DB04315)
drugbank_target|Q7Z2Z2	-	1120	sp|Q8I335|GUF1_PLA	-	1085	6.2e-75	250.8	2.9	3	3	8.2e-16	1.1e-13	48.0	0.0	886	954	980	1049	974	1064	0.90	Elongation factor Tu GTP-binding domain-containing protein 1 (DB02750; DB03619; DB04315)
drugbank_target|Q83JC4	-	394	sp|Q8I335|GUF1_PLA	-	1085	9e-54	180.7	0.0	1	1	8.1e-56	1.1e-53	180.4	0.0	225	448	3	243	1	257	0.92	Elongation factor Tu (DB02975; DB04315)
drugbank_target|Q01698	-	406	sp|Q8I335|GUF1_PLA	-	1085	3.3e-53	178.8	0.0	1	1	3e-55	4.1e-53	178.5	0.0	225	448	3	254	1	266	0.90	Elongation factor Tu (DB04315; DB08185)
drugbank_target|P60339	-	406	sp|Q8I335|GUF1_PLA	-	1085	4.7e-53	178.3	0.0	1	1	4.3e-55	5.8e-53	178.0	0.0	225	448	3	254	1	266	0.91	Elongation factor Tu-B (DB04124; DB04315)
drugbank_target|Q9X1F8	-	439	sp|Q8I335|GUF1_PLA	-	1085	8.6e-53	177.4	0.5	1	2	1.2e-23	1.6e-21	73.9	0.1	273	415	26	174	4	182	0.89	GTPase Der (DB04315)
drugbank_target|Q9X1F8	-	439	sp|Q8I335|GUF1_PLA	-	1085	8.6e-53	177.4	0.5	2	2	4.2e-32	5.6e-30	101.9	0.1	310	455	254	405	178	413	0.86	GTPase Der (DB04315)
drugbank_target|P49411	-	452	sp|Q8I335|GUF1_PLA	-	1085	4.5e-50	168.4	0.0	1	1	4.4e-52	6e-50	168.0	0.0	225	449	48	291	43	306	0.88	Elongation factor Tu, mitochondrial (DB01593; DB04315; DB14487; DB14533; DB14548)
drugbank_target|Q00080	-	443	sp|Q8I335|GUF1_PLA	-	1085	3e-38	129.3	0.0	1	1	2.7e-40	3.7e-38	129.0	0.0	229	457	2	273	1	314	0.80	Elongation factor 1-alpha (DB11638)
drugbank_target|P41091	-	472	sp|Q8I335|GUF1_PLA	-	1085	1e-37	127.5	0.0	1	1	1.1e-39	1.5e-37	127.0	0.0	219	430	26	268	15	283	0.92	Eukaryotic translation initiation factor 2 subunit 3 (DB04315)
drugbank_target|P68104	-	462	sp|Q8I335|GUF1_PLA	-	1085	1.2e-37	127.3	0.2	1	1	1.2e-39	1.6e-37	126.9	0.2	229	375	2	172	1	191	0.89	Elongation factor 1-alpha 1 (DB01593; DB04315; DB09130; DB11638; DB14487; DB14533; DB14548)
drugbank_target|Q8I487	-	337	sp|Q8I335|GUF1_PLA	-	1085	8.7e-37	124.5	35.6	1	1	8.3e-39	1.1e-36	124.1	35.6	517	623	224	329	205	335	0.88	Skeleton-binding protein 1 (DB11638)
drugbank_target|P15170	-	499	sp|Q8I335|GUF1_PLA	-	1085	1.9e-34	116.7	0.1	1	2	2.6e-36	3.5e-34	115.8	0.0	231	374	71	238	67	356	0.81	Eukaryotic peptide chain release factor GTP-binding subunit ERF3A (DB04315)
drugbank_target|P15170	-	499	sp|Q8I335|GUF1_PLA	-	1085	1.9e-34	116.7	0.1	2	2	1.6	2.2e+02	-2.7	0.2	778	810	393	424	384	442	0.73	Eukaryotic peptide chain release factor GTP-binding subunit ERF3A (DB04315)
drugbank_target|Q96RE1	-	398	sp|Q8I335|GUF1_PLA	-	1085	8.7e-22	74.8	0.0	1	1	8.9e-24	1.2e-21	74.3	0.0	278	375	3	108	1	127	0.91	Translation elongation factor 1 alpha 1-like 14 (DB09130)
drugbank_target|P62491	-	216	sp|Q8I335|GUF1_PLA	-	1085	7.6e-17	58.4	0.0	1	1	6.9e-19	9.3e-17	58.1	0.0	273	406	35	173	16	185	0.88	Ras-related protein Rab-11A (DB01864; DB04315)
drugbank_target|Q26000	-	207	sp|Q8I335|GUF1_PLA	-	1085	3.3e-12	43.1	0.8	1	1	2.9e-14	3.9e-12	42.8	0.8	268	419	30	186	11	202	0.78	GTPase (Rab6) (DB04315)
drugbank_target|Q92930	-	207	sp|Q8I335|GUF1_PLA	-	1085	1.3e-11	41.1	0.3	1	1	1.2e-13	1.7e-11	40.7	0.3	281	410	42	174	30	187	0.82	Ras-related protein Rab-8B (DB02082; DB04315)
drugbank_target|P20339	-	215	sp|Q8I335|GUF1_PLA	-	1085	3.9e-10	36.2	0.0	1	1	3.5e-12	4.7e-10	35.9	0.0	279	408	52	184	32	195	0.79	Ras-related protein Rab-5A (DB02467; DB04137; DB04315)
drugbank_target|P51149	-	207	sp|Q8I335|GUF1_PLA	-	1085	4.2e-09	32.8	0.0	1	1	3.7e-11	5e-09	32.5	0.0	275	409	34	177	3	191	0.71	Ras-related protein Rab-7a (DB04315)
drugbank_target|P01116	-	189	sp|Q8I335|GUF1_PLA	-	1085	1.1e-07	28.2	0.1	1	1	8.8e-10	1.2e-07	28.0	0.1	287	407	42	165	16	178	0.78	GTPase KRas (DB07771; DB07780; DB15568; DB15569)
drugbank_target|P01112	-	189	sp|Q8I335|GUF1_PLA	-	1085	1.3e-07	27.9	0.0	1	1	1.1e-09	1.4e-07	27.7	0.0	287	408	42	166	16	174	0.79	GTPase HRas (DB02210; DB03226; DB04137; DB04315; DB08751)
drugbank_target|P10114	-	183	sp|Q8I335|GUF1_PLA	-	1085	3.4e-07	26.5	0.0	1	1	2.8e-09	3.8e-07	26.3	0.0	287	406	42	165	17	173	0.80	Ras-related protein Rap-2a (DB04137; DB04315)
drugbank_target|P40616	-	181	sp|Q8I335|GUF1_PLA	-	1085	7.7e-07	25.3	0.0	1	1	6.6e-09	8.9e-07	25.1	0.0	283	406	48	178	39	181	0.77	ADP-ribosylation factor-like protein 1 (DB04315)
drugbank_target|Q15382	-	184	sp|Q8I335|GUF1_PLA	-	1085	3.8e-06	23.0	0.2	1	1	3.4e-08	4.6e-06	22.7	0.2	287	405	45	167	4	176	0.79	GTP-binding protein Rheb (DB04137; DB04315)
drugbank_target|P38545	-	214	sp|Q8I335|GUF1_PLA	-	1085	3.8e-06	23.0	0.0	1	1	3.4e-08	4.5e-06	22.8	0.0	284	396	46	158	27	174	0.77	GTP-binding nuclear protein Ran (DB11638)
drugbank_target|P62826	-	216	sp|Q8I335|GUF1_PLA	-	1085	5.4e-06	22.5	0.0	1	1	4.6e-08	6.2e-06	22.3	0.0	285	398	46	161	20	177	0.79	GTP-binding nuclear protein Ran (DB04315)
drugbank_target|P51151	-	201	sp|Q8I335|GUF1_PLA	-	1085	8.4e-06	21.9	0.0	1	1	6.9e-08	9.3e-06	21.7	0.0	245	405	2	172	1	188	0.73	Ras-related protein Rab-9A (DB04315)
drugbank_target|Q9X242	-	295	sp|Q8I335|GUF1_PLA	-	1085	1.3e-05	21.2	0.1	1	1	1.4e-07	1.9e-05	20.7	0.1	316	406	75	166	63	179	0.83	Putative ribosome biogenesis GTPase RsgA (DB04315)
drugbank_target|P36405	-	182	sp|Q8I335|GUF1_PLA	-	1085	2.4e-05	20.4	0.0	1	1	2e-07	2.7e-05	20.2	0.0	285	407	50	179	23	182	0.74	ADP-ribosylation factor-like protein 3 (DB03814; DB04315)
drugbank_target|Q9Y689	-	179	sp|Q8I335|GUF1_PLA	-	1085	3.8e-05	19.7	0.1	1	1	3.1e-07	4.2e-05	19.5	0.1	282	381	46	150	24	177	0.75	ADP-ribosylation factor-like protein 5A (DB04315)
drugbank_target|Q96KC2	-	179	sp|Q8I335|GUF1_PLA	-	1085	3.8e-05	19.7	0.0	1	1	2.9e-07	3.9e-05	19.7	0.0	281	377	45	146	20	178	0.73	ADP-ribosylation factor-like protein 5B (DB04315)
drugbank_target|P84077	-	181	sp|Q8I335|GUF1_PLA	-	1085	8.4e-05	18.5	0.0	1	1	7.2e-07	9.7e-05	18.3	0.0	283	373	48	143	38	179	0.72	ADP-ribosylation factor 1 (DB02774; DB04121; DB04137; DB04315; DB07348; DB08231; DB09462)
drugbank_target|P18085	-	180	sp|Q8I335|GUF1_PLA	-	1085	0.00014	17.9	0.0	1	1	1.1e-06	0.00015	17.7	0.0	283	389	48	161	37	179	0.71	ADP-ribosylation factor 4 (DB04315)
drugbank_target|P36404	-	184	sp|Q8I335|GUF1_PLA	-	1085	0.00021	17.2	0.0	1	1	1.7e-06	0.00023	17.1	0.0	283	407	47	178	5	184	0.74	ADP-ribosylation factor-like protein 2 (DB14731)
drugbank_target|P62330	-	175	sp|Q8I335|GUF1_PLA	-	1085	0.00062	15.7	0.0	1	1	5.3e-06	0.00071	15.5	0.0	283	368	44	134	34	159	0.75	ADP-ribosylation factor 6 (DB01864; DB04315; DB08231)
drugbank_target|Q9Y6B6	-	198	sp|Q8I335|GUF1_PLA	-	1085	0.00091	15.1	0.0	1	1	7.8e-06	0.001	14.9	0.0	283	372	56	150	32	167	0.76	GTP-binding protein SAR1b (DB04315)
drugbank_target|P62745	-	196	sp|Q8I335|GUF1_PLA	-	1085	0.0012	14.7	0.0	1	1	1.1e-05	0.0015	14.4	0.0	289	401	46	174	40	184	0.76	Rho-related GTP-binding protein RhoB (DB00083)
drugbank_target|P61586	-	193	sp|Q8I335|GUF1_PLA	-	1085	0.018	10.8	0.0	1	1	0.00016	0.021	10.6	0.0	289	369	46	135	40	181	0.71	Transforming protein RhoA (DB04315)
drugbank_target|P54819	-	239	sp|Q8I236|KAD6_PLA	-	186	9.7e-24	82.5	0.0	1	1	8.3e-26	1.6e-23	81.9	0.0	7	96	17	101	13	130	0.91	Adenylate kinase 2, mitochondrial (DB01717; DB03366)
drugbank_target|P69441	-	214	sp|Q8I236|KAD6_PLA	-	186	5.4e-21	73.6	0.0	1	1	3.6e-23	6.8e-21	73.3	0.0	7	82	2	79	1	121	0.92	Adenylate kinase (DB01717)
drugbank_target|P84139	-	217	sp|Q8I236|KAD6_PLA	-	186	2e-15	55.4	0.0	1	2	4.8e-17	9.1e-15	53.3	0.0	7	77	2	74	1	87	0.91	Adenylate kinase (DB01717)
drugbank_target|P84139	-	217	sp|Q8I236|KAD6_PLA	-	186	2e-15	55.4	0.0	2	2	2	3.7e+02	-0.8	0.0	58	89	103	135	93	143	0.72	Adenylate kinase (DB01717)
drugbank_target|P27142	-	217	sp|Q8I236|KAD6_PLA	-	186	8.6e-15	53.4	0.0	1	1	7.5e-17	1.4e-14	52.7	0.0	7	83	2	80	1	133	0.81	Adenylate kinase (DB01717)
drugbank_target|P16304	-	217	sp|Q8I236|KAD6_PLA	-	186	4.2e-14	51.1	0.0	1	1	4.2e-16	7.9e-14	50.2	0.0	7	82	2	79	1	130	0.86	Adenylate kinase (DB01717)
drugbank_target|P00568	-	194	sp|Q8I236|KAD6_PLA	-	186	9.4e-14	50.0	0.1	1	1	6.5e-16	1.2e-13	49.6	0.1	3	65	6	70	4	174	0.74	Adenylate kinase isoenzyme 1 (DB01717)
drugbank_target|Q96MA6	-	479	sp|Q8I236|KAD6_PLA	-	186	2.4e-13	48.7	0.0	1	2	9.9e-11	1.9e-08	32.7	0.0	4	79	56	130	53	140	0.75	Adenylate kinase 8 (DB01717)
drugbank_target|Q96MA6	-	479	sp|Q8I236|KAD6_PLA	-	186	2.4e-13	48.7	0.0	2	2	7.3e-05	0.014	13.6	0.0	5	54	268	318	266	392	0.80	Adenylate kinase 8 (DB01717)
drugbank_target|P30085	-	196	sp|Q8I236|KAD6_PLA	-	186	1.9e-11	42.5	0.2	1	2	1.6e-13	3e-11	41.8	0.0	7	94	5	92	1	125	0.83	UMP-CMP kinase (DB00441; DB03403; DB03435; DB03664; DB04444)
drugbank_target|P30085	-	196	sp|Q8I236|KAD6_PLA	-	186	1.9e-11	42.5	0.2	2	2	6.7	1.3e+03	-2.6	0.1	86	105	156	176	142	191	0.48	UMP-CMP kinase (DB00441; DB03403; DB03435; DB03664; DB04444)
drugbank_target|Q7BK04	-	330	sp|Q8I236|KAD6_PLA	-	186	8.1e-08	30.6	0.1	1	1	8.5e-10	1.6e-07	29.7	0.1	6	48	172	216	169	228	0.89	Cag alpha (DB02930)
drugbank_target|P0A6I0	-	227	sp|Q8I236|KAD6_PLA	-	186	8.5e-08	30.6	0.0	1	1	9.1e-10	1.7e-07	29.6	0.0	4	44	4	44	1	81	0.77	Cytidylate kinase (DB02456; DB02883; DB03403; DB04555)
drugbank_target|P46459	-	744	sp|Q8I236|KAD6_PLA	-	186	1.5e-05	23.3	0.0	1	2	0.001	0.2	9.8	0.0	3	32	251	280	249	308	0.90	Vesicle-fusing ATPase (DB01902)
drugbank_target|P46459	-	744	sp|Q8I236|KAD6_PLA	-	186	1.5e-05	23.3	0.0	2	2	0.00084	0.16	10.1	0.0	7	64	538	591	533	608	0.73	Vesicle-fusing ATPase (DB01902)
drugbank_target|Q9WZ40	-	294	sp|Q8I236|KAD6_PLA	-	186	0.00082	17.6	0.0	1	3	5	9.4e+02	-2.2	0.1	117	125	53	61	20	79	0.56	Signal recognition particle receptor FtsY (DB04272)
drugbank_target|Q9WZ40	-	294	sp|Q8I236|KAD6_PLA	-	186	0.00082	17.6	0.0	2	3	4.4e-06	0.00082	17.6	0.0	7	42	94	133	90	146	0.79	Signal recognition particle receptor FtsY (DB04272)
drugbank_target|Q9WZ40	-	294	sp|Q8I236|KAD6_PLA	-	186	0.00082	17.6	0.0	3	3	0.46	86	1.2	0.0	96	135	169	208	163	222	0.79	Signal recognition particle receptor FtsY (DB04272)
drugbank_target|P23919	-	212	sp|Q8I236|KAD6_PLA	-	186	0.0035	15.5	0.0	1	1	3e-05	0.0056	14.9	0.0	4	54	5	54	2	93	0.78	Thymidylate kinase (DB01643; DB03150; DB03195; DB03233; DB03280; DB03666; DB03845; DB04395)
drugbank_target|Q9RA63	-	854	sp|Q8I236|KAD6_PLA	-	186	0.0043	15.2	0.1	1	2	0.0027	0.5	8.5	0.0	3	70	189	255	187	262	0.84	Chaperone protein ClpB (DB04395)
drugbank_target|Q9RA63	-	854	sp|Q8I236|KAD6_PLA	-	186	0.0043	15.2	0.1	2	2	0.11	21	3.2	0.0	8	46	591	631	585	639	0.71	Chaperone protein ClpB (DB04395)
drugbank_target|Q2M3G0	-	1257	sp|Q8I236|KAD6_PLA	-	186	0.006	14.8	0.2	1	3	0.0049	0.92	7.6	0.0	6	45	415	458	411	485	0.78	ATP-binding cassette sub-family B member 5 (DB04851; DB14067)
drugbank_target|Q2M3G0	-	1257	sp|Q8I236|KAD6_PLA	-	186	0.006	14.8	0.2	2	3	2.2	4.1e+02	-1.0	0.0	122	163	630	671	619	676	0.85	ATP-binding cassette sub-family B member 5 (DB04851; DB14067)
drugbank_target|Q2M3G0	-	1257	sp|Q8I236|KAD6_PLA	-	186	0.006	14.8	0.2	3	3	0.15	29	2.8	0.0	6	29	1044	1067	1040	1075	0.85	ATP-binding cassette sub-family B member 5 (DB04851; DB14067)
drugbank_target|Q56313	-	334	sp|Q8I236|KAD6_PLA	-	186	0.0073	14.5	0.5	1	2	8.1e-05	0.015	13.5	0.0	6	66	52	122	24	134	0.73	Holliday junction ATP-dependent DNA helicase RuvB (DB02210)
drugbank_target|Q56313	-	334	sp|Q8I236|KAD6_PLA	-	186	0.0073	14.5	0.5	2	2	5.2	9.8e+02	-2.2	0.1	56	81	220	244	181	268	0.53	Holliday junction ATP-dependent DNA helicase RuvB (DB02210)
drugbank_target|O25926	-	446	sp|Q8I236|KAD6_PLA	-	186	0.0081	14.3	0.7	1	2	2	3.8e+02	-0.9	0.1	65	99	64	100	39	133	0.65	ATP-dependent Clp protease ATP-binding subunit ClpX (DB09275)
drugbank_target|O25926	-	446	sp|Q8I236|KAD6_PLA	-	186	0.0081	14.3	0.7	2	2	0.00022	0.041	12.0	0.0	6	32	143	169	138	193	0.86	ATP-dependent Clp protease ATP-binding subunit ClpX (DB09275)
drugbank_target|P0A6H7	-	443	sp|Q8I236|KAD6_PLA	-	186	0.0086	14.3	0.0	1	1	0.00012	0.022	12.9	0.0	6	56	51	103	46	132	0.81	ATP-dependent protease ATPase subunit HslU (DB04395)
drugbank_target|P16384	-	316	sp|Q8I236|KAD6_PLA	-	186	0.009	14.2	0.0	1	1	7.6e-05	0.014	13.5	0.0	6	38	11	43	6	56	0.89	tRNA dimethylallyltransferase (DB02270)
drugbank_target|P55072	-	806	sp|Q8I236|KAD6_PLA	-	186	0.0096	14.1	0.0	1	2	0.045	8.4	4.5	0.0	7	30	240	263	235	308	0.81	Transitional endoplasmic reticulum ATPase (DB04395; DB12695)
drugbank_target|P55072	-	806	sp|Q8I236|KAD6_PLA	-	186	0.0096	14.1	0.0	2	2	0.0089	1.7	6.8	0.0	7	37	513	543	509	573	0.83	Transitional endoplasmic reticulum ATPase (DB04395; DB12695)
drugbank_target|Q9BZX2	-	261	sp|Q8I236|KAD6_PLA	-	186	0.013	13.6	0.0	1	1	0.00011	0.02	13.1	0.0	8	91	23	105	20	122	0.82	Uridine-cytidine kinase 2 (DB02097; DB02431; DB03403; DB04005)
drugbank_target|O00142	-	265	sp|Q8I236|KAD6_PLA	-	186	0.013	13.6	0.0	1	2	0.0095	1.8	6.7	0.0	2	35	47	80	46	102	0.88	Thymidine kinase 2, mitochondrial (DB02452; DB02594; DB03312; DB04485)
drugbank_target|O00142	-	265	sp|Q8I236|KAD6_PLA	-	186	0.013	13.6	0.0	2	2	0.027	5.1	5.2	0.0	75	135	142	204	111	236	0.76	Thymidine kinase 2, mitochondrial (DB02452; DB02594; DB03312; DB04485)
drugbank_target|Q9X1F8	-	439	sp|Q8I236|KAD6_PLA	-	186	0.018	13.2	0.1	1	2	0.0084	1.6	6.9	0.0	7	29	3	25	1	38	0.86	GTPase Der (DB04315)
drugbank_target|Q9X1F8	-	439	sp|Q8I236|KAD6_PLA	-	186	0.018	13.2	0.1	2	2	0.091	17	3.5	0.0	7	27	182	202	178	207	0.86	GTPase Der (DB04315)
drugbank_target|P0A721	-	213	sp|Q8I236|KAD6_PLA	-	186	0.021	13.0	0.0	1	1	0.00014	0.026	12.7	0.0	5	40	3	36	1	105	0.79	Thymidylate kinase (DB03280)
drugbank_target|P46859	-	175	sp|Q8I236|KAD6_PLA	-	186	0.024	12.8	0.0	1	1	0.00017	0.033	12.4	0.0	8	36	11	39	5	119	0.81	Thermoresistant gluconokinase (DB02076; DB03909)
drugbank_target|P40616	-	181	sp|Q8I236|KAD6_PLA	-	186	0.03	12.5	0.1	1	2	0.0012	0.23	9.6	0.0	7	26	19	38	15	68	0.79	ADP-ribosylation factor-like protein 1 (DB04315)
drugbank_target|P40616	-	181	sp|Q8I236|KAD6_PLA	-	186	0.03	12.5	0.1	2	2	0.65	1.2e+02	0.7	0.0	47	77	105	141	88	156	0.56	ADP-ribosylation factor-like protein 1 (DB04315)
drugbank_target|Q16774	-	197	sp|Q8I236|KAD6_PLA	-	186	0.036	12.2	0.0	1	1	0.00046	0.086	11.0	0.0	8	28	7	27	3	37	0.89	Guanylate kinase (DB01972)
drugbank_target|Q5SL87	-	324	sp|Q8I236|KAD6_PLA	-	186	0.078	11.1	0.0	1	1	0.00084	0.16	10.1	0.0	6	32	39	65	33	75	0.86	Holliday junction ATP-dependent DNA helicase RuvB (DB00173)
drugbank_target|P05067	-	770	sp|O97239|DOP1_PLA	-	3933	6.3e-09	30.7	4.8	1	1	6.5e-12	8.6e-09	30.2	4.8	1221	1317	229	332	216	340	0.72	Amyloid beta A4 protein (DB00746; DB01370; DB01593; DB02235; DB02709; DB03754; DB04892; DB05088; DB05150; DB05846; DB05938; DB06782; DB09130; DB09148; DB09149; DB09151; DB14487; DB14517; DB14518; DB14533; DB14548)
drugbank_target|P06748	-	294	sp|O97239|DOP1_PLA	-	3933	5.8e-07	24.1	24.7	1	1	6e-10	7.8e-07	23.7	24.7	1222	1272	160	209	150	224	0.89	Nucleophosmin (DB11638)
drugbank_target|P27824	-	592	sp|O97239|DOP1_PLA	-	3933	0.96	3.5	5.6	1	1	0.0011	1.5	2.9	5.6	1216	1260	518	562	482	586	0.65	Calnexin (DB00025; DB00031; DB06245; DB11093; DB11348; DB13998; DB13999; DB14481)
drugbank_target|Q15910	-	746	sp|O97239|DOP1_PLA	-	3933	6.3	0.8	10.8	1	1	0.008	10	0.0	10.8	1215	1249	179	213	149	248	0.71	Histone-lysine N-methyltransferase EZH2 (DB12887; DB14581)
drugbank_target|P45568	-	398	sp|Q8IKG4|DXR_PLAF	-	488	5.7e-211	699.7	0.0	1	1	1.3e-214	6.8e-211	699.5	0.0	79	455	3	371	1	393	0.97	1-deoxy-D-xylulose 5-phosphate reductoisomerase (DB02496; DB02948; DB03649)
